{
    "51631154298dcd4e5100004e_010": [
        {
            "text": "multiple myeloma",
            "probability": 0.9989051942016631,
            "start_logit": 9.323408126831055,
            "end_logit": 9.00887680053711
        },
        {
            "text": "multiple",
            "probability": 0.0009592799764376306,
            "start_logit": 9.323408126831055,
            "end_logit": 2.0606446266174316
        },
        {
            "text": "oma",
            "probability": 0.00012916984251084903,
            "start_logit": 0.3701211214065552,
            "end_logit": 9.00887680053711
        },
        {
            "text": "myeloma",
            "probability": 2.378973552020345e-06,
            "start_logit": -3.624337911605835,
            "end_logit": 9.00887680053711
        },
        {
            "text": "against multiple myeloma",
            "probability": 1.8785366574310656e-06,
            "start_logit": -3.860513925552368,
            "end_logit": 9.00887680053711
        },
        {
            "text": "effective against multiple myeloma",
            "probability": 4.789554432976776e-07,
            "start_logit": -5.227154731750488,
            "end_logit": 9.00887680053711
        },
        {
            "text": "eloma",
            "probability": 4.4964552545186055e-07,
            "start_logit": -5.290302753448486,
            "end_logit": 9.00887680053711
        },
        {
            "text": "multiple myeloma (MM)",
            "probability": 3.827018271289042e-07,
            "start_logit": 9.323408126831055,
            "end_logit": -5.766037464141846
        },
        {
            "text": "is remarkably effective against multiple myeloma",
            "probability": 1.8510257868712704e-07,
            "start_logit": -6.177852153778076,
            "end_logit": 9.00887680053711
        },
        {
            "text": "the 26S proteasome, is remarkably effective against multiple myeloma",
            "probability": 1.296042814349833e-07,
            "start_logit": -6.534276485443115,
            "end_logit": 9.00887680053711
        },
        {
            "text": "remarkably effective against multiple myeloma",
            "probability": 1.255695855512143e-07,
            "start_logit": -6.565902233123779,
            "end_logit": 9.00887680053711
        },
        {
            "text": "26S proteasome, is remarkably effective against multiple myeloma",
            "probability": 1.008270564363608e-07,
            "start_logit": -6.785355567932129,
            "end_logit": 9.00887680053711
        },
        {
            "text": "multiple myeloma (MM) but not against solid",
            "probability": 8.182884303604877e-08,
            "start_logit": 9.323408126831055,
            "end_logit": -7.308663845062256
        },
        {
            "text": "multiple myeloma (MM) but not against solid tumors.",
            "probability": 5.948138444384647e-08,
            "start_logit": 9.323408126831055,
            "end_logit": -7.627630233764648
        },
        {
            "text": "multiple myeloma (MM) but",
            "probability": 5.912948117669077e-08,
            "start_logit": 9.323408126831055,
            "end_logit": -7.633563995361328
        },
        {
            "text": "multiple myeloma (MM) but not against",
            "probability": 4.3015171934321635e-08,
            "start_logit": 9.323408126831055,
            "end_logit": -7.951740741729736
        },
        {
            "text": "against multiple",
            "probability": 1.8040176494606292e-09,
            "start_logit": -3.860513925552368,
            "end_logit": 2.0606446266174316
        },
        {
            "text": "effective against multiple",
            "probability": 4.5995592877907774e-10,
            "start_logit": -5.227154731750488,
            "end_logit": 2.0606446266174316
        },
        {
            "text": "is remarkably effective against multiple",
            "probability": 1.7775980979200341e-10,
            "start_logit": -6.177852153778076,
            "end_logit": 2.0606446266174316
        },
        {
            "text": "dipeptidyl boronic acid and potent inhibitor of the 26S proteasome, is remarkably effective against multiple",
            "probability": 1.662665345242426e-10,
            "start_logit": -6.244693279266357,
            "end_logit": 2.0606446266174316
        }
    ],
    "51631154298dcd4e5100004e_011": [
        {
            "text": "multiple myeloma",
            "probability": 0.8175756224057761,
            "start_logit": 4.731542587280273,
            "end_logit": 4.072582721710205
        },
        {
            "text": "multiple myeloma,",
            "probability": 0.17429498634062512,
            "start_logit": 3.807715892791748,
            "end_logit": 3.450815200805664
        },
        {
            "text": "multiple",
            "probability": 0.006956708426862233,
            "start_logit": 4.731542587280273,
            "end_logit": -0.6940542459487915
        },
        {
            "text": "oma",
            "probability": 0.0005776230091100134,
            "start_logit": -2.523634672164917,
            "end_logit": 4.072582721710205
        },
        {
            "text": ",",
            "probability": 0.000171352960943306,
            "start_logit": -3.117063045501709,
            "end_logit": 3.450815200805664
        },
        {
            "text": "CONCLUSION: It is suggested that BOR has therapeutic efficacy for multiple myeloma",
            "probability": 0.00011907741707190627,
            "start_logit": -4.102782249450684,
            "end_logit": 4.072582721710205
        },
        {
            "text": "myeloma",
            "probability": 7.397581757545982e-05,
            "start_logit": -4.578817844390869,
            "end_logit": 4.072582721710205
        },
        {
            "text": "for multiple myeloma",
            "probability": 5.908520643323794e-05,
            "start_logit": -4.80357551574707,
            "end_logit": 4.072582721710205
        },
        {
            "text": "RESULTS: BOR showed a higher rate of effectiveness than THAL for refractory multiple myeloma,",
            "probability": 4.371096521760549e-05,
            "start_logit": -4.483189582824707,
            "end_logit": 3.450815200805664
        },
        {
            "text": "multiple myeloma as a first-line medical treatment and/or for patients with THAL resistance,",
            "probability": 3.47431803077201e-05,
            "start_logit": 4.731542587280273,
            "end_logit": -5.993532657623291
        },
        {
            "text": "refractory multiple myeloma,",
            "probability": 3.233593841037621e-05,
            "start_logit": -4.784609317779541,
            "end_logit": 3.450815200805664
        },
        {
            "text": "PURPOSE: We studied the efficacy and safety of bortezomib (BOR) for treatment of multiple myeloma",
            "probability": 1.4798175812151094e-05,
            "start_logit": -5.264216899871826,
            "end_logit": 3.148747444152832
        },
        {
            "text": "myeloma,",
            "probability": 1.3738481542772865e-05,
            "start_logit": -5.64058780670166,
            "end_logit": 3.450815200805664
        },
        {
            "text": "multiple myeloma as a first-line medical treatment and/or for patients with THAL resistance, and can improve prognosis",
            "probability": 1.1524067065846625e-05,
            "start_logit": 4.731542587280273,
            "end_logit": -7.097078323364258
        },
        {
            "text": "eloma",
            "probability": 9.475782900837599e-06,
            "start_logit": -6.633816719055176,
            "end_logit": 4.072582721710205
        },
        {
            "text": "multiple myeloma, and",
            "probability": 4.820966073062802e-06,
            "start_logit": 3.807715892791748,
            "end_logit": -7.04471492767334
        },
        {
            "text": "METHODS: Biochemical data of patients receiving BOR and THAL for treatment of multiple myeloma",
            "probability": 4.383773733582676e-06,
            "start_logit": -5.435614109039307,
            "end_logit": 2.103550672531128
        },
        {
            "text": "CONCLUSION: It is suggested that BOR has therapeutic efficacy for multiple",
            "probability": 1.0132235454324455e-06,
            "start_logit": -4.102782249450684,
            "end_logit": -0.6940542459487915
        },
        {
            "text": "multiple myeloma in comparison with thalidomide. PURPOSE: We studied the efficacy and safety",
            "probability": 5.211080459777141e-07,
            "start_logit": 1.7232601642608643,
            "end_logit": -7.185031414031982
        },
        {
            "text": "for multiple",
            "probability": 5.027529469231116e-07,
            "start_logit": -4.80357551574707,
            "end_logit": -0.6940542459487915
        }
    ],
    "51631154298dcd4e5100004e_012": [
        {
            "text": "multiple myeloma",
            "probability": 0.8175756224057761,
            "start_logit": 4.731542587280273,
            "end_logit": 4.072582721710205
        },
        {
            "text": "multiple myeloma,",
            "probability": 0.17429498634062512,
            "start_logit": 3.807715892791748,
            "end_logit": 3.450815200805664
        },
        {
            "text": "multiple",
            "probability": 0.006956708426862233,
            "start_logit": 4.731542587280273,
            "end_logit": -0.6940542459487915
        },
        {
            "text": "oma",
            "probability": 0.0005776230091100134,
            "start_logit": -2.523634672164917,
            "end_logit": 4.072582721710205
        },
        {
            "text": ",",
            "probability": 0.000171352960943306,
            "start_logit": -3.117063045501709,
            "end_logit": 3.450815200805664
        },
        {
            "text": "CONCLUSION: It is suggested that BOR has therapeutic efficacy for multiple myeloma",
            "probability": 0.00011907741707190627,
            "start_logit": -4.102782249450684,
            "end_logit": 4.072582721710205
        },
        {
            "text": "myeloma",
            "probability": 7.397581757545982e-05,
            "start_logit": -4.578817844390869,
            "end_logit": 4.072582721710205
        },
        {
            "text": "for multiple myeloma",
            "probability": 5.908520643323794e-05,
            "start_logit": -4.80357551574707,
            "end_logit": 4.072582721710205
        },
        {
            "text": "RESULTS: BOR showed a higher rate of effectiveness than THAL for refractory multiple myeloma,",
            "probability": 4.371096521760549e-05,
            "start_logit": -4.483189582824707,
            "end_logit": 3.450815200805664
        },
        {
            "text": "multiple myeloma as a first-line medical treatment and/or for patients with THAL resistance,",
            "probability": 3.47431803077201e-05,
            "start_logit": 4.731542587280273,
            "end_logit": -5.993532657623291
        },
        {
            "text": "refractory multiple myeloma,",
            "probability": 3.233593841037621e-05,
            "start_logit": -4.784609317779541,
            "end_logit": 3.450815200805664
        },
        {
            "text": "PURPOSE: We studied the efficacy and safety of bortezomib (BOR) for treatment of multiple myeloma",
            "probability": 1.4798175812151094e-05,
            "start_logit": -5.264216899871826,
            "end_logit": 3.148747444152832
        },
        {
            "text": "myeloma,",
            "probability": 1.3738481542772865e-05,
            "start_logit": -5.64058780670166,
            "end_logit": 3.450815200805664
        },
        {
            "text": "multiple myeloma as a first-line medical treatment and/or for patients with THAL resistance, and can improve prognosis",
            "probability": 1.1524067065846625e-05,
            "start_logit": 4.731542587280273,
            "end_logit": -7.097078323364258
        },
        {
            "text": "eloma",
            "probability": 9.475782900837599e-06,
            "start_logit": -6.633816719055176,
            "end_logit": 4.072582721710205
        },
        {
            "text": "multiple myeloma, and",
            "probability": 4.820966073062802e-06,
            "start_logit": 3.807715892791748,
            "end_logit": -7.04471492767334
        },
        {
            "text": "METHODS: Biochemical data of patients receiving BOR and THAL for treatment of multiple myeloma",
            "probability": 4.383773733582676e-06,
            "start_logit": -5.435614109039307,
            "end_logit": 2.103550672531128
        },
        {
            "text": "CONCLUSION: It is suggested that BOR has therapeutic efficacy for multiple",
            "probability": 1.0132235454324455e-06,
            "start_logit": -4.102782249450684,
            "end_logit": -0.6940542459487915
        },
        {
            "text": "multiple myeloma in comparison with thalidomide. PURPOSE: We studied the efficacy and safety",
            "probability": 5.211080459777141e-07,
            "start_logit": 1.7232601642608643,
            "end_logit": -7.185031414031982
        },
        {
            "text": "for multiple",
            "probability": 5.027529469231116e-07,
            "start_logit": -4.80357551574707,
            "end_logit": -0.6940542459487915
        }
    ],
    "51631154298dcd4e5100004e_013": [
        {
            "text": "multiple myeloma",
            "probability": 0.8175756224057761,
            "start_logit": 4.731542587280273,
            "end_logit": 4.072582721710205
        },
        {
            "text": "multiple myeloma,",
            "probability": 0.17429498634062512,
            "start_logit": 3.807715892791748,
            "end_logit": 3.450815200805664
        },
        {
            "text": "multiple",
            "probability": 0.006956708426862233,
            "start_logit": 4.731542587280273,
            "end_logit": -0.6940542459487915
        },
        {
            "text": "oma",
            "probability": 0.0005776230091100134,
            "start_logit": -2.523634672164917,
            "end_logit": 4.072582721710205
        },
        {
            "text": ",",
            "probability": 0.000171352960943306,
            "start_logit": -3.117063045501709,
            "end_logit": 3.450815200805664
        },
        {
            "text": "CONCLUSION: It is suggested that BOR has therapeutic efficacy for multiple myeloma",
            "probability": 0.00011907741707190627,
            "start_logit": -4.102782249450684,
            "end_logit": 4.072582721710205
        },
        {
            "text": "myeloma",
            "probability": 7.397581757545982e-05,
            "start_logit": -4.578817844390869,
            "end_logit": 4.072582721710205
        },
        {
            "text": "for multiple myeloma",
            "probability": 5.908520643323794e-05,
            "start_logit": -4.80357551574707,
            "end_logit": 4.072582721710205
        },
        {
            "text": "RESULTS: BOR showed a higher rate of effectiveness than THAL for refractory multiple myeloma,",
            "probability": 4.371096521760549e-05,
            "start_logit": -4.483189582824707,
            "end_logit": 3.450815200805664
        },
        {
            "text": "multiple myeloma as a first-line medical treatment and/or for patients with THAL resistance,",
            "probability": 3.47431803077201e-05,
            "start_logit": 4.731542587280273,
            "end_logit": -5.993532657623291
        },
        {
            "text": "refractory multiple myeloma,",
            "probability": 3.233593841037621e-05,
            "start_logit": -4.784609317779541,
            "end_logit": 3.450815200805664
        },
        {
            "text": "PURPOSE: We studied the efficacy and safety of bortezomib (BOR) for treatment of multiple myeloma",
            "probability": 1.4798175812151094e-05,
            "start_logit": -5.264216899871826,
            "end_logit": 3.148747444152832
        },
        {
            "text": "myeloma,",
            "probability": 1.3738481542772865e-05,
            "start_logit": -5.64058780670166,
            "end_logit": 3.450815200805664
        },
        {
            "text": "multiple myeloma as a first-line medical treatment and/or for patients with THAL resistance, and can improve prognosis",
            "probability": 1.1524067065846625e-05,
            "start_logit": 4.731542587280273,
            "end_logit": -7.097078323364258
        },
        {
            "text": "eloma",
            "probability": 9.475782900837599e-06,
            "start_logit": -6.633816719055176,
            "end_logit": 4.072582721710205
        },
        {
            "text": "multiple myeloma, and",
            "probability": 4.820966073062802e-06,
            "start_logit": 3.807715892791748,
            "end_logit": -7.04471492767334
        },
        {
            "text": "METHODS: Biochemical data of patients receiving BOR and THAL for treatment of multiple myeloma",
            "probability": 4.383773733582676e-06,
            "start_logit": -5.435614109039307,
            "end_logit": 2.103550672531128
        },
        {
            "text": "CONCLUSION: It is suggested that BOR has therapeutic efficacy for multiple",
            "probability": 1.0132235454324455e-06,
            "start_logit": -4.102782249450684,
            "end_logit": -0.6940542459487915
        },
        {
            "text": "multiple myeloma in comparison with thalidomide. PURPOSE: We studied the efficacy and safety",
            "probability": 5.211080459777141e-07,
            "start_logit": 1.7232601642608643,
            "end_logit": -7.185031414031982
        },
        {
            "text": "for multiple",
            "probability": 5.027529469231116e-07,
            "start_logit": -4.80357551574707,
            "end_logit": -0.6940542459487915
        }
    ],
    "51631154298dcd4e5100004e_014": [
        {
            "text": "multiple myeloma.",
            "probability": 0.5326547382373255,
            "start_logit": 7.674373149871826,
            "end_logit": 7.621915817260742
        },
        {
            "text": "multiple myeloma",
            "probability": 0.4665702310816251,
            "start_logit": 7.963550567626953,
            "end_logit": 7.200273513793945
        },
        {
            "text": "multiple",
            "probability": 0.0005652447516907012,
            "start_logit": 7.963550567626953,
            "end_logit": 0.4843685030937195
        },
        {
            "text": ".",
            "probability": 9.519232629922475e-05,
            "start_logit": -0.955356240272522,
            "end_logit": 7.621915817260742
        },
        {
            "text": "myeloma. Here, we investigated whether the combination of these compounds would yield increased antitumor efficacy in multiple myeloma",
            "probability": 6.244318035835896e-05,
            "start_logit": -0.955356240272522,
            "end_logit": 7.200273513793945
        },
        {
            "text": "oma",
            "probability": 4.000118680593254e-05,
            "start_logit": -1.4007041454315186,
            "end_logit": 7.200273513793945
        },
        {
            "text": "for multiple myeloma.",
            "probability": 3.6399157939417864e-06,
            "start_logit": -4.219295024871826,
            "end_logit": 7.621915817260742
        },
        {
            "text": "myeloma",
            "probability": 2.373113504192453e-06,
            "start_logit": -4.225410461425781,
            "end_logit": 7.200273513793945
        },
        {
            "text": "myeloma.",
            "probability": 2.1469974742033644e-06,
            "start_logit": -4.747185230255127,
            "end_logit": 7.621915817260742
        },
        {
            "text": "increased antitumor efficacy in multiple myeloma",
            "probability": 6.425598962246545e-07,
            "start_logit": -5.5319085121154785,
            "end_logit": 7.200273513793945
        },
        {
            "text": "use for multiple myeloma.",
            "probability": 5.68552471875597e-07,
            "start_logit": -6.0759172439575195,
            "end_logit": 7.621915817260742
        },
        {
            "text": "eloma",
            "probability": 4.0762692118476203e-07,
            "start_logit": -5.987016201019287,
            "end_logit": 7.200273513793945
        },
        {
            "text": "in clinical use for multiple myeloma.",
            "probability": 3.927895477905522e-07,
            "start_logit": -6.445736885070801,
            "end_logit": 7.621915817260742
        },
        {
            "text": "in multiple myeloma",
            "probability": 3.619171548694887e-07,
            "start_logit": -6.105953216552734,
            "end_logit": 7.200273513793945
        },
        {
            "text": "clinical use for multiple myeloma.",
            "probability": 3.42137737382432e-07,
            "start_logit": -6.583797454833984,
            "end_logit": 7.621915817260742
        },
        {
            "text": "investigated whether the combination of these compounds would yield increased antitumor efficacy in multiple myeloma",
            "probability": 3.3688976388650117e-07,
            "start_logit": -6.177612781524658,
            "end_logit": 7.200273513793945
        },
        {
            "text": "multiple myeloma and glioblastoma cell lines",
            "probability": 3.1731699525752093e-07,
            "start_logit": 7.963550567626953,
            "end_logit": -7.000744342803955
        },
        {
            "text": "multiple myeloma. Here, we investigated whether the combination of these compounds would yield increased antitumor",
            "probability": 2.4264495769013374e-07,
            "start_logit": 7.674373149871826,
            "end_logit": -6.9798688888549805
        },
        {
            "text": "would yield increased antitumor efficacy in multiple myeloma",
            "probability": 2.2270961383735407e-07,
            "start_logit": -6.5914998054504395,
            "end_logit": 7.200273513793945
        },
        {
            "text": "multiple myeloma. Here, we investigated whether the combination of these compounds would yield increased antitumor efficacy",
            "probability": 1.540640631032183e-07,
            "start_logit": 7.674373149871826,
            "end_logit": -7.4340996742248535
        }
    ],
    "51631154298dcd4e5100004e_015": [
        {
            "text": "multiple myeloma.",
            "probability": 0.5326547382373255,
            "start_logit": 7.674373149871826,
            "end_logit": 7.621915817260742
        },
        {
            "text": "multiple myeloma",
            "probability": 0.4665702310816251,
            "start_logit": 7.963550567626953,
            "end_logit": 7.200273513793945
        },
        {
            "text": "multiple",
            "probability": 0.0005652447516907012,
            "start_logit": 7.963550567626953,
            "end_logit": 0.4843685030937195
        },
        {
            "text": ".",
            "probability": 9.519232629922475e-05,
            "start_logit": -0.955356240272522,
            "end_logit": 7.621915817260742
        },
        {
            "text": "myeloma. Here, we investigated whether the combination of these compounds would yield increased antitumor efficacy in multiple myeloma",
            "probability": 6.244318035835896e-05,
            "start_logit": -0.955356240272522,
            "end_logit": 7.200273513793945
        },
        {
            "text": "oma",
            "probability": 4.000118680593254e-05,
            "start_logit": -1.4007041454315186,
            "end_logit": 7.200273513793945
        },
        {
            "text": "for multiple myeloma.",
            "probability": 3.6399157939417864e-06,
            "start_logit": -4.219295024871826,
            "end_logit": 7.621915817260742
        },
        {
            "text": "myeloma",
            "probability": 2.373113504192453e-06,
            "start_logit": -4.225410461425781,
            "end_logit": 7.200273513793945
        },
        {
            "text": "myeloma.",
            "probability": 2.1469974742033644e-06,
            "start_logit": -4.747185230255127,
            "end_logit": 7.621915817260742
        },
        {
            "text": "increased antitumor efficacy in multiple myeloma",
            "probability": 6.425598962246545e-07,
            "start_logit": -5.5319085121154785,
            "end_logit": 7.200273513793945
        },
        {
            "text": "use for multiple myeloma.",
            "probability": 5.68552471875597e-07,
            "start_logit": -6.0759172439575195,
            "end_logit": 7.621915817260742
        },
        {
            "text": "eloma",
            "probability": 4.0762692118476203e-07,
            "start_logit": -5.987016201019287,
            "end_logit": 7.200273513793945
        },
        {
            "text": "in clinical use for multiple myeloma.",
            "probability": 3.927895477905522e-07,
            "start_logit": -6.445736885070801,
            "end_logit": 7.621915817260742
        },
        {
            "text": "in multiple myeloma",
            "probability": 3.619171548694887e-07,
            "start_logit": -6.105953216552734,
            "end_logit": 7.200273513793945
        },
        {
            "text": "clinical use for multiple myeloma.",
            "probability": 3.42137737382432e-07,
            "start_logit": -6.583797454833984,
            "end_logit": 7.621915817260742
        },
        {
            "text": "investigated whether the combination of these compounds would yield increased antitumor efficacy in multiple myeloma",
            "probability": 3.3688976388650117e-07,
            "start_logit": -6.177612781524658,
            "end_logit": 7.200273513793945
        },
        {
            "text": "multiple myeloma and glioblastoma cell lines",
            "probability": 3.1731699525752093e-07,
            "start_logit": 7.963550567626953,
            "end_logit": -7.000744342803955
        },
        {
            "text": "multiple myeloma. Here, we investigated whether the combination of these compounds would yield increased antitumor",
            "probability": 2.4264495769013374e-07,
            "start_logit": 7.674373149871826,
            "end_logit": -6.9798688888549805
        },
        {
            "text": "would yield increased antitumor efficacy in multiple myeloma",
            "probability": 2.2270961383735407e-07,
            "start_logit": -6.5914998054504395,
            "end_logit": 7.200273513793945
        },
        {
            "text": "multiple myeloma. Here, we investigated whether the combination of these compounds would yield increased antitumor efficacy",
            "probability": 1.540640631032183e-07,
            "start_logit": 7.674373149871826,
            "end_logit": -7.4340996742248535
        }
    ],
    "51631154298dcd4e5100004e_016": [
        {
            "text": "multiple myeloma,",
            "probability": 0.9982323703036472,
            "start_logit": 8.497747421264648,
            "end_logit": 8.520167350769043
        },
        {
            "text": "multiple",
            "probability": 0.0013271928185069936,
            "start_logit": 8.497747421264648,
            "end_logit": 1.897247314453125
        },
        {
            "text": "multiple myeloma, lymphoma",
            "probability": 0.00031836546791891063,
            "start_logit": 8.497747421264648,
            "end_logit": 0.46962597966194153
        },
        {
            "text": ",",
            "probability": 0.00011742382725475858,
            "start_logit": -0.5502040982246399,
            "end_logit": 8.520167350769043
        },
        {
            "text": "multiple myeloma, lymphoma and leukemia.",
            "probability": 2.9003416862242564e-06,
            "start_logit": 8.497747421264648,
            "end_logit": -4.228745460510254
        },
        {
            "text": "refractory and relapsed multiple myeloma,",
            "probability": 1.6677855039754188e-06,
            "start_logit": -4.804497241973877,
            "end_logit": 8.520167350769043
        },
        {
            "text": "myeloma, lymphoma",
            "probability": 3.7449889245145386e-08,
            "start_logit": -0.5502040982246399,
            "end_logit": 0.46962597966194153
        },
        {
            "text": "multiple myeloma, two of lymphoma and one of acute myeloblastic leukemia). Six",
            "probability": 1.4154729292625759e-08,
            "start_logit": 5.107448101043701,
            "end_logit": -6.160981178283691
        },
        {
            "text": "ten refractory or relapsed patients (seven of multiple myeloma,",
            "probability": 9.06933024497709e-09,
            "start_logit": -4.375910758972168,
            "end_logit": 2.877227306365967
        },
        {
            "text": "myeloma, lymphoma and leukemia. We used bortezomib in ten refractory or relapsed patients (seven of multiple",
            "probability": 7.865949661504045e-09,
            "start_logit": -0.5502040982246399,
            "end_logit": -1.0908344984054565
        },
        {
            "text": "(seven of multiple myeloma,",
            "probability": 7.201164494873443e-09,
            "start_logit": -4.606566429138184,
            "end_logit": 2.877227306365967
        },
        {
            "text": "refractory and relapsed multiple",
            "probability": 2.217392472469048e-09,
            "start_logit": -4.804497241973877,
            "end_logit": 1.897247314453125
        },
        {
            "text": "refractory and relapsed multiple myeloma, lymphoma",
            "probability": 5.319055243620267e-10,
            "start_logit": -4.804497241973877,
            "end_logit": 0.46962597966194153
        },
        {
            "text": "myeloma, lymphoma and leukemia.",
            "probability": 3.411722874097704e-10,
            "start_logit": -0.5502040982246399,
            "end_logit": -4.228745460510254
        },
        {
            "text": "varicella herpes zoster",
            "probability": 2.0715379496565138e-10,
            "start_logit": -1.0959265232086182,
            "end_logit": -4.181949138641357
        },
        {
            "text": "ten refractory or relapsed patients (seven of multiple",
            "probability": 1.7150147938494435e-10,
            "start_logit": -4.375910758972168,
            "end_logit": -1.0908344984054565
        },
        {
            "text": "(seven of multiple",
            "probability": 1.3617437349898274e-10,
            "start_logit": -4.606566429138184,
            "end_logit": -1.0908344984054565
        },
        {
            "text": "varicella",
            "probability": 5.545919998246285e-11,
            "start_logit": -1.0959265232086182,
            "end_logit": -5.499763011932373
        },
        {
            "text": "varicella herpes zoster after the complete of one cycle of bortezomib. The incidence of varicella",
            "probability": 2.833508862404349e-11,
            "start_logit": -1.390894889831543,
            "end_logit": -5.876341342926025
        },
        {
            "text": "incidence of varicella herpes zoster",
            "probability": 2.5324888485065642e-11,
            "start_logit": -3.1976003646850586,
            "end_logit": -4.181949138641357
        }
    ],
    "51631154298dcd4e5100004e_017": [
        {
            "text": "multiple myeloma",
            "probability": 0.9986036060002801,
            "start_logit": 8.598361015319824,
            "end_logit": 7.618024826049805
        },
        {
            "text": "multiple",
            "probability": 0.0012272302504479815,
            "start_logit": 8.598361015319824,
            "end_logit": 0.9164267182350159
        },
        {
            "text": "relapsed, refractory multiple myeloma",
            "probability": 7.741064479479467e-05,
            "start_logit": -0.8666278719902039,
            "end_logit": 7.618024826049805
        },
        {
            "text": "oma",
            "probability": 6.610461550530078e-05,
            "start_logit": -1.024513602256775,
            "end_logit": 7.618024826049805
        },
        {
            "text": "refractory multiple myeloma",
            "probability": 6.281536299729724e-06,
            "start_logit": -3.3781375885009766,
            "end_logit": 7.618024826049805
        },
        {
            "text": "shown clinical activity in relapsed, refractory multiple myeloma",
            "probability": 5.792103496303653e-06,
            "start_logit": -3.459256649017334,
            "end_logit": 7.618024826049805
        },
        {
            "text": "myeloma",
            "probability": 3.6664703121345523e-06,
            "start_logit": -3.916522741317749,
            "end_logit": 7.618024826049805
        },
        {
            "text": "multiple myeloma in a pivotal Phase II trial, SUMMIT.",
            "probability": 1.9938383842077308e-06,
            "start_logit": 8.598361015319824,
            "end_logit": -5.506026744842529
        },
        {
            "text": "in relapsed, refractory multiple myeloma",
            "probability": 1.8100228892612594e-06,
            "start_logit": -4.62241268157959,
            "end_logit": 7.618024826049805
        },
        {
            "text": "myeloma.",
            "probability": 1.6728566488913025e-06,
            "start_logit": 0.3962782621383667,
            "end_logit": 2.5205271244049072
        },
        {
            "text": "activity in relapsed, refractory multiple myeloma",
            "probability": 1.5944045286809324e-06,
            "start_logit": -4.749251842498779,
            "end_logit": 7.618024826049805
        },
        {
            "text": "clinical activity in relapsed, refractory multiple myeloma",
            "probability": 8.457084871769255e-07,
            "start_logit": -5.3833327293396,
            "end_logit": 7.618024826049805
        },
        {
            "text": "multiple myeloma in a pivotal Phase II",
            "probability": 7.240388260841841e-07,
            "start_logit": 8.598361015319824,
            "end_logit": -6.518998622894287
        },
        {
            "text": "has shown clinical activity in relapsed, refractory multiple myeloma",
            "probability": 5.023865485291259e-07,
            "start_logit": -5.90413761138916,
            "end_logit": 7.618024826049805
        },
        {
            "text": "first-in-class proteasome inhibitor, has shown clinical activity in relapsed, refractory multiple myeloma",
            "probability": 4.6362949065127954e-07,
            "start_logit": -5.984421730041504,
            "end_logit": 7.618024826049805
        },
        {
            "text": "relapsed, refractory multiple",
            "probability": 9.513352888776665e-08,
            "start_logit": -0.8666278719902039,
            "end_logit": 0.9164267182350159
        },
        {
            "text": "multiple myeloma::",
            "probability": 8.528267454137876e-08,
            "start_logit": 1.232908844947815,
            "end_logit": -1.2924201488494873
        },
        {
            "text": "with relapsed and refractory myeloma.",
            "probability": 5.997103948092597e-08,
            "start_logit": -2.932147979736328,
            "end_logit": 2.5205271244049072
        },
        {
            "text": ".",
            "probability": 3.5892426204176006e-08,
            "start_logit": -3.445483446121216,
            "end_logit": 2.5205271244049072
        },
        {
            "text": "and refractory myeloma.",
            "probability": 2.521339046377024e-08,
            "start_logit": -3.7986345291137695,
            "end_logit": 2.5205271244049072
        }
    ],
    "51631154298dcd4e5100004e_018": [
        {
            "text": "multiple myeloma,",
            "probability": 0.9992570020690794,
            "start_logit": 8.308972358703613,
            "end_logit": 7.785987854003906
        },
        {
            "text": "multiple",
            "probability": 0.0006335205688299612,
            "start_logit": 8.308972358703613,
            "end_logit": 0.42251303791999817
        },
        {
            "text": ",",
            "probability": 9.734545728449645e-05,
            "start_logit": -0.9275288581848145,
            "end_logit": 7.785987854003906
        },
        {
            "text": "was seen against multiple myeloma,",
            "probability": 4.525649117447473e-06,
            "start_logit": -3.9960339069366455,
            "end_logit": 7.785987854003906
        },
        {
            "text": "against multiple myeloma,",
            "probability": 3.928321149702326e-06,
            "start_logit": -4.137582778930664,
            "end_logit": 7.785987854003906
        },
        {
            "text": "myeloma,",
            "probability": 1.0133336160704794e-06,
            "start_logit": -5.492549419403076,
            "end_logit": 7.785987854003906
        },
        {
            "text": "activity was seen against multiple myeloma,",
            "probability": 8.39144232423437e-07,
            "start_logit": -5.6811676025390625,
            "end_logit": 7.785987854003906
        },
        {
            "text": "seen against multiple myeloma,",
            "probability": 7.387121214753562e-07,
            "start_logit": -5.8086419105529785,
            "end_logit": 7.785987854003906
        },
        {
            "text": "Antitumor activity was seen against multiple myeloma,",
            "probability": 7.11616767908293e-07,
            "start_logit": -5.846010684967041,
            "end_logit": 7.785987854003906
        },
        {
            "text": "multiple myeloma, with",
            "probability": 3.6818230999990436e-07,
            "start_logit": 8.308972358703613,
            "end_logit": -7.027956485748291
        },
        {
            "text": "was seen against multiple",
            "probability": 2.8692236304308933e-09,
            "start_logit": -3.9960339069366455,
            "end_logit": 0.42251303791999817
        },
        {
            "text": "against multiple",
            "probability": 2.490522702521069e-09,
            "start_logit": -4.137582778930664,
            "end_logit": 0.42251303791999817
        },
        {
            "text": "activity was seen against multiple",
            "probability": 5.320104140921756e-10,
            "start_logit": -5.6811676025390625,
            "end_logit": 0.42251303791999817
        },
        {
            "text": "seen against multiple",
            "probability": 4.683372970413297e-10,
            "start_logit": -5.8086419105529785,
            "end_logit": 0.42251303791999817
        },
        {
            "text": "Antitumor activity was seen against multiple",
            "probability": 4.5115906984961455e-10,
            "start_logit": -5.846010684967041,
            "end_logit": 0.42251303791999817
        },
        {
            "text": "advanced hematologic malignancies.",
            "probability": 4.6919750655753714e-11,
            "start_logit": -4.071805000305176,
            "end_logit": -3.6150739192962646
        },
        {
            "text": "myeloma, with",
            "probability": 3.586752482773716e-11,
            "start_logit": -0.9275288581848145,
            "end_logit": -7.027956485748291
        },
        {
            "text": "malignancies",
            "probability": 2.0418168199213902e-11,
            "start_logit": -4.9164934158325195,
            "end_logit": -3.6023991107940674
        },
        {
            "text": "with advanced hematologic malignancies.",
            "probability": 1.9980421191690976e-11,
            "start_logit": -4.925490856170654,
            "end_logit": -3.6150739192962646
        },
        {
            "text": "malignancies.",
            "probability": 1.1051629098183901e-11,
            "start_logit": -5.517665863037109,
            "end_logit": -3.6150739192962646
        }
    ],
    "54cf45e7f693c3b16b00000a_001": [
        {
            "text": "Calsequestrin",
            "probability": 0.9990085678608328,
            "start_logit": 9.619769096374512,
            "end_logit": 8.843260765075684
        },
        {
            "text": "Calsequestrin (CS)",
            "probability": 0.0006197284616859108,
            "start_logit": 9.619769096374512,
            "end_logit": 1.4580235481262207
        },
        {
            "text": "C",
            "probability": 0.00030660707638404983,
            "start_logit": 9.619769096374512,
            "end_logit": 0.7543091773986816
        },
        {
            "text": "rin",
            "probability": 3.9768696419556886e-05,
            "start_logit": -0.5116694569587708,
            "end_logit": 8.843260765075684
        },
        {
            "text": "CS",
            "probability": 1.3182950440474335e-05,
            "start_logit": 5.769412040710449,
            "end_logit": 1.4580235481262207
        },
        {
            "text": "Calsequestrin (CS) is the low-affinity, high-capacity",
            "probability": 4.188391307324468e-06,
            "start_logit": 9.619769096374512,
            "end_logit": -3.5389411449432373
        },
        {
            "text": "questrin",
            "probability": 3.0470403231587074e-06,
            "start_logit": -3.0805788040161133,
            "end_logit": 8.843260765075684
        },
        {
            "text": "Calsequestrin (CS) is the low-affinity,",
            "probability": 1.7470943156026504e-06,
            "start_logit": 9.619769096374512,
            "end_logit": -4.413303852081299
        },
        {
            "text": "Calsequestrin (CS) is the low-affinity, high-capacity calcium binding protein",
            "probability": 9.812244046115161e-07,
            "start_logit": 9.619769096374512,
            "end_logit": -4.9902119636535645
        },
        {
            "text": "Calsequestrin (CS) is the low-affinity, high-capacity calcium binding protein segregated",
            "probability": 7.291086134985525e-07,
            "start_logit": 9.619769096374512,
            "end_logit": -5.2871904373168945
        },
        {
            "text": "alsequestrin",
            "probability": 3.33731147942356e-07,
            "start_logit": -5.292169094085693,
            "end_logit": 8.843260765075684
        },
        {
            "text": "Calse",
            "probability": 2.889061858392262e-07,
            "start_logit": 9.619769096374512,
            "end_logit": -6.212911128997803
        },
        {
            "text": "Calsequestrin (CS) is the low-affinity, high-capacity calcium",
            "probability": 1.963559821809329e-07,
            "start_logit": 9.619769096374512,
            "end_logit": -6.59908390045166
        },
        {
            "text": "Calsequestrin (CS) is the low-affinity, high-capacity calcium binding protein segregated to the lumen",
            "probability": 1.9300339833057585e-07,
            "start_logit": 9.619769096374512,
            "end_logit": -6.616305351257324
        },
        {
            "text": "Calsequestrin (CS) is the low-affinity, high-capacity calcium binding protein segregated to",
            "probability": 1.515638018440881e-07,
            "start_logit": 9.619769096374512,
            "end_logit": -6.858006477355957
        },
        {
            "text": "Calsequest",
            "probability": 1.2589183414786705e-07,
            "start_logit": 9.619769096374512,
            "end_logit": -7.043590068817139
        },
        {
            "text": "(CS) is the low-affinity, high-capacity",
            "probability": 8.909604519302532e-08,
            "start_logit": 5.769412040710449,
            "end_logit": -3.5389411449432373
        },
        {
            "text": "(CS) is the low-affinity,",
            "probability": 3.7164434427891604e-08,
            "start_logit": 5.769412040710449,
            "end_logit": -4.413303852081299
        },
        {
            "text": "(CS) is the low-affinity, high-capacity calcium binding protein",
            "probability": 2.087274265536873e-08,
            "start_logit": 5.769412040710449,
            "end_logit": -4.9902119636535645
        },
        {
            "text": "(CS) is the low-affinity, high-capacity calcium binding protein segregated",
            "probability": 1.550970031508058e-08,
            "start_logit": 5.769412040710449,
            "end_logit": -5.2871904373168945
        }
    ],
    "54cf45e7f693c3b16b00000a_002": [
        {
            "text": "calsequestrin (CASQ2),",
            "probability": 0.3456288330203109,
            "start_logit": 10.005422592163086,
            "end_logit": 9.329574584960938
        },
        {
            "text": "CASQ",
            "probability": 0.3342443861024289,
            "start_logit": 9.971929550170898,
            "end_logit": 9.329574584960938
        },
        {
            "text": "calsequestrin",
            "probability": 0.31992370860162045,
            "start_logit": 10.005422592163086,
            "end_logit": 9.252291679382324
        },
        {
            "text": "C",
            "probability": 7.61990148074772e-05,
            "start_logit": 9.971929550170898,
            "end_logit": 0.943295419216156
        },
        {
            "text": "c",
            "probability": 6.73694926436654e-05,
            "start_logit": 10.005422592163086,
            "end_logit": 0.7866461277008057
        },
        {
            "text": "Q",
            "probability": 2.6308529187788478e-05,
            "start_logit": 0.522195041179657,
            "end_logit": 9.329574584960938
        },
        {
            "text": "rin",
            "probability": 2.0283318833658594e-05,
            "start_logit": 0.3393835723400116,
            "end_logit": 9.252291679382324
        },
        {
            "text": "calsequestrin (CASQ2), a high-capacity",
            "probability": 4.695855412496173e-06,
            "start_logit": 10.005422592163086,
            "end_logit": -1.8768658638000488
        },
        {
            "text": "(CASQ2), a high-capacity",
            "probability": 4.541181636554367e-06,
            "start_logit": 9.971929550170898,
            "end_logit": -1.8768658638000488
        },
        {
            "text": "(CASQ2),",
            "probability": 1.644661902043695e-06,
            "start_logit": 9.971929550170898,
            "end_logit": -2.8925182819366455
        },
        {
            "text": "questrin",
            "probability": 5.29078085210128e-07,
            "start_logit": -3.307034492492676,
            "end_logit": 9.252291679382324
        },
        {
            "text": "human cardiac calsequestrin (CASQ2),",
            "probability": 3.157089700192117e-07,
            "start_logit": -3.900632619857788,
            "end_logit": 9.329574584960938
        },
        {
            "text": "human cardiac calsequestrin",
            "probability": 2.922290471102235e-07,
            "start_logit": -3.900632619857788,
            "end_logit": 9.252291679382324
        },
        {
            "text": "alsequestrin",
            "probability": 1.4608822414903142e-07,
            "start_logit": -4.593959808349609,
            "end_logit": 9.252291679382324
        },
        {
            "text": "ASQ",
            "probability": 1.3626331468715035e-07,
            "start_logit": -4.740864276885986,
            "end_logit": 9.329574584960938
        },
        {
            "text": "(CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum (SR),",
            "probability": 1.35499662358402e-07,
            "start_logit": 9.971929550170898,
            "end_logit": -5.388839244842529
        },
        {
            "text": "calsequestrin (CASQ2), a high-capacity calcium-binding protein",
            "probability": 1.354212469705949e-07,
            "start_logit": 10.005422592163086,
            "end_logit": -5.422911167144775
        },
        {
            "text": "(CASQ2), a high-capacity calcium-binding protein",
            "probability": 1.3096069319035073e-07,
            "start_logit": 9.971929550170898,
            "end_logit": -5.422911167144775
        },
        {
            "text": "(CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum",
            "probability": 1.1066434564464702e-07,
            "start_logit": 9.971929550170898,
            "end_logit": -5.591306686401367
        },
        {
            "text": "calsequestrin (CASQ2), a high-capacity calcium-binding protein located",
            "probability": 9.830762669407818e-08,
            "start_logit": 10.005422592163086,
            "end_logit": -5.743199825286865
        }
    ],
    "54cf45e7f693c3b16b00000a_003": [
        {
            "text": "calsequestrin (CASQ2),",
            "probability": 0.3456288330203109,
            "start_logit": 10.005422592163086,
            "end_logit": 9.329574584960938
        },
        {
            "text": "CASQ",
            "probability": 0.3342443861024289,
            "start_logit": 9.971929550170898,
            "end_logit": 9.329574584960938
        },
        {
            "text": "calsequestrin",
            "probability": 0.31992370860162045,
            "start_logit": 10.005422592163086,
            "end_logit": 9.252291679382324
        },
        {
            "text": "C",
            "probability": 7.61990148074772e-05,
            "start_logit": 9.971929550170898,
            "end_logit": 0.943295419216156
        },
        {
            "text": "c",
            "probability": 6.73694926436654e-05,
            "start_logit": 10.005422592163086,
            "end_logit": 0.7866461277008057
        },
        {
            "text": "Q",
            "probability": 2.6308529187788478e-05,
            "start_logit": 0.522195041179657,
            "end_logit": 9.329574584960938
        },
        {
            "text": "rin",
            "probability": 2.0283318833658594e-05,
            "start_logit": 0.3393835723400116,
            "end_logit": 9.252291679382324
        },
        {
            "text": "calsequestrin (CASQ2), a high-capacity",
            "probability": 4.695855412496173e-06,
            "start_logit": 10.005422592163086,
            "end_logit": -1.8768658638000488
        },
        {
            "text": "(CASQ2), a high-capacity",
            "probability": 4.541181636554367e-06,
            "start_logit": 9.971929550170898,
            "end_logit": -1.8768658638000488
        },
        {
            "text": "(CASQ2),",
            "probability": 1.644661902043695e-06,
            "start_logit": 9.971929550170898,
            "end_logit": -2.8925182819366455
        },
        {
            "text": "questrin",
            "probability": 5.29078085210128e-07,
            "start_logit": -3.307034492492676,
            "end_logit": 9.252291679382324
        },
        {
            "text": "human cardiac calsequestrin (CASQ2),",
            "probability": 3.157089700192117e-07,
            "start_logit": -3.900632619857788,
            "end_logit": 9.329574584960938
        },
        {
            "text": "human cardiac calsequestrin",
            "probability": 2.922290471102235e-07,
            "start_logit": -3.900632619857788,
            "end_logit": 9.252291679382324
        },
        {
            "text": "alsequestrin",
            "probability": 1.4608822414903142e-07,
            "start_logit": -4.593959808349609,
            "end_logit": 9.252291679382324
        },
        {
            "text": "ASQ",
            "probability": 1.3626331468715035e-07,
            "start_logit": -4.740864276885986,
            "end_logit": 9.329574584960938
        },
        {
            "text": "(CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum (SR),",
            "probability": 1.35499662358402e-07,
            "start_logit": 9.971929550170898,
            "end_logit": -5.388839244842529
        },
        {
            "text": "calsequestrin (CASQ2), a high-capacity calcium-binding protein",
            "probability": 1.354212469705949e-07,
            "start_logit": 10.005422592163086,
            "end_logit": -5.422911167144775
        },
        {
            "text": "(CASQ2), a high-capacity calcium-binding protein",
            "probability": 1.3096069319035073e-07,
            "start_logit": 9.971929550170898,
            "end_logit": -5.422911167144775
        },
        {
            "text": "(CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum",
            "probability": 1.1066434564464702e-07,
            "start_logit": 9.971929550170898,
            "end_logit": -5.591306686401367
        },
        {
            "text": "calsequestrin (CASQ2), a high-capacity calcium-binding protein located",
            "probability": 9.830762669407818e-08,
            "start_logit": 10.005422592163086,
            "end_logit": -5.743199825286865
        }
    ],
    "54cf45e7f693c3b16b00000a_004": [
        {
            "text": "Calsequestrin",
            "probability": 0.9996611520837273,
            "start_logit": 9.431571006774902,
            "end_logit": 8.78476619720459
        },
        {
            "text": "C",
            "probability": 0.0002765797871247223,
            "start_logit": 9.431571006774902,
            "end_logit": 0.5920938849449158
        },
        {
            "text": "rin",
            "probability": 5.798140550208104e-05,
            "start_logit": -0.3234782814979553,
            "end_logit": 8.78476619720459
        },
        {
            "text": "questrin",
            "probability": 2.0811533799609407e-06,
            "start_logit": -3.6506783962249756,
            "end_logit": 8.78476619720459
        },
        {
            "text": "alsequestrin",
            "probability": 6.203754562706351e-07,
            "start_logit": -4.8610310554504395,
            "end_logit": 8.78476619720459
        },
        {
            "text": "Calsequest",
            "probability": 4.199474144139303e-07,
            "start_logit": 9.431571006774902,
            "end_logit": -5.898031234741211
        },
        {
            "text": "Calse",
            "probability": 3.004156848224538e-07,
            "start_logit": 9.431571006774902,
            "end_logit": -6.2329936027526855
        },
        {
            "text": "Calsequestrin is the major calcium-binding protein of cardiac and skeletal muscles whose function is to sequester",
            "probability": 2.8531024462539544e-07,
            "start_logit": 9.431571006774902,
            "end_logit": -6.284583568572998
        },
        {
            "text": "Calsequestrin is the major calcium-binding protein",
            "probability": 1.405413346711651e-07,
            "start_logit": 9.431571006774902,
            "end_logit": -6.992659091949463
        },
        {
            "text": "Calsequestrin is the",
            "probability": 1.3265058830927505e-07,
            "start_logit": 9.431571006774902,
            "end_logit": -7.050442218780518
        },
        {
            "text": "Calsequestrin is the major calcium-binding protein of cardiac",
            "probability": 1.076097715934894e-07,
            "start_logit": 9.431571006774902,
            "end_logit": -7.259649276733398
        },
        {
            "text": "Calsequestrin is the major calcium-binding protein of cardiac and skeletal muscles whose function is to sequester Ca(2+",
            "probability": 1.0720920518957883e-07,
            "start_logit": 9.431571006774902,
            "end_logit": -7.263378620147705
        },
        {
            "text": "Calsequestrin is the major calcium-binding",
            "probability": 9.143097417058864e-08,
            "start_logit": 9.431571006774902,
            "end_logit": -7.422576427459717
        },
        {
            "text": "(SR). Here we describe the identification and functional characterization of a C. elegans calsequestrin",
            "probability": 1.8036184314370742e-11,
            "start_logit": -4.342737674713135,
            "end_logit": -2.179227352142334
        },
        {
            "text": "to sequester Ca(2+ )in the lumen of the sarcoplasmic reticulum",
            "probability": 1.500921935972695e-11,
            "start_logit": -2.95196270942688,
            "end_logit": -3.7537176609039307
        },
        {
            "text": "reticulum (SR). Here we describe the identification and functional characterization of a C. elegans calsequestrin",
            "probability": 1.36018572535603e-11,
            "start_logit": -4.624911308288574,
            "end_logit": -2.179227352142334
        },
        {
            "text": "sarcoplasmic reticulum",
            "probability": 1.0800602677100364e-11,
            "start_logit": -3.2810254096984863,
            "end_logit": -3.7537176609039307
        },
        {
            "text": "calsequestrin",
            "probability": 1.0089367753316874e-11,
            "start_logit": -4.923635482788086,
            "end_logit": -2.179227352142334
        },
        {
            "text": "Ca(2+ )in the lumen of the sarcoplasmic reticulum",
            "probability": 6.724191071203727e-12,
            "start_logit": -3.754915714263916,
            "end_logit": -3.7537176609039307
        },
        {
            "text": "Calsequestrin is the major calcium-binding protein of cardiac and skeletal muscles whose function is to sequester Ca(2+ )in",
            "probability": 5.330977156066111e-12,
            "start_logit": -0.3234782814979553,
            "end_logit": -7.417332172393799
        }
    ],
    "54cf45e7f693c3b16b00000a_005": [
        {
            "text": "Calsequestrin",
            "probability": 0.9996713885647587,
            "start_logit": 9.343321800231934,
            "end_logit": 8.580775260925293
        },
        {
            "text": "C",
            "probability": 0.00026575481628874015,
            "start_logit": 9.343321800231934,
            "end_logit": 0.3481675088405609
        },
        {
            "text": "rin",
            "probability": 5.134129703226463e-05,
            "start_logit": -0.5333646535873413,
            "end_logit": 8.580775260925293
        },
        {
            "text": "Calsequestrin is a calcium-binding protein known",
            "probability": 6.563108866570824e-06,
            "start_logit": 9.343321800231934,
            "end_logit": -3.3529422283172607
        },
        {
            "text": "Calsequestrin is a calcium-binding protein known to sequester calcium accumulated in the sarcoplasmic reticulum",
            "probability": 1.3973375288537812e-06,
            "start_logit": 9.343321800231934,
            "end_logit": -4.899837970733643
        },
        {
            "text": "Calsequestrin is a calcium-binding protein known to sequester calcium accumulated",
            "probability": 1.0319945100202621e-06,
            "start_logit": 9.343321800231934,
            "end_logit": -5.202913284301758
        },
        {
            "text": "questrin",
            "probability": 7.770004051242546e-07,
            "start_logit": -4.724174499511719,
            "end_logit": 8.580775260925293
        },
        {
            "text": "alsequestrin",
            "probability": 4.2184149459029995e-07,
            "start_logit": -5.334985733032227,
            "end_logit": 8.580775260925293
        },
        {
            "text": "Calsequest",
            "probability": 3.852346841989732e-07,
            "start_logit": 9.343321800231934,
            "end_logit": -6.188309192657471
        },
        {
            "text": "Calse",
            "probability": 2.8127486510824784e-07,
            "start_logit": 9.343321800231934,
            "end_logit": -6.502829551696777
        },
        {
            "text": "Calsequestrin is a calcium-binding protein known to sequester",
            "probability": 1.7533426341372403e-07,
            "start_logit": 9.343321800231934,
            "end_logit": -6.975467681884766
        },
        {
            "text": "Calsequestrin is a calcium-binding protein known to sequester calcium",
            "probability": 1.6549455294947764e-07,
            "start_logit": 9.343321800231934,
            "end_logit": -7.033223628997803
        },
        {
            "text": "Calsequestrin is a calcium-binding protein",
            "probability": 1.3995326742861333e-07,
            "start_logit": 9.343321800231934,
            "end_logit": -7.20085334777832
        },
        {
            "text": "Calsequestrin is",
            "probability": 1.1458679782231165e-07,
            "start_logit": 9.343321800231934,
            "end_logit": -7.400829315185547
        },
        {
            "text": "Calsequestrin is a calcium-binding",
            "probability": 6.210299756164469e-08,
            "start_logit": 9.343321800231934,
            "end_logit": -8.013367652893066
        },
        {
            "text": "known",
            "probability": 3.1841435021188805e-11,
            "start_logit": -2.8928847312927246,
            "end_logit": -3.3529422283172607
        },
        {
            "text": "calcium-binding protein known",
            "probability": 8.175720434297803e-12,
            "start_logit": -4.252484321594238,
            "end_logit": -3.3529422283172607
        },
        {
            "text": "known to sequester calcium accumulated in the sarcoplasmic reticulum",
            "probability": 6.779292105650168e-12,
            "start_logit": -2.8928847312927246,
            "end_logit": -4.899837970733643
        },
        {
            "text": "a calcium-binding protein known",
            "probability": 5.883168105773603e-12,
            "start_logit": -4.581557750701904,
            "end_logit": -3.3529422283172607
        },
        {
            "text": "known to sequester calcium accumulated",
            "probability": 5.006801928946663e-12,
            "start_logit": -2.8928847312927246,
            "end_logit": -5.202913284301758
        }
    ],
    "54cf45e7f693c3b16b00000a_006": [
        {
            "text": "Calsequestrin",
            "probability": 0.3389552330768615,
            "start_logit": 9.838666915893555,
            "end_logit": 9.307795524597168
        },
        {
            "text": "Calsequestrin (CASQ)",
            "probability": 0.3321587289909374,
            "start_logit": 9.838666915893555,
            "end_logit": 9.287540435791016
        },
        {
            "text": "CASQ",
            "probability": 0.32872850887100286,
            "start_logit": 9.828286170959473,
            "end_logit": 9.287540435791016
        },
        {
            "text": "C",
            "probability": 9.692789903649407e-05,
            "start_logit": 9.838666915893555,
            "end_logit": 1.1481395959854126
        },
        {
            "text": "Q",
            "probability": 2.9574070392496782e-05,
            "start_logit": 0.5121966600418091,
            "end_logit": 9.287540435791016
        },
        {
            "text": "rin",
            "probability": 2.8208777618794228e-05,
            "start_logit": 0.44467678666114807,
            "end_logit": 9.307795524597168
        },
        {
            "text": "questrin",
            "probability": 1.288872780520546e-06,
            "start_logit": -2.641188383102417,
            "end_logit": 9.307795524597168
        },
        {
            "text": "(CASQ)",
            "probability": 4.656851790978737e-07,
            "start_logit": -3.638946771621704,
            "end_logit": 9.287540435791016
        },
        {
            "text": "ASQ",
            "probability": 1.994875383064167e-07,
            "start_logit": -4.4867048263549805,
            "end_logit": 9.287540435791016
        },
        {
            "text": "alsequestrin",
            "probability": 1.8873200261089973e-07,
            "start_logit": -4.562383651733398,
            "end_logit": 9.307795524597168
        },
        {
            "text": "Calse",
            "probability": 1.0906638332429473e-07,
            "start_logit": 9.838666915893555,
            "end_logit": -5.641626358032227
        },
        {
            "text": "(CASQ) is the major component of the sarcoplasmic reticulum (SR) lumen in skeletal",
            "probability": 9.230383106522375e-08,
            "start_logit": 9.828286170959473,
            "end_logit": -5.798116683959961
        },
        {
            "text": "CAS",
            "probability": 6.796766034267922e-08,
            "start_logit": 9.828286170959473,
            "end_logit": -6.104170322418213
        },
        {
            "text": "Calsequestrin (CASQ) is the major component",
            "probability": 6.752490405282633e-08,
            "start_logit": 9.838666915893555,
            "end_logit": -6.121086597442627
        },
        {
            "text": "(CASQ) is the major component",
            "probability": 6.682757092784027e-08,
            "start_logit": 9.828286170959473,
            "end_logit": -6.121086597442627
        },
        {
            "text": "Calsequest",
            "probability": 6.092209846644578e-08,
            "start_logit": 9.838666915893555,
            "end_logit": -6.223987102508545
        },
        {
            "text": "Calsequestrin (CASQ) is the major component of the sarcoplasmic reticulum",
            "probability": 6.05710288718445e-08,
            "start_logit": 9.838666915893555,
            "end_logit": -6.229766368865967
        },
        {
            "text": "(CASQ) is the major component of the sarcoplasmic reticulum",
            "probability": 5.994550877019756e-08,
            "start_logit": 9.828286170959473,
            "end_logit": -6.229766368865967
        },
        {
            "text": "Calsequestrin (CASQ) is the major",
            "probability": 4.543845461030921e-08,
            "start_logit": 9.838666915893555,
            "end_logit": -6.517224311828613
        },
        {
            "text": "(CASQ) is the major",
            "probability": 4.4969209374164093e-08,
            "start_logit": 9.828286170959473,
            "end_logit": -6.517224311828613
        }
    ],
    "54cf45e7f693c3b16b00000a_007": [
        {
            "text": "Calsequestrin",
            "probability": 0.3389552330768615,
            "start_logit": 9.838666915893555,
            "end_logit": 9.307795524597168
        },
        {
            "text": "Calsequestrin (CASQ)",
            "probability": 0.3321587289909374,
            "start_logit": 9.838666915893555,
            "end_logit": 9.287540435791016
        },
        {
            "text": "CASQ",
            "probability": 0.32872850887100286,
            "start_logit": 9.828286170959473,
            "end_logit": 9.287540435791016
        },
        {
            "text": "C",
            "probability": 9.692789903649407e-05,
            "start_logit": 9.838666915893555,
            "end_logit": 1.1481395959854126
        },
        {
            "text": "Q",
            "probability": 2.9574070392496782e-05,
            "start_logit": 0.5121966600418091,
            "end_logit": 9.287540435791016
        },
        {
            "text": "rin",
            "probability": 2.8208777618794228e-05,
            "start_logit": 0.44467678666114807,
            "end_logit": 9.307795524597168
        },
        {
            "text": "questrin",
            "probability": 1.288872780520546e-06,
            "start_logit": -2.641188383102417,
            "end_logit": 9.307795524597168
        },
        {
            "text": "(CASQ)",
            "probability": 4.656851790978737e-07,
            "start_logit": -3.638946771621704,
            "end_logit": 9.287540435791016
        },
        {
            "text": "ASQ",
            "probability": 1.994875383064167e-07,
            "start_logit": -4.4867048263549805,
            "end_logit": 9.287540435791016
        },
        {
            "text": "alsequestrin",
            "probability": 1.8873200261089973e-07,
            "start_logit": -4.562383651733398,
            "end_logit": 9.307795524597168
        },
        {
            "text": "Calse",
            "probability": 1.0906638332429473e-07,
            "start_logit": 9.838666915893555,
            "end_logit": -5.641626358032227
        },
        {
            "text": "(CASQ) is the major component of the sarcoplasmic reticulum (SR) lumen in skeletal",
            "probability": 9.230383106522375e-08,
            "start_logit": 9.828286170959473,
            "end_logit": -5.798116683959961
        },
        {
            "text": "CAS",
            "probability": 6.796766034267922e-08,
            "start_logit": 9.828286170959473,
            "end_logit": -6.104170322418213
        },
        {
            "text": "Calsequestrin (CASQ) is the major component",
            "probability": 6.752490405282633e-08,
            "start_logit": 9.838666915893555,
            "end_logit": -6.121086597442627
        },
        {
            "text": "(CASQ) is the major component",
            "probability": 6.682757092784027e-08,
            "start_logit": 9.828286170959473,
            "end_logit": -6.121086597442627
        },
        {
            "text": "Calsequest",
            "probability": 6.092209846644578e-08,
            "start_logit": 9.838666915893555,
            "end_logit": -6.223987102508545
        },
        {
            "text": "Calsequestrin (CASQ) is the major component of the sarcoplasmic reticulum",
            "probability": 6.05710288718445e-08,
            "start_logit": 9.838666915893555,
            "end_logit": -6.229766368865967
        },
        {
            "text": "(CASQ) is the major component of the sarcoplasmic reticulum",
            "probability": 5.994550877019756e-08,
            "start_logit": 9.828286170959473,
            "end_logit": -6.229766368865967
        },
        {
            "text": "Calsequestrin (CASQ) is the major",
            "probability": 4.543845461030921e-08,
            "start_logit": 9.838666915893555,
            "end_logit": -6.517224311828613
        },
        {
            "text": "(CASQ) is the major",
            "probability": 4.4969209374164093e-08,
            "start_logit": 9.828286170959473,
            "end_logit": -6.517224311828613
        }
    ],
    "54cf45e7f693c3b16b00000a_008": [
        {
            "text": "calsequestrin",
            "probability": 0.9995108346650644,
            "start_logit": 9.993410110473633,
            "end_logit": 9.335658073425293
        },
        {
            "text": "rin",
            "probability": 0.00022397422270023333,
            "start_logit": 1.5899198055267334,
            "end_logit": 9.335658073425293
        },
        {
            "text": "c",
            "probability": 0.00018942246936063891,
            "start_logit": 9.993410110473633,
            "end_logit": 0.7646166086196899
        },
        {
            "text": "alsequestrin",
            "probability": 2.5290716570687017e-05,
            "start_logit": -0.5911737680435181,
            "end_logit": 9.335658073425293
        },
        {
            "text": "(calsequestrin,",
            "probability": 1.750030826047478e-05,
            "start_logit": 9.993410110473633,
            "end_logit": -1.6171447038650513
        },
        {
            "text": "questrin",
            "probability": 1.5151397859634928e-05,
            "start_logit": -1.1035183668136597,
            "end_logit": 9.335658073425293
        },
        {
            "text": "(1) luminal calcium-binding proteins (calsequestrin,",
            "probability": 8.233945275789383e-06,
            "start_logit": -1.7133458852767944,
            "end_logit": 9.335658073425293
        },
        {
            "text": "calsequest",
            "probability": 4.729791706438454e-06,
            "start_logit": 9.993410110473633,
            "end_logit": -2.9254820346832275
        },
        {
            "text": "calse",
            "probability": 1.8825459689143387e-06,
            "start_logit": 9.993410110473633,
            "end_logit": -3.84673810005188
        },
        {
            "text": "calcium-binding proteins (calsequestrin,",
            "probability": 1.7259305427060326e-06,
            "start_logit": -3.2758448123931885,
            "end_logit": 9.335658073425293
        },
        {
            "text": "luminal calcium-binding proteins (calsequestrin,",
            "probability": 9.687081212219828e-07,
            "start_logit": -3.853403091430664,
            "end_logit": 9.335658073425293
        },
        {
            "text": "(calsequestrin, histidine-rich",
            "probability": 2.0061649057189153e-07,
            "start_logit": 9.993410110473633,
            "end_logit": -6.085723400115967
        },
        {
            "text": "(calsequestrin, histidine-rich calcium-binding protein,",
            "probability": 8.435997548347179e-08,
            "start_logit": 9.993410110473633,
            "end_logit": -6.952025413513184
        },
        {
            "text": "alsequest",
            "probability": 1.1967836399292815e-10,
            "start_logit": -0.5911737680435181,
            "end_logit": -2.9254820346832275
        },
        {
            "text": "quest",
            "probability": 7.169802812739378e-11,
            "start_logit": -1.1035183668136597,
            "end_logit": -2.9254820346832275
        },
        {
            "text": "three major classes of SR calcium-regulatory proteins: (1) luminal calcium-binding proteins (calsequestrin,",
            "probability": 5.61405796736051e-11,
            "start_logit": -5.03822135925293,
            "end_logit": 0.7646166086196899
        },
        {
            "text": "alse",
            "probability": 4.7634237548866905e-11,
            "start_logit": -0.5911737680435181,
            "end_logit": -3.84673810005188
        },
        {
            "text": "SERCA",
            "probability": 2.380530765671288e-11,
            "start_logit": -2.620966672897339,
            "end_logit": -2.5105884075164795
        },
        {
            "text": "(1) luminal calcium-binding proteins (calsequestrin, histidine-rich",
            "probability": 1.652673635442292e-12,
            "start_logit": -1.7133458852767944,
            "end_logit": -6.085723400115967
        },
        {
            "text": "(1) luminal calcium-binding",
            "probability": 1.4933923141179906e-12,
            "start_logit": -1.7133458852767944,
            "end_logit": -6.18706750869751
        }
    ],
    "54cf45e7f693c3b16b00000a_009": [
        {
            "text": "Calsequestrin",
            "probability": 0.9990085678608328,
            "start_logit": 9.619769096374512,
            "end_logit": 8.843260765075684
        },
        {
            "text": "Calsequestrin (CS)",
            "probability": 0.0006197284616859108,
            "start_logit": 9.619769096374512,
            "end_logit": 1.4580235481262207
        },
        {
            "text": "C",
            "probability": 0.00030660707638404983,
            "start_logit": 9.619769096374512,
            "end_logit": 0.7543091773986816
        },
        {
            "text": "rin",
            "probability": 3.9768696419556886e-05,
            "start_logit": -0.5116694569587708,
            "end_logit": 8.843260765075684
        },
        {
            "text": "CS",
            "probability": 1.3182950440474335e-05,
            "start_logit": 5.769412040710449,
            "end_logit": 1.4580235481262207
        },
        {
            "text": "Calsequestrin (CS) is the low-affinity, high-capacity",
            "probability": 4.188391307324468e-06,
            "start_logit": 9.619769096374512,
            "end_logit": -3.5389411449432373
        },
        {
            "text": "questrin",
            "probability": 3.0470403231587074e-06,
            "start_logit": -3.0805788040161133,
            "end_logit": 8.843260765075684
        },
        {
            "text": "Calsequestrin (CS) is the low-affinity,",
            "probability": 1.7470943156026504e-06,
            "start_logit": 9.619769096374512,
            "end_logit": -4.413303852081299
        },
        {
            "text": "Calsequestrin (CS) is the low-affinity, high-capacity calcium binding protein",
            "probability": 9.812244046115161e-07,
            "start_logit": 9.619769096374512,
            "end_logit": -4.9902119636535645
        },
        {
            "text": "Calsequestrin (CS) is the low-affinity, high-capacity calcium binding protein segregated",
            "probability": 7.291086134985525e-07,
            "start_logit": 9.619769096374512,
            "end_logit": -5.2871904373168945
        },
        {
            "text": "alsequestrin",
            "probability": 3.33731147942356e-07,
            "start_logit": -5.292169094085693,
            "end_logit": 8.843260765075684
        },
        {
            "text": "Calse",
            "probability": 2.889061858392262e-07,
            "start_logit": 9.619769096374512,
            "end_logit": -6.212911128997803
        },
        {
            "text": "Calsequestrin (CS) is the low-affinity, high-capacity calcium",
            "probability": 1.963559821809329e-07,
            "start_logit": 9.619769096374512,
            "end_logit": -6.59908390045166
        },
        {
            "text": "Calsequestrin (CS) is the low-affinity, high-capacity calcium binding protein segregated to the lumen",
            "probability": 1.9300339833057585e-07,
            "start_logit": 9.619769096374512,
            "end_logit": -6.616305351257324
        },
        {
            "text": "Calsequestrin (CS) is the low-affinity, high-capacity calcium binding protein segregated to",
            "probability": 1.515638018440881e-07,
            "start_logit": 9.619769096374512,
            "end_logit": -6.858006477355957
        },
        {
            "text": "Calsequest",
            "probability": 1.2589183414786705e-07,
            "start_logit": 9.619769096374512,
            "end_logit": -7.043590068817139
        },
        {
            "text": "(CS) is the low-affinity, high-capacity",
            "probability": 8.909604519302532e-08,
            "start_logit": 5.769412040710449,
            "end_logit": -3.5389411449432373
        },
        {
            "text": "(CS) is the low-affinity,",
            "probability": 3.7164434427891604e-08,
            "start_logit": 5.769412040710449,
            "end_logit": -4.413303852081299
        },
        {
            "text": "(CS) is the low-affinity, high-capacity calcium binding protein",
            "probability": 2.087274265536873e-08,
            "start_logit": 5.769412040710449,
            "end_logit": -4.9902119636535645
        },
        {
            "text": "(CS) is the low-affinity, high-capacity calcium binding protein segregated",
            "probability": 1.550970031508058e-08,
            "start_logit": 5.769412040710449,
            "end_logit": -5.2871904373168945
        }
    ],
    "54cf45e7f693c3b16b00000a_010": [
        {
            "text": "calsequestrin (CASQ2),",
            "probability": 0.3456288330203109,
            "start_logit": 10.005422592163086,
            "end_logit": 9.329574584960938
        },
        {
            "text": "CASQ",
            "probability": 0.3342443861024289,
            "start_logit": 9.971929550170898,
            "end_logit": 9.329574584960938
        },
        {
            "text": "calsequestrin",
            "probability": 0.31992370860162045,
            "start_logit": 10.005422592163086,
            "end_logit": 9.252291679382324
        },
        {
            "text": "C",
            "probability": 7.61990148074772e-05,
            "start_logit": 9.971929550170898,
            "end_logit": 0.943295419216156
        },
        {
            "text": "c",
            "probability": 6.73694926436654e-05,
            "start_logit": 10.005422592163086,
            "end_logit": 0.7866461277008057
        },
        {
            "text": "Q",
            "probability": 2.6308529187788478e-05,
            "start_logit": 0.522195041179657,
            "end_logit": 9.329574584960938
        },
        {
            "text": "rin",
            "probability": 2.0283318833658594e-05,
            "start_logit": 0.3393835723400116,
            "end_logit": 9.252291679382324
        },
        {
            "text": "calsequestrin (CASQ2), a high-capacity",
            "probability": 4.695855412496173e-06,
            "start_logit": 10.005422592163086,
            "end_logit": -1.8768658638000488
        },
        {
            "text": "(CASQ2), a high-capacity",
            "probability": 4.541181636554367e-06,
            "start_logit": 9.971929550170898,
            "end_logit": -1.8768658638000488
        },
        {
            "text": "(CASQ2),",
            "probability": 1.644661902043695e-06,
            "start_logit": 9.971929550170898,
            "end_logit": -2.8925182819366455
        },
        {
            "text": "questrin",
            "probability": 5.29078085210128e-07,
            "start_logit": -3.307034492492676,
            "end_logit": 9.252291679382324
        },
        {
            "text": "human cardiac calsequestrin (CASQ2),",
            "probability": 3.157089700192117e-07,
            "start_logit": -3.900632619857788,
            "end_logit": 9.329574584960938
        },
        {
            "text": "human cardiac calsequestrin",
            "probability": 2.922290471102235e-07,
            "start_logit": -3.900632619857788,
            "end_logit": 9.252291679382324
        },
        {
            "text": "alsequestrin",
            "probability": 1.4608822414903142e-07,
            "start_logit": -4.593959808349609,
            "end_logit": 9.252291679382324
        },
        {
            "text": "ASQ",
            "probability": 1.3626331468715035e-07,
            "start_logit": -4.740864276885986,
            "end_logit": 9.329574584960938
        },
        {
            "text": "(CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum (SR),",
            "probability": 1.35499662358402e-07,
            "start_logit": 9.971929550170898,
            "end_logit": -5.388839244842529
        },
        {
            "text": "calsequestrin (CASQ2), a high-capacity calcium-binding protein",
            "probability": 1.354212469705949e-07,
            "start_logit": 10.005422592163086,
            "end_logit": -5.422911167144775
        },
        {
            "text": "(CASQ2), a high-capacity calcium-binding protein",
            "probability": 1.3096069319035073e-07,
            "start_logit": 9.971929550170898,
            "end_logit": -5.422911167144775
        },
        {
            "text": "(CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum",
            "probability": 1.1066434564464702e-07,
            "start_logit": 9.971929550170898,
            "end_logit": -5.591306686401367
        },
        {
            "text": "calsequestrin (CASQ2), a high-capacity calcium-binding protein located",
            "probability": 9.830762669407818e-08,
            "start_logit": 10.005422592163086,
            "end_logit": -5.743199825286865
        }
    ],
    "54cf45e7f693c3b16b00000a_011": [
        {
            "text": "calsequestrin (CASQ2),",
            "probability": 0.3456288330203109,
            "start_logit": 10.005422592163086,
            "end_logit": 9.329574584960938
        },
        {
            "text": "CASQ",
            "probability": 0.3342443861024289,
            "start_logit": 9.971929550170898,
            "end_logit": 9.329574584960938
        },
        {
            "text": "calsequestrin",
            "probability": 0.31992370860162045,
            "start_logit": 10.005422592163086,
            "end_logit": 9.252291679382324
        },
        {
            "text": "C",
            "probability": 7.61990148074772e-05,
            "start_logit": 9.971929550170898,
            "end_logit": 0.943295419216156
        },
        {
            "text": "c",
            "probability": 6.73694926436654e-05,
            "start_logit": 10.005422592163086,
            "end_logit": 0.7866461277008057
        },
        {
            "text": "Q",
            "probability": 2.6308529187788478e-05,
            "start_logit": 0.522195041179657,
            "end_logit": 9.329574584960938
        },
        {
            "text": "rin",
            "probability": 2.0283318833658594e-05,
            "start_logit": 0.3393835723400116,
            "end_logit": 9.252291679382324
        },
        {
            "text": "calsequestrin (CASQ2), a high-capacity",
            "probability": 4.695855412496173e-06,
            "start_logit": 10.005422592163086,
            "end_logit": -1.8768658638000488
        },
        {
            "text": "(CASQ2), a high-capacity",
            "probability": 4.541181636554367e-06,
            "start_logit": 9.971929550170898,
            "end_logit": -1.8768658638000488
        },
        {
            "text": "(CASQ2),",
            "probability": 1.644661902043695e-06,
            "start_logit": 9.971929550170898,
            "end_logit": -2.8925182819366455
        },
        {
            "text": "questrin",
            "probability": 5.29078085210128e-07,
            "start_logit": -3.307034492492676,
            "end_logit": 9.252291679382324
        },
        {
            "text": "human cardiac calsequestrin (CASQ2),",
            "probability": 3.157089700192117e-07,
            "start_logit": -3.900632619857788,
            "end_logit": 9.329574584960938
        },
        {
            "text": "human cardiac calsequestrin",
            "probability": 2.922290471102235e-07,
            "start_logit": -3.900632619857788,
            "end_logit": 9.252291679382324
        },
        {
            "text": "alsequestrin",
            "probability": 1.4608822414903142e-07,
            "start_logit": -4.593959808349609,
            "end_logit": 9.252291679382324
        },
        {
            "text": "ASQ",
            "probability": 1.3626331468715035e-07,
            "start_logit": -4.740864276885986,
            "end_logit": 9.329574584960938
        },
        {
            "text": "(CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum (SR),",
            "probability": 1.35499662358402e-07,
            "start_logit": 9.971929550170898,
            "end_logit": -5.388839244842529
        },
        {
            "text": "calsequestrin (CASQ2), a high-capacity calcium-binding protein",
            "probability": 1.354212469705949e-07,
            "start_logit": 10.005422592163086,
            "end_logit": -5.422911167144775
        },
        {
            "text": "(CASQ2), a high-capacity calcium-binding protein",
            "probability": 1.3096069319035073e-07,
            "start_logit": 9.971929550170898,
            "end_logit": -5.422911167144775
        },
        {
            "text": "(CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum",
            "probability": 1.1066434564464702e-07,
            "start_logit": 9.971929550170898,
            "end_logit": -5.591306686401367
        },
        {
            "text": "calsequestrin (CASQ2), a high-capacity calcium-binding protein located",
            "probability": 9.830762669407818e-08,
            "start_logit": 10.005422592163086,
            "end_logit": -5.743199825286865
        }
    ],
    "54cf45e7f693c3b16b00000a_012": [
        {
            "text": "Calsequestrin",
            "probability": 0.9997199658336036,
            "start_logit": 9.539091110229492,
            "end_logit": 8.82686710357666
        },
        {
            "text": "C",
            "probability": 0.00020807407940500112,
            "start_logit": 9.539091110229492,
            "end_logit": 0.34953078627586365
        },
        {
            "text": "rin",
            "probability": 6.331880472654699e-05,
            "start_logit": -0.12795701622962952,
            "end_logit": 8.82686710357666
        },
        {
            "text": "Calsequest",
            "probability": 3.519468402433611e-06,
            "start_logit": 9.539091110229492,
            "end_logit": -3.730053424835205
        },
        {
            "text": "questrin",
            "probability": 2.3827260701486047e-06,
            "start_logit": -3.4078941345214844,
            "end_logit": 8.82686710357666
        },
        {
            "text": "alsequestrin",
            "probability": 9.080118066656833e-07,
            "start_logit": -4.3726372718811035,
            "end_logit": 8.82686710357666
        },
        {
            "text": "Calse",
            "probability": 7.493723665035443e-07,
            "start_logit": 9.539091110229492,
            "end_logit": -5.276882648468018
        },
        {
            "text": "Calsequestrin,",
            "probability": 4.3786394974305236e-07,
            "start_logit": 9.539091110229492,
            "end_logit": -5.814210414886475
        },
        {
            "text": "junctin",
            "probability": 2.4080970601893875e-07,
            "start_logit": 1.4199225902557373,
            "end_logit": 1.7070568799972534
        },
        {
            "text": "(the calcium store in muscle) is the key determinant of muscle force. 2. Calsequestrin,",
            "probability": 1.4546231774441254e-07,
            "start_logit": -6.203977584838867,
            "end_logit": 8.82686710357666
        },
        {
            "text": "Calsequestrin, the main calcium buffer",
            "probability": 8.28527687937983e-08,
            "start_logit": 9.539091110229492,
            "end_logit": -7.479053497314453
        },
        {
            "text": "Calsequestrin, the main calcium buffer in the sarcoplasmic reticulum,",
            "probability": 7.540352775643382e-08,
            "start_logit": 9.539091110229492,
            "end_logit": -7.5732645988464355
        },
        {
            "text": "Calsequestrin, the main calcium",
            "probability": 5.2287811102953434e-08,
            "start_logit": 9.539091110229492,
            "end_logit": -7.939355373382568
        },
        {
            "text": "Calsequestrin, the main calcium buffer in the sarcoplasmic reticulum, provides a pool of calcium",
            "probability": 4.616163527766346e-08,
            "start_logit": 9.539091110229492,
            "end_logit": -8.063969612121582
        },
        {
            "text": "triadin and junctin.",
            "probability": 5.684993762125358e-10,
            "start_logit": -4.628839492797852,
            "end_logit": 1.7070568799972534
        },
        {
            "text": "in",
            "probability": 1.4630419966890188e-10,
            "start_logit": -5.986151695251465,
            "end_logit": 1.7070568799972534
        },
        {
            "text": "and junctin.",
            "probability": 1.172016867674077e-10,
            "start_logit": -6.207943439483643,
            "end_logit": 1.7070568799972534
        },
        {
            "text": "junct",
            "probability": 1.6008847620785674e-11,
            "start_logit": 1.4199225902557373,
            "end_logit": -7.911563873291016
        },
        {
            "text": "quest",
            "probability": 8.388278120013665e-12,
            "start_logit": -3.4078941345214844,
            "end_logit": -3.730053424835205
        },
        {
            "text": "triadin",
            "probability": 5.500531018365166e-12,
            "start_logit": -4.628839492797852,
            "end_logit": -2.931098699569702
        }
    ],
    "54cf45e7f693c3b16b00000a_014": [
        {
            "text": "Calsequestrin",
            "probability": 0.9996673746896864,
            "start_logit": 8.485472679138184,
            "end_logit": 6.874985694885254
        },
        {
            "text": "C",
            "probability": 0.0003109645562869143,
            "start_logit": 8.485472679138184,
            "end_logit": -1.200513243675232
        },
        {
            "text": "rin",
            "probability": 1.2033483203850462e-05,
            "start_logit": -2.8420121669769287,
            "end_logit": 6.874985694885254
        },
        {
            "text": "Calsequest",
            "probability": 2.880811571153471e-06,
            "start_logit": 8.485472679138184,
            "end_logit": -5.882120132446289
        },
        {
            "text": "Calse",
            "probability": 2.4941096366601154e-06,
            "start_logit": 8.485472679138184,
            "end_logit": -6.0262603759765625
        },
        {
            "text": "Calsequestrin,",
            "probability": 9.783229233726749e-07,
            "start_logit": 8.485472679138184,
            "end_logit": -6.9621076583862305
        },
        {
            "text": "questrin",
            "probability": 5.896813280342183e-07,
            "start_logit": -5.8578782081604,
            "end_logit": 6.874985694885254
        },
        {
            "text": "alsequestrin",
            "probability": 4.5137752544131256e-07,
            "start_logit": -6.125156402587891,
            "end_logit": 6.874985694885254
        },
        {
            "text": "Calsequestrin, the main calcium buffer",
            "probability": 4.484570397243914e-07,
            "start_logit": 8.485472679138184,
            "end_logit": -7.7421345710754395
        },
        {
            "text": "Calsequestrin, the main calcium buffer in the sarcoplasmic reticulum,",
            "probability": 3.1145300857495575e-07,
            "start_logit": 8.485472679138184,
            "end_logit": -8.106698989868164
        },
        {
            "text": "Calsequestrin, the main calcium buffer in the sarcoplasmic reticulum, provides a pool of calcium",
            "probability": 2.2177263200258946e-07,
            "start_logit": 8.485472679138184,
            "end_logit": -8.446294784545898
        },
        {
            "text": "Calsequestrin, the main calcium",
            "probability": 2.1029134298803464e-07,
            "start_logit": 8.485472679138184,
            "end_logit": -8.4994535446167
        },
        {
            "text": "Calsequestrin, the main calcium buffer in the sarcoplasmic reticulum, provides",
            "probability": 2.0764147392900752e-07,
            "start_logit": 8.485472679138184,
            "end_logit": -8.512134552001953
        },
        {
            "text": "reticulum. Calsequestrin,",
            "probability": 1.7070172145145388e-07,
            "start_logit": -7.097542762756348,
            "end_logit": 6.874985694885254
        },
        {
            "text": "sarcoplasmic reticulum. Calsequestrin,",
            "probability": 1.5903845371215333e-07,
            "start_logit": -7.168314456939697,
            "end_logit": 6.874985694885254
        },
        {
            "text": "the amount of calcium stored within the sarcoplasmic reticulum. Calsequestrin,",
            "probability": 1.4611610812647277e-07,
            "start_logit": -7.253058910369873,
            "end_logit": 6.874985694885254
        },
        {
            "text": "amount of calcium stored within the sarcoplasmic reticulum. Calsequestrin,",
            "probability": 1.359577695681452e-07,
            "start_logit": -7.325116157531738,
            "end_logit": 6.874985694885254
        },
        {
            "text": "calcium stored within the sarcoplasmic reticulum. Calsequestrin,",
            "probability": 1.1107831128355095e-07,
            "start_logit": -7.527225017547607,
            "end_logit": 6.874985694885254
        },
        {
            "text": "the sarcoplasmic reticulum. Calsequestrin,",
            "probability": 1.1045827725111244e-07,
            "start_logit": -7.532822608947754,
            "end_logit": 6.874985694885254
        },
        {
            "text": "quest",
            "probability": 1.6993260319428212e-12,
            "start_logit": -5.8578782081604,
            "end_logit": -5.882120132446289
        }
    ],
    "54cf45e7f693c3b16b00000a_015": [
        {
            "text": "Calsequestrin",
            "probability": 0.9997199658336036,
            "start_logit": 9.539091110229492,
            "end_logit": 8.82686710357666
        },
        {
            "text": "C",
            "probability": 0.00020807407940500112,
            "start_logit": 9.539091110229492,
            "end_logit": 0.34953078627586365
        },
        {
            "text": "rin",
            "probability": 6.331880472654699e-05,
            "start_logit": -0.12795701622962952,
            "end_logit": 8.82686710357666
        },
        {
            "text": "Calsequest",
            "probability": 3.519468402433611e-06,
            "start_logit": 9.539091110229492,
            "end_logit": -3.730053424835205
        },
        {
            "text": "questrin",
            "probability": 2.3827260701486047e-06,
            "start_logit": -3.4078941345214844,
            "end_logit": 8.82686710357666
        },
        {
            "text": "alsequestrin",
            "probability": 9.080118066656833e-07,
            "start_logit": -4.3726372718811035,
            "end_logit": 8.82686710357666
        },
        {
            "text": "Calse",
            "probability": 7.493723665035443e-07,
            "start_logit": 9.539091110229492,
            "end_logit": -5.276882648468018
        },
        {
            "text": "Calsequestrin,",
            "probability": 4.3786394974305236e-07,
            "start_logit": 9.539091110229492,
            "end_logit": -5.814210414886475
        },
        {
            "text": "junctin",
            "probability": 2.4080970601893875e-07,
            "start_logit": 1.4199225902557373,
            "end_logit": 1.7070568799972534
        },
        {
            "text": "(the calcium store in muscle) is the key determinant of muscle force. 2. Calsequestrin,",
            "probability": 1.4546231774441254e-07,
            "start_logit": -6.203977584838867,
            "end_logit": 8.82686710357666
        },
        {
            "text": "Calsequestrin, the main calcium buffer",
            "probability": 8.28527687937983e-08,
            "start_logit": 9.539091110229492,
            "end_logit": -7.479053497314453
        },
        {
            "text": "Calsequestrin, the main calcium buffer in the sarcoplasmic reticulum,",
            "probability": 7.540352775643382e-08,
            "start_logit": 9.539091110229492,
            "end_logit": -7.5732645988464355
        },
        {
            "text": "Calsequestrin, the main calcium",
            "probability": 5.2287811102953434e-08,
            "start_logit": 9.539091110229492,
            "end_logit": -7.939355373382568
        },
        {
            "text": "Calsequestrin, the main calcium buffer in the sarcoplasmic reticulum, provides a pool of calcium",
            "probability": 4.616163527766346e-08,
            "start_logit": 9.539091110229492,
            "end_logit": -8.063969612121582
        },
        {
            "text": "triadin and junctin.",
            "probability": 5.684993762125358e-10,
            "start_logit": -4.628839492797852,
            "end_logit": 1.7070568799972534
        },
        {
            "text": "in",
            "probability": 1.4630419966890188e-10,
            "start_logit": -5.986151695251465,
            "end_logit": 1.7070568799972534
        },
        {
            "text": "and junctin.",
            "probability": 1.172016867674077e-10,
            "start_logit": -6.207943439483643,
            "end_logit": 1.7070568799972534
        },
        {
            "text": "junct",
            "probability": 1.6008847620785674e-11,
            "start_logit": 1.4199225902557373,
            "end_logit": -7.911563873291016
        },
        {
            "text": "quest",
            "probability": 8.388278120013665e-12,
            "start_logit": -3.4078941345214844,
            "end_logit": -3.730053424835205
        },
        {
            "text": "triadin",
            "probability": 5.500531018365166e-12,
            "start_logit": -4.628839492797852,
            "end_logit": -2.931098699569702
        }
    ],
    "54cf45e7f693c3b16b00000a_016": [
        {
            "text": "Calsequestrin",
            "probability": 0.9996673746896864,
            "start_logit": 8.485472679138184,
            "end_logit": 6.874985694885254
        },
        {
            "text": "C",
            "probability": 0.0003109645562869143,
            "start_logit": 8.485472679138184,
            "end_logit": -1.200513243675232
        },
        {
            "text": "rin",
            "probability": 1.2033483203850462e-05,
            "start_logit": -2.8420121669769287,
            "end_logit": 6.874985694885254
        },
        {
            "text": "Calsequest",
            "probability": 2.880811571153471e-06,
            "start_logit": 8.485472679138184,
            "end_logit": -5.882120132446289
        },
        {
            "text": "Calse",
            "probability": 2.4941096366601154e-06,
            "start_logit": 8.485472679138184,
            "end_logit": -6.0262603759765625
        },
        {
            "text": "Calsequestrin,",
            "probability": 9.783229233726749e-07,
            "start_logit": 8.485472679138184,
            "end_logit": -6.9621076583862305
        },
        {
            "text": "questrin",
            "probability": 5.896813280342183e-07,
            "start_logit": -5.8578782081604,
            "end_logit": 6.874985694885254
        },
        {
            "text": "alsequestrin",
            "probability": 4.5137752544131256e-07,
            "start_logit": -6.125156402587891,
            "end_logit": 6.874985694885254
        },
        {
            "text": "Calsequestrin, the main calcium buffer",
            "probability": 4.484570397243914e-07,
            "start_logit": 8.485472679138184,
            "end_logit": -7.7421345710754395
        },
        {
            "text": "Calsequestrin, the main calcium buffer in the sarcoplasmic reticulum,",
            "probability": 3.1145300857495575e-07,
            "start_logit": 8.485472679138184,
            "end_logit": -8.106698989868164
        },
        {
            "text": "Calsequestrin, the main calcium buffer in the sarcoplasmic reticulum, provides a pool of calcium",
            "probability": 2.2177263200258946e-07,
            "start_logit": 8.485472679138184,
            "end_logit": -8.446294784545898
        },
        {
            "text": "Calsequestrin, the main calcium",
            "probability": 2.1029134298803464e-07,
            "start_logit": 8.485472679138184,
            "end_logit": -8.4994535446167
        },
        {
            "text": "Calsequestrin, the main calcium buffer in the sarcoplasmic reticulum, provides",
            "probability": 2.0764147392900752e-07,
            "start_logit": 8.485472679138184,
            "end_logit": -8.512134552001953
        },
        {
            "text": "reticulum. Calsequestrin,",
            "probability": 1.7070172145145388e-07,
            "start_logit": -7.097542762756348,
            "end_logit": 6.874985694885254
        },
        {
            "text": "sarcoplasmic reticulum. Calsequestrin,",
            "probability": 1.5903845371215333e-07,
            "start_logit": -7.168314456939697,
            "end_logit": 6.874985694885254
        },
        {
            "text": "the amount of calcium stored within the sarcoplasmic reticulum. Calsequestrin,",
            "probability": 1.4611610812647277e-07,
            "start_logit": -7.253058910369873,
            "end_logit": 6.874985694885254
        },
        {
            "text": "amount of calcium stored within the sarcoplasmic reticulum. Calsequestrin,",
            "probability": 1.359577695681452e-07,
            "start_logit": -7.325116157531738,
            "end_logit": 6.874985694885254
        },
        {
            "text": "calcium stored within the sarcoplasmic reticulum. Calsequestrin,",
            "probability": 1.1107831128355095e-07,
            "start_logit": -7.527225017547607,
            "end_logit": 6.874985694885254
        },
        {
            "text": "the sarcoplasmic reticulum. Calsequestrin,",
            "probability": 1.1045827725111244e-07,
            "start_logit": -7.532822608947754,
            "end_logit": 6.874985694885254
        },
        {
            "text": "quest",
            "probability": 1.6993260319428212e-12,
            "start_logit": -5.8578782081604,
            "end_logit": -5.882120132446289
        }
    ],
    "54cf45e7f693c3b16b00000a_017": [
        {
            "text": "Calsequestrin",
            "probability": 0.9997199658336036,
            "start_logit": 9.539091110229492,
            "end_logit": 8.82686710357666
        },
        {
            "text": "C",
            "probability": 0.00020807407940500112,
            "start_logit": 9.539091110229492,
            "end_logit": 0.34953078627586365
        },
        {
            "text": "rin",
            "probability": 6.331880472654699e-05,
            "start_logit": -0.12795701622962952,
            "end_logit": 8.82686710357666
        },
        {
            "text": "Calsequest",
            "probability": 3.519468402433611e-06,
            "start_logit": 9.539091110229492,
            "end_logit": -3.730053424835205
        },
        {
            "text": "questrin",
            "probability": 2.3827260701486047e-06,
            "start_logit": -3.4078941345214844,
            "end_logit": 8.82686710357666
        },
        {
            "text": "alsequestrin",
            "probability": 9.080118066656833e-07,
            "start_logit": -4.3726372718811035,
            "end_logit": 8.82686710357666
        },
        {
            "text": "Calse",
            "probability": 7.493723665035443e-07,
            "start_logit": 9.539091110229492,
            "end_logit": -5.276882648468018
        },
        {
            "text": "Calsequestrin,",
            "probability": 4.3786394974305236e-07,
            "start_logit": 9.539091110229492,
            "end_logit": -5.814210414886475
        },
        {
            "text": "junctin",
            "probability": 2.4080970601893875e-07,
            "start_logit": 1.4199225902557373,
            "end_logit": 1.7070568799972534
        },
        {
            "text": "(the calcium store in muscle) is the key determinant of muscle force. 2. Calsequestrin,",
            "probability": 1.4546231774441254e-07,
            "start_logit": -6.203977584838867,
            "end_logit": 8.82686710357666
        },
        {
            "text": "Calsequestrin, the main calcium buffer",
            "probability": 8.28527687937983e-08,
            "start_logit": 9.539091110229492,
            "end_logit": -7.479053497314453
        },
        {
            "text": "Calsequestrin, the main calcium buffer in the sarcoplasmic reticulum,",
            "probability": 7.540352775643382e-08,
            "start_logit": 9.539091110229492,
            "end_logit": -7.5732645988464355
        },
        {
            "text": "Calsequestrin, the main calcium",
            "probability": 5.2287811102953434e-08,
            "start_logit": 9.539091110229492,
            "end_logit": -7.939355373382568
        },
        {
            "text": "Calsequestrin, the main calcium buffer in the sarcoplasmic reticulum, provides a pool of calcium",
            "probability": 4.616163527766346e-08,
            "start_logit": 9.539091110229492,
            "end_logit": -8.063969612121582
        },
        {
            "text": "triadin and junctin.",
            "probability": 5.684993762125358e-10,
            "start_logit": -4.628839492797852,
            "end_logit": 1.7070568799972534
        },
        {
            "text": "in",
            "probability": 1.4630419966890188e-10,
            "start_logit": -5.986151695251465,
            "end_logit": 1.7070568799972534
        },
        {
            "text": "and junctin.",
            "probability": 1.172016867674077e-10,
            "start_logit": -6.207943439483643,
            "end_logit": 1.7070568799972534
        },
        {
            "text": "junct",
            "probability": 1.6008847620785674e-11,
            "start_logit": 1.4199225902557373,
            "end_logit": -7.911563873291016
        },
        {
            "text": "quest",
            "probability": 8.388278120013665e-12,
            "start_logit": -3.4078941345214844,
            "end_logit": -3.730053424835205
        },
        {
            "text": "triadin",
            "probability": 5.500531018365166e-12,
            "start_logit": -4.628839492797852,
            "end_logit": -2.931098699569702
        }
    ],
    "52f896d62059c6d71c000046_001": [
        {
            "text": "memory loss/lack",
            "probability": 0.9990277537394519,
            "start_logit": 9.505337715148926,
            "end_logit": 9.248530387878418
        },
        {
            "text": "memory",
            "probability": 0.00040358674227592177,
            "start_logit": 9.505337715148926,
            "end_logit": 1.4343839883804321
        },
        {
            "text": "ack",
            "probability": 0.000290394240927842,
            "start_logit": 1.36203932762146,
            "end_logit": 9.248530387878418
        },
        {
            "text": "memory loss/lack of",
            "probability": 0.00013575936572333665,
            "start_logit": 9.505337715148926,
            "end_logit": 0.3448764979839325
        },
        {
            "text": "memory loss/lack of concentration",
            "probability": 0.00010468640087422334,
            "start_logit": 9.505337715148926,
            "end_logit": 0.08496177196502686
        },
        {
            "text": "memory loss/lack of concentration (OR 19.6, 95% CI 15.5-24.8),",
            "probability": 2.1324664440980193e-05,
            "start_logit": 9.505337715148926,
            "end_logit": -1.5061430931091309
        },
        {
            "text": "loss/lack",
            "probability": 6.276370257694159e-06,
            "start_logit": -2.4724082946777344,
            "end_logit": 9.248530387878418
        },
        {
            "text": "lack",
            "probability": 5.274309828007624e-06,
            "start_logit": -2.6463522911071777,
            "end_logit": 9.248530387878418
        },
        {
            "text": "for mood swings (OR 20.9, 95%CI 16.2-27.0), memory loss/lack",
            "probability": 2.3044741875282464e-06,
            "start_logit": -3.2807364463806152,
            "end_logit": 9.054919242858887
        },
        {
            "text": "mood swings (OR 20.9, 95%CI 16.2-27.0), memory loss/lack",
            "probability": 8.919929264740756e-07,
            "start_logit": -4.229886054992676,
            "end_logit": 9.054919242858887
        },
        {
            "text": "16.2-27.0), memory loss/lack",
            "probability": 8.361401335587356e-07,
            "start_logit": -4.4881591796875,
            "end_logit": 9.248530387878418
        },
        {
            "text": "memory loss/lack of concentration (OR 19.6, 95% CI 15.5-24.8), night sweats",
            "probability": 5.546589352586867e-07,
            "start_logit": 9.505337715148926,
            "end_logit": -5.155409336090088
        },
        {
            "text": "swings (OR 20.9, 95%CI 16.2-27.0), memory loss/lack",
            "probability": 1.883636590289252e-07,
            "start_logit": -5.784969806671143,
            "end_logit": 9.054919242858887
        },
        {
            "text": "were for mood swings (OR 20.9, 95%CI 16.2-27.0), memory loss/lack",
            "probability": 9.066590576229026e-08,
            "start_logit": -6.516162872314453,
            "end_logit": 9.054919242858887
        },
        {
            "text": "loss/lack of",
            "probability": 3.946210484193957e-08,
            "start_logit": 1.36203932762146,
            "end_logit": 0.3448764979839325
        },
        {
            "text": "loss/lack of concentration",
            "probability": 3.0429913286739695e-08,
            "start_logit": 1.36203932762146,
            "end_logit": 0.08496177196502686
        },
        {
            "text": "loss/lack of concentration (OR 19.6, 95% CI 15.5-24.8),",
            "probability": 6.198586295726091e-09,
            "start_logit": 1.36203932762146,
            "end_logit": -1.5061430931091309
        },
        {
            "text": "for mood swings (OR 20.9, 95%CI 16.2-27.0), memory",
            "probability": 1.0396622947827223e-09,
            "start_logit": -3.2807364463806152,
            "end_logit": 1.3512073755264282
        },
        {
            "text": "mood swings (OR 20.9, 95%CI 16.2-27.0), memory",
            "probability": 4.0242213077798965e-10,
            "start_logit": -4.229886054992676,
            "end_logit": 1.3512073755264282
        },
        {
            "text": "16.2-27.0), memory",
            "probability": 3.3778348131570835e-10,
            "start_logit": -4.4881591796875,
            "end_logit": 1.4343839883804321
        }
    ],
    "56c04412ef6e39474100001b_001": [
        {
            "text": "multiple myeloma.",
            "probability": 0.972932859519667,
            "start_logit": 4.205234527587891,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 0.02112098783823136,
            "start_logit": 0.3751866817474365,
            "end_logit": 3.777590274810791
        },
        {
            "text": "multiple",
            "probability": 0.00478657432230425,
            "start_logit": 4.205234527587891,
            "end_logit": -1.536909818649292
        },
        {
            "text": "especially multiple myeloma.",
            "probability": 0.0005913174314789603,
            "start_logit": -3.2004828453063965,
            "end_logit": 3.777590274810791
        },
        {
            "text": ".",
            "probability": 0.00020962693230305835,
            "start_logit": -4.23750638961792,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38",
            "probability": 0.00011174453036359338,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple",
            "probability": 0.00010390971695425094,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.536909818649292
        },
        {
            "text": "myeloma.",
            "probability": 4.0446087798711286e-05,
            "start_logit": -5.882865905761719,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 3.39246517989228e-05,
            "start_logit": -6.058693885803223,
            "end_logit": 3.777590274810791
        },
        {
            "text": "malignancies, especially multiple myeloma.",
            "probability": 2.5206417336351562e-05,
            "start_logit": -6.355737209320068,
            "end_logit": 3.777590274810791
        },
        {
            "text": "of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.5082584101015358e-05,
            "start_logit": -6.869295120239258,
            "end_logit": 3.777590274810791
        },
        {
            "text": "targeting CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.3377072744620375e-05,
            "start_logit": -6.989293575286865,
            "end_logit": 3.777590274810791
        },
        {
            "text": "the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 9.68032525739701e-06,
            "start_logit": -7.312740325927734,
            "end_logit": 3.777590274810791
        },
        {
            "text": "especially multiple",
            "probability": 2.9091265714321166e-06,
            "start_logit": -3.2004828453063965,
            "end_logit": -1.536909818649292
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially",
            "probability": 1.28097920456648e-06,
            "start_logit": 0.3751866817474365,
            "end_logit": -5.932807445526123
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies,",
            "probability": 4.3850301603950546e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.004820823669434
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing",
            "probability": 1.7994102463769314e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.8955583572387695
        },
        {
            "text": "CD38-expressing malignancies, especially multiple",
            "probability": 1.6690038331525193e-07,
            "start_logit": -6.058693885803223,
            "end_logit": -1.536909818649292
        },
        {
            "text": "anti-cancer drug targeting CD38,",
            "probability": 1.4366494481776774e-07,
            "start_logit": -6.281300067901611,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38,",
            "probability": 1.434545153728352e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -8.122169494628906
        }
    ],
    "56c04412ef6e39474100001b_002": [
        {
            "text": "multiple myeloma.",
            "probability": 0.972932859519667,
            "start_logit": 4.205234527587891,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 0.02112098783823136,
            "start_logit": 0.3751866817474365,
            "end_logit": 3.777590274810791
        },
        {
            "text": "multiple",
            "probability": 0.00478657432230425,
            "start_logit": 4.205234527587891,
            "end_logit": -1.536909818649292
        },
        {
            "text": "especially multiple myeloma.",
            "probability": 0.0005913174314789603,
            "start_logit": -3.2004828453063965,
            "end_logit": 3.777590274810791
        },
        {
            "text": ".",
            "probability": 0.00020962693230305835,
            "start_logit": -4.23750638961792,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38",
            "probability": 0.00011174453036359338,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple",
            "probability": 0.00010390971695425094,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.536909818649292
        },
        {
            "text": "myeloma.",
            "probability": 4.0446087798711286e-05,
            "start_logit": -5.882865905761719,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 3.39246517989228e-05,
            "start_logit": -6.058693885803223,
            "end_logit": 3.777590274810791
        },
        {
            "text": "malignancies, especially multiple myeloma.",
            "probability": 2.5206417336351562e-05,
            "start_logit": -6.355737209320068,
            "end_logit": 3.777590274810791
        },
        {
            "text": "of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.5082584101015358e-05,
            "start_logit": -6.869295120239258,
            "end_logit": 3.777590274810791
        },
        {
            "text": "targeting CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.3377072744620375e-05,
            "start_logit": -6.989293575286865,
            "end_logit": 3.777590274810791
        },
        {
            "text": "the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 9.68032525739701e-06,
            "start_logit": -7.312740325927734,
            "end_logit": 3.777590274810791
        },
        {
            "text": "especially multiple",
            "probability": 2.9091265714321166e-06,
            "start_logit": -3.2004828453063965,
            "end_logit": -1.536909818649292
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially",
            "probability": 1.28097920456648e-06,
            "start_logit": 0.3751866817474365,
            "end_logit": -5.932807445526123
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies,",
            "probability": 4.3850301603950546e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.004820823669434
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing",
            "probability": 1.7994102463769314e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.8955583572387695
        },
        {
            "text": "CD38-expressing malignancies, especially multiple",
            "probability": 1.6690038331525193e-07,
            "start_logit": -6.058693885803223,
            "end_logit": -1.536909818649292
        },
        {
            "text": "anti-cancer drug targeting CD38,",
            "probability": 1.4366494481776774e-07,
            "start_logit": -6.281300067901611,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38,",
            "probability": 1.434545153728352e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -8.122169494628906
        }
    ],
    "56c04412ef6e39474100001b_003": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56c04412ef6e39474100001b_004": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56c04412ef6e39474100001b_005": [
        {
            "text": "multiple",
            "probability": 0.35932599363380013,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.30124611959165243,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "CD38",
            "probability": 0.2936716113504787,
            "start_logit": 0.5791692137718201,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "BACKGROUND: Daratumumab (DARA), a promising novel therapy for multiple",
            "probability": 0.02380352500528219,
            "start_logit": -2.1097617149353027,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma,",
            "probability": 0.005406201009781236,
            "start_logit": 0.6046346426010132,
            "end_logit": -5.4216413497924805
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma",
            "probability": 0.0025567338818954996,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.170457363128662
        },
        {
            "text": "CD38 on myeloma",
            "probability": 0.002492447570472944,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.170457363128662
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba",
            "probability": 0.001663285202637907,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.600393295288086
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma cells.",
            "probability": 0.0015386798249829299,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.678263187408447
        },
        {
            "text": "CD38 on myeloma cells.",
            "probability": 0.0014999913830184021,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.678263187408447
        },
        {
            "text": "recognizes CD38",
            "probability": 0.0012464217567206375,
            "start_logit": -4.883016109466553,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.0007867646019757443,
            "start_logit": -5.343119144439697,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "that recognizes CD38",
            "probability": 0.0007236739693020412,
            "start_logit": -5.4267072677612305,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes",
            "probability": 0.0006965692246410182,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.470776081085205
        },
        {
            "text": "(DARA), a promising novel therapy for multiple",
            "probability": 0.0006450401680934554,
            "start_logit": -5.718038082122803,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "CD",
            "probability": 0.0006221520319550962,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.558293342590332
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on",
            "probability": 0.0005750440760643755,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.662496566772461
        },
        {
            "text": "CD38 on",
            "probability": 0.0005605852139914236,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.662496566772461
        },
        {
            "text": "for multiple",
            "probability": 0.0005108674348443766,
            "start_logit": -5.951240539550781,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "for multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.00042829306840921335,
            "start_logit": -5.951240539550781,
            "end_logit": -1.4012603759765625
        }
    ],
    "56c04412ef6e39474100001b_006": [
        {
            "text": "multiple",
            "probability": 0.35932599363380013,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.30124611959165243,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "CD38",
            "probability": 0.2936716113504787,
            "start_logit": 0.5791692137718201,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "BACKGROUND: Daratumumab (DARA), a promising novel therapy for multiple",
            "probability": 0.02380352500528219,
            "start_logit": -2.1097617149353027,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma,",
            "probability": 0.005406201009781236,
            "start_logit": 0.6046346426010132,
            "end_logit": -5.4216413497924805
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma",
            "probability": 0.0025567338818954996,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.170457363128662
        },
        {
            "text": "CD38 on myeloma",
            "probability": 0.002492447570472944,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.170457363128662
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba",
            "probability": 0.001663285202637907,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.600393295288086
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma cells.",
            "probability": 0.0015386798249829299,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.678263187408447
        },
        {
            "text": "CD38 on myeloma cells.",
            "probability": 0.0014999913830184021,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.678263187408447
        },
        {
            "text": "recognizes CD38",
            "probability": 0.0012464217567206375,
            "start_logit": -4.883016109466553,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.0007867646019757443,
            "start_logit": -5.343119144439697,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "that recognizes CD38",
            "probability": 0.0007236739693020412,
            "start_logit": -5.4267072677612305,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes",
            "probability": 0.0006965692246410182,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.470776081085205
        },
        {
            "text": "(DARA), a promising novel therapy for multiple",
            "probability": 0.0006450401680934554,
            "start_logit": -5.718038082122803,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "CD",
            "probability": 0.0006221520319550962,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.558293342590332
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on",
            "probability": 0.0005750440760643755,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.662496566772461
        },
        {
            "text": "CD38 on",
            "probability": 0.0005605852139914236,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.662496566772461
        },
        {
            "text": "for multiple",
            "probability": 0.0005108674348443766,
            "start_logit": -5.951240539550781,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "for multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.00042829306840921335,
            "start_logit": -5.951240539550781,
            "end_logit": -1.4012603759765625
        }
    ],
    "56c04412ef6e39474100001b_007": [
        {
            "text": "CD38",
            "probability": 0.8128754885287773,
            "start_logit": 2.666411876678467,
            "end_logit": 0.18259602785110474
        },
        {
            "text": "multiple myeloma patients with daratumumab, a novel anti-CD38",
            "probability": 0.09005893801605612,
            "start_logit": 0.46629825234413147,
            "end_logit": 0.18259602785110474
        },
        {
            "text": "anti-CD38 MoAb, resulted in false-positive",
            "probability": 0.04949228298825999,
            "start_logit": 2.666411876678467,
            "end_logit": -2.6161651611328125
        },
        {
            "text": "multiple",
            "probability": 0.030246170776370228,
            "start_logit": 0.46629825234413147,
            "end_logit": -0.9084987044334412
        },
        {
            "text": "multiple myeloma",
            "probability": 0.008710057254528258,
            "start_logit": 0.46629825234413147,
            "end_logit": -2.1533899307250977
        },
        {
            "text": "multiple myeloma patients with daratumumab, a novel anti-CD38 MoAb, resulted in false-positive",
            "probability": 0.0054832782004288734,
            "start_logit": 0.46629825234413147,
            "end_logit": -2.6161651611328125
        },
        {
            "text": "CD",
            "probability": 0.0009517246004301569,
            "start_logit": 2.666411876678467,
            "end_logit": -6.5674614906311035
        },
        {
            "text": "myeloma patients with daratumumab, a novel anti-CD38",
            "probability": 0.0008750288188016406,
            "start_logit": -4.167664527893066,
            "end_logit": 0.18259602785110474
        },
        {
            "text": "anti-CD38",
            "probability": 0.0006065660732879079,
            "start_logit": -4.534107685089111,
            "end_logit": 0.18259602785110474
        },
        {
            "text": "38",
            "probability": 0.0001835267617445784,
            "start_logit": -5.729560852050781,
            "end_logit": 0.18259602785110474
        },
        {
            "text": "anti-CD38 MoAb, resulted in false-positive indirect",
            "probability": 0.00018296451540189014,
            "start_logit": 2.666411876678467,
            "end_logit": -8.216444969177246
        },
        {
            "text": "anti-CD38 MoAb,",
            "probability": 9.363388045312388e-05,
            "start_logit": 2.666411876678467,
            "end_logit": -8.886344909667969
        },
        {
            "text": "myeloma",
            "probability": 8.462848084846078e-05,
            "start_logit": -4.167664527893066,
            "end_logit": -2.1533899307250977
        },
        {
            "text": "myeloma patients with daratumumab, a novel anti-CD38 MoAb, resulted in false-positive",
            "probability": 5.3276515941445454e-05,
            "start_logit": -4.167664527893066,
            "end_logit": -2.6161651611328125
        },
        {
            "text": "oma",
            "probability": 3.0362891139900863e-05,
            "start_logit": -5.192714214324951,
            "end_logit": -2.1533899307250977
        },
        {
            "text": "multiple myeloma patients with daratumumab, a novel anti-CD38 MoAb, resulted in false-positive indirect",
            "probability": 2.027074279424927e-05,
            "start_logit": 0.46629825234413147,
            "end_logit": -8.216444969177246
        },
        {
            "text": "positive",
            "probability": 1.610554551743211e-05,
            "start_logit": -5.363996505737305,
            "end_logit": -2.6161651611328125
        },
        {
            "text": "eloma",
            "probability": 1.336000340874491e-05,
            "start_logit": -6.013669967651367,
            "end_logit": -2.1533899307250977
        },
        {
            "text": "multiple myeloma patients with daratumumab, a novel",
            "probability": 1.1961654902980385e-05,
            "start_logit": 0.46629825234413147,
            "end_logit": -8.743917465209961
        },
        {
            "text": "multiple myeloma patients with daratumumab, a novel anti-CD38 MoAb,",
            "probability": 1.0373750906418385e-05,
            "start_logit": 0.46629825234413147,
            "end_logit": -8.886344909667969
        }
    ],
    "56c04412ef6e39474100001b_008": [
        {
            "text": "CD38",
            "probability": 0.8128754885287773,
            "start_logit": 2.666411876678467,
            "end_logit": 0.18259602785110474
        },
        {
            "text": "multiple myeloma patients with daratumumab, a novel anti-CD38",
            "probability": 0.09005893801605612,
            "start_logit": 0.46629825234413147,
            "end_logit": 0.18259602785110474
        },
        {
            "text": "anti-CD38 MoAb, resulted in false-positive",
            "probability": 0.04949228298825999,
            "start_logit": 2.666411876678467,
            "end_logit": -2.6161651611328125
        },
        {
            "text": "multiple",
            "probability": 0.030246170776370228,
            "start_logit": 0.46629825234413147,
            "end_logit": -0.9084987044334412
        },
        {
            "text": "multiple myeloma",
            "probability": 0.008710057254528258,
            "start_logit": 0.46629825234413147,
            "end_logit": -2.1533899307250977
        },
        {
            "text": "multiple myeloma patients with daratumumab, a novel anti-CD38 MoAb, resulted in false-positive",
            "probability": 0.0054832782004288734,
            "start_logit": 0.46629825234413147,
            "end_logit": -2.6161651611328125
        },
        {
            "text": "CD",
            "probability": 0.0009517246004301569,
            "start_logit": 2.666411876678467,
            "end_logit": -6.5674614906311035
        },
        {
            "text": "myeloma patients with daratumumab, a novel anti-CD38",
            "probability": 0.0008750288188016406,
            "start_logit": -4.167664527893066,
            "end_logit": 0.18259602785110474
        },
        {
            "text": "anti-CD38",
            "probability": 0.0006065660732879079,
            "start_logit": -4.534107685089111,
            "end_logit": 0.18259602785110474
        },
        {
            "text": "38",
            "probability": 0.0001835267617445784,
            "start_logit": -5.729560852050781,
            "end_logit": 0.18259602785110474
        },
        {
            "text": "anti-CD38 MoAb, resulted in false-positive indirect",
            "probability": 0.00018296451540189014,
            "start_logit": 2.666411876678467,
            "end_logit": -8.216444969177246
        },
        {
            "text": "anti-CD38 MoAb,",
            "probability": 9.363388045312388e-05,
            "start_logit": 2.666411876678467,
            "end_logit": -8.886344909667969
        },
        {
            "text": "myeloma",
            "probability": 8.462848084846078e-05,
            "start_logit": -4.167664527893066,
            "end_logit": -2.1533899307250977
        },
        {
            "text": "myeloma patients with daratumumab, a novel anti-CD38 MoAb, resulted in false-positive",
            "probability": 5.3276515941445454e-05,
            "start_logit": -4.167664527893066,
            "end_logit": -2.6161651611328125
        },
        {
            "text": "oma",
            "probability": 3.0362891139900863e-05,
            "start_logit": -5.192714214324951,
            "end_logit": -2.1533899307250977
        },
        {
            "text": "multiple myeloma patients with daratumumab, a novel anti-CD38 MoAb, resulted in false-positive indirect",
            "probability": 2.027074279424927e-05,
            "start_logit": 0.46629825234413147,
            "end_logit": -8.216444969177246
        },
        {
            "text": "positive",
            "probability": 1.610554551743211e-05,
            "start_logit": -5.363996505737305,
            "end_logit": -2.6161651611328125
        },
        {
            "text": "eloma",
            "probability": 1.336000340874491e-05,
            "start_logit": -6.013669967651367,
            "end_logit": -2.1533899307250977
        },
        {
            "text": "multiple myeloma patients with daratumumab, a novel",
            "probability": 1.1961654902980385e-05,
            "start_logit": 0.46629825234413147,
            "end_logit": -8.743917465209961
        },
        {
            "text": "multiple myeloma patients with daratumumab, a novel anti-CD38 MoAb,",
            "probability": 1.0373750906418385e-05,
            "start_logit": 0.46629825234413147,
            "end_logit": -8.886344909667969
        }
    ],
    "56c04412ef6e39474100001b_009": [
        {
            "text": "multiple myeloma.",
            "probability": 0.972932859519667,
            "start_logit": 4.205234527587891,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 0.02112098783823136,
            "start_logit": 0.3751866817474365,
            "end_logit": 3.777590274810791
        },
        {
            "text": "multiple",
            "probability": 0.00478657432230425,
            "start_logit": 4.205234527587891,
            "end_logit": -1.536909818649292
        },
        {
            "text": "especially multiple myeloma.",
            "probability": 0.0005913174314789603,
            "start_logit": -3.2004828453063965,
            "end_logit": 3.777590274810791
        },
        {
            "text": ".",
            "probability": 0.00020962693230305835,
            "start_logit": -4.23750638961792,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38",
            "probability": 0.00011174453036359338,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple",
            "probability": 0.00010390971695425094,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.536909818649292
        },
        {
            "text": "myeloma.",
            "probability": 4.0446087798711286e-05,
            "start_logit": -5.882865905761719,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 3.39246517989228e-05,
            "start_logit": -6.058693885803223,
            "end_logit": 3.777590274810791
        },
        {
            "text": "malignancies, especially multiple myeloma.",
            "probability": 2.5206417336351562e-05,
            "start_logit": -6.355737209320068,
            "end_logit": 3.777590274810791
        },
        {
            "text": "of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.5082584101015358e-05,
            "start_logit": -6.869295120239258,
            "end_logit": 3.777590274810791
        },
        {
            "text": "targeting CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.3377072744620375e-05,
            "start_logit": -6.989293575286865,
            "end_logit": 3.777590274810791
        },
        {
            "text": "the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 9.68032525739701e-06,
            "start_logit": -7.312740325927734,
            "end_logit": 3.777590274810791
        },
        {
            "text": "especially multiple",
            "probability": 2.9091265714321166e-06,
            "start_logit": -3.2004828453063965,
            "end_logit": -1.536909818649292
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially",
            "probability": 1.28097920456648e-06,
            "start_logit": 0.3751866817474365,
            "end_logit": -5.932807445526123
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies,",
            "probability": 4.3850301603950546e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.004820823669434
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing",
            "probability": 1.7994102463769314e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.8955583572387695
        },
        {
            "text": "CD38-expressing malignancies, especially multiple",
            "probability": 1.6690038331525193e-07,
            "start_logit": -6.058693885803223,
            "end_logit": -1.536909818649292
        },
        {
            "text": "anti-cancer drug targeting CD38,",
            "probability": 1.4366494481776774e-07,
            "start_logit": -6.281300067901611,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38,",
            "probability": 1.434545153728352e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -8.122169494628906
        }
    ],
    "56c04412ef6e39474100001b_010": [
        {
            "text": "multiple myeloma.",
            "probability": 0.972932859519667,
            "start_logit": 4.205234527587891,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 0.02112098783823136,
            "start_logit": 0.3751866817474365,
            "end_logit": 3.777590274810791
        },
        {
            "text": "multiple",
            "probability": 0.00478657432230425,
            "start_logit": 4.205234527587891,
            "end_logit": -1.536909818649292
        },
        {
            "text": "especially multiple myeloma.",
            "probability": 0.0005913174314789603,
            "start_logit": -3.2004828453063965,
            "end_logit": 3.777590274810791
        },
        {
            "text": ".",
            "probability": 0.00020962693230305835,
            "start_logit": -4.23750638961792,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38",
            "probability": 0.00011174453036359338,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple",
            "probability": 0.00010390971695425094,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.536909818649292
        },
        {
            "text": "myeloma.",
            "probability": 4.0446087798711286e-05,
            "start_logit": -5.882865905761719,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 3.39246517989228e-05,
            "start_logit": -6.058693885803223,
            "end_logit": 3.777590274810791
        },
        {
            "text": "malignancies, especially multiple myeloma.",
            "probability": 2.5206417336351562e-05,
            "start_logit": -6.355737209320068,
            "end_logit": 3.777590274810791
        },
        {
            "text": "of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.5082584101015358e-05,
            "start_logit": -6.869295120239258,
            "end_logit": 3.777590274810791
        },
        {
            "text": "targeting CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.3377072744620375e-05,
            "start_logit": -6.989293575286865,
            "end_logit": 3.777590274810791
        },
        {
            "text": "the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 9.68032525739701e-06,
            "start_logit": -7.312740325927734,
            "end_logit": 3.777590274810791
        },
        {
            "text": "especially multiple",
            "probability": 2.9091265714321166e-06,
            "start_logit": -3.2004828453063965,
            "end_logit": -1.536909818649292
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially",
            "probability": 1.28097920456648e-06,
            "start_logit": 0.3751866817474365,
            "end_logit": -5.932807445526123
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies,",
            "probability": 4.3850301603950546e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.004820823669434
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing",
            "probability": 1.7994102463769314e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.8955583572387695
        },
        {
            "text": "CD38-expressing malignancies, especially multiple",
            "probability": 1.6690038331525193e-07,
            "start_logit": -6.058693885803223,
            "end_logit": -1.536909818649292
        },
        {
            "text": "anti-cancer drug targeting CD38,",
            "probability": 1.4366494481776774e-07,
            "start_logit": -6.281300067901611,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38,",
            "probability": 1.434545153728352e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -8.122169494628906
        }
    ],
    "56c04412ef6e39474100001b_011": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56c04412ef6e39474100001b_012": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56c04412ef6e39474100001b_013": [
        {
            "text": "CD38",
            "probability": 0.9781067372226243,
            "start_logit": 6.991227626800537,
            "end_logit": 3.135054111480713
        },
        {
            "text": "anti-CS-1 mAb, elotuzumab, and the anti-CD38",
            "probability": 0.015258476788929304,
            "start_logit": 2.8307440280914307,
            "end_logit": 3.135054111480713
        },
        {
            "text": "CD",
            "probability": 0.004465015472474998,
            "start_logit": 6.991227626800537,
            "end_logit": -2.2542920112609863
        },
        {
            "text": "anti-CS-1",
            "probability": 0.0016166475695532732,
            "start_logit": 2.8307440280914307,
            "end_logit": 0.8902735114097595
        },
        {
            "text": "anti-CD38",
            "probability": 0.00041757884607161033,
            "start_logit": -0.7676730751991272,
            "end_logit": 3.135054111480713
        },
        {
            "text": "anti-CD38 mAb,",
            "probability": 3.1736943233550614e-05,
            "start_logit": 6.991227626800537,
            "end_logit": -7.200838565826416
        },
        {
            "text": "anti-CD38 mAb, daratumumab,",
            "probability": 2.347838629274868e-05,
            "start_logit": 6.991227626800537,
            "end_logit": -7.50223970413208
        },
        {
            "text": "anti-CD38 mAb, daratumumab, which are currently being evaluated in Phase III",
            "probability": 2.2602534343632877e-05,
            "start_logit": 6.991227626800537,
            "end_logit": -7.540257930755615
        },
        {
            "text": "anti-CD38 mAb, daratumumab, which are currently being evaluated in Phase III clinical trials for MM.",
            "probability": 1.7155405430170045e-05,
            "start_logit": 6.991227626800537,
            "end_logit": -7.816006660461426
        },
        {
            "text": "38",
            "probability": 1.6726052053360776e-05,
            "start_logit": -3.9851789474487305,
            "end_logit": 3.135054111480713
        },
        {
            "text": "anti-CD38 mAb, daratumumab, which are currently being evaluated in Phase III clinical trials",
            "probability": 1.597104260368935e-05,
            "start_logit": 6.991227626800537,
            "end_logit": -7.887542724609375
        },
        {
            "text": "the anti-CD38",
            "probability": 2.831380357460385e-06,
            "start_logit": -5.761382102966309,
            "end_logit": 3.135054111480713
        },
        {
            "text": "the anti-CS-1 mAb, elotuzumab, and the anti-CD38",
            "probability": 1.1118069947542202e-06,
            "start_logit": -6.696159839630127,
            "end_logit": 3.135054111480713
        },
        {
            "text": "CS",
            "probability": 1.0185003588669443e-06,
            "start_logit": 2.8307440280914307,
            "end_logit": -6.4795050621032715
        },
        {
            "text": "1",
            "probability": 8.192694170419844e-07,
            "start_logit": -4.756708145141602,
            "end_logit": 0.8902735114097595
        },
        {
            "text": "elotuzumab, and the anti-CD38",
            "probability": 5.827316137848571e-07,
            "start_logit": -7.342175006866455,
            "end_logit": 3.135054111480713
        },
        {
            "text": "anti-CS-1 mAb, elotuzumab, and the anti-CD38 mAb,",
            "probability": 4.950966936959953e-07,
            "start_logit": 2.8307440280914307,
            "end_logit": -7.200838565826416
        },
        {
            "text": "anti-CS-1 mAb, elotuzumab, and the anti-CD38 mAb, daratumumab,",
            "probability": 3.662631067307357e-07,
            "start_logit": 2.8307440280914307,
            "end_logit": -7.50223970413208
        },
        {
            "text": "anti-CS-1 mAb,",
            "probability": 3.64489152128555e-07,
            "start_logit": 2.8307440280914307,
            "end_logit": -7.507094860076904
        },
        {
            "text": "anti-CS-1 mAb, elotuzumab,",
            "probability": 2.841986950944634e-07,
            "start_logit": 2.8307440280914307,
            "end_logit": -7.755918025970459
        }
    ],
    "56c04412ef6e39474100001b_014": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56c04412ef6e39474100001b_015": [
        {
            "text": "CD38",
            "probability": 0.9996208369204432,
            "start_logit": 7.384737491607666,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "CD",
            "probability": 0.00016434281733537862,
            "start_logit": 7.384737491607666,
            "end_logit": -2.8545165061950684
        },
        {
            "text": "anti-CD38",
            "probability": 0.00015070756421380622,
            "start_logit": -1.4150525331497192,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "38",
            "probability": 5.019414862276267e-05,
            "start_logit": -2.514495372772217,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma (MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 4.708033423118722e-06,
            "start_logit": -4.8811235427856445,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.6038989637661698e-06,
            "start_logit": -5.957956314086914,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "(MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.5991909037846911e-06,
            "start_logit": -5.960896015167236,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.4980038503217864e-06,
            "start_logit": -6.0262603759765625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 1.2624169155965069e-06,
            "start_logit": 7.384737491607666,
            "end_logit": -7.723443031311035
        },
        {
            "text": "remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 8.964263862696866e-07,
            "start_logit": -6.539732933044434,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.939986814360017e-07,
            "start_logit": -6.951272010803223,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 5.913720674116558e-07,
            "start_logit": -6.9557037353515625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "an anti-CD38",
            "probability": 5.834854688452387e-07,
            "start_logit": -6.96912956237793,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.81263334108885e-07,
            "start_logit": -6.972945213317871,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma",
            "probability": 1.8931340235937844e-10,
            "start_logit": -4.8811235427856445,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma therapy]. Multiple myeloma",
            "probability": 1.3408125902082662e-10,
            "start_logit": -5.226081371307373,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma",
            "probability": 4.743248031836347e-11,
            "start_logit": -5.226081371307373,
            "end_logit": -5.301855564117432
        },
        {
            "text": "[Daratumumab--breakthrough drug in multiple myeloma therapy]. Multiple myeloma",
            "probability": 3.434595265807506e-11,
            "start_logit": -6.588043212890625,
            "end_logit": -4.262716770172119
        },
        {
            "text": "Multiple",
            "probability": 3.062006762037403e-11,
            "start_logit": -4.8811235427856445,
            "end_logit": -6.084465026855469
        },
        {
            "text": "myeloma therapy]. Multiple myeloma",
            "probability": 2.3597378307973795e-11,
            "start_logit": -6.9633917808532715,
            "end_logit": -4.262716770172119
        }
    ],
    "56c04412ef6e39474100001b_016": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56c04412ef6e39474100001b_017": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56c04412ef6e39474100001b_018": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56c04412ef6e39474100001b_019": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56c04412ef6e39474100001b_020": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56c04412ef6e39474100001b_021": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56c04412ef6e39474100001b_022": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56c04412ef6e39474100001b_023": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56c04412ef6e39474100001b_024": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56c04412ef6e39474100001b_025": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56c04412ef6e39474100001b_026": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56c04412ef6e39474100001b_027": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56c04412ef6e39474100001b_028": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56c04412ef6e39474100001b_029": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56c04412ef6e39474100001b_030": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56c04412ef6e39474100001b_031": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56c04412ef6e39474100001b_032": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56c04412ef6e39474100001b_033": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56c04412ef6e39474100001b_034": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56c04412ef6e39474100001b_035": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56c04412ef6e39474100001b_036": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56c04412ef6e39474100001b_037": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56c04412ef6e39474100001b_038": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56c04412ef6e39474100001b_039": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56c04412ef6e39474100001b_040": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56c04412ef6e39474100001b_041": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56c04412ef6e39474100001b_042": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56c04412ef6e39474100001b_043": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56c04412ef6e39474100001b_044": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56c04412ef6e39474100001b_045": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56c04412ef6e39474100001b_046": [
        {
            "text": "CD38",
            "probability": 0.9996208369204432,
            "start_logit": 7.384737491607666,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "CD",
            "probability": 0.00016434281733537862,
            "start_logit": 7.384737491607666,
            "end_logit": -2.8545165061950684
        },
        {
            "text": "anti-CD38",
            "probability": 0.00015070756421380622,
            "start_logit": -1.4150525331497192,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "38",
            "probability": 5.019414862276267e-05,
            "start_logit": -2.514495372772217,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma (MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 4.708033423118722e-06,
            "start_logit": -4.8811235427856445,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.6038989637661698e-06,
            "start_logit": -5.957956314086914,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "(MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.5991909037846911e-06,
            "start_logit": -5.960896015167236,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.4980038503217864e-06,
            "start_logit": -6.0262603759765625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 1.2624169155965069e-06,
            "start_logit": 7.384737491607666,
            "end_logit": -7.723443031311035
        },
        {
            "text": "remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 8.964263862696866e-07,
            "start_logit": -6.539732933044434,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.939986814360017e-07,
            "start_logit": -6.951272010803223,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 5.913720674116558e-07,
            "start_logit": -6.9557037353515625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "an anti-CD38",
            "probability": 5.834854688452387e-07,
            "start_logit": -6.96912956237793,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.81263334108885e-07,
            "start_logit": -6.972945213317871,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma",
            "probability": 1.8931340235937844e-10,
            "start_logit": -4.8811235427856445,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma therapy]. Multiple myeloma",
            "probability": 1.3408125902082662e-10,
            "start_logit": -5.226081371307373,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma",
            "probability": 4.743248031836347e-11,
            "start_logit": -5.226081371307373,
            "end_logit": -5.301855564117432
        },
        {
            "text": "[Daratumumab--breakthrough drug in multiple myeloma therapy]. Multiple myeloma",
            "probability": 3.434595265807506e-11,
            "start_logit": -6.588043212890625,
            "end_logit": -4.262716770172119
        },
        {
            "text": "Multiple",
            "probability": 3.062006762037403e-11,
            "start_logit": -4.8811235427856445,
            "end_logit": -6.084465026855469
        },
        {
            "text": "myeloma therapy]. Multiple myeloma",
            "probability": 2.3597378307973795e-11,
            "start_logit": -6.9633917808532715,
            "end_logit": -4.262716770172119
        }
    ],
    "56c04412ef6e39474100001b_047": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56c04412ef6e39474100001b_048": [
        {
            "text": "CD38",
            "probability": 0.9996208369204432,
            "start_logit": 7.384737491607666,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "CD",
            "probability": 0.00016434281733537862,
            "start_logit": 7.384737491607666,
            "end_logit": -2.8545165061950684
        },
        {
            "text": "anti-CD38",
            "probability": 0.00015070756421380622,
            "start_logit": -1.4150525331497192,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "38",
            "probability": 5.019414862276267e-05,
            "start_logit": -2.514495372772217,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma (MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 4.708033423118722e-06,
            "start_logit": -4.8811235427856445,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.6038989637661698e-06,
            "start_logit": -5.957956314086914,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "(MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.5991909037846911e-06,
            "start_logit": -5.960896015167236,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.4980038503217864e-06,
            "start_logit": -6.0262603759765625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 1.2624169155965069e-06,
            "start_logit": 7.384737491607666,
            "end_logit": -7.723443031311035
        },
        {
            "text": "remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 8.964263862696866e-07,
            "start_logit": -6.539732933044434,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.939986814360017e-07,
            "start_logit": -6.951272010803223,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 5.913720674116558e-07,
            "start_logit": -6.9557037353515625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "an anti-CD38",
            "probability": 5.834854688452387e-07,
            "start_logit": -6.96912956237793,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.81263334108885e-07,
            "start_logit": -6.972945213317871,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma",
            "probability": 1.8931340235937844e-10,
            "start_logit": -4.8811235427856445,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma therapy]. Multiple myeloma",
            "probability": 1.3408125902082662e-10,
            "start_logit": -5.226081371307373,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma",
            "probability": 4.743248031836347e-11,
            "start_logit": -5.226081371307373,
            "end_logit": -5.301855564117432
        },
        {
            "text": "[Daratumumab--breakthrough drug in multiple myeloma therapy]. Multiple myeloma",
            "probability": 3.434595265807506e-11,
            "start_logit": -6.588043212890625,
            "end_logit": -4.262716770172119
        },
        {
            "text": "Multiple",
            "probability": 3.062006762037403e-11,
            "start_logit": -4.8811235427856445,
            "end_logit": -6.084465026855469
        },
        {
            "text": "myeloma therapy]. Multiple myeloma",
            "probability": 2.3597378307973795e-11,
            "start_logit": -6.9633917808532715,
            "end_logit": -4.262716770172119
        }
    ],
    "56c04412ef6e39474100001b_049": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56c04412ef6e39474100001b_050": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56c04412ef6e39474100001b_051": [
        {
            "text": "CD38",
            "probability": 0.9940513893779875,
            "start_logit": 2.128936529159546,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "human CD38",
            "probability": 0.0035574614519633353,
            "start_logit": -3.330183744430542,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 0.0007522945345324465,
            "start_logit": 2.128936529159546,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "38",
            "probability": 0.00033482357021691485,
            "start_logit": -5.867003917694092,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple",
            "probability": 0.0001929350103905734,
            "start_logit": 2.128936529159546,
            "end_logit": -7.447241306304932
        },
        {
            "text": "CD",
            "probability": 0.00019158799942697047,
            "start_logit": 2.128936529159546,
            "end_logit": -7.45424747467041
        },
        {
            "text": "the human CD38",
            "probability": 0.00018052642620359813,
            "start_logit": -6.3111090660095215,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+",
            "probability": 0.00016927434236433154,
            "start_logit": 2.128936529159546,
            "end_logit": -7.578073978424072
        },
        {
            "text": "enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00015160225669632173,
            "start_logit": -6.4857258796691895,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody daratumumab.",
            "probability": 0.00014401814942305614,
            "start_logit": 1.5851339101791382,
            "end_logit": -7.195852756500244
        },
        {
            "text": "elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.0001252607076437193,
            "start_logit": -6.676589012145996,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00011044724276670223,
            "start_logit": -6.802448272705078,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.172053403685847e-05,
            "start_logit": -3.8886492252349854,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 1.3274022617573006e-06,
            "start_logit": -4.210967540740967,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "multiple",
            "probability": 1.2461911231588266e-06,
            "start_logit": -3.8886492252349854,
            "end_logit": -6.471917152404785
        },
        {
            "text": "myeloma.",
            "probability": 1.103881478302232e-06,
            "start_logit": -7.246780872344971,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody daratumumab.",
            "probability": 1.0561409742157727e-06,
            "start_logit": -3.330183744430542,
            "end_logit": -7.195852756500244
        },
        {
            "text": ".",
            "probability": 8.498050076495867e-07,
            "start_logit": -7.50836181640625,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "of multiple myeloma.",
            "probability": 6.889893064566347e-07,
            "start_logit": -7.718142986297607,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "CD38+ multiple myeloma",
            "probability": 3.859861961953524e-07,
            "start_logit": -5.446145057678223,
            "end_logit": -6.0864667892456055
        }
    ],
    "56c04412ef6e39474100001b_052": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56c04412ef6e39474100001b_053": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56c04412ef6e39474100001b_054": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56c04412ef6e39474100001b_055": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56c04412ef6e39474100001b_056": [
        {
            "text": "CD38",
            "probability": 0.9940513893779875,
            "start_logit": 2.128936529159546,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "human CD38",
            "probability": 0.0035574614519633353,
            "start_logit": -3.330183744430542,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 0.0007522945345324465,
            "start_logit": 2.128936529159546,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "38",
            "probability": 0.00033482357021691485,
            "start_logit": -5.867003917694092,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple",
            "probability": 0.0001929350103905734,
            "start_logit": 2.128936529159546,
            "end_logit": -7.447241306304932
        },
        {
            "text": "CD",
            "probability": 0.00019158799942697047,
            "start_logit": 2.128936529159546,
            "end_logit": -7.45424747467041
        },
        {
            "text": "the human CD38",
            "probability": 0.00018052642620359813,
            "start_logit": -6.3111090660095215,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+",
            "probability": 0.00016927434236433154,
            "start_logit": 2.128936529159546,
            "end_logit": -7.578073978424072
        },
        {
            "text": "enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00015160225669632173,
            "start_logit": -6.4857258796691895,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody daratumumab.",
            "probability": 0.00014401814942305614,
            "start_logit": 1.5851339101791382,
            "end_logit": -7.195852756500244
        },
        {
            "text": "elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.0001252607076437193,
            "start_logit": -6.676589012145996,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00011044724276670223,
            "start_logit": -6.802448272705078,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.172053403685847e-05,
            "start_logit": -3.8886492252349854,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 1.3274022617573006e-06,
            "start_logit": -4.210967540740967,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "multiple",
            "probability": 1.2461911231588266e-06,
            "start_logit": -3.8886492252349854,
            "end_logit": -6.471917152404785
        },
        {
            "text": "myeloma.",
            "probability": 1.103881478302232e-06,
            "start_logit": -7.246780872344971,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody daratumumab.",
            "probability": 1.0561409742157727e-06,
            "start_logit": -3.330183744430542,
            "end_logit": -7.195852756500244
        },
        {
            "text": ".",
            "probability": 8.498050076495867e-07,
            "start_logit": -7.50836181640625,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "of multiple myeloma.",
            "probability": 6.889893064566347e-07,
            "start_logit": -7.718142986297607,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "CD38+ multiple myeloma",
            "probability": 3.859861961953524e-07,
            "start_logit": -5.446145057678223,
            "end_logit": -6.0864667892456055
        }
    ],
    "56c04412ef6e39474100001b_057": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56c04412ef6e39474100001b_058": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56c04412ef6e39474100001b_059": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56c04412ef6e39474100001b_060": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56c04412ef6e39474100001b_061": [
        {
            "text": "CD38",
            "probability": 0.9940513893779875,
            "start_logit": 2.128936529159546,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "human CD38",
            "probability": 0.0035574614519633353,
            "start_logit": -3.330183744430542,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 0.0007522945345324465,
            "start_logit": 2.128936529159546,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "38",
            "probability": 0.00033482357021691485,
            "start_logit": -5.867003917694092,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple",
            "probability": 0.0001929350103905734,
            "start_logit": 2.128936529159546,
            "end_logit": -7.447241306304932
        },
        {
            "text": "CD",
            "probability": 0.00019158799942697047,
            "start_logit": 2.128936529159546,
            "end_logit": -7.45424747467041
        },
        {
            "text": "the human CD38",
            "probability": 0.00018052642620359813,
            "start_logit": -6.3111090660095215,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+",
            "probability": 0.00016927434236433154,
            "start_logit": 2.128936529159546,
            "end_logit": -7.578073978424072
        },
        {
            "text": "enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00015160225669632173,
            "start_logit": -6.4857258796691895,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody daratumumab.",
            "probability": 0.00014401814942305614,
            "start_logit": 1.5851339101791382,
            "end_logit": -7.195852756500244
        },
        {
            "text": "elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.0001252607076437193,
            "start_logit": -6.676589012145996,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00011044724276670223,
            "start_logit": -6.802448272705078,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.172053403685847e-05,
            "start_logit": -3.8886492252349854,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 1.3274022617573006e-06,
            "start_logit": -4.210967540740967,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "multiple",
            "probability": 1.2461911231588266e-06,
            "start_logit": -3.8886492252349854,
            "end_logit": -6.471917152404785
        },
        {
            "text": "myeloma.",
            "probability": 1.103881478302232e-06,
            "start_logit": -7.246780872344971,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody daratumumab.",
            "probability": 1.0561409742157727e-06,
            "start_logit": -3.330183744430542,
            "end_logit": -7.195852756500244
        },
        {
            "text": ".",
            "probability": 8.498050076495867e-07,
            "start_logit": -7.50836181640625,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "of multiple myeloma.",
            "probability": 6.889893064566347e-07,
            "start_logit": -7.718142986297607,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "CD38+ multiple myeloma",
            "probability": 3.859861961953524e-07,
            "start_logit": -5.446145057678223,
            "end_logit": -6.0864667892456055
        }
    ],
    "56c04412ef6e39474100001b_062": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56c04412ef6e39474100001b_063": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56c04412ef6e39474100001b_064": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56c04412ef6e39474100001b_065": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56c04412ef6e39474100001b_066": [
        {
            "text": "CD38",
            "probability": 0.9940513893779875,
            "start_logit": 2.128936529159546,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "human CD38",
            "probability": 0.0035574614519633353,
            "start_logit": -3.330183744430542,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 0.0007522945345324465,
            "start_logit": 2.128936529159546,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "38",
            "probability": 0.00033482357021691485,
            "start_logit": -5.867003917694092,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple",
            "probability": 0.0001929350103905734,
            "start_logit": 2.128936529159546,
            "end_logit": -7.447241306304932
        },
        {
            "text": "CD",
            "probability": 0.00019158799942697047,
            "start_logit": 2.128936529159546,
            "end_logit": -7.45424747467041
        },
        {
            "text": "the human CD38",
            "probability": 0.00018052642620359813,
            "start_logit": -6.3111090660095215,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+",
            "probability": 0.00016927434236433154,
            "start_logit": 2.128936529159546,
            "end_logit": -7.578073978424072
        },
        {
            "text": "enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00015160225669632173,
            "start_logit": -6.4857258796691895,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody daratumumab.",
            "probability": 0.00014401814942305614,
            "start_logit": 1.5851339101791382,
            "end_logit": -7.195852756500244
        },
        {
            "text": "elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.0001252607076437193,
            "start_logit": -6.676589012145996,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00011044724276670223,
            "start_logit": -6.802448272705078,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.172053403685847e-05,
            "start_logit": -3.8886492252349854,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 1.3274022617573006e-06,
            "start_logit": -4.210967540740967,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "multiple",
            "probability": 1.2461911231588266e-06,
            "start_logit": -3.8886492252349854,
            "end_logit": -6.471917152404785
        },
        {
            "text": "myeloma.",
            "probability": 1.103881478302232e-06,
            "start_logit": -7.246780872344971,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody daratumumab.",
            "probability": 1.0561409742157727e-06,
            "start_logit": -3.330183744430542,
            "end_logit": -7.195852756500244
        },
        {
            "text": ".",
            "probability": 8.498050076495867e-07,
            "start_logit": -7.50836181640625,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "of multiple myeloma.",
            "probability": 6.889893064566347e-07,
            "start_logit": -7.718142986297607,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "CD38+ multiple myeloma",
            "probability": 3.859861961953524e-07,
            "start_logit": -5.446145057678223,
            "end_logit": -6.0864667892456055
        }
    ],
    "56c04412ef6e39474100001b_067": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56c04412ef6e39474100001b_068": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56c04412ef6e39474100001b_069": [
        {
            "text": "CD38",
            "probability": 0.9940513893779875,
            "start_logit": 2.128936529159546,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "human CD38",
            "probability": 0.0035574614519633353,
            "start_logit": -3.330183744430542,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 0.0007522945345324465,
            "start_logit": 2.128936529159546,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "38",
            "probability": 0.00033482357021691485,
            "start_logit": -5.867003917694092,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple",
            "probability": 0.0001929350103905734,
            "start_logit": 2.128936529159546,
            "end_logit": -7.447241306304932
        },
        {
            "text": "CD",
            "probability": 0.00019158799942697047,
            "start_logit": 2.128936529159546,
            "end_logit": -7.45424747467041
        },
        {
            "text": "the human CD38",
            "probability": 0.00018052642620359813,
            "start_logit": -6.3111090660095215,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+",
            "probability": 0.00016927434236433154,
            "start_logit": 2.128936529159546,
            "end_logit": -7.578073978424072
        },
        {
            "text": "enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00015160225669632173,
            "start_logit": -6.4857258796691895,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody daratumumab.",
            "probability": 0.00014401814942305614,
            "start_logit": 1.5851339101791382,
            "end_logit": -7.195852756500244
        },
        {
            "text": "elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.0001252607076437193,
            "start_logit": -6.676589012145996,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00011044724276670223,
            "start_logit": -6.802448272705078,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.172053403685847e-05,
            "start_logit": -3.8886492252349854,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 1.3274022617573006e-06,
            "start_logit": -4.210967540740967,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "multiple",
            "probability": 1.2461911231588266e-06,
            "start_logit": -3.8886492252349854,
            "end_logit": -6.471917152404785
        },
        {
            "text": "myeloma.",
            "probability": 1.103881478302232e-06,
            "start_logit": -7.246780872344971,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody daratumumab.",
            "probability": 1.0561409742157727e-06,
            "start_logit": -3.330183744430542,
            "end_logit": -7.195852756500244
        },
        {
            "text": ".",
            "probability": 8.498050076495867e-07,
            "start_logit": -7.50836181640625,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "of multiple myeloma.",
            "probability": 6.889893064566347e-07,
            "start_logit": -7.718142986297607,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "CD38+ multiple myeloma",
            "probability": 3.859861961953524e-07,
            "start_logit": -5.446145057678223,
            "end_logit": -6.0864667892456055
        }
    ],
    "56c04412ef6e39474100001b_070": [
        {
            "text": "CD38",
            "probability": 0.9940513893779875,
            "start_logit": 2.128936529159546,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "human CD38",
            "probability": 0.0035574614519633353,
            "start_logit": -3.330183744430542,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 0.0007522945345324465,
            "start_logit": 2.128936529159546,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "38",
            "probability": 0.00033482357021691485,
            "start_logit": -5.867003917694092,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple",
            "probability": 0.0001929350103905734,
            "start_logit": 2.128936529159546,
            "end_logit": -7.447241306304932
        },
        {
            "text": "CD",
            "probability": 0.00019158799942697047,
            "start_logit": 2.128936529159546,
            "end_logit": -7.45424747467041
        },
        {
            "text": "the human CD38",
            "probability": 0.00018052642620359813,
            "start_logit": -6.3111090660095215,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+",
            "probability": 0.00016927434236433154,
            "start_logit": 2.128936529159546,
            "end_logit": -7.578073978424072
        },
        {
            "text": "enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00015160225669632173,
            "start_logit": -6.4857258796691895,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody daratumumab.",
            "probability": 0.00014401814942305614,
            "start_logit": 1.5851339101791382,
            "end_logit": -7.195852756500244
        },
        {
            "text": "elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.0001252607076437193,
            "start_logit": -6.676589012145996,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00011044724276670223,
            "start_logit": -6.802448272705078,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.172053403685847e-05,
            "start_logit": -3.8886492252349854,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 1.3274022617573006e-06,
            "start_logit": -4.210967540740967,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "multiple",
            "probability": 1.2461911231588266e-06,
            "start_logit": -3.8886492252349854,
            "end_logit": -6.471917152404785
        },
        {
            "text": "myeloma.",
            "probability": 1.103881478302232e-06,
            "start_logit": -7.246780872344971,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody daratumumab.",
            "probability": 1.0561409742157727e-06,
            "start_logit": -3.330183744430542,
            "end_logit": -7.195852756500244
        },
        {
            "text": ".",
            "probability": 8.498050076495867e-07,
            "start_logit": -7.50836181640625,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "of multiple myeloma.",
            "probability": 6.889893064566347e-07,
            "start_logit": -7.718142986297607,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "CD38+ multiple myeloma",
            "probability": 3.859861961953524e-07,
            "start_logit": -5.446145057678223,
            "end_logit": -6.0864667892456055
        }
    ],
    "56c04412ef6e39474100001b_071": [
        {
            "text": "CD38",
            "probability": 0.9940513893779875,
            "start_logit": 2.128936529159546,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "human CD38",
            "probability": 0.0035574614519633353,
            "start_logit": -3.330183744430542,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 0.0007522945345324465,
            "start_logit": 2.128936529159546,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "38",
            "probability": 0.00033482357021691485,
            "start_logit": -5.867003917694092,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple",
            "probability": 0.0001929350103905734,
            "start_logit": 2.128936529159546,
            "end_logit": -7.447241306304932
        },
        {
            "text": "CD",
            "probability": 0.00019158799942697047,
            "start_logit": 2.128936529159546,
            "end_logit": -7.45424747467041
        },
        {
            "text": "the human CD38",
            "probability": 0.00018052642620359813,
            "start_logit": -6.3111090660095215,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+",
            "probability": 0.00016927434236433154,
            "start_logit": 2.128936529159546,
            "end_logit": -7.578073978424072
        },
        {
            "text": "enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00015160225669632173,
            "start_logit": -6.4857258796691895,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody daratumumab.",
            "probability": 0.00014401814942305614,
            "start_logit": 1.5851339101791382,
            "end_logit": -7.195852756500244
        },
        {
            "text": "elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.0001252607076437193,
            "start_logit": -6.676589012145996,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00011044724276670223,
            "start_logit": -6.802448272705078,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.172053403685847e-05,
            "start_logit": -3.8886492252349854,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 1.3274022617573006e-06,
            "start_logit": -4.210967540740967,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "multiple",
            "probability": 1.2461911231588266e-06,
            "start_logit": -3.8886492252349854,
            "end_logit": -6.471917152404785
        },
        {
            "text": "myeloma.",
            "probability": 1.103881478302232e-06,
            "start_logit": -7.246780872344971,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody daratumumab.",
            "probability": 1.0561409742157727e-06,
            "start_logit": -3.330183744430542,
            "end_logit": -7.195852756500244
        },
        {
            "text": ".",
            "probability": 8.498050076495867e-07,
            "start_logit": -7.50836181640625,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "of multiple myeloma.",
            "probability": 6.889893064566347e-07,
            "start_logit": -7.718142986297607,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "CD38+ multiple myeloma",
            "probability": 3.859861961953524e-07,
            "start_logit": -5.446145057678223,
            "end_logit": -6.0864667892456055
        }
    ],
    "56c04412ef6e39474100001b_072": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56c04412ef6e39474100001b_073": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56c04412ef6e39474100001b_074": [
        {
            "text": "CD38",
            "probability": 0.9940513893779875,
            "start_logit": 2.128936529159546,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "human CD38",
            "probability": 0.0035574614519633353,
            "start_logit": -3.330183744430542,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 0.0007522945345324465,
            "start_logit": 2.128936529159546,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "38",
            "probability": 0.00033482357021691485,
            "start_logit": -5.867003917694092,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple",
            "probability": 0.0001929350103905734,
            "start_logit": 2.128936529159546,
            "end_logit": -7.447241306304932
        },
        {
            "text": "CD",
            "probability": 0.00019158799942697047,
            "start_logit": 2.128936529159546,
            "end_logit": -7.45424747467041
        },
        {
            "text": "the human CD38",
            "probability": 0.00018052642620359813,
            "start_logit": -6.3111090660095215,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+",
            "probability": 0.00016927434236433154,
            "start_logit": 2.128936529159546,
            "end_logit": -7.578073978424072
        },
        {
            "text": "enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00015160225669632173,
            "start_logit": -6.4857258796691895,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody daratumumab.",
            "probability": 0.00014401814942305614,
            "start_logit": 1.5851339101791382,
            "end_logit": -7.195852756500244
        },
        {
            "text": "elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.0001252607076437193,
            "start_logit": -6.676589012145996,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00011044724276670223,
            "start_logit": -6.802448272705078,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.172053403685847e-05,
            "start_logit": -3.8886492252349854,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 1.3274022617573006e-06,
            "start_logit": -4.210967540740967,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "multiple",
            "probability": 1.2461911231588266e-06,
            "start_logit": -3.8886492252349854,
            "end_logit": -6.471917152404785
        },
        {
            "text": "myeloma.",
            "probability": 1.103881478302232e-06,
            "start_logit": -7.246780872344971,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody daratumumab.",
            "probability": 1.0561409742157727e-06,
            "start_logit": -3.330183744430542,
            "end_logit": -7.195852756500244
        },
        {
            "text": ".",
            "probability": 8.498050076495867e-07,
            "start_logit": -7.50836181640625,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "of multiple myeloma.",
            "probability": 6.889893064566347e-07,
            "start_logit": -7.718142986297607,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "CD38+ multiple myeloma",
            "probability": 3.859861961953524e-07,
            "start_logit": -5.446145057678223,
            "end_logit": -6.0864667892456055
        }
    ],
    "56c04412ef6e39474100001b_075": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56c04412ef6e39474100001b_076": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56c04412ef6e39474100001b_077": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56c04412ef6e39474100001b_078": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56c04412ef6e39474100001b_079": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56c04412ef6e39474100001b_080": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56c04412ef6e39474100001b_081": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56c04412ef6e39474100001b_082": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56c04412ef6e39474100001b_083": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56c04412ef6e39474100001b_084": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56c04412ef6e39474100001b_085": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56c04412ef6e39474100001b_086": [
        {
            "text": "CD38",
            "probability": 0.9996208369204432,
            "start_logit": 7.384737491607666,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "CD",
            "probability": 0.00016434281733537862,
            "start_logit": 7.384737491607666,
            "end_logit": -2.8545165061950684
        },
        {
            "text": "anti-CD38",
            "probability": 0.00015070756421380622,
            "start_logit": -1.4150525331497192,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "38",
            "probability": 5.019414862276267e-05,
            "start_logit": -2.514495372772217,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma (MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 4.708033423118722e-06,
            "start_logit": -4.8811235427856445,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.6038989637661698e-06,
            "start_logit": -5.957956314086914,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "(MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.5991909037846911e-06,
            "start_logit": -5.960896015167236,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.4980038503217864e-06,
            "start_logit": -6.0262603759765625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 1.2624169155965069e-06,
            "start_logit": 7.384737491607666,
            "end_logit": -7.723443031311035
        },
        {
            "text": "remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 8.964263862696866e-07,
            "start_logit": -6.539732933044434,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.939986814360017e-07,
            "start_logit": -6.951272010803223,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 5.913720674116558e-07,
            "start_logit": -6.9557037353515625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "an anti-CD38",
            "probability": 5.834854688452387e-07,
            "start_logit": -6.96912956237793,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.81263334108885e-07,
            "start_logit": -6.972945213317871,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma",
            "probability": 1.8931340235937844e-10,
            "start_logit": -4.8811235427856445,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma therapy]. Multiple myeloma",
            "probability": 1.3408125902082662e-10,
            "start_logit": -5.226081371307373,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma",
            "probability": 4.743248031836347e-11,
            "start_logit": -5.226081371307373,
            "end_logit": -5.301855564117432
        },
        {
            "text": "[Daratumumab--breakthrough drug in multiple myeloma therapy]. Multiple myeloma",
            "probability": 3.434595265807506e-11,
            "start_logit": -6.588043212890625,
            "end_logit": -4.262716770172119
        },
        {
            "text": "Multiple",
            "probability": 3.062006762037403e-11,
            "start_logit": -4.8811235427856445,
            "end_logit": -6.084465026855469
        },
        {
            "text": "myeloma therapy]. Multiple myeloma",
            "probability": 2.3597378307973795e-11,
            "start_logit": -6.9633917808532715,
            "end_logit": -4.262716770172119
        }
    ],
    "56c04412ef6e39474100001b_087": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56c04412ef6e39474100001b_088": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56c04412ef6e39474100001b_089": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56c04412ef6e39474100001b_090": [
        {
            "text": "CD38",
            "probability": 0.9996208369204432,
            "start_logit": 7.384737491607666,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "CD",
            "probability": 0.00016434281733537862,
            "start_logit": 7.384737491607666,
            "end_logit": -2.8545165061950684
        },
        {
            "text": "anti-CD38",
            "probability": 0.00015070756421380622,
            "start_logit": -1.4150525331497192,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "38",
            "probability": 5.019414862276267e-05,
            "start_logit": -2.514495372772217,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma (MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 4.708033423118722e-06,
            "start_logit": -4.8811235427856445,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.6038989637661698e-06,
            "start_logit": -5.957956314086914,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "(MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.5991909037846911e-06,
            "start_logit": -5.960896015167236,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.4980038503217864e-06,
            "start_logit": -6.0262603759765625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 1.2624169155965069e-06,
            "start_logit": 7.384737491607666,
            "end_logit": -7.723443031311035
        },
        {
            "text": "remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 8.964263862696866e-07,
            "start_logit": -6.539732933044434,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.939986814360017e-07,
            "start_logit": -6.951272010803223,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 5.913720674116558e-07,
            "start_logit": -6.9557037353515625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "an anti-CD38",
            "probability": 5.834854688452387e-07,
            "start_logit": -6.96912956237793,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.81263334108885e-07,
            "start_logit": -6.972945213317871,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma",
            "probability": 1.8931340235937844e-10,
            "start_logit": -4.8811235427856445,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma therapy]. Multiple myeloma",
            "probability": 1.3408125902082662e-10,
            "start_logit": -5.226081371307373,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma",
            "probability": 4.743248031836347e-11,
            "start_logit": -5.226081371307373,
            "end_logit": -5.301855564117432
        },
        {
            "text": "[Daratumumab--breakthrough drug in multiple myeloma therapy]. Multiple myeloma",
            "probability": 3.434595265807506e-11,
            "start_logit": -6.588043212890625,
            "end_logit": -4.262716770172119
        },
        {
            "text": "Multiple",
            "probability": 3.062006762037403e-11,
            "start_logit": -4.8811235427856445,
            "end_logit": -6.084465026855469
        },
        {
            "text": "myeloma therapy]. Multiple myeloma",
            "probability": 2.3597378307973795e-11,
            "start_logit": -6.9633917808532715,
            "end_logit": -4.262716770172119
        }
    ],
    "56c04412ef6e39474100001b_091": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56c04412ef6e39474100001b_092": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56c04412ef6e39474100001b_093": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56c04412ef6e39474100001b_094": [
        {
            "text": "CD38",
            "probability": 0.9996208369204432,
            "start_logit": 7.384737491607666,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "CD",
            "probability": 0.00016434281733537862,
            "start_logit": 7.384737491607666,
            "end_logit": -2.8545165061950684
        },
        {
            "text": "anti-CD38",
            "probability": 0.00015070756421380622,
            "start_logit": -1.4150525331497192,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "38",
            "probability": 5.019414862276267e-05,
            "start_logit": -2.514495372772217,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma (MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 4.708033423118722e-06,
            "start_logit": -4.8811235427856445,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.6038989637661698e-06,
            "start_logit": -5.957956314086914,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "(MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.5991909037846911e-06,
            "start_logit": -5.960896015167236,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.4980038503217864e-06,
            "start_logit": -6.0262603759765625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 1.2624169155965069e-06,
            "start_logit": 7.384737491607666,
            "end_logit": -7.723443031311035
        },
        {
            "text": "remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 8.964263862696866e-07,
            "start_logit": -6.539732933044434,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.939986814360017e-07,
            "start_logit": -6.951272010803223,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 5.913720674116558e-07,
            "start_logit": -6.9557037353515625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "an anti-CD38",
            "probability": 5.834854688452387e-07,
            "start_logit": -6.96912956237793,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.81263334108885e-07,
            "start_logit": -6.972945213317871,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma",
            "probability": 1.8931340235937844e-10,
            "start_logit": -4.8811235427856445,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma therapy]. Multiple myeloma",
            "probability": 1.3408125902082662e-10,
            "start_logit": -5.226081371307373,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma",
            "probability": 4.743248031836347e-11,
            "start_logit": -5.226081371307373,
            "end_logit": -5.301855564117432
        },
        {
            "text": "[Daratumumab--breakthrough drug in multiple myeloma therapy]. Multiple myeloma",
            "probability": 3.434595265807506e-11,
            "start_logit": -6.588043212890625,
            "end_logit": -4.262716770172119
        },
        {
            "text": "Multiple",
            "probability": 3.062006762037403e-11,
            "start_logit": -4.8811235427856445,
            "end_logit": -6.084465026855469
        },
        {
            "text": "myeloma therapy]. Multiple myeloma",
            "probability": 2.3597378307973795e-11,
            "start_logit": -6.9633917808532715,
            "end_logit": -4.262716770172119
        }
    ],
    "56c04412ef6e39474100001b_095": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56c04412ef6e39474100001b_096": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56c04412ef6e39474100001b_097": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56c04412ef6e39474100001b_098": [
        {
            "text": "CD38",
            "probability": 0.9996208369204432,
            "start_logit": 7.384737491607666,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "CD",
            "probability": 0.00016434281733537862,
            "start_logit": 7.384737491607666,
            "end_logit": -2.8545165061950684
        },
        {
            "text": "anti-CD38",
            "probability": 0.00015070756421380622,
            "start_logit": -1.4150525331497192,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "38",
            "probability": 5.019414862276267e-05,
            "start_logit": -2.514495372772217,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma (MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 4.708033423118722e-06,
            "start_logit": -4.8811235427856445,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.6038989637661698e-06,
            "start_logit": -5.957956314086914,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "(MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.5991909037846911e-06,
            "start_logit": -5.960896015167236,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.4980038503217864e-06,
            "start_logit": -6.0262603759765625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 1.2624169155965069e-06,
            "start_logit": 7.384737491607666,
            "end_logit": -7.723443031311035
        },
        {
            "text": "remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 8.964263862696866e-07,
            "start_logit": -6.539732933044434,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.939986814360017e-07,
            "start_logit": -6.951272010803223,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 5.913720674116558e-07,
            "start_logit": -6.9557037353515625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "an anti-CD38",
            "probability": 5.834854688452387e-07,
            "start_logit": -6.96912956237793,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.81263334108885e-07,
            "start_logit": -6.972945213317871,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma",
            "probability": 1.8931340235937844e-10,
            "start_logit": -4.8811235427856445,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma therapy]. Multiple myeloma",
            "probability": 1.3408125902082662e-10,
            "start_logit": -5.226081371307373,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma",
            "probability": 4.743248031836347e-11,
            "start_logit": -5.226081371307373,
            "end_logit": -5.301855564117432
        },
        {
            "text": "[Daratumumab--breakthrough drug in multiple myeloma therapy]. Multiple myeloma",
            "probability": 3.434595265807506e-11,
            "start_logit": -6.588043212890625,
            "end_logit": -4.262716770172119
        },
        {
            "text": "Multiple",
            "probability": 3.062006762037403e-11,
            "start_logit": -4.8811235427856445,
            "end_logit": -6.084465026855469
        },
        {
            "text": "myeloma therapy]. Multiple myeloma",
            "probability": 2.3597378307973795e-11,
            "start_logit": -6.9633917808532715,
            "end_logit": -4.262716770172119
        }
    ],
    "56c04412ef6e39474100001b_099": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56c04412ef6e39474100001b_100": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56c04412ef6e39474100001b_101": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56c04412ef6e39474100001b_102": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56c04412ef6e39474100001b_103": [
        {
            "text": "multiple myeloma.",
            "probability": 0.972932859519667,
            "start_logit": 4.205234527587891,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 0.02112098783823136,
            "start_logit": 0.3751866817474365,
            "end_logit": 3.777590274810791
        },
        {
            "text": "multiple",
            "probability": 0.00478657432230425,
            "start_logit": 4.205234527587891,
            "end_logit": -1.536909818649292
        },
        {
            "text": "especially multiple myeloma.",
            "probability": 0.0005913174314789603,
            "start_logit": -3.2004828453063965,
            "end_logit": 3.777590274810791
        },
        {
            "text": ".",
            "probability": 0.00020962693230305835,
            "start_logit": -4.23750638961792,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38",
            "probability": 0.00011174453036359338,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple",
            "probability": 0.00010390971695425094,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.536909818649292
        },
        {
            "text": "myeloma.",
            "probability": 4.0446087798711286e-05,
            "start_logit": -5.882865905761719,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 3.39246517989228e-05,
            "start_logit": -6.058693885803223,
            "end_logit": 3.777590274810791
        },
        {
            "text": "malignancies, especially multiple myeloma.",
            "probability": 2.5206417336351562e-05,
            "start_logit": -6.355737209320068,
            "end_logit": 3.777590274810791
        },
        {
            "text": "of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.5082584101015358e-05,
            "start_logit": -6.869295120239258,
            "end_logit": 3.777590274810791
        },
        {
            "text": "targeting CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.3377072744620375e-05,
            "start_logit": -6.989293575286865,
            "end_logit": 3.777590274810791
        },
        {
            "text": "the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 9.68032525739701e-06,
            "start_logit": -7.312740325927734,
            "end_logit": 3.777590274810791
        },
        {
            "text": "especially multiple",
            "probability": 2.9091265714321166e-06,
            "start_logit": -3.2004828453063965,
            "end_logit": -1.536909818649292
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially",
            "probability": 1.28097920456648e-06,
            "start_logit": 0.3751866817474365,
            "end_logit": -5.932807445526123
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies,",
            "probability": 4.3850301603950546e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.004820823669434
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing",
            "probability": 1.7994102463769314e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.8955583572387695
        },
        {
            "text": "CD38-expressing malignancies, especially multiple",
            "probability": 1.6690038331525193e-07,
            "start_logit": -6.058693885803223,
            "end_logit": -1.536909818649292
        },
        {
            "text": "anti-cancer drug targeting CD38,",
            "probability": 1.4366494481776774e-07,
            "start_logit": -6.281300067901611,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38,",
            "probability": 1.434545153728352e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -8.122169494628906
        }
    ],
    "56c04412ef6e39474100001b_104": [
        {
            "text": "multiple myeloma.",
            "probability": 0.972932859519667,
            "start_logit": 4.205234527587891,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 0.02112098783823136,
            "start_logit": 0.3751866817474365,
            "end_logit": 3.777590274810791
        },
        {
            "text": "multiple",
            "probability": 0.00478657432230425,
            "start_logit": 4.205234527587891,
            "end_logit": -1.536909818649292
        },
        {
            "text": "especially multiple myeloma.",
            "probability": 0.0005913174314789603,
            "start_logit": -3.2004828453063965,
            "end_logit": 3.777590274810791
        },
        {
            "text": ".",
            "probability": 0.00020962693230305835,
            "start_logit": -4.23750638961792,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38",
            "probability": 0.00011174453036359338,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple",
            "probability": 0.00010390971695425094,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.536909818649292
        },
        {
            "text": "myeloma.",
            "probability": 4.0446087798711286e-05,
            "start_logit": -5.882865905761719,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 3.39246517989228e-05,
            "start_logit": -6.058693885803223,
            "end_logit": 3.777590274810791
        },
        {
            "text": "malignancies, especially multiple myeloma.",
            "probability": 2.5206417336351562e-05,
            "start_logit": -6.355737209320068,
            "end_logit": 3.777590274810791
        },
        {
            "text": "of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.5082584101015358e-05,
            "start_logit": -6.869295120239258,
            "end_logit": 3.777590274810791
        },
        {
            "text": "targeting CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.3377072744620375e-05,
            "start_logit": -6.989293575286865,
            "end_logit": 3.777590274810791
        },
        {
            "text": "the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 9.68032525739701e-06,
            "start_logit": -7.312740325927734,
            "end_logit": 3.777590274810791
        },
        {
            "text": "especially multiple",
            "probability": 2.9091265714321166e-06,
            "start_logit": -3.2004828453063965,
            "end_logit": -1.536909818649292
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially",
            "probability": 1.28097920456648e-06,
            "start_logit": 0.3751866817474365,
            "end_logit": -5.932807445526123
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies,",
            "probability": 4.3850301603950546e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.004820823669434
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing",
            "probability": 1.7994102463769314e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.8955583572387695
        },
        {
            "text": "CD38-expressing malignancies, especially multiple",
            "probability": 1.6690038331525193e-07,
            "start_logit": -6.058693885803223,
            "end_logit": -1.536909818649292
        },
        {
            "text": "anti-cancer drug targeting CD38,",
            "probability": 1.4366494481776774e-07,
            "start_logit": -6.281300067901611,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38,",
            "probability": 1.434545153728352e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -8.122169494628906
        }
    ],
    "56c04412ef6e39474100001b_105": [
        {
            "text": "multiple",
            "probability": 0.35932599363380013,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.30124611959165243,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "CD38",
            "probability": 0.2936716113504787,
            "start_logit": 0.5791692137718201,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "BACKGROUND: Daratumumab (DARA), a promising novel therapy for multiple",
            "probability": 0.02380352500528219,
            "start_logit": -2.1097617149353027,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma,",
            "probability": 0.005406201009781236,
            "start_logit": 0.6046346426010132,
            "end_logit": -5.4216413497924805
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma",
            "probability": 0.0025567338818954996,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.170457363128662
        },
        {
            "text": "CD38 on myeloma",
            "probability": 0.002492447570472944,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.170457363128662
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba",
            "probability": 0.001663285202637907,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.600393295288086
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma cells.",
            "probability": 0.0015386798249829299,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.678263187408447
        },
        {
            "text": "CD38 on myeloma cells.",
            "probability": 0.0014999913830184021,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.678263187408447
        },
        {
            "text": "recognizes CD38",
            "probability": 0.0012464217567206375,
            "start_logit": -4.883016109466553,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.0007867646019757443,
            "start_logit": -5.343119144439697,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "that recognizes CD38",
            "probability": 0.0007236739693020412,
            "start_logit": -5.4267072677612305,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes",
            "probability": 0.0006965692246410182,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.470776081085205
        },
        {
            "text": "(DARA), a promising novel therapy for multiple",
            "probability": 0.0006450401680934554,
            "start_logit": -5.718038082122803,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "CD",
            "probability": 0.0006221520319550962,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.558293342590332
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on",
            "probability": 0.0005750440760643755,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.662496566772461
        },
        {
            "text": "CD38 on",
            "probability": 0.0005605852139914236,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.662496566772461
        },
        {
            "text": "for multiple",
            "probability": 0.0005108674348443766,
            "start_logit": -5.951240539550781,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "for multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.00042829306840921335,
            "start_logit": -5.951240539550781,
            "end_logit": -1.4012603759765625
        }
    ],
    "56c04412ef6e39474100001b_106": [
        {
            "text": "multiple",
            "probability": 0.35932599363380013,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.30124611959165243,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "CD38",
            "probability": 0.2936716113504787,
            "start_logit": 0.5791692137718201,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "BACKGROUND: Daratumumab (DARA), a promising novel therapy for multiple",
            "probability": 0.02380352500528219,
            "start_logit": -2.1097617149353027,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma,",
            "probability": 0.005406201009781236,
            "start_logit": 0.6046346426010132,
            "end_logit": -5.4216413497924805
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma",
            "probability": 0.0025567338818954996,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.170457363128662
        },
        {
            "text": "CD38 on myeloma",
            "probability": 0.002492447570472944,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.170457363128662
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba",
            "probability": 0.001663285202637907,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.600393295288086
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma cells.",
            "probability": 0.0015386798249829299,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.678263187408447
        },
        {
            "text": "CD38 on myeloma cells.",
            "probability": 0.0014999913830184021,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.678263187408447
        },
        {
            "text": "recognizes CD38",
            "probability": 0.0012464217567206375,
            "start_logit": -4.883016109466553,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.0007867646019757443,
            "start_logit": -5.343119144439697,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "that recognizes CD38",
            "probability": 0.0007236739693020412,
            "start_logit": -5.4267072677612305,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes",
            "probability": 0.0006965692246410182,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.470776081085205
        },
        {
            "text": "(DARA), a promising novel therapy for multiple",
            "probability": 0.0006450401680934554,
            "start_logit": -5.718038082122803,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "CD",
            "probability": 0.0006221520319550962,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.558293342590332
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on",
            "probability": 0.0005750440760643755,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.662496566772461
        },
        {
            "text": "CD38 on",
            "probability": 0.0005605852139914236,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.662496566772461
        },
        {
            "text": "for multiple",
            "probability": 0.0005108674348443766,
            "start_logit": -5.951240539550781,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "for multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.00042829306840921335,
            "start_logit": -5.951240539550781,
            "end_logit": -1.4012603759765625
        }
    ],
    "56c04412ef6e39474100001b_107": [
        {
            "text": "multiple",
            "probability": 0.35932599363380013,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.30124611959165243,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "CD38",
            "probability": 0.2936716113504787,
            "start_logit": 0.5791692137718201,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "BACKGROUND: Daratumumab (DARA), a promising novel therapy for multiple",
            "probability": 0.02380352500528219,
            "start_logit": -2.1097617149353027,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma,",
            "probability": 0.005406201009781236,
            "start_logit": 0.6046346426010132,
            "end_logit": -5.4216413497924805
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma",
            "probability": 0.0025567338818954996,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.170457363128662
        },
        {
            "text": "CD38 on myeloma",
            "probability": 0.002492447570472944,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.170457363128662
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba",
            "probability": 0.001663285202637907,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.600393295288086
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma cells.",
            "probability": 0.0015386798249829299,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.678263187408447
        },
        {
            "text": "CD38 on myeloma cells.",
            "probability": 0.0014999913830184021,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.678263187408447
        },
        {
            "text": "recognizes CD38",
            "probability": 0.0012464217567206375,
            "start_logit": -4.883016109466553,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.0007867646019757443,
            "start_logit": -5.343119144439697,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "that recognizes CD38",
            "probability": 0.0007236739693020412,
            "start_logit": -5.4267072677612305,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes",
            "probability": 0.0006965692246410182,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.470776081085205
        },
        {
            "text": "(DARA), a promising novel therapy for multiple",
            "probability": 0.0006450401680934554,
            "start_logit": -5.718038082122803,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "CD",
            "probability": 0.0006221520319550962,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.558293342590332
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on",
            "probability": 0.0005750440760643755,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.662496566772461
        },
        {
            "text": "CD38 on",
            "probability": 0.0005605852139914236,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.662496566772461
        },
        {
            "text": "for multiple",
            "probability": 0.0005108674348443766,
            "start_logit": -5.951240539550781,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "for multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.00042829306840921335,
            "start_logit": -5.951240539550781,
            "end_logit": -1.4012603759765625
        }
    ],
    "56c04412ef6e39474100001b_108": [
        {
            "text": "multiple",
            "probability": 0.35932599363380013,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.30124611959165243,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "CD38",
            "probability": 0.2936716113504787,
            "start_logit": 0.5791692137718201,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "BACKGROUND: Daratumumab (DARA), a promising novel therapy for multiple",
            "probability": 0.02380352500528219,
            "start_logit": -2.1097617149353027,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma,",
            "probability": 0.005406201009781236,
            "start_logit": 0.6046346426010132,
            "end_logit": -5.4216413497924805
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma",
            "probability": 0.0025567338818954996,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.170457363128662
        },
        {
            "text": "CD38 on myeloma",
            "probability": 0.002492447570472944,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.170457363128662
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba",
            "probability": 0.001663285202637907,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.600393295288086
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma cells.",
            "probability": 0.0015386798249829299,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.678263187408447
        },
        {
            "text": "CD38 on myeloma cells.",
            "probability": 0.0014999913830184021,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.678263187408447
        },
        {
            "text": "recognizes CD38",
            "probability": 0.0012464217567206375,
            "start_logit": -4.883016109466553,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.0007867646019757443,
            "start_logit": -5.343119144439697,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "that recognizes CD38",
            "probability": 0.0007236739693020412,
            "start_logit": -5.4267072677612305,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes",
            "probability": 0.0006965692246410182,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.470776081085205
        },
        {
            "text": "(DARA), a promising novel therapy for multiple",
            "probability": 0.0006450401680934554,
            "start_logit": -5.718038082122803,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "CD",
            "probability": 0.0006221520319550962,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.558293342590332
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on",
            "probability": 0.0005750440760643755,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.662496566772461
        },
        {
            "text": "CD38 on",
            "probability": 0.0005605852139914236,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.662496566772461
        },
        {
            "text": "for multiple",
            "probability": 0.0005108674348443766,
            "start_logit": -5.951240539550781,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "for multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.00042829306840921335,
            "start_logit": -5.951240539550781,
            "end_logit": -1.4012603759765625
        }
    ],
    "56c04412ef6e39474100001b_109": [
        {
            "text": "multiple",
            "probability": 0.35932599363380013,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.30124611959165243,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "CD38",
            "probability": 0.2936716113504787,
            "start_logit": 0.5791692137718201,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "BACKGROUND: Daratumumab (DARA), a promising novel therapy for multiple",
            "probability": 0.02380352500528219,
            "start_logit": -2.1097617149353027,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma,",
            "probability": 0.005406201009781236,
            "start_logit": 0.6046346426010132,
            "end_logit": -5.4216413497924805
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma",
            "probability": 0.0025567338818954996,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.170457363128662
        },
        {
            "text": "CD38 on myeloma",
            "probability": 0.002492447570472944,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.170457363128662
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba",
            "probability": 0.001663285202637907,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.600393295288086
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma cells.",
            "probability": 0.0015386798249829299,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.678263187408447
        },
        {
            "text": "CD38 on myeloma cells.",
            "probability": 0.0014999913830184021,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.678263187408447
        },
        {
            "text": "recognizes CD38",
            "probability": 0.0012464217567206375,
            "start_logit": -4.883016109466553,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.0007867646019757443,
            "start_logit": -5.343119144439697,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "that recognizes CD38",
            "probability": 0.0007236739693020412,
            "start_logit": -5.4267072677612305,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes",
            "probability": 0.0006965692246410182,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.470776081085205
        },
        {
            "text": "(DARA), a promising novel therapy for multiple",
            "probability": 0.0006450401680934554,
            "start_logit": -5.718038082122803,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "CD",
            "probability": 0.0006221520319550962,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.558293342590332
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on",
            "probability": 0.0005750440760643755,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.662496566772461
        },
        {
            "text": "CD38 on",
            "probability": 0.0005605852139914236,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.662496566772461
        },
        {
            "text": "for multiple",
            "probability": 0.0005108674348443766,
            "start_logit": -5.951240539550781,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "for multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.00042829306840921335,
            "start_logit": -5.951240539550781,
            "end_logit": -1.4012603759765625
        }
    ],
    "56c04412ef6e39474100001b_110": [
        {
            "text": "multiple",
            "probability": 0.35932599363380013,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.30124611959165243,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "CD38",
            "probability": 0.2936716113504787,
            "start_logit": 0.5791692137718201,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "BACKGROUND: Daratumumab (DARA), a promising novel therapy for multiple",
            "probability": 0.02380352500528219,
            "start_logit": -2.1097617149353027,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma,",
            "probability": 0.005406201009781236,
            "start_logit": 0.6046346426010132,
            "end_logit": -5.4216413497924805
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma",
            "probability": 0.0025567338818954996,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.170457363128662
        },
        {
            "text": "CD38 on myeloma",
            "probability": 0.002492447570472944,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.170457363128662
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba",
            "probability": 0.001663285202637907,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.600393295288086
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma cells.",
            "probability": 0.0015386798249829299,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.678263187408447
        },
        {
            "text": "CD38 on myeloma cells.",
            "probability": 0.0014999913830184021,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.678263187408447
        },
        {
            "text": "recognizes CD38",
            "probability": 0.0012464217567206375,
            "start_logit": -4.883016109466553,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.0007867646019757443,
            "start_logit": -5.343119144439697,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "that recognizes CD38",
            "probability": 0.0007236739693020412,
            "start_logit": -5.4267072677612305,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes",
            "probability": 0.0006965692246410182,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.470776081085205
        },
        {
            "text": "(DARA), a promising novel therapy for multiple",
            "probability": 0.0006450401680934554,
            "start_logit": -5.718038082122803,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "CD",
            "probability": 0.0006221520319550962,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.558293342590332
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on",
            "probability": 0.0005750440760643755,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.662496566772461
        },
        {
            "text": "CD38 on",
            "probability": 0.0005605852139914236,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.662496566772461
        },
        {
            "text": "for multiple",
            "probability": 0.0005108674348443766,
            "start_logit": -5.951240539550781,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "for multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.00042829306840921335,
            "start_logit": -5.951240539550781,
            "end_logit": -1.4012603759765625
        }
    ],
    "56c04412ef6e39474100001b_111": [
        {
            "text": "multiple",
            "probability": 0.35932599363380013,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.30124611959165243,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "CD38",
            "probability": 0.2936716113504787,
            "start_logit": 0.5791692137718201,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "BACKGROUND: Daratumumab (DARA), a promising novel therapy for multiple",
            "probability": 0.02380352500528219,
            "start_logit": -2.1097617149353027,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma,",
            "probability": 0.005406201009781236,
            "start_logit": 0.6046346426010132,
            "end_logit": -5.4216413497924805
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma",
            "probability": 0.0025567338818954996,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.170457363128662
        },
        {
            "text": "CD38 on myeloma",
            "probability": 0.002492447570472944,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.170457363128662
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba",
            "probability": 0.001663285202637907,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.600393295288086
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma cells.",
            "probability": 0.0015386798249829299,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.678263187408447
        },
        {
            "text": "CD38 on myeloma cells.",
            "probability": 0.0014999913830184021,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.678263187408447
        },
        {
            "text": "recognizes CD38",
            "probability": 0.0012464217567206375,
            "start_logit": -4.883016109466553,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.0007867646019757443,
            "start_logit": -5.343119144439697,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "that recognizes CD38",
            "probability": 0.0007236739693020412,
            "start_logit": -5.4267072677612305,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes",
            "probability": 0.0006965692246410182,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.470776081085205
        },
        {
            "text": "(DARA), a promising novel therapy for multiple",
            "probability": 0.0006450401680934554,
            "start_logit": -5.718038082122803,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "CD",
            "probability": 0.0006221520319550962,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.558293342590332
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on",
            "probability": 0.0005750440760643755,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.662496566772461
        },
        {
            "text": "CD38 on",
            "probability": 0.0005605852139914236,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.662496566772461
        },
        {
            "text": "for multiple",
            "probability": 0.0005108674348443766,
            "start_logit": -5.951240539550781,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "for multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.00042829306840921335,
            "start_logit": -5.951240539550781,
            "end_logit": -1.4012603759765625
        }
    ],
    "56ae6e650a360a5e4500000e_001": [
        {
            "text": "OikoBase",
            "probability": 0.9767158071716487,
            "start_logit": 5.2492241859436035,
            "end_logit": 3.377363443374634
        },
        {
            "text": "OikoBase:",
            "probability": 0.012836813073785048,
            "start_logit": 5.2492241859436035,
            "end_logit": -0.9545152187347412
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 0.004779541807547902,
            "start_logit": 1.2623637914657593,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase: a genomics and developmental transcriptomics",
            "probability": 0.0024653737866202215,
            "start_logit": 5.2492241859436035,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "O",
            "probability": 0.0008301234054235274,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.6930131912231445
        },
        {
            "text": "Oiko",
            "probability": 0.0006717801652631293,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.904656410217285
        },
        {
            "text": "OikoBase: a genomics",
            "probability": 0.00040270538879144625,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.416382312774658
        },
        {
            "text": "OikoBase: a genomics and developmental",
            "probability": 0.0003733690841071465,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.492020130157471
        },
        {
            "text": "development of OikoBase",
            "probability": 0.00023875076459838775,
            "start_logit": -1.7343159914016724,
            "end_logit": 2.044372797012329
        },
        {
            "text": "development",
            "probability": 0.00020451956347906057,
            "start_logit": 1.1941827535629272,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "OikoBase facilitates retrieval and mining of a variety of useful genomics",
            "probability": 0.00011051730625689361,
            "start_logit": 4.0375471115112305,
            "end_logit": -4.497738361358643
        },
        {
            "text": "Base",
            "probability": 0.00011028588515007617,
            "start_logit": -3.839650869369507,
            "end_logit": 3.377363443374634
        },
        {
            "text": "the development of OikoBase",
            "probability": 7.092381557796225e-05,
            "start_logit": -2.948129892349243,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome",
            "probability": 6.133601348757512e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -4.434963703155518
        },
        {
            "text": "developmental transcriptomics",
            "probability": 4.575212863029285e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development",
            "probability": 3.443857708810604e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.8885498046875
        },
        {
            "text": "transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.4897410958690085e-05,
            "start_logit": -4.508548736572266,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/),",
            "probability": 1.1601656146915916e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -6.100183010101318
        },
        {
            "text": "OikoBase will provide a valuable resource for research in chordate development,",
            "probability": 1.1255012950133775e-05,
            "start_logit": -1.70566725730896,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "and developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.0207982488720928e-05,
            "start_logit": -4.886566162109375,
            "end_logit": 2.044372797012329
        }
    ],
    "56ae6e650a360a5e4500000e_002": [
        {
            "text": "OikoBase",
            "probability": 0.9767158071716487,
            "start_logit": 5.2492241859436035,
            "end_logit": 3.377363443374634
        },
        {
            "text": "OikoBase:",
            "probability": 0.012836813073785048,
            "start_logit": 5.2492241859436035,
            "end_logit": -0.9545152187347412
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 0.004779541807547902,
            "start_logit": 1.2623637914657593,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase: a genomics and developmental transcriptomics",
            "probability": 0.0024653737866202215,
            "start_logit": 5.2492241859436035,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "O",
            "probability": 0.0008301234054235274,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.6930131912231445
        },
        {
            "text": "Oiko",
            "probability": 0.0006717801652631293,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.904656410217285
        },
        {
            "text": "OikoBase: a genomics",
            "probability": 0.00040270538879144625,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.416382312774658
        },
        {
            "text": "OikoBase: a genomics and developmental",
            "probability": 0.0003733690841071465,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.492020130157471
        },
        {
            "text": "development of OikoBase",
            "probability": 0.00023875076459838775,
            "start_logit": -1.7343159914016724,
            "end_logit": 2.044372797012329
        },
        {
            "text": "development",
            "probability": 0.00020451956347906057,
            "start_logit": 1.1941827535629272,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "OikoBase facilitates retrieval and mining of a variety of useful genomics",
            "probability": 0.00011051730625689361,
            "start_logit": 4.0375471115112305,
            "end_logit": -4.497738361358643
        },
        {
            "text": "Base",
            "probability": 0.00011028588515007617,
            "start_logit": -3.839650869369507,
            "end_logit": 3.377363443374634
        },
        {
            "text": "the development of OikoBase",
            "probability": 7.092381557796225e-05,
            "start_logit": -2.948129892349243,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome",
            "probability": 6.133601348757512e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -4.434963703155518
        },
        {
            "text": "developmental transcriptomics",
            "probability": 4.575212863029285e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development",
            "probability": 3.443857708810604e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.8885498046875
        },
        {
            "text": "transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.4897410958690085e-05,
            "start_logit": -4.508548736572266,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/),",
            "probability": 1.1601656146915916e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -6.100183010101318
        },
        {
            "text": "OikoBase will provide a valuable resource for research in chordate development,",
            "probability": 1.1255012950133775e-05,
            "start_logit": -1.70566725730896,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "and developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.0207982488720928e-05,
            "start_logit": -4.886566162109375,
            "end_logit": 2.044372797012329
        }
    ],
    "56ae6e650a360a5e4500000e_003": [
        {
            "text": "OikoBase",
            "probability": 0.9767158071716487,
            "start_logit": 5.2492241859436035,
            "end_logit": 3.377363443374634
        },
        {
            "text": "OikoBase:",
            "probability": 0.012836813073785048,
            "start_logit": 5.2492241859436035,
            "end_logit": -0.9545152187347412
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 0.004779541807547902,
            "start_logit": 1.2623637914657593,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase: a genomics and developmental transcriptomics",
            "probability": 0.0024653737866202215,
            "start_logit": 5.2492241859436035,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "O",
            "probability": 0.0008301234054235274,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.6930131912231445
        },
        {
            "text": "Oiko",
            "probability": 0.0006717801652631293,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.904656410217285
        },
        {
            "text": "OikoBase: a genomics",
            "probability": 0.00040270538879144625,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.416382312774658
        },
        {
            "text": "OikoBase: a genomics and developmental",
            "probability": 0.0003733690841071465,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.492020130157471
        },
        {
            "text": "development of OikoBase",
            "probability": 0.00023875076459838775,
            "start_logit": -1.7343159914016724,
            "end_logit": 2.044372797012329
        },
        {
            "text": "development",
            "probability": 0.00020451956347906057,
            "start_logit": 1.1941827535629272,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "OikoBase facilitates retrieval and mining of a variety of useful genomics",
            "probability": 0.00011051730625689361,
            "start_logit": 4.0375471115112305,
            "end_logit": -4.497738361358643
        },
        {
            "text": "Base",
            "probability": 0.00011028588515007617,
            "start_logit": -3.839650869369507,
            "end_logit": 3.377363443374634
        },
        {
            "text": "the development of OikoBase",
            "probability": 7.092381557796225e-05,
            "start_logit": -2.948129892349243,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome",
            "probability": 6.133601348757512e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -4.434963703155518
        },
        {
            "text": "developmental transcriptomics",
            "probability": 4.575212863029285e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development",
            "probability": 3.443857708810604e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.8885498046875
        },
        {
            "text": "transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.4897410958690085e-05,
            "start_logit": -4.508548736572266,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/),",
            "probability": 1.1601656146915916e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -6.100183010101318
        },
        {
            "text": "OikoBase will provide a valuable resource for research in chordate development,",
            "probability": 1.1255012950133775e-05,
            "start_logit": -1.70566725730896,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "and developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.0207982488720928e-05,
            "start_logit": -4.886566162109375,
            "end_logit": 2.044372797012329
        }
    ],
    "56ae6e650a360a5e4500000e_004": [
        {
            "text": "OikoBase",
            "probability": 0.9767158071716487,
            "start_logit": 5.2492241859436035,
            "end_logit": 3.377363443374634
        },
        {
            "text": "OikoBase:",
            "probability": 0.012836813073785048,
            "start_logit": 5.2492241859436035,
            "end_logit": -0.9545152187347412
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 0.004779541807547902,
            "start_logit": 1.2623637914657593,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase: a genomics and developmental transcriptomics",
            "probability": 0.0024653737866202215,
            "start_logit": 5.2492241859436035,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "O",
            "probability": 0.0008301234054235274,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.6930131912231445
        },
        {
            "text": "Oiko",
            "probability": 0.0006717801652631293,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.904656410217285
        },
        {
            "text": "OikoBase: a genomics",
            "probability": 0.00040270538879144625,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.416382312774658
        },
        {
            "text": "OikoBase: a genomics and developmental",
            "probability": 0.0003733690841071465,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.492020130157471
        },
        {
            "text": "development of OikoBase",
            "probability": 0.00023875076459838775,
            "start_logit": -1.7343159914016724,
            "end_logit": 2.044372797012329
        },
        {
            "text": "development",
            "probability": 0.00020451956347906057,
            "start_logit": 1.1941827535629272,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "OikoBase facilitates retrieval and mining of a variety of useful genomics",
            "probability": 0.00011051730625689361,
            "start_logit": 4.0375471115112305,
            "end_logit": -4.497738361358643
        },
        {
            "text": "Base",
            "probability": 0.00011028588515007617,
            "start_logit": -3.839650869369507,
            "end_logit": 3.377363443374634
        },
        {
            "text": "the development of OikoBase",
            "probability": 7.092381557796225e-05,
            "start_logit": -2.948129892349243,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome",
            "probability": 6.133601348757512e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -4.434963703155518
        },
        {
            "text": "developmental transcriptomics",
            "probability": 4.575212863029285e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development",
            "probability": 3.443857708810604e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.8885498046875
        },
        {
            "text": "transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.4897410958690085e-05,
            "start_logit": -4.508548736572266,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/),",
            "probability": 1.1601656146915916e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -6.100183010101318
        },
        {
            "text": "OikoBase will provide a valuable resource for research in chordate development,",
            "probability": 1.1255012950133775e-05,
            "start_logit": -1.70566725730896,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "and developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.0207982488720928e-05,
            "start_logit": -4.886566162109375,
            "end_logit": 2.044372797012329
        }
    ],
    "56ae6e650a360a5e4500000e_005": [
        {
            "text": "OikoBase",
            "probability": 0.9767158071716487,
            "start_logit": 5.2492241859436035,
            "end_logit": 3.377363443374634
        },
        {
            "text": "OikoBase:",
            "probability": 0.012836813073785048,
            "start_logit": 5.2492241859436035,
            "end_logit": -0.9545152187347412
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 0.004779541807547902,
            "start_logit": 1.2623637914657593,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase: a genomics and developmental transcriptomics",
            "probability": 0.0024653737866202215,
            "start_logit": 5.2492241859436035,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "O",
            "probability": 0.0008301234054235274,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.6930131912231445
        },
        {
            "text": "Oiko",
            "probability": 0.0006717801652631293,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.904656410217285
        },
        {
            "text": "OikoBase: a genomics",
            "probability": 0.00040270538879144625,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.416382312774658
        },
        {
            "text": "OikoBase: a genomics and developmental",
            "probability": 0.0003733690841071465,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.492020130157471
        },
        {
            "text": "development of OikoBase",
            "probability": 0.00023875076459838775,
            "start_logit": -1.7343159914016724,
            "end_logit": 2.044372797012329
        },
        {
            "text": "development",
            "probability": 0.00020451956347906057,
            "start_logit": 1.1941827535629272,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "OikoBase facilitates retrieval and mining of a variety of useful genomics",
            "probability": 0.00011051730625689361,
            "start_logit": 4.0375471115112305,
            "end_logit": -4.497738361358643
        },
        {
            "text": "Base",
            "probability": 0.00011028588515007617,
            "start_logit": -3.839650869369507,
            "end_logit": 3.377363443374634
        },
        {
            "text": "the development of OikoBase",
            "probability": 7.092381557796225e-05,
            "start_logit": -2.948129892349243,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome",
            "probability": 6.133601348757512e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -4.434963703155518
        },
        {
            "text": "developmental transcriptomics",
            "probability": 4.575212863029285e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development",
            "probability": 3.443857708810604e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.8885498046875
        },
        {
            "text": "transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.4897410958690085e-05,
            "start_logit": -4.508548736572266,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/),",
            "probability": 1.1601656146915916e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -6.100183010101318
        },
        {
            "text": "OikoBase will provide a valuable resource for research in chordate development,",
            "probability": 1.1255012950133775e-05,
            "start_logit": -1.70566725730896,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "and developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.0207982488720928e-05,
            "start_logit": -4.886566162109375,
            "end_logit": 2.044372797012329
        }
    ],
    "56ae6e650a360a5e4500000e_007": [
        {
            "text": "OikoBase",
            "probability": 0.9767158071716487,
            "start_logit": 5.2492241859436035,
            "end_logit": 3.377363443374634
        },
        {
            "text": "OikoBase:",
            "probability": 0.012836813073785048,
            "start_logit": 5.2492241859436035,
            "end_logit": -0.9545152187347412
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 0.004779541807547902,
            "start_logit": 1.2623637914657593,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase: a genomics and developmental transcriptomics",
            "probability": 0.0024653737866202215,
            "start_logit": 5.2492241859436035,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "O",
            "probability": 0.0008301234054235274,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.6930131912231445
        },
        {
            "text": "Oiko",
            "probability": 0.0006717801652631293,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.904656410217285
        },
        {
            "text": "OikoBase: a genomics",
            "probability": 0.00040270538879144625,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.416382312774658
        },
        {
            "text": "OikoBase: a genomics and developmental",
            "probability": 0.0003733690841071465,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.492020130157471
        },
        {
            "text": "development of OikoBase",
            "probability": 0.00023875076459838775,
            "start_logit": -1.7343159914016724,
            "end_logit": 2.044372797012329
        },
        {
            "text": "development",
            "probability": 0.00020451956347906057,
            "start_logit": 1.1941827535629272,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "OikoBase facilitates retrieval and mining of a variety of useful genomics",
            "probability": 0.00011051730625689361,
            "start_logit": 4.0375471115112305,
            "end_logit": -4.497738361358643
        },
        {
            "text": "Base",
            "probability": 0.00011028588515007617,
            "start_logit": -3.839650869369507,
            "end_logit": 3.377363443374634
        },
        {
            "text": "the development of OikoBase",
            "probability": 7.092381557796225e-05,
            "start_logit": -2.948129892349243,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome",
            "probability": 6.133601348757512e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -4.434963703155518
        },
        {
            "text": "developmental transcriptomics",
            "probability": 4.575212863029285e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development",
            "probability": 3.443857708810604e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.8885498046875
        },
        {
            "text": "transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.4897410958690085e-05,
            "start_logit": -4.508548736572266,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/),",
            "probability": 1.1601656146915916e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -6.100183010101318
        },
        {
            "text": "OikoBase will provide a valuable resource for research in chordate development,",
            "probability": 1.1255012950133775e-05,
            "start_logit": -1.70566725730896,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "and developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.0207982488720928e-05,
            "start_logit": -4.886566162109375,
            "end_logit": 2.044372797012329
        }
    ],
    "56ae6e650a360a5e4500000e_008": [
        {
            "text": "OikoBase",
            "probability": 0.9767158071716487,
            "start_logit": 5.2492241859436035,
            "end_logit": 3.377363443374634
        },
        {
            "text": "OikoBase:",
            "probability": 0.012836813073785048,
            "start_logit": 5.2492241859436035,
            "end_logit": -0.9545152187347412
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 0.004779541807547902,
            "start_logit": 1.2623637914657593,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase: a genomics and developmental transcriptomics",
            "probability": 0.0024653737866202215,
            "start_logit": 5.2492241859436035,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "O",
            "probability": 0.0008301234054235274,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.6930131912231445
        },
        {
            "text": "Oiko",
            "probability": 0.0006717801652631293,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.904656410217285
        },
        {
            "text": "OikoBase: a genomics",
            "probability": 0.00040270538879144625,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.416382312774658
        },
        {
            "text": "OikoBase: a genomics and developmental",
            "probability": 0.0003733690841071465,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.492020130157471
        },
        {
            "text": "development of OikoBase",
            "probability": 0.00023875076459838775,
            "start_logit": -1.7343159914016724,
            "end_logit": 2.044372797012329
        },
        {
            "text": "development",
            "probability": 0.00020451956347906057,
            "start_logit": 1.1941827535629272,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "OikoBase facilitates retrieval and mining of a variety of useful genomics",
            "probability": 0.00011051730625689361,
            "start_logit": 4.0375471115112305,
            "end_logit": -4.497738361358643
        },
        {
            "text": "Base",
            "probability": 0.00011028588515007617,
            "start_logit": -3.839650869369507,
            "end_logit": 3.377363443374634
        },
        {
            "text": "the development of OikoBase",
            "probability": 7.092381557796225e-05,
            "start_logit": -2.948129892349243,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome",
            "probability": 6.133601348757512e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -4.434963703155518
        },
        {
            "text": "developmental transcriptomics",
            "probability": 4.575212863029285e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development",
            "probability": 3.443857708810604e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.8885498046875
        },
        {
            "text": "transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.4897410958690085e-05,
            "start_logit": -4.508548736572266,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/),",
            "probability": 1.1601656146915916e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -6.100183010101318
        },
        {
            "text": "OikoBase will provide a valuable resource for research in chordate development,",
            "probability": 1.1255012950133775e-05,
            "start_logit": -1.70566725730896,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "and developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.0207982488720928e-05,
            "start_logit": -4.886566162109375,
            "end_logit": 2.044372797012329
        }
    ],
    "56ae6e650a360a5e4500000e_009": [
        {
            "text": "OikoBase",
            "probability": 0.9767158071716487,
            "start_logit": 5.2492241859436035,
            "end_logit": 3.377363443374634
        },
        {
            "text": "OikoBase:",
            "probability": 0.012836813073785048,
            "start_logit": 5.2492241859436035,
            "end_logit": -0.9545152187347412
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 0.004779541807547902,
            "start_logit": 1.2623637914657593,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase: a genomics and developmental transcriptomics",
            "probability": 0.0024653737866202215,
            "start_logit": 5.2492241859436035,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "O",
            "probability": 0.0008301234054235274,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.6930131912231445
        },
        {
            "text": "Oiko",
            "probability": 0.0006717801652631293,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.904656410217285
        },
        {
            "text": "OikoBase: a genomics",
            "probability": 0.00040270538879144625,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.416382312774658
        },
        {
            "text": "OikoBase: a genomics and developmental",
            "probability": 0.0003733690841071465,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.492020130157471
        },
        {
            "text": "development of OikoBase",
            "probability": 0.00023875076459838775,
            "start_logit": -1.7343159914016724,
            "end_logit": 2.044372797012329
        },
        {
            "text": "development",
            "probability": 0.00020451956347906057,
            "start_logit": 1.1941827535629272,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "OikoBase facilitates retrieval and mining of a variety of useful genomics",
            "probability": 0.00011051730625689361,
            "start_logit": 4.0375471115112305,
            "end_logit": -4.497738361358643
        },
        {
            "text": "Base",
            "probability": 0.00011028588515007617,
            "start_logit": -3.839650869369507,
            "end_logit": 3.377363443374634
        },
        {
            "text": "the development of OikoBase",
            "probability": 7.092381557796225e-05,
            "start_logit": -2.948129892349243,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome",
            "probability": 6.133601348757512e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -4.434963703155518
        },
        {
            "text": "developmental transcriptomics",
            "probability": 4.575212863029285e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development",
            "probability": 3.443857708810604e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.8885498046875
        },
        {
            "text": "transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.4897410958690085e-05,
            "start_logit": -4.508548736572266,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/),",
            "probability": 1.1601656146915916e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -6.100183010101318
        },
        {
            "text": "OikoBase will provide a valuable resource for research in chordate development,",
            "probability": 1.1255012950133775e-05,
            "start_logit": -1.70566725730896,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "and developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.0207982488720928e-05,
            "start_logit": -4.886566162109375,
            "end_logit": 2.044372797012329
        }
    ],
    "56ae6e650a360a5e4500000e_010": [
        {
            "text": "OikoBase",
            "probability": 0.9767158071716487,
            "start_logit": 5.2492241859436035,
            "end_logit": 3.377363443374634
        },
        {
            "text": "OikoBase:",
            "probability": 0.012836813073785048,
            "start_logit": 5.2492241859436035,
            "end_logit": -0.9545152187347412
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 0.004779541807547902,
            "start_logit": 1.2623637914657593,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase: a genomics and developmental transcriptomics",
            "probability": 0.0024653737866202215,
            "start_logit": 5.2492241859436035,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "O",
            "probability": 0.0008301234054235274,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.6930131912231445
        },
        {
            "text": "Oiko",
            "probability": 0.0006717801652631293,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.904656410217285
        },
        {
            "text": "OikoBase: a genomics",
            "probability": 0.00040270538879144625,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.416382312774658
        },
        {
            "text": "OikoBase: a genomics and developmental",
            "probability": 0.0003733690841071465,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.492020130157471
        },
        {
            "text": "development of OikoBase",
            "probability": 0.00023875076459838775,
            "start_logit": -1.7343159914016724,
            "end_logit": 2.044372797012329
        },
        {
            "text": "development",
            "probability": 0.00020451956347906057,
            "start_logit": 1.1941827535629272,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "OikoBase facilitates retrieval and mining of a variety of useful genomics",
            "probability": 0.00011051730625689361,
            "start_logit": 4.0375471115112305,
            "end_logit": -4.497738361358643
        },
        {
            "text": "Base",
            "probability": 0.00011028588515007617,
            "start_logit": -3.839650869369507,
            "end_logit": 3.377363443374634
        },
        {
            "text": "the development of OikoBase",
            "probability": 7.092381557796225e-05,
            "start_logit": -2.948129892349243,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome",
            "probability": 6.133601348757512e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -4.434963703155518
        },
        {
            "text": "developmental transcriptomics",
            "probability": 4.575212863029285e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development",
            "probability": 3.443857708810604e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.8885498046875
        },
        {
            "text": "transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.4897410958690085e-05,
            "start_logit": -4.508548736572266,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/),",
            "probability": 1.1601656146915916e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -6.100183010101318
        },
        {
            "text": "OikoBase will provide a valuable resource for research in chordate development,",
            "probability": 1.1255012950133775e-05,
            "start_logit": -1.70566725730896,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "and developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.0207982488720928e-05,
            "start_logit": -4.886566162109375,
            "end_logit": 2.044372797012329
        }
    ],
    "56ae6e650a360a5e4500000e_011": [
        {
            "text": "OikoBase",
            "probability": 0.9767158071716487,
            "start_logit": 5.2492241859436035,
            "end_logit": 3.377363443374634
        },
        {
            "text": "OikoBase:",
            "probability": 0.012836813073785048,
            "start_logit": 5.2492241859436035,
            "end_logit": -0.9545152187347412
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 0.004779541807547902,
            "start_logit": 1.2623637914657593,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase: a genomics and developmental transcriptomics",
            "probability": 0.0024653737866202215,
            "start_logit": 5.2492241859436035,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "O",
            "probability": 0.0008301234054235274,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.6930131912231445
        },
        {
            "text": "Oiko",
            "probability": 0.0006717801652631293,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.904656410217285
        },
        {
            "text": "OikoBase: a genomics",
            "probability": 0.00040270538879144625,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.416382312774658
        },
        {
            "text": "OikoBase: a genomics and developmental",
            "probability": 0.0003733690841071465,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.492020130157471
        },
        {
            "text": "development of OikoBase",
            "probability": 0.00023875076459838775,
            "start_logit": -1.7343159914016724,
            "end_logit": 2.044372797012329
        },
        {
            "text": "development",
            "probability": 0.00020451956347906057,
            "start_logit": 1.1941827535629272,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "OikoBase facilitates retrieval and mining of a variety of useful genomics",
            "probability": 0.00011051730625689361,
            "start_logit": 4.0375471115112305,
            "end_logit": -4.497738361358643
        },
        {
            "text": "Base",
            "probability": 0.00011028588515007617,
            "start_logit": -3.839650869369507,
            "end_logit": 3.377363443374634
        },
        {
            "text": "the development of OikoBase",
            "probability": 7.092381557796225e-05,
            "start_logit": -2.948129892349243,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome",
            "probability": 6.133601348757512e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -4.434963703155518
        },
        {
            "text": "developmental transcriptomics",
            "probability": 4.575212863029285e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development",
            "probability": 3.443857708810604e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.8885498046875
        },
        {
            "text": "transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.4897410958690085e-05,
            "start_logit": -4.508548736572266,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/),",
            "probability": 1.1601656146915916e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -6.100183010101318
        },
        {
            "text": "OikoBase will provide a valuable resource for research in chordate development,",
            "probability": 1.1255012950133775e-05,
            "start_logit": -1.70566725730896,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "and developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.0207982488720928e-05,
            "start_logit": -4.886566162109375,
            "end_logit": 2.044372797012329
        }
    ],
    "56ae6e650a360a5e4500000e_012": [
        {
            "text": "OikoBase",
            "probability": 0.9767158071716487,
            "start_logit": 5.2492241859436035,
            "end_logit": 3.377363443374634
        },
        {
            "text": "OikoBase:",
            "probability": 0.012836813073785048,
            "start_logit": 5.2492241859436035,
            "end_logit": -0.9545152187347412
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 0.004779541807547902,
            "start_logit": 1.2623637914657593,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase: a genomics and developmental transcriptomics",
            "probability": 0.0024653737866202215,
            "start_logit": 5.2492241859436035,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "O",
            "probability": 0.0008301234054235274,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.6930131912231445
        },
        {
            "text": "Oiko",
            "probability": 0.0006717801652631293,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.904656410217285
        },
        {
            "text": "OikoBase: a genomics",
            "probability": 0.00040270538879144625,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.416382312774658
        },
        {
            "text": "OikoBase: a genomics and developmental",
            "probability": 0.0003733690841071465,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.492020130157471
        },
        {
            "text": "development of OikoBase",
            "probability": 0.00023875076459838775,
            "start_logit": -1.7343159914016724,
            "end_logit": 2.044372797012329
        },
        {
            "text": "development",
            "probability": 0.00020451956347906057,
            "start_logit": 1.1941827535629272,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "OikoBase facilitates retrieval and mining of a variety of useful genomics",
            "probability": 0.00011051730625689361,
            "start_logit": 4.0375471115112305,
            "end_logit": -4.497738361358643
        },
        {
            "text": "Base",
            "probability": 0.00011028588515007617,
            "start_logit": -3.839650869369507,
            "end_logit": 3.377363443374634
        },
        {
            "text": "the development of OikoBase",
            "probability": 7.092381557796225e-05,
            "start_logit": -2.948129892349243,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome",
            "probability": 6.133601348757512e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -4.434963703155518
        },
        {
            "text": "developmental transcriptomics",
            "probability": 4.575212863029285e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development",
            "probability": 3.443857708810604e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.8885498046875
        },
        {
            "text": "transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.4897410958690085e-05,
            "start_logit": -4.508548736572266,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/),",
            "probability": 1.1601656146915916e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -6.100183010101318
        },
        {
            "text": "OikoBase will provide a valuable resource for research in chordate development,",
            "probability": 1.1255012950133775e-05,
            "start_logit": -1.70566725730896,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "and developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.0207982488720928e-05,
            "start_logit": -4.886566162109375,
            "end_logit": 2.044372797012329
        }
    ],
    "56ae6e650a360a5e4500000e_013": [
        {
            "text": "OikoBase",
            "probability": 0.9767158071716487,
            "start_logit": 5.2492241859436035,
            "end_logit": 3.377363443374634
        },
        {
            "text": "OikoBase:",
            "probability": 0.012836813073785048,
            "start_logit": 5.2492241859436035,
            "end_logit": -0.9545152187347412
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 0.004779541807547902,
            "start_logit": 1.2623637914657593,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase: a genomics and developmental transcriptomics",
            "probability": 0.0024653737866202215,
            "start_logit": 5.2492241859436035,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "O",
            "probability": 0.0008301234054235274,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.6930131912231445
        },
        {
            "text": "Oiko",
            "probability": 0.0006717801652631293,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.904656410217285
        },
        {
            "text": "OikoBase: a genomics",
            "probability": 0.00040270538879144625,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.416382312774658
        },
        {
            "text": "OikoBase: a genomics and developmental",
            "probability": 0.0003733690841071465,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.492020130157471
        },
        {
            "text": "development of OikoBase",
            "probability": 0.00023875076459838775,
            "start_logit": -1.7343159914016724,
            "end_logit": 2.044372797012329
        },
        {
            "text": "development",
            "probability": 0.00020451956347906057,
            "start_logit": 1.1941827535629272,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "OikoBase facilitates retrieval and mining of a variety of useful genomics",
            "probability": 0.00011051730625689361,
            "start_logit": 4.0375471115112305,
            "end_logit": -4.497738361358643
        },
        {
            "text": "Base",
            "probability": 0.00011028588515007617,
            "start_logit": -3.839650869369507,
            "end_logit": 3.377363443374634
        },
        {
            "text": "the development of OikoBase",
            "probability": 7.092381557796225e-05,
            "start_logit": -2.948129892349243,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome",
            "probability": 6.133601348757512e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -4.434963703155518
        },
        {
            "text": "developmental transcriptomics",
            "probability": 4.575212863029285e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development",
            "probability": 3.443857708810604e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.8885498046875
        },
        {
            "text": "transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.4897410958690085e-05,
            "start_logit": -4.508548736572266,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/),",
            "probability": 1.1601656146915916e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -6.100183010101318
        },
        {
            "text": "OikoBase will provide a valuable resource for research in chordate development,",
            "probability": 1.1255012950133775e-05,
            "start_logit": -1.70566725730896,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "and developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.0207982488720928e-05,
            "start_logit": -4.886566162109375,
            "end_logit": 2.044372797012329
        }
    ],
    "56ae6e650a360a5e4500000e_014": [
        {
            "text": "OikoBase",
            "probability": 0.9767158071716487,
            "start_logit": 5.2492241859436035,
            "end_logit": 3.377363443374634
        },
        {
            "text": "OikoBase:",
            "probability": 0.012836813073785048,
            "start_logit": 5.2492241859436035,
            "end_logit": -0.9545152187347412
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 0.004779541807547902,
            "start_logit": 1.2623637914657593,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase: a genomics and developmental transcriptomics",
            "probability": 0.0024653737866202215,
            "start_logit": 5.2492241859436035,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "O",
            "probability": 0.0008301234054235274,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.6930131912231445
        },
        {
            "text": "Oiko",
            "probability": 0.0006717801652631293,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.904656410217285
        },
        {
            "text": "OikoBase: a genomics",
            "probability": 0.00040270538879144625,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.416382312774658
        },
        {
            "text": "OikoBase: a genomics and developmental",
            "probability": 0.0003733690841071465,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.492020130157471
        },
        {
            "text": "development of OikoBase",
            "probability": 0.00023875076459838775,
            "start_logit": -1.7343159914016724,
            "end_logit": 2.044372797012329
        },
        {
            "text": "development",
            "probability": 0.00020451956347906057,
            "start_logit": 1.1941827535629272,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "OikoBase facilitates retrieval and mining of a variety of useful genomics",
            "probability": 0.00011051730625689361,
            "start_logit": 4.0375471115112305,
            "end_logit": -4.497738361358643
        },
        {
            "text": "Base",
            "probability": 0.00011028588515007617,
            "start_logit": -3.839650869369507,
            "end_logit": 3.377363443374634
        },
        {
            "text": "the development of OikoBase",
            "probability": 7.092381557796225e-05,
            "start_logit": -2.948129892349243,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome",
            "probability": 6.133601348757512e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -4.434963703155518
        },
        {
            "text": "developmental transcriptomics",
            "probability": 4.575212863029285e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development",
            "probability": 3.443857708810604e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.8885498046875
        },
        {
            "text": "transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.4897410958690085e-05,
            "start_logit": -4.508548736572266,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/),",
            "probability": 1.1601656146915916e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -6.100183010101318
        },
        {
            "text": "OikoBase will provide a valuable resource for research in chordate development,",
            "probability": 1.1255012950133775e-05,
            "start_logit": -1.70566725730896,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "and developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.0207982488720928e-05,
            "start_logit": -4.886566162109375,
            "end_logit": 2.044372797012329
        }
    ],
    "56ae6e650a360a5e4500000e_015": [
        {
            "text": "OikoBase",
            "probability": 0.9767158071716487,
            "start_logit": 5.2492241859436035,
            "end_logit": 3.377363443374634
        },
        {
            "text": "OikoBase:",
            "probability": 0.012836813073785048,
            "start_logit": 5.2492241859436035,
            "end_logit": -0.9545152187347412
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 0.004779541807547902,
            "start_logit": 1.2623637914657593,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase: a genomics and developmental transcriptomics",
            "probability": 0.0024653737866202215,
            "start_logit": 5.2492241859436035,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "O",
            "probability": 0.0008301234054235274,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.6930131912231445
        },
        {
            "text": "Oiko",
            "probability": 0.0006717801652631293,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.904656410217285
        },
        {
            "text": "OikoBase: a genomics",
            "probability": 0.00040270538879144625,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.416382312774658
        },
        {
            "text": "OikoBase: a genomics and developmental",
            "probability": 0.0003733690841071465,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.492020130157471
        },
        {
            "text": "development of OikoBase",
            "probability": 0.00023875076459838775,
            "start_logit": -1.7343159914016724,
            "end_logit": 2.044372797012329
        },
        {
            "text": "development",
            "probability": 0.00020451956347906057,
            "start_logit": 1.1941827535629272,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "OikoBase facilitates retrieval and mining of a variety of useful genomics",
            "probability": 0.00011051730625689361,
            "start_logit": 4.0375471115112305,
            "end_logit": -4.497738361358643
        },
        {
            "text": "Base",
            "probability": 0.00011028588515007617,
            "start_logit": -3.839650869369507,
            "end_logit": 3.377363443374634
        },
        {
            "text": "the development of OikoBase",
            "probability": 7.092381557796225e-05,
            "start_logit": -2.948129892349243,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome",
            "probability": 6.133601348757512e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -4.434963703155518
        },
        {
            "text": "developmental transcriptomics",
            "probability": 4.575212863029285e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development",
            "probability": 3.443857708810604e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.8885498046875
        },
        {
            "text": "transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.4897410958690085e-05,
            "start_logit": -4.508548736572266,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/),",
            "probability": 1.1601656146915916e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -6.100183010101318
        },
        {
            "text": "OikoBase will provide a valuable resource for research in chordate development,",
            "probability": 1.1255012950133775e-05,
            "start_logit": -1.70566725730896,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "and developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.0207982488720928e-05,
            "start_logit": -4.886566162109375,
            "end_logit": 2.044372797012329
        }
    ],
    "56ae6e650a360a5e4500000e_016": [
        {
            "text": "OikoBase",
            "probability": 0.9767158071716487,
            "start_logit": 5.2492241859436035,
            "end_logit": 3.377363443374634
        },
        {
            "text": "OikoBase:",
            "probability": 0.012836813073785048,
            "start_logit": 5.2492241859436035,
            "end_logit": -0.9545152187347412
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 0.004779541807547902,
            "start_logit": 1.2623637914657593,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase: a genomics and developmental transcriptomics",
            "probability": 0.0024653737866202215,
            "start_logit": 5.2492241859436035,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "O",
            "probability": 0.0008301234054235274,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.6930131912231445
        },
        {
            "text": "Oiko",
            "probability": 0.0006717801652631293,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.904656410217285
        },
        {
            "text": "OikoBase: a genomics",
            "probability": 0.00040270538879144625,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.416382312774658
        },
        {
            "text": "OikoBase: a genomics and developmental",
            "probability": 0.0003733690841071465,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.492020130157471
        },
        {
            "text": "development of OikoBase",
            "probability": 0.00023875076459838775,
            "start_logit": -1.7343159914016724,
            "end_logit": 2.044372797012329
        },
        {
            "text": "development",
            "probability": 0.00020451956347906057,
            "start_logit": 1.1941827535629272,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "OikoBase facilitates retrieval and mining of a variety of useful genomics",
            "probability": 0.00011051730625689361,
            "start_logit": 4.0375471115112305,
            "end_logit": -4.497738361358643
        },
        {
            "text": "Base",
            "probability": 0.00011028588515007617,
            "start_logit": -3.839650869369507,
            "end_logit": 3.377363443374634
        },
        {
            "text": "the development of OikoBase",
            "probability": 7.092381557796225e-05,
            "start_logit": -2.948129892349243,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome",
            "probability": 6.133601348757512e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -4.434963703155518
        },
        {
            "text": "developmental transcriptomics",
            "probability": 4.575212863029285e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development",
            "probability": 3.443857708810604e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.8885498046875
        },
        {
            "text": "transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.4897410958690085e-05,
            "start_logit": -4.508548736572266,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/),",
            "probability": 1.1601656146915916e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -6.100183010101318
        },
        {
            "text": "OikoBase will provide a valuable resource for research in chordate development,",
            "probability": 1.1255012950133775e-05,
            "start_logit": -1.70566725730896,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "and developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.0207982488720928e-05,
            "start_logit": -4.886566162109375,
            "end_logit": 2.044372797012329
        }
    ],
    "56ae6e650a360a5e4500000e_017": [
        {
            "text": "OikoBase",
            "probability": 0.9767158071716487,
            "start_logit": 5.2492241859436035,
            "end_logit": 3.377363443374634
        },
        {
            "text": "OikoBase:",
            "probability": 0.012836813073785048,
            "start_logit": 5.2492241859436035,
            "end_logit": -0.9545152187347412
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 0.004779541807547902,
            "start_logit": 1.2623637914657593,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase: a genomics and developmental transcriptomics",
            "probability": 0.0024653737866202215,
            "start_logit": 5.2492241859436035,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "O",
            "probability": 0.0008301234054235274,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.6930131912231445
        },
        {
            "text": "Oiko",
            "probability": 0.0006717801652631293,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.904656410217285
        },
        {
            "text": "OikoBase: a genomics",
            "probability": 0.00040270538879144625,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.416382312774658
        },
        {
            "text": "OikoBase: a genomics and developmental",
            "probability": 0.0003733690841071465,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.492020130157471
        },
        {
            "text": "development of OikoBase",
            "probability": 0.00023875076459838775,
            "start_logit": -1.7343159914016724,
            "end_logit": 2.044372797012329
        },
        {
            "text": "development",
            "probability": 0.00020451956347906057,
            "start_logit": 1.1941827535629272,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "OikoBase facilitates retrieval and mining of a variety of useful genomics",
            "probability": 0.00011051730625689361,
            "start_logit": 4.0375471115112305,
            "end_logit": -4.497738361358643
        },
        {
            "text": "Base",
            "probability": 0.00011028588515007617,
            "start_logit": -3.839650869369507,
            "end_logit": 3.377363443374634
        },
        {
            "text": "the development of OikoBase",
            "probability": 7.092381557796225e-05,
            "start_logit": -2.948129892349243,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome",
            "probability": 6.133601348757512e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -4.434963703155518
        },
        {
            "text": "developmental transcriptomics",
            "probability": 4.575212863029285e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development",
            "probability": 3.443857708810604e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.8885498046875
        },
        {
            "text": "transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.4897410958690085e-05,
            "start_logit": -4.508548736572266,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/),",
            "probability": 1.1601656146915916e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -6.100183010101318
        },
        {
            "text": "OikoBase will provide a valuable resource for research in chordate development,",
            "probability": 1.1255012950133775e-05,
            "start_logit": -1.70566725730896,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "and developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.0207982488720928e-05,
            "start_logit": -4.886566162109375,
            "end_logit": 2.044372797012329
        }
    ],
    "56ae6e650a360a5e4500000e_018": [
        {
            "text": "OikoBase",
            "probability": 0.9767158071716487,
            "start_logit": 5.2492241859436035,
            "end_logit": 3.377363443374634
        },
        {
            "text": "OikoBase:",
            "probability": 0.012836813073785048,
            "start_logit": 5.2492241859436035,
            "end_logit": -0.9545152187347412
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 0.004779541807547902,
            "start_logit": 1.2623637914657593,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase: a genomics and developmental transcriptomics",
            "probability": 0.0024653737866202215,
            "start_logit": 5.2492241859436035,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "O",
            "probability": 0.0008301234054235274,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.6930131912231445
        },
        {
            "text": "Oiko",
            "probability": 0.0006717801652631293,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.904656410217285
        },
        {
            "text": "OikoBase: a genomics",
            "probability": 0.00040270538879144625,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.416382312774658
        },
        {
            "text": "OikoBase: a genomics and developmental",
            "probability": 0.0003733690841071465,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.492020130157471
        },
        {
            "text": "development of OikoBase",
            "probability": 0.00023875076459838775,
            "start_logit": -1.7343159914016724,
            "end_logit": 2.044372797012329
        },
        {
            "text": "development",
            "probability": 0.00020451956347906057,
            "start_logit": 1.1941827535629272,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "OikoBase facilitates retrieval and mining of a variety of useful genomics",
            "probability": 0.00011051730625689361,
            "start_logit": 4.0375471115112305,
            "end_logit": -4.497738361358643
        },
        {
            "text": "Base",
            "probability": 0.00011028588515007617,
            "start_logit": -3.839650869369507,
            "end_logit": 3.377363443374634
        },
        {
            "text": "the development of OikoBase",
            "probability": 7.092381557796225e-05,
            "start_logit": -2.948129892349243,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome",
            "probability": 6.133601348757512e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -4.434963703155518
        },
        {
            "text": "developmental transcriptomics",
            "probability": 4.575212863029285e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development",
            "probability": 3.443857708810604e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.8885498046875
        },
        {
            "text": "transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.4897410958690085e-05,
            "start_logit": -4.508548736572266,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/),",
            "probability": 1.1601656146915916e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -6.100183010101318
        },
        {
            "text": "OikoBase will provide a valuable resource for research in chordate development,",
            "probability": 1.1255012950133775e-05,
            "start_logit": -1.70566725730896,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "and developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.0207982488720928e-05,
            "start_logit": -4.886566162109375,
            "end_logit": 2.044372797012329
        }
    ],
    "56ae6e650a360a5e4500000e_019": [
        {
            "text": "OikoBase",
            "probability": 0.9767158071716487,
            "start_logit": 5.2492241859436035,
            "end_logit": 3.377363443374634
        },
        {
            "text": "OikoBase:",
            "probability": 0.012836813073785048,
            "start_logit": 5.2492241859436035,
            "end_logit": -0.9545152187347412
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 0.004779541807547902,
            "start_logit": 1.2623637914657593,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase: a genomics and developmental transcriptomics",
            "probability": 0.0024653737866202215,
            "start_logit": 5.2492241859436035,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "O",
            "probability": 0.0008301234054235274,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.6930131912231445
        },
        {
            "text": "Oiko",
            "probability": 0.0006717801652631293,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.904656410217285
        },
        {
            "text": "OikoBase: a genomics",
            "probability": 0.00040270538879144625,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.416382312774658
        },
        {
            "text": "OikoBase: a genomics and developmental",
            "probability": 0.0003733690841071465,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.492020130157471
        },
        {
            "text": "development of OikoBase",
            "probability": 0.00023875076459838775,
            "start_logit": -1.7343159914016724,
            "end_logit": 2.044372797012329
        },
        {
            "text": "development",
            "probability": 0.00020451956347906057,
            "start_logit": 1.1941827535629272,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "OikoBase facilitates retrieval and mining of a variety of useful genomics",
            "probability": 0.00011051730625689361,
            "start_logit": 4.0375471115112305,
            "end_logit": -4.497738361358643
        },
        {
            "text": "Base",
            "probability": 0.00011028588515007617,
            "start_logit": -3.839650869369507,
            "end_logit": 3.377363443374634
        },
        {
            "text": "the development of OikoBase",
            "probability": 7.092381557796225e-05,
            "start_logit": -2.948129892349243,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome",
            "probability": 6.133601348757512e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -4.434963703155518
        },
        {
            "text": "developmental transcriptomics",
            "probability": 4.575212863029285e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development",
            "probability": 3.443857708810604e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.8885498046875
        },
        {
            "text": "transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.4897410958690085e-05,
            "start_logit": -4.508548736572266,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/),",
            "probability": 1.1601656146915916e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -6.100183010101318
        },
        {
            "text": "OikoBase will provide a valuable resource for research in chordate development,",
            "probability": 1.1255012950133775e-05,
            "start_logit": -1.70566725730896,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "and developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.0207982488720928e-05,
            "start_logit": -4.886566162109375,
            "end_logit": 2.044372797012329
        }
    ],
    "56ae6e650a360a5e4500000e_020": [
        {
            "text": "OikoBase",
            "probability": 0.9767158071716487,
            "start_logit": 5.2492241859436035,
            "end_logit": 3.377363443374634
        },
        {
            "text": "OikoBase:",
            "probability": 0.012836813073785048,
            "start_logit": 5.2492241859436035,
            "end_logit": -0.9545152187347412
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 0.004779541807547902,
            "start_logit": 1.2623637914657593,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase: a genomics and developmental transcriptomics",
            "probability": 0.0024653737866202215,
            "start_logit": 5.2492241859436035,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "O",
            "probability": 0.0008301234054235274,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.6930131912231445
        },
        {
            "text": "Oiko",
            "probability": 0.0006717801652631293,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.904656410217285
        },
        {
            "text": "OikoBase: a genomics",
            "probability": 0.00040270538879144625,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.416382312774658
        },
        {
            "text": "OikoBase: a genomics and developmental",
            "probability": 0.0003733690841071465,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.492020130157471
        },
        {
            "text": "development of OikoBase",
            "probability": 0.00023875076459838775,
            "start_logit": -1.7343159914016724,
            "end_logit": 2.044372797012329
        },
        {
            "text": "development",
            "probability": 0.00020451956347906057,
            "start_logit": 1.1941827535629272,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "OikoBase facilitates retrieval and mining of a variety of useful genomics",
            "probability": 0.00011051730625689361,
            "start_logit": 4.0375471115112305,
            "end_logit": -4.497738361358643
        },
        {
            "text": "Base",
            "probability": 0.00011028588515007617,
            "start_logit": -3.839650869369507,
            "end_logit": 3.377363443374634
        },
        {
            "text": "the development of OikoBase",
            "probability": 7.092381557796225e-05,
            "start_logit": -2.948129892349243,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome",
            "probability": 6.133601348757512e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -4.434963703155518
        },
        {
            "text": "developmental transcriptomics",
            "probability": 4.575212863029285e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development",
            "probability": 3.443857708810604e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.8885498046875
        },
        {
            "text": "transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.4897410958690085e-05,
            "start_logit": -4.508548736572266,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/),",
            "probability": 1.1601656146915916e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -6.100183010101318
        },
        {
            "text": "OikoBase will provide a valuable resource for research in chordate development,",
            "probability": 1.1255012950133775e-05,
            "start_logit": -1.70566725730896,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "and developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.0207982488720928e-05,
            "start_logit": -4.886566162109375,
            "end_logit": 2.044372797012329
        }
    ],
    "56ae6e650a360a5e4500000e_025": [
        {
            "text": "OikoBase",
            "probability": 0.9767158071716487,
            "start_logit": 5.2492241859436035,
            "end_logit": 3.377363443374634
        },
        {
            "text": "OikoBase:",
            "probability": 0.012836813073785048,
            "start_logit": 5.2492241859436035,
            "end_logit": -0.9545152187347412
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 0.004779541807547902,
            "start_logit": 1.2623637914657593,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase: a genomics and developmental transcriptomics",
            "probability": 0.0024653737866202215,
            "start_logit": 5.2492241859436035,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "O",
            "probability": 0.0008301234054235274,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.6930131912231445
        },
        {
            "text": "Oiko",
            "probability": 0.0006717801652631293,
            "start_logit": 5.2492241859436035,
            "end_logit": -3.904656410217285
        },
        {
            "text": "OikoBase: a genomics",
            "probability": 0.00040270538879144625,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.416382312774658
        },
        {
            "text": "OikoBase: a genomics and developmental",
            "probability": 0.0003733690841071465,
            "start_logit": 5.2492241859436035,
            "end_logit": -4.492020130157471
        },
        {
            "text": "development of OikoBase",
            "probability": 0.00023875076459838775,
            "start_logit": -1.7343159914016724,
            "end_logit": 2.044372797012329
        },
        {
            "text": "development",
            "probability": 0.00020451956347906057,
            "start_logit": 1.1941827535629272,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "OikoBase facilitates retrieval and mining of a variety of useful genomics",
            "probability": 0.00011051730625689361,
            "start_logit": 4.0375471115112305,
            "end_logit": -4.497738361358643
        },
        {
            "text": "Base",
            "probability": 0.00011028588515007617,
            "start_logit": -3.839650869369507,
            "end_logit": 3.377363443374634
        },
        {
            "text": "the development of OikoBase",
            "probability": 7.092381557796225e-05,
            "start_logit": -2.948129892349243,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome",
            "probability": 6.133601348757512e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -4.434963703155518
        },
        {
            "text": "developmental transcriptomics",
            "probability": 4.575212863029285e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.6044888496398926
        },
        {
            "text": "developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development",
            "probability": 3.443857708810604e-05,
            "start_logit": 1.2623637914657593,
            "end_logit": -2.8885498046875
        },
        {
            "text": "transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.4897410958690085e-05,
            "start_logit": -4.508548736572266,
            "end_logit": 2.044372797012329
        },
        {
            "text": "OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/),",
            "probability": 1.1601656146915916e-05,
            "start_logit": 3.385967493057251,
            "end_logit": -6.100183010101318
        },
        {
            "text": "OikoBase will provide a valuable resource for research in chordate development,",
            "probability": 1.1255012950133775e-05,
            "start_logit": -1.70566725730896,
            "end_logit": -1.0388824939727783
        },
        {
            "text": "and developmental transcriptomics resource for the urochordate Oikopleura dioica. We report the development of OikoBase",
            "probability": 1.0207982488720928e-05,
            "start_logit": -4.886566162109375,
            "end_logit": 2.044372797012329
        }
    ],
    "5314bd7ddae131f847000006_001": [
        {
            "text": "insulin",
            "probability": 0.974385383715744,
            "start_logit": 9.597496032714844,
            "end_logit": 8.894697189331055
        },
        {
            "text": "insulin resistance. This disease is caused by a defective insulin",
            "probability": 0.025344122584700233,
            "start_logit": 5.948235988616943,
            "end_logit": 8.894697189331055
        },
        {
            "text": "ins",
            "probability": 0.00011957028365119905,
            "start_logit": 9.597496032714844,
            "end_logit": -0.11096064001321793
        },
        {
            "text": "ulin",
            "probability": 8.651145922178518e-05,
            "start_logit": 0.2682107388973236,
            "end_logit": 8.894697189331055
        },
        {
            "text": "insulin receptor",
            "probability": 4.092724082904097e-05,
            "start_logit": 9.597496032714844,
            "end_logit": -1.183069109916687
        },
        {
            "text": "defective insulin",
            "probability": 8.643642348808586e-06,
            "start_logit": -2.0352420806884766,
            "end_logit": 8.894697189331055
        },
        {
            "text": "caused by a defective insulin",
            "probability": 4.194099167153964e-06,
            "start_logit": -2.758387565612793,
            "end_logit": 8.894697189331055
        },
        {
            "text": "insulin resistance. This disease is caused by a defective",
            "probability": 2.813919574699133e-06,
            "start_logit": 5.948235988616943,
            "end_logit": -0.21102656424045563
        },
        {
            "text": "a defective insulin",
            "probability": 2.240756802534829e-06,
            "start_logit": -3.3852524757385254,
            "end_logit": 8.894697189331055
        },
        {
            "text": "insulin receptor and features abnormal",
            "probability": 1.1410233476062717e-06,
            "start_logit": 9.597496032714844,
            "end_logit": -4.762939453125
        },
        {
            "text": "insulin resistance. This disease is caused by a defective insulin receptor",
            "probability": 1.0645326027667122e-06,
            "start_logit": 5.948235988616943,
            "end_logit": -1.183069109916687
        },
        {
            "text": "characterized by severe insulin resistance. This disease is caused by a defective insulin",
            "probability": 9.821336969888416e-07,
            "start_logit": -4.210093975067139,
            "end_logit": 8.894697189331055
        },
        {
            "text": "This disease is caused by a defective insulin",
            "probability": 5.832461340974635e-07,
            "start_logit": -4.731212139129639,
            "end_logit": 8.894697189331055
        },
        {
            "text": "insulin receptor and features abnormal glucose metabolism",
            "probability": 4.867017383214277e-07,
            "start_logit": 9.597496032714844,
            "end_logit": -5.614968776702881
        },
        {
            "text": "is caused by a defective insulin",
            "probability": 4.5082170002633927e-07,
            "start_logit": -4.9887495040893555,
            "end_logit": 8.894697189331055
        },
        {
            "text": "insulin receptor and",
            "probability": 2.7732685375383357e-07,
            "start_logit": 9.597496032714844,
            "end_logit": -6.177423477172852
        },
        {
            "text": "is characterized by severe insulin resistance. This disease is caused by a defective insulin",
            "probability": 2.132241839989516e-07,
            "start_logit": -5.7374773025512695,
            "end_logit": 8.894697189331055
        },
        {
            "text": "resistance. This disease is caused by a defective insulin",
            "probability": 2.089768538122413e-07,
            "start_logit": -5.757597923278809,
            "end_logit": 8.894697189331055
        },
        {
            "text": "insulin resistance. This disease is caused by",
            "probability": 1.5463241205009225e-07,
            "start_logit": 5.948235988616943,
            "end_logit": -3.112309455871582
        },
        {
            "text": "insulin resistance. This disease is caused by a defective insulin receptor and features abnormal",
            "probability": 2.9678437379120876e-08,
            "start_logit": 5.948235988616943,
            "end_logit": -4.762939453125
        }
    ],
    "5314bd7ddae131f847000006_002": [
        {
            "text": "insulin",
            "probability": 0.5071985436961178,
            "start_logit": 9.779427528381348,
            "end_logit": 8.949786186218262
        },
        {
            "text": "insulin receptor (INSR) gene mutations cause congenital syndromes of severe insulin",
            "probability": 0.4925115533029709,
            "start_logit": 9.779427528381348,
            "end_logit": 8.920401573181152
        },
        {
            "text": "ins",
            "probability": 0.00012694361392720082,
            "start_logit": 9.779427528381348,
            "end_logit": 0.6568713784217834
        },
        {
            "text": "insulin receptor",
            "probability": 0.0001151044240303109,
            "start_logit": 9.779427528381348,
            "end_logit": 0.5589681267738342
        },
        {
            "text": "ulin",
            "probability": 2.847683531686812e-05,
            "start_logit": -0.008139321580529213,
            "end_logit": 8.949786186218262
        },
        {
            "text": "insulin resistance",
            "probability": 6.601667597591643e-06,
            "start_logit": 9.79945182800293,
            "end_logit": -2.3195736408233643
        },
        {
            "text": "insulin receptor (INSR) gene mutations cause congenital syndromes of severe insulin resistance",
            "probability": 6.4707885811472405e-06,
            "start_logit": 9.779427528381348,
            "end_logit": -2.3195736408233643
        },
        {
            "text": "Biallelic insulin",
            "probability": 1.679387088349838e-06,
            "start_logit": -2.838801383972168,
            "end_logit": 8.949786186218262
        },
        {
            "text": "Biallelic insulin receptor (INSR) gene mutations cause congenital syndromes of severe insulin",
            "probability": 1.6307569368252966e-06,
            "start_logit": -2.838801383972168,
            "end_logit": 8.920401573181152
        },
        {
            "text": "insulin receptor: Is a Bartter-like syndrome a feature of congenital SIR? Biallelic insulin",
            "probability": 1.208443655350287e-06,
            "start_logit": -3.1678969860076904,
            "end_logit": 8.949786186218262
        },
        {
            "text": "insulin receptor (INSR) gene",
            "probability": 5.78951075474467e-07,
            "start_logit": 9.779427528381348,
            "end_logit": -4.7334089279174805
        },
        {
            "text": "insulin receptor (INSR) gene mutations",
            "probability": 3.1293157435609067e-07,
            "start_logit": 9.779427528381348,
            "end_logit": -5.348642349243164
        },
        {
            "text": "insulin receptor (INSR)",
            "probability": 2.7832113160809696e-07,
            "start_logit": 9.779427528381348,
            "end_logit": -5.465851306915283
        },
        {
            "text": "receptor (INSR) gene mutations cause congenital syndromes of severe insulin",
            "probability": 2.440189261914752e-07,
            "start_logit": -4.7383551597595215,
            "end_logit": 8.920401573181152
        },
        {
            "text": "severe insulin",
            "probability": 9.069779750182573e-08,
            "start_logit": -5.728067874908447,
            "end_logit": 8.920401573181152
        },
        {
            "text": "(INSR) gene mutations cause congenital syndromes of severe insulin",
            "probability": 6.590980775089054e-08,
            "start_logit": -6.047313690185547,
            "end_logit": 8.920401573181152
        },
        {
            "text": "insulin receptor (INSR) gene mutations cause congenital syndromes of severe",
            "probability": 6.482089456806688e-08,
            "start_logit": 9.779427528381348,
            "end_logit": -6.922998905181885
        },
        {
            "text": "cause congenital syndromes of severe insulin",
            "probability": 6.127305782800728e-08,
            "start_logit": -6.120260715484619,
            "end_logit": 8.920401573181152
        },
        {
            "text": "congenital syndromes of severe insulin",
            "probability": 4.833528862600839e-08,
            "start_logit": -6.357439041137695,
            "end_logit": 8.920401573181152
        },
        {
            "text": "insulin resistance (SIR) known as Donohue syndrome",
            "probability": 4.182422366477656e-08,
            "start_logit": 9.79945182800293,
            "end_logit": -7.381175518035889
        }
    ],
    "5314bd7ddae131f847000006_003": [
        {
            "text": "insulin",
            "probability": 0.5071985436961178,
            "start_logit": 9.779427528381348,
            "end_logit": 8.949786186218262
        },
        {
            "text": "insulin receptor (INSR) gene mutations cause congenital syndromes of severe insulin",
            "probability": 0.4925115533029709,
            "start_logit": 9.779427528381348,
            "end_logit": 8.920401573181152
        },
        {
            "text": "ins",
            "probability": 0.00012694361392720082,
            "start_logit": 9.779427528381348,
            "end_logit": 0.6568713784217834
        },
        {
            "text": "insulin receptor",
            "probability": 0.0001151044240303109,
            "start_logit": 9.779427528381348,
            "end_logit": 0.5589681267738342
        },
        {
            "text": "ulin",
            "probability": 2.847683531686812e-05,
            "start_logit": -0.008139321580529213,
            "end_logit": 8.949786186218262
        },
        {
            "text": "insulin resistance",
            "probability": 6.601667597591643e-06,
            "start_logit": 9.79945182800293,
            "end_logit": -2.3195736408233643
        },
        {
            "text": "insulin receptor (INSR) gene mutations cause congenital syndromes of severe insulin resistance",
            "probability": 6.4707885811472405e-06,
            "start_logit": 9.779427528381348,
            "end_logit": -2.3195736408233643
        },
        {
            "text": "Biallelic insulin",
            "probability": 1.679387088349838e-06,
            "start_logit": -2.838801383972168,
            "end_logit": 8.949786186218262
        },
        {
            "text": "Biallelic insulin receptor (INSR) gene mutations cause congenital syndromes of severe insulin",
            "probability": 1.6307569368252966e-06,
            "start_logit": -2.838801383972168,
            "end_logit": 8.920401573181152
        },
        {
            "text": "insulin receptor: Is a Bartter-like syndrome a feature of congenital SIR? Biallelic insulin",
            "probability": 1.208443655350287e-06,
            "start_logit": -3.1678969860076904,
            "end_logit": 8.949786186218262
        },
        {
            "text": "insulin receptor (INSR) gene",
            "probability": 5.78951075474467e-07,
            "start_logit": 9.779427528381348,
            "end_logit": -4.7334089279174805
        },
        {
            "text": "insulin receptor (INSR) gene mutations",
            "probability": 3.1293157435609067e-07,
            "start_logit": 9.779427528381348,
            "end_logit": -5.348642349243164
        },
        {
            "text": "insulin receptor (INSR)",
            "probability": 2.7832113160809696e-07,
            "start_logit": 9.779427528381348,
            "end_logit": -5.465851306915283
        },
        {
            "text": "receptor (INSR) gene mutations cause congenital syndromes of severe insulin",
            "probability": 2.440189261914752e-07,
            "start_logit": -4.7383551597595215,
            "end_logit": 8.920401573181152
        },
        {
            "text": "severe insulin",
            "probability": 9.069779750182573e-08,
            "start_logit": -5.728067874908447,
            "end_logit": 8.920401573181152
        },
        {
            "text": "(INSR) gene mutations cause congenital syndromes of severe insulin",
            "probability": 6.590980775089054e-08,
            "start_logit": -6.047313690185547,
            "end_logit": 8.920401573181152
        },
        {
            "text": "insulin receptor (INSR) gene mutations cause congenital syndromes of severe",
            "probability": 6.482089456806688e-08,
            "start_logit": 9.779427528381348,
            "end_logit": -6.922998905181885
        },
        {
            "text": "cause congenital syndromes of severe insulin",
            "probability": 6.127305782800728e-08,
            "start_logit": -6.120260715484619,
            "end_logit": 8.920401573181152
        },
        {
            "text": "congenital syndromes of severe insulin",
            "probability": 4.833528862600839e-08,
            "start_logit": -6.357439041137695,
            "end_logit": 8.920401573181152
        },
        {
            "text": "insulin resistance (SIR) known as Donohue syndrome",
            "probability": 4.182422366477656e-08,
            "start_logit": 9.79945182800293,
            "end_logit": -7.381175518035889
        }
    ],
    "5314bd7ddae131f847000006_004": [
        {
            "text": "insulin",
            "probability": 0.2590700114232312,
            "start_logit": 9.181214332580566,
            "end_logit": 8.41797161102295
        },
        {
            "text": "insulin receptor gene (INSR) causing either defects in insulin",
            "probability": 0.2537206485311127,
            "start_logit": 9.181214332580566,
            "end_logit": 8.397107124328613
        },
        {
            "text": "insulin resistance due to mutations in the insulin",
            "probability": 0.24611649147769016,
            "start_logit": 9.129920959472656,
            "end_logit": 8.41797161102295
        },
        {
            "text": "insulin resistance due to mutations in the insulin receptor gene (INSR) causing either defects in insulin",
            "probability": 0.24103459713022615,
            "start_logit": 9.129920959472656,
            "end_logit": 8.397107124328613
        },
        {
            "text": "ins",
            "probability": 3.4210110260101043e-05,
            "start_logit": 9.181214332580566,
            "end_logit": -0.514360785484314
        },
        {
            "text": "ulin",
            "probability": 1.6137362922229193e-05,
            "start_logit": -0.5025020241737366,
            "end_logit": 8.41797161102295
        },
        {
            "text": "decreased insulin",
            "probability": 2.6610290011632843e-06,
            "start_logit": -2.1563210487365723,
            "end_logit": 8.269366264343262
        },
        {
            "text": "the insulin",
            "probability": 8.946198465091517e-07,
            "start_logit": -3.39499568939209,
            "end_logit": 8.41797161102295
        },
        {
            "text": "the insulin receptor gene (INSR) causing either defects in insulin",
            "probability": 8.761474413736507e-07,
            "start_logit": -3.39499568939209,
            "end_logit": 8.397107124328613
        },
        {
            "text": "defects in insulin",
            "probability": 5.011769515805084e-07,
            "start_logit": -3.95357084274292,
            "end_logit": 8.397107124328613
        },
        {
            "text": "insulin receptor",
            "probability": 3.489488645310224e-07,
            "start_logit": 9.074454307556152,
            "end_logit": -4.9929518699646
        },
        {
            "text": "insulin receptor gene (INSR) causing either defects in insulin binding or receptor autophosphorylation",
            "probability": 3.391601851248143e-07,
            "start_logit": 9.181214332580566,
            "end_logit": -5.128164768218994
        },
        {
            "text": "insulin binding or receptor autophosphorylation",
            "probability": 3.345710557107554e-07,
            "start_logit": 9.167591094970703,
            "end_logit": -5.128164768218994
        },
        {
            "text": "insulin resistance",
            "probability": 3.194203226817392e-07,
            "start_logit": 9.129920959472656,
            "end_logit": -5.136836051940918
        },
        {
            "text": "insulin receptor gene (INSR) causing either defects in insulin binding or receptor",
            "probability": 3.1321514039030076e-07,
            "start_logit": 9.181214332580566,
            "end_logit": -5.207746982574463
        },
        {
            "text": "insulin receptor gene (INSR) causing either defects",
            "probability": 3.093186260835149e-07,
            "start_logit": 9.181214332580566,
            "end_logit": -5.2202653884887695
        },
        {
            "text": "insulin binding or receptor",
            "probability": 3.089770697772518e-07,
            "start_logit": 9.167591094970703,
            "end_logit": -5.207746982574463
        },
        {
            "text": "insulin resistance due to mutations in the insulin receptor gene (INSR) causing either defects",
            "probability": 2.9385267164715027e-07,
            "start_logit": 9.129920959472656,
            "end_logit": -5.2202653884887695
        },
        {
            "text": "insulin resistance due to mutations in the insulin receptor",
            "probability": 2.0561906235436835e-07,
            "start_logit": 9.129920959472656,
            "end_logit": -5.5773186683654785
        },
        {
            "text": "causing either defects in insulin",
            "probability": 1.9790831853582165e-07,
            "start_logit": -4.882726192474365,
            "end_logit": 8.397107124328613
        }
    ],
    "5314bd7ddae131f847000006_005": [
        {
            "text": "insulin",
            "probability": 0.2590700114232312,
            "start_logit": 9.181214332580566,
            "end_logit": 8.41797161102295
        },
        {
            "text": "insulin receptor gene (INSR) causing either defects in insulin",
            "probability": 0.2537206485311127,
            "start_logit": 9.181214332580566,
            "end_logit": 8.397107124328613
        },
        {
            "text": "insulin resistance due to mutations in the insulin",
            "probability": 0.24611649147769016,
            "start_logit": 9.129920959472656,
            "end_logit": 8.41797161102295
        },
        {
            "text": "insulin resistance due to mutations in the insulin receptor gene (INSR) causing either defects in insulin",
            "probability": 0.24103459713022615,
            "start_logit": 9.129920959472656,
            "end_logit": 8.397107124328613
        },
        {
            "text": "ins",
            "probability": 3.4210110260101043e-05,
            "start_logit": 9.181214332580566,
            "end_logit": -0.514360785484314
        },
        {
            "text": "ulin",
            "probability": 1.6137362922229193e-05,
            "start_logit": -0.5025020241737366,
            "end_logit": 8.41797161102295
        },
        {
            "text": "decreased insulin",
            "probability": 2.6610290011632843e-06,
            "start_logit": -2.1563210487365723,
            "end_logit": 8.269366264343262
        },
        {
            "text": "the insulin",
            "probability": 8.946198465091517e-07,
            "start_logit": -3.39499568939209,
            "end_logit": 8.41797161102295
        },
        {
            "text": "the insulin receptor gene (INSR) causing either defects in insulin",
            "probability": 8.761474413736507e-07,
            "start_logit": -3.39499568939209,
            "end_logit": 8.397107124328613
        },
        {
            "text": "defects in insulin",
            "probability": 5.011769515805084e-07,
            "start_logit": -3.95357084274292,
            "end_logit": 8.397107124328613
        },
        {
            "text": "insulin receptor",
            "probability": 3.489488645310224e-07,
            "start_logit": 9.074454307556152,
            "end_logit": -4.9929518699646
        },
        {
            "text": "insulin receptor gene (INSR) causing either defects in insulin binding or receptor autophosphorylation",
            "probability": 3.391601851248143e-07,
            "start_logit": 9.181214332580566,
            "end_logit": -5.128164768218994
        },
        {
            "text": "insulin binding or receptor autophosphorylation",
            "probability": 3.345710557107554e-07,
            "start_logit": 9.167591094970703,
            "end_logit": -5.128164768218994
        },
        {
            "text": "insulin resistance",
            "probability": 3.194203226817392e-07,
            "start_logit": 9.129920959472656,
            "end_logit": -5.136836051940918
        },
        {
            "text": "insulin receptor gene (INSR) causing either defects in insulin binding or receptor",
            "probability": 3.1321514039030076e-07,
            "start_logit": 9.181214332580566,
            "end_logit": -5.207746982574463
        },
        {
            "text": "insulin receptor gene (INSR) causing either defects",
            "probability": 3.093186260835149e-07,
            "start_logit": 9.181214332580566,
            "end_logit": -5.2202653884887695
        },
        {
            "text": "insulin binding or receptor",
            "probability": 3.089770697772518e-07,
            "start_logit": 9.167591094970703,
            "end_logit": -5.207746982574463
        },
        {
            "text": "insulin resistance due to mutations in the insulin receptor gene (INSR) causing either defects",
            "probability": 2.9385267164715027e-07,
            "start_logit": 9.129920959472656,
            "end_logit": -5.2202653884887695
        },
        {
            "text": "insulin resistance due to mutations in the insulin receptor",
            "probability": 2.0561906235436835e-07,
            "start_logit": 9.129920959472656,
            "end_logit": -5.5773186683654785
        },
        {
            "text": "causing either defects in insulin",
            "probability": 1.9790831853582165e-07,
            "start_logit": -4.882726192474365,
            "end_logit": 8.397107124328613
        }
    ],
    "5314bd7ddae131f847000006_006": [
        {
            "text": "insulin",
            "probability": 0.2590700114232312,
            "start_logit": 9.181214332580566,
            "end_logit": 8.41797161102295
        },
        {
            "text": "insulin receptor gene (INSR) causing either defects in insulin",
            "probability": 0.2537206485311127,
            "start_logit": 9.181214332580566,
            "end_logit": 8.397107124328613
        },
        {
            "text": "insulin resistance due to mutations in the insulin",
            "probability": 0.24611649147769016,
            "start_logit": 9.129920959472656,
            "end_logit": 8.41797161102295
        },
        {
            "text": "insulin resistance due to mutations in the insulin receptor gene (INSR) causing either defects in insulin",
            "probability": 0.24103459713022615,
            "start_logit": 9.129920959472656,
            "end_logit": 8.397107124328613
        },
        {
            "text": "ins",
            "probability": 3.4210110260101043e-05,
            "start_logit": 9.181214332580566,
            "end_logit": -0.514360785484314
        },
        {
            "text": "ulin",
            "probability": 1.6137362922229193e-05,
            "start_logit": -0.5025020241737366,
            "end_logit": 8.41797161102295
        },
        {
            "text": "decreased insulin",
            "probability": 2.6610290011632843e-06,
            "start_logit": -2.1563210487365723,
            "end_logit": 8.269366264343262
        },
        {
            "text": "the insulin",
            "probability": 8.946198465091517e-07,
            "start_logit": -3.39499568939209,
            "end_logit": 8.41797161102295
        },
        {
            "text": "the insulin receptor gene (INSR) causing either defects in insulin",
            "probability": 8.761474413736507e-07,
            "start_logit": -3.39499568939209,
            "end_logit": 8.397107124328613
        },
        {
            "text": "defects in insulin",
            "probability": 5.011769515805084e-07,
            "start_logit": -3.95357084274292,
            "end_logit": 8.397107124328613
        },
        {
            "text": "insulin receptor",
            "probability": 3.489488645310224e-07,
            "start_logit": 9.074454307556152,
            "end_logit": -4.9929518699646
        },
        {
            "text": "insulin receptor gene (INSR) causing either defects in insulin binding or receptor autophosphorylation",
            "probability": 3.391601851248143e-07,
            "start_logit": 9.181214332580566,
            "end_logit": -5.128164768218994
        },
        {
            "text": "insulin binding or receptor autophosphorylation",
            "probability": 3.345710557107554e-07,
            "start_logit": 9.167591094970703,
            "end_logit": -5.128164768218994
        },
        {
            "text": "insulin resistance",
            "probability": 3.194203226817392e-07,
            "start_logit": 9.129920959472656,
            "end_logit": -5.136836051940918
        },
        {
            "text": "insulin receptor gene (INSR) causing either defects in insulin binding or receptor",
            "probability": 3.1321514039030076e-07,
            "start_logit": 9.181214332580566,
            "end_logit": -5.207746982574463
        },
        {
            "text": "insulin receptor gene (INSR) causing either defects",
            "probability": 3.093186260835149e-07,
            "start_logit": 9.181214332580566,
            "end_logit": -5.2202653884887695
        },
        {
            "text": "insulin binding or receptor",
            "probability": 3.089770697772518e-07,
            "start_logit": 9.167591094970703,
            "end_logit": -5.207746982574463
        },
        {
            "text": "insulin resistance due to mutations in the insulin receptor gene (INSR) causing either defects",
            "probability": 2.9385267164715027e-07,
            "start_logit": 9.129920959472656,
            "end_logit": -5.2202653884887695
        },
        {
            "text": "insulin resistance due to mutations in the insulin receptor",
            "probability": 2.0561906235436835e-07,
            "start_logit": 9.129920959472656,
            "end_logit": -5.5773186683654785
        },
        {
            "text": "causing either defects in insulin",
            "probability": 1.9790831853582165e-07,
            "start_logit": -4.882726192474365,
            "end_logit": 8.397107124328613
        }
    ],
    "5314bd7ddae131f847000006_007": [
        {
            "text": "insulin",
            "probability": 0.2590700114232312,
            "start_logit": 9.181214332580566,
            "end_logit": 8.41797161102295
        },
        {
            "text": "insulin receptor gene (INSR) causing either defects in insulin",
            "probability": 0.2537206485311127,
            "start_logit": 9.181214332580566,
            "end_logit": 8.397107124328613
        },
        {
            "text": "insulin resistance due to mutations in the insulin",
            "probability": 0.24611649147769016,
            "start_logit": 9.129920959472656,
            "end_logit": 8.41797161102295
        },
        {
            "text": "insulin resistance due to mutations in the insulin receptor gene (INSR) causing either defects in insulin",
            "probability": 0.24103459713022615,
            "start_logit": 9.129920959472656,
            "end_logit": 8.397107124328613
        },
        {
            "text": "ins",
            "probability": 3.4210110260101043e-05,
            "start_logit": 9.181214332580566,
            "end_logit": -0.514360785484314
        },
        {
            "text": "ulin",
            "probability": 1.6137362922229193e-05,
            "start_logit": -0.5025020241737366,
            "end_logit": 8.41797161102295
        },
        {
            "text": "decreased insulin",
            "probability": 2.6610290011632843e-06,
            "start_logit": -2.1563210487365723,
            "end_logit": 8.269366264343262
        },
        {
            "text": "the insulin",
            "probability": 8.946198465091517e-07,
            "start_logit": -3.39499568939209,
            "end_logit": 8.41797161102295
        },
        {
            "text": "the insulin receptor gene (INSR) causing either defects in insulin",
            "probability": 8.761474413736507e-07,
            "start_logit": -3.39499568939209,
            "end_logit": 8.397107124328613
        },
        {
            "text": "defects in insulin",
            "probability": 5.011769515805084e-07,
            "start_logit": -3.95357084274292,
            "end_logit": 8.397107124328613
        },
        {
            "text": "insulin receptor",
            "probability": 3.489488645310224e-07,
            "start_logit": 9.074454307556152,
            "end_logit": -4.9929518699646
        },
        {
            "text": "insulin receptor gene (INSR) causing either defects in insulin binding or receptor autophosphorylation",
            "probability": 3.391601851248143e-07,
            "start_logit": 9.181214332580566,
            "end_logit": -5.128164768218994
        },
        {
            "text": "insulin binding or receptor autophosphorylation",
            "probability": 3.345710557107554e-07,
            "start_logit": 9.167591094970703,
            "end_logit": -5.128164768218994
        },
        {
            "text": "insulin resistance",
            "probability": 3.194203226817392e-07,
            "start_logit": 9.129920959472656,
            "end_logit": -5.136836051940918
        },
        {
            "text": "insulin receptor gene (INSR) causing either defects in insulin binding or receptor",
            "probability": 3.1321514039030076e-07,
            "start_logit": 9.181214332580566,
            "end_logit": -5.207746982574463
        },
        {
            "text": "insulin receptor gene (INSR) causing either defects",
            "probability": 3.093186260835149e-07,
            "start_logit": 9.181214332580566,
            "end_logit": -5.2202653884887695
        },
        {
            "text": "insulin binding or receptor",
            "probability": 3.089770697772518e-07,
            "start_logit": 9.167591094970703,
            "end_logit": -5.207746982574463
        },
        {
            "text": "insulin resistance due to mutations in the insulin receptor gene (INSR) causing either defects",
            "probability": 2.9385267164715027e-07,
            "start_logit": 9.129920959472656,
            "end_logit": -5.2202653884887695
        },
        {
            "text": "insulin resistance due to mutations in the insulin receptor",
            "probability": 2.0561906235436835e-07,
            "start_logit": 9.129920959472656,
            "end_logit": -5.5773186683654785
        },
        {
            "text": "causing either defects in insulin",
            "probability": 1.9790831853582165e-07,
            "start_logit": -4.882726192474365,
            "end_logit": 8.397107124328613
        }
    ],
    "5314bd7ddae131f847000006_008": [
        {
            "text": "insulin",
            "probability": 0.5211605625256729,
            "start_logit": 9.54006290435791,
            "end_logit": 8.564249992370605
        },
        {
            "text": "insulin receptor gene. Leprechaunism (Donohue syndrome) is the most severe type of insulin",
            "probability": 0.47738485984056633,
            "start_logit": 9.452327728271484,
            "end_logit": 8.564249992370605
        },
        {
            "text": "insulin receptor",
            "probability": 0.0013536600324062101,
            "start_logit": 9.54006290435791,
            "end_logit": 2.611003875732422
        },
        {
            "text": "ins",
            "probability": 7.822623923259943e-05,
            "start_logit": 9.54006290435791,
            "end_logit": -0.23995833098888397
        },
        {
            "text": "ulin",
            "probability": 2.190250473623488e-05,
            "start_logit": -0.5542632341384888,
            "end_logit": 8.581363677978516
        },
        {
            "text": "insulin receptor gene. Leprechaunism",
            "probability": 1.3128513433017247e-07,
            "start_logit": 9.452327728271484,
            "end_logit": -6.542212009429932
        },
        {
            "text": "Leprechaunism (Donohue syndrome): a case bearing novel compound heterozygous mutations in the insulin",
            "probability": 1.05035967764837e-07,
            "start_logit": -5.894316673278809,
            "end_logit": 8.581363677978516
        },
        {
            "text": "Leprechaunism (Donohue syndrome) is the most severe type of insulin",
            "probability": 8.255756315221038e-08,
            "start_logit": -6.1180100440979,
            "end_logit": 8.564249992370605
        },
        {
            "text": "receptor gene. Leprechaunism (Donohue syndrome) is the most severe type of insulin",
            "probability": 6.869693779344327e-08,
            "start_logit": -6.3018012046813965,
            "end_logit": 8.564249992370605
        },
        {
            "text": "insulin receptor gene.",
            "probability": 6.60179942970649e-08,
            "start_logit": 9.452327728271484,
            "end_logit": -7.229656219482422
        },
        {
            "text": "(Donohue syndrome): a case bearing novel compound heterozygous mutations in the insulin",
            "probability": 5.632898515061353e-08,
            "start_logit": -6.5174102783203125,
            "end_logit": 8.581363677978516
        },
        {
            "text": "insulin receptor gene. Leprechaunism (Donohue syndrome) is the most severe type of insulin receptor",
            "probability": 5.59241595184363e-08,
            "start_logit": -0.5542632341384888,
            "end_logit": 2.611003875732422
        },
        {
            "text": "the insulin",
            "probability": 5.0626900578544085e-08,
            "start_logit": -6.624136447906494,
            "end_logit": 8.581363677978516
        },
        {
            "text": "the insulin receptor gene. Leprechaunism (Donohue syndrome) is the most severe type of insulin",
            "probability": 4.976785936546624e-08,
            "start_logit": -6.624136447906494,
            "end_logit": 8.564249992370605
        },
        {
            "text": "insulin receptor (INSR)",
            "probability": 3.4214116346049416e-08,
            "start_logit": 9.54006290435791,
            "end_logit": -7.974680423736572
        },
        {
            "text": "insulin receptor (INSR) gene",
            "probability": 3.3789075987844253e-08,
            "start_logit": 9.54006290435791,
            "end_logit": -7.987181186676025
        },
        {
            "text": "the most severe type of insulin",
            "probability": 2.7645000585471318e-08,
            "start_logit": -7.212060928344727,
            "end_logit": 8.564249992370605
        },
        {
            "text": "a case bearing novel compound heterozygous mutations in the insulin",
            "probability": 2.598876809244788e-08,
            "start_logit": -7.290955066680908,
            "end_logit": 8.581363677978516
        },
        {
            "text": "ceptor",
            "probability": 7.211491500999153e-10,
            "start_logit": -4.9051690101623535,
            "end_logit": 2.611003875732422
        },
        {
            "text": "receptor",
            "probability": 2.577738595725264e-10,
            "start_logit": -5.933932304382324,
            "end_logit": 2.611003875732422
        }
    ],
    "5314bd7ddae131f847000006_009": [
        {
            "text": "insulin",
            "probability": 0.5211605625256729,
            "start_logit": 9.54006290435791,
            "end_logit": 8.564249992370605
        },
        {
            "text": "insulin receptor gene. Leprechaunism (Donohue syndrome) is the most severe type of insulin",
            "probability": 0.47738485984056633,
            "start_logit": 9.452327728271484,
            "end_logit": 8.564249992370605
        },
        {
            "text": "insulin receptor",
            "probability": 0.0013536600324062101,
            "start_logit": 9.54006290435791,
            "end_logit": 2.611003875732422
        },
        {
            "text": "ins",
            "probability": 7.822623923259943e-05,
            "start_logit": 9.54006290435791,
            "end_logit": -0.23995833098888397
        },
        {
            "text": "ulin",
            "probability": 2.190250473623488e-05,
            "start_logit": -0.5542632341384888,
            "end_logit": 8.581363677978516
        },
        {
            "text": "insulin receptor gene. Leprechaunism",
            "probability": 1.3128513433017247e-07,
            "start_logit": 9.452327728271484,
            "end_logit": -6.542212009429932
        },
        {
            "text": "Leprechaunism (Donohue syndrome): a case bearing novel compound heterozygous mutations in the insulin",
            "probability": 1.05035967764837e-07,
            "start_logit": -5.894316673278809,
            "end_logit": 8.581363677978516
        },
        {
            "text": "Leprechaunism (Donohue syndrome) is the most severe type of insulin",
            "probability": 8.255756315221038e-08,
            "start_logit": -6.1180100440979,
            "end_logit": 8.564249992370605
        },
        {
            "text": "receptor gene. Leprechaunism (Donohue syndrome) is the most severe type of insulin",
            "probability": 6.869693779344327e-08,
            "start_logit": -6.3018012046813965,
            "end_logit": 8.564249992370605
        },
        {
            "text": "insulin receptor gene.",
            "probability": 6.60179942970649e-08,
            "start_logit": 9.452327728271484,
            "end_logit": -7.229656219482422
        },
        {
            "text": "(Donohue syndrome): a case bearing novel compound heterozygous mutations in the insulin",
            "probability": 5.632898515061353e-08,
            "start_logit": -6.5174102783203125,
            "end_logit": 8.581363677978516
        },
        {
            "text": "insulin receptor gene. Leprechaunism (Donohue syndrome) is the most severe type of insulin receptor",
            "probability": 5.59241595184363e-08,
            "start_logit": -0.5542632341384888,
            "end_logit": 2.611003875732422
        },
        {
            "text": "the insulin",
            "probability": 5.0626900578544085e-08,
            "start_logit": -6.624136447906494,
            "end_logit": 8.581363677978516
        },
        {
            "text": "the insulin receptor gene. Leprechaunism (Donohue syndrome) is the most severe type of insulin",
            "probability": 4.976785936546624e-08,
            "start_logit": -6.624136447906494,
            "end_logit": 8.564249992370605
        },
        {
            "text": "insulin receptor (INSR)",
            "probability": 3.4214116346049416e-08,
            "start_logit": 9.54006290435791,
            "end_logit": -7.974680423736572
        },
        {
            "text": "insulin receptor (INSR) gene",
            "probability": 3.3789075987844253e-08,
            "start_logit": 9.54006290435791,
            "end_logit": -7.987181186676025
        },
        {
            "text": "the most severe type of insulin",
            "probability": 2.7645000585471318e-08,
            "start_logit": -7.212060928344727,
            "end_logit": 8.564249992370605
        },
        {
            "text": "a case bearing novel compound heterozygous mutations in the insulin",
            "probability": 2.598876809244788e-08,
            "start_logit": -7.290955066680908,
            "end_logit": 8.581363677978516
        },
        {
            "text": "ceptor",
            "probability": 7.211491500999153e-10,
            "start_logit": -4.9051690101623535,
            "end_logit": 2.611003875732422
        },
        {
            "text": "receptor",
            "probability": 2.577738595725264e-10,
            "start_logit": -5.933932304382324,
            "end_logit": 2.611003875732422
        }
    ],
    "5314bd7ddae131f847000006_010": [
        {
            "text": "insulin",
            "probability": 0.9994273307798066,
            "start_logit": 9.482487678527832,
            "end_logit": 8.672887802124023
        },
        {
            "text": "insulin receptor.",
            "probability": 0.0003835743051270011,
            "start_logit": 9.482487678527832,
            "end_logit": 0.807483434677124
        },
        {
            "text": "ins",
            "probability": 0.00012775370830721706,
            "start_logit": 9.482487678527832,
            "end_logit": -0.2919456660747528
        },
        {
            "text": "ulin",
            "probability": 4.6977769808419546e-05,
            "start_logit": -0.4827755391597748,
            "end_logit": 8.672887802124023
        },
        {
            "text": "the insulin",
            "probability": 9.090067211025664e-06,
            "start_logit": -2.125267744064331,
            "end_logit": 8.672887802124023
        },
        {
            "text": "insulin receptor",
            "probability": 2.3910391842632078e-06,
            "start_logit": 9.312027931213379,
            "end_logit": -4.099862098693848
        },
        {
            "text": "insulin receptor. It is characterised by",
            "probability": 6.580649443629544e-07,
            "start_logit": 9.482487678527832,
            "end_logit": -5.560501575469971
        },
        {
            "text": "encoding the insulin",
            "probability": 5.866454770694485e-07,
            "start_logit": -4.865784645080566,
            "end_logit": 8.672887802124023
        },
        {
            "text": "caused by mutations in the gene encoding the insulin",
            "probability": 3.474801594276867e-07,
            "start_logit": -5.389497756958008,
            "end_logit": 8.672887802124023
        },
        {
            "text": "insulin receptor. It is characterised",
            "probability": 2.9215953726849505e-07,
            "start_logit": 9.482487678527832,
            "end_logit": -6.372505187988281
        },
        {
            "text": "insulin receptor. It is characterised by severe metabolic and endocrine derangement, prenatal and postnatal linear growth",
            "probability": 2.459034837612666e-07,
            "start_logit": 9.482487678527832,
            "end_logit": -6.54486608505249
        },
        {
            "text": "insulin receptor. It is characterised by severe metabolic and endocrine",
            "probability": 2.2707072542980823e-07,
            "start_logit": 9.482487678527832,
            "end_logit": -6.6245436668396
        },
        {
            "text": "insulin receptor. It is characterised by severe metabolic and endocrine derangement,",
            "probability": 1.946395128614383e-07,
            "start_logit": 9.482487678527832,
            "end_logit": -6.778656005859375
        },
        {
            "text": "insulin receptor. It is characterised by severe",
            "probability": 1.2888826726195968e-07,
            "start_logit": 9.482487678527832,
            "end_logit": -7.190859317779541
        },
        {
            "text": "(DS) is a rare autosomal recessive condition caused by mutations in the gene encoding the insulin",
            "probability": 9.872692175539651e-08,
            "start_logit": -6.647847652435303,
            "end_logit": 8.672887802124023
        },
        {
            "text": "the gene encoding the insulin",
            "probability": 9.843942030262483e-08,
            "start_logit": -6.650763988494873,
            "end_logit": 8.672887802124023
        },
        {
            "text": "the insulin receptor.",
            "probability": 3.48871409320614e-09,
            "start_logit": -2.125267744064331,
            "end_logit": 0.807483434677124
        },
        {
            "text": "receptor.",
            "probability": 4.6487969366207934e-10,
            "start_logit": -4.140777587890625,
            "end_logit": 0.807483434677124
        },
        {
            "text": "encoding the insulin receptor.",
            "probability": 2.2515106830952624e-10,
            "start_logit": -4.865784645080566,
            "end_logit": 0.807483434677124
        },
        {
            "text": "caused by mutations in the gene encoding the insulin receptor.",
            "probability": 1.3336083234175598e-10,
            "start_logit": -5.389497756958008,
            "end_logit": 0.807483434677124
        }
    ],
    "5314bd7ddae131f847000006_011": [
        {
            "text": "insulin",
            "probability": 0.9994273307798066,
            "start_logit": 9.482487678527832,
            "end_logit": 8.672887802124023
        },
        {
            "text": "insulin receptor.",
            "probability": 0.0003835743051270011,
            "start_logit": 9.482487678527832,
            "end_logit": 0.807483434677124
        },
        {
            "text": "ins",
            "probability": 0.00012775370830721706,
            "start_logit": 9.482487678527832,
            "end_logit": -0.2919456660747528
        },
        {
            "text": "ulin",
            "probability": 4.6977769808419546e-05,
            "start_logit": -0.4827755391597748,
            "end_logit": 8.672887802124023
        },
        {
            "text": "the insulin",
            "probability": 9.090067211025664e-06,
            "start_logit": -2.125267744064331,
            "end_logit": 8.672887802124023
        },
        {
            "text": "insulin receptor",
            "probability": 2.3910391842632078e-06,
            "start_logit": 9.312027931213379,
            "end_logit": -4.099862098693848
        },
        {
            "text": "insulin receptor. It is characterised by",
            "probability": 6.580649443629544e-07,
            "start_logit": 9.482487678527832,
            "end_logit": -5.560501575469971
        },
        {
            "text": "encoding the insulin",
            "probability": 5.866454770694485e-07,
            "start_logit": -4.865784645080566,
            "end_logit": 8.672887802124023
        },
        {
            "text": "caused by mutations in the gene encoding the insulin",
            "probability": 3.474801594276867e-07,
            "start_logit": -5.389497756958008,
            "end_logit": 8.672887802124023
        },
        {
            "text": "insulin receptor. It is characterised",
            "probability": 2.9215953726849505e-07,
            "start_logit": 9.482487678527832,
            "end_logit": -6.372505187988281
        },
        {
            "text": "insulin receptor. It is characterised by severe metabolic and endocrine derangement, prenatal and postnatal linear growth",
            "probability": 2.459034837612666e-07,
            "start_logit": 9.482487678527832,
            "end_logit": -6.54486608505249
        },
        {
            "text": "insulin receptor. It is characterised by severe metabolic and endocrine",
            "probability": 2.2707072542980823e-07,
            "start_logit": 9.482487678527832,
            "end_logit": -6.6245436668396
        },
        {
            "text": "insulin receptor. It is characterised by severe metabolic and endocrine derangement,",
            "probability": 1.946395128614383e-07,
            "start_logit": 9.482487678527832,
            "end_logit": -6.778656005859375
        },
        {
            "text": "insulin receptor. It is characterised by severe",
            "probability": 1.2888826726195968e-07,
            "start_logit": 9.482487678527832,
            "end_logit": -7.190859317779541
        },
        {
            "text": "(DS) is a rare autosomal recessive condition caused by mutations in the gene encoding the insulin",
            "probability": 9.872692175539651e-08,
            "start_logit": -6.647847652435303,
            "end_logit": 8.672887802124023
        },
        {
            "text": "the gene encoding the insulin",
            "probability": 9.843942030262483e-08,
            "start_logit": -6.650763988494873,
            "end_logit": 8.672887802124023
        },
        {
            "text": "the insulin receptor.",
            "probability": 3.48871409320614e-09,
            "start_logit": -2.125267744064331,
            "end_logit": 0.807483434677124
        },
        {
            "text": "receptor.",
            "probability": 4.6487969366207934e-10,
            "start_logit": -4.140777587890625,
            "end_logit": 0.807483434677124
        },
        {
            "text": "encoding the insulin receptor.",
            "probability": 2.2515106830952624e-10,
            "start_logit": -4.865784645080566,
            "end_logit": 0.807483434677124
        },
        {
            "text": "caused by mutations in the gene encoding the insulin receptor.",
            "probability": 1.3336083234175598e-10,
            "start_logit": -5.389497756958008,
            "end_logit": 0.807483434677124
        }
    ],
    "5314bd7ddae131f847000006_012": [
        {
            "text": "insulin",
            "probability": 0.1837243983001237,
            "start_logit": 9.372400283813477,
            "end_logit": 8.588549613952637
        },
        {
            "text": "insulin signalling pathway as a result of insulin",
            "probability": 0.1819858008038991,
            "start_logit": 9.362892150878906,
            "end_logit": 8.588549613952637
        },
        {
            "text": "insulin receptor gene mutations is linked with various forms of insulin",
            "probability": 0.16221539983284172,
            "start_logit": 9.372400283813477,
            "end_logit": 8.464037895202637
        },
        {
            "text": "insulin signalling pathway as a result of insulin receptor gene mutations is linked with various forms of insulin",
            "probability": 0.16068034357135522,
            "start_logit": 9.362892150878906,
            "end_logit": 8.464037895202637
        },
        {
            "text": "insulin receptor gene mutations is linked with various forms of insulin resistance, including insulin",
            "probability": 0.15898823553483282,
            "start_logit": 9.372400283813477,
            "end_logit": 8.44394302368164
        },
        {
            "text": "insulin resistance, including insulin",
            "probability": 0.1501123073084656,
            "start_logit": 9.314953804016113,
            "end_logit": 8.44394302368164
        },
        {
            "text": "insulin receptor gene mutations is linked with various forms of insulin resistance, including insulin resistance",
            "probability": 0.0007609076884644386,
            "start_logit": 9.372400283813477,
            "end_logit": 3.101869583129883
        },
        {
            "text": "insulin resistance, including insulin resistance",
            "probability": 0.0007184280546287535,
            "start_logit": 9.314953804016113,
            "end_logit": 3.101869583129883
        },
        {
            "text": "insulin resistance",
            "probability": 0.0007021672771153623,
            "start_logit": 9.292059898376465,
            "end_logit": 3.101869583129883
        },
        {
            "text": "ins",
            "probability": 4.389520391480856e-05,
            "start_logit": 9.372400283813477,
            "end_logit": 0.24916259944438934
        },
        {
            "text": "ulin",
            "probability": 1.651364527039347e-05,
            "start_logit": 0.055395230650901794,
            "end_logit": 8.588549613952637
        },
        {
            "text": "insulin receptor",
            "probability": 1.2360313595900745e-05,
            "start_logit": 9.372400283813477,
            "end_logit": -1.0181516408920288
        },
        {
            "text": "insulin signalling pathway as a result of insulin receptor",
            "probability": 1.224334703909494e-05,
            "start_logit": 9.362892150878906,
            "end_logit": -1.0181516408920288
        },
        {
            "text": "insulin receptor gene",
            "probability": 6.721343639937554e-06,
            "start_logit": 9.372400283813477,
            "end_logit": -1.627354383468628
        },
        {
            "text": "insulin signalling pathway as a result of insulin receptor gene",
            "probability": 6.657739070638209e-06,
            "start_logit": 9.362892150878906,
            "end_logit": -1.627354383468628
        },
        {
            "text": "Any dysfunction of insulin signalling pathway as a result of insulin",
            "probability": 6.018922197077956e-06,
            "start_logit": -0.9538835883140564,
            "end_logit": 8.588549613952637
        },
        {
            "text": "Any dysfunction of insulin",
            "probability": 5.992192717874153e-06,
            "start_logit": -0.9538835883140564,
            "end_logit": 8.584098815917969
        },
        {
            "text": "insulin receptor gene mutations",
            "probability": 5.744040108438403e-07,
            "start_logit": 9.372400283813477,
            "end_logit": -4.087064743041992
        },
        {
            "text": "insulin signalling pathway as a result of insulin receptor gene mutations",
            "probability": 5.689683834349912e-07,
            "start_logit": 9.362892150878906,
            "end_logit": -4.087064743041992
        },
        {
            "text": "insulin signalling",
            "probability": 4.6554843332968737e-07,
            "start_logit": 9.362892150878906,
            "end_logit": -4.287673473358154
        }
    ],
    "5314bd7ddae131f847000006_013": [
        {
            "text": "insulin",
            "probability": 0.1837243983001237,
            "start_logit": 9.372400283813477,
            "end_logit": 8.588549613952637
        },
        {
            "text": "insulin signalling pathway as a result of insulin",
            "probability": 0.1819858008038991,
            "start_logit": 9.362892150878906,
            "end_logit": 8.588549613952637
        },
        {
            "text": "insulin receptor gene mutations is linked with various forms of insulin",
            "probability": 0.16221539983284172,
            "start_logit": 9.372400283813477,
            "end_logit": 8.464037895202637
        },
        {
            "text": "insulin signalling pathway as a result of insulin receptor gene mutations is linked with various forms of insulin",
            "probability": 0.16068034357135522,
            "start_logit": 9.362892150878906,
            "end_logit": 8.464037895202637
        },
        {
            "text": "insulin receptor gene mutations is linked with various forms of insulin resistance, including insulin",
            "probability": 0.15898823553483282,
            "start_logit": 9.372400283813477,
            "end_logit": 8.44394302368164
        },
        {
            "text": "insulin resistance, including insulin",
            "probability": 0.1501123073084656,
            "start_logit": 9.314953804016113,
            "end_logit": 8.44394302368164
        },
        {
            "text": "insulin receptor gene mutations is linked with various forms of insulin resistance, including insulin resistance",
            "probability": 0.0007609076884644386,
            "start_logit": 9.372400283813477,
            "end_logit": 3.101869583129883
        },
        {
            "text": "insulin resistance, including insulin resistance",
            "probability": 0.0007184280546287535,
            "start_logit": 9.314953804016113,
            "end_logit": 3.101869583129883
        },
        {
            "text": "insulin resistance",
            "probability": 0.0007021672771153623,
            "start_logit": 9.292059898376465,
            "end_logit": 3.101869583129883
        },
        {
            "text": "ins",
            "probability": 4.389520391480856e-05,
            "start_logit": 9.372400283813477,
            "end_logit": 0.24916259944438934
        },
        {
            "text": "ulin",
            "probability": 1.651364527039347e-05,
            "start_logit": 0.055395230650901794,
            "end_logit": 8.588549613952637
        },
        {
            "text": "insulin receptor",
            "probability": 1.2360313595900745e-05,
            "start_logit": 9.372400283813477,
            "end_logit": -1.0181516408920288
        },
        {
            "text": "insulin signalling pathway as a result of insulin receptor",
            "probability": 1.224334703909494e-05,
            "start_logit": 9.362892150878906,
            "end_logit": -1.0181516408920288
        },
        {
            "text": "insulin receptor gene",
            "probability": 6.721343639937554e-06,
            "start_logit": 9.372400283813477,
            "end_logit": -1.627354383468628
        },
        {
            "text": "insulin signalling pathway as a result of insulin receptor gene",
            "probability": 6.657739070638209e-06,
            "start_logit": 9.362892150878906,
            "end_logit": -1.627354383468628
        },
        {
            "text": "Any dysfunction of insulin signalling pathway as a result of insulin",
            "probability": 6.018922197077956e-06,
            "start_logit": -0.9538835883140564,
            "end_logit": 8.588549613952637
        },
        {
            "text": "Any dysfunction of insulin",
            "probability": 5.992192717874153e-06,
            "start_logit": -0.9538835883140564,
            "end_logit": 8.584098815917969
        },
        {
            "text": "insulin receptor gene mutations",
            "probability": 5.744040108438403e-07,
            "start_logit": 9.372400283813477,
            "end_logit": -4.087064743041992
        },
        {
            "text": "insulin signalling pathway as a result of insulin receptor gene mutations",
            "probability": 5.689683834349912e-07,
            "start_logit": 9.362892150878906,
            "end_logit": -4.087064743041992
        },
        {
            "text": "insulin signalling",
            "probability": 4.6554843332968737e-07,
            "start_logit": 9.362892150878906,
            "end_logit": -4.287673473358154
        }
    ],
    "5314bd7ddae131f847000006_014": [
        {
            "text": "insulin",
            "probability": 0.1837243983001237,
            "start_logit": 9.372400283813477,
            "end_logit": 8.588549613952637
        },
        {
            "text": "insulin signalling pathway as a result of insulin",
            "probability": 0.1819858008038991,
            "start_logit": 9.362892150878906,
            "end_logit": 8.588549613952637
        },
        {
            "text": "insulin receptor gene mutations is linked with various forms of insulin",
            "probability": 0.16221539983284172,
            "start_logit": 9.372400283813477,
            "end_logit": 8.464037895202637
        },
        {
            "text": "insulin signalling pathway as a result of insulin receptor gene mutations is linked with various forms of insulin",
            "probability": 0.16068034357135522,
            "start_logit": 9.362892150878906,
            "end_logit": 8.464037895202637
        },
        {
            "text": "insulin receptor gene mutations is linked with various forms of insulin resistance, including insulin",
            "probability": 0.15898823553483282,
            "start_logit": 9.372400283813477,
            "end_logit": 8.44394302368164
        },
        {
            "text": "insulin resistance, including insulin",
            "probability": 0.1501123073084656,
            "start_logit": 9.314953804016113,
            "end_logit": 8.44394302368164
        },
        {
            "text": "insulin receptor gene mutations is linked with various forms of insulin resistance, including insulin resistance",
            "probability": 0.0007609076884644386,
            "start_logit": 9.372400283813477,
            "end_logit": 3.101869583129883
        },
        {
            "text": "insulin resistance, including insulin resistance",
            "probability": 0.0007184280546287535,
            "start_logit": 9.314953804016113,
            "end_logit": 3.101869583129883
        },
        {
            "text": "insulin resistance",
            "probability": 0.0007021672771153623,
            "start_logit": 9.292059898376465,
            "end_logit": 3.101869583129883
        },
        {
            "text": "ins",
            "probability": 4.389520391480856e-05,
            "start_logit": 9.372400283813477,
            "end_logit": 0.24916259944438934
        },
        {
            "text": "ulin",
            "probability": 1.651364527039347e-05,
            "start_logit": 0.055395230650901794,
            "end_logit": 8.588549613952637
        },
        {
            "text": "insulin receptor",
            "probability": 1.2360313595900745e-05,
            "start_logit": 9.372400283813477,
            "end_logit": -1.0181516408920288
        },
        {
            "text": "insulin signalling pathway as a result of insulin receptor",
            "probability": 1.224334703909494e-05,
            "start_logit": 9.362892150878906,
            "end_logit": -1.0181516408920288
        },
        {
            "text": "insulin receptor gene",
            "probability": 6.721343639937554e-06,
            "start_logit": 9.372400283813477,
            "end_logit": -1.627354383468628
        },
        {
            "text": "insulin signalling pathway as a result of insulin receptor gene",
            "probability": 6.657739070638209e-06,
            "start_logit": 9.362892150878906,
            "end_logit": -1.627354383468628
        },
        {
            "text": "Any dysfunction of insulin signalling pathway as a result of insulin",
            "probability": 6.018922197077956e-06,
            "start_logit": -0.9538835883140564,
            "end_logit": 8.588549613952637
        },
        {
            "text": "Any dysfunction of insulin",
            "probability": 5.992192717874153e-06,
            "start_logit": -0.9538835883140564,
            "end_logit": 8.584098815917969
        },
        {
            "text": "insulin receptor gene mutations",
            "probability": 5.744040108438403e-07,
            "start_logit": 9.372400283813477,
            "end_logit": -4.087064743041992
        },
        {
            "text": "insulin signalling pathway as a result of insulin receptor gene mutations",
            "probability": 5.689683834349912e-07,
            "start_logit": 9.362892150878906,
            "end_logit": -4.087064743041992
        },
        {
            "text": "insulin signalling",
            "probability": 4.6554843332968737e-07,
            "start_logit": 9.362892150878906,
            "end_logit": -4.287673473358154
        }
    ],
    "5314bd7ddae131f847000006_015": [
        {
            "text": "insulin",
            "probability": 0.1837243983001237,
            "start_logit": 9.372400283813477,
            "end_logit": 8.588549613952637
        },
        {
            "text": "insulin signalling pathway as a result of insulin",
            "probability": 0.1819858008038991,
            "start_logit": 9.362892150878906,
            "end_logit": 8.588549613952637
        },
        {
            "text": "insulin receptor gene mutations is linked with various forms of insulin",
            "probability": 0.16221539983284172,
            "start_logit": 9.372400283813477,
            "end_logit": 8.464037895202637
        },
        {
            "text": "insulin signalling pathway as a result of insulin receptor gene mutations is linked with various forms of insulin",
            "probability": 0.16068034357135522,
            "start_logit": 9.362892150878906,
            "end_logit": 8.464037895202637
        },
        {
            "text": "insulin receptor gene mutations is linked with various forms of insulin resistance, including insulin",
            "probability": 0.15898823553483282,
            "start_logit": 9.372400283813477,
            "end_logit": 8.44394302368164
        },
        {
            "text": "insulin resistance, including insulin",
            "probability": 0.1501123073084656,
            "start_logit": 9.314953804016113,
            "end_logit": 8.44394302368164
        },
        {
            "text": "insulin receptor gene mutations is linked with various forms of insulin resistance, including insulin resistance",
            "probability": 0.0007609076884644386,
            "start_logit": 9.372400283813477,
            "end_logit": 3.101869583129883
        },
        {
            "text": "insulin resistance, including insulin resistance",
            "probability": 0.0007184280546287535,
            "start_logit": 9.314953804016113,
            "end_logit": 3.101869583129883
        },
        {
            "text": "insulin resistance",
            "probability": 0.0007021672771153623,
            "start_logit": 9.292059898376465,
            "end_logit": 3.101869583129883
        },
        {
            "text": "ins",
            "probability": 4.389520391480856e-05,
            "start_logit": 9.372400283813477,
            "end_logit": 0.24916259944438934
        },
        {
            "text": "ulin",
            "probability": 1.651364527039347e-05,
            "start_logit": 0.055395230650901794,
            "end_logit": 8.588549613952637
        },
        {
            "text": "insulin receptor",
            "probability": 1.2360313595900745e-05,
            "start_logit": 9.372400283813477,
            "end_logit": -1.0181516408920288
        },
        {
            "text": "insulin signalling pathway as a result of insulin receptor",
            "probability": 1.224334703909494e-05,
            "start_logit": 9.362892150878906,
            "end_logit": -1.0181516408920288
        },
        {
            "text": "insulin receptor gene",
            "probability": 6.721343639937554e-06,
            "start_logit": 9.372400283813477,
            "end_logit": -1.627354383468628
        },
        {
            "text": "insulin signalling pathway as a result of insulin receptor gene",
            "probability": 6.657739070638209e-06,
            "start_logit": 9.362892150878906,
            "end_logit": -1.627354383468628
        },
        {
            "text": "Any dysfunction of insulin signalling pathway as a result of insulin",
            "probability": 6.018922197077956e-06,
            "start_logit": -0.9538835883140564,
            "end_logit": 8.588549613952637
        },
        {
            "text": "Any dysfunction of insulin",
            "probability": 5.992192717874153e-06,
            "start_logit": -0.9538835883140564,
            "end_logit": 8.584098815917969
        },
        {
            "text": "insulin receptor gene mutations",
            "probability": 5.744040108438403e-07,
            "start_logit": 9.372400283813477,
            "end_logit": -4.087064743041992
        },
        {
            "text": "insulin signalling pathway as a result of insulin receptor gene mutations",
            "probability": 5.689683834349912e-07,
            "start_logit": 9.362892150878906,
            "end_logit": -4.087064743041992
        },
        {
            "text": "insulin signalling",
            "probability": 4.6554843332968737e-07,
            "start_logit": 9.362892150878906,
            "end_logit": -4.287673473358154
        }
    ],
    "5314bd7ddae131f847000006_016": [
        {
            "text": "insulin",
            "probability": 0.5064404819518001,
            "start_logit": 9.550628662109375,
            "end_logit": 8.780250549316406
        },
        {
            "text": "insulin receptor gene. Donohue syndrome describes the clinical consequences of the most severe genetic loss of insulin",
            "probability": 0.49342625091713493,
            "start_logit": 9.550628662109375,
            "end_logit": 8.754217147827148
        },
        {
            "text": "ins",
            "probability": 8.255729739013645e-05,
            "start_logit": 9.5532808303833,
            "end_logit": 0.05592885985970497
        },
        {
            "text": "ulin",
            "probability": 2.765086962691488e-05,
            "start_logit": -0.26487624645233154,
            "end_logit": 8.780250549316406
        },
        {
            "text": "insulin receptor function.",
            "probability": 1.582708221402726e-05,
            "start_logit": 9.5532808303833,
            "end_logit": -1.5958411693572998
        },
        {
            "text": "exon 3 of the insulin",
            "probability": 2.0820984113087886e-06,
            "start_logit": -2.8511571884155273,
            "end_logit": 8.780250549316406
        },
        {
            "text": "insulin receptor",
            "probability": 1.7071536354628198e-06,
            "start_logit": 9.5532808303833,
            "end_logit": -3.8227362632751465
        },
        {
            "text": "insulin receptor gene.",
            "probability": 1.5740897199542503e-06,
            "start_logit": 9.550628662109375,
            "end_logit": -3.9012343883514404
        },
        {
            "text": "insulin receptor function. The cardinal features are severe linear growth",
            "probability": 3.661401578596665e-07,
            "start_logit": 9.5532808303833,
            "end_logit": -5.362302780151367
        },
        {
            "text": "loss of insulin",
            "probability": 2.847629896915334e-07,
            "start_logit": -4.814598083496094,
            "end_logit": 8.754217147827148
        },
        {
            "text": "describes the clinical consequences of the most severe genetic loss of insulin",
            "probability": 2.55827727966557e-07,
            "start_logit": -4.921751022338867,
            "end_logit": 8.754217147827148
        },
        {
            "text": "3 of the insulin",
            "probability": 1.655423110972119e-07,
            "start_logit": -5.38306188583374,
            "end_logit": 8.780250549316406
        },
        {
            "text": "deletion of exon 3 of the insulin",
            "probability": 1.2801277336996924e-07,
            "start_logit": -5.640158653259277,
            "end_logit": 8.780250549316406
        },
        {
            "text": "insulin receptor gene. Donohue syndrome describes the clinical consequences of the most severe",
            "probability": 1.1641370720561122e-07,
            "start_logit": 9.550628662109375,
            "end_logit": -6.505516529083252
        },
        {
            "text": "insulin receptor gene. Donohue syndrome describes the clinical consequences of the most severe genetic",
            "probability": 1.156408043500428e-07,
            "start_logit": 9.550628662109375,
            "end_logit": -6.51217794418335
        },
        {
            "text": "the insulin",
            "probability": 1.0934684339178796e-07,
            "start_logit": -5.797763824462891,
            "end_logit": 8.780250549316406
        },
        {
            "text": "receptor gene. Donohue syndrome describes the clinical consequences of the most severe genetic loss of insulin",
            "probability": 9.63693136972445e-08,
            "start_logit": -5.898067474365234,
            "end_logit": 8.754217147827148
        },
        {
            "text": "of the most severe genetic loss of insulin",
            "probability": 8.087967613388757e-08,
            "start_logit": -6.0732927322387695,
            "end_logit": 8.754217147827148
        },
        {
            "text": "of insulin",
            "probability": 7.522756011108913e-08,
            "start_logit": -6.145737648010254,
            "end_logit": 8.754217147827148
        },
        {
            "text": "insulin receptor gene. Donohue syndrome",
            "probability": 7.437620225618829e-08,
            "start_logit": 9.550628662109375,
            "end_logit": -6.953530788421631
        }
    ],
    "5314bd7ddae131f847000006_017": [
        {
            "text": "insulin",
            "probability": 0.5064404819518001,
            "start_logit": 9.550628662109375,
            "end_logit": 8.780250549316406
        },
        {
            "text": "insulin receptor gene. Donohue syndrome describes the clinical consequences of the most severe genetic loss of insulin",
            "probability": 0.49342625091713493,
            "start_logit": 9.550628662109375,
            "end_logit": 8.754217147827148
        },
        {
            "text": "ins",
            "probability": 8.255729739013645e-05,
            "start_logit": 9.5532808303833,
            "end_logit": 0.05592885985970497
        },
        {
            "text": "ulin",
            "probability": 2.765086962691488e-05,
            "start_logit": -0.26487624645233154,
            "end_logit": 8.780250549316406
        },
        {
            "text": "insulin receptor function.",
            "probability": 1.582708221402726e-05,
            "start_logit": 9.5532808303833,
            "end_logit": -1.5958411693572998
        },
        {
            "text": "exon 3 of the insulin",
            "probability": 2.0820984113087886e-06,
            "start_logit": -2.8511571884155273,
            "end_logit": 8.780250549316406
        },
        {
            "text": "insulin receptor",
            "probability": 1.7071536354628198e-06,
            "start_logit": 9.5532808303833,
            "end_logit": -3.8227362632751465
        },
        {
            "text": "insulin receptor gene.",
            "probability": 1.5740897199542503e-06,
            "start_logit": 9.550628662109375,
            "end_logit": -3.9012343883514404
        },
        {
            "text": "insulin receptor function. The cardinal features are severe linear growth",
            "probability": 3.661401578596665e-07,
            "start_logit": 9.5532808303833,
            "end_logit": -5.362302780151367
        },
        {
            "text": "loss of insulin",
            "probability": 2.847629896915334e-07,
            "start_logit": -4.814598083496094,
            "end_logit": 8.754217147827148
        },
        {
            "text": "describes the clinical consequences of the most severe genetic loss of insulin",
            "probability": 2.55827727966557e-07,
            "start_logit": -4.921751022338867,
            "end_logit": 8.754217147827148
        },
        {
            "text": "3 of the insulin",
            "probability": 1.655423110972119e-07,
            "start_logit": -5.38306188583374,
            "end_logit": 8.780250549316406
        },
        {
            "text": "deletion of exon 3 of the insulin",
            "probability": 1.2801277336996924e-07,
            "start_logit": -5.640158653259277,
            "end_logit": 8.780250549316406
        },
        {
            "text": "insulin receptor gene. Donohue syndrome describes the clinical consequences of the most severe",
            "probability": 1.1641370720561122e-07,
            "start_logit": 9.550628662109375,
            "end_logit": -6.505516529083252
        },
        {
            "text": "insulin receptor gene. Donohue syndrome describes the clinical consequences of the most severe genetic",
            "probability": 1.156408043500428e-07,
            "start_logit": 9.550628662109375,
            "end_logit": -6.51217794418335
        },
        {
            "text": "the insulin",
            "probability": 1.0934684339178796e-07,
            "start_logit": -5.797763824462891,
            "end_logit": 8.780250549316406
        },
        {
            "text": "receptor gene. Donohue syndrome describes the clinical consequences of the most severe genetic loss of insulin",
            "probability": 9.63693136972445e-08,
            "start_logit": -5.898067474365234,
            "end_logit": 8.754217147827148
        },
        {
            "text": "of the most severe genetic loss of insulin",
            "probability": 8.087967613388757e-08,
            "start_logit": -6.0732927322387695,
            "end_logit": 8.754217147827148
        },
        {
            "text": "of insulin",
            "probability": 7.522756011108913e-08,
            "start_logit": -6.145737648010254,
            "end_logit": 8.754217147827148
        },
        {
            "text": "insulin receptor gene. Donohue syndrome",
            "probability": 7.437620225618829e-08,
            "start_logit": 9.550628662109375,
            "end_logit": -6.953530788421631
        }
    ],
    "5314bd7ddae131f847000006_018": [
        {
            "text": "insulin",
            "probability": 0.2579459331164325,
            "start_logit": 9.45296573638916,
            "end_logit": 8.711457252502441
        },
        {
            "text": "insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin",
            "probability": 0.24993491592302264,
            "start_logit": 9.421416282653809,
            "end_logit": 8.711457252502441
        },
        {
            "text": "insulin receptor (INSR) are usually associated with severe impairment of insulin",
            "probability": 0.2480655990390972,
            "start_logit": 9.413908958435059,
            "end_logit": 8.711457252502441
        },
        {
            "text": "insulin binding domain of the human insulin",
            "probability": 0.23932687630131477,
            "start_logit": 9.421416282653809,
            "end_logit": 8.668087005615234
        },
        {
            "text": "hyperinsulinism and prolonged survival due to two novel INSR missense mutations within the insulin",
            "probability": 0.00405849041758652,
            "start_logit": 6.631087303161621,
            "end_logit": 7.381396770477295
        },
        {
            "text": "insulin binding",
            "probability": 0.00017046803674737018,
            "start_logit": 9.45296573638916,
            "end_logit": 1.3894997835159302
        },
        {
            "text": "insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin binding",
            "probability": 0.00016517381730839348,
            "start_logit": 9.421416282653809,
            "end_logit": 1.3894997835159302
        },
        {
            "text": "insulin receptor (INSR) are usually associated with severe impairment of insulin binding",
            "probability": 0.00016393844687470787,
            "start_logit": 9.413908958435059,
            "end_logit": 1.3894997835159302
        },
        {
            "text": "hyperinsulinism,",
            "probability": 6.606473262870966e-05,
            "start_logit": 9.365859985351562,
            "end_logit": 0.5286927819252014
        },
        {
            "text": "ins",
            "probability": 3.232264001471364e-05,
            "start_logit": 9.45296573638916,
            "end_logit": -0.2732801139354706
        },
        {
            "text": "hyperinsulin",
            "probability": 2.4490395211074933e-05,
            "start_logit": 0.15290920436382294,
            "end_logit": 8.749289512634277
        },
        {
            "text": "ulin",
            "probability": 1.6823534677268316e-05,
            "start_logit": -0.2225930243730545,
            "end_logit": 8.749289512634277
        },
        {
            "text": "human insulin receptor (INSR) are usually associated with severe impairment of insulin",
            "probability": 1.0459776318806558e-05,
            "start_logit": -0.6600024700164795,
            "end_logit": 8.711457252502441
        },
        {
            "text": "human insulin",
            "probability": 1.0015829856927355e-05,
            "start_logit": -0.6600024700164795,
            "end_logit": 8.668087005615234
        },
        {
            "text": "insulinism",
            "probability": 4.788946447944271e-06,
            "start_logit": 6.631087303161621,
            "end_logit": 0.6391408443450928
        },
        {
            "text": "insulin binding domain of the human insulin receptor",
            "probability": 1.0954660410410672e-06,
            "start_logit": 9.421416282653809,
            "end_logit": -3.6263186931610107
        },
        {
            "text": "insulin receptor",
            "probability": 1.087272815381809e-06,
            "start_logit": 9.413908958435059,
            "end_logit": -3.6263186931610107
        },
        {
            "text": "characterized by excessive hyperglycemia with hyperinsulinism,",
            "probability": 8.758247133816403e-07,
            "start_logit": -3.1779611110687256,
            "end_logit": 8.749289512634277
        },
        {
            "text": "the human insulin receptor (INSR) are usually associated with severe impairment of insulin",
            "probability": 2.965343805416073e-07,
            "start_logit": -4.2231316566467285,
            "end_logit": 8.711457252502441
        },
        {
            "text": "the human insulin",
            "probability": 2.83948510150642e-07,
            "start_logit": -4.2231316566467285,
            "end_logit": 8.668087005615234
        }
    ],
    "5314bd7ddae131f847000006_019": [
        {
            "text": "insulin",
            "probability": 0.2579459331164325,
            "start_logit": 9.45296573638916,
            "end_logit": 8.711457252502441
        },
        {
            "text": "insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin",
            "probability": 0.24993491592302264,
            "start_logit": 9.421416282653809,
            "end_logit": 8.711457252502441
        },
        {
            "text": "insulin receptor (INSR) are usually associated with severe impairment of insulin",
            "probability": 0.2480655990390972,
            "start_logit": 9.413908958435059,
            "end_logit": 8.711457252502441
        },
        {
            "text": "insulin binding domain of the human insulin",
            "probability": 0.23932687630131477,
            "start_logit": 9.421416282653809,
            "end_logit": 8.668087005615234
        },
        {
            "text": "hyperinsulinism and prolonged survival due to two novel INSR missense mutations within the insulin",
            "probability": 0.00405849041758652,
            "start_logit": 6.631087303161621,
            "end_logit": 7.381396770477295
        },
        {
            "text": "insulin binding",
            "probability": 0.00017046803674737018,
            "start_logit": 9.45296573638916,
            "end_logit": 1.3894997835159302
        },
        {
            "text": "insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin binding",
            "probability": 0.00016517381730839348,
            "start_logit": 9.421416282653809,
            "end_logit": 1.3894997835159302
        },
        {
            "text": "insulin receptor (INSR) are usually associated with severe impairment of insulin binding",
            "probability": 0.00016393844687470787,
            "start_logit": 9.413908958435059,
            "end_logit": 1.3894997835159302
        },
        {
            "text": "hyperinsulinism,",
            "probability": 6.606473262870966e-05,
            "start_logit": 9.365859985351562,
            "end_logit": 0.5286927819252014
        },
        {
            "text": "ins",
            "probability": 3.232264001471364e-05,
            "start_logit": 9.45296573638916,
            "end_logit": -0.2732801139354706
        },
        {
            "text": "hyperinsulin",
            "probability": 2.4490395211074933e-05,
            "start_logit": 0.15290920436382294,
            "end_logit": 8.749289512634277
        },
        {
            "text": "ulin",
            "probability": 1.6823534677268316e-05,
            "start_logit": -0.2225930243730545,
            "end_logit": 8.749289512634277
        },
        {
            "text": "human insulin receptor (INSR) are usually associated with severe impairment of insulin",
            "probability": 1.0459776318806558e-05,
            "start_logit": -0.6600024700164795,
            "end_logit": 8.711457252502441
        },
        {
            "text": "human insulin",
            "probability": 1.0015829856927355e-05,
            "start_logit": -0.6600024700164795,
            "end_logit": 8.668087005615234
        },
        {
            "text": "insulinism",
            "probability": 4.788946447944271e-06,
            "start_logit": 6.631087303161621,
            "end_logit": 0.6391408443450928
        },
        {
            "text": "insulin binding domain of the human insulin receptor",
            "probability": 1.0954660410410672e-06,
            "start_logit": 9.421416282653809,
            "end_logit": -3.6263186931610107
        },
        {
            "text": "insulin receptor",
            "probability": 1.087272815381809e-06,
            "start_logit": 9.413908958435059,
            "end_logit": -3.6263186931610107
        },
        {
            "text": "characterized by excessive hyperglycemia with hyperinsulinism,",
            "probability": 8.758247133816403e-07,
            "start_logit": -3.1779611110687256,
            "end_logit": 8.749289512634277
        },
        {
            "text": "the human insulin receptor (INSR) are usually associated with severe impairment of insulin",
            "probability": 2.965343805416073e-07,
            "start_logit": -4.2231316566467285,
            "end_logit": 8.711457252502441
        },
        {
            "text": "the human insulin",
            "probability": 2.83948510150642e-07,
            "start_logit": -4.2231316566467285,
            "end_logit": 8.668087005615234
        }
    ],
    "5314bd7ddae131f847000006_020": [
        {
            "text": "insulin",
            "probability": 0.2579459331164325,
            "start_logit": 9.45296573638916,
            "end_logit": 8.711457252502441
        },
        {
            "text": "insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin",
            "probability": 0.24993491592302264,
            "start_logit": 9.421416282653809,
            "end_logit": 8.711457252502441
        },
        {
            "text": "insulin receptor (INSR) are usually associated with severe impairment of insulin",
            "probability": 0.2480655990390972,
            "start_logit": 9.413908958435059,
            "end_logit": 8.711457252502441
        },
        {
            "text": "insulin binding domain of the human insulin",
            "probability": 0.23932687630131477,
            "start_logit": 9.421416282653809,
            "end_logit": 8.668087005615234
        },
        {
            "text": "hyperinsulinism and prolonged survival due to two novel INSR missense mutations within the insulin",
            "probability": 0.00405849041758652,
            "start_logit": 6.631087303161621,
            "end_logit": 7.381396770477295
        },
        {
            "text": "insulin binding",
            "probability": 0.00017046803674737018,
            "start_logit": 9.45296573638916,
            "end_logit": 1.3894997835159302
        },
        {
            "text": "insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin binding",
            "probability": 0.00016517381730839348,
            "start_logit": 9.421416282653809,
            "end_logit": 1.3894997835159302
        },
        {
            "text": "insulin receptor (INSR) are usually associated with severe impairment of insulin binding",
            "probability": 0.00016393844687470787,
            "start_logit": 9.413908958435059,
            "end_logit": 1.3894997835159302
        },
        {
            "text": "hyperinsulinism,",
            "probability": 6.606473262870966e-05,
            "start_logit": 9.365859985351562,
            "end_logit": 0.5286927819252014
        },
        {
            "text": "ins",
            "probability": 3.232264001471364e-05,
            "start_logit": 9.45296573638916,
            "end_logit": -0.2732801139354706
        },
        {
            "text": "hyperinsulin",
            "probability": 2.4490395211074933e-05,
            "start_logit": 0.15290920436382294,
            "end_logit": 8.749289512634277
        },
        {
            "text": "ulin",
            "probability": 1.6823534677268316e-05,
            "start_logit": -0.2225930243730545,
            "end_logit": 8.749289512634277
        },
        {
            "text": "human insulin receptor (INSR) are usually associated with severe impairment of insulin",
            "probability": 1.0459776318806558e-05,
            "start_logit": -0.6600024700164795,
            "end_logit": 8.711457252502441
        },
        {
            "text": "human insulin",
            "probability": 1.0015829856927355e-05,
            "start_logit": -0.6600024700164795,
            "end_logit": 8.668087005615234
        },
        {
            "text": "insulinism",
            "probability": 4.788946447944271e-06,
            "start_logit": 6.631087303161621,
            "end_logit": 0.6391408443450928
        },
        {
            "text": "insulin binding domain of the human insulin receptor",
            "probability": 1.0954660410410672e-06,
            "start_logit": 9.421416282653809,
            "end_logit": -3.6263186931610107
        },
        {
            "text": "insulin receptor",
            "probability": 1.087272815381809e-06,
            "start_logit": 9.413908958435059,
            "end_logit": -3.6263186931610107
        },
        {
            "text": "characterized by excessive hyperglycemia with hyperinsulinism,",
            "probability": 8.758247133816403e-07,
            "start_logit": -3.1779611110687256,
            "end_logit": 8.749289512634277
        },
        {
            "text": "the human insulin receptor (INSR) are usually associated with severe impairment of insulin",
            "probability": 2.965343805416073e-07,
            "start_logit": -4.2231316566467285,
            "end_logit": 8.711457252502441
        },
        {
            "text": "the human insulin",
            "probability": 2.83948510150642e-07,
            "start_logit": -4.2231316566467285,
            "end_logit": 8.668087005615234
        }
    ],
    "5314bd7ddae131f847000006_021": [
        {
            "text": "insulin",
            "probability": 0.2579459331164325,
            "start_logit": 9.45296573638916,
            "end_logit": 8.711457252502441
        },
        {
            "text": "insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin",
            "probability": 0.24993491592302264,
            "start_logit": 9.421416282653809,
            "end_logit": 8.711457252502441
        },
        {
            "text": "insulin receptor (INSR) are usually associated with severe impairment of insulin",
            "probability": 0.2480655990390972,
            "start_logit": 9.413908958435059,
            "end_logit": 8.711457252502441
        },
        {
            "text": "insulin binding domain of the human insulin",
            "probability": 0.23932687630131477,
            "start_logit": 9.421416282653809,
            "end_logit": 8.668087005615234
        },
        {
            "text": "hyperinsulinism and prolonged survival due to two novel INSR missense mutations within the insulin",
            "probability": 0.00405849041758652,
            "start_logit": 6.631087303161621,
            "end_logit": 7.381396770477295
        },
        {
            "text": "insulin binding",
            "probability": 0.00017046803674737018,
            "start_logit": 9.45296573638916,
            "end_logit": 1.3894997835159302
        },
        {
            "text": "insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin binding",
            "probability": 0.00016517381730839348,
            "start_logit": 9.421416282653809,
            "end_logit": 1.3894997835159302
        },
        {
            "text": "insulin receptor (INSR) are usually associated with severe impairment of insulin binding",
            "probability": 0.00016393844687470787,
            "start_logit": 9.413908958435059,
            "end_logit": 1.3894997835159302
        },
        {
            "text": "hyperinsulinism,",
            "probability": 6.606473262870966e-05,
            "start_logit": 9.365859985351562,
            "end_logit": 0.5286927819252014
        },
        {
            "text": "ins",
            "probability": 3.232264001471364e-05,
            "start_logit": 9.45296573638916,
            "end_logit": -0.2732801139354706
        },
        {
            "text": "hyperinsulin",
            "probability": 2.4490395211074933e-05,
            "start_logit": 0.15290920436382294,
            "end_logit": 8.749289512634277
        },
        {
            "text": "ulin",
            "probability": 1.6823534677268316e-05,
            "start_logit": -0.2225930243730545,
            "end_logit": 8.749289512634277
        },
        {
            "text": "human insulin receptor (INSR) are usually associated with severe impairment of insulin",
            "probability": 1.0459776318806558e-05,
            "start_logit": -0.6600024700164795,
            "end_logit": 8.711457252502441
        },
        {
            "text": "human insulin",
            "probability": 1.0015829856927355e-05,
            "start_logit": -0.6600024700164795,
            "end_logit": 8.668087005615234
        },
        {
            "text": "insulinism",
            "probability": 4.788946447944271e-06,
            "start_logit": 6.631087303161621,
            "end_logit": 0.6391408443450928
        },
        {
            "text": "insulin binding domain of the human insulin receptor",
            "probability": 1.0954660410410672e-06,
            "start_logit": 9.421416282653809,
            "end_logit": -3.6263186931610107
        },
        {
            "text": "insulin receptor",
            "probability": 1.087272815381809e-06,
            "start_logit": 9.413908958435059,
            "end_logit": -3.6263186931610107
        },
        {
            "text": "characterized by excessive hyperglycemia with hyperinsulinism,",
            "probability": 8.758247133816403e-07,
            "start_logit": -3.1779611110687256,
            "end_logit": 8.749289512634277
        },
        {
            "text": "the human insulin receptor (INSR) are usually associated with severe impairment of insulin",
            "probability": 2.965343805416073e-07,
            "start_logit": -4.2231316566467285,
            "end_logit": 8.711457252502441
        },
        {
            "text": "the human insulin",
            "probability": 2.83948510150642e-07,
            "start_logit": -4.2231316566467285,
            "end_logit": 8.668087005615234
        }
    ],
    "55180ef46487737b43000006_001": [
        {
            "text": "Dermatitis herpetiformis",
            "probability": 0.9995637234076034,
            "start_logit": 9.416993141174316,
            "end_logit": 9.039251327514648
        },
        {
            "text": "Der",
            "probability": 0.00033270460041806966,
            "start_logit": 9.416993141174316,
            "end_logit": 1.0314321517944336
        },
        {
            "text": "is",
            "probability": 8.85494289615729e-05,
            "start_logit": 0.08547987043857574,
            "end_logit": 9.039251327514648
        },
        {
            "text": "herpetiformis",
            "probability": 9.614641070572857e-06,
            "start_logit": -2.134793996810913,
            "end_logit": 9.039251327514648
        },
        {
            "text": "Dermatitis herpetiformis (DH)",
            "probability": 1.1305963719278093e-06,
            "start_logit": 9.416993141174316,
            "end_logit": -4.653077602386475
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmunity-driven inflammatory blistering dermatosis",
            "probability": 9.138292754826142e-07,
            "start_logit": 9.416993141174316,
            "end_logit": -4.865934371948242
        },
        {
            "text": "dermatitis herpetiformis. Dermatitis herpetiformis",
            "probability": 8.773153968725493e-07,
            "start_logit": -4.528969764709473,
            "end_logit": 9.039251327514648
        },
        {
            "text": "iformis",
            "probability": 6.816024777438165e-07,
            "start_logit": -4.7813897132873535,
            "end_logit": 9.039251327514648
        },
        {
            "text": "petiformis",
            "probability": 5.120113024840111e-07,
            "start_logit": -5.0674896240234375,
            "end_logit": 9.039251327514648
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmunity-driven inflammatory blistering",
            "probability": 5.066222634577303e-07,
            "start_logit": 9.416993141174316,
            "end_logit": -5.455812454223633
        },
        {
            "text": "Dermat",
            "probability": 1.869798811321119e-07,
            "start_logit": 9.416993141174316,
            "end_logit": -6.452577114105225
        },
        {
            "text": "Dermatitis",
            "probability": 1.6208989704590446e-07,
            "start_logit": 9.416993141174316,
            "end_logit": -6.5954270362854
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmunity-driven inflammatory blistering dermatosis associated with",
            "probability": 1.5569112819830166e-07,
            "start_logit": 9.416993141174316,
            "end_logit": -6.635704040527344
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an",
            "probability": 1.0835392943439669e-07,
            "start_logit": 9.416993141174316,
            "end_logit": -6.998175144195557
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmunity-driven inflammatory blistering dermatosis associated with a gluten-dependent",
            "probability": 6.239385817511568e-08,
            "start_logit": 9.416993141174316,
            "end_logit": -7.550111293792725
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmunity-driven inflammatory blistering dermatosis associated",
            "probability": 5.842589273276744e-08,
            "start_logit": 9.416993141174316,
            "end_logit": -7.615818977355957
        },
        {
            "text": "Dermatitis herpetiformis (DH) is",
            "probability": 5.153714589188148e-08,
            "start_logit": 9.416993141174316,
            "end_logit": -7.741275310516357
        },
        {
            "text": "dermatitis herpetiformis. Dermatitis",
            "probability": 2.920142675466782e-10,
            "start_logit": -4.528969764709473,
            "end_logit": 1.0314321517944336
        },
        {
            "text": "herpetiformis (DH)",
            "probability": 1.001573594317099e-10,
            "start_logit": 0.08547987043857574,
            "end_logit": -4.653077602386475
        },
        {
            "text": "herpetiformis (DH) is an autoimmunity-driven inflammatory blistering dermatosis",
            "probability": 8.095437901296875e-11,
            "start_logit": 0.08547987043857574,
            "end_logit": -4.865934371948242
        }
    ],
    "55180ef46487737b43000006_002": [
        {
            "text": "Dermatitis herpetiformis",
            "probability": 0.7007324238055026,
            "start_logit": 8.164535522460938,
            "end_logit": 7.367751121520996
        },
        {
            "text": "dermatitis herpetiformis",
            "probability": 0.2988649741741903,
            "start_logit": 7.785123348236084,
            "end_logit": 6.895029067993164
        },
        {
            "text": "dermatitis herpetiformis. Treatment of dermatitis herpetiformis",
            "probability": 0.0001418381837617435,
            "start_logit": 0.13206304609775543,
            "end_logit": 6.895029067993164
        },
        {
            "text": "Der",
            "probability": 9.888352121266014e-05,
            "start_logit": 8.164535522460938,
            "end_logit": -1.4981876611709595
        },
        {
            "text": "is",
            "probability": 6.537666378155322e-05,
            "start_logit": -1.115180492401123,
            "end_logit": 7.367751121520996
        },
        {
            "text": "Dermatitis herpetiformis is an autoimmune blistering",
            "probability": 5.353494409727745e-05,
            "start_logit": 8.164535522460938,
            "end_logit": -2.111795663833618
        },
        {
            "text": "der",
            "probability": 2.6576591470283044e-05,
            "start_logit": 7.785123348236084,
            "end_logit": -2.432687282562256
        },
        {
            "text": "herpetiformis",
            "probability": 7.039416564510577e-06,
            "start_logit": -3.343820571899414,
            "end_logit": 7.367751121520996
        },
        {
            "text": "Dermatitis herpetiformis is an autoimmune blistering disease that appears as a cutaneous",
            "probability": 2.7743310777782838e-06,
            "start_logit": 8.164535522460938,
            "end_logit": -5.071720600128174
        },
        {
            "text": "Dermatitis herpetiformis is an autoimmune blistering disease that appears",
            "probability": 1.9334493845070775e-06,
            "start_logit": 8.164535522460938,
            "end_logit": -5.432824611663818
        },
        {
            "text": "Dermatitis herpetiformis is an autoimmune blistering disease that appears as a cutaneous manifestation",
            "probability": 1.5196071797502318e-06,
            "start_logit": 8.164535522460938,
            "end_logit": -5.673678398132324
        },
        {
            "text": "Dermatitis herpetiformis is an autoimmune",
            "probability": 1.4470464672516577e-06,
            "start_logit": 8.164535522460938,
            "end_logit": -5.7226057052612305
        },
        {
            "text": "Dermatitis herpetiformis is an autoimmune blistering disease",
            "probability": 1.3149636691015397e-06,
            "start_logit": 8.164535522460938,
            "end_logit": -5.818321228027344
        },
        {
            "text": "dermatitis",
            "probability": 3.0154694508732786e-07,
            "start_logit": 7.785123348236084,
            "end_logit": -6.911547660827637
        },
        {
            "text": "dapsone, a drug that is only effective for the skin",
            "probability": 3.459971138747947e-08,
            "start_logit": -0.4324658513069153,
            "end_logit": -0.8590388298034668
        },
        {
            "text": "dermatitis herpetiformis. Treatment of dermatitis",
            "probability": 1.2612971711183978e-08,
            "start_logit": 0.13206304609775543,
            "end_logit": -2.432687282562256
        },
        {
            "text": "skin",
            "probability": 6.785255788192469e-09,
            "start_logit": -2.0615592002868652,
            "end_logit": -0.8590388298034668
        },
        {
            "text": "herpetiformis is an autoimmune blistering",
            "probability": 4.994682594826536e-09,
            "start_logit": -1.115180492401123,
            "end_logit": -2.111795663833618
        },
        {
            "text": "dermatitis herpetiformis.",
            "probability": 1.4198615315215043e-09,
            "start_logit": 0.13206304609775543,
            "end_logit": -4.616853713989258
        },
        {
            "text": "dapsone",
            "probability": 1.3422124261717144e-09,
            "start_logit": -0.4324658513069153,
            "end_logit": -4.108564853668213
        }
    ],
    "55180ef46487737b43000006_003": [
        {
            "text": "Dermatitis herpetiformis",
            "probability": 0.7007324238055026,
            "start_logit": 8.164535522460938,
            "end_logit": 7.367751121520996
        },
        {
            "text": "dermatitis herpetiformis",
            "probability": 0.2988649741741903,
            "start_logit": 7.785123348236084,
            "end_logit": 6.895029067993164
        },
        {
            "text": "dermatitis herpetiformis. Treatment of dermatitis herpetiformis",
            "probability": 0.0001418381837617435,
            "start_logit": 0.13206304609775543,
            "end_logit": 6.895029067993164
        },
        {
            "text": "Der",
            "probability": 9.888352121266014e-05,
            "start_logit": 8.164535522460938,
            "end_logit": -1.4981876611709595
        },
        {
            "text": "is",
            "probability": 6.537666378155322e-05,
            "start_logit": -1.115180492401123,
            "end_logit": 7.367751121520996
        },
        {
            "text": "Dermatitis herpetiformis is an autoimmune blistering",
            "probability": 5.353494409727745e-05,
            "start_logit": 8.164535522460938,
            "end_logit": -2.111795663833618
        },
        {
            "text": "der",
            "probability": 2.6576591470283044e-05,
            "start_logit": 7.785123348236084,
            "end_logit": -2.432687282562256
        },
        {
            "text": "herpetiformis",
            "probability": 7.039416564510577e-06,
            "start_logit": -3.343820571899414,
            "end_logit": 7.367751121520996
        },
        {
            "text": "Dermatitis herpetiformis is an autoimmune blistering disease that appears as a cutaneous",
            "probability": 2.7743310777782838e-06,
            "start_logit": 8.164535522460938,
            "end_logit": -5.071720600128174
        },
        {
            "text": "Dermatitis herpetiformis is an autoimmune blistering disease that appears",
            "probability": 1.9334493845070775e-06,
            "start_logit": 8.164535522460938,
            "end_logit": -5.432824611663818
        },
        {
            "text": "Dermatitis herpetiformis is an autoimmune blistering disease that appears as a cutaneous manifestation",
            "probability": 1.5196071797502318e-06,
            "start_logit": 8.164535522460938,
            "end_logit": -5.673678398132324
        },
        {
            "text": "Dermatitis herpetiformis is an autoimmune",
            "probability": 1.4470464672516577e-06,
            "start_logit": 8.164535522460938,
            "end_logit": -5.7226057052612305
        },
        {
            "text": "Dermatitis herpetiformis is an autoimmune blistering disease",
            "probability": 1.3149636691015397e-06,
            "start_logit": 8.164535522460938,
            "end_logit": -5.818321228027344
        },
        {
            "text": "dermatitis",
            "probability": 3.0154694508732786e-07,
            "start_logit": 7.785123348236084,
            "end_logit": -6.911547660827637
        },
        {
            "text": "dapsone, a drug that is only effective for the skin",
            "probability": 3.459971138747947e-08,
            "start_logit": -0.4324658513069153,
            "end_logit": -0.8590388298034668
        },
        {
            "text": "dermatitis herpetiformis. Treatment of dermatitis",
            "probability": 1.2612971711183978e-08,
            "start_logit": 0.13206304609775543,
            "end_logit": -2.432687282562256
        },
        {
            "text": "skin",
            "probability": 6.785255788192469e-09,
            "start_logit": -2.0615592002868652,
            "end_logit": -0.8590388298034668
        },
        {
            "text": "herpetiformis is an autoimmune blistering",
            "probability": 4.994682594826536e-09,
            "start_logit": -1.115180492401123,
            "end_logit": -2.111795663833618
        },
        {
            "text": "dermatitis herpetiformis.",
            "probability": 1.4198615315215043e-09,
            "start_logit": 0.13206304609775543,
            "end_logit": -4.616853713989258
        },
        {
            "text": "dapsone",
            "probability": 1.3422124261717144e-09,
            "start_logit": -0.4324658513069153,
            "end_logit": -4.108564853668213
        }
    ],
    "55180ef46487737b43000006_004": [
        {
            "text": "Dermatitis herpetiformis",
            "probability": 0.9905736799555241,
            "start_logit": 8.57829475402832,
            "end_logit": 7.950338363647461
        },
        {
            "text": "Dermatitis herpetiformis and coeliac disease",
            "probability": 0.009034736860267071,
            "start_logit": 8.57829475402832,
            "end_logit": 3.2531309127807617
        },
        {
            "text": "Der",
            "probability": 0.00019381111402776876,
            "start_logit": 8.57829475402832,
            "end_logit": -0.5888171195983887
        },
        {
            "text": "coeliac disease",
            "probability": 0.00010548664039055948,
            "start_logit": 4.128046989440918,
            "end_logit": 3.2531309127807617
        },
        {
            "text": "is",
            "probability": 6.767178338418834e-05,
            "start_logit": -1.0130754709243774,
            "end_logit": 7.950338363647461
        },
        {
            "text": "herpetiformis",
            "probability": 5.917477083688581e-06,
            "start_logit": -3.4498345851898193,
            "end_logit": 7.950338363647461
        },
        {
            "text": "Dermatitis herpetiformis and",
            "probability": 4.304466034267676e-06,
            "start_logit": 8.57829475402832,
            "end_logit": -4.396048069000244
        },
        {
            "text": "Dermatitis herpetiformis and coeliac disease are gluten-sensitive diseases that share",
            "probability": 4.2393099406651185e-06,
            "start_logit": 8.57829475402832,
            "end_logit": -4.4113006591796875
        },
        {
            "text": "Dermatitis herpetiformis and coeliac",
            "probability": 2.8768011573848456e-06,
            "start_logit": 8.57829475402832,
            "end_logit": -4.799022197723389
        },
        {
            "text": "Dermatitis herpetiformis and coeliac disease are gluten-sensitive diseases that share immunopathological",
            "probability": 1.540036755168226e-06,
            "start_logit": 8.57829475402832,
            "end_logit": -5.423894882202148
        },
        {
            "text": "Dermatitis herpetiformis and coeliac disease are gluten-sensitive",
            "probability": 1.4125360428376905e-06,
            "start_logit": 8.57829475402832,
            "end_logit": -5.510314464569092
        },
        {
            "text": "Dermatitis herpetiformis and coeliac disease are gluten-sensitive diseases",
            "probability": 1.1309516748402993e-06,
            "start_logit": 8.57829475402832,
            "end_logit": -5.732641696929932
        },
        {
            "text": "Dermatitis herpetiformis and coeliac disease are",
            "probability": 1.0718117471802802e-06,
            "start_logit": 8.57829475402832,
            "end_logit": -5.786350727081299
        },
        {
            "text": "iformis",
            "probability": 8.111720920509126e-07,
            "start_logit": -5.4370198249816895,
            "end_logit": 7.950338363647461
        },
        {
            "text": "herpetiformis and coeliac disease",
            "probability": 6.172148201722725e-07,
            "start_logit": -1.0130754709243774,
            "end_logit": 3.2531309127807617
        },
        {
            "text": "petiformis",
            "probability": 4.6867568522606574e-07,
            "start_logit": -5.985589027404785,
            "end_logit": 7.950338363647461
        },
        {
            "text": "dermatitis herpetiformis,",
            "probability": 1.0897467099646213e-07,
            "start_logit": 2.3864974975585938,
            "end_logit": -1.8805437088012695
        },
        {
            "text": "coeliac disease are gluten-sensitive diseases that share",
            "probability": 4.949679997673405e-08,
            "start_logit": 4.128046989440918,
            "end_logit": -4.4113006591796875
        },
        {
            "text": "co",
            "probability": 3.358859188237941e-08,
            "start_logit": 4.128046989440918,
            "end_logit": -4.799022197723389
        },
        {
            "text": "and coeliac disease",
            "probability": 3.1133309715233655e-08,
            "start_logit": -4.000014305114746,
            "end_logit": 3.2531309127807617
        }
    ],
    "55180ef46487737b43000006_005": [
        {
            "text": "dermatitis herpetiformis",
            "probability": 0.9997310374748777,
            "start_logit": 8.240571975708008,
            "end_logit": 7.55362606048584
        },
        {
            "text": "der",
            "probability": 0.0001192238837490269,
            "start_logit": 8.240571975708008,
            "end_logit": -1.4806123971939087
        },
        {
            "text": "is",
            "probability": 9.48520621969477e-05,
            "start_logit": -1.0223511457443237,
            "end_logit": 7.55362606048584
        },
        {
            "text": "Dermatitis herpetiformis",
            "probability": 4.424115352053877e-05,
            "start_logit": 3.3534889221191406,
            "end_logit": 2.4151229858398438
        },
        {
            "text": "dermatitis herpetiformis (DH)",
            "probability": 3.1630588444627134e-06,
            "start_logit": 8.240571975708008,
            "end_logit": -5.110075950622559
        },
        {
            "text": "herpetiformis",
            "probability": 1.5362075405302645e-06,
            "start_logit": -5.145352840423584,
            "end_logit": 7.55362606048584
        },
        {
            "text": "pruritic skin lesions, subsequently proven to be dermatitis herpetiformis",
            "probability": 1.4962478229507204e-06,
            "start_logit": -5.171709060668945,
            "end_logit": 7.55362606048584
        },
        {
            "text": "dermatitis herpetiformis (DH) as the first sign of gluten-sensitive disease.",
            "probability": 1.3145519650330123e-06,
            "start_logit": 8.240571975708008,
            "end_logit": -5.988119602203369
        },
        {
            "text": "to be dermatitis herpetiformis",
            "probability": 9.283222441137031e-07,
            "start_logit": -5.649045944213867,
            "end_logit": 7.55362606048584
        },
        {
            "text": "be dermatitis herpetiformis",
            "probability": 6.093996437374549e-07,
            "start_logit": -6.069950580596924,
            "end_logit": 7.55362606048584
        },
        {
            "text": "dermatitis",
            "probability": 5.914863350481672e-07,
            "start_logit": 8.240571975708008,
            "end_logit": -6.786732196807861
        },
        {
            "text": "dermat",
            "probability": 3.5714351900540713e-07,
            "start_logit": 8.240571975708008,
            "end_logit": -7.291233062744141
        },
        {
            "text": "iformis",
            "probability": 3.2274506780254016e-07,
            "start_logit": -6.705562114715576,
            "end_logit": 7.55362606048584
        },
        {
            "text": "subsequently proven to be dermatitis herpetiformis",
            "probability": 3.088877658609488e-07,
            "start_logit": -6.749446868896484,
            "end_logit": 7.55362606048584
        },
        {
            "text": "Der",
            "probability": 1.65882637586618e-08,
            "start_logit": 3.3534889221191406,
            "end_logit": -5.473592281341553
        },
        {
            "text": "herpetiformis (DH)",
            "probability": 3.00103370807993e-10,
            "start_logit": -1.0223511457443237,
            "end_logit": -5.110075950622559
        },
        {
            "text": "pruritic skin lesions, subsequently proven to be dermatitis",
            "probability": 1.7843646922654836e-10,
            "start_logit": -5.171709060668945,
            "end_logit": -1.4806123971939087
        },
        {
            "text": "herpetiformis (DH) as the first sign of gluten-sensitive disease.",
            "probability": 1.24721510160741e-10,
            "start_logit": -1.0223511457443237,
            "end_logit": -5.988119602203369
        },
        {
            "text": "to be dermatitis",
            "probability": 1.1070795960621475e-10,
            "start_logit": -5.649045944213867,
            "end_logit": -1.4806123971939087
        },
        {
            "text": "be dermatitis",
            "probability": 7.267453900917674e-11,
            "start_logit": -6.069950580596924,
            "end_logit": -1.4806123971939087
        }
    ],
    "55180ef46487737b43000006_006": [
        {
            "text": "Dermatitis herpetiformis",
            "probability": 0.9997160272536386,
            "start_logit": 9.099928855895996,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Der",
            "probability": 0.00016314146789815032,
            "start_logit": 9.099928855895996,
            "end_logit": -0.05978881195187569
        },
        {
            "text": "is",
            "probability": 7.591920209160514e-05,
            "start_logit": -0.3856280446052551,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Dermatitis herpetiformis (DH)",
            "probability": 3.02091920984203e-05,
            "start_logit": 9.099928855895996,
            "end_logit": -1.7462602853775024
        },
        {
            "text": "herpetiformis",
            "probability": 7.59730905372186e-06,
            "start_logit": -2.6875035762786865,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering",
            "probability": 2.8666277495011186e-06,
            "start_logit": 9.099928855895996,
            "end_logit": -4.1012701988220215
        },
        {
            "text": "iformis",
            "probability": 1.1650531340202988e-06,
            "start_logit": -4.562530994415283,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin",
            "probability": 9.291235859778858e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -5.227920055389404
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated",
            "probability": 6.175756975354585e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -5.636360168457031
        },
        {
            "text": "petiformis",
            "probability": 5.093377108508433e-07,
            "start_logit": -5.389941692352295,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune",
            "probability": 4.936999938589619e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -5.860233783721924
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder",
            "probability": 2.660166578581971e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -6.478602886199951
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity.",
            "probability": 2.548318736329573e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -6.521557807922363
        },
        {
            "text": "herpetiformis (DH)",
            "probability": 2.2941092244410093e-09,
            "start_logit": -0.3856280446052551,
            "end_logit": -1.7462602853775024
        },
        {
            "text": "(DH)",
            "probability": 4.500230761798997e-10,
            "start_logit": -2.0144290924072266,
            "end_logit": -1.7462602853775024
        },
        {
            "text": "herpetiformis (DH) is an autoimmune blistering",
            "probability": 2.176939105734304e-10,
            "start_logit": -0.3856280446052551,
            "end_logit": -4.1012701988220215
        },
        {
            "text": "DH",
            "probability": 1.7885899204709837e-10,
            "start_logit": -2.9371302127838135,
            "end_logit": -1.7462602853775024
        },
        {
            "text": "herpetiformis (DH) is an autoimmune blistering skin",
            "probability": 7.05583579426157e-11,
            "start_logit": -0.3856280446052551,
            "end_logit": -5.227920055389404
        },
        {
            "text": "herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity. It presents",
            "probability": 5.0674055935107086e-11,
            "start_logit": -0.3856280446052551,
            "end_logit": -5.558946132659912
        },
        {
            "text": "herpetiformis (DH) is an autoimmune blistering skin disorder that is associated",
            "probability": 4.689917227481144e-11,
            "start_logit": -0.3856280446052551,
            "end_logit": -5.636360168457031
        }
    ],
    "55180ef46487737b43000006_007": [
        {
            "text": "dermatitis herpetiformis",
            "probability": 0.9996395813155363,
            "start_logit": 7.973487377166748,
            "end_logit": 7.148780345916748
        },
        {
            "text": "der",
            "probability": 0.00017842702881221023,
            "start_logit": 7.973487377166748,
            "end_logit": -1.4821900129318237
        },
        {
            "text": "is",
            "probability": 0.00016017025017320784,
            "start_logit": -0.7654253840446472,
            "end_logit": 7.148780345916748
        },
        {
            "text": "herpetiformis",
            "probability": 1.061869233093901e-05,
            "start_logit": -3.4790468215942383,
            "end_logit": 7.148780345916748
        },
        {
            "text": "the fact, that dermatitis herpetiformis",
            "probability": 2.3055336771664643e-06,
            "start_logit": -4.963457107543945,
            "end_logit": 7.105886936187744
        },
        {
            "text": "dermatitis herpetiformis is associated",
            "probability": 1.2931749492021519e-06,
            "start_logit": 7.922741413116455,
            "end_logit": -6.358523368835449
        },
        {
            "text": "that dermatitis herpetiformis",
            "probability": 1.1533831946971865e-06,
            "start_logit": -5.656069755554199,
            "end_logit": 7.105886936187744
        },
        {
            "text": "iformis",
            "probability": 1.142560714774263e-06,
            "start_logit": -5.708390712738037,
            "end_logit": 7.148780345916748
        },
        {
            "text": "growing evidence that dermatitis herpetiformis",
            "probability": 9.909694855409064e-07,
            "start_logit": -5.850734233856201,
            "end_logit": 7.148780345916748
        },
        {
            "text": "evidence that dermatitis herpetiformis",
            "probability": 9.651538007991063e-07,
            "start_logit": -5.877130508422852,
            "end_logit": 7.148780345916748
        },
        {
            "text": "dermatitis herpetiformis should be considered as the skin manifestation",
            "probability": 9.016617659032299e-07,
            "start_logit": 7.973487377166748,
            "end_logit": -6.769885540008545
        },
        {
            "text": "dermatitis herpetiformis should be considered as the skin",
            "probability": 8.150159528735838e-07,
            "start_logit": 7.973487377166748,
            "end_logit": -6.870917320251465
        },
        {
            "text": "dermatitis",
            "probability": 6.730493149531672e-07,
            "start_logit": 7.973487377166748,
            "end_logit": -7.0623064041137695
        },
        {
            "text": "dermatitis herpetiformis is associated with gluten sensitive",
            "probability": 3.6199844048774824e-07,
            "start_logit": 7.922741413116455,
            "end_logit": -7.631739139556885
        },
        {
            "text": "dermatitis herpetiformis is",
            "probability": 3.02378965522453e-07,
            "start_logit": 7.922741413116455,
            "end_logit": -7.811697959899902
        },
        {
            "text": "dermat",
            "probability": 2.9687209668853965e-07,
            "start_logit": 7.922741413116455,
            "end_logit": -7.830077648162842
        },
        {
            "text": "the fact, that dermatitis",
            "probability": 4.0768582212034655e-10,
            "start_logit": -4.963457107543945,
            "end_logit": -1.534438967704773
        },
        {
            "text": "that dermatitis",
            "probability": 2.0395190085786089e-10,
            "start_logit": -5.656069755554199,
            "end_logit": -1.534438967704773
        },
        {
            "text": "growing evidence that dermatitis",
            "probability": 1.7687949162230755e-10,
            "start_logit": -5.850734233856201,
            "end_logit": -1.4821900129318237
        },
        {
            "text": "evidence that dermatitis",
            "probability": 1.7227161493222066e-10,
            "start_logit": -5.877130508422852,
            "end_logit": -1.4821900129318237
        }
    ],
    "55180ef46487737b43000006_008": [
        {
            "text": "dermatitis herpetiformis",
            "probability": 0.9996395813155363,
            "start_logit": 7.973487377166748,
            "end_logit": 7.148780345916748
        },
        {
            "text": "der",
            "probability": 0.00017842702881221023,
            "start_logit": 7.973487377166748,
            "end_logit": -1.4821900129318237
        },
        {
            "text": "is",
            "probability": 0.00016017025017320784,
            "start_logit": -0.7654253840446472,
            "end_logit": 7.148780345916748
        },
        {
            "text": "herpetiformis",
            "probability": 1.061869233093901e-05,
            "start_logit": -3.4790468215942383,
            "end_logit": 7.148780345916748
        },
        {
            "text": "the fact, that dermatitis herpetiformis",
            "probability": 2.3055336771664643e-06,
            "start_logit": -4.963457107543945,
            "end_logit": 7.105886936187744
        },
        {
            "text": "dermatitis herpetiformis is associated",
            "probability": 1.2931749492021519e-06,
            "start_logit": 7.922741413116455,
            "end_logit": -6.358523368835449
        },
        {
            "text": "that dermatitis herpetiformis",
            "probability": 1.1533831946971865e-06,
            "start_logit": -5.656069755554199,
            "end_logit": 7.105886936187744
        },
        {
            "text": "iformis",
            "probability": 1.142560714774263e-06,
            "start_logit": -5.708390712738037,
            "end_logit": 7.148780345916748
        },
        {
            "text": "growing evidence that dermatitis herpetiformis",
            "probability": 9.909694855409064e-07,
            "start_logit": -5.850734233856201,
            "end_logit": 7.148780345916748
        },
        {
            "text": "evidence that dermatitis herpetiformis",
            "probability": 9.651538007991063e-07,
            "start_logit": -5.877130508422852,
            "end_logit": 7.148780345916748
        },
        {
            "text": "dermatitis herpetiformis should be considered as the skin manifestation",
            "probability": 9.016617659032299e-07,
            "start_logit": 7.973487377166748,
            "end_logit": -6.769885540008545
        },
        {
            "text": "dermatitis herpetiformis should be considered as the skin",
            "probability": 8.150159528735838e-07,
            "start_logit": 7.973487377166748,
            "end_logit": -6.870917320251465
        },
        {
            "text": "dermatitis",
            "probability": 6.730493149531672e-07,
            "start_logit": 7.973487377166748,
            "end_logit": -7.0623064041137695
        },
        {
            "text": "dermatitis herpetiformis is associated with gluten sensitive",
            "probability": 3.6199844048774824e-07,
            "start_logit": 7.922741413116455,
            "end_logit": -7.631739139556885
        },
        {
            "text": "dermatitis herpetiformis is",
            "probability": 3.02378965522453e-07,
            "start_logit": 7.922741413116455,
            "end_logit": -7.811697959899902
        },
        {
            "text": "dermat",
            "probability": 2.9687209668853965e-07,
            "start_logit": 7.922741413116455,
            "end_logit": -7.830077648162842
        },
        {
            "text": "the fact, that dermatitis",
            "probability": 4.0768582212034655e-10,
            "start_logit": -4.963457107543945,
            "end_logit": -1.534438967704773
        },
        {
            "text": "that dermatitis",
            "probability": 2.0395190085786089e-10,
            "start_logit": -5.656069755554199,
            "end_logit": -1.534438967704773
        },
        {
            "text": "growing evidence that dermatitis",
            "probability": 1.7687949162230755e-10,
            "start_logit": -5.850734233856201,
            "end_logit": -1.4821900129318237
        },
        {
            "text": "evidence that dermatitis",
            "probability": 1.7227161493222066e-10,
            "start_logit": -5.877130508422852,
            "end_logit": -1.4821900129318237
        }
    ],
    "55180ef46487737b43000006_009": [
        {
            "text": "dermatitis herpetiformis",
            "probability": 0.5556359782457321,
            "start_logit": 3.7557058334350586,
            "end_logit": 2.6963086128234863
        },
        {
            "text": "dermatitis herpetiformis,",
            "probability": 0.44055079562549726,
            "start_logit": 3.4536337852478027,
            "end_logit": 2.7662930488586426
        },
        {
            "text": "with dermatitis herpetiformis",
            "probability": 0.0010203131576010385,
            "start_logit": -2.544297933578491,
            "end_logit": 2.6963086128234863
        },
        {
            "text": "der",
            "probability": 0.0007759204172263235,
            "start_logit": 3.7557058334350586,
            "end_logit": -3.8775100708007812
        },
        {
            "text": ",",
            "probability": 0.0007715684777532229,
            "start_logit": -2.89372181892395,
            "end_logit": 2.7662930488586426
        },
        {
            "text": "is",
            "probability": 0.0005593650718225315,
            "start_logit": -3.1453604698181152,
            "end_logit": 2.6963086128234863
        },
        {
            "text": "dermatitis herpetiformis, which is considered to be coeliac disease of the skin.",
            "probability": 0.0002209752869514712,
            "start_logit": 3.4536337852478027,
            "end_logit": -4.831437110900879
        },
        {
            "text": "dermatitis herpetiformis, which is considered to be coeliac disease",
            "probability": 9.677408085779465e-05,
            "start_logit": 3.4536337852478027,
            "end_logit": -5.657108783721924
        },
        {
            "text": "herpetiformis",
            "probability": 8.051972676803463e-05,
            "start_logit": -5.08366060256958,
            "end_logit": 2.6963086128234863
        },
        {
            "text": "dermatitis",
            "probability": 6.960796499184758e-05,
            "start_logit": 3.7557058334350586,
            "end_logit": -6.2886810302734375
        },
        {
            "text": "dermatitis herpetiformis, which",
            "probability": 5.264752972253636e-05,
            "start_logit": 3.4536337852478027,
            "end_logit": -6.265868663787842
        },
        {
            "text": "dermat",
            "probability": 3.7737576750189045e-05,
            "start_logit": 3.7557058334350586,
            "end_logit": -6.900903701782227
        },
        {
            "text": "BACKGROUND: A life-long gluten-free diet is the treatment of choice for dermatitis herpetiformis,",
            "probability": 2.6887598652218308e-05,
            "start_logit": -6.250482082366943,
            "end_logit": 2.7662930488586426
        },
        {
            "text": "herpetiformis,",
            "probability": 2.578645633683444e-05,
            "start_logit": -6.292297840118408,
            "end_logit": 2.7662930488586426
        },
        {
            "text": "for dermatitis herpetiformis,",
            "probability": 2.343504586375273e-05,
            "start_logit": -6.387914657592773,
            "end_logit": 2.7662930488586426
        },
        {
            "text": "dermatitis herpetiformis after the reintroduction of dietary gluten.",
            "probability": 1.4470092615288516e-05,
            "start_logit": 3.7557058334350586,
            "end_logit": -7.859476089477539
        },
        {
            "text": "dermatitis herpetiformis, which is considered to be coeliac",
            "probability": 1.1932744742870487e-05,
            "start_logit": 3.4536337852478027,
            "end_logit": -7.75020170211792
        },
        {
            "text": "petiformis",
            "probability": 9.827602029116239e-06,
            "start_logit": -7.186967849731445,
            "end_logit": 2.6963086128234863
        },
        {
            "text": "iformis",
            "probability": 9.51291952026003e-06,
            "start_logit": -7.219511985778809,
            "end_logit": 2.6963086128234863
        },
        {
            "text": "patients with dermatitis herpetiformis",
            "probability": 5.9443785653752266e-06,
            "start_logit": -7.689716815948486,
            "end_logit": 2.6963086128234863
        }
    ],
    "55180ef46487737b43000006_010": [
        {
            "text": "dermatitis herpetiformis",
            "probability": 0.5556359782457321,
            "start_logit": 3.7557058334350586,
            "end_logit": 2.6963086128234863
        },
        {
            "text": "dermatitis herpetiformis,",
            "probability": 0.44055079562549726,
            "start_logit": 3.4536337852478027,
            "end_logit": 2.7662930488586426
        },
        {
            "text": "with dermatitis herpetiformis",
            "probability": 0.0010203131576010385,
            "start_logit": -2.544297933578491,
            "end_logit": 2.6963086128234863
        },
        {
            "text": "der",
            "probability": 0.0007759204172263235,
            "start_logit": 3.7557058334350586,
            "end_logit": -3.8775100708007812
        },
        {
            "text": ",",
            "probability": 0.0007715684777532229,
            "start_logit": -2.89372181892395,
            "end_logit": 2.7662930488586426
        },
        {
            "text": "is",
            "probability": 0.0005593650718225315,
            "start_logit": -3.1453604698181152,
            "end_logit": 2.6963086128234863
        },
        {
            "text": "dermatitis herpetiformis, which is considered to be coeliac disease of the skin.",
            "probability": 0.0002209752869514712,
            "start_logit": 3.4536337852478027,
            "end_logit": -4.831437110900879
        },
        {
            "text": "dermatitis herpetiformis, which is considered to be coeliac disease",
            "probability": 9.677408085779465e-05,
            "start_logit": 3.4536337852478027,
            "end_logit": -5.657108783721924
        },
        {
            "text": "herpetiformis",
            "probability": 8.051972676803463e-05,
            "start_logit": -5.08366060256958,
            "end_logit": 2.6963086128234863
        },
        {
            "text": "dermatitis",
            "probability": 6.960796499184758e-05,
            "start_logit": 3.7557058334350586,
            "end_logit": -6.2886810302734375
        },
        {
            "text": "dermatitis herpetiformis, which",
            "probability": 5.264752972253636e-05,
            "start_logit": 3.4536337852478027,
            "end_logit": -6.265868663787842
        },
        {
            "text": "dermat",
            "probability": 3.7737576750189045e-05,
            "start_logit": 3.7557058334350586,
            "end_logit": -6.900903701782227
        },
        {
            "text": "BACKGROUND: A life-long gluten-free diet is the treatment of choice for dermatitis herpetiformis,",
            "probability": 2.6887598652218308e-05,
            "start_logit": -6.250482082366943,
            "end_logit": 2.7662930488586426
        },
        {
            "text": "herpetiformis,",
            "probability": 2.578645633683444e-05,
            "start_logit": -6.292297840118408,
            "end_logit": 2.7662930488586426
        },
        {
            "text": "for dermatitis herpetiformis,",
            "probability": 2.343504586375273e-05,
            "start_logit": -6.387914657592773,
            "end_logit": 2.7662930488586426
        },
        {
            "text": "dermatitis herpetiformis after the reintroduction of dietary gluten.",
            "probability": 1.4470092615288516e-05,
            "start_logit": 3.7557058334350586,
            "end_logit": -7.859476089477539
        },
        {
            "text": "dermatitis herpetiformis, which is considered to be coeliac",
            "probability": 1.1932744742870487e-05,
            "start_logit": 3.4536337852478027,
            "end_logit": -7.75020170211792
        },
        {
            "text": "petiformis",
            "probability": 9.827602029116239e-06,
            "start_logit": -7.186967849731445,
            "end_logit": 2.6963086128234863
        },
        {
            "text": "iformis",
            "probability": 9.51291952026003e-06,
            "start_logit": -7.219511985778809,
            "end_logit": 2.6963086128234863
        },
        {
            "text": "patients with dermatitis herpetiformis",
            "probability": 5.9443785653752266e-06,
            "start_logit": -7.689716815948486,
            "end_logit": 2.6963086128234863
        }
    ],
    "55180ef46487737b43000006_011": [
        {
            "text": "dermatitis herpetiformis",
            "probability": 0.9988680654682593,
            "start_logit": 7.274821758270264,
            "end_logit": 6.37642240524292
        },
        {
            "text": "coeliac disease (cCD) and dermatitis herpetiformis",
            "probability": 0.000806120430713555,
            "start_logit": 0.15267692506313324,
            "end_logit": 6.37642240524292
        },
        {
            "text": "der",
            "probability": 0.0001552585924271623,
            "start_logit": 7.274821758270264,
            "end_logit": -2.3928635120391846
        },
        {
            "text": "is",
            "probability": 0.00012790051733661402,
            "start_logit": -1.6883034706115723,
            "end_logit": 6.37642240524292
        },
        {
            "text": "classical coeliac disease (cCD) and dermatitis herpetiformis",
            "probability": 1.2509680778345174e-05,
            "start_logit": -4.0130534172058105,
            "end_logit": 6.37642240524292
        },
        {
            "text": "herpetiformis",
            "probability": 6.901988944799227e-06,
            "start_logit": -4.607746601104736,
            "end_logit": 6.37642240524292
        },
        {
            "text": "disease (cCD) and dermatitis herpetiformis",
            "probability": 4.185924581185765e-06,
            "start_logit": -5.107828617095947,
            "end_logit": 6.37642240524292
        },
        {
            "text": "(cCD) and dermatitis herpetiformis",
            "probability": 4.0573248810335646e-06,
            "start_logit": -5.139032363891602,
            "end_logit": 6.37642240524292
        },
        {
            "text": "and dermatitis herpetiformis",
            "probability": 2.984681921942429e-06,
            "start_logit": -5.446063041687012,
            "end_logit": 6.37642240524292
        },
        {
            "text": "of which the two major forms are classical coeliac disease (cCD) and dermatitis herpetiformis",
            "probability": 2.82744937947258e-06,
            "start_logit": -5.500181198120117,
            "end_logit": 6.37642240524292
        },
        {
            "text": "coeliac disease",
            "probability": 2.3173398058122026e-06,
            "start_logit": 0.15267692506313324,
            "end_logit": 0.5246091485023499
        },
        {
            "text": "the two major forms are classical coeliac disease (cCD) and dermatitis herpetiformis",
            "probability": 2.171675663266175e-06,
            "start_logit": -5.764057159423828,
            "end_logit": 6.37642240524292
        },
        {
            "text": "dermatitis",
            "probability": 1.7153829200340747e-06,
            "start_logit": 7.274821758270264,
            "end_logit": -6.898319244384766
        },
        {
            "text": "dermatitis herpetiformis (DH).",
            "probability": 1.6201061808109882e-06,
            "start_logit": 7.274821758270264,
            "end_logit": -6.955463886260986
        },
        {
            "text": "dermat",
            "probability": 1.1261928661306877e-06,
            "start_logit": 7.274821758270264,
            "end_logit": -7.319112777709961
        },
        {
            "text": "coeliac disease (cCD) and dermatitis",
            "probability": 1.252989536117485e-07,
            "start_logit": 0.15267692506313324,
            "end_logit": -2.3928635120391846
        },
        {
            "text": "classical coeliac disease",
            "probability": 3.5961352821690244e-08,
            "start_logit": -4.0130534172058105,
            "end_logit": 0.5246091485023499
        },
        {
            "text": "has various manifestations, of which the two major forms are classical coeliac disease",
            "probability": 3.5291467914285777e-08,
            "start_logit": -4.031857013702393,
            "end_logit": 0.5246091485023499
        },
        {
            "text": "various manifestations, of which the two major forms are classical coeliac disease",
            "probability": 2.7122385235741085e-08,
            "start_logit": -4.295138835906982,
            "end_logit": 0.5246091485023499
        },
        {
            "text": "manifestations, of which the two major forms are classical coeliac disease",
            "probability": 1.3569181047450318e-08,
            "start_logit": -4.987697124481201,
            "end_logit": 0.5246091485023499
        }
    ],
    "55180ef46487737b43000006_012": [
        {
            "text": "Dermatitis herpetiformis",
            "probability": 0.9996383460974423,
            "start_logit": 9.400184631347656,
            "end_logit": 9.05683708190918
        },
        {
            "text": "Der",
            "probability": 0.00023382362293624594,
            "start_logit": 9.400184631347656,
            "end_logit": 0.6962553262710571
        },
        {
            "text": "is",
            "probability": 0.00011405980596946323,
            "start_logit": 0.3217587172985077,
            "end_logit": 9.05683708190918
        },
        {
            "text": "herpetiformis",
            "probability": 4.074799905440934e-06,
            "start_logit": -3.0101425647735596,
            "end_logit": 9.05683708190918
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a specific dermatological manifestation of coeliac disease and 80%",
            "probability": 2.0753537775700875e-06,
            "start_logit": 9.400184631347656,
            "end_logit": -4.028180122375488
        },
        {
            "text": "Dermatitis herpetiformis (DH)",
            "probability": 2.0295444597883118e-06,
            "start_logit": 9.400184631347656,
            "end_logit": -4.050500392913818
        },
        {
            "text": "dermatitis herpetiformis. BACKGROUND: Dermatitis herpetiformis",
            "probability": 1.7032101923205407e-06,
            "start_logit": -3.8824493885040283,
            "end_logit": 9.05683708190918
        },
        {
            "text": "BACKGROUND: Dermatitis herpetiformis",
            "probability": 1.4868444339367132e-06,
            "start_logit": -4.018308162689209,
            "end_logit": 9.05683708190918
        },
        {
            "text": "iformis",
            "probability": 8.282566503716158e-07,
            "start_logit": -4.603396415710449,
            "end_logit": 9.05683708190918
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a specific dermatological",
            "probability": 7.667178279456719e-07,
            "start_logit": 9.400184631347656,
            "end_logit": -5.0239481925964355
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a specific",
            "probability": 2.4315056640368954e-07,
            "start_logit": 9.400184631347656,
            "end_logit": -6.172386169433594
        },
        {
            "text": "Dermatitis",
            "probability": 1.998740549277759e-07,
            "start_logit": 9.400184631347656,
            "end_logit": -6.368379592895508
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a specific dermatological manifestation",
            "probability": 1.8370086913740358e-07,
            "start_logit": 9.400184631347656,
            "end_logit": -6.452758312225342
        },
        {
            "text": "Dermat",
            "probability": 9.64641407644629e-08,
            "start_logit": 9.400184631347656,
            "end_logit": -7.096895694732666
        },
        {
            "text": "Dermatitis herpetiformis (DH) is",
            "probability": 8.125473683389585e-08,
            "start_logit": 9.400184631347656,
            "end_logit": -7.268477916717529
        },
        {
            "text": "dermatitis herpetiformis. BACKGROUND: Dermatitis",
            "probability": 3.983948588457896e-10,
            "start_logit": -3.8824493885040283,
            "end_logit": 0.6962553262710571
        },
        {
            "text": "BACKGROUND: Dermatitis",
            "probability": 3.47785130135239e-10,
            "start_logit": -4.018308162689209,
            "end_logit": 0.6962553262710571
        },
        {
            "text": "herpetiformis (DH) is a specific dermatological manifestation of coeliac disease and 80%",
            "probability": 2.368000888639004e-10,
            "start_logit": 0.3217587172985077,
            "end_logit": -4.028180122375488
        },
        {
            "text": "herpetiformis (DH)",
            "probability": 2.315731966401466e-10,
            "start_logit": 0.3217587172985077,
            "end_logit": -4.050500392913818
        },
        {
            "text": "herpetiformis (DH) is a specific dermatological",
            "probability": 8.748332537484217e-11,
            "start_logit": 0.3217587172985077,
            "end_logit": -5.0239481925964355
        }
    ],
    "55180ef46487737b43000006_013": [
        {
            "text": "dermatitis herpetiformis,",
            "probability": 0.7522668987060644,
            "start_logit": 3.936316967010498,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "dermatitis herpetiformis",
            "probability": 0.24139725925255417,
            "start_logit": 3.454698085784912,
            "end_logit": 2.444568634033203
        },
        {
            "text": "with dermatitis herpetiformis",
            "probability": 0.0016538126294339285,
            "start_logit": -1.5286625623703003,
            "end_logit": 2.444568634033203
        },
        {
            "text": "dermatitis herpetiformis, and",
            "probability": 0.001012407548744192,
            "start_logit": 3.936316967010498,
            "end_logit": -3.5111629962921143
        },
        {
            "text": ",",
            "probability": 0.0009235209891796472,
            "start_logit": -2.766335964202881,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 0.0007302872947628083,
            "start_logit": -3.001091480255127,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "der",
            "probability": 0.0007122281805271311,
            "start_logit": 3.936316967010498,
            "end_logit": -3.862851142883301
        },
        {
            "text": "is",
            "probability": 0.0003784276878534489,
            "start_logit": -3.003476142883301,
            "end_logit": 2.444568634033203
        },
        {
            "text": "rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 0.0003250048294724672,
            "start_logit": -3.8106894493103027,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "PATIENTS/METHODS: Eleven patients with dermatitis herpetiformis",
            "probability": 0.00020070412795316028,
            "start_logit": -3.254108190536499,
            "end_logit": 2.061007499694824
        },
        {
            "text": "indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 7.520006876669431e-05,
            "start_logit": -5.274377346038818,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "herpetiformis,",
            "probability": 6.325458058736249e-05,
            "start_logit": -5.447361946105957,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "in dermatitis herpetiformis,",
            "probability": 5.050379244673944e-05,
            "start_logit": -5.672481060028076,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "dermatitis herpetiformis, and this was used to study whether patients with this disease",
            "probability": 4.536316654501324e-05,
            "start_logit": 3.936316967010498,
            "end_logit": -6.616549015045166
        },
        {
            "text": "presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 3.847934298795039e-05,
            "start_logit": -5.944407939910889,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "herpetiformis",
            "probability": 3.8064409247576217e-05,
            "start_logit": -5.3002214431762695,
            "end_logit": 2.444568634033203
        },
        {
            "text": "dermatitis",
            "probability": 3.259035159255494e-05,
            "start_logit": 3.454698085784912,
            "end_logit": -6.465614318847656
        },
        {
            "text": "dermat",
            "probability": 2.3658565780663513e-05,
            "start_logit": 3.936316967010498,
            "end_logit": -7.267524242401123
        },
        {
            "text": "rash in patients with dermatitis herpetiformis",
            "probability": 1.7317265044899396e-05,
            "start_logit": -6.087797164916992,
            "end_logit": 2.444568634033203
        },
        {
            "text": "dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.",
            "probability": 1.501721045520395e-05,
            "start_logit": 3.936316967010498,
            "end_logit": -7.722052574157715
        }
    ],
    "55180ef46487737b43000006_014": [
        {
            "text": "dermatitis herpetiformis,",
            "probability": 0.7522668987060644,
            "start_logit": 3.936316967010498,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "dermatitis herpetiformis",
            "probability": 0.24139725925255417,
            "start_logit": 3.454698085784912,
            "end_logit": 2.444568634033203
        },
        {
            "text": "with dermatitis herpetiformis",
            "probability": 0.0016538126294339285,
            "start_logit": -1.5286625623703003,
            "end_logit": 2.444568634033203
        },
        {
            "text": "dermatitis herpetiformis, and",
            "probability": 0.001012407548744192,
            "start_logit": 3.936316967010498,
            "end_logit": -3.5111629962921143
        },
        {
            "text": ",",
            "probability": 0.0009235209891796472,
            "start_logit": -2.766335964202881,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 0.0007302872947628083,
            "start_logit": -3.001091480255127,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "der",
            "probability": 0.0007122281805271311,
            "start_logit": 3.936316967010498,
            "end_logit": -3.862851142883301
        },
        {
            "text": "is",
            "probability": 0.0003784276878534489,
            "start_logit": -3.003476142883301,
            "end_logit": 2.444568634033203
        },
        {
            "text": "rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 0.0003250048294724672,
            "start_logit": -3.8106894493103027,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "PATIENTS/METHODS: Eleven patients with dermatitis herpetiformis",
            "probability": 0.00020070412795316028,
            "start_logit": -3.254108190536499,
            "end_logit": 2.061007499694824
        },
        {
            "text": "indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 7.520006876669431e-05,
            "start_logit": -5.274377346038818,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "herpetiformis,",
            "probability": 6.325458058736249e-05,
            "start_logit": -5.447361946105957,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "in dermatitis herpetiformis,",
            "probability": 5.050379244673944e-05,
            "start_logit": -5.672481060028076,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "dermatitis herpetiformis, and this was used to study whether patients with this disease",
            "probability": 4.536316654501324e-05,
            "start_logit": 3.936316967010498,
            "end_logit": -6.616549015045166
        },
        {
            "text": "presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 3.847934298795039e-05,
            "start_logit": -5.944407939910889,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "herpetiformis",
            "probability": 3.8064409247576217e-05,
            "start_logit": -5.3002214431762695,
            "end_logit": 2.444568634033203
        },
        {
            "text": "dermatitis",
            "probability": 3.259035159255494e-05,
            "start_logit": 3.454698085784912,
            "end_logit": -6.465614318847656
        },
        {
            "text": "dermat",
            "probability": 2.3658565780663513e-05,
            "start_logit": 3.936316967010498,
            "end_logit": -7.267524242401123
        },
        {
            "text": "rash in patients with dermatitis herpetiformis",
            "probability": 1.7317265044899396e-05,
            "start_logit": -6.087797164916992,
            "end_logit": 2.444568634033203
        },
        {
            "text": "dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.",
            "probability": 1.501721045520395e-05,
            "start_logit": 3.936316967010498,
            "end_logit": -7.722052574157715
        }
    ],
    "55180ef46487737b43000006_015": [
        {
            "text": "Dermatitis herpetiformis",
            "probability": 0.9997403873342139,
            "start_logit": 9.144495010375977,
            "end_logit": 8.6416015625
        },
        {
            "text": "Der",
            "probability": 0.00019190039544138645,
            "start_logit": 9.144495010375977,
            "end_logit": 0.08332711458206177
        },
        {
            "text": "is",
            "probability": 5.5331215947497984e-05,
            "start_logit": -0.6574186682701111,
            "end_logit": 8.6416015625
        },
        {
            "text": "Dermatitis herpetiformis (DH)",
            "probability": 4.355912213131874e-06,
            "start_logit": 9.144495010375977,
            "end_logit": -3.702115297317505
        },
        {
            "text": "herpetiformis",
            "probability": 4.3111546088728175e-06,
            "start_logit": -3.209550142288208,
            "end_logit": 8.6416015625
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a lifelong, gluten-sensitive, blistering",
            "probability": 1.176676028580804e-06,
            "start_logit": 9.144495010375977,
            "end_logit": -5.010955810546875
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a lifelong, gluten-sensitive, blistering skin disease",
            "probability": 6.782626009320237e-07,
            "start_logit": 9.144495010375977,
            "end_logit": -5.561870098114014
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a lifelong, gluten-sensitive, blistering skin",
            "probability": 6.340754349464805e-07,
            "start_logit": 9.144495010375977,
            "end_logit": -5.629236698150635
        },
        {
            "text": "petiformis",
            "probability": 3.603268261847936e-07,
            "start_logit": -5.691499710083008,
            "end_logit": 8.6416015625
        },
        {
            "text": "iformis",
            "probability": 3.316464398136369e-07,
            "start_logit": -5.774441719055176,
            "end_logit": 8.6416015625
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a lifelong,",
            "probability": 1.9182520877384988e-07,
            "start_logit": 9.144495010375977,
            "end_logit": -6.824820041656494
        },
        {
            "text": "Dermatitis",
            "probability": 1.7542087905815099e-07,
            "start_logit": 9.144495010375977,
            "end_logit": -6.9142165184021
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a lifelong, gluten-sensitive,",
            "probability": 1.653084793770492e-07,
            "start_logit": 9.144495010375977,
            "end_logit": -6.973591327667236
        },
        {
            "text": "herpetiformis (DH)",
            "probability": 2.4108050686620015e-10,
            "start_logit": -0.6574186682701111,
            "end_logit": -3.702115297317505
        },
        {
            "text": "herpetiformis (DH) is a lifelong, gluten-sensitive, blistering",
            "probability": 6.512382240678999e-11,
            "start_logit": -0.6574186682701111,
            "end_logit": -5.010955810546875
        },
        {
            "text": "(DH)",
            "probability": 4.290976102035254e-11,
            "start_logit": -2.3834502696990967,
            "end_logit": -3.702115297317505
        },
        {
            "text": "herpetiformis (DH) is a lifelong, gluten-sensitive, blistering skin disease",
            "probability": 3.7538839999604274e-11,
            "start_logit": -0.6574186682701111,
            "end_logit": -5.561870098114014
        },
        {
            "text": "herpetiformis (DH) is a lifelong, gluten-sensitive, blistering skin",
            "probability": 3.5093275476825125e-11,
            "start_logit": -0.6574186682701111,
            "end_logit": -5.629236698150635
        },
        {
            "text": "herpetiformis (DH) is a lifelong, gluten-sensitive, blistering skin disease with pathognomonic",
            "probability": 1.2339721970566876e-11,
            "start_logit": -0.6574186682701111,
            "end_logit": -6.674422740936279
        },
        {
            "text": "(DH) is a lifelong, gluten-sensitive, blistering",
            "probability": 1.1591346361977573e-11,
            "start_logit": -2.3834502696990967,
            "end_logit": -5.010955810546875
        }
    ],
    "55180ef46487737b43000006_016": [
        {
            "text": "dermatitis herpetiformis",
            "probability": 0.9993736110848069,
            "start_logit": 6.858436584472656,
            "end_logit": 5.95504903793335
        },
        {
            "text": "der",
            "probability": 0.00022960881898141915,
            "start_logit": 6.858436584472656,
            "end_logit": -2.4234578609466553
        },
        {
            "text": "herpetiformis",
            "probability": 0.00020264685061414754,
            "start_logit": -1.6449825763702393,
            "end_logit": 5.95504903793335
        },
        {
            "text": "is",
            "probability": 0.000168318011159083,
            "start_logit": -1.8305922746658325,
            "end_logit": 5.95504903793335
        },
        {
            "text": "dermatitis",
            "probability": 1.0931599330011708e-05,
            "start_logit": 6.858436584472656,
            "end_logit": -5.468177318572998
        },
        {
            "text": "with dermatitis herpetiformis",
            "probability": 7.094517052179794e-06,
            "start_logit": -4.997125148773193,
            "end_logit": 5.95504903793335
        },
        {
            "text": "CONCLUSIONS: Patients with dermatitis herpetiformis",
            "probability": 3.249155311139259e-06,
            "start_logit": -5.77805233001709,
            "end_logit": 5.95504903793335
        },
        {
            "text": "petiformis",
            "probability": 1.6560904018053658e-06,
            "start_logit": -6.4519877433776855,
            "end_logit": 5.95504903793335
        },
        {
            "text": "iformis",
            "probability": 1.4405978615894453e-06,
            "start_logit": -6.591389179229736,
            "end_logit": 5.95504903793335
        },
        {
            "text": "dermat",
            "probability": 1.0022032910030498e-06,
            "start_logit": 6.858436584472656,
            "end_logit": -7.8576340675354
        },
        {
            "text": "dermatitis herpetiformis can include moderate amounts of oats in their gluten-free diets without deleterious",
            "probability": 4.303052229673243e-07,
            "start_logit": 6.858436584472656,
            "end_logit": -8.703095436096191
        },
        {
            "text": "herpetiformis can include moderate amounts of oats in their gluten-free diets without deleterious effects to the skin",
            "probability": 3.2201142295296386e-09,
            "start_logit": -1.6449825763702393,
            "end_logit": -5.094754219055176
        },
        {
            "text": "dermatitis herpetiformis can include moderate amounts of oats in their gluten-free diets without deleterious effects to the skin",
            "probability": 1.997402788109556e-09,
            "start_logit": -2.122551679611206,
            "end_logit": -5.094754219055176
        },
        {
            "text": "with dermatitis",
            "probability": 1.629984685933745e-09,
            "start_logit": -4.997125148773193,
            "end_logit": -2.4234578609466553
        },
        {
            "text": "itis",
            "probability": 1.374959988163264e-09,
            "start_logit": -2.122551679611206,
            "end_logit": -5.468177318572998
        },
        {
            "text": "CONCLUSIONS: Patients with dermatitis",
            "probability": 7.465023144528299e-10,
            "start_logit": -5.77805233001709,
            "end_logit": -2.4234578609466553
        },
        {
            "text": "gluten sensitivity",
            "probability": 6.064532565083454e-10,
            "start_logit": -4.163209915161133,
            "end_logit": -4.2460713386535645
        },
        {
            "text": "herpetiform",
            "probability": 6.058834071230065e-10,
            "start_logit": -1.6449825763702393,
            "end_logit": -6.7652387619018555
        },
        {
            "text": "herpet",
            "probability": 3.17838257969123e-10,
            "start_logit": -1.6449825763702393,
            "end_logit": -7.410383701324463
        },
        {
            "text": "herpetiformis can include moderate amounts of oats in their gluten-free diets without deleterious effects to the skin or intestine.",
            "probability": 2.6682845958614806e-10,
            "start_logit": -1.8305922746658325,
            "end_logit": -7.399710655212402
        }
    ],
    "55180ef46487737b43000006_017": [
        {
            "text": "Dermatitis herpetiformis",
            "probability": 0.9997597614525058,
            "start_logit": 8.837861061096191,
            "end_logit": 8.165608406066895
        },
        {
            "text": "Der",
            "probability": 0.00018341059114238437,
            "start_logit": 8.837861061096191,
            "end_logit": -0.4379345774650574
        },
        {
            "text": "is",
            "probability": 4.7094081108974e-05,
            "start_logit": -1.125261902809143,
            "end_logit": 8.165608406066895
        },
        {
            "text": "herpetiformis",
            "probability": 3.2496823808634777e-06,
            "start_logit": -3.79885196685791,
            "end_logit": 8.165608406066895
        },
        {
            "text": "Dermatitis herpetiformis (DH)",
            "probability": 3.0922794370568116e-06,
            "start_logit": 8.837861061096191,
            "end_logit": -4.520753383636475
        },
        {
            "text": "BACKGROUND: Dermatitis herpetiformis",
            "probability": 1.6643292158800307e-06,
            "start_logit": -4.467987060546875,
            "end_logit": 8.165608406066895
        },
        {
            "text": "petiformis",
            "probability": 3.296046057673816e-07,
            "start_logit": -6.087270736694336,
            "end_logit": 8.165608406066895
        },
        {
            "text": "iformis",
            "probability": 3.0205214560368094e-07,
            "start_logit": -6.174564838409424,
            "end_logit": 8.165608406066895
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated with gluten-sensitive",
            "probability": 2.8349923225163547e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -6.910207748413086
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a chronic papulovesicular immune-mediated",
            "probability": 2.478038202996578e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -7.0447797775268555
        },
        {
            "text": "Dermatitis",
            "probability": 1.6546578216937402e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -7.448652744293213
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated",
            "probability": 1.4937999166921156e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -7.550923824310303
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated with",
            "probability": 1.2941514766841178e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -7.69439172744751
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a chronic papulovesicular",
            "probability": 1.198452976273247e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -7.771215438842773
        },
        {
            "text": "BACKGROUND: Dermatitis",
            "probability": 3.053289571252652e-10,
            "start_logit": -4.467987060546875,
            "end_logit": -0.4379345774650574
        },
        {
            "text": "herpetiformis (DH)",
            "probability": 1.4566305250052225e-10,
            "start_logit": -1.125261902809143,
            "end_logit": -4.520753383636475
        },
        {
            "text": "herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated with gluten-sensitive enteropathy.",
            "probability": 2.8515184073529106e-11,
            "start_logit": -1.125261902809143,
            "end_logit": -6.151612758636475
        },
        {
            "text": "(DH)",
            "probability": 1.3650971495035657e-11,
            "start_logit": -3.4927473068237305,
            "end_logit": -4.520753383636475
        },
        {
            "text": "herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated with gluten-sensitive",
            "probability": 1.3354344066211586e-11,
            "start_logit": -1.125261902809143,
            "end_logit": -6.910207748413086
        },
        {
            "text": "herpetiformis (DH) is a chronic papulovesicular immune-mediated",
            "probability": 1.1672897492244286e-11,
            "start_logit": -1.125261902809143,
            "end_logit": -7.0447797775268555
        }
    ],
    "55180ef46487737b43000006_018": [
        {
            "text": "dermatitis herpetiformis",
            "probability": 0.9994584242651255,
            "start_logit": 7.103842735290527,
            "end_logit": 6.017373561859131
        },
        {
            "text": "dermatitis herpetiformis (DH),",
            "probability": 0.00022055214435059612,
            "start_logit": 7.103842735290527,
            "end_logit": -2.401461124420166
        },
        {
            "text": "der",
            "probability": 0.00014280661287717296,
            "start_logit": 7.103842735290527,
            "end_logit": -2.836103916168213
        },
        {
            "text": "is",
            "probability": 8.445775031397115e-05,
            "start_logit": -2.274874687194824,
            "end_logit": 6.017373561859131
        },
        {
            "text": "increased in untreated patients with coeliac disease and dermatitis herpetiformis",
            "probability": 5.7390407801329195e-05,
            "start_logit": -2.6612489223480225,
            "end_logit": 6.017373561859131
        },
        {
            "text": "and dermatitis herpetiformis",
            "probability": 7.917517750151268e-06,
            "start_logit": -4.642048358917236,
            "end_logit": 6.017373561859131
        },
        {
            "text": "are increased in untreated patients with coeliac disease and dermatitis herpetiformis",
            "probability": 4.951528956158814e-06,
            "start_logit": -5.111429691314697,
            "end_logit": 6.017373561859131
        },
        {
            "text": "with coeliac disease and dermatitis herpetiformis",
            "probability": 4.59559216775733e-06,
            "start_logit": -5.186028480529785,
            "end_logit": 6.017373561859131
        },
        {
            "text": "herpetiformis",
            "probability": 4.342574978201634e-06,
            "start_logit": -5.242658615112305,
            "end_logit": 6.017373561859131
        },
        {
            "text": "dermatitis herpetiformis (DH), and",
            "probability": 3.807604086888651e-06,
            "start_logit": 7.103842735290527,
            "end_logit": -6.46059513092041
        },
        {
            "text": "dermatitis herpetiformis (DH), and it has been suggested that salivary IgA-AGA",
            "probability": 2.838480659946532e-06,
            "start_logit": 7.103842735290527,
            "end_logit": -6.754326343536377
        },
        {
            "text": "patients with coeliac disease and dermatitis herpetiformis",
            "probability": 2.6752578148312787e-06,
            "start_logit": -5.727080345153809,
            "end_logit": 6.017373561859131
        },
        {
            "text": "dermat",
            "probability": 1.93863981439294e-06,
            "start_logit": 7.103842735290527,
            "end_logit": -7.135608673095703
        },
        {
            "text": "(IgA-AGA) are increased in untreated patients with coeliac disease and dermatitis herpetiformis",
            "probability": 1.7534047160751064e-06,
            "start_logit": -6.149566650390625,
            "end_logit": 6.017373561859131
        },
        {
            "text": "dermatitis",
            "probability": 1.4984769649880358e-06,
            "start_logit": 7.103842735290527,
            "end_logit": -7.39314603805542
        },
        {
            "text": "herpetiformis (DH),",
            "probability": 1.8637431519444886e-08,
            "start_logit": -2.274874687194824,
            "end_logit": -2.401461124420166
        },
        {
            "text": "increased in untreated patients with coeliac disease and dermatitis herpetiformis (DH),",
            "probability": 1.2664436257111048e-08,
            "start_logit": -2.6612489223480225,
            "end_logit": -2.401461124420166
        },
        {
            "text": "increased in untreated patients with coeliac disease and dermatitis",
            "probability": 8.200170763254712e-09,
            "start_logit": -2.6612489223480225,
            "end_logit": -2.836103916168213
        },
        {
            "text": "increased",
            "probability": 7.054778763805949e-09,
            "start_logit": -2.6612489223480225,
            "end_logit": -2.98655366897583
        },
        {
            "text": "antigliadin antibodies (IgA-AGA) are increased",
            "probability": 3.184805286028178e-09,
            "start_logit": -3.4565629959106445,
            "end_logit": -2.98655366897583
        }
    ],
    "55180ef46487737b43000006_019": [
        {
            "text": "dermatitis herpetiformis",
            "probability": 0.9950424959545878,
            "start_logit": 7.327815055847168,
            "end_logit": 6.519309043884277
        },
        {
            "text": "childhood dermatitis herpetiformis",
            "probability": 0.00459411604863878,
            "start_logit": 1.9498059749603271,
            "end_logit": 6.519309043884277
        },
        {
            "text": "is",
            "probability": 0.00018563767199877932,
            "start_logit": -1.258928894996643,
            "end_logit": 6.519309043884277
        },
        {
            "text": "der",
            "probability": 0.00015338464421014463,
            "start_logit": 7.327815055847168,
            "end_logit": -2.2582828998565674
        },
        {
            "text": "The central role of gluten in childhood dermatitis herpetiformis",
            "probability": 1.07115662003395e-05,
            "start_logit": -4.111401557922363,
            "end_logit": 6.519309043884277
        },
        {
            "text": "herpetiformis",
            "probability": 6.138371680058618e-06,
            "start_logit": -4.668166160583496,
            "end_logit": 6.519309043884277
        },
        {
            "text": "dermatitis herpetiformis is evidenced by the fact that a gluten free diet helps the damaged",
            "probability": 2.174931430854637e-06,
            "start_logit": 7.327815055847168,
            "end_logit": -6.51423454284668
        },
        {
            "text": "in childhood dermatitis herpetiformis",
            "probability": 1.998337584318787e-06,
            "start_logit": -5.790410041809082,
            "end_logit": 6.519309043884277
        },
        {
            "text": "dermatitis herpetiformis is evidenced by the fact that a gluten free diet helps the damaged jejunal",
            "probability": 1.0177889038800017e-06,
            "start_logit": 7.327815055847168,
            "end_logit": -7.273599147796631
        },
        {
            "text": "childhood dermatitis",
            "probability": 7.081776491410621e-07,
            "start_logit": 1.9498059749603271,
            "end_logit": -2.2582828998565674
        },
        {
            "text": "dermatitis herpetiformis is evidenced by the fact that a gluten free diet",
            "probability": 6.974593945168344e-07,
            "start_logit": 7.327815055847168,
            "end_logit": -7.651542663574219
        },
        {
            "text": "dermatitis",
            "probability": 6.852885190041498e-07,
            "start_logit": 7.327815055847168,
            "end_logit": -7.66914701461792
        },
        {
            "text": "childhood",
            "probability": 1.9391076357366996e-07,
            "start_logit": 1.9498059749603271,
            "end_logit": -3.553579807281494
        },
        {
            "text": "child",
            "probability": 1.889740553761861e-08,
            "start_logit": 1.9498059749603271,
            "end_logit": -5.881953239440918
        },
        {
            "text": "childhood dermatitis herpetiformis is evidenced by the fact that a gluten free diet helps the damaged",
            "probability": 1.0041669005897623e-08,
            "start_logit": 1.9498059749603271,
            "end_logit": -6.51423454284668
        },
        {
            "text": "childhood dermatitis herpetiformis is evidenced by the fact that a gluten free diet helps the damaged jejunal",
            "probability": 4.699136324781636e-09,
            "start_logit": 1.9498059749603271,
            "end_logit": -7.273599147796631
        },
        {
            "text": "childhood dermatitis herpetiformis is evidenced by the fact that a gluten free diet",
            "probability": 3.2201734203821483e-09,
            "start_logit": 1.9498059749603271,
            "end_logit": -7.651542663574219
        },
        {
            "text": "The central role of gluten in childhood dermatitis",
            "probability": 1.6511754796927475e-09,
            "start_logit": -4.111401557922363,
            "end_logit": -2.2582828998565674
        },
        {
            "text": "herpetiformis is evidenced by the fact that a gluten free diet helps the damaged jejunal mucosa",
            "probability": 8.867601196173735e-10,
            "start_logit": -1.258928894996643,
            "end_logit": -5.732423782348633
        },
        {
            "text": "The central role of gluten in childhood",
            "probability": 4.521191800527504e-10,
            "start_logit": -4.111401557922363,
            "end_logit": -3.553579807281494
        }
    ],
    "55180ef46487737b43000006_020": [
        {
            "text": "dermatitis herpetiformis,",
            "probability": 0.7522668987060644,
            "start_logit": 3.936316967010498,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "dermatitis herpetiformis",
            "probability": 0.24139725925255417,
            "start_logit": 3.454698085784912,
            "end_logit": 2.444568634033203
        },
        {
            "text": "with dermatitis herpetiformis",
            "probability": 0.0016538126294339285,
            "start_logit": -1.5286625623703003,
            "end_logit": 2.444568634033203
        },
        {
            "text": "dermatitis herpetiformis, and",
            "probability": 0.001012407548744192,
            "start_logit": 3.936316967010498,
            "end_logit": -3.5111629962921143
        },
        {
            "text": ",",
            "probability": 0.0009235209891796472,
            "start_logit": -2.766335964202881,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 0.0007302872947628083,
            "start_logit": -3.001091480255127,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "der",
            "probability": 0.0007122281805271311,
            "start_logit": 3.936316967010498,
            "end_logit": -3.862851142883301
        },
        {
            "text": "is",
            "probability": 0.0003784276878534489,
            "start_logit": -3.003476142883301,
            "end_logit": 2.444568634033203
        },
        {
            "text": "rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 0.0003250048294724672,
            "start_logit": -3.8106894493103027,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "PATIENTS/METHODS: Eleven patients with dermatitis herpetiformis",
            "probability": 0.00020070412795316028,
            "start_logit": -3.254108190536499,
            "end_logit": 2.061007499694824
        },
        {
            "text": "indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 7.520006876669431e-05,
            "start_logit": -5.274377346038818,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "herpetiformis,",
            "probability": 6.325458058736249e-05,
            "start_logit": -5.447361946105957,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "in dermatitis herpetiformis,",
            "probability": 5.050379244673944e-05,
            "start_logit": -5.672481060028076,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "dermatitis herpetiformis, and this was used to study whether patients with this disease",
            "probability": 4.536316654501324e-05,
            "start_logit": 3.936316967010498,
            "end_logit": -6.616549015045166
        },
        {
            "text": "presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 3.847934298795039e-05,
            "start_logit": -5.944407939910889,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "herpetiformis",
            "probability": 3.8064409247576217e-05,
            "start_logit": -5.3002214431762695,
            "end_logit": 2.444568634033203
        },
        {
            "text": "dermatitis",
            "probability": 3.259035159255494e-05,
            "start_logit": 3.454698085784912,
            "end_logit": -6.465614318847656
        },
        {
            "text": "dermat",
            "probability": 2.3658565780663513e-05,
            "start_logit": 3.936316967010498,
            "end_logit": -7.267524242401123
        },
        {
            "text": "rash in patients with dermatitis herpetiformis",
            "probability": 1.7317265044899396e-05,
            "start_logit": -6.087797164916992,
            "end_logit": 2.444568634033203
        },
        {
            "text": "dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.",
            "probability": 1.501721045520395e-05,
            "start_logit": 3.936316967010498,
            "end_logit": -7.722052574157715
        }
    ],
    "55180ef46487737b43000006_021": [
        {
            "text": "dermatitis herpetiformis,",
            "probability": 0.7522668987060644,
            "start_logit": 3.936316967010498,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "dermatitis herpetiformis",
            "probability": 0.24139725925255417,
            "start_logit": 3.454698085784912,
            "end_logit": 2.444568634033203
        },
        {
            "text": "with dermatitis herpetiformis",
            "probability": 0.0016538126294339285,
            "start_logit": -1.5286625623703003,
            "end_logit": 2.444568634033203
        },
        {
            "text": "dermatitis herpetiformis, and",
            "probability": 0.001012407548744192,
            "start_logit": 3.936316967010498,
            "end_logit": -3.5111629962921143
        },
        {
            "text": ",",
            "probability": 0.0009235209891796472,
            "start_logit": -2.766335964202881,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 0.0007302872947628083,
            "start_logit": -3.001091480255127,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "der",
            "probability": 0.0007122281805271311,
            "start_logit": 3.936316967010498,
            "end_logit": -3.862851142883301
        },
        {
            "text": "is",
            "probability": 0.0003784276878534489,
            "start_logit": -3.003476142883301,
            "end_logit": 2.444568634033203
        },
        {
            "text": "rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 0.0003250048294724672,
            "start_logit": -3.8106894493103027,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "PATIENTS/METHODS: Eleven patients with dermatitis herpetiformis",
            "probability": 0.00020070412795316028,
            "start_logit": -3.254108190536499,
            "end_logit": 2.061007499694824
        },
        {
            "text": "indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 7.520006876669431e-05,
            "start_logit": -5.274377346038818,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "herpetiformis,",
            "probability": 6.325458058736249e-05,
            "start_logit": -5.447361946105957,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "in dermatitis herpetiformis,",
            "probability": 5.050379244673944e-05,
            "start_logit": -5.672481060028076,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "dermatitis herpetiformis, and this was used to study whether patients with this disease",
            "probability": 4.536316654501324e-05,
            "start_logit": 3.936316967010498,
            "end_logit": -6.616549015045166
        },
        {
            "text": "presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 3.847934298795039e-05,
            "start_logit": -5.944407939910889,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "herpetiformis",
            "probability": 3.8064409247576217e-05,
            "start_logit": -5.3002214431762695,
            "end_logit": 2.444568634033203
        },
        {
            "text": "dermatitis",
            "probability": 3.259035159255494e-05,
            "start_logit": 3.454698085784912,
            "end_logit": -6.465614318847656
        },
        {
            "text": "dermat",
            "probability": 2.3658565780663513e-05,
            "start_logit": 3.936316967010498,
            "end_logit": -7.267524242401123
        },
        {
            "text": "rash in patients with dermatitis herpetiformis",
            "probability": 1.7317265044899396e-05,
            "start_logit": -6.087797164916992,
            "end_logit": 2.444568634033203
        },
        {
            "text": "dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.",
            "probability": 1.501721045520395e-05,
            "start_logit": 3.936316967010498,
            "end_logit": -7.722052574157715
        }
    ],
    "55180ef46487737b43000006_022": [
        {
            "text": "dermatitis herpetiformis,",
            "probability": 0.7522668987060644,
            "start_logit": 3.936316967010498,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "dermatitis herpetiformis",
            "probability": 0.24139725925255417,
            "start_logit": 3.454698085784912,
            "end_logit": 2.444568634033203
        },
        {
            "text": "with dermatitis herpetiformis",
            "probability": 0.0016538126294339285,
            "start_logit": -1.5286625623703003,
            "end_logit": 2.444568634033203
        },
        {
            "text": "dermatitis herpetiformis, and",
            "probability": 0.001012407548744192,
            "start_logit": 3.936316967010498,
            "end_logit": -3.5111629962921143
        },
        {
            "text": ",",
            "probability": 0.0009235209891796472,
            "start_logit": -2.766335964202881,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 0.0007302872947628083,
            "start_logit": -3.001091480255127,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "der",
            "probability": 0.0007122281805271311,
            "start_logit": 3.936316967010498,
            "end_logit": -3.862851142883301
        },
        {
            "text": "is",
            "probability": 0.0003784276878534489,
            "start_logit": -3.003476142883301,
            "end_logit": 2.444568634033203
        },
        {
            "text": "rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 0.0003250048294724672,
            "start_logit": -3.8106894493103027,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "PATIENTS/METHODS: Eleven patients with dermatitis herpetiformis",
            "probability": 0.00020070412795316028,
            "start_logit": -3.254108190536499,
            "end_logit": 2.061007499694824
        },
        {
            "text": "indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 7.520006876669431e-05,
            "start_logit": -5.274377346038818,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "herpetiformis,",
            "probability": 6.325458058736249e-05,
            "start_logit": -5.447361946105957,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "in dermatitis herpetiformis,",
            "probability": 5.050379244673944e-05,
            "start_logit": -5.672481060028076,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "dermatitis herpetiformis, and this was used to study whether patients with this disease",
            "probability": 4.536316654501324e-05,
            "start_logit": 3.936316967010498,
            "end_logit": -6.616549015045166
        },
        {
            "text": "presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 3.847934298795039e-05,
            "start_logit": -5.944407939910889,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "herpetiformis",
            "probability": 3.8064409247576217e-05,
            "start_logit": -5.3002214431762695,
            "end_logit": 2.444568634033203
        },
        {
            "text": "dermatitis",
            "probability": 3.259035159255494e-05,
            "start_logit": 3.454698085784912,
            "end_logit": -6.465614318847656
        },
        {
            "text": "dermat",
            "probability": 2.3658565780663513e-05,
            "start_logit": 3.936316967010498,
            "end_logit": -7.267524242401123
        },
        {
            "text": "rash in patients with dermatitis herpetiformis",
            "probability": 1.7317265044899396e-05,
            "start_logit": -6.087797164916992,
            "end_logit": 2.444568634033203
        },
        {
            "text": "dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.",
            "probability": 1.501721045520395e-05,
            "start_logit": 3.936316967010498,
            "end_logit": -7.722052574157715
        }
    ],
    "55180ef46487737b43000006_023": [
        {
            "text": "dermatitis herpetiformis,",
            "probability": 0.7522668987060644,
            "start_logit": 3.936316967010498,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "dermatitis herpetiformis",
            "probability": 0.24139725925255417,
            "start_logit": 3.454698085784912,
            "end_logit": 2.444568634033203
        },
        {
            "text": "with dermatitis herpetiformis",
            "probability": 0.0016538126294339285,
            "start_logit": -1.5286625623703003,
            "end_logit": 2.444568634033203
        },
        {
            "text": "dermatitis herpetiformis, and",
            "probability": 0.001012407548744192,
            "start_logit": 3.936316967010498,
            "end_logit": -3.5111629962921143
        },
        {
            "text": ",",
            "probability": 0.0009235209891796472,
            "start_logit": -2.766335964202881,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 0.0007302872947628083,
            "start_logit": -3.001091480255127,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "der",
            "probability": 0.0007122281805271311,
            "start_logit": 3.936316967010498,
            "end_logit": -3.862851142883301
        },
        {
            "text": "is",
            "probability": 0.0003784276878534489,
            "start_logit": -3.003476142883301,
            "end_logit": 2.444568634033203
        },
        {
            "text": "rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 0.0003250048294724672,
            "start_logit": -3.8106894493103027,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "PATIENTS/METHODS: Eleven patients with dermatitis herpetiformis",
            "probability": 0.00020070412795316028,
            "start_logit": -3.254108190536499,
            "end_logit": 2.061007499694824
        },
        {
            "text": "indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 7.520006876669431e-05,
            "start_logit": -5.274377346038818,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "herpetiformis,",
            "probability": 6.325458058736249e-05,
            "start_logit": -5.447361946105957,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "in dermatitis herpetiformis,",
            "probability": 5.050379244673944e-05,
            "start_logit": -5.672481060028076,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "dermatitis herpetiformis, and this was used to study whether patients with this disease",
            "probability": 4.536316654501324e-05,
            "start_logit": 3.936316967010498,
            "end_logit": -6.616549015045166
        },
        {
            "text": "presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 3.847934298795039e-05,
            "start_logit": -5.944407939910889,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "herpetiformis",
            "probability": 3.8064409247576217e-05,
            "start_logit": -5.3002214431762695,
            "end_logit": 2.444568634033203
        },
        {
            "text": "dermatitis",
            "probability": 3.259035159255494e-05,
            "start_logit": 3.454698085784912,
            "end_logit": -6.465614318847656
        },
        {
            "text": "dermat",
            "probability": 2.3658565780663513e-05,
            "start_logit": 3.936316967010498,
            "end_logit": -7.267524242401123
        },
        {
            "text": "rash in patients with dermatitis herpetiformis",
            "probability": 1.7317265044899396e-05,
            "start_logit": -6.087797164916992,
            "end_logit": 2.444568634033203
        },
        {
            "text": "dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.",
            "probability": 1.501721045520395e-05,
            "start_logit": 3.936316967010498,
            "end_logit": -7.722052574157715
        }
    ],
    "55180ef46487737b43000006_024": [
        {
            "text": "dermatitis herpetiformis,",
            "probability": 0.7522668987060644,
            "start_logit": 3.936316967010498,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "dermatitis herpetiformis",
            "probability": 0.24139725925255417,
            "start_logit": 3.454698085784912,
            "end_logit": 2.444568634033203
        },
        {
            "text": "with dermatitis herpetiformis",
            "probability": 0.0016538126294339285,
            "start_logit": -1.5286625623703003,
            "end_logit": 2.444568634033203
        },
        {
            "text": "dermatitis herpetiformis, and",
            "probability": 0.001012407548744192,
            "start_logit": 3.936316967010498,
            "end_logit": -3.5111629962921143
        },
        {
            "text": ",",
            "probability": 0.0009235209891796472,
            "start_logit": -2.766335964202881,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 0.0007302872947628083,
            "start_logit": -3.001091480255127,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "der",
            "probability": 0.0007122281805271311,
            "start_logit": 3.936316967010498,
            "end_logit": -3.862851142883301
        },
        {
            "text": "is",
            "probability": 0.0003784276878534489,
            "start_logit": -3.003476142883301,
            "end_logit": 2.444568634033203
        },
        {
            "text": "rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 0.0003250048294724672,
            "start_logit": -3.8106894493103027,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "PATIENTS/METHODS: Eleven patients with dermatitis herpetiformis",
            "probability": 0.00020070412795316028,
            "start_logit": -3.254108190536499,
            "end_logit": 2.061007499694824
        },
        {
            "text": "indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 7.520006876669431e-05,
            "start_logit": -5.274377346038818,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "herpetiformis,",
            "probability": 6.325458058736249e-05,
            "start_logit": -5.447361946105957,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "in dermatitis herpetiformis,",
            "probability": 5.050379244673944e-05,
            "start_logit": -5.672481060028076,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "dermatitis herpetiformis, and this was used to study whether patients with this disease",
            "probability": 4.536316654501324e-05,
            "start_logit": 3.936316967010498,
            "end_logit": -6.616549015045166
        },
        {
            "text": "presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis,",
            "probability": 3.847934298795039e-05,
            "start_logit": -5.944407939910889,
            "end_logit": 3.0995969772338867
        },
        {
            "text": "herpetiformis",
            "probability": 3.8064409247576217e-05,
            "start_logit": -5.3002214431762695,
            "end_logit": 2.444568634033203
        },
        {
            "text": "dermatitis",
            "probability": 3.259035159255494e-05,
            "start_logit": 3.454698085784912,
            "end_logit": -6.465614318847656
        },
        {
            "text": "dermat",
            "probability": 2.3658565780663513e-05,
            "start_logit": 3.936316967010498,
            "end_logit": -7.267524242401123
        },
        {
            "text": "rash in patients with dermatitis herpetiformis",
            "probability": 1.7317265044899396e-05,
            "start_logit": -6.087797164916992,
            "end_logit": 2.444568634033203
        },
        {
            "text": "dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.",
            "probability": 1.501721045520395e-05,
            "start_logit": 3.936316967010498,
            "end_logit": -7.722052574157715
        }
    ],
    "55180ef46487737b43000006_025": [
        {
            "text": "Dermatitis herpetiformis",
            "probability": 0.9995637234076034,
            "start_logit": 9.416993141174316,
            "end_logit": 9.039251327514648
        },
        {
            "text": "Der",
            "probability": 0.00033270460041806966,
            "start_logit": 9.416993141174316,
            "end_logit": 1.0314321517944336
        },
        {
            "text": "is",
            "probability": 8.85494289615729e-05,
            "start_logit": 0.08547987043857574,
            "end_logit": 9.039251327514648
        },
        {
            "text": "herpetiformis",
            "probability": 9.614641070572857e-06,
            "start_logit": -2.134793996810913,
            "end_logit": 9.039251327514648
        },
        {
            "text": "Dermatitis herpetiformis (DH)",
            "probability": 1.1305963719278093e-06,
            "start_logit": 9.416993141174316,
            "end_logit": -4.653077602386475
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmunity-driven inflammatory blistering dermatosis",
            "probability": 9.138292754826142e-07,
            "start_logit": 9.416993141174316,
            "end_logit": -4.865934371948242
        },
        {
            "text": "dermatitis herpetiformis. Dermatitis herpetiformis",
            "probability": 8.773153968725493e-07,
            "start_logit": -4.528969764709473,
            "end_logit": 9.039251327514648
        },
        {
            "text": "iformis",
            "probability": 6.816024777438165e-07,
            "start_logit": -4.7813897132873535,
            "end_logit": 9.039251327514648
        },
        {
            "text": "petiformis",
            "probability": 5.120113024840111e-07,
            "start_logit": -5.0674896240234375,
            "end_logit": 9.039251327514648
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmunity-driven inflammatory blistering",
            "probability": 5.066222634577303e-07,
            "start_logit": 9.416993141174316,
            "end_logit": -5.455812454223633
        },
        {
            "text": "Dermat",
            "probability": 1.869798811321119e-07,
            "start_logit": 9.416993141174316,
            "end_logit": -6.452577114105225
        },
        {
            "text": "Dermatitis",
            "probability": 1.6208989704590446e-07,
            "start_logit": 9.416993141174316,
            "end_logit": -6.5954270362854
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmunity-driven inflammatory blistering dermatosis associated with",
            "probability": 1.5569112819830166e-07,
            "start_logit": 9.416993141174316,
            "end_logit": -6.635704040527344
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an",
            "probability": 1.0835392943439669e-07,
            "start_logit": 9.416993141174316,
            "end_logit": -6.998175144195557
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmunity-driven inflammatory blistering dermatosis associated with a gluten-dependent",
            "probability": 6.239385817511568e-08,
            "start_logit": 9.416993141174316,
            "end_logit": -7.550111293792725
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmunity-driven inflammatory blistering dermatosis associated",
            "probability": 5.842589273276744e-08,
            "start_logit": 9.416993141174316,
            "end_logit": -7.615818977355957
        },
        {
            "text": "Dermatitis herpetiformis (DH) is",
            "probability": 5.153714589188148e-08,
            "start_logit": 9.416993141174316,
            "end_logit": -7.741275310516357
        },
        {
            "text": "dermatitis herpetiformis. Dermatitis",
            "probability": 2.920142675466782e-10,
            "start_logit": -4.528969764709473,
            "end_logit": 1.0314321517944336
        },
        {
            "text": "herpetiformis (DH)",
            "probability": 1.001573594317099e-10,
            "start_logit": 0.08547987043857574,
            "end_logit": -4.653077602386475
        },
        {
            "text": "herpetiformis (DH) is an autoimmunity-driven inflammatory blistering dermatosis",
            "probability": 8.095437901296875e-11,
            "start_logit": 0.08547987043857574,
            "end_logit": -4.865934371948242
        }
    ],
    "55180ef46487737b43000006_026": [
        {
            "text": "Dermatitis herpetiformis",
            "probability": 0.7007324238055026,
            "start_logit": 8.164535522460938,
            "end_logit": 7.367751121520996
        },
        {
            "text": "dermatitis herpetiformis",
            "probability": 0.2988649741741903,
            "start_logit": 7.785123348236084,
            "end_logit": 6.895029067993164
        },
        {
            "text": "dermatitis herpetiformis. Treatment of dermatitis herpetiformis",
            "probability": 0.0001418381837617435,
            "start_logit": 0.13206304609775543,
            "end_logit": 6.895029067993164
        },
        {
            "text": "Der",
            "probability": 9.888352121266014e-05,
            "start_logit": 8.164535522460938,
            "end_logit": -1.4981876611709595
        },
        {
            "text": "is",
            "probability": 6.537666378155322e-05,
            "start_logit": -1.115180492401123,
            "end_logit": 7.367751121520996
        },
        {
            "text": "Dermatitis herpetiformis is an autoimmune blistering",
            "probability": 5.353494409727745e-05,
            "start_logit": 8.164535522460938,
            "end_logit": -2.111795663833618
        },
        {
            "text": "der",
            "probability": 2.6576591470283044e-05,
            "start_logit": 7.785123348236084,
            "end_logit": -2.432687282562256
        },
        {
            "text": "herpetiformis",
            "probability": 7.039416564510577e-06,
            "start_logit": -3.343820571899414,
            "end_logit": 7.367751121520996
        },
        {
            "text": "Dermatitis herpetiformis is an autoimmune blistering disease that appears as a cutaneous",
            "probability": 2.7743310777782838e-06,
            "start_logit": 8.164535522460938,
            "end_logit": -5.071720600128174
        },
        {
            "text": "Dermatitis herpetiformis is an autoimmune blistering disease that appears",
            "probability": 1.9334493845070775e-06,
            "start_logit": 8.164535522460938,
            "end_logit": -5.432824611663818
        },
        {
            "text": "Dermatitis herpetiformis is an autoimmune blistering disease that appears as a cutaneous manifestation",
            "probability": 1.5196071797502318e-06,
            "start_logit": 8.164535522460938,
            "end_logit": -5.673678398132324
        },
        {
            "text": "Dermatitis herpetiformis is an autoimmune",
            "probability": 1.4470464672516577e-06,
            "start_logit": 8.164535522460938,
            "end_logit": -5.7226057052612305
        },
        {
            "text": "Dermatitis herpetiformis is an autoimmune blistering disease",
            "probability": 1.3149636691015397e-06,
            "start_logit": 8.164535522460938,
            "end_logit": -5.818321228027344
        },
        {
            "text": "dermatitis",
            "probability": 3.0154694508732786e-07,
            "start_logit": 7.785123348236084,
            "end_logit": -6.911547660827637
        },
        {
            "text": "dapsone, a drug that is only effective for the skin",
            "probability": 3.459971138747947e-08,
            "start_logit": -0.4324658513069153,
            "end_logit": -0.8590388298034668
        },
        {
            "text": "dermatitis herpetiformis. Treatment of dermatitis",
            "probability": 1.2612971711183978e-08,
            "start_logit": 0.13206304609775543,
            "end_logit": -2.432687282562256
        },
        {
            "text": "skin",
            "probability": 6.785255788192469e-09,
            "start_logit": -2.0615592002868652,
            "end_logit": -0.8590388298034668
        },
        {
            "text": "herpetiformis is an autoimmune blistering",
            "probability": 4.994682594826536e-09,
            "start_logit": -1.115180492401123,
            "end_logit": -2.111795663833618
        },
        {
            "text": "dermatitis herpetiformis.",
            "probability": 1.4198615315215043e-09,
            "start_logit": 0.13206304609775543,
            "end_logit": -4.616853713989258
        },
        {
            "text": "dapsone",
            "probability": 1.3422124261717144e-09,
            "start_logit": -0.4324658513069153,
            "end_logit": -4.108564853668213
        }
    ],
    "55180ef46487737b43000006_027": [
        {
            "text": "Dermatitis herpetiformis",
            "probability": 0.9997160272536386,
            "start_logit": 9.099928855895996,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Der",
            "probability": 0.00016314146789815032,
            "start_logit": 9.099928855895996,
            "end_logit": -0.05978881195187569
        },
        {
            "text": "is",
            "probability": 7.591920209160514e-05,
            "start_logit": -0.3856280446052551,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Dermatitis herpetiformis (DH)",
            "probability": 3.02091920984203e-05,
            "start_logit": 9.099928855895996,
            "end_logit": -1.7462602853775024
        },
        {
            "text": "herpetiformis",
            "probability": 7.59730905372186e-06,
            "start_logit": -2.6875035762786865,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering",
            "probability": 2.8666277495011186e-06,
            "start_logit": 9.099928855895996,
            "end_logit": -4.1012701988220215
        },
        {
            "text": "iformis",
            "probability": 1.1650531340202988e-06,
            "start_logit": -4.562530994415283,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin",
            "probability": 9.291235859778858e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -5.227920055389404
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated",
            "probability": 6.175756975354585e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -5.636360168457031
        },
        {
            "text": "petiformis",
            "probability": 5.093377108508433e-07,
            "start_logit": -5.389941692352295,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune",
            "probability": 4.936999938589619e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -5.860233783721924
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder",
            "probability": 2.660166578581971e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -6.478602886199951
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity.",
            "probability": 2.548318736329573e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -6.521557807922363
        },
        {
            "text": "herpetiformis (DH)",
            "probability": 2.2941092244410093e-09,
            "start_logit": -0.3856280446052551,
            "end_logit": -1.7462602853775024
        },
        {
            "text": "(DH)",
            "probability": 4.500230761798997e-10,
            "start_logit": -2.0144290924072266,
            "end_logit": -1.7462602853775024
        },
        {
            "text": "herpetiformis (DH) is an autoimmune blistering",
            "probability": 2.176939105734304e-10,
            "start_logit": -0.3856280446052551,
            "end_logit": -4.1012701988220215
        },
        {
            "text": "DH",
            "probability": 1.7885899204709837e-10,
            "start_logit": -2.9371302127838135,
            "end_logit": -1.7462602853775024
        },
        {
            "text": "herpetiformis (DH) is an autoimmune blistering skin",
            "probability": 7.05583579426157e-11,
            "start_logit": -0.3856280446052551,
            "end_logit": -5.227920055389404
        },
        {
            "text": "herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity. It presents",
            "probability": 5.0674055935107086e-11,
            "start_logit": -0.3856280446052551,
            "end_logit": -5.558946132659912
        },
        {
            "text": "herpetiformis (DH) is an autoimmune blistering skin disorder that is associated",
            "probability": 4.689917227481144e-11,
            "start_logit": -0.3856280446052551,
            "end_logit": -5.636360168457031
        }
    ],
    "55180ef46487737b43000006_028": [
        {
            "text": "dermatitis herpetiformis,",
            "probability": 0.9995821313221342,
            "start_logit": 8.201643943786621,
            "end_logit": 8.068968772888184
        },
        {
            "text": ",",
            "probability": 0.000256085004017968,
            "start_logit": -0.06793922185897827,
            "end_logit": 8.068968772888184
        },
        {
            "text": "contrasts to the situation in dermatitis herpetiformis,",
            "probability": 6.345337782041644e-05,
            "start_logit": -1.463143229484558,
            "end_logit": 8.068968772888184
        },
        {
            "text": "der",
            "probability": 4.3607249640573056e-05,
            "start_logit": 8.201643943786621,
            "end_logit": -1.9709004163742065
        },
        {
            "text": "the situation in dermatitis herpetiformis,",
            "probability": 1.8085536904916933e-05,
            "start_logit": -2.7183361053466797,
            "end_logit": 8.068968772888184
        },
        {
            "text": "herpetiformis,",
            "probability": 7.879038851411168e-06,
            "start_logit": -3.5492427349090576,
            "end_logit": 8.068968772888184
        },
        {
            "text": "situation in dermatitis herpetiformis,",
            "probability": 6.731294054289996e-06,
            "start_logit": -3.706681251525879,
            "end_logit": 8.068968772888184
        },
        {
            "text": "dermatitis herpetiformis, where",
            "probability": 6.352342139013553e-06,
            "start_logit": 8.201643943786621,
            "end_logit": -3.8973002433776855
        },
        {
            "text": "This contrasts to the situation in dermatitis herpetiformis,",
            "probability": 5.030907502572477e-06,
            "start_logit": -3.9978482723236084,
            "end_logit": 8.068968772888184
        },
        {
            "text": "dermatitis herpetiformis",
            "probability": 4.75597361584921e-06,
            "start_logit": 2.576552391052246,
            "end_logit": 1.4383691549301147
        },
        {
            "text": "to the situation in dermatitis herpetiformis,",
            "probability": 2.2738720499294117e-06,
            "start_logit": -4.791964530944824,
            "end_logit": 8.068968772888184
        },
        {
            "text": "dermatitis herpetiformis, where both the rash and the enteropathy are gluten dependent.",
            "probability": 1.208506684579971e-06,
            "start_logit": 8.201643943786621,
            "end_logit": -5.556738376617432
        },
        {
            "text": "in dermatitis herpetiformis,",
            "probability": 1.1157774963764855e-06,
            "start_logit": -5.503897190093994,
            "end_logit": 8.068968772888184
        },
        {
            "text": "dermatitis herpetiformis, where both the rash and the enteropathy",
            "probability": 9.111423258177499e-07,
            "start_logit": 8.201643943786621,
            "end_logit": -5.839179992675781
        },
        {
            "text": "dermatitis",
            "probability": 3.692699885944827e-07,
            "start_logit": 8.201643943786621,
            "end_logit": -6.742351055145264
        },
        {
            "text": "contrasts to the situation in dermatitis",
            "probability": 2.7681840245509293e-09,
            "start_logit": -1.463143229484558,
            "end_logit": -1.9709004163742065
        },
        {
            "text": "is",
            "probability": 1.922720639727608e-09,
            "start_logit": -5.236863136291504,
            "end_logit": 1.4383691549301147
        },
        {
            "text": "enteropathy are gluten dependent. These data add further to the evidence that LAD and dermatitis herpetiformis",
            "probability": 1.7686945839520828e-09,
            "start_logit": -5.320362567901611,
            "end_logit": 1.4383691549301147
        },
        {
            "text": "herpetiformis, where",
            "probability": 1.627419609873504e-09,
            "start_logit": -0.06793922185897827,
            "end_logit": -3.8973002433776855
        },
        {
            "text": "gluten dependent. These data add further to the evidence that LAD and dermatitis herpetiformis",
            "probability": 1.2977547760905132e-09,
            "start_logit": -5.629968643188477,
            "end_logit": 1.4383691549301147
        }
    ],
    "55180ef46487737b43000006_030": [
        {
            "text": "Dermatitis herpetiformis",
            "probability": 0.9997160272536386,
            "start_logit": 9.099928855895996,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Der",
            "probability": 0.00016314146789815032,
            "start_logit": 9.099928855895996,
            "end_logit": -0.05978881195187569
        },
        {
            "text": "is",
            "probability": 7.591920209160514e-05,
            "start_logit": -0.3856280446052551,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Dermatitis herpetiformis (DH)",
            "probability": 3.02091920984203e-05,
            "start_logit": 9.099928855895996,
            "end_logit": -1.7462602853775024
        },
        {
            "text": "herpetiformis",
            "probability": 7.59730905372186e-06,
            "start_logit": -2.6875035762786865,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering",
            "probability": 2.8666277495011186e-06,
            "start_logit": 9.099928855895996,
            "end_logit": -4.1012701988220215
        },
        {
            "text": "iformis",
            "probability": 1.1650531340202988e-06,
            "start_logit": -4.562530994415283,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin",
            "probability": 9.291235859778858e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -5.227920055389404
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated",
            "probability": 6.175756975354585e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -5.636360168457031
        },
        {
            "text": "petiformis",
            "probability": 5.093377108508433e-07,
            "start_logit": -5.389941692352295,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune",
            "probability": 4.936999938589619e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -5.860233783721924
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder",
            "probability": 2.660166578581971e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -6.478602886199951
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity.",
            "probability": 2.548318736329573e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -6.521557807922363
        },
        {
            "text": "herpetiformis (DH)",
            "probability": 2.2941092244410093e-09,
            "start_logit": -0.3856280446052551,
            "end_logit": -1.7462602853775024
        },
        {
            "text": "(DH)",
            "probability": 4.500230761798997e-10,
            "start_logit": -2.0144290924072266,
            "end_logit": -1.7462602853775024
        },
        {
            "text": "herpetiformis (DH) is an autoimmune blistering",
            "probability": 2.176939105734304e-10,
            "start_logit": -0.3856280446052551,
            "end_logit": -4.1012701988220215
        },
        {
            "text": "DH",
            "probability": 1.7885899204709837e-10,
            "start_logit": -2.9371302127838135,
            "end_logit": -1.7462602853775024
        },
        {
            "text": "herpetiformis (DH) is an autoimmune blistering skin",
            "probability": 7.05583579426157e-11,
            "start_logit": -0.3856280446052551,
            "end_logit": -5.227920055389404
        },
        {
            "text": "herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity. It presents",
            "probability": 5.0674055935107086e-11,
            "start_logit": -0.3856280446052551,
            "end_logit": -5.558946132659912
        },
        {
            "text": "herpetiformis (DH) is an autoimmune blistering skin disorder that is associated",
            "probability": 4.689917227481144e-11,
            "start_logit": -0.3856280446052551,
            "end_logit": -5.636360168457031
        }
    ],
    "55180ef46487737b43000006_031": [
        {
            "text": "Dermatitis herpetiformis",
            "probability": 0.9997597614525058,
            "start_logit": 8.837861061096191,
            "end_logit": 8.165608406066895
        },
        {
            "text": "Der",
            "probability": 0.00018341059114238437,
            "start_logit": 8.837861061096191,
            "end_logit": -0.4379345774650574
        },
        {
            "text": "is",
            "probability": 4.7094081108974e-05,
            "start_logit": -1.125261902809143,
            "end_logit": 8.165608406066895
        },
        {
            "text": "herpetiformis",
            "probability": 3.2496823808634777e-06,
            "start_logit": -3.79885196685791,
            "end_logit": 8.165608406066895
        },
        {
            "text": "Dermatitis herpetiformis (DH)",
            "probability": 3.0922794370568116e-06,
            "start_logit": 8.837861061096191,
            "end_logit": -4.520753383636475
        },
        {
            "text": "BACKGROUND: Dermatitis herpetiformis",
            "probability": 1.6643292158800307e-06,
            "start_logit": -4.467987060546875,
            "end_logit": 8.165608406066895
        },
        {
            "text": "petiformis",
            "probability": 3.296046057673816e-07,
            "start_logit": -6.087270736694336,
            "end_logit": 8.165608406066895
        },
        {
            "text": "iformis",
            "probability": 3.0205214560368094e-07,
            "start_logit": -6.174564838409424,
            "end_logit": 8.165608406066895
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated with gluten-sensitive",
            "probability": 2.8349923225163547e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -6.910207748413086
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a chronic papulovesicular immune-mediated",
            "probability": 2.478038202996578e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -7.0447797775268555
        },
        {
            "text": "Dermatitis",
            "probability": 1.6546578216937402e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -7.448652744293213
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated",
            "probability": 1.4937999166921156e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -7.550923824310303
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated with",
            "probability": 1.2941514766841178e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -7.69439172744751
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a chronic papulovesicular",
            "probability": 1.198452976273247e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -7.771215438842773
        },
        {
            "text": "BACKGROUND: Dermatitis",
            "probability": 3.053289571252652e-10,
            "start_logit": -4.467987060546875,
            "end_logit": -0.4379345774650574
        },
        {
            "text": "herpetiformis (DH)",
            "probability": 1.4566305250052225e-10,
            "start_logit": -1.125261902809143,
            "end_logit": -4.520753383636475
        },
        {
            "text": "herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated with gluten-sensitive enteropathy.",
            "probability": 2.8515184073529106e-11,
            "start_logit": -1.125261902809143,
            "end_logit": -6.151612758636475
        },
        {
            "text": "(DH)",
            "probability": 1.3650971495035657e-11,
            "start_logit": -3.4927473068237305,
            "end_logit": -4.520753383636475
        },
        {
            "text": "herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated with gluten-sensitive",
            "probability": 1.3354344066211586e-11,
            "start_logit": -1.125261902809143,
            "end_logit": -6.910207748413086
        },
        {
            "text": "herpetiformis (DH) is a chronic papulovesicular immune-mediated",
            "probability": 1.1672897492244286e-11,
            "start_logit": -1.125261902809143,
            "end_logit": -7.0447797775268555
        }
    ],
    "55180ef46487737b43000006_032": [
        {
            "text": "Dermatitis herpetiformis",
            "probability": 0.9997160272536386,
            "start_logit": 9.099928855895996,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Der",
            "probability": 0.00016314146789815032,
            "start_logit": 9.099928855895996,
            "end_logit": -0.05978881195187569
        },
        {
            "text": "is",
            "probability": 7.591920209160514e-05,
            "start_logit": -0.3856280446052551,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Dermatitis herpetiformis (DH)",
            "probability": 3.02091920984203e-05,
            "start_logit": 9.099928855895996,
            "end_logit": -1.7462602853775024
        },
        {
            "text": "herpetiformis",
            "probability": 7.59730905372186e-06,
            "start_logit": -2.6875035762786865,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering",
            "probability": 2.8666277495011186e-06,
            "start_logit": 9.099928855895996,
            "end_logit": -4.1012701988220215
        },
        {
            "text": "iformis",
            "probability": 1.1650531340202988e-06,
            "start_logit": -4.562530994415283,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin",
            "probability": 9.291235859778858e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -5.227920055389404
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated",
            "probability": 6.175756975354585e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -5.636360168457031
        },
        {
            "text": "petiformis",
            "probability": 5.093377108508433e-07,
            "start_logit": -5.389941692352295,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune",
            "probability": 4.936999938589619e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -5.860233783721924
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder",
            "probability": 2.660166578581971e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -6.478602886199951
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity.",
            "probability": 2.548318736329573e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -6.521557807922363
        },
        {
            "text": "herpetiformis (DH)",
            "probability": 2.2941092244410093e-09,
            "start_logit": -0.3856280446052551,
            "end_logit": -1.7462602853775024
        },
        {
            "text": "(DH)",
            "probability": 4.500230761798997e-10,
            "start_logit": -2.0144290924072266,
            "end_logit": -1.7462602853775024
        },
        {
            "text": "herpetiformis (DH) is an autoimmune blistering",
            "probability": 2.176939105734304e-10,
            "start_logit": -0.3856280446052551,
            "end_logit": -4.1012701988220215
        },
        {
            "text": "DH",
            "probability": 1.7885899204709837e-10,
            "start_logit": -2.9371302127838135,
            "end_logit": -1.7462602853775024
        },
        {
            "text": "herpetiformis (DH) is an autoimmune blistering skin",
            "probability": 7.05583579426157e-11,
            "start_logit": -0.3856280446052551,
            "end_logit": -5.227920055389404
        },
        {
            "text": "herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity. It presents",
            "probability": 5.0674055935107086e-11,
            "start_logit": -0.3856280446052551,
            "end_logit": -5.558946132659912
        },
        {
            "text": "herpetiformis (DH) is an autoimmune blistering skin disorder that is associated",
            "probability": 4.689917227481144e-11,
            "start_logit": -0.3856280446052551,
            "end_logit": -5.636360168457031
        }
    ],
    "55180ef46487737b43000006_033": [
        {
            "text": "Dermatitis herpetiformis",
            "probability": 0.9997597614525058,
            "start_logit": 8.837861061096191,
            "end_logit": 8.165608406066895
        },
        {
            "text": "Der",
            "probability": 0.00018341059114238437,
            "start_logit": 8.837861061096191,
            "end_logit": -0.4379345774650574
        },
        {
            "text": "is",
            "probability": 4.7094081108974e-05,
            "start_logit": -1.125261902809143,
            "end_logit": 8.165608406066895
        },
        {
            "text": "herpetiformis",
            "probability": 3.2496823808634777e-06,
            "start_logit": -3.79885196685791,
            "end_logit": 8.165608406066895
        },
        {
            "text": "Dermatitis herpetiformis (DH)",
            "probability": 3.0922794370568116e-06,
            "start_logit": 8.837861061096191,
            "end_logit": -4.520753383636475
        },
        {
            "text": "BACKGROUND: Dermatitis herpetiformis",
            "probability": 1.6643292158800307e-06,
            "start_logit": -4.467987060546875,
            "end_logit": 8.165608406066895
        },
        {
            "text": "petiformis",
            "probability": 3.296046057673816e-07,
            "start_logit": -6.087270736694336,
            "end_logit": 8.165608406066895
        },
        {
            "text": "iformis",
            "probability": 3.0205214560368094e-07,
            "start_logit": -6.174564838409424,
            "end_logit": 8.165608406066895
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated with gluten-sensitive",
            "probability": 2.8349923225163547e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -6.910207748413086
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a chronic papulovesicular immune-mediated",
            "probability": 2.478038202996578e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -7.0447797775268555
        },
        {
            "text": "Dermatitis",
            "probability": 1.6546578216937402e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -7.448652744293213
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated",
            "probability": 1.4937999166921156e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -7.550923824310303
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated with",
            "probability": 1.2941514766841178e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -7.69439172744751
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a chronic papulovesicular",
            "probability": 1.198452976273247e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -7.771215438842773
        },
        {
            "text": "BACKGROUND: Dermatitis",
            "probability": 3.053289571252652e-10,
            "start_logit": -4.467987060546875,
            "end_logit": -0.4379345774650574
        },
        {
            "text": "herpetiformis (DH)",
            "probability": 1.4566305250052225e-10,
            "start_logit": -1.125261902809143,
            "end_logit": -4.520753383636475
        },
        {
            "text": "herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated with gluten-sensitive enteropathy.",
            "probability": 2.8515184073529106e-11,
            "start_logit": -1.125261902809143,
            "end_logit": -6.151612758636475
        },
        {
            "text": "(DH)",
            "probability": 1.3650971495035657e-11,
            "start_logit": -3.4927473068237305,
            "end_logit": -4.520753383636475
        },
        {
            "text": "herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated with gluten-sensitive",
            "probability": 1.3354344066211586e-11,
            "start_logit": -1.125261902809143,
            "end_logit": -6.910207748413086
        },
        {
            "text": "herpetiformis (DH) is a chronic papulovesicular immune-mediated",
            "probability": 1.1672897492244286e-11,
            "start_logit": -1.125261902809143,
            "end_logit": -7.0447797775268555
        }
    ],
    "55180ef46487737b43000006_034": [
        {
            "text": "Dermatitis herpetiformis",
            "probability": 0.9997160272536386,
            "start_logit": 9.099928855895996,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Der",
            "probability": 0.00016314146789815032,
            "start_logit": 9.099928855895996,
            "end_logit": -0.05978881195187569
        },
        {
            "text": "is",
            "probability": 7.591920209160514e-05,
            "start_logit": -0.3856280446052551,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Dermatitis herpetiformis (DH)",
            "probability": 3.02091920984203e-05,
            "start_logit": 9.099928855895996,
            "end_logit": -1.7462602853775024
        },
        {
            "text": "herpetiformis",
            "probability": 7.59730905372186e-06,
            "start_logit": -2.6875035762786865,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering",
            "probability": 2.8666277495011186e-06,
            "start_logit": 9.099928855895996,
            "end_logit": -4.1012701988220215
        },
        {
            "text": "iformis",
            "probability": 1.1650531340202988e-06,
            "start_logit": -4.562530994415283,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin",
            "probability": 9.291235859778858e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -5.227920055389404
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated",
            "probability": 6.175756975354585e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -5.636360168457031
        },
        {
            "text": "petiformis",
            "probability": 5.093377108508433e-07,
            "start_logit": -5.389941692352295,
            "end_logit": 8.660820007324219
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune",
            "probability": 4.936999938589619e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -5.860233783721924
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder",
            "probability": 2.660166578581971e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -6.478602886199951
        },
        {
            "text": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity.",
            "probability": 2.548318736329573e-07,
            "start_logit": 9.099928855895996,
            "end_logit": -6.521557807922363
        },
        {
            "text": "herpetiformis (DH)",
            "probability": 2.2941092244410093e-09,
            "start_logit": -0.3856280446052551,
            "end_logit": -1.7462602853775024
        },
        {
            "text": "(DH)",
            "probability": 4.500230761798997e-10,
            "start_logit": -2.0144290924072266,
            "end_logit": -1.7462602853775024
        },
        {
            "text": "herpetiformis (DH) is an autoimmune blistering",
            "probability": 2.176939105734304e-10,
            "start_logit": -0.3856280446052551,
            "end_logit": -4.1012701988220215
        },
        {
            "text": "DH",
            "probability": 1.7885899204709837e-10,
            "start_logit": -2.9371302127838135,
            "end_logit": -1.7462602853775024
        },
        {
            "text": "herpetiformis (DH) is an autoimmune blistering skin",
            "probability": 7.05583579426157e-11,
            "start_logit": -0.3856280446052551,
            "end_logit": -5.227920055389404
        },
        {
            "text": "herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity. It presents",
            "probability": 5.0674055935107086e-11,
            "start_logit": -0.3856280446052551,
            "end_logit": -5.558946132659912
        },
        {
            "text": "herpetiformis (DH) is an autoimmune blistering skin disorder that is associated",
            "probability": 4.689917227481144e-11,
            "start_logit": -0.3856280446052551,
            "end_logit": -5.636360168457031
        }
    ],
    "55180ef46487737b43000006_035": [
        {
            "text": "Dermatitis herpetiformis",
            "probability": 0.9997597614525058,
            "start_logit": 8.837861061096191,
            "end_logit": 8.165608406066895
        },
        {
            "text": "Der",
            "probability": 0.00018341059114238437,
            "start_logit": 8.837861061096191,
            "end_logit": -0.4379345774650574
        },
        {
            "text": "is",
            "probability": 4.7094081108974e-05,
            "start_logit": -1.125261902809143,
            "end_logit": 8.165608406066895
        },
        {
            "text": "herpetiformis",
            "probability": 3.2496823808634777e-06,
            "start_logit": -3.79885196685791,
            "end_logit": 8.165608406066895
        },
        {
            "text": "Dermatitis herpetiformis (DH)",
            "probability": 3.0922794370568116e-06,
            "start_logit": 8.837861061096191,
            "end_logit": -4.520753383636475
        },
        {
            "text": "BACKGROUND: Dermatitis herpetiformis",
            "probability": 1.6643292158800307e-06,
            "start_logit": -4.467987060546875,
            "end_logit": 8.165608406066895
        },
        {
            "text": "petiformis",
            "probability": 3.296046057673816e-07,
            "start_logit": -6.087270736694336,
            "end_logit": 8.165608406066895
        },
        {
            "text": "iformis",
            "probability": 3.0205214560368094e-07,
            "start_logit": -6.174564838409424,
            "end_logit": 8.165608406066895
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated with gluten-sensitive",
            "probability": 2.8349923225163547e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -6.910207748413086
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a chronic papulovesicular immune-mediated",
            "probability": 2.478038202996578e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -7.0447797775268555
        },
        {
            "text": "Dermatitis",
            "probability": 1.6546578216937402e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -7.448652744293213
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated",
            "probability": 1.4937999166921156e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -7.550923824310303
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated with",
            "probability": 1.2941514766841178e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -7.69439172744751
        },
        {
            "text": "Dermatitis herpetiformis (DH) is a chronic papulovesicular",
            "probability": 1.198452976273247e-07,
            "start_logit": 8.837861061096191,
            "end_logit": -7.771215438842773
        },
        {
            "text": "BACKGROUND: Dermatitis",
            "probability": 3.053289571252652e-10,
            "start_logit": -4.467987060546875,
            "end_logit": -0.4379345774650574
        },
        {
            "text": "herpetiformis (DH)",
            "probability": 1.4566305250052225e-10,
            "start_logit": -1.125261902809143,
            "end_logit": -4.520753383636475
        },
        {
            "text": "herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated with gluten-sensitive enteropathy.",
            "probability": 2.8515184073529106e-11,
            "start_logit": -1.125261902809143,
            "end_logit": -6.151612758636475
        },
        {
            "text": "(DH)",
            "probability": 1.3650971495035657e-11,
            "start_logit": -3.4927473068237305,
            "end_logit": -4.520753383636475
        },
        {
            "text": "herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated with gluten-sensitive",
            "probability": 1.3354344066211586e-11,
            "start_logit": -1.125261902809143,
            "end_logit": -6.910207748413086
        },
        {
            "text": "herpetiformis (DH) is a chronic papulovesicular immune-mediated",
            "probability": 1.1672897492244286e-11,
            "start_logit": -1.125261902809143,
            "end_logit": -7.0447797775268555
        }
    ],
    "51716e808ed59a060a00000b_001": [
        {
            "text": "(Ixodes ricinus)",
            "probability": 0.9997288408341481,
            "start_logit": 9.447965621948242,
            "end_logit": 9.124267578125
        },
        {
            "text": ")",
            "probability": 0.0001637780609578997,
            "start_logit": 0.7312384843826294,
            "end_logit": 9.124267578125
        },
        {
            "text": "(",
            "probability": 9.912642453578153e-05,
            "start_logit": 9.447965621948242,
            "end_logit": -0.09457573294639587
        },
        {
            "text": "(Ixodes ricinus) that transmits LIV to red grouse Lagopus lagopus scoticus,",
            "probability": 4.09841615241165e-06,
            "start_logit": 9.447965621948242,
            "end_logit": -3.2803711891174316
        },
        {
            "text": "ricinus)",
            "probability": 1.7155722421865868e-06,
            "start_logit": -3.8275270462036133,
            "end_logit": 9.124267578125
        },
        {
            "text": "the vector (Ixodes ricinus)",
            "probability": 9.406470073980699e-07,
            "start_logit": -4.428461074829102,
            "end_logit": 9.124267578125
        },
        {
            "text": "Deer are the key hosts of the vector (Ixodes ricinus)",
            "probability": 7.244984142127515e-07,
            "start_logit": -4.689549446105957,
            "end_logit": 9.124267578125
        },
        {
            "text": "of the vector (Ixodes ricinus)",
            "probability": 1.3499458281245065e-07,
            "start_logit": -6.3697943687438965,
            "end_logit": 9.124267578125
        },
        {
            "text": "vector (Ixodes ricinus)",
            "probability": 1.2218748296555597e-07,
            "start_logit": -6.469472408294678,
            "end_logit": 9.124267578125
        },
        {
            "text": "the key hosts of the vector (Ixodes ricinus)",
            "probability": 1.214886370993748e-07,
            "start_logit": -6.475208282470703,
            "end_logit": 9.124267578125
        },
        {
            "text": "(LIV) system. Deer are the key hosts of the vector (Ixodes ricinus)",
            "probability": 1.1532573576306156e-07,
            "start_logit": -6.527268409729004,
            "end_logit": 9.124267578125
        },
        {
            "text": "(Ixodes",
            "probability": 1.0282091301985798e-07,
            "start_logit": 9.447965621948242,
            "end_logit": -6.965738296508789
        },
        {
            "text": "are the key hosts of the vector (Ixodes ricinus)",
            "probability": 9.36938192049688e-08,
            "start_logit": -6.734996795654297,
            "end_logit": 9.124267578125
        },
        {
            "text": "(Ixodes ricinus) that transmits LIV to red grouse Lagopus lagopus scoticus, causing high",
            "probability": 4.4089485978387545e-08,
            "start_logit": 9.447965621948242,
            "end_logit": -7.812505722045898
        },
        {
            "text": "(Ixodes ricinus) that transmits LIV to red grouse Lagopus lagopus scoticus, causing",
            "probability": 4.004026020012126e-08,
            "start_logit": 9.447965621948242,
            "end_logit": -7.908841609954834
        },
        {
            "text": "ricinus) that transmits LIV to red grouse Lagopus lagopus scoticus,",
            "probability": 6.714127101509428e-10,
            "start_logit": 0.7312384843826294,
            "end_logit": -3.2803711891174316
        },
        {
            "text": "the vector (Ixodes",
            "probability": 9.326826513862895e-11,
            "start_logit": -4.428461074829102,
            "end_logit": -0.09457573294639587
        },
        {
            "text": "Deer are the key hosts of the vector (Ixodes",
            "probability": 7.183641648552569e-11,
            "start_logit": -4.689549446105957,
            "end_logit": -0.09457573294639587
        },
        {
            "text": "ricinus) that transmits LIV to red grouse Lagopus lagopus scoticus, causing high mortality.",
            "probability": 5.572224301495065e-11,
            "start_logit": 0.7312384843826294,
            "end_logit": -5.769375801086426
        },
        {
            "text": "of the vector (Ixodes",
            "probability": 1.3385159834673262e-11,
            "start_logit": -6.3697943687438965,
            "end_logit": -0.09457573294639587
        }
    ],
    "51716e808ed59a060a00000b_002": [
        {
            "text": "Ixodes ricinus",
            "probability": 0.9996676911389689,
            "start_logit": 8.082475662231445,
            "end_logit": 7.322719097137451
        },
        {
            "text": "I",
            "probability": 0.00018569439720001192,
            "start_logit": 8.082475662231445,
            "end_logit": -1.2683568000793457
        },
        {
            "text": "inus",
            "probability": 0.00011230047514708278,
            "start_logit": -1.0115244388580322,
            "end_logit": 7.322719097137451
        },
        {
            "text": "ricinus",
            "probability": 2.598119825884099e-05,
            "start_logit": -2.4753293991088867,
            "end_logit": 7.322719097137451
        },
        {
            "text": "Ix",
            "probability": 2.9707800117485933e-06,
            "start_logit": 8.082475662231445,
            "end_logit": -5.403634548187256
        },
        {
            "text": "Ixodes ricinus ticks and reported tick-borne disease",
            "probability": 2.304632342930075e-06,
            "start_logit": 8.082475662231445,
            "end_logit": -5.657537937164307
        },
        {
            "text": "Ixodes",
            "probability": 1.0550651251511262e-06,
            "start_logit": 8.082475662231445,
            "end_logit": -6.438856601715088
        },
        {
            "text": "Ixodes ricinus ticks",
            "probability": 6.180236509975089e-07,
            "start_logit": 8.082475662231445,
            "end_logit": -6.973687648773193
        },
        {
            "text": "Ixodes ricinus ticks and reported tick-borne disease cases are currently increasing",
            "probability": 4.804542025919584e-07,
            "start_logit": 8.082475662231445,
            "end_logit": -7.22548246383667
        },
        {
            "text": "wildlife. Ixodes ricinus",
            "probability": 2.490857397961604e-07,
            "start_logit": -7.1226606369018555,
            "end_logit": 7.322719097137451
        },
        {
            "text": "Ixodes ricinus ticks and reported",
            "probability": 2.390062552981066e-07,
            "start_logit": 8.082475662231445,
            "end_logit": -7.92372465133667
        },
        {
            "text": "Ixodes ricinus ticks and reported tick-borne disease cases",
            "probability": 2.191679649644878e-07,
            "start_logit": 8.082475662231445,
            "end_logit": -8.0103759765625
        },
        {
            "text": "Ixodes ricinus ticks and reported tick-borne",
            "probability": 1.960730680582845e-07,
            "start_logit": 8.082475662231445,
            "end_logit": -8.121726989746094
        },
        {
            "text": "ricinus ticks and reported tick-borne disease",
            "probability": 2.5889734103090397e-10,
            "start_logit": -1.0115244388580322,
            "end_logit": -5.657537937164307
        },
        {
            "text": "ricinus ticks",
            "probability": 6.942742100635406e-11,
            "start_logit": -1.0115244388580322,
            "end_logit": -6.973687648773193
        },
        {
            "text": "ricinus ticks and reported tick-borne disease cases are currently increasing",
            "probability": 5.39731710004711e-11,
            "start_logit": -1.0115244388580322,
            "end_logit": -7.22548246383667
        },
        {
            "text": "wildlife. Ixodes",
            "probability": 4.6269201968373955e-11,
            "start_logit": -7.1226606369018555,
            "end_logit": -1.2683568000793457
        },
        {
            "text": "ricinus ticks and reported",
            "probability": 2.6849438339376226e-11,
            "start_logit": -1.0115244388580322,
            "end_logit": -7.92372465133667
        },
        {
            "text": "ricinus ticks and reported tick-borne disease cases",
            "probability": 2.4620848328596865e-11,
            "start_logit": -1.0115244388580322,
            "end_logit": -8.0103759765625
        },
        {
            "text": "ricinus ticks and reported tick-borne",
            "probability": 2.2026418280463022e-11,
            "start_logit": -1.0115244388580322,
            "end_logit": -8.121726989746094
        }
    ],
    "5156be17d24251bc05000086_001": [
        {
            "text": "major depression.",
            "probability": 0.9994586791831173,
            "start_logit": 9.297346115112305,
            "end_logit": 8.167656898498535
        },
        {
            "text": "major",
            "probability": 0.000365852134419113,
            "start_logit": 9.297346115112305,
            "end_logit": 0.25491705536842346
        },
        {
            "text": "geriatric depression.",
            "probability": 0.00011200444415862003,
            "start_logit": 3.8830459117889404,
            "end_logit": 4.4855265617370605
        },
        {
            "text": ".",
            "probability": 4.168804947341682e-05,
            "start_logit": -0.7874084711074829,
            "end_logit": 8.167656898498535
        },
        {
            "text": "with major depression.",
            "probability": 1.0921749389543915e-05,
            "start_logit": -2.1268668174743652,
            "end_logit": 8.167656898498535
        },
        {
            "text": "depression.",
            "probability": 9.562935897681469e-06,
            "start_logit": 1.4224021434783936,
            "end_logit": 4.4855265617370605
        },
        {
            "text": "major depression. INTERVENTIONS: Antidepressant",
            "probability": 1.1446893546621762e-06,
            "start_logit": 9.297346115112305,
            "end_logit": -5.512178897857666
        },
        {
            "text": "geriatric major depression.",
            "probability": 9.719469351071835e-08,
            "start_logit": -2.4432177543640137,
            "end_logit": 3.7622125148773193
        },
        {
            "text": "antidepressants with differing pharmacologic profiles, in geriatric depression.",
            "probability": 2.985327430133535e-08,
            "start_logit": -4.346953392028809,
            "end_logit": 4.4855265617370605
        },
        {
            "text": "ger",
            "probability": 4.921502129794845e-09,
            "start_logit": 3.8830459117889404,
            "end_logit": -5.547153472900391
        },
        {
            "text": "depression",
            "probability": 4.788195875713891e-09,
            "start_logit": 1.4224021434783936,
            "end_logit": -3.1139698028564453
        },
        {
            "text": "with major",
            "probability": 3.997909477379403e-09,
            "start_logit": -2.1268668174743652,
            "end_logit": 0.25491705536842346
        },
        {
            "text": "geriatric",
            "probability": 3.7007244344388783e-09,
            "start_logit": 3.8830459117889404,
            "end_logit": -5.832238674163818
        },
        {
            "text": "major depression. BACKGROUND: The \"long/short\"polymorphism",
            "probability": 2.2293308597777667e-09,
            "start_logit": 3.9337239265441895,
            "end_logit": -6.389743804931641
        },
        {
            "text": "depression. INTERVENTIONS: Antidepressant",
            "probability": 4.774571219677939e-11,
            "start_logit": -0.7874084711074829,
            "end_logit": -5.512178897857666
        },
        {
            "text": "geriatric major",
            "probability": 3.534248296748042e-11,
            "start_logit": -2.4432177543640137,
            "end_logit": -4.157173156738281
        },
        {
            "text": "with",
            "probability": 1.859981818799223e-11,
            "start_logit": -2.1268668174743652,
            "end_logit": -5.115458011627197
        },
        {
            "text": "with major depression. INTERVENTIONS: Antidepressant",
            "probability": 1.2508781524332e-11,
            "start_logit": -2.1268668174743652,
            "end_logit": -5.512178897857666
        },
        {
            "text": "OBJECTIVE: To determine if the 5HTTLPR polymorphism",
            "probability": 7.622394600087621e-12,
            "start_logit": -4.277187347412109,
            "end_logit": -3.857198715209961
        },
        {
            "text": "5HTTLPR polymorphism",
            "probability": 6.739598174567838e-12,
            "start_logit": -4.400277614593506,
            "end_logit": -3.857198715209961
        }
    ],
    "5540b9800083d1bf0e000002_001": [
        {
            "text": "antiparallel",
            "probability": 0.9994980638850074,
            "start_logit": 9.089695930480957,
            "end_logit": 8.301920890808105
        },
        {
            "text": "antiparallel chains",
            "probability": 0.00028205193879904107,
            "start_logit": 9.089695930480957,
            "end_logit": 0.1290036290884018
        },
        {
            "text": "ant",
            "probability": 0.00014239763405085045,
            "start_logit": 9.089695930480957,
            "end_logit": -0.5544642210006714
        },
        {
            "text": "allel",
            "probability": 7.412189339700929e-05,
            "start_logit": -0.4196016192436218,
            "end_logit": 8.301920890808105
        },
        {
            "text": "iparallel",
            "probability": 2.0367493170571595e-06,
            "start_logit": -4.013957500457764,
            "end_logit": 8.301920890808105
        },
        {
            "text": "arallel",
            "probability": 6.63757541808224e-07,
            "start_logit": -5.135150909423828,
            "end_logit": 8.301920890808105
        },
        {
            "text": "antip",
            "probability": 4.016457251168819e-07,
            "start_logit": 9.089695930480957,
            "end_logit": -6.425272464752197
        },
        {
            "text": "antipar",
            "probability": 1.0364863880494551e-07,
            "start_logit": 9.089695930480957,
            "end_logit": -7.779836177825928
        },
        {
            "text": "these antiparallel",
            "probability": 7.717726033123609e-08,
            "start_logit": -7.286962985992432,
            "end_logit": 8.301920890808105
        },
        {
            "text": "identifies Cys in these antiparallel",
            "probability": 2.068275888936687e-08,
            "start_logit": -8.603767395019531,
            "end_logit": 8.301920890808105
        },
        {
            "text": "antiparallel chains that are either force-enhanced or force-independent in labeling, with structural",
            "probability": 2.0483461285750972e-08,
            "start_logit": 9.089695930480957,
            "end_logit": -9.401225090026855
        },
        {
            "text": "Cys in these antiparallel",
            "probability": 2.0391815458838765e-08,
            "start_logit": -8.617934226989746,
            "end_logit": 8.301920890808105
        },
        {
            "text": "labeling kinetics of \u03b1- and \u03b2-spectrin by LC-MS/MS identifies Cys in these antiparallel",
            "probability": 1.909152002712902e-08,
            "start_logit": -8.683823585510254,
            "end_logit": 8.301920890808105
        },
        {
            "text": "chains",
            "probability": 9.80919546896075e-10,
            "start_logit": -3.4794154167175293,
            "end_logit": 0.1290036290884018
        },
        {
            "text": "these antiparallel chains",
            "probability": 2.177892753790054e-11,
            "start_logit": -7.286962985992432,
            "end_logit": 0.1290036290884018
        },
        {
            "text": "identifies Cys in these antiparallel chains",
            "probability": 5.8365418155829316e-12,
            "start_logit": -8.603767395019531,
            "end_logit": 0.1290036290884018
        },
        {
            "text": "Cys in these antiparallel chains",
            "probability": 5.754439446777606e-12,
            "start_logit": -8.617934226989746,
            "end_logit": 0.1290036290884018
        },
        {
            "text": "labeling kinetics of \u03b1- and \u03b2-spectrin by LC-MS/MS identifies Cys in these antiparallel chains",
            "probability": 5.3875044213111985e-12,
            "start_logit": -8.683823585510254,
            "end_logit": 0.1290036290884018
        },
        {
            "text": "ip",
            "probability": 8.184624722043022e-13,
            "start_logit": -4.013957500457764,
            "end_logit": -6.425272464752197
        },
        {
            "text": "ipar",
            "probability": 2.1121230938588874e-13,
            "start_logit": -4.013957500457764,
            "end_logit": -7.779836177825928
        }
    ],
    "5540b9800083d1bf0e000002_002": [
        {
            "text": "antiparallel",
            "probability": 0.9997288716921988,
            "start_logit": 9.071869850158691,
            "end_logit": 8.403250694274902
        },
        {
            "text": "ant",
            "probability": 0.0001602929844312561,
            "start_logit": 9.071869850158691,
            "end_logit": -0.3349854052066803
        },
        {
            "text": "allel",
            "probability": 0.00010595189328572953,
            "start_logit": -0.08038438856601715,
            "end_logit": 8.403250694274902
        },
        {
            "text": "iparallel",
            "probability": 1.7542605778213042e-06,
            "start_logit": -4.18132209777832,
            "end_logit": 8.403250694274902
        },
        {
            "text": "arallel",
            "probability": 8.843486793741289e-07,
            "start_logit": -4.866273403167725,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antip",
            "probability": 5.085002382341106e-07,
            "start_logit": 9.071869850158691,
            "end_logit": -6.088278293609619
        },
        {
            "text": "Influence of lateral association on forced unfolding of antiparallel",
            "probability": 4.975348691038132e-07,
            "start_logit": -5.4414591789245605,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antiparallel spectrin",
            "probability": 3.936851478568171e-07,
            "start_logit": 9.071869850158691,
            "end_logit": -6.3441925048828125
        },
        {
            "text": "of antiparallel",
            "probability": 3.147163190344618e-07,
            "start_logit": -5.899453163146973,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antiparallel spectrin heterodimers.",
            "probability": 1.329415571544325e-07,
            "start_logit": 9.071869850158691,
            "end_logit": -7.429834365844727
        },
        {
            "text": "unfolding of antiparallel",
            "probability": 9.742165349362867e-08,
            "start_logit": -7.072076320648193,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antipar",
            "probability": 8.814046819383983e-08,
            "start_logit": 9.071869850158691,
            "end_logit": -7.8408122062683105
        },
        {
            "text": "on forced unfolding of antiparallel",
            "probability": 8.257674510643526e-08,
            "start_logit": -7.237396717071533,
            "end_logit": 8.403250694274902
        },
        {
            "text": "forced unfolding of antiparallel",
            "probability": 6.682448978226553e-08,
            "start_logit": -7.449055194854736,
            "end_logit": 8.403250694274902
        },
        {
            "text": "association on forced unfolding of antiparallel",
            "probability": 3.1678758657482714e-08,
            "start_logit": -8.195478439331055,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antiparallel spectrin heterodimers. Protein",
            "probability": 3.07992133230845e-08,
            "start_logit": 9.071869850158691,
            "end_logit": -8.892254829406738
        },
        {
            "text": "ip",
            "probability": 8.922838451558572e-13,
            "start_logit": -4.18132209777832,
            "end_logit": -6.088278293609619
        },
        {
            "text": "Influence of lateral association on forced unfolding of antiparallel spectrin",
            "probability": 1.959252093775309e-13,
            "start_logit": -5.4414591789245605,
            "end_logit": -6.3441925048828125
        },
        {
            "text": "ipar",
            "probability": 1.546632822571631e-13,
            "start_logit": -4.18132209777832,
            "end_logit": -7.8408122062683105
        },
        {
            "text": "of antiparallel spectrin",
            "probability": 1.2393274226672723e-13,
            "start_logit": -5.899453163146973,
            "end_logit": -6.3441925048828125
        }
    ],
    "5540b9800083d1bf0e000002_003": [
        {
            "text": "antiparallel",
            "probability": 0.9996330127969768,
            "start_logit": 9.275218963623047,
            "end_logit": 8.422232627868652
        },
        {
            "text": "ant",
            "probability": 0.00029119042722510385,
            "start_logit": 9.275218963623047,
            "end_logit": 0.28106656670570374
        },
        {
            "text": "allel",
            "probability": 6.984151981797334e-05,
            "start_logit": -0.293695867061615,
            "end_logit": 8.422232627868652
        },
        {
            "text": "iparallel",
            "probability": 2.1462601617926178e-06,
            "start_logit": -3.776197671890259,
            "end_logit": 8.422232627868652
        },
        {
            "text": "each other on antiparallel",
            "probability": 1.301728210155248e-06,
            "start_logit": -4.27623176574707,
            "end_logit": 8.422232627868652
        },
        {
            "text": "arallel",
            "probability": 5.8028147756822e-07,
            "start_logit": -5.084166526794434,
            "end_logit": 8.422232627868652
        },
        {
            "text": "on antiparallel",
            "probability": 4.828287567530763e-07,
            "start_logit": -5.268017768859863,
            "end_logit": 8.422232627868652
        },
        {
            "text": "opposite each other on antiparallel",
            "probability": 4.58025042335079e-07,
            "start_logit": -5.320755958557129,
            "end_logit": 8.422232627868652
        },
        {
            "text": "antiparallel spectrin dimers.",
            "probability": 4.5202259170220606e-07,
            "start_logit": 9.275218963623047,
            "end_logit": -6.186933994293213
        },
        {
            "text": "antip",
            "probability": 3.28541842817271e-07,
            "start_logit": 9.275218963623047,
            "end_logit": -6.506001949310303
        },
        {
            "text": "antipar",
            "probability": 8.542304588989638e-08,
            "start_logit": 9.275218963623047,
            "end_logit": -7.853050231933594
        },
        {
            "text": "antiparallel spectrin",
            "probability": 8.109734385325729e-08,
            "start_logit": 9.275218963623047,
            "end_logit": -7.90501594543457
        },
        {
            "text": "other on antiparallel",
            "probability": 3.902340149072792e-08,
            "start_logit": -7.783518314361572,
            "end_logit": 8.422232627868652
        },
        {
            "text": "human erythroid beta-spectrin repeats 8 and 9 (HEbeta8,9), are located opposite each other on antiparallel",
            "probability": 1.2619308958502872e-11,
            "start_logit": -8.216041564941406,
            "end_logit": 0.818067193031311
        },
        {
            "text": "erythroid beta-spectrin repeats 8 and 9 (HEbeta8,9), are located opposite each other on antiparallel",
            "probability": 9.445793890960976e-12,
            "start_logit": -8.50570011138916,
            "end_logit": 0.818067193031311
        },
        {
            "text": "ip",
            "probability": 7.053951397099892e-13,
            "start_logit": -3.776197671890259,
            "end_logit": -6.506001949310303
        },
        {
            "text": "each other on antiparallel spectrin dimers.",
            "probability": 5.886265776676126e-13,
            "start_logit": -4.27623176574707,
            "end_logit": -6.186933994293213
        },
        {
            "text": "each other",
            "probability": 3.209530019593217e-13,
            "start_logit": -4.27623176574707,
            "end_logit": -6.793431282043457
        },
        {
            "text": "on antiparallel spectrin dimers.",
            "probability": 2.183296301561877e-13,
            "start_logit": -5.268017768859863,
            "end_logit": -6.186933994293213
        },
        {
            "text": "opposite each other on antiparallel spectrin dimers.",
            "probability": 2.071136747690264e-13,
            "start_logit": -5.320755958557129,
            "end_logit": -6.186933994293213
        }
    ],
    "5540b9800083d1bf0e000002_004": [
        {
            "text": "antiparallel",
            "probability": 0.9993790117115041,
            "start_logit": 9.841666221618652,
            "end_logit": 9.322422981262207
        },
        {
            "text": "ant",
            "probability": 0.0003355414241517852,
            "start_logit": 9.841666221618652,
            "end_logit": 1.3232790231704712
        },
        {
            "text": "allel",
            "probability": 0.000262720414925184,
            "start_logit": 1.5978672504425049,
            "end_logit": 9.322422981262207
        },
        {
            "text": "antiparallel dimers",
            "probability": 1.1206618791623467e-05,
            "start_logit": 9.841666221618652,
            "end_logit": -2.0759618282318115
        },
        {
            "text": "iparallel",
            "probability": 5.714462343646729e-06,
            "start_logit": -2.2302229404449463,
            "end_logit": 9.322422981262207
        },
        {
            "text": "form antiparallel",
            "probability": 1.6569587566499812e-06,
            "start_logit": -3.4682393074035645,
            "end_logit": 9.322422981262207
        },
        {
            "text": "the \u03b1- and \u03b2-chains form antiparallel",
            "probability": 1.3054454033913026e-06,
            "start_logit": -3.706678867340088,
            "end_logit": 9.322422981262207
        },
        {
            "text": "arallel",
            "probability": 1.2778157574513605e-06,
            "start_logit": -3.7280709743499756,
            "end_logit": 9.322422981262207
        },
        {
            "text": "\u03b1- and \u03b2-chains form antiparallel",
            "probability": 5.355105644180445e-07,
            "start_logit": -4.597757816314697,
            "end_logit": 9.322422981262207
        },
        {
            "text": "antip",
            "probability": 2.966099417841179e-07,
            "start_logit": 9.841666221618652,
            "end_logit": -5.707803726196289
        },
        {
            "text": "\u03b2-chains form antiparallel",
            "probability": 1.9551861578847745e-07,
            "start_logit": -5.60532283782959,
            "end_logit": 9.322422981262207
        },
        {
            "text": "antipar",
            "probability": 1.3068429652673318e-07,
            "start_logit": 9.841666221618652,
            "end_logit": -6.527437210083008
        },
        {
            "text": "about 106 amino acids; the \u03b1- and \u03b2-chains form antiparallel",
            "probability": 1.237760819670908e-07,
            "start_logit": -6.062504291534424,
            "end_logit": 9.322422981262207
        },
        {
            "text": "antiparallel dimers by lateral association,",
            "probability": 1.1576938076435586e-07,
            "start_logit": 9.841666221618652,
            "end_logit": -6.648621559143066
        },
        {
            "text": "repeating units of about 106 amino acids; the \u03b1- and \u03b2-chains form antiparallel",
            "probability": 9.764837973195332e-08,
            "start_logit": -6.299605369567871,
            "end_logit": 9.322422981262207
        },
        {
            "text": "antiparallel dimers by lateral association, and tetramers through head-to-head contacts",
            "probability": 6.951441095521299e-08,
            "start_logit": 9.841666221618652,
            "end_logit": -7.158687591552734
        },
        {
            "text": "predominantly of a series of homologous repeating units of about 106 amino acids; the \u03b1- and \u03b2-chains form antiparallel",
            "probability": 7.747005973663252e-11,
            "start_logit": -5.439698219299316,
            "end_logit": 1.3232790231704712
        },
        {
            "text": "form antiparallel dimers",
            "probability": 1.8580443376950883e-11,
            "start_logit": -3.4682393074035645,
            "end_logit": -2.0759618282318115
        },
        {
            "text": "the \u03b1- and \u03b2-chains form antiparallel dimers",
            "probability": 1.463871946242819e-11,
            "start_logit": -3.706678867340088,
            "end_logit": -2.0759618282318115
        },
        {
            "text": "\u03b1- and \u03b2-chains form antiparallel dimers",
            "probability": 6.004991783890457e-12,
            "start_logit": -4.597757816314697,
            "end_logit": -2.0759618282318115
        }
    ],
    "5540b9800083d1bf0e000002_005": [
        {
            "text": "antiparallel",
            "probability": 0.9994420843029911,
            "start_logit": 9.908915519714355,
            "end_logit": 9.320019721984863
        },
        {
            "text": "ant",
            "probability": 0.00037561373833505673,
            "start_logit": 9.908915519714355,
            "end_logit": 1.4336285591125488
        },
        {
            "text": "allel",
            "probability": 0.00015480765224806767,
            "start_logit": 1.1361464262008667,
            "end_logit": 9.320019721984863
        },
        {
            "text": "The spectrin heterodimer is formed by the antiparallel",
            "probability": 1.7658310383909434e-05,
            "start_logit": -1.0348304510116577,
            "end_logit": 9.320019721984863
        },
        {
            "text": "iparallel",
            "probability": 5.571364718159305e-06,
            "start_logit": -2.18839693069458,
            "end_logit": 9.320019721984863
        },
        {
            "text": "arallel",
            "probability": 1.109414454803806e-06,
            "start_logit": -3.8022046089172363,
            "end_logit": 9.320019721984863
        },
        {
            "text": "the antiparallel",
            "probability": 1.0095868096252424e-06,
            "start_logit": -3.896495819091797,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antiparallel lateral association",
            "probability": 7.694563752906257e-07,
            "start_logit": 9.908915519714355,
            "end_logit": -4.7570037841796875
        },
        {
            "text": "formed by the antiparallel",
            "probability": 5.092751166157208e-07,
            "start_logit": -4.580803871154785,
            "end_logit": 9.320019721984863
        },
        {
            "text": "is formed by the antiparallel",
            "probability": 2.6741656202034416e-07,
            "start_logit": -5.224984645843506,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antip",
            "probability": 2.002196729797102e-07,
            "start_logit": 9.908915519714355,
            "end_logit": -6.103272914886475
        },
        {
            "text": "heterodimer is formed by the antiparallel",
            "probability": 9.802170000732718e-08,
            "start_logit": -6.228603363037109,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antiparallel lateral",
            "probability": 9.112349108578021e-08,
            "start_logit": 9.908915519714355,
            "end_logit": -6.890472412109375
        },
        {
            "text": "bundles. The spectrin heterodimer is formed by the antiparallel",
            "probability": 6.664426329639931e-08,
            "start_logit": -6.6144232749938965,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antipar",
            "probability": 5.5639174860724635e-08,
            "start_logit": 9.908915519714355,
            "end_logit": -7.383800506591797
        },
        {
            "text": "spectrin heterodimer is formed by the antiparallel",
            "probability": 4.6132325068580995e-08,
            "start_logit": -6.982278347015381,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antiparallel lateral association of an alpha and a beta subunit,",
            "probability": 4.1682687173724426e-08,
            "start_logit": 9.908915519714355,
            "end_logit": -7.67260217666626
        },
        {
            "text": "The spectrin heterodimer is formed by the antiparallel lateral association",
            "probability": 1.359488430111038e-11,
            "start_logit": -1.0348304510116577,
            "end_logit": -4.7570037841796875
        },
        {
            "text": "The spectrin heterodimer is formed by",
            "probability": 2.619439290609317e-12,
            "start_logit": -1.0348304510116577,
            "end_logit": -6.4037370681762695
        },
        {
            "text": "The spectrin",
            "probability": 2.476898710918561e-12,
            "start_logit": -1.0348304510116577,
            "end_logit": -6.459690093994141
        }
    ],
    "5540b9800083d1bf0e000002_009": [
        {
            "text": "antiparallel",
            "probability": 0.9996330127969768,
            "start_logit": 9.275218963623047,
            "end_logit": 8.422232627868652
        },
        {
            "text": "ant",
            "probability": 0.00029119042722510385,
            "start_logit": 9.275218963623047,
            "end_logit": 0.28106656670570374
        },
        {
            "text": "allel",
            "probability": 6.984151981797334e-05,
            "start_logit": -0.293695867061615,
            "end_logit": 8.422232627868652
        },
        {
            "text": "iparallel",
            "probability": 2.1462601617926178e-06,
            "start_logit": -3.776197671890259,
            "end_logit": 8.422232627868652
        },
        {
            "text": "each other on antiparallel",
            "probability": 1.301728210155248e-06,
            "start_logit": -4.27623176574707,
            "end_logit": 8.422232627868652
        },
        {
            "text": "arallel",
            "probability": 5.8028147756822e-07,
            "start_logit": -5.084166526794434,
            "end_logit": 8.422232627868652
        },
        {
            "text": "on antiparallel",
            "probability": 4.828287567530763e-07,
            "start_logit": -5.268017768859863,
            "end_logit": 8.422232627868652
        },
        {
            "text": "opposite each other on antiparallel",
            "probability": 4.58025042335079e-07,
            "start_logit": -5.320755958557129,
            "end_logit": 8.422232627868652
        },
        {
            "text": "antiparallel spectrin dimers.",
            "probability": 4.5202259170220606e-07,
            "start_logit": 9.275218963623047,
            "end_logit": -6.186933994293213
        },
        {
            "text": "antip",
            "probability": 3.28541842817271e-07,
            "start_logit": 9.275218963623047,
            "end_logit": -6.506001949310303
        },
        {
            "text": "antipar",
            "probability": 8.542304588989638e-08,
            "start_logit": 9.275218963623047,
            "end_logit": -7.853050231933594
        },
        {
            "text": "antiparallel spectrin",
            "probability": 8.109734385325729e-08,
            "start_logit": 9.275218963623047,
            "end_logit": -7.90501594543457
        },
        {
            "text": "other on antiparallel",
            "probability": 3.902340149072792e-08,
            "start_logit": -7.783518314361572,
            "end_logit": 8.422232627868652
        },
        {
            "text": "human erythroid beta-spectrin repeats 8 and 9 (HEbeta8,9), are located opposite each other on antiparallel",
            "probability": 1.2619308958502872e-11,
            "start_logit": -8.216041564941406,
            "end_logit": 0.818067193031311
        },
        {
            "text": "erythroid beta-spectrin repeats 8 and 9 (HEbeta8,9), are located opposite each other on antiparallel",
            "probability": 9.445793890960976e-12,
            "start_logit": -8.50570011138916,
            "end_logit": 0.818067193031311
        },
        {
            "text": "ip",
            "probability": 7.053951397099892e-13,
            "start_logit": -3.776197671890259,
            "end_logit": -6.506001949310303
        },
        {
            "text": "each other on antiparallel spectrin dimers.",
            "probability": 5.886265776676126e-13,
            "start_logit": -4.27623176574707,
            "end_logit": -6.186933994293213
        },
        {
            "text": "each other",
            "probability": 3.209530019593217e-13,
            "start_logit": -4.27623176574707,
            "end_logit": -6.793431282043457
        },
        {
            "text": "on antiparallel spectrin dimers.",
            "probability": 2.183296301561877e-13,
            "start_logit": -5.268017768859863,
            "end_logit": -6.186933994293213
        },
        {
            "text": "opposite each other on antiparallel spectrin dimers.",
            "probability": 2.071136747690264e-13,
            "start_logit": -5.320755958557129,
            "end_logit": -6.186933994293213
        }
    ],
    "5540b9800083d1bf0e000002_010": [
        {
            "text": "antiparallel",
            "probability": 0.9997288716921988,
            "start_logit": 9.071869850158691,
            "end_logit": 8.403250694274902
        },
        {
            "text": "ant",
            "probability": 0.0001602929844312561,
            "start_logit": 9.071869850158691,
            "end_logit": -0.3349854052066803
        },
        {
            "text": "allel",
            "probability": 0.00010595189328572953,
            "start_logit": -0.08038438856601715,
            "end_logit": 8.403250694274902
        },
        {
            "text": "iparallel",
            "probability": 1.7542605778213042e-06,
            "start_logit": -4.18132209777832,
            "end_logit": 8.403250694274902
        },
        {
            "text": "arallel",
            "probability": 8.843486793741289e-07,
            "start_logit": -4.866273403167725,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antip",
            "probability": 5.085002382341106e-07,
            "start_logit": 9.071869850158691,
            "end_logit": -6.088278293609619
        },
        {
            "text": "Influence of lateral association on forced unfolding of antiparallel",
            "probability": 4.975348691038132e-07,
            "start_logit": -5.4414591789245605,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antiparallel spectrin",
            "probability": 3.936851478568171e-07,
            "start_logit": 9.071869850158691,
            "end_logit": -6.3441925048828125
        },
        {
            "text": "of antiparallel",
            "probability": 3.147163190344618e-07,
            "start_logit": -5.899453163146973,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antiparallel spectrin heterodimers.",
            "probability": 1.329415571544325e-07,
            "start_logit": 9.071869850158691,
            "end_logit": -7.429834365844727
        },
        {
            "text": "unfolding of antiparallel",
            "probability": 9.742165349362867e-08,
            "start_logit": -7.072076320648193,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antipar",
            "probability": 8.814046819383983e-08,
            "start_logit": 9.071869850158691,
            "end_logit": -7.8408122062683105
        },
        {
            "text": "on forced unfolding of antiparallel",
            "probability": 8.257674510643526e-08,
            "start_logit": -7.237396717071533,
            "end_logit": 8.403250694274902
        },
        {
            "text": "forced unfolding of antiparallel",
            "probability": 6.682448978226553e-08,
            "start_logit": -7.449055194854736,
            "end_logit": 8.403250694274902
        },
        {
            "text": "association on forced unfolding of antiparallel",
            "probability": 3.1678758657482714e-08,
            "start_logit": -8.195478439331055,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antiparallel spectrin heterodimers. Protein",
            "probability": 3.07992133230845e-08,
            "start_logit": 9.071869850158691,
            "end_logit": -8.892254829406738
        },
        {
            "text": "ip",
            "probability": 8.922838451558572e-13,
            "start_logit": -4.18132209777832,
            "end_logit": -6.088278293609619
        },
        {
            "text": "Influence of lateral association on forced unfolding of antiparallel spectrin",
            "probability": 1.959252093775309e-13,
            "start_logit": -5.4414591789245605,
            "end_logit": -6.3441925048828125
        },
        {
            "text": "ipar",
            "probability": 1.546632822571631e-13,
            "start_logit": -4.18132209777832,
            "end_logit": -7.8408122062683105
        },
        {
            "text": "of antiparallel spectrin",
            "probability": 1.2393274226672723e-13,
            "start_logit": -5.899453163146973,
            "end_logit": -6.3441925048828125
        }
    ],
    "5540b9800083d1bf0e000002_011": [
        {
            "text": "antiparallel",
            "probability": 0.9995741456652645,
            "start_logit": 9.3597993850708,
            "end_logit": 8.427495002746582
        },
        {
            "text": "The antiparallel",
            "probability": 0.00019549353987690507,
            "start_logit": 0.8202421069145203,
            "end_logit": 8.427495002746582
        },
        {
            "text": "ant",
            "probability": 0.00016371271532591503,
            "start_logit": 9.3597993850708,
            "end_logit": -0.2894764542579651
        },
        {
            "text": "allel",
            "probability": 6.228595489174665e-05,
            "start_logit": -0.3235492706298828,
            "end_logit": 8.427495002746582
        },
        {
            "text": "iparallel",
            "probability": 1.7233370641616216e-06,
            "start_logit": -3.911022663116455,
            "end_logit": 8.427495002746582
        },
        {
            "text": "antiparallel side-to-side association",
            "probability": 1.148987230474519e-06,
            "start_logit": 9.3597993850708,
            "end_logit": -5.248708724975586
        },
        {
            "text": "arallel",
            "probability": 4.82141891522074e-07,
            "start_logit": -5.184802055358887,
            "end_logit": 8.427495002746582
        },
        {
            "text": "antip",
            "probability": 3.3146830134541397e-07,
            "start_logit": 9.3597993850708,
            "end_logit": -6.491812705993652
        },
        {
            "text": "antiparallel side-to-side association of spectrin",
            "probability": 1.532302895636822e-07,
            "start_logit": 9.3597993850708,
            "end_logit": -7.263402938842773
        },
        {
            "text": "antiparallel side-to-side association of spectrin alpha and beta",
            "probability": 1.4631051590341803e-07,
            "start_logit": 9.3597993850708,
            "end_logit": -7.3096137046813965
        },
        {
            "text": "antiparallel side-to-side",
            "probability": 1.211958323762927e-07,
            "start_logit": 9.3597993850708,
            "end_logit": -7.497937202453613
        },
        {
            "text": "antipar",
            "probability": 9.443184194215381e-08,
            "start_logit": 9.3597993850708,
            "end_logit": -7.747466564178467
        },
        {
            "text": "antiparallel side-to-side association of spectrin alpha",
            "probability": 6.357590929344869e-08,
            "start_logit": 9.3597993850708,
            "end_logit": -8.143110275268555
        },
        {
            "text": "antiparallel side-to-side association of spectrin alpha and beta monomers",
            "probability": 5.5157011394492515e-08,
            "start_logit": 9.3597993850708,
            "end_logit": -8.285161018371582
        },
        {
            "text": "site. The antiparallel",
            "probability": 4.191976401256514e-08,
            "start_logit": -7.627283096313477,
            "end_logit": 8.427495002746582
        },
        {
            "text": "The antiparallel side-to-side association",
            "probability": 2.2471527693358857e-10,
            "start_logit": 0.8202421069145203,
            "end_logit": -5.248708724975586
        },
        {
            "text": "The",
            "probability": 6.19875302818797e-11,
            "start_logit": 0.8202421069145203,
            "end_logit": -6.536609649658203
        },
        {
            "text": "The antiparallel side-to-side association of spectrin",
            "probability": 2.9968293851008504e-11,
            "start_logit": 0.8202421069145203,
            "end_logit": -7.263402938842773
        },
        {
            "text": "The antiparallel side-to-side association of spectrin alpha and beta",
            "probability": 2.8614946474169658e-11,
            "start_logit": 0.8202421069145203,
            "end_logit": -7.3096137046813965
        },
        {
            "text": "The antiparallel side-to-side",
            "probability": 2.370309635589929e-11,
            "start_logit": 0.8202421069145203,
            "end_logit": -7.497937202453613
        }
    ],
    "5540b9800083d1bf0e000002_012": [
        {
            "text": "antiparallel",
            "probability": 0.9994420843029911,
            "start_logit": 9.908915519714355,
            "end_logit": 9.320019721984863
        },
        {
            "text": "ant",
            "probability": 0.00037561373833505673,
            "start_logit": 9.908915519714355,
            "end_logit": 1.4336285591125488
        },
        {
            "text": "allel",
            "probability": 0.00015480765224806767,
            "start_logit": 1.1361464262008667,
            "end_logit": 9.320019721984863
        },
        {
            "text": "The spectrin heterodimer is formed by the antiparallel",
            "probability": 1.7658310383909434e-05,
            "start_logit": -1.0348304510116577,
            "end_logit": 9.320019721984863
        },
        {
            "text": "iparallel",
            "probability": 5.571364718159305e-06,
            "start_logit": -2.18839693069458,
            "end_logit": 9.320019721984863
        },
        {
            "text": "arallel",
            "probability": 1.109414454803806e-06,
            "start_logit": -3.8022046089172363,
            "end_logit": 9.320019721984863
        },
        {
            "text": "the antiparallel",
            "probability": 1.0095868096252424e-06,
            "start_logit": -3.896495819091797,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antiparallel lateral association",
            "probability": 7.694563752906257e-07,
            "start_logit": 9.908915519714355,
            "end_logit": -4.7570037841796875
        },
        {
            "text": "formed by the antiparallel",
            "probability": 5.092751166157208e-07,
            "start_logit": -4.580803871154785,
            "end_logit": 9.320019721984863
        },
        {
            "text": "is formed by the antiparallel",
            "probability": 2.6741656202034416e-07,
            "start_logit": -5.224984645843506,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antip",
            "probability": 2.002196729797102e-07,
            "start_logit": 9.908915519714355,
            "end_logit": -6.103272914886475
        },
        {
            "text": "heterodimer is formed by the antiparallel",
            "probability": 9.802170000732718e-08,
            "start_logit": -6.228603363037109,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antiparallel lateral",
            "probability": 9.112349108578021e-08,
            "start_logit": 9.908915519714355,
            "end_logit": -6.890472412109375
        },
        {
            "text": "bundles. The spectrin heterodimer is formed by the antiparallel",
            "probability": 6.664426329639931e-08,
            "start_logit": -6.6144232749938965,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antipar",
            "probability": 5.5639174860724635e-08,
            "start_logit": 9.908915519714355,
            "end_logit": -7.383800506591797
        },
        {
            "text": "spectrin heterodimer is formed by the antiparallel",
            "probability": 4.6132325068580995e-08,
            "start_logit": -6.982278347015381,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antiparallel lateral association of an alpha and a beta subunit,",
            "probability": 4.1682687173724426e-08,
            "start_logit": 9.908915519714355,
            "end_logit": -7.67260217666626
        },
        {
            "text": "The spectrin heterodimer is formed by the antiparallel lateral association",
            "probability": 1.359488430111038e-11,
            "start_logit": -1.0348304510116577,
            "end_logit": -4.7570037841796875
        },
        {
            "text": "The spectrin heterodimer is formed by",
            "probability": 2.619439290609317e-12,
            "start_logit": -1.0348304510116577,
            "end_logit": -6.4037370681762695
        },
        {
            "text": "The spectrin",
            "probability": 2.476898710918561e-12,
            "start_logit": -1.0348304510116577,
            "end_logit": -6.459690093994141
        }
    ],
    "5540b9800083d1bf0e000002_013": [
        {
            "text": "antiparallel",
            "probability": 0.9995336520313216,
            "start_logit": 9.900726318359375,
            "end_logit": 9.358675956726074
        },
        {
            "text": "ant",
            "probability": 0.0002889183691103592,
            "start_logit": 9.900726318359375,
            "end_logit": 1.2097760438919067
        },
        {
            "text": "allel",
            "probability": 0.00017145946603182045,
            "start_logit": 1.2300291061401367,
            "end_logit": 9.358675956726074
        },
        {
            "text": "iparallel",
            "probability": 2.71122278022055e-06,
            "start_logit": -2.9169180393218994,
            "end_logit": 9.358675956726074
        },
        {
            "text": "arallel",
            "probability": 1.1433023174399235e-06,
            "start_logit": -3.7803969383239746,
            "end_logit": 9.358675956726074
        },
        {
            "text": "antip",
            "probability": 4.1533353677137524e-07,
            "start_logit": 9.900726318359375,
            "end_logit": -5.335041522979736
        },
        {
            "text": "antiparallel heterodimer comprised",
            "probability": 3.7146434777599326e-07,
            "start_logit": 9.900726318359375,
            "end_logit": -5.4466705322265625
        },
        {
            "text": "Human erythrocyte spectrin is an antiparallel",
            "probability": 3.6965427295665544e-07,
            "start_logit": -4.9095048904418945,
            "end_logit": 9.358675956726074
        },
        {
            "text": "is an antiparallel",
            "probability": 2.3847687135742057e-07,
            "start_logit": -5.3478007316589355,
            "end_logit": 9.358675956726074
        },
        {
            "text": "antiparallel heterodimer comprised of a 280 kDa",
            "probability": 1.3615891959383036e-07,
            "start_logit": 9.900726318359375,
            "end_logit": -6.450300693511963
        },
        {
            "text": "antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa",
            "probability": 1.1894376753512582e-07,
            "start_logit": 9.900726318359375,
            "end_logit": -6.585472583770752
        },
        {
            "text": "antipar",
            "probability": 8.095842565957669e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -6.970187664031982
        },
        {
            "text": "antiparallel heterodimer comprised of",
            "probability": 7.354261197564998e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -7.066258430480957
        },
        {
            "text": "antiparallel heterodimer",
            "probability": 7.06850843712393e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -7.105888843536377
        },
        {
            "text": "spectrin is an antiparallel",
            "probability": 6.31651965957286e-08,
            "start_logit": -6.676319599151611,
            "end_logit": 9.358675956726074
        },
        {
            "text": "antiparallel heterodimer comprised of a 280 kDa alpha subunit",
            "probability": 5.406361982324003e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -7.373961925506592
        },
        {
            "text": "an antiparallel",
            "probability": 4.750650389093769e-08,
            "start_logit": -6.961206436157227,
            "end_logit": 9.358675956726074
        },
        {
            "text": "antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa beta subunit",
            "probability": 4.563053974858617e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -7.543546199798584
        },
        {
            "text": "antiparallel heterodimer comprised of a 280",
            "probability": 3.001501374696521e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -7.962425708770752
        },
        {
            "text": "antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa beta subunit which further associates",
            "probability": 9.726931797388073e-12,
            "start_logit": 1.2300291061401367,
            "end_logit": -7.326282978057861
        }
    ],
    "5540b9800083d1bf0e000002_014": [
        {
            "text": "antiparallel",
            "probability": 0.9994420843029911,
            "start_logit": 9.908915519714355,
            "end_logit": 9.320019721984863
        },
        {
            "text": "ant",
            "probability": 0.00037561373833505673,
            "start_logit": 9.908915519714355,
            "end_logit": 1.4336285591125488
        },
        {
            "text": "allel",
            "probability": 0.00015480765224806767,
            "start_logit": 1.1361464262008667,
            "end_logit": 9.320019721984863
        },
        {
            "text": "The spectrin heterodimer is formed by the antiparallel",
            "probability": 1.7658310383909434e-05,
            "start_logit": -1.0348304510116577,
            "end_logit": 9.320019721984863
        },
        {
            "text": "iparallel",
            "probability": 5.571364718159305e-06,
            "start_logit": -2.18839693069458,
            "end_logit": 9.320019721984863
        },
        {
            "text": "arallel",
            "probability": 1.109414454803806e-06,
            "start_logit": -3.8022046089172363,
            "end_logit": 9.320019721984863
        },
        {
            "text": "the antiparallel",
            "probability": 1.0095868096252424e-06,
            "start_logit": -3.896495819091797,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antiparallel lateral association",
            "probability": 7.694563752906257e-07,
            "start_logit": 9.908915519714355,
            "end_logit": -4.7570037841796875
        },
        {
            "text": "formed by the antiparallel",
            "probability": 5.092751166157208e-07,
            "start_logit": -4.580803871154785,
            "end_logit": 9.320019721984863
        },
        {
            "text": "is formed by the antiparallel",
            "probability": 2.6741656202034416e-07,
            "start_logit": -5.224984645843506,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antip",
            "probability": 2.002196729797102e-07,
            "start_logit": 9.908915519714355,
            "end_logit": -6.103272914886475
        },
        {
            "text": "heterodimer is formed by the antiparallel",
            "probability": 9.802170000732718e-08,
            "start_logit": -6.228603363037109,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antiparallel lateral",
            "probability": 9.112349108578021e-08,
            "start_logit": 9.908915519714355,
            "end_logit": -6.890472412109375
        },
        {
            "text": "bundles. The spectrin heterodimer is formed by the antiparallel",
            "probability": 6.664426329639931e-08,
            "start_logit": -6.6144232749938965,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antipar",
            "probability": 5.5639174860724635e-08,
            "start_logit": 9.908915519714355,
            "end_logit": -7.383800506591797
        },
        {
            "text": "spectrin heterodimer is formed by the antiparallel",
            "probability": 4.6132325068580995e-08,
            "start_logit": -6.982278347015381,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antiparallel lateral association of an alpha and a beta subunit,",
            "probability": 4.1682687173724426e-08,
            "start_logit": 9.908915519714355,
            "end_logit": -7.67260217666626
        },
        {
            "text": "The spectrin heterodimer is formed by the antiparallel lateral association",
            "probability": 1.359488430111038e-11,
            "start_logit": -1.0348304510116577,
            "end_logit": -4.7570037841796875
        },
        {
            "text": "The spectrin heterodimer is formed by",
            "probability": 2.619439290609317e-12,
            "start_logit": -1.0348304510116577,
            "end_logit": -6.4037370681762695
        },
        {
            "text": "The spectrin",
            "probability": 2.476898710918561e-12,
            "start_logit": -1.0348304510116577,
            "end_logit": -6.459690093994141
        }
    ],
    "5540b9800083d1bf0e000002_015": [
        {
            "text": "antiparallel",
            "probability": 0.9994687635504412,
            "start_logit": 9.925772666931152,
            "end_logit": 9.344905853271484
        },
        {
            "text": "ant",
            "probability": 0.0002666468084164114,
            "start_logit": 9.925772666931152,
            "end_logit": 1.115851640701294
        },
        {
            "text": "allel",
            "probability": 0.00025130952377399105,
            "start_logit": 1.6374788284301758,
            "end_logit": 9.344905853271484
        },
        {
            "text": "iparallel",
            "probability": 7.033299363433545e-06,
            "start_logit": -1.938550591468811,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antiparallel heterodimer composed",
            "probability": 2.1054899309019123e-06,
            "start_logit": 9.925772666931152,
            "end_logit": -3.725525140762329
        },
        {
            "text": "arallel",
            "probability": 9.066550056143185e-07,
            "start_logit": -3.9871997833251953,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antiparallel heterodimer composed of",
            "probability": 8.276554489451312e-07,
            "start_logit": 9.925772666931152,
            "end_logit": -4.659231662750244
        },
        {
            "text": "The basic unit of spectrin is an antiparallel",
            "probability": 6.832935882148619e-07,
            "start_logit": -4.2700371742248535,
            "end_logit": 9.344905853271484
        },
        {
            "text": "is an antiparallel",
            "probability": 5.382355183035916e-07,
            "start_logit": -4.508665561676025,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antip",
            "probability": 2.9131831930703693e-07,
            "start_logit": 9.925772666931152,
            "end_logit": -5.703412055969238
        },
        {
            "text": "of spectrin is an antiparallel",
            "probability": 1.9157795621568537e-07,
            "start_logit": -5.5416669845581055,
            "end_logit": 9.344905853271484
        },
        {
            "text": "an antiparallel",
            "probability": 1.45824210104058e-07,
            "start_logit": -5.8145599365234375,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antiparallel heterodimer composed of two homologous chains, beta and alpha.",
            "probability": 1.2482977821478283e-07,
            "start_logit": 9.925772666931152,
            "end_logit": -6.550877571105957
        },
        {
            "text": "antiparallel heterodimer",
            "probability": 1.1512768108767469e-07,
            "start_logit": 9.925772666931152,
            "end_logit": -6.631786823272705
        },
        {
            "text": "spectrin is an antiparallel",
            "probability": 8.10898959071963e-08,
            "start_logit": -6.401403427124023,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antiparallel heterodimer composed of two",
            "probability": 6.84878886635301e-08,
            "start_logit": 9.925772666931152,
            "end_logit": -7.151171684265137
        },
        {
            "text": "antipar",
            "probability": 5.7247571585038586e-08,
            "start_logit": 9.925772666931152,
            "end_logit": -7.330443382263184
        },
        {
            "text": "antiparallel heterodimer composed of two homologous chains,",
            "probability": 4.5328641826456376e-08,
            "start_logit": 9.925772666931152,
            "end_logit": -7.563889503479004
        },
        {
            "text": "basic unit of spectrin is an antiparallel",
            "probability": 4.3812165332878884e-08,
            "start_logit": -7.017050266265869,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antiparallel heterodimer composed of two homologous",
            "probability": 2.084440446385898e-08,
            "start_logit": 9.925772666931152,
            "end_logit": -8.340743064880371
        }
    ],
    "5540b9800083d1bf0e000002_016": [
        {
            "text": "antiparallel",
            "probability": 0.9997288716921988,
            "start_logit": 9.071869850158691,
            "end_logit": 8.403250694274902
        },
        {
            "text": "ant",
            "probability": 0.0001602929844312561,
            "start_logit": 9.071869850158691,
            "end_logit": -0.3349854052066803
        },
        {
            "text": "allel",
            "probability": 0.00010595189328572953,
            "start_logit": -0.08038438856601715,
            "end_logit": 8.403250694274902
        },
        {
            "text": "iparallel",
            "probability": 1.7542605778213042e-06,
            "start_logit": -4.18132209777832,
            "end_logit": 8.403250694274902
        },
        {
            "text": "arallel",
            "probability": 8.843486793741289e-07,
            "start_logit": -4.866273403167725,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antip",
            "probability": 5.085002382341106e-07,
            "start_logit": 9.071869850158691,
            "end_logit": -6.088278293609619
        },
        {
            "text": "Influence of lateral association on forced unfolding of antiparallel",
            "probability": 4.975348691038132e-07,
            "start_logit": -5.4414591789245605,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antiparallel spectrin",
            "probability": 3.936851478568171e-07,
            "start_logit": 9.071869850158691,
            "end_logit": -6.3441925048828125
        },
        {
            "text": "of antiparallel",
            "probability": 3.147163190344618e-07,
            "start_logit": -5.899453163146973,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antiparallel spectrin heterodimers.",
            "probability": 1.329415571544325e-07,
            "start_logit": 9.071869850158691,
            "end_logit": -7.429834365844727
        },
        {
            "text": "unfolding of antiparallel",
            "probability": 9.742165349362867e-08,
            "start_logit": -7.072076320648193,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antipar",
            "probability": 8.814046819383983e-08,
            "start_logit": 9.071869850158691,
            "end_logit": -7.8408122062683105
        },
        {
            "text": "on forced unfolding of antiparallel",
            "probability": 8.257674510643526e-08,
            "start_logit": -7.237396717071533,
            "end_logit": 8.403250694274902
        },
        {
            "text": "forced unfolding of antiparallel",
            "probability": 6.682448978226553e-08,
            "start_logit": -7.449055194854736,
            "end_logit": 8.403250694274902
        },
        {
            "text": "association on forced unfolding of antiparallel",
            "probability": 3.1678758657482714e-08,
            "start_logit": -8.195478439331055,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antiparallel spectrin heterodimers. Protein",
            "probability": 3.07992133230845e-08,
            "start_logit": 9.071869850158691,
            "end_logit": -8.892254829406738
        },
        {
            "text": "ip",
            "probability": 8.922838451558572e-13,
            "start_logit": -4.18132209777832,
            "end_logit": -6.088278293609619
        },
        {
            "text": "Influence of lateral association on forced unfolding of antiparallel spectrin",
            "probability": 1.959252093775309e-13,
            "start_logit": -5.4414591789245605,
            "end_logit": -6.3441925048828125
        },
        {
            "text": "ipar",
            "probability": 1.546632822571631e-13,
            "start_logit": -4.18132209777832,
            "end_logit": -7.8408122062683105
        },
        {
            "text": "of antiparallel spectrin",
            "probability": 1.2393274226672723e-13,
            "start_logit": -5.899453163146973,
            "end_logit": -6.3441925048828125
        }
    ],
    "5540b9800083d1bf0e000002_017": [
        {
            "text": "antiparallel",
            "probability": 0.9994420843029911,
            "start_logit": 9.908915519714355,
            "end_logit": 9.320019721984863
        },
        {
            "text": "ant",
            "probability": 0.00037561373833505673,
            "start_logit": 9.908915519714355,
            "end_logit": 1.4336285591125488
        },
        {
            "text": "allel",
            "probability": 0.00015480765224806767,
            "start_logit": 1.1361464262008667,
            "end_logit": 9.320019721984863
        },
        {
            "text": "The spectrin heterodimer is formed by the antiparallel",
            "probability": 1.7658310383909434e-05,
            "start_logit": -1.0348304510116577,
            "end_logit": 9.320019721984863
        },
        {
            "text": "iparallel",
            "probability": 5.571364718159305e-06,
            "start_logit": -2.18839693069458,
            "end_logit": 9.320019721984863
        },
        {
            "text": "arallel",
            "probability": 1.109414454803806e-06,
            "start_logit": -3.8022046089172363,
            "end_logit": 9.320019721984863
        },
        {
            "text": "the antiparallel",
            "probability": 1.0095868096252424e-06,
            "start_logit": -3.896495819091797,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antiparallel lateral association",
            "probability": 7.694563752906257e-07,
            "start_logit": 9.908915519714355,
            "end_logit": -4.7570037841796875
        },
        {
            "text": "formed by the antiparallel",
            "probability": 5.092751166157208e-07,
            "start_logit": -4.580803871154785,
            "end_logit": 9.320019721984863
        },
        {
            "text": "is formed by the antiparallel",
            "probability": 2.6741656202034416e-07,
            "start_logit": -5.224984645843506,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antip",
            "probability": 2.002196729797102e-07,
            "start_logit": 9.908915519714355,
            "end_logit": -6.103272914886475
        },
        {
            "text": "heterodimer is formed by the antiparallel",
            "probability": 9.802170000732718e-08,
            "start_logit": -6.228603363037109,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antiparallel lateral",
            "probability": 9.112349108578021e-08,
            "start_logit": 9.908915519714355,
            "end_logit": -6.890472412109375
        },
        {
            "text": "bundles. The spectrin heterodimer is formed by the antiparallel",
            "probability": 6.664426329639931e-08,
            "start_logit": -6.6144232749938965,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antipar",
            "probability": 5.5639174860724635e-08,
            "start_logit": 9.908915519714355,
            "end_logit": -7.383800506591797
        },
        {
            "text": "spectrin heterodimer is formed by the antiparallel",
            "probability": 4.6132325068580995e-08,
            "start_logit": -6.982278347015381,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antiparallel lateral association of an alpha and a beta subunit,",
            "probability": 4.1682687173724426e-08,
            "start_logit": 9.908915519714355,
            "end_logit": -7.67260217666626
        },
        {
            "text": "The spectrin heterodimer is formed by the antiparallel lateral association",
            "probability": 1.359488430111038e-11,
            "start_logit": -1.0348304510116577,
            "end_logit": -4.7570037841796875
        },
        {
            "text": "The spectrin heterodimer is formed by",
            "probability": 2.619439290609317e-12,
            "start_logit": -1.0348304510116577,
            "end_logit": -6.4037370681762695
        },
        {
            "text": "The spectrin",
            "probability": 2.476898710918561e-12,
            "start_logit": -1.0348304510116577,
            "end_logit": -6.459690093994141
        }
    ],
    "5540b9800083d1bf0e000002_018": [
        {
            "text": "antiparallel",
            "probability": 0.9995336520313216,
            "start_logit": 9.900726318359375,
            "end_logit": 9.358675956726074
        },
        {
            "text": "ant",
            "probability": 0.0002889183691103592,
            "start_logit": 9.900726318359375,
            "end_logit": 1.2097760438919067
        },
        {
            "text": "allel",
            "probability": 0.00017145946603182045,
            "start_logit": 1.2300291061401367,
            "end_logit": 9.358675956726074
        },
        {
            "text": "iparallel",
            "probability": 2.71122278022055e-06,
            "start_logit": -2.9169180393218994,
            "end_logit": 9.358675956726074
        },
        {
            "text": "arallel",
            "probability": 1.1433023174399235e-06,
            "start_logit": -3.7803969383239746,
            "end_logit": 9.358675956726074
        },
        {
            "text": "antip",
            "probability": 4.1533353677137524e-07,
            "start_logit": 9.900726318359375,
            "end_logit": -5.335041522979736
        },
        {
            "text": "antiparallel heterodimer comprised",
            "probability": 3.7146434777599326e-07,
            "start_logit": 9.900726318359375,
            "end_logit": -5.4466705322265625
        },
        {
            "text": "Human erythrocyte spectrin is an antiparallel",
            "probability": 3.6965427295665544e-07,
            "start_logit": -4.9095048904418945,
            "end_logit": 9.358675956726074
        },
        {
            "text": "is an antiparallel",
            "probability": 2.3847687135742057e-07,
            "start_logit": -5.3478007316589355,
            "end_logit": 9.358675956726074
        },
        {
            "text": "antiparallel heterodimer comprised of a 280 kDa",
            "probability": 1.3615891959383036e-07,
            "start_logit": 9.900726318359375,
            "end_logit": -6.450300693511963
        },
        {
            "text": "antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa",
            "probability": 1.1894376753512582e-07,
            "start_logit": 9.900726318359375,
            "end_logit": -6.585472583770752
        },
        {
            "text": "antipar",
            "probability": 8.095842565957669e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -6.970187664031982
        },
        {
            "text": "antiparallel heterodimer comprised of",
            "probability": 7.354261197564998e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -7.066258430480957
        },
        {
            "text": "antiparallel heterodimer",
            "probability": 7.06850843712393e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -7.105888843536377
        },
        {
            "text": "spectrin is an antiparallel",
            "probability": 6.31651965957286e-08,
            "start_logit": -6.676319599151611,
            "end_logit": 9.358675956726074
        },
        {
            "text": "antiparallel heterodimer comprised of a 280 kDa alpha subunit",
            "probability": 5.406361982324003e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -7.373961925506592
        },
        {
            "text": "an antiparallel",
            "probability": 4.750650389093769e-08,
            "start_logit": -6.961206436157227,
            "end_logit": 9.358675956726074
        },
        {
            "text": "antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa beta subunit",
            "probability": 4.563053974858617e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -7.543546199798584
        },
        {
            "text": "antiparallel heterodimer comprised of a 280",
            "probability": 3.001501374696521e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -7.962425708770752
        },
        {
            "text": "antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa beta subunit which further associates",
            "probability": 9.726931797388073e-12,
            "start_logit": 1.2300291061401367,
            "end_logit": -7.326282978057861
        }
    ],
    "5540b9800083d1bf0e000002_019": [
        {
            "text": "antiparallel",
            "probability": 0.9994687635504412,
            "start_logit": 9.925772666931152,
            "end_logit": 9.344905853271484
        },
        {
            "text": "ant",
            "probability": 0.0002666468084164114,
            "start_logit": 9.925772666931152,
            "end_logit": 1.115851640701294
        },
        {
            "text": "allel",
            "probability": 0.00025130952377399105,
            "start_logit": 1.6374788284301758,
            "end_logit": 9.344905853271484
        },
        {
            "text": "iparallel",
            "probability": 7.033299363433545e-06,
            "start_logit": -1.938550591468811,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antiparallel heterodimer composed",
            "probability": 2.1054899309019123e-06,
            "start_logit": 9.925772666931152,
            "end_logit": -3.725525140762329
        },
        {
            "text": "arallel",
            "probability": 9.066550056143185e-07,
            "start_logit": -3.9871997833251953,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antiparallel heterodimer composed of",
            "probability": 8.276554489451312e-07,
            "start_logit": 9.925772666931152,
            "end_logit": -4.659231662750244
        },
        {
            "text": "The basic unit of spectrin is an antiparallel",
            "probability": 6.832935882148619e-07,
            "start_logit": -4.2700371742248535,
            "end_logit": 9.344905853271484
        },
        {
            "text": "is an antiparallel",
            "probability": 5.382355183035916e-07,
            "start_logit": -4.508665561676025,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antip",
            "probability": 2.9131831930703693e-07,
            "start_logit": 9.925772666931152,
            "end_logit": -5.703412055969238
        },
        {
            "text": "of spectrin is an antiparallel",
            "probability": 1.9157795621568537e-07,
            "start_logit": -5.5416669845581055,
            "end_logit": 9.344905853271484
        },
        {
            "text": "an antiparallel",
            "probability": 1.45824210104058e-07,
            "start_logit": -5.8145599365234375,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antiparallel heterodimer composed of two homologous chains, beta and alpha.",
            "probability": 1.2482977821478283e-07,
            "start_logit": 9.925772666931152,
            "end_logit": -6.550877571105957
        },
        {
            "text": "antiparallel heterodimer",
            "probability": 1.1512768108767469e-07,
            "start_logit": 9.925772666931152,
            "end_logit": -6.631786823272705
        },
        {
            "text": "spectrin is an antiparallel",
            "probability": 8.10898959071963e-08,
            "start_logit": -6.401403427124023,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antiparallel heterodimer composed of two",
            "probability": 6.84878886635301e-08,
            "start_logit": 9.925772666931152,
            "end_logit": -7.151171684265137
        },
        {
            "text": "antipar",
            "probability": 5.7247571585038586e-08,
            "start_logit": 9.925772666931152,
            "end_logit": -7.330443382263184
        },
        {
            "text": "antiparallel heterodimer composed of two homologous chains,",
            "probability": 4.5328641826456376e-08,
            "start_logit": 9.925772666931152,
            "end_logit": -7.563889503479004
        },
        {
            "text": "basic unit of spectrin is an antiparallel",
            "probability": 4.3812165332878884e-08,
            "start_logit": -7.017050266265869,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antiparallel heterodimer composed of two homologous",
            "probability": 2.084440446385898e-08,
            "start_logit": 9.925772666931152,
            "end_logit": -8.340743064880371
        }
    ],
    "5540b9800083d1bf0e000002_020": [
        {
            "text": "antiparallel",
            "probability": 0.9997288716921988,
            "start_logit": 9.071869850158691,
            "end_logit": 8.403250694274902
        },
        {
            "text": "ant",
            "probability": 0.0001602929844312561,
            "start_logit": 9.071869850158691,
            "end_logit": -0.3349854052066803
        },
        {
            "text": "allel",
            "probability": 0.00010595189328572953,
            "start_logit": -0.08038438856601715,
            "end_logit": 8.403250694274902
        },
        {
            "text": "iparallel",
            "probability": 1.7542605778213042e-06,
            "start_logit": -4.18132209777832,
            "end_logit": 8.403250694274902
        },
        {
            "text": "arallel",
            "probability": 8.843486793741289e-07,
            "start_logit": -4.866273403167725,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antip",
            "probability": 5.085002382341106e-07,
            "start_logit": 9.071869850158691,
            "end_logit": -6.088278293609619
        },
        {
            "text": "Influence of lateral association on forced unfolding of antiparallel",
            "probability": 4.975348691038132e-07,
            "start_logit": -5.4414591789245605,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antiparallel spectrin",
            "probability": 3.936851478568171e-07,
            "start_logit": 9.071869850158691,
            "end_logit": -6.3441925048828125
        },
        {
            "text": "of antiparallel",
            "probability": 3.147163190344618e-07,
            "start_logit": -5.899453163146973,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antiparallel spectrin heterodimers.",
            "probability": 1.329415571544325e-07,
            "start_logit": 9.071869850158691,
            "end_logit": -7.429834365844727
        },
        {
            "text": "unfolding of antiparallel",
            "probability": 9.742165349362867e-08,
            "start_logit": -7.072076320648193,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antipar",
            "probability": 8.814046819383983e-08,
            "start_logit": 9.071869850158691,
            "end_logit": -7.8408122062683105
        },
        {
            "text": "on forced unfolding of antiparallel",
            "probability": 8.257674510643526e-08,
            "start_logit": -7.237396717071533,
            "end_logit": 8.403250694274902
        },
        {
            "text": "forced unfolding of antiparallel",
            "probability": 6.682448978226553e-08,
            "start_logit": -7.449055194854736,
            "end_logit": 8.403250694274902
        },
        {
            "text": "association on forced unfolding of antiparallel",
            "probability": 3.1678758657482714e-08,
            "start_logit": -8.195478439331055,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antiparallel spectrin heterodimers. Protein",
            "probability": 3.07992133230845e-08,
            "start_logit": 9.071869850158691,
            "end_logit": -8.892254829406738
        },
        {
            "text": "ip",
            "probability": 8.922838451558572e-13,
            "start_logit": -4.18132209777832,
            "end_logit": -6.088278293609619
        },
        {
            "text": "Influence of lateral association on forced unfolding of antiparallel spectrin",
            "probability": 1.959252093775309e-13,
            "start_logit": -5.4414591789245605,
            "end_logit": -6.3441925048828125
        },
        {
            "text": "ipar",
            "probability": 1.546632822571631e-13,
            "start_logit": -4.18132209777832,
            "end_logit": -7.8408122062683105
        },
        {
            "text": "of antiparallel spectrin",
            "probability": 1.2393274226672723e-13,
            "start_logit": -5.899453163146973,
            "end_logit": -6.3441925048828125
        }
    ],
    "5540b9800083d1bf0e000002_021": [
        {
            "text": "antiparallel",
            "probability": 0.9994420843029911,
            "start_logit": 9.908915519714355,
            "end_logit": 9.320019721984863
        },
        {
            "text": "ant",
            "probability": 0.00037561373833505673,
            "start_logit": 9.908915519714355,
            "end_logit": 1.4336285591125488
        },
        {
            "text": "allel",
            "probability": 0.00015480765224806767,
            "start_logit": 1.1361464262008667,
            "end_logit": 9.320019721984863
        },
        {
            "text": "The spectrin heterodimer is formed by the antiparallel",
            "probability": 1.7658310383909434e-05,
            "start_logit": -1.0348304510116577,
            "end_logit": 9.320019721984863
        },
        {
            "text": "iparallel",
            "probability": 5.571364718159305e-06,
            "start_logit": -2.18839693069458,
            "end_logit": 9.320019721984863
        },
        {
            "text": "arallel",
            "probability": 1.109414454803806e-06,
            "start_logit": -3.8022046089172363,
            "end_logit": 9.320019721984863
        },
        {
            "text": "the antiparallel",
            "probability": 1.0095868096252424e-06,
            "start_logit": -3.896495819091797,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antiparallel lateral association",
            "probability": 7.694563752906257e-07,
            "start_logit": 9.908915519714355,
            "end_logit": -4.7570037841796875
        },
        {
            "text": "formed by the antiparallel",
            "probability": 5.092751166157208e-07,
            "start_logit": -4.580803871154785,
            "end_logit": 9.320019721984863
        },
        {
            "text": "is formed by the antiparallel",
            "probability": 2.6741656202034416e-07,
            "start_logit": -5.224984645843506,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antip",
            "probability": 2.002196729797102e-07,
            "start_logit": 9.908915519714355,
            "end_logit": -6.103272914886475
        },
        {
            "text": "heterodimer is formed by the antiparallel",
            "probability": 9.802170000732718e-08,
            "start_logit": -6.228603363037109,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antiparallel lateral",
            "probability": 9.112349108578021e-08,
            "start_logit": 9.908915519714355,
            "end_logit": -6.890472412109375
        },
        {
            "text": "bundles. The spectrin heterodimer is formed by the antiparallel",
            "probability": 6.664426329639931e-08,
            "start_logit": -6.6144232749938965,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antipar",
            "probability": 5.5639174860724635e-08,
            "start_logit": 9.908915519714355,
            "end_logit": -7.383800506591797
        },
        {
            "text": "spectrin heterodimer is formed by the antiparallel",
            "probability": 4.6132325068580995e-08,
            "start_logit": -6.982278347015381,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antiparallel lateral association of an alpha and a beta subunit,",
            "probability": 4.1682687173724426e-08,
            "start_logit": 9.908915519714355,
            "end_logit": -7.67260217666626
        },
        {
            "text": "The spectrin heterodimer is formed by the antiparallel lateral association",
            "probability": 1.359488430111038e-11,
            "start_logit": -1.0348304510116577,
            "end_logit": -4.7570037841796875
        },
        {
            "text": "The spectrin heterodimer is formed by",
            "probability": 2.619439290609317e-12,
            "start_logit": -1.0348304510116577,
            "end_logit": -6.4037370681762695
        },
        {
            "text": "The spectrin",
            "probability": 2.476898710918561e-12,
            "start_logit": -1.0348304510116577,
            "end_logit": -6.459690093994141
        }
    ],
    "5540b9800083d1bf0e000002_022": [
        {
            "text": "antiparallel",
            "probability": 0.9995336520313216,
            "start_logit": 9.900726318359375,
            "end_logit": 9.358675956726074
        },
        {
            "text": "ant",
            "probability": 0.0002889183691103592,
            "start_logit": 9.900726318359375,
            "end_logit": 1.2097760438919067
        },
        {
            "text": "allel",
            "probability": 0.00017145946603182045,
            "start_logit": 1.2300291061401367,
            "end_logit": 9.358675956726074
        },
        {
            "text": "iparallel",
            "probability": 2.71122278022055e-06,
            "start_logit": -2.9169180393218994,
            "end_logit": 9.358675956726074
        },
        {
            "text": "arallel",
            "probability": 1.1433023174399235e-06,
            "start_logit": -3.7803969383239746,
            "end_logit": 9.358675956726074
        },
        {
            "text": "antip",
            "probability": 4.1533353677137524e-07,
            "start_logit": 9.900726318359375,
            "end_logit": -5.335041522979736
        },
        {
            "text": "antiparallel heterodimer comprised",
            "probability": 3.7146434777599326e-07,
            "start_logit": 9.900726318359375,
            "end_logit": -5.4466705322265625
        },
        {
            "text": "Human erythrocyte spectrin is an antiparallel",
            "probability": 3.6965427295665544e-07,
            "start_logit": -4.9095048904418945,
            "end_logit": 9.358675956726074
        },
        {
            "text": "is an antiparallel",
            "probability": 2.3847687135742057e-07,
            "start_logit": -5.3478007316589355,
            "end_logit": 9.358675956726074
        },
        {
            "text": "antiparallel heterodimer comprised of a 280 kDa",
            "probability": 1.3615891959383036e-07,
            "start_logit": 9.900726318359375,
            "end_logit": -6.450300693511963
        },
        {
            "text": "antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa",
            "probability": 1.1894376753512582e-07,
            "start_logit": 9.900726318359375,
            "end_logit": -6.585472583770752
        },
        {
            "text": "antipar",
            "probability": 8.095842565957669e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -6.970187664031982
        },
        {
            "text": "antiparallel heterodimer comprised of",
            "probability": 7.354261197564998e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -7.066258430480957
        },
        {
            "text": "antiparallel heterodimer",
            "probability": 7.06850843712393e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -7.105888843536377
        },
        {
            "text": "spectrin is an antiparallel",
            "probability": 6.31651965957286e-08,
            "start_logit": -6.676319599151611,
            "end_logit": 9.358675956726074
        },
        {
            "text": "antiparallel heterodimer comprised of a 280 kDa alpha subunit",
            "probability": 5.406361982324003e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -7.373961925506592
        },
        {
            "text": "an antiparallel",
            "probability": 4.750650389093769e-08,
            "start_logit": -6.961206436157227,
            "end_logit": 9.358675956726074
        },
        {
            "text": "antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa beta subunit",
            "probability": 4.563053974858617e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -7.543546199798584
        },
        {
            "text": "antiparallel heterodimer comprised of a 280",
            "probability": 3.001501374696521e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -7.962425708770752
        },
        {
            "text": "antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa beta subunit which further associates",
            "probability": 9.726931797388073e-12,
            "start_logit": 1.2300291061401367,
            "end_logit": -7.326282978057861
        }
    ],
    "5540b9800083d1bf0e000002_023": [
        {
            "text": "antiparallel",
            "probability": 0.9994687635504412,
            "start_logit": 9.925772666931152,
            "end_logit": 9.344905853271484
        },
        {
            "text": "ant",
            "probability": 0.0002666468084164114,
            "start_logit": 9.925772666931152,
            "end_logit": 1.115851640701294
        },
        {
            "text": "allel",
            "probability": 0.00025130952377399105,
            "start_logit": 1.6374788284301758,
            "end_logit": 9.344905853271484
        },
        {
            "text": "iparallel",
            "probability": 7.033299363433545e-06,
            "start_logit": -1.938550591468811,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antiparallel heterodimer composed",
            "probability": 2.1054899309019123e-06,
            "start_logit": 9.925772666931152,
            "end_logit": -3.725525140762329
        },
        {
            "text": "arallel",
            "probability": 9.066550056143185e-07,
            "start_logit": -3.9871997833251953,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antiparallel heterodimer composed of",
            "probability": 8.276554489451312e-07,
            "start_logit": 9.925772666931152,
            "end_logit": -4.659231662750244
        },
        {
            "text": "The basic unit of spectrin is an antiparallel",
            "probability": 6.832935882148619e-07,
            "start_logit": -4.2700371742248535,
            "end_logit": 9.344905853271484
        },
        {
            "text": "is an antiparallel",
            "probability": 5.382355183035916e-07,
            "start_logit": -4.508665561676025,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antip",
            "probability": 2.9131831930703693e-07,
            "start_logit": 9.925772666931152,
            "end_logit": -5.703412055969238
        },
        {
            "text": "of spectrin is an antiparallel",
            "probability": 1.9157795621568537e-07,
            "start_logit": -5.5416669845581055,
            "end_logit": 9.344905853271484
        },
        {
            "text": "an antiparallel",
            "probability": 1.45824210104058e-07,
            "start_logit": -5.8145599365234375,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antiparallel heterodimer composed of two homologous chains, beta and alpha.",
            "probability": 1.2482977821478283e-07,
            "start_logit": 9.925772666931152,
            "end_logit": -6.550877571105957
        },
        {
            "text": "antiparallel heterodimer",
            "probability": 1.1512768108767469e-07,
            "start_logit": 9.925772666931152,
            "end_logit": -6.631786823272705
        },
        {
            "text": "spectrin is an antiparallel",
            "probability": 8.10898959071963e-08,
            "start_logit": -6.401403427124023,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antiparallel heterodimer composed of two",
            "probability": 6.84878886635301e-08,
            "start_logit": 9.925772666931152,
            "end_logit": -7.151171684265137
        },
        {
            "text": "antipar",
            "probability": 5.7247571585038586e-08,
            "start_logit": 9.925772666931152,
            "end_logit": -7.330443382263184
        },
        {
            "text": "antiparallel heterodimer composed of two homologous chains,",
            "probability": 4.5328641826456376e-08,
            "start_logit": 9.925772666931152,
            "end_logit": -7.563889503479004
        },
        {
            "text": "basic unit of spectrin is an antiparallel",
            "probability": 4.3812165332878884e-08,
            "start_logit": -7.017050266265869,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antiparallel heterodimer composed of two homologous",
            "probability": 2.084440446385898e-08,
            "start_logit": 9.925772666931152,
            "end_logit": -8.340743064880371
        }
    ],
    "5540b9800083d1bf0e000002_024": [
        {
            "text": "antiparallel",
            "probability": 0.9997288716921988,
            "start_logit": 9.071869850158691,
            "end_logit": 8.403250694274902
        },
        {
            "text": "ant",
            "probability": 0.0001602929844312561,
            "start_logit": 9.071869850158691,
            "end_logit": -0.3349854052066803
        },
        {
            "text": "allel",
            "probability": 0.00010595189328572953,
            "start_logit": -0.08038438856601715,
            "end_logit": 8.403250694274902
        },
        {
            "text": "iparallel",
            "probability": 1.7542605778213042e-06,
            "start_logit": -4.18132209777832,
            "end_logit": 8.403250694274902
        },
        {
            "text": "arallel",
            "probability": 8.843486793741289e-07,
            "start_logit": -4.866273403167725,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antip",
            "probability": 5.085002382341106e-07,
            "start_logit": 9.071869850158691,
            "end_logit": -6.088278293609619
        },
        {
            "text": "Influence of lateral association on forced unfolding of antiparallel",
            "probability": 4.975348691038132e-07,
            "start_logit": -5.4414591789245605,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antiparallel spectrin",
            "probability": 3.936851478568171e-07,
            "start_logit": 9.071869850158691,
            "end_logit": -6.3441925048828125
        },
        {
            "text": "of antiparallel",
            "probability": 3.147163190344618e-07,
            "start_logit": -5.899453163146973,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antiparallel spectrin heterodimers.",
            "probability": 1.329415571544325e-07,
            "start_logit": 9.071869850158691,
            "end_logit": -7.429834365844727
        },
        {
            "text": "unfolding of antiparallel",
            "probability": 9.742165349362867e-08,
            "start_logit": -7.072076320648193,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antipar",
            "probability": 8.814046819383983e-08,
            "start_logit": 9.071869850158691,
            "end_logit": -7.8408122062683105
        },
        {
            "text": "on forced unfolding of antiparallel",
            "probability": 8.257674510643526e-08,
            "start_logit": -7.237396717071533,
            "end_logit": 8.403250694274902
        },
        {
            "text": "forced unfolding of antiparallel",
            "probability": 6.682448978226553e-08,
            "start_logit": -7.449055194854736,
            "end_logit": 8.403250694274902
        },
        {
            "text": "association on forced unfolding of antiparallel",
            "probability": 3.1678758657482714e-08,
            "start_logit": -8.195478439331055,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antiparallel spectrin heterodimers. Protein",
            "probability": 3.07992133230845e-08,
            "start_logit": 9.071869850158691,
            "end_logit": -8.892254829406738
        },
        {
            "text": "ip",
            "probability": 8.922838451558572e-13,
            "start_logit": -4.18132209777832,
            "end_logit": -6.088278293609619
        },
        {
            "text": "Influence of lateral association on forced unfolding of antiparallel spectrin",
            "probability": 1.959252093775309e-13,
            "start_logit": -5.4414591789245605,
            "end_logit": -6.3441925048828125
        },
        {
            "text": "ipar",
            "probability": 1.546632822571631e-13,
            "start_logit": -4.18132209777832,
            "end_logit": -7.8408122062683105
        },
        {
            "text": "of antiparallel spectrin",
            "probability": 1.2393274226672723e-13,
            "start_logit": -5.899453163146973,
            "end_logit": -6.3441925048828125
        }
    ],
    "5540b9800083d1bf0e000002_025": [
        {
            "text": "antiparallel",
            "probability": 0.9994420843029911,
            "start_logit": 9.908915519714355,
            "end_logit": 9.320019721984863
        },
        {
            "text": "ant",
            "probability": 0.00037561373833505673,
            "start_logit": 9.908915519714355,
            "end_logit": 1.4336285591125488
        },
        {
            "text": "allel",
            "probability": 0.00015480765224806767,
            "start_logit": 1.1361464262008667,
            "end_logit": 9.320019721984863
        },
        {
            "text": "The spectrin heterodimer is formed by the antiparallel",
            "probability": 1.7658310383909434e-05,
            "start_logit": -1.0348304510116577,
            "end_logit": 9.320019721984863
        },
        {
            "text": "iparallel",
            "probability": 5.571364718159305e-06,
            "start_logit": -2.18839693069458,
            "end_logit": 9.320019721984863
        },
        {
            "text": "arallel",
            "probability": 1.109414454803806e-06,
            "start_logit": -3.8022046089172363,
            "end_logit": 9.320019721984863
        },
        {
            "text": "the antiparallel",
            "probability": 1.0095868096252424e-06,
            "start_logit": -3.896495819091797,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antiparallel lateral association",
            "probability": 7.694563752906257e-07,
            "start_logit": 9.908915519714355,
            "end_logit": -4.7570037841796875
        },
        {
            "text": "formed by the antiparallel",
            "probability": 5.092751166157208e-07,
            "start_logit": -4.580803871154785,
            "end_logit": 9.320019721984863
        },
        {
            "text": "is formed by the antiparallel",
            "probability": 2.6741656202034416e-07,
            "start_logit": -5.224984645843506,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antip",
            "probability": 2.002196729797102e-07,
            "start_logit": 9.908915519714355,
            "end_logit": -6.103272914886475
        },
        {
            "text": "heterodimer is formed by the antiparallel",
            "probability": 9.802170000732718e-08,
            "start_logit": -6.228603363037109,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antiparallel lateral",
            "probability": 9.112349108578021e-08,
            "start_logit": 9.908915519714355,
            "end_logit": -6.890472412109375
        },
        {
            "text": "bundles. The spectrin heterodimer is formed by the antiparallel",
            "probability": 6.664426329639931e-08,
            "start_logit": -6.6144232749938965,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antipar",
            "probability": 5.5639174860724635e-08,
            "start_logit": 9.908915519714355,
            "end_logit": -7.383800506591797
        },
        {
            "text": "spectrin heterodimer is formed by the antiparallel",
            "probability": 4.6132325068580995e-08,
            "start_logit": -6.982278347015381,
            "end_logit": 9.320019721984863
        },
        {
            "text": "antiparallel lateral association of an alpha and a beta subunit,",
            "probability": 4.1682687173724426e-08,
            "start_logit": 9.908915519714355,
            "end_logit": -7.67260217666626
        },
        {
            "text": "The spectrin heterodimer is formed by the antiparallel lateral association",
            "probability": 1.359488430111038e-11,
            "start_logit": -1.0348304510116577,
            "end_logit": -4.7570037841796875
        },
        {
            "text": "The spectrin heterodimer is formed by",
            "probability": 2.619439290609317e-12,
            "start_logit": -1.0348304510116577,
            "end_logit": -6.4037370681762695
        },
        {
            "text": "The spectrin",
            "probability": 2.476898710918561e-12,
            "start_logit": -1.0348304510116577,
            "end_logit": -6.459690093994141
        }
    ],
    "5540b9800083d1bf0e000002_026": [
        {
            "text": "antiparallel",
            "probability": 0.9994687635504412,
            "start_logit": 9.925772666931152,
            "end_logit": 9.344905853271484
        },
        {
            "text": "ant",
            "probability": 0.0002666468084164114,
            "start_logit": 9.925772666931152,
            "end_logit": 1.115851640701294
        },
        {
            "text": "allel",
            "probability": 0.00025130952377399105,
            "start_logit": 1.6374788284301758,
            "end_logit": 9.344905853271484
        },
        {
            "text": "iparallel",
            "probability": 7.033299363433545e-06,
            "start_logit": -1.938550591468811,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antiparallel heterodimer composed",
            "probability": 2.1054899309019123e-06,
            "start_logit": 9.925772666931152,
            "end_logit": -3.725525140762329
        },
        {
            "text": "arallel",
            "probability": 9.066550056143185e-07,
            "start_logit": -3.9871997833251953,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antiparallel heterodimer composed of",
            "probability": 8.276554489451312e-07,
            "start_logit": 9.925772666931152,
            "end_logit": -4.659231662750244
        },
        {
            "text": "The basic unit of spectrin is an antiparallel",
            "probability": 6.832935882148619e-07,
            "start_logit": -4.2700371742248535,
            "end_logit": 9.344905853271484
        },
        {
            "text": "is an antiparallel",
            "probability": 5.382355183035916e-07,
            "start_logit": -4.508665561676025,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antip",
            "probability": 2.9131831930703693e-07,
            "start_logit": 9.925772666931152,
            "end_logit": -5.703412055969238
        },
        {
            "text": "of spectrin is an antiparallel",
            "probability": 1.9157795621568537e-07,
            "start_logit": -5.5416669845581055,
            "end_logit": 9.344905853271484
        },
        {
            "text": "an antiparallel",
            "probability": 1.45824210104058e-07,
            "start_logit": -5.8145599365234375,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antiparallel heterodimer composed of two homologous chains, beta and alpha.",
            "probability": 1.2482977821478283e-07,
            "start_logit": 9.925772666931152,
            "end_logit": -6.550877571105957
        },
        {
            "text": "antiparallel heterodimer",
            "probability": 1.1512768108767469e-07,
            "start_logit": 9.925772666931152,
            "end_logit": -6.631786823272705
        },
        {
            "text": "spectrin is an antiparallel",
            "probability": 8.10898959071963e-08,
            "start_logit": -6.401403427124023,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antiparallel heterodimer composed of two",
            "probability": 6.84878886635301e-08,
            "start_logit": 9.925772666931152,
            "end_logit": -7.151171684265137
        },
        {
            "text": "antipar",
            "probability": 5.7247571585038586e-08,
            "start_logit": 9.925772666931152,
            "end_logit": -7.330443382263184
        },
        {
            "text": "antiparallel heterodimer composed of two homologous chains,",
            "probability": 4.5328641826456376e-08,
            "start_logit": 9.925772666931152,
            "end_logit": -7.563889503479004
        },
        {
            "text": "basic unit of spectrin is an antiparallel",
            "probability": 4.3812165332878884e-08,
            "start_logit": -7.017050266265869,
            "end_logit": 9.344905853271484
        },
        {
            "text": "antiparallel heterodimer composed of two homologous",
            "probability": 2.084440446385898e-08,
            "start_logit": 9.925772666931152,
            "end_logit": -8.340743064880371
        }
    ],
    "5540b9800083d1bf0e000002_027": [
        {
            "text": "antiparallel",
            "probability": 0.9995336520313216,
            "start_logit": 9.900726318359375,
            "end_logit": 9.358675956726074
        },
        {
            "text": "ant",
            "probability": 0.0002889183691103592,
            "start_logit": 9.900726318359375,
            "end_logit": 1.2097760438919067
        },
        {
            "text": "allel",
            "probability": 0.00017145946603182045,
            "start_logit": 1.2300291061401367,
            "end_logit": 9.358675956726074
        },
        {
            "text": "iparallel",
            "probability": 2.71122278022055e-06,
            "start_logit": -2.9169180393218994,
            "end_logit": 9.358675956726074
        },
        {
            "text": "arallel",
            "probability": 1.1433023174399235e-06,
            "start_logit": -3.7803969383239746,
            "end_logit": 9.358675956726074
        },
        {
            "text": "antip",
            "probability": 4.1533353677137524e-07,
            "start_logit": 9.900726318359375,
            "end_logit": -5.335041522979736
        },
        {
            "text": "antiparallel heterodimer comprised",
            "probability": 3.7146434777599326e-07,
            "start_logit": 9.900726318359375,
            "end_logit": -5.4466705322265625
        },
        {
            "text": "Human erythrocyte spectrin is an antiparallel",
            "probability": 3.6965427295665544e-07,
            "start_logit": -4.9095048904418945,
            "end_logit": 9.358675956726074
        },
        {
            "text": "is an antiparallel",
            "probability": 2.3847687135742057e-07,
            "start_logit": -5.3478007316589355,
            "end_logit": 9.358675956726074
        },
        {
            "text": "antiparallel heterodimer comprised of a 280 kDa",
            "probability": 1.3615891959383036e-07,
            "start_logit": 9.900726318359375,
            "end_logit": -6.450300693511963
        },
        {
            "text": "antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa",
            "probability": 1.1894376753512582e-07,
            "start_logit": 9.900726318359375,
            "end_logit": -6.585472583770752
        },
        {
            "text": "antipar",
            "probability": 8.095842565957669e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -6.970187664031982
        },
        {
            "text": "antiparallel heterodimer comprised of",
            "probability": 7.354261197564998e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -7.066258430480957
        },
        {
            "text": "antiparallel heterodimer",
            "probability": 7.06850843712393e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -7.105888843536377
        },
        {
            "text": "spectrin is an antiparallel",
            "probability": 6.31651965957286e-08,
            "start_logit": -6.676319599151611,
            "end_logit": 9.358675956726074
        },
        {
            "text": "antiparallel heterodimer comprised of a 280 kDa alpha subunit",
            "probability": 5.406361982324003e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -7.373961925506592
        },
        {
            "text": "an antiparallel",
            "probability": 4.750650389093769e-08,
            "start_logit": -6.961206436157227,
            "end_logit": 9.358675956726074
        },
        {
            "text": "antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa beta subunit",
            "probability": 4.563053974858617e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -7.543546199798584
        },
        {
            "text": "antiparallel heterodimer comprised of a 280",
            "probability": 3.001501374696521e-08,
            "start_logit": 9.900726318359375,
            "end_logit": -7.962425708770752
        },
        {
            "text": "antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa beta subunit which further associates",
            "probability": 9.726931797388073e-12,
            "start_logit": 1.2300291061401367,
            "end_logit": -7.326282978057861
        }
    ],
    "5540b9800083d1bf0e000002_028": [
        {
            "text": "antiparallel",
            "probability": 0.9997288716921988,
            "start_logit": 9.071869850158691,
            "end_logit": 8.403250694274902
        },
        {
            "text": "ant",
            "probability": 0.0001602929844312561,
            "start_logit": 9.071869850158691,
            "end_logit": -0.3349854052066803
        },
        {
            "text": "allel",
            "probability": 0.00010595189328572953,
            "start_logit": -0.08038438856601715,
            "end_logit": 8.403250694274902
        },
        {
            "text": "iparallel",
            "probability": 1.7542605778213042e-06,
            "start_logit": -4.18132209777832,
            "end_logit": 8.403250694274902
        },
        {
            "text": "arallel",
            "probability": 8.843486793741289e-07,
            "start_logit": -4.866273403167725,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antip",
            "probability": 5.085002382341106e-07,
            "start_logit": 9.071869850158691,
            "end_logit": -6.088278293609619
        },
        {
            "text": "Influence of lateral association on forced unfolding of antiparallel",
            "probability": 4.975348691038132e-07,
            "start_logit": -5.4414591789245605,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antiparallel spectrin",
            "probability": 3.936851478568171e-07,
            "start_logit": 9.071869850158691,
            "end_logit": -6.3441925048828125
        },
        {
            "text": "of antiparallel",
            "probability": 3.147163190344618e-07,
            "start_logit": -5.899453163146973,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antiparallel spectrin heterodimers.",
            "probability": 1.329415571544325e-07,
            "start_logit": 9.071869850158691,
            "end_logit": -7.429834365844727
        },
        {
            "text": "unfolding of antiparallel",
            "probability": 9.742165349362867e-08,
            "start_logit": -7.072076320648193,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antipar",
            "probability": 8.814046819383983e-08,
            "start_logit": 9.071869850158691,
            "end_logit": -7.8408122062683105
        },
        {
            "text": "on forced unfolding of antiparallel",
            "probability": 8.257674510643526e-08,
            "start_logit": -7.237396717071533,
            "end_logit": 8.403250694274902
        },
        {
            "text": "forced unfolding of antiparallel",
            "probability": 6.682448978226553e-08,
            "start_logit": -7.449055194854736,
            "end_logit": 8.403250694274902
        },
        {
            "text": "association on forced unfolding of antiparallel",
            "probability": 3.1678758657482714e-08,
            "start_logit": -8.195478439331055,
            "end_logit": 8.403250694274902
        },
        {
            "text": "antiparallel spectrin heterodimers. Protein",
            "probability": 3.07992133230845e-08,
            "start_logit": 9.071869850158691,
            "end_logit": -8.892254829406738
        },
        {
            "text": "ip",
            "probability": 8.922838451558572e-13,
            "start_logit": -4.18132209777832,
            "end_logit": -6.088278293609619
        },
        {
            "text": "Influence of lateral association on forced unfolding of antiparallel spectrin",
            "probability": 1.959252093775309e-13,
            "start_logit": -5.4414591789245605,
            "end_logit": -6.3441925048828125
        },
        {
            "text": "ipar",
            "probability": 1.546632822571631e-13,
            "start_logit": -4.18132209777832,
            "end_logit": -7.8408122062683105
        },
        {
            "text": "of antiparallel spectrin",
            "probability": 1.2393274226672723e-13,
            "start_logit": -5.899453163146973,
            "end_logit": -6.3441925048828125
        }
    ],
    "56c1f01cef6e394741000044_001": [
        {
            "text": "epidermal growth factor receptor",
            "probability": 0.5061594648084149,
            "start_logit": 2.2656445503234863,
            "end_logit": -4.295895576477051
        },
        {
            "text": "epidermal growth factor receptor (EGFR)",
            "probability": 0.23136967609334966,
            "start_logit": 2.2656445503234863,
            "end_logit": -5.078730583190918
        },
        {
            "text": "epidermal growth factor",
            "probability": 0.14832533525469907,
            "start_logit": 2.2656445503234863,
            "end_logit": -5.52333927154541
        },
        {
            "text": "ep",
            "probability": 0.04703968246497288,
            "start_logit": 2.2656445503234863,
            "end_logit": -6.671755790710449
        },
        {
            "text": "epidermal growth factor receptor (EGFR) is overexpressed in many nonsmall cell lung cancers",
            "probability": 0.04395484680399654,
            "start_logit": 2.2656445503234863,
            "end_logit": -6.739584445953369
        },
        {
            "text": "epidermal growth factor receptor (EGFR) is overexpressed in many nonsmall cell lung cancers (NSCLCs).",
            "probability": 0.020874160560254252,
            "start_logit": 2.2656445503234863,
            "end_logit": -7.4842352867126465
        },
        {
            "text": "The epidermal growth factor receptor",
            "probability": 0.00043464510871088355,
            "start_logit": -4.794432640075684,
            "end_logit": -4.295895576477051
        },
        {
            "text": "squamous cell",
            "probability": 0.000321446592391866,
            "start_logit": -2.405866861343384,
            "end_logit": -6.986159801483154
        },
        {
            "text": "squamous cell NSCLC.",
            "probability": 0.00026249721367604164,
            "start_logit": -2.405866861343384,
            "end_logit": -7.188750743865967
        },
        {
            "text": "PURPOSE OF REVIEW: The epidermal growth factor receptor",
            "probability": 0.0002225567428199195,
            "start_logit": -5.463780403137207,
            "end_logit": -4.295895576477051
        },
        {
            "text": "The epidermal growth factor receptor (EGFR)",
            "probability": 0.00019867987266831015,
            "start_logit": -4.794432640075684,
            "end_logit": -5.078730583190918
        },
        {
            "text": "Epidermal growth factor receptor-directed monoclonal antibodies in nonsmall cell lung cancer:",
            "probability": 0.00014954169396294386,
            "start_logit": -5.741365432739258,
            "end_logit": -4.41591739654541
        },
        {
            "text": "(EGFR)",
            "probability": 0.00014055016597620316,
            "start_logit": -5.140563011169434,
            "end_logit": -5.078730583190918
        },
        {
            "text": "The epidermal growth factor",
            "probability": 0.00012736871667658902,
            "start_logit": -4.794432640075684,
            "end_logit": -5.52333927154541
        },
        {
            "text": "OF REVIEW: The epidermal growth factor receptor",
            "probability": 0.00011287331860257108,
            "start_logit": -6.142696380615234,
            "end_logit": -4.295895576477051
        },
        {
            "text": "PURPOSE OF REVIEW: The epidermal growth factor receptor (EGFR)",
            "probability": 0.00010173252715550057,
            "start_logit": -5.463780403137207,
            "end_logit": -5.078730583190918
        },
        {
            "text": "PURPOSE OF REVIEW: The epidermal growth factor",
            "probability": 6.521818870749208e-05,
            "start_logit": -5.463780403137207,
            "end_logit": -5.52333927154541
        },
        {
            "text": "OF REVIEW: The epidermal growth factor receptor (EGFR)",
            "probability": 5.1595327125895446e-05,
            "start_logit": -6.142696380615234,
            "end_logit": -5.078730583190918
        },
        {
            "text": "update. PURPOSE OF REVIEW: The epidermal growth factor receptor",
            "probability": 4.428410373294349e-05,
            "start_logit": -7.078336715698242,
            "end_logit": -4.295895576477051
        },
        {
            "text": "cancer: an update. PURPOSE OF REVIEW: The epidermal growth factor receptor",
            "probability": 4.38444421055295e-05,
            "start_logit": -7.088314533233643,
            "end_logit": -4.295895576477051
        }
    ],
    "56c1f01cef6e394741000044_002": [
        {
            "text": "epidermal growth factor receptor,",
            "probability": 0.9997538313210198,
            "start_logit": 9.334061622619629,
            "end_logit": 7.919651985168457
        },
        {
            "text": "ep",
            "probability": 0.00018550800864287285,
            "start_logit": 9.334061622619629,
            "end_logit": -0.6725143194198608
        },
        {
            "text": "the epidermal growth factor receptor,",
            "probability": 4.493162995965723e-05,
            "start_logit": -0.6760607361793518,
            "end_logit": 7.919651985168457
        },
        {
            "text": ",",
            "probability": 1.3953061259151845e-05,
            "start_logit": -1.845503807067871,
            "end_logit": 7.919651985168457
        },
        {
            "text": "growth factor receptor,",
            "probability": 4.5666389392577424e-07,
            "start_logit": -5.265010356903076,
            "end_logit": 7.919651985168457
        },
        {
            "text": "epidermal growth factor receptor, and to characterize the safety profile, pharmacokinetics, preliminary antitumor activity,",
            "probability": 2.682333931181273e-07,
            "start_logit": 9.334061622619629,
            "end_logit": -7.211510181427002
        },
        {
            "text": "receptor,",
            "probability": 2.54206157164061e-07,
            "start_logit": -5.8508124351501465,
            "end_logit": 7.919651985168457
        },
        {
            "text": "epidermal growth factor receptor, and to characterize the safety profile, pharmacokinetics,",
            "probability": 2.1979294151694104e-07,
            "start_logit": 9.334061622619629,
            "end_logit": -7.41068172454834
        },
        {
            "text": "epider",
            "probability": 2.1175373357151178e-07,
            "start_logit": 9.334061622619629,
            "end_logit": -7.447943687438965
        },
        {
            "text": "epidermal growth factor receptor, and to characterize the safety profile,",
            "probability": 1.8396448056576881e-07,
            "start_logit": 9.334061622619629,
            "end_logit": -7.588624954223633
        },
        {
            "text": "epidermal growth factor receptor, and to characterize the safety profile, pharmacokinetics, preliminary antitumor",
            "probability": 1.716309753143392e-07,
            "start_logit": 9.334061622619629,
            "end_logit": -7.658020973205566
        },
        {
            "text": "the epidermal",
            "probability": 8.337229563682504e-09,
            "start_logit": -0.6760607361793518,
            "end_logit": -0.6725143194198608
        },
        {
            "text": "EGFR",
            "probability": 8.954795179726448e-10,
            "start_logit": -2.601223945617676,
            "end_logit": -0.9784780144691467
        },
        {
            "text": "against EGFR",
            "probability": 3.5978307027416596e-10,
            "start_logit": -3.5130820274353027,
            "end_logit": -0.9784780144691467
        },
        {
            "text": "FR",
            "probability": 6.816289434638999e-11,
            "start_logit": -5.176682949066162,
            "end_logit": -0.9784780144691467
        },
        {
            "text": "necitumumab",
            "probability": 1.9034654308944927e-11,
            "start_logit": -1.0188175439834595,
            "end_logit": -6.411982536315918
        },
        {
            "text": "EGFR in patients with advanced solid malignancies.",
            "probability": 1.7925909065889253e-11,
            "start_logit": -2.601223945617676,
            "end_logit": -4.889590263366699
        },
        {
            "text": "the",
            "probability": 1.532860169386743e-11,
            "start_logit": -0.6760607361793518,
            "end_logit": -6.971280097961426
        },
        {
            "text": "pharmacokinetics, preliminary antitumor activity, and immunogenicity of necitumumab.",
            "probability": 1.0720990305365406e-11,
            "start_logit": -3.8334033489227295,
            "end_logit": -4.171454429626465
        },
        {
            "text": "the epidermal growth factor receptor, and to characterize the safety profile, pharmacokinetics,",
            "probability": 9.878086791560108e-12,
            "start_logit": -0.6760607361793518,
            "end_logit": -7.41068172454834
        }
    ],
    "56b1f4300a360a5e4500001b_001": [
        {
            "text": "The pentapeptide",
            "probability": 0.3248509556677532,
            "start_logit": -4.116377830505371,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide",
            "probability": 0.2125164836275427,
            "start_logit": -4.141547203063965,
            "end_logit": -4.082440376281738
        },
        {
            "text": "pentapeptide",
            "probability": 0.08765695075104878,
            "start_logit": -5.426313400268555,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide prediction",
            "probability": 0.06297342858730172,
            "start_logit": -4.141547203063965,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "'aggregation-prone' pentapeptide",
            "probability": 0.04334304454066098,
            "start_logit": -4.865227222442627,
            "end_logit": -4.948633670806885
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred, an 'aggregation-prone' peptide",
            "probability": 0.043167849197910724,
            "start_logit": -5.735470771789551,
            "end_logit": -4.082440376281738
        },
        {
            "text": "the (47)LQVVR(51) peptide",
            "probability": 0.03688125711764146,
            "start_logit": -5.445095062255859,
            "end_logit": -4.530208587646484
        },
        {
            "text": "The pentapeptide LQVVR",
            "probability": 0.029950183607983086,
            "start_logit": -4.116377830505371,
            "end_logit": -6.067093849182129
        },
        {
            "text": "'aggregation-prone' pentapeptide ((47)LQVVR(51))",
            "probability": 0.02892124990079964,
            "start_logit": -4.865227222442627,
            "end_logit": -5.353203296661377
        },
        {
            "text": "peptide",
            "probability": 0.027109484318717483,
            "start_logit": -5.752914905548096,
            "end_logit": -4.530208587646484
        },
        {
            "text": "(47)LQVVR(51) peptide",
            "probability": 0.017913422604546172,
            "start_logit": -6.167248249053955,
            "end_logit": -4.530208587646484
        },
        {
            "text": "Thus, the (47)LQVVR(51) peptide",
            "probability": 0.01636549041122765,
            "start_logit": -6.257623672485352,
            "end_logit": -4.530208587646484
        },
        {
            "text": "important",
            "probability": 0.013128945382400484,
            "start_logit": -4.549392223358154,
            "end_logit": -6.458795547485352
        },
        {
            "text": "LQVVR",
            "probability": 0.012113651820830733,
            "start_logit": -5.735470771789551,
            "end_logit": -5.353203296661377
        },
        {
            "text": "pentapeptide LQVVR",
            "probability": 0.00808168091767892,
            "start_logit": -5.426313400268555,
            "end_logit": -6.067093849182129
        },
        {
            "text": "peptide prediction",
            "probability": 0.008014580036948058,
            "start_logit": -6.20299768447876,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "The pentapeptide LQVVR plays a pivotal role in human cystatin C",
            "probability": 0.007881804495551422,
            "start_logit": -4.116377830505371,
            "end_logit": -7.402072429656982
        },
        {
            "text": "pentapeptide ((47)LQVVR(51))",
            "probability": 0.006674356467206225,
            "start_logit": -6.331531047821045,
            "end_logit": -5.353203296661377
        },
        {
            "text": "'aggregation-prone'",
            "probability": 0.006482718520869202,
            "start_logit": -4.141547203063965,
            "end_logit": -7.572319984436035
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred,",
            "probability": 0.005972462025381129,
            "start_logit": -5.735470771789551,
            "end_logit": -6.06037712097168
        }
    ],
    "56b1f4300a360a5e4500001b_002": [
        {
            "text": "The pentapeptide",
            "probability": 0.3248509556677532,
            "start_logit": -4.116377830505371,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide",
            "probability": 0.2125164836275427,
            "start_logit": -4.141547203063965,
            "end_logit": -4.082440376281738
        },
        {
            "text": "pentapeptide",
            "probability": 0.08765695075104878,
            "start_logit": -5.426313400268555,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide prediction",
            "probability": 0.06297342858730172,
            "start_logit": -4.141547203063965,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "'aggregation-prone' pentapeptide",
            "probability": 0.04334304454066098,
            "start_logit": -4.865227222442627,
            "end_logit": -4.948633670806885
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred, an 'aggregation-prone' peptide",
            "probability": 0.043167849197910724,
            "start_logit": -5.735470771789551,
            "end_logit": -4.082440376281738
        },
        {
            "text": "the (47)LQVVR(51) peptide",
            "probability": 0.03688125711764146,
            "start_logit": -5.445095062255859,
            "end_logit": -4.530208587646484
        },
        {
            "text": "The pentapeptide LQVVR",
            "probability": 0.029950183607983086,
            "start_logit": -4.116377830505371,
            "end_logit": -6.067093849182129
        },
        {
            "text": "'aggregation-prone' pentapeptide ((47)LQVVR(51))",
            "probability": 0.02892124990079964,
            "start_logit": -4.865227222442627,
            "end_logit": -5.353203296661377
        },
        {
            "text": "peptide",
            "probability": 0.027109484318717483,
            "start_logit": -5.752914905548096,
            "end_logit": -4.530208587646484
        },
        {
            "text": "(47)LQVVR(51) peptide",
            "probability": 0.017913422604546172,
            "start_logit": -6.167248249053955,
            "end_logit": -4.530208587646484
        },
        {
            "text": "Thus, the (47)LQVVR(51) peptide",
            "probability": 0.01636549041122765,
            "start_logit": -6.257623672485352,
            "end_logit": -4.530208587646484
        },
        {
            "text": "important",
            "probability": 0.013128945382400484,
            "start_logit": -4.549392223358154,
            "end_logit": -6.458795547485352
        },
        {
            "text": "LQVVR",
            "probability": 0.012113651820830733,
            "start_logit": -5.735470771789551,
            "end_logit": -5.353203296661377
        },
        {
            "text": "pentapeptide LQVVR",
            "probability": 0.00808168091767892,
            "start_logit": -5.426313400268555,
            "end_logit": -6.067093849182129
        },
        {
            "text": "peptide prediction",
            "probability": 0.008014580036948058,
            "start_logit": -6.20299768447876,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "The pentapeptide LQVVR plays a pivotal role in human cystatin C",
            "probability": 0.007881804495551422,
            "start_logit": -4.116377830505371,
            "end_logit": -7.402072429656982
        },
        {
            "text": "pentapeptide ((47)LQVVR(51))",
            "probability": 0.006674356467206225,
            "start_logit": -6.331531047821045,
            "end_logit": -5.353203296661377
        },
        {
            "text": "'aggregation-prone'",
            "probability": 0.006482718520869202,
            "start_logit": -4.141547203063965,
            "end_logit": -7.572319984436035
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred,",
            "probability": 0.005972462025381129,
            "start_logit": -5.735470771789551,
            "end_logit": -6.06037712097168
        }
    ],
    "56b1f4300a360a5e4500001b_011": [
        {
            "text": "The pentapeptide",
            "probability": 0.3248509556677532,
            "start_logit": -4.116377830505371,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide",
            "probability": 0.2125164836275427,
            "start_logit": -4.141547203063965,
            "end_logit": -4.082440376281738
        },
        {
            "text": "pentapeptide",
            "probability": 0.08765695075104878,
            "start_logit": -5.426313400268555,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide prediction",
            "probability": 0.06297342858730172,
            "start_logit": -4.141547203063965,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "'aggregation-prone' pentapeptide",
            "probability": 0.04334304454066098,
            "start_logit": -4.865227222442627,
            "end_logit": -4.948633670806885
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred, an 'aggregation-prone' peptide",
            "probability": 0.043167849197910724,
            "start_logit": -5.735470771789551,
            "end_logit": -4.082440376281738
        },
        {
            "text": "the (47)LQVVR(51) peptide",
            "probability": 0.03688125711764146,
            "start_logit": -5.445095062255859,
            "end_logit": -4.530208587646484
        },
        {
            "text": "The pentapeptide LQVVR",
            "probability": 0.029950183607983086,
            "start_logit": -4.116377830505371,
            "end_logit": -6.067093849182129
        },
        {
            "text": "'aggregation-prone' pentapeptide ((47)LQVVR(51))",
            "probability": 0.02892124990079964,
            "start_logit": -4.865227222442627,
            "end_logit": -5.353203296661377
        },
        {
            "text": "peptide",
            "probability": 0.027109484318717483,
            "start_logit": -5.752914905548096,
            "end_logit": -4.530208587646484
        },
        {
            "text": "(47)LQVVR(51) peptide",
            "probability": 0.017913422604546172,
            "start_logit": -6.167248249053955,
            "end_logit": -4.530208587646484
        },
        {
            "text": "Thus, the (47)LQVVR(51) peptide",
            "probability": 0.01636549041122765,
            "start_logit": -6.257623672485352,
            "end_logit": -4.530208587646484
        },
        {
            "text": "important",
            "probability": 0.013128945382400484,
            "start_logit": -4.549392223358154,
            "end_logit": -6.458795547485352
        },
        {
            "text": "LQVVR",
            "probability": 0.012113651820830733,
            "start_logit": -5.735470771789551,
            "end_logit": -5.353203296661377
        },
        {
            "text": "pentapeptide LQVVR",
            "probability": 0.00808168091767892,
            "start_logit": -5.426313400268555,
            "end_logit": -6.067093849182129
        },
        {
            "text": "peptide prediction",
            "probability": 0.008014580036948058,
            "start_logit": -6.20299768447876,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "The pentapeptide LQVVR plays a pivotal role in human cystatin C",
            "probability": 0.007881804495551422,
            "start_logit": -4.116377830505371,
            "end_logit": -7.402072429656982
        },
        {
            "text": "pentapeptide ((47)LQVVR(51))",
            "probability": 0.006674356467206225,
            "start_logit": -6.331531047821045,
            "end_logit": -5.353203296661377
        },
        {
            "text": "'aggregation-prone'",
            "probability": 0.006482718520869202,
            "start_logit": -4.141547203063965,
            "end_logit": -7.572319984436035
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred,",
            "probability": 0.005972462025381129,
            "start_logit": -5.735470771789551,
            "end_logit": -6.06037712097168
        }
    ],
    "56b1f4300a360a5e4500001b_012": [
        {
            "text": "The pentapeptide",
            "probability": 0.3248509556677532,
            "start_logit": -4.116377830505371,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide",
            "probability": 0.2125164836275427,
            "start_logit": -4.141547203063965,
            "end_logit": -4.082440376281738
        },
        {
            "text": "pentapeptide",
            "probability": 0.08765695075104878,
            "start_logit": -5.426313400268555,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide prediction",
            "probability": 0.06297342858730172,
            "start_logit": -4.141547203063965,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "'aggregation-prone' pentapeptide",
            "probability": 0.04334304454066098,
            "start_logit": -4.865227222442627,
            "end_logit": -4.948633670806885
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred, an 'aggregation-prone' peptide",
            "probability": 0.043167849197910724,
            "start_logit": -5.735470771789551,
            "end_logit": -4.082440376281738
        },
        {
            "text": "the (47)LQVVR(51) peptide",
            "probability": 0.03688125711764146,
            "start_logit": -5.445095062255859,
            "end_logit": -4.530208587646484
        },
        {
            "text": "The pentapeptide LQVVR",
            "probability": 0.029950183607983086,
            "start_logit": -4.116377830505371,
            "end_logit": -6.067093849182129
        },
        {
            "text": "'aggregation-prone' pentapeptide ((47)LQVVR(51))",
            "probability": 0.02892124990079964,
            "start_logit": -4.865227222442627,
            "end_logit": -5.353203296661377
        },
        {
            "text": "peptide",
            "probability": 0.027109484318717483,
            "start_logit": -5.752914905548096,
            "end_logit": -4.530208587646484
        },
        {
            "text": "(47)LQVVR(51) peptide",
            "probability": 0.017913422604546172,
            "start_logit": -6.167248249053955,
            "end_logit": -4.530208587646484
        },
        {
            "text": "Thus, the (47)LQVVR(51) peptide",
            "probability": 0.01636549041122765,
            "start_logit": -6.257623672485352,
            "end_logit": -4.530208587646484
        },
        {
            "text": "important",
            "probability": 0.013128945382400484,
            "start_logit": -4.549392223358154,
            "end_logit": -6.458795547485352
        },
        {
            "text": "LQVVR",
            "probability": 0.012113651820830733,
            "start_logit": -5.735470771789551,
            "end_logit": -5.353203296661377
        },
        {
            "text": "pentapeptide LQVVR",
            "probability": 0.00808168091767892,
            "start_logit": -5.426313400268555,
            "end_logit": -6.067093849182129
        },
        {
            "text": "peptide prediction",
            "probability": 0.008014580036948058,
            "start_logit": -6.20299768447876,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "The pentapeptide LQVVR plays a pivotal role in human cystatin C",
            "probability": 0.007881804495551422,
            "start_logit": -4.116377830505371,
            "end_logit": -7.402072429656982
        },
        {
            "text": "pentapeptide ((47)LQVVR(51))",
            "probability": 0.006674356467206225,
            "start_logit": -6.331531047821045,
            "end_logit": -5.353203296661377
        },
        {
            "text": "'aggregation-prone'",
            "probability": 0.006482718520869202,
            "start_logit": -4.141547203063965,
            "end_logit": -7.572319984436035
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred,",
            "probability": 0.005972462025381129,
            "start_logit": -5.735470771789551,
            "end_logit": -6.06037712097168
        }
    ],
    "56b1f4300a360a5e4500001b_013": [
        {
            "text": "The pentapeptide",
            "probability": 0.3248509556677532,
            "start_logit": -4.116377830505371,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide",
            "probability": 0.2125164836275427,
            "start_logit": -4.141547203063965,
            "end_logit": -4.082440376281738
        },
        {
            "text": "pentapeptide",
            "probability": 0.08765695075104878,
            "start_logit": -5.426313400268555,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide prediction",
            "probability": 0.06297342858730172,
            "start_logit": -4.141547203063965,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "'aggregation-prone' pentapeptide",
            "probability": 0.04334304454066098,
            "start_logit": -4.865227222442627,
            "end_logit": -4.948633670806885
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred, an 'aggregation-prone' peptide",
            "probability": 0.043167849197910724,
            "start_logit": -5.735470771789551,
            "end_logit": -4.082440376281738
        },
        {
            "text": "the (47)LQVVR(51) peptide",
            "probability": 0.03688125711764146,
            "start_logit": -5.445095062255859,
            "end_logit": -4.530208587646484
        },
        {
            "text": "The pentapeptide LQVVR",
            "probability": 0.029950183607983086,
            "start_logit": -4.116377830505371,
            "end_logit": -6.067093849182129
        },
        {
            "text": "'aggregation-prone' pentapeptide ((47)LQVVR(51))",
            "probability": 0.02892124990079964,
            "start_logit": -4.865227222442627,
            "end_logit": -5.353203296661377
        },
        {
            "text": "peptide",
            "probability": 0.027109484318717483,
            "start_logit": -5.752914905548096,
            "end_logit": -4.530208587646484
        },
        {
            "text": "(47)LQVVR(51) peptide",
            "probability": 0.017913422604546172,
            "start_logit": -6.167248249053955,
            "end_logit": -4.530208587646484
        },
        {
            "text": "Thus, the (47)LQVVR(51) peptide",
            "probability": 0.01636549041122765,
            "start_logit": -6.257623672485352,
            "end_logit": -4.530208587646484
        },
        {
            "text": "important",
            "probability": 0.013128945382400484,
            "start_logit": -4.549392223358154,
            "end_logit": -6.458795547485352
        },
        {
            "text": "LQVVR",
            "probability": 0.012113651820830733,
            "start_logit": -5.735470771789551,
            "end_logit": -5.353203296661377
        },
        {
            "text": "pentapeptide LQVVR",
            "probability": 0.00808168091767892,
            "start_logit": -5.426313400268555,
            "end_logit": -6.067093849182129
        },
        {
            "text": "peptide prediction",
            "probability": 0.008014580036948058,
            "start_logit": -6.20299768447876,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "The pentapeptide LQVVR plays a pivotal role in human cystatin C",
            "probability": 0.007881804495551422,
            "start_logit": -4.116377830505371,
            "end_logit": -7.402072429656982
        },
        {
            "text": "pentapeptide ((47)LQVVR(51))",
            "probability": 0.006674356467206225,
            "start_logit": -6.331531047821045,
            "end_logit": -5.353203296661377
        },
        {
            "text": "'aggregation-prone'",
            "probability": 0.006482718520869202,
            "start_logit": -4.141547203063965,
            "end_logit": -7.572319984436035
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred,",
            "probability": 0.005972462025381129,
            "start_logit": -5.735470771789551,
            "end_logit": -6.06037712097168
        }
    ],
    "56b1f4300a360a5e4500001b_014": [
        {
            "text": "The pentapeptide",
            "probability": 0.3248509556677532,
            "start_logit": -4.116377830505371,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide",
            "probability": 0.2125164836275427,
            "start_logit": -4.141547203063965,
            "end_logit": -4.082440376281738
        },
        {
            "text": "pentapeptide",
            "probability": 0.08765695075104878,
            "start_logit": -5.426313400268555,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide prediction",
            "probability": 0.06297342858730172,
            "start_logit": -4.141547203063965,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "'aggregation-prone' pentapeptide",
            "probability": 0.04334304454066098,
            "start_logit": -4.865227222442627,
            "end_logit": -4.948633670806885
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred, an 'aggregation-prone' peptide",
            "probability": 0.043167849197910724,
            "start_logit": -5.735470771789551,
            "end_logit": -4.082440376281738
        },
        {
            "text": "the (47)LQVVR(51) peptide",
            "probability": 0.03688125711764146,
            "start_logit": -5.445095062255859,
            "end_logit": -4.530208587646484
        },
        {
            "text": "The pentapeptide LQVVR",
            "probability": 0.029950183607983086,
            "start_logit": -4.116377830505371,
            "end_logit": -6.067093849182129
        },
        {
            "text": "'aggregation-prone' pentapeptide ((47)LQVVR(51))",
            "probability": 0.02892124990079964,
            "start_logit": -4.865227222442627,
            "end_logit": -5.353203296661377
        },
        {
            "text": "peptide",
            "probability": 0.027109484318717483,
            "start_logit": -5.752914905548096,
            "end_logit": -4.530208587646484
        },
        {
            "text": "(47)LQVVR(51) peptide",
            "probability": 0.017913422604546172,
            "start_logit": -6.167248249053955,
            "end_logit": -4.530208587646484
        },
        {
            "text": "Thus, the (47)LQVVR(51) peptide",
            "probability": 0.01636549041122765,
            "start_logit": -6.257623672485352,
            "end_logit": -4.530208587646484
        },
        {
            "text": "important",
            "probability": 0.013128945382400484,
            "start_logit": -4.549392223358154,
            "end_logit": -6.458795547485352
        },
        {
            "text": "LQVVR",
            "probability": 0.012113651820830733,
            "start_logit": -5.735470771789551,
            "end_logit": -5.353203296661377
        },
        {
            "text": "pentapeptide LQVVR",
            "probability": 0.00808168091767892,
            "start_logit": -5.426313400268555,
            "end_logit": -6.067093849182129
        },
        {
            "text": "peptide prediction",
            "probability": 0.008014580036948058,
            "start_logit": -6.20299768447876,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "The pentapeptide LQVVR plays a pivotal role in human cystatin C",
            "probability": 0.007881804495551422,
            "start_logit": -4.116377830505371,
            "end_logit": -7.402072429656982
        },
        {
            "text": "pentapeptide ((47)LQVVR(51))",
            "probability": 0.006674356467206225,
            "start_logit": -6.331531047821045,
            "end_logit": -5.353203296661377
        },
        {
            "text": "'aggregation-prone'",
            "probability": 0.006482718520869202,
            "start_logit": -4.141547203063965,
            "end_logit": -7.572319984436035
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred,",
            "probability": 0.005972462025381129,
            "start_logit": -5.735470771789551,
            "end_logit": -6.06037712097168
        }
    ],
    "56b1f4300a360a5e4500001b_015": [
        {
            "text": "The pentapeptide",
            "probability": 0.3248509556677532,
            "start_logit": -4.116377830505371,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide",
            "probability": 0.2125164836275427,
            "start_logit": -4.141547203063965,
            "end_logit": -4.082440376281738
        },
        {
            "text": "pentapeptide",
            "probability": 0.08765695075104878,
            "start_logit": -5.426313400268555,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide prediction",
            "probability": 0.06297342858730172,
            "start_logit": -4.141547203063965,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "'aggregation-prone' pentapeptide",
            "probability": 0.04334304454066098,
            "start_logit": -4.865227222442627,
            "end_logit": -4.948633670806885
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred, an 'aggregation-prone' peptide",
            "probability": 0.043167849197910724,
            "start_logit": -5.735470771789551,
            "end_logit": -4.082440376281738
        },
        {
            "text": "the (47)LQVVR(51) peptide",
            "probability": 0.03688125711764146,
            "start_logit": -5.445095062255859,
            "end_logit": -4.530208587646484
        },
        {
            "text": "The pentapeptide LQVVR",
            "probability": 0.029950183607983086,
            "start_logit": -4.116377830505371,
            "end_logit": -6.067093849182129
        },
        {
            "text": "'aggregation-prone' pentapeptide ((47)LQVVR(51))",
            "probability": 0.02892124990079964,
            "start_logit": -4.865227222442627,
            "end_logit": -5.353203296661377
        },
        {
            "text": "peptide",
            "probability": 0.027109484318717483,
            "start_logit": -5.752914905548096,
            "end_logit": -4.530208587646484
        },
        {
            "text": "(47)LQVVR(51) peptide",
            "probability": 0.017913422604546172,
            "start_logit": -6.167248249053955,
            "end_logit": -4.530208587646484
        },
        {
            "text": "Thus, the (47)LQVVR(51) peptide",
            "probability": 0.01636549041122765,
            "start_logit": -6.257623672485352,
            "end_logit": -4.530208587646484
        },
        {
            "text": "important",
            "probability": 0.013128945382400484,
            "start_logit": -4.549392223358154,
            "end_logit": -6.458795547485352
        },
        {
            "text": "LQVVR",
            "probability": 0.012113651820830733,
            "start_logit": -5.735470771789551,
            "end_logit": -5.353203296661377
        },
        {
            "text": "pentapeptide LQVVR",
            "probability": 0.00808168091767892,
            "start_logit": -5.426313400268555,
            "end_logit": -6.067093849182129
        },
        {
            "text": "peptide prediction",
            "probability": 0.008014580036948058,
            "start_logit": -6.20299768447876,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "The pentapeptide LQVVR plays a pivotal role in human cystatin C",
            "probability": 0.007881804495551422,
            "start_logit": -4.116377830505371,
            "end_logit": -7.402072429656982
        },
        {
            "text": "pentapeptide ((47)LQVVR(51))",
            "probability": 0.006674356467206225,
            "start_logit": -6.331531047821045,
            "end_logit": -5.353203296661377
        },
        {
            "text": "'aggregation-prone'",
            "probability": 0.006482718520869202,
            "start_logit": -4.141547203063965,
            "end_logit": -7.572319984436035
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred,",
            "probability": 0.005972462025381129,
            "start_logit": -5.735470771789551,
            "end_logit": -6.06037712097168
        }
    ],
    "56b1f4300a360a5e4500001b_016": [
        {
            "text": "The pentapeptide",
            "probability": 0.3248509556677532,
            "start_logit": -4.116377830505371,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide",
            "probability": 0.2125164836275427,
            "start_logit": -4.141547203063965,
            "end_logit": -4.082440376281738
        },
        {
            "text": "pentapeptide",
            "probability": 0.08765695075104878,
            "start_logit": -5.426313400268555,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide prediction",
            "probability": 0.06297342858730172,
            "start_logit": -4.141547203063965,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "'aggregation-prone' pentapeptide",
            "probability": 0.04334304454066098,
            "start_logit": -4.865227222442627,
            "end_logit": -4.948633670806885
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred, an 'aggregation-prone' peptide",
            "probability": 0.043167849197910724,
            "start_logit": -5.735470771789551,
            "end_logit": -4.082440376281738
        },
        {
            "text": "the (47)LQVVR(51) peptide",
            "probability": 0.03688125711764146,
            "start_logit": -5.445095062255859,
            "end_logit": -4.530208587646484
        },
        {
            "text": "The pentapeptide LQVVR",
            "probability": 0.029950183607983086,
            "start_logit": -4.116377830505371,
            "end_logit": -6.067093849182129
        },
        {
            "text": "'aggregation-prone' pentapeptide ((47)LQVVR(51))",
            "probability": 0.02892124990079964,
            "start_logit": -4.865227222442627,
            "end_logit": -5.353203296661377
        },
        {
            "text": "peptide",
            "probability": 0.027109484318717483,
            "start_logit": -5.752914905548096,
            "end_logit": -4.530208587646484
        },
        {
            "text": "(47)LQVVR(51) peptide",
            "probability": 0.017913422604546172,
            "start_logit": -6.167248249053955,
            "end_logit": -4.530208587646484
        },
        {
            "text": "Thus, the (47)LQVVR(51) peptide",
            "probability": 0.01636549041122765,
            "start_logit": -6.257623672485352,
            "end_logit": -4.530208587646484
        },
        {
            "text": "important",
            "probability": 0.013128945382400484,
            "start_logit": -4.549392223358154,
            "end_logit": -6.458795547485352
        },
        {
            "text": "LQVVR",
            "probability": 0.012113651820830733,
            "start_logit": -5.735470771789551,
            "end_logit": -5.353203296661377
        },
        {
            "text": "pentapeptide LQVVR",
            "probability": 0.00808168091767892,
            "start_logit": -5.426313400268555,
            "end_logit": -6.067093849182129
        },
        {
            "text": "peptide prediction",
            "probability": 0.008014580036948058,
            "start_logit": -6.20299768447876,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "The pentapeptide LQVVR plays a pivotal role in human cystatin C",
            "probability": 0.007881804495551422,
            "start_logit": -4.116377830505371,
            "end_logit": -7.402072429656982
        },
        {
            "text": "pentapeptide ((47)LQVVR(51))",
            "probability": 0.006674356467206225,
            "start_logit": -6.331531047821045,
            "end_logit": -5.353203296661377
        },
        {
            "text": "'aggregation-prone'",
            "probability": 0.006482718520869202,
            "start_logit": -4.141547203063965,
            "end_logit": -7.572319984436035
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred,",
            "probability": 0.005972462025381129,
            "start_logit": -5.735470771789551,
            "end_logit": -6.06037712097168
        }
    ],
    "56b1f4300a360a5e4500001b_017": [
        {
            "text": "The pentapeptide",
            "probability": 0.3248509556677532,
            "start_logit": -4.116377830505371,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide",
            "probability": 0.2125164836275427,
            "start_logit": -4.141547203063965,
            "end_logit": -4.082440376281738
        },
        {
            "text": "pentapeptide",
            "probability": 0.08765695075104878,
            "start_logit": -5.426313400268555,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide prediction",
            "probability": 0.06297342858730172,
            "start_logit": -4.141547203063965,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "'aggregation-prone' pentapeptide",
            "probability": 0.04334304454066098,
            "start_logit": -4.865227222442627,
            "end_logit": -4.948633670806885
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred, an 'aggregation-prone' peptide",
            "probability": 0.043167849197910724,
            "start_logit": -5.735470771789551,
            "end_logit": -4.082440376281738
        },
        {
            "text": "the (47)LQVVR(51) peptide",
            "probability": 0.03688125711764146,
            "start_logit": -5.445095062255859,
            "end_logit": -4.530208587646484
        },
        {
            "text": "The pentapeptide LQVVR",
            "probability": 0.029950183607983086,
            "start_logit": -4.116377830505371,
            "end_logit": -6.067093849182129
        },
        {
            "text": "'aggregation-prone' pentapeptide ((47)LQVVR(51))",
            "probability": 0.02892124990079964,
            "start_logit": -4.865227222442627,
            "end_logit": -5.353203296661377
        },
        {
            "text": "peptide",
            "probability": 0.027109484318717483,
            "start_logit": -5.752914905548096,
            "end_logit": -4.530208587646484
        },
        {
            "text": "(47)LQVVR(51) peptide",
            "probability": 0.017913422604546172,
            "start_logit": -6.167248249053955,
            "end_logit": -4.530208587646484
        },
        {
            "text": "Thus, the (47)LQVVR(51) peptide",
            "probability": 0.01636549041122765,
            "start_logit": -6.257623672485352,
            "end_logit": -4.530208587646484
        },
        {
            "text": "important",
            "probability": 0.013128945382400484,
            "start_logit": -4.549392223358154,
            "end_logit": -6.458795547485352
        },
        {
            "text": "LQVVR",
            "probability": 0.012113651820830733,
            "start_logit": -5.735470771789551,
            "end_logit": -5.353203296661377
        },
        {
            "text": "pentapeptide LQVVR",
            "probability": 0.00808168091767892,
            "start_logit": -5.426313400268555,
            "end_logit": -6.067093849182129
        },
        {
            "text": "peptide prediction",
            "probability": 0.008014580036948058,
            "start_logit": -6.20299768447876,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "The pentapeptide LQVVR plays a pivotal role in human cystatin C",
            "probability": 0.007881804495551422,
            "start_logit": -4.116377830505371,
            "end_logit": -7.402072429656982
        },
        {
            "text": "pentapeptide ((47)LQVVR(51))",
            "probability": 0.006674356467206225,
            "start_logit": -6.331531047821045,
            "end_logit": -5.353203296661377
        },
        {
            "text": "'aggregation-prone'",
            "probability": 0.006482718520869202,
            "start_logit": -4.141547203063965,
            "end_logit": -7.572319984436035
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred,",
            "probability": 0.005972462025381129,
            "start_logit": -5.735470771789551,
            "end_logit": -6.06037712097168
        }
    ],
    "56b1f4300a360a5e4500001b_018": [
        {
            "text": "The pentapeptide",
            "probability": 0.3248509556677532,
            "start_logit": -4.116377830505371,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide",
            "probability": 0.2125164836275427,
            "start_logit": -4.141547203063965,
            "end_logit": -4.082440376281738
        },
        {
            "text": "pentapeptide",
            "probability": 0.08765695075104878,
            "start_logit": -5.426313400268555,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide prediction",
            "probability": 0.06297342858730172,
            "start_logit": -4.141547203063965,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "'aggregation-prone' pentapeptide",
            "probability": 0.04334304454066098,
            "start_logit": -4.865227222442627,
            "end_logit": -4.948633670806885
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred, an 'aggregation-prone' peptide",
            "probability": 0.043167849197910724,
            "start_logit": -5.735470771789551,
            "end_logit": -4.082440376281738
        },
        {
            "text": "the (47)LQVVR(51) peptide",
            "probability": 0.03688125711764146,
            "start_logit": -5.445095062255859,
            "end_logit": -4.530208587646484
        },
        {
            "text": "The pentapeptide LQVVR",
            "probability": 0.029950183607983086,
            "start_logit": -4.116377830505371,
            "end_logit": -6.067093849182129
        },
        {
            "text": "'aggregation-prone' pentapeptide ((47)LQVVR(51))",
            "probability": 0.02892124990079964,
            "start_logit": -4.865227222442627,
            "end_logit": -5.353203296661377
        },
        {
            "text": "peptide",
            "probability": 0.027109484318717483,
            "start_logit": -5.752914905548096,
            "end_logit": -4.530208587646484
        },
        {
            "text": "(47)LQVVR(51) peptide",
            "probability": 0.017913422604546172,
            "start_logit": -6.167248249053955,
            "end_logit": -4.530208587646484
        },
        {
            "text": "Thus, the (47)LQVVR(51) peptide",
            "probability": 0.01636549041122765,
            "start_logit": -6.257623672485352,
            "end_logit": -4.530208587646484
        },
        {
            "text": "important",
            "probability": 0.013128945382400484,
            "start_logit": -4.549392223358154,
            "end_logit": -6.458795547485352
        },
        {
            "text": "LQVVR",
            "probability": 0.012113651820830733,
            "start_logit": -5.735470771789551,
            "end_logit": -5.353203296661377
        },
        {
            "text": "pentapeptide LQVVR",
            "probability": 0.00808168091767892,
            "start_logit": -5.426313400268555,
            "end_logit": -6.067093849182129
        },
        {
            "text": "peptide prediction",
            "probability": 0.008014580036948058,
            "start_logit": -6.20299768447876,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "The pentapeptide LQVVR plays a pivotal role in human cystatin C",
            "probability": 0.007881804495551422,
            "start_logit": -4.116377830505371,
            "end_logit": -7.402072429656982
        },
        {
            "text": "pentapeptide ((47)LQVVR(51))",
            "probability": 0.006674356467206225,
            "start_logit": -6.331531047821045,
            "end_logit": -5.353203296661377
        },
        {
            "text": "'aggregation-prone'",
            "probability": 0.006482718520869202,
            "start_logit": -4.141547203063965,
            "end_logit": -7.572319984436035
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred,",
            "probability": 0.005972462025381129,
            "start_logit": -5.735470771789551,
            "end_logit": -6.06037712097168
        }
    ],
    "56b1f4300a360a5e4500001b_019": [
        {
            "text": "The pentapeptide",
            "probability": 0.3248509556677532,
            "start_logit": -4.116377830505371,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide",
            "probability": 0.2125164836275427,
            "start_logit": -4.141547203063965,
            "end_logit": -4.082440376281738
        },
        {
            "text": "pentapeptide",
            "probability": 0.08765695075104878,
            "start_logit": -5.426313400268555,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide prediction",
            "probability": 0.06297342858730172,
            "start_logit": -4.141547203063965,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "'aggregation-prone' pentapeptide",
            "probability": 0.04334304454066098,
            "start_logit": -4.865227222442627,
            "end_logit": -4.948633670806885
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred, an 'aggregation-prone' peptide",
            "probability": 0.043167849197910724,
            "start_logit": -5.735470771789551,
            "end_logit": -4.082440376281738
        },
        {
            "text": "the (47)LQVVR(51) peptide",
            "probability": 0.03688125711764146,
            "start_logit": -5.445095062255859,
            "end_logit": -4.530208587646484
        },
        {
            "text": "The pentapeptide LQVVR",
            "probability": 0.029950183607983086,
            "start_logit": -4.116377830505371,
            "end_logit": -6.067093849182129
        },
        {
            "text": "'aggregation-prone' pentapeptide ((47)LQVVR(51))",
            "probability": 0.02892124990079964,
            "start_logit": -4.865227222442627,
            "end_logit": -5.353203296661377
        },
        {
            "text": "peptide",
            "probability": 0.027109484318717483,
            "start_logit": -5.752914905548096,
            "end_logit": -4.530208587646484
        },
        {
            "text": "(47)LQVVR(51) peptide",
            "probability": 0.017913422604546172,
            "start_logit": -6.167248249053955,
            "end_logit": -4.530208587646484
        },
        {
            "text": "Thus, the (47)LQVVR(51) peptide",
            "probability": 0.01636549041122765,
            "start_logit": -6.257623672485352,
            "end_logit": -4.530208587646484
        },
        {
            "text": "important",
            "probability": 0.013128945382400484,
            "start_logit": -4.549392223358154,
            "end_logit": -6.458795547485352
        },
        {
            "text": "LQVVR",
            "probability": 0.012113651820830733,
            "start_logit": -5.735470771789551,
            "end_logit": -5.353203296661377
        },
        {
            "text": "pentapeptide LQVVR",
            "probability": 0.00808168091767892,
            "start_logit": -5.426313400268555,
            "end_logit": -6.067093849182129
        },
        {
            "text": "peptide prediction",
            "probability": 0.008014580036948058,
            "start_logit": -6.20299768447876,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "The pentapeptide LQVVR plays a pivotal role in human cystatin C",
            "probability": 0.007881804495551422,
            "start_logit": -4.116377830505371,
            "end_logit": -7.402072429656982
        },
        {
            "text": "pentapeptide ((47)LQVVR(51))",
            "probability": 0.006674356467206225,
            "start_logit": -6.331531047821045,
            "end_logit": -5.353203296661377
        },
        {
            "text": "'aggregation-prone'",
            "probability": 0.006482718520869202,
            "start_logit": -4.141547203063965,
            "end_logit": -7.572319984436035
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred,",
            "probability": 0.005972462025381129,
            "start_logit": -5.735470771789551,
            "end_logit": -6.06037712097168
        }
    ],
    "56b1f4300a360a5e4500001b_020": [
        {
            "text": "The pentapeptide",
            "probability": 0.3248509556677532,
            "start_logit": -4.116377830505371,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide",
            "probability": 0.2125164836275427,
            "start_logit": -4.141547203063965,
            "end_logit": -4.082440376281738
        },
        {
            "text": "pentapeptide",
            "probability": 0.08765695075104878,
            "start_logit": -5.426313400268555,
            "end_logit": -3.683262825012207
        },
        {
            "text": "'aggregation-prone' peptide prediction",
            "probability": 0.06297342858730172,
            "start_logit": -4.141547203063965,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "'aggregation-prone' pentapeptide",
            "probability": 0.04334304454066098,
            "start_logit": -4.865227222442627,
            "end_logit": -4.948633670806885
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred, an 'aggregation-prone' peptide",
            "probability": 0.043167849197910724,
            "start_logit": -5.735470771789551,
            "end_logit": -4.082440376281738
        },
        {
            "text": "the (47)LQVVR(51) peptide",
            "probability": 0.03688125711764146,
            "start_logit": -5.445095062255859,
            "end_logit": -4.530208587646484
        },
        {
            "text": "The pentapeptide LQVVR",
            "probability": 0.029950183607983086,
            "start_logit": -4.116377830505371,
            "end_logit": -6.067093849182129
        },
        {
            "text": "'aggregation-prone' pentapeptide ((47)LQVVR(51))",
            "probability": 0.02892124990079964,
            "start_logit": -4.865227222442627,
            "end_logit": -5.353203296661377
        },
        {
            "text": "peptide",
            "probability": 0.027109484318717483,
            "start_logit": -5.752914905548096,
            "end_logit": -4.530208587646484
        },
        {
            "text": "(47)LQVVR(51) peptide",
            "probability": 0.017913422604546172,
            "start_logit": -6.167248249053955,
            "end_logit": -4.530208587646484
        },
        {
            "text": "Thus, the (47)LQVVR(51) peptide",
            "probability": 0.01636549041122765,
            "start_logit": -6.257623672485352,
            "end_logit": -4.530208587646484
        },
        {
            "text": "important",
            "probability": 0.013128945382400484,
            "start_logit": -4.549392223358154,
            "end_logit": -6.458795547485352
        },
        {
            "text": "LQVVR",
            "probability": 0.012113651820830733,
            "start_logit": -5.735470771789551,
            "end_logit": -5.353203296661377
        },
        {
            "text": "pentapeptide LQVVR",
            "probability": 0.00808168091767892,
            "start_logit": -5.426313400268555,
            "end_logit": -6.067093849182129
        },
        {
            "text": "peptide prediction",
            "probability": 0.008014580036948058,
            "start_logit": -6.20299768447876,
            "end_logit": -5.2987470626831055
        },
        {
            "text": "The pentapeptide LQVVR plays a pivotal role in human cystatin C",
            "probability": 0.007881804495551422,
            "start_logit": -4.116377830505371,
            "end_logit": -7.402072429656982
        },
        {
            "text": "pentapeptide ((47)LQVVR(51))",
            "probability": 0.006674356467206225,
            "start_logit": -6.331531047821045,
            "end_logit": -5.353203296661377
        },
        {
            "text": "'aggregation-prone'",
            "probability": 0.006482718520869202,
            "start_logit": -4.141547203063965,
            "end_logit": -7.572319984436035
        },
        {
            "text": "((47)LQVVR(51)) was located within the HCC sequence using AmylPred,",
            "probability": 0.005972462025381129,
            "start_logit": -5.735470771789551,
            "end_logit": -6.06037712097168
        }
    ],
    "5325fdf0600967d132000001_001": [
        {
            "text": "artificial urethral sphincter",
            "probability": 0.4628380935829398,
            "start_logit": 9.786532402038574,
            "end_logit": 8.633526802062988
        },
        {
            "text": "(AUS) implantation, and sub-urethral sling positioning. The artificial urethral sphincter",
            "probability": 0.32690529404972085,
            "start_logit": 9.438825607299805,
            "end_logit": 8.633526802062988
        },
        {
            "text": "AUS",
            "probability": 0.2055256049091895,
            "start_logit": 9.438825607299805,
            "end_logit": 8.169426918029785
        },
        {
            "text": "artificial urinary sphincter (AUS)",
            "probability": 0.003893863077140883,
            "start_logit": 5.472656726837158,
            "end_logit": 8.169426918029785
        },
        {
            "text": "art",
            "probability": 0.00012799779742028272,
            "start_logit": 9.786532402038574,
            "end_logit": 0.44040727615356445
        },
        {
            "text": "(AUS) implantation, and sub-urethral sling positioning. The artificial",
            "probability": 9.04056044295669e-05,
            "start_logit": 9.438825607299805,
            "end_logit": 0.44040727615356445
        },
        {
            "text": "(AUS) implantation, and sub-urethral sling positioning.",
            "probability": 8.61074816533422e-05,
            "start_logit": 9.438825607299805,
            "end_logit": 0.39169731736183167
        },
        {
            "text": "artificial urinary sphincter",
            "probability": 8.103388213713571e-05,
            "start_logit": 5.472656726837158,
            "end_logit": 4.297137260437012
        },
        {
            "text": "artificial",
            "probability": 7.57710586183931e-05,
            "start_logit": 9.786532402038574,
            "end_logit": -0.08388937264680862
        },
        {
            "text": "The artificial urethral sphincter",
            "probability": 6.464783877492549e-05,
            "start_logit": 0.910354495048523,
            "end_logit": 8.633526802062988
        },
        {
            "text": "sling positioning. The artificial urethral sphincter",
            "probability": 6.336033582880948e-05,
            "start_logit": 0.8902378678321838,
            "end_logit": 8.633526802062988
        },
        {
            "text": "urethral sphincter",
            "probability": 5.2525994788928386e-05,
            "start_logit": 0.7027080059051514,
            "end_logit": 8.633526802062988
        },
        {
            "text": "er",
            "probability": 4.818244865735766e-05,
            "start_logit": 0.6163946390151978,
            "end_logit": 8.633526802062988
        },
        {
            "text": "sub-urethral sling positioning. The artificial urethral sphincter",
            "probability": 4.772995106219818e-05,
            "start_logit": 0.6069589257240295,
            "end_logit": 8.633526802062988
        },
        {
            "text": "A",
            "probability": 4.2447226525651076e-05,
            "start_logit": 9.438825607299805,
            "end_logit": -0.31563740968704224
        },
        {
            "text": "sphincter (AUS)",
            "probability": 2.2887344034924704e-05,
            "start_logit": 0.3360837996006012,
            "end_logit": 8.169426918029785
        },
        {
            "text": "sphincter",
            "probability": 1.2607951551648192e-05,
            "start_logit": -0.7242724895477295,
            "end_logit": 8.633526802062988
        },
        {
            "text": "US",
            "probability": 8.423493133492946e-06,
            "start_logit": -0.6634756922721863,
            "end_logit": 8.169426918029785
        },
        {
            "text": "(AUS) implantation, and sub-urethral sling",
            "probability": 7.596964564999203e-06,
            "start_logit": 9.438825607299805,
            "end_logit": -2.0361502170562744
        },
        {
            "text": "(AUS) implantation,",
            "probability": 5.4190078274235815e-06,
            "start_logit": 9.438825607299805,
            "end_logit": -2.37398624420166
        }
    ],
    "5325fdf0600967d132000001_002": [
        {
            "text": "artificial urethral sphincter",
            "probability": 0.4628380935829398,
            "start_logit": 9.786532402038574,
            "end_logit": 8.633526802062988
        },
        {
            "text": "(AUS) implantation, and sub-urethral sling positioning. The artificial urethral sphincter",
            "probability": 0.32690529404972085,
            "start_logit": 9.438825607299805,
            "end_logit": 8.633526802062988
        },
        {
            "text": "AUS",
            "probability": 0.2055256049091895,
            "start_logit": 9.438825607299805,
            "end_logit": 8.169426918029785
        },
        {
            "text": "artificial urinary sphincter (AUS)",
            "probability": 0.003893863077140883,
            "start_logit": 5.472656726837158,
            "end_logit": 8.169426918029785
        },
        {
            "text": "art",
            "probability": 0.00012799779742028272,
            "start_logit": 9.786532402038574,
            "end_logit": 0.44040727615356445
        },
        {
            "text": "(AUS) implantation, and sub-urethral sling positioning. The artificial",
            "probability": 9.04056044295669e-05,
            "start_logit": 9.438825607299805,
            "end_logit": 0.44040727615356445
        },
        {
            "text": "(AUS) implantation, and sub-urethral sling positioning.",
            "probability": 8.61074816533422e-05,
            "start_logit": 9.438825607299805,
            "end_logit": 0.39169731736183167
        },
        {
            "text": "artificial urinary sphincter",
            "probability": 8.103388213713571e-05,
            "start_logit": 5.472656726837158,
            "end_logit": 4.297137260437012
        },
        {
            "text": "artificial",
            "probability": 7.57710586183931e-05,
            "start_logit": 9.786532402038574,
            "end_logit": -0.08388937264680862
        },
        {
            "text": "The artificial urethral sphincter",
            "probability": 6.464783877492549e-05,
            "start_logit": 0.910354495048523,
            "end_logit": 8.633526802062988
        },
        {
            "text": "sling positioning. The artificial urethral sphincter",
            "probability": 6.336033582880948e-05,
            "start_logit": 0.8902378678321838,
            "end_logit": 8.633526802062988
        },
        {
            "text": "urethral sphincter",
            "probability": 5.2525994788928386e-05,
            "start_logit": 0.7027080059051514,
            "end_logit": 8.633526802062988
        },
        {
            "text": "er",
            "probability": 4.818244865735766e-05,
            "start_logit": 0.6163946390151978,
            "end_logit": 8.633526802062988
        },
        {
            "text": "sub-urethral sling positioning. The artificial urethral sphincter",
            "probability": 4.772995106219818e-05,
            "start_logit": 0.6069589257240295,
            "end_logit": 8.633526802062988
        },
        {
            "text": "A",
            "probability": 4.2447226525651076e-05,
            "start_logit": 9.438825607299805,
            "end_logit": -0.31563740968704224
        },
        {
            "text": "sphincter (AUS)",
            "probability": 2.2887344034924704e-05,
            "start_logit": 0.3360837996006012,
            "end_logit": 8.169426918029785
        },
        {
            "text": "sphincter",
            "probability": 1.2607951551648192e-05,
            "start_logit": -0.7242724895477295,
            "end_logit": 8.633526802062988
        },
        {
            "text": "US",
            "probability": 8.423493133492946e-06,
            "start_logit": -0.6634756922721863,
            "end_logit": 8.169426918029785
        },
        {
            "text": "(AUS) implantation, and sub-urethral sling",
            "probability": 7.596964564999203e-06,
            "start_logit": 9.438825607299805,
            "end_logit": -2.0361502170562744
        },
        {
            "text": "(AUS) implantation,",
            "probability": 5.4190078274235815e-06,
            "start_logit": 9.438825607299805,
            "end_logit": -2.37398624420166
        }
    ],
    "5325fdf0600967d132000001_003": [
        {
            "text": "BAUS",
            "probability": 0.5052434217418338,
            "start_logit": 7.468509197235107,
            "end_logit": 6.682863235473633
        },
        {
            "text": "AUS",
            "probability": 0.4932388001952154,
            "start_logit": 7.491235733032227,
            "end_logit": 6.63608980178833
        },
        {
            "text": "AUS.",
            "probability": 0.0010692214117951054,
            "start_logit": 7.491235733032227,
            "end_logit": 0.5020270943641663
        },
        {
            "text": "A",
            "probability": 0.0001502659538640534,
            "start_logit": 7.491235733032227,
            "end_logit": -1.4602521657943726
        },
        {
            "text": "BA",
            "probability": 0.0001448603649587658,
            "start_logit": 7.468509197235107,
            "end_logit": -1.4741621017456055
        },
        {
            "text": "US",
            "probability": 5.663379421971292e-05,
            "start_logit": -1.5809071063995361,
            "end_logit": 6.63608980178833
        },
        {
            "text": "CONCLUSIONS: BAUS",
            "probability": 3.433694966765132e-05,
            "start_logit": -2.1280643939971924,
            "end_logit": 6.682863235473633
        },
        {
            "text": "BAUS implantation",
            "probability": 3.1864030389118554e-05,
            "start_logit": 7.468509197235107,
            "end_logit": -2.988454580307007
        },
        {
            "text": "compares favourably with AUS.",
            "probability": 8.767425455851043e-06,
            "start_logit": -3.446469783782959,
            "end_logit": 6.63608980178833
        },
        {
            "text": "favourably with AUS.",
            "probability": 7.482277947605786e-06,
            "start_logit": -3.604975700378418,
            "end_logit": 6.63608980178833
        },
        {
            "text": "It compares favourably with AUS.",
            "probability": 4.8575850707331775e-06,
            "start_logit": -4.036971569061279,
            "end_logit": 6.63608980178833
        },
        {
            "text": "BAUS implantation is a safe, effective, minimally invasive option for iatrogenic male incontinence due to ISD.",
            "probability": 3.02234389046984e-06,
            "start_logit": 7.468509197235107,
            "end_logit": -5.343899726867676
        },
        {
            "text": "with AUS.",
            "probability": 2.150060666333074e-06,
            "start_logit": -4.852016925811768,
            "end_logit": 6.63608980178833
        },
        {
            "text": "BAUS implantation is a safe, effective, minimally invasive option for iatrogenic male incontinence",
            "probability": 1.3010578656648237e-06,
            "start_logit": 7.468509197235107,
            "end_logit": -6.1867547035217285
        },
        {
            "text": "for iatrogenic male incontinence due to ISD. It compares favourably with AUS.",
            "probability": 1.291269095164358e-06,
            "start_logit": -5.361887454986572,
            "end_logit": 6.63608980178833
        },
        {
            "text": "incontinence due to ISD. It compares favourably with AUS.",
            "probability": 1.0057013251536935e-06,
            "start_logit": -5.611827850341797,
            "end_logit": 6.63608980178833
        },
        {
            "text": "BAUS implantation is a safe, effective,",
            "probability": 3.5712446708864095e-07,
            "start_logit": 7.468509197235107,
            "end_logit": -7.479603290557861
        },
        {
            "text": "BAUS implantation is a safe, effective, minimally invasive option for iatrogenic",
            "probability": 3.534128308798981e-07,
            "start_logit": 7.468509197235107,
            "end_logit": -7.490050792694092
        },
        {
            "text": ".",
            "probability": 5.133923722666027e-09,
            "start_logit": -4.755335330963135,
            "end_logit": 0.5020270943641663
        },
        {
            "text": "CONCLUSIONS: BAUS implantation",
            "probability": 2.1655177694500287e-09,
            "start_logit": -2.1280643939971924,
            "end_logit": -2.988454580307007
        }
    ],
    "5325fdf0600967d132000001_004": [
        {
            "text": "BAUS",
            "probability": 0.5052434217418338,
            "start_logit": 7.468509197235107,
            "end_logit": 6.682863235473633
        },
        {
            "text": "AUS",
            "probability": 0.4932388001952154,
            "start_logit": 7.491235733032227,
            "end_logit": 6.63608980178833
        },
        {
            "text": "AUS.",
            "probability": 0.0010692214117951054,
            "start_logit": 7.491235733032227,
            "end_logit": 0.5020270943641663
        },
        {
            "text": "A",
            "probability": 0.0001502659538640534,
            "start_logit": 7.491235733032227,
            "end_logit": -1.4602521657943726
        },
        {
            "text": "BA",
            "probability": 0.0001448603649587658,
            "start_logit": 7.468509197235107,
            "end_logit": -1.4741621017456055
        },
        {
            "text": "US",
            "probability": 5.663379421971292e-05,
            "start_logit": -1.5809071063995361,
            "end_logit": 6.63608980178833
        },
        {
            "text": "CONCLUSIONS: BAUS",
            "probability": 3.433694966765132e-05,
            "start_logit": -2.1280643939971924,
            "end_logit": 6.682863235473633
        },
        {
            "text": "BAUS implantation",
            "probability": 3.1864030389118554e-05,
            "start_logit": 7.468509197235107,
            "end_logit": -2.988454580307007
        },
        {
            "text": "compares favourably with AUS.",
            "probability": 8.767425455851043e-06,
            "start_logit": -3.446469783782959,
            "end_logit": 6.63608980178833
        },
        {
            "text": "favourably with AUS.",
            "probability": 7.482277947605786e-06,
            "start_logit": -3.604975700378418,
            "end_logit": 6.63608980178833
        },
        {
            "text": "It compares favourably with AUS.",
            "probability": 4.8575850707331775e-06,
            "start_logit": -4.036971569061279,
            "end_logit": 6.63608980178833
        },
        {
            "text": "BAUS implantation is a safe, effective, minimally invasive option for iatrogenic male incontinence due to ISD.",
            "probability": 3.02234389046984e-06,
            "start_logit": 7.468509197235107,
            "end_logit": -5.343899726867676
        },
        {
            "text": "with AUS.",
            "probability": 2.150060666333074e-06,
            "start_logit": -4.852016925811768,
            "end_logit": 6.63608980178833
        },
        {
            "text": "BAUS implantation is a safe, effective, minimally invasive option for iatrogenic male incontinence",
            "probability": 1.3010578656648237e-06,
            "start_logit": 7.468509197235107,
            "end_logit": -6.1867547035217285
        },
        {
            "text": "for iatrogenic male incontinence due to ISD. It compares favourably with AUS.",
            "probability": 1.291269095164358e-06,
            "start_logit": -5.361887454986572,
            "end_logit": 6.63608980178833
        },
        {
            "text": "incontinence due to ISD. It compares favourably with AUS.",
            "probability": 1.0057013251536935e-06,
            "start_logit": -5.611827850341797,
            "end_logit": 6.63608980178833
        },
        {
            "text": "BAUS implantation is a safe, effective,",
            "probability": 3.5712446708864095e-07,
            "start_logit": 7.468509197235107,
            "end_logit": -7.479603290557861
        },
        {
            "text": "BAUS implantation is a safe, effective, minimally invasive option for iatrogenic",
            "probability": 3.534128308798981e-07,
            "start_logit": 7.468509197235107,
            "end_logit": -7.490050792694092
        },
        {
            "text": ".",
            "probability": 5.133923722666027e-09,
            "start_logit": -4.755335330963135,
            "end_logit": 0.5020270943641663
        },
        {
            "text": "CONCLUSIONS: BAUS implantation",
            "probability": 2.1655177694500287e-09,
            "start_logit": -2.1280643939971924,
            "end_logit": -2.988454580307007
        }
    ],
    "530f900ee3eabad021000003_001": [
        {
            "text": "thyroid",
            "probability": 0.994458693213461,
            "start_logit": 5.0506911277771,
            "end_logit": 4.2926506996154785
        },
        {
            "text": "thyroid hormone",
            "probability": 0.004179527748460451,
            "start_logit": 4.403996467590332,
            "end_logit": -0.5326549410820007
        },
        {
            "text": "thy",
            "probability": 0.0005597218347227407,
            "start_logit": 5.0506911277771,
            "end_logit": -3.1898632049560547
        },
        {
            "text": "roid",
            "probability": 0.00045295894217003133,
            "start_logit": -2.643461227416992,
            "end_logit": 4.2926506996154785
        },
        {
            "text": "thyroid profile, even in cases with normal brain myelination.",
            "probability": 0.00029153417046003967,
            "start_logit": 5.0506911277771,
            "end_logit": -3.8421459197998047
        },
        {
            "text": "and thyroid",
            "probability": 3.058102719269362e-05,
            "start_logit": -5.338882923126221,
            "end_logit": 4.2926506996154785
        },
        {
            "text": "thyroid profile,",
            "probability": 6.814311929400872e-06,
            "start_logit": 5.0506911277771,
            "end_logit": -7.598278045654297
        },
        {
            "text": "thyroid hormone profile.",
            "probability": 4.5242379617867934e-06,
            "start_logit": 4.403996467590332,
            "end_logit": -7.361159324645996
        },
        {
            "text": "males with the typical neurological and thyroid",
            "probability": 3.504676046626921e-06,
            "start_logit": -7.505164623260498,
            "end_logit": 4.2926506996154785
        },
        {
            "text": "Allan-Herndon-Dudley syndrome should be suspected in males with the typical neurological and thyroid",
            "probability": 2.7781054383777595e-06,
            "start_logit": -7.737493515014648,
            "end_logit": 4.2926506996154785
        },
        {
            "text": "hormone",
            "probability": 2.6168355229968934e-06,
            "start_logit": -2.9719913005828857,
            "end_logit": -0.5326549410820007
        },
        {
            "text": "neurological and thyroid",
            "probability": 2.4826444952125162e-06,
            "start_logit": -7.84993839263916,
            "end_logit": 4.2926506996154785
        },
        {
            "text": "typical thyroid",
            "probability": 2.1829365963660115e-06,
            "start_logit": -7.188573837280273,
            "end_logit": 3.5026328563690186
        },
        {
            "text": "the typical neurological and thyroid",
            "probability": 1.9313292990482408e-06,
            "start_logit": -8.101054191589355,
            "end_logit": 4.2926506996154785
        },
        {
            "text": "one",
            "probability": 6.362423871349154e-08,
            "start_logit": -6.688717842102051,
            "end_logit": -0.5326549410820007
        },
        {
            "text": "typical thyroid hormone",
            "probability": 3.85956090342416e-08,
            "start_logit": -7.188573837280273,
            "end_logit": -0.5326549410820007
        },
        {
            "text": "ormone",
            "probability": 3.2941215595295645e-08,
            "start_logit": -7.346987724304199,
            "end_logit": -0.5326549410820007
        },
        {
            "text": "and thyroid profile, even in cases with normal brain myelination.",
            "probability": 8.965092723589026e-09,
            "start_logit": -5.338882923126221,
            "end_logit": -3.8421459197998047
        },
        {
            "text": "hormone profile.",
            "probability": 2.832661325733694e-09,
            "start_logit": -2.9719913005828857,
            "end_logit": -7.361159324645996
        },
        {
            "text": "males with the typical neurological and thyroid profile, even in cases with normal brain myelination.",
            "probability": 1.0274261072452965e-09,
            "start_logit": -7.505164623260498,
            "end_logit": -3.8421459197998047
        }
    ],
    "530f900ee3eabad021000003_002": [
        {
            "text": "thyroid",
            "probability": 0.994458693213461,
            "start_logit": 5.0506911277771,
            "end_logit": 4.2926506996154785
        },
        {
            "text": "thyroid hormone",
            "probability": 0.004179527748460451,
            "start_logit": 4.403996467590332,
            "end_logit": -0.5326549410820007
        },
        {
            "text": "thy",
            "probability": 0.0005597218347227407,
            "start_logit": 5.0506911277771,
            "end_logit": -3.1898632049560547
        },
        {
            "text": "roid",
            "probability": 0.00045295894217003133,
            "start_logit": -2.643461227416992,
            "end_logit": 4.2926506996154785
        },
        {
            "text": "thyroid profile, even in cases with normal brain myelination.",
            "probability": 0.00029153417046003967,
            "start_logit": 5.0506911277771,
            "end_logit": -3.8421459197998047
        },
        {
            "text": "and thyroid",
            "probability": 3.058102719269362e-05,
            "start_logit": -5.338882923126221,
            "end_logit": 4.2926506996154785
        },
        {
            "text": "thyroid profile,",
            "probability": 6.814311929400872e-06,
            "start_logit": 5.0506911277771,
            "end_logit": -7.598278045654297
        },
        {
            "text": "thyroid hormone profile.",
            "probability": 4.5242379617867934e-06,
            "start_logit": 4.403996467590332,
            "end_logit": -7.361159324645996
        },
        {
            "text": "males with the typical neurological and thyroid",
            "probability": 3.504676046626921e-06,
            "start_logit": -7.505164623260498,
            "end_logit": 4.2926506996154785
        },
        {
            "text": "Allan-Herndon-Dudley syndrome should be suspected in males with the typical neurological and thyroid",
            "probability": 2.7781054383777595e-06,
            "start_logit": -7.737493515014648,
            "end_logit": 4.2926506996154785
        },
        {
            "text": "hormone",
            "probability": 2.6168355229968934e-06,
            "start_logit": -2.9719913005828857,
            "end_logit": -0.5326549410820007
        },
        {
            "text": "neurological and thyroid",
            "probability": 2.4826444952125162e-06,
            "start_logit": -7.84993839263916,
            "end_logit": 4.2926506996154785
        },
        {
            "text": "typical thyroid",
            "probability": 2.1829365963660115e-06,
            "start_logit": -7.188573837280273,
            "end_logit": 3.5026328563690186
        },
        {
            "text": "the typical neurological and thyroid",
            "probability": 1.9313292990482408e-06,
            "start_logit": -8.101054191589355,
            "end_logit": 4.2926506996154785
        },
        {
            "text": "one",
            "probability": 6.362423871349154e-08,
            "start_logit": -6.688717842102051,
            "end_logit": -0.5326549410820007
        },
        {
            "text": "typical thyroid hormone",
            "probability": 3.85956090342416e-08,
            "start_logit": -7.188573837280273,
            "end_logit": -0.5326549410820007
        },
        {
            "text": "ormone",
            "probability": 3.2941215595295645e-08,
            "start_logit": -7.346987724304199,
            "end_logit": -0.5326549410820007
        },
        {
            "text": "and thyroid profile, even in cases with normal brain myelination.",
            "probability": 8.965092723589026e-09,
            "start_logit": -5.338882923126221,
            "end_logit": -3.8421459197998047
        },
        {
            "text": "hormone profile.",
            "probability": 2.832661325733694e-09,
            "start_logit": -2.9719913005828857,
            "end_logit": -7.361159324645996
        },
        {
            "text": "males with the typical neurological and thyroid profile, even in cases with normal brain myelination.",
            "probability": 1.0274261072452965e-09,
            "start_logit": -7.505164623260498,
            "end_logit": -3.8421459197998047
        }
    ],
    "530f900ee3eabad021000003_003": [
        {
            "text": "thyroid",
            "probability": 0.9998199838125496,
            "start_logit": 8.406036376953125,
            "end_logit": 7.67531156539917
        },
        {
            "text": "thy",
            "probability": 8.103389789070251e-05,
            "start_logit": 8.406036376953125,
            "end_logit": -1.745151400566101
        },
        {
            "text": "roid",
            "probability": 7.420884554867375e-05,
            "start_logit": -1.1024107933044434,
            "end_logit": 7.67531156539917
        },
        {
            "text": "altered thyroid",
            "probability": 1.940170405501132e-05,
            "start_logit": -2.4439332485198975,
            "end_logit": 7.67531156539917
        },
        {
            "text": "thyroid hormone",
            "probability": 2.036530173511304e-06,
            "start_logit": 8.406036376953125,
            "end_logit": -5.428771495819092
        },
        {
            "text": "thyroid hormone levels, in particular, high",
            "probability": 1.2386548525570131e-06,
            "start_logit": 8.406036376953125,
            "end_logit": -5.925992965698242
        },
        {
            "text": "thyroid hormone levels,",
            "probability": 1.1748987185804774e-06,
            "start_logit": 8.406036376953125,
            "end_logit": -5.978837013244629
        },
        {
            "text": "thyroid hormone levels, in particular, high serum T3 levels.",
            "probability": 5.468071310559108e-07,
            "start_logit": 8.406036376953125,
            "end_logit": -6.743678092956543
        },
        {
            "text": "combination with altered thyroid",
            "probability": 3.7441467570346255e-07,
            "start_logit": -6.391685485839844,
            "end_logit": 7.67531156539917
        },
        {
            "text": "altered",
            "probability": 1.7723169293527984e-10,
            "start_logit": -2.4439332485198975,
            "end_logit": -3.9281020164489746
        },
        {
            "text": "characterized by congenital hypotonia that progresses to spasticity with severe psychomotor delays, in combination with altered",
            "probability": 9.068647326118724e-11,
            "start_logit": -3.113982915878296,
            "end_logit": -3.9281020164489746
        },
        {
            "text": "altered thyroid hormone",
            "probability": 3.9519269833853486e-11,
            "start_logit": -2.4439332485198975,
            "end_logit": -5.428771495819092
        },
        {
            "text": "high",
            "probability": 2.9995819602516507e-11,
            "start_logit": -2.222442150115967,
            "end_logit": -5.925992965698242
        },
        {
            "text": "altered thyroid hormone levels, in particular, high",
            "probability": 2.4036341806227064e-11,
            "start_logit": -2.4439332485198975,
            "end_logit": -5.925992965698242
        },
        {
            "text": "altered thyroid hormone levels,",
            "probability": 2.2799141447030885e-11,
            "start_logit": -2.4439332485198975,
            "end_logit": -5.978837013244629
        },
        {
            "text": "tered",
            "probability": 1.4214476833068994e-11,
            "start_logit": -4.967130184173584,
            "end_logit": -3.9281020164489746
        },
        {
            "text": "high serum T3 levels.",
            "probability": 1.3241725914740037e-11,
            "start_logit": -2.222442150115967,
            "end_logit": -6.743678092956543
        },
        {
            "text": "altered thyroid hormone levels, in particular, high serum T3 levels.",
            "probability": 1.0610900265727824e-11,
            "start_logit": -2.4439332485198975,
            "end_logit": -6.743678092956543
        },
        {
            "text": "hormone",
            "probability": 7.504417076985493e-12,
            "start_logit": -4.10522985458374,
            "end_logit": -5.428771495819092
        },
        {
            "text": "hormone levels, in particular, high",
            "probability": 4.564323548417194e-12,
            "start_logit": -4.10522985458374,
            "end_logit": -5.925992965698242
        }
    ],
    "530f900ee3eabad021000003_004": [
        {
            "text": "thyroid",
            "probability": 0.9989050454280197,
            "start_logit": 5.440335273742676,
            "end_logit": 4.779662132263184
        },
        {
            "text": "thy",
            "probability": 0.0004789215041233486,
            "start_logit": 5.440335273742676,
            "end_logit": -2.8632161617279053
        },
        {
            "text": "roid",
            "probability": 0.0003302256937517415,
            "start_logit": -2.574303388595581,
            "end_logit": 4.779662132263184
        },
        {
            "text": "thyroid hormone",
            "probability": 0.00024219074428526096,
            "start_logit": 5.440335273742676,
            "end_logit": -3.545027256011963
        },
        {
            "text": "normal thyroid",
            "probability": 3.0030502013448243e-05,
            "start_logit": -4.941127300262451,
            "end_logit": 4.748923301696777
        },
        {
            "text": "presented normal thyroid",
            "probability": 3.2294237058338373e-06,
            "start_logit": -7.171037197113037,
            "end_logit": 4.748923301696777
        },
        {
            "text": "thyroid hormone profiles.",
            "probability": 3.0046901539264164e-06,
            "start_logit": 5.440335273742676,
            "end_logit": -7.9345784187316895
        },
        {
            "text": "thyroid hormone levels.",
            "probability": 2.7184270734699253e-06,
            "start_logit": 5.42689323425293,
            "end_logit": -8.021257400512695
        },
        {
            "text": "even when they have normal thyroid",
            "probability": 1.7884057898078982e-06,
            "start_logit": -7.792755126953125,
            "end_logit": 4.779662132263184
        },
        {
            "text": "One of them presented normal thyroid",
            "probability": 1.4373376057246188e-06,
            "start_logit": -7.98054838180542,
            "end_logit": 4.748923301696777
        },
        {
            "text": "have normal thyroid",
            "probability": 1.3679398928523188e-06,
            "start_logit": -8.060773849487305,
            "end_logit": 4.779662132263184
        },
        {
            "text": "thyroid hormone levels. Mutation was also detected, although in the heterozygous state, in three females showing thyroid",
            "probability": 2.0977841960949823e-08,
            "start_logit": -2.7828209400177,
            "end_logit": -4.675885200500488
        },
        {
            "text": "hormone",
            "probability": 6.930038243711085e-09,
            "start_logit": -5.021280288696289,
            "end_logit": -3.545027256011963
        },
        {
            "text": "normal thyroid hormone",
            "probability": 6.5446487683103465e-09,
            "start_logit": -5.078497886657715,
            "end_logit": -3.545027256011963
        },
        {
            "text": "hormone levels. Mutation was also detected, although in the heterozygous state, in three females showing thyroid",
            "probability": 1.7328772189295085e-09,
            "start_logit": -5.2765045166015625,
            "end_logit": -4.675885200500488
        },
        {
            "text": "characterized by",
            "probability": 1.4114351792238048e-09,
            "start_logit": -3.690739870071411,
            "end_logit": -6.46682596206665
        },
        {
            "text": "altered",
            "probability": 6.263347503086279e-10,
            "start_logit": -5.058836460113525,
            "end_logit": -5.9112067222595215
        },
        {
            "text": "altered TH",
            "probability": 6.058574060169073e-10,
            "start_logit": -5.058836460113525,
            "end_logit": -5.944447040557861
        },
        {
            "text": "levels. Mutation was also detected, although in the heterozygous state, in three females showing thyroid",
            "probability": 5.376382732058608e-10,
            "start_logit": -6.44685697555542,
            "end_logit": -4.675885200500488
        },
        {
            "text": "TH",
            "probability": 5.369135030142048e-10,
            "start_logit": -5.1796441078186035,
            "end_logit": -5.944447040557861
        }
    ],
    "530f900ee3eabad021000003_005": [
        {
            "text": "thyroid",
            "probability": 0.9989050454280197,
            "start_logit": 5.440335273742676,
            "end_logit": 4.779662132263184
        },
        {
            "text": "thy",
            "probability": 0.0004789215041233486,
            "start_logit": 5.440335273742676,
            "end_logit": -2.8632161617279053
        },
        {
            "text": "roid",
            "probability": 0.0003302256937517415,
            "start_logit": -2.574303388595581,
            "end_logit": 4.779662132263184
        },
        {
            "text": "thyroid hormone",
            "probability": 0.00024219074428526096,
            "start_logit": 5.440335273742676,
            "end_logit": -3.545027256011963
        },
        {
            "text": "normal thyroid",
            "probability": 3.0030502013448243e-05,
            "start_logit": -4.941127300262451,
            "end_logit": 4.748923301696777
        },
        {
            "text": "presented normal thyroid",
            "probability": 3.2294237058338373e-06,
            "start_logit": -7.171037197113037,
            "end_logit": 4.748923301696777
        },
        {
            "text": "thyroid hormone profiles.",
            "probability": 3.0046901539264164e-06,
            "start_logit": 5.440335273742676,
            "end_logit": -7.9345784187316895
        },
        {
            "text": "thyroid hormone levels.",
            "probability": 2.7184270734699253e-06,
            "start_logit": 5.42689323425293,
            "end_logit": -8.021257400512695
        },
        {
            "text": "even when they have normal thyroid",
            "probability": 1.7884057898078982e-06,
            "start_logit": -7.792755126953125,
            "end_logit": 4.779662132263184
        },
        {
            "text": "One of them presented normal thyroid",
            "probability": 1.4373376057246188e-06,
            "start_logit": -7.98054838180542,
            "end_logit": 4.748923301696777
        },
        {
            "text": "have normal thyroid",
            "probability": 1.3679398928523188e-06,
            "start_logit": -8.060773849487305,
            "end_logit": 4.779662132263184
        },
        {
            "text": "thyroid hormone levels. Mutation was also detected, although in the heterozygous state, in three females showing thyroid",
            "probability": 2.0977841960949823e-08,
            "start_logit": -2.7828209400177,
            "end_logit": -4.675885200500488
        },
        {
            "text": "hormone",
            "probability": 6.930038243711085e-09,
            "start_logit": -5.021280288696289,
            "end_logit": -3.545027256011963
        },
        {
            "text": "normal thyroid hormone",
            "probability": 6.5446487683103465e-09,
            "start_logit": -5.078497886657715,
            "end_logit": -3.545027256011963
        },
        {
            "text": "hormone levels. Mutation was also detected, although in the heterozygous state, in three females showing thyroid",
            "probability": 1.7328772189295085e-09,
            "start_logit": -5.2765045166015625,
            "end_logit": -4.675885200500488
        },
        {
            "text": "characterized by",
            "probability": 1.4114351792238048e-09,
            "start_logit": -3.690739870071411,
            "end_logit": -6.46682596206665
        },
        {
            "text": "altered",
            "probability": 6.263347503086279e-10,
            "start_logit": -5.058836460113525,
            "end_logit": -5.9112067222595215
        },
        {
            "text": "altered TH",
            "probability": 6.058574060169073e-10,
            "start_logit": -5.058836460113525,
            "end_logit": -5.944447040557861
        },
        {
            "text": "levels. Mutation was also detected, although in the heterozygous state, in three females showing thyroid",
            "probability": 5.376382732058608e-10,
            "start_logit": -6.44685697555542,
            "end_logit": -4.675885200500488
        },
        {
            "text": "TH",
            "probability": 5.369135030142048e-10,
            "start_logit": -5.1796441078186035,
            "end_logit": -5.944447040557861
        }
    ],
    "530f900ee3eabad021000003_006": [
        {
            "text": "thyroid",
            "probability": 0.9996788058506291,
            "start_logit": 8.508150100708008,
            "end_logit": 7.779527187347412
        },
        {
            "text": "thy",
            "probability": 0.00012627785970575211,
            "start_logit": 8.508150100708008,
            "end_logit": -1.1971774101257324
        },
        {
            "text": "roid",
            "probability": 9.08226116913597e-05,
            "start_logit": -0.7981309294700623,
            "end_logit": 7.779527187347412
        },
        {
            "text": "thyroid hormone",
            "probability": 3.6433363067845294e-05,
            "start_logit": 8.508150100708008,
            "end_logit": -2.4401772022247314
        },
        {
            "text": "abnormal thyroid",
            "probability": 3.487628190453663e-05,
            "start_logit": -1.7552322149276733,
            "end_logit": 7.779527187347412
        },
        {
            "text": "characterized by neurological impairment and abnormal thyroid",
            "probability": 2.6921187768380368e-05,
            "start_logit": -2.0141255855560303,
            "end_logit": 7.779527187347412
        },
        {
            "text": "thyroid hormone (TH) levels.",
            "probability": 2.1797611062227223e-06,
            "start_logit": 8.508150100708008,
            "end_logit": -5.256446838378906
        },
        {
            "text": "and abnormal thyroid",
            "probability": 1.1985994197198554e-06,
            "start_logit": -5.125885486602783,
            "end_logit": 7.779527187347412
        },
        {
            "text": "thyroid hormone (TH)",
            "probability": 9.462627894326281e-07,
            "start_logit": 8.508150100708008,
            "end_logit": -6.090897083282471
        },
        {
            "text": "thyroid hormone (TH) levels. Mutations",
            "probability": 5.516778628395427e-07,
            "start_logit": 8.508150100708008,
            "end_logit": -6.630453109741211
        },
        {
            "text": "(AHDS) is a severe psychomotor retardation characterized by neurological impairment and abnormal thyroid",
            "probability": 4.385323059201908e-07,
            "start_logit": -6.13136100769043,
            "end_logit": 7.779527187347412
        },
        {
            "text": "by neurological impairment and abnormal thyroid",
            "probability": 3.5664190249424686e-07,
            "start_logit": -6.338062286376953,
            "end_logit": 7.779527187347412
        },
        {
            "text": "is a severe psychomotor retardation characterized by neurological impairment and abnormal thyroid",
            "probability": 1.8573567446130394e-07,
            "start_logit": -6.990469932556152,
            "end_logit": 7.779527187347412
        },
        {
            "text": "abnormal thyroid hormone",
            "probability": 1.271068500850429e-09,
            "start_logit": -1.7552322149276733,
            "end_logit": -2.4401772022247314
        },
        {
            "text": "hormone",
            "probability": 1.1115082439424597e-09,
            "start_logit": -1.8893722295761108,
            "end_logit": -2.4401772022247314
        },
        {
            "text": "abnormal",
            "probability": 1.0775832836929514e-09,
            "start_logit": -1.7552322149276733,
            "end_logit": -2.605314254760742
        },
        {
            "text": "characterized by neurological impairment and abnormal thyroid hormone",
            "probability": 9.81144546070923e-10,
            "start_logit": -2.0141255855560303,
            "end_logit": -2.4401772022247314
        },
        {
            "text": "characterized by neurological impairment and abnormal",
            "probability": 8.317922763605231e-10,
            "start_logit": -2.0141255855560303,
            "end_logit": -2.605314254760742
        },
        {
            "text": "characterized by",
            "probability": 2.850290844318233e-10,
            "start_logit": -2.0141255855560303,
            "end_logit": -3.6763057708740234
        },
        {
            "text": "abnormal thyroid hormone (TH) levels.",
            "probability": 7.604638848022891e-11,
            "start_logit": -1.7552322149276733,
            "end_logit": -5.256446838378906
        }
    ],
    "530f900ee3eabad021000003_007": [
        {
            "text": "thyroid",
            "probability": 0.9996978437528127,
            "start_logit": 8.660140991210938,
            "end_logit": 7.8453850746154785
        },
        {
            "text": "thy",
            "probability": 9.246769346329233e-05,
            "start_logit": 8.660140991210938,
            "end_logit": -1.44296395778656
        },
        {
            "text": "roid",
            "probability": 8.085507810850226e-05,
            "start_logit": -0.762408971786499,
            "end_logit": 7.8453850746154785
        },
        {
            "text": "thyroid hormone",
            "probability": 6.867224560157904e-05,
            "start_logit": 8.660140991210938,
            "end_logit": -1.7404781579971313
        },
        {
            "text": "disturbed thyroid",
            "probability": 5.092642450462321e-05,
            "start_logit": -1.2246854305267334,
            "end_logit": 7.8453850746154785
        },
        {
            "text": "to disturbed thyroid",
            "probability": 1.8842359959051078e-06,
            "start_logit": -4.521544933319092,
            "end_logit": 7.8453850746154785
        },
        {
            "text": "thyroid hormone levels, especially elevated",
            "probability": 1.833039556643249e-06,
            "start_logit": 8.660140991210938,
            "end_logit": -5.363847732543945
        },
        {
            "text": "thyroid hormone levels, especially",
            "probability": 1.6397541702667276e-06,
            "start_logit": 8.660140991210938,
            "end_logit": -5.475276947021484
        },
        {
            "text": "(Allan-Herndon-Dudley syndrome (AHDS)) that is attributed to disturbed thyroid",
            "probability": 1.3589360236244184e-06,
            "start_logit": -4.848365306854248,
            "end_logit": 7.8453850746154785
        },
        {
            "text": "attributed to disturbed thyroid",
            "probability": 7.549475307431843e-07,
            "start_logit": -5.436174392700195,
            "end_logit": 7.8453850746154785
        },
        {
            "text": "thyroid hormone levels, especially elevated T(3) levels.",
            "probability": 6.550849211677998e-07,
            "start_logit": 8.660140991210938,
            "end_logit": -6.392813682556152
        },
        {
            "text": "thyroid hormone levels,",
            "probability": 5.954925410306962e-07,
            "start_logit": 8.660140991210938,
            "end_logit": -6.488189697265625
        },
        {
            "text": "that is attributed to disturbed thyroid",
            "probability": 5.070994502077573e-07,
            "start_logit": -5.834115505218506,
            "end_logit": 7.8453850746154785
        },
        {
            "text": "disturbed thyroid hormone",
            "probability": 3.498288961055808e-09,
            "start_logit": -1.2246854305267334,
            "end_logit": -1.7404781579971313
        },
        {
            "text": "disturbed",
            "probability": 1.2882958269577559e-09,
            "start_logit": -1.2246854305267334,
            "end_logit": -2.739431858062744
        },
        {
            "text": "hormone",
            "probability": 1.0290412858307532e-09,
            "start_logit": -2.448331832885742,
            "end_logit": -1.7404781579971313
        },
        {
            "text": "to disturbed thyroid hormone",
            "probability": 1.294338263213518e-10,
            "start_logit": -4.521544933319092,
            "end_logit": -1.7404781579971313
        },
        {
            "text": "disturbed thyroid hormone levels, especially elevated",
            "probability": 9.337836545185384e-11,
            "start_logit": -1.2246854305267334,
            "end_logit": -5.363847732543945
        },
        {
            "text": "(Allan-Herndon-Dudley syndrome (AHDS)) that is attributed to disturbed thyroid hormone",
            "probability": 9.33493944738807e-11,
            "start_logit": -4.848365306854248,
            "end_logit": -1.7404781579971313
        },
        {
            "text": "disturbed thyroid hormone levels, especially",
            "probability": 8.353205669099917e-11,
            "start_logit": -1.2246854305267334,
            "end_logit": -5.475276947021484
        }
    ],
    "530f900ee3eabad021000003_008": [
        {
            "text": "thyroid",
            "probability": 0.9996297645795251,
            "start_logit": 8.773032188415527,
            "end_logit": 8.146198272705078
        },
        {
            "text": "thy",
            "probability": 0.0001145926650708192,
            "start_logit": 8.773032188415527,
            "end_logit": -0.927558183670044
        },
        {
            "text": "roid",
            "probability": 0.00011293119308443656,
            "start_logit": -0.31532934308052063,
            "end_logit": 8.146198272705078
        },
        {
            "text": "thyroid hormone",
            "probability": 0.00010211830744498536,
            "start_logit": 8.773032188415527,
            "end_logit": -1.0428099632263184
        },
        {
            "text": "abnormal thyroid",
            "probability": 3.923745775203439e-05,
            "start_logit": -1.3724762201309204,
            "end_logit": 8.146198272705078
        },
        {
            "text": "thyroid hormone constellations.",
            "probability": 7.676144350658345e-07,
            "start_logit": 8.773032188415527,
            "end_logit": -5.933409690856934
        },
        {
            "text": "associated with abnormal thyroid",
            "probability": 3.670187958179029e-07,
            "start_logit": -6.044450283050537,
            "end_logit": 8.146198272705078
        },
        {
            "text": "Allan-Herndon-Dudley syndrome, a severe mental retardation associated with abnormal thyroid",
            "probability": 1.0736601442611974e-07,
            "start_logit": -7.273619651794434,
            "end_logit": 8.146198272705078
        },
        {
            "text": "is mutated in Allan-Herndon-Dudley syndrome, a severe mental retardation associated with abnormal thyroid",
            "probability": 1.0544446740978144e-07,
            "start_logit": -7.2916789054870605,
            "end_logit": 8.146198272705078
        },
        {
            "text": "abnormal thyroid hormone",
            "probability": 4.008346806047017e-09,
            "start_logit": -1.3724762201309204,
            "end_logit": -1.0428099632263184
        },
        {
            "text": "hormone",
            "probability": 3.017270166233504e-09,
            "start_logit": -1.656502604484558,
            "end_logit": -1.0428099632263184
        },
        {
            "text": "abnormal",
            "probability": 1.1290801190263661e-09,
            "start_logit": -1.3724762201309204,
            "end_logit": -2.3097856044769287
        },
        {
            "text": "normal",
            "probability": 5.113181010938326e-11,
            "start_logit": -4.467227935791016,
            "end_logit": -2.3097856044769287
        },
        {
            "text": "associated with abnormal thyroid hormone",
            "probability": 3.749321954732497e-11,
            "start_logit": -6.044450283050537,
            "end_logit": -1.0428099632263184
        },
        {
            "text": "abnormal thyroid hormone constellations.",
            "probability": 3.013039430495199e-11,
            "start_logit": -1.3724762201309204,
            "end_logit": -5.933409690856934
        },
        {
            "text": "hormone constellations.",
            "probability": 2.2680557404871698e-11,
            "start_logit": -1.656502604484558,
            "end_logit": -5.933409690856934
        },
        {
            "text": "ormone",
            "probability": 2.0854113476732596e-11,
            "start_logit": -6.631059169769287,
            "end_logit": -1.0428099632263184
        },
        {
            "text": "one",
            "probability": 1.4893589523126242e-11,
            "start_logit": -6.967679500579834,
            "end_logit": -1.0428099632263184
        },
        {
            "text": "Allan-Herndon-Dudley syndrome, a severe mental retardation associated with abnormal thyroid hormone",
            "probability": 1.0968096448109505e-11,
            "start_logit": -7.273619651794434,
            "end_logit": -1.0428099632263184
        },
        {
            "text": "associated with abnormal",
            "probability": 1.056117417916827e-11,
            "start_logit": -6.044450283050537,
            "end_logit": -2.3097856044769287
        }
    ],
    "530f900ee3eabad021000003_009": [
        {
            "text": "thyroid",
            "probability": 0.9992634345205296,
            "start_logit": 8.851634979248047,
            "end_logit": 7.939284801483154
        },
        {
            "text": "thyroid hormone",
            "probability": 0.0005325741161655579,
            "start_logit": 8.851634979248047,
            "end_logit": 0.40223315358161926
        },
        {
            "text": "thy",
            "probability": 0.0001436507114842738,
            "start_logit": 8.851634979248047,
            "end_logit": -0.9081041812896729
        },
        {
            "text": "roid",
            "probability": 5.9906408939997396e-05,
            "start_logit": -0.8703552484512329,
            "end_logit": 7.939284801483154
        },
        {
            "text": "thyroid hormone (TH) transmembrane transport protein mutated",
            "probability": 2.651148339025165e-07,
            "start_logit": 8.851634979248047,
            "end_logit": -7.203081130981445
        },
        {
            "text": "thyroid hormone (TH) transmembrane transport protein mutated in Allan-Herndon-Dudley",
            "probability": 1.67488152508404e-07,
            "start_logit": 8.851634979248047,
            "end_logit": -7.662331581115723
        },
        {
            "text": "hormone",
            "probability": 1.4833696521926063e-09,
            "start_logit": -3.939526081085205,
            "end_logit": 0.40223315358161926
        },
        {
            "text": "one",
            "probability": 9.634407799354198e-11,
            "start_logit": -6.673671722412109,
            "end_logit": 0.40223315358161926
        },
        {
            "text": "ormone",
            "probability": 5.105625605964561e-11,
            "start_logit": -7.308669567108154,
            "end_logit": 0.40223315358161926
        },
        {
            "text": "thyroid hormone (TH) transmembrane transport protein mutated in Allan-Herndon-Dudley syndrome,",
            "probability": 6.658192988476143e-12,
            "start_logit": -0.8703552484512329,
            "end_logit": -8.073161125183105
        },
        {
            "text": "hormone (TH) transmembrane transport protein mutated",
            "probability": 7.384198499703753e-13,
            "start_logit": -3.939526081085205,
            "end_logit": -7.203081130981445
        },
        {
            "text": "horm",
            "probability": 5.010087955152899e-13,
            "start_logit": -3.939526081085205,
            "end_logit": -7.590970039367676
        },
        {
            "text": "hormone (TH) transmembrane transport protein mutated in Allan-Herndon-Dudley",
            "probability": 4.665019102346692e-13,
            "start_logit": -3.939526081085205,
            "end_logit": -7.662331581115723
        },
        {
            "text": "hormone (TH) transmembrane transport protein mutated in Allan-Herndon-Dudley syndrome,",
            "probability": 4.176909279654231e-13,
            "start_logit": -3.939526081085205,
            "end_logit": -7.772851943969727
        },
        {
            "text": "MCT8",
            "probability": 1.1024706070372417e-13,
            "start_logit": -6.14048433303833,
            "end_logit": -6.903911590576172
        },
        {
            "text": "endocrine phenotypes of patients deficient in MCT8",
            "probability": 6.089564902170736e-14,
            "start_logit": -6.734046459197998,
            "end_logit": -6.903911590576172
        },
        {
            "text": "psychomotor retardation. The neurological and endocrine phenotypes of patients deficient in MCT8",
            "probability": 5.852879859064036e-14,
            "start_logit": -6.773689270019531,
            "end_logit": -6.903911590576172
        },
        {
            "text": "X-linked psychomotor retardation. The neurological and endocrine phenotypes of patients deficient in MCT8",
            "probability": 3.879234859018383e-14,
            "start_logit": -7.184985160827637,
            "end_logit": -6.903911590576172
        },
        {
            "text": "Allan-Herndon-Dudley syndrome, a severe X-linked",
            "probability": 3.8365513622056e-14,
            "start_logit": -6.5051374435424805,
            "end_logit": -7.594823360443115
        },
        {
            "text": "Allan-Herndon-Dudley",
            "probability": 3.586101429533793e-14,
            "start_logit": -6.5051374435424805,
            "end_logit": -7.662331581115723
        }
    ],
    "530f900ee3eabad021000003_010": [
        {
            "text": "thyroid",
            "probability": 0.9997888826216736,
            "start_logit": 7.433268070220947,
            "end_logit": 6.555234909057617
        },
        {
            "text": "thy",
            "probability": 0.00012395345622062112,
            "start_logit": 7.433268070220947,
            "end_logit": -2.4401583671569824
        },
        {
            "text": "roid",
            "probability": 8.156535867306131e-05,
            "start_logit": -1.9806267023086548,
            "end_logit": 6.555234909057617
        },
        {
            "text": "associated with thyroid",
            "probability": 3.2498328247530973e-06,
            "start_logit": -5.203427791595459,
            "end_logit": 6.555234909057617
        },
        {
            "text": "(AHDS), an X-linked learning disability* syndrome associated with thyroid",
            "probability": 1.2390333686853924e-06,
            "start_logit": -6.167699813842773,
            "end_logit": 6.555234909057617
        },
        {
            "text": "with thyroid",
            "probability": 6.021202604923788e-07,
            "start_logit": -6.889329433441162,
            "end_logit": 6.555234909057617
        },
        {
            "text": "thyroid function test (TFT) abnormalities.",
            "probability": 4.953536783439431e-07,
            "start_logit": 7.433268070220947,
            "end_logit": -7.962547779083252
        },
        {
            "text": "thyroid function tests, with high serum tri-iodothyronine",
            "probability": 1.2189109985072202e-08,
            "start_logit": 4.2214250564575195,
            "end_logit": -8.45543384552002
        },
        {
            "text": "AIM: Mutations",
            "probability": 9.068397370698623e-12,
            "start_logit": -5.340322017669678,
            "end_logit": -6.097189426422119
        },
        {
            "text": "AIM: Mutations in the SLC16A2 gene have been implicated in Allan-Herndon-Dudley",
            "probability": 4.904405384751451e-12,
            "start_logit": -5.340322017669678,
            "end_logit": -6.711851119995117
        },
        {
            "text": "Allan-Herndon-Dudley",
            "probability": 3.390755774799855e-12,
            "start_logit": -5.709403038024902,
            "end_logit": -6.711851119995117
        },
        {
            "text": "associated with",
            "probability": 2.731676244522341e-12,
            "start_logit": -5.203427791595459,
            "end_logit": -7.433963775634766
        },
        {
            "text": "Allan-Herndon-Dudley syndrome (AHDS),",
            "probability": 2.6795843761745014e-12,
            "start_logit": -5.709403038024902,
            "end_logit": -6.947242259979248
        },
        {
            "text": "SLC16A2 gene have been implicated in Allan-Herndon-Dudley",
            "probability": 1.872846079605831e-12,
            "start_logit": -6.302996635437012,
            "end_logit": -6.711851119995117
        },
        {
            "text": "(AHDS),",
            "probability": 1.6944613846426086e-12,
            "start_logit": -6.167699813842773,
            "end_logit": -6.947242259979248
        },
        {
            "text": "Allan-Herndon-Dudley syndrome (AHDS), an X-linked learning disability* syndrome associated with",
            "probability": 1.6469748540069037e-12,
            "start_logit": -5.709403038024902,
            "end_logit": -7.433963775634766
        },
        {
            "text": "associated with thyroid function test (TFT) abnormalities.",
            "probability": 1.6101565757793075e-12,
            "start_logit": -5.203427791595459,
            "end_logit": -7.962547779083252
        },
        {
            "text": "AIM: Mutations in the SLC16A2 gene",
            "probability": 1.5701042628052403e-12,
            "start_logit": -5.340322017669678,
            "end_logit": -7.8508429527282715
        },
        {
            "text": "the SLC16A2 gene have been implicated in Allan-Herndon-Dudley",
            "probability": 1.5407793536115154e-12,
            "start_logit": -6.498167514801025,
            "end_logit": -6.711851119995117
        },
        {
            "text": "SLC16A2 gene have been implicated in Allan-Herndon-Dudley syndrome (AHDS),",
            "probability": 1.4800385009114007e-12,
            "start_logit": -6.302996635437012,
            "end_logit": -6.947242259979248
        }
    ],
    "530f900ee3eabad021000003_011": [
        {
            "text": "thyroid",
            "probability": 0.9997888826216736,
            "start_logit": 7.433268070220947,
            "end_logit": 6.555234909057617
        },
        {
            "text": "thy",
            "probability": 0.00012395345622062112,
            "start_logit": 7.433268070220947,
            "end_logit": -2.4401583671569824
        },
        {
            "text": "roid",
            "probability": 8.156535867306131e-05,
            "start_logit": -1.9806267023086548,
            "end_logit": 6.555234909057617
        },
        {
            "text": "associated with thyroid",
            "probability": 3.2498328247530973e-06,
            "start_logit": -5.203427791595459,
            "end_logit": 6.555234909057617
        },
        {
            "text": "(AHDS), an X-linked learning disability* syndrome associated with thyroid",
            "probability": 1.2390333686853924e-06,
            "start_logit": -6.167699813842773,
            "end_logit": 6.555234909057617
        },
        {
            "text": "with thyroid",
            "probability": 6.021202604923788e-07,
            "start_logit": -6.889329433441162,
            "end_logit": 6.555234909057617
        },
        {
            "text": "thyroid function test (TFT) abnormalities.",
            "probability": 4.953536783439431e-07,
            "start_logit": 7.433268070220947,
            "end_logit": -7.962547779083252
        },
        {
            "text": "thyroid function tests, with high serum tri-iodothyronine",
            "probability": 1.2189109985072202e-08,
            "start_logit": 4.2214250564575195,
            "end_logit": -8.45543384552002
        },
        {
            "text": "AIM: Mutations",
            "probability": 9.068397370698623e-12,
            "start_logit": -5.340322017669678,
            "end_logit": -6.097189426422119
        },
        {
            "text": "AIM: Mutations in the SLC16A2 gene have been implicated in Allan-Herndon-Dudley",
            "probability": 4.904405384751451e-12,
            "start_logit": -5.340322017669678,
            "end_logit": -6.711851119995117
        },
        {
            "text": "Allan-Herndon-Dudley",
            "probability": 3.390755774799855e-12,
            "start_logit": -5.709403038024902,
            "end_logit": -6.711851119995117
        },
        {
            "text": "associated with",
            "probability": 2.731676244522341e-12,
            "start_logit": -5.203427791595459,
            "end_logit": -7.433963775634766
        },
        {
            "text": "Allan-Herndon-Dudley syndrome (AHDS),",
            "probability": 2.6795843761745014e-12,
            "start_logit": -5.709403038024902,
            "end_logit": -6.947242259979248
        },
        {
            "text": "SLC16A2 gene have been implicated in Allan-Herndon-Dudley",
            "probability": 1.872846079605831e-12,
            "start_logit": -6.302996635437012,
            "end_logit": -6.711851119995117
        },
        {
            "text": "(AHDS),",
            "probability": 1.6944613846426086e-12,
            "start_logit": -6.167699813842773,
            "end_logit": -6.947242259979248
        },
        {
            "text": "Allan-Herndon-Dudley syndrome (AHDS), an X-linked learning disability* syndrome associated with",
            "probability": 1.6469748540069037e-12,
            "start_logit": -5.709403038024902,
            "end_logit": -7.433963775634766
        },
        {
            "text": "associated with thyroid function test (TFT) abnormalities.",
            "probability": 1.6101565757793075e-12,
            "start_logit": -5.203427791595459,
            "end_logit": -7.962547779083252
        },
        {
            "text": "AIM: Mutations in the SLC16A2 gene",
            "probability": 1.5701042628052403e-12,
            "start_logit": -5.340322017669678,
            "end_logit": -7.8508429527282715
        },
        {
            "text": "the SLC16A2 gene have been implicated in Allan-Herndon-Dudley",
            "probability": 1.5407793536115154e-12,
            "start_logit": -6.498167514801025,
            "end_logit": -6.711851119995117
        },
        {
            "text": "SLC16A2 gene have been implicated in Allan-Herndon-Dudley syndrome (AHDS),",
            "probability": 1.4800385009114007e-12,
            "start_logit": -6.302996635437012,
            "end_logit": -6.947242259979248
        }
    ],
    "530f900ee3eabad021000003_012": [
        {
            "text": "thyroid",
            "probability": 0.9997296110034715,
            "start_logit": 8.59192943572998,
            "end_logit": 7.960389137268066
        },
        {
            "text": "roid",
            "probability": 0.00016362897798213858,
            "start_logit": -0.1257091611623764,
            "end_logit": 7.960389137268066
        },
        {
            "text": "thy",
            "probability": 9.10013858850036e-05,
            "start_logit": 8.59192943572998,
            "end_logit": -1.3439762592315674
        },
        {
            "text": "thyroid hormone",
            "probability": 1.285379887058309e-05,
            "start_logit": 8.59192943572998,
            "end_logit": -3.3012115955352783
        },
        {
            "text": "thyroid hormone transporter and the finding that mutations",
            "probability": 1.249810191041213e-06,
            "start_logit": 8.59192943572998,
            "end_logit": -5.631859302520752
        },
        {
            "text": "With the discovery of monocarboxylate transporter 8 (MCT8) as a specific thyroid",
            "probability": 9.093043874244399e-07,
            "start_logit": -5.318386077880859,
            "end_logit": 7.960389137268066
        },
        {
            "text": "thyroid hormone transporter and the finding that mutations in this transporter lead to a syndrome",
            "probability": 7.439982945317484e-07,
            "start_logit": 8.59192943572998,
            "end_logit": -6.150567531585693
        },
        {
            "text": "thyroid hormone transporter and the finding that mutations in this transporter lead to a syndrome of severe psychomotor retardation",
            "probability": 1.1863646258134623e-09,
            "start_logit": -0.1257091611623764,
            "end_logit": -3.8740739822387695
        },
        {
            "text": "elevated serum 3,3',5-tri-iodothyronine",
            "probability": 1.9776927324764805e-10,
            "start_logit": -2.9830799102783203,
            "end_logit": -2.808251142501831
        },
        {
            "text": "and elevated serum 3,3',5-tri-iodothyronine",
            "probability": 7.185578314214999e-11,
            "start_logit": -3.9955198764801025,
            "end_logit": -2.808251142501831
        },
        {
            "text": "thyroid hormone depends not only on serum thyroid",
            "probability": 5.961497922105695e-11,
            "start_logit": -3.5889875888824463,
            "end_logit": -3.4015376567840576
        },
        {
            "text": "the Allan-Herndon-Dudley syndrome,",
            "probability": 5.128255038093445e-11,
            "start_logit": -3.5855915546417236,
            "end_logit": -3.555490016937256
        },
        {
            "text": "elevated",
            "probability": 4.4463842824740845e-11,
            "start_logit": -2.9830799102783203,
            "end_logit": -4.300675868988037
        },
        {
            "text": "known as the Allan-Herndon-Dudley syndrome,",
            "probability": 2.3529762324858765e-11,
            "start_logit": -4.364675998687744,
            "end_logit": -3.555490016937256
        },
        {
            "text": "Thyroid",
            "probability": 2.1512687748910423e-11,
            "start_logit": -2.811765432357788,
            "end_logit": -5.198023796081543
        },
        {
            "text": "and elevated",
            "probability": 1.6155109412170612e-11,
            "start_logit": -3.9955198764801025,
            "end_logit": -4.300675868988037
        },
        {
            "text": "hormone",
            "probability": 1.5265265385722145e-11,
            "start_logit": -5.051640510559082,
            "end_logit": -3.3012115955352783
        },
        {
            "text": "of severe psychomotor retardation and elevated serum 3,3',5-tri-iodothyronine",
            "probability": 1.2804233687766301e-11,
            "start_logit": -5.720405101776123,
            "end_logit": -2.808251142501831
        },
        {
            "text": "With the discovery of monocarboxylate transporter 8 (MCT8) as a specific thyroid hormone",
            "probability": 1.1691176873675626e-11,
            "start_logit": -5.318386077880859,
            "end_logit": -3.3012115955352783
        },
        {
            "text": "hormone transporter and the finding that mutations in this transporter lead to a syndrome of severe psychomotor retardation",
            "probability": 8.608220549727573e-12,
            "start_logit": -5.051640510559082,
            "end_logit": -3.8740739822387695
        }
    ],
    "530f900ee3eabad021000003_013": [
        {
            "text": "hypothyroidism",
            "probability": 0.999544748186516,
            "start_logit": 8.001152038574219,
            "end_logit": 6.919505596160889
        },
        {
            "text": "hyp",
            "probability": 0.0002358700989278553,
            "start_logit": 8.001152038574219,
            "end_logit": -1.4322683811187744
        },
        {
            "text": "ism",
            "probability": 0.00016148730507564076,
            "start_logit": -0.7294766306877136,
            "end_logit": 6.919505596160889
        },
        {
            "text": "othyroidism",
            "probability": 3.831832399389811e-05,
            "start_logit": -2.1679749488830566,
            "end_logit": 6.919505596160889
        },
        {
            "text": "hypothyroid",
            "probability": 5.7617707767524875e-06,
            "start_logit": 8.001152038574219,
            "end_logit": -5.1443047523498535
        },
        {
            "text": "for neuronal hypothyroidism",
            "probability": 3.466846647970932e-06,
            "start_logit": -4.570657730102539,
            "end_logit": 6.919505596160889
        },
        {
            "text": "roidism",
            "probability": 2.165616135877403e-06,
            "start_logit": -5.041198253631592,
            "end_logit": 6.919505596160889
        },
        {
            "text": "hypothyroidism despite",
            "probability": 1.8138422265051374e-06,
            "start_logit": 8.001152038574219,
            "end_logit": -6.300102233886719
        },
        {
            "text": "hypothyroidism despite elevated",
            "probability": 1.5618480300756593e-06,
            "start_logit": 8.001152038574219,
            "end_logit": -6.449679851531982
        },
        {
            "text": "hypothy",
            "probability": 1.0540483931741312e-06,
            "start_logit": 8.001152038574219,
            "end_logit": -6.842911243438721
        },
        {
            "text": "cause for neuronal hypothyroidism",
            "probability": 9.221470630022571e-07,
            "start_logit": -5.894953727722168,
            "end_logit": 6.919505596160889
        },
        {
            "text": "genetic cause for neuronal hypothyroidism",
            "probability": 6.766808402757305e-07,
            "start_logit": -6.204458713531494,
            "end_logit": 6.919505596160889
        },
        {
            "text": "hypothyroidism despite elevated serum T3 levels.",
            "probability": 6.269714565071056e-07,
            "start_logit": 8.001152038574219,
            "end_logit": -7.362403869628906
        },
        {
            "text": "the genetic cause for neuronal hypothyroidism",
            "probability": 5.443753340473492e-07,
            "start_logit": -6.4220194816589355,
            "end_logit": 6.919505596160889
        },
        {
            "text": "hypothyroidism despite elevated serum",
            "probability": 4.912794519073442e-07,
            "start_logit": 8.001152038574219,
            "end_logit": -7.606291770935059
        },
        {
            "text": "hypothyroidism despite elevated serum T3",
            "probability": 4.900181764725126e-07,
            "start_logit": 8.001152038574219,
            "end_logit": -7.608862400054932
        },
        {
            "text": "thyroid",
            "probability": 3.6530622419780597e-10,
            "start_logit": -2.9587302207946777,
            "end_logit": -3.8504419326782227
        },
        {
            "text": "othyroid",
            "probability": 2.2088195631335337e-10,
            "start_logit": -2.1679749488830566,
            "end_logit": -5.1443047523498535
        },
        {
            "text": "othy",
            "probability": 4.040776354252564e-11,
            "start_logit": -2.1679749488830566,
            "end_logit": -6.842911243438721
        },
        {
            "text": "elevated",
            "probability": 1.43582698112017e-11,
            "start_logit": -3.59590220451355,
            "end_logit": -6.449679851531982
        }
    ],
    "530f900ee3eabad021000003_014": [
        {
            "text": "thyroid",
            "probability": 0.9995939246893465,
            "start_logit": 6.0782389640808105,
            "end_logit": 5.506415367126465
        },
        {
            "text": "roid",
            "probability": 0.00017156655829336152,
            "start_logit": -2.5918941497802734,
            "end_logit": 5.506415367126465
        },
        {
            "text": "thy",
            "probability": 0.0001378960303079597,
            "start_logit": 6.0782389640808105,
            "end_logit": -3.3821890354156494
        },
        {
            "text": "deranged thyroid",
            "probability": 8.269336361748385e-05,
            "start_logit": -3.321726083755493,
            "end_logit": 5.506415367126465
        },
        {
            "text": "child with classical clinical features along with confirmatory deranged thyroid",
            "probability": 6.235217500829482e-06,
            "start_logit": -5.906651973724365,
            "end_logit": 5.506415367126465
        },
        {
            "text": "thyroid levels",
            "probability": 4.08840289361391e-06,
            "start_logit": 6.0782389640808105,
            "end_logit": -6.900534629821777
        },
        {
            "text": "thyroid levels in blood.",
            "probability": 3.1296152204925084e-06,
            "start_logit": 6.0782389640808105,
            "end_logit": -7.167778968811035
        },
        {
            "text": "decreased",
            "probability": 1.8799476806752485e-07,
            "start_logit": -1.8114343881607056,
            "end_logit": -2.0903568267822266
        },
        {
            "text": "elevated free T3 and decreased",
            "probability": 1.536249873129932e-07,
            "start_logit": -2.013334035873413,
            "end_logit": -2.0903568267822266
        },
        {
            "text": "elevated",
            "probability": 6.279350397568625e-08,
            "start_logit": -2.013334035873413,
            "end_logit": -2.9850196838378906
        },
        {
            "text": "elev",
            "probability": 2.6794084207649573e-08,
            "start_logit": -2.013334035873413,
            "end_logit": -3.8366901874542236
        },
        {
            "text": "reflected by elevated free T3 and decreased",
            "probability": 1.4647305202894968e-08,
            "start_logit": -4.363592147827148,
            "end_logit": -2.0903568267822266
        },
        {
            "text": "reflected by elevated",
            "probability": 5.987018346287502e-09,
            "start_logit": -4.363592147827148,
            "end_logit": -2.9850196838378906
        },
        {
            "text": "Abnormal transport function is reflected by elevated free T3 and decreased",
            "probability": 4.155404125494629e-09,
            "start_logit": -5.623438835144043,
            "end_logit": -2.0903568267822266
        },
        {
            "text": "deranged",
            "probability": 3.390514419405075e-09,
            "start_logit": -3.321726083755493,
            "end_logit": -4.5954976081848145
        },
        {
            "text": "Abnormal transport function is reflected by elevated",
            "probability": 1.6985022426280849e-09,
            "start_logit": -5.623438835144043,
            "end_logit": -2.9850196838378906
        },
        {
            "text": "transporter-8. Abnormal transport function is reflected by elevated free T3 and decreased",
            "probability": 1.3676643750377231e-09,
            "start_logit": -6.734744071960449,
            "end_logit": -2.0903568267822266
        },
        {
            "text": "T3 and decreased",
            "probability": 1.3670462735241727e-09,
            "start_logit": -6.735196113586426,
            "end_logit": -2.0903568267822266
        },
        {
            "text": "decreased free T4 levels along with",
            "probability": 1.1539007079314086e-09,
            "start_logit": -1.8114343881607056,
            "end_logit": -7.18362283706665
        },
        {
            "text": "decreased free T4 levels along with clinical features characterized by neurological abnormalities",
            "probability": 1.1481202890148664e-09,
            "start_logit": -1.8114343881607056,
            "end_logit": -7.188644886016846
        }
    ],
    "530f900ee3eabad021000003_015": [
        {
            "text": "thyroid",
            "probability": 0.9993058121122207,
            "start_logit": 6.98457670211792,
            "end_logit": 6.0651535987854
        },
        {
            "text": "thy",
            "probability": 0.00024899648529161047,
            "start_logit": 6.98457670211792,
            "end_logit": -2.2322237491607666
        },
        {
            "text": "roid",
            "probability": 0.00015717987038171545,
            "start_logit": -1.7728486061096191,
            "end_logit": 6.0651535987854
        },
        {
            "text": "thyroid hormone values or clinical symptoms were observed. CONCLUSION: the characteristic thyroid",
            "probability": 0.0001234351210391465,
            "start_logit": -1.6607463359832764,
            "end_logit": 5.711376190185547
        },
        {
            "text": "thyroid hormone",
            "probability": 7.453467157873666e-05,
            "start_logit": 6.98457670211792,
            "end_logit": -3.4383981227874756
        },
        {
            "text": "other than thyroid",
            "probability": 3.400054713741889e-05,
            "start_logit": -3.3038628101348877,
            "end_logit": 6.0651535987854
        },
        {
            "text": "Endocrine functions other than thyroid",
            "probability": 1.9535455438183953e-05,
            "start_logit": -3.85800838470459,
            "end_logit": 6.0651535987854
        },
        {
            "text": "the characteristic thyroid",
            "probability": 1.1576030144085452e-05,
            "start_logit": -4.027525424957275,
            "end_logit": 5.711376190185547
        },
        {
            "text": "CONCLUSION: the characteristic thyroid",
            "probability": 6.811735567227524e-06,
            "start_logit": -4.557815074920654,
            "end_logit": 5.711376190185547
        },
        {
            "text": "thyroid hormone regulation and metabolism",
            "probability": 5.8017620650893146e-06,
            "start_logit": 6.98457670211792,
            "end_logit": -5.9915008544921875
        },
        {
            "text": "than thyroid",
            "probability": 4.456479690746082e-06,
            "start_logit": -5.335880279541016,
            "end_logit": 6.0651535987854
        },
        {
            "text": "thyroid hormone regulation",
            "probability": 4.300223217470171e-06,
            "start_logit": 6.98457670211792,
            "end_logit": -6.2909955978393555
        },
        {
            "text": "characteristic thyroid",
            "probability": 3.537773178313254e-06,
            "start_logit": -5.2129645347595215,
            "end_logit": 5.711376190185547
        },
        {
            "text": "thyroid hormone values or clinical symptoms were observed. CONCLUSION: the characteristic thyroid hormone",
            "probability": 1.3295815308006722e-08,
            "start_logit": -1.6607463359832764,
            "end_logit": -3.42464542388916
        },
        {
            "text": "other than thyroid hormone",
            "probability": 2.5359800610268864e-09,
            "start_logit": -3.3038628101348877,
            "end_logit": -3.4383981227874756
        },
        {
            "text": "thyroid hormone values or clinical symptoms were observed. CONCLUSION: the characteristic",
            "probability": 2.0824639326624886e-09,
            "start_logit": -1.6607463359832764,
            "end_logit": -5.278542995452881
        },
        {
            "text": "Endocrine functions other than thyroid hormone",
            "probability": 1.4570802426820785e-09,
            "start_logit": -3.85800838470459,
            "end_logit": -3.4383981227874756
        },
        {
            "text": "the characteristic thyroid hormone",
            "probability": 1.2469122037549292e-09,
            "start_logit": -4.027525424957275,
            "end_logit": -3.42464542388916
        },
        {
            "text": "CONCLUSION: the characteristic thyroid hormone",
            "probability": 7.33726165344098e-10,
            "start_logit": -4.557815074920654,
            "end_logit": -3.42464542388916
        },
        {
            "text": "characteristic thyroid hormone",
            "probability": 3.810712735928322e-10,
            "start_logit": -5.2129645347595215,
            "end_logit": -3.42464542388916
        }
    ],
    "530f900ee3eabad021000003_016": [
        {
            "text": "thyroid",
            "probability": 0.9993058121122207,
            "start_logit": 6.98457670211792,
            "end_logit": 6.0651535987854
        },
        {
            "text": "thy",
            "probability": 0.00024899648529161047,
            "start_logit": 6.98457670211792,
            "end_logit": -2.2322237491607666
        },
        {
            "text": "roid",
            "probability": 0.00015717987038171545,
            "start_logit": -1.7728486061096191,
            "end_logit": 6.0651535987854
        },
        {
            "text": "thyroid hormone values or clinical symptoms were observed. CONCLUSION: the characteristic thyroid",
            "probability": 0.0001234351210391465,
            "start_logit": -1.6607463359832764,
            "end_logit": 5.711376190185547
        },
        {
            "text": "thyroid hormone",
            "probability": 7.453467157873666e-05,
            "start_logit": 6.98457670211792,
            "end_logit": -3.4383981227874756
        },
        {
            "text": "other than thyroid",
            "probability": 3.400054713741889e-05,
            "start_logit": -3.3038628101348877,
            "end_logit": 6.0651535987854
        },
        {
            "text": "Endocrine functions other than thyroid",
            "probability": 1.9535455438183953e-05,
            "start_logit": -3.85800838470459,
            "end_logit": 6.0651535987854
        },
        {
            "text": "the characteristic thyroid",
            "probability": 1.1576030144085452e-05,
            "start_logit": -4.027525424957275,
            "end_logit": 5.711376190185547
        },
        {
            "text": "CONCLUSION: the characteristic thyroid",
            "probability": 6.811735567227524e-06,
            "start_logit": -4.557815074920654,
            "end_logit": 5.711376190185547
        },
        {
            "text": "thyroid hormone regulation and metabolism",
            "probability": 5.8017620650893146e-06,
            "start_logit": 6.98457670211792,
            "end_logit": -5.9915008544921875
        },
        {
            "text": "than thyroid",
            "probability": 4.456479690746082e-06,
            "start_logit": -5.335880279541016,
            "end_logit": 6.0651535987854
        },
        {
            "text": "thyroid hormone regulation",
            "probability": 4.300223217470171e-06,
            "start_logit": 6.98457670211792,
            "end_logit": -6.2909955978393555
        },
        {
            "text": "characteristic thyroid",
            "probability": 3.537773178313254e-06,
            "start_logit": -5.2129645347595215,
            "end_logit": 5.711376190185547
        },
        {
            "text": "thyroid hormone values or clinical symptoms were observed. CONCLUSION: the characteristic thyroid hormone",
            "probability": 1.3295815308006722e-08,
            "start_logit": -1.6607463359832764,
            "end_logit": -3.42464542388916
        },
        {
            "text": "other than thyroid hormone",
            "probability": 2.5359800610268864e-09,
            "start_logit": -3.3038628101348877,
            "end_logit": -3.4383981227874756
        },
        {
            "text": "thyroid hormone values or clinical symptoms were observed. CONCLUSION: the characteristic",
            "probability": 2.0824639326624886e-09,
            "start_logit": -1.6607463359832764,
            "end_logit": -5.278542995452881
        },
        {
            "text": "Endocrine functions other than thyroid hormone",
            "probability": 1.4570802426820785e-09,
            "start_logit": -3.85800838470459,
            "end_logit": -3.4383981227874756
        },
        {
            "text": "the characteristic thyroid hormone",
            "probability": 1.2469122037549292e-09,
            "start_logit": -4.027525424957275,
            "end_logit": -3.42464542388916
        },
        {
            "text": "CONCLUSION: the characteristic thyroid hormone",
            "probability": 7.33726165344098e-10,
            "start_logit": -4.557815074920654,
            "end_logit": -3.42464542388916
        },
        {
            "text": "characteristic thyroid hormone",
            "probability": 3.810712735928322e-10,
            "start_logit": -5.2129645347595215,
            "end_logit": -3.42464542388916
        }
    ],
    "530f900ee3eabad021000003_017": [
        {
            "text": "thyroid",
            "probability": 0.9991708255051565,
            "start_logit": 8.962695121765137,
            "end_logit": 8.215460777282715
        },
        {
            "text": "thyroid stimulating hormone that are within the normal range. This constellation of measurements of thyroid",
            "probability": 0.0004698786963630192,
            "start_logit": 8.962695121765137,
            "end_logit": 0.5532543063163757
        },
        {
            "text": "roid",
            "probability": 0.00011802533496472196,
            "start_logit": -0.08108661323785782,
            "end_logit": 8.215460777282715
        },
        {
            "text": "elevated serum levels of free T(3), low to below normal serum levels of free T(4), and levels of thyroid",
            "probability": 0.00011567057251580887,
            "start_logit": -0.1012396588921547,
            "end_logit": 8.215460777282715
        },
        {
            "text": "thy",
            "probability": 9.932629645969703e-05,
            "start_logit": 8.962695121765137,
            "end_logit": -1.000809907913208
        },
        {
            "text": "low to below normal serum levels of free T(4), and levels of thyroid",
            "probability": 5.038277329464896e-06,
            "start_logit": -3.23492169380188,
            "end_logit": 8.215460777282715
        },
        {
            "text": "and levels of thyroid",
            "probability": 4.287652946423056e-06,
            "start_logit": -3.3962464332580566,
            "end_logit": 8.215460777282715
        },
        {
            "text": "thyroid stimulating hormone",
            "probability": 3.453108932067002e-06,
            "start_logit": 8.962695121765137,
            "end_logit": -4.359945297241211
        },
        {
            "text": "levels of thyroid",
            "probability": 3.2851352130078027e-06,
            "start_logit": -3.6625781059265137,
            "end_logit": 8.215460777282715
        },
        {
            "text": "thyroid stimulating",
            "probability": 3.214717156709712e-06,
            "start_logit": 8.962695121765137,
            "end_logit": -4.431480884552002
        },
        {
            "text": "below normal serum levels of free T(4), and levels of thyroid",
            "probability": 2.176497862323607e-06,
            "start_logit": -4.074268817901611,
            "end_logit": 8.215460777282715
        },
        {
            "text": "normal serum levels of free T(4), and levels of thyroid",
            "probability": 1.4631621677615105e-06,
            "start_logit": -4.471385955810547,
            "end_logit": 8.215460777282715
        },
        {
            "text": "to below normal serum levels of free T(4), and levels of thyroid",
            "probability": 1.196680636551499e-06,
            "start_logit": -4.672434329986572,
            "end_logit": 8.215460777282715
        },
        {
            "text": "thyroid stimulating hormone that are within the normal range.",
            "probability": 8.636486112696482e-07,
            "start_logit": 8.962695121765137,
            "end_logit": -5.745809555053711
        },
        {
            "text": "of thyroid",
            "probability": 7.928573623218495e-07,
            "start_logit": -5.084097862243652,
            "end_logit": 8.215460777282715
        },
        {
            "text": "thyroid stimulating hormone that are within the normal",
            "probability": 4.72890749653273e-07,
            "start_logit": 8.962695121765137,
            "end_logit": -6.348111152648926
        },
        {
            "text": "Thyroid hormone is essential for the proper development and function of the brain. The active form of thyroid",
            "probability": 2.1880026843945717e-08,
            "start_logit": -0.1343240886926651,
            "end_logit": -0.32438212633132935
        },
        {
            "text": "within the normal range. This constellation of measurements of thyroid",
            "probability": 3.2596667251837705e-09,
            "start_logit": -2.915909767150879,
            "end_logit": 0.5532543063163757
        },
        {
            "text": "and levels of thyroid stimulating hormone that are within the normal range. This constellation of measurements of thyroid",
            "probability": 2.0163486818220017e-09,
            "start_logit": -3.3962464332580566,
            "end_logit": 0.5532543063163757
        },
        {
            "text": "elevated serum levels of free T(3), low to below normal",
            "probability": 1.8095307523209262e-09,
            "start_logit": -0.1012396588921547,
            "end_logit": -2.849973201751709
        }
    ],
    "530f900ee3eabad021000003_018": [
        {
            "text": "thyroid",
            "probability": 0.9997991235901799,
            "start_logit": 7.9495015144348145,
            "end_logit": 6.998043537139893
        },
        {
            "text": "thy",
            "probability": 0.00012241414170086436,
            "start_logit": 7.9495015144348145,
            "end_logit": -2.0098562240600586
        },
        {
            "text": "roid",
            "probability": 7.090480000959684e-05,
            "start_logit": -1.6044700145721436,
            "end_logit": 6.998043537139893
        },
        {
            "text": "thyroid hormone",
            "probability": 4.028187028025375e-06,
            "start_logit": 7.9495015144348145,
            "end_logit": -5.423949718475342
        },
        {
            "text": "thyroid hormone transporter, results in elevated",
            "probability": 3.5287578804872046e-06,
            "start_logit": 7.9495015144348145,
            "end_logit": -5.5563201904296875
        },
        {
            "text": "elevated serum triiodothyronine (T3) levels, which were confirmed in four affected males of this family, while normal",
            "probability": 2.507501243694044e-10,
            "start_logit": -1.8207049369812012,
            "end_logit": -5.338113307952881
        },
        {
            "text": "elevated",
            "probability": 2.0159284416516412e-10,
            "start_logit": -1.8207049369812012,
            "end_logit": -5.5563201904296875
        },
        {
            "text": "elev",
            "probability": 4.4089764062341985e-11,
            "start_logit": -1.8207049369812012,
            "end_logit": -7.076342582702637
        },
        {
            "text": "normal",
            "probability": 1.2964431266024465e-11,
            "start_logit": -4.782952308654785,
            "end_logit": -5.338113307952881
        },
        {
            "text": "hormone",
            "probability": 4.153150366180626e-12,
            "start_logit": -5.835458278656006,
            "end_logit": -5.423949718475342
        },
        {
            "text": "hormone transporter, results in elevated",
            "probability": 3.638227813541303e-12,
            "start_logit": -5.835458278656006,
            "end_logit": -5.5563201904296875
        },
        {
            "text": "results in elevated",
            "probability": 1.643558629416936e-12,
            "start_logit": -6.630091190338135,
            "end_logit": -5.5563201904296875
        },
        {
            "text": "levels, which were confirmed in four affected males of this family, while normal",
            "probability": 1.5278229377798123e-12,
            "start_logit": -6.921318054199219,
            "end_logit": -5.338113307952881
        },
        {
            "text": "(T3) levels, which were confirmed in four affected males of this family, while normal",
            "probability": 1.4708982413381147e-12,
            "start_logit": -6.959288597106934,
            "end_logit": -5.338113307952881
        },
        {
            "text": "characterised by",
            "probability": 4.71126398832975e-13,
            "start_logit": -5.8036675453186035,
            "end_logit": -7.632236480712891
        },
        {
            "text": "characterised by severe mental retardation and neurological dysfunction.",
            "probability": 4.642929233446538e-13,
            "start_logit": -5.8036675453186035,
            "end_logit": -7.646847248077393
        },
        {
            "text": "X linked condition characterised by",
            "probability": 1.4583878987329346e-13,
            "start_logit": -6.976292133331299,
            "end_logit": -7.632236480712891
        },
        {
            "text": "X linked",
            "probability": 1.4560566515508542e-13,
            "start_logit": -6.976292133331299,
            "end_logit": -7.633836269378662
        },
        {
            "text": "X linked condition characterised by severe mental retardation and neurological dysfunction.",
            "probability": 1.437234641383862e-13,
            "start_logit": -6.976292133331299,
            "end_logit": -7.646847248077393
        }
    ],
    "530f900ee3eabad021000003_019": [
        {
            "text": "thyroid",
            "probability": 0.9995435960686475,
            "start_logit": 6.728515148162842,
            "end_logit": 5.954288482666016
        },
        {
            "text": "thy",
            "probability": 0.00023881137729210317,
            "start_logit": 6.728515148162842,
            "end_logit": -2.385091543197632
        },
        {
            "text": "roid",
            "probability": 0.00016900847224043464,
            "start_logit": -1.9565900564193726,
            "end_logit": 5.954288482666016
        },
        {
            "text": "Mct8 transports thyroid",
            "probability": 4.1146098135724186e-05,
            "start_logit": -3.3694097995758057,
            "end_logit": 5.954288482666016
        },
        {
            "text": "thyroid hormones",
            "probability": 2.5520924729933633e-06,
            "start_logit": 6.728515148162842,
            "end_logit": -6.92385196685791
        },
        {
            "text": "transports thyroid",
            "probability": 1.90120450625208e-06,
            "start_logit": -6.444051265716553,
            "end_logit": 5.954288482666016
        },
        {
            "text": "thyroid hormones (T4 and T3),",
            "probability": 8.316582404495673e-07,
            "start_logit": 6.728515148162842,
            "end_logit": -8.045099258422852
        },
        {
            "text": "intellectual deficit and neurological impairment. Mct8 transports thyroid",
            "probability": 6.897467595921174e-07,
            "start_logit": -7.457969665527344,
            "end_logit": 5.954288482666016
        },
        {
            "text": "X-linked syndrome of severe intellectual deficit and neurological impairment. Mct8 transports thyroid",
            "probability": 6.802906133261099e-07,
            "start_logit": -7.471774101257324,
            "end_logit": 5.954288482666016
        },
        {
            "text": "thyroid hormones (T4 and T3), and",
            "probability": 6.066932878398341e-07,
            "start_logit": 6.728515148162842,
            "end_logit": -8.36049747467041
        },
        {
            "text": "hypothyroidism.",
            "probability": 1.7412982464045832e-07,
            "start_logit": -1.8160370588302612,
            "end_logit": -1.0641674995422363
        },
        {
            "text": "hypothyroidism",
            "probability": 9.659920759787736e-10,
            "start_logit": -1.8160370588302612,
            "end_logit": -6.258568286895752
        },
        {
            "text": "Mct8",
            "probability": 5.408273176256705e-10,
            "start_logit": -3.3694097995758057,
            "end_logit": -5.285251140594482
        },
        {
            "text": "Mct8 transports",
            "probability": 1.997879644320284e-10,
            "start_logit": -3.3694097995758057,
            "end_logit": -6.281094551086426
        },
        {
            "text": "hypothyroid",
            "probability": 1.7793298883274908e-10,
            "start_logit": -1.8160370588302612,
            "end_logit": -7.950316905975342
        },
        {
            "text": "Mct8 transports thyroid hormones",
            "probability": 1.0505659558846905e-10,
            "start_logit": -3.3694097995758057,
            "end_logit": -6.92385196685791
        },
        {
            "text": "thyroid hormone action in the fetal brain we administered T4 or T3 to thyroidectomized",
            "probability": 8.041686172517749e-11,
            "start_logit": -3.789935350418091,
            "end_logit": -6.770601749420166
        },
        {
            "text": "Mct8 transports thyroid hormones (T4 and T3),",
            "probability": 3.423511661873671e-11,
            "start_logit": -3.3694097995758057,
            "end_logit": -8.045099258422852
        },
        {
            "text": "fetal brain development. To evaluate the role of Mct8 in thyroid",
            "probability": 3.312719959675425e-11,
            "start_logit": -6.947819232940674,
            "end_logit": -4.499587059020996
        },
        {
            "text": "8",
            "probability": 3.060237579942262e-11,
            "start_logit": -6.241432189941406,
            "end_logit": -5.285251140594482
        }
    ],
    "54e8c7220fc566b149000002_001": [
        {
            "text": "nucleus",
            "probability": 0.9974251680423276,
            "start_logit": 9.409653663635254,
            "end_logit": 8.883978843688965
        },
        {
            "text": "the nucleus",
            "probability": 0.0019577719388759263,
            "start_logit": 3.176283597946167,
            "end_logit": 8.883978843688965
        },
        {
            "text": "us",
            "probability": 0.0002842704573844057,
            "start_logit": 1.2466473579406738,
            "end_logit": 8.883978843688965
        },
        {
            "text": "the cell nucleus.",
            "probability": 0.0001048315160728372,
            "start_logit": 0.5132187008857727,
            "end_logit": 8.61983585357666
        },
        {
            "text": "p53 in the nucleus",
            "probability": 6.392490600162544e-05,
            "start_logit": -0.24556969106197357,
            "end_logit": 8.883978843688965
        },
        {
            "text": "n",
            "probability": 5.783722496007034e-05,
            "start_logit": 9.409653663635254,
            "end_logit": -0.8713209629058838
        },
        {
            "text": "cell nucleus.",
            "probability": 5.236447315272003e-05,
            "start_logit": -0.18090738356113434,
            "end_logit": 8.61983585357666
        },
        {
            "text": "in the nucleus",
            "probability": 2.171066307669164e-05,
            "start_logit": -1.3254752159118652,
            "end_logit": 8.883978843688965
        },
        {
            "text": "interacts with p53 in the nucleus",
            "probability": 1.3400126008325021e-05,
            "start_logit": -1.8080146312713623,
            "end_logit": 8.883978843688965
        },
        {
            "text": "ucleus",
            "probability": 9.55439781360497e-06,
            "start_logit": -2.1462771892547607,
            "end_logit": 8.883978843688965
        },
        {
            "text": "nucleus and promotes p53",
            "probability": 6.1715661605960516e-06,
            "start_logit": 9.409653663635254,
            "end_logit": -3.1090009212493896
        },
        {
            "text": "place in the cell nucleus.",
            "probability": 1.1396269581779168e-06,
            "start_logit": -4.008434772491455,
            "end_logit": 8.61983585357666
        },
        {
            "text": "in the cell nucleus.",
            "probability": 6.87874785995165e-07,
            "start_logit": -4.513284206390381,
            "end_logit": 8.61983585357666
        },
        {
            "text": "nucleus.",
            "probability": 6.593136117092725e-07,
            "start_logit": 8.83409595489502,
            "end_logit": -4.769951820373535
        },
        {
            "text": "nucle",
            "probability": 4.850306214675905e-07,
            "start_logit": 9.409653663635254,
            "end_logit": -5.652496814727783
        },
        {
            "text": "the nucleus and promotes p53",
            "probability": 1.2113709815289565e-08,
            "start_logit": 3.176283597946167,
            "end_logit": -3.1090009212493896
        },
        {
            "text": "the",
            "probability": 5.794349398276651e-09,
            "start_logit": 3.176283597946167,
            "end_logit": -3.8464555740356445
        },
        {
            "text": "p53",
            "probability": 3.7442537449782396e-09,
            "start_logit": -0.24556969106197357,
            "end_logit": -0.8612631559371948
        },
        {
            "text": "interacts with p53",
            "probability": 7.848814355483837e-10,
            "start_logit": -1.8080146312713623,
            "end_logit": -0.8612631559371948
        },
        {
            "text": "p53 in",
            "probability": 4.049940477771557e-10,
            "start_logit": -0.24556969106197357,
            "end_logit": -3.0853683948516846
        }
    ],
    "54e8c7220fc566b149000002_002": [
        {
            "text": "nucleus",
            "probability": 0.9974251680423276,
            "start_logit": 9.409653663635254,
            "end_logit": 8.883978843688965
        },
        {
            "text": "the nucleus",
            "probability": 0.0019577719388759263,
            "start_logit": 3.176283597946167,
            "end_logit": 8.883978843688965
        },
        {
            "text": "us",
            "probability": 0.0002842704573844057,
            "start_logit": 1.2466473579406738,
            "end_logit": 8.883978843688965
        },
        {
            "text": "the cell nucleus.",
            "probability": 0.0001048315160728372,
            "start_logit": 0.5132187008857727,
            "end_logit": 8.61983585357666
        },
        {
            "text": "p53 in the nucleus",
            "probability": 6.392490600162544e-05,
            "start_logit": -0.24556969106197357,
            "end_logit": 8.883978843688965
        },
        {
            "text": "n",
            "probability": 5.783722496007034e-05,
            "start_logit": 9.409653663635254,
            "end_logit": -0.8713209629058838
        },
        {
            "text": "cell nucleus.",
            "probability": 5.236447315272003e-05,
            "start_logit": -0.18090738356113434,
            "end_logit": 8.61983585357666
        },
        {
            "text": "in the nucleus",
            "probability": 2.171066307669164e-05,
            "start_logit": -1.3254752159118652,
            "end_logit": 8.883978843688965
        },
        {
            "text": "interacts with p53 in the nucleus",
            "probability": 1.3400126008325021e-05,
            "start_logit": -1.8080146312713623,
            "end_logit": 8.883978843688965
        },
        {
            "text": "ucleus",
            "probability": 9.55439781360497e-06,
            "start_logit": -2.1462771892547607,
            "end_logit": 8.883978843688965
        },
        {
            "text": "nucleus and promotes p53",
            "probability": 6.1715661605960516e-06,
            "start_logit": 9.409653663635254,
            "end_logit": -3.1090009212493896
        },
        {
            "text": "place in the cell nucleus.",
            "probability": 1.1396269581779168e-06,
            "start_logit": -4.008434772491455,
            "end_logit": 8.61983585357666
        },
        {
            "text": "in the cell nucleus.",
            "probability": 6.87874785995165e-07,
            "start_logit": -4.513284206390381,
            "end_logit": 8.61983585357666
        },
        {
            "text": "nucleus.",
            "probability": 6.593136117092725e-07,
            "start_logit": 8.83409595489502,
            "end_logit": -4.769951820373535
        },
        {
            "text": "nucle",
            "probability": 4.850306214675905e-07,
            "start_logit": 9.409653663635254,
            "end_logit": -5.652496814727783
        },
        {
            "text": "the nucleus and promotes p53",
            "probability": 1.2113709815289565e-08,
            "start_logit": 3.176283597946167,
            "end_logit": -3.1090009212493896
        },
        {
            "text": "the",
            "probability": 5.794349398276651e-09,
            "start_logit": 3.176283597946167,
            "end_logit": -3.8464555740356445
        },
        {
            "text": "p53",
            "probability": 3.7442537449782396e-09,
            "start_logit": -0.24556969106197357,
            "end_logit": -0.8612631559371948
        },
        {
            "text": "interacts with p53",
            "probability": 7.848814355483837e-10,
            "start_logit": -1.8080146312713623,
            "end_logit": -0.8612631559371948
        },
        {
            "text": "p53 in",
            "probability": 4.049940477771557e-10,
            "start_logit": -0.24556969106197357,
            "end_logit": -3.0853683948516846
        }
    ],
    "56bc932aac7ad1001900001c_001": [
        {
            "text": "multiple myeloma.",
            "probability": 0.972932859519667,
            "start_logit": 4.205234527587891,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 0.02112098783823136,
            "start_logit": 0.3751866817474365,
            "end_logit": 3.777590274810791
        },
        {
            "text": "multiple",
            "probability": 0.00478657432230425,
            "start_logit": 4.205234527587891,
            "end_logit": -1.536909818649292
        },
        {
            "text": "especially multiple myeloma.",
            "probability": 0.0005913174314789603,
            "start_logit": -3.2004828453063965,
            "end_logit": 3.777590274810791
        },
        {
            "text": ".",
            "probability": 0.00020962693230305835,
            "start_logit": -4.23750638961792,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38",
            "probability": 0.00011174453036359338,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple",
            "probability": 0.00010390971695425094,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.536909818649292
        },
        {
            "text": "myeloma.",
            "probability": 4.0446087798711286e-05,
            "start_logit": -5.882865905761719,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 3.39246517989228e-05,
            "start_logit": -6.058693885803223,
            "end_logit": 3.777590274810791
        },
        {
            "text": "malignancies, especially multiple myeloma.",
            "probability": 2.5206417336351562e-05,
            "start_logit": -6.355737209320068,
            "end_logit": 3.777590274810791
        },
        {
            "text": "of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.5082584101015358e-05,
            "start_logit": -6.869295120239258,
            "end_logit": 3.777590274810791
        },
        {
            "text": "targeting CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.3377072744620375e-05,
            "start_logit": -6.989293575286865,
            "end_logit": 3.777590274810791
        },
        {
            "text": "the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 9.68032525739701e-06,
            "start_logit": -7.312740325927734,
            "end_logit": 3.777590274810791
        },
        {
            "text": "especially multiple",
            "probability": 2.9091265714321166e-06,
            "start_logit": -3.2004828453063965,
            "end_logit": -1.536909818649292
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially",
            "probability": 1.28097920456648e-06,
            "start_logit": 0.3751866817474365,
            "end_logit": -5.932807445526123
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies,",
            "probability": 4.3850301603950546e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.004820823669434
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing",
            "probability": 1.7994102463769314e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.8955583572387695
        },
        {
            "text": "CD38-expressing malignancies, especially multiple",
            "probability": 1.6690038331525193e-07,
            "start_logit": -6.058693885803223,
            "end_logit": -1.536909818649292
        },
        {
            "text": "anti-cancer drug targeting CD38,",
            "probability": 1.4366494481776774e-07,
            "start_logit": -6.281300067901611,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38,",
            "probability": 1.434545153728352e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -8.122169494628906
        }
    ],
    "56bc932aac7ad1001900001c_002": [
        {
            "text": "multiple myeloma.",
            "probability": 0.972932859519667,
            "start_logit": 4.205234527587891,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 0.02112098783823136,
            "start_logit": 0.3751866817474365,
            "end_logit": 3.777590274810791
        },
        {
            "text": "multiple",
            "probability": 0.00478657432230425,
            "start_logit": 4.205234527587891,
            "end_logit": -1.536909818649292
        },
        {
            "text": "especially multiple myeloma.",
            "probability": 0.0005913174314789603,
            "start_logit": -3.2004828453063965,
            "end_logit": 3.777590274810791
        },
        {
            "text": ".",
            "probability": 0.00020962693230305835,
            "start_logit": -4.23750638961792,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38",
            "probability": 0.00011174453036359338,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple",
            "probability": 0.00010390971695425094,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.536909818649292
        },
        {
            "text": "myeloma.",
            "probability": 4.0446087798711286e-05,
            "start_logit": -5.882865905761719,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 3.39246517989228e-05,
            "start_logit": -6.058693885803223,
            "end_logit": 3.777590274810791
        },
        {
            "text": "malignancies, especially multiple myeloma.",
            "probability": 2.5206417336351562e-05,
            "start_logit": -6.355737209320068,
            "end_logit": 3.777590274810791
        },
        {
            "text": "of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.5082584101015358e-05,
            "start_logit": -6.869295120239258,
            "end_logit": 3.777590274810791
        },
        {
            "text": "targeting CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.3377072744620375e-05,
            "start_logit": -6.989293575286865,
            "end_logit": 3.777590274810791
        },
        {
            "text": "the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 9.68032525739701e-06,
            "start_logit": -7.312740325927734,
            "end_logit": 3.777590274810791
        },
        {
            "text": "especially multiple",
            "probability": 2.9091265714321166e-06,
            "start_logit": -3.2004828453063965,
            "end_logit": -1.536909818649292
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially",
            "probability": 1.28097920456648e-06,
            "start_logit": 0.3751866817474365,
            "end_logit": -5.932807445526123
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies,",
            "probability": 4.3850301603950546e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.004820823669434
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing",
            "probability": 1.7994102463769314e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.8955583572387695
        },
        {
            "text": "CD38-expressing malignancies, especially multiple",
            "probability": 1.6690038331525193e-07,
            "start_logit": -6.058693885803223,
            "end_logit": -1.536909818649292
        },
        {
            "text": "anti-cancer drug targeting CD38,",
            "probability": 1.4366494481776774e-07,
            "start_logit": -6.281300067901611,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38,",
            "probability": 1.434545153728352e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -8.122169494628906
        }
    ],
    "56bc932aac7ad1001900001c_003": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56bc932aac7ad1001900001c_004": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56bc932aac7ad1001900001c_005": [
        {
            "text": "multiple",
            "probability": 0.35932599363380013,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.30124611959165243,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "CD38",
            "probability": 0.2936716113504787,
            "start_logit": 0.5791692137718201,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "BACKGROUND: Daratumumab (DARA), a promising novel therapy for multiple",
            "probability": 0.02380352500528219,
            "start_logit": -2.1097617149353027,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma,",
            "probability": 0.005406201009781236,
            "start_logit": 0.6046346426010132,
            "end_logit": -5.4216413497924805
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma",
            "probability": 0.0025567338818954996,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.170457363128662
        },
        {
            "text": "CD38 on myeloma",
            "probability": 0.002492447570472944,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.170457363128662
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba",
            "probability": 0.001663285202637907,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.600393295288086
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma cells.",
            "probability": 0.0015386798249829299,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.678263187408447
        },
        {
            "text": "CD38 on myeloma cells.",
            "probability": 0.0014999913830184021,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.678263187408447
        },
        {
            "text": "recognizes CD38",
            "probability": 0.0012464217567206375,
            "start_logit": -4.883016109466553,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.0007867646019757443,
            "start_logit": -5.343119144439697,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "that recognizes CD38",
            "probability": 0.0007236739693020412,
            "start_logit": -5.4267072677612305,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes",
            "probability": 0.0006965692246410182,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.470776081085205
        },
        {
            "text": "(DARA), a promising novel therapy for multiple",
            "probability": 0.0006450401680934554,
            "start_logit": -5.718038082122803,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "CD",
            "probability": 0.0006221520319550962,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.558293342590332
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on",
            "probability": 0.0005750440760643755,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.662496566772461
        },
        {
            "text": "CD38 on",
            "probability": 0.0005605852139914236,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.662496566772461
        },
        {
            "text": "for multiple",
            "probability": 0.0005108674348443766,
            "start_logit": -5.951240539550781,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "for multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.00042829306840921335,
            "start_logit": -5.951240539550781,
            "end_logit": -1.4012603759765625
        }
    ],
    "56bc932aac7ad1001900001c_006": [
        {
            "text": "multiple",
            "probability": 0.35932599363380013,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.30124611959165243,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "CD38",
            "probability": 0.2936716113504787,
            "start_logit": 0.5791692137718201,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "BACKGROUND: Daratumumab (DARA), a promising novel therapy for multiple",
            "probability": 0.02380352500528219,
            "start_logit": -2.1097617149353027,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma,",
            "probability": 0.005406201009781236,
            "start_logit": 0.6046346426010132,
            "end_logit": -5.4216413497924805
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma",
            "probability": 0.0025567338818954996,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.170457363128662
        },
        {
            "text": "CD38 on myeloma",
            "probability": 0.002492447570472944,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.170457363128662
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba",
            "probability": 0.001663285202637907,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.600393295288086
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma cells.",
            "probability": 0.0015386798249829299,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.678263187408447
        },
        {
            "text": "CD38 on myeloma cells.",
            "probability": 0.0014999913830184021,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.678263187408447
        },
        {
            "text": "recognizes CD38",
            "probability": 0.0012464217567206375,
            "start_logit": -4.883016109466553,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.0007867646019757443,
            "start_logit": -5.343119144439697,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "that recognizes CD38",
            "probability": 0.0007236739693020412,
            "start_logit": -5.4267072677612305,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes",
            "probability": 0.0006965692246410182,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.470776081085205
        },
        {
            "text": "(DARA), a promising novel therapy for multiple",
            "probability": 0.0006450401680934554,
            "start_logit": -5.718038082122803,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "CD",
            "probability": 0.0006221520319550962,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.558293342590332
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on",
            "probability": 0.0005750440760643755,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.662496566772461
        },
        {
            "text": "CD38 on",
            "probability": 0.0005605852139914236,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.662496566772461
        },
        {
            "text": "for multiple",
            "probability": 0.0005108674348443766,
            "start_logit": -5.951240539550781,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "for multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.00042829306840921335,
            "start_logit": -5.951240539550781,
            "end_logit": -1.4012603759765625
        }
    ],
    "56bc932aac7ad1001900001c_007": [
        {
            "text": "multiple",
            "probability": 0.35932599363380013,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.30124611959165243,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "CD38",
            "probability": 0.2936716113504787,
            "start_logit": 0.5791692137718201,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "BACKGROUND: Daratumumab (DARA), a promising novel therapy for multiple",
            "probability": 0.02380352500528219,
            "start_logit": -2.1097617149353027,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma,",
            "probability": 0.005406201009781236,
            "start_logit": 0.6046346426010132,
            "end_logit": -5.4216413497924805
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma",
            "probability": 0.0025567338818954996,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.170457363128662
        },
        {
            "text": "CD38 on myeloma",
            "probability": 0.002492447570472944,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.170457363128662
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba",
            "probability": 0.001663285202637907,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.600393295288086
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma cells.",
            "probability": 0.0015386798249829299,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.678263187408447
        },
        {
            "text": "CD38 on myeloma cells.",
            "probability": 0.0014999913830184021,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.678263187408447
        },
        {
            "text": "recognizes CD38",
            "probability": 0.0012464217567206375,
            "start_logit": -4.883016109466553,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.0007867646019757443,
            "start_logit": -5.343119144439697,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "that recognizes CD38",
            "probability": 0.0007236739693020412,
            "start_logit": -5.4267072677612305,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes",
            "probability": 0.0006965692246410182,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.470776081085205
        },
        {
            "text": "(DARA), a promising novel therapy for multiple",
            "probability": 0.0006450401680934554,
            "start_logit": -5.718038082122803,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "CD",
            "probability": 0.0006221520319550962,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.558293342590332
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on",
            "probability": 0.0005750440760643755,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.662496566772461
        },
        {
            "text": "CD38 on",
            "probability": 0.0005605852139914236,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.662496566772461
        },
        {
            "text": "for multiple",
            "probability": 0.0005108674348443766,
            "start_logit": -5.951240539550781,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "for multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.00042829306840921335,
            "start_logit": -5.951240539550781,
            "end_logit": -1.4012603759765625
        }
    ],
    "56bc932aac7ad1001900001c_008": [
        {
            "text": "multiple",
            "probability": 0.35932599363380013,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.30124611959165243,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "CD38",
            "probability": 0.2936716113504787,
            "start_logit": 0.5791692137718201,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "BACKGROUND: Daratumumab (DARA), a promising novel therapy for multiple",
            "probability": 0.02380352500528219,
            "start_logit": -2.1097617149353027,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma,",
            "probability": 0.005406201009781236,
            "start_logit": 0.6046346426010132,
            "end_logit": -5.4216413497924805
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma",
            "probability": 0.0025567338818954996,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.170457363128662
        },
        {
            "text": "CD38 on myeloma",
            "probability": 0.002492447570472944,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.170457363128662
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba",
            "probability": 0.001663285202637907,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.600393295288086
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma cells.",
            "probability": 0.0015386798249829299,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.678263187408447
        },
        {
            "text": "CD38 on myeloma cells.",
            "probability": 0.0014999913830184021,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.678263187408447
        },
        {
            "text": "recognizes CD38",
            "probability": 0.0012464217567206375,
            "start_logit": -4.883016109466553,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.0007867646019757443,
            "start_logit": -5.343119144439697,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "that recognizes CD38",
            "probability": 0.0007236739693020412,
            "start_logit": -5.4267072677612305,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes",
            "probability": 0.0006965692246410182,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.470776081085205
        },
        {
            "text": "(DARA), a promising novel therapy for multiple",
            "probability": 0.0006450401680934554,
            "start_logit": -5.718038082122803,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "CD",
            "probability": 0.0006221520319550962,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.558293342590332
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on",
            "probability": 0.0005750440760643755,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.662496566772461
        },
        {
            "text": "CD38 on",
            "probability": 0.0005605852139914236,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.662496566772461
        },
        {
            "text": "for multiple",
            "probability": 0.0005108674348443766,
            "start_logit": -5.951240539550781,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "for multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.00042829306840921335,
            "start_logit": -5.951240539550781,
            "end_logit": -1.4012603759765625
        }
    ],
    "56bc932aac7ad1001900001c_009": [
        {
            "text": "multiple",
            "probability": 0.35932599363380013,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.30124611959165243,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "CD38",
            "probability": 0.2936716113504787,
            "start_logit": 0.5791692137718201,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "BACKGROUND: Daratumumab (DARA), a promising novel therapy for multiple",
            "probability": 0.02380352500528219,
            "start_logit": -2.1097617149353027,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma,",
            "probability": 0.005406201009781236,
            "start_logit": 0.6046346426010132,
            "end_logit": -5.4216413497924805
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma",
            "probability": 0.0025567338818954996,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.170457363128662
        },
        {
            "text": "CD38 on myeloma",
            "probability": 0.002492447570472944,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.170457363128662
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba",
            "probability": 0.001663285202637907,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.600393295288086
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma cells.",
            "probability": 0.0015386798249829299,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.678263187408447
        },
        {
            "text": "CD38 on myeloma cells.",
            "probability": 0.0014999913830184021,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.678263187408447
        },
        {
            "text": "recognizes CD38",
            "probability": 0.0012464217567206375,
            "start_logit": -4.883016109466553,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.0007867646019757443,
            "start_logit": -5.343119144439697,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "that recognizes CD38",
            "probability": 0.0007236739693020412,
            "start_logit": -5.4267072677612305,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes",
            "probability": 0.0006965692246410182,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.470776081085205
        },
        {
            "text": "(DARA), a promising novel therapy for multiple",
            "probability": 0.0006450401680934554,
            "start_logit": -5.718038082122803,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "CD",
            "probability": 0.0006221520319550962,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.558293342590332
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on",
            "probability": 0.0005750440760643755,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.662496566772461
        },
        {
            "text": "CD38 on",
            "probability": 0.0005605852139914236,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.662496566772461
        },
        {
            "text": "for multiple",
            "probability": 0.0005108674348443766,
            "start_logit": -5.951240539550781,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "for multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.00042829306840921335,
            "start_logit": -5.951240539550781,
            "end_logit": -1.4012603759765625
        }
    ],
    "56bc932aac7ad1001900001c_010": [
        {
            "text": "multiple",
            "probability": 0.35932599363380013,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.30124611959165243,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "CD38",
            "probability": 0.2936716113504787,
            "start_logit": 0.5791692137718201,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "BACKGROUND: Daratumumab (DARA), a promising novel therapy for multiple",
            "probability": 0.02380352500528219,
            "start_logit": -2.1097617149353027,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma,",
            "probability": 0.005406201009781236,
            "start_logit": 0.6046346426010132,
            "end_logit": -5.4216413497924805
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma",
            "probability": 0.0025567338818954996,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.170457363128662
        },
        {
            "text": "CD38 on myeloma",
            "probability": 0.002492447570472944,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.170457363128662
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba",
            "probability": 0.001663285202637907,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.600393295288086
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma cells.",
            "probability": 0.0015386798249829299,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.678263187408447
        },
        {
            "text": "CD38 on myeloma cells.",
            "probability": 0.0014999913830184021,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.678263187408447
        },
        {
            "text": "recognizes CD38",
            "probability": 0.0012464217567206375,
            "start_logit": -4.883016109466553,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.0007867646019757443,
            "start_logit": -5.343119144439697,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "that recognizes CD38",
            "probability": 0.0007236739693020412,
            "start_logit": -5.4267072677612305,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes",
            "probability": 0.0006965692246410182,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.470776081085205
        },
        {
            "text": "(DARA), a promising novel therapy for multiple",
            "probability": 0.0006450401680934554,
            "start_logit": -5.718038082122803,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "CD",
            "probability": 0.0006221520319550962,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.558293342590332
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on",
            "probability": 0.0005750440760643755,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.662496566772461
        },
        {
            "text": "CD38 on",
            "probability": 0.0005605852139914236,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.662496566772461
        },
        {
            "text": "for multiple",
            "probability": 0.0005108674348443766,
            "start_logit": -5.951240539550781,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "for multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.00042829306840921335,
            "start_logit": -5.951240539550781,
            "end_logit": -1.4012603759765625
        }
    ],
    "56bc932aac7ad1001900001c_011": [
        {
            "text": "multiple",
            "probability": 0.35932599363380013,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.30124611959165243,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "CD38",
            "probability": 0.2936716113504787,
            "start_logit": 0.5791692137718201,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "BACKGROUND: Daratumumab (DARA), a promising novel therapy for multiple",
            "probability": 0.02380352500528219,
            "start_logit": -2.1097617149353027,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma,",
            "probability": 0.005406201009781236,
            "start_logit": 0.6046346426010132,
            "end_logit": -5.4216413497924805
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma",
            "probability": 0.0025567338818954996,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.170457363128662
        },
        {
            "text": "CD38 on myeloma",
            "probability": 0.002492447570472944,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.170457363128662
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba",
            "probability": 0.001663285202637907,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.600393295288086
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma cells.",
            "probability": 0.0015386798249829299,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.678263187408447
        },
        {
            "text": "CD38 on myeloma cells.",
            "probability": 0.0014999913830184021,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.678263187408447
        },
        {
            "text": "recognizes CD38",
            "probability": 0.0012464217567206375,
            "start_logit": -4.883016109466553,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.0007867646019757443,
            "start_logit": -5.343119144439697,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "that recognizes CD38",
            "probability": 0.0007236739693020412,
            "start_logit": -5.4267072677612305,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes",
            "probability": 0.0006965692246410182,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.470776081085205
        },
        {
            "text": "(DARA), a promising novel therapy for multiple",
            "probability": 0.0006450401680934554,
            "start_logit": -5.718038082122803,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "CD",
            "probability": 0.0006221520319550962,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.558293342590332
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on",
            "probability": 0.0005750440760643755,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.662496566772461
        },
        {
            "text": "CD38 on",
            "probability": 0.0005605852139914236,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.662496566772461
        },
        {
            "text": "for multiple",
            "probability": 0.0005108674348443766,
            "start_logit": -5.951240539550781,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "for multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.00042829306840921335,
            "start_logit": -5.951240539550781,
            "end_logit": -1.4012603759765625
        }
    ],
    "56bc932aac7ad1001900001c_012": [
        {
            "text": "multiple",
            "probability": 0.35932599363380013,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.30124611959165243,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "CD38",
            "probability": 0.2936716113504787,
            "start_logit": 0.5791692137718201,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "BACKGROUND: Daratumumab (DARA), a promising novel therapy for multiple",
            "probability": 0.02380352500528219,
            "start_logit": -2.1097617149353027,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma,",
            "probability": 0.005406201009781236,
            "start_logit": 0.6046346426010132,
            "end_logit": -5.4216413497924805
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma",
            "probability": 0.0025567338818954996,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.170457363128662
        },
        {
            "text": "CD38 on myeloma",
            "probability": 0.002492447570472944,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.170457363128662
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba",
            "probability": 0.001663285202637907,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.600393295288086
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma cells.",
            "probability": 0.0015386798249829299,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.678263187408447
        },
        {
            "text": "CD38 on myeloma cells.",
            "probability": 0.0014999913830184021,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.678263187408447
        },
        {
            "text": "recognizes CD38",
            "probability": 0.0012464217567206375,
            "start_logit": -4.883016109466553,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.0007867646019757443,
            "start_logit": -5.343119144439697,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "that recognizes CD38",
            "probability": 0.0007236739693020412,
            "start_logit": -5.4267072677612305,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes",
            "probability": 0.0006965692246410182,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.470776081085205
        },
        {
            "text": "(DARA), a promising novel therapy for multiple",
            "probability": 0.0006450401680934554,
            "start_logit": -5.718038082122803,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "CD",
            "probability": 0.0006221520319550962,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.558293342590332
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on",
            "probability": 0.0005750440760643755,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.662496566772461
        },
        {
            "text": "CD38 on",
            "probability": 0.0005605852139914236,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.662496566772461
        },
        {
            "text": "for multiple",
            "probability": 0.0005108674348443766,
            "start_logit": -5.951240539550781,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "for multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.00042829306840921335,
            "start_logit": -5.951240539550781,
            "end_logit": -1.4012603759765625
        }
    ],
    "56bc932aac7ad1001900001c_013": [
        {
            "text": "multiple",
            "probability": 0.35932599363380013,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.30124611959165243,
            "start_logit": 0.6046346426010132,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "CD38",
            "probability": 0.2936716113504787,
            "start_logit": 0.5791692137718201,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "BACKGROUND: Daratumumab (DARA), a promising novel therapy for multiple",
            "probability": 0.02380352500528219,
            "start_logit": -2.1097617149353027,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "multiple myeloma,",
            "probability": 0.005406201009781236,
            "start_logit": 0.6046346426010132,
            "end_logit": -5.4216413497924805
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma",
            "probability": 0.0025567338818954996,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.170457363128662
        },
        {
            "text": "CD38 on myeloma",
            "probability": 0.002492447570472944,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.170457363128662
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba",
            "probability": 0.001663285202637907,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.600393295288086
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on myeloma cells.",
            "probability": 0.0015386798249829299,
            "start_logit": 0.6046346426010132,
            "end_logit": -6.678263187408447
        },
        {
            "text": "CD38 on myeloma cells.",
            "probability": 0.0014999913830184021,
            "start_logit": 0.5791692137718201,
            "end_logit": -6.678263187408447
        },
        {
            "text": "recognizes CD38",
            "probability": 0.0012464217567206375,
            "start_logit": -4.883016109466553,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.0007867646019757443,
            "start_logit": -5.343119144439697,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "that recognizes CD38",
            "probability": 0.0007236739693020412,
            "start_logit": -5.4267072677612305,
            "end_logit": -1.4012603759765625
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes",
            "probability": 0.0006965692246410182,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.470776081085205
        },
        {
            "text": "(DARA), a promising novel therapy for multiple",
            "probability": 0.0006450401680934554,
            "start_logit": -5.718038082122803,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "CD",
            "probability": 0.0006221520319550962,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.558293342590332
        },
        {
            "text": "multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38 on",
            "probability": 0.0005750440760643755,
            "start_logit": 0.6046346426010132,
            "end_logit": -7.662496566772461
        },
        {
            "text": "CD38 on",
            "probability": 0.0005605852139914236,
            "start_logit": 0.5791692137718201,
            "end_logit": -7.662496566772461
        },
        {
            "text": "for multiple",
            "probability": 0.0005108674348443766,
            "start_logit": -5.951240539550781,
            "end_logit": -1.2249579429626465
        },
        {
            "text": "for multiple myeloma, is an IgG1\u03ba monoclonal antibody that recognizes CD38",
            "probability": 0.00042829306840921335,
            "start_logit": -5.951240539550781,
            "end_logit": -1.4012603759765625
        }
    ],
    "56bc932aac7ad1001900001c_014": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56bc932aac7ad1001900001c_015": [
        {
            "text": "CD38",
            "probability": 0.9781067372226243,
            "start_logit": 6.991227626800537,
            "end_logit": 3.135054111480713
        },
        {
            "text": "anti-CS-1 mAb, elotuzumab, and the anti-CD38",
            "probability": 0.015258476788929304,
            "start_logit": 2.8307440280914307,
            "end_logit": 3.135054111480713
        },
        {
            "text": "CD",
            "probability": 0.004465015472474998,
            "start_logit": 6.991227626800537,
            "end_logit": -2.2542920112609863
        },
        {
            "text": "anti-CS-1",
            "probability": 0.0016166475695532732,
            "start_logit": 2.8307440280914307,
            "end_logit": 0.8902735114097595
        },
        {
            "text": "anti-CD38",
            "probability": 0.00041757884607161033,
            "start_logit": -0.7676730751991272,
            "end_logit": 3.135054111480713
        },
        {
            "text": "anti-CD38 mAb,",
            "probability": 3.1736943233550614e-05,
            "start_logit": 6.991227626800537,
            "end_logit": -7.200838565826416
        },
        {
            "text": "anti-CD38 mAb, daratumumab,",
            "probability": 2.347838629274868e-05,
            "start_logit": 6.991227626800537,
            "end_logit": -7.50223970413208
        },
        {
            "text": "anti-CD38 mAb, daratumumab, which are currently being evaluated in Phase III",
            "probability": 2.2602534343632877e-05,
            "start_logit": 6.991227626800537,
            "end_logit": -7.540257930755615
        },
        {
            "text": "anti-CD38 mAb, daratumumab, which are currently being evaluated in Phase III clinical trials for MM.",
            "probability": 1.7155405430170045e-05,
            "start_logit": 6.991227626800537,
            "end_logit": -7.816006660461426
        },
        {
            "text": "38",
            "probability": 1.6726052053360776e-05,
            "start_logit": -3.9851789474487305,
            "end_logit": 3.135054111480713
        },
        {
            "text": "anti-CD38 mAb, daratumumab, which are currently being evaluated in Phase III clinical trials",
            "probability": 1.597104260368935e-05,
            "start_logit": 6.991227626800537,
            "end_logit": -7.887542724609375
        },
        {
            "text": "the anti-CD38",
            "probability": 2.831380357460385e-06,
            "start_logit": -5.761382102966309,
            "end_logit": 3.135054111480713
        },
        {
            "text": "the anti-CS-1 mAb, elotuzumab, and the anti-CD38",
            "probability": 1.1118069947542202e-06,
            "start_logit": -6.696159839630127,
            "end_logit": 3.135054111480713
        },
        {
            "text": "CS",
            "probability": 1.0185003588669443e-06,
            "start_logit": 2.8307440280914307,
            "end_logit": -6.4795050621032715
        },
        {
            "text": "1",
            "probability": 8.192694170419844e-07,
            "start_logit": -4.756708145141602,
            "end_logit": 0.8902735114097595
        },
        {
            "text": "elotuzumab, and the anti-CD38",
            "probability": 5.827316137848571e-07,
            "start_logit": -7.342175006866455,
            "end_logit": 3.135054111480713
        },
        {
            "text": "anti-CS-1 mAb, elotuzumab, and the anti-CD38 mAb,",
            "probability": 4.950966936959953e-07,
            "start_logit": 2.8307440280914307,
            "end_logit": -7.200838565826416
        },
        {
            "text": "anti-CS-1 mAb, elotuzumab, and the anti-CD38 mAb, daratumumab,",
            "probability": 3.662631067307357e-07,
            "start_logit": 2.8307440280914307,
            "end_logit": -7.50223970413208
        },
        {
            "text": "anti-CS-1 mAb,",
            "probability": 3.64489152128555e-07,
            "start_logit": 2.8307440280914307,
            "end_logit": -7.507094860076904
        },
        {
            "text": "anti-CS-1 mAb, elotuzumab,",
            "probability": 2.841986950944634e-07,
            "start_logit": 2.8307440280914307,
            "end_logit": -7.755918025970459
        }
    ],
    "56bc932aac7ad1001900001c_016": [
        {
            "text": "multiple myeloma.",
            "probability": 0.972932859519667,
            "start_logit": 4.205234527587891,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 0.02112098783823136,
            "start_logit": 0.3751866817474365,
            "end_logit": 3.777590274810791
        },
        {
            "text": "multiple",
            "probability": 0.00478657432230425,
            "start_logit": 4.205234527587891,
            "end_logit": -1.536909818649292
        },
        {
            "text": "especially multiple myeloma.",
            "probability": 0.0005913174314789603,
            "start_logit": -3.2004828453063965,
            "end_logit": 3.777590274810791
        },
        {
            "text": ".",
            "probability": 0.00020962693230305835,
            "start_logit": -4.23750638961792,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38",
            "probability": 0.00011174453036359338,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple",
            "probability": 0.00010390971695425094,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.536909818649292
        },
        {
            "text": "myeloma.",
            "probability": 4.0446087798711286e-05,
            "start_logit": -5.882865905761719,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 3.39246517989228e-05,
            "start_logit": -6.058693885803223,
            "end_logit": 3.777590274810791
        },
        {
            "text": "malignancies, especially multiple myeloma.",
            "probability": 2.5206417336351562e-05,
            "start_logit": -6.355737209320068,
            "end_logit": 3.777590274810791
        },
        {
            "text": "of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.5082584101015358e-05,
            "start_logit": -6.869295120239258,
            "end_logit": 3.777590274810791
        },
        {
            "text": "targeting CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.3377072744620375e-05,
            "start_logit": -6.989293575286865,
            "end_logit": 3.777590274810791
        },
        {
            "text": "the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 9.68032525739701e-06,
            "start_logit": -7.312740325927734,
            "end_logit": 3.777590274810791
        },
        {
            "text": "especially multiple",
            "probability": 2.9091265714321166e-06,
            "start_logit": -3.2004828453063965,
            "end_logit": -1.536909818649292
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially",
            "probability": 1.28097920456648e-06,
            "start_logit": 0.3751866817474365,
            "end_logit": -5.932807445526123
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies,",
            "probability": 4.3850301603950546e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.004820823669434
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing",
            "probability": 1.7994102463769314e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.8955583572387695
        },
        {
            "text": "CD38-expressing malignancies, especially multiple",
            "probability": 1.6690038331525193e-07,
            "start_logit": -6.058693885803223,
            "end_logit": -1.536909818649292
        },
        {
            "text": "anti-cancer drug targeting CD38,",
            "probability": 1.4366494481776774e-07,
            "start_logit": -6.281300067901611,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38,",
            "probability": 1.434545153728352e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -8.122169494628906
        }
    ],
    "56bc932aac7ad1001900001c_017": [
        {
            "text": "multiple myeloma.",
            "probability": 0.972932859519667,
            "start_logit": 4.205234527587891,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 0.02112098783823136,
            "start_logit": 0.3751866817474365,
            "end_logit": 3.777590274810791
        },
        {
            "text": "multiple",
            "probability": 0.00478657432230425,
            "start_logit": 4.205234527587891,
            "end_logit": -1.536909818649292
        },
        {
            "text": "especially multiple myeloma.",
            "probability": 0.0005913174314789603,
            "start_logit": -3.2004828453063965,
            "end_logit": 3.777590274810791
        },
        {
            "text": ".",
            "probability": 0.00020962693230305835,
            "start_logit": -4.23750638961792,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38",
            "probability": 0.00011174453036359338,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple",
            "probability": 0.00010390971695425094,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.536909818649292
        },
        {
            "text": "myeloma.",
            "probability": 4.0446087798711286e-05,
            "start_logit": -5.882865905761719,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 3.39246517989228e-05,
            "start_logit": -6.058693885803223,
            "end_logit": 3.777590274810791
        },
        {
            "text": "malignancies, especially multiple myeloma.",
            "probability": 2.5206417336351562e-05,
            "start_logit": -6.355737209320068,
            "end_logit": 3.777590274810791
        },
        {
            "text": "of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.5082584101015358e-05,
            "start_logit": -6.869295120239258,
            "end_logit": 3.777590274810791
        },
        {
            "text": "targeting CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.3377072744620375e-05,
            "start_logit": -6.989293575286865,
            "end_logit": 3.777590274810791
        },
        {
            "text": "the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 9.68032525739701e-06,
            "start_logit": -7.312740325927734,
            "end_logit": 3.777590274810791
        },
        {
            "text": "especially multiple",
            "probability": 2.9091265714321166e-06,
            "start_logit": -3.2004828453063965,
            "end_logit": -1.536909818649292
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially",
            "probability": 1.28097920456648e-06,
            "start_logit": 0.3751866817474365,
            "end_logit": -5.932807445526123
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies,",
            "probability": 4.3850301603950546e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.004820823669434
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing",
            "probability": 1.7994102463769314e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.8955583572387695
        },
        {
            "text": "CD38-expressing malignancies, especially multiple",
            "probability": 1.6690038331525193e-07,
            "start_logit": -6.058693885803223,
            "end_logit": -1.536909818649292
        },
        {
            "text": "anti-cancer drug targeting CD38,",
            "probability": 1.4366494481776774e-07,
            "start_logit": -6.281300067901611,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38,",
            "probability": 1.434545153728352e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -8.122169494628906
        }
    ],
    "56bc932aac7ad1001900001c_018": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56bc932aac7ad1001900001c_019": [
        {
            "text": "CD38",
            "probability": 0.8128754885287773,
            "start_logit": 2.666411876678467,
            "end_logit": 0.18259602785110474
        },
        {
            "text": "multiple myeloma patients with daratumumab, a novel anti-CD38",
            "probability": 0.09005893801605612,
            "start_logit": 0.46629825234413147,
            "end_logit": 0.18259602785110474
        },
        {
            "text": "anti-CD38 MoAb, resulted in false-positive",
            "probability": 0.04949228298825999,
            "start_logit": 2.666411876678467,
            "end_logit": -2.6161651611328125
        },
        {
            "text": "multiple",
            "probability": 0.030246170776370228,
            "start_logit": 0.46629825234413147,
            "end_logit": -0.9084987044334412
        },
        {
            "text": "multiple myeloma",
            "probability": 0.008710057254528258,
            "start_logit": 0.46629825234413147,
            "end_logit": -2.1533899307250977
        },
        {
            "text": "multiple myeloma patients with daratumumab, a novel anti-CD38 MoAb, resulted in false-positive",
            "probability": 0.0054832782004288734,
            "start_logit": 0.46629825234413147,
            "end_logit": -2.6161651611328125
        },
        {
            "text": "CD",
            "probability": 0.0009517246004301569,
            "start_logit": 2.666411876678467,
            "end_logit": -6.5674614906311035
        },
        {
            "text": "myeloma patients with daratumumab, a novel anti-CD38",
            "probability": 0.0008750288188016406,
            "start_logit": -4.167664527893066,
            "end_logit": 0.18259602785110474
        },
        {
            "text": "anti-CD38",
            "probability": 0.0006065660732879079,
            "start_logit": -4.534107685089111,
            "end_logit": 0.18259602785110474
        },
        {
            "text": "38",
            "probability": 0.0001835267617445784,
            "start_logit": -5.729560852050781,
            "end_logit": 0.18259602785110474
        },
        {
            "text": "anti-CD38 MoAb, resulted in false-positive indirect",
            "probability": 0.00018296451540189014,
            "start_logit": 2.666411876678467,
            "end_logit": -8.216444969177246
        },
        {
            "text": "anti-CD38 MoAb,",
            "probability": 9.363388045312388e-05,
            "start_logit": 2.666411876678467,
            "end_logit": -8.886344909667969
        },
        {
            "text": "myeloma",
            "probability": 8.462848084846078e-05,
            "start_logit": -4.167664527893066,
            "end_logit": -2.1533899307250977
        },
        {
            "text": "myeloma patients with daratumumab, a novel anti-CD38 MoAb, resulted in false-positive",
            "probability": 5.3276515941445454e-05,
            "start_logit": -4.167664527893066,
            "end_logit": -2.6161651611328125
        },
        {
            "text": "oma",
            "probability": 3.0362891139900863e-05,
            "start_logit": -5.192714214324951,
            "end_logit": -2.1533899307250977
        },
        {
            "text": "multiple myeloma patients with daratumumab, a novel anti-CD38 MoAb, resulted in false-positive indirect",
            "probability": 2.027074279424927e-05,
            "start_logit": 0.46629825234413147,
            "end_logit": -8.216444969177246
        },
        {
            "text": "positive",
            "probability": 1.610554551743211e-05,
            "start_logit": -5.363996505737305,
            "end_logit": -2.6161651611328125
        },
        {
            "text": "eloma",
            "probability": 1.336000340874491e-05,
            "start_logit": -6.013669967651367,
            "end_logit": -2.1533899307250977
        },
        {
            "text": "multiple myeloma patients with daratumumab, a novel",
            "probability": 1.1961654902980385e-05,
            "start_logit": 0.46629825234413147,
            "end_logit": -8.743917465209961
        },
        {
            "text": "multiple myeloma patients with daratumumab, a novel anti-CD38 MoAb,",
            "probability": 1.0373750906418385e-05,
            "start_logit": 0.46629825234413147,
            "end_logit": -8.886344909667969
        }
    ],
    "56bc932aac7ad1001900001c_020": [
        {
            "text": "CD38",
            "probability": 0.8128754885287773,
            "start_logit": 2.666411876678467,
            "end_logit": 0.18259602785110474
        },
        {
            "text": "multiple myeloma patients with daratumumab, a novel anti-CD38",
            "probability": 0.09005893801605612,
            "start_logit": 0.46629825234413147,
            "end_logit": 0.18259602785110474
        },
        {
            "text": "anti-CD38 MoAb, resulted in false-positive",
            "probability": 0.04949228298825999,
            "start_logit": 2.666411876678467,
            "end_logit": -2.6161651611328125
        },
        {
            "text": "multiple",
            "probability": 0.030246170776370228,
            "start_logit": 0.46629825234413147,
            "end_logit": -0.9084987044334412
        },
        {
            "text": "multiple myeloma",
            "probability": 0.008710057254528258,
            "start_logit": 0.46629825234413147,
            "end_logit": -2.1533899307250977
        },
        {
            "text": "multiple myeloma patients with daratumumab, a novel anti-CD38 MoAb, resulted in false-positive",
            "probability": 0.0054832782004288734,
            "start_logit": 0.46629825234413147,
            "end_logit": -2.6161651611328125
        },
        {
            "text": "CD",
            "probability": 0.0009517246004301569,
            "start_logit": 2.666411876678467,
            "end_logit": -6.5674614906311035
        },
        {
            "text": "myeloma patients with daratumumab, a novel anti-CD38",
            "probability": 0.0008750288188016406,
            "start_logit": -4.167664527893066,
            "end_logit": 0.18259602785110474
        },
        {
            "text": "anti-CD38",
            "probability": 0.0006065660732879079,
            "start_logit": -4.534107685089111,
            "end_logit": 0.18259602785110474
        },
        {
            "text": "38",
            "probability": 0.0001835267617445784,
            "start_logit": -5.729560852050781,
            "end_logit": 0.18259602785110474
        },
        {
            "text": "anti-CD38 MoAb, resulted in false-positive indirect",
            "probability": 0.00018296451540189014,
            "start_logit": 2.666411876678467,
            "end_logit": -8.216444969177246
        },
        {
            "text": "anti-CD38 MoAb,",
            "probability": 9.363388045312388e-05,
            "start_logit": 2.666411876678467,
            "end_logit": -8.886344909667969
        },
        {
            "text": "myeloma",
            "probability": 8.462848084846078e-05,
            "start_logit": -4.167664527893066,
            "end_logit": -2.1533899307250977
        },
        {
            "text": "myeloma patients with daratumumab, a novel anti-CD38 MoAb, resulted in false-positive",
            "probability": 5.3276515941445454e-05,
            "start_logit": -4.167664527893066,
            "end_logit": -2.6161651611328125
        },
        {
            "text": "oma",
            "probability": 3.0362891139900863e-05,
            "start_logit": -5.192714214324951,
            "end_logit": -2.1533899307250977
        },
        {
            "text": "multiple myeloma patients with daratumumab, a novel anti-CD38 MoAb, resulted in false-positive indirect",
            "probability": 2.027074279424927e-05,
            "start_logit": 0.46629825234413147,
            "end_logit": -8.216444969177246
        },
        {
            "text": "positive",
            "probability": 1.610554551743211e-05,
            "start_logit": -5.363996505737305,
            "end_logit": -2.6161651611328125
        },
        {
            "text": "eloma",
            "probability": 1.336000340874491e-05,
            "start_logit": -6.013669967651367,
            "end_logit": -2.1533899307250977
        },
        {
            "text": "multiple myeloma patients with daratumumab, a novel",
            "probability": 1.1961654902980385e-05,
            "start_logit": 0.46629825234413147,
            "end_logit": -8.743917465209961
        },
        {
            "text": "multiple myeloma patients with daratumumab, a novel anti-CD38 MoAb,",
            "probability": 1.0373750906418385e-05,
            "start_logit": 0.46629825234413147,
            "end_logit": -8.886344909667969
        }
    ],
    "56bc932aac7ad1001900001c_021": [
        {
            "text": "CD38",
            "probability": 0.9996208369204432,
            "start_logit": 7.384737491607666,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "CD",
            "probability": 0.00016434281733537862,
            "start_logit": 7.384737491607666,
            "end_logit": -2.8545165061950684
        },
        {
            "text": "anti-CD38",
            "probability": 0.00015070756421380622,
            "start_logit": -1.4150525331497192,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "38",
            "probability": 5.019414862276267e-05,
            "start_logit": -2.514495372772217,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma (MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 4.708033423118722e-06,
            "start_logit": -4.8811235427856445,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.6038989637661698e-06,
            "start_logit": -5.957956314086914,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "(MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.5991909037846911e-06,
            "start_logit": -5.960896015167236,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.4980038503217864e-06,
            "start_logit": -6.0262603759765625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 1.2624169155965069e-06,
            "start_logit": 7.384737491607666,
            "end_logit": -7.723443031311035
        },
        {
            "text": "remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 8.964263862696866e-07,
            "start_logit": -6.539732933044434,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.939986814360017e-07,
            "start_logit": -6.951272010803223,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 5.913720674116558e-07,
            "start_logit": -6.9557037353515625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "an anti-CD38",
            "probability": 5.834854688452387e-07,
            "start_logit": -6.96912956237793,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.81263334108885e-07,
            "start_logit": -6.972945213317871,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma",
            "probability": 1.8931340235937844e-10,
            "start_logit": -4.8811235427856445,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma therapy]. Multiple myeloma",
            "probability": 1.3408125902082662e-10,
            "start_logit": -5.226081371307373,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma",
            "probability": 4.743248031836347e-11,
            "start_logit": -5.226081371307373,
            "end_logit": -5.301855564117432
        },
        {
            "text": "[Daratumumab--breakthrough drug in multiple myeloma therapy]. Multiple myeloma",
            "probability": 3.434595265807506e-11,
            "start_logit": -6.588043212890625,
            "end_logit": -4.262716770172119
        },
        {
            "text": "Multiple",
            "probability": 3.062006762037403e-11,
            "start_logit": -4.8811235427856445,
            "end_logit": -6.084465026855469
        },
        {
            "text": "myeloma therapy]. Multiple myeloma",
            "probability": 2.3597378307973795e-11,
            "start_logit": -6.9633917808532715,
            "end_logit": -4.262716770172119
        }
    ],
    "56bc932aac7ad1001900001c_022": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56bc932aac7ad1001900001c_023": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56bc932aac7ad1001900001c_024": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56bc932aac7ad1001900001c_025": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56bc932aac7ad1001900001c_026": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56bc932aac7ad1001900001c_027": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56bc932aac7ad1001900001c_028": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56bc932aac7ad1001900001c_029": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56bc932aac7ad1001900001c_030": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56bc932aac7ad1001900001c_031": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56bc932aac7ad1001900001c_032": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56bc932aac7ad1001900001c_033": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56bc932aac7ad1001900001c_034": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56bc932aac7ad1001900001c_035": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56bc932aac7ad1001900001c_036": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56bc932aac7ad1001900001c_037": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56bc932aac7ad1001900001c_038": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56bc932aac7ad1001900001c_039": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56bc932aac7ad1001900001c_040": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56bc932aac7ad1001900001c_041": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56bc932aac7ad1001900001c_042": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56bc932aac7ad1001900001c_043": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56bc932aac7ad1001900001c_044": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56bc932aac7ad1001900001c_045": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56bc932aac7ad1001900001c_046": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56bc932aac7ad1001900001c_047": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56bc932aac7ad1001900001c_048": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56bc932aac7ad1001900001c_049": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56bc932aac7ad1001900001c_050": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56bc932aac7ad1001900001c_051": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56bc932aac7ad1001900001c_052": [
        {
            "text": "CD38",
            "probability": 0.9996208369204432,
            "start_logit": 7.384737491607666,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "CD",
            "probability": 0.00016434281733537862,
            "start_logit": 7.384737491607666,
            "end_logit": -2.8545165061950684
        },
        {
            "text": "anti-CD38",
            "probability": 0.00015070756421380622,
            "start_logit": -1.4150525331497192,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "38",
            "probability": 5.019414862276267e-05,
            "start_logit": -2.514495372772217,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma (MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 4.708033423118722e-06,
            "start_logit": -4.8811235427856445,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.6038989637661698e-06,
            "start_logit": -5.957956314086914,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "(MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.5991909037846911e-06,
            "start_logit": -5.960896015167236,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.4980038503217864e-06,
            "start_logit": -6.0262603759765625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 1.2624169155965069e-06,
            "start_logit": 7.384737491607666,
            "end_logit": -7.723443031311035
        },
        {
            "text": "remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 8.964263862696866e-07,
            "start_logit": -6.539732933044434,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.939986814360017e-07,
            "start_logit": -6.951272010803223,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 5.913720674116558e-07,
            "start_logit": -6.9557037353515625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "an anti-CD38",
            "probability": 5.834854688452387e-07,
            "start_logit": -6.96912956237793,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.81263334108885e-07,
            "start_logit": -6.972945213317871,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma",
            "probability": 1.8931340235937844e-10,
            "start_logit": -4.8811235427856445,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma therapy]. Multiple myeloma",
            "probability": 1.3408125902082662e-10,
            "start_logit": -5.226081371307373,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma",
            "probability": 4.743248031836347e-11,
            "start_logit": -5.226081371307373,
            "end_logit": -5.301855564117432
        },
        {
            "text": "[Daratumumab--breakthrough drug in multiple myeloma therapy]. Multiple myeloma",
            "probability": 3.434595265807506e-11,
            "start_logit": -6.588043212890625,
            "end_logit": -4.262716770172119
        },
        {
            "text": "Multiple",
            "probability": 3.062006762037403e-11,
            "start_logit": -4.8811235427856445,
            "end_logit": -6.084465026855469
        },
        {
            "text": "myeloma therapy]. Multiple myeloma",
            "probability": 2.3597378307973795e-11,
            "start_logit": -6.9633917808532715,
            "end_logit": -4.262716770172119
        }
    ],
    "56bc932aac7ad1001900001c_053": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56bc932aac7ad1001900001c_054": [
        {
            "text": "CD38",
            "probability": 0.9996208369204432,
            "start_logit": 7.384737491607666,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "CD",
            "probability": 0.00016434281733537862,
            "start_logit": 7.384737491607666,
            "end_logit": -2.8545165061950684
        },
        {
            "text": "anti-CD38",
            "probability": 0.00015070756421380622,
            "start_logit": -1.4150525331497192,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "38",
            "probability": 5.019414862276267e-05,
            "start_logit": -2.514495372772217,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma (MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 4.708033423118722e-06,
            "start_logit": -4.8811235427856445,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.6038989637661698e-06,
            "start_logit": -5.957956314086914,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "(MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.5991909037846911e-06,
            "start_logit": -5.960896015167236,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.4980038503217864e-06,
            "start_logit": -6.0262603759765625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 1.2624169155965069e-06,
            "start_logit": 7.384737491607666,
            "end_logit": -7.723443031311035
        },
        {
            "text": "remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 8.964263862696866e-07,
            "start_logit": -6.539732933044434,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.939986814360017e-07,
            "start_logit": -6.951272010803223,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 5.913720674116558e-07,
            "start_logit": -6.9557037353515625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "an anti-CD38",
            "probability": 5.834854688452387e-07,
            "start_logit": -6.96912956237793,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.81263334108885e-07,
            "start_logit": -6.972945213317871,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma",
            "probability": 1.8931340235937844e-10,
            "start_logit": -4.8811235427856445,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma therapy]. Multiple myeloma",
            "probability": 1.3408125902082662e-10,
            "start_logit": -5.226081371307373,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma",
            "probability": 4.743248031836347e-11,
            "start_logit": -5.226081371307373,
            "end_logit": -5.301855564117432
        },
        {
            "text": "[Daratumumab--breakthrough drug in multiple myeloma therapy]. Multiple myeloma",
            "probability": 3.434595265807506e-11,
            "start_logit": -6.588043212890625,
            "end_logit": -4.262716770172119
        },
        {
            "text": "Multiple",
            "probability": 3.062006762037403e-11,
            "start_logit": -4.8811235427856445,
            "end_logit": -6.084465026855469
        },
        {
            "text": "myeloma therapy]. Multiple myeloma",
            "probability": 2.3597378307973795e-11,
            "start_logit": -6.9633917808532715,
            "end_logit": -4.262716770172119
        }
    ],
    "56bc932aac7ad1001900001c_055": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56bc932aac7ad1001900001c_056": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56bc932aac7ad1001900001c_057": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56bc932aac7ad1001900001c_058": [
        {
            "text": "CD38",
            "probability": 0.9940513893779875,
            "start_logit": 2.128936529159546,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "human CD38",
            "probability": 0.0035574614519633353,
            "start_logit": -3.330183744430542,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 0.0007522945345324465,
            "start_logit": 2.128936529159546,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "38",
            "probability": 0.00033482357021691485,
            "start_logit": -5.867003917694092,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple",
            "probability": 0.0001929350103905734,
            "start_logit": 2.128936529159546,
            "end_logit": -7.447241306304932
        },
        {
            "text": "CD",
            "probability": 0.00019158799942697047,
            "start_logit": 2.128936529159546,
            "end_logit": -7.45424747467041
        },
        {
            "text": "the human CD38",
            "probability": 0.00018052642620359813,
            "start_logit": -6.3111090660095215,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+",
            "probability": 0.00016927434236433154,
            "start_logit": 2.128936529159546,
            "end_logit": -7.578073978424072
        },
        {
            "text": "enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00015160225669632173,
            "start_logit": -6.4857258796691895,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody daratumumab.",
            "probability": 0.00014401814942305614,
            "start_logit": 1.5851339101791382,
            "end_logit": -7.195852756500244
        },
        {
            "text": "elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.0001252607076437193,
            "start_logit": -6.676589012145996,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00011044724276670223,
            "start_logit": -6.802448272705078,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.172053403685847e-05,
            "start_logit": -3.8886492252349854,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 1.3274022617573006e-06,
            "start_logit": -4.210967540740967,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "multiple",
            "probability": 1.2461911231588266e-06,
            "start_logit": -3.8886492252349854,
            "end_logit": -6.471917152404785
        },
        {
            "text": "myeloma.",
            "probability": 1.103881478302232e-06,
            "start_logit": -7.246780872344971,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody daratumumab.",
            "probability": 1.0561409742157727e-06,
            "start_logit": -3.330183744430542,
            "end_logit": -7.195852756500244
        },
        {
            "text": ".",
            "probability": 8.498050076495867e-07,
            "start_logit": -7.50836181640625,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "of multiple myeloma.",
            "probability": 6.889893064566347e-07,
            "start_logit": -7.718142986297607,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "CD38+ multiple myeloma",
            "probability": 3.859861961953524e-07,
            "start_logit": -5.446145057678223,
            "end_logit": -6.0864667892456055
        }
    ],
    "56bc932aac7ad1001900001c_059": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56bc932aac7ad1001900001c_060": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56bc932aac7ad1001900001c_061": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56bc932aac7ad1001900001c_062": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56bc932aac7ad1001900001c_063": [
        {
            "text": "CD38",
            "probability": 0.9940513893779875,
            "start_logit": 2.128936529159546,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "human CD38",
            "probability": 0.0035574614519633353,
            "start_logit": -3.330183744430542,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 0.0007522945345324465,
            "start_logit": 2.128936529159546,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "38",
            "probability": 0.00033482357021691485,
            "start_logit": -5.867003917694092,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple",
            "probability": 0.0001929350103905734,
            "start_logit": 2.128936529159546,
            "end_logit": -7.447241306304932
        },
        {
            "text": "CD",
            "probability": 0.00019158799942697047,
            "start_logit": 2.128936529159546,
            "end_logit": -7.45424747467041
        },
        {
            "text": "the human CD38",
            "probability": 0.00018052642620359813,
            "start_logit": -6.3111090660095215,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+",
            "probability": 0.00016927434236433154,
            "start_logit": 2.128936529159546,
            "end_logit": -7.578073978424072
        },
        {
            "text": "enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00015160225669632173,
            "start_logit": -6.4857258796691895,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody daratumumab.",
            "probability": 0.00014401814942305614,
            "start_logit": 1.5851339101791382,
            "end_logit": -7.195852756500244
        },
        {
            "text": "elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.0001252607076437193,
            "start_logit": -6.676589012145996,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00011044724276670223,
            "start_logit": -6.802448272705078,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.172053403685847e-05,
            "start_logit": -3.8886492252349854,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 1.3274022617573006e-06,
            "start_logit": -4.210967540740967,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "multiple",
            "probability": 1.2461911231588266e-06,
            "start_logit": -3.8886492252349854,
            "end_logit": -6.471917152404785
        },
        {
            "text": "myeloma.",
            "probability": 1.103881478302232e-06,
            "start_logit": -7.246780872344971,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody daratumumab.",
            "probability": 1.0561409742157727e-06,
            "start_logit": -3.330183744430542,
            "end_logit": -7.195852756500244
        },
        {
            "text": ".",
            "probability": 8.498050076495867e-07,
            "start_logit": -7.50836181640625,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "of multiple myeloma.",
            "probability": 6.889893064566347e-07,
            "start_logit": -7.718142986297607,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "CD38+ multiple myeloma",
            "probability": 3.859861961953524e-07,
            "start_logit": -5.446145057678223,
            "end_logit": -6.0864667892456055
        }
    ],
    "56bc932aac7ad1001900001c_064": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56bc932aac7ad1001900001c_065": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56bc932aac7ad1001900001c_066": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56bc932aac7ad1001900001c_067": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56bc932aac7ad1001900001c_068": [
        {
            "text": "CD38",
            "probability": 0.9940513893779875,
            "start_logit": 2.128936529159546,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "human CD38",
            "probability": 0.0035574614519633353,
            "start_logit": -3.330183744430542,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 0.0007522945345324465,
            "start_logit": 2.128936529159546,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "38",
            "probability": 0.00033482357021691485,
            "start_logit": -5.867003917694092,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple",
            "probability": 0.0001929350103905734,
            "start_logit": 2.128936529159546,
            "end_logit": -7.447241306304932
        },
        {
            "text": "CD",
            "probability": 0.00019158799942697047,
            "start_logit": 2.128936529159546,
            "end_logit": -7.45424747467041
        },
        {
            "text": "the human CD38",
            "probability": 0.00018052642620359813,
            "start_logit": -6.3111090660095215,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+",
            "probability": 0.00016927434236433154,
            "start_logit": 2.128936529159546,
            "end_logit": -7.578073978424072
        },
        {
            "text": "enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00015160225669632173,
            "start_logit": -6.4857258796691895,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody daratumumab.",
            "probability": 0.00014401814942305614,
            "start_logit": 1.5851339101791382,
            "end_logit": -7.195852756500244
        },
        {
            "text": "elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.0001252607076437193,
            "start_logit": -6.676589012145996,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00011044724276670223,
            "start_logit": -6.802448272705078,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.172053403685847e-05,
            "start_logit": -3.8886492252349854,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 1.3274022617573006e-06,
            "start_logit": -4.210967540740967,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "multiple",
            "probability": 1.2461911231588266e-06,
            "start_logit": -3.8886492252349854,
            "end_logit": -6.471917152404785
        },
        {
            "text": "myeloma.",
            "probability": 1.103881478302232e-06,
            "start_logit": -7.246780872344971,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody daratumumab.",
            "probability": 1.0561409742157727e-06,
            "start_logit": -3.330183744430542,
            "end_logit": -7.195852756500244
        },
        {
            "text": ".",
            "probability": 8.498050076495867e-07,
            "start_logit": -7.50836181640625,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "of multiple myeloma.",
            "probability": 6.889893064566347e-07,
            "start_logit": -7.718142986297607,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "CD38+ multiple myeloma",
            "probability": 3.859861961953524e-07,
            "start_logit": -5.446145057678223,
            "end_logit": -6.0864667892456055
        }
    ],
    "56bc932aac7ad1001900001c_069": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56bc932aac7ad1001900001c_070": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56bc932aac7ad1001900001c_071": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56bc932aac7ad1001900001c_072": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56bc932aac7ad1001900001c_073": [
        {
            "text": "CD38",
            "probability": 0.9940513893779875,
            "start_logit": 2.128936529159546,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "human CD38",
            "probability": 0.0035574614519633353,
            "start_logit": -3.330183744430542,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 0.0007522945345324465,
            "start_logit": 2.128936529159546,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "38",
            "probability": 0.00033482357021691485,
            "start_logit": -5.867003917694092,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple",
            "probability": 0.0001929350103905734,
            "start_logit": 2.128936529159546,
            "end_logit": -7.447241306304932
        },
        {
            "text": "CD",
            "probability": 0.00019158799942697047,
            "start_logit": 2.128936529159546,
            "end_logit": -7.45424747467041
        },
        {
            "text": "the human CD38",
            "probability": 0.00018052642620359813,
            "start_logit": -6.3111090660095215,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+",
            "probability": 0.00016927434236433154,
            "start_logit": 2.128936529159546,
            "end_logit": -7.578073978424072
        },
        {
            "text": "enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00015160225669632173,
            "start_logit": -6.4857258796691895,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody daratumumab.",
            "probability": 0.00014401814942305614,
            "start_logit": 1.5851339101791382,
            "end_logit": -7.195852756500244
        },
        {
            "text": "elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.0001252607076437193,
            "start_logit": -6.676589012145996,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00011044724276670223,
            "start_logit": -6.802448272705078,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.172053403685847e-05,
            "start_logit": -3.8886492252349854,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 1.3274022617573006e-06,
            "start_logit": -4.210967540740967,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "multiple",
            "probability": 1.2461911231588266e-06,
            "start_logit": -3.8886492252349854,
            "end_logit": -6.471917152404785
        },
        {
            "text": "myeloma.",
            "probability": 1.103881478302232e-06,
            "start_logit": -7.246780872344971,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody daratumumab.",
            "probability": 1.0561409742157727e-06,
            "start_logit": -3.330183744430542,
            "end_logit": -7.195852756500244
        },
        {
            "text": ".",
            "probability": 8.498050076495867e-07,
            "start_logit": -7.50836181640625,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "of multiple myeloma.",
            "probability": 6.889893064566347e-07,
            "start_logit": -7.718142986297607,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "CD38+ multiple myeloma",
            "probability": 3.859861961953524e-07,
            "start_logit": -5.446145057678223,
            "end_logit": -6.0864667892456055
        }
    ],
    "56bc932aac7ad1001900001c_074": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56bc932aac7ad1001900001c_075": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56bc932aac7ad1001900001c_076": [
        {
            "text": "CD38",
            "probability": 0.9940513893779875,
            "start_logit": 2.128936529159546,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "human CD38",
            "probability": 0.0035574614519633353,
            "start_logit": -3.330183744430542,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 0.0007522945345324465,
            "start_logit": 2.128936529159546,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "38",
            "probability": 0.00033482357021691485,
            "start_logit": -5.867003917694092,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple",
            "probability": 0.0001929350103905734,
            "start_logit": 2.128936529159546,
            "end_logit": -7.447241306304932
        },
        {
            "text": "CD",
            "probability": 0.00019158799942697047,
            "start_logit": 2.128936529159546,
            "end_logit": -7.45424747467041
        },
        {
            "text": "the human CD38",
            "probability": 0.00018052642620359813,
            "start_logit": -6.3111090660095215,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+",
            "probability": 0.00016927434236433154,
            "start_logit": 2.128936529159546,
            "end_logit": -7.578073978424072
        },
        {
            "text": "enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00015160225669632173,
            "start_logit": -6.4857258796691895,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody daratumumab.",
            "probability": 0.00014401814942305614,
            "start_logit": 1.5851339101791382,
            "end_logit": -7.195852756500244
        },
        {
            "text": "elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.0001252607076437193,
            "start_logit": -6.676589012145996,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00011044724276670223,
            "start_logit": -6.802448272705078,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.172053403685847e-05,
            "start_logit": -3.8886492252349854,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 1.3274022617573006e-06,
            "start_logit": -4.210967540740967,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "multiple",
            "probability": 1.2461911231588266e-06,
            "start_logit": -3.8886492252349854,
            "end_logit": -6.471917152404785
        },
        {
            "text": "myeloma.",
            "probability": 1.103881478302232e-06,
            "start_logit": -7.246780872344971,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody daratumumab.",
            "probability": 1.0561409742157727e-06,
            "start_logit": -3.330183744430542,
            "end_logit": -7.195852756500244
        },
        {
            "text": ".",
            "probability": 8.498050076495867e-07,
            "start_logit": -7.50836181640625,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "of multiple myeloma.",
            "probability": 6.889893064566347e-07,
            "start_logit": -7.718142986297607,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "CD38+ multiple myeloma",
            "probability": 3.859861961953524e-07,
            "start_logit": -5.446145057678223,
            "end_logit": -6.0864667892456055
        }
    ],
    "56bc932aac7ad1001900001c_077": [
        {
            "text": "CD38",
            "probability": 0.9940513893779875,
            "start_logit": 2.128936529159546,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "human CD38",
            "probability": 0.0035574614519633353,
            "start_logit": -3.330183744430542,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 0.0007522945345324465,
            "start_logit": 2.128936529159546,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "38",
            "probability": 0.00033482357021691485,
            "start_logit": -5.867003917694092,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple",
            "probability": 0.0001929350103905734,
            "start_logit": 2.128936529159546,
            "end_logit": -7.447241306304932
        },
        {
            "text": "CD",
            "probability": 0.00019158799942697047,
            "start_logit": 2.128936529159546,
            "end_logit": -7.45424747467041
        },
        {
            "text": "the human CD38",
            "probability": 0.00018052642620359813,
            "start_logit": -6.3111090660095215,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+",
            "probability": 0.00016927434236433154,
            "start_logit": 2.128936529159546,
            "end_logit": -7.578073978424072
        },
        {
            "text": "enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00015160225669632173,
            "start_logit": -6.4857258796691895,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody daratumumab.",
            "probability": 0.00014401814942305614,
            "start_logit": 1.5851339101791382,
            "end_logit": -7.195852756500244
        },
        {
            "text": "elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.0001252607076437193,
            "start_logit": -6.676589012145996,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00011044724276670223,
            "start_logit": -6.802448272705078,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.172053403685847e-05,
            "start_logit": -3.8886492252349854,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 1.3274022617573006e-06,
            "start_logit": -4.210967540740967,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "multiple",
            "probability": 1.2461911231588266e-06,
            "start_logit": -3.8886492252349854,
            "end_logit": -6.471917152404785
        },
        {
            "text": "myeloma.",
            "probability": 1.103881478302232e-06,
            "start_logit": -7.246780872344971,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody daratumumab.",
            "probability": 1.0561409742157727e-06,
            "start_logit": -3.330183744430542,
            "end_logit": -7.195852756500244
        },
        {
            "text": ".",
            "probability": 8.498050076495867e-07,
            "start_logit": -7.50836181640625,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "of multiple myeloma.",
            "probability": 6.889893064566347e-07,
            "start_logit": -7.718142986297607,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "CD38+ multiple myeloma",
            "probability": 3.859861961953524e-07,
            "start_logit": -5.446145057678223,
            "end_logit": -6.0864667892456055
        }
    ],
    "56bc932aac7ad1001900001c_078": [
        {
            "text": "CD38",
            "probability": 0.9940513893779875,
            "start_logit": 2.128936529159546,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "human CD38",
            "probability": 0.0035574614519633353,
            "start_logit": -3.330183744430542,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 0.0007522945345324465,
            "start_logit": 2.128936529159546,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "38",
            "probability": 0.00033482357021691485,
            "start_logit": -5.867003917694092,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple",
            "probability": 0.0001929350103905734,
            "start_logit": 2.128936529159546,
            "end_logit": -7.447241306304932
        },
        {
            "text": "CD",
            "probability": 0.00019158799942697047,
            "start_logit": 2.128936529159546,
            "end_logit": -7.45424747467041
        },
        {
            "text": "the human CD38",
            "probability": 0.00018052642620359813,
            "start_logit": -6.3111090660095215,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+",
            "probability": 0.00016927434236433154,
            "start_logit": 2.128936529159546,
            "end_logit": -7.578073978424072
        },
        {
            "text": "enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00015160225669632173,
            "start_logit": -6.4857258796691895,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody daratumumab.",
            "probability": 0.00014401814942305614,
            "start_logit": 1.5851339101791382,
            "end_logit": -7.195852756500244
        },
        {
            "text": "elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.0001252607076437193,
            "start_logit": -6.676589012145996,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00011044724276670223,
            "start_logit": -6.802448272705078,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.172053403685847e-05,
            "start_logit": -3.8886492252349854,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 1.3274022617573006e-06,
            "start_logit": -4.210967540740967,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "multiple",
            "probability": 1.2461911231588266e-06,
            "start_logit": -3.8886492252349854,
            "end_logit": -6.471917152404785
        },
        {
            "text": "myeloma.",
            "probability": 1.103881478302232e-06,
            "start_logit": -7.246780872344971,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody daratumumab.",
            "probability": 1.0561409742157727e-06,
            "start_logit": -3.330183744430542,
            "end_logit": -7.195852756500244
        },
        {
            "text": ".",
            "probability": 8.498050076495867e-07,
            "start_logit": -7.50836181640625,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "of multiple myeloma.",
            "probability": 6.889893064566347e-07,
            "start_logit": -7.718142986297607,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "CD38+ multiple myeloma",
            "probability": 3.859861961953524e-07,
            "start_logit": -5.446145057678223,
            "end_logit": -6.0864667892456055
        }
    ],
    "56bc932aac7ad1001900001c_079": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56bc932aac7ad1001900001c_080": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56bc932aac7ad1001900001c_081": [
        {
            "text": "CD38",
            "probability": 0.9940513893779875,
            "start_logit": 2.128936529159546,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "human CD38",
            "probability": 0.0035574614519633353,
            "start_logit": -3.330183744430542,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 0.0007522945345324465,
            "start_logit": 2.128936529159546,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "38",
            "probability": 0.00033482357021691485,
            "start_logit": -5.867003917694092,
            "end_logit": 1.0999494791030884
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+ multiple",
            "probability": 0.0001929350103905734,
            "start_logit": 2.128936529159546,
            "end_logit": -7.447241306304932
        },
        {
            "text": "CD",
            "probability": 0.00019158799942697047,
            "start_logit": 2.128936529159546,
            "end_logit": -7.45424747467041
        },
        {
            "text": "the human CD38",
            "probability": 0.00018052642620359813,
            "start_logit": -6.3111090660095215,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody which kills CD38+",
            "probability": 0.00016927434236433154,
            "start_logit": 2.128936529159546,
            "end_logit": -7.578073978424072
        },
        {
            "text": "enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00015160225669632173,
            "start_logit": -6.4857258796691895,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "CD38 monoclonal antibody daratumumab.",
            "probability": 0.00014401814942305614,
            "start_logit": 1.5851339101791382,
            "end_logit": -7.195852756500244
        },
        {
            "text": "elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.0001252607076437193,
            "start_logit": -6.676589012145996,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38",
            "probability": 0.00011044724276670223,
            "start_logit": -6.802448272705078,
            "end_logit": 0.9263280630111694
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.172053403685847e-05,
            "start_logit": -3.8886492252349854,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody which kills CD38+ multiple myeloma",
            "probability": 1.3274022617573006e-06,
            "start_logit": -4.210967540740967,
            "end_logit": -6.0864667892456055
        },
        {
            "text": "multiple",
            "probability": 1.2461911231588266e-06,
            "start_logit": -3.8886492252349854,
            "end_logit": -6.471917152404785
        },
        {
            "text": "myeloma.",
            "probability": 1.103881478302232e-06,
            "start_logit": -7.246780872344971,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "human CD38 monoclonal antibody daratumumab.",
            "probability": 1.0561409742157727e-06,
            "start_logit": -3.330183744430542,
            "end_logit": -7.195852756500244
        },
        {
            "text": ".",
            "probability": 8.498050076495867e-07,
            "start_logit": -7.50836181640625,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "of multiple myeloma.",
            "probability": 6.889893064566347e-07,
            "start_logit": -7.718142986297607,
            "end_logit": -3.2350447177886963
        },
        {
            "text": "CD38+ multiple myeloma",
            "probability": 3.859861961953524e-07,
            "start_logit": -5.446145057678223,
            "end_logit": -6.0864667892456055
        }
    ],
    "56bc932aac7ad1001900001c_082": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56bc932aac7ad1001900001c_083": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56bc932aac7ad1001900001c_084": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56bc932aac7ad1001900001c_085": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56bc932aac7ad1001900001c_086": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56bc932aac7ad1001900001c_087": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56bc932aac7ad1001900001c_088": [
        {
            "text": "CD38",
            "probability": 0.9208184506323341,
            "start_logit": 3.6100568771362305,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 0.0696726888032458,
            "start_logit": 3.6100568771362305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. CD38,",
            "probability": 0.004511479041718656,
            "start_logit": 3.6100568771362305,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple",
            "probability": 0.003045631074508566,
            "start_logit": 3.6100568771362305,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0009814073152145844,
            "start_logit": -0.6525192260742188,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "38",
            "probability": 0.0002957932709932007,
            "start_logit": -4.433300495147705,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD",
            "probability": 0.0002643080585349994,
            "start_logit": 3.6100568771362305,
            "end_logit": -5.539218425750732
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38",
            "probability": 0.00012808239694262012,
            "start_logit": -5.27028751373291,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "multiple myeloma and other hematological tumors. CD38,",
            "probability": 6.354855266865641e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -2.701953411102295
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma",
            "probability": 6.223084771434949e-05,
            "start_logit": 0.0706939846277237,
            "end_logit": -3.446120023727417
        },
        {
            "text": "multiple",
            "probability": 4.2900664052286655e-05,
            "start_logit": -0.6525192260742188,
            "end_logit": -3.0948703289031982
        },
        {
            "text": "human CD38",
            "probability": 3.1195475255222765e-05,
            "start_logit": -6.682688236236572,
            "end_logit": 2.6166844367980957
        },
        {
            "text": "CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological",
            "probability": 2.5644392622146624e-05,
            "start_logit": 3.6100568771362305,
            "end_logit": -7.872008800506592
        },
        {
            "text": "oma",
            "probability": 1.9199039403305587e-05,
            "start_logit": -4.586646556854248,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple",
            "probability": 9.96725984570486e-06,
            "start_logit": 0.0706939846277237,
            "end_logit": -5.277665138244629
        },
        {
            "text": "induces killing of multiple myeloma",
            "probability": 9.884378482184818e-06,
            "start_logit": -5.250551223754883,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 9.691210006955103e-06,
            "start_logit": -5.27028751373291,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "myeloma",
            "probability": 2.9366167292273373e-06,
            "start_logit": -6.4642486572265625,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "of multiple myeloma",
            "probability": 2.6005993003730055e-06,
            "start_logit": -6.5857648849487305,
            "end_logit": 0.035229943692684174
        },
        {
            "text": "human CD38 monoclonal antibody, induces killing of multiple myeloma",
            "probability": 2.3603704270195147e-06,
            "start_logit": -6.682688236236572,
            "end_logit": 0.035229943692684174
        }
    ],
    "56bc932aac7ad1001900001c_089": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56bc932aac7ad1001900001c_090": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56bc932aac7ad1001900001c_091": [
        {
            "text": "CD38",
            "probability": 0.9996208369204432,
            "start_logit": 7.384737491607666,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "CD",
            "probability": 0.00016434281733537862,
            "start_logit": 7.384737491607666,
            "end_logit": -2.8545165061950684
        },
        {
            "text": "anti-CD38",
            "probability": 0.00015070756421380622,
            "start_logit": -1.4150525331497192,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "38",
            "probability": 5.019414862276267e-05,
            "start_logit": -2.514495372772217,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma (MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 4.708033423118722e-06,
            "start_logit": -4.8811235427856445,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.6038989637661698e-06,
            "start_logit": -5.957956314086914,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "(MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.5991909037846911e-06,
            "start_logit": -5.960896015167236,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.4980038503217864e-06,
            "start_logit": -6.0262603759765625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 1.2624169155965069e-06,
            "start_logit": 7.384737491607666,
            "end_logit": -7.723443031311035
        },
        {
            "text": "remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 8.964263862696866e-07,
            "start_logit": -6.539732933044434,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.939986814360017e-07,
            "start_logit": -6.951272010803223,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 5.913720674116558e-07,
            "start_logit": -6.9557037353515625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "an anti-CD38",
            "probability": 5.834854688452387e-07,
            "start_logit": -6.96912956237793,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.81263334108885e-07,
            "start_logit": -6.972945213317871,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma",
            "probability": 1.8931340235937844e-10,
            "start_logit": -4.8811235427856445,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma therapy]. Multiple myeloma",
            "probability": 1.3408125902082662e-10,
            "start_logit": -5.226081371307373,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma",
            "probability": 4.743248031836347e-11,
            "start_logit": -5.226081371307373,
            "end_logit": -5.301855564117432
        },
        {
            "text": "[Daratumumab--breakthrough drug in multiple myeloma therapy]. Multiple myeloma",
            "probability": 3.434595265807506e-11,
            "start_logit": -6.588043212890625,
            "end_logit": -4.262716770172119
        },
        {
            "text": "Multiple",
            "probability": 3.062006762037403e-11,
            "start_logit": -4.8811235427856445,
            "end_logit": -6.084465026855469
        },
        {
            "text": "myeloma therapy]. Multiple myeloma",
            "probability": 2.3597378307973795e-11,
            "start_logit": -6.9633917808532715,
            "end_logit": -4.262716770172119
        }
    ],
    "56bc932aac7ad1001900001c_092": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56bc932aac7ad1001900001c_093": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56bc932aac7ad1001900001c_094": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56bc932aac7ad1001900001c_095": [
        {
            "text": "CD38",
            "probability": 0.9996208369204432,
            "start_logit": 7.384737491607666,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "CD",
            "probability": 0.00016434281733537862,
            "start_logit": 7.384737491607666,
            "end_logit": -2.8545165061950684
        },
        {
            "text": "anti-CD38",
            "probability": 0.00015070756421380622,
            "start_logit": -1.4150525331497192,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "38",
            "probability": 5.019414862276267e-05,
            "start_logit": -2.514495372772217,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma (MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 4.708033423118722e-06,
            "start_logit": -4.8811235427856445,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.6038989637661698e-06,
            "start_logit": -5.957956314086914,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "(MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.5991909037846911e-06,
            "start_logit": -5.960896015167236,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.4980038503217864e-06,
            "start_logit": -6.0262603759765625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 1.2624169155965069e-06,
            "start_logit": 7.384737491607666,
            "end_logit": -7.723443031311035
        },
        {
            "text": "remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 8.964263862696866e-07,
            "start_logit": -6.539732933044434,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.939986814360017e-07,
            "start_logit": -6.951272010803223,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 5.913720674116558e-07,
            "start_logit": -6.9557037353515625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "an anti-CD38",
            "probability": 5.834854688452387e-07,
            "start_logit": -6.96912956237793,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.81263334108885e-07,
            "start_logit": -6.972945213317871,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma",
            "probability": 1.8931340235937844e-10,
            "start_logit": -4.8811235427856445,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma therapy]. Multiple myeloma",
            "probability": 1.3408125902082662e-10,
            "start_logit": -5.226081371307373,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma",
            "probability": 4.743248031836347e-11,
            "start_logit": -5.226081371307373,
            "end_logit": -5.301855564117432
        },
        {
            "text": "[Daratumumab--breakthrough drug in multiple myeloma therapy]. Multiple myeloma",
            "probability": 3.434595265807506e-11,
            "start_logit": -6.588043212890625,
            "end_logit": -4.262716770172119
        },
        {
            "text": "Multiple",
            "probability": 3.062006762037403e-11,
            "start_logit": -4.8811235427856445,
            "end_logit": -6.084465026855469
        },
        {
            "text": "myeloma therapy]. Multiple myeloma",
            "probability": 2.3597378307973795e-11,
            "start_logit": -6.9633917808532715,
            "end_logit": -4.262716770172119
        }
    ],
    "56bc932aac7ad1001900001c_096": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56bc932aac7ad1001900001c_097": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56bc932aac7ad1001900001c_098": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56bc932aac7ad1001900001c_099": [
        {
            "text": "CD38",
            "probability": 0.9996208369204432,
            "start_logit": 7.384737491607666,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "CD",
            "probability": 0.00016434281733537862,
            "start_logit": 7.384737491607666,
            "end_logit": -2.8545165061950684
        },
        {
            "text": "anti-CD38",
            "probability": 0.00015070756421380622,
            "start_logit": -1.4150525331497192,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "38",
            "probability": 5.019414862276267e-05,
            "start_logit": -2.514495372772217,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma (MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 4.708033423118722e-06,
            "start_logit": -4.8811235427856445,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.6038989637661698e-06,
            "start_logit": -5.957956314086914,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "(MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.5991909037846911e-06,
            "start_logit": -5.960896015167236,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.4980038503217864e-06,
            "start_logit": -6.0262603759765625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 1.2624169155965069e-06,
            "start_logit": 7.384737491607666,
            "end_logit": -7.723443031311035
        },
        {
            "text": "remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 8.964263862696866e-07,
            "start_logit": -6.539732933044434,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.939986814360017e-07,
            "start_logit": -6.951272010803223,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 5.913720674116558e-07,
            "start_logit": -6.9557037353515625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "an anti-CD38",
            "probability": 5.834854688452387e-07,
            "start_logit": -6.96912956237793,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.81263334108885e-07,
            "start_logit": -6.972945213317871,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma",
            "probability": 1.8931340235937844e-10,
            "start_logit": -4.8811235427856445,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma therapy]. Multiple myeloma",
            "probability": 1.3408125902082662e-10,
            "start_logit": -5.226081371307373,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma",
            "probability": 4.743248031836347e-11,
            "start_logit": -5.226081371307373,
            "end_logit": -5.301855564117432
        },
        {
            "text": "[Daratumumab--breakthrough drug in multiple myeloma therapy]. Multiple myeloma",
            "probability": 3.434595265807506e-11,
            "start_logit": -6.588043212890625,
            "end_logit": -4.262716770172119
        },
        {
            "text": "Multiple",
            "probability": 3.062006762037403e-11,
            "start_logit": -4.8811235427856445,
            "end_logit": -6.084465026855469
        },
        {
            "text": "myeloma therapy]. Multiple myeloma",
            "probability": 2.3597378307973795e-11,
            "start_logit": -6.9633917808532715,
            "end_logit": -4.262716770172119
        }
    ],
    "56bc932aac7ad1001900001c_100": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56bc932aac7ad1001900001c_101": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56bc932aac7ad1001900001c_102": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "56bc932aac7ad1001900001c_103": [
        {
            "text": "CD38",
            "probability": 0.9996208369204432,
            "start_logit": 7.384737491607666,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "CD",
            "probability": 0.00016434281733537862,
            "start_logit": 7.384737491607666,
            "end_logit": -2.8545165061950684
        },
        {
            "text": "anti-CD38",
            "probability": 0.00015070756421380622,
            "start_logit": -1.4150525331497192,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "38",
            "probability": 5.019414862276267e-05,
            "start_logit": -2.514495372772217,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma (MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 4.708033423118722e-06,
            "start_logit": -4.8811235427856445,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.6038989637661698e-06,
            "start_logit": -5.957956314086914,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "(MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.5991909037846911e-06,
            "start_logit": -5.960896015167236,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "treatment. Over the last 2 years, an anti-CD38",
            "probability": 1.4980038503217864e-06,
            "start_logit": -6.0262603759765625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 1.2624169155965069e-06,
            "start_logit": 7.384737491607666,
            "end_logit": -7.723443031311035
        },
        {
            "text": "remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 8.964263862696866e-07,
            "start_logit": -6.539732933044434,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.939986814360017e-07,
            "start_logit": -6.951272010803223,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 5.913720674116558e-07,
            "start_logit": -6.9557037353515625,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "an anti-CD38",
            "probability": 5.834854688452387e-07,
            "start_logit": -6.96912956237793,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "despite important recent advances in treatment. Over the last 2 years, an anti-CD38",
            "probability": 5.81263334108885e-07,
            "start_logit": -6.972945213317871,
            "end_logit": 5.8586602210998535
        },
        {
            "text": "Multiple myeloma",
            "probability": 1.8931340235937844e-10,
            "start_logit": -4.8811235427856445,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma therapy]. Multiple myeloma",
            "probability": 1.3408125902082662e-10,
            "start_logit": -5.226081371307373,
            "end_logit": -4.262716770172119
        },
        {
            "text": "multiple myeloma",
            "probability": 4.743248031836347e-11,
            "start_logit": -5.226081371307373,
            "end_logit": -5.301855564117432
        },
        {
            "text": "[Daratumumab--breakthrough drug in multiple myeloma therapy]. Multiple myeloma",
            "probability": 3.434595265807506e-11,
            "start_logit": -6.588043212890625,
            "end_logit": -4.262716770172119
        },
        {
            "text": "Multiple",
            "probability": 3.062006762037403e-11,
            "start_logit": -4.8811235427856445,
            "end_logit": -6.084465026855469
        },
        {
            "text": "myeloma therapy]. Multiple myeloma",
            "probability": 2.3597378307973795e-11,
            "start_logit": -6.9633917808532715,
            "end_logit": -4.262716770172119
        }
    ],
    "56bc932aac7ad1001900001c_104": [
        {
            "text": "CD38.",
            "probability": 0.9651930191989927,
            "start_logit": -0.47394421696662903,
            "end_logit": -2.626053810119629
        },
        {
            "text": "CD38",
            "probability": 0.02480011155340107,
            "start_logit": -0.47394421696662903,
            "end_logit": -6.287533760070801
        },
        {
            "text": "CD",
            "probability": 0.007617946974954777,
            "start_logit": -0.47394421696662903,
            "end_logit": -7.467875003814697
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 0.001013543753199406,
            "start_logit": -7.33281946182251,
            "end_logit": -2.626053810119629
        },
        {
            "text": "elotuzumab which targets CS1 and daratumumab which targets CD38.",
            "probability": 0.0008992448784941318,
            "start_logit": -7.45247220993042,
            "end_logit": -2.626053810119629
        },
        {
            "text": "myeloma-specific antigens.",
            "probability": 7.669337815672836e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antigens.",
            "probability": 4.1717990651682384e-05,
            "start_logit": -6.674309730529785,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple myeloma.",
            "probability": 4.1125007204076227e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.879631996154785
        },
        {
            "text": "myeloma-specific",
            "probability": 4.0628543643930435e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.1101837158203125
        },
        {
            "text": "for multiple myeloma. Multiple myeloma",
            "probability": 3.75886648878923e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -6.969545841217041
        },
        {
            "text": "multiple myeloma.",
            "probability": 3.5809029919061026e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.879631996154785
        },
        {
            "text": "multiple myeloma. Multiple myeloma",
            "probability": 3.2729808870518076e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -6.969545841217041
        },
        {
            "text": "myeloma",
            "probability": 2.8577941308438752e-05,
            "start_logit": -6.065426826477051,
            "end_logit": -7.462019443511963
        },
        {
            "text": "against myeloma-specific antigens.",
            "probability": 2.7206659617428278e-05,
            "start_logit": -7.101780414581299,
            "end_logit": -6.474839210510254
        },
        {
            "text": "for multiple",
            "probability": 2.158745402959392e-05,
            "start_logit": -6.283833026885986,
            "end_logit": -7.524136066436768
        },
        {
            "text": "immunotherapy using monoclonal antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 2.1126703662895446e-05,
            "start_logit": -7.3547043800354,
            "end_logit": -6.474839210510254
        },
        {
            "text": "antibodies (MoAbs) against myeloma-specific antigens.",
            "probability": 1.9034761909095325e-05,
            "start_logit": -7.458975315093994,
            "end_logit": -6.474839210510254
        },
        {
            "text": "multiple",
            "probability": 1.8796976335738182e-05,
            "start_logit": -6.4222493171691895,
            "end_logit": -7.524136066436768
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma.",
            "probability": 1.750812274498057e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.879631996154785
        },
        {
            "text": "daratumumab: emerging new monoclonal antibodies for multiple myeloma. Multiple myeloma",
            "probability": 1.60025980156407e-05,
            "start_logit": -7.137784481048584,
            "end_logit": -6.969545841217041
        }
    ],
    "56bc932aac7ad1001900001c_105": [
        {
            "text": "CD38.",
            "probability": 0.9994331066703492,
            "start_logit": 3.9432260990142822,
            "end_logit": 4.875473976135254
        },
        {
            "text": ".",
            "probability": 0.00036653960155539516,
            "start_logit": -3.9676108360290527,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD",
            "probability": 7.776413413931418e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -4.585789203643799
        },
        {
            "text": "targets CD38.",
            "probability": 6.969593588484011e-05,
            "start_logit": -5.627575397491455,
            "end_logit": 4.875473976135254
        },
        {
            "text": "CD38",
            "probability": 2.526002141731855e-05,
            "start_logit": 3.9432260990142822,
            "end_logit": -5.710246562957764
        },
        {
            "text": "which targets CD38.",
            "probability": 1.6671252782942314e-05,
            "start_logit": -7.0580315589904785,
            "end_logit": 4.875473976135254
        },
        {
            "text": "and daratumumab which targets CD38.",
            "probability": 1.0922008958436564e-05,
            "start_logit": -7.480937480926514,
            "end_logit": 4.875473976135254
        },
        {
            "text": "multiple myeloma].",
            "probability": 2.3521669998799888e-08,
            "start_logit": -4.693934440612793,
            "end_logit": -4.052142143249512
        },
        {
            "text": "against multiple myeloma].",
            "probability": 4.488538579494073e-09,
            "start_logit": -6.350329399108887,
            "end_logit": -4.052142143249512
        },
        {
            "text": "multiple myeloma]. Multiple myeloma",
            "probability": 3.222525583216343e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.039898872375488
        },
        {
            "text": "multiple",
            "probability": 3.134386619523361e-09,
            "start_logit": -4.693934440612793,
            "end_logit": -6.067630767822266
        },
        {
            "text": "myeloma].",
            "probability": 2.057036028586886e-09,
            "start_logit": -7.130590438842773,
            "end_logit": -4.052142143249512
        },
        {
            "text": "38",
            "probability": 6.939544462966828e-10,
            "start_logit": -6.559101104736328,
            "end_logit": -5.710246562957764
        },
        {
            "text": "targets",
            "probability": 6.275744712082264e-10,
            "start_logit": -5.627575397491455,
            "end_logit": -6.742316246032715
        },
        {
            "text": "against multiple myeloma]. Multiple myeloma",
            "probability": 6.149406230259668e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.039898872375488
        },
        {
            "text": "against multiple",
            "probability": 5.981214456923522e-10,
            "start_logit": -6.350329399108887,
            "end_logit": -6.067630767822266
        },
        {
            "text": "multiple myeloma]. Multiple",
            "probability": 5.12583225647189e-10,
            "start_logit": -4.693934440612793,
            "end_logit": -7.878356456756592
        },
        {
            "text": "Multiple myeloma",
            "probability": 4.097723951755541e-10,
            "start_logit": -6.756253242492676,
            "end_logit": -6.039898872375488
        },
        {
            "text": "myeloma]. Multiple myeloma",
            "probability": 2.818189026568777e-10,
            "start_logit": -7.130590438842773,
            "end_logit": -6.039898872375488
        },
        {
            "text": "ets",
            "probability": 2.1199028326196794e-10,
            "start_logit": -6.712897300720215,
            "end_logit": -6.742316246032715
        }
    ],
    "56bc932aac7ad1001900001c_106": [
        {
            "text": "CD38",
            "probability": 0.9982112558855035,
            "start_logit": 6.1450371742248535,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "CD38 epitope",
            "probability": 0.0010482787166685092,
            "start_logit": 6.1450371742248535,
            "end_logit": -3.456615686416626
        },
        {
            "text": "CD",
            "probability": 0.0004134036757701611,
            "start_logit": 6.1450371742248535,
            "end_logit": -4.387095928192139
        },
        {
            "text": "CD38 epitope with broad-spectrum killing activity.",
            "probability": 0.00016980807231891263,
            "start_logit": 6.1450371742248535,
            "end_logit": -5.276851654052734
        },
        {
            "text": "CD38 antigen",
            "probability": 3.649755245156182e-05,
            "start_logit": 4.7079758644104,
            "end_logit": -5.377213954925537
        },
        {
            "text": "Daratumumab is a novel, high-affinity, therapeutic human monoclonal antibody against unique CD38",
            "probability": 2.809256623507023e-05,
            "start_logit": -4.3331780433654785,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "unique CD38",
            "probability": 2.6125423518701468e-05,
            "start_logit": -4.405774116516113,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "38",
            "probability": 2.2859349104069274e-05,
            "start_logit": -4.539322853088379,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "multiple myeloma:",
            "probability": 2.2557732248622083e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "multiple",
            "probability": 1.4748399564234494e-05,
            "start_logit": 0.09913600981235504,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "against unique CD38",
            "probability": 4.258828598317194e-06,
            "start_logit": -6.219688892364502,
            "end_logit": 3.4021997451782227
        },
        {
            "text": "the CD38",
            "probability": 1.3040894545982005e-06,
            "start_logit": -6.037924766540527,
            "end_logit": 2.0369465351104736
        },
        {
            "text": "multiple myeloma: overview of the preclinical",
            "probability": 2.8634339643869487e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -5.616182804107666
        },
        {
            "text": "multiple myeloma: overview of the preclinical and clinical",
            "probability": 1.030572773760867e-07,
            "start_logit": 0.09913600981235504,
            "end_logit": -6.638089656829834
        },
        {
            "text": "treatment of multiple myeloma:",
            "probability": 8.747944454988746e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "myeloma:",
            "probability": 8.580580797505322e-08,
            "start_logit": -5.4726104736328125,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "the treatment of multiple myeloma:",
            "probability": 7.529101730744271e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "of multiple myeloma:",
            "probability": 6.531117968962931e-08,
            "start_logit": -5.7455339431762695,
            "end_logit": -1.2495414018630981
        },
        {
            "text": "treatment of multiple",
            "probability": 5.719465891602845e-08,
            "start_logit": -5.453293323516846,
            "end_logit": -1.6744847297668457
        },
        {
            "text": "the treatment of multiple",
            "probability": 4.9225781856493524e-08,
            "start_logit": -5.603336334228516,
            "end_logit": -1.6744847297668457
        }
    ],
    "56bc932aac7ad1001900001c_107": [
        {
            "text": "CD38",
            "probability": 0.7833978402552834,
            "start_logit": 1.9642837047576904,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1 (elotuzumab) and CD38",
            "probability": 0.19463849365010932,
            "start_logit": 0.5717869997024536,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CS-1",
            "probability": 0.016177273868747604,
            "start_logit": 0.5717869997024536,
            "end_logit": -2.282301902770996
        },
        {
            "text": "CD",
            "probability": 0.0022892979739696446,
            "start_logit": 1.9642837047576904,
            "end_logit": -5.630160808563232
        },
        {
            "text": "and CD38",
            "probability": 0.0004190570592524518,
            "start_logit": -5.56910514831543,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III",
            "probability": 0.00038266345776498406,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.419005393981934
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 0.0003459271046994729,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.519933223724365
        },
        {
            "text": "multiple",
            "probability": 0.0002828651739870647,
            "start_logit": -1.692991018295288,
            "end_logit": -4.063916206359863
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase II/III trials.",
            "probability": 0.0002799899344589221,
            "start_logit": 1.9642837047576904,
            "end_logit": -7.731407642364502
        },
        {
            "text": "multiple myeloma",
            "probability": 0.0002636544305405168,
            "start_logit": -1.692991018295288,
            "end_logit": -4.134247303009033
        },
        {
            "text": "Antibodies targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.0002579660901617602,
            "start_logit": -6.05428409576416,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "targeting CS-1 (elotuzumab) and CD38",
            "probability": 0.00025065816561867124,
            "start_logit": -6.083022117614746,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab)",
            "probability": 0.00020674451233438187,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.034677505493164
        },
        {
            "text": "38",
            "probability": 0.00018469819748376343,
            "start_logit": -6.3883891105651855,
            "end_logit": 0.20523464679718018
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced clinical phase",
            "probability": 0.00013192072115622498,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.483960151672363
        },
        {
            "text": "CD38 (daratumumab) in particular are currently undergoing advanced",
            "probability": 0.00012069275804373273,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.57291316986084
        },
        {
            "text": "CD38 (daratumumab) in particular are currently",
            "probability": 0.00011834570742657692,
            "start_logit": 1.9642837047576904,
            "end_logit": -8.592551231384277
        },
        {
            "text": "CS",
            "probability": 9.46132344975803e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.423867225646973
        },
        {
            "text": "CS-1 (elotuzumab) and CD38 (daratumumab) in particular are currently undergoing advanced clinical",
            "probability": 8.594704645791238e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.519933223724365
        },
        {
            "text": "CS-1 (elotuzumab)",
            "probability": 7.13506580061773e-05,
            "start_logit": 0.5717869997024536,
            "end_logit": -7.706058025360107
        }
    ],
    "56bc932aac7ad1001900001c_108": [
        {
            "text": "multiple myeloma.",
            "probability": 0.972932859519667,
            "start_logit": 4.205234527587891,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 0.02112098783823136,
            "start_logit": 0.3751866817474365,
            "end_logit": 3.777590274810791
        },
        {
            "text": "multiple",
            "probability": 0.00478657432230425,
            "start_logit": 4.205234527587891,
            "end_logit": -1.536909818649292
        },
        {
            "text": "especially multiple myeloma.",
            "probability": 0.0005913174314789603,
            "start_logit": -3.2004828453063965,
            "end_logit": 3.777590274810791
        },
        {
            "text": ".",
            "probability": 0.00020962693230305835,
            "start_logit": -4.23750638961792,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38",
            "probability": 0.00011174453036359338,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple",
            "probability": 0.00010390971695425094,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.536909818649292
        },
        {
            "text": "myeloma.",
            "probability": 4.0446087798711286e-05,
            "start_logit": -5.882865905761719,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 3.39246517989228e-05,
            "start_logit": -6.058693885803223,
            "end_logit": 3.777590274810791
        },
        {
            "text": "malignancies, especially multiple myeloma.",
            "probability": 2.5206417336351562e-05,
            "start_logit": -6.355737209320068,
            "end_logit": 3.777590274810791
        },
        {
            "text": "of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.5082584101015358e-05,
            "start_logit": -6.869295120239258,
            "end_logit": 3.777590274810791
        },
        {
            "text": "targeting CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.3377072744620375e-05,
            "start_logit": -6.989293575286865,
            "end_logit": 3.777590274810791
        },
        {
            "text": "the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 9.68032525739701e-06,
            "start_logit": -7.312740325927734,
            "end_logit": 3.777590274810791
        },
        {
            "text": "especially multiple",
            "probability": 2.9091265714321166e-06,
            "start_logit": -3.2004828453063965,
            "end_logit": -1.536909818649292
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially",
            "probability": 1.28097920456648e-06,
            "start_logit": 0.3751866817474365,
            "end_logit": -5.932807445526123
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies,",
            "probability": 4.3850301603950546e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.004820823669434
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing",
            "probability": 1.7994102463769314e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.8955583572387695
        },
        {
            "text": "CD38-expressing malignancies, especially multiple",
            "probability": 1.6690038331525193e-07,
            "start_logit": -6.058693885803223,
            "end_logit": -1.536909818649292
        },
        {
            "text": "anti-cancer drug targeting CD38,",
            "probability": 1.4366494481776774e-07,
            "start_logit": -6.281300067901611,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38,",
            "probability": 1.434545153728352e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -8.122169494628906
        }
    ],
    "56bc932aac7ad1001900001c_109": [
        {
            "text": "multiple myeloma.",
            "probability": 0.972932859519667,
            "start_logit": 4.205234527587891,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 0.02112098783823136,
            "start_logit": 0.3751866817474365,
            "end_logit": 3.777590274810791
        },
        {
            "text": "multiple",
            "probability": 0.00478657432230425,
            "start_logit": 4.205234527587891,
            "end_logit": -1.536909818649292
        },
        {
            "text": "especially multiple myeloma.",
            "probability": 0.0005913174314789603,
            "start_logit": -3.2004828453063965,
            "end_logit": 3.777590274810791
        },
        {
            "text": ".",
            "probability": 0.00020962693230305835,
            "start_logit": -4.23750638961792,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38",
            "probability": 0.00011174453036359338,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple",
            "probability": 0.00010390971695425094,
            "start_logit": 0.3751866817474365,
            "end_logit": -1.536909818649292
        },
        {
            "text": "myeloma.",
            "probability": 4.0446087798711286e-05,
            "start_logit": -5.882865905761719,
            "end_logit": 3.777590274810791
        },
        {
            "text": "CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 3.39246517989228e-05,
            "start_logit": -6.058693885803223,
            "end_logit": 3.777590274810791
        },
        {
            "text": "malignancies, especially multiple myeloma.",
            "probability": 2.5206417336351562e-05,
            "start_logit": -6.355737209320068,
            "end_logit": 3.777590274810791
        },
        {
            "text": "of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.5082584101015358e-05,
            "start_logit": -6.869295120239258,
            "end_logit": 3.777590274810791
        },
        {
            "text": "targeting CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 1.3377072744620375e-05,
            "start_logit": -6.989293575286865,
            "end_logit": 3.777590274810791
        },
        {
            "text": "the treatment of CD38-expressing malignancies, especially multiple myeloma.",
            "probability": 9.68032525739701e-06,
            "start_logit": -7.312740325927734,
            "end_logit": 3.777590274810791
        },
        {
            "text": "especially multiple",
            "probability": 2.9091265714321166e-06,
            "start_logit": -3.2004828453063965,
            "end_logit": -1.536909818649292
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies, especially",
            "probability": 1.28097920456648e-06,
            "start_logit": 0.3751866817474365,
            "end_logit": -5.932807445526123
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing malignancies,",
            "probability": 4.3850301603950546e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.004820823669434
        },
        {
            "text": "CD38, has been of great interest in the treatment of CD38-expressing",
            "probability": 1.7994102463769314e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -7.8955583572387695
        },
        {
            "text": "CD38-expressing malignancies, especially multiple",
            "probability": 1.6690038331525193e-07,
            "start_logit": -6.058693885803223,
            "end_logit": -1.536909818649292
        },
        {
            "text": "anti-cancer drug targeting CD38,",
            "probability": 1.4366494481776774e-07,
            "start_logit": -6.281300067901611,
            "end_logit": -1.464216947555542
        },
        {
            "text": "CD38,",
            "probability": 1.434545153728352e-07,
            "start_logit": 0.3751866817474365,
            "end_logit": -8.122169494628906
        }
    ],
    "56bc932aac7ad1001900001c_110": [
        {
            "text": "CD38",
            "probability": 0.9854350147614448,
            "start_logit": 5.355559825897217,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38",
            "probability": 0.014183153316916693,
            "start_logit": 1.1145315170288086,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "CD",
            "probability": 0.00021214423935522438,
            "start_logit": 5.355559825897217,
            "end_logit": -4.52622127532959
        },
        {
            "text": "38",
            "probability": 0.00012068833171809283,
            "start_logit": -3.652067184448242,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 1.6367413378375107e-05,
            "start_logit": 5.355559825897217,
            "end_logit": -7.088195323944092
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted",
            "probability": 6.484349036790827e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.0140962600708
        },
        {
            "text": "anti-CD38 monoclonal antibody",
            "probability": 5.7433467515543665e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.135445594787598
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab",
            "probability": 5.013771021114878e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.271299362182617
        },
        {
            "text": "anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy",
            "probability": 4.384593650810805e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.405390739440918
        },
        {
            "text": "anti-CD38 monoclonal",
            "probability": 4.1991701562661e-06,
            "start_logit": 5.355559825897217,
            "end_logit": -8.448600769042969
        },
        {
            "text": "Over the last 2 years, an anti-CD38",
            "probability": 3.267888349497152e-06,
            "start_logit": -7.261134624481201,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "an anti-CD38",
            "probability": 3.256009631640211e-06,
            "start_logit": -7.264776229858398,
            "end_logit": 3.9173507690429688
        },
        {
            "text": "anti",
            "probability": 2.824598631972456e-07,
            "start_logit": 1.1145315170288086,
            "end_logit": -6.906678199768066
        },
        {
            "text": "Multiple myeloma",
            "probability": 6.316990788936908e-11,
            "start_logit": -6.601231098175049,
            "end_logit": -7.596379280090332
        },
        {
            "text": "Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.4277429449311785e-11,
            "start_logit": -7.261134624481201,
            "end_logit": -7.088195323944092
        },
        {
            "text": "an anti-CD38 monoclonal antibody daratumumab (DARA)",
            "probability": 5.408013192826043e-11,
            "start_logit": -7.264776229858398,
            "end_logit": -7.088195323944092
        },
        {
            "text": "DARA",
            "probability": 5.167446393511055e-11,
            "start_logit": -7.310279369354248,
            "end_logit": -7.088195323944092
        },
        {
            "text": "daratumumab (DARA)",
            "probability": 4.8752929100021843e-11,
            "start_logit": -7.368477821350098,
            "end_logit": -7.088195323944092
        },
        {
            "text": "(DARA)",
            "probability": 4.505246723846571e-11,
            "start_logit": -7.447415351867676,
            "end_logit": -7.088195323944092
        },
        {
            "text": "monoclonal antibody daratumumab (DARA)",
            "probability": 3.1718524305404125e-11,
            "start_logit": -7.798342227935791,
            "end_logit": -7.088195323944092
        }
    ],
    "517194ef8ed59a060a000011_001": [
        {
            "text": "Plasmodium spp.,",
            "probability": 0.9995508207641581,
            "start_logit": 9.563980102539062,
            "end_logit": 8.521429061889648
        },
        {
            "text": "Pl",
            "probability": 0.00040017919375920325,
            "start_logit": 9.563980102539062,
            "end_logit": 0.6982802152633667
        },
        {
            "text": "spp.,",
            "probability": 4.675067953290971e-05,
            "start_logit": -0.406252384185791,
            "end_logit": 8.521429061889648
        },
        {
            "text": "Plasmodium spp., the",
            "probability": 9.72363164248e-07,
            "start_logit": 9.563980102539062,
            "end_logit": -5.321658134460449
        },
        {
            "text": "Plasmodium",
            "probability": 3.8032487567663163e-07,
            "start_logit": 9.563980102539062,
            "end_logit": -6.260361671447754
        },
        {
            "text": "Plas",
            "probability": 3.485364057935427e-07,
            "start_logit": 9.563980102539062,
            "end_logit": -6.347644805908203
        },
        {
            "text": "Plasmodium spp., the causative",
            "probability": 1.5117858101671455e-07,
            "start_logit": 9.563980102539062,
            "end_logit": -7.182925701141357
        },
        {
            "text": "Plasmodium spp., the causative agent of malaria,",
            "probability": 9.579277689115866e-08,
            "start_logit": 9.563980102539062,
            "end_logit": -7.639200210571289
        },
        {
            "text": "Plasmodium spp., the causative agent of malaria, rely mainly",
            "probability": 8.898172987734944e-08,
            "start_logit": 9.563980102539062,
            "end_logit": -7.712956428527832
        },
        {
            "text": "Plasmodium spp., the causative agent",
            "probability": 7.704201360875064e-08,
            "start_logit": 9.563980102539062,
            "end_logit": -7.857036590576172
        },
        {
            "text": "Plasmod",
            "probability": 6.977651706716665e-08,
            "start_logit": 9.563980102539062,
            "end_logit": -7.956089973449707
        },
        {
            "text": "central roles in energy production of most eukaryotes. In contrast, it has been thought that Plasmodium spp.,",
            "probability": 6.517782766310736e-08,
            "start_logit": -6.981717109680176,
            "end_logit": 8.521429061889648
        },
        {
            "text": "pp",
            "probability": 4.693753614994482e-11,
            "start_logit": -4.456573009490967,
            "end_logit": -1.2397719621658325
        },
        {
            "text": "spp., the",
            "probability": 4.5479066933896474e-11,
            "start_logit": -0.406252384185791,
            "end_logit": -5.321658134460449
        },
        {
            "text": "central roles in energy production of most eukaryotes. In contrast, it has been thought that Plasmodium",
            "probability": 2.609453164698344e-11,
            "start_logit": -6.981717109680176,
            "end_logit": 0.6982802152633667
        },
        {
            "text": "the mitochondria play central roles in energy production of most eukaryotes. In contrast, it has been thought that Plasmodium",
            "probability": 2.4334065461605578e-11,
            "start_logit": -7.051565647125244,
            "end_logit": 0.6982802152633667
        },
        {
            "text": "spp",
            "probability": 1.9819797972023432e-11,
            "start_logit": -5.318709373474121,
            "end_logit": -1.2397719621658325
        },
        {
            "text": "spp., the causative agent of malaria, rely mainly on cytosolic glycolysis but not mitochondrial oxidative",
            "probability": 1.093826531355362e-11,
            "start_logit": -0.406252384185791,
            "end_logit": -6.74664306640625
        },
        {
            "text": "spp., the causative agent of malaria, rely mainly on cytosolic glycolysis but not mitochondrial",
            "probability": 7.98354507764233e-12,
            "start_logit": -0.406252384185791,
            "end_logit": -7.061527729034424
        },
        {
            "text": "spp., the causative",
            "probability": 7.070877484697757e-12,
            "start_logit": -0.406252384185791,
            "end_logit": -7.182925701141357
        }
    ],
    "517194ef8ed59a060a000011_002": [
        {
            "text": "Plasmodium spp.",
            "probability": 0.9995676288802323,
            "start_logit": 9.29472827911377,
            "end_logit": 8.712043762207031
        },
        {
            "text": ".",
            "probability": 0.00029154224531207485,
            "start_logit": 1.1548351049423218,
            "end_logit": 8.712043762207031
        },
        {
            "text": "Pl",
            "probability": 0.00013498959194194912,
            "start_logit": 9.29472827911377,
            "end_logit": -0.19783665239810944
        },
        {
            "text": "spp.",
            "probability": 3.92854746264072e-06,
            "start_logit": -3.1520800590515137,
            "end_logit": 8.712043762207031
        },
        {
            "text": "the liver stages of the causative agent, Plasmodium spp.",
            "probability": 5.433491522478871e-07,
            "start_logit": -5.130352973937988,
            "end_logit": 8.712043762207031
        },
        {
            "text": "the causative agent, Plasmodium spp.",
            "probability": 3.212595738211818e-07,
            "start_logit": -5.655855655670166,
            "end_logit": 8.712043762207031
        },
        {
            "text": "agent, Plasmodium spp.",
            "probability": 2.2201172678649172e-07,
            "start_logit": -6.025374889373779,
            "end_logit": 8.712043762207031
        },
        {
            "text": "causative agent, Plasmodium spp.",
            "probability": 2.0964873734334075e-07,
            "start_logit": -6.082671642303467,
            "end_logit": 8.712043762207031
        },
        {
            "text": "Plas",
            "probability": 2.0800503787057238e-07,
            "start_logit": 9.29472827911377,
            "end_logit": -6.673227310180664
        },
        {
            "text": "liver stages of the causative agent, Plasmodium spp.",
            "probability": 2.0200801737918145e-07,
            "start_logit": -6.119797706604004,
            "end_logit": 8.712043762207031
        },
        {
            "text": "Plasmodium",
            "probability": 1.3030899940671325e-07,
            "start_logit": 9.29472827911377,
            "end_logit": -7.140881061553955
        },
        {
            "text": "Plasmod",
            "probability": 7.383412113399082e-08,
            "start_logit": 9.29472827911377,
            "end_logit": -7.708968639373779
        },
        {
            "text": "malaria, requires strong CD8(+) T cell responses targeted against the liver stages of the causative agent, Plasmodium",
            "probability": 7.405849198265822e-11,
            "start_logit": -5.121124744415283,
            "end_logit": -0.19783665239810944
        },
        {
            "text": "the liver stages of the causative agent, Plasmodium",
            "probability": 7.337820696145675e-11,
            "start_logit": -5.130352973937988,
            "end_logit": -0.19783665239810944
        },
        {
            "text": "the causative agent, Plasmodium",
            "probability": 4.338545739636192e-11,
            "start_logit": -5.655855655670166,
            "end_logit": -0.19783665239810944
        },
        {
            "text": "agent, Plasmodium",
            "probability": 2.9982235858127126e-11,
            "start_logit": -6.025374889373779,
            "end_logit": -0.19783665239810944
        },
        {
            "text": "causative agent, Plasmodium",
            "probability": 2.8312639072581827e-11,
            "start_logit": -6.082671642303467,
            "end_logit": -0.19783665239810944
        },
        {
            "text": "liver stages of the causative agent, Plasmodium",
            "probability": 2.7280775254362727e-11,
            "start_logit": -6.119797706604004,
            "end_logit": -0.19783665239810944
        },
        {
            "text": "requires strong CD8(+) T cell responses targeted against the liver stages of the causative agent, Plasmodium",
            "probability": 2.099407680842942e-11,
            "start_logit": -6.381739616394043,
            "end_logit": -0.19783665239810944
        },
        {
            "text": "pp",
            "probability": 1.2293298835276206e-11,
            "start_logit": -3.1520800590515137,
            "end_logit": -3.9626822471618652
        }
    ],
    "517194ef8ed59a060a000011_003": [
        {
            "text": "Plasmodium species,",
            "probability": 0.9996855925564199,
            "start_logit": 9.59717845916748,
            "end_logit": 8.927979469299316
        },
        {
            "text": "Pl",
            "probability": 0.00019613124271305985,
            "start_logit": 9.59717845916748,
            "end_logit": 0.3915674090385437
        },
        {
            "text": ",",
            "probability": 9.08509008188747e-05,
            "start_logit": 0.2912020683288574,
            "end_logit": 8.927979469299316
        },
        {
            "text": "species,",
            "probability": 1.4693257606128516e-05,
            "start_logit": -1.5306289196014404,
            "end_logit": 8.927979469299316
        },
        {
            "text": "Infection by Plasmodium species,",
            "probability": 4.556039916146711e-06,
            "start_logit": -2.701563835144043,
            "end_logit": 8.927979469299316
        },
        {
            "text": "Plasmodium species, the",
            "probability": 3.5516735863803186e-06,
            "start_logit": 9.59717845916748,
            "end_logit": -3.619797706604004
        },
        {
            "text": "Plasmodium species, the causative agent of malaria,",
            "probability": 3.2131450382885146e-06,
            "start_logit": 9.59717845916748,
            "end_logit": -3.719966411590576
        },
        {
            "text": "by Plasmodium species,",
            "probability": 7.413089528743979e-07,
            "start_logit": -4.517355442047119,
            "end_logit": 8.927979469299316
        },
        {
            "text": "Plasmodium species, the causative",
            "probability": 3.8696340285209987e-07,
            "start_logit": 9.59717845916748,
            "end_logit": -5.836641788482666
        },
        {
            "text": "Plasmodium species, the causative agent",
            "probability": 1.804418043357851e-07,
            "start_logit": 9.59717845916748,
            "end_logit": -6.5995635986328125
        },
        {
            "text": "Plas",
            "probability": 9.893280723522812e-08,
            "start_logit": 9.59717845916748,
            "end_logit": -7.200531005859375
        },
        {
            "text": "species",
            "probability": 1.8004524244760124e-09,
            "start_logit": -1.5306289196014404,
            "end_logit": -0.07912655174732208
        },
        {
            "text": "Infection by Plasmodium",
            "probability": 8.938628077244474e-10,
            "start_logit": -2.701563835144043,
            "end_logit": 0.3915674090385437
        },
        {
            "text": "species, the",
            "probability": 3.2277422735693216e-10,
            "start_logit": 0.2912020683288574,
            "end_logit": -3.619797706604004
        },
        {
            "text": "species, the causative agent of malaria,",
            "probability": 2.920089309716985e-10,
            "start_logit": 0.2912020683288574,
            "end_logit": -3.719966411590576
        },
        {
            "text": "by Plasmodium",
            "probability": 1.4543957344605533e-10,
            "start_logit": -4.517355442047119,
            "end_logit": 0.3915674090385437
        },
        {
            "text": "species, the causative",
            "probability": 3.5167030509211084e-11,
            "start_logit": 0.2912020683288574,
            "end_logit": -5.836641788482666
        },
        {
            "text": "species, the causative agent",
            "probability": 1.639845626600246e-11,
            "start_logit": 0.2912020683288574,
            "end_logit": -6.5995635986328125
        },
        {
            "text": "Infection by Plasmodium species, the",
            "probability": 1.6186655833753473e-11,
            "start_logit": -2.701563835144043,
            "end_logit": -3.619797706604004
        },
        {
            "text": "Infection by Plasmodium species, the causative agent of malaria,",
            "probability": 1.4643821177191787e-11,
            "start_logit": -2.701563835144043,
            "end_logit": -3.719966411590576
        }
    ],
    "53551206a0726bee57000001_001": [
        {
            "text": "cardiotoxicity",
            "probability": 0.998861285065391,
            "start_logit": 8.791321754455566,
            "end_logit": 8.234162330627441
        },
        {
            "text": "severe cardiotoxicity,",
            "probability": 0.0009534506989217473,
            "start_logit": 1.837038278579712,
            "end_logit": 8.234162330627441
        },
        {
            "text": "oxicity",
            "probability": 0.00010382703785814822,
            "start_logit": -0.38032302260398865,
            "end_logit": 8.234162330627441
        },
        {
            "text": "card",
            "probability": 4.9675226021616985e-05,
            "start_logit": 8.791321754455566,
            "end_logit": -1.674702525138855
        },
        {
            "text": "cardiotoxicity,",
            "probability": 1.9296285644200082e-05,
            "start_logit": 8.791321754455566,
            "end_logit": -2.6202962398529053
        },
        {
            "text": "the severe cardiotoxicity,",
            "probability": 6.944523191454531e-06,
            "start_logit": -3.0850961208343506,
            "end_logit": 8.234162330627441
        },
        {
            "text": "cardiotoxicity, the major adverse effect",
            "probability": 1.8747222075062138e-06,
            "start_logit": 8.791321754455566,
            "end_logit": -4.951748371124268
        },
        {
            "text": "cardiotoxicity, the major",
            "probability": 9.555408326053542e-07,
            "start_logit": 8.791321754455566,
            "end_logit": -5.6256866455078125
        },
        {
            "text": "cardiot",
            "probability": 8.723786264732577e-07,
            "start_logit": 8.791321754455566,
            "end_logit": -5.716740608215332
        },
        {
            "text": "iotoxicity",
            "probability": 5.561190808300783e-07,
            "start_logit": -5.6098222732543945,
            "end_logit": 8.234162330627441
        },
        {
            "text": "cardiotoxicity, the major adverse effect of the drug that limits its clinical usefulness.",
            "probability": 4.514346225306613e-07,
            "start_logit": 8.791321754455566,
            "end_logit": -6.375533580780029
        },
        {
            "text": "cardiotoxicity, the",
            "probability": 4.444137379255197e-07,
            "start_logit": 8.791321754455566,
            "end_logit": -6.391208171844482
        },
        {
            "text": "cardiotoxicity, the major adverse",
            "probability": 1.7692618326316404e-07,
            "start_logit": 8.791321754455566,
            "end_logit": -7.312231540679932
        },
        {
            "text": "adriamycin of these systems is related to the severe cardiotoxicity,",
            "probability": 1.073874761722932e-07,
            "start_logit": -7.254361152648926,
            "end_logit": 8.234162330627441
        },
        {
            "text": "related to the severe cardiotoxicity,",
            "probability": 7.332022637169159e-08,
            "start_logit": -7.635968208312988,
            "end_logit": 8.234162330627441
        },
        {
            "text": "severe",
            "probability": 5.3632643484028405e-09,
            "start_logit": 1.837038278579712,
            "end_logit": -3.8541078567504883
        },
        {
            "text": "severe cardiotoxicity, the major adverse effect",
            "probability": 1.7894929213458342e-09,
            "start_logit": 1.837038278579712,
            "end_logit": -4.951748371124268
        },
        {
            "text": "severe cardiotoxicity, the major",
            "probability": 9.120996962418063e-10,
            "start_logit": 1.837038278579712,
            "end_logit": -5.6256866455078125
        },
        {
            "text": "severe cardiotoxicity, the major adverse effect of the drug that limits its clinical usefulness.",
            "probability": 4.3091134154944907e-10,
            "start_logit": 1.837038278579712,
            "end_logit": -6.375533580780029
        },
        {
            "text": "severe cardiotoxicity, the",
            "probability": 4.242096428912785e-10,
            "start_logit": 1.837038278579712,
            "end_logit": -6.391208171844482
        }
    ],
    "53551206a0726bee57000001_002": [
        {
            "text": "Cardiotoxicity",
            "probability": 0.8677785419806472,
            "start_logit": 8.83482837677002,
            "end_logit": 8.068878173828125
        },
        {
            "text": "cardiotoxicity",
            "probability": 0.13175051432581428,
            "start_logit": 7.975954532623291,
            "end_logit": 7.042725563049316
        },
        {
            "text": "chronic cardiotoxicity",
            "probability": 0.00020489708211614884,
            "start_logit": 1.5097969770431519,
            "end_logit": 7.042725563049316
        },
        {
            "text": "Card",
            "probability": 0.00013244386556123005,
            "start_logit": 8.83482837677002,
            "end_logit": -0.7186547517776489
        },
        {
            "text": "oxicity",
            "probability": 0.00010102165946323034,
            "start_logit": -0.22352850437164307,
            "end_logit": 8.068878173828125
        },
        {
            "text": "card",
            "probability": 2.5998583439274697e-05,
            "start_logit": 7.975954532623291,
            "end_logit": -1.4878977537155151
        },
        {
            "text": "iotoxicity",
            "probability": 2.006897550247592e-06,
            "start_logit": -4.142273426055908,
            "end_logit": 8.068878173828125
        },
        {
            "text": "Cardiotoxicity is a major",
            "probability": 1.318769548595805e-06,
            "start_logit": 8.83482837677002,
            "end_logit": -5.3281145095825195
        },
        {
            "text": "Cardiotoxicity is a major adverse effect",
            "probability": 8.864867988141227e-07,
            "start_logit": 8.83482837677002,
            "end_logit": -5.725302696228027
        },
        {
            "text": "Cardiotoxicity is",
            "probability": 5.968876218968951e-07,
            "start_logit": 8.83482837677002,
            "end_logit": -6.120840072631836
        },
        {
            "text": "cardiotoxicity represents",
            "probability": 5.844017994852796e-07,
            "start_logit": 7.975954532623291,
            "end_logit": -5.283106327056885
        },
        {
            "text": "Cardiot",
            "probability": 5.01470615329464e-07,
            "start_logit": 8.83482837677002,
            "end_logit": -6.2950239181518555
        },
        {
            "text": "cardiotoxicity represents a serious",
            "probability": 2.9929275082423304e-07,
            "start_logit": 7.975954532623291,
            "end_logit": -5.952272891998291
        },
        {
            "text": "cardiot",
            "probability": 1.6044426802143297e-07,
            "start_logit": 7.975954532623291,
            "end_logit": -6.575748443603516
        },
        {
            "text": "cardiotoxicity represents a serious adverse effect",
            "probability": 1.5202782553345343e-07,
            "start_logit": 7.975954532623291,
            "end_logit": -6.629631519317627
        },
        {
            "text": "cardiotoxicity represents a serious adverse",
            "probability": 7.20534082875101e-08,
            "start_logit": 7.975954532623291,
            "end_logit": -7.376287460327148
        },
        {
            "text": "chronic",
            "probability": 2.1600264805654297e-09,
            "start_logit": 1.5097969770431519,
            "end_logit": -4.417417049407959
        },
        {
            "text": "chronic cardiotoxicity represents",
            "probability": 9.088558333961585e-10,
            "start_logit": 1.5097969770431519,
            "end_logit": -5.283106327056885
        },
        {
            "text": "chronic cardiotoxicity represents a serious",
            "probability": 4.654570925677631e-10,
            "start_logit": 1.5097969770431519,
            "end_logit": -5.952272891998291
        },
        {
            "text": "chronic cardiotoxicity represents a serious adverse effect",
            "probability": 2.364321536934162e-10,
            "start_logit": 1.5097969770431519,
            "end_logit": -6.629631519317627
        }
    ],
    "53551206a0726bee57000001_003": [
        {
            "text": "Cardiotoxicity",
            "probability": 0.8677785419806472,
            "start_logit": 8.83482837677002,
            "end_logit": 8.068878173828125
        },
        {
            "text": "cardiotoxicity",
            "probability": 0.13175051432581428,
            "start_logit": 7.975954532623291,
            "end_logit": 7.042725563049316
        },
        {
            "text": "chronic cardiotoxicity",
            "probability": 0.00020489708211614884,
            "start_logit": 1.5097969770431519,
            "end_logit": 7.042725563049316
        },
        {
            "text": "Card",
            "probability": 0.00013244386556123005,
            "start_logit": 8.83482837677002,
            "end_logit": -0.7186547517776489
        },
        {
            "text": "oxicity",
            "probability": 0.00010102165946323034,
            "start_logit": -0.22352850437164307,
            "end_logit": 8.068878173828125
        },
        {
            "text": "card",
            "probability": 2.5998583439274697e-05,
            "start_logit": 7.975954532623291,
            "end_logit": -1.4878977537155151
        },
        {
            "text": "iotoxicity",
            "probability": 2.006897550247592e-06,
            "start_logit": -4.142273426055908,
            "end_logit": 8.068878173828125
        },
        {
            "text": "Cardiotoxicity is a major",
            "probability": 1.318769548595805e-06,
            "start_logit": 8.83482837677002,
            "end_logit": -5.3281145095825195
        },
        {
            "text": "Cardiotoxicity is a major adverse effect",
            "probability": 8.864867988141227e-07,
            "start_logit": 8.83482837677002,
            "end_logit": -5.725302696228027
        },
        {
            "text": "Cardiotoxicity is",
            "probability": 5.968876218968951e-07,
            "start_logit": 8.83482837677002,
            "end_logit": -6.120840072631836
        },
        {
            "text": "cardiotoxicity represents",
            "probability": 5.844017994852796e-07,
            "start_logit": 7.975954532623291,
            "end_logit": -5.283106327056885
        },
        {
            "text": "Cardiot",
            "probability": 5.01470615329464e-07,
            "start_logit": 8.83482837677002,
            "end_logit": -6.2950239181518555
        },
        {
            "text": "cardiotoxicity represents a serious",
            "probability": 2.9929275082423304e-07,
            "start_logit": 7.975954532623291,
            "end_logit": -5.952272891998291
        },
        {
            "text": "cardiot",
            "probability": 1.6044426802143297e-07,
            "start_logit": 7.975954532623291,
            "end_logit": -6.575748443603516
        },
        {
            "text": "cardiotoxicity represents a serious adverse effect",
            "probability": 1.5202782553345343e-07,
            "start_logit": 7.975954532623291,
            "end_logit": -6.629631519317627
        },
        {
            "text": "cardiotoxicity represents a serious adverse",
            "probability": 7.20534082875101e-08,
            "start_logit": 7.975954532623291,
            "end_logit": -7.376287460327148
        },
        {
            "text": "chronic",
            "probability": 2.1600264805654297e-09,
            "start_logit": 1.5097969770431519,
            "end_logit": -4.417417049407959
        },
        {
            "text": "chronic cardiotoxicity represents",
            "probability": 9.088558333961585e-10,
            "start_logit": 1.5097969770431519,
            "end_logit": -5.283106327056885
        },
        {
            "text": "chronic cardiotoxicity represents a serious",
            "probability": 4.654570925677631e-10,
            "start_logit": 1.5097969770431519,
            "end_logit": -5.952272891998291
        },
        {
            "text": "chronic cardiotoxicity represents a serious adverse effect",
            "probability": 2.364321536934162e-10,
            "start_logit": 1.5097969770431519,
            "end_logit": -6.629631519317627
        }
    ],
    "53551206a0726bee57000001_004": [
        {
            "text": "cardiotoxicity",
            "probability": 0.9994972820513631,
            "start_logit": 8.88099479675293,
            "end_logit": 8.645353317260742
        },
        {
            "text": "oxicity",
            "probability": 0.00025222602712921894,
            "start_logit": 0.5963127017021179,
            "end_logit": 8.645353317260742
        },
        {
            "text": "card",
            "probability": 8.16798877144815e-05,
            "start_logit": 8.88099479675293,
            "end_logit": -0.7668465971946716
        },
        {
            "text": "the dose-dependent cardiotoxicity,",
            "probability": 8.1368426769422e-05,
            "start_logit": -0.5350255966186523,
            "end_logit": 8.645353317260742
        },
        {
            "text": "dose-dependent cardiotoxicity,",
            "probability": 7.655225366156076e-05,
            "start_logit": -0.596039354801178,
            "end_logit": 8.645353317260742
        },
        {
            "text": "its major adverse effect, the dose-dependent cardiotoxicity,",
            "probability": 4.021558599427337e-06,
            "start_logit": -3.5423433780670166,
            "end_logit": 8.645353317260742
        },
        {
            "text": "major adverse effect, the dose-dependent cardiotoxicity,",
            "probability": 2.6314500548797987e-06,
            "start_logit": -3.966477870941162,
            "end_logit": 8.645353317260742
        },
        {
            "text": "cardiot",
            "probability": 1.8652818342869412e-06,
            "start_logit": 8.88099479675293,
            "end_logit": -4.5462422370910645
        },
        {
            "text": "iotoxicity",
            "probability": 8.790505286333471e-07,
            "start_logit": -5.062925815582275,
            "end_logit": 8.645353317260742
        },
        {
            "text": "effect, the dose-dependent cardiotoxicity,",
            "probability": 6.468213580113254e-07,
            "start_logit": -5.3696980476379395,
            "end_logit": 8.645353317260742
        },
        {
            "text": "adverse effect, the dose-dependent cardiotoxicity,",
            "probability": 4.094785016789954e-07,
            "start_logit": -5.826883792877197,
            "end_logit": 8.645353317260742
        },
        {
            "text": "cardiotoxicity, cannot be prevented yet.",
            "probability": 1.445942065588215e-07,
            "start_logit": 8.88099479675293,
            "end_logit": -7.10347843170166
        },
        {
            "text": "this drug its major adverse effect, the dose-dependent cardiotoxicity,",
            "probability": 1.1455345745510482e-07,
            "start_logit": -7.10072660446167,
            "end_logit": 8.645353317260742
        },
        {
            "text": "In spite of the routine use of this drug its major adverse effect, the dose-dependent cardiotoxicity,",
            "probability": 9.770819206376474e-08,
            "start_logit": -7.259782791137695,
            "end_logit": 8.645353317260742
        },
        {
            "text": "cardiotoxicity,",
            "probability": 8.055504521421146e-08,
            "start_logit": 8.88099479675293,
            "end_logit": -7.688468933105469
        },
        {
            "text": "the dose-dependent",
            "probability": 1.3860881970023398e-10,
            "start_logit": -0.5350255966186523,
            "end_logit": -4.637488842010498
        },
        {
            "text": "dependent",
            "probability": 1.3040460466920768e-10,
            "start_logit": -0.596039354801178,
            "end_logit": -4.637488842010498
        },
        {
            "text": "the dose-dependent cardiotoxicity, cannot be prevented yet.",
            "probability": 1.1771320761890311e-11,
            "start_logit": -0.5350255966186523,
            "end_logit": -7.10347843170166
        },
        {
            "text": "dose-dependent cardiotoxicity, cannot be prevented yet.",
            "probability": 1.1074579768506254e-11,
            "start_logit": -0.596039354801178,
            "end_logit": -7.10347843170166
        },
        {
            "text": "the",
            "probability": 9.724407525118698e-12,
            "start_logit": -0.5350255966186523,
            "end_logit": -7.294505596160889
        }
    ],
    "53551206a0726bee57000001_005": [
        {
            "text": "cardiotoxicity",
            "probability": 0.3921825209361992,
            "start_logit": 9.188590049743652,
            "end_logit": 8.835689544677734
        },
        {
            "text": "cardiotoxicity. Cardiac toxicity",
            "probability": 0.3333584646827178,
            "start_logit": 9.188590049743652,
            "end_logit": 8.67318058013916
        },
        {
            "text": "Cardiac toxicity",
            "probability": 0.27423699173357163,
            "start_logit": 8.993364334106445,
            "end_logit": 8.67318058013916
        },
        {
            "text": "oxicity",
            "probability": 7.496949746410584e-05,
            "start_logit": 0.6261887550354004,
            "end_logit": 8.835689544677734
        },
        {
            "text": "cardiotoxicity. Cardiac",
            "probability": 5.134384937250272e-05,
            "start_logit": 9.188590049743652,
            "end_logit": -0.10524792969226837
        },
        {
            "text": "card",
            "probability": 4.231973271179361e-05,
            "start_logit": 9.188590049743652,
            "end_logit": -0.2985396087169647
        },
        {
            "text": "Card",
            "probability": 4.223796389672638e-05,
            "start_logit": 8.993364334106445,
            "end_logit": -0.10524792969226837
        },
        {
            "text": "doxorubicin-induced cardiotoxicity.",
            "probability": 1.8666838353528417e-06,
            "start_logit": -3.0667290687561035,
            "end_logit": 8.835689544677734
        },
        {
            "text": "doxorubicin-induced cardiotoxicity. Cardiac toxicity",
            "probability": 1.5866970713427157e-06,
            "start_logit": -3.0667290687561035,
            "end_logit": 8.67318058013916
        },
        {
            "text": "cardiotoxicity. Cardiac toxicity is a major adverse effect caused",
            "probability": 1.0837856990813827e-06,
            "start_logit": 9.188590049743652,
            "end_logit": -3.9633328914642334
        },
        {
            "text": "cardiotoxicity. Cardiac toxicity is a major",
            "probability": 9.89006712637356e-07,
            "start_logit": 9.188590049743652,
            "end_logit": -4.054847240447998
        },
        {
            "text": "Cardiac",
            "probability": 9.02167152926276e-07,
            "start_logit": 8.993364334106445,
            "end_logit": -3.9515228271484375
        },
        {
            "text": "Cardiac toxicity is a major adverse effect caused",
            "probability": 8.91575169938538e-07,
            "start_logit": 8.993364334106445,
            "end_logit": -3.9633328914642334
        },
        {
            "text": "cardiotoxicity. Cardiac toxicity is a major adverse effect",
            "probability": 8.569896641060487e-07,
            "start_logit": 9.188590049743652,
            "end_logit": -4.198122501373291
        },
        {
            "text": "Cardiac toxicity is a major",
            "probability": 8.136053360340494e-07,
            "start_logit": 8.993364334106445,
            "end_logit": -4.054847240447998
        },
        {
            "text": "Cardiac toxicity is a major adverse effect",
            "probability": 7.050016493653199e-07,
            "start_logit": 8.993364334106445,
            "end_logit": -4.198122501373291
        },
        {
            "text": "cardiot",
            "probability": 4.418817452535669e-07,
            "start_logit": 9.188590049743652,
            "end_logit": -4.860506057739258
        },
        {
            "text": "cardiotoxicity. Cardiac toxicity is a",
            "probability": 3.89533127874055e-07,
            "start_logit": 9.188590049743652,
            "end_logit": -4.986599445343018
        },
        {
            "text": "Cardiac toxicity is a",
            "probability": 3.2044901955743723e-07,
            "start_logit": 8.993364334106445,
            "end_logit": -4.986599445343018
        },
        {
            "text": "on doxorubicin-induced cardiotoxicity.",
            "probability": 3.0422788283902813e-07,
            "start_logit": -4.880870819091797,
            "end_logit": 8.835689544677734
        }
    ],
    "53551206a0726bee57000001_006": [
        {
            "text": "cardiotoxicity",
            "probability": 0.3921825209361992,
            "start_logit": 9.188590049743652,
            "end_logit": 8.835689544677734
        },
        {
            "text": "cardiotoxicity. Cardiac toxicity",
            "probability": 0.3333584646827178,
            "start_logit": 9.188590049743652,
            "end_logit": 8.67318058013916
        },
        {
            "text": "Cardiac toxicity",
            "probability": 0.27423699173357163,
            "start_logit": 8.993364334106445,
            "end_logit": 8.67318058013916
        },
        {
            "text": "oxicity",
            "probability": 7.496949746410584e-05,
            "start_logit": 0.6261887550354004,
            "end_logit": 8.835689544677734
        },
        {
            "text": "cardiotoxicity. Cardiac",
            "probability": 5.134384937250272e-05,
            "start_logit": 9.188590049743652,
            "end_logit": -0.10524792969226837
        },
        {
            "text": "card",
            "probability": 4.231973271179361e-05,
            "start_logit": 9.188590049743652,
            "end_logit": -0.2985396087169647
        },
        {
            "text": "Card",
            "probability": 4.223796389672638e-05,
            "start_logit": 8.993364334106445,
            "end_logit": -0.10524792969226837
        },
        {
            "text": "doxorubicin-induced cardiotoxicity.",
            "probability": 1.8666838353528417e-06,
            "start_logit": -3.0667290687561035,
            "end_logit": 8.835689544677734
        },
        {
            "text": "doxorubicin-induced cardiotoxicity. Cardiac toxicity",
            "probability": 1.5866970713427157e-06,
            "start_logit": -3.0667290687561035,
            "end_logit": 8.67318058013916
        },
        {
            "text": "cardiotoxicity. Cardiac toxicity is a major adverse effect caused",
            "probability": 1.0837856990813827e-06,
            "start_logit": 9.188590049743652,
            "end_logit": -3.9633328914642334
        },
        {
            "text": "cardiotoxicity. Cardiac toxicity is a major",
            "probability": 9.89006712637356e-07,
            "start_logit": 9.188590049743652,
            "end_logit": -4.054847240447998
        },
        {
            "text": "Cardiac",
            "probability": 9.02167152926276e-07,
            "start_logit": 8.993364334106445,
            "end_logit": -3.9515228271484375
        },
        {
            "text": "Cardiac toxicity is a major adverse effect caused",
            "probability": 8.91575169938538e-07,
            "start_logit": 8.993364334106445,
            "end_logit": -3.9633328914642334
        },
        {
            "text": "cardiotoxicity. Cardiac toxicity is a major adverse effect",
            "probability": 8.569896641060487e-07,
            "start_logit": 9.188590049743652,
            "end_logit": -4.198122501373291
        },
        {
            "text": "Cardiac toxicity is a major",
            "probability": 8.136053360340494e-07,
            "start_logit": 8.993364334106445,
            "end_logit": -4.054847240447998
        },
        {
            "text": "Cardiac toxicity is a major adverse effect",
            "probability": 7.050016493653199e-07,
            "start_logit": 8.993364334106445,
            "end_logit": -4.198122501373291
        },
        {
            "text": "cardiot",
            "probability": 4.418817452535669e-07,
            "start_logit": 9.188590049743652,
            "end_logit": -4.860506057739258
        },
        {
            "text": "cardiotoxicity. Cardiac toxicity is a",
            "probability": 3.89533127874055e-07,
            "start_logit": 9.188590049743652,
            "end_logit": -4.986599445343018
        },
        {
            "text": "Cardiac toxicity is a",
            "probability": 3.2044901955743723e-07,
            "start_logit": 8.993364334106445,
            "end_logit": -4.986599445343018
        },
        {
            "text": "on doxorubicin-induced cardiotoxicity.",
            "probability": 3.0422788283902813e-07,
            "start_logit": -4.880870819091797,
            "end_logit": 8.835689544677734
        }
    ],
    "56ffdc1ccf1c32585100000b_001": [
        {
            "text": "A-to-I editing,",
            "probability": 0.5993928566158465,
            "start_logit": -0.5509060025215149,
            "end_logit": 3.639751672744751
        },
        {
            "text": "One of the most common forms of pre-mRNA editing is A-to-I editing,",
            "probability": 0.3757985346984189,
            "start_logit": -1.0177700519561768,
            "end_logit": 3.639751672744751
        },
        {
            "text": ",",
            "probability": 0.022271362152907436,
            "start_logit": -3.8435215950012207,
            "end_logit": 3.639751672744751
        },
        {
            "text": "adenosine is deaminated to inosine,",
            "probability": 0.0006584446718422935,
            "start_logit": -0.39480623602867126,
            "end_logit": -3.3301401138305664
        },
        {
            "text": "A-to-I editing, in which adenosine is deaminated to inosine,",
            "probability": 0.0005632821908534743,
            "start_logit": -0.5509060025215149,
            "end_logit": -3.3301401138305664
        },
        {
            "text": "One",
            "probability": 0.0003605616343942773,
            "start_logit": -1.0177700519561768,
            "end_logit": -3.309393882751465
        },
        {
            "text": "increased diversity",
            "probability": 0.00023961306368657542,
            "start_logit": -2.3220059871673584,
            "end_logit": -2.4137954711914062
        },
        {
            "text": "RNA editing",
            "probability": 0.00013748403941271436,
            "start_logit": -4.0015387535095215,
            "end_logit": -1.2897802591323853
        },
        {
            "text": "post-transcriptional modification of pre-mRNA that results in increased diversity",
            "probability": 9.266123777252213e-05,
            "start_logit": -3.272081136703491,
            "end_logit": -2.4137954711914062
        },
        {
            "text": "inosine,",
            "probability": 8.026382475422455e-05,
            "start_logit": -2.4993677139282227,
            "end_logit": -3.3301401138305664
        },
        {
            "text": "adenosine is deaminated to inosine, which is read as guanosine during translation.",
            "probability": 7.027901786814338e-05,
            "start_logit": -0.39480623602867126,
            "end_logit": -5.56754732131958
        },
        {
            "text": "A-to-I",
            "probability": 5.9974886546163025e-05,
            "start_logit": -0.5509060025215149,
            "end_logit": -5.569994926452637
        },
        {
            "text": "RNA editing is a post-transcriptional modification of pre-mRNA that results in increased diversity",
            "probability": 4.4678509817757504e-05,
            "start_logit": -4.0015387535095215,
            "end_logit": -2.4137954711914062
        },
        {
            "text": "occurs in a wide variety of eukaryotic organisms and in some viruses. One",
            "probability": 4.3314852213025286e-05,
            "start_logit": -3.136937379837036,
            "end_logit": -3.309393882751465
        },
        {
            "text": "post-transcriptional modification",
            "probability": 3.910558411302947e-05,
            "start_logit": -3.272081136703491,
            "end_logit": -3.2764804363250732
        },
        {
            "text": "One of the most common forms of pre-mRNA editing is A-to-I",
            "probability": 3.76021739898662e-05,
            "start_logit": -1.0177700519561768,
            "end_logit": -5.569994926452637
        },
        {
            "text": "increased diversity in transcriptomes and proteomes. It occurs",
            "probability": 3.236853158876946e-05,
            "start_logit": -2.3220059871673584,
            "end_logit": -4.4156341552734375
        },
        {
            "text": "One of the most common forms of pre-mRNA editing",
            "probability": 3.183344383901993e-05,
            "start_logit": -1.0177700519561768,
            "end_logit": -5.736539363861084
        },
        {
            "text": "It occurs in a wide variety of eukaryotic organisms and in some viruses. One",
            "probability": 2.3333502611516624e-05,
            "start_logit": -3.755542755126953,
            "end_logit": -3.309393882751465
        },
        {
            "text": "that results in increased diversity",
            "probability": 2.244536752398023e-05,
            "start_logit": -4.689947128295898,
            "end_logit": -2.4137954711914062
        }
    ],
    "56ffdc1ccf1c32585100000b_002": [
        {
            "text": "A-to-I RNA editing",
            "probability": 0.39283542182965375,
            "start_logit": -4.1707539558410645,
            "end_logit": -3.9562442302703857
        },
        {
            "text": "Insulin-like growth factor-binding protein-7 (IGFBP7) was suggested to function as a tumor",
            "probability": 0.13873463378927964,
            "start_logit": -2.5027501583099365,
            "end_logit": -6.665075778961182
        },
        {
            "text": "Insulin-like growth factor-binding protein-7 (IGFBP7) was suggested to function as a tumor suppressor",
            "probability": 0.08182955295009842,
            "start_logit": -2.5027501583099365,
            "end_logit": -7.193000316619873
        },
        {
            "text": "Insulin-like growth factor-binding protein-7",
            "probability": 0.0685312501379584,
            "start_logit": -2.5027501583099365,
            "end_logit": -7.370348930358887
        },
        {
            "text": "A-to-I RNA editing can alter codons,",
            "probability": 0.04795882846092939,
            "start_logit": -3.64884352684021,
            "end_logit": -6.581202507019043
        },
        {
            "text": "editing",
            "probability": 0.04694643639455542,
            "start_logit": -6.295137405395508,
            "end_logit": -3.9562442302703857
        },
        {
            "text": "affect protein sequence, structure, and function. Two editing",
            "probability": 0.04100208747453964,
            "start_logit": -4.188937664031982,
            "end_logit": -6.19782829284668
        },
        {
            "text": "alter codons, substitute amino acids and affect protein sequence, structure, and function. Two editing",
            "probability": 0.033353604295844094,
            "start_logit": -4.395394802093506,
            "end_logit": -6.19782829284668
        },
        {
            "text": "alter codons,",
            "probability": 0.022732409264989012,
            "start_logit": -4.395394802093506,
            "end_logit": -6.581202507019043
        },
        {
            "text": "A-to-I RNA editing can alter codons, substitute amino acids and affect",
            "probability": 0.01807283220447074,
            "start_logit": -3.64884352684021,
            "end_logit": -7.557135581970215
        },
        {
            "text": "diversify transcriptome and proteome repertoire in eukaryotic cells. A-to-I RNA editing",
            "probability": 0.017135169549875023,
            "start_logit": -6.131399154663086,
            "end_logit": -5.127856731414795
        },
        {
            "text": "affect protein sequence, structure, and function.",
            "probability": 0.011515199072063192,
            "start_logit": -4.188937664031982,
            "end_logit": -7.467783451080322
        },
        {
            "text": "affect",
            "probability": 0.010530919984706566,
            "start_logit": -4.188937664031982,
            "end_logit": -7.557135581970215
        },
        {
            "text": "affect protein sequence, structure, and function. Two editing sites were identified within the IGFBP7 transcript.",
            "probability": 0.010457830278486912,
            "start_logit": -4.188937664031982,
            "end_logit": -7.56410026550293
        },
        {
            "text": "affect protein sequence, structure, and function. Two",
            "probability": 0.01043152874033344,
            "start_logit": -4.188937664031982,
            "end_logit": -7.5666184425354
        },
        {
            "text": "function. Two editing",
            "probability": 0.010055403680591121,
            "start_logit": -5.5944504737854,
            "end_logit": -6.19782829284668
        },
        {
            "text": "structure, and function. Two editing",
            "probability": 0.009705369232233491,
            "start_logit": -5.629881381988525,
            "end_logit": -6.19782829284668
        },
        {
            "text": "frequently used to expand and diversify transcriptome and proteome repertoire",
            "probability": 0.009499903786588142,
            "start_logit": -4.541823863983154,
            "end_logit": -7.307283401489258
        },
        {
            "text": "alter codons, substitute amino acids and affect protein sequence, structure, and function.",
            "probability": 0.009367166817444556,
            "start_logit": -4.395394802093506,
            "end_logit": -7.467783451080322
        },
        {
            "text": "affect protein sequence, structure, and function. Two editing sites",
            "probability": 0.009304452055359234,
            "start_logit": -4.188937664031982,
            "end_logit": -7.680958271026611
        }
    ],
    "56ffdc1ccf1c32585100000b_003": [
        {
            "text": "A-to-I RNA editing",
            "probability": 0.39283542182965375,
            "start_logit": -4.1707539558410645,
            "end_logit": -3.9562442302703857
        },
        {
            "text": "Insulin-like growth factor-binding protein-7 (IGFBP7) was suggested to function as a tumor",
            "probability": 0.13873463378927964,
            "start_logit": -2.5027501583099365,
            "end_logit": -6.665075778961182
        },
        {
            "text": "Insulin-like growth factor-binding protein-7 (IGFBP7) was suggested to function as a tumor suppressor",
            "probability": 0.08182955295009842,
            "start_logit": -2.5027501583099365,
            "end_logit": -7.193000316619873
        },
        {
            "text": "Insulin-like growth factor-binding protein-7",
            "probability": 0.0685312501379584,
            "start_logit": -2.5027501583099365,
            "end_logit": -7.370348930358887
        },
        {
            "text": "A-to-I RNA editing can alter codons,",
            "probability": 0.04795882846092939,
            "start_logit": -3.64884352684021,
            "end_logit": -6.581202507019043
        },
        {
            "text": "editing",
            "probability": 0.04694643639455542,
            "start_logit": -6.295137405395508,
            "end_logit": -3.9562442302703857
        },
        {
            "text": "affect protein sequence, structure, and function. Two editing",
            "probability": 0.04100208747453964,
            "start_logit": -4.188937664031982,
            "end_logit": -6.19782829284668
        },
        {
            "text": "alter codons, substitute amino acids and affect protein sequence, structure, and function. Two editing",
            "probability": 0.033353604295844094,
            "start_logit": -4.395394802093506,
            "end_logit": -6.19782829284668
        },
        {
            "text": "alter codons,",
            "probability": 0.022732409264989012,
            "start_logit": -4.395394802093506,
            "end_logit": -6.581202507019043
        },
        {
            "text": "A-to-I RNA editing can alter codons, substitute amino acids and affect",
            "probability": 0.01807283220447074,
            "start_logit": -3.64884352684021,
            "end_logit": -7.557135581970215
        },
        {
            "text": "diversify transcriptome and proteome repertoire in eukaryotic cells. A-to-I RNA editing",
            "probability": 0.017135169549875023,
            "start_logit": -6.131399154663086,
            "end_logit": -5.127856731414795
        },
        {
            "text": "affect protein sequence, structure, and function.",
            "probability": 0.011515199072063192,
            "start_logit": -4.188937664031982,
            "end_logit": -7.467783451080322
        },
        {
            "text": "affect",
            "probability": 0.010530919984706566,
            "start_logit": -4.188937664031982,
            "end_logit": -7.557135581970215
        },
        {
            "text": "affect protein sequence, structure, and function. Two editing sites were identified within the IGFBP7 transcript.",
            "probability": 0.010457830278486912,
            "start_logit": -4.188937664031982,
            "end_logit": -7.56410026550293
        },
        {
            "text": "affect protein sequence, structure, and function. Two",
            "probability": 0.01043152874033344,
            "start_logit": -4.188937664031982,
            "end_logit": -7.5666184425354
        },
        {
            "text": "function. Two editing",
            "probability": 0.010055403680591121,
            "start_logit": -5.5944504737854,
            "end_logit": -6.19782829284668
        },
        {
            "text": "structure, and function. Two editing",
            "probability": 0.009705369232233491,
            "start_logit": -5.629881381988525,
            "end_logit": -6.19782829284668
        },
        {
            "text": "frequently used to expand and diversify transcriptome and proteome repertoire",
            "probability": 0.009499903786588142,
            "start_logit": -4.541823863983154,
            "end_logit": -7.307283401489258
        },
        {
            "text": "alter codons, substitute amino acids and affect protein sequence, structure, and function.",
            "probability": 0.009367166817444556,
            "start_logit": -4.395394802093506,
            "end_logit": -7.467783451080322
        },
        {
            "text": "affect protein sequence, structure, and function. Two editing sites",
            "probability": 0.009304452055359234,
            "start_logit": -4.188937664031982,
            "end_logit": -7.680958271026611
        }
    ],
    "56ffdc1ccf1c32585100000b_004": [
        {
            "text": "A-to-I RNA editing",
            "probability": 0.39283542182965375,
            "start_logit": -4.1707539558410645,
            "end_logit": -3.9562442302703857
        },
        {
            "text": "Insulin-like growth factor-binding protein-7 (IGFBP7) was suggested to function as a tumor",
            "probability": 0.13873463378927964,
            "start_logit": -2.5027501583099365,
            "end_logit": -6.665075778961182
        },
        {
            "text": "Insulin-like growth factor-binding protein-7 (IGFBP7) was suggested to function as a tumor suppressor",
            "probability": 0.08182955295009842,
            "start_logit": -2.5027501583099365,
            "end_logit": -7.193000316619873
        },
        {
            "text": "Insulin-like growth factor-binding protein-7",
            "probability": 0.0685312501379584,
            "start_logit": -2.5027501583099365,
            "end_logit": -7.370348930358887
        },
        {
            "text": "A-to-I RNA editing can alter codons,",
            "probability": 0.04795882846092939,
            "start_logit": -3.64884352684021,
            "end_logit": -6.581202507019043
        },
        {
            "text": "editing",
            "probability": 0.04694643639455542,
            "start_logit": -6.295137405395508,
            "end_logit": -3.9562442302703857
        },
        {
            "text": "affect protein sequence, structure, and function. Two editing",
            "probability": 0.04100208747453964,
            "start_logit": -4.188937664031982,
            "end_logit": -6.19782829284668
        },
        {
            "text": "alter codons, substitute amino acids and affect protein sequence, structure, and function. Two editing",
            "probability": 0.033353604295844094,
            "start_logit": -4.395394802093506,
            "end_logit": -6.19782829284668
        },
        {
            "text": "alter codons,",
            "probability": 0.022732409264989012,
            "start_logit": -4.395394802093506,
            "end_logit": -6.581202507019043
        },
        {
            "text": "A-to-I RNA editing can alter codons, substitute amino acids and affect",
            "probability": 0.01807283220447074,
            "start_logit": -3.64884352684021,
            "end_logit": -7.557135581970215
        },
        {
            "text": "diversify transcriptome and proteome repertoire in eukaryotic cells. A-to-I RNA editing",
            "probability": 0.017135169549875023,
            "start_logit": -6.131399154663086,
            "end_logit": -5.127856731414795
        },
        {
            "text": "affect protein sequence, structure, and function.",
            "probability": 0.011515199072063192,
            "start_logit": -4.188937664031982,
            "end_logit": -7.467783451080322
        },
        {
            "text": "affect",
            "probability": 0.010530919984706566,
            "start_logit": -4.188937664031982,
            "end_logit": -7.557135581970215
        },
        {
            "text": "affect protein sequence, structure, and function. Two editing sites were identified within the IGFBP7 transcript.",
            "probability": 0.010457830278486912,
            "start_logit": -4.188937664031982,
            "end_logit": -7.56410026550293
        },
        {
            "text": "affect protein sequence, structure, and function. Two",
            "probability": 0.01043152874033344,
            "start_logit": -4.188937664031982,
            "end_logit": -7.5666184425354
        },
        {
            "text": "function. Two editing",
            "probability": 0.010055403680591121,
            "start_logit": -5.5944504737854,
            "end_logit": -6.19782829284668
        },
        {
            "text": "structure, and function. Two editing",
            "probability": 0.009705369232233491,
            "start_logit": -5.629881381988525,
            "end_logit": -6.19782829284668
        },
        {
            "text": "frequently used to expand and diversify transcriptome and proteome repertoire",
            "probability": 0.009499903786588142,
            "start_logit": -4.541823863983154,
            "end_logit": -7.307283401489258
        },
        {
            "text": "alter codons, substitute amino acids and affect protein sequence, structure, and function.",
            "probability": 0.009367166817444556,
            "start_logit": -4.395394802093506,
            "end_logit": -7.467783451080322
        },
        {
            "text": "affect protein sequence, structure, and function. Two editing sites",
            "probability": 0.009304452055359234,
            "start_logit": -4.188937664031982,
            "end_logit": -7.680958271026611
        }
    ],
    "56ffdc1ccf1c32585100000b_009": [
        {
            "text": "adenosine-to-inosine (A-to-I) conversion,",
            "probability": 0.836755162944272,
            "start_logit": 9.214470863342285,
            "end_logit": 9.031526565551758
        },
        {
            "text": "adenosine-to-inosine",
            "probability": 0.16141318291354034,
            "start_logit": 9.214470863342285,
            "end_logit": 7.38596248626709
        },
        {
            "text": "Adenosine deaminases that act on RNA (ADARs) catalyze the adenosine-to-inosine",
            "probability": 0.0009734947218783222,
            "start_logit": 4.103640556335449,
            "end_logit": 7.38596248626709
        },
        {
            "text": "adenosine-to-inosine (A-to-I)",
            "probability": 0.00042418658137782707,
            "start_logit": 9.214470863342285,
            "end_logit": 1.444413185119629
        },
        {
            "text": ",",
            "probability": 0.00015275383043904467,
            "start_logit": 0.6060117483139038,
            "end_logit": 9.031526565551758
        },
        {
            "text": "the adenosine-to-inosine (A-to-I) conversion,",
            "probability": 8.074519665468589e-05,
            "start_logit": -0.031517449766397476,
            "end_logit": 9.031526565551758
        },
        {
            "text": "(A-to-I) conversion,",
            "probability": 6.291601853957091e-05,
            "start_logit": -0.2810151278972626,
            "end_logit": 9.031526565551758
        },
        {
            "text": "ad",
            "probability": 4.9484382340424135e-05,
            "start_logit": 9.214470863342285,
            "end_logit": -0.7041031122207642
        },
        {
            "text": "catalyze the adenosine-to-inosine (A-to-I) conversion,",
            "probability": 3.8858946849763315e-05,
            "start_logit": -0.7628775835037231,
            "end_logit": 9.031526565551758
        },
        {
            "text": "ine",
            "probability": 1.7684076469692075e-05,
            "start_logit": 0.09541275352239609,
            "end_logit": 7.38596248626709
        },
        {
            "text": "the adenosine-to-inosine",
            "probability": 1.557604873467703e-05,
            "start_logit": -0.031517449766397476,
            "end_logit": 7.38596248626709
        },
        {
            "text": "catalyze the adenosine-to-inosine",
            "probability": 7.496035367882311e-06,
            "start_logit": -0.7628775835037231,
            "end_logit": 7.38596248626709
        },
        {
            "text": "conversion,",
            "probability": 3.313778272925658e-06,
            "start_logit": -3.224726915359497,
            "end_logit": 9.031526565551758
        },
        {
            "text": "inosine",
            "probability": 2.251346700054962e-06,
            "start_logit": -1.9657232761383057,
            "end_logit": 7.38596248626709
        },
        {
            "text": "adenosine-to-inosine (A-to-I) conversion, the",
            "probability": 1.49536466814446e-06,
            "start_logit": 9.214470863342285,
            "end_logit": -4.203390121459961
        },
        {
            "text": "adenosine-to-inosine (A-to-I) conversion, the most common type of RNA editing",
            "probability": 5.501530047518802e-07,
            "start_logit": 9.214470863342285,
            "end_logit": -5.203319072723389
        },
        {
            "text": "adenosine-to-inosine (A-to-I) conversion, the most common type of RNA editing in higher",
            "probability": 3.18250671569386e-07,
            "start_logit": 9.214470863342285,
            "end_logit": -5.750676155090332
        },
        {
            "text": "adenosine-to-inosine (A-to-I) conversion, the most common type",
            "probability": 2.7385491243866763e-07,
            "start_logit": 9.214470863342285,
            "end_logit": -5.900917053222656
        },
        {
            "text": "adenosine-to-inosine (A-to-I) conversion, the most common",
            "probability": 1.6702421809551212e-07,
            "start_logit": 9.214470863342285,
            "end_logit": -6.395376682281494
        },
        {
            "text": "Adenosine deaminases",
            "probability": 8.853108774836e-08,
            "start_logit": 4.103640556335449,
            "end_logit": -1.919331431388855
        }
    ],
    "56ffdc1ccf1c32585100000b_011": [
        {
            "text": "A-to-I editing,",
            "probability": 0.5993928566158465,
            "start_logit": -0.5509060025215149,
            "end_logit": 3.639751672744751
        },
        {
            "text": "One of the most common forms of pre-mRNA editing is A-to-I editing,",
            "probability": 0.3757985346984189,
            "start_logit": -1.0177700519561768,
            "end_logit": 3.639751672744751
        },
        {
            "text": ",",
            "probability": 0.022271362152907436,
            "start_logit": -3.8435215950012207,
            "end_logit": 3.639751672744751
        },
        {
            "text": "adenosine is deaminated to inosine,",
            "probability": 0.0006584446718422935,
            "start_logit": -0.39480623602867126,
            "end_logit": -3.3301401138305664
        },
        {
            "text": "A-to-I editing, in which adenosine is deaminated to inosine,",
            "probability": 0.0005632821908534743,
            "start_logit": -0.5509060025215149,
            "end_logit": -3.3301401138305664
        },
        {
            "text": "One",
            "probability": 0.0003605616343942773,
            "start_logit": -1.0177700519561768,
            "end_logit": -3.309393882751465
        },
        {
            "text": "increased diversity",
            "probability": 0.00023961306368657542,
            "start_logit": -2.3220059871673584,
            "end_logit": -2.4137954711914062
        },
        {
            "text": "RNA editing",
            "probability": 0.00013748403941271436,
            "start_logit": -4.0015387535095215,
            "end_logit": -1.2897802591323853
        },
        {
            "text": "post-transcriptional modification of pre-mRNA that results in increased diversity",
            "probability": 9.266123777252213e-05,
            "start_logit": -3.272081136703491,
            "end_logit": -2.4137954711914062
        },
        {
            "text": "inosine,",
            "probability": 8.026382475422455e-05,
            "start_logit": -2.4993677139282227,
            "end_logit": -3.3301401138305664
        },
        {
            "text": "adenosine is deaminated to inosine, which is read as guanosine during translation.",
            "probability": 7.027901786814338e-05,
            "start_logit": -0.39480623602867126,
            "end_logit": -5.56754732131958
        },
        {
            "text": "A-to-I",
            "probability": 5.9974886546163025e-05,
            "start_logit": -0.5509060025215149,
            "end_logit": -5.569994926452637
        },
        {
            "text": "RNA editing is a post-transcriptional modification of pre-mRNA that results in increased diversity",
            "probability": 4.4678509817757504e-05,
            "start_logit": -4.0015387535095215,
            "end_logit": -2.4137954711914062
        },
        {
            "text": "occurs in a wide variety of eukaryotic organisms and in some viruses. One",
            "probability": 4.3314852213025286e-05,
            "start_logit": -3.136937379837036,
            "end_logit": -3.309393882751465
        },
        {
            "text": "post-transcriptional modification",
            "probability": 3.910558411302947e-05,
            "start_logit": -3.272081136703491,
            "end_logit": -3.2764804363250732
        },
        {
            "text": "One of the most common forms of pre-mRNA editing is A-to-I",
            "probability": 3.76021739898662e-05,
            "start_logit": -1.0177700519561768,
            "end_logit": -5.569994926452637
        },
        {
            "text": "increased diversity in transcriptomes and proteomes. It occurs",
            "probability": 3.236853158876946e-05,
            "start_logit": -2.3220059871673584,
            "end_logit": -4.4156341552734375
        },
        {
            "text": "One of the most common forms of pre-mRNA editing",
            "probability": 3.183344383901993e-05,
            "start_logit": -1.0177700519561768,
            "end_logit": -5.736539363861084
        },
        {
            "text": "It occurs in a wide variety of eukaryotic organisms and in some viruses. One",
            "probability": 2.3333502611516624e-05,
            "start_logit": -3.755542755126953,
            "end_logit": -3.309393882751465
        },
        {
            "text": "that results in increased diversity",
            "probability": 2.244536752398023e-05,
            "start_logit": -4.689947128295898,
            "end_logit": -2.4137954711914062
        }
    ],
    "56ffdc1ccf1c32585100000b_012": [
        {
            "text": "adenosine deamination (A-to-I)",
            "probability": 0.7136396855645434,
            "start_logit": 1.4379559755325317,
            "end_logit": 6.502650260925293
        },
        {
            "text": "(A-to-I)",
            "probability": 0.24668893605983425,
            "start_logit": 0.3757059574127197,
            "end_logit": 6.502650260925293
        },
        {
            "text": "RNA editing by adenosine deamination (A-to-I)",
            "probability": 0.017850273194634805,
            "start_logit": -2.25040340423584,
            "end_logit": 6.502650260925293
        },
        {
            "text": ")",
            "probability": 0.017768955452440283,
            "start_logit": -2.254969358444214,
            "end_logit": 6.502650260925293
        },
        {
            "text": "by adenosine deamination (A-to-I)",
            "probability": 0.0025508372569703237,
            "start_logit": -4.196000576019287,
            "end_logit": 6.502650260925293
        },
        {
            "text": "deamination (A-to-I)",
            "probability": 0.0012979434603857206,
            "start_logit": -4.871641159057617,
            "end_logit": 6.502650260925293
        },
        {
            "text": "adenosine deamination",
            "probability": 0.00016860319763891202,
            "start_logit": 1.4379559755325317,
            "end_logit": -1.8479351997375488
        },
        {
            "text": "adenosine deamination (A-to-I) is widespread",
            "probability": 1.408413361984193e-05,
            "start_logit": 1.4379559755325317,
            "end_logit": -4.330434322357178
        },
        {
            "text": "(A-to-I) is widespread",
            "probability": 4.868563237559907e-06,
            "start_logit": 0.3757059574127197,
            "end_logit": -4.330434322357178
        },
        {
            "text": "RNA editing by adenosine deamination",
            "probability": 4.217272666055213e-06,
            "start_logit": -2.25040340423584,
            "end_logit": -1.8479351997375488
        },
        {
            "text": "adenosine deamination (A-to-I) is widespread in humans and can lead",
            "probability": 2.190224401177286e-06,
            "start_logit": 1.4379559755325317,
            "end_logit": -6.191479206085205
        },
        {
            "text": "adenosine deamination (A-to-I) is widespread in humans and can lead to",
            "probability": 1.8296074786613714e-06,
            "start_logit": 1.4379559755325317,
            "end_logit": -6.371381759643555
        },
        {
            "text": "adenosine deamination (A-to-I) is widespread in humans and can lead to a variety of biological",
            "probability": 1.5795436048461068e-06,
            "start_logit": 1.4379559755325317,
            "end_logit": -6.518347263336182
        },
        {
            "text": "adenosine deamination (A-to-I) is widespread in humans and can lead to a variety",
            "probability": 1.4562425622347608e-06,
            "start_logit": 1.4379559755325317,
            "end_logit": -6.599623680114746
        },
        {
            "text": "adenosine deamination (A-to-I) is widespread in humans and can lead to a variety of biological effects",
            "probability": 1.1025151333219214e-06,
            "start_logit": 1.4379559755325317,
            "end_logit": -6.877889156341553
        },
        {
            "text": "adenosine deamination (A-to-I) is",
            "probability": 8.994785507099831e-07,
            "start_logit": 1.4379559755325317,
            "end_logit": -7.081423282623291
        },
        {
            "text": "(A-to-I) is widespread in humans and can lead",
            "probability": 7.571105393771515e-07,
            "start_logit": 0.3757059574127197,
            "end_logit": -6.191479206085205
        },
        {
            "text": "(A-to-I) is widespread in humans and can lead to",
            "probability": 6.324535076283518e-07,
            "start_logit": 0.3757059574127197,
            "end_logit": -6.371381759643555
        },
        {
            "text": "by adenosine deamination",
            "probability": 6.026561118744989e-07,
            "start_logit": -4.196000576019287,
            "end_logit": -1.8479351997375488
        },
        {
            "text": "(A-to-I) is widespread in humans and can lead to a variety of biological",
            "probability": 5.460121392090938e-07,
            "start_logit": 0.3757059574127197,
            "end_logit": -6.518347263336182
        }
    ],
    "56ffdc1ccf1c32585100000b_013": [
        {
            "text": "A-to-I editing,",
            "probability": 0.5993928566158465,
            "start_logit": -0.5509060025215149,
            "end_logit": 3.639751672744751
        },
        {
            "text": "One of the most common forms of pre-mRNA editing is A-to-I editing,",
            "probability": 0.3757985346984189,
            "start_logit": -1.0177700519561768,
            "end_logit": 3.639751672744751
        },
        {
            "text": ",",
            "probability": 0.022271362152907436,
            "start_logit": -3.8435215950012207,
            "end_logit": 3.639751672744751
        },
        {
            "text": "adenosine is deaminated to inosine,",
            "probability": 0.0006584446718422935,
            "start_logit": -0.39480623602867126,
            "end_logit": -3.3301401138305664
        },
        {
            "text": "A-to-I editing, in which adenosine is deaminated to inosine,",
            "probability": 0.0005632821908534743,
            "start_logit": -0.5509060025215149,
            "end_logit": -3.3301401138305664
        },
        {
            "text": "One",
            "probability": 0.0003605616343942773,
            "start_logit": -1.0177700519561768,
            "end_logit": -3.309393882751465
        },
        {
            "text": "increased diversity",
            "probability": 0.00023961306368657542,
            "start_logit": -2.3220059871673584,
            "end_logit": -2.4137954711914062
        },
        {
            "text": "RNA editing",
            "probability": 0.00013748403941271436,
            "start_logit": -4.0015387535095215,
            "end_logit": -1.2897802591323853
        },
        {
            "text": "post-transcriptional modification of pre-mRNA that results in increased diversity",
            "probability": 9.266123777252213e-05,
            "start_logit": -3.272081136703491,
            "end_logit": -2.4137954711914062
        },
        {
            "text": "inosine,",
            "probability": 8.026382475422455e-05,
            "start_logit": -2.4993677139282227,
            "end_logit": -3.3301401138305664
        },
        {
            "text": "adenosine is deaminated to inosine, which is read as guanosine during translation.",
            "probability": 7.027901786814338e-05,
            "start_logit": -0.39480623602867126,
            "end_logit": -5.56754732131958
        },
        {
            "text": "A-to-I",
            "probability": 5.9974886546163025e-05,
            "start_logit": -0.5509060025215149,
            "end_logit": -5.569994926452637
        },
        {
            "text": "RNA editing is a post-transcriptional modification of pre-mRNA that results in increased diversity",
            "probability": 4.4678509817757504e-05,
            "start_logit": -4.0015387535095215,
            "end_logit": -2.4137954711914062
        },
        {
            "text": "occurs in a wide variety of eukaryotic organisms and in some viruses. One",
            "probability": 4.3314852213025286e-05,
            "start_logit": -3.136937379837036,
            "end_logit": -3.309393882751465
        },
        {
            "text": "post-transcriptional modification",
            "probability": 3.910558411302947e-05,
            "start_logit": -3.272081136703491,
            "end_logit": -3.2764804363250732
        },
        {
            "text": "One of the most common forms of pre-mRNA editing is A-to-I",
            "probability": 3.76021739898662e-05,
            "start_logit": -1.0177700519561768,
            "end_logit": -5.569994926452637
        },
        {
            "text": "increased diversity in transcriptomes and proteomes. It occurs",
            "probability": 3.236853158876946e-05,
            "start_logit": -2.3220059871673584,
            "end_logit": -4.4156341552734375
        },
        {
            "text": "One of the most common forms of pre-mRNA editing",
            "probability": 3.183344383901993e-05,
            "start_logit": -1.0177700519561768,
            "end_logit": -5.736539363861084
        },
        {
            "text": "It occurs in a wide variety of eukaryotic organisms and in some viruses. One",
            "probability": 2.3333502611516624e-05,
            "start_logit": -3.755542755126953,
            "end_logit": -3.309393882751465
        },
        {
            "text": "that results in increased diversity",
            "probability": 2.244536752398023e-05,
            "start_logit": -4.689947128295898,
            "end_logit": -2.4137954711914062
        }
    ],
    "56ffdc1ccf1c32585100000b_014": [
        {
            "text": "adenosine deamination (A-to-I)",
            "probability": 0.7136396855645434,
            "start_logit": 1.4379559755325317,
            "end_logit": 6.502650260925293
        },
        {
            "text": "(A-to-I)",
            "probability": 0.24668893605983425,
            "start_logit": 0.3757059574127197,
            "end_logit": 6.502650260925293
        },
        {
            "text": "RNA editing by adenosine deamination (A-to-I)",
            "probability": 0.017850273194634805,
            "start_logit": -2.25040340423584,
            "end_logit": 6.502650260925293
        },
        {
            "text": ")",
            "probability": 0.017768955452440283,
            "start_logit": -2.254969358444214,
            "end_logit": 6.502650260925293
        },
        {
            "text": "by adenosine deamination (A-to-I)",
            "probability": 0.0025508372569703237,
            "start_logit": -4.196000576019287,
            "end_logit": 6.502650260925293
        },
        {
            "text": "deamination (A-to-I)",
            "probability": 0.0012979434603857206,
            "start_logit": -4.871641159057617,
            "end_logit": 6.502650260925293
        },
        {
            "text": "adenosine deamination",
            "probability": 0.00016860319763891202,
            "start_logit": 1.4379559755325317,
            "end_logit": -1.8479351997375488
        },
        {
            "text": "adenosine deamination (A-to-I) is widespread",
            "probability": 1.408413361984193e-05,
            "start_logit": 1.4379559755325317,
            "end_logit": -4.330434322357178
        },
        {
            "text": "(A-to-I) is widespread",
            "probability": 4.868563237559907e-06,
            "start_logit": 0.3757059574127197,
            "end_logit": -4.330434322357178
        },
        {
            "text": "RNA editing by adenosine deamination",
            "probability": 4.217272666055213e-06,
            "start_logit": -2.25040340423584,
            "end_logit": -1.8479351997375488
        },
        {
            "text": "adenosine deamination (A-to-I) is widespread in humans and can lead",
            "probability": 2.190224401177286e-06,
            "start_logit": 1.4379559755325317,
            "end_logit": -6.191479206085205
        },
        {
            "text": "adenosine deamination (A-to-I) is widespread in humans and can lead to",
            "probability": 1.8296074786613714e-06,
            "start_logit": 1.4379559755325317,
            "end_logit": -6.371381759643555
        },
        {
            "text": "adenosine deamination (A-to-I) is widespread in humans and can lead to a variety of biological",
            "probability": 1.5795436048461068e-06,
            "start_logit": 1.4379559755325317,
            "end_logit": -6.518347263336182
        },
        {
            "text": "adenosine deamination (A-to-I) is widespread in humans and can lead to a variety",
            "probability": 1.4562425622347608e-06,
            "start_logit": 1.4379559755325317,
            "end_logit": -6.599623680114746
        },
        {
            "text": "adenosine deamination (A-to-I) is widespread in humans and can lead to a variety of biological effects",
            "probability": 1.1025151333219214e-06,
            "start_logit": 1.4379559755325317,
            "end_logit": -6.877889156341553
        },
        {
            "text": "adenosine deamination (A-to-I) is",
            "probability": 8.994785507099831e-07,
            "start_logit": 1.4379559755325317,
            "end_logit": -7.081423282623291
        },
        {
            "text": "(A-to-I) is widespread in humans and can lead",
            "probability": 7.571105393771515e-07,
            "start_logit": 0.3757059574127197,
            "end_logit": -6.191479206085205
        },
        {
            "text": "(A-to-I) is widespread in humans and can lead to",
            "probability": 6.324535076283518e-07,
            "start_logit": 0.3757059574127197,
            "end_logit": -6.371381759643555
        },
        {
            "text": "by adenosine deamination",
            "probability": 6.026561118744989e-07,
            "start_logit": -4.196000576019287,
            "end_logit": -1.8479351997375488
        },
        {
            "text": "(A-to-I) is widespread in humans and can lead to a variety of biological",
            "probability": 5.460121392090938e-07,
            "start_logit": 0.3757059574127197,
            "end_logit": -6.518347263336182
        }
    ],
    "56ffdc1ccf1c32585100000b_016": [
        {
            "text": "A-to-I editing,",
            "probability": 0.5993928566158465,
            "start_logit": -0.5509060025215149,
            "end_logit": 3.639751672744751
        },
        {
            "text": "One of the most common forms of pre-mRNA editing is A-to-I editing,",
            "probability": 0.3757985346984189,
            "start_logit": -1.0177700519561768,
            "end_logit": 3.639751672744751
        },
        {
            "text": ",",
            "probability": 0.022271362152907436,
            "start_logit": -3.8435215950012207,
            "end_logit": 3.639751672744751
        },
        {
            "text": "adenosine is deaminated to inosine,",
            "probability": 0.0006584446718422935,
            "start_logit": -0.39480623602867126,
            "end_logit": -3.3301401138305664
        },
        {
            "text": "A-to-I editing, in which adenosine is deaminated to inosine,",
            "probability": 0.0005632821908534743,
            "start_logit": -0.5509060025215149,
            "end_logit": -3.3301401138305664
        },
        {
            "text": "One",
            "probability": 0.0003605616343942773,
            "start_logit": -1.0177700519561768,
            "end_logit": -3.309393882751465
        },
        {
            "text": "increased diversity",
            "probability": 0.00023961306368657542,
            "start_logit": -2.3220059871673584,
            "end_logit": -2.4137954711914062
        },
        {
            "text": "RNA editing",
            "probability": 0.00013748403941271436,
            "start_logit": -4.0015387535095215,
            "end_logit": -1.2897802591323853
        },
        {
            "text": "post-transcriptional modification of pre-mRNA that results in increased diversity",
            "probability": 9.266123777252213e-05,
            "start_logit": -3.272081136703491,
            "end_logit": -2.4137954711914062
        },
        {
            "text": "inosine,",
            "probability": 8.026382475422455e-05,
            "start_logit": -2.4993677139282227,
            "end_logit": -3.3301401138305664
        },
        {
            "text": "adenosine is deaminated to inosine, which is read as guanosine during translation.",
            "probability": 7.027901786814338e-05,
            "start_logit": -0.39480623602867126,
            "end_logit": -5.56754732131958
        },
        {
            "text": "A-to-I",
            "probability": 5.9974886546163025e-05,
            "start_logit": -0.5509060025215149,
            "end_logit": -5.569994926452637
        },
        {
            "text": "RNA editing is a post-transcriptional modification of pre-mRNA that results in increased diversity",
            "probability": 4.4678509817757504e-05,
            "start_logit": -4.0015387535095215,
            "end_logit": -2.4137954711914062
        },
        {
            "text": "occurs in a wide variety of eukaryotic organisms and in some viruses. One",
            "probability": 4.3314852213025286e-05,
            "start_logit": -3.136937379837036,
            "end_logit": -3.309393882751465
        },
        {
            "text": "post-transcriptional modification",
            "probability": 3.910558411302947e-05,
            "start_logit": -3.272081136703491,
            "end_logit": -3.2764804363250732
        },
        {
            "text": "One of the most common forms of pre-mRNA editing is A-to-I",
            "probability": 3.76021739898662e-05,
            "start_logit": -1.0177700519561768,
            "end_logit": -5.569994926452637
        },
        {
            "text": "increased diversity in transcriptomes and proteomes. It occurs",
            "probability": 3.236853158876946e-05,
            "start_logit": -2.3220059871673584,
            "end_logit": -4.4156341552734375
        },
        {
            "text": "One of the most common forms of pre-mRNA editing",
            "probability": 3.183344383901993e-05,
            "start_logit": -1.0177700519561768,
            "end_logit": -5.736539363861084
        },
        {
            "text": "It occurs in a wide variety of eukaryotic organisms and in some viruses. One",
            "probability": 2.3333502611516624e-05,
            "start_logit": -3.755542755126953,
            "end_logit": -3.309393882751465
        },
        {
            "text": "that results in increased diversity",
            "probability": 2.244536752398023e-05,
            "start_logit": -4.689947128295898,
            "end_logit": -2.4137954711914062
        }
    ],
    "56cae3eb5795f9a73e000021_001": [
        {
            "text": "Younger age at diagnosis (younger than 20 years),",
            "probability": 0.8588716397767895,
            "start_logit": 0.839357316493988,
            "end_logit": -1.3972896337509155
        },
        {
            "text": "Young",
            "probability": 0.044805837668363546,
            "start_logit": 0.839357316493988,
            "end_logit": -4.3505706787109375
        },
        {
            "text": "Younger",
            "probability": 0.023078964467522056,
            "start_logit": 0.839357316493988,
            "end_logit": -5.0139875411987305
        },
        {
            "text": "Younger age at diagnosis",
            "probability": 0.01629216855947969,
            "start_logit": 0.839357316493988,
            "end_logit": -5.362224578857422
        },
        {
            "text": "Younger age at diagnosis (younger than 20 years), compared with an older age (40 years or older),",
            "probability": 0.015123809387671992,
            "start_logit": 0.839357316493988,
            "end_logit": -5.436638832092285
        },
        {
            "text": "Younger age",
            "probability": 0.010521081358848942,
            "start_logit": 0.839357316493988,
            "end_logit": -5.799528121948242
        },
        {
            "text": "20 years),",
            "probability": 0.008860975429214976,
            "start_logit": -3.734605312347412,
            "end_logit": -1.3972896337509155
        },
        {
            "text": "Younger age at diagnosis (younger than 20",
            "probability": 0.005634712043828025,
            "start_logit": 0.839357316493988,
            "end_logit": -6.4239630699157715
        },
        {
            "text": "RESULTS: Younger age at diagnosis (younger than 20 years),",
            "probability": 0.00394721839440849,
            "start_logit": -4.543251037597656,
            "end_logit": -1.3972896337509155
        },
        {
            "text": "(younger than 20 years),",
            "probability": 0.0035808389272267657,
            "start_logit": -4.640665054321289,
            "end_logit": -1.3972896337509155
        },
        {
            "text": "Crohn's disease",
            "probability": 0.002698460428662183,
            "start_logit": -2.531005620956421,
            "end_logit": -3.7898647785186768
        },
        {
            "text": "years),",
            "probability": 0.0019662391948951476,
            "start_logit": -5.240139484405518,
            "end_logit": -1.3972896337509155
        },
        {
            "text": "age at diagnosis (younger than 20 years),",
            "probability": 0.0018609739199567028,
            "start_logit": -5.295162200927734,
            "end_logit": -1.3972896337509155
        },
        {
            "text": "& AIMS: Crohn's disease",
            "probability": 0.0007301190738474203,
            "start_logit": -3.8382346630096436,
            "end_logit": -3.7898647785186768
        },
        {
            "text": "Crohn's disease has a bimodal age distribution",
            "probability": 0.0005318492438228789,
            "start_logit": -2.531005620956421,
            "end_logit": -5.413941383361816
        },
        {
            "text": "Crohn's disease: influence of age at diagnosis on site and clinical type of disease.",
            "probability": 0.0005090000623325352,
            "start_logit": -4.363197326660156,
            "end_logit": -3.625661611557007
        },
        {
            "text": "Crohn's",
            "probability": 0.00030723443954337233,
            "start_logit": -2.531005620956421,
            "end_logit": -5.962690353393555
        },
        {
            "text": "BACKGROUND & AIMS: Crohn's disease",
            "probability": 0.0002537989589922484,
            "start_logit": -4.894899845123291,
            "end_logit": -3.7898647785186768
        },
        {
            "text": "Crohn's disease has a bimodal age distribution of disease",
            "probability": 0.00021915915528558053,
            "start_logit": -2.531005620956421,
            "end_logit": -6.300503253936768
        },
        {
            "text": "RESULTS: Younger",
            "probability": 0.00020591950930806005,
            "start_logit": -4.543251037597656,
            "end_logit": -4.3505706787109375
        }
    ],
    "5509bd6a1180f13250000002_001": [
        {
            "text": "celiac disease",
            "probability": 0.8395535935041215,
            "start_logit": 4.941971778869629,
            "end_logit": 3.8353230953216553
        },
        {
            "text": "celiac disease.",
            "probability": 0.15715560150865515,
            "start_logit": 3.932265520095825,
            "end_logit": 3.1693954467773438
        },
        {
            "text": "celiac disease is likely.",
            "probability": 0.0014662135349152205,
            "start_logit": 4.941971778869629,
            "end_logit": -2.514863967895508
        },
        {
            "text": "ce",
            "probability": 0.0006150593171633146,
            "start_logit": 4.941971778869629,
            "end_logit": -3.3835837841033936
        },
        {
            "text": "disease.",
            "probability": 0.000489491628279353,
            "start_logit": -1.8393588066101074,
            "end_logit": 3.1693954467773438
        },
        {
            "text": "ase",
            "probability": 0.0003465723914494473,
            "start_logit": -2.85056209564209,
            "end_logit": 3.8353230953216553
        },
        {
            "text": "disease",
            "probability": 0.00020985445219097508,
            "start_logit": -3.3522396087646484,
            "end_logit": 3.8353230953216553
        },
        {
            "text": ".",
            "probability": 6.323534104027896e-05,
            "start_logit": -3.8858628273010254,
            "end_logit": 3.1693954467773438
        },
        {
            "text": "celiac",
            "probability": 3.438930421962637e-05,
            "start_logit": 3.932265520095825,
            "end_logit": -5.257850646972656
        },
        {
            "text": "celi",
            "probability": 2.0102120019653238e-05,
            "start_logit": 4.941971778869629,
            "end_logit": -6.804477214813232
        },
        {
            "text": "underlying celiac disease",
            "probability": 1.6327364511273858e-05,
            "start_logit": -5.905811309814453,
            "end_logit": 3.8353230953216553
        },
        {
            "text": "isease",
            "probability": 6.539281414190971e-06,
            "start_logit": -6.820826530456543,
            "end_logit": 3.8353230953216553
        },
        {
            "text": "the presence of underlying celiac disease",
            "probability": 5.84033006678672e-06,
            "start_logit": -6.933866500854492,
            "end_logit": 3.8353230953216553
        },
        {
            "text": "presence of underlying celiac disease",
            "probability": 4.699301790200837e-06,
            "start_logit": -7.15123987197876,
            "end_logit": 3.8353230953216553
        },
        {
            "text": "histologic subtype and the presence of underlying celiac disease.",
            "probability": 3.1658477638832783e-06,
            "start_logit": -6.880305290222168,
            "end_logit": 3.1693954467773438
        },
        {
            "text": "underlying celiac disease.",
            "probability": 3.082754069234328e-06,
            "start_logit": -6.90690279006958,
            "end_logit": 3.1693954467773438
        },
        {
            "text": "the underlying histologic subtype and whether the presence of underlying celiac disease",
            "probability": 2.798825085044576e-06,
            "start_logit": -7.669454097747803,
            "end_logit": 3.8353230953216553
        },
        {
            "text": "the presence of underlying celiac disease.",
            "probability": 2.7788996140920533e-06,
            "start_logit": -7.010671138763428,
            "end_logit": 3.1693954467773438
        },
        {
            "text": "disease is likely.",
            "probability": 6.052610995924718e-07,
            "start_logit": -2.85056209564209,
            "end_logit": -2.514863967895508
        },
        {
            "text": "d",
            "probability": 4.9032530723617887e-08,
            "start_logit": -1.8393588066101074,
            "end_logit": -6.039243221282959
        }
    ],
    "5509bd6a1180f13250000002_002": [
        {
            "text": "celiac disease",
            "probability": 0.8395535935041215,
            "start_logit": 4.941971778869629,
            "end_logit": 3.8353230953216553
        },
        {
            "text": "celiac disease.",
            "probability": 0.15715560150865515,
            "start_logit": 3.932265520095825,
            "end_logit": 3.1693954467773438
        },
        {
            "text": "celiac disease is likely.",
            "probability": 0.0014662135349152205,
            "start_logit": 4.941971778869629,
            "end_logit": -2.514863967895508
        },
        {
            "text": "ce",
            "probability": 0.0006150593171633146,
            "start_logit": 4.941971778869629,
            "end_logit": -3.3835837841033936
        },
        {
            "text": "disease.",
            "probability": 0.000489491628279353,
            "start_logit": -1.8393588066101074,
            "end_logit": 3.1693954467773438
        },
        {
            "text": "ase",
            "probability": 0.0003465723914494473,
            "start_logit": -2.85056209564209,
            "end_logit": 3.8353230953216553
        },
        {
            "text": "disease",
            "probability": 0.00020985445219097508,
            "start_logit": -3.3522396087646484,
            "end_logit": 3.8353230953216553
        },
        {
            "text": ".",
            "probability": 6.323534104027896e-05,
            "start_logit": -3.8858628273010254,
            "end_logit": 3.1693954467773438
        },
        {
            "text": "celiac",
            "probability": 3.438930421962637e-05,
            "start_logit": 3.932265520095825,
            "end_logit": -5.257850646972656
        },
        {
            "text": "celi",
            "probability": 2.0102120019653238e-05,
            "start_logit": 4.941971778869629,
            "end_logit": -6.804477214813232
        },
        {
            "text": "underlying celiac disease",
            "probability": 1.6327364511273858e-05,
            "start_logit": -5.905811309814453,
            "end_logit": 3.8353230953216553
        },
        {
            "text": "isease",
            "probability": 6.539281414190971e-06,
            "start_logit": -6.820826530456543,
            "end_logit": 3.8353230953216553
        },
        {
            "text": "the presence of underlying celiac disease",
            "probability": 5.84033006678672e-06,
            "start_logit": -6.933866500854492,
            "end_logit": 3.8353230953216553
        },
        {
            "text": "presence of underlying celiac disease",
            "probability": 4.699301790200837e-06,
            "start_logit": -7.15123987197876,
            "end_logit": 3.8353230953216553
        },
        {
            "text": "histologic subtype and the presence of underlying celiac disease.",
            "probability": 3.1658477638832783e-06,
            "start_logit": -6.880305290222168,
            "end_logit": 3.1693954467773438
        },
        {
            "text": "underlying celiac disease.",
            "probability": 3.082754069234328e-06,
            "start_logit": -6.90690279006958,
            "end_logit": 3.1693954467773438
        },
        {
            "text": "the underlying histologic subtype and whether the presence of underlying celiac disease",
            "probability": 2.798825085044576e-06,
            "start_logit": -7.669454097747803,
            "end_logit": 3.8353230953216553
        },
        {
            "text": "the presence of underlying celiac disease.",
            "probability": 2.7788996140920533e-06,
            "start_logit": -7.010671138763428,
            "end_logit": 3.1693954467773438
        },
        {
            "text": "disease is likely.",
            "probability": 6.052610995924718e-07,
            "start_logit": -2.85056209564209,
            "end_logit": -2.514863967895508
        },
        {
            "text": "d",
            "probability": 4.9032530723617887e-08,
            "start_logit": -1.8393588066101074,
            "end_logit": -6.039243221282959
        }
    ],
    "5509bd6a1180f13250000002_003": [
        {
            "text": "Celiac disease",
            "probability": 0.999583442478041,
            "start_logit": 9.120906829833984,
            "end_logit": 7.294310092926025
        },
        {
            "text": "C",
            "probability": 0.00034250421387875443,
            "start_logit": 9.120906829833984,
            "end_logit": -0.6844998598098755
        },
        {
            "text": "Celiac disease is an autoimmune disorder triggered by ingestion of gluten-containing foods.",
            "probability": 2.7154730353307408e-05,
            "start_logit": 9.120906829833984,
            "end_logit": -3.2192325592041016
        },
        {
            "text": "ase",
            "probability": 1.9910086715373198e-05,
            "start_logit": -1.7029606103897095,
            "end_logit": 7.294310092926025
        },
        {
            "text": "Celiac disease is an autoimmune",
            "probability": 9.45569980409897e-06,
            "start_logit": 9.120906829833984,
            "end_logit": -4.274166107177734
        },
        {
            "text": "Celiac",
            "probability": 4.737542525297024e-06,
            "start_logit": 9.120906829833984,
            "end_logit": -4.965265274047852
        },
        {
            "text": "disease",
            "probability": 3.952484104355538e-06,
            "start_logit": -3.31984281539917,
            "end_logit": 7.294310092926025
        },
        {
            "text": "Celiac disease is an autoimmune disorder triggered",
            "probability": 2.541899897029877e-06,
            "start_logit": 9.120906829833984,
            "end_logit": -5.58787202835083
        },
        {
            "text": "Celiac disease is",
            "probability": 2.3114153139544676e-06,
            "start_logit": 9.120906829833984,
            "end_logit": -5.682923793792725
        },
        {
            "text": "Celiac disease is an autoimmune disorder",
            "probability": 1.9442668470429643e-06,
            "start_logit": 9.120906829833984,
            "end_logit": -5.855898857116699
        },
        {
            "text": "Celiac disease is an autoimmune disorder triggered by",
            "probability": 1.6653970571105647e-06,
            "start_logit": 9.120906829833984,
            "end_logit": -6.010720252990723
        },
        {
            "text": "celiac disease",
            "probability": 3.683200196839432e-07,
            "start_logit": 0.5003741979598999,
            "end_logit": 1.1009457111358643
        },
        {
            "text": "small bowel lymphoma. Corrao et al. recently demonstrated that patients with celiac disease",
            "probability": 3.869370292849249e-09,
            "start_logit": -4.05548620223999,
            "end_logit": 1.1009457111358643
        },
        {
            "text": "with celiac disease",
            "probability": 3.667579833616272e-09,
            "start_logit": -4.10904598236084,
            "end_logit": 1.1009457111358643
        },
        {
            "text": "lymphoma. Corrao et al. recently demonstrated that patients with celiac disease",
            "probability": 1.5551125658817489e-09,
            "start_logit": -4.967030048370361,
            "end_logit": 1.1009457111358643
        },
        {
            "text": "established its association with gastrointestinal malignancies, particularly small bowel lymphoma.",
            "probability": 1.291901008100804e-09,
            "start_logit": -1.3884339332580566,
            "end_logit": -2.663083553314209
        },
        {
            "text": "disease is an autoimmune disorder triggered by ingestion of gluten-containing foods.",
            "probability": 5.408783430091724e-10,
            "start_logit": -1.7029606103897095,
            "end_logit": -3.2192325592041016
        },
        {
            "text": "established its association",
            "probability": 1.9887967991928815e-10,
            "start_logit": -1.3884339332580566,
            "end_logit": -4.5342535972595215
        },
        {
            "text": "disease is an autoimmune",
            "probability": 1.8834225843860326e-10,
            "start_logit": -1.7029606103897095,
            "end_logit": -4.274166107177734
        },
        {
            "text": "established its",
            "probability": 1.5337856109355594e-10,
            "start_logit": -1.3884339332580566,
            "end_logit": -4.794044494628906
        }
    ],
    "5509bd6a1180f13250000002_004": [
        {
            "text": "celiac sprue",
            "probability": 0.9996258404467401,
            "start_logit": 8.84476089477539,
            "end_logit": 7.914274215698242
        },
        {
            "text": "ce",
            "probability": 0.00013947851453798913,
            "start_logit": 8.84476089477539,
            "end_logit": -0.9629515409469604
        },
        {
            "text": "ue",
            "probability": 9.278223456921175e-05,
            "start_logit": -0.44012024998664856,
            "end_logit": 7.914274215698242
        },
        {
            "text": "increased incidence of small bowel lymphoma in patients with long-standing celiac sprue",
            "probability": 4.159289042690271e-05,
            "start_logit": -1.2424461841583252,
            "end_logit": 7.914274215698242
        },
        {
            "text": "long-standing celiac sprue",
            "probability": 2.7376249410974275e-05,
            "start_logit": -1.6606996059417725,
            "end_logit": 7.914274215698242
        },
        {
            "text": "celiac sprue is well documented",
            "probability": 2.510734420235985e-05,
            "start_logit": 8.84476089477539,
            "end_logit": -2.677701711654663
        },
        {
            "text": "with long-standing celiac sprue",
            "probability": 1.8749297641859865e-05,
            "start_logit": -2.0392191410064697,
            "end_logit": 7.914274215698242
        },
        {
            "text": "sprue",
            "probability": 1.6968283596858742e-05,
            "start_logit": -2.1390295028686523,
            "end_logit": 7.914274215698242
        },
        {
            "text": "celiac sprue is well documented in the literature.",
            "probability": 2.697284617894258e-06,
            "start_logit": 8.84476089477539,
            "end_logit": -4.908616542816162
        },
        {
            "text": "An increased incidence of small bowel lymphoma in patients with long-standing celiac sprue",
            "probability": 2.2461000793304533e-06,
            "start_logit": -4.161180019378662,
            "end_logit": 7.914274215698242
        },
        {
            "text": "celiac sprue is",
            "probability": 1.6949586720649116e-06,
            "start_logit": 8.84476089477539,
            "end_logit": -5.373203754425049
        },
        {
            "text": "incidence of small bowel lymphoma in patients with long-standing celiac sprue",
            "probability": 1.5135316678120134e-06,
            "start_logit": -4.555929660797119,
            "end_logit": 7.914274215698242
        },
        {
            "text": "lymphoma in patients with long-standing celiac sprue",
            "probability": 1.085556908006917e-06,
            "start_logit": -4.888282299041748,
            "end_logit": 7.914274215698242
        },
        {
            "text": "celiac sprue is well documented in the literature. Less common is the association of adenocarcinoma",
            "probability": 8.571180025172209e-07,
            "start_logit": 8.84476089477539,
            "end_logit": -6.055041790008545
        },
        {
            "text": "celi",
            "probability": 7.110689489654096e-07,
            "start_logit": 8.84476089477539,
            "end_logit": -6.241847991943359
        },
        {
            "text": "small bowel lymphoma in patients with long-standing celiac sprue",
            "probability": 4.77352232892299e-07,
            "start_logit": -5.70987606048584,
            "end_logit": 7.914274215698242
        },
        {
            "text": "celiac sprue is well documented in the literature. Less common",
            "probability": 4.0707918757242013e-07,
            "start_logit": 8.84476089477539,
            "end_logit": -6.799609661102295
        },
        {
            "text": "celiac sprue is well documented in the literature. Less",
            "probability": 4.050652427308383e-07,
            "start_logit": 8.84476089477539,
            "end_logit": -6.804569244384766
        },
        {
            "text": "increased incidence of small bowel lymphoma in patients with long-standing celiac",
            "probability": 5.8034860018155284e-09,
            "start_logit": -1.2424461841583252,
            "end_logit": -0.9629515409469604
        },
        {
            "text": "long-standing celiac",
            "probability": 3.819827826537299e-09,
            "start_logit": -1.6606996059417725,
            "end_logit": -0.9629515409469604
        }
    ],
    "54e0d7471388e8454a000015_001": [
        {
            "text": "anti-interleukin-17A",
            "probability": 0.9993417983823284,
            "start_logit": 9.555038452148438,
            "end_logit": 9.074005126953125
        },
        {
            "text": "Secukinumab is a fully human anti-interleukin-17A",
            "probability": 0.0003931257671053827,
            "start_logit": 1.7143158912658691,
            "end_logit": 9.074005126953125
        },
        {
            "text": "inter",
            "probability": 0.0001596960623538011,
            "start_logit": 9.555038452148438,
            "end_logit": 0.33242538571357727
        },
        {
            "text": "A",
            "probability": 7.26744973068012e-05,
            "start_logit": 0.02617684192955494,
            "end_logit": 9.074005126953125
        },
        {
            "text": "fully human anti-interleukin-17A",
            "probability": 2.8916405841657422e-05,
            "start_logit": -0.895404577255249,
            "end_logit": 9.074005126953125
        },
        {
            "text": "BACKGROUND: Secukinumab is a fully human anti-interleukin-17A",
            "probability": 1.5501260873667092e-06,
            "start_logit": -3.8214774131774902,
            "end_logit": 9.074005126953125
        },
        {
            "text": "17A",
            "probability": 4.855697988707317e-07,
            "start_logit": -4.982245922088623,
            "end_logit": 9.074005126953125
        },
        {
            "text": "human anti-interleukin-17A",
            "probability": 4.225012697151643e-07,
            "start_logit": -5.1213765144348145,
            "end_logit": 9.074005126953125
        },
        {
            "text": "a fully human anti-interleukin-17A",
            "probability": 2.886582411164248e-07,
            "start_logit": -5.502325534820557,
            "end_logit": 9.074005126953125
        },
        {
            "text": "anti-interleukin-17A monoclonal antibody.",
            "probability": 2.8094424128158197e-07,
            "start_logit": 9.555038452148438,
            "end_logit": -6.010446071624756
        },
        {
            "text": "interleukin",
            "probability": 2.8006613846991764e-07,
            "start_logit": 9.555038452148438,
            "end_logit": -6.013576507568359
        },
        {
            "text": "interleuk",
            "probability": 1.78871083235901e-07,
            "start_logit": 9.555038452148438,
            "end_logit": -6.461936950683594
        },
        {
            "text": "interle",
            "probability": 1.578654464468771e-07,
            "start_logit": 9.555038452148438,
            "end_logit": -6.586859226226807
        },
        {
            "text": "is a fully human anti-interleukin-17A",
            "probability": 1.4249861382742952e-07,
            "start_logit": -6.2082366943359375,
            "end_logit": 9.074005126953125
        },
        {
            "text": "Secukinumab is a fully",
            "probability": 1.1450029962603382e-09,
            "start_logit": 1.7143158912658691,
            "end_logit": -3.6724724769592285
        },
        {
            "text": "Secukinumab",
            "probability": 1.6357906065414437e-10,
            "start_logit": 1.7143158912658691,
            "end_logit": -5.618338584899902
        },
        {
            "text": "Secuk",
            "probability": 1.5644873165278727e-10,
            "start_logit": 1.7143158912658691,
            "end_logit": -5.662906646728516
        },
        {
            "text": "Secukinumab is a fully human",
            "probability": 1.2437308104817473e-10,
            "start_logit": 1.7143158912658691,
            "end_logit": -5.8923492431640625
        },
        {
            "text": "Secukinumab is a fully human anti-interleukin-17A monoclonal antibody.",
            "probability": 1.1051916426036154e-10,
            "start_logit": 1.7143158912658691,
            "end_logit": -6.010446071624756
        },
        {
            "text": "fully",
            "probability": 8.42208120153627e-11,
            "start_logit": -0.895404577255249,
            "end_logit": -3.6724724769592285
        }
    ],
    "54e0d7471388e8454a000015_002": [
        {
            "text": "anti-interleukin-17A",
            "probability": 0.9980187177899904,
            "start_logit": 9.469182968139648,
            "end_logit": 9.054118156433105
        },
        {
            "text": "Secukinumab, a fully human anti-interleukin-17A",
            "probability": 0.0017410447807431385,
            "start_logit": 3.117896318435669,
            "end_logit": 9.054118156433105
        },
        {
            "text": "inter",
            "probability": 0.00014775494981235363,
            "start_logit": 9.469182968139648,
            "end_logit": 0.2361460030078888
        },
        {
            "text": "A",
            "probability": 7.617915076608563e-05,
            "start_logit": -0.01125652901828289,
            "end_logit": 9.054118156433105
        },
        {
            "text": "fully human anti-interleukin-17A",
            "probability": 1.360828767732833e-05,
            "start_logit": -1.7336653470993042,
            "end_logit": 9.054118156433105
        },
        {
            "text": "BACKGROUND: Secukinumab, a fully human anti-interleukin-17A",
            "probability": 1.3492029625869778e-06,
            "start_logit": -4.044830322265625,
            "end_logit": 9.054118156433105
        },
        {
            "text": "17A",
            "probability": 5.376289348686305e-07,
            "start_logit": -4.964931011199951,
            "end_logit": 9.054118156433105
        },
        {
            "text": "interleukin",
            "probability": 1.721280654202593e-07,
            "start_logit": 9.469182968139648,
            "end_logit": -6.518925666809082
        },
        {
            "text": "anti-interleukin-17A monoclonal antibody, demonstrated efficacy and safety",
            "probability": 1.5029844346312265e-07,
            "start_logit": 9.469182968139648,
            "end_logit": -6.654541492462158
        },
        {
            "text": "interleuk",
            "probability": 1.1619497913793423e-07,
            "start_logit": 9.469182968139648,
            "end_logit": -6.911894798278809
        },
        {
            "text": "human anti-interleukin-17A",
            "probability": 1.1554754113930093e-07,
            "start_logit": -6.50241756439209,
            "end_logit": 9.054118156433105
        },
        {
            "text": "interle",
            "probability": 1.1139117312760031e-07,
            "start_logit": 9.469182968139648,
            "end_logit": -6.954116344451904
        },
        {
            "text": "anti-interleukin-17A monoclonal antibody, demonstrated efficacy",
            "probability": 7.454705684621212e-08,
            "start_logit": 9.469182968139648,
            "end_logit": -7.355733871459961
        },
        {
            "text": "anti-interleukin-17A monoclonal antibody, demonstrated",
            "probability": 3.952217355599207e-08,
            "start_logit": 9.469182968139648,
            "end_logit": -7.990302562713623
        },
        {
            "text": "Secukinumab",
            "probability": 2.234931998935537e-08,
            "start_logit": 3.117896318435669,
            "end_logit": -2.2090818881988525
        },
        {
            "text": "Secuk",
            "probability": 2.9684041497140998e-09,
            "start_logit": 3.117896318435669,
            "end_logit": -4.227853298187256
        },
        {
            "text": "Secukinumab, a fully",
            "probability": 2.6347869396914676e-09,
            "start_logit": 3.117896318435669,
            "end_logit": -4.347075462341309
        },
        {
            "text": "Sec",
            "probability": 3.786007434338939e-10,
            "start_logit": 3.117896318435669,
            "end_logit": -6.287150859832764
        },
        {
            "text": "Secukinumab, a fully human",
            "probability": 1.2773675493619246e-10,
            "start_logit": 3.117896318435669,
            "end_logit": -7.373661518096924
        },
        {
            "text": "Secukinum",
            "probability": 1.2083232040720223e-10,
            "start_logit": 3.117896318435669,
            "end_logit": -7.429229259490967
        }
    ],
    "54e0d7471388e8454a000015_003": [
        {
            "text": "anti-interleukin-17A",
            "probability": 0.9998081797876957,
            "start_logit": 9.31281852722168,
            "end_logit": 8.891242980957031
        },
        {
            "text": "inter",
            "probability": 0.00011789928397117264,
            "start_logit": 9.31281852722168,
            "end_logit": -0.15424500405788422
        },
        {
            "text": "A",
            "probability": 7.172492029454002e-05,
            "start_logit": -0.2296619415283203,
            "end_logit": 8.891242980957031
        },
        {
            "text": "fully human anti-interleukin-17A",
            "probability": 1.1577288421224297e-06,
            "start_logit": -4.356040000915527,
            "end_logit": 8.891242980957031
        },
        {
            "text": "17A",
            "probability": 4.0687454982339334e-07,
            "start_logit": -5.401750564575195,
            "end_logit": 8.891242980957031
        },
        {
            "text": "secukinumab, a fully human anti-interleukin-17A",
            "probability": 2.3734038525652218e-07,
            "start_logit": -5.940760135650635,
            "end_logit": 8.891242980957031
        },
        {
            "text": "anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe plaque psoriasis.",
            "probability": 1.315828020279119e-07,
            "start_logit": 9.31281852722168,
            "end_logit": -6.952194690704346
        },
        {
            "text": "interle",
            "probability": 9.420422495763613e-08,
            "start_logit": 9.31281852722168,
            "end_logit": -7.286365985870361
        },
        {
            "text": "interleuk",
            "probability": 8.596026180357328e-08,
            "start_logit": 9.31281852722168,
            "end_logit": -7.377945899963379
        },
        {
            "text": "interleukin",
            "probability": 7.738445465796586e-08,
            "start_logit": 9.31281852722168,
            "end_logit": -7.4830451011657715
        },
        {
            "text": "Interleukin-17A",
            "probability": 4.859628581628392e-09,
            "start_logit": -0.4397560954093933,
            "end_logit": -0.4982943832874298
        },
        {
            "text": "BACKGROUND: Interleukin-17A",
            "probability": 4.238461971972311e-11,
            "start_logit": -5.181687831878662,
            "end_logit": -0.4982943832874298
        },
        {
            "text": "considered to be central to the pathogenesis of psoriasis. We evaluated secukinumab, a fully human anti-interleukin-17A",
            "probability": 8.862080952708241e-12,
            "start_logit": -7.090741157531738,
            "end_logit": -0.15424500405788422
        },
        {
            "text": "is considered to be central to the pathogenesis of psoriasis. We evaluated secukinumab, a fully human anti-interleukin-17A",
            "probability": 7.690945052199784e-12,
            "start_logit": -7.232479095458984,
            "end_logit": -0.15424500405788422
        },
        {
            "text": "Inter",
            "probability": 3.827708509869175e-12,
            "start_logit": -0.4397560954093933,
            "end_logit": -7.644745349884033
        },
        {
            "text": "Interleukin-17A is considered to be central to the pathogenesis",
            "probability": 3.3671180813821112e-12,
            "start_logit": -0.4397560954093933,
            "end_logit": -7.77295446395874
        },
        {
            "text": "Interleukin-17A is considered to be central to the pathogenesis of psoriasis. We evaluated secukinumab,",
            "probability": 3.3562147063452615e-12,
            "start_logit": -0.4397560954093933,
            "end_logit": -7.776197910308838
        },
        {
            "text": "Interleukin-17A is considered to be central to the pathogenesis of psoriasis.",
            "probability": 2.702204469311866e-12,
            "start_logit": -0.4397560954093933,
            "end_logit": -7.99294376373291
        },
        {
            "text": "interleukin-17A",
            "probability": 4.997039423858347e-13,
            "start_logit": -4.792865753173828,
            "end_logit": -5.327641487121582
        },
        {
            "text": "fully",
            "probability": 1.9873968430674888e-13,
            "start_logit": -4.356040000915527,
            "end_logit": -6.686487197875977
        }
    ],
    "54e0d7471388e8454a000015_004": [
        {
            "text": "Anti-interleukin-17A",
            "probability": 0.9996778841734402,
            "start_logit": 9.19591236114502,
            "end_logit": 8.810006141662598
        },
        {
            "text": "inter",
            "probability": 0.00013484199005452233,
            "start_logit": 9.19591236114502,
            "end_logit": -0.10107859969139099
        },
        {
            "text": "Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis:",
            "probability": 0.00010513531208994487,
            "start_logit": 9.19591236114502,
            "end_logit": -0.34993404150009155
        },
        {
            "text": "A",
            "probability": 7.761193442637299e-05,
            "start_logit": -0.2675548195838928,
            "end_logit": 8.810006141662598
        },
        {
            "text": "Anti-interleukin-17A monoclonal antibody secukinumab",
            "probability": 3.296327886638181e-06,
            "start_logit": 9.19591236114502,
            "end_logit": -3.812373161315918
        },
        {
            "text": "17A",
            "probability": 6.875554309341831e-07,
            "start_logit": -4.993888854980469,
            "end_logit": 8.810006141662598
        },
        {
            "text": "interle",
            "probability": 1.3093810771721233e-07,
            "start_logit": 9.19591236114502,
            "end_logit": -7.038212776184082
        },
        {
            "text": "interleukin",
            "probability": 1.1027266661428881e-07,
            "start_logit": 9.19591236114502,
            "end_logit": -7.209981441497803
        },
        {
            "text": "interleuk",
            "probability": 8.67266560901623e-08,
            "start_logit": 9.19591236114502,
            "end_logit": -7.450176239013672
        },
        {
            "text": "Anti-interleukin-17A monoclonal antibody",
            "probability": 7.443025408429564e-08,
            "start_logit": 9.19591236114502,
            "end_logit": -7.60307502746582
        },
        {
            "text": "Anti-interleukin-17A monoclonal antibody secukinumab in",
            "probability": 7.331126915544288e-08,
            "start_logit": 9.19591236114502,
            "end_logit": -7.618223190307617
        },
        {
            "text": "Anti-interleukin-17A monoclonal antibody secukinumab in treatment of",
            "probability": 5.8988521461820543e-08,
            "start_logit": 9.19591236114502,
            "end_logit": -7.835594654083252
        },
        {
            "text": "secukinumab in treatment of ankylosing spondylitis:",
            "probability": 7.416302313347495e-09,
            "start_logit": -0.3634105324745178,
            "end_logit": -0.34993404150009155
        },
        {
            "text": "secukinumab",
            "probability": 2.3252476875050495e-10,
            "start_logit": -0.3634105324745178,
            "end_logit": -3.812373161315918
        },
        {
            "text": "ankylosing spondylitis:",
            "probability": 1.6872360337972347e-10,
            "start_logit": -4.146584510803223,
            "end_logit": -0.34993404150009155
        },
        {
            "text": "anti-IL-17A",
            "probability": 5.3226523419184454e-11,
            "start_logit": -3.986041784286499,
            "end_logit": -1.6641818284988403
        },
        {
            "text": "treatment of ankylosing spondylitis:",
            "probability": 5.204125178844271e-11,
            "start_logit": -5.32280969619751,
            "end_logit": -0.34993404150009155
        },
        {
            "text": "secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.",
            "probability": 4.890373066102347e-11,
            "start_logit": -0.3634105324745178,
            "end_logit": -5.371516227722168
        },
        {
            "text": "of ankylosing spondylitis:",
            "probability": 4.597541192860197e-11,
            "start_logit": -5.446739673614502,
            "end_logit": -0.34993404150009155
        },
        {
            "text": ":",
            "probability": 2.149894752088618e-11,
            "start_logit": -6.206842422485352,
            "end_logit": -0.34993404150009155
        }
    ],
    "54e0d7471388e8454a000015_005": [
        {
            "text": "anti-interleukin-17A",
            "probability": 0.998748585982859,
            "start_logit": 9.186925888061523,
            "end_logit": 8.835448265075684
        },
        {
            "text": "secukinumab, a fully human anti-interleukin-17A",
            "probability": 0.0009785640565925556,
            "start_logit": 2.258753776550293,
            "end_logit": 8.835448265075684
        },
        {
            "text": "inter",
            "probability": 0.00012133150787268932,
            "start_logit": 9.186925888061523,
            "end_logit": -0.1802835613489151
        },
        {
            "text": "A",
            "probability": 9.386090181064112e-05,
            "start_logit": -0.08551855385303497,
            "end_logit": 8.835448265075684
        },
        {
            "text": "anti-interleukin (IL)-17A",
            "probability": 4.9674707015187084e-05,
            "start_logit": 8.007638931274414,
            "end_logit": 0.10597275197505951
        },
        {
            "text": "Efficacy and safety of secukinumab, a fully human anti-interleukin-17A",
            "probability": 5.302920659317551e-06,
            "start_logit": -2.9590747356414795,
            "end_logit": 8.835448265075684
        },
        {
            "text": "17A",
            "probability": 8.07217919031034e-07,
            "start_logit": -4.841494083404541,
            "end_logit": 8.835448265075684
        },
        {
            "text": "interleukin",
            "probability": 7.128685222216079e-07,
            "start_logit": 8.007638931274414,
            "end_logit": -4.137981414794922
        },
        {
            "text": "and safety of secukinumab, a fully human anti-interleukin-17A",
            "probability": 5.88046734334766e-07,
            "start_logit": -5.158281326293945,
            "end_logit": 8.835448265075684
        },
        {
            "text": "of secukinumab, a fully human anti-interleukin-17A",
            "probability": 3.574079353657109e-07,
            "start_logit": -5.656209945678711,
            "end_logit": 8.835448265075684
        },
        {
            "text": "interle",
            "probability": 1.3497100535182389e-07,
            "start_logit": 9.186925888061523,
            "end_logit": -6.981505393981934
        },
        {
            "text": "interleuk",
            "probability": 7.675754423761649e-08,
            "start_logit": 8.007638931274414,
            "end_logit": -6.366626739501953
        },
        {
            "text": "secukinumab, a fully human, anti-interleukin (IL)-17A",
            "probability": 7.960153053854742e-10,
            "start_logit": -3.0337491035461426,
            "end_logit": 0.10597275197505951
        },
        {
            "text": "secukinumab",
            "probability": 6.148422972790255e-10,
            "start_logit": 2.258753776550293,
            "end_logit": -5.444782733917236
        },
        {
            "text": "secuk",
            "probability": 5.579108984848162e-10,
            "start_logit": 2.258753776550293,
            "end_logit": -5.541949272155762
        },
        {
            "text": "(IL)-17A",
            "probability": 3.9780558239551723e-10,
            "start_logit": -3.7274041175842285,
            "end_logit": 0.10597275197505951
        },
        {
            "text": "sec",
            "probability": 2.2900132992297503e-10,
            "start_logit": 2.258753776550293,
            "end_logit": -6.43242073059082
        },
        {
            "text": "secukinumab, a fully human, anti-interleukin",
            "probability": 3.970055164522757e-11,
            "start_logit": -3.0337491035461426,
            "end_logit": -2.8922805786132812
        },
        {
            "text": "Efficacy",
            "probability": 9.266395645585887e-12,
            "start_logit": -2.9590747356414795,
            "end_logit": -4.4219255447387695
        },
        {
            "text": "anti-interleukin",
            "probability": 8.987559849589513e-12,
            "start_logit": -4.519272804260254,
            "end_logit": -2.8922805786132812
        }
    ],
    "54e0d7471388e8454a000015_006": [
        {
            "text": "interleukin-17A",
            "probability": 0.999809891223165,
            "start_logit": 9.21497917175293,
            "end_logit": 8.726264953613281
        },
        {
            "text": "inter",
            "probability": 0.00011250284401298118,
            "start_logit": 9.21497917175293,
            "end_logit": -0.3660769760608673
        },
        {
            "text": "A",
            "probability": 6.938610539665825e-05,
            "start_logit": -0.3606546223163605,
            "end_logit": 8.726264953613281
        },
        {
            "text": "secukinumab, a fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 5.4060065969755975e-06,
            "start_logit": -2.9128305912017822,
            "end_logit": 8.726264953613281
        },
        {
            "text": "fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 1.42760057805319e-06,
            "start_logit": -4.2443461418151855,
            "end_logit": 8.726264953613281
        },
        {
            "text": "17A",
            "probability": 3.318229397702244e-07,
            "start_logit": -5.703495025634766,
            "end_logit": 8.726264953613281
        },
        {
            "text": "targeted interleukin-17A",
            "probability": 2.3229628000598465e-07,
            "start_logit": -6.060082912445068,
            "end_logit": 8.726264953613281
        },
        {
            "text": "interleukin-17A blockade, in patients with noninfectious uveitis.",
            "probability": 1.90583686274361e-07,
            "start_logit": 9.21497917175293,
            "end_logit": -6.7467193603515625
        },
        {
            "text": "interle",
            "probability": 1.5284145552614568e-07,
            "start_logit": 9.21497917175293,
            "end_logit": -6.967409610748291
        },
        {
            "text": "interleukin-17A blockade,",
            "probability": 1.3751638743949472e-07,
            "start_logit": 9.21497917175293,
            "end_logit": -7.073067665100098
        },
        {
            "text": "for targeted interleukin-17A",
            "probability": 1.1391993619259006e-07,
            "start_logit": -6.7726006507873535,
            "end_logit": 8.726264953613281
        },
        {
            "text": "interleuk",
            "probability": 9.611940096527832e-08,
            "start_logit": 9.21497917175293,
            "end_logit": -7.431219577789307
        },
        {
            "text": "interleukin",
            "probability": 8.36884502936877e-08,
            "start_logit": 9.21497917175293,
            "end_logit": -7.569709777832031
        },
        {
            "text": "a fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 4.7424627914677025e-08,
            "start_logit": -7.64895486831665,
            "end_logit": 8.726264953613281
        },
        {
            "text": "secukinumab, a fully human monoclonal antibody for targeted",
            "probability": 2.161646488747325e-12,
            "start_logit": -2.9128305912017822,
            "end_logit": -6.005886077880859
        },
        {
            "text": "17",
            "probability": 1.3593505653871412e-12,
            "start_logit": -5.703495025634766,
            "end_logit": -3.6790847778320312
        },
        {
            "text": "secukinumab",
            "probability": 1.1376425823856684e-12,
            "start_logit": -2.9128305912017822,
            "end_logit": -6.64779806137085
        },
        {
            "text": "secukinumab, a fully",
            "probability": 1.1132021285516952e-12,
            "start_logit": -2.9128305912017822,
            "end_logit": -6.669515609741211
        },
        {
            "text": "secukinumab, a fully human monoclonal antibody for targeted interleukin-17A blockade,",
            "probability": 7.435558541841081e-13,
            "start_logit": -2.9128305912017822,
            "end_logit": -7.073067665100098
        },
        {
            "text": "fully human monoclonal antibody for targeted",
            "probability": 5.708405495858591e-13,
            "start_logit": -4.2443461418151855,
            "end_logit": -6.005886077880859
        }
    ],
    "54e0d7471388e8454a000015_007": [
        {
            "text": "interleukin-17A-blocking",
            "probability": 0.5059048736992192,
            "start_logit": 9.117594718933105,
            "end_logit": 8.718863487243652
        },
        {
            "text": "anti-interleukin-17A",
            "probability": 0.493976861612499,
            "start_logit": 9.133731842041016,
            "end_logit": 8.678866386413574
        },
        {
            "text": "inter",
            "probability": 6.573090867007666e-05,
            "start_logit": 9.117594718933105,
            "end_logit": -0.2296711802482605
        },
        {
            "text": "A",
            "probability": 3.507810278417165e-05,
            "start_logit": -0.45893213152885437,
            "end_logit": 8.718863487243652
        },
        {
            "text": "anti-interleukin-17A (IL-17A)",
            "probability": 1.1346707122853359e-05,
            "start_logit": 9.133731842041016,
            "end_logit": -2.0024499893188477
        },
        {
            "text": "interleukin-17A-blocking antibody secukinumab",
            "probability": 5.567665511511642e-06,
            "start_logit": 9.117594718933105,
            "end_logit": -2.6982645988464355
        },
        {
            "text": "17A",
            "probability": 2.545109592442183e-07,
            "start_logit": -5.384920597076416,
            "end_logit": 8.718863487243652
        },
        {
            "text": "the interleukin-17A-blocking",
            "probability": 1.0581539510070555e-07,
            "start_logit": -6.262568473815918,
            "end_logit": 8.718863487243652
        },
        {
            "text": "interleuk",
            "probability": 6.346829023978117e-08,
            "start_logit": 9.133731842041016,
            "end_logit": -7.188592433929443
        },
        {
            "text": "interleukin",
            "probability": 5.9533622610755364e-08,
            "start_logit": 9.133731842041016,
            "end_logit": -7.252591609954834
        },
        {
            "text": "interle",
            "probability": 5.4233721621505086e-08,
            "start_logit": 9.117594718933105,
            "end_logit": -7.329692840576172
        },
        {
            "text": "secukinumab",
            "probability": 3.5564475757121385e-09,
            "start_logit": 1.7616257667541504,
            "end_logit": -2.6982645988464355
        },
        {
            "text": "(IL-17A)",
            "probability": 1.4706746450106946e-10,
            "start_logit": -2.119814872741699,
            "end_logit": -2.0024499893188477
        },
        {
            "text": "secuk",
            "probability": 3.631077087668114e-11,
            "start_logit": 1.7616257667541504,
            "end_logit": -7.282667636871338
        },
        {
            "text": "the interleukin-17A-blocking antibody secukinumab",
            "probability": 1.1645365690614921e-12,
            "start_logit": -6.262568473815918,
            "end_logit": -2.6982645988464355
        },
        {
            "text": "antibody secukinumab",
            "probability": 8.048796577476693e-13,
            "start_logit": -6.631954193115234,
            "end_logit": -2.6982645988464355
        },
        {
            "text": "17",
            "probability": 1.3010679616826394e-13,
            "start_logit": -5.384920597076416,
            "end_logit": -5.767635345458984
        },
        {
            "text": "leukin",
            "probability": 1.0493660682166713e-13,
            "start_logit": -4.110301494598389,
            "end_logit": -7.257253646850586
        },
        {
            "text": "le",
            "probability": 9.760387832336234e-14,
            "start_logit": -4.110301494598389,
            "end_logit": -7.329692840576172
        },
        {
            "text": "leuk",
            "probability": 7.639314945212062e-14,
            "start_logit": -4.110301494598389,
            "end_logit": -7.574717044830322
        }
    ],
    "54e0d7471388e8454a000015_008": [
        {
            "text": "interleukin-17A-blocking",
            "probability": 0.5059048736992192,
            "start_logit": 9.117594718933105,
            "end_logit": 8.718863487243652
        },
        {
            "text": "anti-interleukin-17A",
            "probability": 0.493976861612499,
            "start_logit": 9.133731842041016,
            "end_logit": 8.678866386413574
        },
        {
            "text": "inter",
            "probability": 6.573090867007666e-05,
            "start_logit": 9.117594718933105,
            "end_logit": -0.2296711802482605
        },
        {
            "text": "A",
            "probability": 3.507810278417165e-05,
            "start_logit": -0.45893213152885437,
            "end_logit": 8.718863487243652
        },
        {
            "text": "anti-interleukin-17A (IL-17A)",
            "probability": 1.1346707122853359e-05,
            "start_logit": 9.133731842041016,
            "end_logit": -2.0024499893188477
        },
        {
            "text": "interleukin-17A-blocking antibody secukinumab",
            "probability": 5.567665511511642e-06,
            "start_logit": 9.117594718933105,
            "end_logit": -2.6982645988464355
        },
        {
            "text": "17A",
            "probability": 2.545109592442183e-07,
            "start_logit": -5.384920597076416,
            "end_logit": 8.718863487243652
        },
        {
            "text": "the interleukin-17A-blocking",
            "probability": 1.0581539510070555e-07,
            "start_logit": -6.262568473815918,
            "end_logit": 8.718863487243652
        },
        {
            "text": "interleuk",
            "probability": 6.346829023978117e-08,
            "start_logit": 9.133731842041016,
            "end_logit": -7.188592433929443
        },
        {
            "text": "interleukin",
            "probability": 5.9533622610755364e-08,
            "start_logit": 9.133731842041016,
            "end_logit": -7.252591609954834
        },
        {
            "text": "interle",
            "probability": 5.4233721621505086e-08,
            "start_logit": 9.117594718933105,
            "end_logit": -7.329692840576172
        },
        {
            "text": "secukinumab",
            "probability": 3.5564475757121385e-09,
            "start_logit": 1.7616257667541504,
            "end_logit": -2.6982645988464355
        },
        {
            "text": "(IL-17A)",
            "probability": 1.4706746450106946e-10,
            "start_logit": -2.119814872741699,
            "end_logit": -2.0024499893188477
        },
        {
            "text": "secuk",
            "probability": 3.631077087668114e-11,
            "start_logit": 1.7616257667541504,
            "end_logit": -7.282667636871338
        },
        {
            "text": "the interleukin-17A-blocking antibody secukinumab",
            "probability": 1.1645365690614921e-12,
            "start_logit": -6.262568473815918,
            "end_logit": -2.6982645988464355
        },
        {
            "text": "antibody secukinumab",
            "probability": 8.048796577476693e-13,
            "start_logit": -6.631954193115234,
            "end_logit": -2.6982645988464355
        },
        {
            "text": "17",
            "probability": 1.3010679616826394e-13,
            "start_logit": -5.384920597076416,
            "end_logit": -5.767635345458984
        },
        {
            "text": "leukin",
            "probability": 1.0493660682166713e-13,
            "start_logit": -4.110301494598389,
            "end_logit": -7.257253646850586
        },
        {
            "text": "le",
            "probability": 9.760387832336234e-14,
            "start_logit": -4.110301494598389,
            "end_logit": -7.329692840576172
        },
        {
            "text": "leuk",
            "probability": 7.639314945212062e-14,
            "start_logit": -4.110301494598389,
            "end_logit": -7.574717044830322
        }
    ],
    "54e0d7471388e8454a000015_009": [
        {
            "text": "interleukin-17A",
            "probability": 0.999809891223165,
            "start_logit": 9.21497917175293,
            "end_logit": 8.726264953613281
        },
        {
            "text": "inter",
            "probability": 0.00011250284401298118,
            "start_logit": 9.21497917175293,
            "end_logit": -0.3660769760608673
        },
        {
            "text": "A",
            "probability": 6.938610539665825e-05,
            "start_logit": -0.3606546223163605,
            "end_logit": 8.726264953613281
        },
        {
            "text": "secukinumab, a fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 5.4060065969755975e-06,
            "start_logit": -2.9128305912017822,
            "end_logit": 8.726264953613281
        },
        {
            "text": "fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 1.42760057805319e-06,
            "start_logit": -4.2443461418151855,
            "end_logit": 8.726264953613281
        },
        {
            "text": "17A",
            "probability": 3.318229397702244e-07,
            "start_logit": -5.703495025634766,
            "end_logit": 8.726264953613281
        },
        {
            "text": "targeted interleukin-17A",
            "probability": 2.3229628000598465e-07,
            "start_logit": -6.060082912445068,
            "end_logit": 8.726264953613281
        },
        {
            "text": "interleukin-17A blockade, in patients with noninfectious uveitis.",
            "probability": 1.90583686274361e-07,
            "start_logit": 9.21497917175293,
            "end_logit": -6.7467193603515625
        },
        {
            "text": "interle",
            "probability": 1.5284145552614568e-07,
            "start_logit": 9.21497917175293,
            "end_logit": -6.967409610748291
        },
        {
            "text": "interleukin-17A blockade,",
            "probability": 1.3751638743949472e-07,
            "start_logit": 9.21497917175293,
            "end_logit": -7.073067665100098
        },
        {
            "text": "for targeted interleukin-17A",
            "probability": 1.1391993619259006e-07,
            "start_logit": -6.7726006507873535,
            "end_logit": 8.726264953613281
        },
        {
            "text": "interleuk",
            "probability": 9.611940096527832e-08,
            "start_logit": 9.21497917175293,
            "end_logit": -7.431219577789307
        },
        {
            "text": "interleukin",
            "probability": 8.36884502936877e-08,
            "start_logit": 9.21497917175293,
            "end_logit": -7.569709777832031
        },
        {
            "text": "a fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 4.7424627914677025e-08,
            "start_logit": -7.64895486831665,
            "end_logit": 8.726264953613281
        },
        {
            "text": "secukinumab, a fully human monoclonal antibody for targeted",
            "probability": 2.161646488747325e-12,
            "start_logit": -2.9128305912017822,
            "end_logit": -6.005886077880859
        },
        {
            "text": "17",
            "probability": 1.3593505653871412e-12,
            "start_logit": -5.703495025634766,
            "end_logit": -3.6790847778320312
        },
        {
            "text": "secukinumab",
            "probability": 1.1376425823856684e-12,
            "start_logit": -2.9128305912017822,
            "end_logit": -6.64779806137085
        },
        {
            "text": "secukinumab, a fully",
            "probability": 1.1132021285516952e-12,
            "start_logit": -2.9128305912017822,
            "end_logit": -6.669515609741211
        },
        {
            "text": "secukinumab, a fully human monoclonal antibody for targeted interleukin-17A blockade,",
            "probability": 7.435558541841081e-13,
            "start_logit": -2.9128305912017822,
            "end_logit": -7.073067665100098
        },
        {
            "text": "fully human monoclonal antibody for targeted",
            "probability": 5.708405495858591e-13,
            "start_logit": -4.2443461418151855,
            "end_logit": -6.005886077880859
        }
    ],
    "54f9c40ddd3fc62544000001_001": [
        {
            "text": "calcineurin",
            "probability": 0.9993473570862778,
            "start_logit": 9.664521217346191,
            "end_logit": 9.142529487609863
        },
        {
            "text": "cal",
            "probability": 0.00031171780647577894,
            "start_logit": 9.664521217346191,
            "end_logit": 1.069770097732544
        },
        {
            "text": "ineurin",
            "probability": 0.0001397253332267976,
            "start_logit": 0.7893421053886414,
            "end_logit": 9.142529487609863
        },
        {
            "text": "in",
            "probability": 0.00011606163699872067,
            "start_logit": 0.6037849187850952,
            "end_logit": 9.142529487609863
        },
        {
            "text": "cineurin",
            "probability": 4.968137020427588e-05,
            "start_logit": -0.24470646679401398,
            "end_logit": 9.142529487609863
        },
        {
            "text": "urin",
            "probability": 2.1720429078223614e-05,
            "start_logit": -1.0720832347869873,
            "end_logit": 9.142529487609863
        },
        {
            "text": "calcine",
            "probability": 6.122267561221912e-06,
            "start_logit": 9.664521217346191,
            "end_logit": -2.860395669937134
        },
        {
            "text": "calc",
            "probability": 1.6580087941992878e-06,
            "start_logit": 9.664521217346191,
            "end_logit": -4.16671085357666
        },
        {
            "text": "phosphatase calcineurin.",
            "probability": 1.5085896860801254e-06,
            "start_logit": -3.739161252975464,
            "end_logit": 9.142529487609863
        },
        {
            "text": "the calmodulin-dependent serine/threonine phosphatase calcineurin.",
            "probability": 1.3747427336745108e-06,
            "start_logit": -3.8320698738098145,
            "end_logit": 9.142529487609863
        },
        {
            "text": "calcineurin. The importance of the Ca(2+)/calcineurin/NFAT",
            "probability": 1.3187018250738978e-06,
            "start_logit": 9.664521217346191,
            "end_logit": -4.3956804275512695
        },
        {
            "text": "calcineur",
            "probability": 7.192195084389677e-07,
            "start_logit": 9.664521217346191,
            "end_logit": -5.001916885375977
        },
        {
            "text": "dephosphorylated by the calmodulin-dependent serine/threonine phosphatase calcineurin.",
            "probability": 3.1226293895364267e-07,
            "start_logit": -5.31424617767334,
            "end_logit": 9.142529487609863
        },
        {
            "text": "serine/threonine phosphatase calcineurin.",
            "probability": 2.943565206950762e-07,
            "start_logit": -5.373300075531006,
            "end_logit": 9.142529487609863
        },
        {
            "text": "calmodulin-dependent serine/threonine phosphatase calcineurin.",
            "probability": 2.257872040045574e-07,
            "start_logit": -5.638498783111572,
            "end_logit": 9.142529487609863
        },
        {
            "text": "when dephosphorylated by the calmodulin-dependent serine/threonine phosphatase calcineurin.",
            "probability": 9.750165902252687e-08,
            "start_logit": -6.478222370147705,
            "end_logit": 9.142529487609863
        },
        {
            "text": "by the calmodulin-dependent serine/threonine phosphatase calcineurin.",
            "probability": 7.213214084338198e-08,
            "start_logit": -6.779592037200928,
            "end_logit": 9.142529487609863
        },
        {
            "text": "calcineurin.",
            "probability": 3.160680993461408e-08,
            "start_logit": 9.664521217346191,
            "end_logit": -8.126710891723633
        },
        {
            "text": "ine",
            "probability": 8.559945338620551e-10,
            "start_logit": 0.7893421053886414,
            "end_logit": -2.860395669937134
        },
        {
            "text": "cine",
            "probability": 3.0436128043158013e-10,
            "start_logit": -0.24470646679401398,
            "end_logit": -2.860395669937134
        }
    ],
    "54f9c40ddd3fc62544000001_002": [
        {
            "text": "Calcineurin",
            "probability": 0.998315316234788,
            "start_logit": 5.07603120803833,
            "end_logit": 4.085821151733398
        },
        {
            "text": "Cal",
            "probability": 0.0009614098976695524,
            "start_logit": 5.07603120803833,
            "end_logit": -2.859602451324463
        },
        {
            "text": "in",
            "probability": 0.00018605787964334707,
            "start_logit": -3.511735439300537,
            "end_logit": 4.085821151733398
        },
        {
            "text": "Calc",
            "probability": 0.00013741890908559065,
            "start_logit": 5.07603120803833,
            "end_logit": -4.804969310760498
        },
        {
            "text": "Calcine",
            "probability": 8.425305383875215e-05,
            "start_logit": 5.07603120803833,
            "end_logit": -5.294178485870361
        },
        {
            "text": "Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Calcineurin",
            "probability": 8.310980756039736e-05,
            "start_logit": -4.15012264251709,
            "end_logit": 3.9183132648468018
        },
        {
            "text": "Calcineurin is a calmodulin-dependent, calcium-activated protein phosphatase composed",
            "probability": 5.041986078331486e-05,
            "start_logit": 5.07603120803833,
            "end_logit": -5.807618141174316
        },
        {
            "text": "developmental processes in a variety of organ systems. Calcineurin",
            "probability": 3.804339435291728e-05,
            "start_logit": -5.099065780639648,
            "end_logit": 4.085821151733398
        },
        {
            "text": "Calcineurin signaling has been implicated in a broad spectrum of developmental",
            "probability": 3.688614647931555e-05,
            "start_logit": 5.013962268829346,
            "end_logit": -6.058098316192627
        },
        {
            "text": "cineurin",
            "probability": 3.498696445458665e-05,
            "start_logit": -5.015309810638428,
            "end_logit": 3.9183132648468018
        },
        {
            "text": "Calcineur",
            "probability": 3.2329976461908274e-05,
            "start_logit": 5.07603120803833,
            "end_logit": -6.252008438110352
        },
        {
            "text": "signaling has been implicated in a broad spectrum of developmental processes in a variety of organ systems. Calcineurin",
            "probability": 1.6924839882486888e-05,
            "start_logit": -5.909010887145996,
            "end_logit": 4.085821151733398
        },
        {
            "text": "ineurin",
            "probability": 1.3641886003243292e-05,
            "start_logit": -5.807551860809326,
            "end_logit": 3.7687246799468994
        },
        {
            "text": "developmentally important cell types. Calcineurin",
            "probability": 9.011363269465973e-06,
            "start_logit": -6.22221040725708,
            "end_logit": 3.7687246799468994
        },
        {
            "text": "Calcineurin signaling has been implicated in a broad spectrum of developmental processes in a variety of organ systems. Calcineurin",
            "probability": 1.6534328442541962e-07,
            "start_logit": -3.5921010971069336,
            "end_logit": -2.859602451324463
        },
        {
            "text": "calcineurin",
            "probability": 1.374610642394748e-08,
            "start_logit": -5.564657688140869,
            "end_logit": -3.374314069747925
        },
        {
            "text": "c",
            "probability": 4.5545243040187245e-09,
            "start_logit": -5.015309810638428,
            "end_logit": -5.02829647064209
        },
        {
            "text": "cine",
            "probability": 2.7496256540254348e-09,
            "start_logit": -5.015309810638428,
            "end_logit": -5.532952785491943
        },
        {
            "text": "composed",
            "probability": 1.89653251551655e-09,
            "start_logit": -5.112082004547119,
            "end_logit": -5.807618141174316
        },
        {
            "text": "development",
            "probability": 1.4956535610585106e-09,
            "start_logit": -5.099065780639648,
            "end_logit": -6.058098316192627
        }
    ],
    "54f9c40ddd3fc62544000001_003": [
        {
            "text": "Calcineurin",
            "probability": 0.998315316234788,
            "start_logit": 5.07603120803833,
            "end_logit": 4.085821151733398
        },
        {
            "text": "Cal",
            "probability": 0.0009614098976695524,
            "start_logit": 5.07603120803833,
            "end_logit": -2.859602451324463
        },
        {
            "text": "in",
            "probability": 0.00018605787964334707,
            "start_logit": -3.511735439300537,
            "end_logit": 4.085821151733398
        },
        {
            "text": "Calc",
            "probability": 0.00013741890908559065,
            "start_logit": 5.07603120803833,
            "end_logit": -4.804969310760498
        },
        {
            "text": "Calcine",
            "probability": 8.425305383875215e-05,
            "start_logit": 5.07603120803833,
            "end_logit": -5.294178485870361
        },
        {
            "text": "Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Calcineurin",
            "probability": 8.310980756039736e-05,
            "start_logit": -4.15012264251709,
            "end_logit": 3.9183132648468018
        },
        {
            "text": "Calcineurin is a calmodulin-dependent, calcium-activated protein phosphatase composed",
            "probability": 5.041986078331486e-05,
            "start_logit": 5.07603120803833,
            "end_logit": -5.807618141174316
        },
        {
            "text": "developmental processes in a variety of organ systems. Calcineurin",
            "probability": 3.804339435291728e-05,
            "start_logit": -5.099065780639648,
            "end_logit": 4.085821151733398
        },
        {
            "text": "Calcineurin signaling has been implicated in a broad spectrum of developmental",
            "probability": 3.688614647931555e-05,
            "start_logit": 5.013962268829346,
            "end_logit": -6.058098316192627
        },
        {
            "text": "cineurin",
            "probability": 3.498696445458665e-05,
            "start_logit": -5.015309810638428,
            "end_logit": 3.9183132648468018
        },
        {
            "text": "Calcineur",
            "probability": 3.2329976461908274e-05,
            "start_logit": 5.07603120803833,
            "end_logit": -6.252008438110352
        },
        {
            "text": "signaling has been implicated in a broad spectrum of developmental processes in a variety of organ systems. Calcineurin",
            "probability": 1.6924839882486888e-05,
            "start_logit": -5.909010887145996,
            "end_logit": 4.085821151733398
        },
        {
            "text": "ineurin",
            "probability": 1.3641886003243292e-05,
            "start_logit": -5.807551860809326,
            "end_logit": 3.7687246799468994
        },
        {
            "text": "developmentally important cell types. Calcineurin",
            "probability": 9.011363269465973e-06,
            "start_logit": -6.22221040725708,
            "end_logit": 3.7687246799468994
        },
        {
            "text": "Calcineurin signaling has been implicated in a broad spectrum of developmental processes in a variety of organ systems. Calcineurin",
            "probability": 1.6534328442541962e-07,
            "start_logit": -3.5921010971069336,
            "end_logit": -2.859602451324463
        },
        {
            "text": "calcineurin",
            "probability": 1.374610642394748e-08,
            "start_logit": -5.564657688140869,
            "end_logit": -3.374314069747925
        },
        {
            "text": "c",
            "probability": 4.5545243040187245e-09,
            "start_logit": -5.015309810638428,
            "end_logit": -5.02829647064209
        },
        {
            "text": "cine",
            "probability": 2.7496256540254348e-09,
            "start_logit": -5.015309810638428,
            "end_logit": -5.532952785491943
        },
        {
            "text": "composed",
            "probability": 1.89653251551655e-09,
            "start_logit": -5.112082004547119,
            "end_logit": -5.807618141174316
        },
        {
            "text": "development",
            "probability": 1.4956535610585106e-09,
            "start_logit": -5.099065780639648,
            "end_logit": -6.058098316192627
        }
    ],
    "54f9c40ddd3fc62544000001_004": [
        {
            "text": "Calcineurin",
            "probability": 0.998315316234788,
            "start_logit": 5.07603120803833,
            "end_logit": 4.085821151733398
        },
        {
            "text": "Cal",
            "probability": 0.0009614098976695524,
            "start_logit": 5.07603120803833,
            "end_logit": -2.859602451324463
        },
        {
            "text": "in",
            "probability": 0.00018605787964334707,
            "start_logit": -3.511735439300537,
            "end_logit": 4.085821151733398
        },
        {
            "text": "Calc",
            "probability": 0.00013741890908559065,
            "start_logit": 5.07603120803833,
            "end_logit": -4.804969310760498
        },
        {
            "text": "Calcine",
            "probability": 8.425305383875215e-05,
            "start_logit": 5.07603120803833,
            "end_logit": -5.294178485870361
        },
        {
            "text": "Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Calcineurin",
            "probability": 8.310980756039736e-05,
            "start_logit": -4.15012264251709,
            "end_logit": 3.9183132648468018
        },
        {
            "text": "Calcineurin is a calmodulin-dependent, calcium-activated protein phosphatase composed",
            "probability": 5.041986078331486e-05,
            "start_logit": 5.07603120803833,
            "end_logit": -5.807618141174316
        },
        {
            "text": "developmental processes in a variety of organ systems. Calcineurin",
            "probability": 3.804339435291728e-05,
            "start_logit": -5.099065780639648,
            "end_logit": 4.085821151733398
        },
        {
            "text": "Calcineurin signaling has been implicated in a broad spectrum of developmental",
            "probability": 3.688614647931555e-05,
            "start_logit": 5.013962268829346,
            "end_logit": -6.058098316192627
        },
        {
            "text": "cineurin",
            "probability": 3.498696445458665e-05,
            "start_logit": -5.015309810638428,
            "end_logit": 3.9183132648468018
        },
        {
            "text": "Calcineur",
            "probability": 3.2329976461908274e-05,
            "start_logit": 5.07603120803833,
            "end_logit": -6.252008438110352
        },
        {
            "text": "signaling has been implicated in a broad spectrum of developmental processes in a variety of organ systems. Calcineurin",
            "probability": 1.6924839882486888e-05,
            "start_logit": -5.909010887145996,
            "end_logit": 4.085821151733398
        },
        {
            "text": "ineurin",
            "probability": 1.3641886003243292e-05,
            "start_logit": -5.807551860809326,
            "end_logit": 3.7687246799468994
        },
        {
            "text": "developmentally important cell types. Calcineurin",
            "probability": 9.011363269465973e-06,
            "start_logit": -6.22221040725708,
            "end_logit": 3.7687246799468994
        },
        {
            "text": "Calcineurin signaling has been implicated in a broad spectrum of developmental processes in a variety of organ systems. Calcineurin",
            "probability": 1.6534328442541962e-07,
            "start_logit": -3.5921010971069336,
            "end_logit": -2.859602451324463
        },
        {
            "text": "calcineurin",
            "probability": 1.374610642394748e-08,
            "start_logit": -5.564657688140869,
            "end_logit": -3.374314069747925
        },
        {
            "text": "c",
            "probability": 4.5545243040187245e-09,
            "start_logit": -5.015309810638428,
            "end_logit": -5.02829647064209
        },
        {
            "text": "cine",
            "probability": 2.7496256540254348e-09,
            "start_logit": -5.015309810638428,
            "end_logit": -5.532952785491943
        },
        {
            "text": "composed",
            "probability": 1.89653251551655e-09,
            "start_logit": -5.112082004547119,
            "end_logit": -5.807618141174316
        },
        {
            "text": "development",
            "probability": 1.4956535610585106e-09,
            "start_logit": -5.099065780639648,
            "end_logit": -6.058098316192627
        }
    ],
    "54f9c40ddd3fc62544000001_005": [
        {
            "text": "calcineurin",
            "probability": 0.22952879441939347,
            "start_logit": 9.592002868652344,
            "end_logit": 9.175621032714844
        },
        {
            "text": "phosphatase 2B/calcineurin",
            "probability": 0.2154973588442947,
            "start_logit": 9.528923034667969,
            "end_logit": 9.175621032714844
        },
        {
            "text": "2B/calcineurin (CaN).",
            "probability": 0.12216169575727592,
            "start_logit": 9.592002868652344,
            "end_logit": 8.544938087463379
        },
        {
            "text": "phosphatase 2B/calcineurin (CaN).",
            "probability": 0.11469377013993035,
            "start_logit": 9.528923034667969,
            "end_logit": 8.544938087463379
        },
        {
            "text": "CaN",
            "probability": 0.09756601442614489,
            "start_logit": 9.367186546325684,
            "end_logit": 8.544938087463379
        },
        {
            "text": "2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.08051603455313049,
            "start_logit": 9.592002868652344,
            "end_logit": 8.12804889678955
        },
        {
            "text": "phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.07559396996226964,
            "start_logit": 9.528923034667969,
            "end_logit": 8.12804889678955
        },
        {
            "text": "(CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.0643051698001567,
            "start_logit": 9.367186546325684,
            "end_logit": 8.12804889678955
        },
        {
            "text": "ph",
            "probability": 2.602118732975388e-05,
            "start_logit": 9.528923034667969,
            "end_logit": 0.1538282036781311
        },
        {
            "text": "cal",
            "probability": 2.517393634230196e-05,
            "start_logit": 9.592002868652344,
            "end_logit": 0.05764645338058472
        },
        {
            "text": "in",
            "probability": 2.2351672920427954e-05,
            "start_logit": 0.3551202714443207,
            "end_logit": 9.175621032714844
        },
        {
            "text": "Ca",
            "probability": 1.9095883810982335e-05,
            "start_logit": 9.367186546325684,
            "end_logit": 0.006126393098384142
        },
        {
            "text": "2B/calcineurin",
            "probability": 1.0450754476694406e-05,
            "start_logit": -0.40510672330856323,
            "end_logit": 9.175621032714844
        },
        {
            "text": "cineurin",
            "probability": 7.648644667840791e-06,
            "start_logit": -0.7172524333000183,
            "end_logit": 9.175621032714844
        },
        {
            "text": "urin",
            "probability": 7.052805615309587e-06,
            "start_logit": -0.7983554005622864,
            "end_logit": 9.175621032714844
        },
        {
            "text": "N",
            "probability": 5.944778263704398e-06,
            "start_logit": -0.3385847210884094,
            "end_logit": 8.544938087463379
        },
        {
            "text": "ineurin",
            "probability": 5.207424936142191e-06,
            "start_logit": -1.1016954183578491,
            "end_logit": 9.175621032714844
        },
        {
            "text": "protein phosphatase 2B/calcineurin",
            "probability": 4.378617343477506e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 9.175621032714844
        },
        {
            "text": "protein phosphatase 2B/calcineurin (CaN).",
            "probability": 2.330423601555047e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 8.544938087463379
        },
        {
            "text": "protein phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 1.5359680959165252e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 8.12804889678955
        }
    ],
    "54f9c40ddd3fc62544000001_006": [
        {
            "text": "calcineurin",
            "probability": 0.22952879441939347,
            "start_logit": 9.592002868652344,
            "end_logit": 9.175621032714844
        },
        {
            "text": "phosphatase 2B/calcineurin",
            "probability": 0.2154973588442947,
            "start_logit": 9.528923034667969,
            "end_logit": 9.175621032714844
        },
        {
            "text": "2B/calcineurin (CaN).",
            "probability": 0.12216169575727592,
            "start_logit": 9.592002868652344,
            "end_logit": 8.544938087463379
        },
        {
            "text": "phosphatase 2B/calcineurin (CaN).",
            "probability": 0.11469377013993035,
            "start_logit": 9.528923034667969,
            "end_logit": 8.544938087463379
        },
        {
            "text": "CaN",
            "probability": 0.09756601442614489,
            "start_logit": 9.367186546325684,
            "end_logit": 8.544938087463379
        },
        {
            "text": "2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.08051603455313049,
            "start_logit": 9.592002868652344,
            "end_logit": 8.12804889678955
        },
        {
            "text": "phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.07559396996226964,
            "start_logit": 9.528923034667969,
            "end_logit": 8.12804889678955
        },
        {
            "text": "(CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.0643051698001567,
            "start_logit": 9.367186546325684,
            "end_logit": 8.12804889678955
        },
        {
            "text": "ph",
            "probability": 2.602118732975388e-05,
            "start_logit": 9.528923034667969,
            "end_logit": 0.1538282036781311
        },
        {
            "text": "cal",
            "probability": 2.517393634230196e-05,
            "start_logit": 9.592002868652344,
            "end_logit": 0.05764645338058472
        },
        {
            "text": "in",
            "probability": 2.2351672920427954e-05,
            "start_logit": 0.3551202714443207,
            "end_logit": 9.175621032714844
        },
        {
            "text": "Ca",
            "probability": 1.9095883810982335e-05,
            "start_logit": 9.367186546325684,
            "end_logit": 0.006126393098384142
        },
        {
            "text": "2B/calcineurin",
            "probability": 1.0450754476694406e-05,
            "start_logit": -0.40510672330856323,
            "end_logit": 9.175621032714844
        },
        {
            "text": "cineurin",
            "probability": 7.648644667840791e-06,
            "start_logit": -0.7172524333000183,
            "end_logit": 9.175621032714844
        },
        {
            "text": "urin",
            "probability": 7.052805615309587e-06,
            "start_logit": -0.7983554005622864,
            "end_logit": 9.175621032714844
        },
        {
            "text": "N",
            "probability": 5.944778263704398e-06,
            "start_logit": -0.3385847210884094,
            "end_logit": 8.544938087463379
        },
        {
            "text": "ineurin",
            "probability": 5.207424936142191e-06,
            "start_logit": -1.1016954183578491,
            "end_logit": 9.175621032714844
        },
        {
            "text": "protein phosphatase 2B/calcineurin",
            "probability": 4.378617343477506e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 9.175621032714844
        },
        {
            "text": "protein phosphatase 2B/calcineurin (CaN).",
            "probability": 2.330423601555047e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 8.544938087463379
        },
        {
            "text": "protein phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 1.5359680959165252e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 8.12804889678955
        }
    ],
    "54f9c40ddd3fc62544000001_007": [
        {
            "text": "calcineurin",
            "probability": 0.22952879441939347,
            "start_logit": 9.592002868652344,
            "end_logit": 9.175621032714844
        },
        {
            "text": "phosphatase 2B/calcineurin",
            "probability": 0.2154973588442947,
            "start_logit": 9.528923034667969,
            "end_logit": 9.175621032714844
        },
        {
            "text": "2B/calcineurin (CaN).",
            "probability": 0.12216169575727592,
            "start_logit": 9.592002868652344,
            "end_logit": 8.544938087463379
        },
        {
            "text": "phosphatase 2B/calcineurin (CaN).",
            "probability": 0.11469377013993035,
            "start_logit": 9.528923034667969,
            "end_logit": 8.544938087463379
        },
        {
            "text": "CaN",
            "probability": 0.09756601442614489,
            "start_logit": 9.367186546325684,
            "end_logit": 8.544938087463379
        },
        {
            "text": "2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.08051603455313049,
            "start_logit": 9.592002868652344,
            "end_logit": 8.12804889678955
        },
        {
            "text": "phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.07559396996226964,
            "start_logit": 9.528923034667969,
            "end_logit": 8.12804889678955
        },
        {
            "text": "(CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.0643051698001567,
            "start_logit": 9.367186546325684,
            "end_logit": 8.12804889678955
        },
        {
            "text": "ph",
            "probability": 2.602118732975388e-05,
            "start_logit": 9.528923034667969,
            "end_logit": 0.1538282036781311
        },
        {
            "text": "cal",
            "probability": 2.517393634230196e-05,
            "start_logit": 9.592002868652344,
            "end_logit": 0.05764645338058472
        },
        {
            "text": "in",
            "probability": 2.2351672920427954e-05,
            "start_logit": 0.3551202714443207,
            "end_logit": 9.175621032714844
        },
        {
            "text": "Ca",
            "probability": 1.9095883810982335e-05,
            "start_logit": 9.367186546325684,
            "end_logit": 0.006126393098384142
        },
        {
            "text": "2B/calcineurin",
            "probability": 1.0450754476694406e-05,
            "start_logit": -0.40510672330856323,
            "end_logit": 9.175621032714844
        },
        {
            "text": "cineurin",
            "probability": 7.648644667840791e-06,
            "start_logit": -0.7172524333000183,
            "end_logit": 9.175621032714844
        },
        {
            "text": "urin",
            "probability": 7.052805615309587e-06,
            "start_logit": -0.7983554005622864,
            "end_logit": 9.175621032714844
        },
        {
            "text": "N",
            "probability": 5.944778263704398e-06,
            "start_logit": -0.3385847210884094,
            "end_logit": 8.544938087463379
        },
        {
            "text": "ineurin",
            "probability": 5.207424936142191e-06,
            "start_logit": -1.1016954183578491,
            "end_logit": 9.175621032714844
        },
        {
            "text": "protein phosphatase 2B/calcineurin",
            "probability": 4.378617343477506e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 9.175621032714844
        },
        {
            "text": "protein phosphatase 2B/calcineurin (CaN).",
            "probability": 2.330423601555047e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 8.544938087463379
        },
        {
            "text": "protein phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 1.5359680959165252e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 8.12804889678955
        }
    ],
    "54f9c40ddd3fc62544000001_008": [
        {
            "text": "calcineurin",
            "probability": 0.22952879441939347,
            "start_logit": 9.592002868652344,
            "end_logit": 9.175621032714844
        },
        {
            "text": "phosphatase 2B/calcineurin",
            "probability": 0.2154973588442947,
            "start_logit": 9.528923034667969,
            "end_logit": 9.175621032714844
        },
        {
            "text": "2B/calcineurin (CaN).",
            "probability": 0.12216169575727592,
            "start_logit": 9.592002868652344,
            "end_logit": 8.544938087463379
        },
        {
            "text": "phosphatase 2B/calcineurin (CaN).",
            "probability": 0.11469377013993035,
            "start_logit": 9.528923034667969,
            "end_logit": 8.544938087463379
        },
        {
            "text": "CaN",
            "probability": 0.09756601442614489,
            "start_logit": 9.367186546325684,
            "end_logit": 8.544938087463379
        },
        {
            "text": "2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.08051603455313049,
            "start_logit": 9.592002868652344,
            "end_logit": 8.12804889678955
        },
        {
            "text": "phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.07559396996226964,
            "start_logit": 9.528923034667969,
            "end_logit": 8.12804889678955
        },
        {
            "text": "(CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.0643051698001567,
            "start_logit": 9.367186546325684,
            "end_logit": 8.12804889678955
        },
        {
            "text": "ph",
            "probability": 2.602118732975388e-05,
            "start_logit": 9.528923034667969,
            "end_logit": 0.1538282036781311
        },
        {
            "text": "cal",
            "probability": 2.517393634230196e-05,
            "start_logit": 9.592002868652344,
            "end_logit": 0.05764645338058472
        },
        {
            "text": "in",
            "probability": 2.2351672920427954e-05,
            "start_logit": 0.3551202714443207,
            "end_logit": 9.175621032714844
        },
        {
            "text": "Ca",
            "probability": 1.9095883810982335e-05,
            "start_logit": 9.367186546325684,
            "end_logit": 0.006126393098384142
        },
        {
            "text": "2B/calcineurin",
            "probability": 1.0450754476694406e-05,
            "start_logit": -0.40510672330856323,
            "end_logit": 9.175621032714844
        },
        {
            "text": "cineurin",
            "probability": 7.648644667840791e-06,
            "start_logit": -0.7172524333000183,
            "end_logit": 9.175621032714844
        },
        {
            "text": "urin",
            "probability": 7.052805615309587e-06,
            "start_logit": -0.7983554005622864,
            "end_logit": 9.175621032714844
        },
        {
            "text": "N",
            "probability": 5.944778263704398e-06,
            "start_logit": -0.3385847210884094,
            "end_logit": 8.544938087463379
        },
        {
            "text": "ineurin",
            "probability": 5.207424936142191e-06,
            "start_logit": -1.1016954183578491,
            "end_logit": 9.175621032714844
        },
        {
            "text": "protein phosphatase 2B/calcineurin",
            "probability": 4.378617343477506e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 9.175621032714844
        },
        {
            "text": "protein phosphatase 2B/calcineurin (CaN).",
            "probability": 2.330423601555047e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 8.544938087463379
        },
        {
            "text": "protein phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 1.5359680959165252e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 8.12804889678955
        }
    ],
    "54f9c40ddd3fc62544000001_009": [
        {
            "text": "calcineurin",
            "probability": 0.9990613169826132,
            "start_logit": 8.918136596679688,
            "end_logit": 8.201827049255371
        },
        {
            "text": "calcineurin and the calcium-sensing protein calmodulin.",
            "probability": 0.0006239143109940736,
            "start_logit": 8.918136596679688,
            "end_logit": 0.8232686519622803
        },
        {
            "text": "cal",
            "probability": 0.00023756173036082231,
            "start_logit": 8.918136596679688,
            "end_logit": -0.14231687784194946
        },
        {
            "text": "in",
            "probability": 4.4261961970409114e-05,
            "start_logit": -1.106309175491333,
            "end_logit": 8.201827049255371
        },
        {
            "text": "the ubiquitous phosphatase calcineurin",
            "probability": 6.83448520434859e-06,
            "start_logit": -2.9744536876678467,
            "end_logit": 8.201827049255371
        },
        {
            "text": "phosphatase calcineurin",
            "probability": 5.313450359167588e-06,
            "start_logit": -3.226193428039551,
            "end_logit": 8.201827049255371
        },
        {
            "text": "ineurin",
            "probability": 5.156081163746841e-06,
            "start_logit": -3.256258010864258,
            "end_logit": 8.201827049255371
        },
        {
            "text": "urin",
            "probability": 4.782368740269768e-06,
            "start_logit": -3.331498861312866,
            "end_logit": 8.201827049255371
        },
        {
            "text": "calcium driven association between the ubiquitous phosphatase calcineurin",
            "probability": 2.4896225797327925e-06,
            "start_logit": -3.9843037128448486,
            "end_logit": 8.201827049255371
        },
        {
            "text": "cineurin",
            "probability": 2.0473389299075924e-06,
            "start_logit": -4.179893970489502,
            "end_logit": 8.201827049255371
        },
        {
            "text": "calcine",
            "probability": 1.7934827999506575e-06,
            "start_logit": 8.918136596679688,
            "end_logit": -5.028584957122803
        },
        {
            "text": "calc",
            "probability": 1.2623843061994377e-06,
            "start_logit": 8.918136596679688,
            "end_logit": -5.37974214553833
        },
        {
            "text": "calcineur",
            "probability": 8.993059525470693e-07,
            "start_logit": 8.918136596679688,
            "end_logit": -5.718876361846924
        },
        {
            "text": "a calcium driven association between the ubiquitous phosphatase calcineurin",
            "probability": 6.374902859175111e-07,
            "start_logit": -5.346651077270508,
            "end_logit": 8.201827049255371
        },
        {
            "text": "calmodulin",
            "probability": 5.629498331744576e-07,
            "start_logit": 1.907558798789978,
            "end_logit": 0.8232686519622803
        },
        {
            "text": "between the ubiquitous phosphatase calcineurin",
            "probability": 4.559451808369444e-07,
            "start_logit": -5.681817531585693,
            "end_logit": 8.201827049255371
        },
        {
            "text": "association between the ubiquitous phosphatase calcineurin",
            "probability": 3.101988579781236e-07,
            "start_logit": -6.066976547241211,
            "end_logit": 8.201827049255371
        },
        {
            "text": "ubiquitous phosphatase calcineurin",
            "probability": 1.7059839462955462e-07,
            "start_logit": -6.664877891540527,
            "end_logit": 8.201827049255371
        },
        {
            "text": "by a calcium driven association between the ubiquitous phosphatase calcineurin",
            "probability": 1.3453680212233478e-07,
            "start_logit": -6.902352333068848,
            "end_logit": 8.201827049255371
        },
        {
            "text": "calcineurin and the calcium-sensing",
            "probability": 9.47746705576827e-08,
            "start_logit": 8.918136596679688,
            "end_logit": -7.968997478485107
        }
    ],
    "54f9c40ddd3fc62544000001_010": [
        {
            "text": "calcineurin",
            "probability": 0.999413648746812,
            "start_logit": 9.696331977844238,
            "end_logit": 9.137103080749512
        },
        {
            "text": "cal",
            "probability": 0.0003040520070392131,
            "start_logit": 9.696331977844238,
            "end_logit": 1.0393778085708618
        },
        {
            "text": "ineurin",
            "probability": 8.467360925450692e-05,
            "start_logit": 0.32021191716194153,
            "end_logit": 9.137103080749512
        },
        {
            "text": "in",
            "probability": 8.066493999443331e-05,
            "start_logit": 0.27171197533607483,
            "end_logit": 9.137103080749512
        },
        {
            "text": "phosphatase calcineurin.",
            "probability": 5.080560797337425e-05,
            "start_logit": -0.19058531522750854,
            "end_logit": 9.137103080749512
        },
        {
            "text": "cineurin",
            "probability": 3.894951720066254e-05,
            "start_logit": -0.4563256800174713,
            "end_logit": 9.137103080749512
        },
        {
            "text": "urin",
            "probability": 1.3023256636518498e-05,
            "start_logit": -1.5518553256988525,
            "end_logit": 9.137103080749512
        },
        {
            "text": "calcine",
            "probability": 4.0151186359843555e-06,
            "start_logit": 9.696331977844238,
            "end_logit": -3.2877540588378906
        },
        {
            "text": "the Ca(2+)/calmodulin-dependent phosphatase calcineurin.",
            "probability": 2.959118299938911e-06,
            "start_logit": -3.033700704574585,
            "end_logit": 9.137103080749512
        },
        {
            "text": "calc",
            "probability": 1.795077991257302e-06,
            "start_logit": 9.696331977844238,
            "end_logit": -4.092772483825684
        },
        {
            "text": "import by the Ca(2+)/calmodulin-dependent phosphatase calcineurin.",
            "probability": 1.7208475144218623e-06,
            "start_logit": -3.575775146484375,
            "end_logit": 9.137103080749512
        },
        {
            "text": "Ca(2+)/calmodulin-dependent phosphatase calcineurin.",
            "probability": 1.1874317464919398e-06,
            "start_logit": -3.9467992782592773,
            "end_logit": 9.137103080749512
        },
        {
            "text": "nuclear import by the Ca(2+)/calmodulin-dependent phosphatase calcineurin.",
            "probability": 5.424110024704549e-07,
            "start_logit": -4.730323314666748,
            "end_logit": 9.137103080749512
        },
        {
            "text": "calcineur",
            "probability": 5.06353245367618e-07,
            "start_logit": 9.696331977844238,
            "end_logit": -5.358341693878174
        },
        {
            "text": "its nuclear import by the Ca(2+)/calmodulin-dependent phosphatase calcineurin.",
            "probability": 4.893361156315254e-07,
            "start_logit": -4.8332977294921875,
            "end_logit": 9.137103080749512
        },
        {
            "text": "regulation of its nuclear import by the Ca(2+)/calmodulin-dependent phosphatase calcineurin.",
            "probability": 4.314804894750573e-07,
            "start_logit": -4.95912504196167,
            "end_logit": 9.137103080749512
        },
        {
            "text": "the regulation of its nuclear import by the Ca(2+)/calmodulin-dependent phosphatase calcineurin.",
            "probability": 2.4077079177344814e-07,
            "start_logit": -5.542501926422119,
            "end_logit": 9.137103080749512
        },
        {
            "text": "calcineurin.",
            "probability": 1.5417539477060852e-07,
            "start_logit": 9.696331977844238,
            "end_logit": -6.5474853515625
        },
        {
            "text": "by the Ca(2+)/calmodulin-dependent phosphatase calcineurin.",
            "probability": 9.082128417720943e-08,
            "start_logit": -6.517453670501709,
            "end_logit": 9.137103080749512
        },
        {
            "text": "of its nuclear import by the Ca(2+)/calmodulin-dependent phosphatase calcineurin.",
            "probability": 4.937257778762855e-08,
            "start_logit": -7.126952171325684,
            "end_logit": 9.137103080749512
        }
    ],
    "54f9c40ddd3fc62544000001_011": [
        {
            "text": "calcineurin",
            "probability": 0.9965801317452007,
            "start_logit": 9.799848556518555,
            "end_logit": 9.260783195495605
        },
        {
            "text": "calcineurin. The c-Jun amino-terminal kinase (JNK)",
            "probability": 0.002792017364112251,
            "start_logit": 9.799848556518555,
            "end_logit": 3.3832180500030518
        },
        {
            "text": "cal",
            "probability": 0.00019438867740661348,
            "start_logit": 9.799848556518555,
            "end_logit": 0.7185580134391785
        },
        {
            "text": "ineurin",
            "probability": 0.0001522405850480934,
            "start_logit": 1.013225793838501,
            "end_logit": 9.260783195495605
        },
        {
            "text": "in",
            "probability": 9.851314276128424e-05,
            "start_logit": 0.5779536962509155,
            "end_logit": 9.260783195495605
        },
        {
            "text": "cineurin",
            "probability": 4.543282839288719e-05,
            "start_logit": -0.196001335978508,
            "end_logit": 9.260783195495605
        },
        {
            "text": "phosphatase calcineurin.",
            "probability": 4.0104649059929454e-05,
            "start_logit": -0.32074400782585144,
            "end_logit": 9.260783195495605
        },
        {
            "text": "calcineurin.",
            "probability": 3.987049413355659e-05,
            "start_logit": 9.799848556518555,
            "end_logit": -0.865665078163147
        },
        {
            "text": "JNK",
            "probability": 2.0256682836628546e-05,
            "start_logit": 4.873813629150391,
            "end_logit": 3.3832180500030518
        },
        {
            "text": "urin",
            "probability": 1.1303123933834085e-05,
            "start_logit": -1.587157130241394,
            "end_logit": 9.260783195495605
        },
        {
            "text": "calcine",
            "probability": 7.255992297235108e-06,
            "start_logit": 9.799848556518555,
            "end_logit": -2.5694739818573
        },
        {
            "text": "the phosphatase calcineurin.",
            "probability": 5.709431554267652e-06,
            "start_logit": -2.2701168060302734,
            "end_logit": 9.260783195495605
        },
        {
            "text": "caused by the phosphatase calcineurin.",
            "probability": 5.14226439238367e-06,
            "start_logit": -2.3747427463531494,
            "end_logit": 9.260783195495605
        },
        {
            "text": "calcium-dependent dephosphorylation of NFAT caused by the phosphatase calcineurin.",
            "probability": 3.1605476109368296e-06,
            "start_logit": -2.8614909648895264,
            "end_logit": 9.260783195495605
        },
        {
            "text": "calc",
            "probability": 2.1828481259033704e-06,
            "start_logit": 9.799848556518555,
            "end_logit": -3.7706711292266846
        },
        {
            "text": "calcineur",
            "probability": 1.1774658733065843e-06,
            "start_logit": 9.799848556518555,
            "end_logit": -4.387937068939209
        },
        {
            "text": "requires calcium-dependent dephosphorylation of NFAT caused by the phosphatase calcineurin.",
            "probability": 5.335236519554718e-07,
            "start_logit": -4.640488147735596,
            "end_logit": 9.260783195495605
        },
        {
            "text": "dephosphorylation of NFAT caused by the phosphatase calcineurin.",
            "probability": 2.4516787236942927e-07,
            "start_logit": -5.41804838180542,
            "end_logit": 9.260783195495605
        },
        {
            "text": "This process requires calcium-dependent dephosphorylation of NFAT caused by the phosphatase calcineurin.",
            "probability": 2.211086129056203e-07,
            "start_logit": -5.521337509155273,
            "end_logit": 9.260783195495605
        },
        {
            "text": "phosphatase calcineurin. The c-Jun amino-terminal kinase (JNK)",
            "probability": 1.1235712311549433e-07,
            "start_logit": -0.32074400782585144,
            "end_logit": 3.3832180500030518
        }
    ],
    "54f9c40ddd3fc62544000001_012": [
        {
            "text": "calcineurin",
            "probability": 0.9994613190293798,
            "start_logit": 9.45979118347168,
            "end_logit": 8.69540786743164
        },
        {
            "text": "cal",
            "probability": 0.00025719941868810415,
            "start_logit": 9.45979118347168,
            "end_logit": 0.4302878677845001
        },
        {
            "text": "The calcium-regulated protein phosphatase calcineurin",
            "probability": 0.0001318175004762583,
            "start_logit": 0.5262378454208374,
            "end_logit": 8.69540786743164
        },
        {
            "text": "in",
            "probability": 5.2455654501762844e-05,
            "start_logit": -0.39521241188049316,
            "end_logit": 8.69540786743164
        },
        {
            "text": "ineurin",
            "probability": 4.4883838737675474e-05,
            "start_logit": -0.5511027574539185,
            "end_logit": 8.69540786743164
        },
        {
            "text": "calcium-regulated protein phosphatase calcineurin",
            "probability": 2.8008753163338066e-05,
            "start_logit": -1.0226634740829468,
            "end_logit": 8.69540786743164
        },
        {
            "text": "cineurin",
            "probability": 1.1190324042784238e-05,
            "start_logit": -1.9401310682296753,
            "end_logit": 8.69540786743164
        },
        {
            "text": "calcineur",
            "probability": 3.5736654411067487e-06,
            "start_logit": 9.45979118347168,
            "end_logit": -3.8459720611572266
        },
        {
            "text": "phosphatase calcineurin",
            "probability": 2.6081517114616365e-06,
            "start_logit": -3.396538734436035,
            "end_logit": 8.69540786743164
        },
        {
            "text": "calcine",
            "probability": 2.4200631597454587e-06,
            "start_logit": 9.45979118347168,
            "end_logit": -4.235770225524902
        },
        {
            "text": "urin",
            "probability": 2.241244296336984e-06,
            "start_logit": -3.548149347305298,
            "end_logit": 8.69540786743164
        },
        {
            "text": "calc",
            "probability": 1.922191675523751e-06,
            "start_logit": 9.45979118347168,
            "end_logit": -4.466097831726074
        },
        {
            "text": "protein phosphatase calcineurin",
            "probability": 2.7767760352023146e-07,
            "start_logit": -5.636475086212158,
            "end_logit": 8.69540786743164
        },
        {
            "text": "calcineurin (PP2B) functions",
            "probability": 4.2848579707470045e-08,
            "start_logit": 9.45979118347168,
            "end_logit": -8.269646644592285
        },
        {
            "text": "calcineurin (PP2B)",
            "probability": 3.925618392712004e-08,
            "start_logit": 9.45979118347168,
            "end_logit": -8.357210159301758
        },
        {
            "text": "ineur",
            "probability": 1.6048627426303042e-10,
            "start_logit": -0.5511027574539185,
            "end_logit": -3.8459720611572266
        },
        {
            "text": "ine",
            "probability": 1.0868026858957561e-10,
            "start_logit": -0.5511027574539185,
            "end_logit": -4.235770225524902
        },
        {
            "text": "The calcium-regulated protein phosphatase",
            "probability": 4.608465690208346e-11,
            "start_logit": 0.5262378454208374,
            "end_logit": -6.171041011810303
        },
        {
            "text": "cineur",
            "probability": 4.001202802457675e-11,
            "start_logit": -1.9401310682296753,
            "end_logit": -3.8459720611572266
        },
        {
            "text": "cine",
            "probability": 2.7095887000265117e-11,
            "start_logit": -1.9401310682296753,
            "end_logit": -4.235770225524902
        }
    ],
    "54f9c40ddd3fc62544000001_013": [
        {
            "text": "Calcineurin",
            "probability": 0.9989643617380423,
            "start_logit": 5.971899509429932,
            "end_logit": 4.943278789520264
        },
        {
            "text": "Cal",
            "probability": 0.0007824172179993858,
            "start_logit": 5.971899509429932,
            "end_logit": -2.2088074684143066
        },
        {
            "text": "Calc",
            "probability": 9.235966486981394e-05,
            "start_logit": 5.971899509429932,
            "end_logit": -4.345505237579346
        },
        {
            "text": "in",
            "probability": 8.073413567786391e-05,
            "start_logit": -3.45141339302063,
            "end_logit": 4.943278789520264
        },
        {
            "text": "Calcine",
            "probability": 2.5853548967842983e-05,
            "start_logit": 5.971899509429932,
            "end_logit": -5.618747711181641
        },
        {
            "text": "Calcineur",
            "probability": 1.5977422235731625e-05,
            "start_logit": 5.971899509429932,
            "end_logit": -6.1000189781188965
        },
        {
            "text": "cineurin",
            "probability": 9.502403368596333e-06,
            "start_logit": -5.591030120849609,
            "end_logit": 4.943278789520264
        },
        {
            "text": "Calcineurin,",
            "probability": 8.383962370478097e-06,
            "start_logit": 5.971899509429932,
            "end_logit": -6.744874954223633
        },
        {
            "text": "ineurin",
            "probability": 5.150003298523298e-06,
            "start_logit": -6.203577518463135,
            "end_logit": 4.943278789520264
        },
        {
            "text": "Calcineurin, a Ca(2+)/calmodulin-stimulated",
            "probability": 5.125563282037336e-06,
            "start_logit": 5.971899509429932,
            "end_logit": -7.236955165863037
        },
        {
            "text": "calcineurin phosphatase activity by a calcineurin B homologous protein. Calcineurin,",
            "probability": 3.915689632507383e-06,
            "start_logit": -6.477583408355713,
            "end_logit": 4.943278789520264
        },
        {
            "text": "Calcineurin, a Ca(2+)/calmodulin-stimulated protein phosphatase, plays",
            "probability": 2.198595415737179e-06,
            "start_logit": 5.971899509429932,
            "end_logit": -8.08337688446045
        },
        {
            "text": "urin",
            "probability": 2.08934483114614e-06,
            "start_logit": -7.105724334716797,
            "end_logit": 4.943278789520264
        },
        {
            "text": "calcineurin B homologous protein. Calcineurin,",
            "probability": 1.9291527705604606e-06,
            "start_logit": -7.1854939460754395,
            "end_logit": 4.943278789520264
        },
        {
            "text": "c",
            "probability": 8.785486491774278e-10,
            "start_logit": -5.591030120849609,
            "end_logit": -4.345505237579346
        },
        {
            "text": "cine",
            "probability": 2.4592554070174486e-10,
            "start_logit": -5.591030120849609,
            "end_logit": -5.618747711181641
        },
        {
            "text": "cineur",
            "probability": 1.5198130853252082e-10,
            "start_logit": -5.591030120849609,
            "end_logit": -6.1000189781188965
        },
        {
            "text": "ine",
            "probability": 1.3328389636570413e-10,
            "start_logit": -6.203577518463135,
            "end_logit": -5.618747711181641
        },
        {
            "text": "ineur",
            "probability": 8.236908178861997e-11,
            "start_logit": -6.203577518463135,
            "end_logit": -6.1000189781188965
        },
        {
            "text": "plays",
            "probability": 6.512929974146507e-11,
            "start_logit": -4.455055236816406,
            "end_logit": -8.08337688446045
        }
    ],
    "54f9c40ddd3fc62544000001_014": [
        {
            "text": "calcineurin",
            "probability": 0.9987068184122712,
            "start_logit": 8.284934997558594,
            "end_logit": 7.266107082366943
        },
        {
            "text": "phosphatase calcineurin,",
            "probability": 0.0004595473189983741,
            "start_logit": 0.600960373878479,
            "end_logit": 7.266107082366943
        },
        {
            "text": "cal",
            "probability": 0.00035730147739255905,
            "start_logit": 8.284934997558594,
            "end_logit": -0.6695295572280884
        },
        {
            "text": "calcineurin,",
            "probability": 0.000245562595376226,
            "start_logit": 8.284934997558594,
            "end_logit": -1.0445575714111328
        },
        {
            "text": "The calcium/calmodulin-dependent phosphatase calcineurin,",
            "probability": 6.0450043410755987e-05,
            "start_logit": -1.427464246749878,
            "end_logit": 7.266107082366943
        },
        {
            "text": "in",
            "probability": 5.336764830449221e-05,
            "start_logit": -1.552076816558838,
            "end_logit": 7.266107082366943
        },
        {
            "text": "calcium/calmodulin-dependent phosphatase calcineurin,",
            "probability": 4.333609594948278e-05,
            "start_logit": -1.7602956295013428,
            "end_logit": 7.266107082366943
        },
        {
            "text": "cineurin",
            "probability": 2.9352102461072236e-05,
            "start_logit": -2.1499173641204834,
            "end_logit": 7.266107082366943
        },
        {
            "text": "ineurin",
            "probability": 2.3111492437853288e-05,
            "start_logit": -2.388951539993286,
            "end_logit": 7.266107082366943
        },
        {
            "text": "calcine",
            "probability": 6.124074553499237e-06,
            "start_logit": 8.284934997558594,
            "end_logit": -4.735881805419922
        },
        {
            "text": "calc",
            "probability": 5.28470490857431e-06,
            "start_logit": 8.284934997558594,
            "end_logit": -4.8832926750183105
        },
        {
            "text": "urin",
            "probability": 4.846825745613012e-06,
            "start_logit": -3.9509575366973877,
            "end_logit": 7.266107082366943
        },
        {
            "text": "calcineurin, which signals",
            "probability": 2.1960381037130858e-06,
            "start_logit": 8.284934997558594,
            "end_logit": -5.7614545822143555
        },
        {
            "text": "calcineur",
            "probability": 1.8448836130060223e-06,
            "start_logit": 8.284934997558594,
            "end_logit": -5.935693264007568
        },
        {
            "text": "calcineurin, which",
            "probability": 8.529312879707151e-07,
            "start_logit": 8.284934997558594,
            "end_logit": -6.707185745239258
        },
        {
            "text": "phosphatase",
            "probability": 1.5125173668016898e-09,
            "start_logit": 0.600960373878479,
            "end_logit": -5.358114719390869
        },
        {
            "text": "phosphatase calcineurin, which signals",
            "probability": 1.0104901702623863e-09,
            "start_logit": 0.600960373878479,
            "end_logit": -5.7614545822143555
        },
        {
            "text": "phosphatase calcineurin, which",
            "probability": 3.9246982142357656e-10,
            "start_logit": 0.600960373878479,
            "end_logit": -6.707185745239258
        },
        {
            "text": "phosph",
            "probability": 2.4074775354578794e-10,
            "start_logit": 0.600960373878479,
            "end_logit": -7.195895671844482
        },
        {
            "text": "The calcium/calmodulin-dependent phosphatase",
            "probability": 1.9896044803823126e-10,
            "start_logit": -1.427464246749878,
            "end_logit": -5.358114719390869
        }
    ],
    "54f9c40ddd3fc62544000001_015": [
        {
            "text": "Calcineurin",
            "probability": 0.998315316234788,
            "start_logit": 5.07603120803833,
            "end_logit": 4.085821151733398
        },
        {
            "text": "Cal",
            "probability": 0.0009614098976695524,
            "start_logit": 5.07603120803833,
            "end_logit": -2.859602451324463
        },
        {
            "text": "in",
            "probability": 0.00018605787964334707,
            "start_logit": -3.511735439300537,
            "end_logit": 4.085821151733398
        },
        {
            "text": "Calc",
            "probability": 0.00013741890908559065,
            "start_logit": 5.07603120803833,
            "end_logit": -4.804969310760498
        },
        {
            "text": "Calcine",
            "probability": 8.425305383875215e-05,
            "start_logit": 5.07603120803833,
            "end_logit": -5.294178485870361
        },
        {
            "text": "Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Calcineurin",
            "probability": 8.310980756039736e-05,
            "start_logit": -4.15012264251709,
            "end_logit": 3.9183132648468018
        },
        {
            "text": "Calcineurin is a calmodulin-dependent, calcium-activated protein phosphatase composed",
            "probability": 5.041986078331486e-05,
            "start_logit": 5.07603120803833,
            "end_logit": -5.807618141174316
        },
        {
            "text": "developmental processes in a variety of organ systems. Calcineurin",
            "probability": 3.804339435291728e-05,
            "start_logit": -5.099065780639648,
            "end_logit": 4.085821151733398
        },
        {
            "text": "Calcineurin signaling has been implicated in a broad spectrum of developmental",
            "probability": 3.688614647931555e-05,
            "start_logit": 5.013962268829346,
            "end_logit": -6.058098316192627
        },
        {
            "text": "cineurin",
            "probability": 3.498696445458665e-05,
            "start_logit": -5.015309810638428,
            "end_logit": 3.9183132648468018
        },
        {
            "text": "Calcineur",
            "probability": 3.2329976461908274e-05,
            "start_logit": 5.07603120803833,
            "end_logit": -6.252008438110352
        },
        {
            "text": "signaling has been implicated in a broad spectrum of developmental processes in a variety of organ systems. Calcineurin",
            "probability": 1.6924839882486888e-05,
            "start_logit": -5.909010887145996,
            "end_logit": 4.085821151733398
        },
        {
            "text": "ineurin",
            "probability": 1.3641886003243292e-05,
            "start_logit": -5.807551860809326,
            "end_logit": 3.7687246799468994
        },
        {
            "text": "developmentally important cell types. Calcineurin",
            "probability": 9.011363269465973e-06,
            "start_logit": -6.22221040725708,
            "end_logit": 3.7687246799468994
        },
        {
            "text": "Calcineurin signaling has been implicated in a broad spectrum of developmental processes in a variety of organ systems. Calcineurin",
            "probability": 1.6534328442541962e-07,
            "start_logit": -3.5921010971069336,
            "end_logit": -2.859602451324463
        },
        {
            "text": "calcineurin",
            "probability": 1.374610642394748e-08,
            "start_logit": -5.564657688140869,
            "end_logit": -3.374314069747925
        },
        {
            "text": "c",
            "probability": 4.5545243040187245e-09,
            "start_logit": -5.015309810638428,
            "end_logit": -5.02829647064209
        },
        {
            "text": "cine",
            "probability": 2.7496256540254348e-09,
            "start_logit": -5.015309810638428,
            "end_logit": -5.532952785491943
        },
        {
            "text": "composed",
            "probability": 1.89653251551655e-09,
            "start_logit": -5.112082004547119,
            "end_logit": -5.807618141174316
        },
        {
            "text": "development",
            "probability": 1.4956535610585106e-09,
            "start_logit": -5.099065780639648,
            "end_logit": -6.058098316192627
        }
    ],
    "54f9c40ddd3fc62544000001_016": [
        {
            "text": "Calcineurin",
            "probability": 0.998315316234788,
            "start_logit": 5.07603120803833,
            "end_logit": 4.085821151733398
        },
        {
            "text": "Cal",
            "probability": 0.0009614098976695524,
            "start_logit": 5.07603120803833,
            "end_logit": -2.859602451324463
        },
        {
            "text": "in",
            "probability": 0.00018605787964334707,
            "start_logit": -3.511735439300537,
            "end_logit": 4.085821151733398
        },
        {
            "text": "Calc",
            "probability": 0.00013741890908559065,
            "start_logit": 5.07603120803833,
            "end_logit": -4.804969310760498
        },
        {
            "text": "Calcine",
            "probability": 8.425305383875215e-05,
            "start_logit": 5.07603120803833,
            "end_logit": -5.294178485870361
        },
        {
            "text": "Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Calcineurin",
            "probability": 8.310980756039736e-05,
            "start_logit": -4.15012264251709,
            "end_logit": 3.9183132648468018
        },
        {
            "text": "Calcineurin is a calmodulin-dependent, calcium-activated protein phosphatase composed",
            "probability": 5.041986078331486e-05,
            "start_logit": 5.07603120803833,
            "end_logit": -5.807618141174316
        },
        {
            "text": "developmental processes in a variety of organ systems. Calcineurin",
            "probability": 3.804339435291728e-05,
            "start_logit": -5.099065780639648,
            "end_logit": 4.085821151733398
        },
        {
            "text": "Calcineurin signaling has been implicated in a broad spectrum of developmental",
            "probability": 3.688614647931555e-05,
            "start_logit": 5.013962268829346,
            "end_logit": -6.058098316192627
        },
        {
            "text": "cineurin",
            "probability": 3.498696445458665e-05,
            "start_logit": -5.015309810638428,
            "end_logit": 3.9183132648468018
        },
        {
            "text": "Calcineur",
            "probability": 3.2329976461908274e-05,
            "start_logit": 5.07603120803833,
            "end_logit": -6.252008438110352
        },
        {
            "text": "signaling has been implicated in a broad spectrum of developmental processes in a variety of organ systems. Calcineurin",
            "probability": 1.6924839882486888e-05,
            "start_logit": -5.909010887145996,
            "end_logit": 4.085821151733398
        },
        {
            "text": "ineurin",
            "probability": 1.3641886003243292e-05,
            "start_logit": -5.807551860809326,
            "end_logit": 3.7687246799468994
        },
        {
            "text": "developmentally important cell types. Calcineurin",
            "probability": 9.011363269465973e-06,
            "start_logit": -6.22221040725708,
            "end_logit": 3.7687246799468994
        },
        {
            "text": "Calcineurin signaling has been implicated in a broad spectrum of developmental processes in a variety of organ systems. Calcineurin",
            "probability": 1.6534328442541962e-07,
            "start_logit": -3.5921010971069336,
            "end_logit": -2.859602451324463
        },
        {
            "text": "calcineurin",
            "probability": 1.374610642394748e-08,
            "start_logit": -5.564657688140869,
            "end_logit": -3.374314069747925
        },
        {
            "text": "c",
            "probability": 4.5545243040187245e-09,
            "start_logit": -5.015309810638428,
            "end_logit": -5.02829647064209
        },
        {
            "text": "cine",
            "probability": 2.7496256540254348e-09,
            "start_logit": -5.015309810638428,
            "end_logit": -5.532952785491943
        },
        {
            "text": "composed",
            "probability": 1.89653251551655e-09,
            "start_logit": -5.112082004547119,
            "end_logit": -5.807618141174316
        },
        {
            "text": "development",
            "probability": 1.4956535610585106e-09,
            "start_logit": -5.099065780639648,
            "end_logit": -6.058098316192627
        }
    ],
    "54f9c40ddd3fc62544000001_017": [
        {
            "text": "Calcineurin",
            "probability": 0.998315316234788,
            "start_logit": 5.07603120803833,
            "end_logit": 4.085821151733398
        },
        {
            "text": "Cal",
            "probability": 0.0009614098976695524,
            "start_logit": 5.07603120803833,
            "end_logit": -2.859602451324463
        },
        {
            "text": "in",
            "probability": 0.00018605787964334707,
            "start_logit": -3.511735439300537,
            "end_logit": 4.085821151733398
        },
        {
            "text": "Calc",
            "probability": 0.00013741890908559065,
            "start_logit": 5.07603120803833,
            "end_logit": -4.804969310760498
        },
        {
            "text": "Calcine",
            "probability": 8.425305383875215e-05,
            "start_logit": 5.07603120803833,
            "end_logit": -5.294178485870361
        },
        {
            "text": "Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Calcineurin",
            "probability": 8.310980756039736e-05,
            "start_logit": -4.15012264251709,
            "end_logit": 3.9183132648468018
        },
        {
            "text": "Calcineurin is a calmodulin-dependent, calcium-activated protein phosphatase composed",
            "probability": 5.041986078331486e-05,
            "start_logit": 5.07603120803833,
            "end_logit": -5.807618141174316
        },
        {
            "text": "developmental processes in a variety of organ systems. Calcineurin",
            "probability": 3.804339435291728e-05,
            "start_logit": -5.099065780639648,
            "end_logit": 4.085821151733398
        },
        {
            "text": "Calcineurin signaling has been implicated in a broad spectrum of developmental",
            "probability": 3.688614647931555e-05,
            "start_logit": 5.013962268829346,
            "end_logit": -6.058098316192627
        },
        {
            "text": "cineurin",
            "probability": 3.498696445458665e-05,
            "start_logit": -5.015309810638428,
            "end_logit": 3.9183132648468018
        },
        {
            "text": "Calcineur",
            "probability": 3.2329976461908274e-05,
            "start_logit": 5.07603120803833,
            "end_logit": -6.252008438110352
        },
        {
            "text": "signaling has been implicated in a broad spectrum of developmental processes in a variety of organ systems. Calcineurin",
            "probability": 1.6924839882486888e-05,
            "start_logit": -5.909010887145996,
            "end_logit": 4.085821151733398
        },
        {
            "text": "ineurin",
            "probability": 1.3641886003243292e-05,
            "start_logit": -5.807551860809326,
            "end_logit": 3.7687246799468994
        },
        {
            "text": "developmentally important cell types. Calcineurin",
            "probability": 9.011363269465973e-06,
            "start_logit": -6.22221040725708,
            "end_logit": 3.7687246799468994
        },
        {
            "text": "Calcineurin signaling has been implicated in a broad spectrum of developmental processes in a variety of organ systems. Calcineurin",
            "probability": 1.6534328442541962e-07,
            "start_logit": -3.5921010971069336,
            "end_logit": -2.859602451324463
        },
        {
            "text": "calcineurin",
            "probability": 1.374610642394748e-08,
            "start_logit": -5.564657688140869,
            "end_logit": -3.374314069747925
        },
        {
            "text": "c",
            "probability": 4.5545243040187245e-09,
            "start_logit": -5.015309810638428,
            "end_logit": -5.02829647064209
        },
        {
            "text": "cine",
            "probability": 2.7496256540254348e-09,
            "start_logit": -5.015309810638428,
            "end_logit": -5.532952785491943
        },
        {
            "text": "composed",
            "probability": 1.89653251551655e-09,
            "start_logit": -5.112082004547119,
            "end_logit": -5.807618141174316
        },
        {
            "text": "development",
            "probability": 1.4956535610585106e-09,
            "start_logit": -5.099065780639648,
            "end_logit": -6.058098316192627
        }
    ],
    "54f9c40ddd3fc62544000001_018": [
        {
            "text": "calcineurin",
            "probability": 0.9993919982947558,
            "start_logit": 9.643735885620117,
            "end_logit": 9.138826370239258
        },
        {
            "text": "cal",
            "probability": 0.0002479431865782864,
            "start_logit": 9.643735885620117,
            "end_logit": 0.8371236324310303
        },
        {
            "text": "phosphatase calcineurin.",
            "probability": 0.0001307264955259511,
            "start_logit": 0.7019408345222473,
            "end_logit": 9.138826370239258
        },
        {
            "text": "in",
            "probability": 8.361397804497617e-05,
            "start_logit": 0.25504422187805176,
            "end_logit": 9.138826370239258
        },
        {
            "text": "ineurin",
            "probability": 5.682817683219188e-05,
            "start_logit": -0.13113421201705933,
            "end_logit": 9.138826370239258
        },
        {
            "text": "cineurin",
            "probability": 2.4615643133633033e-05,
            "start_logit": -0.9677843451499939,
            "end_logit": 9.138826370239258
        },
        {
            "text": "calcineurin. Here we show that the binding of calcineurin",
            "probability": 2.062986744038015e-05,
            "start_logit": 9.643735885620117,
            "end_logit": -1.6493360996246338
        },
        {
            "text": "calcium- and calmodulin-dependent phosphatase calcineurin.",
            "probability": 1.789935817901616e-05,
            "start_logit": -1.286401629447937,
            "end_logit": 9.138826370239258
        },
        {
            "text": "the calcium- and calmodulin-dependent phosphatase calcineurin.",
            "probability": 8.701246409699145e-06,
            "start_logit": -2.007700204849243,
            "end_logit": 9.138826370239258
        },
        {
            "text": "urin",
            "probability": 6.96465905390214e-06,
            "start_logit": -2.2303178310394287,
            "end_logit": 9.138826370239258
        },
        {
            "text": "calcineurin.",
            "probability": 3.801980070342355e-06,
            "start_logit": 9.643735885620117,
            "end_logit": -3.3405539989471436
        },
        {
            "text": "calcine",
            "probability": 3.6356650591290795e-06,
            "start_logit": 9.643735885620117,
            "end_logit": -3.385283946990967
        },
        {
            "text": "calc",
            "probability": 1.3861921992233134e-06,
            "start_logit": 9.643735885620117,
            "end_logit": -4.349515438079834
        },
        {
            "text": "calcineur",
            "probability": 8.37781399194517e-07,
            "start_logit": 9.643735885620117,
            "end_logit": -4.853074073791504
        },
        {
            "text": "directly controlled by the calcium- and calmodulin-dependent phosphatase calcineurin.",
            "probability": 2.1545245064288062e-07,
            "start_logit": -5.706181526184082,
            "end_logit": 9.138826370239258
        },
        {
            "text": "by the calcium- and calmodulin-dependent phosphatase calcineurin.",
            "probability": 7.672920537424486e-08,
            "start_logit": -6.7386393547058105,
            "end_logit": 9.138826370239258
        },
        {
            "text": "controlled by the calcium- and calmodulin-dependent phosphatase calcineurin.",
            "probability": 6.975910961227509e-08,
            "start_logit": -6.833873748779297,
            "end_logit": 9.138826370239258
        },
        {
            "text": "are directly controlled by the calcium- and calmodulin-dependent phosphatase calcineurin.",
            "probability": 4.716472437332003e-08,
            "start_logit": -7.22527551651001,
            "end_logit": 9.138826370239258
        },
        {
            "text": "calcineurin to NFAT is substantially increased when calcineurin",
            "probability": 5.67131780688342e-09,
            "start_logit": 1.0339826345443726,
            "end_logit": -1.2386565208435059
        },
        {
            "text": "phosphatase calcineurin. Here we show that the binding of calcineurin",
            "probability": 2.6985109729189752e-09,
            "start_logit": 0.7019408345222473,
            "end_logit": -1.6493360996246338
        }
    ],
    "54f9c40ddd3fc62544000001_019": [
        {
            "text": "calcineurin",
            "probability": 0.9993473570862778,
            "start_logit": 9.664521217346191,
            "end_logit": 9.142529487609863
        },
        {
            "text": "cal",
            "probability": 0.00031171780647577894,
            "start_logit": 9.664521217346191,
            "end_logit": 1.069770097732544
        },
        {
            "text": "ineurin",
            "probability": 0.0001397253332267976,
            "start_logit": 0.7893421053886414,
            "end_logit": 9.142529487609863
        },
        {
            "text": "in",
            "probability": 0.00011606163699872067,
            "start_logit": 0.6037849187850952,
            "end_logit": 9.142529487609863
        },
        {
            "text": "cineurin",
            "probability": 4.968137020427588e-05,
            "start_logit": -0.24470646679401398,
            "end_logit": 9.142529487609863
        },
        {
            "text": "urin",
            "probability": 2.1720429078223614e-05,
            "start_logit": -1.0720832347869873,
            "end_logit": 9.142529487609863
        },
        {
            "text": "calcine",
            "probability": 6.122267561221912e-06,
            "start_logit": 9.664521217346191,
            "end_logit": -2.860395669937134
        },
        {
            "text": "calc",
            "probability": 1.6580087941992878e-06,
            "start_logit": 9.664521217346191,
            "end_logit": -4.16671085357666
        },
        {
            "text": "phosphatase calcineurin.",
            "probability": 1.5085896860801254e-06,
            "start_logit": -3.739161252975464,
            "end_logit": 9.142529487609863
        },
        {
            "text": "the calmodulin-dependent serine/threonine phosphatase calcineurin.",
            "probability": 1.3747427336745108e-06,
            "start_logit": -3.8320698738098145,
            "end_logit": 9.142529487609863
        },
        {
            "text": "calcineurin. The importance of the Ca(2+)/calcineurin/NFAT",
            "probability": 1.3187018250738978e-06,
            "start_logit": 9.664521217346191,
            "end_logit": -4.3956804275512695
        },
        {
            "text": "calcineur",
            "probability": 7.192195084389677e-07,
            "start_logit": 9.664521217346191,
            "end_logit": -5.001916885375977
        },
        {
            "text": "dephosphorylated by the calmodulin-dependent serine/threonine phosphatase calcineurin.",
            "probability": 3.1226293895364267e-07,
            "start_logit": -5.31424617767334,
            "end_logit": 9.142529487609863
        },
        {
            "text": "serine/threonine phosphatase calcineurin.",
            "probability": 2.943565206950762e-07,
            "start_logit": -5.373300075531006,
            "end_logit": 9.142529487609863
        },
        {
            "text": "calmodulin-dependent serine/threonine phosphatase calcineurin.",
            "probability": 2.257872040045574e-07,
            "start_logit": -5.638498783111572,
            "end_logit": 9.142529487609863
        },
        {
            "text": "when dephosphorylated by the calmodulin-dependent serine/threonine phosphatase calcineurin.",
            "probability": 9.750165902252687e-08,
            "start_logit": -6.478222370147705,
            "end_logit": 9.142529487609863
        },
        {
            "text": "by the calmodulin-dependent serine/threonine phosphatase calcineurin.",
            "probability": 7.213214084338198e-08,
            "start_logit": -6.779592037200928,
            "end_logit": 9.142529487609863
        },
        {
            "text": "calcineurin.",
            "probability": 3.160680993461408e-08,
            "start_logit": 9.664521217346191,
            "end_logit": -8.126710891723633
        },
        {
            "text": "ine",
            "probability": 8.559945338620551e-10,
            "start_logit": 0.7893421053886414,
            "end_logit": -2.860395669937134
        },
        {
            "text": "cine",
            "probability": 3.0436128043158013e-10,
            "start_logit": -0.24470646679401398,
            "end_logit": -2.860395669937134
        }
    ],
    "54f9c40ddd3fc62544000001_020": [
        {
            "text": "calcineurin",
            "probability": 0.22952879441939347,
            "start_logit": 9.592002868652344,
            "end_logit": 9.175621032714844
        },
        {
            "text": "phosphatase 2B/calcineurin",
            "probability": 0.2154973588442947,
            "start_logit": 9.528923034667969,
            "end_logit": 9.175621032714844
        },
        {
            "text": "2B/calcineurin (CaN).",
            "probability": 0.12216169575727592,
            "start_logit": 9.592002868652344,
            "end_logit": 8.544938087463379
        },
        {
            "text": "phosphatase 2B/calcineurin (CaN).",
            "probability": 0.11469377013993035,
            "start_logit": 9.528923034667969,
            "end_logit": 8.544938087463379
        },
        {
            "text": "CaN",
            "probability": 0.09756601442614489,
            "start_logit": 9.367186546325684,
            "end_logit": 8.544938087463379
        },
        {
            "text": "2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.08051603455313049,
            "start_logit": 9.592002868652344,
            "end_logit": 8.12804889678955
        },
        {
            "text": "phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.07559396996226964,
            "start_logit": 9.528923034667969,
            "end_logit": 8.12804889678955
        },
        {
            "text": "(CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.0643051698001567,
            "start_logit": 9.367186546325684,
            "end_logit": 8.12804889678955
        },
        {
            "text": "ph",
            "probability": 2.602118732975388e-05,
            "start_logit": 9.528923034667969,
            "end_logit": 0.1538282036781311
        },
        {
            "text": "cal",
            "probability": 2.517393634230196e-05,
            "start_logit": 9.592002868652344,
            "end_logit": 0.05764645338058472
        },
        {
            "text": "in",
            "probability": 2.2351672920427954e-05,
            "start_logit": 0.3551202714443207,
            "end_logit": 9.175621032714844
        },
        {
            "text": "Ca",
            "probability": 1.9095883810982335e-05,
            "start_logit": 9.367186546325684,
            "end_logit": 0.006126393098384142
        },
        {
            "text": "2B/calcineurin",
            "probability": 1.0450754476694406e-05,
            "start_logit": -0.40510672330856323,
            "end_logit": 9.175621032714844
        },
        {
            "text": "cineurin",
            "probability": 7.648644667840791e-06,
            "start_logit": -0.7172524333000183,
            "end_logit": 9.175621032714844
        },
        {
            "text": "urin",
            "probability": 7.052805615309587e-06,
            "start_logit": -0.7983554005622864,
            "end_logit": 9.175621032714844
        },
        {
            "text": "N",
            "probability": 5.944778263704398e-06,
            "start_logit": -0.3385847210884094,
            "end_logit": 8.544938087463379
        },
        {
            "text": "ineurin",
            "probability": 5.207424936142191e-06,
            "start_logit": -1.1016954183578491,
            "end_logit": 9.175621032714844
        },
        {
            "text": "protein phosphatase 2B/calcineurin",
            "probability": 4.378617343477506e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 9.175621032714844
        },
        {
            "text": "protein phosphatase 2B/calcineurin (CaN).",
            "probability": 2.330423601555047e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 8.544938087463379
        },
        {
            "text": "protein phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 1.5359680959165252e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 8.12804889678955
        }
    ],
    "54f9c40ddd3fc62544000001_021": [
        {
            "text": "calcineurin",
            "probability": 0.22952879441939347,
            "start_logit": 9.592002868652344,
            "end_logit": 9.175621032714844
        },
        {
            "text": "phosphatase 2B/calcineurin",
            "probability": 0.2154973588442947,
            "start_logit": 9.528923034667969,
            "end_logit": 9.175621032714844
        },
        {
            "text": "2B/calcineurin (CaN).",
            "probability": 0.12216169575727592,
            "start_logit": 9.592002868652344,
            "end_logit": 8.544938087463379
        },
        {
            "text": "phosphatase 2B/calcineurin (CaN).",
            "probability": 0.11469377013993035,
            "start_logit": 9.528923034667969,
            "end_logit": 8.544938087463379
        },
        {
            "text": "CaN",
            "probability": 0.09756601442614489,
            "start_logit": 9.367186546325684,
            "end_logit": 8.544938087463379
        },
        {
            "text": "2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.08051603455313049,
            "start_logit": 9.592002868652344,
            "end_logit": 8.12804889678955
        },
        {
            "text": "phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.07559396996226964,
            "start_logit": 9.528923034667969,
            "end_logit": 8.12804889678955
        },
        {
            "text": "(CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.0643051698001567,
            "start_logit": 9.367186546325684,
            "end_logit": 8.12804889678955
        },
        {
            "text": "ph",
            "probability": 2.602118732975388e-05,
            "start_logit": 9.528923034667969,
            "end_logit": 0.1538282036781311
        },
        {
            "text": "cal",
            "probability": 2.517393634230196e-05,
            "start_logit": 9.592002868652344,
            "end_logit": 0.05764645338058472
        },
        {
            "text": "in",
            "probability": 2.2351672920427954e-05,
            "start_logit": 0.3551202714443207,
            "end_logit": 9.175621032714844
        },
        {
            "text": "Ca",
            "probability": 1.9095883810982335e-05,
            "start_logit": 9.367186546325684,
            "end_logit": 0.006126393098384142
        },
        {
            "text": "2B/calcineurin",
            "probability": 1.0450754476694406e-05,
            "start_logit": -0.40510672330856323,
            "end_logit": 9.175621032714844
        },
        {
            "text": "cineurin",
            "probability": 7.648644667840791e-06,
            "start_logit": -0.7172524333000183,
            "end_logit": 9.175621032714844
        },
        {
            "text": "urin",
            "probability": 7.052805615309587e-06,
            "start_logit": -0.7983554005622864,
            "end_logit": 9.175621032714844
        },
        {
            "text": "N",
            "probability": 5.944778263704398e-06,
            "start_logit": -0.3385847210884094,
            "end_logit": 8.544938087463379
        },
        {
            "text": "ineurin",
            "probability": 5.207424936142191e-06,
            "start_logit": -1.1016954183578491,
            "end_logit": 9.175621032714844
        },
        {
            "text": "protein phosphatase 2B/calcineurin",
            "probability": 4.378617343477506e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 9.175621032714844
        },
        {
            "text": "protein phosphatase 2B/calcineurin (CaN).",
            "probability": 2.330423601555047e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 8.544938087463379
        },
        {
            "text": "protein phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 1.5359680959165252e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 8.12804889678955
        }
    ],
    "54f9c40ddd3fc62544000001_022": [
        {
            "text": "calcineurin",
            "probability": 0.22952879441939347,
            "start_logit": 9.592002868652344,
            "end_logit": 9.175621032714844
        },
        {
            "text": "phosphatase 2B/calcineurin",
            "probability": 0.2154973588442947,
            "start_logit": 9.528923034667969,
            "end_logit": 9.175621032714844
        },
        {
            "text": "2B/calcineurin (CaN).",
            "probability": 0.12216169575727592,
            "start_logit": 9.592002868652344,
            "end_logit": 8.544938087463379
        },
        {
            "text": "phosphatase 2B/calcineurin (CaN).",
            "probability": 0.11469377013993035,
            "start_logit": 9.528923034667969,
            "end_logit": 8.544938087463379
        },
        {
            "text": "CaN",
            "probability": 0.09756601442614489,
            "start_logit": 9.367186546325684,
            "end_logit": 8.544938087463379
        },
        {
            "text": "2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.08051603455313049,
            "start_logit": 9.592002868652344,
            "end_logit": 8.12804889678955
        },
        {
            "text": "phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.07559396996226964,
            "start_logit": 9.528923034667969,
            "end_logit": 8.12804889678955
        },
        {
            "text": "(CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.0643051698001567,
            "start_logit": 9.367186546325684,
            "end_logit": 8.12804889678955
        },
        {
            "text": "ph",
            "probability": 2.602118732975388e-05,
            "start_logit": 9.528923034667969,
            "end_logit": 0.1538282036781311
        },
        {
            "text": "cal",
            "probability": 2.517393634230196e-05,
            "start_logit": 9.592002868652344,
            "end_logit": 0.05764645338058472
        },
        {
            "text": "in",
            "probability": 2.2351672920427954e-05,
            "start_logit": 0.3551202714443207,
            "end_logit": 9.175621032714844
        },
        {
            "text": "Ca",
            "probability": 1.9095883810982335e-05,
            "start_logit": 9.367186546325684,
            "end_logit": 0.006126393098384142
        },
        {
            "text": "2B/calcineurin",
            "probability": 1.0450754476694406e-05,
            "start_logit": -0.40510672330856323,
            "end_logit": 9.175621032714844
        },
        {
            "text": "cineurin",
            "probability": 7.648644667840791e-06,
            "start_logit": -0.7172524333000183,
            "end_logit": 9.175621032714844
        },
        {
            "text": "urin",
            "probability": 7.052805615309587e-06,
            "start_logit": -0.7983554005622864,
            "end_logit": 9.175621032714844
        },
        {
            "text": "N",
            "probability": 5.944778263704398e-06,
            "start_logit": -0.3385847210884094,
            "end_logit": 8.544938087463379
        },
        {
            "text": "ineurin",
            "probability": 5.207424936142191e-06,
            "start_logit": -1.1016954183578491,
            "end_logit": 9.175621032714844
        },
        {
            "text": "protein phosphatase 2B/calcineurin",
            "probability": 4.378617343477506e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 9.175621032714844
        },
        {
            "text": "protein phosphatase 2B/calcineurin (CaN).",
            "probability": 2.330423601555047e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 8.544938087463379
        },
        {
            "text": "protein phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 1.5359680959165252e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 8.12804889678955
        }
    ],
    "54f9c40ddd3fc62544000001_023": [
        {
            "text": "calcineurin",
            "probability": 0.22952879441939347,
            "start_logit": 9.592002868652344,
            "end_logit": 9.175621032714844
        },
        {
            "text": "phosphatase 2B/calcineurin",
            "probability": 0.2154973588442947,
            "start_logit": 9.528923034667969,
            "end_logit": 9.175621032714844
        },
        {
            "text": "2B/calcineurin (CaN).",
            "probability": 0.12216169575727592,
            "start_logit": 9.592002868652344,
            "end_logit": 8.544938087463379
        },
        {
            "text": "phosphatase 2B/calcineurin (CaN).",
            "probability": 0.11469377013993035,
            "start_logit": 9.528923034667969,
            "end_logit": 8.544938087463379
        },
        {
            "text": "CaN",
            "probability": 0.09756601442614489,
            "start_logit": 9.367186546325684,
            "end_logit": 8.544938087463379
        },
        {
            "text": "2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.08051603455313049,
            "start_logit": 9.592002868652344,
            "end_logit": 8.12804889678955
        },
        {
            "text": "phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.07559396996226964,
            "start_logit": 9.528923034667969,
            "end_logit": 8.12804889678955
        },
        {
            "text": "(CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.0643051698001567,
            "start_logit": 9.367186546325684,
            "end_logit": 8.12804889678955
        },
        {
            "text": "ph",
            "probability": 2.602118732975388e-05,
            "start_logit": 9.528923034667969,
            "end_logit": 0.1538282036781311
        },
        {
            "text": "cal",
            "probability": 2.517393634230196e-05,
            "start_logit": 9.592002868652344,
            "end_logit": 0.05764645338058472
        },
        {
            "text": "in",
            "probability": 2.2351672920427954e-05,
            "start_logit": 0.3551202714443207,
            "end_logit": 9.175621032714844
        },
        {
            "text": "Ca",
            "probability": 1.9095883810982335e-05,
            "start_logit": 9.367186546325684,
            "end_logit": 0.006126393098384142
        },
        {
            "text": "2B/calcineurin",
            "probability": 1.0450754476694406e-05,
            "start_logit": -0.40510672330856323,
            "end_logit": 9.175621032714844
        },
        {
            "text": "cineurin",
            "probability": 7.648644667840791e-06,
            "start_logit": -0.7172524333000183,
            "end_logit": 9.175621032714844
        },
        {
            "text": "urin",
            "probability": 7.052805615309587e-06,
            "start_logit": -0.7983554005622864,
            "end_logit": 9.175621032714844
        },
        {
            "text": "N",
            "probability": 5.944778263704398e-06,
            "start_logit": -0.3385847210884094,
            "end_logit": 8.544938087463379
        },
        {
            "text": "ineurin",
            "probability": 5.207424936142191e-06,
            "start_logit": -1.1016954183578491,
            "end_logit": 9.175621032714844
        },
        {
            "text": "protein phosphatase 2B/calcineurin",
            "probability": 4.378617343477506e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 9.175621032714844
        },
        {
            "text": "protein phosphatase 2B/calcineurin (CaN).",
            "probability": 2.330423601555047e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 8.544938087463379
        },
        {
            "text": "protein phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 1.5359680959165252e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 8.12804889678955
        }
    ],
    "54f9c40ddd3fc62544000001_024": [
        {
            "text": "calcineurin",
            "probability": 0.22952879441939347,
            "start_logit": 9.592002868652344,
            "end_logit": 9.175621032714844
        },
        {
            "text": "phosphatase 2B/calcineurin",
            "probability": 0.2154973588442947,
            "start_logit": 9.528923034667969,
            "end_logit": 9.175621032714844
        },
        {
            "text": "2B/calcineurin (CaN).",
            "probability": 0.12216169575727592,
            "start_logit": 9.592002868652344,
            "end_logit": 8.544938087463379
        },
        {
            "text": "phosphatase 2B/calcineurin (CaN).",
            "probability": 0.11469377013993035,
            "start_logit": 9.528923034667969,
            "end_logit": 8.544938087463379
        },
        {
            "text": "CaN",
            "probability": 0.09756601442614489,
            "start_logit": 9.367186546325684,
            "end_logit": 8.544938087463379
        },
        {
            "text": "2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.08051603455313049,
            "start_logit": 9.592002868652344,
            "end_logit": 8.12804889678955
        },
        {
            "text": "phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.07559396996226964,
            "start_logit": 9.528923034667969,
            "end_logit": 8.12804889678955
        },
        {
            "text": "(CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.0643051698001567,
            "start_logit": 9.367186546325684,
            "end_logit": 8.12804889678955
        },
        {
            "text": "ph",
            "probability": 2.602118732975388e-05,
            "start_logit": 9.528923034667969,
            "end_logit": 0.1538282036781311
        },
        {
            "text": "cal",
            "probability": 2.517393634230196e-05,
            "start_logit": 9.592002868652344,
            "end_logit": 0.05764645338058472
        },
        {
            "text": "in",
            "probability": 2.2351672920427954e-05,
            "start_logit": 0.3551202714443207,
            "end_logit": 9.175621032714844
        },
        {
            "text": "Ca",
            "probability": 1.9095883810982335e-05,
            "start_logit": 9.367186546325684,
            "end_logit": 0.006126393098384142
        },
        {
            "text": "2B/calcineurin",
            "probability": 1.0450754476694406e-05,
            "start_logit": -0.40510672330856323,
            "end_logit": 9.175621032714844
        },
        {
            "text": "cineurin",
            "probability": 7.648644667840791e-06,
            "start_logit": -0.7172524333000183,
            "end_logit": 9.175621032714844
        },
        {
            "text": "urin",
            "probability": 7.052805615309587e-06,
            "start_logit": -0.7983554005622864,
            "end_logit": 9.175621032714844
        },
        {
            "text": "N",
            "probability": 5.944778263704398e-06,
            "start_logit": -0.3385847210884094,
            "end_logit": 8.544938087463379
        },
        {
            "text": "ineurin",
            "probability": 5.207424936142191e-06,
            "start_logit": -1.1016954183578491,
            "end_logit": 9.175621032714844
        },
        {
            "text": "protein phosphatase 2B/calcineurin",
            "probability": 4.378617343477506e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 9.175621032714844
        },
        {
            "text": "protein phosphatase 2B/calcineurin (CaN).",
            "probability": 2.330423601555047e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 8.544938087463379
        },
        {
            "text": "protein phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 1.5359680959165252e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 8.12804889678955
        }
    ],
    "54f9c40ddd3fc62544000001_025": [
        {
            "text": "calcineurin",
            "probability": 0.22952879441939347,
            "start_logit": 9.592002868652344,
            "end_logit": 9.175621032714844
        },
        {
            "text": "phosphatase 2B/calcineurin",
            "probability": 0.2154973588442947,
            "start_logit": 9.528923034667969,
            "end_logit": 9.175621032714844
        },
        {
            "text": "2B/calcineurin (CaN).",
            "probability": 0.12216169575727592,
            "start_logit": 9.592002868652344,
            "end_logit": 8.544938087463379
        },
        {
            "text": "phosphatase 2B/calcineurin (CaN).",
            "probability": 0.11469377013993035,
            "start_logit": 9.528923034667969,
            "end_logit": 8.544938087463379
        },
        {
            "text": "CaN",
            "probability": 0.09756601442614489,
            "start_logit": 9.367186546325684,
            "end_logit": 8.544938087463379
        },
        {
            "text": "2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.08051603455313049,
            "start_logit": 9.592002868652344,
            "end_logit": 8.12804889678955
        },
        {
            "text": "phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.07559396996226964,
            "start_logit": 9.528923034667969,
            "end_logit": 8.12804889678955
        },
        {
            "text": "(CaN). Dephosphorylation of NFAT by CaN",
            "probability": 0.0643051698001567,
            "start_logit": 9.367186546325684,
            "end_logit": 8.12804889678955
        },
        {
            "text": "ph",
            "probability": 2.602118732975388e-05,
            "start_logit": 9.528923034667969,
            "end_logit": 0.1538282036781311
        },
        {
            "text": "cal",
            "probability": 2.517393634230196e-05,
            "start_logit": 9.592002868652344,
            "end_logit": 0.05764645338058472
        },
        {
            "text": "in",
            "probability": 2.2351672920427954e-05,
            "start_logit": 0.3551202714443207,
            "end_logit": 9.175621032714844
        },
        {
            "text": "Ca",
            "probability": 1.9095883810982335e-05,
            "start_logit": 9.367186546325684,
            "end_logit": 0.006126393098384142
        },
        {
            "text": "2B/calcineurin",
            "probability": 1.0450754476694406e-05,
            "start_logit": -0.40510672330856323,
            "end_logit": 9.175621032714844
        },
        {
            "text": "cineurin",
            "probability": 7.648644667840791e-06,
            "start_logit": -0.7172524333000183,
            "end_logit": 9.175621032714844
        },
        {
            "text": "urin",
            "probability": 7.052805615309587e-06,
            "start_logit": -0.7983554005622864,
            "end_logit": 9.175621032714844
        },
        {
            "text": "N",
            "probability": 5.944778263704398e-06,
            "start_logit": -0.3385847210884094,
            "end_logit": 8.544938087463379
        },
        {
            "text": "ineurin",
            "probability": 5.207424936142191e-06,
            "start_logit": -1.1016954183578491,
            "end_logit": 9.175621032714844
        },
        {
            "text": "protein phosphatase 2B/calcineurin",
            "probability": 4.378617343477506e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 9.175621032714844
        },
        {
            "text": "protein phosphatase 2B/calcineurin (CaN).",
            "probability": 2.330423601555047e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 8.544938087463379
        },
        {
            "text": "protein phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN",
            "probability": 1.5359680959165252e-06,
            "start_logit": -1.2750478982925415,
            "end_logit": 8.12804889678955
        }
    ],
    "54f9c40ddd3fc62544000001_027": [
        {
            "text": "calcineurin",
            "probability": 0.9993919982947558,
            "start_logit": 9.643735885620117,
            "end_logit": 9.138826370239258
        },
        {
            "text": "cal",
            "probability": 0.0002479431865782864,
            "start_logit": 9.643735885620117,
            "end_logit": 0.8371236324310303
        },
        {
            "text": "phosphatase calcineurin.",
            "probability": 0.0001307264955259511,
            "start_logit": 0.7019408345222473,
            "end_logit": 9.138826370239258
        },
        {
            "text": "in",
            "probability": 8.361397804497617e-05,
            "start_logit": 0.25504422187805176,
            "end_logit": 9.138826370239258
        },
        {
            "text": "ineurin",
            "probability": 5.682817683219188e-05,
            "start_logit": -0.13113421201705933,
            "end_logit": 9.138826370239258
        },
        {
            "text": "cineurin",
            "probability": 2.4615643133633033e-05,
            "start_logit": -0.9677843451499939,
            "end_logit": 9.138826370239258
        },
        {
            "text": "calcineurin. Here we show that the binding of calcineurin",
            "probability": 2.062986744038015e-05,
            "start_logit": 9.643735885620117,
            "end_logit": -1.6493360996246338
        },
        {
            "text": "calcium- and calmodulin-dependent phosphatase calcineurin.",
            "probability": 1.789935817901616e-05,
            "start_logit": -1.286401629447937,
            "end_logit": 9.138826370239258
        },
        {
            "text": "the calcium- and calmodulin-dependent phosphatase calcineurin.",
            "probability": 8.701246409699145e-06,
            "start_logit": -2.007700204849243,
            "end_logit": 9.138826370239258
        },
        {
            "text": "urin",
            "probability": 6.96465905390214e-06,
            "start_logit": -2.2303178310394287,
            "end_logit": 9.138826370239258
        },
        {
            "text": "calcineurin.",
            "probability": 3.801980070342355e-06,
            "start_logit": 9.643735885620117,
            "end_logit": -3.3405539989471436
        },
        {
            "text": "calcine",
            "probability": 3.6356650591290795e-06,
            "start_logit": 9.643735885620117,
            "end_logit": -3.385283946990967
        },
        {
            "text": "calc",
            "probability": 1.3861921992233134e-06,
            "start_logit": 9.643735885620117,
            "end_logit": -4.349515438079834
        },
        {
            "text": "calcineur",
            "probability": 8.37781399194517e-07,
            "start_logit": 9.643735885620117,
            "end_logit": -4.853074073791504
        },
        {
            "text": "directly controlled by the calcium- and calmodulin-dependent phosphatase calcineurin.",
            "probability": 2.1545245064288062e-07,
            "start_logit": -5.706181526184082,
            "end_logit": 9.138826370239258
        },
        {
            "text": "by the calcium- and calmodulin-dependent phosphatase calcineurin.",
            "probability": 7.672920537424486e-08,
            "start_logit": -6.7386393547058105,
            "end_logit": 9.138826370239258
        },
        {
            "text": "controlled by the calcium- and calmodulin-dependent phosphatase calcineurin.",
            "probability": 6.975910961227509e-08,
            "start_logit": -6.833873748779297,
            "end_logit": 9.138826370239258
        },
        {
            "text": "are directly controlled by the calcium- and calmodulin-dependent phosphatase calcineurin.",
            "probability": 4.716472437332003e-08,
            "start_logit": -7.22527551651001,
            "end_logit": 9.138826370239258
        },
        {
            "text": "calcineurin to NFAT is substantially increased when calcineurin",
            "probability": 5.67131780688342e-09,
            "start_logit": 1.0339826345443726,
            "end_logit": -1.2386565208435059
        },
        {
            "text": "phosphatase calcineurin. Here we show that the binding of calcineurin",
            "probability": 2.6985109729189752e-09,
            "start_logit": 0.7019408345222473,
            "end_logit": -1.6493360996246338
        }
    ],
    "532ff917d6d3ac6a34000038_001": [
        {
            "text": "H3K36Me3",
            "probability": 0.9994429979093584,
            "start_logit": 9.692001342773438,
            "end_logit": 9.356849670410156
        },
        {
            "text": "3",
            "probability": 0.0002626986828746956,
            "start_logit": 1.448055624961853,
            "end_logit": 9.356849670410156
        },
        {
            "text": "H",
            "probability": 0.00018936757511615865,
            "start_logit": 9.692001342773438,
            "end_logit": 0.7855862379074097
        },
        {
            "text": "Me3",
            "probability": 2.7241348173693532e-05,
            "start_logit": -0.81821608543396,
            "end_logit": 9.356849670410156
        },
        {
            "text": "K36Me3",
            "probability": 2.2155094639706625e-05,
            "start_logit": -1.024884581565857,
            "end_logit": 9.356849670410156
        },
        {
            "text": "36Me3",
            "probability": 1.8614617690129597e-05,
            "start_logit": -1.199004888534546,
            "end_logit": 9.356849670410156
        },
        {
            "text": "3K36Me3",
            "probability": 1.5305875109459286e-05,
            "start_logit": -1.3947153091430664,
            "end_logit": 9.356849670410156
        },
        {
            "text": "H3 lysine 36 tri-methylation (H3K36Me3),",
            "probability": 9.740498318099597e-06,
            "start_logit": -1.846659779548645,
            "end_logit": 9.356849670410156
        },
        {
            "text": "histone H3 lysine 36 tri-methylation (H3K36Me3),",
            "probability": 4.039564278188396e-06,
            "start_logit": -2.7268152236938477,
            "end_logit": 9.356849670410156
        },
        {
            "text": "the histone modification mark, histone H3 lysine 36 tri-methylation (H3K36Me3),",
            "probability": 1.6164572021943033e-06,
            "start_logit": -3.6427152156829834,
            "end_logit": 9.356849670410156
        },
        {
            "text": "(H3K36Me3),",
            "probability": 1.5109637541996224e-06,
            "start_logit": -3.7102043628692627,
            "end_logit": 9.356849670410156
        },
        {
            "text": "H3K36",
            "probability": 1.4525292510031859e-06,
            "start_logit": 9.692001342773438,
            "end_logit": -4.084797382354736
        },
        {
            "text": "H3",
            "probability": 8.668428876685039e-07,
            "start_logit": 9.692001342773438,
            "end_logit": -4.601001262664795
        },
        {
            "text": "mark, histone H3 lysine 36 tri-methylation (H3K36Me3),",
            "probability": 8.586796054206712e-07,
            "start_logit": -4.275311470031738,
            "end_logit": 9.356849670410156
        },
        {
            "text": "histone modification mark, histone H3 lysine 36 tri-methylation (H3K36Me3),",
            "probability": 4.990796345272462e-07,
            "start_logit": -4.817941665649414,
            "end_logit": 9.356849670410156
        },
        {
            "text": "H3K",
            "probability": 4.912374054234267e-07,
            "start_logit": 9.692001342773438,
            "end_logit": -5.168931484222412
        },
        {
            "text": "H3K36Me",
            "probability": 2.3186593549159534e-07,
            "start_logit": 9.692001342773438,
            "end_logit": -5.919699668884277
        },
        {
            "text": "modification mark, histone H3 lysine 36 tri-methylation (H3K36Me3),",
            "probability": 1.4959957198190348e-07,
            "start_logit": -6.022745132446289,
            "end_logit": 9.356849670410156
        },
        {
            "text": "tri-methylation (H3K36Me3),",
            "probability": 8.77128682765511e-08,
            "start_logit": -6.556638717651367,
            "end_logit": 9.356849670410156
        },
        {
            "text": "36 tri-methylation (H3K36Me3),",
            "probability": 7.386632484094038e-08,
            "start_logit": -6.728450298309326,
            "end_logit": 9.356849670410156
        }
    ],
    "532ff917d6d3ac6a34000038_002": [
        {
            "text": "H3K36me3",
            "probability": 0.9989521686706208,
            "start_logit": 9.56446361541748,
            "end_logit": 9.250166893005371
        },
        {
            "text": "H3 trimethylation on lysine 36 (H3K36me3),",
            "probability": 0.0006917626982719055,
            "start_logit": 2.2892444133758545,
            "end_logit": 9.250166893005371
        },
        {
            "text": "3",
            "probability": 0.0002249475092116996,
            "start_logit": 1.1658685207366943,
            "end_logit": 9.250166893005371
        },
        {
            "text": "H",
            "probability": 7.336777477384984e-05,
            "start_logit": 9.56446361541748,
            "end_logit": -0.2688104808330536
        },
        {
            "text": "36me3",
            "probability": 3.3395757267724074e-05,
            "start_logit": -0.7415696978569031,
            "end_logit": 9.250166893005371
        },
        {
            "text": "K36me3",
            "probability": 1.2886836163736124e-05,
            "start_logit": -1.6937922239303589,
            "end_logit": 9.250166893005371
        },
        {
            "text": "me3",
            "probability": 5.696369578014099e-06,
            "start_logit": -2.510169506072998,
            "end_logit": 9.250166893005371
        },
        {
            "text": "3K36me3",
            "probability": 1.57741797932274e-06,
            "start_logit": -3.7942092418670654,
            "end_logit": 9.250166893005371
        },
        {
            "text": "36 (H3K36me3),",
            "probability": 8.763819675454212e-07,
            "start_logit": -4.381951808929443,
            "end_logit": 9.250166893005371
        },
        {
            "text": "H3K36me",
            "probability": 8.362515091436228e-07,
            "start_logit": 9.56446361541748,
            "end_logit": -4.743121147155762
        },
        {
            "text": "(H3K36me3),",
            "probability": 6.351169516527846e-07,
            "start_logit": -4.703944683074951,
            "end_logit": 9.250166893005371
        },
        {
            "text": "lysine 36 (H3K36me3),",
            "probability": 5.258657837126751e-07,
            "start_logit": -4.892707824707031,
            "end_logit": 9.250166893005371
        },
        {
            "text": "on lysine 36 (H3K36me3),",
            "probability": 3.886003704450638e-07,
            "start_logit": -5.195202350616455,
            "end_logit": 9.250166893005371
        },
        {
            "text": "trimethylation on lysine 36 (H3K36me3),",
            "probability": 2.5565316665225506e-07,
            "start_logit": -5.613932132720947,
            "end_logit": 9.250166893005371
        },
        {
            "text": "H3K",
            "probability": 2.0263522926630144e-07,
            "start_logit": 9.56446361541748,
            "end_logit": -6.160643100738525
        },
        {
            "text": "H3",
            "probability": 1.997881982558967e-07,
            "start_logit": 9.56446361541748,
            "end_logit": -6.174792766571045
        },
        {
            "text": "(H3K36me3), which functionally correlates with alternative RNA splicing",
            "probability": 1.199099630396747e-07,
            "start_logit": 9.56446361541748,
            "end_logit": -6.685309410095215
        },
        {
            "text": "H3K36",
            "probability": 9.080705526029982e-08,
            "start_logit": 9.56446361541748,
            "end_logit": -6.963313579559326
        },
        {
            "text": "(H3K36me3), which functionally correlates with alternative RNA splicing in humans.",
            "probability": 6.318723638856365e-08,
            "start_logit": 9.56446361541748,
            "end_logit": -7.325948238372803
        },
        {
            "text": "H2BK123ub1",
            "probability": 2.7687019887879754e-09,
            "start_logit": -0.8802152276039124,
            "end_logit": -0.008993105962872505
        }
    ],
    "532ff917d6d3ac6a34000038_003": [
        {
            "text": "H3K36me3",
            "probability": 0.9995933457947087,
            "start_logit": 9.54580020904541,
            "end_logit": 9.083735466003418
        },
        {
            "text": "3",
            "probability": 0.000260578596284084,
            "start_logit": 1.2936009168624878,
            "end_logit": 9.083735466003418
        },
        {
            "text": "H",
            "probability": 0.00010504447561640027,
            "start_logit": 9.54580020904541,
            "end_logit": -0.07698451727628708
        },
        {
            "text": "K36me3",
            "probability": 2.012616617918436e-05,
            "start_logit": -1.2672828435897827,
            "end_logit": 9.083735466003418
        },
        {
            "text": "36me3",
            "probability": 7.268634750611545e-06,
            "start_logit": -2.2857351303100586,
            "end_logit": 9.083735466003418
        },
        {
            "text": "me3",
            "probability": 5.1744760266571055e-06,
            "start_logit": -2.625565528869629,
            "end_logit": 9.083735466003418
        },
        {
            "text": "3K36me3",
            "probability": 5.019064850627245e-06,
            "start_logit": -2.656059980392456,
            "end_logit": 9.083735466003418
        },
        {
            "text": "(H3K36me3) relative to intronless genes. In intron-containing genes, H3K36me3",
            "probability": 6.96488124481097e-07,
            "start_logit": 9.54580020904541,
            "end_logit": -5.093072891235352
        },
        {
            "text": "histone H3 Lys36 trimethylation (H3K36me3)",
            "probability": 5.229340717359184e-07,
            "start_logit": -4.917603492736816,
            "end_logit": 9.083735466003418
        },
        {
            "text": "(H3K36me3)",
            "probability": 5.218833519008177e-07,
            "start_logit": -4.919614791870117,
            "end_logit": 9.083735466003418
        },
        {
            "text": "H3K36me",
            "probability": 4.652302958482904e-07,
            "start_logit": 9.54580020904541,
            "end_logit": -5.496591091156006
        },
        {
            "text": "H3 Lys36 trimethylation (H3K36me3)",
            "probability": 3.6500467706867343e-07,
            "start_logit": -5.277148723602295,
            "end_logit": 9.083735466003418
        },
        {
            "text": "H3",
            "probability": 2.4156278187622803e-07,
            "start_logit": 9.54580020904541,
            "end_logit": -6.151994228363037
        },
        {
            "text": "H3K",
            "probability": 2.2711061006527185e-07,
            "start_logit": 9.54580020904541,
            "end_logit": -6.213686466217041
        },
        {
            "text": "marked with histone H3 Lys36 trimethylation (H3K36me3)",
            "probability": 2.0348028451372222e-07,
            "start_logit": -5.861489772796631,
            "end_logit": 9.083735466003418
        },
        {
            "text": "H3K36",
            "probability": 1.9906544803288529e-07,
            "start_logit": 9.54580020904541,
            "end_logit": -6.345489978790283
        },
        {
            "text": "intron-containing genes are preferentially marked with histone H3 Lys36 trimethylation (H3K36me3)",
            "probability": 1.3990347666638299e-11,
            "start_logit": -6.285726547241211,
            "end_logit": -0.07698451727628708
        },
        {
            "text": "K36me",
            "probability": 9.367111421084613e-12,
            "start_logit": -1.2672828435897827,
            "end_logit": -5.496591091156006
        },
        {
            "text": "K",
            "probability": 4.572725397242032e-12,
            "start_logit": -1.2672828435897827,
            "end_logit": -6.213686466217041
        },
        {
            "text": "K36",
            "probability": 4.0080541797308605e-12,
            "start_logit": -1.2672828435897827,
            "end_logit": -6.345489978790283
        }
    ],
    "532ff917d6d3ac6a34000038_004": [
        {
            "text": "H3K36me3",
            "probability": 0.9991257413505947,
            "start_logit": 9.792956352233887,
            "end_logit": 9.342570304870605
        },
        {
            "text": "3",
            "probability": 0.0004595448534111777,
            "start_logit": 2.1085569858551025,
            "end_logit": 9.342570304870605
        },
        {
            "text": "H",
            "probability": 0.0001916064326438836,
            "start_logit": 9.792956352233887,
            "end_logit": 0.7833778262138367
        },
        {
            "text": "36me3",
            "probability": 7.29196850117635e-05,
            "start_logit": 0.2676790654659271,
            "end_logit": 9.342570304870605
        },
        {
            "text": "K36me3",
            "probability": 6.44156675687716e-05,
            "start_logit": 0.14367732405662537,
            "end_logit": 9.342570304870605
        },
        {
            "text": "me3",
            "probability": 5.364111201583408e-05,
            "start_logit": -0.03936377540230751,
            "end_logit": 9.342570304870605
        },
        {
            "text": "3K36me3",
            "probability": 2.4931190036348222e-05,
            "start_logit": -0.8055599331855774,
            "end_logit": 9.342570304870605
        },
        {
            "text": "3 (H3K36me3)",
            "probability": 1.5715700757192412e-06,
            "start_logit": -3.5696043968200684,
            "end_logit": 9.342570304870605
        },
        {
            "text": "H3K36",
            "probability": 1.3655945221294446e-06,
            "start_logit": 9.792956352233887,
            "end_logit": -4.160475730895996
        },
        {
            "text": "(H3K36me3)",
            "probability": 1.2275005881631111e-06,
            "start_logit": -3.816699504852295,
            "end_logit": 9.342570304870605
        },
        {
            "text": "H3K36me",
            "probability": 8.696843848536393e-07,
            "start_logit": 9.792956352233887,
            "end_logit": -4.611690521240234
        },
        {
            "text": "of lysine 36 in histone subunit 3 (H3K36me3)",
            "probability": 3.4151830199266786e-07,
            "start_logit": -5.096033573150635,
            "end_logit": 9.342570304870605
        },
        {
            "text": "H3K",
            "probability": 2.958115527205284e-07,
            "start_logit": 9.792956352233887,
            "end_logit": -5.690098285675049
        },
        {
            "text": "H3",
            "probability": 2.948608286425865e-07,
            "start_logit": 9.792956352233887,
            "end_logit": -5.693317413330078
        },
        {
            "text": "trimethylation of lysine 36 in histone subunit 3 (H3K36me3)",
            "probability": 2.715648332496634e-07,
            "start_logit": -5.3252339363098145,
            "end_logit": 9.342570304870605
        },
        {
            "text": "with trimethylation of lysine 36 in histone subunit 3 (H3K36me3)",
            "probability": 2.1343204906863685e-07,
            "start_logit": -5.5661163330078125,
            "end_logit": 9.342570304870605
        },
        {
            "text": "(H3K36me3) are enriched at internal exons",
            "probability": 2.0354168602600154e-07,
            "start_logit": 9.792956352233887,
            "end_logit": -6.063950061798096
        },
        {
            "text": "lysine 36 in histone subunit 3 (H3K36me3)",
            "probability": 1.9323969122163408e-07,
            "start_logit": -5.66550350189209,
            "end_logit": 9.342570304870605
        },
        {
            "text": "nucleosomes with trimethylation of lysine 36 in histone subunit 3 (H3K36me3)",
            "probability": 1.7772880450559544e-07,
            "start_logit": -5.749176025390625,
            "end_logit": 9.342570304870605
        },
        {
            "text": "histone subunit 3 (H3K36me3)",
            "probability": 1.73661399001554e-07,
            "start_logit": -5.772327423095703,
            "end_logit": 9.342570304870605
        }
    ],
    "569e7721ceceede94d000001_003": [
        {
            "text": "Functional Annotation Of the Mammalian Genomes 4",
            "probability": 0.1318090507771113,
            "start_logit": -3.308681011199951,
            "end_logit": -3.8703396320343018
        },
        {
            "text": "The international Functional Annotation Of the Mammalian Genomes 4",
            "probability": 0.09301950625034962,
            "start_logit": -3.657226085662842,
            "end_logit": -3.8703396320343018
        },
        {
            "text": "Functional Annotation Of the Mammalian Genomes 4 (FANTOM4) research collaboration set out",
            "probability": 0.07207008936420144,
            "start_logit": -3.308681011199951,
            "end_logit": -4.47405481338501
        },
        {
            "text": "better understand the transcriptional network that regulates",
            "probability": 0.06279563861559552,
            "start_logit": -3.3317360877990723,
            "end_logit": -4.5887532234191895
        },
        {
            "text": "the transcriptional network that regulates",
            "probability": 0.060118979730490706,
            "start_logit": -3.375296115875244,
            "end_logit": -4.5887532234191895
        },
        {
            "text": "(FANTOM4) research collaboration set out",
            "probability": 0.057593846683227236,
            "start_logit": -3.5329043865203857,
            "end_logit": -4.47405481338501
        },
        {
            "text": "international Functional Annotation Of the Mammalian Genomes 4",
            "probability": 0.05674494330509923,
            "start_logit": -4.151468753814697,
            "end_logit": -3.8703396320343018
        },
        {
            "text": "Functional Annotation Of the Mammalian Genomes",
            "probability": 0.05257934623373521,
            "start_logit": -3.308681011199951,
            "end_logit": -4.789370536804199
        },
        {
            "text": "that regulates",
            "probability": 0.05219771626476842,
            "start_logit": -3.51658296585083,
            "end_logit": -4.5887532234191895
        },
        {
            "text": "(FANTOM4) research collaboration set out to better understand the transcriptional network that regulates",
            "probability": 0.051352690151661225,
            "start_logit": -3.5329043865203857,
            "end_logit": -4.5887532234191895
        },
        {
            "text": "The international Functional Annotation Of the Mammalian Genomes 4 (FANTOM4) research collaboration set out",
            "probability": 0.05086087858574223,
            "start_logit": -3.657226085662842,
            "end_logit": -4.47405481338501
        },
        {
            "text": "The international Functional Annotation Of the Mammalian Genomes",
            "probability": 0.037105986248992376,
            "start_logit": -3.657226085662842,
            "end_logit": -4.789370536804199
        },
        {
            "text": "Functional Annotation Of the Mammalian Genomes 4 (FANTOM4) research collaboration",
            "probability": 0.03457222056875879,
            "start_logit": -3.308681011199951,
            "end_logit": -5.208643436431885
        },
        {
            "text": "research collaboration set out",
            "probability": 0.03192459509281893,
            "start_logit": -4.12294340133667,
            "end_logit": -4.47405481338501
        },
        {
            "text": "international Functional Annotation Of the Mammalian Genomes 4 (FANTOM4) research collaboration set out",
            "probability": 0.0310268005941456,
            "start_logit": -4.151468753814697,
            "end_logit": -4.47405481338501
        },
        {
            "text": "research collaboration set out to better understand the transcriptional network that regulates",
            "probability": 0.028465086713789743,
            "start_logit": -4.12294340133667,
            "end_logit": -4.5887532234191895
        },
        {
            "text": "(FANTOM4) research collaboration",
            "probability": 0.027627927042988373,
            "start_logit": -3.5329043865203857,
            "end_logit": -5.208643436431885
        },
        {
            "text": "The international Functional Annotation Of the Mammalian Genomes 4 (FANTOM4) research collaboration",
            "probability": 0.02439810368350339,
            "start_logit": -3.657226085662842,
            "end_logit": -5.208643436431885
        },
        {
            "text": "international Functional Annotation Of the Mammalian Genomes",
            "probability": 0.022635866076433295,
            "start_logit": -4.151468753814697,
            "end_logit": -4.789370536804199
        },
        {
            "text": "better understand the transcriptional network that regulates macrophage differentiation",
            "probability": 0.02110072801658718,
            "start_logit": -3.3317360877990723,
            "end_logit": -5.679331302642822
        }
    ],
    "56a24dfffe92d6fd19000002_011": [
        {
            "text": "(eteplirsen)",
            "probability": 0.9883632192489537,
            "start_logit": 2.759019374847412,
            "end_logit": -0.5102217197418213
        },
        {
            "text": "ete",
            "probability": 0.00802227104323343,
            "start_logit": 2.759019374847412,
            "end_logit": -5.324050426483154
        },
        {
            "text": "eteplirsen",
            "probability": 0.0017389298744930899,
            "start_logit": 2.759019374847412,
            "end_logit": -6.853002071380615
        },
        {
            "text": "etepl",
            "probability": 0.0009202141078797465,
            "start_logit": 2.759019374847412,
            "end_logit": -7.4894208908081055
        },
        {
            "text": "eteplir",
            "probability": 0.0004106423154905568,
            "start_logit": 2.759019374847412,
            "end_logit": -8.296304702758789
        },
        {
            "text": "(eteplirsen) that induces skipping",
            "probability": 0.00032197982111856075,
            "start_logit": 2.759019374847412,
            "end_logit": -8.539538383483887
        },
        {
            "text": "the morpholino splice-switching oligonucleotide AVI-4658 (eteplirsen)",
            "probability": 6.210350870514489e-05,
            "start_logit": -6.9159836769104,
            "end_logit": -0.5102217197418213
        },
        {
            "text": "patients using the morpholino splice-switching oligonucleotide AVI-4658 (eteplirsen)",
            "probability": 5.988993762432653e-05,
            "start_logit": -6.952277660369873,
            "end_logit": -0.5102217197418213
        },
        {
            "text": "using the morpholino splice-switching oligonucleotide AVI-4658 (eteplirsen)",
            "probability": 5.603322949039305e-05,
            "start_logit": -7.01884126663208,
            "end_logit": -0.5102217197418213
        },
        {
            "text": "AVI-4658 (eteplirsen)",
            "probability": 4.202861013722815e-05,
            "start_logit": -7.306435585021973,
            "end_logit": -0.5102217197418213
        },
        {
            "text": "(DMD) patients using the morpholino splice-switching oligonucleotide AVI-4658 (eteplirsen)",
            "probability": 7.110740737448578e-07,
            "start_logit": -6.571936130523682,
            "end_logit": -5.324050426483154
        },
        {
            "text": "study in Duchenne muscular dystrophy",
            "probability": 4.164795320931331e-07,
            "start_logit": -6.424013137817383,
            "end_logit": -6.006912708282471
        },
        {
            "text": "proof of principle; dose escalation study in Duchenne muscular dystrophy",
            "probability": 4.074036976774395e-07,
            "start_logit": -6.446045875549316,
            "end_logit": -6.006912708282471
        },
        {
            "text": "previously conducted a proof of principle; dose escalation study in Duchenne muscular dystrophy",
            "probability": 2.4724179156991963e-07,
            "start_logit": -6.945483684539795,
            "end_logit": -6.006912708282471
        },
        {
            "text": "Duchenne muscular dystrophy",
            "probability": 2.194875009099739e-07,
            "start_logit": -7.0645551681518555,
            "end_logit": -6.006912708282471
        },
        {
            "text": "dose escalation study in Duchenne muscular dystrophy",
            "probability": 1.7859793857955297e-07,
            "start_logit": -7.2707133293151855,
            "end_logit": -6.006912708282471
        },
        {
            "text": "escalation study in Duchenne muscular dystrophy",
            "probability": 1.4258718530624552e-07,
            "start_logit": -7.495896816253662,
            "end_logit": -6.006912708282471
        },
        {
            "text": "We previously conducted a proof of principle; dose escalation study in Duchenne muscular dystrophy",
            "probability": 1.4064719401487212e-07,
            "start_logit": -7.50959587097168,
            "end_logit": -6.006912708282471
        },
        {
            "text": "proof of principle; dose escalation",
            "probability": 1.2305054695618847e-07,
            "start_logit": -6.446045875549316,
            "end_logit": -7.204122066497803
        },
        {
            "text": "plirsen",
            "probability": 1.0173341284839105e-07,
            "start_logit": -6.987405300140381,
            "end_logit": -6.853002071380615
        }
    ],
    "5324ce779b2d7acc7e00001e_001": [
        {
            "text": "pregabalin",
            "probability": 0.7227041260774819,
            "start_logit": 7.828995704650879,
            "end_logit": 6.864020824432373
        },
        {
            "text": "Pregabalin",
            "probability": 0.2759701933653031,
            "start_logit": 7.283426284790039,
            "end_logit": 6.446883201599121
        },
        {
            "text": "Oral pregabalin,",
            "probability": 0.0008568011673158649,
            "start_logit": 1.0914463996887207,
            "end_logit": 6.864020824432373
        },
        {
            "text": "p",
            "probability": 0.0003263566087583957,
            "start_logit": 7.828995704650879,
            "end_logit": -0.8387436866760254
        },
        {
            "text": "P",
            "probability": 8.617287376641125e-05,
            "start_logit": 7.283426284790039,
            "end_logit": -1.6248095035552979
        },
        {
            "text": "alin",
            "probability": 3.158027995015642e-05,
            "start_logit": -2.209226608276367,
            "end_logit": 6.864020824432373
        },
        {
            "text": "Pregabalin is, therefore, a valuable option in the first-line treatment of patients with fibromyalgia.",
            "probability": 1.590956772386399e-05,
            "start_logit": 7.283426284790039,
            "end_logit": -3.314244270324707
        },
        {
            "text": "Pregabalin: a review of its use in fibromyalgia. Oral pregabalin,",
            "probability": 2.91427811771899e-06,
            "start_logit": -4.592137336730957,
            "end_logit": 6.864020824432373
        },
        {
            "text": "pregabalin, a calcium channel alpha(2)delta-subunit ligand with analgesic,",
            "probability": 2.0779959277924544e-06,
            "start_logit": 7.828995704650879,
            "end_logit": -5.895330429077148
        },
        {
            "text": "pregabalin,",
            "probability": 1.2702037648339376e-06,
            "start_logit": 7.828995704650879,
            "end_logit": -6.387557029724121
        },
        {
            "text": "pregabalin, a calcium channel alpha(2)delta-subunit",
            "probability": 9.593754237592392e-07,
            "start_logit": 7.828995704650879,
            "end_logit": -6.668207168579102
        },
        {
            "text": "fibromyalgia. Oral pregabalin,",
            "probability": 8.128210609609879e-07,
            "start_logit": -5.869003772735596,
            "end_logit": 6.864020824432373
        },
        {
            "text": "preg",
            "probability": 8.086933506242094e-07,
            "start_logit": 7.828995704650879,
            "end_logit": -6.839069843292236
        },
        {
            "text": "Oral",
            "probability": 1.1960201047291087e-08,
            "start_logit": 1.0914463996887207,
            "end_logit": -4.3153557777404785
        },
        {
            "text": "Oral pregabalin, a calcium channel alpha(2)delta-subunit ligand with analgesic,",
            "probability": 2.463566032580402e-09,
            "start_logit": 1.0914463996887207,
            "end_logit": -5.895330429077148
        },
        {
            "text": "Oral pregabalin, a calcium channel alpha(2)delta-subunit",
            "probability": 1.137386591982653e-09,
            "start_logit": 1.0914463996887207,
            "end_logit": -6.668207168579102
        },
        {
            "text": "fibromyalgia.",
            "probability": 8.106505129931771e-10,
            "start_logit": -2.601167917251587,
            "end_logit": -3.314244270324707
        },
        {
            "text": "fibromyalgia. Pregabalin",
            "probability": 1.325414058018879e-10,
            "start_logit": -3.968337059020996,
            "end_logit": -3.758017063140869
        },
        {
            "text": "pregabalin, a calcium channel alpha(2)delta-subunit ligand with analgesic, anxiolytic",
            "probability": 1.250101932712467e-10,
            "start_logit": -2.209226608276367,
            "end_logit": -5.575627326965332
        },
        {
            "text": "with fibromyalgia.",
            "probability": 6.269906815313523e-11,
            "start_logit": -5.160658359527588,
            "end_logit": -3.314244270324707
        }
    ],
    "5324ce779b2d7acc7e00001e_002": [
        {
            "text": "pregabalin",
            "probability": 0.7227041260774819,
            "start_logit": 7.828995704650879,
            "end_logit": 6.864020824432373
        },
        {
            "text": "Pregabalin",
            "probability": 0.2759701933653031,
            "start_logit": 7.283426284790039,
            "end_logit": 6.446883201599121
        },
        {
            "text": "Oral pregabalin,",
            "probability": 0.0008568011673158649,
            "start_logit": 1.0914463996887207,
            "end_logit": 6.864020824432373
        },
        {
            "text": "p",
            "probability": 0.0003263566087583957,
            "start_logit": 7.828995704650879,
            "end_logit": -0.8387436866760254
        },
        {
            "text": "P",
            "probability": 8.617287376641125e-05,
            "start_logit": 7.283426284790039,
            "end_logit": -1.6248095035552979
        },
        {
            "text": "alin",
            "probability": 3.158027995015642e-05,
            "start_logit": -2.209226608276367,
            "end_logit": 6.864020824432373
        },
        {
            "text": "Pregabalin is, therefore, a valuable option in the first-line treatment of patients with fibromyalgia.",
            "probability": 1.590956772386399e-05,
            "start_logit": 7.283426284790039,
            "end_logit": -3.314244270324707
        },
        {
            "text": "Pregabalin: a review of its use in fibromyalgia. Oral pregabalin,",
            "probability": 2.91427811771899e-06,
            "start_logit": -4.592137336730957,
            "end_logit": 6.864020824432373
        },
        {
            "text": "pregabalin, a calcium channel alpha(2)delta-subunit ligand with analgesic,",
            "probability": 2.0779959277924544e-06,
            "start_logit": 7.828995704650879,
            "end_logit": -5.895330429077148
        },
        {
            "text": "pregabalin,",
            "probability": 1.2702037648339376e-06,
            "start_logit": 7.828995704650879,
            "end_logit": -6.387557029724121
        },
        {
            "text": "pregabalin, a calcium channel alpha(2)delta-subunit",
            "probability": 9.593754237592392e-07,
            "start_logit": 7.828995704650879,
            "end_logit": -6.668207168579102
        },
        {
            "text": "fibromyalgia. Oral pregabalin,",
            "probability": 8.128210609609879e-07,
            "start_logit": -5.869003772735596,
            "end_logit": 6.864020824432373
        },
        {
            "text": "preg",
            "probability": 8.086933506242094e-07,
            "start_logit": 7.828995704650879,
            "end_logit": -6.839069843292236
        },
        {
            "text": "Oral",
            "probability": 1.1960201047291087e-08,
            "start_logit": 1.0914463996887207,
            "end_logit": -4.3153557777404785
        },
        {
            "text": "Oral pregabalin, a calcium channel alpha(2)delta-subunit ligand with analgesic,",
            "probability": 2.463566032580402e-09,
            "start_logit": 1.0914463996887207,
            "end_logit": -5.895330429077148
        },
        {
            "text": "Oral pregabalin, a calcium channel alpha(2)delta-subunit",
            "probability": 1.137386591982653e-09,
            "start_logit": 1.0914463996887207,
            "end_logit": -6.668207168579102
        },
        {
            "text": "fibromyalgia.",
            "probability": 8.106505129931771e-10,
            "start_logit": -2.601167917251587,
            "end_logit": -3.314244270324707
        },
        {
            "text": "fibromyalgia. Pregabalin",
            "probability": 1.325414058018879e-10,
            "start_logit": -3.968337059020996,
            "end_logit": -3.758017063140869
        },
        {
            "text": "pregabalin, a calcium channel alpha(2)delta-subunit ligand with analgesic, anxiolytic",
            "probability": 1.250101932712467e-10,
            "start_logit": -2.209226608276367,
            "end_logit": -5.575627326965332
        },
        {
            "text": "with fibromyalgia.",
            "probability": 6.269906815313523e-11,
            "start_logit": -5.160658359527588,
            "end_logit": -3.314244270324707
        }
    ],
    "56c3184050c68dd416000003_001": [
        {
            "text": "essential hypertension",
            "probability": 0.8467777303185308,
            "start_logit": -1.1116750240325928,
            "end_logit": -2.4144327640533447
        },
        {
            "text": "hypertension",
            "probability": 0.08200190053428016,
            "start_logit": -3.446370840072632,
            "end_logit": -2.4144327640533447
        },
        {
            "text": "antihypertensive",
            "probability": 0.020054182448643636,
            "start_logit": -3.9534103870391846,
            "end_logit": -3.3156979084014893
        },
        {
            "text": "with essential hypertension",
            "probability": 0.012439198495865094,
            "start_logit": -5.332260608673096,
            "end_logit": -2.4144327640533447
        },
        {
            "text": "essential",
            "probability": 0.006724047522085264,
            "start_logit": -1.1116750240325928,
            "end_logit": -7.250180721282959
        },
        {
            "text": "3 years to patients with essential hypertension",
            "probability": 0.005314370347286085,
            "start_logit": -6.182698726654053,
            "end_logit": -2.4144327640533447
        },
        {
            "text": "plasma lipids. These are the preliminary data of an open multicenter trial of antihypertensive",
            "probability": 0.0052292575508859455,
            "start_logit": -5.297578811645508,
            "end_logit": -3.3156979084014893
        },
        {
            "text": "essential hypertension (WHO classification I or II).",
            "probability": 0.005099521265451123,
            "start_logit": -1.1116750240325928,
            "end_logit": -7.526724338531494
        },
        {
            "text": "effects on blood pressure and plasma lipids. These are the preliminary data of an open multicenter trial of antihypertensive",
            "probability": 0.004457544267459288,
            "start_logit": -5.457250118255615,
            "end_logit": -3.3156979084014893
        },
        {
            "text": "blood pressure and plasma lipids. These are the preliminary data of an open multicenter trial of antihypertensive",
            "probability": 0.002186361121068929,
            "start_logit": -6.169609546661377,
            "end_logit": -3.3156979084014893
        },
        {
            "text": "hyperlipidemia or NIDDM.",
            "probability": 0.00218123524482339,
            "start_logit": -3.5169878005981445,
            "end_logit": -5.970666885375977
        },
        {
            "text": "preliminary data of an open multicenter trial of antihypertensive",
            "probability": 0.0020211830117168672,
            "start_logit": -6.248165130615234,
            "end_logit": -3.3156979084014893
        },
        {
            "text": "ypertensive",
            "probability": 0.0018884548720127417,
            "start_logit": -6.316089153289795,
            "end_logit": -3.3156979084014893
        },
        {
            "text": "hyperlipidemia",
            "probability": 0.001151546682609528,
            "start_logit": -3.5169878005981445,
            "end_logit": -6.609452247619629
        },
        {
            "text": "hypert",
            "probability": 0.0007105518632948262,
            "start_logit": -3.446370840072632,
            "end_logit": -7.162888526916504
        },
        {
            "text": "hypertension (WHO classification I or II).",
            "probability": 0.0004938373089059241,
            "start_logit": -3.446370840072632,
            "end_logit": -7.526724338531494
        },
        {
            "text": "antihypert",
            "probability": 0.0003805447027127225,
            "start_logit": -3.9534103870391846,
            "end_logit": -7.280287265777588
        },
        {
            "text": "with either hyperlipidemia or NIDDM.",
            "probability": 0.00037272574455897504,
            "start_logit": -5.283791542053223,
            "end_logit": -5.970666885375977
        },
        {
            "text": "NIDDM.",
            "probability": 0.00029800163240634354,
            "start_logit": -5.507535457611084,
            "end_logit": -5.970666885375977
        },
        {
            "text": "hypertensive patients with either hyperlipidemia or NIDDM.",
            "probability": 0.00021780506540211735,
            "start_logit": -5.821033954620361,
            "end_logit": -5.970666885375977
        }
    ],
    "56c3184050c68dd416000003_002": [
        {
            "text": "antihypertensive",
            "probability": 0.9683117574790385,
            "start_logit": 0.6086745858192444,
            "end_logit": 0.44856351613998413
        },
        {
            "text": "antihypertensive drug in blacks with essential hypertension,",
            "probability": 0.01713539257961499,
            "start_logit": 0.6086745858192444,
            "end_logit": -3.5858445167541504
        },
        {
            "text": "Isradipine monotherapy was an effective antihypertensive",
            "probability": 0.003394657025249038,
            "start_logit": -5.044676780700684,
            "end_logit": 0.44856351613998413
        },
        {
            "text": "antihypertensive drug in blacks with essential hypertension, resulting in regression",
            "probability": 0.0023031378100432766,
            "start_logit": 0.6086745858192444,
            "end_logit": -5.592718124389648
        },
        {
            "text": "ensive",
            "probability": 0.0012873064176460265,
            "start_logit": -6.014327526092529,
            "end_logit": 0.44856351613998413
        },
        {
            "text": "antihypert",
            "probability": 0.0010325274953283936,
            "start_logit": 0.6086745858192444,
            "end_logit": -6.3949809074401855
        },
        {
            "text": "was an effective antihypertensive",
            "probability": 0.000909311511571119,
            "start_logit": -6.361947059631348,
            "end_logit": 0.44856351613998413
        },
        {
            "text": "pertensive",
            "probability": 0.0008652041907946783,
            "start_logit": -6.4116692543029785,
            "end_logit": 0.44856351613998413
        },
        {
            "text": "ypertensive",
            "probability": 0.0007268926690782036,
            "start_logit": -6.585855960845947,
            "end_logit": 0.44856351613998413
        },
        {
            "text": "ihypertensive",
            "probability": 0.0007206728373707359,
            "start_logit": -6.594449520111084,
            "end_logit": 0.44856351613998413
        },
        {
            "text": "antihypertensive drug in blacks with essential hypertension, resulting in regression of left ventricular wall thickness and mass",
            "probability": 0.0006860938461113944,
            "start_logit": 0.6086745858192444,
            "end_logit": -6.803731441497803
        },
        {
            "text": "effective antihypertensive",
            "probability": 0.0006500744400601696,
            "start_logit": -6.697547912597656,
            "end_logit": 0.44856351613998413
        },
        {
            "text": "antihy",
            "probability": 0.00048574333506215946,
            "start_logit": 0.6086745858192444,
            "end_logit": -7.1490654945373535
        },
        {
            "text": "ant",
            "probability": 0.00043471941944316024,
            "start_logit": 0.6086745858192444,
            "end_logit": -7.260045051574707
        },
        {
            "text": "antih",
            "probability": 0.00038591013483810194,
            "start_logit": 0.6086745858192444,
            "end_logit": -7.379141330718994
        },
        {
            "text": "hypertension,",
            "probability": 0.00034384871303116694,
            "start_logit": -3.30002498626709,
            "end_logit": -3.5858445167541504
        },
        {
            "text": "essential hypertension,",
            "probability": 0.00016293568850499294,
            "start_logit": -4.046871185302734,
            "end_logit": -3.5858445167541504
        },
        {
            "text": "Isradipine monotherapy was an effective antihypertensive drug in blacks with essential hypertension,",
            "probability": 6.007236858533081e-05,
            "start_logit": -5.044676780700684,
            "end_logit": -3.5858445167541504
        },
        {
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening",
            "probability": 5.752594125940674e-05,
            "start_logit": -3.30002498626709,
            "end_logit": -5.373810291290283
        },
        {
            "text": "hypertension, resulting in regression",
            "probability": 4.621609736907437e-05,
            "start_logit": -3.30002498626709,
            "end_logit": -5.592718124389648
        }
    ],
    "56c3184050c68dd416000003_003": [
        {
            "text": "essential hypertension",
            "probability": 0.8467777303185308,
            "start_logit": -1.1116750240325928,
            "end_logit": -2.4144327640533447
        },
        {
            "text": "hypertension",
            "probability": 0.08200190053428016,
            "start_logit": -3.446370840072632,
            "end_logit": -2.4144327640533447
        },
        {
            "text": "antihypertensive",
            "probability": 0.020054182448643636,
            "start_logit": -3.9534103870391846,
            "end_logit": -3.3156979084014893
        },
        {
            "text": "with essential hypertension",
            "probability": 0.012439198495865094,
            "start_logit": -5.332260608673096,
            "end_logit": -2.4144327640533447
        },
        {
            "text": "essential",
            "probability": 0.006724047522085264,
            "start_logit": -1.1116750240325928,
            "end_logit": -7.250180721282959
        },
        {
            "text": "3 years to patients with essential hypertension",
            "probability": 0.005314370347286085,
            "start_logit": -6.182698726654053,
            "end_logit": -2.4144327640533447
        },
        {
            "text": "plasma lipids. These are the preliminary data of an open multicenter trial of antihypertensive",
            "probability": 0.0052292575508859455,
            "start_logit": -5.297578811645508,
            "end_logit": -3.3156979084014893
        },
        {
            "text": "essential hypertension (WHO classification I or II).",
            "probability": 0.005099521265451123,
            "start_logit": -1.1116750240325928,
            "end_logit": -7.526724338531494
        },
        {
            "text": "effects on blood pressure and plasma lipids. These are the preliminary data of an open multicenter trial of antihypertensive",
            "probability": 0.004457544267459288,
            "start_logit": -5.457250118255615,
            "end_logit": -3.3156979084014893
        },
        {
            "text": "blood pressure and plasma lipids. These are the preliminary data of an open multicenter trial of antihypertensive",
            "probability": 0.002186361121068929,
            "start_logit": -6.169609546661377,
            "end_logit": -3.3156979084014893
        },
        {
            "text": "hyperlipidemia or NIDDM.",
            "probability": 0.00218123524482339,
            "start_logit": -3.5169878005981445,
            "end_logit": -5.970666885375977
        },
        {
            "text": "preliminary data of an open multicenter trial of antihypertensive",
            "probability": 0.0020211830117168672,
            "start_logit": -6.248165130615234,
            "end_logit": -3.3156979084014893
        },
        {
            "text": "ypertensive",
            "probability": 0.0018884548720127417,
            "start_logit": -6.316089153289795,
            "end_logit": -3.3156979084014893
        },
        {
            "text": "hyperlipidemia",
            "probability": 0.001151546682609528,
            "start_logit": -3.5169878005981445,
            "end_logit": -6.609452247619629
        },
        {
            "text": "hypert",
            "probability": 0.0007105518632948262,
            "start_logit": -3.446370840072632,
            "end_logit": -7.162888526916504
        },
        {
            "text": "hypertension (WHO classification I or II).",
            "probability": 0.0004938373089059241,
            "start_logit": -3.446370840072632,
            "end_logit": -7.526724338531494
        },
        {
            "text": "antihypert",
            "probability": 0.0003805447027127225,
            "start_logit": -3.9534103870391846,
            "end_logit": -7.280287265777588
        },
        {
            "text": "with either hyperlipidemia or NIDDM.",
            "probability": 0.00037272574455897504,
            "start_logit": -5.283791542053223,
            "end_logit": -5.970666885375977
        },
        {
            "text": "NIDDM.",
            "probability": 0.00029800163240634354,
            "start_logit": -5.507535457611084,
            "end_logit": -5.970666885375977
        },
        {
            "text": "hypertensive patients with either hyperlipidemia or NIDDM.",
            "probability": 0.00021780506540211735,
            "start_logit": -5.821033954620361,
            "end_logit": -5.970666885375977
        }
    ],
    "56c3184050c68dd416000003_004": [
        {
            "text": "hypertension",
            "probability": 0.9035228379913516,
            "start_logit": -0.15045510232448578,
            "end_logit": 0.29703211784362793
        },
        {
            "text": "antihypertensive effect of isradipine was studied in 45 patients with mild-to-moderate hypertension",
            "probability": 0.03017978528904149,
            "start_logit": -3.549584150314331,
            "end_logit": 0.29703211784362793
        },
        {
            "text": "mild-to-moderate hypertension",
            "probability": 0.024672931012972847,
            "start_logit": -3.751049757003784,
            "end_logit": 0.29703211784362793
        },
        {
            "text": "The antihypertensive effect of isradipine was studied in 45 patients with mild-to-moderate hypertension",
            "probability": 0.019575500783030254,
            "start_logit": -3.9824776649475098,
            "end_logit": 0.29703211784362793
        },
        {
            "text": "with mild-to-moderate hypertension",
            "probability": 0.007811389786755943,
            "start_logit": -4.9011735916137695,
            "end_logit": 0.29703211784362793
        },
        {
            "text": "45 patients with mild-to-moderate hypertension",
            "probability": 0.002920430357224677,
            "start_logit": -5.885025501251221,
            "end_logit": 0.29703211784362793
        },
        {
            "text": "ension",
            "probability": 0.0025509531361156777,
            "start_logit": -6.020289421081543,
            "end_logit": 0.29703211784362793
        },
        {
            "text": "hypert",
            "probability": 0.0017126658959056918,
            "start_logit": -0.15045510232448578,
            "end_logit": -5.971218109130859
        },
        {
            "text": "effect of isradipine was studied in 45 patients with mild-to-moderate hypertension",
            "probability": 0.0015865457887945722,
            "start_logit": -6.495197296142578,
            "end_logit": 0.29703211784362793
        },
        {
            "text": "studied in 45 patients with mild-to-moderate hypertension",
            "probability": 0.0013137657317431582,
            "start_logit": -6.683858871459961,
            "end_logit": 0.29703211784362793
        },
        {
            "text": "pertension",
            "probability": 0.0012573234393957735,
            "start_logit": -6.727771282196045,
            "end_logit": 0.29703211784362793
        },
        {
            "text": "hypertension (mean age 59 years)",
            "probability": 0.0006510982283094327,
            "start_logit": -0.15045510232448578,
            "end_logit": -6.938364028930664
        },
        {
            "text": "antihypertensive",
            "probability": 0.0006062017031679426,
            "start_logit": -3.549584150314331,
            "end_logit": -3.610682725906372
        },
        {
            "text": "The antihypertensive",
            "probability": 0.00039320034259313384,
            "start_logit": -3.9824776649475098,
            "end_logit": -3.610682725906372
        },
        {
            "text": "hy",
            "probability": 0.0003353750234690497,
            "start_logit": -0.15045510232448578,
            "end_logit": -7.601775169372559
        },
        {
            "text": "hypertension (mean age 59 years) using casual and ambulatory 24-h blood pressure",
            "probability": 0.00031098690270127096,
            "start_logit": -0.15045510232448578,
            "end_logit": -7.677273750305176
        },
        {
            "text": "hypertension (mean",
            "probability": 0.0002764467655914993,
            "start_logit": -0.15045510232448578,
            "end_logit": -7.795006275177002
        },
        {
            "text": "hypertension (mean age 59",
            "probability": 0.00019364238489371765,
            "start_logit": -0.15045510232448578,
            "end_logit": -8.15101146697998
        },
        {
            "text": "antihypertensive effect of isradipine was studied in 45 patients with mild-to-moderate",
            "probability": 6.77962092577286e-05,
            "start_logit": -3.549584150314331,
            "end_logit": -5.801389217376709
        },
        {
            "text": "antihypertensive effect of isradipine was studied in 45",
            "probability": 6.112322768453075e-05,
            "start_logit": -3.549584150314331,
            "end_logit": -5.905003547668457
        }
    ],
    "56c3184050c68dd416000003_005": [
        {
            "text": "Antihypertensive",
            "probability": 0.7124550967231175,
            "start_logit": -2.899944543838501,
            "end_logit": -1.0018621683120728
        },
        {
            "text": "antihypertensive",
            "probability": 0.19848732328128033,
            "start_logit": -2.7195885181427,
            "end_logit": -2.460209846496582
        },
        {
            "text": "ihypertensive",
            "probability": 0.019943444545277335,
            "start_logit": -6.4757609367370605,
            "end_logit": -1.0018621683120728
        },
        {
            "text": "[Long-term antihypertensive",
            "probability": 0.01818123310666958,
            "start_logit": -5.109923839569092,
            "end_logit": -2.460209846496582
        },
        {
            "text": "ensive",
            "probability": 0.014747464313252957,
            "start_logit": -6.777590274810791,
            "end_logit": -1.0018621683120728
        },
        {
            "text": "antihypertensive therapy with isradipine.",
            "probability": 0.013953245745238574,
            "start_logit": -2.7195885181427,
            "end_logit": -5.115222930908203
        },
        {
            "text": "antihypertensive therapy",
            "probability": 0.005689732307615069,
            "start_logit": -2.7195885181427,
            "end_logit": -6.012271881103516
        },
        {
            "text": "pertensive",
            "probability": 0.0039312850036383965,
            "start_logit": -6.641347408294678,
            "end_logit": -2.460209846496582
        },
        {
            "text": "Antihypertensive Long-term Therapy with Isradipine/Improvement",
            "probability": 0.0033429475481375494,
            "start_logit": -2.899944543838501,
            "end_logit": -6.3637261390686035
        },
        {
            "text": "Antihypertensive Long-term Therapy",
            "probability": 0.0017006039495009511,
            "start_logit": -2.899944543838501,
            "end_logit": -7.039595603942871
        },
        {
            "text": "[Long-term antihypertensive therapy with isradipine.",
            "probability": 0.0012781028495674903,
            "start_logit": -5.109923839569092,
            "end_logit": -5.115222930908203
        },
        {
            "text": "Antihypert",
            "probability": 0.0011195501628841426,
            "start_logit": -2.899944543838501,
            "end_logit": -7.4576520919799805
        },
        {
            "text": "Antih",
            "probability": 0.0010459845508749668,
            "start_logit": -2.899944543838501,
            "end_logit": -7.525620460510254
        },
        {
            "text": "Antihypertensive Long-term",
            "probability": 0.0010158489464209153,
            "start_logit": -2.899944543838501,
            "end_logit": -7.554854393005371
        },
        {
            "text": "Antihypertensive Long-term Therapy with Isradipine/Improvement of coronary flow reserve",
            "probability": 0.0008241621529476072,
            "start_logit": -2.899944543838501,
            "end_logit": -7.763967037200928
        },
        {
            "text": "Antihy",
            "probability": 0.0007973352866130774,
            "start_logit": -2.899944543838501,
            "end_logit": -7.797059059143066
        },
        {
            "text": "[Long-term antihypertensive therapy",
            "probability": 0.0005211735827214654,
            "start_logit": -5.109923839569092,
            "end_logit": -6.012271881103516
        },
        {
            "text": "Long-term Therapy with Isradipine/Improvement",
            "probability": 0.00040975965783394334,
            "start_logit": -4.998981952667236,
            "end_logit": -6.3637261390686035
        },
        {
            "text": "with isradipine.",
            "probability": 0.0002782298802876604,
            "start_logit": -6.634608268737793,
            "end_logit": -5.115222930908203
        },
        {
            "text": "Isradipine/Improvement of coronary flow reserve in patients with arterial and microvascular angina",
            "probability": 0.00027747640612027985,
            "start_logit": -5.920731067657471,
            "end_logit": -5.831811904907227
        }
    ],
    "56c3184050c68dd416000003_006": [
        {
            "text": "hypertension",
            "probability": 0.14482385042140125,
            "start_logit": -6.870082378387451,
            "end_logit": -6.400177955627441
        },
        {
            "text": "pertension",
            "probability": 0.1063095968958536,
            "start_logit": -7.1792449951171875,
            "end_logit": -6.400177955627441
        },
        {
            "text": "[Isradipine in arterial hypertension",
            "probability": 0.09216799354435583,
            "start_logit": -7.321987628936768,
            "end_logit": -6.400177955627441
        },
        {
            "text": "arterial hypertension",
            "probability": 0.08163829089654948,
            "start_logit": -7.443302154541016,
            "end_logit": -6.400177955627441
        },
        {
            "text": "hypertension in motor vehicle drivers].",
            "probability": 0.072627254793628,
            "start_logit": -6.870082378387451,
            "end_logit": -7.09035587310791
        },
        {
            "text": "[Isradipine",
            "probability": 0.06343621146191226,
            "start_logit": -7.321987628936768,
            "end_logit": -6.77375602722168
        },
        {
            "text": "Isradipine",
            "probability": 0.047723371563617514,
            "start_logit": -7.606601238250732,
            "end_logit": -6.77375602722168
        },
        {
            "text": "and safe method correcting arterial hypertension",
            "probability": 0.046721586042899436,
            "start_logit": -7.398022651672363,
            "end_logit": -7.003549575805664
        },
        {
            "text": "[Isradipine in arterial hypertension in motor vehicle drivers].",
            "probability": 0.04622103563388067,
            "start_logit": -7.321987628936768,
            "end_logit": -7.09035587310791
        },
        {
            "text": "Isradipine (Lomir) as effective and safe method correcting arterial hypertension",
            "probability": 0.04313725821208144,
            "start_logit": -7.477841854095459,
            "end_logit": -7.003549575805664
        },
        {
            "text": "arterial hypertension in motor vehicle drivers].",
            "probability": 0.04094052834949237,
            "start_logit": -7.443302154541016,
            "end_logit": -7.09035587310791
        },
        {
            "text": "correcting arterial hypertension",
            "probability": 0.039156007317966084,
            "start_logit": -7.5746750831604,
            "end_logit": -7.003549575805664
        },
        {
            "text": "hypertension in motor vehicle drivers]. The study covered influence of Isradipine",
            "probability": 0.026329171819712813,
            "start_logit": -6.870082378387451,
            "end_logit": -8.105018615722656
        },
        {
            "text": "hypertension in motor vehicle drivers]. The study covered influence of Isradipine (2.5 mg administered twice daily",
            "probability": 0.02603811669842374,
            "start_logit": -6.870082378387451,
            "end_logit": -8.116134643554688
        },
        {
            "text": "hypertension in motor vehicle",
            "probability": 0.023665303793667315,
            "start_logit": -6.870082378387451,
            "end_logit": -8.211686134338379
        },
        {
            "text": "hypertension in",
            "probability": 0.021446802191734806,
            "start_logit": -6.870082378387451,
            "end_logit": -8.310120582580566
        },
        {
            "text": "(AH).",
            "probability": 0.019927300075496205,
            "start_logit": -6.842399597167969,
            "end_logit": -8.411288261413574
        },
        {
            "text": "hypertension in motor vehicle drivers]. The study covered influence of Isradipine (2.5 mg administered twice",
            "probability": 0.019400532470331907,
            "start_logit": -6.870082378387451,
            "end_logit": -8.410395622253418
        },
        {
            "text": "influence of Isradipine",
            "probability": 0.019251300399577963,
            "start_logit": -7.183181285858154,
            "end_logit": -8.105018615722656
        },
        {
            "text": "influence of Isradipine (2.5 mg administered twice daily",
            "probability": 0.019038487417417378,
            "start_logit": -7.183181285858154,
            "end_logit": -8.116134643554688
        }
    ],
    "56c3184050c68dd416000003_007": [
        {
            "text": "Hypertension",
            "probability": 0.5200831305258304,
            "start_logit": -2.4445621967315674,
            "end_logit": -1.4399539232254028
        },
        {
            "text": "Isradipine Hypertension",
            "probability": 0.3114072883264754,
            "start_logit": -2.957449197769165,
            "end_logit": -1.4399539232254028
        },
        {
            "text": "Isradipine",
            "probability": 0.038136214572744874,
            "start_logit": -2.957449197769165,
            "end_logit": -3.539891242980957
        },
        {
            "text": "British Isradipine Hypertension",
            "probability": 0.03513053684898315,
            "start_logit": -5.139480113983154,
            "end_logit": -1.4399539232254028
        },
        {
            "text": "The British Isradipine Hypertension",
            "probability": 0.014084951433677707,
            "start_logit": -6.053443908691406,
            "end_logit": -1.4399539232254028
        },
        {
            "text": "essential hypertension. The British Isradipine Hypertension",
            "probability": 0.011070196581756526,
            "start_logit": -6.294294357299805,
            "end_logit": -1.4399539232254028
        },
        {
            "text": "hypertension",
            "probability": 0.009230528814347896,
            "start_logit": -4.5521039962768555,
            "end_logit": -3.363884449005127
        },
        {
            "text": "Hypert",
            "probability": 0.00902972567366484,
            "start_logit": -2.4445621967315674,
            "end_logit": -5.493420600891113
        },
        {
            "text": "Hypertension Group. One hundred eighteen patients, aged between 65 and 87 years with mild-to-moderate hypertension",
            "probability": 0.00788647940614898,
            "start_logit": -2.4445621967315674,
            "end_logit": -5.628792762756348
        },
        {
            "text": "hypertension. The British Isradipine Hypertension",
            "probability": 0.007719348296246985,
            "start_logit": -6.654820919036865,
            "end_logit": -1.4399539232254028
        },
        {
            "text": "ension",
            "probability": 0.007129973152428104,
            "start_logit": -6.734243392944336,
            "end_logit": -1.4399539232254028
        },
        {
            "text": "isradipine",
            "probability": 0.004980459706591119,
            "start_logit": -3.636523485183716,
            "end_logit": -4.896459102630615
        },
        {
            "text": "Hypertension Group. One hundred eighteen patients, aged between 65 and 87 years with mild-to-moderate",
            "probability": 0.004767826991127215,
            "start_logit": -2.4445621967315674,
            "end_logit": -6.132051944732666
        },
        {
            "text": "British Isradipine",
            "probability": 0.004302229721495696,
            "start_logit": -5.139480113983154,
            "end_logit": -3.539891242980957
        },
        {
            "text": "for mild-to-moderate hypertension",
            "probability": 0.004190052701431937,
            "start_logit": -5.341907024383545,
            "end_logit": -3.363884449005127
        },
        {
            "text": "Hypertension Group.",
            "probability": 0.0029475045137364654,
            "start_logit": -2.4445621967315674,
            "end_logit": -6.612983703613281
        },
        {
            "text": "Isradipine Hypertension Group. One hundred eighteen patients, aged between 65 and 87 years with mild-to-moderate",
            "probability": 0.0028548052943296984,
            "start_logit": -2.957449197769165,
            "end_logit": -6.132051944732666
        },
        {
            "text": "Isradipine Hypertension Group.",
            "probability": 0.0017648609118021215,
            "start_logit": -2.957449197769165,
            "end_logit": -6.612983703613281
        },
        {
            "text": "The British Isradipine",
            "probability": 0.0017249009585102771,
            "start_logit": -6.053443908691406,
            "end_logit": -3.539891242980957
        },
        {
            "text": "mild-to-moderate hypertension",
            "probability": 0.0015589855686704835,
            "start_logit": -6.33058500289917,
            "end_logit": -3.363884449005127
        }
    ],
    "56c3184050c68dd416000003_008": [
        {
            "text": "Hypertension",
            "probability": 0.8054575252055399,
            "start_logit": 2.3090786933898926,
            "end_logit": 1.5678658485412598
        },
        {
            "text": "Hypertension Study Group. A total of 152 patients with essential hypertension",
            "probability": 0.1680115622480634,
            "start_logit": 2.3090786933898926,
            "end_logit": 0.00048817822244018316
        },
        {
            "text": "essential hypertension",
            "probability": 0.01719102809250838,
            "start_logit": 0.029433518648147583,
            "end_logit": 0.00048817822244018316
        },
        {
            "text": "Hypert",
            "probability": 0.0035103986411904224,
            "start_logit": 2.3090786933898926,
            "end_logit": -3.8678150177001953
        },
        {
            "text": "hypertension",
            "probability": 0.001362009871590149,
            "start_logit": -2.5059926509857178,
            "end_logit": 0.00048817822244018316
        },
        {
            "text": "ension",
            "probability": 0.0007896984756179464,
            "start_logit": -4.618435859680176,
            "end_logit": 1.5678658485412598
        },
        {
            "text": "Hy",
            "probability": 0.0007394444542488575,
            "start_logit": 2.3090786933898926,
            "end_logit": -5.425400733947754
        },
        {
            "text": "Isradipine in Hypertension",
            "probability": 0.000508747116803048,
            "start_logit": -5.058135986328125,
            "end_logit": 1.5678658485412598
        },
        {
            "text": "Hypertension Study",
            "probability": 0.0004372385721613173,
            "start_logit": 2.3090786933898926,
            "end_logit": -5.9508209228515625
        },
        {
            "text": "in Hypertension",
            "probability": 0.00042940136641990114,
            "start_logit": -5.227694988250732,
            "end_logit": 1.5678658485412598
        },
        {
            "text": "Hypertension Study Group. A total of 152 patients with essential",
            "probability": 0.0003190432934034123,
            "start_logit": 2.3090786933898926,
            "end_logit": -6.265973091125488
        },
        {
            "text": "Hypertension Study Group. A total of 152 patients with essential hypertension (World Health Organization classification I/II)",
            "probability": 0.00023243466735370548,
            "start_logit": 2.3090786933898926,
            "end_logit": -6.582690715789795
        },
        {
            "text": "Hypertension Study Group.",
            "probability": 0.00021410587732989447,
            "start_logit": 2.3090786933898926,
            "end_logit": -6.664829254150391
        },
        {
            "text": "pertension",
            "probability": 0.00016257789961827762,
            "start_logit": -6.198929786682129,
            "end_logit": 1.5678658485412598
        },
        {
            "text": "hypertension. Isradipine in Hypertension",
            "probability": 0.00014849539053254687,
            "start_logit": -6.2895331382751465,
            "end_logit": 1.5678658485412598
        },
        {
            "text": "Hypertension Study Group. A total of 152 patients with essential hypertension (World Health Organization",
            "probability": 0.0001090284890410456,
            "start_logit": 2.3090786933898926,
            "end_logit": -7.339690685272217
        },
        {
            "text": "Isradipine in Hypertension Study Group. A total of 152 patients with essential hypertension",
            "probability": 0.00010612030455791709,
            "start_logit": -5.058135986328125,
            "end_logit": 0.00048817822244018316
        },
        {
            "text": "Hypertension Study Group. A total of 152 patients with essential hypertension (World Health Organization classification",
            "probability": 0.00010311122919539511,
            "start_logit": 2.3090786933898926,
            "end_logit": -7.395491600036621
        },
        {
            "text": "in Hypertension Study Group. A total of 152 patients with essential hypertension",
            "probability": 8.956945853259065e-05,
            "start_logit": -5.227694988250732,
            "end_logit": 0.00048817822244018316
        },
        {
            "text": "Hypertension Study Group. A total of 152 patients with essential hypertension (World",
            "probability": 7.845934629216594e-05,
            "start_logit": 2.3090786933898926,
            "end_logit": -7.668719291687012
        }
    ],
    "56c3184050c68dd416000003_012": [
        {
            "text": "antagonist",
            "probability": 0.26011419115674256,
            "start_logit": -3.2478737831115723,
            "end_logit": -2.607333183288574
        },
        {
            "text": "collagen.",
            "probability": 0.20888360611665227,
            "start_logit": -4.694095611572266,
            "end_logit": -1.3804548978805542
        },
        {
            "text": "caused by isradipine, a dihydropyridine-derivative calcium antagonist.",
            "probability": 0.14240279573119413,
            "start_logit": -3.27773380279541,
            "end_logit": -3.17993426322937
        },
        {
            "text": "type I collagen.",
            "probability": 0.09480639180511286,
            "start_logit": -5.484035968780518,
            "end_logit": -1.3804548978805542
        },
        {
            "text": "Ca superset 2+ antagonist",
            "probability": 0.05071762925402609,
            "start_logit": -4.882720947265625,
            "end_logit": -2.607333183288574
        },
        {
            "text": "isradipine, a Ca superset 2+ antagonist",
            "probability": 0.04339956347090895,
            "start_logit": -5.03854513168335,
            "end_logit": -2.607333183288574
        },
        {
            "text": "bFGF in the culture medium. The same concentration, also significantly enhanced the production of type I collagen.",
            "probability": 0.033985082733864885,
            "start_logit": -6.509951114654541,
            "end_logit": -1.3804548978805542
        },
        {
            "text": "calcium antagonist. As it was reported earlier that isradipine, a Ca superset 2+ antagonist",
            "probability": 0.032891926293994386,
            "start_logit": -5.315767288208008,
            "end_logit": -2.607333183288574
        },
        {
            "text": "antagonist. As it was reported earlier that isradipine, a Ca superset 2+ antagonist",
            "probability": 0.02912794795001616,
            "start_logit": -5.437296390533447,
            "end_logit": -2.607333183288574
        },
        {
            "text": "calcium antagonist.",
            "probability": 0.01855290065398984,
            "start_logit": -5.315767288208008,
            "end_logit": -3.17993426322937
        },
        {
            "text": "fibroblasts caused by isradipine, a dihydropyridine-derivative calcium antagonist.",
            "probability": 0.017359266156250462,
            "start_logit": -5.382266998291016,
            "end_logit": -3.17993426322937
        },
        {
            "text": "antagonist.",
            "probability": 0.016429804680363393,
            "start_logit": -5.437296390533447,
            "end_logit": -3.17993426322937
        },
        {
            "text": "production of type I collagen.",
            "probability": 0.008502925552305423,
            "start_logit": -7.895462512969971,
            "end_logit": -1.3804548978805542
        },
        {
            "text": "a Ca superset 2+ antagonist",
            "probability": 0.007561399193151152,
            "start_logit": -6.785938262939453,
            "end_logit": -2.607333183288574
        },
        {
            "text": "As it was reported earlier that isradipine, a Ca superset 2+ antagonist",
            "probability": 0.0073590608555842004,
            "start_logit": -6.8130621910095215,
            "end_logit": -2.607333183288574
        },
        {
            "text": "antagonist of dihydropyridine derivative class, caused regression of nifedipine-induced hyperplasia",
            "probability": 0.0061960877635587035,
            "start_logit": -3.2478737831115723,
            "end_logit": -6.344535827636719
        },
        {
            "text": "caused",
            "probability": 0.005639695132119666,
            "start_logit": -3.27773380279541,
            "end_logit": -6.408763885498047
        },
        {
            "text": "antagonist of dihydropyridine derivative class, caused regression",
            "probability": 0.0054510156885152535,
            "start_logit": -3.2478737831115723,
            "end_logit": -6.472651958465576
        },
        {
            "text": "Proliferation",
            "probability": 0.0053444633449455025,
            "start_logit": -3.9937689304351807,
            "end_logit": -5.746497631072998
        },
        {
            "text": "caused by isradipine, a dihydropyridine-derivative calcium",
            "probability": 0.005274246466704073,
            "start_logit": -3.27773380279541,
            "end_logit": -6.475758075714111
        }
    ],
    "530cf4c54a5037880c000008_001": [
        {
            "text": "ibrutinib",
            "probability": 0.9996075343497758,
            "start_logit": 8.446104049682617,
            "end_logit": 7.731679439544678
        },
        {
            "text": "ibr",
            "probability": 0.0002690022404648134,
            "start_logit": 8.446104049682617,
            "end_logit": -0.4887188673019409
        },
        {
            "text": "ib",
            "probability": 0.0001092488243921731,
            "start_logit": -0.6753858923912048,
            "end_logit": 7.731679439544678
        },
        {
            "text": "ibrutin",
            "probability": 4.4332906573484895e-06,
            "start_logit": 8.339574813842773,
            "end_logit": -4.487767219543457
        },
        {
            "text": "inib",
            "probability": 3.2316717121853336e-06,
            "start_logit": -4.079808235168457,
            "end_logit": 7.61547327041626
        },
        {
            "text": "BTK kinase activity through either targeted genetic inactivation or ibrutinib",
            "probability": 3.046011804490622e-06,
            "start_logit": -4.255180835723877,
            "end_logit": 7.731679439544678
        },
        {
            "text": "ibrut",
            "probability": 1.9540374819192063e-06,
            "start_logit": 8.446104049682617,
            "end_logit": -5.413540840148926
        },
        {
            "text": "Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib",
            "probability": 5.098040903710886e-07,
            "start_logit": -6.042742729187012,
            "end_logit": 7.731679439544678
        },
        {
            "text": "BTK kinase activity is an important target of ibrutinib",
            "probability": 3.880739945694689e-07,
            "start_logit": -6.09577751159668,
            "end_logit": 7.511883735656738
        },
        {
            "text": "by ibrutinib,",
            "probability": 3.269706284144062e-07,
            "start_logit": -6.329305171966553,
            "end_logit": 7.574085712432861
        },
        {
            "text": "of ibrutinib.",
            "probability": 3.246926228926695e-07,
            "start_logit": -6.377684116363525,
            "end_logit": 7.61547327041626
        },
        {
            "text": "in",
            "probability": 1.790839557284845e-11,
            "start_logit": -4.079808235168457,
            "end_logit": -4.487767219543457
        },
        {
            "text": "BTK",
            "probability": 1.1323344943105192e-11,
            "start_logit": -4.255180835723877,
            "end_logit": -4.7707977294921875
        },
        {
            "text": "Inhibition of BTK",
            "probability": 1.8951625729642116e-12,
            "start_logit": -6.042742729187012,
            "end_logit": -4.7707977294921875
        },
        {
            "text": "Bruton's tyrosine kinase",
            "probability": 1.247954273391537e-12,
            "start_logit": -5.182845115661621,
            "end_logit": -6.048494338989258
        }
    ],
    "530cf4c54a5037880c000008_002": [
        {
            "text": "ibrutinib",
            "probability": 0.9996075343497758,
            "start_logit": 8.446104049682617,
            "end_logit": 7.731679439544678
        },
        {
            "text": "ibr",
            "probability": 0.0002690022404648134,
            "start_logit": 8.446104049682617,
            "end_logit": -0.4887188673019409
        },
        {
            "text": "ib",
            "probability": 0.0001092488243921731,
            "start_logit": -0.6753858923912048,
            "end_logit": 7.731679439544678
        },
        {
            "text": "ibrutin",
            "probability": 4.4332906573484895e-06,
            "start_logit": 8.339574813842773,
            "end_logit": -4.487767219543457
        },
        {
            "text": "inib",
            "probability": 3.2316717121853336e-06,
            "start_logit": -4.079808235168457,
            "end_logit": 7.61547327041626
        },
        {
            "text": "BTK kinase activity through either targeted genetic inactivation or ibrutinib",
            "probability": 3.046011804490622e-06,
            "start_logit": -4.255180835723877,
            "end_logit": 7.731679439544678
        },
        {
            "text": "ibrut",
            "probability": 1.9540374819192063e-06,
            "start_logit": 8.446104049682617,
            "end_logit": -5.413540840148926
        },
        {
            "text": "Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib",
            "probability": 5.098040903710886e-07,
            "start_logit": -6.042742729187012,
            "end_logit": 7.731679439544678
        },
        {
            "text": "BTK kinase activity is an important target of ibrutinib",
            "probability": 3.880739945694689e-07,
            "start_logit": -6.09577751159668,
            "end_logit": 7.511883735656738
        },
        {
            "text": "by ibrutinib,",
            "probability": 3.269706284144062e-07,
            "start_logit": -6.329305171966553,
            "end_logit": 7.574085712432861
        },
        {
            "text": "of ibrutinib.",
            "probability": 3.246926228926695e-07,
            "start_logit": -6.377684116363525,
            "end_logit": 7.61547327041626
        },
        {
            "text": "in",
            "probability": 1.790839557284845e-11,
            "start_logit": -4.079808235168457,
            "end_logit": -4.487767219543457
        },
        {
            "text": "BTK",
            "probability": 1.1323344943105192e-11,
            "start_logit": -4.255180835723877,
            "end_logit": -4.7707977294921875
        },
        {
            "text": "Inhibition of BTK",
            "probability": 1.8951625729642116e-12,
            "start_logit": -6.042742729187012,
            "end_logit": -4.7707977294921875
        },
        {
            "text": "Bruton's tyrosine kinase",
            "probability": 1.247954273391537e-12,
            "start_logit": -5.182845115661621,
            "end_logit": -6.048494338989258
        }
    ],
    "530cf4c54a5037880c000008_003": [
        {
            "text": "ibrutinib",
            "probability": 0.9996075343497758,
            "start_logit": 8.446104049682617,
            "end_logit": 7.731679439544678
        },
        {
            "text": "ibr",
            "probability": 0.0002690022404648134,
            "start_logit": 8.446104049682617,
            "end_logit": -0.4887188673019409
        },
        {
            "text": "ib",
            "probability": 0.0001092488243921731,
            "start_logit": -0.6753858923912048,
            "end_logit": 7.731679439544678
        },
        {
            "text": "ibrutin",
            "probability": 4.4332906573484895e-06,
            "start_logit": 8.339574813842773,
            "end_logit": -4.487767219543457
        },
        {
            "text": "inib",
            "probability": 3.2316717121853336e-06,
            "start_logit": -4.079808235168457,
            "end_logit": 7.61547327041626
        },
        {
            "text": "BTK kinase activity through either targeted genetic inactivation or ibrutinib",
            "probability": 3.046011804490622e-06,
            "start_logit": -4.255180835723877,
            "end_logit": 7.731679439544678
        },
        {
            "text": "ibrut",
            "probability": 1.9540374819192063e-06,
            "start_logit": 8.446104049682617,
            "end_logit": -5.413540840148926
        },
        {
            "text": "Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib",
            "probability": 5.098040903710886e-07,
            "start_logit": -6.042742729187012,
            "end_logit": 7.731679439544678
        },
        {
            "text": "BTK kinase activity is an important target of ibrutinib",
            "probability": 3.880739945694689e-07,
            "start_logit": -6.09577751159668,
            "end_logit": 7.511883735656738
        },
        {
            "text": "by ibrutinib,",
            "probability": 3.269706284144062e-07,
            "start_logit": -6.329305171966553,
            "end_logit": 7.574085712432861
        },
        {
            "text": "of ibrutinib.",
            "probability": 3.246926228926695e-07,
            "start_logit": -6.377684116363525,
            "end_logit": 7.61547327041626
        },
        {
            "text": "in",
            "probability": 1.790839557284845e-11,
            "start_logit": -4.079808235168457,
            "end_logit": -4.487767219543457
        },
        {
            "text": "BTK",
            "probability": 1.1323344943105192e-11,
            "start_logit": -4.255180835723877,
            "end_logit": -4.7707977294921875
        },
        {
            "text": "Inhibition of BTK",
            "probability": 1.8951625729642116e-12,
            "start_logit": -6.042742729187012,
            "end_logit": -4.7707977294921875
        },
        {
            "text": "Bruton's tyrosine kinase",
            "probability": 1.247954273391537e-12,
            "start_logit": -5.182845115661621,
            "end_logit": -6.048494338989258
        }
    ],
    "530cf4c54a5037880c000008_004": [
        {
            "text": "ibrutinib",
            "probability": 0.9996075343497758,
            "start_logit": 8.446104049682617,
            "end_logit": 7.731679439544678
        },
        {
            "text": "ibr",
            "probability": 0.0002690022404648134,
            "start_logit": 8.446104049682617,
            "end_logit": -0.4887188673019409
        },
        {
            "text": "ib",
            "probability": 0.0001092488243921731,
            "start_logit": -0.6753858923912048,
            "end_logit": 7.731679439544678
        },
        {
            "text": "ibrutin",
            "probability": 4.4332906573484895e-06,
            "start_logit": 8.339574813842773,
            "end_logit": -4.487767219543457
        },
        {
            "text": "inib",
            "probability": 3.2316717121853336e-06,
            "start_logit": -4.079808235168457,
            "end_logit": 7.61547327041626
        },
        {
            "text": "BTK kinase activity through either targeted genetic inactivation or ibrutinib",
            "probability": 3.046011804490622e-06,
            "start_logit": -4.255180835723877,
            "end_logit": 7.731679439544678
        },
        {
            "text": "ibrut",
            "probability": 1.9540374819192063e-06,
            "start_logit": 8.446104049682617,
            "end_logit": -5.413540840148926
        },
        {
            "text": "Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib",
            "probability": 5.098040903710886e-07,
            "start_logit": -6.042742729187012,
            "end_logit": 7.731679439544678
        },
        {
            "text": "BTK kinase activity is an important target of ibrutinib",
            "probability": 3.880739945694689e-07,
            "start_logit": -6.09577751159668,
            "end_logit": 7.511883735656738
        },
        {
            "text": "by ibrutinib,",
            "probability": 3.269706284144062e-07,
            "start_logit": -6.329305171966553,
            "end_logit": 7.574085712432861
        },
        {
            "text": "of ibrutinib.",
            "probability": 3.246926228926695e-07,
            "start_logit": -6.377684116363525,
            "end_logit": 7.61547327041626
        },
        {
            "text": "in",
            "probability": 1.790839557284845e-11,
            "start_logit": -4.079808235168457,
            "end_logit": -4.487767219543457
        },
        {
            "text": "BTK",
            "probability": 1.1323344943105192e-11,
            "start_logit": -4.255180835723877,
            "end_logit": -4.7707977294921875
        },
        {
            "text": "Inhibition of BTK",
            "probability": 1.8951625729642116e-12,
            "start_logit": -6.042742729187012,
            "end_logit": -4.7707977294921875
        },
        {
            "text": "Bruton's tyrosine kinase",
            "probability": 1.247954273391537e-12,
            "start_logit": -5.182845115661621,
            "end_logit": -6.048494338989258
        }
    ],
    "530cf4c54a5037880c000008_005": [
        {
            "text": "Ibrutinib",
            "probability": 0.999112603925671,
            "start_logit": 9.54019832611084,
            "end_logit": 9.050993919372559
        },
        {
            "text": "I",
            "probability": 0.000673093319623737,
            "start_logit": 9.54019832611084,
            "end_logit": 1.7482551336288452
        },
        {
            "text": "ib",
            "probability": 0.0001818675055461404,
            "start_logit": 0.9288539886474609,
            "end_logit": 9.050993919372559
        },
        {
            "text": "inib",
            "probability": 1.4413853203130343e-05,
            "start_logit": -1.6062346696853638,
            "end_logit": 9.050993919372559
        },
        {
            "text": "Ibrutinib,",
            "probability": 1.1319705222492038e-05,
            "start_logit": 9.54019832611084,
            "end_logit": -2.3370838165283203
        },
        {
            "text": "brutinib",
            "probability": 3.395929337828193e-06,
            "start_logit": -3.051846981048584,
            "end_logit": 9.050993919372559
        },
        {
            "text": "Ibr",
            "probability": 9.666659632181718e-07,
            "start_logit": 9.54019832611084,
            "end_logit": -4.7975311279296875
        },
        {
            "text": "Ibrutin",
            "probability": 7.23227141455208e-07,
            "start_logit": 9.54019832611084,
            "end_logit": -5.087660789489746
        },
        {
            "text": "Ibrut",
            "probability": 3.3611301424184875e-07,
            "start_logit": 9.54019832611084,
            "end_logit": -5.853936672210693
        },
        {
            "text": "Ibrutinib, an inhibitor of Bruton's",
            "probability": 3.0742707318335083e-07,
            "start_logit": 9.54019832611084,
            "end_logit": -5.943146228790283
        },
        {
            "text": "Ibrutinib, an inhibitor of Bruton's tyrosine kinase",
            "probability": 2.9379355698227554e-07,
            "start_logit": 9.54019832611084,
            "end_logit": -5.98850679397583
        },
        {
            "text": "utinib",
            "probability": 2.864523092407181e-07,
            "start_logit": -5.5246076583862305,
            "end_logit": 9.050993919372559
        },
        {
            "text": "Ibrutinib, an inhibitor",
            "probability": 1.9590589446154803e-07,
            "start_logit": 9.54019832611084,
            "end_logit": -6.393749713897705
        },
        {
            "text": "Ibrutinib, an inhibitor of Bruton's tyrosine kinase is showing impressive responses",
            "probability": 1.2758183650500792e-07,
            "start_logit": 9.54019832611084,
            "end_logit": -6.822626113891602
        },
        {
            "text": "Ibrutinib, an inhibitor of Bruton's tyrosine",
            "probability": 6.85759753408294e-08,
            "start_logit": 9.54019832611084,
            "end_logit": -7.443441867828369
        },
        {
            "text": "in",
            "probability": 1.0433748717107047e-11,
            "start_logit": -1.6062346696853638,
            "end_logit": -5.087660789489746
        },
        {
            "text": "br",
            "probability": 3.2856449728230603e-12,
            "start_logit": -3.051846981048584,
            "end_logit": -4.7975311279296875
        },
        {
            "text": "brutin",
            "probability": 2.458209673195232e-12,
            "start_logit": -3.051846981048584,
            "end_logit": -5.087660789489746
        },
        {
            "text": "Bruton's tyrosine kinase is showing impressive responses in heavily pre-treated high-risk CLL,",
            "probability": 1.310343239949332e-12,
            "start_logit": -3.4591012001037598,
            "end_logit": -5.309550762176514
        },
        {
            "text": "brut",
            "probability": 1.1424298336393273e-12,
            "start_logit": -3.051846981048584,
            "end_logit": -5.853936672210693
        }
    ],
    "530cf4c54a5037880c000008_006": [
        {
            "text": "Ibrutinib",
            "probability": 0.9993769475285067,
            "start_logit": 9.389485359191895,
            "end_logit": 8.835562705993652
        },
        {
            "text": "I",
            "probability": 0.0004214536390606078,
            "start_logit": 9.389485359191895,
            "end_logit": 1.064385175704956
        },
        {
            "text": "ib",
            "probability": 0.00019361937750706848,
            "start_logit": 0.840492308139801,
            "end_logit": 8.835562705993652
        },
        {
            "text": "Ibrutinib acts by inhibiting the Bruton's tyrosine kinase (BTK) while idelalisib",
            "probability": 3.595435122693381e-06,
            "start_logit": 9.389485359191895,
            "end_logit": -3.699659585952759
        },
        {
            "text": "inib",
            "probability": 1.6065410467971527e-06,
            "start_logit": -3.9513185024261475,
            "end_logit": 8.835562705993652
        },
        {
            "text": "Ibr",
            "probability": 6.364088692912277e-07,
            "start_logit": 9.389485359191895,
            "end_logit": -5.431238651275635
        },
        {
            "text": "brutinib",
            "probability": 4.433717933446266e-07,
            "start_logit": -5.238748550415039,
            "end_logit": 8.835562705993652
        },
        {
            "text": "Ibrutinib acts by inhibiting the Bruton's tyrosine kinase (BTK)",
            "probability": 3.139521441042074e-07,
            "start_logit": 9.389485359191895,
            "end_logit": -6.137839317321777
        },
        {
            "text": "Ibrutin",
            "probability": 2.891981352203375e-07,
            "start_logit": 9.389485359191895,
            "end_logit": -6.219967842102051
        },
        {
            "text": "Ibrut",
            "probability": 2.619888239779351e-07,
            "start_logit": 9.389485359191895,
            "end_logit": -6.318778038024902
        },
        {
            "text": "Ibrutinib acts",
            "probability": 2.1819881939201274e-07,
            "start_logit": 9.389485359191895,
            "end_logit": -6.501673221588135
        },
        {
            "text": "Ibrutinib acts by inhibiting the Bruton's tyrosine kinase",
            "probability": 2.0903362687766964e-07,
            "start_logit": 9.389485359191895,
            "end_logit": -6.54458475112915
        },
        {
            "text": "Ibrutinib acts by inhibiting the Bruton's",
            "probability": 1.9298252423613285e-07,
            "start_logit": 9.389485359191895,
            "end_logit": -6.624480247497559
        },
        {
            "text": "Ibrutinib acts by inhibiting the Bruton's tyrosine kinase (BTK) while idelalisib represents",
            "probability": 1.0657740954558904e-07,
            "start_logit": 9.389485359191895,
            "end_logit": -7.218208312988281
        },
        {
            "text": "Ibrutinib acts by inhibiting",
            "probability": 1.0567371784149408e-07,
            "start_logit": 9.389485359191895,
            "end_logit": -7.226723670959473
        },
        {
            "text": "while idelalisib",
            "probability": 3.6523330436357487e-11,
            "start_logit": -3.2918760776519775,
            "end_logit": -2.5155224800109863
        },
        {
            "text": "Bruton's tyrosine kinase (BTK) while idelalisib",
            "probability": 1.7228070284683092e-11,
            "start_logit": -4.04328727722168,
            "end_logit": -2.5155224800109863
        },
        {
            "text": "idelalisib",
            "probability": 1.4400193528662327e-11,
            "start_logit": -4.222585678100586,
            "end_logit": -2.5155224800109863
        },
        {
            "text": "the Bruton's tyrosine kinase (BTK) while idelalisib",
            "probability": 1.3618014670383028e-11,
            "start_logit": -4.278433799743652,
            "end_logit": -2.5155224800109863
        },
        {
            "text": "tyrosine kinase (BTK) while idelalisib",
            "probability": 1.1122461407667674e-11,
            "start_logit": -4.480860710144043,
            "end_logit": -2.5155224800109863
        }
    ],
    "530cf4c54a5037880c000008_007": [
        {
            "text": "ibrutinib",
            "probability": 0.9994887861295709,
            "start_logit": 9.537707328796387,
            "end_logit": 8.952544212341309
        },
        {
            "text": "ib",
            "probability": 0.00025438660726192336,
            "start_logit": 1.2615633010864258,
            "end_logit": 8.952544212341309
        },
        {
            "text": "ibr",
            "probability": 0.0002488424300068885,
            "start_logit": 9.537707328796387,
            "end_logit": 0.6543648838996887
        },
        {
            "text": "ibrutin",
            "probability": 3.215701824049635e-06,
            "start_logit": 9.537707328796387,
            "end_logit": -3.6944093704223633
        },
        {
            "text": "inib",
            "probability": 1.9354275528682546e-06,
            "start_logit": -3.6169636249542236,
            "end_logit": 8.952544212341309
        },
        {
            "text": "ibrut",
            "probability": 9.176267422655151e-07,
            "start_logit": 9.537707328796387,
            "end_logit": -4.948419570922852
        },
        {
            "text": "ibrutinib or the PI3K inhibitor idelalisib",
            "probability": 6.872565825493436e-07,
            "start_logit": 9.537707328796387,
            "end_logit": -5.237502574920654
        },
        {
            "text": "the Bruton's tyrosine kinase inhibitor ibrutinib",
            "probability": 5.437468898001735e-07,
            "start_logit": -4.886563301086426,
            "end_logit": 8.952544212341309
        },
        {
            "text": "Bruton's tyrosine kinase inhibitor ibrutinib",
            "probability": 2.498907354719238e-07,
            "start_logit": -5.664023399353027,
            "end_logit": 8.952544212341309
        },
        {
            "text": "inhibitor ibrutinib",
            "probability": 1.6878752334715297e-07,
            "start_logit": -6.056406497955322,
            "end_logit": 8.952544212341309
        },
        {
            "text": "utinib",
            "probability": 1.0381020818330419e-07,
            "start_logit": -6.542482852935791,
            "end_logit": 8.952544212341309
        },
        {
            "text": "tyrosine kinase inhibitor ibrutinib",
            "probability": 8.197392191742379e-08,
            "start_logit": -6.778645992279053,
            "end_logit": 8.952544212341309
        },
        {
            "text": "ibrutinib or the PI3K",
            "probability": 5.095515270659939e-08,
            "start_logit": 9.537707328796387,
            "end_logit": -7.839264392852783
        },
        {
            "text": "kinase inhibitor ibrutinib",
            "probability": 2.96486816947975e-08,
            "start_logit": -7.795629501342773,
            "end_logit": 8.952544212341309
        },
        {
            "text": "in",
            "probability": 6.2269412107916705e-12,
            "start_logit": -3.6169636249542236,
            "end_logit": -3.6944093704223633
        },
        {
            "text": "the Bruton's tyrosine kinase inhibitor ibrutinib or the PI3K inhibitor idelalisib",
            "probability": 3.7388476433337115e-13,
            "start_logit": -4.886563301086426,
            "end_logit": -5.237502574920654
        },
        {
            "text": "utin",
            "probability": 3.3399341787787484e-13,
            "start_logit": -6.542482852935791,
            "end_logit": -3.6944093704223633
        },
        {
            "text": "Bruton's tyrosine kinase inhibitor ibrutinib or the PI3K inhibitor idelalisib",
            "probability": 1.7182689316227367e-13,
            "start_logit": -5.664023399353027,
            "end_logit": -5.237502574920654
        },
        {
            "text": "the PI3K inhibitor idelalisib",
            "probability": 1.2226021571165974e-13,
            "start_logit": -6.004359245300293,
            "end_logit": -5.237502574920654
        },
        {
            "text": "inhibitor ibrutinib or the PI3K inhibitor idelalisib",
            "probability": 1.1605966778450074e-13,
            "start_logit": -6.056406497955322,
            "end_logit": -5.237502574920654
        }
    ],
    "530cf4c54a5037880c000008_008": [
        {
            "text": "ibrutinib",
            "probability": 0.9994673375934422,
            "start_logit": 7.638669013977051,
            "end_logit": 6.476902484893799
        },
        {
            "text": "ibr",
            "probability": 0.00040405293420026826,
            "start_logit": 7.627834320068359,
            "end_logit": -1.3256946802139282
        },
        {
            "text": "ib",
            "probability": 0.00010518908724834447,
            "start_logit": -1.5205491781234741,
            "end_logit": 6.476902484893799
        },
        {
            "text": "ibrutinib in relapsed chronic lymphocytic leukemia.",
            "probability": 5.513994563582777e-06,
            "start_logit": 7.638669013977051,
            "end_logit": -5.630785942077637
        },
        {
            "text": "ibrut",
            "probability": 3.90791256934536e-06,
            "start_logit": 7.627834320068359,
            "end_logit": -5.964237213134766
        },
        {
            "text": "inib",
            "probability": 3.1268517795209797e-06,
            "start_logit": -5.036282062530518,
            "end_logit": 6.476902484893799
        },
        {
            "text": "pharmacokinetics, and pharmacodynamics of ibrutinib",
            "probability": 2.473653043407904e-06,
            "start_logit": -5.156883239746094,
            "end_logit": 6.363173007965088
        },
        {
            "text": "pharmacodynamics of ibrutinib",
            "probability": 2.093564978712539e-06,
            "start_logit": -5.323710918426514,
            "end_logit": 6.363173007965088
        },
        {
            "text": "ibrutin",
            "probability": 1.6508431172933304e-06,
            "start_logit": 7.638669013977051,
            "end_logit": -6.836789131164551
        },
        {
            "text": "of ibrutinib",
            "probability": 1.1469093050703706e-06,
            "start_logit": -5.925508499145508,
            "end_logit": 6.363173007965088
        },
        {
            "text": "Targeting BTK with ibrutinib",
            "probability": 1.0252674168945743e-06,
            "start_logit": -6.151355266571045,
            "end_logit": 6.476902484893799
        },
        {
            "text": "with ibrutinib",
            "probability": 9.422268937313792e-07,
            "start_logit": -6.235817909240723,
            "end_logit": 6.476902484893799
        },
        {
            "text": "BTK with ibrutinib",
            "probability": 8.258731301982368e-07,
            "start_logit": -6.3676228523254395,
            "end_logit": 6.476902484893799
        },
        {
            "text": "ibrutinib (PCI-32765),",
            "probability": 7.13263851604114e-07,
            "start_logit": 7.627834320068359,
            "end_logit": -7.665144443511963
        },
        {
            "text": "Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.",
            "probability": 5.656331878325839e-12,
            "start_logit": -6.151355266571045,
            "end_logit": -5.630785942077637
        },
        {
            "text": "with ibrutinib in relapsed chronic lymphocytic leukemia.",
            "probability": 5.198202856939866e-12,
            "start_logit": -6.235817909240723,
            "end_logit": -5.630785942077637
        },
        {
            "text": "in",
            "probability": 5.164692776702181e-12,
            "start_logit": -5.036282062530518,
            "end_logit": -6.836789131164551
        },
        {
            "text": "BTK with ibrutinib in relapsed chronic lymphocytic leukemia.",
            "probability": 4.556286912874148e-12,
            "start_logit": -6.3676228523254395,
            "end_logit": -5.630785942077637
        },
        {
            "text": "pharmacokinetics, and pharmacodynamics of ibrutinib (PCI-32765),",
            "probability": 1.9994839644208767e-12,
            "start_logit": -5.156883239746094,
            "end_logit": -7.665144443511963
        },
        {
            "text": "Targeting BTK",
            "probability": 1.884638545554438e-12,
            "start_logit": -6.151355266571045,
            "end_logit": -6.729825496673584
        }
    ],
    "530cf4c54a5037880c000008_009": [
        {
            "text": "ibrutinib",
            "probability": 0.9994673375934422,
            "start_logit": 7.638669013977051,
            "end_logit": 6.476902484893799
        },
        {
            "text": "ibr",
            "probability": 0.00040405293420026826,
            "start_logit": 7.627834320068359,
            "end_logit": -1.3256946802139282
        },
        {
            "text": "ib",
            "probability": 0.00010518908724834447,
            "start_logit": -1.5205491781234741,
            "end_logit": 6.476902484893799
        },
        {
            "text": "ibrutinib in relapsed chronic lymphocytic leukemia.",
            "probability": 5.513994563582777e-06,
            "start_logit": 7.638669013977051,
            "end_logit": -5.630785942077637
        },
        {
            "text": "ibrut",
            "probability": 3.90791256934536e-06,
            "start_logit": 7.627834320068359,
            "end_logit": -5.964237213134766
        },
        {
            "text": "inib",
            "probability": 3.1268517795209797e-06,
            "start_logit": -5.036282062530518,
            "end_logit": 6.476902484893799
        },
        {
            "text": "pharmacokinetics, and pharmacodynamics of ibrutinib",
            "probability": 2.473653043407904e-06,
            "start_logit": -5.156883239746094,
            "end_logit": 6.363173007965088
        },
        {
            "text": "pharmacodynamics of ibrutinib",
            "probability": 2.093564978712539e-06,
            "start_logit": -5.323710918426514,
            "end_logit": 6.363173007965088
        },
        {
            "text": "ibrutin",
            "probability": 1.6508431172933304e-06,
            "start_logit": 7.638669013977051,
            "end_logit": -6.836789131164551
        },
        {
            "text": "of ibrutinib",
            "probability": 1.1469093050703706e-06,
            "start_logit": -5.925508499145508,
            "end_logit": 6.363173007965088
        },
        {
            "text": "Targeting BTK with ibrutinib",
            "probability": 1.0252674168945743e-06,
            "start_logit": -6.151355266571045,
            "end_logit": 6.476902484893799
        },
        {
            "text": "with ibrutinib",
            "probability": 9.422268937313792e-07,
            "start_logit": -6.235817909240723,
            "end_logit": 6.476902484893799
        },
        {
            "text": "BTK with ibrutinib",
            "probability": 8.258731301982368e-07,
            "start_logit": -6.3676228523254395,
            "end_logit": 6.476902484893799
        },
        {
            "text": "ibrutinib (PCI-32765),",
            "probability": 7.13263851604114e-07,
            "start_logit": 7.627834320068359,
            "end_logit": -7.665144443511963
        },
        {
            "text": "Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.",
            "probability": 5.656331878325839e-12,
            "start_logit": -6.151355266571045,
            "end_logit": -5.630785942077637
        },
        {
            "text": "with ibrutinib in relapsed chronic lymphocytic leukemia.",
            "probability": 5.198202856939866e-12,
            "start_logit": -6.235817909240723,
            "end_logit": -5.630785942077637
        },
        {
            "text": "in",
            "probability": 5.164692776702181e-12,
            "start_logit": -5.036282062530518,
            "end_logit": -6.836789131164551
        },
        {
            "text": "BTK with ibrutinib in relapsed chronic lymphocytic leukemia.",
            "probability": 4.556286912874148e-12,
            "start_logit": -6.3676228523254395,
            "end_logit": -5.630785942077637
        },
        {
            "text": "pharmacokinetics, and pharmacodynamics of ibrutinib (PCI-32765),",
            "probability": 1.9994839644208767e-12,
            "start_logit": -5.156883239746094,
            "end_logit": -7.665144443511963
        },
        {
            "text": "Targeting BTK",
            "probability": 1.884638545554438e-12,
            "start_logit": -6.151355266571045,
            "end_logit": -6.729825496673584
        }
    ],
    "530cf4c54a5037880c000008_010": [
        {
            "text": "ibrutinib",
            "probability": 0.9995957957536856,
            "start_logit": 9.026795387268066,
            "end_logit": 8.354181289672852
        },
        {
            "text": "ibr",
            "probability": 0.0002517189391762952,
            "start_logit": 9.026795387268066,
            "end_logit": 0.06738816201686859
        },
        {
            "text": "ib",
            "probability": 0.00011783663453727722,
            "start_logit": -0.01901167258620262,
            "end_logit": 8.354181289672852
        },
        {
            "text": "remarkable activity of ibrutinib,",
            "probability": 8.892226291987868e-06,
            "start_logit": -2.6031334400177,
            "end_logit": 8.354181289672852
        },
        {
            "text": "inib",
            "probability": 6.6932308911415765e-06,
            "start_logit": -2.887214183807373,
            "end_logit": 8.354181289672852
        },
        {
            "text": "ibrut",
            "probability": 5.279514873713619e-06,
            "start_logit": 9.026795387268066,
            "end_logit": -3.797090768814087
        },
        {
            "text": "suggest remarkable activity of ibrutinib,",
            "probability": 3.241446071758495e-06,
            "start_logit": -3.6122913360595703,
            "end_logit": 8.354181289672852
        },
        {
            "text": "of ibrutinib,",
            "probability": 2.224729400362394e-06,
            "start_logit": -3.988675594329834,
            "end_logit": 8.354181289672852
        },
        {
            "text": "activity of ibrutinib,",
            "probability": 1.5728215983407785e-06,
            "start_logit": -4.335439682006836,
            "end_logit": 8.354181289672852
        },
        {
            "text": "ibrutinib, the first-in-class covalent inhibitor of Bruton's tyrosine kinase (BTK),",
            "probability": 1.3180676941022568e-06,
            "start_logit": 9.026795387268066,
            "end_logit": -5.184758186340332
        },
        {
            "text": "Recent clinical data suggest remarkable activity of ibrutinib,",
            "probability": 1.1488242052712798e-06,
            "start_logit": -4.649571895599365,
            "end_logit": 8.354181289672852
        },
        {
            "text": "ibrutin",
            "probability": 7.430166928463591e-07,
            "start_logit": 9.026795387268066,
            "end_logit": -5.757961750030518
        },
        {
            "text": "Ibrutinib in chronic lymphocytic leukemia and B cell malignancies. Recent clinical data suggest remarkable activity of ibrutinib,",
            "probability": 6.990061309156603e-07,
            "start_logit": -5.146406650543213,
            "end_logit": 8.354181289672852
        },
        {
            "text": "data suggest remarkable activity of ibrutinib,",
            "probability": 6.141450429100773e-07,
            "start_logit": -5.275835037231445,
            "end_logit": 8.354181289672852
        },
        {
            "text": "ibrutinib, the first-in-class covalent inhibitor of Bruton's tyrosine kinase",
            "probability": 5.784680376751746e-07,
            "start_logit": 9.026795387268066,
            "end_logit": -6.008296966552734
        },
        {
            "text": "clinical data suggest remarkable activity of ibrutinib,",
            "probability": 4.817405149541794e-07,
            "start_logit": -5.518660545349121,
            "end_logit": 8.354181289672852
        },
        {
            "text": "ibrutinib, the first-in-class covalent",
            "probability": 3.959323623637654e-07,
            "start_logit": 9.026795387268066,
            "end_logit": -6.387436866760254
        },
        {
            "text": "ibrutinib, the first-in-class",
            "probability": 2.9228793768963036e-07,
            "start_logit": 9.026795387268066,
            "end_logit": -6.690940856933594
        },
        {
            "text": "ibrutinib, the first-in-class covalent inhibitor",
            "probability": 2.461320594877965e-07,
            "start_logit": 9.026795387268066,
            "end_logit": -6.862812042236328
        },
        {
            "text": "ibrutinib, the first-in-class covalent inhibitor of Bruton's",
            "probability": 2.2708279517424065e-07,
            "start_logit": 9.026795387268066,
            "end_logit": -6.943365573883057
        }
    ],
    "530cf4c54a5037880c000008_011": [
        {
            "text": "ibrutinib",
            "probability": 0.9987104134191392,
            "start_logit": 9.296673774719238,
            "end_logit": 8.610751152038574
        },
        {
            "text": "ibrutinib, a Bruton's tyrosine kinase inhibitor in clinical development. Ibrutinib",
            "probability": 0.000957292272742546,
            "start_logit": 9.296673774719238,
            "end_logit": 1.660639762878418
        },
        {
            "text": "ibr",
            "probability": 0.00023653987413417587,
            "start_logit": 9.296673774719238,
            "end_logit": 0.262647807598114
        },
        {
            "text": "ib",
            "probability": 9.026453617213158e-05,
            "start_logit": -0.014801714569330215,
            "end_logit": 8.610751152038574
        },
        {
            "text": "inib",
            "probability": 1.5582570801629737e-06,
            "start_logit": -4.073978424072266,
            "end_logit": 8.610751152038574
        },
        {
            "text": "ibrut",
            "probability": 8.976300829264845e-07,
            "start_logit": 9.296673774719238,
            "end_logit": -5.311466217041016
        },
        {
            "text": "ibrutinib,",
            "probability": 7.313681163402891e-07,
            "start_logit": 9.296673774719238,
            "end_logit": -5.516307353973389
        },
        {
            "text": "ibrutin",
            "probability": 5.956000436676107e-07,
            "start_logit": 9.296673774719238,
            "end_logit": -5.721654891967773
        },
        {
            "text": "Ibrutinib",
            "probability": 5.049306013225846e-07,
            "start_logit": 1.7492307424545288,
            "end_logit": 1.660639762878418
        },
        {
            "text": "ibrutinib, a Bruton's tyrosine kinase inhibitor",
            "probability": 5.040913144237993e-07,
            "start_logit": 9.296673774719238,
            "end_logit": -5.888466835021973
        },
        {
            "text": "ibrutinib, a Bruton's tyrosine kinase",
            "probability": 2.8831799551597526e-07,
            "start_logit": 9.296673774719238,
            "end_logit": -6.447160243988037
        },
        {
            "text": "ibrutinib, a Bruton's",
            "probability": 1.297047472776181e-07,
            "start_logit": 9.296673774719238,
            "end_logit": -7.2459635734558105
        },
        {
            "text": "utinib",
            "probability": 1.1384345150086211e-07,
            "start_logit": -6.69047737121582,
            "end_logit": 8.610751152038574
        },
        {
            "text": "ibrutinib, a Bruton's tyrosine",
            "probability": 8.217602855055992e-08,
            "start_logit": 9.296673774719238,
            "end_logit": -7.7023606300354
        },
        {
            "text": "ibrutinib, a",
            "probability": 8.207792976786169e-08,
            "start_logit": 9.296673774719238,
            "end_logit": -7.703555107116699
        },
        {
            "text": "development. Ibrutinib",
            "probability": 7.171673900293569e-10,
            "start_logit": -4.807636260986328,
            "end_logit": 1.660639762878418
        },
        {
            "text": "a Bruton's tyrosine kinase inhibitor in clinical development. Ibrutinib",
            "probability": 3.6871295431403054e-10,
            "start_logit": -5.472927093505859,
            "end_logit": 1.660639762878418
        },
        {
            "text": "Bruton's tyrosine kinase inhibitor in clinical development. Ibrutinib",
            "probability": 3.526922322181728e-10,
            "start_logit": -5.517349720001221,
            "end_logit": 1.660639762878418
        },
        {
            "text": "I",
            "probability": 2.800565430572827e-10,
            "start_logit": 1.7492307424545288,
            "end_logit": -5.836544990539551
        },
        {
            "text": "brutinib",
            "probability": 1.8179183311864295e-10,
            "start_logit": -6.180083274841309,
            "end_logit": 1.660639762878418
        }
    ],
    "530cf4c54a5037880c000008_012": [
        {
            "text": "Ibrutinib",
            "probability": 0.9992868345130219,
            "start_logit": 8.96500301361084,
            "end_logit": 8.191658020019531
        },
        {
            "text": "I",
            "probability": 0.0005572109873126444,
            "start_logit": 8.96500301361084,
            "end_logit": 0.6998048424720764
        },
        {
            "text": "ib",
            "probability": 0.00012299006708510067,
            "start_logit": -0.037690527737140656,
            "end_logit": 8.191658020019531
        },
        {
            "text": "Ibrutinib:",
            "probability": 1.3963558629191752e-05,
            "start_logit": 8.754632949829102,
            "end_logit": -2.776318073272705
        },
        {
            "text": "ibrutinib",
            "probability": 6.01630632602653e-06,
            "start_logit": 3.4118378162384033,
            "end_logit": 1.7244995832443237
        },
        {
            "text": "inib",
            "probability": 3.6385297979718856e-06,
            "start_logit": -3.5582144260406494,
            "end_logit": 8.191658020019531
        },
        {
            "text": "brutinib",
            "probability": 3.525511303188672e-06,
            "start_logit": -3.438051462173462,
            "end_logit": 8.03994083404541
        },
        {
            "text": "Ibrutinib: a novel",
            "probability": 1.729963323718386e-06,
            "start_logit": 8.754632949829102,
            "end_logit": -4.864668846130371
        },
        {
            "text": "Ibr",
            "probability": 1.0213419745042593e-06,
            "start_logit": 8.96500301361084,
            "end_logit": -5.60202169418335
        },
        {
            "text": "Ibrut",
            "probability": 7.03692036266133e-07,
            "start_logit": 8.96500301361084,
            "end_logit": -5.97455358505249
        },
        {
            "text": "Ibrutinib,",
            "probability": 5.700373084028596e-07,
            "start_logit": 8.96500301361084,
            "end_logit": -6.185192584991455
        },
        {
            "text": "Ibrutin",
            "probability": 5.64769292398182e-07,
            "start_logit": 8.96500301361084,
            "end_logit": -6.194477081298828
        },
        {
            "text": "Ibrutinib: a novel Bruton's tyrosine kinase inhibitor with outstanding responses",
            "probability": 4.1029203460915245e-07,
            "start_logit": 8.754632949829102,
            "end_logit": -6.30365514755249
        },
        {
            "text": "Ibrutinib: a novel Bruton's tyrosine kinase",
            "probability": 4.072884276542094e-07,
            "start_logit": 8.754632949829102,
            "end_logit": -6.311002731323242
        },
        {
            "text": "Ibrutinib, a Bruton's tyrosine kinase",
            "probability": 4.0590625332967197e-07,
            "start_logit": 8.96500301361084,
            "end_logit": -6.5247721672058105
        },
        {
            "text": "ibr",
            "probability": 5.605921369329759e-09,
            "start_logit": 3.4118378162384033,
            "end_logit": -5.253905773162842
        },
        {
            "text": "ibrut",
            "probability": 1.6182958741549635e-09,
            "start_logit": 3.4118378162384033,
            "end_logit": -6.4963555335998535
        },
        {
            "text": ":",
            "probability": 6.155773755940107e-12,
            "start_logit": -5.879938125610352,
            "end_logit": -2.776318073272705
        },
        {
            "text": "br",
            "probability": 3.4441559264090676e-12,
            "start_logit": -3.438051462173462,
            "end_logit": -5.798916339874268
        },
        {
            "text": "in",
            "probability": 2.0563964503462126e-12,
            "start_logit": -3.5582144260406494,
            "end_logit": -6.194477081298828
        }
    ],
    "530cf4c54a5037880c000008_013": [
        {
            "text": "Ibrutinib",
            "probability": 0.9992868345130219,
            "start_logit": 8.96500301361084,
            "end_logit": 8.191658020019531
        },
        {
            "text": "I",
            "probability": 0.0005572109873126444,
            "start_logit": 8.96500301361084,
            "end_logit": 0.6998048424720764
        },
        {
            "text": "ib",
            "probability": 0.00012299006708510067,
            "start_logit": -0.037690527737140656,
            "end_logit": 8.191658020019531
        },
        {
            "text": "Ibrutinib:",
            "probability": 1.3963558629191752e-05,
            "start_logit": 8.754632949829102,
            "end_logit": -2.776318073272705
        },
        {
            "text": "ibrutinib",
            "probability": 6.01630632602653e-06,
            "start_logit": 3.4118378162384033,
            "end_logit": 1.7244995832443237
        },
        {
            "text": "inib",
            "probability": 3.6385297979718856e-06,
            "start_logit": -3.5582144260406494,
            "end_logit": 8.191658020019531
        },
        {
            "text": "brutinib",
            "probability": 3.525511303188672e-06,
            "start_logit": -3.438051462173462,
            "end_logit": 8.03994083404541
        },
        {
            "text": "Ibrutinib: a novel",
            "probability": 1.729963323718386e-06,
            "start_logit": 8.754632949829102,
            "end_logit": -4.864668846130371
        },
        {
            "text": "Ibr",
            "probability": 1.0213419745042593e-06,
            "start_logit": 8.96500301361084,
            "end_logit": -5.60202169418335
        },
        {
            "text": "Ibrut",
            "probability": 7.03692036266133e-07,
            "start_logit": 8.96500301361084,
            "end_logit": -5.97455358505249
        },
        {
            "text": "Ibrutinib,",
            "probability": 5.700373084028596e-07,
            "start_logit": 8.96500301361084,
            "end_logit": -6.185192584991455
        },
        {
            "text": "Ibrutin",
            "probability": 5.64769292398182e-07,
            "start_logit": 8.96500301361084,
            "end_logit": -6.194477081298828
        },
        {
            "text": "Ibrutinib: a novel Bruton's tyrosine kinase inhibitor with outstanding responses",
            "probability": 4.1029203460915245e-07,
            "start_logit": 8.754632949829102,
            "end_logit": -6.30365514755249
        },
        {
            "text": "Ibrutinib: a novel Bruton's tyrosine kinase",
            "probability": 4.072884276542094e-07,
            "start_logit": 8.754632949829102,
            "end_logit": -6.311002731323242
        },
        {
            "text": "Ibrutinib, a Bruton's tyrosine kinase",
            "probability": 4.0590625332967197e-07,
            "start_logit": 8.96500301361084,
            "end_logit": -6.5247721672058105
        },
        {
            "text": "ibr",
            "probability": 5.605921369329759e-09,
            "start_logit": 3.4118378162384033,
            "end_logit": -5.253905773162842
        },
        {
            "text": "ibrut",
            "probability": 1.6182958741549635e-09,
            "start_logit": 3.4118378162384033,
            "end_logit": -6.4963555335998535
        },
        {
            "text": ":",
            "probability": 6.155773755940107e-12,
            "start_logit": -5.879938125610352,
            "end_logit": -2.776318073272705
        },
        {
            "text": "br",
            "probability": 3.4441559264090676e-12,
            "start_logit": -3.438051462173462,
            "end_logit": -5.798916339874268
        },
        {
            "text": "in",
            "probability": 2.0563964503462126e-12,
            "start_logit": -3.5582144260406494,
            "end_logit": -6.194477081298828
        }
    ],
    "530cf4c54a5037880c000008_014": [
        {
            "text": "ibrutinib",
            "probability": 0.9996044514162481,
            "start_logit": 9.123013496398926,
            "end_logit": 8.5147123336792
        },
        {
            "text": "ibr",
            "probability": 0.0002452510066691404,
            "start_logit": 9.123013496398926,
            "end_logit": 0.2018796056509018
        },
        {
            "text": "ib",
            "probability": 0.00013632658921295928,
            "start_logit": 0.2229519635438919,
            "end_logit": 8.5147123336792
        },
        {
            "text": "ibrut",
            "probability": 6.824781433139426e-06,
            "start_logit": 9.123013496398926,
            "end_logit": -3.3798422813415527
        },
        {
            "text": "inib",
            "probability": 6.0677190691962406e-06,
            "start_logit": -2.8891186714172363,
            "end_logit": 8.5147123336792
        },
        {
            "text": "ibrutin",
            "probability": 5.41858395773509e-07,
            "start_logit": 9.123013496398926,
            "end_logit": -5.913153171539307
        },
        {
            "text": "ibrutinib -inhibitor of Btk, fostamatinib-inhibitor",
            "probability": 1.8579812477874222e-07,
            "start_logit": 9.123013496398926,
            "end_logit": -6.983497142791748
        },
        {
            "text": "utinib",
            "probability": 1.0927597941391352e-07,
            "start_logit": -6.905980110168457,
            "end_logit": 8.5147123336792
        },
        {
            "text": "ibrutinib -inhibitor",
            "probability": 9.383573261073958e-08,
            "start_logit": 9.123013496398926,
            "end_logit": -7.666612148284912
        },
        {
            "text": "spleen tyrosine kinase (Syk), Bruton's tyrosine kinase",
            "probability": 8.538943202581918e-08,
            "start_logit": 1.2203599214553833,
            "end_logit": 0.1417180448770523
        },
        {
            "text": "spleen tyrosine kinase",
            "probability": 5.8308382756350206e-08,
            "start_logit": 1.2203599214553833,
            "end_logit": -0.2397584319114685
        },
        {
            "text": "(PI3K) inhibitor. The clinical activity of ibrutinib,",
            "probability": 1.6446462471994036e-09,
            "start_logit": -3.660304307937622,
            "end_logit": 1.0726852416992188
        },
        {
            "text": "Bruton's tyrosine kinase",
            "probability": 1.61515882008606e-09,
            "start_logit": -2.747429132461548,
            "end_logit": 0.1417180448770523
        },
        {
            "text": "(Syk), Bruton's tyrosine kinase",
            "probability": 2.2576798993564887e-10,
            "start_logit": -4.715109825134277,
            "end_logit": 0.1417180448770523
        },
        {
            "text": "PI3K (PI3K) inhibitor. The clinical activity of ibrutinib,",
            "probability": 1.422230033071162e-10,
            "start_logit": -6.108188629150391,
            "end_logit": 1.0726852416992188
        },
        {
            "text": "spleen tyrosine kinase (Syk),",
            "probability": 9.334679381288418e-11,
            "start_logit": 1.2203599214553833,
            "end_logit": -6.676938056945801
        },
        {
            "text": "spleen tyrosine kinase (Syk), Bruton's",
            "probability": 8.642216089508389e-11,
            "start_logit": 1.2203599214553833,
            "end_logit": -6.7540154457092285
        },
        {
            "text": "sple",
            "probability": 7.611411971933273e-11,
            "start_logit": 1.2203599214553833,
            "end_logit": -6.881025791168213
        },
        {
            "text": "spleen tyrosine kinase (Syk), Bruton's tyrosine kinase (Btk)",
            "probability": 7.506396838865795e-11,
            "start_logit": 1.2203599214553833,
            "end_logit": -6.894918918609619
        },
        {
            "text": "tyrosine kinase",
            "probability": 6.257675744294154e-11,
            "start_logit": -5.998223781585693,
            "end_logit": 0.1417180448770523
        }
    ],
    "530cf4c54a5037880c000008_015": [
        {
            "text": "Ibrutinib",
            "probability": 0.99921894485233,
            "start_logit": 9.806653022766113,
            "end_logit": 9.100272178649902
        },
        {
            "text": "I",
            "probability": 0.0006082554392643185,
            "start_logit": 9.806653022766113,
            "end_logit": 1.6961379051208496
        },
        {
            "text": "ib",
            "probability": 0.00015546691689135192,
            "start_logit": 1.0383567810058594,
            "end_logit": 9.100272178649902
        },
        {
            "text": "inib",
            "probability": 5.329180594680114e-06,
            "start_logit": -2.33487868309021,
            "end_logit": 9.100272178649902
        },
        {
            "text": "brutinib",
            "probability": 4.304292713951515e-06,
            "start_logit": -2.5484633445739746,
            "end_logit": 9.100272178649902
        },
        {
            "text": "Bruton's tyrosine kinase (Btk), Ibrutinib",
            "probability": 3.4694981409754317e-06,
            "start_logit": -2.764066219329834,
            "end_logit": 9.100272178649902
        },
        {
            "text": "Ibr",
            "probability": 2.6200893516781944e-06,
            "start_logit": 9.806653022766113,
            "end_logit": -3.751248598098755
        },
        {
            "text": "Ibrut",
            "probability": 4.870455828777837e-07,
            "start_logit": 9.806653022766113,
            "end_logit": -5.433854579925537
        },
        {
            "text": "Ibrutinib (PCI-32765), demonstrated that Btk",
            "probability": 3.347421650980471e-07,
            "start_logit": 9.806653022766113,
            "end_logit": -5.808851718902588
        },
        {
            "text": "utinib",
            "probability": 1.9445422779036298e-07,
            "start_logit": -5.645634651184082,
            "end_logit": 9.100272178649902
        },
        {
            "text": "(Btk), Ibrutinib",
            "probability": 1.9268023328232013e-07,
            "start_logit": -5.654799461364746,
            "end_logit": 9.100272178649902
        },
        {
            "text": "the selective small molecule inhibitor of Bruton's tyrosine kinase (Btk), Ibrutinib",
            "probability": 1.5181287840392827e-07,
            "start_logit": -5.893182754516602,
            "end_logit": 9.100272178649902
        },
        {
            "text": "Ibrutin",
            "probability": 1.0614835862194639e-07,
            "start_logit": 9.806653022766113,
            "end_logit": -6.957374572753906
        },
        {
            "text": "tyrosine kinase (Btk), Ibrutinib",
            "probability": 7.15374182175715e-08,
            "start_logit": -6.645610809326172,
            "end_logit": 9.100272178649902
        },
        {
            "text": "Ibrutinib (PCI-32765), demonstrated that Btk inhibition sensitizes CLL",
            "probability": 7.123222558572133e-08,
            "start_logit": 9.806653022766113,
            "end_logit": -7.356266975402832
        },
        {
            "text": "first studies on the selective small molecule inhibitor of Bruton's tyrosine kinase (Btk), Ibrutinib",
            "probability": 4.730199125033308e-11,
            "start_logit": -6.562900066375732,
            "end_logit": 1.6961379051208496
        },
        {
            "text": "Ibrutinib (PCI-32765), demonstrated that Btk inhibition sensitizes CLL cells to apoptosis",
            "probability": 1.401196938633754e-11,
            "start_logit": 1.0383567810058594,
            "end_logit": -7.121759414672852
        },
        {
            "text": "br",
            "probability": 1.1286446843736604e-11,
            "start_logit": -2.5484633445739746,
            "end_logit": -3.751248598098755
        },
        {
            "text": "Bruton's tyrosine kinase",
            "probability": 2.92470976326209e-12,
            "start_logit": -2.764066219329834,
            "end_logit": -4.886053085327148
        },
        {
            "text": "brut",
            "probability": 2.0980254273030504e-12,
            "start_logit": -2.5484633445739746,
            "end_logit": -5.433854579925537
        }
    ],
    "530cf4c54a5037880c000008_016": [
        {
            "text": "ibrutinib",
            "probability": 0.9994734360026456,
            "start_logit": 9.56583023071289,
            "end_logit": 9.140022277832031
        },
        {
            "text": "ib",
            "probability": 0.0002640281945251431,
            "start_logit": 1.3269022703170776,
            "end_logit": 9.140022277832031
        },
        {
            "text": "ibr",
            "probability": 0.00025146095580007153,
            "start_logit": 9.56583023071289,
            "end_logit": 0.8523261547088623
        },
        {
            "text": "inib",
            "probability": 3.7123410354442987e-06,
            "start_logit": -2.937490940093994,
            "end_logit": 9.140022277832031
        },
        {
            "text": "ibrut",
            "probability": 2.3831416965025753e-06,
            "start_logit": 9.56583023071289,
            "end_logit": -3.806541919708252
        },
        {
            "text": "ibrutin",
            "probability": 2.0711694995846575e-06,
            "start_logit": 9.56583023071289,
            "end_logit": -3.946848154067993
        },
        {
            "text": "Bruton's tyrosine kinase (Btk) inhibitor ibrutinib",
            "probability": 1.567669275202197e-06,
            "start_logit": -3.7995636463165283,
            "end_logit": 9.140022277832031
        },
        {
            "text": "BCR signaling kinases, Bruton's tyrosine kinase (Btk) inhibitor ibrutinib",
            "probability": 7.083954627522642e-07,
            "start_logit": -4.593906402587891,
            "end_logit": 9.140022277832031
        },
        {
            "text": "utinib",
            "probability": 2.5464809552599506e-07,
            "start_logit": -5.617026329040527,
            "end_logit": 9.140022277832031
        },
        {
            "text": "inhibitor ibrutinib",
            "probability": 2.481840383982171e-07,
            "start_logit": -5.642738342285156,
            "end_logit": 9.140022277832031
        },
        {
            "text": "kinases, Bruton's tyrosine kinase (Btk) inhibitor ibrutinib",
            "probability": 1.292714002824064e-07,
            "start_logit": -6.294994831085205,
            "end_logit": 9.140022277832031
        },
        {
            "text": "ibrutinib and the phosphoinositide 3'-kinase delta (PI3K\u03b4) inhibitor GS-1101,",
            "probability": 1.4713812566085835e-11,
            "start_logit": 1.3269022703170776,
            "end_logit": -7.56275749206543
        },
        {
            "text": "in",
            "probability": 7.692938349037228e-12,
            "start_logit": -2.937490940093994,
            "end_logit": -3.946848154067993
        },
        {
            "text": "Bruton's tyrosine kinase (Btk) inhibitor",
            "probability": 1.3172705973733643e-12,
            "start_logit": -3.7995636463165283,
            "end_logit": -4.84951639175415
        },
        {
            "text": "ut",
            "probability": 6.071822146770525e-13,
            "start_logit": -5.617026329040527,
            "end_logit": -3.806541919708252
        },
        {
            "text": "BCR signaling kinases, Bruton's tyrosine kinase (Btk) inhibitor",
            "probability": 5.95245776106634e-13,
            "start_logit": -4.593906402587891,
            "end_logit": -4.84951639175415
        },
        {
            "text": "BCR",
            "probability": 5.83126202834386e-13,
            "start_logit": -4.539811134338379,
            "end_logit": -4.924182415008545
        },
        {
            "text": "utin",
            "probability": 5.276972349461874e-13,
            "start_logit": -5.617026329040527,
            "end_logit": -3.946848154067993
        },
        {
            "text": "Bruton's tyrosine kinase",
            "probability": 2.792763051415352e-13,
            "start_logit": -3.7995636463165283,
            "end_logit": -6.400631904602051
        },
        {
            "text": "inhibitor",
            "probability": 2.0854241496643914e-13,
            "start_logit": -5.642738342285156,
            "end_logit": -4.84951639175415
        }
    ],
    "530cf4c54a5037880c000008_017": [
        {
            "text": "Ibrutinib",
            "probability": 0.9992913306197662,
            "start_logit": 9.772825241088867,
            "end_logit": 9.18999195098877
        },
        {
            "text": "I",
            "probability": 0.00042703475276134,
            "start_logit": 9.772825241088867,
            "end_logit": 1.4320557117462158
        },
        {
            "text": "ib",
            "probability": 0.0002549991740332788,
            "start_logit": 1.4992839097976685,
            "end_logit": 9.18999195098877
        },
        {
            "text": "inib",
            "probability": 1.1693927304409364e-05,
            "start_logit": -1.582906723022461,
            "end_logit": 9.18999195098877
        },
        {
            "text": "(Ibrutinib,",
            "probability": 5.799357396491165e-06,
            "start_logit": 9.772825241088867,
            "end_logit": -2.867062568664551
        },
        {
            "text": "brutinib",
            "probability": 2.4427909414146474e-06,
            "start_logit": -3.1488351821899414,
            "end_logit": 9.18999195098877
        },
        {
            "text": "Ibr",
            "probability": 2.237827875482704e-06,
            "start_logit": 9.772825241088867,
            "end_logit": -3.8193039894104004
        },
        {
            "text": "Ibrutin",
            "probability": 2.0625339714011534e-06,
            "start_logit": 9.772825241088867,
            "end_logit": -3.900874376296997
        },
        {
            "text": "Ibrut",
            "probability": 1.2100271266861869e-06,
            "start_logit": 9.772825241088867,
            "end_logit": -4.43416690826416
        },
        {
            "text": "Bruton's tyrosine kinase inhibitors (Ibrutinib,",
            "probability": 5.927343960843976e-07,
            "start_logit": -4.564985275268555,
            "end_logit": 9.18999195098877
        },
        {
            "text": "utinib",
            "probability": 1.7071783616648061e-07,
            "start_logit": -5.809719562530518,
            "end_logit": 9.18999195098877
        },
        {
            "text": "tyrosine kinase inhibitors (Ibrutinib,",
            "probability": 1.2978625706466374e-07,
            "start_logit": -6.083842754364014,
            "end_logit": 9.18999195098877
        },
        {
            "text": "and Bruton's tyrosine kinase inhibitors (Ibrutinib,",
            "probability": 8.224974782052546e-08,
            "start_logit": -6.539971351623535,
            "end_logit": 9.18999195098877
        },
        {
            "text": "PI3K",
            "probability": 6.846624551470017e-08,
            "start_logit": 1.7061471939086914,
            "end_logit": 0.7604539394378662
        },
        {
            "text": "(Ibrutinib, AVL-263).",
            "probability": 5.897909712312079e-08,
            "start_logit": 9.772825241088867,
            "end_logit": -7.455381870269775
        },
        {
            "text": "inhibitors (Ibrutinib,",
            "probability": 5.623417407001678e-08,
            "start_logit": -6.9202070236206055,
            "end_logit": 9.18999195098877
        },
        {
            "text": "imatinib",
            "probability": 2.7843269863555883e-08,
            "start_logit": 1.4013580083847046,
            "end_logit": 0.16549354791641235
        },
        {
            "text": "spleen tyrosine kinase",
            "probability": 1.6872696386013786e-09,
            "start_logit": 0.24950118362903595,
            "end_logit": -1.4861292839050293
        },
        {
            "text": "1998, was imatinib",
            "probability": 1.4652268803050358e-10,
            "start_logit": -3.845808267593384,
            "end_logit": 0.16549354791641235
        },
        {
            "text": "bosutinib",
            "probability": 1.4400736567780916e-10,
            "start_logit": -3.4902987480163574,
            "end_logit": -0.2073318064212799
        }
    ],
    "54f2210164850a5854000001_001": [
        {
            "text": "Hepcidin contains eight cysteine residues that form four disulfide bridges,",
            "probability": 0.9921212287051892,
            "start_logit": 8.529592514038086,
            "end_logit": 9.27320671081543
        },
        {
            "text": "Hepcidin",
            "probability": 0.00663821717266242,
            "start_logit": 8.529592514038086,
            "end_logit": 4.266204833984375
        },
        {
            "text": ",",
            "probability": 0.0005763719494371862,
            "start_logit": 1.0787451267242432,
            "end_logit": 9.27320671081543
        },
        {
            "text": "Hepcidin contains eight",
            "probability": 0.00020062394186514402,
            "start_logit": 8.529592514038086,
            "end_logit": 0.7670383453369141
        },
        {
            "text": "Hepcidin contains eight cysteine residues that form four",
            "probability": 0.00013488407747838806,
            "start_logit": 8.529592514038086,
            "end_logit": 0.37002184987068176
        },
        {
            "text": "Hepcidin contains",
            "probability": 7.98761699695684e-05,
            "start_logit": 8.529592514038086,
            "end_logit": -0.15391631424427032
        },
        {
            "text": "eight cysteine residues that form four disulfide bridges,",
            "probability": 5.086643316027497e-05,
            "start_logit": -1.3488048315048218,
            "end_logit": 9.27320671081543
        },
        {
            "text": "contains eight cysteine residues that form four disulfide bridges,",
            "probability": 3.773073041507261e-05,
            "start_logit": -1.6475331783294678,
            "end_logit": 9.27320671081543
        },
        {
            "text": "four disulfide bridges,",
            "probability": 3.49275206611104e-05,
            "start_logit": -1.7247329950332642,
            "end_logit": 9.27320671081543
        },
        {
            "text": "H",
            "probability": 2.5613512442559703e-05,
            "start_logit": 8.529592514038086,
            "end_logit": -1.291273832321167
        },
        {
            "text": "Hepcidin contains eight cysteine residues that form",
            "probability": 2.2648363356879565e-05,
            "start_logit": 8.529592514038086,
            "end_logit": -1.4143062829971313
        },
        {
            "text": "Hepcidin contains eight cysteine",
            "probability": 1.725742094391259e-05,
            "start_logit": 8.529592514038086,
            "end_logit": -1.6861516237258911
        },
        {
            "text": "disulfide bridges,",
            "probability": 1.1441121160182459e-05,
            "start_logit": -2.840794086456299,
            "end_logit": 9.27320671081543
        },
        {
            "text": "Hepcidin contains eight cysteine residues that form four disulfide bridges, which",
            "probability": 1.0388032891840735e-05,
            "start_logit": 8.529592514038086,
            "end_logit": -2.193739414215088
        },
        {
            "text": "cysteine residues that form four disulfide bridges,",
            "probability": 9.675386820424878e-06,
            "start_logit": -3.0084228515625,
            "end_logit": 9.27320671081543
        },
        {
            "text": "Hepcidin contains eight cysteine residues that form four disulfide bridges, which stabilize",
            "probability": 8.425518454406237e-06,
            "start_logit": 8.529592514038086,
            "end_logit": -2.4031288623809814
        },
        {
            "text": "residues that form four disulfide bridges,",
            "probability": 8.270445607173213e-06,
            "start_logit": -3.1653196811676025,
            "end_logit": 9.27320671081543
        },
        {
            "text": "Hepcidin contains eight cysteine residues that form four disulfide bridges, which stabilize a hairpin-shaped",
            "probability": 6.181368749101917e-06,
            "start_logit": 8.529592514038086,
            "end_logit": -2.7128541469573975
        },
        {
            "text": "Hepcidin contains eight cysteine residues",
            "probability": 2.804536835892094e-06,
            "start_logit": 8.529592514038086,
            "end_logit": -3.503155469894409
        },
        {
            "text": "that form four disulfide bridges,",
            "probability": 2.5675918993163856e-06,
            "start_logit": -4.3350396156311035,
            "end_logit": 9.27320671081543
        }
    ],
    "55242d512c8b63434a000006_001": [
        {
            "text": "5-HT2ARs",
            "probability": 0.5755064668725747,
            "start_logit": 8.309171676635742,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(5-HT2AR)",
            "probability": 0.42409374218265095,
            "start_logit": 8.114241600036621,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5",
            "probability": 0.00014977364545178576,
            "start_logit": 8.309171676635742,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "s",
            "probability": 8.835525368407642e-05,
            "start_logit": -0.47246840596199036,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(",
            "probability": 7.513536578080681e-05,
            "start_logit": 8.114241600036621,
            "end_logit": -1.0326817035675049
        },
        {
            "text": ")",
            "probability": 5.652879274791656e-05,
            "start_logit": -0.8087180852890015,
            "end_logit": 7.60573673248291
        },
        {
            "text": "quantifying cerebral 5-HT2ARs",
            "probability": 7.434116063834184e-06,
            "start_logit": -2.947754383087158,
            "end_logit": 7.716102600097656
        },
        {
            "text": "well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 5.835288196807674e-06,
            "start_logit": -3.189910411834717,
            "end_logit": 7.716102600097656
        },
        {
            "text": "5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 5.303377029256705e-06,
            "start_logit": -3.175124406814575,
            "end_logit": 7.60573673248291
        },
        {
            "text": "for quantifying cerebral 5-HT2ARs",
            "probability": 2.704281080182175e-06,
            "start_logit": -3.958997964859009,
            "end_logit": 7.716102600097656
        },
        {
            "text": "the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 2.5070188414051633e-06,
            "start_logit": -3.9243738651275635,
            "end_logit": 7.60573673248291
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established",
            "probability": 1.8508622619912786e-06,
            "start_logit": 8.114241600036621,
            "end_logit": -4.736321449279785
        },
        {
            "text": "receptor (5-HT2AR)",
            "probability": 1.6514184880742904e-06,
            "start_logit": -4.341833591461182,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5-HT2AR",
            "probability": 1.1953673872915587e-06,
            "start_logit": 1.7927563190460205,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET)",
            "probability": 9.325950952212353e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -5.616687297821045
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET) in albino rats.",
            "probability": 3.309560725662402e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -6.65267276763916
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established in humans,",
            "probability": 2.471080328859431e-07,
            "start_logit": 8.114241600036621,
            "end_logit": -6.749902725219727
        },
        {
            "text": "AR",
            "probability": 2.0589976003118943e-09,
            "start_logit": -4.57123327255249,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "[18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 1.8492413114800943e-09,
            "start_logit": -2.9929332733154297,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "quantification of 5-HT2AR",
            "probability": 1.5903213843150035e-09,
            "start_logit": -4.829516410827637,
            "end_logit": 1.1479657888412476
        }
    ],
    "55242d512c8b63434a000006_002": [
        {
            "text": "5-HT2ARs",
            "probability": 0.5755064668725747,
            "start_logit": 8.309171676635742,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(5-HT2AR)",
            "probability": 0.42409374218265095,
            "start_logit": 8.114241600036621,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5",
            "probability": 0.00014977364545178576,
            "start_logit": 8.309171676635742,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "s",
            "probability": 8.835525368407642e-05,
            "start_logit": -0.47246840596199036,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(",
            "probability": 7.513536578080681e-05,
            "start_logit": 8.114241600036621,
            "end_logit": -1.0326817035675049
        },
        {
            "text": ")",
            "probability": 5.652879274791656e-05,
            "start_logit": -0.8087180852890015,
            "end_logit": 7.60573673248291
        },
        {
            "text": "quantifying cerebral 5-HT2ARs",
            "probability": 7.434116063834184e-06,
            "start_logit": -2.947754383087158,
            "end_logit": 7.716102600097656
        },
        {
            "text": "well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 5.835288196807674e-06,
            "start_logit": -3.189910411834717,
            "end_logit": 7.716102600097656
        },
        {
            "text": "5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 5.303377029256705e-06,
            "start_logit": -3.175124406814575,
            "end_logit": 7.60573673248291
        },
        {
            "text": "for quantifying cerebral 5-HT2ARs",
            "probability": 2.704281080182175e-06,
            "start_logit": -3.958997964859009,
            "end_logit": 7.716102600097656
        },
        {
            "text": "the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 2.5070188414051633e-06,
            "start_logit": -3.9243738651275635,
            "end_logit": 7.60573673248291
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established",
            "probability": 1.8508622619912786e-06,
            "start_logit": 8.114241600036621,
            "end_logit": -4.736321449279785
        },
        {
            "text": "receptor (5-HT2AR)",
            "probability": 1.6514184880742904e-06,
            "start_logit": -4.341833591461182,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5-HT2AR",
            "probability": 1.1953673872915587e-06,
            "start_logit": 1.7927563190460205,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET)",
            "probability": 9.325950952212353e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -5.616687297821045
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET) in albino rats.",
            "probability": 3.309560725662402e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -6.65267276763916
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established in humans,",
            "probability": 2.471080328859431e-07,
            "start_logit": 8.114241600036621,
            "end_logit": -6.749902725219727
        },
        {
            "text": "AR",
            "probability": 2.0589976003118943e-09,
            "start_logit": -4.57123327255249,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "[18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 1.8492413114800943e-09,
            "start_logit": -2.9929332733154297,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "quantification of 5-HT2AR",
            "probability": 1.5903213843150035e-09,
            "start_logit": -4.829516410827637,
            "end_logit": 1.1479657888412476
        }
    ],
    "55242d512c8b63434a000006_003": [
        {
            "text": "5-HT2ARs",
            "probability": 0.5755064668725747,
            "start_logit": 8.309171676635742,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(5-HT2AR)",
            "probability": 0.42409374218265095,
            "start_logit": 8.114241600036621,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5",
            "probability": 0.00014977364545178576,
            "start_logit": 8.309171676635742,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "s",
            "probability": 8.835525368407642e-05,
            "start_logit": -0.47246840596199036,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(",
            "probability": 7.513536578080681e-05,
            "start_logit": 8.114241600036621,
            "end_logit": -1.0326817035675049
        },
        {
            "text": ")",
            "probability": 5.652879274791656e-05,
            "start_logit": -0.8087180852890015,
            "end_logit": 7.60573673248291
        },
        {
            "text": "quantifying cerebral 5-HT2ARs",
            "probability": 7.434116063834184e-06,
            "start_logit": -2.947754383087158,
            "end_logit": 7.716102600097656
        },
        {
            "text": "well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 5.835288196807674e-06,
            "start_logit": -3.189910411834717,
            "end_logit": 7.716102600097656
        },
        {
            "text": "5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 5.303377029256705e-06,
            "start_logit": -3.175124406814575,
            "end_logit": 7.60573673248291
        },
        {
            "text": "for quantifying cerebral 5-HT2ARs",
            "probability": 2.704281080182175e-06,
            "start_logit": -3.958997964859009,
            "end_logit": 7.716102600097656
        },
        {
            "text": "the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 2.5070188414051633e-06,
            "start_logit": -3.9243738651275635,
            "end_logit": 7.60573673248291
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established",
            "probability": 1.8508622619912786e-06,
            "start_logit": 8.114241600036621,
            "end_logit": -4.736321449279785
        },
        {
            "text": "receptor (5-HT2AR)",
            "probability": 1.6514184880742904e-06,
            "start_logit": -4.341833591461182,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5-HT2AR",
            "probability": 1.1953673872915587e-06,
            "start_logit": 1.7927563190460205,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET)",
            "probability": 9.325950952212353e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -5.616687297821045
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET) in albino rats.",
            "probability": 3.309560725662402e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -6.65267276763916
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established in humans,",
            "probability": 2.471080328859431e-07,
            "start_logit": 8.114241600036621,
            "end_logit": -6.749902725219727
        },
        {
            "text": "AR",
            "probability": 2.0589976003118943e-09,
            "start_logit": -4.57123327255249,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "[18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 1.8492413114800943e-09,
            "start_logit": -2.9929332733154297,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "quantification of 5-HT2AR",
            "probability": 1.5903213843150035e-09,
            "start_logit": -4.829516410827637,
            "end_logit": 1.1479657888412476
        }
    ],
    "55242d512c8b63434a000006_004": [
        {
            "text": "(5-HT2A",
            "probability": 0.9620275683772639,
            "start_logit": 6.619503021240234,
            "end_logit": 5.661994457244873
        },
        {
            "text": "5-HT2A",
            "probability": 0.037105633773021285,
            "start_logit": 4.8947834968566895,
            "end_logit": 4.131439685821533
        },
        {
            "text": "5",
            "probability": 0.00037127515670678715,
            "start_logit": 6.619503021240234,
            "end_logit": -2.1978604793548584
        },
        {
            "text": "5-HT2A receptor imaging with PET. Imaging the cerebral serotonin 2A (5-HT2A",
            "probability": 0.00030153146248879537,
            "start_logit": -1.4484210014343262,
            "end_logit": 5.661994457244873
        },
        {
            "text": "A",
            "probability": 0.00011037843511251403,
            "start_logit": -2.453380584716797,
            "end_logit": 5.661994457244873
        },
        {
            "text": "Imaging the cerebral serotonin 2A (5-HT2A",
            "probability": 4.808264815031864e-05,
            "start_logit": -3.2843739986419678,
            "end_logit": 5.661994457244873
        },
        {
            "text": "serotonin 2A (5-HT2A",
            "probability": 8.051849974429083e-06,
            "start_logit": -5.0713934898376465,
            "end_logit": 5.661994457244873
        },
        {
            "text": "the cerebral serotonin 2A (5-HT2A",
            "probability": 7.134438374597543e-06,
            "start_logit": -5.192361831665039,
            "end_logit": 5.661994457244873
        },
        {
            "text": "HT2A",
            "probability": 6.06774910763313e-06,
            "start_logit": -5.354307651519775,
            "end_logit": 5.661994457244873
        },
        {
            "text": "(5-HT2A ) receptors with positron emission tomography (PET)",
            "probability": 2.6310526147027082e-06,
            "start_logit": 6.619503021240234,
            "end_logit": -7.1474199295043945
        },
        {
            "text": "(5-HT2A ) receptors with positron emission tomography",
            "probability": 2.3365976914567168e-06,
            "start_logit": 6.619503021240234,
            "end_logit": -7.26610803604126
        },
        {
            "text": "to 5-HT2A",
            "probability": 2.0238767270465718e-06,
            "start_logit": -4.921725749969482,
            "end_logit": 4.131439685821533
        },
        {
            "text": "(5-HT2A ) receptors",
            "probability": 1.615550730447268e-06,
            "start_logit": 6.619503021240234,
            "end_logit": -7.635128021240234
        },
        {
            "text": "cerebral serotonin 2A (5-HT2A",
            "probability": 1.441660754292074e-06,
            "start_logit": -6.791499614715576,
            "end_logit": 5.661994457244873
        },
        {
            "text": "2A (5-HT2A",
            "probability": 1.168092739013996e-06,
            "start_logit": -7.001923084259033,
            "end_logit": 5.661994457244873
        },
        {
            "text": "2A",
            "probability": 1.0314715246239304e-06,
            "start_logit": -7.126308917999268,
            "end_logit": 5.661994457244873
        },
        {
            "text": "(5-HT2A )",
            "probability": 9.64700442803548e-07,
            "start_logit": 6.619503021240234,
            "end_logit": -8.150741577148438
        },
        {
            "text": "5-HT2A receptors",
            "probability": 5.372265631536832e-07,
            "start_logit": 4.8947834968566895,
            "end_logit": -7.011419773101807
        },
        {
            "text": "bind to 5-HT2A",
            "probability": 4.3154812773033934e-07,
            "start_logit": -6.467116832733154,
            "end_logit": 4.131439685821533
        },
        {
            "text": "5-HT2A receptors in the pig brain.",
            "probability": 9.433188471029201e-08,
            "start_logit": 4.8947834968566895,
            "end_logit": -8.751020431518555
        }
    ],
    "55242d512c8b63434a000006_005": [
        {
            "text": "(5-HT2A",
            "probability": 0.9620275683772639,
            "start_logit": 6.619503021240234,
            "end_logit": 5.661994457244873
        },
        {
            "text": "5-HT2A",
            "probability": 0.037105633773021285,
            "start_logit": 4.8947834968566895,
            "end_logit": 4.131439685821533
        },
        {
            "text": "5",
            "probability": 0.00037127515670678715,
            "start_logit": 6.619503021240234,
            "end_logit": -2.1978604793548584
        },
        {
            "text": "5-HT2A receptor imaging with PET. Imaging the cerebral serotonin 2A (5-HT2A",
            "probability": 0.00030153146248879537,
            "start_logit": -1.4484210014343262,
            "end_logit": 5.661994457244873
        },
        {
            "text": "A",
            "probability": 0.00011037843511251403,
            "start_logit": -2.453380584716797,
            "end_logit": 5.661994457244873
        },
        {
            "text": "Imaging the cerebral serotonin 2A (5-HT2A",
            "probability": 4.808264815031864e-05,
            "start_logit": -3.2843739986419678,
            "end_logit": 5.661994457244873
        },
        {
            "text": "serotonin 2A (5-HT2A",
            "probability": 8.051849974429083e-06,
            "start_logit": -5.0713934898376465,
            "end_logit": 5.661994457244873
        },
        {
            "text": "the cerebral serotonin 2A (5-HT2A",
            "probability": 7.134438374597543e-06,
            "start_logit": -5.192361831665039,
            "end_logit": 5.661994457244873
        },
        {
            "text": "HT2A",
            "probability": 6.06774910763313e-06,
            "start_logit": -5.354307651519775,
            "end_logit": 5.661994457244873
        },
        {
            "text": "(5-HT2A ) receptors with positron emission tomography (PET)",
            "probability": 2.6310526147027082e-06,
            "start_logit": 6.619503021240234,
            "end_logit": -7.1474199295043945
        },
        {
            "text": "(5-HT2A ) receptors with positron emission tomography",
            "probability": 2.3365976914567168e-06,
            "start_logit": 6.619503021240234,
            "end_logit": -7.26610803604126
        },
        {
            "text": "to 5-HT2A",
            "probability": 2.0238767270465718e-06,
            "start_logit": -4.921725749969482,
            "end_logit": 4.131439685821533
        },
        {
            "text": "(5-HT2A ) receptors",
            "probability": 1.615550730447268e-06,
            "start_logit": 6.619503021240234,
            "end_logit": -7.635128021240234
        },
        {
            "text": "cerebral serotonin 2A (5-HT2A",
            "probability": 1.441660754292074e-06,
            "start_logit": -6.791499614715576,
            "end_logit": 5.661994457244873
        },
        {
            "text": "2A (5-HT2A",
            "probability": 1.168092739013996e-06,
            "start_logit": -7.001923084259033,
            "end_logit": 5.661994457244873
        },
        {
            "text": "2A",
            "probability": 1.0314715246239304e-06,
            "start_logit": -7.126308917999268,
            "end_logit": 5.661994457244873
        },
        {
            "text": "(5-HT2A )",
            "probability": 9.64700442803548e-07,
            "start_logit": 6.619503021240234,
            "end_logit": -8.150741577148438
        },
        {
            "text": "5-HT2A receptors",
            "probability": 5.372265631536832e-07,
            "start_logit": 4.8947834968566895,
            "end_logit": -7.011419773101807
        },
        {
            "text": "bind to 5-HT2A",
            "probability": 4.3154812773033934e-07,
            "start_logit": -6.467116832733154,
            "end_logit": 4.131439685821533
        },
        {
            "text": "5-HT2A receptors in the pig brain.",
            "probability": 9.433188471029201e-08,
            "start_logit": 4.8947834968566895,
            "end_logit": -8.751020431518555
        }
    ],
    "55242d512c8b63434a000006_006": [
        {
            "text": "(5-HT2AR)",
            "probability": 0.3604058307732247,
            "start_logit": 9.389631271362305,
            "end_logit": 9.18984317779541
        },
        {
            "text": "5-HT2A receptor binding (5-HT2AR)",
            "probability": 0.35450674414367783,
            "start_logit": 9.373127937316895,
            "end_logit": 9.18984317779541
        },
        {
            "text": "5-HT2A",
            "probability": 0.28473113690014823,
            "start_logit": 9.373127937316895,
            "end_logit": 8.970661163330078
        },
        {
            "text": "(",
            "probability": 0.000101590190162926,
            "start_logit": 9.389631271362305,
            "end_logit": 1.0158041715621948
        },
        {
            "text": "5",
            "probability": 0.00010082398093139071,
            "start_logit": 9.373127937316895,
            "end_logit": 1.024736762046814
        },
        {
            "text": "frontal cortex 5-HT2A receptor binding (5-HT2AR)",
            "probability": 4.391816749444941e-05,
            "start_logit": 0.37697336077690125,
            "end_logit": 9.18984317779541
        },
        {
            "text": ")",
            "probability": 3.685629828284582e-05,
            "start_logit": 0.2016718089580536,
            "end_logit": 9.18984317779541
        },
        {
            "text": "frontal cortex 5-HT2A",
            "probability": 3.52739968077945e-05,
            "start_logit": 0.37697336077690125,
            "end_logit": 8.970661163330078
        },
        {
            "text": "A",
            "probability": 3.2888397258886595e-05,
            "start_logit": 0.3069472312927246,
            "end_logit": 8.970661163330078
        },
        {
            "text": "cortex 5-HT2A receptor binding (5-HT2AR)",
            "probability": 1.5684681490861478e-06,
            "start_logit": -2.9552552700042725,
            "end_logit": 9.18984317779541
        },
        {
            "text": "cortex 5-HT2A",
            "probability": 1.2597552138527752e-06,
            "start_logit": -2.9552552700042725,
            "end_logit": 8.970661163330078
        },
        {
            "text": "5-HT2A receptor",
            "probability": 7.028312143079908e-07,
            "start_logit": 9.373127937316895,
            "end_logit": -3.9412779808044434
        },
        {
            "text": "HT2A",
            "probability": 3.790465053143567e-07,
            "start_logit": -4.156269073486328,
            "end_logit": 8.970661163330078
        },
        {
            "text": "receptor binding (5-HT2AR)",
            "probability": 3.7788754624022923e-07,
            "start_logit": -4.378513336181641,
            "end_logit": 9.18984317779541
        },
        {
            "text": "related to frontal cortex 5-HT2A receptor binding (5-HT2AR)",
            "probability": 1.672651679124696e-07,
            "start_logit": -5.1935296058654785,
            "end_logit": 9.18984317779541
        },
        {
            "text": "5-HT2A receptor binding",
            "probability": 1.5611486677007985e-07,
            "start_logit": 9.373127937316895,
            "end_logit": -5.445802688598633
        },
        {
            "text": "binding (5-HT2AR)",
            "probability": 1.3499577921222304e-07,
            "start_logit": -5.407866477966309,
            "end_logit": 9.18984317779541
        },
        {
            "text": "related to frontal cortex 5-HT2A",
            "probability": 1.343432874275856e-07,
            "start_logit": -5.1935296058654785,
            "end_logit": 8.970661163330078
        },
        {
            "text": "(5-HT2AR) as measured",
            "probability": 2.845501487911042e-08,
            "start_logit": 9.389631271362305,
            "end_logit": -7.164573669433594
        },
        {
            "text": "5-HT2A receptor binding (5-HT2AR) as measured",
            "probability": 2.7989266038541474e-08,
            "start_logit": 9.373127937316895,
            "end_logit": -7.164573669433594
        }
    ],
    "55242d512c8b63434a000006_007": [
        {
            "text": "(5-HT2AR)",
            "probability": 0.3604058307732247,
            "start_logit": 9.389631271362305,
            "end_logit": 9.18984317779541
        },
        {
            "text": "5-HT2A receptor binding (5-HT2AR)",
            "probability": 0.35450674414367783,
            "start_logit": 9.373127937316895,
            "end_logit": 9.18984317779541
        },
        {
            "text": "5-HT2A",
            "probability": 0.28473113690014823,
            "start_logit": 9.373127937316895,
            "end_logit": 8.970661163330078
        },
        {
            "text": "(",
            "probability": 0.000101590190162926,
            "start_logit": 9.389631271362305,
            "end_logit": 1.0158041715621948
        },
        {
            "text": "5",
            "probability": 0.00010082398093139071,
            "start_logit": 9.373127937316895,
            "end_logit": 1.024736762046814
        },
        {
            "text": "frontal cortex 5-HT2A receptor binding (5-HT2AR)",
            "probability": 4.391816749444941e-05,
            "start_logit": 0.37697336077690125,
            "end_logit": 9.18984317779541
        },
        {
            "text": ")",
            "probability": 3.685629828284582e-05,
            "start_logit": 0.2016718089580536,
            "end_logit": 9.18984317779541
        },
        {
            "text": "frontal cortex 5-HT2A",
            "probability": 3.52739968077945e-05,
            "start_logit": 0.37697336077690125,
            "end_logit": 8.970661163330078
        },
        {
            "text": "A",
            "probability": 3.2888397258886595e-05,
            "start_logit": 0.3069472312927246,
            "end_logit": 8.970661163330078
        },
        {
            "text": "cortex 5-HT2A receptor binding (5-HT2AR)",
            "probability": 1.5684681490861478e-06,
            "start_logit": -2.9552552700042725,
            "end_logit": 9.18984317779541
        },
        {
            "text": "cortex 5-HT2A",
            "probability": 1.2597552138527752e-06,
            "start_logit": -2.9552552700042725,
            "end_logit": 8.970661163330078
        },
        {
            "text": "5-HT2A receptor",
            "probability": 7.028312143079908e-07,
            "start_logit": 9.373127937316895,
            "end_logit": -3.9412779808044434
        },
        {
            "text": "HT2A",
            "probability": 3.790465053143567e-07,
            "start_logit": -4.156269073486328,
            "end_logit": 8.970661163330078
        },
        {
            "text": "receptor binding (5-HT2AR)",
            "probability": 3.7788754624022923e-07,
            "start_logit": -4.378513336181641,
            "end_logit": 9.18984317779541
        },
        {
            "text": "related to frontal cortex 5-HT2A receptor binding (5-HT2AR)",
            "probability": 1.672651679124696e-07,
            "start_logit": -5.1935296058654785,
            "end_logit": 9.18984317779541
        },
        {
            "text": "5-HT2A receptor binding",
            "probability": 1.5611486677007985e-07,
            "start_logit": 9.373127937316895,
            "end_logit": -5.445802688598633
        },
        {
            "text": "binding (5-HT2AR)",
            "probability": 1.3499577921222304e-07,
            "start_logit": -5.407866477966309,
            "end_logit": 9.18984317779541
        },
        {
            "text": "related to frontal cortex 5-HT2A",
            "probability": 1.343432874275856e-07,
            "start_logit": -5.1935296058654785,
            "end_logit": 8.970661163330078
        },
        {
            "text": "(5-HT2AR) as measured",
            "probability": 2.845501487911042e-08,
            "start_logit": 9.389631271362305,
            "end_logit": -7.164573669433594
        },
        {
            "text": "5-HT2A receptor binding (5-HT2AR) as measured",
            "probability": 2.7989266038541474e-08,
            "start_logit": 9.373127937316895,
            "end_logit": -7.164573669433594
        }
    ],
    "55242d512c8b63434a000006_008": [
        {
            "text": "5-HT2A receptor",
            "probability": 0.4400339853246589,
            "start_logit": 7.225019454956055,
            "end_logit": 6.248005390167236
        },
        {
            "text": "5-HT2A receptor PET imaging in vivo (11). 5-HT2A antagonists",
            "probability": 0.23625198128840721,
            "start_logit": 7.225019454956055,
            "end_logit": 5.626052379608154
        },
        {
            "text": "5-HT2A antagonists",
            "probability": 0.14440575100464662,
            "start_logit": 6.732747554779053,
            "end_logit": 5.626052379608154
        },
        {
            "text": "5-HT2A antagonists bind to the total pool of receptors, whereas 5-HT2A agonists",
            "probability": 0.13392157355633788,
            "start_logit": 6.732747554779053,
            "end_logit": 5.550679683685303
        },
        {
            "text": "5-HT2A",
            "probability": 0.043875611039109426,
            "start_logit": 5.971557140350342,
            "end_logit": 5.195974349975586
        },
        {
            "text": "5-HT2A agonists",
            "probability": 0.0009008895528509706,
            "start_logit": 4.0524001121521,
            "end_logit": 3.229400157928467
        },
        {
            "text": "5",
            "probability": 0.00019750612843715508,
            "start_logit": 7.225019454956055,
            "end_logit": -1.4608322381973267
        },
        {
            "text": "5-HT2A receptor PET imaging in vivo (11). 5-HT2A",
            "probability": 0.0001371505122709267,
            "start_logit": 7.225019454956055,
            "end_logit": -1.8255228996276855
        },
        {
            "text": "ceptor",
            "probability": 7.318175434837228e-05,
            "start_logit": -1.4766416549682617,
            "end_logit": 6.248005390167236
        },
        {
            "text": "5-HT2A antagonists bind to the total pool of receptors, whereas 5-HT2A",
            "probability": 7.02839511268266e-05,
            "start_logit": 6.732747554779053,
            "end_logit": -2.001786470413208
        },
        {
            "text": "receptor PET imaging in vivo (11). 5-HT2A antagonists",
            "probability": 3.9290907147111184e-05,
            "start_logit": -1.4766416549682617,
            "end_logit": 5.626052379608154
        },
        {
            "text": "agonists",
            "probability": 2.8106137185088046e-05,
            "start_logit": -1.811646819114685,
            "end_logit": 5.626052379608154
        },
        {
            "text": "antagonists bind to the total pool of receptors, whereas 5-HT2A agonists",
            "probability": 2.6065569357387814e-05,
            "start_logit": -1.811646819114685,
            "end_logit": 5.550679683685303
        },
        {
            "text": "A",
            "probability": 1.3247068301772726e-05,
            "start_logit": -2.1337804794311523,
            "end_logit": 5.195974349975586
        },
        {
            "text": "5-HT2A agonist",
            "probability": 1.055512120849002e-05,
            "start_logit": 1.4017404317855835,
            "end_logit": 1.433288335800171
        },
        {
            "text": "5-HT2A receptor PET imaging",
            "probability": 8.161453258652145e-06,
            "start_logit": 7.225019454956055,
            "end_logit": -4.64717960357666
        },
        {
            "text": "of 5-HT2A",
            "probability": 2.3367857467781022e-06,
            "start_logit": -3.8687803745269775,
            "end_logit": 5.195974349975586
        },
        {
            "text": "5-HT2A receptor PET",
            "probability": 2.3080525506193907e-06,
            "start_logit": 7.225019454956055,
            "end_logit": -5.910197734832764
        },
        {
            "text": "5-HT2A receptors",
            "probability": 1.343065982899212e-06,
            "start_logit": 5.971557140350342,
            "end_logit": -5.198184490203857
        },
        {
            "text": "HT2A",
            "probability": 6.717270666106031e-07,
            "start_logit": -5.11545991897583,
            "end_logit": 5.195974349975586
        }
    ],
    "55242d512c8b63434a000006_009": [
        {
            "text": "5-HT2A receptor",
            "probability": 0.4400339853246589,
            "start_logit": 7.225019454956055,
            "end_logit": 6.248005390167236
        },
        {
            "text": "5-HT2A receptor PET imaging in vivo (11). 5-HT2A antagonists",
            "probability": 0.23625198128840721,
            "start_logit": 7.225019454956055,
            "end_logit": 5.626052379608154
        },
        {
            "text": "5-HT2A antagonists",
            "probability": 0.14440575100464662,
            "start_logit": 6.732747554779053,
            "end_logit": 5.626052379608154
        },
        {
            "text": "5-HT2A antagonists bind to the total pool of receptors, whereas 5-HT2A agonists",
            "probability": 0.13392157355633788,
            "start_logit": 6.732747554779053,
            "end_logit": 5.550679683685303
        },
        {
            "text": "5-HT2A",
            "probability": 0.043875611039109426,
            "start_logit": 5.971557140350342,
            "end_logit": 5.195974349975586
        },
        {
            "text": "5-HT2A agonists",
            "probability": 0.0009008895528509706,
            "start_logit": 4.0524001121521,
            "end_logit": 3.229400157928467
        },
        {
            "text": "5",
            "probability": 0.00019750612843715508,
            "start_logit": 7.225019454956055,
            "end_logit": -1.4608322381973267
        },
        {
            "text": "5-HT2A receptor PET imaging in vivo (11). 5-HT2A",
            "probability": 0.0001371505122709267,
            "start_logit": 7.225019454956055,
            "end_logit": -1.8255228996276855
        },
        {
            "text": "ceptor",
            "probability": 7.318175434837228e-05,
            "start_logit": -1.4766416549682617,
            "end_logit": 6.248005390167236
        },
        {
            "text": "5-HT2A antagonists bind to the total pool of receptors, whereas 5-HT2A",
            "probability": 7.02839511268266e-05,
            "start_logit": 6.732747554779053,
            "end_logit": -2.001786470413208
        },
        {
            "text": "receptor PET imaging in vivo (11). 5-HT2A antagonists",
            "probability": 3.9290907147111184e-05,
            "start_logit": -1.4766416549682617,
            "end_logit": 5.626052379608154
        },
        {
            "text": "agonists",
            "probability": 2.8106137185088046e-05,
            "start_logit": -1.811646819114685,
            "end_logit": 5.626052379608154
        },
        {
            "text": "antagonists bind to the total pool of receptors, whereas 5-HT2A agonists",
            "probability": 2.6065569357387814e-05,
            "start_logit": -1.811646819114685,
            "end_logit": 5.550679683685303
        },
        {
            "text": "A",
            "probability": 1.3247068301772726e-05,
            "start_logit": -2.1337804794311523,
            "end_logit": 5.195974349975586
        },
        {
            "text": "5-HT2A agonist",
            "probability": 1.055512120849002e-05,
            "start_logit": 1.4017404317855835,
            "end_logit": 1.433288335800171
        },
        {
            "text": "5-HT2A receptor PET imaging",
            "probability": 8.161453258652145e-06,
            "start_logit": 7.225019454956055,
            "end_logit": -4.64717960357666
        },
        {
            "text": "of 5-HT2A",
            "probability": 2.3367857467781022e-06,
            "start_logit": -3.8687803745269775,
            "end_logit": 5.195974349975586
        },
        {
            "text": "5-HT2A receptor PET",
            "probability": 2.3080525506193907e-06,
            "start_logit": 7.225019454956055,
            "end_logit": -5.910197734832764
        },
        {
            "text": "5-HT2A receptors",
            "probability": 1.343065982899212e-06,
            "start_logit": 5.971557140350342,
            "end_logit": -5.198184490203857
        },
        {
            "text": "HT2A",
            "probability": 6.717270666106031e-07,
            "start_logit": -5.11545991897583,
            "end_logit": 5.195974349975586
        }
    ],
    "55242d512c8b63434a000006_010": [
        {
            "text": "5-HT2A receptor",
            "probability": 0.41624184627835203,
            "start_logit": 7.085555076599121,
            "end_logit": 6.142329692840576
        },
        {
            "text": "5-HT2A receptor PET imaging in vivo (11). 5-HT2A antagonists",
            "probability": 0.2440582003354766,
            "start_logit": 7.085555076599121,
            "end_logit": 5.6084699630737305
        },
        {
            "text": "5-HT2A antagonists",
            "probability": 0.15969653042134382,
            "start_logit": 6.661423683166504,
            "end_logit": 5.6084699630737305
        },
        {
            "text": "5-HT2A antagonists bind to the total pool of receptors, whereas 5-HT2A agonists",
            "probability": 0.151693607592396,
            "start_logit": 6.661423683166504,
            "end_logit": 5.5570573806762695
        },
        {
            "text": "5-HT2A",
            "probability": 0.025610786799061754,
            "start_logit": 5.668877601623535,
            "end_logit": 4.770754337310791
        },
        {
            "text": "5-HT2A agonists",
            "probability": 0.0020899082243538195,
            "start_logit": 4.4205145835876465,
            "end_logit": 3.513223886489868
        },
        {
            "text": "5",
            "probability": 0.00018731772340476285,
            "start_logit": 7.085555076599121,
            "end_logit": -1.5638858079910278
        },
        {
            "text": "5-HT2A receptor PET imaging in vivo (11). 5-HT2A",
            "probability": 0.00013924300872271834,
            "start_logit": 7.085555076599121,
            "end_logit": -1.8604713678359985
        },
        {
            "text": "5-HT2A antagonists bind to the total pool of receptors, whereas 5-HT2A",
            "probability": 8.138586884533477e-05,
            "start_logit": 6.661423683166504,
            "end_logit": -1.9733589887619019
        },
        {
            "text": "ceptor",
            "probability": 7.18419584816491e-05,
            "start_logit": -1.5789979696273804,
            "end_logit": 6.142329692840576
        },
        {
            "text": "receptor PET imaging in vivo (11). 5-HT2A antagonists",
            "probability": 4.2123633777758406e-05,
            "start_logit": -1.5789979696273804,
            "end_logit": 5.6084699630737305
        },
        {
            "text": "agonists",
            "probability": 3.28735471395663e-05,
            "start_logit": -1.8269386291503906,
            "end_logit": 5.6084699630737305
        },
        {
            "text": "antagonists bind to the total pool of receptors, whereas 5-HT2A agonists",
            "probability": 3.1226144655757766e-05,
            "start_logit": -1.8269386291503906,
            "end_logit": 5.5570573806762695
        },
        {
            "text": "A",
            "probability": 8.142131518900746e-06,
            "start_logit": -2.3848392963409424,
            "end_logit": 4.770754337310791
        },
        {
            "text": "5-HT2A receptor PET",
            "probability": 3.7471282737926433e-06,
            "start_logit": 7.085555076599121,
            "end_logit": -5.475702285766602
        },
        {
            "text": "5-HT2A agonist",
            "probability": 3.694105794102869e-06,
            "start_logit": 0.6286105513572693,
            "end_logit": 0.9669910073280334
        },
        {
            "text": "5-HT2A receptor PET imaging",
            "probability": 3.067282701912739e-06,
            "start_logit": 7.085555076599121,
            "end_logit": -5.675899982452393
        },
        {
            "text": "5-HT2A receptors",
            "probability": 2.16077808033417e-06,
            "start_logit": 5.668877601623535,
            "end_logit": -4.609546184539795
        },
        {
            "text": "of 5-HT2A",
            "probability": 1.7256649930228536e-06,
            "start_logit": -3.936278820037842,
            "end_logit": 4.770754337310791
        },
        {
            "text": "HT2A",
            "probability": 5.713726265350294e-07,
            "start_logit": -5.041604995727539,
            "end_logit": 4.770754337310791
        }
    ],
    "55242d512c8b63434a000006_011": [
        {
            "text": "5-HT2A receptor",
            "probability": 0.41624184627835203,
            "start_logit": 7.085555076599121,
            "end_logit": 6.142329692840576
        },
        {
            "text": "5-HT2A receptor PET imaging in vivo (11). 5-HT2A antagonists",
            "probability": 0.2440582003354766,
            "start_logit": 7.085555076599121,
            "end_logit": 5.6084699630737305
        },
        {
            "text": "5-HT2A antagonists",
            "probability": 0.15969653042134382,
            "start_logit": 6.661423683166504,
            "end_logit": 5.6084699630737305
        },
        {
            "text": "5-HT2A antagonists bind to the total pool of receptors, whereas 5-HT2A agonists",
            "probability": 0.151693607592396,
            "start_logit": 6.661423683166504,
            "end_logit": 5.5570573806762695
        },
        {
            "text": "5-HT2A",
            "probability": 0.025610786799061754,
            "start_logit": 5.668877601623535,
            "end_logit": 4.770754337310791
        },
        {
            "text": "5-HT2A agonists",
            "probability": 0.0020899082243538195,
            "start_logit": 4.4205145835876465,
            "end_logit": 3.513223886489868
        },
        {
            "text": "5",
            "probability": 0.00018731772340476285,
            "start_logit": 7.085555076599121,
            "end_logit": -1.5638858079910278
        },
        {
            "text": "5-HT2A receptor PET imaging in vivo (11). 5-HT2A",
            "probability": 0.00013924300872271834,
            "start_logit": 7.085555076599121,
            "end_logit": -1.8604713678359985
        },
        {
            "text": "5-HT2A antagonists bind to the total pool of receptors, whereas 5-HT2A",
            "probability": 8.138586884533477e-05,
            "start_logit": 6.661423683166504,
            "end_logit": -1.9733589887619019
        },
        {
            "text": "ceptor",
            "probability": 7.18419584816491e-05,
            "start_logit": -1.5789979696273804,
            "end_logit": 6.142329692840576
        },
        {
            "text": "receptor PET imaging in vivo (11). 5-HT2A antagonists",
            "probability": 4.2123633777758406e-05,
            "start_logit": -1.5789979696273804,
            "end_logit": 5.6084699630737305
        },
        {
            "text": "agonists",
            "probability": 3.28735471395663e-05,
            "start_logit": -1.8269386291503906,
            "end_logit": 5.6084699630737305
        },
        {
            "text": "antagonists bind to the total pool of receptors, whereas 5-HT2A agonists",
            "probability": 3.1226144655757766e-05,
            "start_logit": -1.8269386291503906,
            "end_logit": 5.5570573806762695
        },
        {
            "text": "A",
            "probability": 8.142131518900746e-06,
            "start_logit": -2.3848392963409424,
            "end_logit": 4.770754337310791
        },
        {
            "text": "5-HT2A receptor PET",
            "probability": 3.7471282737926433e-06,
            "start_logit": 7.085555076599121,
            "end_logit": -5.475702285766602
        },
        {
            "text": "5-HT2A agonist",
            "probability": 3.694105794102869e-06,
            "start_logit": 0.6286105513572693,
            "end_logit": 0.9669910073280334
        },
        {
            "text": "5-HT2A receptor PET imaging",
            "probability": 3.067282701912739e-06,
            "start_logit": 7.085555076599121,
            "end_logit": -5.675899982452393
        },
        {
            "text": "5-HT2A receptors",
            "probability": 2.16077808033417e-06,
            "start_logit": 5.668877601623535,
            "end_logit": -4.609546184539795
        },
        {
            "text": "of 5-HT2A",
            "probability": 1.7256649930228536e-06,
            "start_logit": -3.936278820037842,
            "end_logit": 4.770754337310791
        },
        {
            "text": "HT2A",
            "probability": 5.713726265350294e-07,
            "start_logit": -5.041604995727539,
            "end_logit": 4.770754337310791
        }
    ],
    "55242d512c8b63434a000006_012": [
        {
            "text": "5-HT2A receptor",
            "probability": 0.41624184627835203,
            "start_logit": 7.085555076599121,
            "end_logit": 6.142329692840576
        },
        {
            "text": "5-HT2A receptor PET imaging in vivo (11). 5-HT2A antagonists",
            "probability": 0.2440582003354766,
            "start_logit": 7.085555076599121,
            "end_logit": 5.6084699630737305
        },
        {
            "text": "5-HT2A antagonists",
            "probability": 0.15969653042134382,
            "start_logit": 6.661423683166504,
            "end_logit": 5.6084699630737305
        },
        {
            "text": "5-HT2A antagonists bind to the total pool of receptors, whereas 5-HT2A agonists",
            "probability": 0.151693607592396,
            "start_logit": 6.661423683166504,
            "end_logit": 5.5570573806762695
        },
        {
            "text": "5-HT2A",
            "probability": 0.025610786799061754,
            "start_logit": 5.668877601623535,
            "end_logit": 4.770754337310791
        },
        {
            "text": "5-HT2A agonists",
            "probability": 0.0020899082243538195,
            "start_logit": 4.4205145835876465,
            "end_logit": 3.513223886489868
        },
        {
            "text": "5",
            "probability": 0.00018731772340476285,
            "start_logit": 7.085555076599121,
            "end_logit": -1.5638858079910278
        },
        {
            "text": "5-HT2A receptor PET imaging in vivo (11). 5-HT2A",
            "probability": 0.00013924300872271834,
            "start_logit": 7.085555076599121,
            "end_logit": -1.8604713678359985
        },
        {
            "text": "5-HT2A antagonists bind to the total pool of receptors, whereas 5-HT2A",
            "probability": 8.138586884533477e-05,
            "start_logit": 6.661423683166504,
            "end_logit": -1.9733589887619019
        },
        {
            "text": "ceptor",
            "probability": 7.18419584816491e-05,
            "start_logit": -1.5789979696273804,
            "end_logit": 6.142329692840576
        },
        {
            "text": "receptor PET imaging in vivo (11). 5-HT2A antagonists",
            "probability": 4.2123633777758406e-05,
            "start_logit": -1.5789979696273804,
            "end_logit": 5.6084699630737305
        },
        {
            "text": "agonists",
            "probability": 3.28735471395663e-05,
            "start_logit": -1.8269386291503906,
            "end_logit": 5.6084699630737305
        },
        {
            "text": "antagonists bind to the total pool of receptors, whereas 5-HT2A agonists",
            "probability": 3.1226144655757766e-05,
            "start_logit": -1.8269386291503906,
            "end_logit": 5.5570573806762695
        },
        {
            "text": "A",
            "probability": 8.142131518900746e-06,
            "start_logit": -2.3848392963409424,
            "end_logit": 4.770754337310791
        },
        {
            "text": "5-HT2A receptor PET",
            "probability": 3.7471282737926433e-06,
            "start_logit": 7.085555076599121,
            "end_logit": -5.475702285766602
        },
        {
            "text": "5-HT2A agonist",
            "probability": 3.694105794102869e-06,
            "start_logit": 0.6286105513572693,
            "end_logit": 0.9669910073280334
        },
        {
            "text": "5-HT2A receptor PET imaging",
            "probability": 3.067282701912739e-06,
            "start_logit": 7.085555076599121,
            "end_logit": -5.675899982452393
        },
        {
            "text": "5-HT2A receptors",
            "probability": 2.16077808033417e-06,
            "start_logit": 5.668877601623535,
            "end_logit": -4.609546184539795
        },
        {
            "text": "of 5-HT2A",
            "probability": 1.7256649930228536e-06,
            "start_logit": -3.936278820037842,
            "end_logit": 4.770754337310791
        },
        {
            "text": "HT2A",
            "probability": 5.713726265350294e-07,
            "start_logit": -5.041604995727539,
            "end_logit": 4.770754337310791
        }
    ],
    "55242d512c8b63434a000006_013": [
        {
            "text": "5-HT2A receptor",
            "probability": 0.41624184627835203,
            "start_logit": 7.085555076599121,
            "end_logit": 6.142329692840576
        },
        {
            "text": "5-HT2A receptor PET imaging in vivo (11). 5-HT2A antagonists",
            "probability": 0.2440582003354766,
            "start_logit": 7.085555076599121,
            "end_logit": 5.6084699630737305
        },
        {
            "text": "5-HT2A antagonists",
            "probability": 0.15969653042134382,
            "start_logit": 6.661423683166504,
            "end_logit": 5.6084699630737305
        },
        {
            "text": "5-HT2A antagonists bind to the total pool of receptors, whereas 5-HT2A agonists",
            "probability": 0.151693607592396,
            "start_logit": 6.661423683166504,
            "end_logit": 5.5570573806762695
        },
        {
            "text": "5-HT2A",
            "probability": 0.025610786799061754,
            "start_logit": 5.668877601623535,
            "end_logit": 4.770754337310791
        },
        {
            "text": "5-HT2A agonists",
            "probability": 0.0020899082243538195,
            "start_logit": 4.4205145835876465,
            "end_logit": 3.513223886489868
        },
        {
            "text": "5",
            "probability": 0.00018731772340476285,
            "start_logit": 7.085555076599121,
            "end_logit": -1.5638858079910278
        },
        {
            "text": "5-HT2A receptor PET imaging in vivo (11). 5-HT2A",
            "probability": 0.00013924300872271834,
            "start_logit": 7.085555076599121,
            "end_logit": -1.8604713678359985
        },
        {
            "text": "5-HT2A antagonists bind to the total pool of receptors, whereas 5-HT2A",
            "probability": 8.138586884533477e-05,
            "start_logit": 6.661423683166504,
            "end_logit": -1.9733589887619019
        },
        {
            "text": "ceptor",
            "probability": 7.18419584816491e-05,
            "start_logit": -1.5789979696273804,
            "end_logit": 6.142329692840576
        },
        {
            "text": "receptor PET imaging in vivo (11). 5-HT2A antagonists",
            "probability": 4.2123633777758406e-05,
            "start_logit": -1.5789979696273804,
            "end_logit": 5.6084699630737305
        },
        {
            "text": "agonists",
            "probability": 3.28735471395663e-05,
            "start_logit": -1.8269386291503906,
            "end_logit": 5.6084699630737305
        },
        {
            "text": "antagonists bind to the total pool of receptors, whereas 5-HT2A agonists",
            "probability": 3.1226144655757766e-05,
            "start_logit": -1.8269386291503906,
            "end_logit": 5.5570573806762695
        },
        {
            "text": "A",
            "probability": 8.142131518900746e-06,
            "start_logit": -2.3848392963409424,
            "end_logit": 4.770754337310791
        },
        {
            "text": "5-HT2A receptor PET",
            "probability": 3.7471282737926433e-06,
            "start_logit": 7.085555076599121,
            "end_logit": -5.475702285766602
        },
        {
            "text": "5-HT2A agonist",
            "probability": 3.694105794102869e-06,
            "start_logit": 0.6286105513572693,
            "end_logit": 0.9669910073280334
        },
        {
            "text": "5-HT2A receptor PET imaging",
            "probability": 3.067282701912739e-06,
            "start_logit": 7.085555076599121,
            "end_logit": -5.675899982452393
        },
        {
            "text": "5-HT2A receptors",
            "probability": 2.16077808033417e-06,
            "start_logit": 5.668877601623535,
            "end_logit": -4.609546184539795
        },
        {
            "text": "of 5-HT2A",
            "probability": 1.7256649930228536e-06,
            "start_logit": -3.936278820037842,
            "end_logit": 4.770754337310791
        },
        {
            "text": "HT2A",
            "probability": 5.713726265350294e-07,
            "start_logit": -5.041604995727539,
            "end_logit": 4.770754337310791
        }
    ],
    "55242d512c8b63434a000006_014": [
        {
            "text": "5-HT2A",
            "probability": 0.9993132380560443,
            "start_logit": 9.197022438049316,
            "end_logit": 8.427734375
        },
        {
            "text": "5",
            "probability": 0.00045948021873637907,
            "start_logit": 9.197022438049316,
            "end_logit": 0.743006706237793
        },
        {
            "text": "A",
            "probability": 0.00021534374996694735,
            "start_logit": 0.7544344663619995,
            "end_logit": 8.427734375
        },
        {
            "text": "HT2A",
            "probability": 4.191567981213414e-06,
            "start_logit": -3.1847262382507324,
            "end_logit": 8.427734375
        },
        {
            "text": "partial volume corrected levels of 5-HT2A",
            "probability": 4.052673560917598e-06,
            "start_logit": -3.2184243202209473,
            "end_logit": 8.427734375
        },
        {
            "text": "Baseline and follow-up partial volume corrected levels of 5-HT2A",
            "probability": 1.0843427408512164e-06,
            "start_logit": -4.536827087402344,
            "end_logit": 8.427734375
        },
        {
            "text": "5-HT2A in four neocortical lobes and the posterior cingulate gyrus were investigated",
            "probability": 7.739787416282218e-07,
            "start_logit": 9.197022438049316,
            "end_logit": -5.6433000564575195
        },
        {
            "text": "of 5-HT2A",
            "probability": 6.85190741952598e-07,
            "start_logit": -4.995859146118164,
            "end_logit": 8.427734375
        },
        {
            "text": "levels of 5-HT2A",
            "probability": 5.764123448530463e-07,
            "start_logit": -5.1687331199646,
            "end_logit": 8.427734375
        },
        {
            "text": "2A",
            "probability": 5.048850293956024e-07,
            "start_logit": -5.301225662231445,
            "end_logit": 8.427734375
        },
        {
            "text": "5-HT2A in four neocortical lobes and the posterior cingulate gyrus were investigated using [18F]altanserin",
            "probability": 6.891012927876276e-08,
            "start_logit": 9.197022438049316,
            "end_logit": -8.062041282653809
        },
        {
            "text": "-",
            "probability": 5.351564166057361e-12,
            "start_logit": -2.355105400085449,
            "end_logit": -5.973083019256592
        },
        {
            "text": "HT2",
            "probability": 4.4746070989286674e-12,
            "start_logit": -3.1847262382507324,
            "end_logit": -5.322432518005371
        },
        {
            "text": "partial volume corrected",
            "probability": 6.948159109282197e-13,
            "start_logit": -3.2184243202209473,
            "end_logit": -7.151261329650879
        },
        {
            "text": "Baseline",
            "probability": 6.725715636172342e-13,
            "start_logit": -4.536827087402344,
            "end_logit": -5.865396976470947
        },
        {
            "text": "HT",
            "probability": 6.610470917319798e-13,
            "start_logit": -3.1847262382507324,
            "end_logit": -7.234781265258789
        },
        {
            "text": "partial volume corrected levels of",
            "probability": 6.112630959505905e-13,
            "start_logit": -3.2184243202209473,
            "end_logit": -7.279380798339844
        },
        {
            "text": "2",
            "probability": 5.389778113588817e-13,
            "start_logit": -5.301225662231445,
            "end_logit": -5.322432518005371
        },
        {
            "text": "of 5-HT2A in four neocortical lobes and the posterior cingulate gyrus were investigated",
            "probability": 5.30687524227551e-13,
            "start_logit": -4.995859146118164,
            "end_logit": -5.6433000564575195
        },
        {
            "text": "levels of 5-HT2A in four neocortical lobes and the posterior cingulate gyrus were investigated",
            "probability": 4.4643749761204815e-13,
            "start_logit": -5.1687331199646,
            "end_logit": -5.6433000564575195
        }
    ],
    "55242d512c8b63434a000006_015": [
        {
            "text": "5-HT2A receptor",
            "probability": 0.8170464817360977,
            "start_logit": 7.091490745544434,
            "end_logit": 6.225499153137207
        },
        {
            "text": "5-HT2A",
            "probability": 0.1824359807809404,
            "start_logit": 6.297756671905518,
            "end_logit": 5.519936561584473
        },
        {
            "text": "5",
            "probability": 0.0002923427865155711,
            "start_logit": 7.091490745544434,
            "end_logit": -1.7100250720977783
        },
        {
            "text": "ceptor",
            "probability": 0.00014734375270487507,
            "start_logit": -1.5291922092437744,
            "end_logit": 6.225499153137207
        },
        {
            "text": "A",
            "probability": 4.457205103761594e-05,
            "start_logit": -2.0192909240722656,
            "end_logit": 5.519936561584473
        },
        {
            "text": "5-HT2A receptor PET imaging",
            "probability": 1.138084046129163e-05,
            "start_logit": 7.091490745544434,
            "end_logit": -4.956020832061768
        },
        {
            "text": "5-HT2A receptors",
            "probability": 6.6634045561616855e-06,
            "start_logit": 6.297756671905518,
            "end_logit": -4.697587490081787
        },
        {
            "text": "of 5-HT2A",
            "probability": 6.015628898860074e-06,
            "start_logit": -4.022037029266357,
            "end_logit": 5.519936561584473
        },
        {
            "text": "for 5-HT2A receptor",
            "probability": 3.6267970007973056e-06,
            "start_logit": -5.2336106300354,
            "end_logit": 6.225499153137207
        },
        {
            "text": "HT2A",
            "probability": 2.256214794842793e-06,
            "start_logit": -5.00270938873291,
            "end_logit": 5.519936561584473
        },
        {
            "text": "5-HT2A receptor PET",
            "probability": 1.9797475858936697e-06,
            "start_logit": 7.091490745544434,
            "end_logit": -6.704982757568359
        },
        {
            "text": "inhibitor of 5-HT2A",
            "probability": 8.598643041840704e-07,
            "start_logit": -5.967378616333008,
            "end_logit": 5.519936561584473
        },
        {
            "text": "5-HT2A receptors with >100-fold selectivity",
            "probability": 4.916239118559943e-07,
            "start_logit": 6.297756671905518,
            "end_logit": -7.304259300231934
        },
        {
            "text": "receptor PET imaging",
            "probability": 2.0523872019362298e-09,
            "start_logit": -1.5291922092437744,
            "end_logit": -4.956020832061768
        },
        {
            "text": "for 5-HT2A",
            "probability": 1.2976837487709322e-09,
            "start_logit": -5.2336106300354,
            "end_logit": -1.7100250720977783
        },
        {
            "text": "3-[2-[4-(4-[18F]fluorobenzoyl)-1-piperidyl]ethyl]-2-sulfanyl-3H-quinazolin-4-one ([18F]altanserin) as a useful tool for 5-HT2A",
            "probability": 6.119403849667568e-10,
            "start_logit": -5.985311985015869,
            "end_logit": -1.7100250720977783
        },
        {
            "text": "receptor PET",
            "probability": 3.570218405373529e-10,
            "start_logit": -1.5291922092437744,
            "end_logit": -6.704982757568359
        },
        {
            "text": "of 5-HT2A receptors",
            "probability": 2.1971854916587745e-10,
            "start_logit": -4.022037029266357,
            "end_logit": -4.697587490081787
        },
        {
            "text": "receptors",
            "probability": 1.7184168434282463e-10,
            "start_logit": -4.267810821533203,
            "end_logit": -4.697587490081787
        },
        {
            "text": "-",
            "probability": 6.059660195074802e-11,
            "start_logit": -3.1326072216033936,
            "end_logit": -6.875125885009766
        }
    ],
    "55242d512c8b63434a000006_016": [
        {
            "text": "5-HT2A receptor",
            "probability": 0.8170464817360977,
            "start_logit": 7.091490745544434,
            "end_logit": 6.225499153137207
        },
        {
            "text": "5-HT2A",
            "probability": 0.1824359807809404,
            "start_logit": 6.297756671905518,
            "end_logit": 5.519936561584473
        },
        {
            "text": "5",
            "probability": 0.0002923427865155711,
            "start_logit": 7.091490745544434,
            "end_logit": -1.7100250720977783
        },
        {
            "text": "ceptor",
            "probability": 0.00014734375270487507,
            "start_logit": -1.5291922092437744,
            "end_logit": 6.225499153137207
        },
        {
            "text": "A",
            "probability": 4.457205103761594e-05,
            "start_logit": -2.0192909240722656,
            "end_logit": 5.519936561584473
        },
        {
            "text": "5-HT2A receptor PET imaging",
            "probability": 1.138084046129163e-05,
            "start_logit": 7.091490745544434,
            "end_logit": -4.956020832061768
        },
        {
            "text": "5-HT2A receptors",
            "probability": 6.6634045561616855e-06,
            "start_logit": 6.297756671905518,
            "end_logit": -4.697587490081787
        },
        {
            "text": "of 5-HT2A",
            "probability": 6.015628898860074e-06,
            "start_logit": -4.022037029266357,
            "end_logit": 5.519936561584473
        },
        {
            "text": "for 5-HT2A receptor",
            "probability": 3.6267970007973056e-06,
            "start_logit": -5.2336106300354,
            "end_logit": 6.225499153137207
        },
        {
            "text": "HT2A",
            "probability": 2.256214794842793e-06,
            "start_logit": -5.00270938873291,
            "end_logit": 5.519936561584473
        },
        {
            "text": "5-HT2A receptor PET",
            "probability": 1.9797475858936697e-06,
            "start_logit": 7.091490745544434,
            "end_logit": -6.704982757568359
        },
        {
            "text": "inhibitor of 5-HT2A",
            "probability": 8.598643041840704e-07,
            "start_logit": -5.967378616333008,
            "end_logit": 5.519936561584473
        },
        {
            "text": "5-HT2A receptors with >100-fold selectivity",
            "probability": 4.916239118559943e-07,
            "start_logit": 6.297756671905518,
            "end_logit": -7.304259300231934
        },
        {
            "text": "receptor PET imaging",
            "probability": 2.0523872019362298e-09,
            "start_logit": -1.5291922092437744,
            "end_logit": -4.956020832061768
        },
        {
            "text": "for 5-HT2A",
            "probability": 1.2976837487709322e-09,
            "start_logit": -5.2336106300354,
            "end_logit": -1.7100250720977783
        },
        {
            "text": "3-[2-[4-(4-[18F]fluorobenzoyl)-1-piperidyl]ethyl]-2-sulfanyl-3H-quinazolin-4-one ([18F]altanserin) as a useful tool for 5-HT2A",
            "probability": 6.119403849667568e-10,
            "start_logit": -5.985311985015869,
            "end_logit": -1.7100250720977783
        },
        {
            "text": "receptor PET",
            "probability": 3.570218405373529e-10,
            "start_logit": -1.5291922092437744,
            "end_logit": -6.704982757568359
        },
        {
            "text": "of 5-HT2A receptors",
            "probability": 2.1971854916587745e-10,
            "start_logit": -4.022037029266357,
            "end_logit": -4.697587490081787
        },
        {
            "text": "receptors",
            "probability": 1.7184168434282463e-10,
            "start_logit": -4.267810821533203,
            "end_logit": -4.697587490081787
        },
        {
            "text": "-",
            "probability": 6.059660195074802e-11,
            "start_logit": -3.1326072216033936,
            "end_logit": -6.875125885009766
        }
    ],
    "55242d512c8b63434a000006_017": [
        {
            "text": "5-HT2A",
            "probability": 0.8465905697159448,
            "start_logit": 9.141499519348145,
            "end_logit": 8.445551872253418
        },
        {
            "text": "5-HT1A receptor, and [18F]altanserin was used to assess postsynaptic 5-HT2A",
            "probability": 0.14360231016419006,
            "start_logit": 7.367330074310303,
            "end_logit": 8.445551872253418
        },
        {
            "text": "5-HT1A",
            "probability": 0.009473631622028618,
            "start_logit": 7.367330074310303,
            "end_logit": 5.727016448974609
        },
        {
            "text": "5",
            "probability": 0.0001944483156627297,
            "start_logit": 9.141499519348145,
            "end_logit": 0.0667458027601242
        },
        {
            "text": "A",
            "probability": 8.162831406323837e-05,
            "start_logit": -0.10529676079750061,
            "end_logit": 8.445551872253418
        },
        {
            "text": "5-HT2A receptor",
            "probability": 3.8212973632072026e-05,
            "start_logit": 9.141499519348145,
            "end_logit": -1.5602455139160156
        },
        {
            "text": "postsynaptic 5-HT2A",
            "probability": 1.7224326768776788e-05,
            "start_logit": -1.6611502170562744,
            "end_logit": 8.445551872253418
        },
        {
            "text": "assess postsynaptic 5-HT2A",
            "probability": 5.608528514928814e-07,
            "start_logit": -5.0857696533203125,
            "end_logit": 8.445551872253418
        },
        {
            "text": "[18F]altanserin was used to assess postsynaptic 5-HT2A",
            "probability": 5.196805106021869e-07,
            "start_logit": -5.162014007568359,
            "end_logit": 8.445551872253418
        },
        {
            "text": "5-HT1A receptor, and [18F]altanserin was used to assess postsynaptic",
            "probability": 4.0210356683840766e-07,
            "start_logit": 7.367330074310303,
            "end_logit": -4.340296745300293
        },
        {
            "text": "HT2A",
            "probability": 2.092407897764458e-07,
            "start_logit": -6.071742534637451,
            "end_logit": 8.445551872253418
        },
        {
            "text": "2A",
            "probability": 1.3593579364444823e-07,
            "start_logit": -6.503045558929443,
            "end_logit": 8.445551872253418
        },
        {
            "text": "5-HT2A receptor BP.",
            "probability": 7.692108098596111e-08,
            "start_logit": 9.141499519348145,
            "end_logit": -7.768395900726318
        },
        {
            "text": "5-HT1A receptor, and [18F]altanserin was used to assess",
            "probability": 3.0976632251253076e-08,
            "start_logit": 7.367330074310303,
            "end_logit": -6.903773307800293
        },
        {
            "text": "5-HT1A receptor,",
            "probability": 1.939186453716583e-08,
            "start_logit": 7.367330074310303,
            "end_logit": -7.372152805328369
        },
        {
            "text": "binding potential (BP) of the 5-HT1A",
            "probability": 1.047879957436758e-08,
            "start_logit": -6.347338676452637,
            "end_logit": 5.727016448974609
        },
        {
            "text": "potential (BP) of the 5-HT1A",
            "probability": 7.98224979314006e-09,
            "start_logit": -6.619472503662109,
            "end_logit": 5.727016448974609
        },
        {
            "text": "postsynaptic 5-HT2A receptor",
            "probability": 7.774628825198254e-10,
            "start_logit": -1.6611502170562744,
            "end_logit": -1.5602455139160156
        },
        {
            "text": "5-HT1A receptor, and [18F]altanserin was used to assess postsynaptic 5-HT2A receptor",
            "probability": 1.3996924279555003e-10,
            "start_logit": -3.375763416290283,
            "end_logit": -1.5602455139160156
        },
        {
            "text": "receptor",
            "probability": 8.613786304101035e-11,
            "start_logit": -3.861237049102783,
            "end_logit": -1.5602455139160156
        }
    ],
    "55242d512c8b63434a000006_018": [
        {
            "text": "5-HT2A",
            "probability": 0.9970027042640318,
            "start_logit": 5.179903507232666,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors.",
            "probability": 0.0010020489555284595,
            "start_logit": 5.179903507232666,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "A",
            "probability": 0.0005837884790899236,
            "start_logit": -2.263066530227661,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5",
            "probability": 0.0005404629295053089,
            "start_logit": 5.179903507232666,
            "end_logit": -3.065509080886841
        },
        {
            "text": "of 5-HT2A",
            "probability": 0.0002761162937371416,
            "start_logit": -3.0117831230163574,
            "end_logit": 4.454573631286621
        },
        {
            "text": "the known regional distribution of 5-HT2A",
            "probability": 0.0002195415307727951,
            "start_logit": -3.2410638332366943,
            "end_logit": 4.454573631286621
        },
        {
            "text": "known regional distribution of 5-HT2A",
            "probability": 0.00015150832160135241,
            "start_logit": -3.611964702606201,
            "end_logit": 4.454573631286621
        },
        {
            "text": "regional distribution of 5-HT2A",
            "probability": 0.0001072938297245234,
            "start_logit": -3.957034111022949,
            "end_logit": 4.454573631286621
        },
        {
            "text": "distribution of 5-HT2A",
            "probability": 4.358386406608003e-05,
            "start_logit": -4.8579182624816895,
            "end_logit": 4.454573631286621
        },
        {
            "text": "HT2A",
            "probability": 2.2137194943166774e-05,
            "start_logit": -5.535346031188965,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors. These",
            "probability": 1.656856485078623e-05,
            "start_logit": 5.179903507232666,
            "end_logit": -6.5504279136657715
        },
        {
            "text": "with the known regional distribution of 5-HT2A",
            "probability": 1.3389791841011778e-05,
            "start_logit": -6.038112640380859,
            "end_logit": 4.454573631286621
        },
        {
            "text": "binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A",
            "probability": 9.499389725461025e-06,
            "start_logit": -6.381377696990967,
            "end_logit": 4.454573631286621
        },
        {
            "text": "correlated with the known regional distribution of 5-HT2A",
            "probability": 9.316343439322603e-06,
            "start_logit": -6.400835037231445,
            "end_logit": 4.454573631286621
        },
        {
            "text": "receptors.",
            "probability": 8.965144834788948e-07,
            "start_logit": -1.839139461517334,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "of 5-HT2A receptors.",
            "probability": 2.775138347773424e-07,
            "start_logit": -3.0117831230163574,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "2A",
            "probability": 2.6205423954828773e-07,
            "start_logit": -7.240525722503662,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "serotonin 5-HT2A",
            "probability": 2.3123669300286974e-07,
            "start_logit": -7.365635395050049,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "the known regional distribution of 5-HT2A receptors.",
            "probability": 2.206527230719919e-07,
            "start_logit": -3.2410638332366943,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "known regional distribution of 5-HT2A receptors.",
            "probability": 1.5227516912963118e-07,
            "start_logit": -3.611964702606201,
            "end_logit": -2.4481329917907715
        }
    ],
    "55242d512c8b63434a000006_019": [
        {
            "text": "5-HT2A",
            "probability": 0.9990429060547718,
            "start_logit": 9.250387191772461,
            "end_logit": 8.648663520812988
        },
        {
            "text": "5",
            "probability": 0.0004976761064301731,
            "start_logit": 9.250387191772461,
            "end_logit": 1.0440599918365479
        },
        {
            "text": "PET quantification of 5-HT2A",
            "probability": 0.00016715861267131395,
            "start_logit": 0.5547773241996765,
            "end_logit": 8.648663520812988
        },
        {
            "text": "5-HT2A receptors",
            "probability": 0.00014356959646611475,
            "start_logit": 9.250387191772461,
            "end_logit": -0.1990695744752884
        },
        {
            "text": "A",
            "probability": 0.00014168058008557627,
            "start_logit": 0.38940927386283875,
            "end_logit": 8.648663520812988
        },
        {
            "text": "quantification of 5-HT2A",
            "probability": 2.143288312352537e-06,
            "start_logit": -3.8018245697021484,
            "end_logit": 8.648663520812988
        },
        {
            "text": "HT2A",
            "probability": 2.0408161523131203e-06,
            "start_logit": -3.850816011428833,
            "end_logit": 8.648663520812988
        },
        {
            "text": "of 5-HT2A",
            "probability": 1.5025395189090548e-06,
            "start_logit": -4.157009124755859,
            "end_logit": 8.648663520812988
        },
        {
            "text": "5-HT2A receptors in the human brain:",
            "probability": 5.927337125660655e-07,
            "start_logit": 9.250387191772461,
            "end_logit": -5.688899517059326
        },
        {
            "text": "2A",
            "probability": 5.498037401276468e-07,
            "start_logit": -5.162359714508057,
            "end_logit": 8.648663520812988
        },
        {
            "text": "5-HT2A receptors in the human brain: a constant infusion paradigm",
            "probability": 1.0335477704854289e-07,
            "start_logit": 9.250387191772461,
            "end_logit": -7.435477256774902
        },
        {
            "text": "PET",
            "probability": 3.974294575653312e-08,
            "start_logit": 0.5547773241996765,
            "end_logit": 0.30439746379852295
        },
        {
            "text": "PET quantification of 5-HT2A receptors",
            "probability": 2.4021885768478097e-08,
            "start_logit": 0.5547773241996765,
            "end_logit": -0.1990695744752884
        },
        {
            "text": "PET quantification",
            "probability": 8.182746400706468e-09,
            "start_logit": 0.5547773241996765,
            "end_logit": -1.276007056236267
        },
        {
            "text": "receptors",
            "probability": 3.033838479401757e-09,
            "start_logit": -1.5143593549728394,
            "end_logit": -0.1990695744752884
        },
        {
            "text": "5-HT2A receptors, which are believed to be important in the pathophysiology of schizophrenia and depression.",
            "probability": 6.688386861555868e-10,
            "start_logit": 1.9480215311050415,
            "end_logit": -5.173491477966309
        },
        {
            "text": "quantification of 5-HT2A receptors",
            "probability": 3.080058286286694e-10,
            "start_logit": -3.8018245697021484,
            "end_logit": -0.1990695744752884
        },
        {
            "text": "5-HT2A receptors, which are believed to be important in the pathophysiology of schizophrenia",
            "probability": 2.342570789248381e-10,
            "start_logit": 1.9480215311050415,
            "end_logit": -6.2226152420043945
        },
        {
            "text": "of 5-HT2A receptors",
            "probability": 2.1592565353978556e-10,
            "start_logit": -4.157009124755859,
            "end_logit": -0.1990695744752884
        },
        {
            "text": "quantification",
            "probability": 1.0491822373558531e-10,
            "start_logit": -3.8018245697021484,
            "end_logit": -1.276007056236267
        }
    ],
    "55242d512c8b63434a000006_020": [
        {
            "text": "5-HT2A",
            "probability": 0.9992262306662333,
            "start_logit": 8.933757781982422,
            "end_logit": 7.871456146240234
        },
        {
            "text": "5",
            "probability": 0.0005439298361227838,
            "start_logit": 8.933757781982422,
            "end_logit": 0.3555399179458618
        },
        {
            "text": "5-HT2A receptors",
            "probability": 0.0001562056103000775,
            "start_logit": 8.933757781982422,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "A",
            "probability": 6.859652411028126e-05,
            "start_logit": -0.6527368426322937,
            "end_logit": 7.871456146240234
        },
        {
            "text": "image serotonin 5-HT2A",
            "probability": 2.1330171671250507e-06,
            "start_logit": -4.123441219329834,
            "end_logit": 7.871456146240234
        },
        {
            "text": "5-HT2A receptors in humans.",
            "probability": 1.2104705490092027e-06,
            "start_logit": 8.933757781982422,
            "end_logit": -5.7522711753845215
        },
        {
            "text": "HT2A",
            "probability": 5.681049450139427e-07,
            "start_logit": -5.446427822113037,
            "end_logit": 7.871456146240234
        },
        {
            "text": "[18F]altanserin and positron emission tomography (PET) to image serotonin 5-HT2A",
            "probability": 3.142615405477987e-07,
            "start_logit": -6.038508415222168,
            "end_logit": 7.871456146240234
        },
        {
            "text": "2A",
            "probability": 2.8469046444178897e-07,
            "start_logit": -6.137331485748291,
            "end_logit": 7.871456146240234
        },
        {
            "text": "5-HT2A receptors with age",
            "probability": 2.6668741446195965e-07,
            "start_logit": 7.521975994110107,
            "end_logit": -5.853176593780518
        },
        {
            "text": "Visualisation of loss of 5-HT2A",
            "probability": 1.257706846111178e-07,
            "start_logit": -5.415449619293213,
            "end_logit": 6.332632064819336
        },
        {
            "text": "loss of 5-HT2A",
            "probability": 6.761726837225087e-08,
            "start_logit": -6.036046504974365,
            "end_logit": 6.332632064819336
        },
        {
            "text": "5-HT2A receptors with age in healthy volunteers using [18F]altanserin",
            "probability": 6.596363664587506e-08,
            "start_logit": 7.521975994110107,
            "end_logit": -7.250150203704834
        },
        {
            "text": "receptors",
            "probability": 3.9569236928478083e-10,
            "start_logit": -3.952288866043091,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "image serotonin 5-HT2A receptors",
            "probability": 3.3344725963524527e-10,
            "start_logit": -4.123441219329834,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "ors",
            "probability": 4.140670331265796e-11,
            "start_logit": -6.2094831466674805,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "receptors in humans.",
            "probability": 3.0663044596591105e-12,
            "start_logit": -3.952288866043091,
            "end_logit": -5.7522711753845215
        },
        {
            "text": "image serotonin 5-HT2A receptors in humans.",
            "probability": 2.583953845581493e-12,
            "start_logit": -4.123441219329834,
            "end_logit": -5.7522711753845215
        },
        {
            "text": "image serotonin",
            "probability": 1.8531723318394427e-12,
            "start_logit": -4.123441219329834,
            "end_logit": -6.08469295501709
        },
        {
            "text": "humans.",
            "probability": 1.5136479206293815e-12,
            "start_logit": -4.658239364624023,
            "end_logit": -5.7522711753845215
        }
    ],
    "55242d512c8b63434a000006_021": [
        {
            "text": "5-HT2A",
            "probability": 0.999212101642674,
            "start_logit": 9.275700569152832,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5",
            "probability": 0.0004922400739281395,
            "start_logit": 9.275700569152832,
            "end_logit": 1.0822317600250244
        },
        {
            "text": "A",
            "probability": 0.00014044654872061952,
            "start_logit": 0.40580520033836365,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5-HT2A receptors",
            "probability": 0.0001371911699062332,
            "start_logit": 9.275700569152832,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "Quantification of 5-HT2A",
            "probability": 8.66231775917288e-06,
            "start_logit": -2.3800394535064697,
            "end_logit": 8.69798755645752
        },
        {
            "text": "HT2A",
            "probability": 3.286529878678067e-06,
            "start_logit": -3.349189519882202,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5-HT2A receptors in the human brain using [18F]altanserin-PET",
            "probability": 2.9253137474166718e-06,
            "start_logit": 9.275700569152832,
            "end_logit": -4.043333053588867
        },
        {
            "text": "2A",
            "probability": 1.8890847903279713e-06,
            "start_logit": -3.9029293060302734,
            "end_logit": 8.69798755645752
        },
        {
            "text": "of 5-HT2A",
            "probability": 9.965986074487928e-07,
            "start_logit": -4.542428970336914,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5-HT2A receptors in the human brain",
            "probability": 1.7654420561210245e-07,
            "start_logit": 9.275700569152832,
            "end_logit": -6.850918769836426
        },
        {
            "text": "5-HT2A receptors in",
            "probability": 8.1339462130903e-08,
            "start_logit": 9.275700569152832,
            "end_logit": -7.625858783721924
        },
        {
            "text": "Quantification of 5-HT2A receptors",
            "probability": 1.1893305790900502e-09,
            "start_logit": -2.3800394535064697,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "receptors",
            "probability": 1.0316206502143792e-09,
            "start_logit": -2.52229905128479,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "Quantification",
            "probability": 3.659926092264606e-10,
            "start_logit": -2.3800394535064697,
            "end_logit": -1.3738921880722046
        },
        {
            "text": "of 5-HT2A receptors",
            "probability": 1.368323388578379e-10,
            "start_logit": -4.542428970336914,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "ors",
            "probability": 3.478380082451379e-11,
            "start_logit": -5.912033557891846,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET",
            "probability": 2.5359978310652785e-11,
            "start_logit": -2.3800394535064697,
            "end_logit": -4.043333053588867
        },
        {
            "text": "ification",
            "probability": 2.33495288631202e-11,
            "start_logit": -5.132075786590576,
            "end_logit": -1.3738921880722046
        },
        {
            "text": "receptors in the human brain using [18F]altanserin-PET",
            "probability": 2.1997145095079007e-11,
            "start_logit": -2.52229905128479,
            "end_logit": -4.043333053588867
        },
        {
            "text": "-",
            "probability": 7.054012252585516e-12,
            "start_logit": -1.5865741968154907,
            "end_logit": -6.1163740158081055
        }
    ],
    "55242d512c8b63434a000006_022": [
        {
            "text": "5-HT2A",
            "probability": 0.9970027042640318,
            "start_logit": 5.179903507232666,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors.",
            "probability": 0.0010020489555284595,
            "start_logit": 5.179903507232666,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "A",
            "probability": 0.0005837884790899236,
            "start_logit": -2.263066530227661,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5",
            "probability": 0.0005404629295053089,
            "start_logit": 5.179903507232666,
            "end_logit": -3.065509080886841
        },
        {
            "text": "of 5-HT2A",
            "probability": 0.0002761162937371416,
            "start_logit": -3.0117831230163574,
            "end_logit": 4.454573631286621
        },
        {
            "text": "the known regional distribution of 5-HT2A",
            "probability": 0.0002195415307727951,
            "start_logit": -3.2410638332366943,
            "end_logit": 4.454573631286621
        },
        {
            "text": "known regional distribution of 5-HT2A",
            "probability": 0.00015150832160135241,
            "start_logit": -3.611964702606201,
            "end_logit": 4.454573631286621
        },
        {
            "text": "regional distribution of 5-HT2A",
            "probability": 0.0001072938297245234,
            "start_logit": -3.957034111022949,
            "end_logit": 4.454573631286621
        },
        {
            "text": "distribution of 5-HT2A",
            "probability": 4.358386406608003e-05,
            "start_logit": -4.8579182624816895,
            "end_logit": 4.454573631286621
        },
        {
            "text": "HT2A",
            "probability": 2.2137194943166774e-05,
            "start_logit": -5.535346031188965,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors. These",
            "probability": 1.656856485078623e-05,
            "start_logit": 5.179903507232666,
            "end_logit": -6.5504279136657715
        },
        {
            "text": "with the known regional distribution of 5-HT2A",
            "probability": 1.3389791841011778e-05,
            "start_logit": -6.038112640380859,
            "end_logit": 4.454573631286621
        },
        {
            "text": "binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A",
            "probability": 9.499389725461025e-06,
            "start_logit": -6.381377696990967,
            "end_logit": 4.454573631286621
        },
        {
            "text": "correlated with the known regional distribution of 5-HT2A",
            "probability": 9.316343439322603e-06,
            "start_logit": -6.400835037231445,
            "end_logit": 4.454573631286621
        },
        {
            "text": "receptors.",
            "probability": 8.965144834788948e-07,
            "start_logit": -1.839139461517334,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "of 5-HT2A receptors.",
            "probability": 2.775138347773424e-07,
            "start_logit": -3.0117831230163574,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "2A",
            "probability": 2.6205423954828773e-07,
            "start_logit": -7.240525722503662,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "serotonin 5-HT2A",
            "probability": 2.3123669300286974e-07,
            "start_logit": -7.365635395050049,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "the known regional distribution of 5-HT2A receptors.",
            "probability": 2.206527230719919e-07,
            "start_logit": -3.2410638332366943,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "known regional distribution of 5-HT2A receptors.",
            "probability": 1.5227516912963118e-07,
            "start_logit": -3.611964702606201,
            "end_logit": -2.4481329917907715
        }
    ],
    "55242d512c8b63434a000006_023": [
        {
            "text": "5-HT2A",
            "probability": 0.9970027042640318,
            "start_logit": 5.179903507232666,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors.",
            "probability": 0.0010020489555284595,
            "start_logit": 5.179903507232666,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "A",
            "probability": 0.0005837884790899236,
            "start_logit": -2.263066530227661,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5",
            "probability": 0.0005404629295053089,
            "start_logit": 5.179903507232666,
            "end_logit": -3.065509080886841
        },
        {
            "text": "of 5-HT2A",
            "probability": 0.0002761162937371416,
            "start_logit": -3.0117831230163574,
            "end_logit": 4.454573631286621
        },
        {
            "text": "the known regional distribution of 5-HT2A",
            "probability": 0.0002195415307727951,
            "start_logit": -3.2410638332366943,
            "end_logit": 4.454573631286621
        },
        {
            "text": "known regional distribution of 5-HT2A",
            "probability": 0.00015150832160135241,
            "start_logit": -3.611964702606201,
            "end_logit": 4.454573631286621
        },
        {
            "text": "regional distribution of 5-HT2A",
            "probability": 0.0001072938297245234,
            "start_logit": -3.957034111022949,
            "end_logit": 4.454573631286621
        },
        {
            "text": "distribution of 5-HT2A",
            "probability": 4.358386406608003e-05,
            "start_logit": -4.8579182624816895,
            "end_logit": 4.454573631286621
        },
        {
            "text": "HT2A",
            "probability": 2.2137194943166774e-05,
            "start_logit": -5.535346031188965,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors. These",
            "probability": 1.656856485078623e-05,
            "start_logit": 5.179903507232666,
            "end_logit": -6.5504279136657715
        },
        {
            "text": "with the known regional distribution of 5-HT2A",
            "probability": 1.3389791841011778e-05,
            "start_logit": -6.038112640380859,
            "end_logit": 4.454573631286621
        },
        {
            "text": "binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A",
            "probability": 9.499389725461025e-06,
            "start_logit": -6.381377696990967,
            "end_logit": 4.454573631286621
        },
        {
            "text": "correlated with the known regional distribution of 5-HT2A",
            "probability": 9.316343439322603e-06,
            "start_logit": -6.400835037231445,
            "end_logit": 4.454573631286621
        },
        {
            "text": "receptors.",
            "probability": 8.965144834788948e-07,
            "start_logit": -1.839139461517334,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "of 5-HT2A receptors.",
            "probability": 2.775138347773424e-07,
            "start_logit": -3.0117831230163574,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "2A",
            "probability": 2.6205423954828773e-07,
            "start_logit": -7.240525722503662,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "serotonin 5-HT2A",
            "probability": 2.3123669300286974e-07,
            "start_logit": -7.365635395050049,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "the known regional distribution of 5-HT2A receptors.",
            "probability": 2.206527230719919e-07,
            "start_logit": -3.2410638332366943,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "known regional distribution of 5-HT2A receptors.",
            "probability": 1.5227516912963118e-07,
            "start_logit": -3.611964702606201,
            "end_logit": -2.4481329917907715
        }
    ],
    "55242d512c8b63434a000006_024": [
        {
            "text": "5-HT2A",
            "probability": 0.9990429060547718,
            "start_logit": 9.250387191772461,
            "end_logit": 8.648663520812988
        },
        {
            "text": "5",
            "probability": 0.0004976761064301731,
            "start_logit": 9.250387191772461,
            "end_logit": 1.0440599918365479
        },
        {
            "text": "PET quantification of 5-HT2A",
            "probability": 0.00016715861267131395,
            "start_logit": 0.5547773241996765,
            "end_logit": 8.648663520812988
        },
        {
            "text": "5-HT2A receptors",
            "probability": 0.00014356959646611475,
            "start_logit": 9.250387191772461,
            "end_logit": -0.1990695744752884
        },
        {
            "text": "A",
            "probability": 0.00014168058008557627,
            "start_logit": 0.38940927386283875,
            "end_logit": 8.648663520812988
        },
        {
            "text": "quantification of 5-HT2A",
            "probability": 2.143288312352537e-06,
            "start_logit": -3.8018245697021484,
            "end_logit": 8.648663520812988
        },
        {
            "text": "HT2A",
            "probability": 2.0408161523131203e-06,
            "start_logit": -3.850816011428833,
            "end_logit": 8.648663520812988
        },
        {
            "text": "of 5-HT2A",
            "probability": 1.5025395189090548e-06,
            "start_logit": -4.157009124755859,
            "end_logit": 8.648663520812988
        },
        {
            "text": "5-HT2A receptors in the human brain:",
            "probability": 5.927337125660655e-07,
            "start_logit": 9.250387191772461,
            "end_logit": -5.688899517059326
        },
        {
            "text": "2A",
            "probability": 5.498037401276468e-07,
            "start_logit": -5.162359714508057,
            "end_logit": 8.648663520812988
        },
        {
            "text": "5-HT2A receptors in the human brain: a constant infusion paradigm",
            "probability": 1.0335477704854289e-07,
            "start_logit": 9.250387191772461,
            "end_logit": -7.435477256774902
        },
        {
            "text": "PET",
            "probability": 3.974294575653312e-08,
            "start_logit": 0.5547773241996765,
            "end_logit": 0.30439746379852295
        },
        {
            "text": "PET quantification of 5-HT2A receptors",
            "probability": 2.4021885768478097e-08,
            "start_logit": 0.5547773241996765,
            "end_logit": -0.1990695744752884
        },
        {
            "text": "PET quantification",
            "probability": 8.182746400706468e-09,
            "start_logit": 0.5547773241996765,
            "end_logit": -1.276007056236267
        },
        {
            "text": "receptors",
            "probability": 3.033838479401757e-09,
            "start_logit": -1.5143593549728394,
            "end_logit": -0.1990695744752884
        },
        {
            "text": "5-HT2A receptors, which are believed to be important in the pathophysiology of schizophrenia and depression.",
            "probability": 6.688386861555868e-10,
            "start_logit": 1.9480215311050415,
            "end_logit": -5.173491477966309
        },
        {
            "text": "quantification of 5-HT2A receptors",
            "probability": 3.080058286286694e-10,
            "start_logit": -3.8018245697021484,
            "end_logit": -0.1990695744752884
        },
        {
            "text": "5-HT2A receptors, which are believed to be important in the pathophysiology of schizophrenia",
            "probability": 2.342570789248381e-10,
            "start_logit": 1.9480215311050415,
            "end_logit": -6.2226152420043945
        },
        {
            "text": "of 5-HT2A receptors",
            "probability": 2.1592565353978556e-10,
            "start_logit": -4.157009124755859,
            "end_logit": -0.1990695744752884
        },
        {
            "text": "quantification",
            "probability": 1.0491822373558531e-10,
            "start_logit": -3.8018245697021484,
            "end_logit": -1.276007056236267
        }
    ],
    "55242d512c8b63434a000006_025": [
        {
            "text": "5-HT2A",
            "probability": 0.9992262306662333,
            "start_logit": 8.933757781982422,
            "end_logit": 7.871456146240234
        },
        {
            "text": "5",
            "probability": 0.0005439298361227838,
            "start_logit": 8.933757781982422,
            "end_logit": 0.3555399179458618
        },
        {
            "text": "5-HT2A receptors",
            "probability": 0.0001562056103000775,
            "start_logit": 8.933757781982422,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "A",
            "probability": 6.859652411028126e-05,
            "start_logit": -0.6527368426322937,
            "end_logit": 7.871456146240234
        },
        {
            "text": "image serotonin 5-HT2A",
            "probability": 2.1330171671250507e-06,
            "start_logit": -4.123441219329834,
            "end_logit": 7.871456146240234
        },
        {
            "text": "5-HT2A receptors in humans.",
            "probability": 1.2104705490092027e-06,
            "start_logit": 8.933757781982422,
            "end_logit": -5.7522711753845215
        },
        {
            "text": "HT2A",
            "probability": 5.681049450139427e-07,
            "start_logit": -5.446427822113037,
            "end_logit": 7.871456146240234
        },
        {
            "text": "[18F]altanserin and positron emission tomography (PET) to image serotonin 5-HT2A",
            "probability": 3.142615405477987e-07,
            "start_logit": -6.038508415222168,
            "end_logit": 7.871456146240234
        },
        {
            "text": "2A",
            "probability": 2.8469046444178897e-07,
            "start_logit": -6.137331485748291,
            "end_logit": 7.871456146240234
        },
        {
            "text": "5-HT2A receptors with age",
            "probability": 2.6668741446195965e-07,
            "start_logit": 7.521975994110107,
            "end_logit": -5.853176593780518
        },
        {
            "text": "Visualisation of loss of 5-HT2A",
            "probability": 1.257706846111178e-07,
            "start_logit": -5.415449619293213,
            "end_logit": 6.332632064819336
        },
        {
            "text": "loss of 5-HT2A",
            "probability": 6.761726837225087e-08,
            "start_logit": -6.036046504974365,
            "end_logit": 6.332632064819336
        },
        {
            "text": "5-HT2A receptors with age in healthy volunteers using [18F]altanserin",
            "probability": 6.596363664587506e-08,
            "start_logit": 7.521975994110107,
            "end_logit": -7.250150203704834
        },
        {
            "text": "receptors",
            "probability": 3.9569236928478083e-10,
            "start_logit": -3.952288866043091,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "image serotonin 5-HT2A receptors",
            "probability": 3.3344725963524527e-10,
            "start_logit": -4.123441219329834,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "ors",
            "probability": 4.140670331265796e-11,
            "start_logit": -6.2094831466674805,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "receptors in humans.",
            "probability": 3.0663044596591105e-12,
            "start_logit": -3.952288866043091,
            "end_logit": -5.7522711753845215
        },
        {
            "text": "image serotonin 5-HT2A receptors in humans.",
            "probability": 2.583953845581493e-12,
            "start_logit": -4.123441219329834,
            "end_logit": -5.7522711753845215
        },
        {
            "text": "image serotonin",
            "probability": 1.8531723318394427e-12,
            "start_logit": -4.123441219329834,
            "end_logit": -6.08469295501709
        },
        {
            "text": "humans.",
            "probability": 1.5136479206293815e-12,
            "start_logit": -4.658239364624023,
            "end_logit": -5.7522711753845215
        }
    ],
    "55242d512c8b63434a000006_026": [
        {
            "text": "5-HT2A",
            "probability": 0.999212101642674,
            "start_logit": 9.275700569152832,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5",
            "probability": 0.0004922400739281395,
            "start_logit": 9.275700569152832,
            "end_logit": 1.0822317600250244
        },
        {
            "text": "A",
            "probability": 0.00014044654872061952,
            "start_logit": 0.40580520033836365,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5-HT2A receptors",
            "probability": 0.0001371911699062332,
            "start_logit": 9.275700569152832,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "Quantification of 5-HT2A",
            "probability": 8.66231775917288e-06,
            "start_logit": -2.3800394535064697,
            "end_logit": 8.69798755645752
        },
        {
            "text": "HT2A",
            "probability": 3.286529878678067e-06,
            "start_logit": -3.349189519882202,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5-HT2A receptors in the human brain using [18F]altanserin-PET",
            "probability": 2.9253137474166718e-06,
            "start_logit": 9.275700569152832,
            "end_logit": -4.043333053588867
        },
        {
            "text": "2A",
            "probability": 1.8890847903279713e-06,
            "start_logit": -3.9029293060302734,
            "end_logit": 8.69798755645752
        },
        {
            "text": "of 5-HT2A",
            "probability": 9.965986074487928e-07,
            "start_logit": -4.542428970336914,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5-HT2A receptors in the human brain",
            "probability": 1.7654420561210245e-07,
            "start_logit": 9.275700569152832,
            "end_logit": -6.850918769836426
        },
        {
            "text": "5-HT2A receptors in",
            "probability": 8.1339462130903e-08,
            "start_logit": 9.275700569152832,
            "end_logit": -7.625858783721924
        },
        {
            "text": "Quantification of 5-HT2A receptors",
            "probability": 1.1893305790900502e-09,
            "start_logit": -2.3800394535064697,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "receptors",
            "probability": 1.0316206502143792e-09,
            "start_logit": -2.52229905128479,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "Quantification",
            "probability": 3.659926092264606e-10,
            "start_logit": -2.3800394535064697,
            "end_logit": -1.3738921880722046
        },
        {
            "text": "of 5-HT2A receptors",
            "probability": 1.368323388578379e-10,
            "start_logit": -4.542428970336914,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "ors",
            "probability": 3.478380082451379e-11,
            "start_logit": -5.912033557891846,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET",
            "probability": 2.5359978310652785e-11,
            "start_logit": -2.3800394535064697,
            "end_logit": -4.043333053588867
        },
        {
            "text": "ification",
            "probability": 2.33495288631202e-11,
            "start_logit": -5.132075786590576,
            "end_logit": -1.3738921880722046
        },
        {
            "text": "receptors in the human brain using [18F]altanserin-PET",
            "probability": 2.1997145095079007e-11,
            "start_logit": -2.52229905128479,
            "end_logit": -4.043333053588867
        },
        {
            "text": "-",
            "probability": 7.054012252585516e-12,
            "start_logit": -1.5865741968154907,
            "end_logit": -6.1163740158081055
        }
    ],
    "55242d512c8b63434a000006_027": [
        {
            "text": "5-HT2A",
            "probability": 0.9970027042640318,
            "start_logit": 5.179903507232666,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors.",
            "probability": 0.0010020489555284595,
            "start_logit": 5.179903507232666,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "A",
            "probability": 0.0005837884790899236,
            "start_logit": -2.263066530227661,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5",
            "probability": 0.0005404629295053089,
            "start_logit": 5.179903507232666,
            "end_logit": -3.065509080886841
        },
        {
            "text": "of 5-HT2A",
            "probability": 0.0002761162937371416,
            "start_logit": -3.0117831230163574,
            "end_logit": 4.454573631286621
        },
        {
            "text": "the known regional distribution of 5-HT2A",
            "probability": 0.0002195415307727951,
            "start_logit": -3.2410638332366943,
            "end_logit": 4.454573631286621
        },
        {
            "text": "known regional distribution of 5-HT2A",
            "probability": 0.00015150832160135241,
            "start_logit": -3.611964702606201,
            "end_logit": 4.454573631286621
        },
        {
            "text": "regional distribution of 5-HT2A",
            "probability": 0.0001072938297245234,
            "start_logit": -3.957034111022949,
            "end_logit": 4.454573631286621
        },
        {
            "text": "distribution of 5-HT2A",
            "probability": 4.358386406608003e-05,
            "start_logit": -4.8579182624816895,
            "end_logit": 4.454573631286621
        },
        {
            "text": "HT2A",
            "probability": 2.2137194943166774e-05,
            "start_logit": -5.535346031188965,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors. These",
            "probability": 1.656856485078623e-05,
            "start_logit": 5.179903507232666,
            "end_logit": -6.5504279136657715
        },
        {
            "text": "with the known regional distribution of 5-HT2A",
            "probability": 1.3389791841011778e-05,
            "start_logit": -6.038112640380859,
            "end_logit": 4.454573631286621
        },
        {
            "text": "binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A",
            "probability": 9.499389725461025e-06,
            "start_logit": -6.381377696990967,
            "end_logit": 4.454573631286621
        },
        {
            "text": "correlated with the known regional distribution of 5-HT2A",
            "probability": 9.316343439322603e-06,
            "start_logit": -6.400835037231445,
            "end_logit": 4.454573631286621
        },
        {
            "text": "receptors.",
            "probability": 8.965144834788948e-07,
            "start_logit": -1.839139461517334,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "of 5-HT2A receptors.",
            "probability": 2.775138347773424e-07,
            "start_logit": -3.0117831230163574,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "2A",
            "probability": 2.6205423954828773e-07,
            "start_logit": -7.240525722503662,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "serotonin 5-HT2A",
            "probability": 2.3123669300286974e-07,
            "start_logit": -7.365635395050049,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "the known regional distribution of 5-HT2A receptors.",
            "probability": 2.206527230719919e-07,
            "start_logit": -3.2410638332366943,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "known regional distribution of 5-HT2A receptors.",
            "probability": 1.5227516912963118e-07,
            "start_logit": -3.611964702606201,
            "end_logit": -2.4481329917907715
        }
    ],
    "55242d512c8b63434a000006_028": [
        {
            "text": "5-HT2A",
            "probability": 0.9970027042640318,
            "start_logit": 5.179903507232666,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors.",
            "probability": 0.0010020489555284595,
            "start_logit": 5.179903507232666,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "A",
            "probability": 0.0005837884790899236,
            "start_logit": -2.263066530227661,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5",
            "probability": 0.0005404629295053089,
            "start_logit": 5.179903507232666,
            "end_logit": -3.065509080886841
        },
        {
            "text": "of 5-HT2A",
            "probability": 0.0002761162937371416,
            "start_logit": -3.0117831230163574,
            "end_logit": 4.454573631286621
        },
        {
            "text": "the known regional distribution of 5-HT2A",
            "probability": 0.0002195415307727951,
            "start_logit": -3.2410638332366943,
            "end_logit": 4.454573631286621
        },
        {
            "text": "known regional distribution of 5-HT2A",
            "probability": 0.00015150832160135241,
            "start_logit": -3.611964702606201,
            "end_logit": 4.454573631286621
        },
        {
            "text": "regional distribution of 5-HT2A",
            "probability": 0.0001072938297245234,
            "start_logit": -3.957034111022949,
            "end_logit": 4.454573631286621
        },
        {
            "text": "distribution of 5-HT2A",
            "probability": 4.358386406608003e-05,
            "start_logit": -4.8579182624816895,
            "end_logit": 4.454573631286621
        },
        {
            "text": "HT2A",
            "probability": 2.2137194943166774e-05,
            "start_logit": -5.535346031188965,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors. These",
            "probability": 1.656856485078623e-05,
            "start_logit": 5.179903507232666,
            "end_logit": -6.5504279136657715
        },
        {
            "text": "with the known regional distribution of 5-HT2A",
            "probability": 1.3389791841011778e-05,
            "start_logit": -6.038112640380859,
            "end_logit": 4.454573631286621
        },
        {
            "text": "binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A",
            "probability": 9.499389725461025e-06,
            "start_logit": -6.381377696990967,
            "end_logit": 4.454573631286621
        },
        {
            "text": "correlated with the known regional distribution of 5-HT2A",
            "probability": 9.316343439322603e-06,
            "start_logit": -6.400835037231445,
            "end_logit": 4.454573631286621
        },
        {
            "text": "receptors.",
            "probability": 8.965144834788948e-07,
            "start_logit": -1.839139461517334,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "of 5-HT2A receptors.",
            "probability": 2.775138347773424e-07,
            "start_logit": -3.0117831230163574,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "2A",
            "probability": 2.6205423954828773e-07,
            "start_logit": -7.240525722503662,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "serotonin 5-HT2A",
            "probability": 2.3123669300286974e-07,
            "start_logit": -7.365635395050049,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "the known regional distribution of 5-HT2A receptors.",
            "probability": 2.206527230719919e-07,
            "start_logit": -3.2410638332366943,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "known regional distribution of 5-HT2A receptors.",
            "probability": 1.5227516912963118e-07,
            "start_logit": -3.611964702606201,
            "end_logit": -2.4481329917907715
        }
    ],
    "55242d512c8b63434a000006_029": [
        {
            "text": "5-HT2A",
            "probability": 0.9990429060547718,
            "start_logit": 9.250387191772461,
            "end_logit": 8.648663520812988
        },
        {
            "text": "5",
            "probability": 0.0004976761064301731,
            "start_logit": 9.250387191772461,
            "end_logit": 1.0440599918365479
        },
        {
            "text": "PET quantification of 5-HT2A",
            "probability": 0.00016715861267131395,
            "start_logit": 0.5547773241996765,
            "end_logit": 8.648663520812988
        },
        {
            "text": "5-HT2A receptors",
            "probability": 0.00014356959646611475,
            "start_logit": 9.250387191772461,
            "end_logit": -0.1990695744752884
        },
        {
            "text": "A",
            "probability": 0.00014168058008557627,
            "start_logit": 0.38940927386283875,
            "end_logit": 8.648663520812988
        },
        {
            "text": "quantification of 5-HT2A",
            "probability": 2.143288312352537e-06,
            "start_logit": -3.8018245697021484,
            "end_logit": 8.648663520812988
        },
        {
            "text": "HT2A",
            "probability": 2.0408161523131203e-06,
            "start_logit": -3.850816011428833,
            "end_logit": 8.648663520812988
        },
        {
            "text": "of 5-HT2A",
            "probability": 1.5025395189090548e-06,
            "start_logit": -4.157009124755859,
            "end_logit": 8.648663520812988
        },
        {
            "text": "5-HT2A receptors in the human brain:",
            "probability": 5.927337125660655e-07,
            "start_logit": 9.250387191772461,
            "end_logit": -5.688899517059326
        },
        {
            "text": "2A",
            "probability": 5.498037401276468e-07,
            "start_logit": -5.162359714508057,
            "end_logit": 8.648663520812988
        },
        {
            "text": "5-HT2A receptors in the human brain: a constant infusion paradigm",
            "probability": 1.0335477704854289e-07,
            "start_logit": 9.250387191772461,
            "end_logit": -7.435477256774902
        },
        {
            "text": "PET",
            "probability": 3.974294575653312e-08,
            "start_logit": 0.5547773241996765,
            "end_logit": 0.30439746379852295
        },
        {
            "text": "PET quantification of 5-HT2A receptors",
            "probability": 2.4021885768478097e-08,
            "start_logit": 0.5547773241996765,
            "end_logit": -0.1990695744752884
        },
        {
            "text": "PET quantification",
            "probability": 8.182746400706468e-09,
            "start_logit": 0.5547773241996765,
            "end_logit": -1.276007056236267
        },
        {
            "text": "receptors",
            "probability": 3.033838479401757e-09,
            "start_logit": -1.5143593549728394,
            "end_logit": -0.1990695744752884
        },
        {
            "text": "5-HT2A receptors, which are believed to be important in the pathophysiology of schizophrenia and depression.",
            "probability": 6.688386861555868e-10,
            "start_logit": 1.9480215311050415,
            "end_logit": -5.173491477966309
        },
        {
            "text": "quantification of 5-HT2A receptors",
            "probability": 3.080058286286694e-10,
            "start_logit": -3.8018245697021484,
            "end_logit": -0.1990695744752884
        },
        {
            "text": "5-HT2A receptors, which are believed to be important in the pathophysiology of schizophrenia",
            "probability": 2.342570789248381e-10,
            "start_logit": 1.9480215311050415,
            "end_logit": -6.2226152420043945
        },
        {
            "text": "of 5-HT2A receptors",
            "probability": 2.1592565353978556e-10,
            "start_logit": -4.157009124755859,
            "end_logit": -0.1990695744752884
        },
        {
            "text": "quantification",
            "probability": 1.0491822373558531e-10,
            "start_logit": -3.8018245697021484,
            "end_logit": -1.276007056236267
        }
    ],
    "55242d512c8b63434a000006_030": [
        {
            "text": "5-HT2A",
            "probability": 0.9992262306662333,
            "start_logit": 8.933757781982422,
            "end_logit": 7.871456146240234
        },
        {
            "text": "5",
            "probability": 0.0005439298361227838,
            "start_logit": 8.933757781982422,
            "end_logit": 0.3555399179458618
        },
        {
            "text": "5-HT2A receptors",
            "probability": 0.0001562056103000775,
            "start_logit": 8.933757781982422,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "A",
            "probability": 6.859652411028126e-05,
            "start_logit": -0.6527368426322937,
            "end_logit": 7.871456146240234
        },
        {
            "text": "image serotonin 5-HT2A",
            "probability": 2.1330171671250507e-06,
            "start_logit": -4.123441219329834,
            "end_logit": 7.871456146240234
        },
        {
            "text": "5-HT2A receptors in humans.",
            "probability": 1.2104705490092027e-06,
            "start_logit": 8.933757781982422,
            "end_logit": -5.7522711753845215
        },
        {
            "text": "HT2A",
            "probability": 5.681049450139427e-07,
            "start_logit": -5.446427822113037,
            "end_logit": 7.871456146240234
        },
        {
            "text": "[18F]altanserin and positron emission tomography (PET) to image serotonin 5-HT2A",
            "probability": 3.142615405477987e-07,
            "start_logit": -6.038508415222168,
            "end_logit": 7.871456146240234
        },
        {
            "text": "2A",
            "probability": 2.8469046444178897e-07,
            "start_logit": -6.137331485748291,
            "end_logit": 7.871456146240234
        },
        {
            "text": "5-HT2A receptors with age",
            "probability": 2.6668741446195965e-07,
            "start_logit": 7.521975994110107,
            "end_logit": -5.853176593780518
        },
        {
            "text": "Visualisation of loss of 5-HT2A",
            "probability": 1.257706846111178e-07,
            "start_logit": -5.415449619293213,
            "end_logit": 6.332632064819336
        },
        {
            "text": "loss of 5-HT2A",
            "probability": 6.761726837225087e-08,
            "start_logit": -6.036046504974365,
            "end_logit": 6.332632064819336
        },
        {
            "text": "5-HT2A receptors with age in healthy volunteers using [18F]altanserin",
            "probability": 6.596363664587506e-08,
            "start_logit": 7.521975994110107,
            "end_logit": -7.250150203704834
        },
        {
            "text": "receptors",
            "probability": 3.9569236928478083e-10,
            "start_logit": -3.952288866043091,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "image serotonin 5-HT2A receptors",
            "probability": 3.3344725963524527e-10,
            "start_logit": -4.123441219329834,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "ors",
            "probability": 4.140670331265796e-11,
            "start_logit": -6.2094831466674805,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "receptors in humans.",
            "probability": 3.0663044596591105e-12,
            "start_logit": -3.952288866043091,
            "end_logit": -5.7522711753845215
        },
        {
            "text": "image serotonin 5-HT2A receptors in humans.",
            "probability": 2.583953845581493e-12,
            "start_logit": -4.123441219329834,
            "end_logit": -5.7522711753845215
        },
        {
            "text": "image serotonin",
            "probability": 1.8531723318394427e-12,
            "start_logit": -4.123441219329834,
            "end_logit": -6.08469295501709
        },
        {
            "text": "humans.",
            "probability": 1.5136479206293815e-12,
            "start_logit": -4.658239364624023,
            "end_logit": -5.7522711753845215
        }
    ],
    "55242d512c8b63434a000006_031": [
        {
            "text": "5-HT2A",
            "probability": 0.999212101642674,
            "start_logit": 9.275700569152832,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5",
            "probability": 0.0004922400739281395,
            "start_logit": 9.275700569152832,
            "end_logit": 1.0822317600250244
        },
        {
            "text": "A",
            "probability": 0.00014044654872061952,
            "start_logit": 0.40580520033836365,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5-HT2A receptors",
            "probability": 0.0001371911699062332,
            "start_logit": 9.275700569152832,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "Quantification of 5-HT2A",
            "probability": 8.66231775917288e-06,
            "start_logit": -2.3800394535064697,
            "end_logit": 8.69798755645752
        },
        {
            "text": "HT2A",
            "probability": 3.286529878678067e-06,
            "start_logit": -3.349189519882202,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5-HT2A receptors in the human brain using [18F]altanserin-PET",
            "probability": 2.9253137474166718e-06,
            "start_logit": 9.275700569152832,
            "end_logit": -4.043333053588867
        },
        {
            "text": "2A",
            "probability": 1.8890847903279713e-06,
            "start_logit": -3.9029293060302734,
            "end_logit": 8.69798755645752
        },
        {
            "text": "of 5-HT2A",
            "probability": 9.965986074487928e-07,
            "start_logit": -4.542428970336914,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5-HT2A receptors in the human brain",
            "probability": 1.7654420561210245e-07,
            "start_logit": 9.275700569152832,
            "end_logit": -6.850918769836426
        },
        {
            "text": "5-HT2A receptors in",
            "probability": 8.1339462130903e-08,
            "start_logit": 9.275700569152832,
            "end_logit": -7.625858783721924
        },
        {
            "text": "Quantification of 5-HT2A receptors",
            "probability": 1.1893305790900502e-09,
            "start_logit": -2.3800394535064697,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "receptors",
            "probability": 1.0316206502143792e-09,
            "start_logit": -2.52229905128479,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "Quantification",
            "probability": 3.659926092264606e-10,
            "start_logit": -2.3800394535064697,
            "end_logit": -1.3738921880722046
        },
        {
            "text": "of 5-HT2A receptors",
            "probability": 1.368323388578379e-10,
            "start_logit": -4.542428970336914,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "ors",
            "probability": 3.478380082451379e-11,
            "start_logit": -5.912033557891846,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET",
            "probability": 2.5359978310652785e-11,
            "start_logit": -2.3800394535064697,
            "end_logit": -4.043333053588867
        },
        {
            "text": "ification",
            "probability": 2.33495288631202e-11,
            "start_logit": -5.132075786590576,
            "end_logit": -1.3738921880722046
        },
        {
            "text": "receptors in the human brain using [18F]altanserin-PET",
            "probability": 2.1997145095079007e-11,
            "start_logit": -2.52229905128479,
            "end_logit": -4.043333053588867
        },
        {
            "text": "-",
            "probability": 7.054012252585516e-12,
            "start_logit": -1.5865741968154907,
            "end_logit": -6.1163740158081055
        }
    ],
    "55242d512c8b63434a000006_032": [
        {
            "text": "5-HT2A",
            "probability": 0.9970027042640318,
            "start_logit": 5.179903507232666,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors.",
            "probability": 0.0010020489555284595,
            "start_logit": 5.179903507232666,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "A",
            "probability": 0.0005837884790899236,
            "start_logit": -2.263066530227661,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5",
            "probability": 0.0005404629295053089,
            "start_logit": 5.179903507232666,
            "end_logit": -3.065509080886841
        },
        {
            "text": "of 5-HT2A",
            "probability": 0.0002761162937371416,
            "start_logit": -3.0117831230163574,
            "end_logit": 4.454573631286621
        },
        {
            "text": "the known regional distribution of 5-HT2A",
            "probability": 0.0002195415307727951,
            "start_logit": -3.2410638332366943,
            "end_logit": 4.454573631286621
        },
        {
            "text": "known regional distribution of 5-HT2A",
            "probability": 0.00015150832160135241,
            "start_logit": -3.611964702606201,
            "end_logit": 4.454573631286621
        },
        {
            "text": "regional distribution of 5-HT2A",
            "probability": 0.0001072938297245234,
            "start_logit": -3.957034111022949,
            "end_logit": 4.454573631286621
        },
        {
            "text": "distribution of 5-HT2A",
            "probability": 4.358386406608003e-05,
            "start_logit": -4.8579182624816895,
            "end_logit": 4.454573631286621
        },
        {
            "text": "HT2A",
            "probability": 2.2137194943166774e-05,
            "start_logit": -5.535346031188965,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors. These",
            "probability": 1.656856485078623e-05,
            "start_logit": 5.179903507232666,
            "end_logit": -6.5504279136657715
        },
        {
            "text": "with the known regional distribution of 5-HT2A",
            "probability": 1.3389791841011778e-05,
            "start_logit": -6.038112640380859,
            "end_logit": 4.454573631286621
        },
        {
            "text": "binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A",
            "probability": 9.499389725461025e-06,
            "start_logit": -6.381377696990967,
            "end_logit": 4.454573631286621
        },
        {
            "text": "correlated with the known regional distribution of 5-HT2A",
            "probability": 9.316343439322603e-06,
            "start_logit": -6.400835037231445,
            "end_logit": 4.454573631286621
        },
        {
            "text": "receptors.",
            "probability": 8.965144834788948e-07,
            "start_logit": -1.839139461517334,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "of 5-HT2A receptors.",
            "probability": 2.775138347773424e-07,
            "start_logit": -3.0117831230163574,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "2A",
            "probability": 2.6205423954828773e-07,
            "start_logit": -7.240525722503662,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "serotonin 5-HT2A",
            "probability": 2.3123669300286974e-07,
            "start_logit": -7.365635395050049,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "the known regional distribution of 5-HT2A receptors.",
            "probability": 2.206527230719919e-07,
            "start_logit": -3.2410638332366943,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "known regional distribution of 5-HT2A receptors.",
            "probability": 1.5227516912963118e-07,
            "start_logit": -3.611964702606201,
            "end_logit": -2.4481329917907715
        }
    ],
    "55242d512c8b63434a000006_033": [
        {
            "text": "5-HT2A",
            "probability": 0.9970027042640318,
            "start_logit": 5.179903507232666,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors.",
            "probability": 0.0010020489555284595,
            "start_logit": 5.179903507232666,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "A",
            "probability": 0.0005837884790899236,
            "start_logit": -2.263066530227661,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5",
            "probability": 0.0005404629295053089,
            "start_logit": 5.179903507232666,
            "end_logit": -3.065509080886841
        },
        {
            "text": "of 5-HT2A",
            "probability": 0.0002761162937371416,
            "start_logit": -3.0117831230163574,
            "end_logit": 4.454573631286621
        },
        {
            "text": "the known regional distribution of 5-HT2A",
            "probability": 0.0002195415307727951,
            "start_logit": -3.2410638332366943,
            "end_logit": 4.454573631286621
        },
        {
            "text": "known regional distribution of 5-HT2A",
            "probability": 0.00015150832160135241,
            "start_logit": -3.611964702606201,
            "end_logit": 4.454573631286621
        },
        {
            "text": "regional distribution of 5-HT2A",
            "probability": 0.0001072938297245234,
            "start_logit": -3.957034111022949,
            "end_logit": 4.454573631286621
        },
        {
            "text": "distribution of 5-HT2A",
            "probability": 4.358386406608003e-05,
            "start_logit": -4.8579182624816895,
            "end_logit": 4.454573631286621
        },
        {
            "text": "HT2A",
            "probability": 2.2137194943166774e-05,
            "start_logit": -5.535346031188965,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors. These",
            "probability": 1.656856485078623e-05,
            "start_logit": 5.179903507232666,
            "end_logit": -6.5504279136657715
        },
        {
            "text": "with the known regional distribution of 5-HT2A",
            "probability": 1.3389791841011778e-05,
            "start_logit": -6.038112640380859,
            "end_logit": 4.454573631286621
        },
        {
            "text": "binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A",
            "probability": 9.499389725461025e-06,
            "start_logit": -6.381377696990967,
            "end_logit": 4.454573631286621
        },
        {
            "text": "correlated with the known regional distribution of 5-HT2A",
            "probability": 9.316343439322603e-06,
            "start_logit": -6.400835037231445,
            "end_logit": 4.454573631286621
        },
        {
            "text": "receptors.",
            "probability": 8.965144834788948e-07,
            "start_logit": -1.839139461517334,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "of 5-HT2A receptors.",
            "probability": 2.775138347773424e-07,
            "start_logit": -3.0117831230163574,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "2A",
            "probability": 2.6205423954828773e-07,
            "start_logit": -7.240525722503662,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "serotonin 5-HT2A",
            "probability": 2.3123669300286974e-07,
            "start_logit": -7.365635395050049,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "the known regional distribution of 5-HT2A receptors.",
            "probability": 2.206527230719919e-07,
            "start_logit": -3.2410638332366943,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "known regional distribution of 5-HT2A receptors.",
            "probability": 1.5227516912963118e-07,
            "start_logit": -3.611964702606201,
            "end_logit": -2.4481329917907715
        }
    ],
    "55242d512c8b63434a000006_034": [
        {
            "text": "5-HT2A",
            "probability": 0.9990429060547718,
            "start_logit": 9.250387191772461,
            "end_logit": 8.648663520812988
        },
        {
            "text": "5",
            "probability": 0.0004976761064301731,
            "start_logit": 9.250387191772461,
            "end_logit": 1.0440599918365479
        },
        {
            "text": "PET quantification of 5-HT2A",
            "probability": 0.00016715861267131395,
            "start_logit": 0.5547773241996765,
            "end_logit": 8.648663520812988
        },
        {
            "text": "5-HT2A receptors",
            "probability": 0.00014356959646611475,
            "start_logit": 9.250387191772461,
            "end_logit": -0.1990695744752884
        },
        {
            "text": "A",
            "probability": 0.00014168058008557627,
            "start_logit": 0.38940927386283875,
            "end_logit": 8.648663520812988
        },
        {
            "text": "quantification of 5-HT2A",
            "probability": 2.143288312352537e-06,
            "start_logit": -3.8018245697021484,
            "end_logit": 8.648663520812988
        },
        {
            "text": "HT2A",
            "probability": 2.0408161523131203e-06,
            "start_logit": -3.850816011428833,
            "end_logit": 8.648663520812988
        },
        {
            "text": "of 5-HT2A",
            "probability": 1.5025395189090548e-06,
            "start_logit": -4.157009124755859,
            "end_logit": 8.648663520812988
        },
        {
            "text": "5-HT2A receptors in the human brain:",
            "probability": 5.927337125660655e-07,
            "start_logit": 9.250387191772461,
            "end_logit": -5.688899517059326
        },
        {
            "text": "2A",
            "probability": 5.498037401276468e-07,
            "start_logit": -5.162359714508057,
            "end_logit": 8.648663520812988
        },
        {
            "text": "5-HT2A receptors in the human brain: a constant infusion paradigm",
            "probability": 1.0335477704854289e-07,
            "start_logit": 9.250387191772461,
            "end_logit": -7.435477256774902
        },
        {
            "text": "PET",
            "probability": 3.974294575653312e-08,
            "start_logit": 0.5547773241996765,
            "end_logit": 0.30439746379852295
        },
        {
            "text": "PET quantification of 5-HT2A receptors",
            "probability": 2.4021885768478097e-08,
            "start_logit": 0.5547773241996765,
            "end_logit": -0.1990695744752884
        },
        {
            "text": "PET quantification",
            "probability": 8.182746400706468e-09,
            "start_logit": 0.5547773241996765,
            "end_logit": -1.276007056236267
        },
        {
            "text": "receptors",
            "probability": 3.033838479401757e-09,
            "start_logit": -1.5143593549728394,
            "end_logit": -0.1990695744752884
        },
        {
            "text": "5-HT2A receptors, which are believed to be important in the pathophysiology of schizophrenia and depression.",
            "probability": 6.688386861555868e-10,
            "start_logit": 1.9480215311050415,
            "end_logit": -5.173491477966309
        },
        {
            "text": "quantification of 5-HT2A receptors",
            "probability": 3.080058286286694e-10,
            "start_logit": -3.8018245697021484,
            "end_logit": -0.1990695744752884
        },
        {
            "text": "5-HT2A receptors, which are believed to be important in the pathophysiology of schizophrenia",
            "probability": 2.342570789248381e-10,
            "start_logit": 1.9480215311050415,
            "end_logit": -6.2226152420043945
        },
        {
            "text": "of 5-HT2A receptors",
            "probability": 2.1592565353978556e-10,
            "start_logit": -4.157009124755859,
            "end_logit": -0.1990695744752884
        },
        {
            "text": "quantification",
            "probability": 1.0491822373558531e-10,
            "start_logit": -3.8018245697021484,
            "end_logit": -1.276007056236267
        }
    ],
    "55242d512c8b63434a000006_035": [
        {
            "text": "5-HT2A",
            "probability": 0.9992262306662333,
            "start_logit": 8.933757781982422,
            "end_logit": 7.871456146240234
        },
        {
            "text": "5",
            "probability": 0.0005439298361227838,
            "start_logit": 8.933757781982422,
            "end_logit": 0.3555399179458618
        },
        {
            "text": "5-HT2A receptors",
            "probability": 0.0001562056103000775,
            "start_logit": 8.933757781982422,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "A",
            "probability": 6.859652411028126e-05,
            "start_logit": -0.6527368426322937,
            "end_logit": 7.871456146240234
        },
        {
            "text": "image serotonin 5-HT2A",
            "probability": 2.1330171671250507e-06,
            "start_logit": -4.123441219329834,
            "end_logit": 7.871456146240234
        },
        {
            "text": "5-HT2A receptors in humans.",
            "probability": 1.2104705490092027e-06,
            "start_logit": 8.933757781982422,
            "end_logit": -5.7522711753845215
        },
        {
            "text": "HT2A",
            "probability": 5.681049450139427e-07,
            "start_logit": -5.446427822113037,
            "end_logit": 7.871456146240234
        },
        {
            "text": "[18F]altanserin and positron emission tomography (PET) to image serotonin 5-HT2A",
            "probability": 3.142615405477987e-07,
            "start_logit": -6.038508415222168,
            "end_logit": 7.871456146240234
        },
        {
            "text": "2A",
            "probability": 2.8469046444178897e-07,
            "start_logit": -6.137331485748291,
            "end_logit": 7.871456146240234
        },
        {
            "text": "5-HT2A receptors with age",
            "probability": 2.6668741446195965e-07,
            "start_logit": 7.521975994110107,
            "end_logit": -5.853176593780518
        },
        {
            "text": "Visualisation of loss of 5-HT2A",
            "probability": 1.257706846111178e-07,
            "start_logit": -5.415449619293213,
            "end_logit": 6.332632064819336
        },
        {
            "text": "loss of 5-HT2A",
            "probability": 6.761726837225087e-08,
            "start_logit": -6.036046504974365,
            "end_logit": 6.332632064819336
        },
        {
            "text": "5-HT2A receptors with age in healthy volunteers using [18F]altanserin",
            "probability": 6.596363664587506e-08,
            "start_logit": 7.521975994110107,
            "end_logit": -7.250150203704834
        },
        {
            "text": "receptors",
            "probability": 3.9569236928478083e-10,
            "start_logit": -3.952288866043091,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "image serotonin 5-HT2A receptors",
            "probability": 3.3344725963524527e-10,
            "start_logit": -4.123441219329834,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "ors",
            "probability": 4.140670331265796e-11,
            "start_logit": -6.2094831466674805,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "receptors in humans.",
            "probability": 3.0663044596591105e-12,
            "start_logit": -3.952288866043091,
            "end_logit": -5.7522711753845215
        },
        {
            "text": "image serotonin 5-HT2A receptors in humans.",
            "probability": 2.583953845581493e-12,
            "start_logit": -4.123441219329834,
            "end_logit": -5.7522711753845215
        },
        {
            "text": "image serotonin",
            "probability": 1.8531723318394427e-12,
            "start_logit": -4.123441219329834,
            "end_logit": -6.08469295501709
        },
        {
            "text": "humans.",
            "probability": 1.5136479206293815e-12,
            "start_logit": -4.658239364624023,
            "end_logit": -5.7522711753845215
        }
    ],
    "55242d512c8b63434a000006_036": [
        {
            "text": "5-HT2A",
            "probability": 0.999212101642674,
            "start_logit": 9.275700569152832,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5",
            "probability": 0.0004922400739281395,
            "start_logit": 9.275700569152832,
            "end_logit": 1.0822317600250244
        },
        {
            "text": "A",
            "probability": 0.00014044654872061952,
            "start_logit": 0.40580520033836365,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5-HT2A receptors",
            "probability": 0.0001371911699062332,
            "start_logit": 9.275700569152832,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "Quantification of 5-HT2A",
            "probability": 8.66231775917288e-06,
            "start_logit": -2.3800394535064697,
            "end_logit": 8.69798755645752
        },
        {
            "text": "HT2A",
            "probability": 3.286529878678067e-06,
            "start_logit": -3.349189519882202,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5-HT2A receptors in the human brain using [18F]altanserin-PET",
            "probability": 2.9253137474166718e-06,
            "start_logit": 9.275700569152832,
            "end_logit": -4.043333053588867
        },
        {
            "text": "2A",
            "probability": 1.8890847903279713e-06,
            "start_logit": -3.9029293060302734,
            "end_logit": 8.69798755645752
        },
        {
            "text": "of 5-HT2A",
            "probability": 9.965986074487928e-07,
            "start_logit": -4.542428970336914,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5-HT2A receptors in the human brain",
            "probability": 1.7654420561210245e-07,
            "start_logit": 9.275700569152832,
            "end_logit": -6.850918769836426
        },
        {
            "text": "5-HT2A receptors in",
            "probability": 8.1339462130903e-08,
            "start_logit": 9.275700569152832,
            "end_logit": -7.625858783721924
        },
        {
            "text": "Quantification of 5-HT2A receptors",
            "probability": 1.1893305790900502e-09,
            "start_logit": -2.3800394535064697,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "receptors",
            "probability": 1.0316206502143792e-09,
            "start_logit": -2.52229905128479,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "Quantification",
            "probability": 3.659926092264606e-10,
            "start_logit": -2.3800394535064697,
            "end_logit": -1.3738921880722046
        },
        {
            "text": "of 5-HT2A receptors",
            "probability": 1.368323388578379e-10,
            "start_logit": -4.542428970336914,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "ors",
            "probability": 3.478380082451379e-11,
            "start_logit": -5.912033557891846,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET",
            "probability": 2.5359978310652785e-11,
            "start_logit": -2.3800394535064697,
            "end_logit": -4.043333053588867
        },
        {
            "text": "ification",
            "probability": 2.33495288631202e-11,
            "start_logit": -5.132075786590576,
            "end_logit": -1.3738921880722046
        },
        {
            "text": "receptors in the human brain using [18F]altanserin-PET",
            "probability": 2.1997145095079007e-11,
            "start_logit": -2.52229905128479,
            "end_logit": -4.043333053588867
        },
        {
            "text": "-",
            "probability": 7.054012252585516e-12,
            "start_logit": -1.5865741968154907,
            "end_logit": -6.1163740158081055
        }
    ],
    "55242d512c8b63434a000006_037": [
        {
            "text": "5-HT2A",
            "probability": 0.9970027042640318,
            "start_logit": 5.179903507232666,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors.",
            "probability": 0.0010020489555284595,
            "start_logit": 5.179903507232666,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "A",
            "probability": 0.0005837884790899236,
            "start_logit": -2.263066530227661,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5",
            "probability": 0.0005404629295053089,
            "start_logit": 5.179903507232666,
            "end_logit": -3.065509080886841
        },
        {
            "text": "of 5-HT2A",
            "probability": 0.0002761162937371416,
            "start_logit": -3.0117831230163574,
            "end_logit": 4.454573631286621
        },
        {
            "text": "the known regional distribution of 5-HT2A",
            "probability": 0.0002195415307727951,
            "start_logit": -3.2410638332366943,
            "end_logit": 4.454573631286621
        },
        {
            "text": "known regional distribution of 5-HT2A",
            "probability": 0.00015150832160135241,
            "start_logit": -3.611964702606201,
            "end_logit": 4.454573631286621
        },
        {
            "text": "regional distribution of 5-HT2A",
            "probability": 0.0001072938297245234,
            "start_logit": -3.957034111022949,
            "end_logit": 4.454573631286621
        },
        {
            "text": "distribution of 5-HT2A",
            "probability": 4.358386406608003e-05,
            "start_logit": -4.8579182624816895,
            "end_logit": 4.454573631286621
        },
        {
            "text": "HT2A",
            "probability": 2.2137194943166774e-05,
            "start_logit": -5.535346031188965,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors. These",
            "probability": 1.656856485078623e-05,
            "start_logit": 5.179903507232666,
            "end_logit": -6.5504279136657715
        },
        {
            "text": "with the known regional distribution of 5-HT2A",
            "probability": 1.3389791841011778e-05,
            "start_logit": -6.038112640380859,
            "end_logit": 4.454573631286621
        },
        {
            "text": "binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A",
            "probability": 9.499389725461025e-06,
            "start_logit": -6.381377696990967,
            "end_logit": 4.454573631286621
        },
        {
            "text": "correlated with the known regional distribution of 5-HT2A",
            "probability": 9.316343439322603e-06,
            "start_logit": -6.400835037231445,
            "end_logit": 4.454573631286621
        },
        {
            "text": "receptors.",
            "probability": 8.965144834788948e-07,
            "start_logit": -1.839139461517334,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "of 5-HT2A receptors.",
            "probability": 2.775138347773424e-07,
            "start_logit": -3.0117831230163574,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "2A",
            "probability": 2.6205423954828773e-07,
            "start_logit": -7.240525722503662,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "serotonin 5-HT2A",
            "probability": 2.3123669300286974e-07,
            "start_logit": -7.365635395050049,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "the known regional distribution of 5-HT2A receptors.",
            "probability": 2.206527230719919e-07,
            "start_logit": -3.2410638332366943,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "known regional distribution of 5-HT2A receptors.",
            "probability": 1.5227516912963118e-07,
            "start_logit": -3.611964702606201,
            "end_logit": -2.4481329917907715
        }
    ],
    "55242d512c8b63434a000006_038": [
        {
            "text": "5-HT2A",
            "probability": 0.9994718589838286,
            "start_logit": 8.972574234008789,
            "end_logit": 8.107715606689453
        },
        {
            "text": "5",
            "probability": 0.0004113838426745815,
            "start_logit": 8.972574234008789,
            "end_logit": 0.3122600317001343
        },
        {
            "text": "A",
            "probability": 7.867229819485746e-05,
            "start_logit": -0.4771169424057007,
            "end_logit": 8.107715606689453
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors",
            "probability": 2.3220336183292563e-05,
            "start_logit": 8.972574234008789,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification",
            "probability": 5.606631036071198e-06,
            "start_logit": 8.972574234008789,
            "end_logit": -3.983316659927368
        },
        {
            "text": "5-HT2A receptor",
            "probability": 3.6224686097141098e-06,
            "start_logit": 8.462964057922363,
            "end_logit": -3.9105007648468018
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target",
            "probability": 1.8496929668756592e-06,
            "start_logit": 8.972574234008789,
            "end_logit": -5.092247009277344
        },
        {
            "text": "the radiometabolites of the serotonin 5-HT2A",
            "probability": 8.81583681999443e-07,
            "start_logit": -4.968443393707275,
            "end_logit": 8.107715606689453
        },
        {
            "text": "identify and characterize the radiometabolites of the serotonin 5-HT2A",
            "probability": 7.17134055707314e-07,
            "start_logit": -5.174900531768799,
            "end_logit": 8.107715606689453
        },
        {
            "text": "HT2A",
            "probability": 5.272366072162762e-07,
            "start_logit": -5.482513904571533,
            "end_logit": 8.107715606689453
        },
        {
            "text": "and characterize the radiometabolites of the serotonin 5-HT2A",
            "probability": 4.966738980517174e-07,
            "start_logit": -5.542229652404785,
            "end_logit": 8.107715606689453
        },
        {
            "text": "radiometabolites of the serotonin 5-HT2A",
            "probability": 4.955766823239009e-07,
            "start_logit": -5.544441223144531,
            "end_logit": 8.107715606689453
        },
        {
            "text": "Characterization of radioactive metabolites of 5-HT2A",
            "probability": 3.534254908138493e-07,
            "start_logit": -5.050318241119385,
            "end_logit": 7.275543212890625
        },
        {
            "text": "5-HT2A receptor PET ligand [18F]altanserin",
            "probability": 3.1348543841936713e-07,
            "start_logit": 8.462964057922363,
            "end_logit": -6.357658863067627
        },
        {
            "text": "target receptors",
            "probability": 2.1731176389893257e-10,
            "start_logit": -2.6066317558288574,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "receptors",
            "probability": 1.8721835962678654e-10,
            "start_logit": -2.7556891441345215,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "the target receptors",
            "probability": 9.375737786414606e-11,
            "start_logit": -3.4472544193267822,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "quantification of the target receptors",
            "probability": 8.058097552581176e-11,
            "start_logit": -3.5987021923065186,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "supporting quantification of the target receptors",
            "probability": 2.8342377295338325e-11,
            "start_logit": -4.643606662750244,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "[18F]altanserin in supporting quantification of the target receptors",
            "probability": 2.3440344717251864e-11,
            "start_logit": -4.833506107330322,
            "end_logit": -2.5622382164001465
        }
    ],
    "55242d512c8b63434a000006_039": [
        {
            "text": "5-HT2A",
            "probability": 0.9994650500805999,
            "start_logit": 8.705791473388672,
            "end_logit": 7.640470027923584
        },
        {
            "text": "5",
            "probability": 0.00041682766449397833,
            "start_logit": 8.705791473388672,
            "end_logit": -0.14183257520198822
        },
        {
            "text": "A",
            "probability": 7.819847551554725e-05,
            "start_logit": -0.7499338388442993,
            "end_logit": 7.640470027923584
        },
        {
            "text": "5-HT2A receptors",
            "probability": 2.1736819859497895e-05,
            "start_logit": 8.705791473388672,
            "end_logit": -3.0954978466033936
        },
        {
            "text": "HT2A",
            "probability": 8.952103526693742e-06,
            "start_logit": -2.917295455932617,
            "end_logit": 7.640470027923584
        },
        {
            "text": "PURPOSE: To determine the reproducibility of measurements of brain 5-HT2A",
            "probability": 2.666490429116663e-06,
            "start_logit": -4.128420829772949,
            "end_logit": 7.640470027923584
        },
        {
            "text": "brain 5-HT2A",
            "probability": 2.25914609767436e-06,
            "start_logit": -4.294197082519531,
            "end_logit": 7.640470027923584
        },
        {
            "text": "the reproducibility of measurements of brain 5-HT2A",
            "probability": 1.831783604178933e-06,
            "start_logit": -4.503893852233887,
            "end_logit": 7.640470027923584
        },
        {
            "text": "determine the reproducibility of measurements of brain 5-HT2A",
            "probability": 5.461206179291144e-07,
            "start_logit": -5.714099407196045,
            "end_logit": 7.640470027923584
        },
        {
            "text": "To determine the reproducibility of measurements of brain 5-HT2A",
            "probability": 5.278201196803161e-07,
            "start_logit": -5.748183727264404,
            "end_logit": 7.640470027923584
        },
        {
            "text": "reproducibility of measurements of brain 5-HT2A",
            "probability": 4.495644996029026e-07,
            "start_logit": -5.908659934997559,
            "end_logit": 7.640470027923584
        },
        {
            "text": "2A",
            "probability": 4.1144814249595296e-07,
            "start_logit": -5.997256278991699,
            "end_logit": 7.640470027923584
        },
        {
            "text": "of brain 5-HT2A",
            "probability": 2.742727296087387e-07,
            "start_logit": -6.402816295623779,
            "end_logit": 7.640470027923584
        },
        {
            "text": "measurements of brain 5-HT2A",
            "probability": 2.663561188613091e-07,
            "start_logit": -6.43210506439209,
            "end_logit": 7.640470027923584
        },
        {
            "text": "5-HT2A receptor",
            "probability": 1.2376483340947578e-09,
            "start_logit": 2.135146141052246,
            "end_logit": -6.298402309417725
        },
        {
            "text": "RESULTS: In cortical brain regions with a high density of 5-HT2A",
            "probability": 4.1364858962096743e-10,
            "start_logit": -5.980667591094971,
            "end_logit": 0.7214598655700684
        },
        {
            "text": "PURPOSE: To determine the reproducibility of measurements of brain 5-HT2A receptors",
            "probability": 5.7992044954558416e-11,
            "start_logit": -4.128420829772949,
            "end_logit": -3.0954978466033936
        },
        {
            "text": "receptors",
            "probability": 5.538457209872789e-11,
            "start_logit": -4.1744256019592285,
            "end_logit": -3.0954978466033936
        },
        {
            "text": "brain 5-HT2A receptors",
            "probability": 4.9132935421278695e-11,
            "start_logit": -4.294197082519531,
            "end_logit": -3.0954978466033936
        },
        {
            "text": "the reproducibility of measurements of brain 5-HT2A receptors",
            "probability": 3.9838461807552235e-11,
            "start_logit": -4.503893852233887,
            "end_logit": -3.0954978466033936
        }
    ],
    "55242d512c8b63434a000006_040": [
        {
            "text": "5-HT2A",
            "probability": 0.999212101642674,
            "start_logit": 9.275700569152832,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5",
            "probability": 0.0004922400739281395,
            "start_logit": 9.275700569152832,
            "end_logit": 1.0822317600250244
        },
        {
            "text": "A",
            "probability": 0.00014044654872061952,
            "start_logit": 0.40580520033836365,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5-HT2A receptors",
            "probability": 0.0001371911699062332,
            "start_logit": 9.275700569152832,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "Quantification of 5-HT2A",
            "probability": 8.66231775917288e-06,
            "start_logit": -2.3800394535064697,
            "end_logit": 8.69798755645752
        },
        {
            "text": "HT2A",
            "probability": 3.286529878678067e-06,
            "start_logit": -3.349189519882202,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5-HT2A receptors in the human brain using [18F]altanserin-PET",
            "probability": 2.9253137474166718e-06,
            "start_logit": 9.275700569152832,
            "end_logit": -4.043333053588867
        },
        {
            "text": "2A",
            "probability": 1.8890847903279713e-06,
            "start_logit": -3.9029293060302734,
            "end_logit": 8.69798755645752
        },
        {
            "text": "of 5-HT2A",
            "probability": 9.965986074487928e-07,
            "start_logit": -4.542428970336914,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5-HT2A receptors in the human brain",
            "probability": 1.7654420561210245e-07,
            "start_logit": 9.275700569152832,
            "end_logit": -6.850918769836426
        },
        {
            "text": "5-HT2A receptors in",
            "probability": 8.1339462130903e-08,
            "start_logit": 9.275700569152832,
            "end_logit": -7.625858783721924
        },
        {
            "text": "Quantification of 5-HT2A receptors",
            "probability": 1.1893305790900502e-09,
            "start_logit": -2.3800394535064697,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "receptors",
            "probability": 1.0316206502143792e-09,
            "start_logit": -2.52229905128479,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "Quantification",
            "probability": 3.659926092264606e-10,
            "start_logit": -2.3800394535064697,
            "end_logit": -1.3738921880722046
        },
        {
            "text": "of 5-HT2A receptors",
            "probability": 1.368323388578379e-10,
            "start_logit": -4.542428970336914,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "ors",
            "probability": 3.478380082451379e-11,
            "start_logit": -5.912033557891846,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET",
            "probability": 2.5359978310652785e-11,
            "start_logit": -2.3800394535064697,
            "end_logit": -4.043333053588867
        },
        {
            "text": "ification",
            "probability": 2.33495288631202e-11,
            "start_logit": -5.132075786590576,
            "end_logit": -1.3738921880722046
        },
        {
            "text": "receptors in the human brain using [18F]altanserin-PET",
            "probability": 2.1997145095079007e-11,
            "start_logit": -2.52229905128479,
            "end_logit": -4.043333053588867
        },
        {
            "text": "-",
            "probability": 7.054012252585516e-12,
            "start_logit": -1.5865741968154907,
            "end_logit": -6.1163740158081055
        }
    ],
    "55242d512c8b63434a000006_041": [
        {
            "text": "5-HT2A",
            "probability": 0.9970027042640318,
            "start_logit": 5.179903507232666,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors.",
            "probability": 0.0010020489555284595,
            "start_logit": 5.179903507232666,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "A",
            "probability": 0.0005837884790899236,
            "start_logit": -2.263066530227661,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5",
            "probability": 0.0005404629295053089,
            "start_logit": 5.179903507232666,
            "end_logit": -3.065509080886841
        },
        {
            "text": "of 5-HT2A",
            "probability": 0.0002761162937371416,
            "start_logit": -3.0117831230163574,
            "end_logit": 4.454573631286621
        },
        {
            "text": "the known regional distribution of 5-HT2A",
            "probability": 0.0002195415307727951,
            "start_logit": -3.2410638332366943,
            "end_logit": 4.454573631286621
        },
        {
            "text": "known regional distribution of 5-HT2A",
            "probability": 0.00015150832160135241,
            "start_logit": -3.611964702606201,
            "end_logit": 4.454573631286621
        },
        {
            "text": "regional distribution of 5-HT2A",
            "probability": 0.0001072938297245234,
            "start_logit": -3.957034111022949,
            "end_logit": 4.454573631286621
        },
        {
            "text": "distribution of 5-HT2A",
            "probability": 4.358386406608003e-05,
            "start_logit": -4.8579182624816895,
            "end_logit": 4.454573631286621
        },
        {
            "text": "HT2A",
            "probability": 2.2137194943166774e-05,
            "start_logit": -5.535346031188965,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors. These",
            "probability": 1.656856485078623e-05,
            "start_logit": 5.179903507232666,
            "end_logit": -6.5504279136657715
        },
        {
            "text": "with the known regional distribution of 5-HT2A",
            "probability": 1.3389791841011778e-05,
            "start_logit": -6.038112640380859,
            "end_logit": 4.454573631286621
        },
        {
            "text": "binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A",
            "probability": 9.499389725461025e-06,
            "start_logit": -6.381377696990967,
            "end_logit": 4.454573631286621
        },
        {
            "text": "correlated with the known regional distribution of 5-HT2A",
            "probability": 9.316343439322603e-06,
            "start_logit": -6.400835037231445,
            "end_logit": 4.454573631286621
        },
        {
            "text": "receptors.",
            "probability": 8.965144834788948e-07,
            "start_logit": -1.839139461517334,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "of 5-HT2A receptors.",
            "probability": 2.775138347773424e-07,
            "start_logit": -3.0117831230163574,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "2A",
            "probability": 2.6205423954828773e-07,
            "start_logit": -7.240525722503662,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "serotonin 5-HT2A",
            "probability": 2.3123669300286974e-07,
            "start_logit": -7.365635395050049,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "the known regional distribution of 5-HT2A receptors.",
            "probability": 2.206527230719919e-07,
            "start_logit": -3.2410638332366943,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "known regional distribution of 5-HT2A receptors.",
            "probability": 1.5227516912963118e-07,
            "start_logit": -3.611964702606201,
            "end_logit": -2.4481329917907715
        }
    ],
    "55242d512c8b63434a000006_042": [
        {
            "text": "5-HT2A",
            "probability": 0.9970027042640318,
            "start_logit": 5.179903507232666,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors.",
            "probability": 0.0010020489555284595,
            "start_logit": 5.179903507232666,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "A",
            "probability": 0.0005837884790899236,
            "start_logit": -2.263066530227661,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5",
            "probability": 0.0005404629295053089,
            "start_logit": 5.179903507232666,
            "end_logit": -3.065509080886841
        },
        {
            "text": "of 5-HT2A",
            "probability": 0.0002761162937371416,
            "start_logit": -3.0117831230163574,
            "end_logit": 4.454573631286621
        },
        {
            "text": "the known regional distribution of 5-HT2A",
            "probability": 0.0002195415307727951,
            "start_logit": -3.2410638332366943,
            "end_logit": 4.454573631286621
        },
        {
            "text": "known regional distribution of 5-HT2A",
            "probability": 0.00015150832160135241,
            "start_logit": -3.611964702606201,
            "end_logit": 4.454573631286621
        },
        {
            "text": "regional distribution of 5-HT2A",
            "probability": 0.0001072938297245234,
            "start_logit": -3.957034111022949,
            "end_logit": 4.454573631286621
        },
        {
            "text": "distribution of 5-HT2A",
            "probability": 4.358386406608003e-05,
            "start_logit": -4.8579182624816895,
            "end_logit": 4.454573631286621
        },
        {
            "text": "HT2A",
            "probability": 2.2137194943166774e-05,
            "start_logit": -5.535346031188965,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors. These",
            "probability": 1.656856485078623e-05,
            "start_logit": 5.179903507232666,
            "end_logit": -6.5504279136657715
        },
        {
            "text": "with the known regional distribution of 5-HT2A",
            "probability": 1.3389791841011778e-05,
            "start_logit": -6.038112640380859,
            "end_logit": 4.454573631286621
        },
        {
            "text": "binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A",
            "probability": 9.499389725461025e-06,
            "start_logit": -6.381377696990967,
            "end_logit": 4.454573631286621
        },
        {
            "text": "correlated with the known regional distribution of 5-HT2A",
            "probability": 9.316343439322603e-06,
            "start_logit": -6.400835037231445,
            "end_logit": 4.454573631286621
        },
        {
            "text": "receptors.",
            "probability": 8.965144834788948e-07,
            "start_logit": -1.839139461517334,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "of 5-HT2A receptors.",
            "probability": 2.775138347773424e-07,
            "start_logit": -3.0117831230163574,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "2A",
            "probability": 2.6205423954828773e-07,
            "start_logit": -7.240525722503662,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "serotonin 5-HT2A",
            "probability": 2.3123669300286974e-07,
            "start_logit": -7.365635395050049,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "the known regional distribution of 5-HT2A receptors.",
            "probability": 2.206527230719919e-07,
            "start_logit": -3.2410638332366943,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "known regional distribution of 5-HT2A receptors.",
            "probability": 1.5227516912963118e-07,
            "start_logit": -3.611964702606201,
            "end_logit": -2.4481329917907715
        }
    ],
    "55242d512c8b63434a000006_043": [
        {
            "text": "5-HT2A",
            "probability": 0.9970027042640318,
            "start_logit": 5.179903507232666,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors.",
            "probability": 0.0010020489555284595,
            "start_logit": 5.179903507232666,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "A",
            "probability": 0.0005837884790899236,
            "start_logit": -2.263066530227661,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5",
            "probability": 0.0005404629295053089,
            "start_logit": 5.179903507232666,
            "end_logit": -3.065509080886841
        },
        {
            "text": "of 5-HT2A",
            "probability": 0.0002761162937371416,
            "start_logit": -3.0117831230163574,
            "end_logit": 4.454573631286621
        },
        {
            "text": "the known regional distribution of 5-HT2A",
            "probability": 0.0002195415307727951,
            "start_logit": -3.2410638332366943,
            "end_logit": 4.454573631286621
        },
        {
            "text": "known regional distribution of 5-HT2A",
            "probability": 0.00015150832160135241,
            "start_logit": -3.611964702606201,
            "end_logit": 4.454573631286621
        },
        {
            "text": "regional distribution of 5-HT2A",
            "probability": 0.0001072938297245234,
            "start_logit": -3.957034111022949,
            "end_logit": 4.454573631286621
        },
        {
            "text": "distribution of 5-HT2A",
            "probability": 4.358386406608003e-05,
            "start_logit": -4.8579182624816895,
            "end_logit": 4.454573631286621
        },
        {
            "text": "HT2A",
            "probability": 2.2137194943166774e-05,
            "start_logit": -5.535346031188965,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors. These",
            "probability": 1.656856485078623e-05,
            "start_logit": 5.179903507232666,
            "end_logit": -6.5504279136657715
        },
        {
            "text": "with the known regional distribution of 5-HT2A",
            "probability": 1.3389791841011778e-05,
            "start_logit": -6.038112640380859,
            "end_logit": 4.454573631286621
        },
        {
            "text": "binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A",
            "probability": 9.499389725461025e-06,
            "start_logit": -6.381377696990967,
            "end_logit": 4.454573631286621
        },
        {
            "text": "correlated with the known regional distribution of 5-HT2A",
            "probability": 9.316343439322603e-06,
            "start_logit": -6.400835037231445,
            "end_logit": 4.454573631286621
        },
        {
            "text": "receptors.",
            "probability": 8.965144834788948e-07,
            "start_logit": -1.839139461517334,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "of 5-HT2A receptors.",
            "probability": 2.775138347773424e-07,
            "start_logit": -3.0117831230163574,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "2A",
            "probability": 2.6205423954828773e-07,
            "start_logit": -7.240525722503662,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "serotonin 5-HT2A",
            "probability": 2.3123669300286974e-07,
            "start_logit": -7.365635395050049,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "the known regional distribution of 5-HT2A receptors.",
            "probability": 2.206527230719919e-07,
            "start_logit": -3.2410638332366943,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "known regional distribution of 5-HT2A receptors.",
            "probability": 1.5227516912963118e-07,
            "start_logit": -3.611964702606201,
            "end_logit": -2.4481329917907715
        }
    ],
    "55242d512c8b63434a000006_044": [
        {
            "text": "5-HT2ARs",
            "probability": 0.5755064668725747,
            "start_logit": 8.309171676635742,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(5-HT2AR)",
            "probability": 0.42409374218265095,
            "start_logit": 8.114241600036621,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5",
            "probability": 0.00014977364545178576,
            "start_logit": 8.309171676635742,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "s",
            "probability": 8.835525368407642e-05,
            "start_logit": -0.47246840596199036,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(",
            "probability": 7.513536578080681e-05,
            "start_logit": 8.114241600036621,
            "end_logit": -1.0326817035675049
        },
        {
            "text": ")",
            "probability": 5.652879274791656e-05,
            "start_logit": -0.8087180852890015,
            "end_logit": 7.60573673248291
        },
        {
            "text": "quantifying cerebral 5-HT2ARs",
            "probability": 7.434116063834184e-06,
            "start_logit": -2.947754383087158,
            "end_logit": 7.716102600097656
        },
        {
            "text": "well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 5.835288196807674e-06,
            "start_logit": -3.189910411834717,
            "end_logit": 7.716102600097656
        },
        {
            "text": "5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 5.303377029256705e-06,
            "start_logit": -3.175124406814575,
            "end_logit": 7.60573673248291
        },
        {
            "text": "for quantifying cerebral 5-HT2ARs",
            "probability": 2.704281080182175e-06,
            "start_logit": -3.958997964859009,
            "end_logit": 7.716102600097656
        },
        {
            "text": "the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 2.5070188414051633e-06,
            "start_logit": -3.9243738651275635,
            "end_logit": 7.60573673248291
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established",
            "probability": 1.8508622619912786e-06,
            "start_logit": 8.114241600036621,
            "end_logit": -4.736321449279785
        },
        {
            "text": "receptor (5-HT2AR)",
            "probability": 1.6514184880742904e-06,
            "start_logit": -4.341833591461182,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5-HT2AR",
            "probability": 1.1953673872915587e-06,
            "start_logit": 1.7927563190460205,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET)",
            "probability": 9.325950952212353e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -5.616687297821045
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET) in albino rats.",
            "probability": 3.309560725662402e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -6.65267276763916
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established in humans,",
            "probability": 2.471080328859431e-07,
            "start_logit": 8.114241600036621,
            "end_logit": -6.749902725219727
        },
        {
            "text": "AR",
            "probability": 2.0589976003118943e-09,
            "start_logit": -4.57123327255249,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "[18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 1.8492413114800943e-09,
            "start_logit": -2.9929332733154297,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "quantification of 5-HT2AR",
            "probability": 1.5903213843150035e-09,
            "start_logit": -4.829516410827637,
            "end_logit": 1.1479657888412476
        }
    ],
    "55242d512c8b63434a000006_045": [
        {
            "text": "5-HT2ARs",
            "probability": 0.5755064668725747,
            "start_logit": 8.309171676635742,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(5-HT2AR)",
            "probability": 0.42409374218265095,
            "start_logit": 8.114241600036621,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5",
            "probability": 0.00014977364545178576,
            "start_logit": 8.309171676635742,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "s",
            "probability": 8.835525368407642e-05,
            "start_logit": -0.47246840596199036,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(",
            "probability": 7.513536578080681e-05,
            "start_logit": 8.114241600036621,
            "end_logit": -1.0326817035675049
        },
        {
            "text": ")",
            "probability": 5.652879274791656e-05,
            "start_logit": -0.8087180852890015,
            "end_logit": 7.60573673248291
        },
        {
            "text": "quantifying cerebral 5-HT2ARs",
            "probability": 7.434116063834184e-06,
            "start_logit": -2.947754383087158,
            "end_logit": 7.716102600097656
        },
        {
            "text": "well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 5.835288196807674e-06,
            "start_logit": -3.189910411834717,
            "end_logit": 7.716102600097656
        },
        {
            "text": "5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 5.303377029256705e-06,
            "start_logit": -3.175124406814575,
            "end_logit": 7.60573673248291
        },
        {
            "text": "for quantifying cerebral 5-HT2ARs",
            "probability": 2.704281080182175e-06,
            "start_logit": -3.958997964859009,
            "end_logit": 7.716102600097656
        },
        {
            "text": "the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 2.5070188414051633e-06,
            "start_logit": -3.9243738651275635,
            "end_logit": 7.60573673248291
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established",
            "probability": 1.8508622619912786e-06,
            "start_logit": 8.114241600036621,
            "end_logit": -4.736321449279785
        },
        {
            "text": "receptor (5-HT2AR)",
            "probability": 1.6514184880742904e-06,
            "start_logit": -4.341833591461182,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5-HT2AR",
            "probability": 1.1953673872915587e-06,
            "start_logit": 1.7927563190460205,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET)",
            "probability": 9.325950952212353e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -5.616687297821045
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET) in albino rats.",
            "probability": 3.309560725662402e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -6.65267276763916
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established in humans,",
            "probability": 2.471080328859431e-07,
            "start_logit": 8.114241600036621,
            "end_logit": -6.749902725219727
        },
        {
            "text": "AR",
            "probability": 2.0589976003118943e-09,
            "start_logit": -4.57123327255249,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "[18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 1.8492413114800943e-09,
            "start_logit": -2.9929332733154297,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "quantification of 5-HT2AR",
            "probability": 1.5903213843150035e-09,
            "start_logit": -4.829516410827637,
            "end_logit": 1.1479657888412476
        }
    ],
    "55242d512c8b63434a000006_046": [
        {
            "text": "5-HT2ARs",
            "probability": 0.5755064668725747,
            "start_logit": 8.309171676635742,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(5-HT2AR)",
            "probability": 0.42409374218265095,
            "start_logit": 8.114241600036621,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5",
            "probability": 0.00014977364545178576,
            "start_logit": 8.309171676635742,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "s",
            "probability": 8.835525368407642e-05,
            "start_logit": -0.47246840596199036,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(",
            "probability": 7.513536578080681e-05,
            "start_logit": 8.114241600036621,
            "end_logit": -1.0326817035675049
        },
        {
            "text": ")",
            "probability": 5.652879274791656e-05,
            "start_logit": -0.8087180852890015,
            "end_logit": 7.60573673248291
        },
        {
            "text": "quantifying cerebral 5-HT2ARs",
            "probability": 7.434116063834184e-06,
            "start_logit": -2.947754383087158,
            "end_logit": 7.716102600097656
        },
        {
            "text": "well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 5.835288196807674e-06,
            "start_logit": -3.189910411834717,
            "end_logit": 7.716102600097656
        },
        {
            "text": "5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 5.303377029256705e-06,
            "start_logit": -3.175124406814575,
            "end_logit": 7.60573673248291
        },
        {
            "text": "for quantifying cerebral 5-HT2ARs",
            "probability": 2.704281080182175e-06,
            "start_logit": -3.958997964859009,
            "end_logit": 7.716102600097656
        },
        {
            "text": "the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 2.5070188414051633e-06,
            "start_logit": -3.9243738651275635,
            "end_logit": 7.60573673248291
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established",
            "probability": 1.8508622619912786e-06,
            "start_logit": 8.114241600036621,
            "end_logit": -4.736321449279785
        },
        {
            "text": "receptor (5-HT2AR)",
            "probability": 1.6514184880742904e-06,
            "start_logit": -4.341833591461182,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5-HT2AR",
            "probability": 1.1953673872915587e-06,
            "start_logit": 1.7927563190460205,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET)",
            "probability": 9.325950952212353e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -5.616687297821045
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET) in albino rats.",
            "probability": 3.309560725662402e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -6.65267276763916
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established in humans,",
            "probability": 2.471080328859431e-07,
            "start_logit": 8.114241600036621,
            "end_logit": -6.749902725219727
        },
        {
            "text": "AR",
            "probability": 2.0589976003118943e-09,
            "start_logit": -4.57123327255249,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "[18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 1.8492413114800943e-09,
            "start_logit": -2.9929332733154297,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "quantification of 5-HT2AR",
            "probability": 1.5903213843150035e-09,
            "start_logit": -4.829516410827637,
            "end_logit": 1.1479657888412476
        }
    ],
    "55242d512c8b63434a000006_047": [
        {
            "text": "5-HT2A",
            "probability": 0.9992262306662333,
            "start_logit": 8.933757781982422,
            "end_logit": 7.871456146240234
        },
        {
            "text": "5",
            "probability": 0.0005439298361227838,
            "start_logit": 8.933757781982422,
            "end_logit": 0.3555399179458618
        },
        {
            "text": "5-HT2A receptors",
            "probability": 0.0001562056103000775,
            "start_logit": 8.933757781982422,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "A",
            "probability": 6.859652411028126e-05,
            "start_logit": -0.6527368426322937,
            "end_logit": 7.871456146240234
        },
        {
            "text": "image serotonin 5-HT2A",
            "probability": 2.1330171671250507e-06,
            "start_logit": -4.123441219329834,
            "end_logit": 7.871456146240234
        },
        {
            "text": "5-HT2A receptors in humans.",
            "probability": 1.2104705490092027e-06,
            "start_logit": 8.933757781982422,
            "end_logit": -5.7522711753845215
        },
        {
            "text": "HT2A",
            "probability": 5.681049450139427e-07,
            "start_logit": -5.446427822113037,
            "end_logit": 7.871456146240234
        },
        {
            "text": "[18F]altanserin and positron emission tomography (PET) to image serotonin 5-HT2A",
            "probability": 3.142615405477987e-07,
            "start_logit": -6.038508415222168,
            "end_logit": 7.871456146240234
        },
        {
            "text": "2A",
            "probability": 2.8469046444178897e-07,
            "start_logit": -6.137331485748291,
            "end_logit": 7.871456146240234
        },
        {
            "text": "5-HT2A receptors with age",
            "probability": 2.6668741446195965e-07,
            "start_logit": 7.521975994110107,
            "end_logit": -5.853176593780518
        },
        {
            "text": "Visualisation of loss of 5-HT2A",
            "probability": 1.257706846111178e-07,
            "start_logit": -5.415449619293213,
            "end_logit": 6.332632064819336
        },
        {
            "text": "loss of 5-HT2A",
            "probability": 6.761726837225087e-08,
            "start_logit": -6.036046504974365,
            "end_logit": 6.332632064819336
        },
        {
            "text": "5-HT2A receptors with age in healthy volunteers using [18F]altanserin",
            "probability": 6.596363664587506e-08,
            "start_logit": 7.521975994110107,
            "end_logit": -7.250150203704834
        },
        {
            "text": "receptors",
            "probability": 3.9569236928478083e-10,
            "start_logit": -3.952288866043091,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "image serotonin 5-HT2A receptors",
            "probability": 3.3344725963524527e-10,
            "start_logit": -4.123441219329834,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "ors",
            "probability": 4.140670331265796e-11,
            "start_logit": -6.2094831466674805,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "receptors in humans.",
            "probability": 3.0663044596591105e-12,
            "start_logit": -3.952288866043091,
            "end_logit": -5.7522711753845215
        },
        {
            "text": "image serotonin 5-HT2A receptors in humans.",
            "probability": 2.583953845581493e-12,
            "start_logit": -4.123441219329834,
            "end_logit": -5.7522711753845215
        },
        {
            "text": "image serotonin",
            "probability": 1.8531723318394427e-12,
            "start_logit": -4.123441219329834,
            "end_logit": -6.08469295501709
        },
        {
            "text": "humans.",
            "probability": 1.5136479206293815e-12,
            "start_logit": -4.658239364624023,
            "end_logit": -5.7522711753845215
        }
    ],
    "55242d512c8b63434a000006_048": [
        {
            "text": "5-HT2A",
            "probability": 0.9992262306662333,
            "start_logit": 8.933757781982422,
            "end_logit": 7.871456146240234
        },
        {
            "text": "5",
            "probability": 0.0005439298361227838,
            "start_logit": 8.933757781982422,
            "end_logit": 0.3555399179458618
        },
        {
            "text": "5-HT2A receptors",
            "probability": 0.0001562056103000775,
            "start_logit": 8.933757781982422,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "A",
            "probability": 6.859652411028126e-05,
            "start_logit": -0.6527368426322937,
            "end_logit": 7.871456146240234
        },
        {
            "text": "image serotonin 5-HT2A",
            "probability": 2.1330171671250507e-06,
            "start_logit": -4.123441219329834,
            "end_logit": 7.871456146240234
        },
        {
            "text": "5-HT2A receptors in humans.",
            "probability": 1.2104705490092027e-06,
            "start_logit": 8.933757781982422,
            "end_logit": -5.7522711753845215
        },
        {
            "text": "HT2A",
            "probability": 5.681049450139427e-07,
            "start_logit": -5.446427822113037,
            "end_logit": 7.871456146240234
        },
        {
            "text": "[18F]altanserin and positron emission tomography (PET) to image serotonin 5-HT2A",
            "probability": 3.142615405477987e-07,
            "start_logit": -6.038508415222168,
            "end_logit": 7.871456146240234
        },
        {
            "text": "2A",
            "probability": 2.8469046444178897e-07,
            "start_logit": -6.137331485748291,
            "end_logit": 7.871456146240234
        },
        {
            "text": "5-HT2A receptors with age",
            "probability": 2.6668741446195965e-07,
            "start_logit": 7.521975994110107,
            "end_logit": -5.853176593780518
        },
        {
            "text": "Visualisation of loss of 5-HT2A",
            "probability": 1.257706846111178e-07,
            "start_logit": -5.415449619293213,
            "end_logit": 6.332632064819336
        },
        {
            "text": "loss of 5-HT2A",
            "probability": 6.761726837225087e-08,
            "start_logit": -6.036046504974365,
            "end_logit": 6.332632064819336
        },
        {
            "text": "5-HT2A receptors with age in healthy volunteers using [18F]altanserin",
            "probability": 6.596363664587506e-08,
            "start_logit": 7.521975994110107,
            "end_logit": -7.250150203704834
        },
        {
            "text": "receptors",
            "probability": 3.9569236928478083e-10,
            "start_logit": -3.952288866043091,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "image serotonin 5-HT2A receptors",
            "probability": 3.3344725963524527e-10,
            "start_logit": -4.123441219329834,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "ors",
            "probability": 4.140670331265796e-11,
            "start_logit": -6.2094831466674805,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "receptors in humans.",
            "probability": 3.0663044596591105e-12,
            "start_logit": -3.952288866043091,
            "end_logit": -5.7522711753845215
        },
        {
            "text": "image serotonin 5-HT2A receptors in humans.",
            "probability": 2.583953845581493e-12,
            "start_logit": -4.123441219329834,
            "end_logit": -5.7522711753845215
        },
        {
            "text": "image serotonin",
            "probability": 1.8531723318394427e-12,
            "start_logit": -4.123441219329834,
            "end_logit": -6.08469295501709
        },
        {
            "text": "humans.",
            "probability": 1.5136479206293815e-12,
            "start_logit": -4.658239364624023,
            "end_logit": -5.7522711753845215
        }
    ],
    "55242d512c8b63434a000006_049": [
        {
            "text": "5-HT2A",
            "probability": 0.999212101642674,
            "start_logit": 9.275700569152832,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5",
            "probability": 0.0004922400739281395,
            "start_logit": 9.275700569152832,
            "end_logit": 1.0822317600250244
        },
        {
            "text": "A",
            "probability": 0.00014044654872061952,
            "start_logit": 0.40580520033836365,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5-HT2A receptors",
            "probability": 0.0001371911699062332,
            "start_logit": 9.275700569152832,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "Quantification of 5-HT2A",
            "probability": 8.66231775917288e-06,
            "start_logit": -2.3800394535064697,
            "end_logit": 8.69798755645752
        },
        {
            "text": "HT2A",
            "probability": 3.286529878678067e-06,
            "start_logit": -3.349189519882202,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5-HT2A receptors in the human brain using [18F]altanserin-PET",
            "probability": 2.9253137474166718e-06,
            "start_logit": 9.275700569152832,
            "end_logit": -4.043333053588867
        },
        {
            "text": "2A",
            "probability": 1.8890847903279713e-06,
            "start_logit": -3.9029293060302734,
            "end_logit": 8.69798755645752
        },
        {
            "text": "of 5-HT2A",
            "probability": 9.965986074487928e-07,
            "start_logit": -4.542428970336914,
            "end_logit": 8.69798755645752
        },
        {
            "text": "5-HT2A receptors in the human brain",
            "probability": 1.7654420561210245e-07,
            "start_logit": 9.275700569152832,
            "end_logit": -6.850918769836426
        },
        {
            "text": "5-HT2A receptors in",
            "probability": 8.1339462130903e-08,
            "start_logit": 9.275700569152832,
            "end_logit": -7.625858783721924
        },
        {
            "text": "Quantification of 5-HT2A receptors",
            "probability": 1.1893305790900502e-09,
            "start_logit": -2.3800394535064697,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "receptors",
            "probability": 1.0316206502143792e-09,
            "start_logit": -2.52229905128479,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "Quantification",
            "probability": 3.659926092264606e-10,
            "start_logit": -2.3800394535064697,
            "end_logit": -1.3738921880722046
        },
        {
            "text": "of 5-HT2A receptors",
            "probability": 1.368323388578379e-10,
            "start_logit": -4.542428970336914,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "ors",
            "probability": 3.478380082451379e-11,
            "start_logit": -5.912033557891846,
            "end_logit": -0.19535943865776062
        },
        {
            "text": "Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET",
            "probability": 2.5359978310652785e-11,
            "start_logit": -2.3800394535064697,
            "end_logit": -4.043333053588867
        },
        {
            "text": "ification",
            "probability": 2.33495288631202e-11,
            "start_logit": -5.132075786590576,
            "end_logit": -1.3738921880722046
        },
        {
            "text": "receptors in the human brain using [18F]altanserin-PET",
            "probability": 2.1997145095079007e-11,
            "start_logit": -2.52229905128479,
            "end_logit": -4.043333053588867
        },
        {
            "text": "-",
            "probability": 7.054012252585516e-12,
            "start_logit": -1.5865741968154907,
            "end_logit": -6.1163740158081055
        }
    ],
    "55242d512c8b63434a000006_050": [
        {
            "text": "5-HT2A",
            "probability": 0.9994718589838286,
            "start_logit": 8.972574234008789,
            "end_logit": 8.107715606689453
        },
        {
            "text": "5",
            "probability": 0.0004113838426745815,
            "start_logit": 8.972574234008789,
            "end_logit": 0.3122600317001343
        },
        {
            "text": "A",
            "probability": 7.867229819485746e-05,
            "start_logit": -0.4771169424057007,
            "end_logit": 8.107715606689453
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors",
            "probability": 2.3220336183292563e-05,
            "start_logit": 8.972574234008789,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification",
            "probability": 5.606631036071198e-06,
            "start_logit": 8.972574234008789,
            "end_logit": -3.983316659927368
        },
        {
            "text": "5-HT2A receptor",
            "probability": 3.6224686097141098e-06,
            "start_logit": 8.462964057922363,
            "end_logit": -3.9105007648468018
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target",
            "probability": 1.8496929668756592e-06,
            "start_logit": 8.972574234008789,
            "end_logit": -5.092247009277344
        },
        {
            "text": "the radiometabolites of the serotonin 5-HT2A",
            "probability": 8.81583681999443e-07,
            "start_logit": -4.968443393707275,
            "end_logit": 8.107715606689453
        },
        {
            "text": "identify and characterize the radiometabolites of the serotonin 5-HT2A",
            "probability": 7.17134055707314e-07,
            "start_logit": -5.174900531768799,
            "end_logit": 8.107715606689453
        },
        {
            "text": "HT2A",
            "probability": 5.272366072162762e-07,
            "start_logit": -5.482513904571533,
            "end_logit": 8.107715606689453
        },
        {
            "text": "and characterize the radiometabolites of the serotonin 5-HT2A",
            "probability": 4.966738980517174e-07,
            "start_logit": -5.542229652404785,
            "end_logit": 8.107715606689453
        },
        {
            "text": "radiometabolites of the serotonin 5-HT2A",
            "probability": 4.955766823239009e-07,
            "start_logit": -5.544441223144531,
            "end_logit": 8.107715606689453
        },
        {
            "text": "Characterization of radioactive metabolites of 5-HT2A",
            "probability": 3.534254908138493e-07,
            "start_logit": -5.050318241119385,
            "end_logit": 7.275543212890625
        },
        {
            "text": "5-HT2A receptor PET ligand [18F]altanserin",
            "probability": 3.1348543841936713e-07,
            "start_logit": 8.462964057922363,
            "end_logit": -6.357658863067627
        },
        {
            "text": "target receptors",
            "probability": 2.1731176389893257e-10,
            "start_logit": -2.6066317558288574,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "receptors",
            "probability": 1.8721835962678654e-10,
            "start_logit": -2.7556891441345215,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "the target receptors",
            "probability": 9.375737786414606e-11,
            "start_logit": -3.4472544193267822,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "quantification of the target receptors",
            "probability": 8.058097552581176e-11,
            "start_logit": -3.5987021923065186,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "supporting quantification of the target receptors",
            "probability": 2.8342377295338325e-11,
            "start_logit": -4.643606662750244,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "[18F]altanserin in supporting quantification of the target receptors",
            "probability": 2.3440344717251864e-11,
            "start_logit": -4.833506107330322,
            "end_logit": -2.5622382164001465
        }
    ],
    "55242d512c8b63434a000006_051": [
        {
            "text": "(5-HT2A",
            "probability": 0.9620275683772639,
            "start_logit": 6.619503021240234,
            "end_logit": 5.661994457244873
        },
        {
            "text": "5-HT2A",
            "probability": 0.037105633773021285,
            "start_logit": 4.8947834968566895,
            "end_logit": 4.131439685821533
        },
        {
            "text": "5",
            "probability": 0.00037127515670678715,
            "start_logit": 6.619503021240234,
            "end_logit": -2.1978604793548584
        },
        {
            "text": "5-HT2A receptor imaging with PET. Imaging the cerebral serotonin 2A (5-HT2A",
            "probability": 0.00030153146248879537,
            "start_logit": -1.4484210014343262,
            "end_logit": 5.661994457244873
        },
        {
            "text": "A",
            "probability": 0.00011037843511251403,
            "start_logit": -2.453380584716797,
            "end_logit": 5.661994457244873
        },
        {
            "text": "Imaging the cerebral serotonin 2A (5-HT2A",
            "probability": 4.808264815031864e-05,
            "start_logit": -3.2843739986419678,
            "end_logit": 5.661994457244873
        },
        {
            "text": "serotonin 2A (5-HT2A",
            "probability": 8.051849974429083e-06,
            "start_logit": -5.0713934898376465,
            "end_logit": 5.661994457244873
        },
        {
            "text": "the cerebral serotonin 2A (5-HT2A",
            "probability": 7.134438374597543e-06,
            "start_logit": -5.192361831665039,
            "end_logit": 5.661994457244873
        },
        {
            "text": "HT2A",
            "probability": 6.06774910763313e-06,
            "start_logit": -5.354307651519775,
            "end_logit": 5.661994457244873
        },
        {
            "text": "(5-HT2A ) receptors with positron emission tomography (PET)",
            "probability": 2.6310526147027082e-06,
            "start_logit": 6.619503021240234,
            "end_logit": -7.1474199295043945
        },
        {
            "text": "(5-HT2A ) receptors with positron emission tomography",
            "probability": 2.3365976914567168e-06,
            "start_logit": 6.619503021240234,
            "end_logit": -7.26610803604126
        },
        {
            "text": "to 5-HT2A",
            "probability": 2.0238767270465718e-06,
            "start_logit": -4.921725749969482,
            "end_logit": 4.131439685821533
        },
        {
            "text": "(5-HT2A ) receptors",
            "probability": 1.615550730447268e-06,
            "start_logit": 6.619503021240234,
            "end_logit": -7.635128021240234
        },
        {
            "text": "cerebral serotonin 2A (5-HT2A",
            "probability": 1.441660754292074e-06,
            "start_logit": -6.791499614715576,
            "end_logit": 5.661994457244873
        },
        {
            "text": "2A (5-HT2A",
            "probability": 1.168092739013996e-06,
            "start_logit": -7.001923084259033,
            "end_logit": 5.661994457244873
        },
        {
            "text": "2A",
            "probability": 1.0314715246239304e-06,
            "start_logit": -7.126308917999268,
            "end_logit": 5.661994457244873
        },
        {
            "text": "(5-HT2A )",
            "probability": 9.64700442803548e-07,
            "start_logit": 6.619503021240234,
            "end_logit": -8.150741577148438
        },
        {
            "text": "5-HT2A receptors",
            "probability": 5.372265631536832e-07,
            "start_logit": 4.8947834968566895,
            "end_logit": -7.011419773101807
        },
        {
            "text": "bind to 5-HT2A",
            "probability": 4.3154812773033934e-07,
            "start_logit": -6.467116832733154,
            "end_logit": 4.131439685821533
        },
        {
            "text": "5-HT2A receptors in the pig brain.",
            "probability": 9.433188471029201e-08,
            "start_logit": 4.8947834968566895,
            "end_logit": -8.751020431518555
        }
    ],
    "55242d512c8b63434a000006_052": [
        {
            "text": "5-HT2aR",
            "probability": 0.9990836167641848,
            "start_logit": 8.188986778259277,
            "end_logit": 7.30662727355957
        },
        {
            "text": "5-HT2a",
            "probability": 0.00053233850683268,
            "start_logit": 5.932469367980957,
            "end_logit": 2.0258305072784424
        },
        {
            "text": "5",
            "probability": 0.0002888592117662445,
            "start_logit": 8.188986778259277,
            "end_logit": -0.8420270681381226
        },
        {
            "text": "a",
            "probability": 9.072313020628207e-05,
            "start_logit": -1.1177946329116821,
            "end_logit": 7.30662727355957
        },
        {
            "text": "aR",
            "probability": 1.934053351397579e-06,
            "start_logit": -1.1177946329116821,
            "end_logit": 3.458432912826538
        },
        {
            "text": "5-HT2aR antagonist",
            "probability": 7.376431555476124e-07,
            "start_logit": 8.188986778259277,
            "end_logit": -6.812261581420898
        },
        {
            "text": "identify brain regions with WM-induced changes in the binding potential (BP(nd)) of the 5-HT2aR",
            "probability": 4.805997804858631e-07,
            "start_logit": -6.358327388763428,
            "end_logit": 7.30662727355957
        },
        {
            "text": "the 5-HT2aR",
            "probability": 4.307068287147597e-07,
            "start_logit": -6.467934608459473,
            "end_logit": 7.30662727355957
        },
        {
            "text": "HT2a",
            "probability": 3.731488443996325e-07,
            "start_logit": -6.611384868621826,
            "end_logit": 7.30662727355957
        },
        {
            "text": "changes in the binding potential (BP(nd)) of the 5-HT2aR",
            "probability": 2.886735374122402e-07,
            "start_logit": -6.86806583404541,
            "end_logit": 7.30662727355957
        },
        {
            "text": "5-HT2a receptor",
            "probability": 1.7378454359976368e-07,
            "start_logit": 5.932469367980957,
            "end_logit": -6.001388072967529
        },
        {
            "text": "R",
            "probability": 3.3735895606589895e-08,
            "start_logit": -5.166605472564697,
            "end_logit": 3.458432912826538
        },
        {
            "text": "HT2aR",
            "probability": 7.954859708216616e-09,
            "start_logit": -6.611384868621826,
            "end_logit": 3.458432912826538
        },
        {
            "text": "the 5-HT2a",
            "probability": 1.9343337742208958e-09,
            "start_logit": -6.59280252456665,
            "end_logit": 2.0258305072784424
        },
        {
            "text": "5-HT2a receptor (5-HT2aR)",
            "probability": 1.1470156401978753e-10,
            "start_logit": -2.0310564041137695,
            "end_logit": -5.361100196838379
        },
        {
            "text": "(5-HT2aR)",
            "probability": 1.8776516087032158e-11,
            "start_logit": -3.84078311920166,
            "end_logit": -5.361100196838379
        },
        {
            "text": "[18F]altanserin. Behavioral and cellular studies indicate that serotonin interacting with the 5-HT2a",
            "probability": 8.726633745846374e-12,
            "start_logit": -4.101347923278809,
            "end_logit": -5.866762638092041
        },
        {
            "text": "serotonin in the orbitofrontal cortex: a controlled cross-over PET study of a delayed match-to-sample task using the 5-HT2a",
            "probability": 6.648108765818304e-12,
            "start_logit": -6.688520431518555,
            "end_logit": -3.5516374111175537
        },
        {
            "text": "HT2",
            "probability": 2.3952205693482213e-12,
            "start_logit": -6.611384868621826,
            "end_logit": -4.649630069732666
        },
        {
            "text": "the 5-HT2a receptor",
            "probability": 6.314728463335544e-13,
            "start_logit": -6.59280252456665,
            "end_logit": -6.001388072967529
        }
    ],
    "55242d512c8b63434a000006_053": [
        {
            "text": "(5-HT2A",
            "probability": 0.9620275683772639,
            "start_logit": 6.619503021240234,
            "end_logit": 5.661994457244873
        },
        {
            "text": "5-HT2A",
            "probability": 0.037105633773021285,
            "start_logit": 4.8947834968566895,
            "end_logit": 4.131439685821533
        },
        {
            "text": "5",
            "probability": 0.00037127515670678715,
            "start_logit": 6.619503021240234,
            "end_logit": -2.1978604793548584
        },
        {
            "text": "5-HT2A receptor imaging with PET. Imaging the cerebral serotonin 2A (5-HT2A",
            "probability": 0.00030153146248879537,
            "start_logit": -1.4484210014343262,
            "end_logit": 5.661994457244873
        },
        {
            "text": "A",
            "probability": 0.00011037843511251403,
            "start_logit": -2.453380584716797,
            "end_logit": 5.661994457244873
        },
        {
            "text": "Imaging the cerebral serotonin 2A (5-HT2A",
            "probability": 4.808264815031864e-05,
            "start_logit": -3.2843739986419678,
            "end_logit": 5.661994457244873
        },
        {
            "text": "serotonin 2A (5-HT2A",
            "probability": 8.051849974429083e-06,
            "start_logit": -5.0713934898376465,
            "end_logit": 5.661994457244873
        },
        {
            "text": "the cerebral serotonin 2A (5-HT2A",
            "probability": 7.134438374597543e-06,
            "start_logit": -5.192361831665039,
            "end_logit": 5.661994457244873
        },
        {
            "text": "HT2A",
            "probability": 6.06774910763313e-06,
            "start_logit": -5.354307651519775,
            "end_logit": 5.661994457244873
        },
        {
            "text": "(5-HT2A ) receptors with positron emission tomography (PET)",
            "probability": 2.6310526147027082e-06,
            "start_logit": 6.619503021240234,
            "end_logit": -7.1474199295043945
        },
        {
            "text": "(5-HT2A ) receptors with positron emission tomography",
            "probability": 2.3365976914567168e-06,
            "start_logit": 6.619503021240234,
            "end_logit": -7.26610803604126
        },
        {
            "text": "to 5-HT2A",
            "probability": 2.0238767270465718e-06,
            "start_logit": -4.921725749969482,
            "end_logit": 4.131439685821533
        },
        {
            "text": "(5-HT2A ) receptors",
            "probability": 1.615550730447268e-06,
            "start_logit": 6.619503021240234,
            "end_logit": -7.635128021240234
        },
        {
            "text": "cerebral serotonin 2A (5-HT2A",
            "probability": 1.441660754292074e-06,
            "start_logit": -6.791499614715576,
            "end_logit": 5.661994457244873
        },
        {
            "text": "2A (5-HT2A",
            "probability": 1.168092739013996e-06,
            "start_logit": -7.001923084259033,
            "end_logit": 5.661994457244873
        },
        {
            "text": "2A",
            "probability": 1.0314715246239304e-06,
            "start_logit": -7.126308917999268,
            "end_logit": 5.661994457244873
        },
        {
            "text": "(5-HT2A )",
            "probability": 9.64700442803548e-07,
            "start_logit": 6.619503021240234,
            "end_logit": -8.150741577148438
        },
        {
            "text": "5-HT2A receptors",
            "probability": 5.372265631536832e-07,
            "start_logit": 4.8947834968566895,
            "end_logit": -7.011419773101807
        },
        {
            "text": "bind to 5-HT2A",
            "probability": 4.3154812773033934e-07,
            "start_logit": -6.467116832733154,
            "end_logit": 4.131439685821533
        },
        {
            "text": "5-HT2A receptors in the pig brain.",
            "probability": 9.433188471029201e-08,
            "start_logit": 4.8947834968566895,
            "end_logit": -8.751020431518555
        }
    ],
    "55242d512c8b63434a000006_054": [
        {
            "text": "5-HT2A",
            "probability": 0.9995301710246578,
            "start_logit": 9.231576919555664,
            "end_logit": 8.420754432678223
        },
        {
            "text": "5",
            "probability": 0.00038553067011905316,
            "start_logit": 9.231576919555664,
            "end_logit": 0.5603345632553101
        },
        {
            "text": "A",
            "probability": 7.53517282048149e-05,
            "start_logit": -0.2612968385219574,
            "end_logit": 8.420754432678223
        },
        {
            "text": "to evaluate 5-HT2A",
            "probability": 2.214910114246344e-06,
            "start_logit": -3.7882518768310547,
            "end_logit": 8.420754432678223
        },
        {
            "text": "evaluate 5-HT2A",
            "probability": 1.3502897850389228e-06,
            "start_logit": -4.283144474029541,
            "end_logit": 8.420754432678223
        },
        {
            "text": "[18F]altanserin to evaluate 5-HT2A",
            "probability": 1.3169081845211183e-06,
            "start_logit": -4.3081769943237305,
            "end_logit": 8.420754432678223
        },
        {
            "text": "5-HT2A receptor",
            "probability": 1.0373973836190995e-06,
            "start_logit": 9.231576919555664,
            "end_logit": -5.357571125030518
        },
        {
            "text": "5-HT2A receptor binding in 11 elderly patients with depression",
            "probability": 6.534869916148808e-07,
            "start_logit": 9.231576919555664,
            "end_logit": -5.819718837738037
        },
        {
            "text": "HT2A",
            "probability": 4.49182792666574e-07,
            "start_logit": -5.3837890625,
            "end_logit": 8.420754432678223
        },
        {
            "text": "5-HT2A receptor binding",
            "probability": 4.218020161977843e-07,
            "start_logit": 9.231576919555664,
            "end_logit": -6.257505416870117
        },
        {
            "text": "METHOD: PET was performed by using [18F]altanserin to evaluate 5-HT2A",
            "probability": 3.642967210737604e-07,
            "start_logit": -5.593250274658203,
            "end_logit": 8.420754432678223
        },
        {
            "text": "2A",
            "probability": 3.3453569924278616e-07,
            "start_logit": -5.678475379943848,
            "end_logit": 8.420754432678223
        },
        {
            "text": "PET was performed by using [18F]altanserin to evaluate 5-HT2A",
            "probability": 2.874662801895128e-07,
            "start_logit": -5.830113410949707,
            "end_logit": 8.420754432678223
        },
        {
            "text": "performed by using [18F]altanserin to evaluate 5-HT2A",
            "probability": 2.1142147159068034e-07,
            "start_logit": -6.137365341186523,
            "end_logit": 8.420754432678223
        },
        {
            "text": "by using [18F]altanserin to evaluate 5-HT2A",
            "probability": 1.6380631471176224e-07,
            "start_logit": -6.392534255981445,
            "end_logit": 8.420754432678223
        },
        {
            "text": "using [18F]altanserin to evaluate 5-HT2A",
            "probability": 1.406840292029831e-07,
            "start_logit": -6.544702529907227,
            "end_logit": 8.420754432678223
        },
        {
            "text": "(5-HT2A)",
            "probability": 3.8041169641900367e-10,
            "start_logit": -4.09015417098999,
            "end_logit": 0.053188424557447433
        },
        {
            "text": "5-HT2A receptor binding in 11 elderly patients with depression (four men, seven women; mean age = 65.0 years,",
            "probability": 5.076279958680133e-12,
            "start_logit": -0.2612968385219574,
            "end_logit": -8.092344284057617
        },
        {
            "text": "to evaluate 5-HT2A receptor",
            "probability": 2.298822010660401e-12,
            "start_logit": -3.7882518768310547,
            "end_logit": -5.357571125030518
        },
        {
            "text": "to evaluate 5-HT2A receptor binding in 11 elderly patients with depression",
            "probability": 1.4480953043892744e-12,
            "start_logit": -3.7882518768310547,
            "end_logit": -5.819718837738037
        }
    ],
    "55242d512c8b63434a000006_055": [
        {
            "text": "5-HT2ARs",
            "probability": 0.5755064668725747,
            "start_logit": 8.309171676635742,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(5-HT2AR)",
            "probability": 0.42409374218265095,
            "start_logit": 8.114241600036621,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5",
            "probability": 0.00014977364545178576,
            "start_logit": 8.309171676635742,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "s",
            "probability": 8.835525368407642e-05,
            "start_logit": -0.47246840596199036,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(",
            "probability": 7.513536578080681e-05,
            "start_logit": 8.114241600036621,
            "end_logit": -1.0326817035675049
        },
        {
            "text": ")",
            "probability": 5.652879274791656e-05,
            "start_logit": -0.8087180852890015,
            "end_logit": 7.60573673248291
        },
        {
            "text": "quantifying cerebral 5-HT2ARs",
            "probability": 7.434116063834184e-06,
            "start_logit": -2.947754383087158,
            "end_logit": 7.716102600097656
        },
        {
            "text": "well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 5.835288196807674e-06,
            "start_logit": -3.189910411834717,
            "end_logit": 7.716102600097656
        },
        {
            "text": "5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 5.303377029256705e-06,
            "start_logit": -3.175124406814575,
            "end_logit": 7.60573673248291
        },
        {
            "text": "for quantifying cerebral 5-HT2ARs",
            "probability": 2.704281080182175e-06,
            "start_logit": -3.958997964859009,
            "end_logit": 7.716102600097656
        },
        {
            "text": "the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 2.5070188414051633e-06,
            "start_logit": -3.9243738651275635,
            "end_logit": 7.60573673248291
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established",
            "probability": 1.8508622619912786e-06,
            "start_logit": 8.114241600036621,
            "end_logit": -4.736321449279785
        },
        {
            "text": "receptor (5-HT2AR)",
            "probability": 1.6514184880742904e-06,
            "start_logit": -4.341833591461182,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5-HT2AR",
            "probability": 1.1953673872915587e-06,
            "start_logit": 1.7927563190460205,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET)",
            "probability": 9.325950952212353e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -5.616687297821045
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET) in albino rats.",
            "probability": 3.309560725662402e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -6.65267276763916
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established in humans,",
            "probability": 2.471080328859431e-07,
            "start_logit": 8.114241600036621,
            "end_logit": -6.749902725219727
        },
        {
            "text": "AR",
            "probability": 2.0589976003118943e-09,
            "start_logit": -4.57123327255249,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "[18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 1.8492413114800943e-09,
            "start_logit": -2.9929332733154297,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "quantification of 5-HT2AR",
            "probability": 1.5903213843150035e-09,
            "start_logit": -4.829516410827637,
            "end_logit": 1.1479657888412476
        }
    ],
    "55242d512c8b63434a000006_056": [
        {
            "text": "5-HT2ARs",
            "probability": 0.5755064668725747,
            "start_logit": 8.309171676635742,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(5-HT2AR)",
            "probability": 0.42409374218265095,
            "start_logit": 8.114241600036621,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5",
            "probability": 0.00014977364545178576,
            "start_logit": 8.309171676635742,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "s",
            "probability": 8.835525368407642e-05,
            "start_logit": -0.47246840596199036,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(",
            "probability": 7.513536578080681e-05,
            "start_logit": 8.114241600036621,
            "end_logit": -1.0326817035675049
        },
        {
            "text": ")",
            "probability": 5.652879274791656e-05,
            "start_logit": -0.8087180852890015,
            "end_logit": 7.60573673248291
        },
        {
            "text": "quantifying cerebral 5-HT2ARs",
            "probability": 7.434116063834184e-06,
            "start_logit": -2.947754383087158,
            "end_logit": 7.716102600097656
        },
        {
            "text": "well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 5.835288196807674e-06,
            "start_logit": -3.189910411834717,
            "end_logit": 7.716102600097656
        },
        {
            "text": "5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 5.303377029256705e-06,
            "start_logit": -3.175124406814575,
            "end_logit": 7.60573673248291
        },
        {
            "text": "for quantifying cerebral 5-HT2ARs",
            "probability": 2.704281080182175e-06,
            "start_logit": -3.958997964859009,
            "end_logit": 7.716102600097656
        },
        {
            "text": "the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 2.5070188414051633e-06,
            "start_logit": -3.9243738651275635,
            "end_logit": 7.60573673248291
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established",
            "probability": 1.8508622619912786e-06,
            "start_logit": 8.114241600036621,
            "end_logit": -4.736321449279785
        },
        {
            "text": "receptor (5-HT2AR)",
            "probability": 1.6514184880742904e-06,
            "start_logit": -4.341833591461182,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5-HT2AR",
            "probability": 1.1953673872915587e-06,
            "start_logit": 1.7927563190460205,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET)",
            "probability": 9.325950952212353e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -5.616687297821045
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET) in albino rats.",
            "probability": 3.309560725662402e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -6.65267276763916
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established in humans,",
            "probability": 2.471080328859431e-07,
            "start_logit": 8.114241600036621,
            "end_logit": -6.749902725219727
        },
        {
            "text": "AR",
            "probability": 2.0589976003118943e-09,
            "start_logit": -4.57123327255249,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "[18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 1.8492413114800943e-09,
            "start_logit": -2.9929332733154297,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "quantification of 5-HT2AR",
            "probability": 1.5903213843150035e-09,
            "start_logit": -4.829516410827637,
            "end_logit": 1.1479657888412476
        }
    ],
    "55242d512c8b63434a000006_057": [
        {
            "text": "5-HT2A",
            "probability": 0.9994718589838286,
            "start_logit": 8.972574234008789,
            "end_logit": 8.107715606689453
        },
        {
            "text": "5",
            "probability": 0.0004113838426745815,
            "start_logit": 8.972574234008789,
            "end_logit": 0.3122600317001343
        },
        {
            "text": "A",
            "probability": 7.867229819485746e-05,
            "start_logit": -0.4771169424057007,
            "end_logit": 8.107715606689453
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors",
            "probability": 2.3220336183292563e-05,
            "start_logit": 8.972574234008789,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification",
            "probability": 5.606631036071198e-06,
            "start_logit": 8.972574234008789,
            "end_logit": -3.983316659927368
        },
        {
            "text": "5-HT2A receptor",
            "probability": 3.6224686097141098e-06,
            "start_logit": 8.462964057922363,
            "end_logit": -3.9105007648468018
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target",
            "probability": 1.8496929668756592e-06,
            "start_logit": 8.972574234008789,
            "end_logit": -5.092247009277344
        },
        {
            "text": "the radiometabolites of the serotonin 5-HT2A",
            "probability": 8.81583681999443e-07,
            "start_logit": -4.968443393707275,
            "end_logit": 8.107715606689453
        },
        {
            "text": "identify and characterize the radiometabolites of the serotonin 5-HT2A",
            "probability": 7.17134055707314e-07,
            "start_logit": -5.174900531768799,
            "end_logit": 8.107715606689453
        },
        {
            "text": "HT2A",
            "probability": 5.272366072162762e-07,
            "start_logit": -5.482513904571533,
            "end_logit": 8.107715606689453
        },
        {
            "text": "and characterize the radiometabolites of the serotonin 5-HT2A",
            "probability": 4.966738980517174e-07,
            "start_logit": -5.542229652404785,
            "end_logit": 8.107715606689453
        },
        {
            "text": "radiometabolites of the serotonin 5-HT2A",
            "probability": 4.955766823239009e-07,
            "start_logit": -5.544441223144531,
            "end_logit": 8.107715606689453
        },
        {
            "text": "Characterization of radioactive metabolites of 5-HT2A",
            "probability": 3.534254908138493e-07,
            "start_logit": -5.050318241119385,
            "end_logit": 7.275543212890625
        },
        {
            "text": "5-HT2A receptor PET ligand [18F]altanserin",
            "probability": 3.1348543841936713e-07,
            "start_logit": 8.462964057922363,
            "end_logit": -6.357658863067627
        },
        {
            "text": "target receptors",
            "probability": 2.1731176389893257e-10,
            "start_logit": -2.6066317558288574,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "receptors",
            "probability": 1.8721835962678654e-10,
            "start_logit": -2.7556891441345215,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "the target receptors",
            "probability": 9.375737786414606e-11,
            "start_logit": -3.4472544193267822,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "quantification of the target receptors",
            "probability": 8.058097552581176e-11,
            "start_logit": -3.5987021923065186,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "supporting quantification of the target receptors",
            "probability": 2.8342377295338325e-11,
            "start_logit": -4.643606662750244,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "[18F]altanserin in supporting quantification of the target receptors",
            "probability": 2.3440344717251864e-11,
            "start_logit": -4.833506107330322,
            "end_logit": -2.5622382164001465
        }
    ],
    "55242d512c8b63434a000006_058": [
        {
            "text": "5-HT2A",
            "probability": 0.9970027042640318,
            "start_logit": 5.179903507232666,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors.",
            "probability": 0.0010020489555284595,
            "start_logit": 5.179903507232666,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "A",
            "probability": 0.0005837884790899236,
            "start_logit": -2.263066530227661,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5",
            "probability": 0.0005404629295053089,
            "start_logit": 5.179903507232666,
            "end_logit": -3.065509080886841
        },
        {
            "text": "of 5-HT2A",
            "probability": 0.0002761162937371416,
            "start_logit": -3.0117831230163574,
            "end_logit": 4.454573631286621
        },
        {
            "text": "the known regional distribution of 5-HT2A",
            "probability": 0.0002195415307727951,
            "start_logit": -3.2410638332366943,
            "end_logit": 4.454573631286621
        },
        {
            "text": "known regional distribution of 5-HT2A",
            "probability": 0.00015150832160135241,
            "start_logit": -3.611964702606201,
            "end_logit": 4.454573631286621
        },
        {
            "text": "regional distribution of 5-HT2A",
            "probability": 0.0001072938297245234,
            "start_logit": -3.957034111022949,
            "end_logit": 4.454573631286621
        },
        {
            "text": "distribution of 5-HT2A",
            "probability": 4.358386406608003e-05,
            "start_logit": -4.8579182624816895,
            "end_logit": 4.454573631286621
        },
        {
            "text": "HT2A",
            "probability": 2.2137194943166774e-05,
            "start_logit": -5.535346031188965,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors. These",
            "probability": 1.656856485078623e-05,
            "start_logit": 5.179903507232666,
            "end_logit": -6.5504279136657715
        },
        {
            "text": "with the known regional distribution of 5-HT2A",
            "probability": 1.3389791841011778e-05,
            "start_logit": -6.038112640380859,
            "end_logit": 4.454573631286621
        },
        {
            "text": "binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A",
            "probability": 9.499389725461025e-06,
            "start_logit": -6.381377696990967,
            "end_logit": 4.454573631286621
        },
        {
            "text": "correlated with the known regional distribution of 5-HT2A",
            "probability": 9.316343439322603e-06,
            "start_logit": -6.400835037231445,
            "end_logit": 4.454573631286621
        },
        {
            "text": "receptors.",
            "probability": 8.965144834788948e-07,
            "start_logit": -1.839139461517334,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "of 5-HT2A receptors.",
            "probability": 2.775138347773424e-07,
            "start_logit": -3.0117831230163574,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "2A",
            "probability": 2.6205423954828773e-07,
            "start_logit": -7.240525722503662,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "serotonin 5-HT2A",
            "probability": 2.3123669300286974e-07,
            "start_logit": -7.365635395050049,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "the known regional distribution of 5-HT2A receptors.",
            "probability": 2.206527230719919e-07,
            "start_logit": -3.2410638332366943,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "known regional distribution of 5-HT2A receptors.",
            "probability": 1.5227516912963118e-07,
            "start_logit": -3.611964702606201,
            "end_logit": -2.4481329917907715
        }
    ],
    "55242d512c8b63434a000006_059": [
        {
            "text": "5-HT2A",
            "probability": 0.9970027042640318,
            "start_logit": 5.179903507232666,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors.",
            "probability": 0.0010020489555284595,
            "start_logit": 5.179903507232666,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "A",
            "probability": 0.0005837884790899236,
            "start_logit": -2.263066530227661,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5",
            "probability": 0.0005404629295053089,
            "start_logit": 5.179903507232666,
            "end_logit": -3.065509080886841
        },
        {
            "text": "of 5-HT2A",
            "probability": 0.0002761162937371416,
            "start_logit": -3.0117831230163574,
            "end_logit": 4.454573631286621
        },
        {
            "text": "the known regional distribution of 5-HT2A",
            "probability": 0.0002195415307727951,
            "start_logit": -3.2410638332366943,
            "end_logit": 4.454573631286621
        },
        {
            "text": "known regional distribution of 5-HT2A",
            "probability": 0.00015150832160135241,
            "start_logit": -3.611964702606201,
            "end_logit": 4.454573631286621
        },
        {
            "text": "regional distribution of 5-HT2A",
            "probability": 0.0001072938297245234,
            "start_logit": -3.957034111022949,
            "end_logit": 4.454573631286621
        },
        {
            "text": "distribution of 5-HT2A",
            "probability": 4.358386406608003e-05,
            "start_logit": -4.8579182624816895,
            "end_logit": 4.454573631286621
        },
        {
            "text": "HT2A",
            "probability": 2.2137194943166774e-05,
            "start_logit": -5.535346031188965,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors. These",
            "probability": 1.656856485078623e-05,
            "start_logit": 5.179903507232666,
            "end_logit": -6.5504279136657715
        },
        {
            "text": "with the known regional distribution of 5-HT2A",
            "probability": 1.3389791841011778e-05,
            "start_logit": -6.038112640380859,
            "end_logit": 4.454573631286621
        },
        {
            "text": "binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A",
            "probability": 9.499389725461025e-06,
            "start_logit": -6.381377696990967,
            "end_logit": 4.454573631286621
        },
        {
            "text": "correlated with the known regional distribution of 5-HT2A",
            "probability": 9.316343439322603e-06,
            "start_logit": -6.400835037231445,
            "end_logit": 4.454573631286621
        },
        {
            "text": "receptors.",
            "probability": 8.965144834788948e-07,
            "start_logit": -1.839139461517334,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "of 5-HT2A receptors.",
            "probability": 2.775138347773424e-07,
            "start_logit": -3.0117831230163574,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "2A",
            "probability": 2.6205423954828773e-07,
            "start_logit": -7.240525722503662,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "serotonin 5-HT2A",
            "probability": 2.3123669300286974e-07,
            "start_logit": -7.365635395050049,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "the known regional distribution of 5-HT2A receptors.",
            "probability": 2.206527230719919e-07,
            "start_logit": -3.2410638332366943,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "known regional distribution of 5-HT2A receptors.",
            "probability": 1.5227516912963118e-07,
            "start_logit": -3.611964702606201,
            "end_logit": -2.4481329917907715
        }
    ],
    "55242d512c8b63434a000006_060": [
        {
            "text": "5-HT2A",
            "probability": 0.9994718589838286,
            "start_logit": 8.972574234008789,
            "end_logit": 8.107715606689453
        },
        {
            "text": "5",
            "probability": 0.0004113838426745815,
            "start_logit": 8.972574234008789,
            "end_logit": 0.3122600317001343
        },
        {
            "text": "A",
            "probability": 7.867229819485746e-05,
            "start_logit": -0.4771169424057007,
            "end_logit": 8.107715606689453
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors",
            "probability": 2.3220336183292563e-05,
            "start_logit": 8.972574234008789,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification",
            "probability": 5.606631036071198e-06,
            "start_logit": 8.972574234008789,
            "end_logit": -3.983316659927368
        },
        {
            "text": "5-HT2A receptor",
            "probability": 3.6224686097141098e-06,
            "start_logit": 8.462964057922363,
            "end_logit": -3.9105007648468018
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target",
            "probability": 1.8496929668756592e-06,
            "start_logit": 8.972574234008789,
            "end_logit": -5.092247009277344
        },
        {
            "text": "the radiometabolites of the serotonin 5-HT2A",
            "probability": 8.81583681999443e-07,
            "start_logit": -4.968443393707275,
            "end_logit": 8.107715606689453
        },
        {
            "text": "identify and characterize the radiometabolites of the serotonin 5-HT2A",
            "probability": 7.17134055707314e-07,
            "start_logit": -5.174900531768799,
            "end_logit": 8.107715606689453
        },
        {
            "text": "HT2A",
            "probability": 5.272366072162762e-07,
            "start_logit": -5.482513904571533,
            "end_logit": 8.107715606689453
        },
        {
            "text": "and characterize the radiometabolites of the serotonin 5-HT2A",
            "probability": 4.966738980517174e-07,
            "start_logit": -5.542229652404785,
            "end_logit": 8.107715606689453
        },
        {
            "text": "radiometabolites of the serotonin 5-HT2A",
            "probability": 4.955766823239009e-07,
            "start_logit": -5.544441223144531,
            "end_logit": 8.107715606689453
        },
        {
            "text": "Characterization of radioactive metabolites of 5-HT2A",
            "probability": 3.534254908138493e-07,
            "start_logit": -5.050318241119385,
            "end_logit": 7.275543212890625
        },
        {
            "text": "5-HT2A receptor PET ligand [18F]altanserin",
            "probability": 3.1348543841936713e-07,
            "start_logit": 8.462964057922363,
            "end_logit": -6.357658863067627
        },
        {
            "text": "target receptors",
            "probability": 2.1731176389893257e-10,
            "start_logit": -2.6066317558288574,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "receptors",
            "probability": 1.8721835962678654e-10,
            "start_logit": -2.7556891441345215,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "the target receptors",
            "probability": 9.375737786414606e-11,
            "start_logit": -3.4472544193267822,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "quantification of the target receptors",
            "probability": 8.058097552581176e-11,
            "start_logit": -3.5987021923065186,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "supporting quantification of the target receptors",
            "probability": 2.8342377295338325e-11,
            "start_logit": -4.643606662750244,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "[18F]altanserin in supporting quantification of the target receptors",
            "probability": 2.3440344717251864e-11,
            "start_logit": -4.833506107330322,
            "end_logit": -2.5622382164001465
        }
    ],
    "55242d512c8b63434a000006_061": [
        {
            "text": "5-HT2ARs",
            "probability": 0.5755064668725747,
            "start_logit": 8.309171676635742,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(5-HT2AR)",
            "probability": 0.42409374218265095,
            "start_logit": 8.114241600036621,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5",
            "probability": 0.00014977364545178576,
            "start_logit": 8.309171676635742,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "s",
            "probability": 8.835525368407642e-05,
            "start_logit": -0.47246840596199036,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(",
            "probability": 7.513536578080681e-05,
            "start_logit": 8.114241600036621,
            "end_logit": -1.0326817035675049
        },
        {
            "text": ")",
            "probability": 5.652879274791656e-05,
            "start_logit": -0.8087180852890015,
            "end_logit": 7.60573673248291
        },
        {
            "text": "quantifying cerebral 5-HT2ARs",
            "probability": 7.434116063834184e-06,
            "start_logit": -2.947754383087158,
            "end_logit": 7.716102600097656
        },
        {
            "text": "well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 5.835288196807674e-06,
            "start_logit": -3.189910411834717,
            "end_logit": 7.716102600097656
        },
        {
            "text": "5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 5.303377029256705e-06,
            "start_logit": -3.175124406814575,
            "end_logit": 7.60573673248291
        },
        {
            "text": "for quantifying cerebral 5-HT2ARs",
            "probability": 2.704281080182175e-06,
            "start_logit": -3.958997964859009,
            "end_logit": 7.716102600097656
        },
        {
            "text": "the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 2.5070188414051633e-06,
            "start_logit": -3.9243738651275635,
            "end_logit": 7.60573673248291
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established",
            "probability": 1.8508622619912786e-06,
            "start_logit": 8.114241600036621,
            "end_logit": -4.736321449279785
        },
        {
            "text": "receptor (5-HT2AR)",
            "probability": 1.6514184880742904e-06,
            "start_logit": -4.341833591461182,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5-HT2AR",
            "probability": 1.1953673872915587e-06,
            "start_logit": 1.7927563190460205,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET)",
            "probability": 9.325950952212353e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -5.616687297821045
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET) in albino rats.",
            "probability": 3.309560725662402e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -6.65267276763916
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established in humans,",
            "probability": 2.471080328859431e-07,
            "start_logit": 8.114241600036621,
            "end_logit": -6.749902725219727
        },
        {
            "text": "AR",
            "probability": 2.0589976003118943e-09,
            "start_logit": -4.57123327255249,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "[18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 1.8492413114800943e-09,
            "start_logit": -2.9929332733154297,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "quantification of 5-HT2AR",
            "probability": 1.5903213843150035e-09,
            "start_logit": -4.829516410827637,
            "end_logit": 1.1479657888412476
        }
    ],
    "55242d512c8b63434a000006_062": [
        {
            "text": "5-HT2ARs",
            "probability": 0.5755064668725747,
            "start_logit": 8.309171676635742,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(5-HT2AR)",
            "probability": 0.42409374218265095,
            "start_logit": 8.114241600036621,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5",
            "probability": 0.00014977364545178576,
            "start_logit": 8.309171676635742,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "s",
            "probability": 8.835525368407642e-05,
            "start_logit": -0.47246840596199036,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(",
            "probability": 7.513536578080681e-05,
            "start_logit": 8.114241600036621,
            "end_logit": -1.0326817035675049
        },
        {
            "text": ")",
            "probability": 5.652879274791656e-05,
            "start_logit": -0.8087180852890015,
            "end_logit": 7.60573673248291
        },
        {
            "text": "quantifying cerebral 5-HT2ARs",
            "probability": 7.434116063834184e-06,
            "start_logit": -2.947754383087158,
            "end_logit": 7.716102600097656
        },
        {
            "text": "well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 5.835288196807674e-06,
            "start_logit": -3.189910411834717,
            "end_logit": 7.716102600097656
        },
        {
            "text": "5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 5.303377029256705e-06,
            "start_logit": -3.175124406814575,
            "end_logit": 7.60573673248291
        },
        {
            "text": "for quantifying cerebral 5-HT2ARs",
            "probability": 2.704281080182175e-06,
            "start_logit": -3.958997964859009,
            "end_logit": 7.716102600097656
        },
        {
            "text": "the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 2.5070188414051633e-06,
            "start_logit": -3.9243738651275635,
            "end_logit": 7.60573673248291
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established",
            "probability": 1.8508622619912786e-06,
            "start_logit": 8.114241600036621,
            "end_logit": -4.736321449279785
        },
        {
            "text": "receptor (5-HT2AR)",
            "probability": 1.6514184880742904e-06,
            "start_logit": -4.341833591461182,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5-HT2AR",
            "probability": 1.1953673872915587e-06,
            "start_logit": 1.7927563190460205,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET)",
            "probability": 9.325950952212353e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -5.616687297821045
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET) in albino rats.",
            "probability": 3.309560725662402e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -6.65267276763916
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established in humans,",
            "probability": 2.471080328859431e-07,
            "start_logit": 8.114241600036621,
            "end_logit": -6.749902725219727
        },
        {
            "text": "AR",
            "probability": 2.0589976003118943e-09,
            "start_logit": -4.57123327255249,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "[18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 1.8492413114800943e-09,
            "start_logit": -2.9929332733154297,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "quantification of 5-HT2AR",
            "probability": 1.5903213843150035e-09,
            "start_logit": -4.829516410827637,
            "end_logit": 1.1479657888412476
        }
    ],
    "55242d512c8b63434a000006_063": [
        {
            "text": "5-HT2A",
            "probability": 0.9970027042640318,
            "start_logit": 5.179903507232666,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors.",
            "probability": 0.0010020489555284595,
            "start_logit": 5.179903507232666,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "A",
            "probability": 0.0005837884790899236,
            "start_logit": -2.263066530227661,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5",
            "probability": 0.0005404629295053089,
            "start_logit": 5.179903507232666,
            "end_logit": -3.065509080886841
        },
        {
            "text": "of 5-HT2A",
            "probability": 0.0002761162937371416,
            "start_logit": -3.0117831230163574,
            "end_logit": 4.454573631286621
        },
        {
            "text": "the known regional distribution of 5-HT2A",
            "probability": 0.0002195415307727951,
            "start_logit": -3.2410638332366943,
            "end_logit": 4.454573631286621
        },
        {
            "text": "known regional distribution of 5-HT2A",
            "probability": 0.00015150832160135241,
            "start_logit": -3.611964702606201,
            "end_logit": 4.454573631286621
        },
        {
            "text": "regional distribution of 5-HT2A",
            "probability": 0.0001072938297245234,
            "start_logit": -3.957034111022949,
            "end_logit": 4.454573631286621
        },
        {
            "text": "distribution of 5-HT2A",
            "probability": 4.358386406608003e-05,
            "start_logit": -4.8579182624816895,
            "end_logit": 4.454573631286621
        },
        {
            "text": "HT2A",
            "probability": 2.2137194943166774e-05,
            "start_logit": -5.535346031188965,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors. These",
            "probability": 1.656856485078623e-05,
            "start_logit": 5.179903507232666,
            "end_logit": -6.5504279136657715
        },
        {
            "text": "with the known regional distribution of 5-HT2A",
            "probability": 1.3389791841011778e-05,
            "start_logit": -6.038112640380859,
            "end_logit": 4.454573631286621
        },
        {
            "text": "binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A",
            "probability": 9.499389725461025e-06,
            "start_logit": -6.381377696990967,
            "end_logit": 4.454573631286621
        },
        {
            "text": "correlated with the known regional distribution of 5-HT2A",
            "probability": 9.316343439322603e-06,
            "start_logit": -6.400835037231445,
            "end_logit": 4.454573631286621
        },
        {
            "text": "receptors.",
            "probability": 8.965144834788948e-07,
            "start_logit": -1.839139461517334,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "of 5-HT2A receptors.",
            "probability": 2.775138347773424e-07,
            "start_logit": -3.0117831230163574,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "2A",
            "probability": 2.6205423954828773e-07,
            "start_logit": -7.240525722503662,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "serotonin 5-HT2A",
            "probability": 2.3123669300286974e-07,
            "start_logit": -7.365635395050049,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "the known regional distribution of 5-HT2A receptors.",
            "probability": 2.206527230719919e-07,
            "start_logit": -3.2410638332366943,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "known regional distribution of 5-HT2A receptors.",
            "probability": 1.5227516912963118e-07,
            "start_logit": -3.611964702606201,
            "end_logit": -2.4481329917907715
        }
    ],
    "55242d512c8b63434a000006_064": [
        {
            "text": "5-HT2A",
            "probability": 0.9994718589838286,
            "start_logit": 8.972574234008789,
            "end_logit": 8.107715606689453
        },
        {
            "text": "5",
            "probability": 0.0004113838426745815,
            "start_logit": 8.972574234008789,
            "end_logit": 0.3122600317001343
        },
        {
            "text": "A",
            "probability": 7.867229819485746e-05,
            "start_logit": -0.4771169424057007,
            "end_logit": 8.107715606689453
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors",
            "probability": 2.3220336183292563e-05,
            "start_logit": 8.972574234008789,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification",
            "probability": 5.606631036071198e-06,
            "start_logit": 8.972574234008789,
            "end_logit": -3.983316659927368
        },
        {
            "text": "5-HT2A receptor",
            "probability": 3.6224686097141098e-06,
            "start_logit": 8.462964057922363,
            "end_logit": -3.9105007648468018
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target",
            "probability": 1.8496929668756592e-06,
            "start_logit": 8.972574234008789,
            "end_logit": -5.092247009277344
        },
        {
            "text": "the radiometabolites of the serotonin 5-HT2A",
            "probability": 8.81583681999443e-07,
            "start_logit": -4.968443393707275,
            "end_logit": 8.107715606689453
        },
        {
            "text": "identify and characterize the radiometabolites of the serotonin 5-HT2A",
            "probability": 7.17134055707314e-07,
            "start_logit": -5.174900531768799,
            "end_logit": 8.107715606689453
        },
        {
            "text": "HT2A",
            "probability": 5.272366072162762e-07,
            "start_logit": -5.482513904571533,
            "end_logit": 8.107715606689453
        },
        {
            "text": "and characterize the radiometabolites of the serotonin 5-HT2A",
            "probability": 4.966738980517174e-07,
            "start_logit": -5.542229652404785,
            "end_logit": 8.107715606689453
        },
        {
            "text": "radiometabolites of the serotonin 5-HT2A",
            "probability": 4.955766823239009e-07,
            "start_logit": -5.544441223144531,
            "end_logit": 8.107715606689453
        },
        {
            "text": "Characterization of radioactive metabolites of 5-HT2A",
            "probability": 3.534254908138493e-07,
            "start_logit": -5.050318241119385,
            "end_logit": 7.275543212890625
        },
        {
            "text": "5-HT2A receptor PET ligand [18F]altanserin",
            "probability": 3.1348543841936713e-07,
            "start_logit": 8.462964057922363,
            "end_logit": -6.357658863067627
        },
        {
            "text": "target receptors",
            "probability": 2.1731176389893257e-10,
            "start_logit": -2.6066317558288574,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "receptors",
            "probability": 1.8721835962678654e-10,
            "start_logit": -2.7556891441345215,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "the target receptors",
            "probability": 9.375737786414606e-11,
            "start_logit": -3.4472544193267822,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "quantification of the target receptors",
            "probability": 8.058097552581176e-11,
            "start_logit": -3.5987021923065186,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "supporting quantification of the target receptors",
            "probability": 2.8342377295338325e-11,
            "start_logit": -4.643606662750244,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "[18F]altanserin in supporting quantification of the target receptors",
            "probability": 2.3440344717251864e-11,
            "start_logit": -4.833506107330322,
            "end_logit": -2.5622382164001465
        }
    ],
    "55242d512c8b63434a000006_065": [
        {
            "text": "5-HT2A",
            "probability": 0.9970027042640318,
            "start_logit": 5.179903507232666,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors.",
            "probability": 0.0010020489555284595,
            "start_logit": 5.179903507232666,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "A",
            "probability": 0.0005837884790899236,
            "start_logit": -2.263066530227661,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5",
            "probability": 0.0005404629295053089,
            "start_logit": 5.179903507232666,
            "end_logit": -3.065509080886841
        },
        {
            "text": "of 5-HT2A",
            "probability": 0.0002761162937371416,
            "start_logit": -3.0117831230163574,
            "end_logit": 4.454573631286621
        },
        {
            "text": "the known regional distribution of 5-HT2A",
            "probability": 0.0002195415307727951,
            "start_logit": -3.2410638332366943,
            "end_logit": 4.454573631286621
        },
        {
            "text": "known regional distribution of 5-HT2A",
            "probability": 0.00015150832160135241,
            "start_logit": -3.611964702606201,
            "end_logit": 4.454573631286621
        },
        {
            "text": "regional distribution of 5-HT2A",
            "probability": 0.0001072938297245234,
            "start_logit": -3.957034111022949,
            "end_logit": 4.454573631286621
        },
        {
            "text": "distribution of 5-HT2A",
            "probability": 4.358386406608003e-05,
            "start_logit": -4.8579182624816895,
            "end_logit": 4.454573631286621
        },
        {
            "text": "HT2A",
            "probability": 2.2137194943166774e-05,
            "start_logit": -5.535346031188965,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors. These",
            "probability": 1.656856485078623e-05,
            "start_logit": 5.179903507232666,
            "end_logit": -6.5504279136657715
        },
        {
            "text": "with the known regional distribution of 5-HT2A",
            "probability": 1.3389791841011778e-05,
            "start_logit": -6.038112640380859,
            "end_logit": 4.454573631286621
        },
        {
            "text": "binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A",
            "probability": 9.499389725461025e-06,
            "start_logit": -6.381377696990967,
            "end_logit": 4.454573631286621
        },
        {
            "text": "correlated with the known regional distribution of 5-HT2A",
            "probability": 9.316343439322603e-06,
            "start_logit": -6.400835037231445,
            "end_logit": 4.454573631286621
        },
        {
            "text": "receptors.",
            "probability": 8.965144834788948e-07,
            "start_logit": -1.839139461517334,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "of 5-HT2A receptors.",
            "probability": 2.775138347773424e-07,
            "start_logit": -3.0117831230163574,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "2A",
            "probability": 2.6205423954828773e-07,
            "start_logit": -7.240525722503662,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "serotonin 5-HT2A",
            "probability": 2.3123669300286974e-07,
            "start_logit": -7.365635395050049,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "the known regional distribution of 5-HT2A receptors.",
            "probability": 2.206527230719919e-07,
            "start_logit": -3.2410638332366943,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "known regional distribution of 5-HT2A receptors.",
            "probability": 1.5227516912963118e-07,
            "start_logit": -3.611964702606201,
            "end_logit": -2.4481329917907715
        }
    ],
    "55242d512c8b63434a000006_066": [
        {
            "text": "5-HT2A",
            "probability": 0.9994718589838286,
            "start_logit": 8.972574234008789,
            "end_logit": 8.107715606689453
        },
        {
            "text": "5",
            "probability": 0.0004113838426745815,
            "start_logit": 8.972574234008789,
            "end_logit": 0.3122600317001343
        },
        {
            "text": "A",
            "probability": 7.867229819485746e-05,
            "start_logit": -0.4771169424057007,
            "end_logit": 8.107715606689453
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors",
            "probability": 2.3220336183292563e-05,
            "start_logit": 8.972574234008789,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification",
            "probability": 5.606631036071198e-06,
            "start_logit": 8.972574234008789,
            "end_logit": -3.983316659927368
        },
        {
            "text": "5-HT2A receptor",
            "probability": 3.6224686097141098e-06,
            "start_logit": 8.462964057922363,
            "end_logit": -3.9105007648468018
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target",
            "probability": 1.8496929668756592e-06,
            "start_logit": 8.972574234008789,
            "end_logit": -5.092247009277344
        },
        {
            "text": "the radiometabolites of the serotonin 5-HT2A",
            "probability": 8.81583681999443e-07,
            "start_logit": -4.968443393707275,
            "end_logit": 8.107715606689453
        },
        {
            "text": "identify and characterize the radiometabolites of the serotonin 5-HT2A",
            "probability": 7.17134055707314e-07,
            "start_logit": -5.174900531768799,
            "end_logit": 8.107715606689453
        },
        {
            "text": "HT2A",
            "probability": 5.272366072162762e-07,
            "start_logit": -5.482513904571533,
            "end_logit": 8.107715606689453
        },
        {
            "text": "and characterize the radiometabolites of the serotonin 5-HT2A",
            "probability": 4.966738980517174e-07,
            "start_logit": -5.542229652404785,
            "end_logit": 8.107715606689453
        },
        {
            "text": "radiometabolites of the serotonin 5-HT2A",
            "probability": 4.955766823239009e-07,
            "start_logit": -5.544441223144531,
            "end_logit": 8.107715606689453
        },
        {
            "text": "Characterization of radioactive metabolites of 5-HT2A",
            "probability": 3.534254908138493e-07,
            "start_logit": -5.050318241119385,
            "end_logit": 7.275543212890625
        },
        {
            "text": "5-HT2A receptor PET ligand [18F]altanserin",
            "probability": 3.1348543841936713e-07,
            "start_logit": 8.462964057922363,
            "end_logit": -6.357658863067627
        },
        {
            "text": "target receptors",
            "probability": 2.1731176389893257e-10,
            "start_logit": -2.6066317558288574,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "receptors",
            "probability": 1.8721835962678654e-10,
            "start_logit": -2.7556891441345215,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "the target receptors",
            "probability": 9.375737786414606e-11,
            "start_logit": -3.4472544193267822,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "quantification of the target receptors",
            "probability": 8.058097552581176e-11,
            "start_logit": -3.5987021923065186,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "supporting quantification of the target receptors",
            "probability": 2.8342377295338325e-11,
            "start_logit": -4.643606662750244,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "[18F]altanserin in supporting quantification of the target receptors",
            "probability": 2.3440344717251864e-11,
            "start_logit": -4.833506107330322,
            "end_logit": -2.5622382164001465
        }
    ],
    "55242d512c8b63434a000006_067": [
        {
            "text": "5-HT2A",
            "probability": 0.9995301710246578,
            "start_logit": 9.231576919555664,
            "end_logit": 8.420754432678223
        },
        {
            "text": "5",
            "probability": 0.00038553067011905316,
            "start_logit": 9.231576919555664,
            "end_logit": 0.5603345632553101
        },
        {
            "text": "A",
            "probability": 7.53517282048149e-05,
            "start_logit": -0.2612968385219574,
            "end_logit": 8.420754432678223
        },
        {
            "text": "to evaluate 5-HT2A",
            "probability": 2.214910114246344e-06,
            "start_logit": -3.7882518768310547,
            "end_logit": 8.420754432678223
        },
        {
            "text": "evaluate 5-HT2A",
            "probability": 1.3502897850389228e-06,
            "start_logit": -4.283144474029541,
            "end_logit": 8.420754432678223
        },
        {
            "text": "[18F]altanserin to evaluate 5-HT2A",
            "probability": 1.3169081845211183e-06,
            "start_logit": -4.3081769943237305,
            "end_logit": 8.420754432678223
        },
        {
            "text": "5-HT2A receptor",
            "probability": 1.0373973836190995e-06,
            "start_logit": 9.231576919555664,
            "end_logit": -5.357571125030518
        },
        {
            "text": "5-HT2A receptor binding in 11 elderly patients with depression",
            "probability": 6.534869916148808e-07,
            "start_logit": 9.231576919555664,
            "end_logit": -5.819718837738037
        },
        {
            "text": "HT2A",
            "probability": 4.49182792666574e-07,
            "start_logit": -5.3837890625,
            "end_logit": 8.420754432678223
        },
        {
            "text": "5-HT2A receptor binding",
            "probability": 4.218020161977843e-07,
            "start_logit": 9.231576919555664,
            "end_logit": -6.257505416870117
        },
        {
            "text": "METHOD: PET was performed by using [18F]altanserin to evaluate 5-HT2A",
            "probability": 3.642967210737604e-07,
            "start_logit": -5.593250274658203,
            "end_logit": 8.420754432678223
        },
        {
            "text": "2A",
            "probability": 3.3453569924278616e-07,
            "start_logit": -5.678475379943848,
            "end_logit": 8.420754432678223
        },
        {
            "text": "PET was performed by using [18F]altanserin to evaluate 5-HT2A",
            "probability": 2.874662801895128e-07,
            "start_logit": -5.830113410949707,
            "end_logit": 8.420754432678223
        },
        {
            "text": "performed by using [18F]altanserin to evaluate 5-HT2A",
            "probability": 2.1142147159068034e-07,
            "start_logit": -6.137365341186523,
            "end_logit": 8.420754432678223
        },
        {
            "text": "by using [18F]altanserin to evaluate 5-HT2A",
            "probability": 1.6380631471176224e-07,
            "start_logit": -6.392534255981445,
            "end_logit": 8.420754432678223
        },
        {
            "text": "using [18F]altanserin to evaluate 5-HT2A",
            "probability": 1.406840292029831e-07,
            "start_logit": -6.544702529907227,
            "end_logit": 8.420754432678223
        },
        {
            "text": "(5-HT2A)",
            "probability": 3.8041169641900367e-10,
            "start_logit": -4.09015417098999,
            "end_logit": 0.053188424557447433
        },
        {
            "text": "5-HT2A receptor binding in 11 elderly patients with depression (four men, seven women; mean age = 65.0 years,",
            "probability": 5.076279958680133e-12,
            "start_logit": -0.2612968385219574,
            "end_logit": -8.092344284057617
        },
        {
            "text": "to evaluate 5-HT2A receptor",
            "probability": 2.298822010660401e-12,
            "start_logit": -3.7882518768310547,
            "end_logit": -5.357571125030518
        },
        {
            "text": "to evaluate 5-HT2A receptor binding in 11 elderly patients with depression",
            "probability": 1.4480953043892744e-12,
            "start_logit": -3.7882518768310547,
            "end_logit": -5.819718837738037
        }
    ],
    "55242d512c8b63434a000006_068": [
        {
            "text": "5-HT2ARs",
            "probability": 0.5755064668725747,
            "start_logit": 8.309171676635742,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(5-HT2AR)",
            "probability": 0.42409374218265095,
            "start_logit": 8.114241600036621,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5",
            "probability": 0.00014977364545178576,
            "start_logit": 8.309171676635742,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "s",
            "probability": 8.835525368407642e-05,
            "start_logit": -0.47246840596199036,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(",
            "probability": 7.513536578080681e-05,
            "start_logit": 8.114241600036621,
            "end_logit": -1.0326817035675049
        },
        {
            "text": ")",
            "probability": 5.652879274791656e-05,
            "start_logit": -0.8087180852890015,
            "end_logit": 7.60573673248291
        },
        {
            "text": "quantifying cerebral 5-HT2ARs",
            "probability": 7.434116063834184e-06,
            "start_logit": -2.947754383087158,
            "end_logit": 7.716102600097656
        },
        {
            "text": "well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 5.835288196807674e-06,
            "start_logit": -3.189910411834717,
            "end_logit": 7.716102600097656
        },
        {
            "text": "5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 5.303377029256705e-06,
            "start_logit": -3.175124406814575,
            "end_logit": 7.60573673248291
        },
        {
            "text": "for quantifying cerebral 5-HT2ARs",
            "probability": 2.704281080182175e-06,
            "start_logit": -3.958997964859009,
            "end_logit": 7.716102600097656
        },
        {
            "text": "the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 2.5070188414051633e-06,
            "start_logit": -3.9243738651275635,
            "end_logit": 7.60573673248291
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established",
            "probability": 1.8508622619912786e-06,
            "start_logit": 8.114241600036621,
            "end_logit": -4.736321449279785
        },
        {
            "text": "receptor (5-HT2AR)",
            "probability": 1.6514184880742904e-06,
            "start_logit": -4.341833591461182,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5-HT2AR",
            "probability": 1.1953673872915587e-06,
            "start_logit": 1.7927563190460205,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET)",
            "probability": 9.325950952212353e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -5.616687297821045
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET) in albino rats.",
            "probability": 3.309560725662402e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -6.65267276763916
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established in humans,",
            "probability": 2.471080328859431e-07,
            "start_logit": 8.114241600036621,
            "end_logit": -6.749902725219727
        },
        {
            "text": "AR",
            "probability": 2.0589976003118943e-09,
            "start_logit": -4.57123327255249,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "[18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 1.8492413114800943e-09,
            "start_logit": -2.9929332733154297,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "quantification of 5-HT2AR",
            "probability": 1.5903213843150035e-09,
            "start_logit": -4.829516410827637,
            "end_logit": 1.1479657888412476
        }
    ],
    "55242d512c8b63434a000006_069": [
        {
            "text": "5-HT2ARs",
            "probability": 0.5755064668725747,
            "start_logit": 8.309171676635742,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(5-HT2AR)",
            "probability": 0.42409374218265095,
            "start_logit": 8.114241600036621,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5",
            "probability": 0.00014977364545178576,
            "start_logit": 8.309171676635742,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "s",
            "probability": 8.835525368407642e-05,
            "start_logit": -0.47246840596199036,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(",
            "probability": 7.513536578080681e-05,
            "start_logit": 8.114241600036621,
            "end_logit": -1.0326817035675049
        },
        {
            "text": ")",
            "probability": 5.652879274791656e-05,
            "start_logit": -0.8087180852890015,
            "end_logit": 7.60573673248291
        },
        {
            "text": "quantifying cerebral 5-HT2ARs",
            "probability": 7.434116063834184e-06,
            "start_logit": -2.947754383087158,
            "end_logit": 7.716102600097656
        },
        {
            "text": "well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 5.835288196807674e-06,
            "start_logit": -3.189910411834717,
            "end_logit": 7.716102600097656
        },
        {
            "text": "5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 5.303377029256705e-06,
            "start_logit": -3.175124406814575,
            "end_logit": 7.60573673248291
        },
        {
            "text": "for quantifying cerebral 5-HT2ARs",
            "probability": 2.704281080182175e-06,
            "start_logit": -3.958997964859009,
            "end_logit": 7.716102600097656
        },
        {
            "text": "the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 2.5070188414051633e-06,
            "start_logit": -3.9243738651275635,
            "end_logit": 7.60573673248291
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established",
            "probability": 1.8508622619912786e-06,
            "start_logit": 8.114241600036621,
            "end_logit": -4.736321449279785
        },
        {
            "text": "receptor (5-HT2AR)",
            "probability": 1.6514184880742904e-06,
            "start_logit": -4.341833591461182,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5-HT2AR",
            "probability": 1.1953673872915587e-06,
            "start_logit": 1.7927563190460205,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET)",
            "probability": 9.325950952212353e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -5.616687297821045
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET) in albino rats.",
            "probability": 3.309560725662402e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -6.65267276763916
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established in humans,",
            "probability": 2.471080328859431e-07,
            "start_logit": 8.114241600036621,
            "end_logit": -6.749902725219727
        },
        {
            "text": "AR",
            "probability": 2.0589976003118943e-09,
            "start_logit": -4.57123327255249,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "[18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 1.8492413114800943e-09,
            "start_logit": -2.9929332733154297,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "quantification of 5-HT2AR",
            "probability": 1.5903213843150035e-09,
            "start_logit": -4.829516410827637,
            "end_logit": 1.1479657888412476
        }
    ],
    "55242d512c8b63434a000006_070": [
        {
            "text": "5-HT2A",
            "probability": 0.9970027042640318,
            "start_logit": 5.179903507232666,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors.",
            "probability": 0.0010020489555284595,
            "start_logit": 5.179903507232666,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "A",
            "probability": 0.0005837884790899236,
            "start_logit": -2.263066530227661,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5",
            "probability": 0.0005404629295053089,
            "start_logit": 5.179903507232666,
            "end_logit": -3.065509080886841
        },
        {
            "text": "of 5-HT2A",
            "probability": 0.0002761162937371416,
            "start_logit": -3.0117831230163574,
            "end_logit": 4.454573631286621
        },
        {
            "text": "the known regional distribution of 5-HT2A",
            "probability": 0.0002195415307727951,
            "start_logit": -3.2410638332366943,
            "end_logit": 4.454573631286621
        },
        {
            "text": "known regional distribution of 5-HT2A",
            "probability": 0.00015150832160135241,
            "start_logit": -3.611964702606201,
            "end_logit": 4.454573631286621
        },
        {
            "text": "regional distribution of 5-HT2A",
            "probability": 0.0001072938297245234,
            "start_logit": -3.957034111022949,
            "end_logit": 4.454573631286621
        },
        {
            "text": "distribution of 5-HT2A",
            "probability": 4.358386406608003e-05,
            "start_logit": -4.8579182624816895,
            "end_logit": 4.454573631286621
        },
        {
            "text": "HT2A",
            "probability": 2.2137194943166774e-05,
            "start_logit": -5.535346031188965,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors. These",
            "probability": 1.656856485078623e-05,
            "start_logit": 5.179903507232666,
            "end_logit": -6.5504279136657715
        },
        {
            "text": "with the known regional distribution of 5-HT2A",
            "probability": 1.3389791841011778e-05,
            "start_logit": -6.038112640380859,
            "end_logit": 4.454573631286621
        },
        {
            "text": "binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A",
            "probability": 9.499389725461025e-06,
            "start_logit": -6.381377696990967,
            "end_logit": 4.454573631286621
        },
        {
            "text": "correlated with the known regional distribution of 5-HT2A",
            "probability": 9.316343439322603e-06,
            "start_logit": -6.400835037231445,
            "end_logit": 4.454573631286621
        },
        {
            "text": "receptors.",
            "probability": 8.965144834788948e-07,
            "start_logit": -1.839139461517334,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "of 5-HT2A receptors.",
            "probability": 2.775138347773424e-07,
            "start_logit": -3.0117831230163574,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "2A",
            "probability": 2.6205423954828773e-07,
            "start_logit": -7.240525722503662,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "serotonin 5-HT2A",
            "probability": 2.3123669300286974e-07,
            "start_logit": -7.365635395050049,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "the known regional distribution of 5-HT2A receptors.",
            "probability": 2.206527230719919e-07,
            "start_logit": -3.2410638332366943,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "known regional distribution of 5-HT2A receptors.",
            "probability": 1.5227516912963118e-07,
            "start_logit": -3.611964702606201,
            "end_logit": -2.4481329917907715
        }
    ],
    "55242d512c8b63434a000006_071": [
        {
            "text": "5-HT2A",
            "probability": 0.9970027042640318,
            "start_logit": 5.179903507232666,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors.",
            "probability": 0.0010020489555284595,
            "start_logit": 5.179903507232666,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "A",
            "probability": 0.0005837884790899236,
            "start_logit": -2.263066530227661,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5",
            "probability": 0.0005404629295053089,
            "start_logit": 5.179903507232666,
            "end_logit": -3.065509080886841
        },
        {
            "text": "of 5-HT2A",
            "probability": 0.0002761162937371416,
            "start_logit": -3.0117831230163574,
            "end_logit": 4.454573631286621
        },
        {
            "text": "the known regional distribution of 5-HT2A",
            "probability": 0.0002195415307727951,
            "start_logit": -3.2410638332366943,
            "end_logit": 4.454573631286621
        },
        {
            "text": "known regional distribution of 5-HT2A",
            "probability": 0.00015150832160135241,
            "start_logit": -3.611964702606201,
            "end_logit": 4.454573631286621
        },
        {
            "text": "regional distribution of 5-HT2A",
            "probability": 0.0001072938297245234,
            "start_logit": -3.957034111022949,
            "end_logit": 4.454573631286621
        },
        {
            "text": "distribution of 5-HT2A",
            "probability": 4.358386406608003e-05,
            "start_logit": -4.8579182624816895,
            "end_logit": 4.454573631286621
        },
        {
            "text": "HT2A",
            "probability": 2.2137194943166774e-05,
            "start_logit": -5.535346031188965,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors. These",
            "probability": 1.656856485078623e-05,
            "start_logit": 5.179903507232666,
            "end_logit": -6.5504279136657715
        },
        {
            "text": "with the known regional distribution of 5-HT2A",
            "probability": 1.3389791841011778e-05,
            "start_logit": -6.038112640380859,
            "end_logit": 4.454573631286621
        },
        {
            "text": "binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A",
            "probability": 9.499389725461025e-06,
            "start_logit": -6.381377696990967,
            "end_logit": 4.454573631286621
        },
        {
            "text": "correlated with the known regional distribution of 5-HT2A",
            "probability": 9.316343439322603e-06,
            "start_logit": -6.400835037231445,
            "end_logit": 4.454573631286621
        },
        {
            "text": "receptors.",
            "probability": 8.965144834788948e-07,
            "start_logit": -1.839139461517334,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "of 5-HT2A receptors.",
            "probability": 2.775138347773424e-07,
            "start_logit": -3.0117831230163574,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "2A",
            "probability": 2.6205423954828773e-07,
            "start_logit": -7.240525722503662,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "serotonin 5-HT2A",
            "probability": 2.3123669300286974e-07,
            "start_logit": -7.365635395050049,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "the known regional distribution of 5-HT2A receptors.",
            "probability": 2.206527230719919e-07,
            "start_logit": -3.2410638332366943,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "known regional distribution of 5-HT2A receptors.",
            "probability": 1.5227516912963118e-07,
            "start_logit": -3.611964702606201,
            "end_logit": -2.4481329917907715
        }
    ],
    "55242d512c8b63434a000006_072": [
        {
            "text": "5-HT2A",
            "probability": 0.9994718589838286,
            "start_logit": 8.972574234008789,
            "end_logit": 8.107715606689453
        },
        {
            "text": "5",
            "probability": 0.0004113838426745815,
            "start_logit": 8.972574234008789,
            "end_logit": 0.3122600317001343
        },
        {
            "text": "A",
            "probability": 7.867229819485746e-05,
            "start_logit": -0.4771169424057007,
            "end_logit": 8.107715606689453
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors",
            "probability": 2.3220336183292563e-05,
            "start_logit": 8.972574234008789,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification",
            "probability": 5.606631036071198e-06,
            "start_logit": 8.972574234008789,
            "end_logit": -3.983316659927368
        },
        {
            "text": "5-HT2A receptor",
            "probability": 3.6224686097141098e-06,
            "start_logit": 8.462964057922363,
            "end_logit": -3.9105007648468018
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target",
            "probability": 1.8496929668756592e-06,
            "start_logit": 8.972574234008789,
            "end_logit": -5.092247009277344
        },
        {
            "text": "the radiometabolites of the serotonin 5-HT2A",
            "probability": 8.81583681999443e-07,
            "start_logit": -4.968443393707275,
            "end_logit": 8.107715606689453
        },
        {
            "text": "identify and characterize the radiometabolites of the serotonin 5-HT2A",
            "probability": 7.17134055707314e-07,
            "start_logit": -5.174900531768799,
            "end_logit": 8.107715606689453
        },
        {
            "text": "HT2A",
            "probability": 5.272366072162762e-07,
            "start_logit": -5.482513904571533,
            "end_logit": 8.107715606689453
        },
        {
            "text": "and characterize the radiometabolites of the serotonin 5-HT2A",
            "probability": 4.966738980517174e-07,
            "start_logit": -5.542229652404785,
            "end_logit": 8.107715606689453
        },
        {
            "text": "radiometabolites of the serotonin 5-HT2A",
            "probability": 4.955766823239009e-07,
            "start_logit": -5.544441223144531,
            "end_logit": 8.107715606689453
        },
        {
            "text": "Characterization of radioactive metabolites of 5-HT2A",
            "probability": 3.534254908138493e-07,
            "start_logit": -5.050318241119385,
            "end_logit": 7.275543212890625
        },
        {
            "text": "5-HT2A receptor PET ligand [18F]altanserin",
            "probability": 3.1348543841936713e-07,
            "start_logit": 8.462964057922363,
            "end_logit": -6.357658863067627
        },
        {
            "text": "target receptors",
            "probability": 2.1731176389893257e-10,
            "start_logit": -2.6066317558288574,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "receptors",
            "probability": 1.8721835962678654e-10,
            "start_logit": -2.7556891441345215,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "the target receptors",
            "probability": 9.375737786414606e-11,
            "start_logit": -3.4472544193267822,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "quantification of the target receptors",
            "probability": 8.058097552581176e-11,
            "start_logit": -3.5987021923065186,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "supporting quantification of the target receptors",
            "probability": 2.8342377295338325e-11,
            "start_logit": -4.643606662750244,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "[18F]altanserin in supporting quantification of the target receptors",
            "probability": 2.3440344717251864e-11,
            "start_logit": -4.833506107330322,
            "end_logit": -2.5622382164001465
        }
    ],
    "55242d512c8b63434a000006_073": [
        {
            "text": "5-HT2A",
            "probability": 0.9995301710246578,
            "start_logit": 9.231576919555664,
            "end_logit": 8.420754432678223
        },
        {
            "text": "5",
            "probability": 0.00038553067011905316,
            "start_logit": 9.231576919555664,
            "end_logit": 0.5603345632553101
        },
        {
            "text": "A",
            "probability": 7.53517282048149e-05,
            "start_logit": -0.2612968385219574,
            "end_logit": 8.420754432678223
        },
        {
            "text": "to evaluate 5-HT2A",
            "probability": 2.214910114246344e-06,
            "start_logit": -3.7882518768310547,
            "end_logit": 8.420754432678223
        },
        {
            "text": "evaluate 5-HT2A",
            "probability": 1.3502897850389228e-06,
            "start_logit": -4.283144474029541,
            "end_logit": 8.420754432678223
        },
        {
            "text": "[18F]altanserin to evaluate 5-HT2A",
            "probability": 1.3169081845211183e-06,
            "start_logit": -4.3081769943237305,
            "end_logit": 8.420754432678223
        },
        {
            "text": "5-HT2A receptor",
            "probability": 1.0373973836190995e-06,
            "start_logit": 9.231576919555664,
            "end_logit": -5.357571125030518
        },
        {
            "text": "5-HT2A receptor binding in 11 elderly patients with depression",
            "probability": 6.534869916148808e-07,
            "start_logit": 9.231576919555664,
            "end_logit": -5.819718837738037
        },
        {
            "text": "HT2A",
            "probability": 4.49182792666574e-07,
            "start_logit": -5.3837890625,
            "end_logit": 8.420754432678223
        },
        {
            "text": "5-HT2A receptor binding",
            "probability": 4.218020161977843e-07,
            "start_logit": 9.231576919555664,
            "end_logit": -6.257505416870117
        },
        {
            "text": "METHOD: PET was performed by using [18F]altanserin to evaluate 5-HT2A",
            "probability": 3.642967210737604e-07,
            "start_logit": -5.593250274658203,
            "end_logit": 8.420754432678223
        },
        {
            "text": "2A",
            "probability": 3.3453569924278616e-07,
            "start_logit": -5.678475379943848,
            "end_logit": 8.420754432678223
        },
        {
            "text": "PET was performed by using [18F]altanserin to evaluate 5-HT2A",
            "probability": 2.874662801895128e-07,
            "start_logit": -5.830113410949707,
            "end_logit": 8.420754432678223
        },
        {
            "text": "performed by using [18F]altanserin to evaluate 5-HT2A",
            "probability": 2.1142147159068034e-07,
            "start_logit": -6.137365341186523,
            "end_logit": 8.420754432678223
        },
        {
            "text": "by using [18F]altanserin to evaluate 5-HT2A",
            "probability": 1.6380631471176224e-07,
            "start_logit": -6.392534255981445,
            "end_logit": 8.420754432678223
        },
        {
            "text": "using [18F]altanserin to evaluate 5-HT2A",
            "probability": 1.406840292029831e-07,
            "start_logit": -6.544702529907227,
            "end_logit": 8.420754432678223
        },
        {
            "text": "(5-HT2A)",
            "probability": 3.8041169641900367e-10,
            "start_logit": -4.09015417098999,
            "end_logit": 0.053188424557447433
        },
        {
            "text": "5-HT2A receptor binding in 11 elderly patients with depression (four men, seven women; mean age = 65.0 years,",
            "probability": 5.076279958680133e-12,
            "start_logit": -0.2612968385219574,
            "end_logit": -8.092344284057617
        },
        {
            "text": "to evaluate 5-HT2A receptor",
            "probability": 2.298822010660401e-12,
            "start_logit": -3.7882518768310547,
            "end_logit": -5.357571125030518
        },
        {
            "text": "to evaluate 5-HT2A receptor binding in 11 elderly patients with depression",
            "probability": 1.4480953043892744e-12,
            "start_logit": -3.7882518768310547,
            "end_logit": -5.819718837738037
        }
    ],
    "55242d512c8b63434a000006_074": [
        {
            "text": "5-HT2ARs",
            "probability": 0.5755064668725747,
            "start_logit": 8.309171676635742,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(5-HT2AR)",
            "probability": 0.42409374218265095,
            "start_logit": 8.114241600036621,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5",
            "probability": 0.00014977364545178576,
            "start_logit": 8.309171676635742,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "s",
            "probability": 8.835525368407642e-05,
            "start_logit": -0.47246840596199036,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(",
            "probability": 7.513536578080681e-05,
            "start_logit": 8.114241600036621,
            "end_logit": -1.0326817035675049
        },
        {
            "text": ")",
            "probability": 5.652879274791656e-05,
            "start_logit": -0.8087180852890015,
            "end_logit": 7.60573673248291
        },
        {
            "text": "quantifying cerebral 5-HT2ARs",
            "probability": 7.434116063834184e-06,
            "start_logit": -2.947754383087158,
            "end_logit": 7.716102600097656
        },
        {
            "text": "well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 5.835288196807674e-06,
            "start_logit": -3.189910411834717,
            "end_logit": 7.716102600097656
        },
        {
            "text": "5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 5.303377029256705e-06,
            "start_logit": -3.175124406814575,
            "end_logit": 7.60573673248291
        },
        {
            "text": "for quantifying cerebral 5-HT2ARs",
            "probability": 2.704281080182175e-06,
            "start_logit": -3.958997964859009,
            "end_logit": 7.716102600097656
        },
        {
            "text": "the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 2.5070188414051633e-06,
            "start_logit": -3.9243738651275635,
            "end_logit": 7.60573673248291
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established",
            "probability": 1.8508622619912786e-06,
            "start_logit": 8.114241600036621,
            "end_logit": -4.736321449279785
        },
        {
            "text": "receptor (5-HT2AR)",
            "probability": 1.6514184880742904e-06,
            "start_logit": -4.341833591461182,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5-HT2AR",
            "probability": 1.1953673872915587e-06,
            "start_logit": 1.7927563190460205,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET)",
            "probability": 9.325950952212353e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -5.616687297821045
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET) in albino rats.",
            "probability": 3.309560725662402e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -6.65267276763916
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established in humans,",
            "probability": 2.471080328859431e-07,
            "start_logit": 8.114241600036621,
            "end_logit": -6.749902725219727
        },
        {
            "text": "AR",
            "probability": 2.0589976003118943e-09,
            "start_logit": -4.57123327255249,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "[18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 1.8492413114800943e-09,
            "start_logit": -2.9929332733154297,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "quantification of 5-HT2AR",
            "probability": 1.5903213843150035e-09,
            "start_logit": -4.829516410827637,
            "end_logit": 1.1479657888412476
        }
    ],
    "55242d512c8b63434a000006_075": [
        {
            "text": "5-HT2ARs",
            "probability": 0.5755064668725747,
            "start_logit": 8.309171676635742,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(5-HT2AR)",
            "probability": 0.42409374218265095,
            "start_logit": 8.114241600036621,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5",
            "probability": 0.00014977364545178576,
            "start_logit": 8.309171676635742,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "s",
            "probability": 8.835525368407642e-05,
            "start_logit": -0.47246840596199036,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(",
            "probability": 7.513536578080681e-05,
            "start_logit": 8.114241600036621,
            "end_logit": -1.0326817035675049
        },
        {
            "text": ")",
            "probability": 5.652879274791656e-05,
            "start_logit": -0.8087180852890015,
            "end_logit": 7.60573673248291
        },
        {
            "text": "quantifying cerebral 5-HT2ARs",
            "probability": 7.434116063834184e-06,
            "start_logit": -2.947754383087158,
            "end_logit": 7.716102600097656
        },
        {
            "text": "well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 5.835288196807674e-06,
            "start_logit": -3.189910411834717,
            "end_logit": 7.716102600097656
        },
        {
            "text": "5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 5.303377029256705e-06,
            "start_logit": -3.175124406814575,
            "end_logit": 7.60573673248291
        },
        {
            "text": "for quantifying cerebral 5-HT2ARs",
            "probability": 2.704281080182175e-06,
            "start_logit": -3.958997964859009,
            "end_logit": 7.716102600097656
        },
        {
            "text": "the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 2.5070188414051633e-06,
            "start_logit": -3.9243738651275635,
            "end_logit": 7.60573673248291
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established",
            "probability": 1.8508622619912786e-06,
            "start_logit": 8.114241600036621,
            "end_logit": -4.736321449279785
        },
        {
            "text": "receptor (5-HT2AR)",
            "probability": 1.6514184880742904e-06,
            "start_logit": -4.341833591461182,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5-HT2AR",
            "probability": 1.1953673872915587e-06,
            "start_logit": 1.7927563190460205,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET)",
            "probability": 9.325950952212353e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -5.616687297821045
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET) in albino rats.",
            "probability": 3.309560725662402e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -6.65267276763916
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established in humans,",
            "probability": 2.471080328859431e-07,
            "start_logit": 8.114241600036621,
            "end_logit": -6.749902725219727
        },
        {
            "text": "AR",
            "probability": 2.0589976003118943e-09,
            "start_logit": -4.57123327255249,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "[18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 1.8492413114800943e-09,
            "start_logit": -2.9929332733154297,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "quantification of 5-HT2AR",
            "probability": 1.5903213843150035e-09,
            "start_logit": -4.829516410827637,
            "end_logit": 1.1479657888412476
        }
    ],
    "55242d512c8b63434a000006_076": [
        {
            "text": "5-HT2A",
            "probability": 0.9970027042640318,
            "start_logit": 5.179903507232666,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors.",
            "probability": 0.0010020489555284595,
            "start_logit": 5.179903507232666,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "A",
            "probability": 0.0005837884790899236,
            "start_logit": -2.263066530227661,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5",
            "probability": 0.0005404629295053089,
            "start_logit": 5.179903507232666,
            "end_logit": -3.065509080886841
        },
        {
            "text": "of 5-HT2A",
            "probability": 0.0002761162937371416,
            "start_logit": -3.0117831230163574,
            "end_logit": 4.454573631286621
        },
        {
            "text": "the known regional distribution of 5-HT2A",
            "probability": 0.0002195415307727951,
            "start_logit": -3.2410638332366943,
            "end_logit": 4.454573631286621
        },
        {
            "text": "known regional distribution of 5-HT2A",
            "probability": 0.00015150832160135241,
            "start_logit": -3.611964702606201,
            "end_logit": 4.454573631286621
        },
        {
            "text": "regional distribution of 5-HT2A",
            "probability": 0.0001072938297245234,
            "start_logit": -3.957034111022949,
            "end_logit": 4.454573631286621
        },
        {
            "text": "distribution of 5-HT2A",
            "probability": 4.358386406608003e-05,
            "start_logit": -4.8579182624816895,
            "end_logit": 4.454573631286621
        },
        {
            "text": "HT2A",
            "probability": 2.2137194943166774e-05,
            "start_logit": -5.535346031188965,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors. These",
            "probability": 1.656856485078623e-05,
            "start_logit": 5.179903507232666,
            "end_logit": -6.5504279136657715
        },
        {
            "text": "with the known regional distribution of 5-HT2A",
            "probability": 1.3389791841011778e-05,
            "start_logit": -6.038112640380859,
            "end_logit": 4.454573631286621
        },
        {
            "text": "binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A",
            "probability": 9.499389725461025e-06,
            "start_logit": -6.381377696990967,
            "end_logit": 4.454573631286621
        },
        {
            "text": "correlated with the known regional distribution of 5-HT2A",
            "probability": 9.316343439322603e-06,
            "start_logit": -6.400835037231445,
            "end_logit": 4.454573631286621
        },
        {
            "text": "receptors.",
            "probability": 8.965144834788948e-07,
            "start_logit": -1.839139461517334,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "of 5-HT2A receptors.",
            "probability": 2.775138347773424e-07,
            "start_logit": -3.0117831230163574,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "2A",
            "probability": 2.6205423954828773e-07,
            "start_logit": -7.240525722503662,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "serotonin 5-HT2A",
            "probability": 2.3123669300286974e-07,
            "start_logit": -7.365635395050049,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "the known regional distribution of 5-HT2A receptors.",
            "probability": 2.206527230719919e-07,
            "start_logit": -3.2410638332366943,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "known regional distribution of 5-HT2A receptors.",
            "probability": 1.5227516912963118e-07,
            "start_logit": -3.611964702606201,
            "end_logit": -2.4481329917907715
        }
    ],
    "55242d512c8b63434a000006_077": [
        {
            "text": "5-HT2A",
            "probability": 0.9970027042640318,
            "start_logit": 5.179903507232666,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors.",
            "probability": 0.0010020489555284595,
            "start_logit": 5.179903507232666,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "A",
            "probability": 0.0005837884790899236,
            "start_logit": -2.263066530227661,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5",
            "probability": 0.0005404629295053089,
            "start_logit": 5.179903507232666,
            "end_logit": -3.065509080886841
        },
        {
            "text": "of 5-HT2A",
            "probability": 0.0002761162937371416,
            "start_logit": -3.0117831230163574,
            "end_logit": 4.454573631286621
        },
        {
            "text": "the known regional distribution of 5-HT2A",
            "probability": 0.0002195415307727951,
            "start_logit": -3.2410638332366943,
            "end_logit": 4.454573631286621
        },
        {
            "text": "known regional distribution of 5-HT2A",
            "probability": 0.00015150832160135241,
            "start_logit": -3.611964702606201,
            "end_logit": 4.454573631286621
        },
        {
            "text": "regional distribution of 5-HT2A",
            "probability": 0.0001072938297245234,
            "start_logit": -3.957034111022949,
            "end_logit": 4.454573631286621
        },
        {
            "text": "distribution of 5-HT2A",
            "probability": 4.358386406608003e-05,
            "start_logit": -4.8579182624816895,
            "end_logit": 4.454573631286621
        },
        {
            "text": "HT2A",
            "probability": 2.2137194943166774e-05,
            "start_logit": -5.535346031188965,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors. These",
            "probability": 1.656856485078623e-05,
            "start_logit": 5.179903507232666,
            "end_logit": -6.5504279136657715
        },
        {
            "text": "with the known regional distribution of 5-HT2A",
            "probability": 1.3389791841011778e-05,
            "start_logit": -6.038112640380859,
            "end_logit": 4.454573631286621
        },
        {
            "text": "binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A",
            "probability": 9.499389725461025e-06,
            "start_logit": -6.381377696990967,
            "end_logit": 4.454573631286621
        },
        {
            "text": "correlated with the known regional distribution of 5-HT2A",
            "probability": 9.316343439322603e-06,
            "start_logit": -6.400835037231445,
            "end_logit": 4.454573631286621
        },
        {
            "text": "receptors.",
            "probability": 8.965144834788948e-07,
            "start_logit": -1.839139461517334,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "of 5-HT2A receptors.",
            "probability": 2.775138347773424e-07,
            "start_logit": -3.0117831230163574,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "2A",
            "probability": 2.6205423954828773e-07,
            "start_logit": -7.240525722503662,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "serotonin 5-HT2A",
            "probability": 2.3123669300286974e-07,
            "start_logit": -7.365635395050049,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "the known regional distribution of 5-HT2A receptors.",
            "probability": 2.206527230719919e-07,
            "start_logit": -3.2410638332366943,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "known regional distribution of 5-HT2A receptors.",
            "probability": 1.5227516912963118e-07,
            "start_logit": -3.611964702606201,
            "end_logit": -2.4481329917907715
        }
    ],
    "55242d512c8b63434a000006_078": [
        {
            "text": "5-HT2A",
            "probability": 0.9994718589838286,
            "start_logit": 8.972574234008789,
            "end_logit": 8.107715606689453
        },
        {
            "text": "5",
            "probability": 0.0004113838426745815,
            "start_logit": 8.972574234008789,
            "end_logit": 0.3122600317001343
        },
        {
            "text": "A",
            "probability": 7.867229819485746e-05,
            "start_logit": -0.4771169424057007,
            "end_logit": 8.107715606689453
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors",
            "probability": 2.3220336183292563e-05,
            "start_logit": 8.972574234008789,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification",
            "probability": 5.606631036071198e-06,
            "start_logit": 8.972574234008789,
            "end_logit": -3.983316659927368
        },
        {
            "text": "5-HT2A receptor",
            "probability": 3.6224686097141098e-06,
            "start_logit": 8.462964057922363,
            "end_logit": -3.9105007648468018
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target",
            "probability": 1.8496929668756592e-06,
            "start_logit": 8.972574234008789,
            "end_logit": -5.092247009277344
        },
        {
            "text": "the radiometabolites of the serotonin 5-HT2A",
            "probability": 8.81583681999443e-07,
            "start_logit": -4.968443393707275,
            "end_logit": 8.107715606689453
        },
        {
            "text": "identify and characterize the radiometabolites of the serotonin 5-HT2A",
            "probability": 7.17134055707314e-07,
            "start_logit": -5.174900531768799,
            "end_logit": 8.107715606689453
        },
        {
            "text": "HT2A",
            "probability": 5.272366072162762e-07,
            "start_logit": -5.482513904571533,
            "end_logit": 8.107715606689453
        },
        {
            "text": "and characterize the radiometabolites of the serotonin 5-HT2A",
            "probability": 4.966738980517174e-07,
            "start_logit": -5.542229652404785,
            "end_logit": 8.107715606689453
        },
        {
            "text": "radiometabolites of the serotonin 5-HT2A",
            "probability": 4.955766823239009e-07,
            "start_logit": -5.544441223144531,
            "end_logit": 8.107715606689453
        },
        {
            "text": "Characterization of radioactive metabolites of 5-HT2A",
            "probability": 3.534254908138493e-07,
            "start_logit": -5.050318241119385,
            "end_logit": 7.275543212890625
        },
        {
            "text": "5-HT2A receptor PET ligand [18F]altanserin",
            "probability": 3.1348543841936713e-07,
            "start_logit": 8.462964057922363,
            "end_logit": -6.357658863067627
        },
        {
            "text": "target receptors",
            "probability": 2.1731176389893257e-10,
            "start_logit": -2.6066317558288574,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "receptors",
            "probability": 1.8721835962678654e-10,
            "start_logit": -2.7556891441345215,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "the target receptors",
            "probability": 9.375737786414606e-11,
            "start_logit": -3.4472544193267822,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "quantification of the target receptors",
            "probability": 8.058097552581176e-11,
            "start_logit": -3.5987021923065186,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "supporting quantification of the target receptors",
            "probability": 2.8342377295338325e-11,
            "start_logit": -4.643606662750244,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "[18F]altanserin in supporting quantification of the target receptors",
            "probability": 2.3440344717251864e-11,
            "start_logit": -4.833506107330322,
            "end_logit": -2.5622382164001465
        }
    ],
    "55242d512c8b63434a000006_079": [
        {
            "text": "5-HT2A",
            "probability": 0.9995301710246578,
            "start_logit": 9.231576919555664,
            "end_logit": 8.420754432678223
        },
        {
            "text": "5",
            "probability": 0.00038553067011905316,
            "start_logit": 9.231576919555664,
            "end_logit": 0.5603345632553101
        },
        {
            "text": "A",
            "probability": 7.53517282048149e-05,
            "start_logit": -0.2612968385219574,
            "end_logit": 8.420754432678223
        },
        {
            "text": "to evaluate 5-HT2A",
            "probability": 2.214910114246344e-06,
            "start_logit": -3.7882518768310547,
            "end_logit": 8.420754432678223
        },
        {
            "text": "evaluate 5-HT2A",
            "probability": 1.3502897850389228e-06,
            "start_logit": -4.283144474029541,
            "end_logit": 8.420754432678223
        },
        {
            "text": "[18F]altanserin to evaluate 5-HT2A",
            "probability": 1.3169081845211183e-06,
            "start_logit": -4.3081769943237305,
            "end_logit": 8.420754432678223
        },
        {
            "text": "5-HT2A receptor",
            "probability": 1.0373973836190995e-06,
            "start_logit": 9.231576919555664,
            "end_logit": -5.357571125030518
        },
        {
            "text": "5-HT2A receptor binding in 11 elderly patients with depression",
            "probability": 6.534869916148808e-07,
            "start_logit": 9.231576919555664,
            "end_logit": -5.819718837738037
        },
        {
            "text": "HT2A",
            "probability": 4.49182792666574e-07,
            "start_logit": -5.3837890625,
            "end_logit": 8.420754432678223
        },
        {
            "text": "5-HT2A receptor binding",
            "probability": 4.218020161977843e-07,
            "start_logit": 9.231576919555664,
            "end_logit": -6.257505416870117
        },
        {
            "text": "METHOD: PET was performed by using [18F]altanserin to evaluate 5-HT2A",
            "probability": 3.642967210737604e-07,
            "start_logit": -5.593250274658203,
            "end_logit": 8.420754432678223
        },
        {
            "text": "2A",
            "probability": 3.3453569924278616e-07,
            "start_logit": -5.678475379943848,
            "end_logit": 8.420754432678223
        },
        {
            "text": "PET was performed by using [18F]altanserin to evaluate 5-HT2A",
            "probability": 2.874662801895128e-07,
            "start_logit": -5.830113410949707,
            "end_logit": 8.420754432678223
        },
        {
            "text": "performed by using [18F]altanserin to evaluate 5-HT2A",
            "probability": 2.1142147159068034e-07,
            "start_logit": -6.137365341186523,
            "end_logit": 8.420754432678223
        },
        {
            "text": "by using [18F]altanserin to evaluate 5-HT2A",
            "probability": 1.6380631471176224e-07,
            "start_logit": -6.392534255981445,
            "end_logit": 8.420754432678223
        },
        {
            "text": "using [18F]altanserin to evaluate 5-HT2A",
            "probability": 1.406840292029831e-07,
            "start_logit": -6.544702529907227,
            "end_logit": 8.420754432678223
        },
        {
            "text": "(5-HT2A)",
            "probability": 3.8041169641900367e-10,
            "start_logit": -4.09015417098999,
            "end_logit": 0.053188424557447433
        },
        {
            "text": "5-HT2A receptor binding in 11 elderly patients with depression (four men, seven women; mean age = 65.0 years,",
            "probability": 5.076279958680133e-12,
            "start_logit": -0.2612968385219574,
            "end_logit": -8.092344284057617
        },
        {
            "text": "to evaluate 5-HT2A receptor",
            "probability": 2.298822010660401e-12,
            "start_logit": -3.7882518768310547,
            "end_logit": -5.357571125030518
        },
        {
            "text": "to evaluate 5-HT2A receptor binding in 11 elderly patients with depression",
            "probability": 1.4480953043892744e-12,
            "start_logit": -3.7882518768310547,
            "end_logit": -5.819718837738037
        }
    ],
    "55242d512c8b63434a000006_080": [
        {
            "text": "5-HT2ARs",
            "probability": 0.5755064668725747,
            "start_logit": 8.309171676635742,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(5-HT2AR)",
            "probability": 0.42409374218265095,
            "start_logit": 8.114241600036621,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5",
            "probability": 0.00014977364545178576,
            "start_logit": 8.309171676635742,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "s",
            "probability": 8.835525368407642e-05,
            "start_logit": -0.47246840596199036,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(",
            "probability": 7.513536578080681e-05,
            "start_logit": 8.114241600036621,
            "end_logit": -1.0326817035675049
        },
        {
            "text": ")",
            "probability": 5.652879274791656e-05,
            "start_logit": -0.8087180852890015,
            "end_logit": 7.60573673248291
        },
        {
            "text": "quantifying cerebral 5-HT2ARs",
            "probability": 7.434116063834184e-06,
            "start_logit": -2.947754383087158,
            "end_logit": 7.716102600097656
        },
        {
            "text": "well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 5.835288196807674e-06,
            "start_logit": -3.189910411834717,
            "end_logit": 7.716102600097656
        },
        {
            "text": "5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 5.303377029256705e-06,
            "start_logit": -3.175124406814575,
            "end_logit": 7.60573673248291
        },
        {
            "text": "for quantifying cerebral 5-HT2ARs",
            "probability": 2.704281080182175e-06,
            "start_logit": -3.958997964859009,
            "end_logit": 7.716102600097656
        },
        {
            "text": "the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 2.5070188414051633e-06,
            "start_logit": -3.9243738651275635,
            "end_logit": 7.60573673248291
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established",
            "probability": 1.8508622619912786e-06,
            "start_logit": 8.114241600036621,
            "end_logit": -4.736321449279785
        },
        {
            "text": "receptor (5-HT2AR)",
            "probability": 1.6514184880742904e-06,
            "start_logit": -4.341833591461182,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5-HT2AR",
            "probability": 1.1953673872915587e-06,
            "start_logit": 1.7927563190460205,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET)",
            "probability": 9.325950952212353e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -5.616687297821045
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET) in albino rats.",
            "probability": 3.309560725662402e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -6.65267276763916
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established in humans,",
            "probability": 2.471080328859431e-07,
            "start_logit": 8.114241600036621,
            "end_logit": -6.749902725219727
        },
        {
            "text": "AR",
            "probability": 2.0589976003118943e-09,
            "start_logit": -4.57123327255249,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "[18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 1.8492413114800943e-09,
            "start_logit": -2.9929332733154297,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "quantification of 5-HT2AR",
            "probability": 1.5903213843150035e-09,
            "start_logit": -4.829516410827637,
            "end_logit": 1.1479657888412476
        }
    ],
    "55242d512c8b63434a000006_081": [
        {
            "text": "5-HT2ARs",
            "probability": 0.5755064668725747,
            "start_logit": 8.309171676635742,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(5-HT2AR)",
            "probability": 0.42409374218265095,
            "start_logit": 8.114241600036621,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5",
            "probability": 0.00014977364545178576,
            "start_logit": 8.309171676635742,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "s",
            "probability": 8.835525368407642e-05,
            "start_logit": -0.47246840596199036,
            "end_logit": 7.716102600097656
        },
        {
            "text": "(",
            "probability": 7.513536578080681e-05,
            "start_logit": 8.114241600036621,
            "end_logit": -1.0326817035675049
        },
        {
            "text": ")",
            "probability": 5.652879274791656e-05,
            "start_logit": -0.8087180852890015,
            "end_logit": 7.60573673248291
        },
        {
            "text": "quantifying cerebral 5-HT2ARs",
            "probability": 7.434116063834184e-06,
            "start_logit": -2.947754383087158,
            "end_logit": 7.716102600097656
        },
        {
            "text": "well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 5.835288196807674e-06,
            "start_logit": -3.189910411834717,
            "end_logit": 7.716102600097656
        },
        {
            "text": "5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 5.303377029256705e-06,
            "start_logit": -3.175124406814575,
            "end_logit": 7.60573673248291
        },
        {
            "text": "for quantifying cerebral 5-HT2ARs",
            "probability": 2.704281080182175e-06,
            "start_logit": -3.958997964859009,
            "end_logit": 7.716102600097656
        },
        {
            "text": "the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 2.5070188414051633e-06,
            "start_logit": -3.9243738651275635,
            "end_logit": 7.60573673248291
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established",
            "probability": 1.8508622619912786e-06,
            "start_logit": 8.114241600036621,
            "end_logit": -4.736321449279785
        },
        {
            "text": "receptor (5-HT2AR)",
            "probability": 1.6514184880742904e-06,
            "start_logit": -4.341833591461182,
            "end_logit": 7.60573673248291
        },
        {
            "text": "5-HT2AR",
            "probability": 1.1953673872915587e-06,
            "start_logit": 1.7927563190460205,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET)",
            "probability": 9.325950952212353e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -5.616687297821045
        },
        {
            "text": "5-HT2ARs with positron emission tomography (PET) in albino rats.",
            "probability": 3.309560725662402e-07,
            "start_logit": 8.309171676635742,
            "end_logit": -6.65267276763916
        },
        {
            "text": "(5-HT2AR) radiotracer [18F]altanserin is well established in humans,",
            "probability": 2.471080328859431e-07,
            "start_logit": 8.114241600036621,
            "end_logit": -6.749902725219727
        },
        {
            "text": "AR",
            "probability": 2.0589976003118943e-09,
            "start_logit": -4.57123327255249,
            "end_logit": 1.1479657888412476
        },
        {
            "text": "[18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs",
            "probability": 1.8492413114800943e-09,
            "start_logit": -2.9929332733154297,
            "end_logit": -0.5377780199050903
        },
        {
            "text": "quantification of 5-HT2AR",
            "probability": 1.5903213843150035e-09,
            "start_logit": -4.829516410827637,
            "end_logit": 1.1479657888412476
        }
    ],
    "55242d512c8b63434a000006_082": [
        {
            "text": "5-HT2A",
            "probability": 0.9994718589838286,
            "start_logit": 8.972574234008789,
            "end_logit": 8.107715606689453
        },
        {
            "text": "5",
            "probability": 0.0004113838426745815,
            "start_logit": 8.972574234008789,
            "end_logit": 0.3122600317001343
        },
        {
            "text": "A",
            "probability": 7.867229819485746e-05,
            "start_logit": -0.4771169424057007,
            "end_logit": 8.107715606689453
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors",
            "probability": 2.3220336183292563e-05,
            "start_logit": 8.972574234008789,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification",
            "probability": 5.606631036071198e-06,
            "start_logit": 8.972574234008789,
            "end_logit": -3.983316659927368
        },
        {
            "text": "5-HT2A receptor",
            "probability": 3.6224686097141098e-06,
            "start_logit": 8.462964057922363,
            "end_logit": -3.9105007648468018
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target",
            "probability": 1.8496929668756592e-06,
            "start_logit": 8.972574234008789,
            "end_logit": -5.092247009277344
        },
        {
            "text": "the radiometabolites of the serotonin 5-HT2A",
            "probability": 8.81583681999443e-07,
            "start_logit": -4.968443393707275,
            "end_logit": 8.107715606689453
        },
        {
            "text": "identify and characterize the radiometabolites of the serotonin 5-HT2A",
            "probability": 7.17134055707314e-07,
            "start_logit": -5.174900531768799,
            "end_logit": 8.107715606689453
        },
        {
            "text": "HT2A",
            "probability": 5.272366072162762e-07,
            "start_logit": -5.482513904571533,
            "end_logit": 8.107715606689453
        },
        {
            "text": "and characterize the radiometabolites of the serotonin 5-HT2A",
            "probability": 4.966738980517174e-07,
            "start_logit": -5.542229652404785,
            "end_logit": 8.107715606689453
        },
        {
            "text": "radiometabolites of the serotonin 5-HT2A",
            "probability": 4.955766823239009e-07,
            "start_logit": -5.544441223144531,
            "end_logit": 8.107715606689453
        },
        {
            "text": "Characterization of radioactive metabolites of 5-HT2A",
            "probability": 3.534254908138493e-07,
            "start_logit": -5.050318241119385,
            "end_logit": 7.275543212890625
        },
        {
            "text": "5-HT2A receptor PET ligand [18F]altanserin",
            "probability": 3.1348543841936713e-07,
            "start_logit": 8.462964057922363,
            "end_logit": -6.357658863067627
        },
        {
            "text": "target receptors",
            "probability": 2.1731176389893257e-10,
            "start_logit": -2.6066317558288574,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "receptors",
            "probability": 1.8721835962678654e-10,
            "start_logit": -2.7556891441345215,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "the target receptors",
            "probability": 9.375737786414606e-11,
            "start_logit": -3.4472544193267822,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "quantification of the target receptors",
            "probability": 8.058097552581176e-11,
            "start_logit": -3.5987021923065186,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "supporting quantification of the target receptors",
            "probability": 2.8342377295338325e-11,
            "start_logit": -4.643606662750244,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "[18F]altanserin in supporting quantification of the target receptors",
            "probability": 2.3440344717251864e-11,
            "start_logit": -4.833506107330322,
            "end_logit": -2.5622382164001465
        }
    ],
    "55242d512c8b63434a000006_083": [
        {
            "text": "5-HT2A",
            "probability": 0.9970027042640318,
            "start_logit": 5.179903507232666,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors.",
            "probability": 0.0010020489555284595,
            "start_logit": 5.179903507232666,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "A",
            "probability": 0.0005837884790899236,
            "start_logit": -2.263066530227661,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5",
            "probability": 0.0005404629295053089,
            "start_logit": 5.179903507232666,
            "end_logit": -3.065509080886841
        },
        {
            "text": "of 5-HT2A",
            "probability": 0.0002761162937371416,
            "start_logit": -3.0117831230163574,
            "end_logit": 4.454573631286621
        },
        {
            "text": "the known regional distribution of 5-HT2A",
            "probability": 0.0002195415307727951,
            "start_logit": -3.2410638332366943,
            "end_logit": 4.454573631286621
        },
        {
            "text": "known regional distribution of 5-HT2A",
            "probability": 0.00015150832160135241,
            "start_logit": -3.611964702606201,
            "end_logit": 4.454573631286621
        },
        {
            "text": "regional distribution of 5-HT2A",
            "probability": 0.0001072938297245234,
            "start_logit": -3.957034111022949,
            "end_logit": 4.454573631286621
        },
        {
            "text": "distribution of 5-HT2A",
            "probability": 4.358386406608003e-05,
            "start_logit": -4.8579182624816895,
            "end_logit": 4.454573631286621
        },
        {
            "text": "HT2A",
            "probability": 2.2137194943166774e-05,
            "start_logit": -5.535346031188965,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors. These",
            "probability": 1.656856485078623e-05,
            "start_logit": 5.179903507232666,
            "end_logit": -6.5504279136657715
        },
        {
            "text": "with the known regional distribution of 5-HT2A",
            "probability": 1.3389791841011778e-05,
            "start_logit": -6.038112640380859,
            "end_logit": 4.454573631286621
        },
        {
            "text": "binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A",
            "probability": 9.499389725461025e-06,
            "start_logit": -6.381377696990967,
            "end_logit": 4.454573631286621
        },
        {
            "text": "correlated with the known regional distribution of 5-HT2A",
            "probability": 9.316343439322603e-06,
            "start_logit": -6.400835037231445,
            "end_logit": 4.454573631286621
        },
        {
            "text": "receptors.",
            "probability": 8.965144834788948e-07,
            "start_logit": -1.839139461517334,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "of 5-HT2A receptors.",
            "probability": 2.775138347773424e-07,
            "start_logit": -3.0117831230163574,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "2A",
            "probability": 2.6205423954828773e-07,
            "start_logit": -7.240525722503662,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "serotonin 5-HT2A",
            "probability": 2.3123669300286974e-07,
            "start_logit": -7.365635395050049,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "the known regional distribution of 5-HT2A receptors.",
            "probability": 2.206527230719919e-07,
            "start_logit": -3.2410638332366943,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "known regional distribution of 5-HT2A receptors.",
            "probability": 1.5227516912963118e-07,
            "start_logit": -3.611964702606201,
            "end_logit": -2.4481329917907715
        }
    ],
    "55242d512c8b63434a000006_084": [
        {
            "text": "5-HT2A",
            "probability": 0.9970027042640318,
            "start_logit": 5.179903507232666,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors.",
            "probability": 0.0010020489555284595,
            "start_logit": 5.179903507232666,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "A",
            "probability": 0.0005837884790899236,
            "start_logit": -2.263066530227661,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5",
            "probability": 0.0005404629295053089,
            "start_logit": 5.179903507232666,
            "end_logit": -3.065509080886841
        },
        {
            "text": "of 5-HT2A",
            "probability": 0.0002761162937371416,
            "start_logit": -3.0117831230163574,
            "end_logit": 4.454573631286621
        },
        {
            "text": "the known regional distribution of 5-HT2A",
            "probability": 0.0002195415307727951,
            "start_logit": -3.2410638332366943,
            "end_logit": 4.454573631286621
        },
        {
            "text": "known regional distribution of 5-HT2A",
            "probability": 0.00015150832160135241,
            "start_logit": -3.611964702606201,
            "end_logit": 4.454573631286621
        },
        {
            "text": "regional distribution of 5-HT2A",
            "probability": 0.0001072938297245234,
            "start_logit": -3.957034111022949,
            "end_logit": 4.454573631286621
        },
        {
            "text": "distribution of 5-HT2A",
            "probability": 4.358386406608003e-05,
            "start_logit": -4.8579182624816895,
            "end_logit": 4.454573631286621
        },
        {
            "text": "HT2A",
            "probability": 2.2137194943166774e-05,
            "start_logit": -5.535346031188965,
            "end_logit": 4.454573631286621
        },
        {
            "text": "5-HT2A receptors. These",
            "probability": 1.656856485078623e-05,
            "start_logit": 5.179903507232666,
            "end_logit": -6.5504279136657715
        },
        {
            "text": "with the known regional distribution of 5-HT2A",
            "probability": 1.3389791841011778e-05,
            "start_logit": -6.038112640380859,
            "end_logit": 4.454573631286621
        },
        {
            "text": "binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A",
            "probability": 9.499389725461025e-06,
            "start_logit": -6.381377696990967,
            "end_logit": 4.454573631286621
        },
        {
            "text": "correlated with the known regional distribution of 5-HT2A",
            "probability": 9.316343439322603e-06,
            "start_logit": -6.400835037231445,
            "end_logit": 4.454573631286621
        },
        {
            "text": "receptors.",
            "probability": 8.965144834788948e-07,
            "start_logit": -1.839139461517334,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "of 5-HT2A receptors.",
            "probability": 2.775138347773424e-07,
            "start_logit": -3.0117831230163574,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "2A",
            "probability": 2.6205423954828773e-07,
            "start_logit": -7.240525722503662,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "serotonin 5-HT2A",
            "probability": 2.3123669300286974e-07,
            "start_logit": -7.365635395050049,
            "end_logit": 1.7232903242111206
        },
        {
            "text": "the known regional distribution of 5-HT2A receptors.",
            "probability": 2.206527230719919e-07,
            "start_logit": -3.2410638332366943,
            "end_logit": -2.4481329917907715
        },
        {
            "text": "known regional distribution of 5-HT2A receptors.",
            "probability": 1.5227516912963118e-07,
            "start_logit": -3.611964702606201,
            "end_logit": -2.4481329917907715
        }
    ],
    "55242d512c8b63434a000006_085": [
        {
            "text": "5-HT2A",
            "probability": 0.9994718589838286,
            "start_logit": 8.972574234008789,
            "end_logit": 8.107715606689453
        },
        {
            "text": "5",
            "probability": 0.0004113838426745815,
            "start_logit": 8.972574234008789,
            "end_logit": 0.3122600317001343
        },
        {
            "text": "A",
            "probability": 7.867229819485746e-05,
            "start_logit": -0.4771169424057007,
            "end_logit": 8.107715606689453
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors",
            "probability": 2.3220336183292563e-05,
            "start_logit": 8.972574234008789,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification",
            "probability": 5.606631036071198e-06,
            "start_logit": 8.972574234008789,
            "end_logit": -3.983316659927368
        },
        {
            "text": "5-HT2A receptor",
            "probability": 3.6224686097141098e-06,
            "start_logit": 8.462964057922363,
            "end_logit": -3.9105007648468018
        },
        {
            "text": "5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target",
            "probability": 1.8496929668756592e-06,
            "start_logit": 8.972574234008789,
            "end_logit": -5.092247009277344
        },
        {
            "text": "the radiometabolites of the serotonin 5-HT2A",
            "probability": 8.81583681999443e-07,
            "start_logit": -4.968443393707275,
            "end_logit": 8.107715606689453
        },
        {
            "text": "identify and characterize the radiometabolites of the serotonin 5-HT2A",
            "probability": 7.17134055707314e-07,
            "start_logit": -5.174900531768799,
            "end_logit": 8.107715606689453
        },
        {
            "text": "HT2A",
            "probability": 5.272366072162762e-07,
            "start_logit": -5.482513904571533,
            "end_logit": 8.107715606689453
        },
        {
            "text": "and characterize the radiometabolites of the serotonin 5-HT2A",
            "probability": 4.966738980517174e-07,
            "start_logit": -5.542229652404785,
            "end_logit": 8.107715606689453
        },
        {
            "text": "radiometabolites of the serotonin 5-HT2A",
            "probability": 4.955766823239009e-07,
            "start_logit": -5.544441223144531,
            "end_logit": 8.107715606689453
        },
        {
            "text": "Characterization of radioactive metabolites of 5-HT2A",
            "probability": 3.534254908138493e-07,
            "start_logit": -5.050318241119385,
            "end_logit": 7.275543212890625
        },
        {
            "text": "5-HT2A receptor PET ligand [18F]altanserin",
            "probability": 3.1348543841936713e-07,
            "start_logit": 8.462964057922363,
            "end_logit": -6.357658863067627
        },
        {
            "text": "target receptors",
            "probability": 2.1731176389893257e-10,
            "start_logit": -2.6066317558288574,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "receptors",
            "probability": 1.8721835962678654e-10,
            "start_logit": -2.7556891441345215,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "the target receptors",
            "probability": 9.375737786414606e-11,
            "start_logit": -3.4472544193267822,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "quantification of the target receptors",
            "probability": 8.058097552581176e-11,
            "start_logit": -3.5987021923065186,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "supporting quantification of the target receptors",
            "probability": 2.8342377295338325e-11,
            "start_logit": -4.643606662750244,
            "end_logit": -2.5622382164001465
        },
        {
            "text": "[18F]altanserin in supporting quantification of the target receptors",
            "probability": 2.3440344717251864e-11,
            "start_logit": -4.833506107330322,
            "end_logit": -2.5622382164001465
        }
    ],
    "55242d512c8b63434a000006_086": [
        {
            "text": "5-HT2A",
            "probability": 0.9992262306662333,
            "start_logit": 8.933757781982422,
            "end_logit": 7.871456146240234
        },
        {
            "text": "5",
            "probability": 0.0005439298361227838,
            "start_logit": 8.933757781982422,
            "end_logit": 0.3555399179458618
        },
        {
            "text": "5-HT2A receptors",
            "probability": 0.0001562056103000775,
            "start_logit": 8.933757781982422,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "A",
            "probability": 6.859652411028126e-05,
            "start_logit": -0.6527368426322937,
            "end_logit": 7.871456146240234
        },
        {
            "text": "image serotonin 5-HT2A",
            "probability": 2.1330171671250507e-06,
            "start_logit": -4.123441219329834,
            "end_logit": 7.871456146240234
        },
        {
            "text": "5-HT2A receptors in humans.",
            "probability": 1.2104705490092027e-06,
            "start_logit": 8.933757781982422,
            "end_logit": -5.7522711753845215
        },
        {
            "text": "HT2A",
            "probability": 5.681049450139427e-07,
            "start_logit": -5.446427822113037,
            "end_logit": 7.871456146240234
        },
        {
            "text": "[18F]altanserin and positron emission tomography (PET) to image serotonin 5-HT2A",
            "probability": 3.142615405477987e-07,
            "start_logit": -6.038508415222168,
            "end_logit": 7.871456146240234
        },
        {
            "text": "2A",
            "probability": 2.8469046444178897e-07,
            "start_logit": -6.137331485748291,
            "end_logit": 7.871456146240234
        },
        {
            "text": "5-HT2A receptors with age",
            "probability": 2.6668741446195965e-07,
            "start_logit": 7.521975994110107,
            "end_logit": -5.853176593780518
        },
        {
            "text": "Visualisation of loss of 5-HT2A",
            "probability": 1.257706846111178e-07,
            "start_logit": -5.415449619293213,
            "end_logit": 6.332632064819336
        },
        {
            "text": "loss of 5-HT2A",
            "probability": 6.761726837225087e-08,
            "start_logit": -6.036046504974365,
            "end_logit": 6.332632064819336
        },
        {
            "text": "5-HT2A receptors with age in healthy volunteers using [18F]altanserin",
            "probability": 6.596363664587506e-08,
            "start_logit": 7.521975994110107,
            "end_logit": -7.250150203704834
        },
        {
            "text": "receptors",
            "probability": 3.9569236928478083e-10,
            "start_logit": -3.952288866043091,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "image serotonin 5-HT2A receptors",
            "probability": 3.3344725963524527e-10,
            "start_logit": -4.123441219329834,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "ors",
            "probability": 4.140670331265796e-11,
            "start_logit": -6.2094831466674805,
            "end_logit": -0.8921071887016296
        },
        {
            "text": "receptors in humans.",
            "probability": 3.0663044596591105e-12,
            "start_logit": -3.952288866043091,
            "end_logit": -5.7522711753845215
        },
        {
            "text": "image serotonin 5-HT2A receptors in humans.",
            "probability": 2.583953845581493e-12,
            "start_logit": -4.123441219329834,
            "end_logit": -5.7522711753845215
        },
        {
            "text": "image serotonin",
            "probability": 1.8531723318394427e-12,
            "start_logit": -4.123441219329834,
            "end_logit": -6.08469295501709
        },
        {
            "text": "humans.",
            "probability": 1.5136479206293815e-12,
            "start_logit": -4.658239364624023,
            "end_logit": -5.7522711753845215
        }
    ],
    "56f6c11109dd18d46b00000e_001": [
        {
            "text": "BACKGROUND: Since its isolation in 1970,",
            "probability": 0.20561224250628898,
            "start_logit": -5.727047443389893,
            "end_logit": -7.760900020599365
        },
        {
            "text": "BACKGROUND: Since its isolation in 1970, and discovery of its potent inhibitory activity on T-cell",
            "probability": 0.1462623719289031,
            "start_logit": -5.727047443389893,
            "end_logit": -8.101490020751953
        },
        {
            "text": "BACKGROUND: Since its isolation in 1970, and discovery of its potent inhibitory activity on T-cell proliferation,",
            "probability": 0.08425206377462748,
            "start_logit": -5.727047443389893,
            "end_logit": -8.65307903289795
        },
        {
            "text": "1970,",
            "probability": 0.07795279022612482,
            "start_logit": -6.696936130523682,
            "end_logit": -7.760900020599365
        },
        {
            "text": "and drug targets.",
            "probability": 0.06014838557617966,
            "start_logit": -6.434370040893555,
            "end_logit": -8.282754898071289
        },
        {
            "text": "1970, and discovery of its potent inhibitory activity on T-cell",
            "probability": 0.055451756461439766,
            "start_logit": -6.696936130523682,
            "end_logit": -8.101490020751953
        },
        {
            "text": "CONCLUSIONS",
            "probability": 0.03850667754772368,
            "start_logit": -6.131930351257324,
            "end_logit": -9.031177520751953
        },
        {
            "text": "T-cell",
            "probability": 0.03459127499847359,
            "start_logit": -7.168848037719727,
            "end_logit": -8.101490020751953
        },
        {
            "text": "1970, and discovery of its potent inhibitory activity on T-cell proliferation,",
            "probability": 0.03194208366917035,
            "start_logit": -6.696936130523682,
            "end_logit": -8.65307903289795
        },
        {
            "text": "MAJ",
            "probability": 0.02837769461547877,
            "start_logit": -6.909604072570801,
            "end_logit": -8.558732032775879
        },
        {
            "text": "inhibitory activity on T-cell",
            "probability": 0.027164418835009533,
            "start_logit": -7.410541534423828,
            "end_logit": -8.101490020751953
        },
        {
            "text": "and drug",
            "probability": 0.026595528277356405,
            "start_logit": -6.434370040893555,
            "end_logit": -9.09882640838623
        },
        {
            "text": "isolation in 1970,",
            "probability": 0.026519445441242052,
            "start_logit": -7.775161266326904,
            "end_logit": -7.760900020599365
        },
        {
            "text": "1970, and discovery of its potent inhibitory activity on T-cell proliferation, cyclosporin A",
            "probability": 0.026444021586722585,
            "start_logit": -6.696936130523682,
            "end_logit": -8.841973304748535
        },
        {
            "text": "discovery of its potent inhibitory activity on T-cell",
            "probability": 0.025081278346682234,
            "start_logit": -7.490327835083008,
            "end_logit": -8.101490020751953
        },
        {
            "text": "1970, and discovery of its potent inhibitory activity on T-cell proliferation, cyclosporin A (CsA)",
            "probability": 0.022871996448872275,
            "start_logit": -6.696936130523682,
            "end_logit": -8.987090110778809
        },
        {
            "text": "cell",
            "probability": 0.021835874522947166,
            "start_logit": -7.628895282745361,
            "end_logit": -8.101490020751953
        },
        {
            "text": "of its potent inhibitory activity on T-cell",
            "probability": 0.021599732273020845,
            "start_logit": -7.639768600463867,
            "end_logit": -8.101490020751953
        },
        {
            "text": "T-cell proliferation,",
            "probability": 0.01992574213574037,
            "start_logit": -7.168848037719727,
            "end_logit": -8.65307903289795
        },
        {
            "text": "isolation in 1970, and discovery of its potent inhibitory activity on T-cell",
            "probability": 0.01886462082799646,
            "start_logit": -7.775161266326904,
            "end_logit": -8.101490020751953
        }
    ],
    "56f6c11109dd18d46b00000e_002": [
        {
            "text": "FK506",
            "probability": 0.40031307641736624,
            "start_logit": -3.4181110858917236,
            "end_logit": -3.1394689083099365
        },
        {
            "text": "FK506 is a cis-trans peptidyl-prolyl isomerase. The structurally novel macrolide FK506",
            "probability": 0.36369111113488695,
            "start_logit": -3.5140531063079834,
            "end_logit": -3.1394689083099365
        },
        {
            "text": "cyclophilin",
            "probability": 0.08884894742508394,
            "start_logit": -0.6339308023452759,
            "end_logit": -7.428958415985107
        },
        {
            "text": "cycl",
            "probability": 0.036148198706224814,
            "start_logit": -0.6339308023452759,
            "end_logit": -8.328269004821777
        },
        {
            "text": "cycloph",
            "probability": 0.02618568063864841,
            "start_logit": -0.6339308023452759,
            "end_logit": -8.650683403015137
        },
        {
            "text": "cyclophil",
            "probability": 0.02177196939493522,
            "start_logit": -0.6339308023452759,
            "end_logit": -8.835272789001465
        },
        {
            "text": "cyclophilin,",
            "probability": 0.021028408385374786,
            "start_logit": -0.6339308023452759,
            "end_logit": -8.87002182006836
        },
        {
            "text": "cis-trans peptidyl-prolyl isomerase. The structurally novel macrolide FK506",
            "probability": 0.019462475575012413,
            "start_logit": -6.441869735717773,
            "end_logit": -3.1394689083099365
        },
        {
            "text": "The structurally novel macrolide FK506",
            "probability": 0.008620465690902107,
            "start_logit": -7.256218910217285,
            "end_logit": -3.1394689083099365
        },
        {
            "text": "FK506 is a cis-trans peptidyl-prolyl isomerase.",
            "probability": 0.003170752295154731,
            "start_logit": -3.5140531063079834,
            "end_logit": -7.881804943084717
        },
        {
            "text": "FK506 (refs 1,2) has recently been demonstrated to have potent immunosuppressive",
            "probability": 0.0026285983490811444,
            "start_logit": -3.4181110858917236,
            "end_logit": -8.165265083312988
        },
        {
            "text": "receptor for the immunosuppressant FK506",
            "probability": 0.0021449314718315696,
            "start_logit": -7.3338117599487305,
            "end_logit": -4.452907562255859
        },
        {
            "text": "immunosuppressant FK506",
            "probability": 0.001762956290157439,
            "start_logit": -7.5299272537231445,
            "end_logit": -4.452907562255859
        },
        {
            "text": "mechanisms of immunosuppression mediated by FK506",
            "probability": 0.001229360553161283,
            "start_logit": -7.1618475914001465,
            "end_logit": -5.181485176086426
        },
        {
            "text": "FK506 (refs 1,2) has recently been demonstrated",
            "probability": 0.0011814307194658348,
            "start_logit": -3.4181110858917236,
            "end_logit": -8.96498966217041
        },
        {
            "text": "immunosuppression mediated by FK506",
            "probability": 0.0010796568879454889,
            "start_logit": -7.291698455810547,
            "end_logit": -5.181485176086426
        },
        {
            "text": "the CsA receptor, cyclophilin,",
            "probability": 0.00030999310724955196,
            "start_logit": -6.292073726654053,
            "end_logit": -7.428958415985107
        },
        {
            "text": "cis-trans peptidyl-prolyl isomerase.",
            "probability": 0.00016967884891741562,
            "start_logit": -6.441869735717773,
            "end_logit": -7.881804943084717
        },
        {
            "text": "receptor, cyclophilin,",
            "probability": 0.00016805264999657422,
            "start_logit": -6.904346466064453,
            "end_logit": -7.428958415985107
        },
        {
            "text": "ophilin",
            "probability": 8.425545860425684e-05,
            "start_logit": -7.594770431518555,
            "end_logit": -7.428958415985107
        }
    ],
    "56f6c11109dd18d46b00000e_003": [
        {
            "text": "cyclophilin",
            "probability": 0.9972283397929026,
            "start_logit": 3.541646957397461,
            "end_logit": 0.8449243307113647
        },
        {
            "text": "cycl",
            "probability": 0.002176730780042292,
            "start_logit": 3.541646957397461,
            "end_logit": -5.282231330871582
        },
        {
            "text": "cyclophil",
            "probability": 0.00021941608118527714,
            "start_logit": 3.541646957397461,
            "end_logit": -7.576840877532959
        },
        {
            "text": "cycloph",
            "probability": 0.0001977085144718795,
            "start_logit": 3.541646957397461,
            "end_logit": -7.68101692199707
        },
        {
            "text": "cyclophilin as the major, if not only, intracellular receptor protein for CsA.",
            "probability": 8.545464242229591e-05,
            "start_logit": 3.541646957397461,
            "end_logit": -8.519824981689453
        },
        {
            "text": "ophilin",
            "probability": 4.413307404388916e-05,
            "start_logit": -6.4838786125183105,
            "end_logit": 0.8449243307113647
        },
        {
            "text": "in",
            "probability": 4.142353781166787e-05,
            "start_logit": -6.547238826751709,
            "end_logit": 0.8449243307113647
        },
        {
            "text": "support cyclophilin",
            "probability": 6.7147901563518295e-06,
            "start_logit": -8.366775512695312,
            "end_logit": 0.8449243307113647
        },
        {
            "text": "calmodulin",
            "probability": 3.512406542470051e-08,
            "start_logit": -5.571329116821289,
            "end_logit": -7.2037034034729
        },
        {
            "text": "ophil",
            "probability": 9.71042014247292e-09,
            "start_logit": -6.4838786125183105,
            "end_logit": -7.576840877532959
        },
        {
            "text": "oph",
            "probability": 8.749735802842144e-09,
            "start_logit": -6.4838786125183105,
            "end_logit": -7.68101692199707
        },
        {
            "text": "calmod",
            "probability": 5.7240308099155525e-09,
            "start_logit": -5.571329116821289,
            "end_logit": -9.017916679382324
        },
        {
            "text": "calmodulin,",
            "probability": 4.325565390261714e-09,
            "start_logit": -5.571329116821289,
            "end_logit": -9.298047065734863
        },
        {
            "text": "calmodulin, is an important Ca++-binding",
            "probability": 4.160768126430414e-09,
            "start_logit": -5.571329116821289,
            "end_logit": -9.33689022064209
        },
        {
            "text": "intracellular CsA-receptor proteins. One of these, calmodulin,",
            "probability": 3.4862826757148996e-09,
            "start_logit": -7.8813796043396,
            "end_logit": -7.2037034034729
        },
        {
            "text": "proteins. One of these, calmodulin,",
            "probability": 2.4684776845285886e-09,
            "start_logit": -8.226613998413086,
            "end_logit": -7.2037034034729
        },
        {
            "text": "proteins have been identified as putative intracellular CsA-receptor proteins. One of these, calmodulin,",
            "probability": 2.371076768486023e-09,
            "start_logit": -8.266871452331543,
            "end_logit": -7.2037034034729
        },
        {
            "text": "cyclophilin and/or the 45 KD phosphoprotein and the immunosuppressive",
            "probability": 9.320309295603568e-10,
            "start_logit": -7.328584671020508,
            "end_logit": -9.075723648071289
        },
        {
            "text": ".",
            "probability": 8.7420745492667e-10,
            "start_logit": -7.948531627655029,
            "end_logit": -8.519824981689453
        },
        {
            "text": "cyclophilin and/or the 45 KD",
            "probability": 8.603024906012963e-10,
            "start_logit": -7.328584671020508,
            "end_logit": -9.155805587768555
        }
    ],
    "536e46f27d100faa09000012_001": [
        {
            "text": "HEXA",
            "probability": 0.9994874433906267,
            "start_logit": 9.07747745513916,
            "end_logit": 8.640071868896484
        },
        {
            "text": "H",
            "probability": 0.00021608504252085611,
            "start_logit": 9.07747745513916,
            "end_logit": 0.20074604451656342
        },
        {
            "text": "A",
            "probability": 0.00018793550473210314,
            "start_logit": 0.49857842922210693,
            "end_logit": 8.640071868896484
        },
        {
            "text": "HEXA gene",
            "probability": 7.321772662336356e-05,
            "start_logit": 9.07747745513916,
            "end_logit": -0.8814884424209595
        },
        {
            "text": "Specific mutations in the HEXA",
            "probability": 2.0886195662371735e-05,
            "start_logit": -1.6984319686889648,
            "end_logit": 8.640071868896484
        },
        {
            "text": "the HEXA",
            "probability": 6.5581522323175184e-06,
            "start_logit": -2.8568115234375,
            "end_logit": 8.640071868896484
        },
        {
            "text": "EXA",
            "probability": 4.576569953264183e-06,
            "start_logit": -3.2165706157684326,
            "end_logit": 8.640071868896484
        },
        {
            "text": "HEXA gene among Iraqi Jewish Tay-Sachs disease carriers:",
            "probability": 2.0108635355751096e-06,
            "start_logit": 9.07747745513916,
            "end_logit": -4.4763617515563965
        },
        {
            "text": "mutations in the HEXA",
            "probability": 6.490193540940943e-07,
            "start_logit": -5.16981315612793,
            "end_logit": 8.640071868896484
        },
        {
            "text": "HEX",
            "probability": 2.2156033564901168e-07,
            "start_logit": 9.07747745513916,
            "end_logit": -6.681986331939697
        },
        {
            "text": "HEXA gene among Iraqi",
            "probability": 1.7387692261730816e-07,
            "start_logit": 9.07747745513916,
            "end_logit": -6.924333572387695
        },
        {
            "text": "HEXA gene among Iraqi Jewish Tay-Sachs disease",
            "probability": 1.587878254565925e-07,
            "start_logit": 9.07747745513916,
            "end_logit": -7.015112400054932
        },
        {
            "text": "HEXA gene among Iraqi Jewish Tay-Sachs",
            "probability": 8.083155843538406e-08,
            "start_logit": 9.07747745513916,
            "end_logit": -7.690313816070557
        },
        {
            "text": "Specific mutations in the HEXA gene",
            "probability": 1.5300239881172247e-09,
            "start_logit": -1.6984319686889648,
            "end_logit": -0.8814884424209595
        },
        {
            "text": "the HEXA gene",
            "probability": 4.804192393566279e-10,
            "start_logit": -2.8568115234375,
            "end_logit": -0.8814884424209595
        },
        {
            "text": "Specific mutations",
            "probability": 2.1640001280383942e-10,
            "start_logit": -1.6984319686889648,
            "end_logit": -2.8373985290527344
        },
        {
            "text": "Specific",
            "probability": 1.3600414991517558e-10,
            "start_logit": -1.6984319686889648,
            "end_logit": -3.3018417358398438
        },
        {
            "text": "mutations in the HEXA gene",
            "probability": 4.7544090679247684e-11,
            "start_logit": -5.16981315612793,
            "end_logit": -0.8814884424209595
        },
        {
            "text": "Specific mutations in the HEXA gene among Iraqi Jewish Tay-Sachs disease carriers:",
            "probability": 4.202082730711794e-11,
            "start_logit": -1.6984319686889648,
            "end_logit": -4.4763617515563965
        },
        {
            "text": "1:29",
            "probability": 2.570557875528842e-11,
            "start_logit": -1.9523290395736694,
            "end_logit": -4.713922023773193
        }
    ],
    "536e46f27d100faa09000012_002": [
        {
            "text": "HEXA",
            "probability": 0.9991548419204734,
            "start_logit": 8.539693832397461,
            "end_logit": 7.598077297210693
        },
        {
            "text": "H",
            "probability": 0.00025736267828414204,
            "start_logit": 8.539693832397461,
            "end_logit": -0.6661014556884766
        },
        {
            "text": "HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease. Two affected HEXA",
            "probability": 0.00020798935201625656,
            "start_logit": 8.539693832397461,
            "end_logit": -0.8791008591651917
        },
        {
            "text": "Two mutated HEXA",
            "probability": 0.00020046692996311858,
            "start_logit": 0.025678085163235664,
            "end_logit": 7.598077297210693
        },
        {
            "text": "A",
            "probability": 0.00012694280262517122,
            "start_logit": -0.43123459815979004,
            "end_logit": 7.598077297210693
        },
        {
            "text": "mutated HEXA",
            "probability": 1.843587066337686e-05,
            "start_logit": -2.360672950744629,
            "end_logit": 7.598077297210693
        },
        {
            "text": "Two affected HEXA",
            "probability": 8.418084117245854e-06,
            "start_logit": -3.027017593383789,
            "end_logit": 7.48050594329834
        },
        {
            "text": "HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease. Two",
            "probability": 7.724201527595848e-06,
            "start_logit": 8.539693832397461,
            "end_logit": -4.172229290008545
        },
        {
            "text": "HEXA alleles",
            "probability": 4.752350089450415e-06,
            "start_logit": 8.501808166503906,
            "end_logit": -4.620062828063965
        },
        {
            "text": "HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease. Two affected",
            "probability": 4.395280789563796e-06,
            "start_logit": 8.539693832397461,
            "end_logit": -4.736056327819824
        },
        {
            "text": "affected HEXA",
            "probability": 3.443128619631948e-06,
            "start_logit": -3.9210193157196045,
            "end_logit": 7.48050594329834
        },
        {
            "text": "EXA",
            "probability": 2.4920120362601688e-06,
            "start_logit": -4.361880779266357,
            "end_logit": 7.598077297210693
        },
        {
            "text": "alleles in a Druze patient with late-infantile Tay-Sachs disease. Two affected HEXA",
            "probability": 9.583801298251823e-07,
            "start_logit": -5.199910640716553,
            "end_logit": 7.48050594329834
        },
        {
            "text": "HEX",
            "probability": 4.927837747571275e-07,
            "start_logit": 8.539693832397461,
            "end_logit": -6.924272537231445
        },
        {
            "text": "HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease.",
            "probability": 2.4931838799769923e-07,
            "start_logit": 8.539693832397461,
            "end_logit": -7.605612277984619
        },
        {
            "text": "HEXA alleles were found in an Israeli Druze Tay-Sachs",
            "probability": 2.4470736018970465e-07,
            "start_logit": 8.501808166503906,
            "end_logit": -7.586394309997559
        },
        {
            "text": "in a Druze patient with late-infantile Tay-Sachs disease. Two affected HEXA",
            "probability": 2.115153862045119e-07,
            "start_logit": -6.710857391357422,
            "end_logit": 7.48050594329834
        },
        {
            "text": "late-infantile Tay-Sachs disease. Two affected HEXA",
            "probability": 2.051679276578945e-07,
            "start_logit": -6.741326332092285,
            "end_logit": 7.48050594329834
        },
        {
            "text": "Tay-Sachs disease. Two affected HEXA",
            "probability": 1.9010069991085678e-07,
            "start_logit": -6.817601203918457,
            "end_logit": 7.48050594329834
        },
        {
            "text": "HEXA alleles were found",
            "probability": 1.8341512818154695e-07,
            "start_logit": 8.501808166503906,
            "end_logit": -7.8747053146362305
        }
    ],
    "536e46f27d100faa09000012_003": [
        {
            "text": "HEXA",
            "probability": 0.9991548419204734,
            "start_logit": 8.539693832397461,
            "end_logit": 7.598077297210693
        },
        {
            "text": "H",
            "probability": 0.00025736267828414204,
            "start_logit": 8.539693832397461,
            "end_logit": -0.6661014556884766
        },
        {
            "text": "HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease. Two affected HEXA",
            "probability": 0.00020798935201625656,
            "start_logit": 8.539693832397461,
            "end_logit": -0.8791008591651917
        },
        {
            "text": "Two mutated HEXA",
            "probability": 0.00020046692996311858,
            "start_logit": 0.025678085163235664,
            "end_logit": 7.598077297210693
        },
        {
            "text": "A",
            "probability": 0.00012694280262517122,
            "start_logit": -0.43123459815979004,
            "end_logit": 7.598077297210693
        },
        {
            "text": "mutated HEXA",
            "probability": 1.843587066337686e-05,
            "start_logit": -2.360672950744629,
            "end_logit": 7.598077297210693
        },
        {
            "text": "Two affected HEXA",
            "probability": 8.418084117245854e-06,
            "start_logit": -3.027017593383789,
            "end_logit": 7.48050594329834
        },
        {
            "text": "HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease. Two",
            "probability": 7.724201527595848e-06,
            "start_logit": 8.539693832397461,
            "end_logit": -4.172229290008545
        },
        {
            "text": "HEXA alleles",
            "probability": 4.752350089450415e-06,
            "start_logit": 8.501808166503906,
            "end_logit": -4.620062828063965
        },
        {
            "text": "HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease. Two affected",
            "probability": 4.395280789563796e-06,
            "start_logit": 8.539693832397461,
            "end_logit": -4.736056327819824
        },
        {
            "text": "affected HEXA",
            "probability": 3.443128619631948e-06,
            "start_logit": -3.9210193157196045,
            "end_logit": 7.48050594329834
        },
        {
            "text": "EXA",
            "probability": 2.4920120362601688e-06,
            "start_logit": -4.361880779266357,
            "end_logit": 7.598077297210693
        },
        {
            "text": "alleles in a Druze patient with late-infantile Tay-Sachs disease. Two affected HEXA",
            "probability": 9.583801298251823e-07,
            "start_logit": -5.199910640716553,
            "end_logit": 7.48050594329834
        },
        {
            "text": "HEX",
            "probability": 4.927837747571275e-07,
            "start_logit": 8.539693832397461,
            "end_logit": -6.924272537231445
        },
        {
            "text": "HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease.",
            "probability": 2.4931838799769923e-07,
            "start_logit": 8.539693832397461,
            "end_logit": -7.605612277984619
        },
        {
            "text": "HEXA alleles were found in an Israeli Druze Tay-Sachs",
            "probability": 2.4470736018970465e-07,
            "start_logit": 8.501808166503906,
            "end_logit": -7.586394309997559
        },
        {
            "text": "in a Druze patient with late-infantile Tay-Sachs disease. Two affected HEXA",
            "probability": 2.115153862045119e-07,
            "start_logit": -6.710857391357422,
            "end_logit": 7.48050594329834
        },
        {
            "text": "late-infantile Tay-Sachs disease. Two affected HEXA",
            "probability": 2.051679276578945e-07,
            "start_logit": -6.741326332092285,
            "end_logit": 7.48050594329834
        },
        {
            "text": "Tay-Sachs disease. Two affected HEXA",
            "probability": 1.9010069991085678e-07,
            "start_logit": -6.817601203918457,
            "end_logit": 7.48050594329834
        },
        {
            "text": "HEXA alleles were found",
            "probability": 1.8341512818154695e-07,
            "start_logit": 8.501808166503906,
            "end_logit": -7.8747053146362305
        }
    ],
    "536e46f27d100faa09000012_004": [
        {
            "text": "HEXA",
            "probability": 0.99756607101682,
            "start_logit": 7.878135681152344,
            "end_logit": 7.207425117492676
        },
        {
            "text": "Ten novel mutations in the HEXA",
            "probability": 0.0020080149718568192,
            "start_logit": 1.6699639558792114,
            "end_logit": 7.207425117492676
        },
        {
            "text": "H",
            "probability": 0.00024301605042907853,
            "start_logit": 7.878135681152344,
            "end_logit": -1.1125210523605347
        },
        {
            "text": "A",
            "probability": 0.0001533452146410917,
            "start_logit": -0.9022462964057922,
            "end_logit": 7.207425117492676
        },
        {
            "text": "EXA",
            "probability": 8.480846409931155e-06,
            "start_logit": -3.7971277236938477,
            "end_logit": 7.207425117492676
        },
        {
            "text": "novel mutations in the HEXA",
            "probability": 7.808917948840652e-06,
            "start_logit": -3.879671573638916,
            "end_logit": 7.207425117492676
        },
        {
            "text": "mutations in the HEXA",
            "probability": 3.7632576739779136e-06,
            "start_logit": -4.609652996063232,
            "end_logit": 7.207425117492676
        },
        {
            "text": "HEXA gene",
            "probability": 2.9478671070096794e-06,
            "start_logit": 7.878135681152344,
            "end_logit": -5.524566650390625
        },
        {
            "text": "the HEXA",
            "probability": 2.8973694032918436e-06,
            "start_logit": -4.8711347579956055,
            "end_logit": 7.207425117492676
        },
        {
            "text": "Ten",
            "probability": 1.6490495131932348e-06,
            "start_logit": 1.6699639558792114,
            "end_logit": 0.10272224992513657
        },
        {
            "text": "HEX",
            "probability": 5.800610528959101e-07,
            "start_logit": 7.878135681152344,
            "end_logit": -7.150270462036133
        },
        {
            "text": "HEXA gene in non-Jewish Tay-Sachs patients. The heterogeneity of mutations",
            "probability": 5.799722728034746e-07,
            "start_logit": 7.878135681152344,
            "end_logit": -7.150423526763916
        },
        {
            "text": "HEXA gene in non-Jewish Tay-Sachs patients. The heterogeneity",
            "probability": 2.612264503365174e-07,
            "start_logit": 7.878135681152344,
            "end_logit": -7.948016166687012
        },
        {
            "text": "in the HEXA",
            "probability": 2.089861373394554e-07,
            "start_logit": -7.500425338745117,
            "end_logit": 7.207425117492676
        },
        {
            "text": "HEXA gene in non-Jewish Tay-Sachs patients. The heterogeneity of mutations causing",
            "probability": 1.6217583569682102e-07,
            "start_logit": 7.878135681152344,
            "end_logit": -8.424722671508789
        },
        {
            "text": "HEXA gene in non-Jewish Tay-Sachs",
            "probability": 1.2045243303337236e-07,
            "start_logit": 7.878135681152344,
            "end_logit": -8.722148895263672
        },
        {
            "text": "Ten novel mutations",
            "probability": 8.249165421061849e-08,
            "start_logit": 1.6699639558792114,
            "end_logit": -2.8925349712371826
        },
        {
            "text": "Ten novel mutations in the HEXA gene",
            "probability": 5.93380374282986e-09,
            "start_logit": 1.6699639558792114,
            "end_logit": -5.524566650390625
        },
        {
            "text": "Ten novel",
            "probability": 3.612730771523824e-09,
            "start_logit": 1.6699639558792114,
            "end_logit": -6.020768165588379
        },
        {
            "text": "Ten novel mutations in the HEXA gene in non-Jewish Tay-Sachs patients. The heterogeneity",
            "probability": 5.258264475515571e-10,
            "start_logit": 1.6699639558792114,
            "end_logit": -7.948016166687012
        }
    ],
    "536e46f27d100faa09000012_005": [
        {
            "text": "HEXA",
            "probability": 0.9996064689648612,
            "start_logit": 9.1375150680542,
            "end_logit": 8.45089054107666
        },
        {
            "text": "H",
            "probability": 0.00023339528813051707,
            "start_logit": 9.1375150680542,
            "end_logit": 0.08850712329149246
        },
        {
            "text": "A",
            "probability": 0.00014432764390855888,
            "start_logit": 0.29448413848876953,
            "end_logit": 8.45089054107666
        },
        {
            "text": "the HEXA",
            "probability": 8.375845040456205e-06,
            "start_logit": -2.5522499084472656,
            "end_logit": 8.45089054107666
        },
        {
            "text": "resulting from mutation of the HEXA",
            "probability": 2.8290889371089595e-06,
            "start_logit": -3.6376471519470215,
            "end_logit": 8.45089054107666
        },
        {
            "text": "EXA",
            "probability": 2.3579715646546945e-06,
            "start_logit": -3.8198001384735107,
            "end_logit": 8.45089054107666
        },
        {
            "text": "HEX",
            "probability": 6.658613314994908e-07,
            "start_logit": 9.1375150680542,
            "end_logit": -5.770900249481201
        },
        {
            "text": "autosomal recessive genetic disorder resulting from mutation of the HEXA",
            "probability": 4.7549152113628373e-07,
            "start_logit": -5.421008110046387,
            "end_logit": 8.45089054107666
        },
        {
            "text": "of the HEXA",
            "probability": 3.098969681258384e-07,
            "start_logit": -5.849117279052734,
            "end_logit": 8.45089054107666
        },
        {
            "text": "HEXA gene encoding",
            "probability": 3.0664912061130113e-07,
            "start_logit": 9.1375150680542,
            "end_logit": -6.5462775230407715
        },
        {
            "text": "HEXA gene",
            "probability": 2.5053846721248416e-07,
            "start_logit": 9.1375150680542,
            "end_logit": -6.748369216918945
        },
        {
            "text": "mutation of the HEXA",
            "probability": 2.3667877995812327e-07,
            "start_logit": -6.118653297424316,
            "end_logit": 8.45089054107666
        },
        {
            "text": "HEXA gene encoding the alpha-subunit of the lysosomal enzyme, beta-N-acetylhexosaminidase A",
            "probability": 6.775626892529135e-11,
            "start_logit": 0.29448413848876953,
            "end_logit": -6.120789051055908
        },
        {
            "text": "the HEXA gene encoding",
            "probability": 2.569456676978259e-12,
            "start_logit": -2.5522499084472656,
            "end_logit": -6.5462775230407715
        },
        {
            "text": "encoding the alpha-subunit of the lysosomal enzyme, beta-N-acetylhexosaminidase A",
            "probability": 2.4842430687295566e-12,
            "start_logit": -3.011464834213257,
            "end_logit": -6.120789051055908
        },
        {
            "text": "the HEXA gene",
            "probability": 2.0992975167700238e-12,
            "start_logit": -2.5522499084472656,
            "end_logit": -6.748369216918945
        },
        {
            "text": "resulting from",
            "probability": 2.0212288397418343e-12,
            "start_logit": -3.6376471519470215,
            "end_logit": -5.700869083404541
        },
        {
            "text": "encoding",
            "probability": 1.6233299123704944e-12,
            "start_logit": -3.011464834213257,
            "end_logit": -6.5462775230407715
        },
        {
            "text": "EX",
            "probability": 1.570700204956462e-12,
            "start_logit": -3.8198001384735107,
            "end_logit": -5.770900249481201
        },
        {
            "text": "resulting from mutation",
            "probability": 1.2447603162912032e-12,
            "start_logit": -3.6376471519470215,
            "end_logit": -6.18563175201416
        }
    ],
    "536e46f27d100faa09000012_006": [
        {
            "text": "HEXA",
            "probability": 0.9994927766593714,
            "start_logit": 8.600119590759277,
            "end_logit": 7.819540977478027
        },
        {
            "text": "H",
            "probability": 0.00014797693459587752,
            "start_logit": 8.600119590759277,
            "end_logit": -0.9984058141708374
        },
        {
            "text": "A",
            "probability": 0.00012574395768428202,
            "start_logit": -0.3806358575820923,
            "end_logit": 7.819540977478027
        },
        {
            "text": "HEXA gene",
            "probability": 9.605425642655677e-05,
            "start_logit": 8.600119590759277,
            "end_logit": -1.4305490255355835
        },
        {
            "text": "HEXA gene.",
            "probability": 4.1638458405925764e-05,
            "start_logit": 8.431638717651367,
            "end_logit": -2.097957134246826
        },
        {
            "text": "caused by mutations in the HEXA",
            "probability": 2.7717787174364136e-05,
            "start_logit": -1.6970499753952026,
            "end_logit": 7.623781681060791
        },
        {
            "text": "the HEXA",
            "probability": 2.57188887172125e-05,
            "start_logit": -1.771898627281189,
            "end_logit": 7.623781681060791
        },
        {
            "text": "novel mutations in HEXA",
            "probability": 1.745196998358458e-05,
            "start_logit": -2.355431079864502,
            "end_logit": 7.819540977478027
        },
        {
            "text": "Identification of novel mutations in HEXA",
            "probability": 1.2097907511627428e-05,
            "start_logit": -2.721851110458374,
            "end_logit": 7.819540977478027
        },
        {
            "text": "EXA",
            "probability": 3.2306520939152894e-06,
            "start_logit": -4.042199611663818,
            "end_logit": 7.819540977478027
        },
        {
            "text": "due to \u03b2-hexosaminidase A deficiency caused by mutations in the HEXA",
            "probability": 2.4481663110061876e-06,
            "start_logit": -4.123785018920898,
            "end_logit": 7.623781681060791
        },
        {
            "text": "HEXA gene. The mutations",
            "probability": 2.2277822966542044e-06,
            "start_logit": 8.431638717651367,
            "end_logit": -5.025974750518799
        },
        {
            "text": "mutations in HEXA",
            "probability": 1.5138967676806401e-06,
            "start_logit": -4.800196647644043,
            "end_logit": 7.819540977478027
        },
        {
            "text": "mutations in the HEXA",
            "probability": 7.964421650491821e-07,
            "start_logit": -5.246725082397461,
            "end_logit": 7.623781681060791
        },
        {
            "text": "of novel mutations in HEXA",
            "probability": 7.414155250985419e-07,
            "start_logit": -5.514077663421631,
            "end_logit": 7.819540977478027
        },
        {
            "text": "HEXA gene. The",
            "probability": 6.593632183599623e-07,
            "start_logit": 8.431638717651367,
            "end_logit": -6.243462085723877
        },
        {
            "text": "deficiency caused by mutations in the HEXA",
            "probability": 6.415266265979634e-07,
            "start_logit": -5.463028907775879,
            "end_logit": 7.623781681060791
        },
        {
            "text": "HEX",
            "probability": 5.605958231123669e-07,
            "start_logit": 8.431638717651367,
            "end_logit": -6.405736446380615
        },
        {
            "text": "novel mutations in HEXA gene",
            "probability": 1.6771867081967941e-09,
            "start_logit": -2.355431079864502,
            "end_logit": -1.4305490255355835
        },
        {
            "text": "caused by mutations in the HEXA gene.",
            "probability": 1.6621148658061862e-09,
            "start_logit": -1.6970499753952026,
            "end_logit": -2.097957134246826
        }
    ],
    "536e46f27d100faa09000012_007": [
        {
            "text": "HEXA",
            "probability": 0.9995123537730083,
            "start_logit": 8.902278900146484,
            "end_logit": 7.99023962020874
        },
        {
            "text": "H",
            "probability": 0.0001996677603636536,
            "start_logit": 8.902278900146484,
            "end_logit": -0.5281283855438232
        },
        {
            "text": "A",
            "probability": 0.00013244481670331585,
            "start_logit": -0.026577811688184738,
            "end_logit": 7.99023962020874
        },
        {
            "text": "HEXA gene.",
            "probability": 0.00010122071779984601,
            "start_logit": 8.902278900146484,
            "end_logit": -1.20747971534729
        },
        {
            "text": "the HEXA",
            "probability": 2.5154032696262642e-05,
            "start_logit": -1.6877256631851196,
            "end_logit": 7.99023962020874
        },
        {
            "text": "HEXA gene",
            "probability": 1.890833252528611e-05,
            "start_logit": 8.80246639251709,
            "end_logit": -2.785367965698242
        },
        {
            "text": "Molecular analysis of HEXA",
            "probability": 3.214037708622895e-06,
            "start_logit": -3.566385269165039,
            "end_logit": 7.811408996582031
        },
        {
            "text": "EXA",
            "probability": 2.3208557115197373e-06,
            "start_logit": -4.070807933807373,
            "end_logit": 7.99023962020874
        },
        {
            "text": "due to mutations in the HEXA",
            "probability": 2.0470251566264887e-06,
            "start_logit": -4.196356296539307,
            "end_logit": 7.99023962020874
        },
        {
            "text": "of HEXA",
            "probability": 5.134447872822789e-07,
            "start_logit": -5.40052604675293,
            "end_logit": 7.811408996582031
        },
        {
            "text": "HEX",
            "probability": 4.546032444162386e-07,
            "start_logit": 8.902278900146484,
            "end_logit": -6.6131134033203125
        },
        {
            "text": "HEXA gene in Argentinean patients affected with Tay-Sachs disease:",
            "probability": 3.8665935209243806e-07,
            "start_logit": 8.80246639251709,
            "end_logit": -6.675181865692139
        },
        {
            "text": "mutations in the HEXA",
            "probability": 3.229244403018983e-07,
            "start_logit": -6.043080806732178,
            "end_logit": 7.99023962020874
        },
        {
            "text": "HEXA gene in Argentinean patients affected with Tay-Sachs disease: possible",
            "probability": 2.7873238076716215e-07,
            "start_logit": 8.80246639251709,
            "end_logit": -7.002473831176758
        },
        {
            "text": "caused by the deficient activity of hexosaminidase A due to mutations in the HEXA",
            "probability": 2.5624871824692455e-07,
            "start_logit": -6.274350643157959,
            "end_logit": 7.99023962020874
        },
        {
            "text": "in the HEXA",
            "probability": 2.5057748059094035e-07,
            "start_logit": -6.296730995178223,
            "end_logit": 7.99023962020874
        },
        {
            "text": "HEXA gene in Argentinean patients affected with Tay-Sachs disease: possible common origin",
            "probability": 2.0262292901378126e-07,
            "start_logit": 8.80246639251709,
            "end_logit": -7.3213791847229
        },
        {
            "text": "the HEXA gene.",
            "probability": 2.5473514514005983e-09,
            "start_logit": -1.6877256631851196,
            "end_logit": -1.20747971534729
        },
        {
            "text": "due to mutations in the HEXA gene.",
            "probability": 2.0730244596369574e-10,
            "start_logit": -4.196356296539307,
            "end_logit": -1.20747971534729
        },
        {
            "text": "Molecular analysis of HEXA gene",
            "probability": 8.033951527921696e-11,
            "start_logit": -3.566385269165039,
            "end_logit": -2.785367965698242
        }
    ],
    "536e46f27d100faa09000012_008": [
        {
            "text": "HEXA",
            "probability": 0.9995123537730083,
            "start_logit": 8.902278900146484,
            "end_logit": 7.99023962020874
        },
        {
            "text": "H",
            "probability": 0.0001996677603636536,
            "start_logit": 8.902278900146484,
            "end_logit": -0.5281283855438232
        },
        {
            "text": "A",
            "probability": 0.00013244481670331585,
            "start_logit": -0.026577811688184738,
            "end_logit": 7.99023962020874
        },
        {
            "text": "HEXA gene.",
            "probability": 0.00010122071779984601,
            "start_logit": 8.902278900146484,
            "end_logit": -1.20747971534729
        },
        {
            "text": "the HEXA",
            "probability": 2.5154032696262642e-05,
            "start_logit": -1.6877256631851196,
            "end_logit": 7.99023962020874
        },
        {
            "text": "HEXA gene",
            "probability": 1.890833252528611e-05,
            "start_logit": 8.80246639251709,
            "end_logit": -2.785367965698242
        },
        {
            "text": "Molecular analysis of HEXA",
            "probability": 3.214037708622895e-06,
            "start_logit": -3.566385269165039,
            "end_logit": 7.811408996582031
        },
        {
            "text": "EXA",
            "probability": 2.3208557115197373e-06,
            "start_logit": -4.070807933807373,
            "end_logit": 7.99023962020874
        },
        {
            "text": "due to mutations in the HEXA",
            "probability": 2.0470251566264887e-06,
            "start_logit": -4.196356296539307,
            "end_logit": 7.99023962020874
        },
        {
            "text": "of HEXA",
            "probability": 5.134447872822789e-07,
            "start_logit": -5.40052604675293,
            "end_logit": 7.811408996582031
        },
        {
            "text": "HEX",
            "probability": 4.546032444162386e-07,
            "start_logit": 8.902278900146484,
            "end_logit": -6.6131134033203125
        },
        {
            "text": "HEXA gene in Argentinean patients affected with Tay-Sachs disease:",
            "probability": 3.8665935209243806e-07,
            "start_logit": 8.80246639251709,
            "end_logit": -6.675181865692139
        },
        {
            "text": "mutations in the HEXA",
            "probability": 3.229244403018983e-07,
            "start_logit": -6.043080806732178,
            "end_logit": 7.99023962020874
        },
        {
            "text": "HEXA gene in Argentinean patients affected with Tay-Sachs disease: possible",
            "probability": 2.7873238076716215e-07,
            "start_logit": 8.80246639251709,
            "end_logit": -7.002473831176758
        },
        {
            "text": "caused by the deficient activity of hexosaminidase A due to mutations in the HEXA",
            "probability": 2.5624871824692455e-07,
            "start_logit": -6.274350643157959,
            "end_logit": 7.99023962020874
        },
        {
            "text": "in the HEXA",
            "probability": 2.5057748059094035e-07,
            "start_logit": -6.296730995178223,
            "end_logit": 7.99023962020874
        },
        {
            "text": "HEXA gene in Argentinean patients affected with Tay-Sachs disease: possible common origin",
            "probability": 2.0262292901378126e-07,
            "start_logit": 8.80246639251709,
            "end_logit": -7.3213791847229
        },
        {
            "text": "the HEXA gene.",
            "probability": 2.5473514514005983e-09,
            "start_logit": -1.6877256631851196,
            "end_logit": -1.20747971534729
        },
        {
            "text": "due to mutations in the HEXA gene.",
            "probability": 2.0730244596369574e-10,
            "start_logit": -4.196356296539307,
            "end_logit": -1.20747971534729
        },
        {
            "text": "Molecular analysis of HEXA gene",
            "probability": 8.033951527921696e-11,
            "start_logit": -3.566385269165039,
            "end_logit": -2.785367965698242
        }
    ],
    "536e46f27d100faa09000012_009": [
        {
            "text": "HEXA",
            "probability": 0.9994874433906267,
            "start_logit": 9.07747745513916,
            "end_logit": 8.640071868896484
        },
        {
            "text": "H",
            "probability": 0.00021608504252085611,
            "start_logit": 9.07747745513916,
            "end_logit": 0.20074604451656342
        },
        {
            "text": "A",
            "probability": 0.00018793550473210314,
            "start_logit": 0.49857842922210693,
            "end_logit": 8.640071868896484
        },
        {
            "text": "HEXA gene",
            "probability": 7.321772662336356e-05,
            "start_logit": 9.07747745513916,
            "end_logit": -0.8814884424209595
        },
        {
            "text": "Specific mutations in the HEXA",
            "probability": 2.0886195662371735e-05,
            "start_logit": -1.6984319686889648,
            "end_logit": 8.640071868896484
        },
        {
            "text": "the HEXA",
            "probability": 6.5581522323175184e-06,
            "start_logit": -2.8568115234375,
            "end_logit": 8.640071868896484
        },
        {
            "text": "EXA",
            "probability": 4.576569953264183e-06,
            "start_logit": -3.2165706157684326,
            "end_logit": 8.640071868896484
        },
        {
            "text": "HEXA gene among Iraqi Jewish Tay-Sachs disease carriers:",
            "probability": 2.0108635355751096e-06,
            "start_logit": 9.07747745513916,
            "end_logit": -4.4763617515563965
        },
        {
            "text": "mutations in the HEXA",
            "probability": 6.490193540940943e-07,
            "start_logit": -5.16981315612793,
            "end_logit": 8.640071868896484
        },
        {
            "text": "HEX",
            "probability": 2.2156033564901168e-07,
            "start_logit": 9.07747745513916,
            "end_logit": -6.681986331939697
        },
        {
            "text": "HEXA gene among Iraqi",
            "probability": 1.7387692261730816e-07,
            "start_logit": 9.07747745513916,
            "end_logit": -6.924333572387695
        },
        {
            "text": "HEXA gene among Iraqi Jewish Tay-Sachs disease",
            "probability": 1.587878254565925e-07,
            "start_logit": 9.07747745513916,
            "end_logit": -7.015112400054932
        },
        {
            "text": "HEXA gene among Iraqi Jewish Tay-Sachs",
            "probability": 8.083155843538406e-08,
            "start_logit": 9.07747745513916,
            "end_logit": -7.690313816070557
        },
        {
            "text": "Specific mutations in the HEXA gene",
            "probability": 1.5300239881172247e-09,
            "start_logit": -1.6984319686889648,
            "end_logit": -0.8814884424209595
        },
        {
            "text": "the HEXA gene",
            "probability": 4.804192393566279e-10,
            "start_logit": -2.8568115234375,
            "end_logit": -0.8814884424209595
        },
        {
            "text": "Specific mutations",
            "probability": 2.1640001280383942e-10,
            "start_logit": -1.6984319686889648,
            "end_logit": -2.8373985290527344
        },
        {
            "text": "Specific",
            "probability": 1.3600414991517558e-10,
            "start_logit": -1.6984319686889648,
            "end_logit": -3.3018417358398438
        },
        {
            "text": "mutations in the HEXA gene",
            "probability": 4.7544090679247684e-11,
            "start_logit": -5.16981315612793,
            "end_logit": -0.8814884424209595
        },
        {
            "text": "Specific mutations in the HEXA gene among Iraqi Jewish Tay-Sachs disease carriers:",
            "probability": 4.202082730711794e-11,
            "start_logit": -1.6984319686889648,
            "end_logit": -4.4763617515563965
        },
        {
            "text": "1:29",
            "probability": 2.570557875528842e-11,
            "start_logit": -1.9523290395736694,
            "end_logit": -4.713922023773193
        }
    ],
    "536e46f27d100faa09000012_010": [
        {
            "text": "HEXA",
            "probability": 0.9991548419204734,
            "start_logit": 8.539693832397461,
            "end_logit": 7.598077297210693
        },
        {
            "text": "H",
            "probability": 0.00025736267828414204,
            "start_logit": 8.539693832397461,
            "end_logit": -0.6661014556884766
        },
        {
            "text": "HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease. Two affected HEXA",
            "probability": 0.00020798935201625656,
            "start_logit": 8.539693832397461,
            "end_logit": -0.8791008591651917
        },
        {
            "text": "Two mutated HEXA",
            "probability": 0.00020046692996311858,
            "start_logit": 0.025678085163235664,
            "end_logit": 7.598077297210693
        },
        {
            "text": "A",
            "probability": 0.00012694280262517122,
            "start_logit": -0.43123459815979004,
            "end_logit": 7.598077297210693
        },
        {
            "text": "mutated HEXA",
            "probability": 1.843587066337686e-05,
            "start_logit": -2.360672950744629,
            "end_logit": 7.598077297210693
        },
        {
            "text": "Two affected HEXA",
            "probability": 8.418084117245854e-06,
            "start_logit": -3.027017593383789,
            "end_logit": 7.48050594329834
        },
        {
            "text": "HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease. Two",
            "probability": 7.724201527595848e-06,
            "start_logit": 8.539693832397461,
            "end_logit": -4.172229290008545
        },
        {
            "text": "HEXA alleles",
            "probability": 4.752350089450415e-06,
            "start_logit": 8.501808166503906,
            "end_logit": -4.620062828063965
        },
        {
            "text": "HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease. Two affected",
            "probability": 4.395280789563796e-06,
            "start_logit": 8.539693832397461,
            "end_logit": -4.736056327819824
        },
        {
            "text": "affected HEXA",
            "probability": 3.443128619631948e-06,
            "start_logit": -3.9210193157196045,
            "end_logit": 7.48050594329834
        },
        {
            "text": "EXA",
            "probability": 2.4920120362601688e-06,
            "start_logit": -4.361880779266357,
            "end_logit": 7.598077297210693
        },
        {
            "text": "alleles in a Druze patient with late-infantile Tay-Sachs disease. Two affected HEXA",
            "probability": 9.583801298251823e-07,
            "start_logit": -5.199910640716553,
            "end_logit": 7.48050594329834
        },
        {
            "text": "HEX",
            "probability": 4.927837747571275e-07,
            "start_logit": 8.539693832397461,
            "end_logit": -6.924272537231445
        },
        {
            "text": "HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease.",
            "probability": 2.4931838799769923e-07,
            "start_logit": 8.539693832397461,
            "end_logit": -7.605612277984619
        },
        {
            "text": "HEXA alleles were found in an Israeli Druze Tay-Sachs",
            "probability": 2.4470736018970465e-07,
            "start_logit": 8.501808166503906,
            "end_logit": -7.586394309997559
        },
        {
            "text": "in a Druze patient with late-infantile Tay-Sachs disease. Two affected HEXA",
            "probability": 2.115153862045119e-07,
            "start_logit": -6.710857391357422,
            "end_logit": 7.48050594329834
        },
        {
            "text": "late-infantile Tay-Sachs disease. Two affected HEXA",
            "probability": 2.051679276578945e-07,
            "start_logit": -6.741326332092285,
            "end_logit": 7.48050594329834
        },
        {
            "text": "Tay-Sachs disease. Two affected HEXA",
            "probability": 1.9010069991085678e-07,
            "start_logit": -6.817601203918457,
            "end_logit": 7.48050594329834
        },
        {
            "text": "HEXA alleles were found",
            "probability": 1.8341512818154695e-07,
            "start_logit": 8.501808166503906,
            "end_logit": -7.8747053146362305
        }
    ],
    "536e46f27d100faa09000012_011": [
        {
            "text": "HEXA",
            "probability": 0.9992779160837122,
            "start_logit": 8.745765686035156,
            "end_logit": 8.236335754394531
        },
        {
            "text": "three mutations in the beta-hexoseaminidase A (HEXA)",
            "probability": 0.000472184802189135,
            "start_logit": 1.0883479118347168,
            "end_logit": 8.236335754394531
        },
        {
            "text": "H",
            "probability": 0.000123033805826211,
            "start_logit": 8.745765686035156,
            "end_logit": -0.7659932971000671
        },
        {
            "text": "A",
            "probability": 0.00010353060164355096,
            "start_logit": -0.42915529012680054,
            "end_logit": 8.236335754394531
        },
        {
            "text": "A (HEXA)",
            "probability": 1.4094198642370811e-05,
            "start_logit": -2.4232592582702637,
            "end_logit": 8.236335754394531
        },
        {
            "text": "EXA",
            "probability": 3.6857902544191584e-06,
            "start_logit": -3.7645375728607178,
            "end_logit": 8.236335754394531
        },
        {
            "text": "(HEXA)",
            "probability": 2.064635139948944e-06,
            "start_logit": -4.344069004058838,
            "end_logit": 8.236335754394531
        },
        {
            "text": "reduced level of HEXA",
            "probability": 9.264752163474464e-07,
            "start_logit": -4.996189117431641,
            "end_logit": 8.08713436126709
        },
        {
            "text": "exhibited a reduced level of HEXA",
            "probability": 4.425415320815558e-07,
            "start_logit": -5.735042095184326,
            "end_logit": 8.08713436126709
        },
        {
            "text": "three mutations in the beta-hexoseaminidase A",
            "probability": 4.372762858325786e-07,
            "start_logit": 1.0883479118347168,
            "end_logit": 1.2517752647399902
        },
        {
            "text": "identified three mutations in the beta-hexoseaminidase A (HEXA)",
            "probability": 4.030971937837443e-07,
            "start_logit": -5.97760009765625,
            "end_logit": 8.236335754394531
        },
        {
            "text": "HEX",
            "probability": 3.4782819480501146e-07,
            "start_logit": 8.745765686035156,
            "end_logit": -6.6344990730285645
        },
        {
            "text": "(HEXA) gene",
            "probability": 2.756653438266584e-07,
            "start_logit": 8.745765686035156,
            "end_logit": -6.867020130157471
        },
        {
            "text": "a reduced level of HEXA",
            "probability": 2.62858396735218e-07,
            "start_logit": -6.255960941314697,
            "end_logit": 8.08713436126709
        },
        {
            "text": "level of HEXA",
            "probability": 2.443920816025236e-07,
            "start_logit": -6.328802585601807,
            "end_logit": 8.08713436126709
        },
        {
            "text": "three",
            "probability": 1.4342428828186616e-07,
            "start_logit": 1.0883479118347168,
            "end_logit": 0.13701732456684113
        },
        {
            "text": "HEXA identified in a juvenile Tay-Sachs patient: role of alternative splicing",
            "probability": 5.58640903480327e-09,
            "start_logit": 5.165088653564453,
            "end_logit": -7.18519401550293
        },
        {
            "text": "three mutations",
            "probability": 4.3409434466889616e-10,
            "start_logit": 1.0883479118347168,
            "end_logit": -5.663283348083496
        },
        {
            "text": "identified three mutations in the beta-hexoseaminidase A",
            "probability": 3.7329630879709575e-10,
            "start_logit": -5.97760009765625,
            "end_logit": 1.2517752647399902
        },
        {
            "text": "three mutations in the beta-hexoseaminidase A (HEXA) gene",
            "probability": 1.302590438056737e-10,
            "start_logit": 1.0883479118347168,
            "end_logit": -6.867020130157471
        }
    ],
    "536e46f27d100faa09000012_012": [
        {
            "text": "HEXA",
            "probability": 0.9992779160837122,
            "start_logit": 8.745765686035156,
            "end_logit": 8.236335754394531
        },
        {
            "text": "three mutations in the beta-hexoseaminidase A (HEXA)",
            "probability": 0.000472184802189135,
            "start_logit": 1.0883479118347168,
            "end_logit": 8.236335754394531
        },
        {
            "text": "H",
            "probability": 0.000123033805826211,
            "start_logit": 8.745765686035156,
            "end_logit": -0.7659932971000671
        },
        {
            "text": "A",
            "probability": 0.00010353060164355096,
            "start_logit": -0.42915529012680054,
            "end_logit": 8.236335754394531
        },
        {
            "text": "A (HEXA)",
            "probability": 1.4094198642370811e-05,
            "start_logit": -2.4232592582702637,
            "end_logit": 8.236335754394531
        },
        {
            "text": "EXA",
            "probability": 3.6857902544191584e-06,
            "start_logit": -3.7645375728607178,
            "end_logit": 8.236335754394531
        },
        {
            "text": "(HEXA)",
            "probability": 2.064635139948944e-06,
            "start_logit": -4.344069004058838,
            "end_logit": 8.236335754394531
        },
        {
            "text": "reduced level of HEXA",
            "probability": 9.264752163474464e-07,
            "start_logit": -4.996189117431641,
            "end_logit": 8.08713436126709
        },
        {
            "text": "exhibited a reduced level of HEXA",
            "probability": 4.425415320815558e-07,
            "start_logit": -5.735042095184326,
            "end_logit": 8.08713436126709
        },
        {
            "text": "three mutations in the beta-hexoseaminidase A",
            "probability": 4.372762858325786e-07,
            "start_logit": 1.0883479118347168,
            "end_logit": 1.2517752647399902
        },
        {
            "text": "identified three mutations in the beta-hexoseaminidase A (HEXA)",
            "probability": 4.030971937837443e-07,
            "start_logit": -5.97760009765625,
            "end_logit": 8.236335754394531
        },
        {
            "text": "HEX",
            "probability": 3.4782819480501146e-07,
            "start_logit": 8.745765686035156,
            "end_logit": -6.6344990730285645
        },
        {
            "text": "(HEXA) gene",
            "probability": 2.756653438266584e-07,
            "start_logit": 8.745765686035156,
            "end_logit": -6.867020130157471
        },
        {
            "text": "a reduced level of HEXA",
            "probability": 2.62858396735218e-07,
            "start_logit": -6.255960941314697,
            "end_logit": 8.08713436126709
        },
        {
            "text": "level of HEXA",
            "probability": 2.443920816025236e-07,
            "start_logit": -6.328802585601807,
            "end_logit": 8.08713436126709
        },
        {
            "text": "three",
            "probability": 1.4342428828186616e-07,
            "start_logit": 1.0883479118347168,
            "end_logit": 0.13701732456684113
        },
        {
            "text": "HEXA identified in a juvenile Tay-Sachs patient: role of alternative splicing",
            "probability": 5.58640903480327e-09,
            "start_logit": 5.165088653564453,
            "end_logit": -7.18519401550293
        },
        {
            "text": "three mutations",
            "probability": 4.3409434466889616e-10,
            "start_logit": 1.0883479118347168,
            "end_logit": -5.663283348083496
        },
        {
            "text": "identified three mutations in the beta-hexoseaminidase A",
            "probability": 3.7329630879709575e-10,
            "start_logit": -5.97760009765625,
            "end_logit": 1.2517752647399902
        },
        {
            "text": "three mutations in the beta-hexoseaminidase A (HEXA) gene",
            "probability": 1.302590438056737e-10,
            "start_logit": 1.0883479118347168,
            "end_logit": -6.867020130157471
        }
    ],
    "536e46f27d100faa09000012_013": [
        {
            "text": "HEXA",
            "probability": 0.9994874433906267,
            "start_logit": 9.07747745513916,
            "end_logit": 8.640071868896484
        },
        {
            "text": "H",
            "probability": 0.00021608504252085611,
            "start_logit": 9.07747745513916,
            "end_logit": 0.20074604451656342
        },
        {
            "text": "A",
            "probability": 0.00018793550473210314,
            "start_logit": 0.49857842922210693,
            "end_logit": 8.640071868896484
        },
        {
            "text": "HEXA gene",
            "probability": 7.321772662336356e-05,
            "start_logit": 9.07747745513916,
            "end_logit": -0.8814884424209595
        },
        {
            "text": "Specific mutations in the HEXA",
            "probability": 2.0886195662371735e-05,
            "start_logit": -1.6984319686889648,
            "end_logit": 8.640071868896484
        },
        {
            "text": "the HEXA",
            "probability": 6.5581522323175184e-06,
            "start_logit": -2.8568115234375,
            "end_logit": 8.640071868896484
        },
        {
            "text": "EXA",
            "probability": 4.576569953264183e-06,
            "start_logit": -3.2165706157684326,
            "end_logit": 8.640071868896484
        },
        {
            "text": "HEXA gene among Iraqi Jewish Tay-Sachs disease carriers:",
            "probability": 2.0108635355751096e-06,
            "start_logit": 9.07747745513916,
            "end_logit": -4.4763617515563965
        },
        {
            "text": "mutations in the HEXA",
            "probability": 6.490193540940943e-07,
            "start_logit": -5.16981315612793,
            "end_logit": 8.640071868896484
        },
        {
            "text": "HEX",
            "probability": 2.2156033564901168e-07,
            "start_logit": 9.07747745513916,
            "end_logit": -6.681986331939697
        },
        {
            "text": "HEXA gene among Iraqi",
            "probability": 1.7387692261730816e-07,
            "start_logit": 9.07747745513916,
            "end_logit": -6.924333572387695
        },
        {
            "text": "HEXA gene among Iraqi Jewish Tay-Sachs disease",
            "probability": 1.587878254565925e-07,
            "start_logit": 9.07747745513916,
            "end_logit": -7.015112400054932
        },
        {
            "text": "HEXA gene among Iraqi Jewish Tay-Sachs",
            "probability": 8.083155843538406e-08,
            "start_logit": 9.07747745513916,
            "end_logit": -7.690313816070557
        },
        {
            "text": "Specific mutations in the HEXA gene",
            "probability": 1.5300239881172247e-09,
            "start_logit": -1.6984319686889648,
            "end_logit": -0.8814884424209595
        },
        {
            "text": "the HEXA gene",
            "probability": 4.804192393566279e-10,
            "start_logit": -2.8568115234375,
            "end_logit": -0.8814884424209595
        },
        {
            "text": "Specific mutations",
            "probability": 2.1640001280383942e-10,
            "start_logit": -1.6984319686889648,
            "end_logit": -2.8373985290527344
        },
        {
            "text": "Specific",
            "probability": 1.3600414991517558e-10,
            "start_logit": -1.6984319686889648,
            "end_logit": -3.3018417358398438
        },
        {
            "text": "mutations in the HEXA gene",
            "probability": 4.7544090679247684e-11,
            "start_logit": -5.16981315612793,
            "end_logit": -0.8814884424209595
        },
        {
            "text": "Specific mutations in the HEXA gene among Iraqi Jewish Tay-Sachs disease carriers:",
            "probability": 4.202082730711794e-11,
            "start_logit": -1.6984319686889648,
            "end_logit": -4.4763617515563965
        },
        {
            "text": "1:29",
            "probability": 2.570557875528842e-11,
            "start_logit": -1.9523290395736694,
            "end_logit": -4.713922023773193
        }
    ],
    "536e46f27d100faa09000012_016": [
        {
            "text": "HEXA",
            "probability": 0.9991548419204734,
            "start_logit": 8.539693832397461,
            "end_logit": 7.598077297210693
        },
        {
            "text": "H",
            "probability": 0.00025736267828414204,
            "start_logit": 8.539693832397461,
            "end_logit": -0.6661014556884766
        },
        {
            "text": "HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease. Two affected HEXA",
            "probability": 0.00020798935201625656,
            "start_logit": 8.539693832397461,
            "end_logit": -0.8791008591651917
        },
        {
            "text": "Two mutated HEXA",
            "probability": 0.00020046692996311858,
            "start_logit": 0.025678085163235664,
            "end_logit": 7.598077297210693
        },
        {
            "text": "A",
            "probability": 0.00012694280262517122,
            "start_logit": -0.43123459815979004,
            "end_logit": 7.598077297210693
        },
        {
            "text": "mutated HEXA",
            "probability": 1.843587066337686e-05,
            "start_logit": -2.360672950744629,
            "end_logit": 7.598077297210693
        },
        {
            "text": "Two affected HEXA",
            "probability": 8.418084117245854e-06,
            "start_logit": -3.027017593383789,
            "end_logit": 7.48050594329834
        },
        {
            "text": "HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease. Two",
            "probability": 7.724201527595848e-06,
            "start_logit": 8.539693832397461,
            "end_logit": -4.172229290008545
        },
        {
            "text": "HEXA alleles",
            "probability": 4.752350089450415e-06,
            "start_logit": 8.501808166503906,
            "end_logit": -4.620062828063965
        },
        {
            "text": "HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease. Two affected",
            "probability": 4.395280789563796e-06,
            "start_logit": 8.539693832397461,
            "end_logit": -4.736056327819824
        },
        {
            "text": "affected HEXA",
            "probability": 3.443128619631948e-06,
            "start_logit": -3.9210193157196045,
            "end_logit": 7.48050594329834
        },
        {
            "text": "EXA",
            "probability": 2.4920120362601688e-06,
            "start_logit": -4.361880779266357,
            "end_logit": 7.598077297210693
        },
        {
            "text": "alleles in a Druze patient with late-infantile Tay-Sachs disease. Two affected HEXA",
            "probability": 9.583801298251823e-07,
            "start_logit": -5.199910640716553,
            "end_logit": 7.48050594329834
        },
        {
            "text": "HEX",
            "probability": 4.927837747571275e-07,
            "start_logit": 8.539693832397461,
            "end_logit": -6.924272537231445
        },
        {
            "text": "HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease.",
            "probability": 2.4931838799769923e-07,
            "start_logit": 8.539693832397461,
            "end_logit": -7.605612277984619
        },
        {
            "text": "HEXA alleles were found in an Israeli Druze Tay-Sachs",
            "probability": 2.4470736018970465e-07,
            "start_logit": 8.501808166503906,
            "end_logit": -7.586394309997559
        },
        {
            "text": "in a Druze patient with late-infantile Tay-Sachs disease. Two affected HEXA",
            "probability": 2.115153862045119e-07,
            "start_logit": -6.710857391357422,
            "end_logit": 7.48050594329834
        },
        {
            "text": "late-infantile Tay-Sachs disease. Two affected HEXA",
            "probability": 2.051679276578945e-07,
            "start_logit": -6.741326332092285,
            "end_logit": 7.48050594329834
        },
        {
            "text": "Tay-Sachs disease. Two affected HEXA",
            "probability": 1.9010069991085678e-07,
            "start_logit": -6.817601203918457,
            "end_logit": 7.48050594329834
        },
        {
            "text": "HEXA alleles were found",
            "probability": 1.8341512818154695e-07,
            "start_logit": 8.501808166503906,
            "end_logit": -7.8747053146362305
        }
    ],
    "53148a07dae131f847000002_001": [
        {
            "text": "hypothyroidism",
            "probability": 0.9995805558242986,
            "start_logit": 8.329345703125,
            "end_logit": 7.380064964294434
        },
        {
            "text": "hyp",
            "probability": 0.00025346016925163,
            "start_logit": 8.329345703125,
            "end_logit": -0.8998193740844727
        },
        {
            "text": "ism",
            "probability": 0.0001371090776559499,
            "start_logit": -0.5649685263633728,
            "end_logit": 7.380064964294434
        },
        {
            "text": "othyroidism",
            "probability": 1.982124908814235e-05,
            "start_logit": -2.498990774154663,
            "end_logit": 7.380064964294434
        },
        {
            "text": "hypothyroid",
            "probability": 3.70755534258769e-06,
            "start_logit": 8.329345703125,
            "end_logit": -5.124653339385986
        },
        {
            "text": "roidism",
            "probability": 2.847709197238381e-06,
            "start_logit": -4.439230442047119,
            "end_logit": 7.380064964294434
        },
        {
            "text": "hypothy",
            "probability": 1.2351094613141117e-06,
            "start_logit": 8.329345703125,
            "end_logit": -6.2238664627075195
        },
        {
            "text": "hypothyroidism and goiter.",
            "probability": 5.615600931011227e-07,
            "start_logit": 8.329345703125,
            "end_logit": -7.0120625495910645
        },
        {
            "text": "to hypothyroidism",
            "probability": 5.363758539279772e-07,
            "start_logit": -6.108665466308594,
            "end_logit": 7.380064964294434
        },
        {
            "text": "hypothyroidism and",
            "probability": 1.6434832564776024e-07,
            "start_logit": 8.329345703125,
            "end_logit": -8.240793228149414
        },
        {
            "text": "thyroid",
            "probability": 6.961728445235494e-10,
            "start_logit": -3.1725547313690186,
            "end_logit": -2.203038215637207
        },
        {
            "text": "thyroid.",
            "probability": 1.8588019696791065e-10,
            "start_logit": -2.6764605045318604,
            "end_logit": -4.019628047943115
        },
        {
            "text": "othyroid",
            "probability": 7.35192151601046e-11,
            "start_logit": -2.498990774154663,
            "end_logit": -5.124653339385986
        },
        {
            "text": "thyroid. Accordingly pendrin protein expression was again significantly increased by DOCA treatment in kidney, heart, lung and thyroid.",
            "probability": 2.9500662028807957e-11,
            "start_logit": -2.6764605045318604,
            "end_logit": -5.860317707061768
        },
        {
            "text": "othy",
            "probability": 2.4491685178529578e-11,
            "start_logit": -2.498990774154663,
            "end_logit": -6.2238664627075195
        },
        {
            "text": "roid",
            "probability": 1.0562469814802102e-11,
            "start_logit": -4.439230442047119,
            "end_logit": -5.124653339385986
        },
        {
            "text": "CONCLUSION: The observations reveal mineralocorticoid sensitivity of pendrin expression in kidney, heart, thyroid",
            "probability": 4.3400966054094e-13,
            "start_logit": -6.911625862121582,
            "end_logit": -5.8442535400390625
        },
        {
            "text": "and goiter.",
            "probability": 3.555452547188623e-13,
            "start_logit": -5.943231105804443,
            "end_logit": -7.0120625495910645
        },
        {
            "text": "to hypothyroidism and goiter.",
            "probability": 3.0133366712060554e-13,
            "start_logit": -6.108665466308594,
            "end_logit": -7.0120625495910645
        },
        {
            "text": "thyroid tissues.",
            "probability": 2.1400569812071416e-13,
            "start_logit": -5.258266925811768,
            "end_logit": -8.204676628112793
        }
    ],
    "53148a07dae131f847000002_002": [
        {
            "text": "hypothyroidism",
            "probability": 0.6345516425376253,
            "start_logit": 5.721649646759033,
            "end_logit": 4.506195545196533
        },
        {
            "text": "thyroid",
            "probability": 0.3554588238411516,
            "start_logit": 5.3878960609436035,
            "end_logit": 4.260439872741699
        },
        {
            "text": "development and hypothyroidism",
            "probability": 0.009025027075194784,
            "start_logit": 1.468732476234436,
            "end_logit": 4.506195545196533
        },
        {
            "text": "thy",
            "probability": 0.0002539978769181494,
            "start_logit": 5.3878960609436035,
            "end_logit": -2.983398914337158
        },
        {
            "text": "hyp",
            "probability": 0.00021570272316446753,
            "start_logit": 5.721649646759033,
            "end_logit": -3.480577230453491
        },
        {
            "text": "ism",
            "probability": 0.00018837094769259453,
            "start_logit": -2.400611162185669,
            "end_logit": 4.506195545196533
        },
        {
            "text": "roid",
            "probability": 7.723996182411692e-05,
            "start_logit": -3.046351671218872,
            "end_logit": 4.260439872741699
        },
        {
            "text": "hypothyroid",
            "probability": 6.889007005714327e-05,
            "start_logit": 5.721649646759033,
            "end_logit": -4.621966361999512
        },
        {
            "text": "development",
            "probability": 5.8398547098024184e-05,
            "start_logit": 1.468732476234436,
            "end_logit": -0.5342702269554138
        },
        {
            "text": "thyroid hormone",
            "probability": 5.3433095530153695e-05,
            "start_logit": 5.3878960609436035,
            "end_logit": -4.542294502258301
        },
        {
            "text": "othyroidism",
            "probability": 2.6353265350284138e-05,
            "start_logit": -4.367432117462158,
            "end_logit": 4.506195545196533
        },
        {
            "text": "hypothy",
            "probability": 6.282722546980544e-06,
            "start_logit": 5.721649646759033,
            "end_logit": -7.016674995422363
        },
        {
            "text": "Goiter development and hypothyroidism",
            "probability": 5.128319753442768e-06,
            "start_logit": -6.004246234893799,
            "end_logit": 4.506195545196533
        },
        {
            "text": "and hypothyroidism",
            "probability": 4.488503062483253e-06,
            "start_logit": -6.137505054473877,
            "end_logit": 4.506195545196533
        },
        {
            "text": "roidism",
            "probability": 2.267163872988666e-06,
            "start_logit": -6.820494651794434,
            "end_logit": 4.506195545196533
        },
        {
            "text": "thyroid hormone synthesis, and chloride/bicarbonate",
            "probability": 2.081287098138422e-06,
            "start_logit": 5.3878960609436035,
            "end_logit": -7.78773832321167
        },
        {
            "text": "the pathophysiology of the inner ear, thyroid",
            "probability": 1.8351623670643925e-06,
            "start_logit": -6.786135673522949,
            "end_logit": 4.260439872741699
        },
        {
            "text": "Goiter development",
            "probability": 3.3183991600234785e-08,
            "start_logit": -6.004246234893799,
            "end_logit": -0.5342702269554138
        },
        {
            "text": "othyroid",
            "probability": 2.86104104774721e-09,
            "start_logit": -4.367432117462158,
            "end_logit": -4.621966361999512
        },
        {
            "text": "thyroid, pendrin is expressed at the apical membrane of thyroid",
            "probability": 8.546595412609661e-10,
            "start_logit": -4.527287483215332,
            "end_logit": -5.670348644256592
        }
    ],
    "53148a07dae131f847000002_003": [
        {
            "text": "hypothyroidism",
            "probability": 0.6345516425376253,
            "start_logit": 5.721649646759033,
            "end_logit": 4.506195545196533
        },
        {
            "text": "thyroid",
            "probability": 0.3554588238411516,
            "start_logit": 5.3878960609436035,
            "end_logit": 4.260439872741699
        },
        {
            "text": "development and hypothyroidism",
            "probability": 0.009025027075194784,
            "start_logit": 1.468732476234436,
            "end_logit": 4.506195545196533
        },
        {
            "text": "thy",
            "probability": 0.0002539978769181494,
            "start_logit": 5.3878960609436035,
            "end_logit": -2.983398914337158
        },
        {
            "text": "hyp",
            "probability": 0.00021570272316446753,
            "start_logit": 5.721649646759033,
            "end_logit": -3.480577230453491
        },
        {
            "text": "ism",
            "probability": 0.00018837094769259453,
            "start_logit": -2.400611162185669,
            "end_logit": 4.506195545196533
        },
        {
            "text": "roid",
            "probability": 7.723996182411692e-05,
            "start_logit": -3.046351671218872,
            "end_logit": 4.260439872741699
        },
        {
            "text": "hypothyroid",
            "probability": 6.889007005714327e-05,
            "start_logit": 5.721649646759033,
            "end_logit": -4.621966361999512
        },
        {
            "text": "development",
            "probability": 5.8398547098024184e-05,
            "start_logit": 1.468732476234436,
            "end_logit": -0.5342702269554138
        },
        {
            "text": "thyroid hormone",
            "probability": 5.3433095530153695e-05,
            "start_logit": 5.3878960609436035,
            "end_logit": -4.542294502258301
        },
        {
            "text": "othyroidism",
            "probability": 2.6353265350284138e-05,
            "start_logit": -4.367432117462158,
            "end_logit": 4.506195545196533
        },
        {
            "text": "hypothy",
            "probability": 6.282722546980544e-06,
            "start_logit": 5.721649646759033,
            "end_logit": -7.016674995422363
        },
        {
            "text": "Goiter development and hypothyroidism",
            "probability": 5.128319753442768e-06,
            "start_logit": -6.004246234893799,
            "end_logit": 4.506195545196533
        },
        {
            "text": "and hypothyroidism",
            "probability": 4.488503062483253e-06,
            "start_logit": -6.137505054473877,
            "end_logit": 4.506195545196533
        },
        {
            "text": "roidism",
            "probability": 2.267163872988666e-06,
            "start_logit": -6.820494651794434,
            "end_logit": 4.506195545196533
        },
        {
            "text": "thyroid hormone synthesis, and chloride/bicarbonate",
            "probability": 2.081287098138422e-06,
            "start_logit": 5.3878960609436035,
            "end_logit": -7.78773832321167
        },
        {
            "text": "the pathophysiology of the inner ear, thyroid",
            "probability": 1.8351623670643925e-06,
            "start_logit": -6.786135673522949,
            "end_logit": 4.260439872741699
        },
        {
            "text": "Goiter development",
            "probability": 3.3183991600234785e-08,
            "start_logit": -6.004246234893799,
            "end_logit": -0.5342702269554138
        },
        {
            "text": "othyroid",
            "probability": 2.86104104774721e-09,
            "start_logit": -4.367432117462158,
            "end_logit": -4.621966361999512
        },
        {
            "text": "thyroid, pendrin is expressed at the apical membrane of thyroid",
            "probability": 8.546595412609661e-10,
            "start_logit": -4.527287483215332,
            "end_logit": -5.670348644256592
        }
    ],
    "53148a07dae131f847000002_004": [
        {
            "text": "Thyroid",
            "probability": 0.9993429689297884,
            "start_logit": 6.827577590942383,
            "end_logit": 6.121242523193359
        },
        {
            "text": "Thyroid goiter",
            "probability": 0.0002495506805348966,
            "start_logit": 6.827577590942383,
            "end_logit": -2.1739487648010254
        },
        {
            "text": "roid",
            "probability": 0.0001900576953354861,
            "start_logit": -1.739948034286499,
            "end_logit": 6.121242523193359
        },
        {
            "text": "Th",
            "probability": 0.0001843307004482323,
            "start_logit": 6.827577590942383,
            "end_logit": -2.476879358291626
        },
        {
            "text": "yroid",
            "probability": 3.1347163736594924e-05,
            "start_logit": -3.542151927947998,
            "end_logit": 6.121242523193359
        },
        {
            "text": "Thy",
            "probability": 1.7392243881270642e-06,
            "start_logit": 6.827577590942383,
            "end_logit": -7.140171527862549
        },
        {
            "text": "AND",
            "probability": 3.57949414686559e-09,
            "start_logit": 0.43667662143707275,
            "end_logit": -6.935243606567383
        },
        {
            "text": "goiter",
            "probability": 1.485431417259621e-09,
            "start_logit": -5.204134464263916,
            "end_logit": -2.1739487648010254
        },
        {
            "text": "characterized by great intrafamilial phenotype variability.",
            "probability": 8.935973822812176e-11,
            "start_logit": -3.721787691116333,
            "end_logit": -6.467085838317871
        },
        {
            "text": "characterized by",
            "probability": 7.996683531677556e-11,
            "start_logit": -3.721787691116333,
            "end_logit": -6.578144073486328
        },
        {
            "text": "Hormone analysis was normal and perchlorate test negative in all cases. A single Pendred syndrome",
            "probability": 7.138200665679711e-11,
            "start_logit": -4.641749858856201,
            "end_logit": -5.771748065948486
        },
        {
            "text": "Hormone",
            "probability": 6.242238438338439e-11,
            "start_logit": -4.641749858856201,
            "end_logit": -5.905869960784912
        },
        {
            "text": "y",
            "probability": 5.4555596391181125e-11,
            "start_logit": -3.542151927947998,
            "end_logit": -7.140171527862549
        },
        {
            "text": "DISCUSSION:",
            "probability": 4.631633397081749e-11,
            "start_logit": -3.536236047744751,
            "end_logit": -7.309813022613525
        },
        {
            "text": "DISCUSSION: Pendred syndrome is the most frequent congenital deafness syndrome.",
            "probability": 4.261348399470456e-11,
            "start_logit": -3.536236047744751,
            "end_logit": -7.393136978149414
        },
        {
            "text": "characterized by great",
            "probability": 3.6374394667137116e-11,
            "start_logit": -3.721787691116333,
            "end_logit": -7.365890979766846
        },
        {
            "text": "characterized by great intrafamilial",
            "probability": 3.077787616729848e-11,
            "start_logit": -3.721787691116333,
            "end_logit": -7.532959938049316
        },
        {
            "text": "phenotype variability.",
            "probability": 1.0076152888261084e-11,
            "start_logit": -5.9042863845825195,
            "end_logit": -6.467085838317871
        },
        {
            "text": "great intrafamilial phenotype variability.",
            "probability": 9.442237093582037e-12,
            "start_logit": -5.969264984130859,
            "end_logit": -6.467085838317871
        },
        {
            "text": "intrafamilial phenotype variability.",
            "probability": 7.556213962706455e-12,
            "start_logit": -6.192087650299072,
            "end_logit": -6.467085838317871
        }
    ],
    "53148a07dae131f847000002_005": [
        {
            "text": "thyroid",
            "probability": 0.9991527063744983,
            "start_logit": 5.458469867706299,
            "end_logit": 4.4095845222473145
        },
        {
            "text": "thy",
            "probability": 0.0005779157744884121,
            "start_logit": 5.458469867706299,
            "end_logit": -3.0456502437591553
        },
        {
            "text": "roid",
            "probability": 0.0002402208078688478,
            "start_logit": -2.8746345043182373,
            "end_logit": 4.4095845222473145
        },
        {
            "text": "her thyroid",
            "probability": 7.600258348785147e-06,
            "start_logit": -5.673217296600342,
            "end_logit": 3.754791021347046
        },
        {
            "text": "increased thyroidal",
            "probability": 6.779434364987107e-06,
            "start_logit": -6.4422993659973145,
            "end_logit": 4.4095845222473145
        },
        {
            "text": "thyroglobulin and increased thyroidal",
            "probability": 6.0289889867614605e-06,
            "start_logit": -6.5596137046813965,
            "end_logit": 4.4095845222473145
        },
        {
            "text": "thyroidal iodine uptake, but normal serum TSH",
            "probability": 3.25389873450685e-06,
            "start_logit": 5.458469867706299,
            "end_logit": -8.225224494934082
        },
        {
            "text": "accompanied by elevated serum thyroglobulin and increased thyroidal",
            "probability": 2.074807511527697e-06,
            "start_logit": -7.626324653625488,
            "end_logit": 4.4095845222473145
        },
        {
            "text": "elevated serum thyroglobulin and increased thyroidal",
            "probability": 2.035508741136718e-06,
            "start_logit": -7.645447254180908,
            "end_logit": 4.4095845222473145
        },
        {
            "text": "thyroid gland showed progressive",
            "probability": 1.3820637494637397e-06,
            "start_logit": 4.697714805603027,
            "end_logit": -8.320745468139648
        },
        {
            "text": "thyrotropin",
            "probability": 4.752167104301392e-10,
            "start_logit": -5.590890884399414,
            "end_logit": -6.007457256317139
        },
        {
            "text": "thyrotropin and iodine organification. Biallelic mutations of SLC26A4",
            "probability": 4.293454493949763e-10,
            "start_logit": -5.590890884399414,
            "end_logit": -6.10896635055542
        },
        {
            "text": "SLC26A4",
            "probability": 2.4737703465157245e-10,
            "start_logit": -6.142239093780518,
            "end_logit": -6.10896635055542
        },
        {
            "text": "thyrotropin and iodine organification. Biallelic mutations",
            "probability": 2.1696275721101036e-10,
            "start_logit": -5.590890884399414,
            "end_logit": -6.791502475738525
        },
        {
            "text": "Biallelic mutations of SLC26A4",
            "probability": 2.0324727497411233e-10,
            "start_logit": -6.338729381561279,
            "end_logit": -6.10896635055542
        },
        {
            "text": "serum thyrotropin",
            "probability": 1.2460768688521777e-10,
            "start_logit": -6.9294915199279785,
            "end_logit": -6.007457256317139
        },
        {
            "text": "serum thyrotropin and iodine organification. Biallelic mutations of SLC26A4",
            "probability": 1.1257967607110744e-10,
            "start_logit": -6.9294915199279785,
            "end_logit": -6.10896635055542
        },
        {
            "text": "Biallelic mutations",
            "probability": 1.0270771295270138e-10,
            "start_logit": -6.338729381561279,
            "end_logit": -6.791502475738525
        },
        {
            "text": "26A4",
            "probability": 8.78345616722712e-11,
            "start_logit": -7.177697658538818,
            "end_logit": -6.10896635055542
        },
        {
            "text": "thyrotropin and iodine organification.",
            "probability": 8.282841607908642e-11,
            "start_logit": -5.590890884399414,
            "end_logit": -7.754456996917725
        }
    ],
    "53148a07dae131f847000002_006": [
        {
            "text": "thyroid",
            "probability": 0.9991527063744983,
            "start_logit": 5.458469867706299,
            "end_logit": 4.4095845222473145
        },
        {
            "text": "thy",
            "probability": 0.0005779157744884121,
            "start_logit": 5.458469867706299,
            "end_logit": -3.0456502437591553
        },
        {
            "text": "roid",
            "probability": 0.0002402208078688478,
            "start_logit": -2.8746345043182373,
            "end_logit": 4.4095845222473145
        },
        {
            "text": "her thyroid",
            "probability": 7.600258348785147e-06,
            "start_logit": -5.673217296600342,
            "end_logit": 3.754791021347046
        },
        {
            "text": "increased thyroidal",
            "probability": 6.779434364987107e-06,
            "start_logit": -6.4422993659973145,
            "end_logit": 4.4095845222473145
        },
        {
            "text": "thyroglobulin and increased thyroidal",
            "probability": 6.0289889867614605e-06,
            "start_logit": -6.5596137046813965,
            "end_logit": 4.4095845222473145
        },
        {
            "text": "thyroidal iodine uptake, but normal serum TSH",
            "probability": 3.25389873450685e-06,
            "start_logit": 5.458469867706299,
            "end_logit": -8.225224494934082
        },
        {
            "text": "accompanied by elevated serum thyroglobulin and increased thyroidal",
            "probability": 2.074807511527697e-06,
            "start_logit": -7.626324653625488,
            "end_logit": 4.4095845222473145
        },
        {
            "text": "elevated serum thyroglobulin and increased thyroidal",
            "probability": 2.035508741136718e-06,
            "start_logit": -7.645447254180908,
            "end_logit": 4.4095845222473145
        },
        {
            "text": "thyroid gland showed progressive",
            "probability": 1.3820637494637397e-06,
            "start_logit": 4.697714805603027,
            "end_logit": -8.320745468139648
        },
        {
            "text": "thyrotropin",
            "probability": 4.752167104301392e-10,
            "start_logit": -5.590890884399414,
            "end_logit": -6.007457256317139
        },
        {
            "text": "thyrotropin and iodine organification. Biallelic mutations of SLC26A4",
            "probability": 4.293454493949763e-10,
            "start_logit": -5.590890884399414,
            "end_logit": -6.10896635055542
        },
        {
            "text": "SLC26A4",
            "probability": 2.4737703465157245e-10,
            "start_logit": -6.142239093780518,
            "end_logit": -6.10896635055542
        },
        {
            "text": "thyrotropin and iodine organification. Biallelic mutations",
            "probability": 2.1696275721101036e-10,
            "start_logit": -5.590890884399414,
            "end_logit": -6.791502475738525
        },
        {
            "text": "Biallelic mutations of SLC26A4",
            "probability": 2.0324727497411233e-10,
            "start_logit": -6.338729381561279,
            "end_logit": -6.10896635055542
        },
        {
            "text": "serum thyrotropin",
            "probability": 1.2460768688521777e-10,
            "start_logit": -6.9294915199279785,
            "end_logit": -6.007457256317139
        },
        {
            "text": "serum thyrotropin and iodine organification. Biallelic mutations of SLC26A4",
            "probability": 1.1257967607110744e-10,
            "start_logit": -6.9294915199279785,
            "end_logit": -6.10896635055542
        },
        {
            "text": "Biallelic mutations",
            "probability": 1.0270771295270138e-10,
            "start_logit": -6.338729381561279,
            "end_logit": -6.791502475738525
        },
        {
            "text": "26A4",
            "probability": 8.78345616722712e-11,
            "start_logit": -7.177697658538818,
            "end_logit": -6.10896635055542
        },
        {
            "text": "thyrotropin and iodine organification.",
            "probability": 8.282841607908642e-11,
            "start_logit": -5.590890884399414,
            "end_logit": -7.754456996917725
        }
    ],
    "53148a07dae131f847000002_007": [
        {
            "text": "thyroid",
            "probability": 0.5121354777769336,
            "start_logit": 6.739399433135986,
            "end_logit": 6.11088752746582
        },
        {
            "text": "thyroid function in the Pendred thyroid.",
            "probability": 0.487653747965146,
            "start_logit": 6.690415859222412,
            "end_logit": 6.11088752746582
        },
        {
            "text": "thy",
            "probability": 0.00011351325086460513,
            "start_logit": 6.739399433135986,
            "end_logit": -2.303537368774414
        },
        {
            "text": "roid",
            "probability": 8.320937873280397e-05,
            "start_logit": -1.9855849742889404,
            "end_logit": 6.11088752746582
        },
        {
            "text": "thyroid.",
            "probability": 3.441250379377435e-06,
            "start_logit": 6.739399433135986,
            "end_logit": -5.799622058868408
        },
        {
            "text": "appropriate thyroid function in the Pendred thyroid.",
            "probability": 2.1522711864822735e-06,
            "start_logit": -5.640421390533447,
            "end_logit": 6.11088752746582
        },
        {
            "text": "appropriate thyroid",
            "probability": 1.8358980164735787e-06,
            "start_logit": -5.640421390533447,
            "end_logit": 5.951897621154785
        },
        {
            "text": "the Pendred thyroid.",
            "probability": 9.8028731714527e-07,
            "start_logit": -6.426854610443115,
            "end_logit": 6.11088752746582
        },
        {
            "text": "thyroid. CONTEXT: Pendred syndrome is caused by mutations",
            "probability": 8.42499560819639e-07,
            "start_logit": 6.739399433135986,
            "end_logit": -7.206839084625244
        },
        {
            "text": "thyroid function in the Pendred thyroid. CONTEXT: Pendred syndrome is caused by mutations",
            "probability": 8.022253609066232e-07,
            "start_logit": 6.690415859222412,
            "end_logit": -7.206839084625244
        },
        {
            "text": "proteins is required to maintain an appropriate thyroid function in the Pendred thyroid.",
            "probability": 7.008029413026769e-07,
            "start_logit": -6.7624735832214355,
            "end_logit": 6.11088752746582
        },
        {
            "text": "differentiation proteins is required to maintain an appropriate thyroid function in the Pendred thyroid.",
            "probability": 6.146055296093522e-07,
            "start_logit": -6.893719673156738,
            "end_logit": 6.11088752746582
        },
        {
            "text": "proteins is required to maintain an appropriate thyroid",
            "probability": 5.977883911456764e-07,
            "start_logit": -6.7624735832214355,
            "end_logit": 5.951897621154785
        },
        {
            "text": "differentiation proteins is required to maintain an appropriate thyroid",
            "probability": 5.242615706655962e-07,
            "start_logit": -6.893719673156738,
            "end_logit": 5.951897621154785
        },
        {
            "text": "thyroid. CONTEXT:",
            "probability": 3.4698250184959487e-07,
            "start_logit": 6.739399433135986,
            "end_logit": -8.093937873840332
        },
        {
            "text": "thyroid function in the Pendred thyroid. CONTEXT:",
            "probability": 3.303956176591583e-07,
            "start_logit": 6.690415859222412,
            "end_logit": -8.093937873840332
        },
        {
            "text": "thyroid. CONTEXT: Pendred syndrome is caused by",
            "probability": 3.288323858492419e-07,
            "start_logit": 6.739399433135986,
            "end_logit": -8.147664070129395
        },
        {
            "text": "thyroid function in the Pendred thyroid. CONTEXT: Pendred syndrome is caused by",
            "probability": 3.131131358205745e-07,
            "start_logit": 6.690415859222412,
            "end_logit": -8.147664070129395
        },
        {
            "text": "thyroid function in the Pendred",
            "probability": 2.3370537120002258e-07,
            "start_logit": 6.690415859222412,
            "end_logit": -8.440167427062988
        },
        {
            "text": "the thyroid",
            "probability": 6.709056776587104e-09,
            "start_logit": -6.076998233795166,
            "end_logit": 0.7766438126564026
        }
    ],
    "53148a07dae131f847000002_008": [
        {
            "text": "thyroid",
            "probability": 0.5121354777769336,
            "start_logit": 6.739399433135986,
            "end_logit": 6.11088752746582
        },
        {
            "text": "thyroid function in the Pendred thyroid.",
            "probability": 0.487653747965146,
            "start_logit": 6.690415859222412,
            "end_logit": 6.11088752746582
        },
        {
            "text": "thy",
            "probability": 0.00011351325086460513,
            "start_logit": 6.739399433135986,
            "end_logit": -2.303537368774414
        },
        {
            "text": "roid",
            "probability": 8.320937873280397e-05,
            "start_logit": -1.9855849742889404,
            "end_logit": 6.11088752746582
        },
        {
            "text": "thyroid.",
            "probability": 3.441250379377435e-06,
            "start_logit": 6.739399433135986,
            "end_logit": -5.799622058868408
        },
        {
            "text": "appropriate thyroid function in the Pendred thyroid.",
            "probability": 2.1522711864822735e-06,
            "start_logit": -5.640421390533447,
            "end_logit": 6.11088752746582
        },
        {
            "text": "appropriate thyroid",
            "probability": 1.8358980164735787e-06,
            "start_logit": -5.640421390533447,
            "end_logit": 5.951897621154785
        },
        {
            "text": "the Pendred thyroid.",
            "probability": 9.8028731714527e-07,
            "start_logit": -6.426854610443115,
            "end_logit": 6.11088752746582
        },
        {
            "text": "thyroid. CONTEXT: Pendred syndrome is caused by mutations",
            "probability": 8.42499560819639e-07,
            "start_logit": 6.739399433135986,
            "end_logit": -7.206839084625244
        },
        {
            "text": "thyroid function in the Pendred thyroid. CONTEXT: Pendred syndrome is caused by mutations",
            "probability": 8.022253609066232e-07,
            "start_logit": 6.690415859222412,
            "end_logit": -7.206839084625244
        },
        {
            "text": "proteins is required to maintain an appropriate thyroid function in the Pendred thyroid.",
            "probability": 7.008029413026769e-07,
            "start_logit": -6.7624735832214355,
            "end_logit": 6.11088752746582
        },
        {
            "text": "differentiation proteins is required to maintain an appropriate thyroid function in the Pendred thyroid.",
            "probability": 6.146055296093522e-07,
            "start_logit": -6.893719673156738,
            "end_logit": 6.11088752746582
        },
        {
            "text": "proteins is required to maintain an appropriate thyroid",
            "probability": 5.977883911456764e-07,
            "start_logit": -6.7624735832214355,
            "end_logit": 5.951897621154785
        },
        {
            "text": "differentiation proteins is required to maintain an appropriate thyroid",
            "probability": 5.242615706655962e-07,
            "start_logit": -6.893719673156738,
            "end_logit": 5.951897621154785
        },
        {
            "text": "thyroid. CONTEXT:",
            "probability": 3.4698250184959487e-07,
            "start_logit": 6.739399433135986,
            "end_logit": -8.093937873840332
        },
        {
            "text": "thyroid function in the Pendred thyroid. CONTEXT:",
            "probability": 3.303956176591583e-07,
            "start_logit": 6.690415859222412,
            "end_logit": -8.093937873840332
        },
        {
            "text": "thyroid. CONTEXT: Pendred syndrome is caused by",
            "probability": 3.288323858492419e-07,
            "start_logit": 6.739399433135986,
            "end_logit": -8.147664070129395
        },
        {
            "text": "thyroid function in the Pendred thyroid. CONTEXT: Pendred syndrome is caused by",
            "probability": 3.131131358205745e-07,
            "start_logit": 6.690415859222412,
            "end_logit": -8.147664070129395
        },
        {
            "text": "thyroid function in the Pendred",
            "probability": 2.3370537120002258e-07,
            "start_logit": 6.690415859222412,
            "end_logit": -8.440167427062988
        },
        {
            "text": "the thyroid",
            "probability": 6.709056776587104e-09,
            "start_logit": -6.076998233795166,
            "end_logit": 0.7766438126564026
        }
    ],
    "53148a07dae131f847000002_009": [
        {
            "text": "thyroid",
            "probability": 0.9995327844253264,
            "start_logit": 7.208982467651367,
            "end_logit": 6.505949020385742
        },
        {
            "text": "thyroid hormone",
            "probability": 0.00023604693105619203,
            "start_logit": 7.208982467651367,
            "end_logit": -1.84506356716156
        },
        {
            "text": "roid",
            "probability": 0.00012786364839431397,
            "start_logit": -1.7550963163375854,
            "end_logit": 6.505949020385742
        },
        {
            "text": "thy",
            "probability": 9.769911616733201e-05,
            "start_logit": 7.208982467651367,
            "end_logit": -2.7272017002105713
        },
        {
            "text": "this anion exchanger may be involved in mediating iodide efflux into the follicular lumen, a key step in thyroid",
            "probability": 2.919998360580947e-06,
            "start_logit": -5.534477710723877,
            "end_logit": 6.505949020385742
        },
        {
            "text": "may be involved in mediating iodide efflux into the follicular lumen, a key step in thyroid",
            "probability": 2.5560558301384294e-06,
            "start_logit": -5.667595386505127,
            "end_logit": 6.505949020385742
        },
        {
            "text": "pendrin",
            "probability": 1.0096429518097412e-07,
            "start_logit": -0.5875114798545837,
            "end_logit": -1.8055886030197144
        },
        {
            "text": "pendrin/SLC26A4. In human thyroid",
            "probability": 1.17501693146361e-08,
            "start_logit": -0.5875114798545837,
            "end_logit": -3.9564878940582275
        },
        {
            "text": "the fact that pendrin",
            "probability": 4.54561784929579e-09,
            "start_logit": -2.136813163757324,
            "end_logit": -3.3568902015686035
        },
        {
            "text": "caused by biallelic mutations in the multifunctional anion transporter pendrin/SLC26A4.",
            "probability": 3.6088154931406525e-09,
            "start_logit": -3.918898820877075,
            "end_logit": -1.8055886030197144
        },
        {
            "text": "hormone",
            "probability": 2.635867471827692e-09,
            "start_logit": -4.193591117858887,
            "end_logit": -1.84506356716156
        },
        {
            "text": "The clinical phenotype of patients with Pendred syndrome and the fact that pendrin",
            "probability": 1.3323360435226091e-09,
            "start_logit": -3.3640429973602295,
            "end_logit": -3.3568902015686035
        },
        {
            "text": "thyroid tissue, pendrin is localized at the apical membrane of thyroid",
            "probability": 1.294866393872552e-09,
            "start_logit": -3.9535059928894043,
            "end_logit": -2.7959535121917725
        },
        {
            "text": "thyroid follicular cells. The clinical phenotype of patients with Pendred syndrome and the fact that pendrin",
            "probability": 1.0906785491603852e-09,
            "start_logit": -3.5641767978668213,
            "end_logit": -3.3568902015686035
        },
        {
            "text": "pendrin can mediate iodide",
            "probability": 6.999323423329764e-10,
            "start_logit": -0.7779539227485657,
            "end_logit": -6.586684703826904
        },
        {
            "text": "may be involved in mediating iodide efflux into the follicular lumen, a key step in thyroid hormone",
            "probability": 6.036311601918634e-10,
            "start_logit": -5.667595386505127,
            "end_logit": -1.84506356716156
        },
        {
            "text": "fact that pendrin",
            "probability": 4.2015802319049533e-10,
            "start_logit": -4.518101215362549,
            "end_logit": -3.3568902015686035
        },
        {
            "text": "and the fact that pendrin",
            "probability": 3.4195632021279606e-10,
            "start_logit": -4.724049091339111,
            "end_logit": -3.3568902015686035
        },
        {
            "text": "defined by",
            "probability": 3.069125357663468e-10,
            "start_logit": -3.585078001022339,
            "end_logit": -4.6039814949035645
        },
        {
            "text": "The clinical phenotype",
            "probability": 2.2962771605730528e-10,
            "start_logit": -3.3640429973602295,
            "end_logit": -5.115119934082031
        }
    ],
    "53148a07dae131f847000002_010": [
        {
            "text": "thyroid",
            "probability": 0.9979570225001169,
            "start_logit": 4.903505802154541,
            "end_logit": 4.182340621948242
        },
        {
            "text": "thyroid hormone",
            "probability": 0.0009725517030333913,
            "start_logit": 4.744471549987793,
            "end_logit": -2.592167377471924
        },
        {
            "text": "thy",
            "probability": 0.0006563617681822824,
            "start_logit": 4.903505802154541,
            "end_logit": -3.1444127559661865
        },
        {
            "text": "roid",
            "probability": 0.0003669396075639456,
            "start_logit": -3.0047624111175537,
            "end_logit": 4.182340621948242
        },
        {
            "text": "pendrin",
            "probability": 2.980733617855853e-05,
            "start_logit": 0.651803731918335,
            "end_logit": -1.984668254852295
        },
        {
            "text": "thyroid cells.",
            "probability": 7.167542890972893e-06,
            "start_logit": 4.903505802154541,
            "end_logit": -7.661561965942383
        },
        {
            "text": "thyroid hormone synthesis.",
            "probability": 7.084514791500249e-06,
            "start_logit": 4.744471549987793,
            "end_logit": -7.514179229736328
        },
        {
            "text": "and thyroid",
            "probability": 2.4895195005047644e-06,
            "start_logit": -7.70652961730957,
            "end_logit": 3.891000270843506
        },
        {
            "text": "possible role for the encoded protein, pendrin,",
            "probability": 1.0367414862153807e-07,
            "start_logit": -5.009453296661377,
            "end_logit": -1.984668254852295
        },
        {
            "text": "pend",
            "probability": 8.96181033763376e-08,
            "start_logit": 0.651803731918335,
            "end_logit": -7.79162073135376
        },
        {
            "text": "pendrin, as an apical iodide",
            "probability": 8.060354390873581e-08,
            "start_logit": 0.651803731918335,
            "end_logit": -7.897635459899902
        },
        {
            "text": "suggested a possible role for the encoded protein, pendrin,",
            "probability": 6.71489809834739e-08,
            "start_logit": -5.443792343139648,
            "end_logit": -1.984668254852295
        },
        {
            "text": "pendrin, as an apical iodide transporter.",
            "probability": 6.550709832476523e-08,
            "start_logit": 0.651803731918335,
            "end_logit": -8.105019569396973
        },
        {
            "text": "the encoded protein, pendrin,",
            "probability": 3.5810944020977245e-08,
            "start_logit": -6.072452545166016,
            "end_logit": -1.984668254852295
        },
        {
            "text": "hormone",
            "probability": 3.0845286924534226e-08,
            "start_logit": -5.614223003387451,
            "end_logit": -2.592167377471924
        },
        {
            "text": "for the encoded protein, pendrin,",
            "probability": 2.3451527617161644e-08,
            "start_logit": -6.495770454406738,
            "end_logit": -1.984668254852295
        },
        {
            "text": "and defective iodide organification) suggested a possible role for the encoded protein, pendrin,",
            "probability": 2.2742055583265022e-08,
            "start_logit": -6.526490211486816,
            "end_logit": -1.984668254852295
        },
        {
            "text": "iodide organification) suggested a possible role for the encoded protein, pendrin,",
            "probability": 1.889184818901275e-08,
            "start_logit": -6.711975574493408,
            "end_logit": -1.984668254852295
        },
        {
            "text": "protein, pendrin,",
            "probability": 1.8627296474685777e-08,
            "start_logit": -6.726078033447266,
            "end_logit": -1.984668254852295
        },
        {
            "text": "encoded protein, pendrin,",
            "probability": 1.8586908606990983e-08,
            "start_logit": -6.728248596191406,
            "end_logit": -1.984668254852295
        }
    ],
    "53148a07dae131f847000002_011": [
        {
            "text": "thyroid",
            "probability": 0.9979570225001169,
            "start_logit": 4.903505802154541,
            "end_logit": 4.182340621948242
        },
        {
            "text": "thyroid hormone",
            "probability": 0.0009725517030333913,
            "start_logit": 4.744471549987793,
            "end_logit": -2.592167377471924
        },
        {
            "text": "thy",
            "probability": 0.0006563617681822824,
            "start_logit": 4.903505802154541,
            "end_logit": -3.1444127559661865
        },
        {
            "text": "roid",
            "probability": 0.0003669396075639456,
            "start_logit": -3.0047624111175537,
            "end_logit": 4.182340621948242
        },
        {
            "text": "pendrin",
            "probability": 2.980733617855853e-05,
            "start_logit": 0.651803731918335,
            "end_logit": -1.984668254852295
        },
        {
            "text": "thyroid cells.",
            "probability": 7.167542890972893e-06,
            "start_logit": 4.903505802154541,
            "end_logit": -7.661561965942383
        },
        {
            "text": "thyroid hormone synthesis.",
            "probability": 7.084514791500249e-06,
            "start_logit": 4.744471549987793,
            "end_logit": -7.514179229736328
        },
        {
            "text": "and thyroid",
            "probability": 2.4895195005047644e-06,
            "start_logit": -7.70652961730957,
            "end_logit": 3.891000270843506
        },
        {
            "text": "possible role for the encoded protein, pendrin,",
            "probability": 1.0367414862153807e-07,
            "start_logit": -5.009453296661377,
            "end_logit": -1.984668254852295
        },
        {
            "text": "pend",
            "probability": 8.96181033763376e-08,
            "start_logit": 0.651803731918335,
            "end_logit": -7.79162073135376
        },
        {
            "text": "pendrin, as an apical iodide",
            "probability": 8.060354390873581e-08,
            "start_logit": 0.651803731918335,
            "end_logit": -7.897635459899902
        },
        {
            "text": "suggested a possible role for the encoded protein, pendrin,",
            "probability": 6.71489809834739e-08,
            "start_logit": -5.443792343139648,
            "end_logit": -1.984668254852295
        },
        {
            "text": "pendrin, as an apical iodide transporter.",
            "probability": 6.550709832476523e-08,
            "start_logit": 0.651803731918335,
            "end_logit": -8.105019569396973
        },
        {
            "text": "the encoded protein, pendrin,",
            "probability": 3.5810944020977245e-08,
            "start_logit": -6.072452545166016,
            "end_logit": -1.984668254852295
        },
        {
            "text": "hormone",
            "probability": 3.0845286924534226e-08,
            "start_logit": -5.614223003387451,
            "end_logit": -2.592167377471924
        },
        {
            "text": "for the encoded protein, pendrin,",
            "probability": 2.3451527617161644e-08,
            "start_logit": -6.495770454406738,
            "end_logit": -1.984668254852295
        },
        {
            "text": "and defective iodide organification) suggested a possible role for the encoded protein, pendrin,",
            "probability": 2.2742055583265022e-08,
            "start_logit": -6.526490211486816,
            "end_logit": -1.984668254852295
        },
        {
            "text": "iodide organification) suggested a possible role for the encoded protein, pendrin,",
            "probability": 1.889184818901275e-08,
            "start_logit": -6.711975574493408,
            "end_logit": -1.984668254852295
        },
        {
            "text": "protein, pendrin,",
            "probability": 1.8627296474685777e-08,
            "start_logit": -6.726078033447266,
            "end_logit": -1.984668254852295
        },
        {
            "text": "encoded protein, pendrin,",
            "probability": 1.8586908606990983e-08,
            "start_logit": -6.728248596191406,
            "end_logit": -1.984668254852295
        }
    ],
    "53148a07dae131f847000002_012": [
        {
            "text": "thyroid, the inner ear, and the kidney. In the thyroid,",
            "probability": 0.38571706280793655,
            "start_logit": 6.326775074005127,
            "end_logit": 5.016515254974365
        },
        {
            "text": "thyroid",
            "probability": 0.37059024390625456,
            "start_logit": 6.326775074005127,
            "end_logit": 4.976508140563965
        },
        {
            "text": "hypothyroidism",
            "probability": 0.24225270165372995,
            "start_logit": 6.0035481452941895,
            "end_logit": 4.874619483947754
        },
        {
            "text": "the thyroid,",
            "probability": 0.0007343860885520036,
            "start_logit": 0.06295058876276016,
            "end_logit": 5.016515254974365
        },
        {
            "text": "thy",
            "probability": 0.00013253938084502125,
            "start_logit": 6.326775074005127,
            "end_logit": -2.9594643115997314
        },
        {
            "text": "thyroid,",
            "probability": 0.00012514339961487356,
            "start_logit": 6.248937129974365,
            "end_logit": -2.9390459060668945
        },
        {
            "text": "pendrin, a multifunctional anion exchanger. Pendrin is mainly expressed in the thyroid,",
            "probability": 8.776444604684388e-05,
            "start_logit": -2.02142071723938,
            "end_logit": 4.976508140563965
        },
        {
            "text": "hyp",
            "probability": 7.496545916971185e-05,
            "start_logit": 6.0035481452941895,
            "end_logit": -3.206089735031128
        },
        {
            "text": "ism",
            "probability": 6.192156187952298e-05,
            "start_logit": -2.268320083618164,
            "end_logit": 4.874619483947754
        },
        {
            "text": "hypothyroid",
            "probability": 4.348391995321899e-05,
            "start_logit": 6.0035481452941895,
            "end_logit": -3.7507259845733643
        },
        {
            "text": "roid",
            "probability": 4.3350996077671317e-05,
            "start_logit": -2.766754627227783,
            "end_logit": 5.016515254974365
        },
        {
            "text": "thyroid, the inner ear, and the kidney. In the thyroid, pendrin",
            "probability": 3.019106972093391e-05,
            "start_logit": 6.326775074005127,
            "end_logit": -4.438797950744629
        },
        {
            "text": "the thyroid, the inner ear, and the kidney. In the thyroid,",
            "probability": 2.873193530705954e-05,
            "start_logit": -3.178075075149536,
            "end_logit": 5.016515254974365
        },
        {
            "text": "thyroid, pendrin",
            "probability": 2.7930191378661083e-05,
            "start_logit": 6.248937129974365,
            "end_logit": -4.438797950744629
        },
        {
            "text": "In the thyroid,",
            "probability": 2.6374701658422586e-05,
            "start_logit": -3.263679027557373,
            "end_logit": 5.016515254974365
        },
        {
            "text": "othyroidism",
            "probability": 1.3664585691619163e-05,
            "start_logit": -3.779381036758423,
            "end_logit": 4.874619483947754
        },
        {
            "text": "thyroid, pendrin localizes to the apical membrane of thyrocytes,",
            "probability": 2.6853644825035317e-06,
            "start_logit": 6.248937129974365,
            "end_logit": -6.780689716339111
        },
        {
            "text": "thyroid, the inner ear, and the kidney. In the thyroid, pendrin localizes to the apical membrane",
            "probability": 2.344718506495122e-06,
            "start_logit": 6.326775074005127,
            "end_logit": -6.994178771972656
        },
        {
            "text": "hypothy",
            "probability": 2.344680493140347e-06,
            "start_logit": 6.0035481452941895,
            "end_logit": -6.670968055725098
        },
        {
            "text": "thyroid, pendrin localizes to the apical membrane",
            "probability": 2.1691327011870897e-06,
            "start_logit": 6.248937129974365,
            "end_logit": -6.994178771972656
        }
    ],
    "53148a07dae131f847000002_013": [
        {
            "text": "thyroid, the inner ear, and the kidney. In the thyroid,",
            "probability": 0.38571706280793655,
            "start_logit": 6.326775074005127,
            "end_logit": 5.016515254974365
        },
        {
            "text": "thyroid",
            "probability": 0.37059024390625456,
            "start_logit": 6.326775074005127,
            "end_logit": 4.976508140563965
        },
        {
            "text": "hypothyroidism",
            "probability": 0.24225270165372995,
            "start_logit": 6.0035481452941895,
            "end_logit": 4.874619483947754
        },
        {
            "text": "the thyroid,",
            "probability": 0.0007343860885520036,
            "start_logit": 0.06295058876276016,
            "end_logit": 5.016515254974365
        },
        {
            "text": "thy",
            "probability": 0.00013253938084502125,
            "start_logit": 6.326775074005127,
            "end_logit": -2.9594643115997314
        },
        {
            "text": "thyroid,",
            "probability": 0.00012514339961487356,
            "start_logit": 6.248937129974365,
            "end_logit": -2.9390459060668945
        },
        {
            "text": "pendrin, a multifunctional anion exchanger. Pendrin is mainly expressed in the thyroid,",
            "probability": 8.776444604684388e-05,
            "start_logit": -2.02142071723938,
            "end_logit": 4.976508140563965
        },
        {
            "text": "hyp",
            "probability": 7.496545916971185e-05,
            "start_logit": 6.0035481452941895,
            "end_logit": -3.206089735031128
        },
        {
            "text": "ism",
            "probability": 6.192156187952298e-05,
            "start_logit": -2.268320083618164,
            "end_logit": 4.874619483947754
        },
        {
            "text": "hypothyroid",
            "probability": 4.348391995321899e-05,
            "start_logit": 6.0035481452941895,
            "end_logit": -3.7507259845733643
        },
        {
            "text": "roid",
            "probability": 4.3350996077671317e-05,
            "start_logit": -2.766754627227783,
            "end_logit": 5.016515254974365
        },
        {
            "text": "thyroid, the inner ear, and the kidney. In the thyroid, pendrin",
            "probability": 3.019106972093391e-05,
            "start_logit": 6.326775074005127,
            "end_logit": -4.438797950744629
        },
        {
            "text": "the thyroid, the inner ear, and the kidney. In the thyroid,",
            "probability": 2.873193530705954e-05,
            "start_logit": -3.178075075149536,
            "end_logit": 5.016515254974365
        },
        {
            "text": "thyroid, pendrin",
            "probability": 2.7930191378661083e-05,
            "start_logit": 6.248937129974365,
            "end_logit": -4.438797950744629
        },
        {
            "text": "In the thyroid,",
            "probability": 2.6374701658422586e-05,
            "start_logit": -3.263679027557373,
            "end_logit": 5.016515254974365
        },
        {
            "text": "othyroidism",
            "probability": 1.3664585691619163e-05,
            "start_logit": -3.779381036758423,
            "end_logit": 4.874619483947754
        },
        {
            "text": "thyroid, pendrin localizes to the apical membrane of thyrocytes,",
            "probability": 2.6853644825035317e-06,
            "start_logit": 6.248937129974365,
            "end_logit": -6.780689716339111
        },
        {
            "text": "thyroid, the inner ear, and the kidney. In the thyroid, pendrin localizes to the apical membrane",
            "probability": 2.344718506495122e-06,
            "start_logit": 6.326775074005127,
            "end_logit": -6.994178771972656
        },
        {
            "text": "hypothy",
            "probability": 2.344680493140347e-06,
            "start_logit": 6.0035481452941895,
            "end_logit": -6.670968055725098
        },
        {
            "text": "thyroid, pendrin localizes to the apical membrane",
            "probability": 2.1691327011870897e-06,
            "start_logit": 6.248937129974365,
            "end_logit": -6.994178771972656
        }
    ],
    "53148a07dae131f847000002_014": [
        {
            "text": "thyroid, the inner ear, and the kidney. In the thyroid,",
            "probability": 0.38571706280793655,
            "start_logit": 6.326775074005127,
            "end_logit": 5.016515254974365
        },
        {
            "text": "thyroid",
            "probability": 0.37059024390625456,
            "start_logit": 6.326775074005127,
            "end_logit": 4.976508140563965
        },
        {
            "text": "hypothyroidism",
            "probability": 0.24225270165372995,
            "start_logit": 6.0035481452941895,
            "end_logit": 4.874619483947754
        },
        {
            "text": "the thyroid,",
            "probability": 0.0007343860885520036,
            "start_logit": 0.06295058876276016,
            "end_logit": 5.016515254974365
        },
        {
            "text": "thy",
            "probability": 0.00013253938084502125,
            "start_logit": 6.326775074005127,
            "end_logit": -2.9594643115997314
        },
        {
            "text": "thyroid,",
            "probability": 0.00012514339961487356,
            "start_logit": 6.248937129974365,
            "end_logit": -2.9390459060668945
        },
        {
            "text": "pendrin, a multifunctional anion exchanger. Pendrin is mainly expressed in the thyroid,",
            "probability": 8.776444604684388e-05,
            "start_logit": -2.02142071723938,
            "end_logit": 4.976508140563965
        },
        {
            "text": "hyp",
            "probability": 7.496545916971185e-05,
            "start_logit": 6.0035481452941895,
            "end_logit": -3.206089735031128
        },
        {
            "text": "ism",
            "probability": 6.192156187952298e-05,
            "start_logit": -2.268320083618164,
            "end_logit": 4.874619483947754
        },
        {
            "text": "hypothyroid",
            "probability": 4.348391995321899e-05,
            "start_logit": 6.0035481452941895,
            "end_logit": -3.7507259845733643
        },
        {
            "text": "roid",
            "probability": 4.3350996077671317e-05,
            "start_logit": -2.766754627227783,
            "end_logit": 5.016515254974365
        },
        {
            "text": "thyroid, the inner ear, and the kidney. In the thyroid, pendrin",
            "probability": 3.019106972093391e-05,
            "start_logit": 6.326775074005127,
            "end_logit": -4.438797950744629
        },
        {
            "text": "the thyroid, the inner ear, and the kidney. In the thyroid,",
            "probability": 2.873193530705954e-05,
            "start_logit": -3.178075075149536,
            "end_logit": 5.016515254974365
        },
        {
            "text": "thyroid, pendrin",
            "probability": 2.7930191378661083e-05,
            "start_logit": 6.248937129974365,
            "end_logit": -4.438797950744629
        },
        {
            "text": "In the thyroid,",
            "probability": 2.6374701658422586e-05,
            "start_logit": -3.263679027557373,
            "end_logit": 5.016515254974365
        },
        {
            "text": "othyroidism",
            "probability": 1.3664585691619163e-05,
            "start_logit": -3.779381036758423,
            "end_logit": 4.874619483947754
        },
        {
            "text": "thyroid, pendrin localizes to the apical membrane of thyrocytes,",
            "probability": 2.6853644825035317e-06,
            "start_logit": 6.248937129974365,
            "end_logit": -6.780689716339111
        },
        {
            "text": "thyroid, the inner ear, and the kidney. In the thyroid, pendrin localizes to the apical membrane",
            "probability": 2.344718506495122e-06,
            "start_logit": 6.326775074005127,
            "end_logit": -6.994178771972656
        },
        {
            "text": "hypothy",
            "probability": 2.344680493140347e-06,
            "start_logit": 6.0035481452941895,
            "end_logit": -6.670968055725098
        },
        {
            "text": "thyroid, pendrin localizes to the apical membrane",
            "probability": 2.1691327011870897e-06,
            "start_logit": 6.248937129974365,
            "end_logit": -6.994178771972656
        }
    ],
    "53148a07dae131f847000002_015": [
        {
            "text": "thyroid",
            "probability": 0.9997361349323335,
            "start_logit": 7.114072799682617,
            "end_logit": 6.141253471374512
        },
        {
            "text": "thy",
            "probability": 0.00017960354016265887,
            "start_logit": 7.114072799682617,
            "end_logit": -2.483241319656372
        },
        {
            "text": "roid",
            "probability": 5.86655131999405e-05,
            "start_logit": -2.629321813583374,
            "end_logit": 6.141253471374512
        },
        {
            "text": "SLC26A4 encodes pendrin, an anion exchanger located in the cochlea, thyroid,",
            "probability": 1.1303132487518044e-05,
            "start_logit": -4.27609395980835,
            "end_logit": 6.141253471374512
        },
        {
            "text": "pendrin, an anion exchanger located in the cochlea, thyroid,",
            "probability": 6.299299533033197e-06,
            "start_logit": -4.8607354164123535,
            "end_logit": 6.141253471374512
        },
        {
            "text": "cochlea, thyroid,",
            "probability": 1.924738281180683e-06,
            "start_logit": -6.046383857727051,
            "end_logit": 6.141253471374512
        },
        {
            "text": "encodes pendrin, an anion exchanger located in the cochlea, thyroid,",
            "probability": 1.1835474417052333e-06,
            "start_logit": -6.532657623291016,
            "end_logit": 6.141253471374512
        },
        {
            "text": "thyroid,",
            "probability": 1.1234171257041805e-06,
            "start_logit": 7.114072799682617,
            "end_logit": -7.557618141174316
        },
        {
            "text": "located in the cochlea, thyroid,",
            "probability": 8.512200753585201e-07,
            "start_logit": -6.862258434295654,
            "end_logit": 6.141253471374512
        },
        {
            "text": "exchanger located in the cochlea, thyroid,",
            "probability": 6.843053361935244e-07,
            "start_logit": -7.080524921417236,
            "end_logit": 6.141253471374512
        },
        {
            "text": "thyroid, and kidney.",
            "probability": 6.102608734923695e-07,
            "start_logit": 7.114072799682617,
            "end_logit": -8.167861938476562
        },
        {
            "text": "anion exchanger located in the cochlea, thyroid,",
            "probability": 6.089408945243684e-07,
            "start_logit": -7.197207927703857,
            "end_logit": 6.141253471374512
        },
        {
            "text": "an anion exchanger located in the cochlea, thyroid,",
            "probability": 5.77541536326413e-07,
            "start_logit": -7.250148773193359,
            "end_logit": 6.141253471374512
        },
        {
            "text": "thyroid, and kidney. The goal of the present study was to determine whether developmental",
            "probability": 4.1915064892668995e-07,
            "start_logit": 7.114072799682617,
            "end_logit": -8.54351806640625
        },
        {
            "text": "euthyroid,",
            "probability": 4.0237307116628855e-09,
            "start_logit": -2.8347232341766357,
            "end_logit": -3.2407429218292236
        },
        {
            "text": "thyroid, that Slc26a4(-/-) mice are systemically euthyroid,",
            "probability": 3.425886180872084e-09,
            "start_logit": -2.995572566986084,
            "end_logit": -3.2407429218292236
        },
        {
            "text": "hypothyroidism",
            "probability": 1.9741950408126726e-09,
            "start_logit": -1.253235101699829,
            "end_logit": -5.534279823303223
        },
        {
            "text": "euthyroid, and that delays in cochlear development, possibly due to local hypothyroidism,",
            "probability": 4.060303406625147e-10,
            "start_logit": -2.8347232341766357,
            "end_logit": -5.534279823303223
        },
        {
            "text": "hypothyroidism, lead to the failure to develop hearing.",
            "probability": 3.536896274108414e-10,
            "start_logit": -1.253235101699829,
            "end_logit": -7.2537760734558105
        },
        {
            "text": "hypothyroid",
            "probability": 2.7653778811506263e-10,
            "start_logit": -1.253235101699829,
            "end_logit": -7.499848365783691
        }
    ],
    "53148a07dae131f847000002_016": [
        {
            "text": "thyroid",
            "probability": 0.9924757258593138,
            "start_logit": 5.8668928146362305,
            "end_logit": 4.91691255569458
        },
        {
            "text": "hypothyroidism,",
            "probability": 0.006891319716646134,
            "start_logit": 3.175185441970825,
            "end_logit": 2.6386799812316895
        },
        {
            "text": "thy",
            "probability": 0.00042982249434134705,
            "start_logit": 5.8668928146362305,
            "end_logit": -2.8276729583740234
        },
        {
            "text": "roid",
            "probability": 0.0001385840851348175,
            "start_logit": -3.0095877647399902,
            "end_logit": 4.91691255569458
        },
        {
            "text": "RESULTS: The elder sister had an elevated TSH level at newborn screening followed by subclinical hypothyroidism,",
            "probability": 3.977227359608803e-05,
            "start_logit": -4.669923305511475,
            "end_logit": 5.3289408683776855
        },
        {
            "text": "hyp",
            "probability": 9.947639952159793e-06,
            "start_logit": 3.175185441970825,
            "end_logit": -3.9020025730133057
        },
        {
            "text": ",",
            "probability": 8.528776486098207e-06,
            "start_logit": -3.5193865299224854,
            "end_logit": 2.6386799812316895
        },
        {
            "text": "hypothyroid",
            "probability": 3.4782906106733694e-06,
            "start_logit": 3.175185441970825,
            "end_logit": -4.952796936035156
        },
        {
            "text": "hypothyroidism",
            "probability": 1.9538609318984172e-06,
            "start_logit": 3.175185441970825,
            "end_logit": -5.5295305252075195
        },
        {
            "text": "hypothy",
            "probability": 3.657563405791908e-07,
            "start_logit": 3.175185441970825,
            "end_logit": -7.20512580871582
        },
        {
            "text": "subclinical hypothyroidism,",
            "probability": 2.0613776454858034e-07,
            "start_logit": -7.2420430183410645,
            "end_logit": 2.6386799812316895
        },
        {
            "text": "elevated TSH level at newborn screening followed by subclinical hypothyroidism,",
            "probability": 1.9818498679865347e-07,
            "start_logit": -7.281386852264404,
            "end_logit": 2.6386799812316895
        },
        {
            "text": "TSH level at newborn screening followed by subclinical hypothyroidism,",
            "probability": 9.528205205899685e-08,
            "start_logit": -8.01374626159668,
            "end_logit": 2.6386799812316895
        },
        {
            "text": "RESULTS: The elder sister had an elevated TSH level at newborn screening followed by subclinical",
            "probability": 4.85939796106341e-10,
            "start_logit": -4.669923305511475,
            "end_logit": -5.983654975891113
        },
        {
            "text": "RESULTS: The elder sister had an elevated TSH",
            "probability": 3.483639041902467e-10,
            "start_logit": -4.669923305511475,
            "end_logit": -6.316492080688477
        },
        {
            "text": "othyroid",
            "probability": 3.277296772429067e-10,
            "start_logit": -6.094676971435547,
            "end_logit": -4.952796936035156
        },
        {
            "text": "ism",
            "probability": 1.9535723503632778e-10,
            "start_logit": -6.035302639007568,
            "end_logit": -5.5295305252075195
        },
        {
            "text": "othyroidism",
            "probability": 1.8409566199663483e-10,
            "start_logit": -6.094676971435547,
            "end_logit": -5.5295305252075195
        },
        {
            "text": "roidism",
            "probability": 6.589447205845675e-11,
            "start_logit": -7.122077941894531,
            "end_logit": -5.5295305252075195
        },
        {
            "text": "othy",
            "probability": 3.4462102470603835e-11,
            "start_logit": -6.094676971435547,
            "end_logit": -7.20512580871582
        }
    ],
    "53148a07dae131f847000002_017": [
        {
            "text": "thyroid",
            "probability": 0.9924757258593138,
            "start_logit": 5.8668928146362305,
            "end_logit": 4.91691255569458
        },
        {
            "text": "hypothyroidism,",
            "probability": 0.006891319716646134,
            "start_logit": 3.175185441970825,
            "end_logit": 2.6386799812316895
        },
        {
            "text": "thy",
            "probability": 0.00042982249434134705,
            "start_logit": 5.8668928146362305,
            "end_logit": -2.8276729583740234
        },
        {
            "text": "roid",
            "probability": 0.0001385840851348175,
            "start_logit": -3.0095877647399902,
            "end_logit": 4.91691255569458
        },
        {
            "text": "RESULTS: The elder sister had an elevated TSH level at newborn screening followed by subclinical hypothyroidism,",
            "probability": 3.977227359608803e-05,
            "start_logit": -4.669923305511475,
            "end_logit": 5.3289408683776855
        },
        {
            "text": "hyp",
            "probability": 9.947639952159793e-06,
            "start_logit": 3.175185441970825,
            "end_logit": -3.9020025730133057
        },
        {
            "text": ",",
            "probability": 8.528776486098207e-06,
            "start_logit": -3.5193865299224854,
            "end_logit": 2.6386799812316895
        },
        {
            "text": "hypothyroid",
            "probability": 3.4782906106733694e-06,
            "start_logit": 3.175185441970825,
            "end_logit": -4.952796936035156
        },
        {
            "text": "hypothyroidism",
            "probability": 1.9538609318984172e-06,
            "start_logit": 3.175185441970825,
            "end_logit": -5.5295305252075195
        },
        {
            "text": "hypothy",
            "probability": 3.657563405791908e-07,
            "start_logit": 3.175185441970825,
            "end_logit": -7.20512580871582
        },
        {
            "text": "subclinical hypothyroidism,",
            "probability": 2.0613776454858034e-07,
            "start_logit": -7.2420430183410645,
            "end_logit": 2.6386799812316895
        },
        {
            "text": "elevated TSH level at newborn screening followed by subclinical hypothyroidism,",
            "probability": 1.9818498679865347e-07,
            "start_logit": -7.281386852264404,
            "end_logit": 2.6386799812316895
        },
        {
            "text": "TSH level at newborn screening followed by subclinical hypothyroidism,",
            "probability": 9.528205205899685e-08,
            "start_logit": -8.01374626159668,
            "end_logit": 2.6386799812316895
        },
        {
            "text": "RESULTS: The elder sister had an elevated TSH level at newborn screening followed by subclinical",
            "probability": 4.85939796106341e-10,
            "start_logit": -4.669923305511475,
            "end_logit": -5.983654975891113
        },
        {
            "text": "RESULTS: The elder sister had an elevated TSH",
            "probability": 3.483639041902467e-10,
            "start_logit": -4.669923305511475,
            "end_logit": -6.316492080688477
        },
        {
            "text": "othyroid",
            "probability": 3.277296772429067e-10,
            "start_logit": -6.094676971435547,
            "end_logit": -4.952796936035156
        },
        {
            "text": "ism",
            "probability": 1.9535723503632778e-10,
            "start_logit": -6.035302639007568,
            "end_logit": -5.5295305252075195
        },
        {
            "text": "othyroidism",
            "probability": 1.8409566199663483e-10,
            "start_logit": -6.094676971435547,
            "end_logit": -5.5295305252075195
        },
        {
            "text": "roidism",
            "probability": 6.589447205845675e-11,
            "start_logit": -7.122077941894531,
            "end_logit": -5.5295305252075195
        },
        {
            "text": "othy",
            "probability": 3.4462102470603835e-11,
            "start_logit": -6.094676971435547,
            "end_logit": -7.20512580871582
        }
    ],
    "53148a07dae131f847000002_018": [
        {
            "text": "thyroid",
            "probability": 0.9924757258593138,
            "start_logit": 5.8668928146362305,
            "end_logit": 4.91691255569458
        },
        {
            "text": "hypothyroidism,",
            "probability": 0.006891319716646134,
            "start_logit": 3.175185441970825,
            "end_logit": 2.6386799812316895
        },
        {
            "text": "thy",
            "probability": 0.00042982249434134705,
            "start_logit": 5.8668928146362305,
            "end_logit": -2.8276729583740234
        },
        {
            "text": "roid",
            "probability": 0.0001385840851348175,
            "start_logit": -3.0095877647399902,
            "end_logit": 4.91691255569458
        },
        {
            "text": "RESULTS: The elder sister had an elevated TSH level at newborn screening followed by subclinical hypothyroidism,",
            "probability": 3.977227359608803e-05,
            "start_logit": -4.669923305511475,
            "end_logit": 5.3289408683776855
        },
        {
            "text": "hyp",
            "probability": 9.947639952159793e-06,
            "start_logit": 3.175185441970825,
            "end_logit": -3.9020025730133057
        },
        {
            "text": ",",
            "probability": 8.528776486098207e-06,
            "start_logit": -3.5193865299224854,
            "end_logit": 2.6386799812316895
        },
        {
            "text": "hypothyroid",
            "probability": 3.4782906106733694e-06,
            "start_logit": 3.175185441970825,
            "end_logit": -4.952796936035156
        },
        {
            "text": "hypothyroidism",
            "probability": 1.9538609318984172e-06,
            "start_logit": 3.175185441970825,
            "end_logit": -5.5295305252075195
        },
        {
            "text": "hypothy",
            "probability": 3.657563405791908e-07,
            "start_logit": 3.175185441970825,
            "end_logit": -7.20512580871582
        },
        {
            "text": "subclinical hypothyroidism,",
            "probability": 2.0613776454858034e-07,
            "start_logit": -7.2420430183410645,
            "end_logit": 2.6386799812316895
        },
        {
            "text": "elevated TSH level at newborn screening followed by subclinical hypothyroidism,",
            "probability": 1.9818498679865347e-07,
            "start_logit": -7.281386852264404,
            "end_logit": 2.6386799812316895
        },
        {
            "text": "TSH level at newborn screening followed by subclinical hypothyroidism,",
            "probability": 9.528205205899685e-08,
            "start_logit": -8.01374626159668,
            "end_logit": 2.6386799812316895
        },
        {
            "text": "RESULTS: The elder sister had an elevated TSH level at newborn screening followed by subclinical",
            "probability": 4.85939796106341e-10,
            "start_logit": -4.669923305511475,
            "end_logit": -5.983654975891113
        },
        {
            "text": "RESULTS: The elder sister had an elevated TSH",
            "probability": 3.483639041902467e-10,
            "start_logit": -4.669923305511475,
            "end_logit": -6.316492080688477
        },
        {
            "text": "othyroid",
            "probability": 3.277296772429067e-10,
            "start_logit": -6.094676971435547,
            "end_logit": -4.952796936035156
        },
        {
            "text": "ism",
            "probability": 1.9535723503632778e-10,
            "start_logit": -6.035302639007568,
            "end_logit": -5.5295305252075195
        },
        {
            "text": "othyroidism",
            "probability": 1.8409566199663483e-10,
            "start_logit": -6.094676971435547,
            "end_logit": -5.5295305252075195
        },
        {
            "text": "roidism",
            "probability": 6.589447205845675e-11,
            "start_logit": -7.122077941894531,
            "end_logit": -5.5295305252075195
        },
        {
            "text": "othy",
            "probability": 3.4462102470603835e-11,
            "start_logit": -6.094676971435547,
            "end_logit": -7.20512580871582
        }
    ],
    "53148a07dae131f847000002_019": [
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid,",
            "probability": 0.15156291751296647,
            "start_logit": 3.4459567070007324,
            "end_logit": 2.3239476680755615
        },
        {
            "text": "thyroid",
            "probability": 0.14691137502549165,
            "start_logit": 3.414785385131836,
            "end_logit": 2.3239476680755615
        },
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid",
            "probability": 0.14387447030927097,
            "start_logit": 3.4459567070007324,
            "end_logit": 2.271888017654419
        },
        {
            "text": "thyroid, which may lead to thyroid",
            "probability": 0.13945889014963692,
            "start_logit": 3.414785385131836,
            "end_logit": 2.271888017654419
        },
        {
            "text": "thyroid, which may lead to thyroid functional disorders of hypothyroidism.",
            "probability": 0.08866491006811382,
            "start_logit": 3.414785385131836,
            "end_logit": 1.8189823627471924
        },
        {
            "text": "thyroid functional disorders of hypothyroidism.",
            "probability": 0.08446614440758321,
            "start_logit": 3.36627197265625,
            "end_logit": 1.8189823627471924
        },
        {
            "text": "hypothyroidism.",
            "probability": 0.05797145894539251,
            "start_logit": 2.9898719787597656,
            "end_logit": 1.8189823627471924
        },
        {
            "text": "hypothyroidism",
            "probability": 0.055490817860468764,
            "start_logit": 2.8000802993774414,
            "end_logit": 1.9650408029556274
        },
        {
            "text": "hypothyroidism in 5, its subclinical form in 1, diffuse thyroid goitre in 4 and nodular thyroid",
            "probability": 0.045129308929646686,
            "start_logit": 2.8000802993774414,
            "end_logit": 1.7583551406860352
        },
        {
            "text": "hypothyroidism in 5, its subclinical form in 1, diffuse thyroid",
            "probability": 0.04495906325598688,
            "start_logit": 2.8000802993774414,
            "end_logit": 1.7545756101608276
        },
        {
            "text": "thyroid goitre in 4 and nodular thyroid",
            "probability": 0.040328278771419784,
            "start_logit": 2.687601327896118,
            "end_logit": 1.7583551406860352
        },
        {
            "text": "thy",
            "probability": 0.00024564356702083516,
            "start_logit": 3.4459567070007324,
            "end_logit": -4.100926876068115
        },
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.",
            "probability": 0.0001712965075060521,
            "start_logit": 3.4459567070007324,
            "end_logit": -4.46141242980957
        },
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional",
            "probability": 0.00015361664549842693,
            "start_logit": 3.4459567070007324,
            "end_logit": -4.570348262786865
        },
        {
            "text": "thyroid, which may lead to thyroid functional",
            "probability": 0.0001489020730618139,
            "start_logit": 3.414785385131836,
            "end_logit": -4.570348262786865
        },
        {
            "text": "thyroid functional",
            "probability": 0.00014185075015770817,
            "start_logit": 3.36627197265625,
            "end_logit": -4.570348262786865
        },
        {
            "text": "hypothyroid",
            "probability": 0.00010856089814037051,
            "start_logit": 2.9898719787597656,
            "end_logit": -4.46141242980957
        },
        {
            "text": "hyp",
            "probability": 8.992426029745799e-05,
            "start_logit": 2.9898719787597656,
            "end_logit": -4.649755954742432
        },
        {
            "text": "roid",
            "probability": 6.535536210827518e-05,
            "start_logit": -4.30295991897583,
            "end_logit": 2.3239476680755615
        },
        {
            "text": "ism",
            "probability": 5.7214700231184876e-05,
            "start_logit": -4.077081680297852,
            "end_logit": 1.9650408029556274
        }
    ],
    "53148a07dae131f847000002_020": [
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid,",
            "probability": 0.15156291751296647,
            "start_logit": 3.4459567070007324,
            "end_logit": 2.3239476680755615
        },
        {
            "text": "thyroid",
            "probability": 0.14691137502549165,
            "start_logit": 3.414785385131836,
            "end_logit": 2.3239476680755615
        },
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid",
            "probability": 0.14387447030927097,
            "start_logit": 3.4459567070007324,
            "end_logit": 2.271888017654419
        },
        {
            "text": "thyroid, which may lead to thyroid",
            "probability": 0.13945889014963692,
            "start_logit": 3.414785385131836,
            "end_logit": 2.271888017654419
        },
        {
            "text": "thyroid, which may lead to thyroid functional disorders of hypothyroidism.",
            "probability": 0.08866491006811382,
            "start_logit": 3.414785385131836,
            "end_logit": 1.8189823627471924
        },
        {
            "text": "thyroid functional disorders of hypothyroidism.",
            "probability": 0.08446614440758321,
            "start_logit": 3.36627197265625,
            "end_logit": 1.8189823627471924
        },
        {
            "text": "hypothyroidism.",
            "probability": 0.05797145894539251,
            "start_logit": 2.9898719787597656,
            "end_logit": 1.8189823627471924
        },
        {
            "text": "hypothyroidism",
            "probability": 0.055490817860468764,
            "start_logit": 2.8000802993774414,
            "end_logit": 1.9650408029556274
        },
        {
            "text": "hypothyroidism in 5, its subclinical form in 1, diffuse thyroid goitre in 4 and nodular thyroid",
            "probability": 0.045129308929646686,
            "start_logit": 2.8000802993774414,
            "end_logit": 1.7583551406860352
        },
        {
            "text": "hypothyroidism in 5, its subclinical form in 1, diffuse thyroid",
            "probability": 0.04495906325598688,
            "start_logit": 2.8000802993774414,
            "end_logit": 1.7545756101608276
        },
        {
            "text": "thyroid goitre in 4 and nodular thyroid",
            "probability": 0.040328278771419784,
            "start_logit": 2.687601327896118,
            "end_logit": 1.7583551406860352
        },
        {
            "text": "thy",
            "probability": 0.00024564356702083516,
            "start_logit": 3.4459567070007324,
            "end_logit": -4.100926876068115
        },
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.",
            "probability": 0.0001712965075060521,
            "start_logit": 3.4459567070007324,
            "end_logit": -4.46141242980957
        },
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional",
            "probability": 0.00015361664549842693,
            "start_logit": 3.4459567070007324,
            "end_logit": -4.570348262786865
        },
        {
            "text": "thyroid, which may lead to thyroid functional",
            "probability": 0.0001489020730618139,
            "start_logit": 3.414785385131836,
            "end_logit": -4.570348262786865
        },
        {
            "text": "thyroid functional",
            "probability": 0.00014185075015770817,
            "start_logit": 3.36627197265625,
            "end_logit": -4.570348262786865
        },
        {
            "text": "hypothyroid",
            "probability": 0.00010856089814037051,
            "start_logit": 2.9898719787597656,
            "end_logit": -4.46141242980957
        },
        {
            "text": "hyp",
            "probability": 8.992426029745799e-05,
            "start_logit": 2.9898719787597656,
            "end_logit": -4.649755954742432
        },
        {
            "text": "roid",
            "probability": 6.535536210827518e-05,
            "start_logit": -4.30295991897583,
            "end_logit": 2.3239476680755615
        },
        {
            "text": "ism",
            "probability": 5.7214700231184876e-05,
            "start_logit": -4.077081680297852,
            "end_logit": 1.9650408029556274
        }
    ],
    "53148a07dae131f847000002_021": [
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid,",
            "probability": 0.15156291751296647,
            "start_logit": 3.4459567070007324,
            "end_logit": 2.3239476680755615
        },
        {
            "text": "thyroid",
            "probability": 0.14691137502549165,
            "start_logit": 3.414785385131836,
            "end_logit": 2.3239476680755615
        },
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid",
            "probability": 0.14387447030927097,
            "start_logit": 3.4459567070007324,
            "end_logit": 2.271888017654419
        },
        {
            "text": "thyroid, which may lead to thyroid",
            "probability": 0.13945889014963692,
            "start_logit": 3.414785385131836,
            "end_logit": 2.271888017654419
        },
        {
            "text": "thyroid, which may lead to thyroid functional disorders of hypothyroidism.",
            "probability": 0.08866491006811382,
            "start_logit": 3.414785385131836,
            "end_logit": 1.8189823627471924
        },
        {
            "text": "thyroid functional disorders of hypothyroidism.",
            "probability": 0.08446614440758321,
            "start_logit": 3.36627197265625,
            "end_logit": 1.8189823627471924
        },
        {
            "text": "hypothyroidism.",
            "probability": 0.05797145894539251,
            "start_logit": 2.9898719787597656,
            "end_logit": 1.8189823627471924
        },
        {
            "text": "hypothyroidism",
            "probability": 0.055490817860468764,
            "start_logit": 2.8000802993774414,
            "end_logit": 1.9650408029556274
        },
        {
            "text": "hypothyroidism in 5, its subclinical form in 1, diffuse thyroid goitre in 4 and nodular thyroid",
            "probability": 0.045129308929646686,
            "start_logit": 2.8000802993774414,
            "end_logit": 1.7583551406860352
        },
        {
            "text": "hypothyroidism in 5, its subclinical form in 1, diffuse thyroid",
            "probability": 0.04495906325598688,
            "start_logit": 2.8000802993774414,
            "end_logit": 1.7545756101608276
        },
        {
            "text": "thyroid goitre in 4 and nodular thyroid",
            "probability": 0.040328278771419784,
            "start_logit": 2.687601327896118,
            "end_logit": 1.7583551406860352
        },
        {
            "text": "thy",
            "probability": 0.00024564356702083516,
            "start_logit": 3.4459567070007324,
            "end_logit": -4.100926876068115
        },
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.",
            "probability": 0.0001712965075060521,
            "start_logit": 3.4459567070007324,
            "end_logit": -4.46141242980957
        },
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional",
            "probability": 0.00015361664549842693,
            "start_logit": 3.4459567070007324,
            "end_logit": -4.570348262786865
        },
        {
            "text": "thyroid, which may lead to thyroid functional",
            "probability": 0.0001489020730618139,
            "start_logit": 3.414785385131836,
            "end_logit": -4.570348262786865
        },
        {
            "text": "thyroid functional",
            "probability": 0.00014185075015770817,
            "start_logit": 3.36627197265625,
            "end_logit": -4.570348262786865
        },
        {
            "text": "hypothyroid",
            "probability": 0.00010856089814037051,
            "start_logit": 2.9898719787597656,
            "end_logit": -4.46141242980957
        },
        {
            "text": "hyp",
            "probability": 8.992426029745799e-05,
            "start_logit": 2.9898719787597656,
            "end_logit": -4.649755954742432
        },
        {
            "text": "roid",
            "probability": 6.535536210827518e-05,
            "start_logit": -4.30295991897583,
            "end_logit": 2.3239476680755615
        },
        {
            "text": "ism",
            "probability": 5.7214700231184876e-05,
            "start_logit": -4.077081680297852,
            "end_logit": 1.9650408029556274
        }
    ],
    "53148a07dae131f847000002_022": [
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid,",
            "probability": 0.15156291751296647,
            "start_logit": 3.4459567070007324,
            "end_logit": 2.3239476680755615
        },
        {
            "text": "thyroid",
            "probability": 0.14691137502549165,
            "start_logit": 3.414785385131836,
            "end_logit": 2.3239476680755615
        },
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid",
            "probability": 0.14387447030927097,
            "start_logit": 3.4459567070007324,
            "end_logit": 2.271888017654419
        },
        {
            "text": "thyroid, which may lead to thyroid",
            "probability": 0.13945889014963692,
            "start_logit": 3.414785385131836,
            "end_logit": 2.271888017654419
        },
        {
            "text": "thyroid, which may lead to thyroid functional disorders of hypothyroidism.",
            "probability": 0.08866491006811382,
            "start_logit": 3.414785385131836,
            "end_logit": 1.8189823627471924
        },
        {
            "text": "thyroid functional disorders of hypothyroidism.",
            "probability": 0.08446614440758321,
            "start_logit": 3.36627197265625,
            "end_logit": 1.8189823627471924
        },
        {
            "text": "hypothyroidism.",
            "probability": 0.05797145894539251,
            "start_logit": 2.9898719787597656,
            "end_logit": 1.8189823627471924
        },
        {
            "text": "hypothyroidism",
            "probability": 0.055490817860468764,
            "start_logit": 2.8000802993774414,
            "end_logit": 1.9650408029556274
        },
        {
            "text": "hypothyroidism in 5, its subclinical form in 1, diffuse thyroid goitre in 4 and nodular thyroid",
            "probability": 0.045129308929646686,
            "start_logit": 2.8000802993774414,
            "end_logit": 1.7583551406860352
        },
        {
            "text": "hypothyroidism in 5, its subclinical form in 1, diffuse thyroid",
            "probability": 0.04495906325598688,
            "start_logit": 2.8000802993774414,
            "end_logit": 1.7545756101608276
        },
        {
            "text": "thyroid goitre in 4 and nodular thyroid",
            "probability": 0.040328278771419784,
            "start_logit": 2.687601327896118,
            "end_logit": 1.7583551406860352
        },
        {
            "text": "thy",
            "probability": 0.00024564356702083516,
            "start_logit": 3.4459567070007324,
            "end_logit": -4.100926876068115
        },
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.",
            "probability": 0.0001712965075060521,
            "start_logit": 3.4459567070007324,
            "end_logit": -4.46141242980957
        },
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional",
            "probability": 0.00015361664549842693,
            "start_logit": 3.4459567070007324,
            "end_logit": -4.570348262786865
        },
        {
            "text": "thyroid, which may lead to thyroid functional",
            "probability": 0.0001489020730618139,
            "start_logit": 3.414785385131836,
            "end_logit": -4.570348262786865
        },
        {
            "text": "thyroid functional",
            "probability": 0.00014185075015770817,
            "start_logit": 3.36627197265625,
            "end_logit": -4.570348262786865
        },
        {
            "text": "hypothyroid",
            "probability": 0.00010856089814037051,
            "start_logit": 2.9898719787597656,
            "end_logit": -4.46141242980957
        },
        {
            "text": "hyp",
            "probability": 8.992426029745799e-05,
            "start_logit": 2.9898719787597656,
            "end_logit": -4.649755954742432
        },
        {
            "text": "roid",
            "probability": 6.535536210827518e-05,
            "start_logit": -4.30295991897583,
            "end_logit": 2.3239476680755615
        },
        {
            "text": "ism",
            "probability": 5.7214700231184876e-05,
            "start_logit": -4.077081680297852,
            "end_logit": 1.9650408029556274
        }
    ],
    "53148a07dae131f847000002_023": [
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid,",
            "probability": 0.15156291751296647,
            "start_logit": 3.4459567070007324,
            "end_logit": 2.3239476680755615
        },
        {
            "text": "thyroid",
            "probability": 0.14691137502549165,
            "start_logit": 3.414785385131836,
            "end_logit": 2.3239476680755615
        },
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid",
            "probability": 0.14387447030927097,
            "start_logit": 3.4459567070007324,
            "end_logit": 2.271888017654419
        },
        {
            "text": "thyroid, which may lead to thyroid",
            "probability": 0.13945889014963692,
            "start_logit": 3.414785385131836,
            "end_logit": 2.271888017654419
        },
        {
            "text": "thyroid, which may lead to thyroid functional disorders of hypothyroidism.",
            "probability": 0.08866491006811382,
            "start_logit": 3.414785385131836,
            "end_logit": 1.8189823627471924
        },
        {
            "text": "thyroid functional disorders of hypothyroidism.",
            "probability": 0.08446614440758321,
            "start_logit": 3.36627197265625,
            "end_logit": 1.8189823627471924
        },
        {
            "text": "hypothyroidism.",
            "probability": 0.05797145894539251,
            "start_logit": 2.9898719787597656,
            "end_logit": 1.8189823627471924
        },
        {
            "text": "hypothyroidism",
            "probability": 0.055490817860468764,
            "start_logit": 2.8000802993774414,
            "end_logit": 1.9650408029556274
        },
        {
            "text": "hypothyroidism in 5, its subclinical form in 1, diffuse thyroid goitre in 4 and nodular thyroid",
            "probability": 0.045129308929646686,
            "start_logit": 2.8000802993774414,
            "end_logit": 1.7583551406860352
        },
        {
            "text": "hypothyroidism in 5, its subclinical form in 1, diffuse thyroid",
            "probability": 0.04495906325598688,
            "start_logit": 2.8000802993774414,
            "end_logit": 1.7545756101608276
        },
        {
            "text": "thyroid goitre in 4 and nodular thyroid",
            "probability": 0.040328278771419784,
            "start_logit": 2.687601327896118,
            "end_logit": 1.7583551406860352
        },
        {
            "text": "thy",
            "probability": 0.00024564356702083516,
            "start_logit": 3.4459567070007324,
            "end_logit": -4.100926876068115
        },
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.",
            "probability": 0.0001712965075060521,
            "start_logit": 3.4459567070007324,
            "end_logit": -4.46141242980957
        },
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional",
            "probability": 0.00015361664549842693,
            "start_logit": 3.4459567070007324,
            "end_logit": -4.570348262786865
        },
        {
            "text": "thyroid, which may lead to thyroid functional",
            "probability": 0.0001489020730618139,
            "start_logit": 3.414785385131836,
            "end_logit": -4.570348262786865
        },
        {
            "text": "thyroid functional",
            "probability": 0.00014185075015770817,
            "start_logit": 3.36627197265625,
            "end_logit": -4.570348262786865
        },
        {
            "text": "hypothyroid",
            "probability": 0.00010856089814037051,
            "start_logit": 2.9898719787597656,
            "end_logit": -4.46141242980957
        },
        {
            "text": "hyp",
            "probability": 8.992426029745799e-05,
            "start_logit": 2.9898719787597656,
            "end_logit": -4.649755954742432
        },
        {
            "text": "roid",
            "probability": 6.535536210827518e-05,
            "start_logit": -4.30295991897583,
            "end_logit": 2.3239476680755615
        },
        {
            "text": "ism",
            "probability": 5.7214700231184876e-05,
            "start_logit": -4.077081680297852,
            "end_logit": 1.9650408029556274
        }
    ],
    "53148a07dae131f847000002_024": [
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid,",
            "probability": 0.15156291751296647,
            "start_logit": 3.4459567070007324,
            "end_logit": 2.3239476680755615
        },
        {
            "text": "thyroid",
            "probability": 0.14691137502549165,
            "start_logit": 3.414785385131836,
            "end_logit": 2.3239476680755615
        },
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid",
            "probability": 0.14387447030927097,
            "start_logit": 3.4459567070007324,
            "end_logit": 2.271888017654419
        },
        {
            "text": "thyroid, which may lead to thyroid",
            "probability": 0.13945889014963692,
            "start_logit": 3.414785385131836,
            "end_logit": 2.271888017654419
        },
        {
            "text": "thyroid, which may lead to thyroid functional disorders of hypothyroidism.",
            "probability": 0.08866491006811382,
            "start_logit": 3.414785385131836,
            "end_logit": 1.8189823627471924
        },
        {
            "text": "thyroid functional disorders of hypothyroidism.",
            "probability": 0.08446614440758321,
            "start_logit": 3.36627197265625,
            "end_logit": 1.8189823627471924
        },
        {
            "text": "hypothyroidism.",
            "probability": 0.05797145894539251,
            "start_logit": 2.9898719787597656,
            "end_logit": 1.8189823627471924
        },
        {
            "text": "hypothyroidism",
            "probability": 0.055490817860468764,
            "start_logit": 2.8000802993774414,
            "end_logit": 1.9650408029556274
        },
        {
            "text": "hypothyroidism in 5, its subclinical form in 1, diffuse thyroid goitre in 4 and nodular thyroid",
            "probability": 0.045129308929646686,
            "start_logit": 2.8000802993774414,
            "end_logit": 1.7583551406860352
        },
        {
            "text": "hypothyroidism in 5, its subclinical form in 1, diffuse thyroid",
            "probability": 0.04495906325598688,
            "start_logit": 2.8000802993774414,
            "end_logit": 1.7545756101608276
        },
        {
            "text": "thyroid goitre in 4 and nodular thyroid",
            "probability": 0.040328278771419784,
            "start_logit": 2.687601327896118,
            "end_logit": 1.7583551406860352
        },
        {
            "text": "thy",
            "probability": 0.00024564356702083516,
            "start_logit": 3.4459567070007324,
            "end_logit": -4.100926876068115
        },
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.",
            "probability": 0.0001712965075060521,
            "start_logit": 3.4459567070007324,
            "end_logit": -4.46141242980957
        },
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional",
            "probability": 0.00015361664549842693,
            "start_logit": 3.4459567070007324,
            "end_logit": -4.570348262786865
        },
        {
            "text": "thyroid, which may lead to thyroid functional",
            "probability": 0.0001489020730618139,
            "start_logit": 3.414785385131836,
            "end_logit": -4.570348262786865
        },
        {
            "text": "thyroid functional",
            "probability": 0.00014185075015770817,
            "start_logit": 3.36627197265625,
            "end_logit": -4.570348262786865
        },
        {
            "text": "hypothyroid",
            "probability": 0.00010856089814037051,
            "start_logit": 2.9898719787597656,
            "end_logit": -4.46141242980957
        },
        {
            "text": "hyp",
            "probability": 8.992426029745799e-05,
            "start_logit": 2.9898719787597656,
            "end_logit": -4.649755954742432
        },
        {
            "text": "roid",
            "probability": 6.535536210827518e-05,
            "start_logit": -4.30295991897583,
            "end_logit": 2.3239476680755615
        },
        {
            "text": "ism",
            "probability": 5.7214700231184876e-05,
            "start_logit": -4.077081680297852,
            "end_logit": 1.9650408029556274
        }
    ],
    "53148a07dae131f847000002_025": [
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid,",
            "probability": 0.15156291751296647,
            "start_logit": 3.4459567070007324,
            "end_logit": 2.3239476680755615
        },
        {
            "text": "thyroid",
            "probability": 0.14691137502549165,
            "start_logit": 3.414785385131836,
            "end_logit": 2.3239476680755615
        },
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid",
            "probability": 0.14387447030927097,
            "start_logit": 3.4459567070007324,
            "end_logit": 2.271888017654419
        },
        {
            "text": "thyroid, which may lead to thyroid",
            "probability": 0.13945889014963692,
            "start_logit": 3.414785385131836,
            "end_logit": 2.271888017654419
        },
        {
            "text": "thyroid, which may lead to thyroid functional disorders of hypothyroidism.",
            "probability": 0.08866491006811382,
            "start_logit": 3.414785385131836,
            "end_logit": 1.8189823627471924
        },
        {
            "text": "thyroid functional disorders of hypothyroidism.",
            "probability": 0.08446614440758321,
            "start_logit": 3.36627197265625,
            "end_logit": 1.8189823627471924
        },
        {
            "text": "hypothyroidism.",
            "probability": 0.05797145894539251,
            "start_logit": 2.9898719787597656,
            "end_logit": 1.8189823627471924
        },
        {
            "text": "hypothyroidism",
            "probability": 0.055490817860468764,
            "start_logit": 2.8000802993774414,
            "end_logit": 1.9650408029556274
        },
        {
            "text": "hypothyroidism in 5, its subclinical form in 1, diffuse thyroid goitre in 4 and nodular thyroid",
            "probability": 0.045129308929646686,
            "start_logit": 2.8000802993774414,
            "end_logit": 1.7583551406860352
        },
        {
            "text": "hypothyroidism in 5, its subclinical form in 1, diffuse thyroid",
            "probability": 0.04495906325598688,
            "start_logit": 2.8000802993774414,
            "end_logit": 1.7545756101608276
        },
        {
            "text": "thyroid goitre in 4 and nodular thyroid",
            "probability": 0.040328278771419784,
            "start_logit": 2.687601327896118,
            "end_logit": 1.7583551406860352
        },
        {
            "text": "thy",
            "probability": 0.00024564356702083516,
            "start_logit": 3.4459567070007324,
            "end_logit": -4.100926876068115
        },
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.",
            "probability": 0.0001712965075060521,
            "start_logit": 3.4459567070007324,
            "end_logit": -4.46141242980957
        },
        {
            "text": "thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional",
            "probability": 0.00015361664549842693,
            "start_logit": 3.4459567070007324,
            "end_logit": -4.570348262786865
        },
        {
            "text": "thyroid, which may lead to thyroid functional",
            "probability": 0.0001489020730618139,
            "start_logit": 3.414785385131836,
            "end_logit": -4.570348262786865
        },
        {
            "text": "thyroid functional",
            "probability": 0.00014185075015770817,
            "start_logit": 3.36627197265625,
            "end_logit": -4.570348262786865
        },
        {
            "text": "hypothyroid",
            "probability": 0.00010856089814037051,
            "start_logit": 2.9898719787597656,
            "end_logit": -4.46141242980957
        },
        {
            "text": "hyp",
            "probability": 8.992426029745799e-05,
            "start_logit": 2.9898719787597656,
            "end_logit": -4.649755954742432
        },
        {
            "text": "roid",
            "probability": 6.535536210827518e-05,
            "start_logit": -4.30295991897583,
            "end_logit": 2.3239476680755615
        },
        {
            "text": "ism",
            "probability": 5.7214700231184876e-05,
            "start_logit": -4.077081680297852,
            "end_logit": 1.9650408029556274
        }
    ],
    "53148a07dae131f847000002_026": [
        {
            "text": "Thyroid",
            "probability": 0.6996220867629,
            "start_logit": 5.889997959136963,
            "end_logit": 4.857213020324707
        },
        {
            "text": "thyroid",
            "probability": 0.29874690633742473,
            "start_logit": 5.366455078125,
            "end_logit": 4.529812335968018
        },
        {
            "text": "Thyroidectomy",
            "probability": 0.0009071849773128763,
            "start_logit": 5.889997959136963,
            "end_logit": -1.790736198425293
        },
        {
            "text": "Th",
            "probability": 0.00024259302133131715,
            "start_logit": 5.889997959136963,
            "end_logit": -3.1096973419189453
        },
        {
            "text": "the thyroid.",
            "probability": 0.00013820665245517063,
            "start_logit": -2.3121469020843506,
            "end_logit": 4.529812335968018
        },
        {
            "text": "yroid",
            "probability": 0.00012463288124559747,
            "start_logit": -2.7429251670837402,
            "end_logit": 4.857213020324707
        },
        {
            "text": "roid",
            "probability": 0.0001029936816790262,
            "start_logit": -2.9336299896240234,
            "end_logit": 4.857213020324707
        },
        {
            "text": "thy",
            "probability": 9.763058673200596e-05,
            "start_logit": 5.366455078125,
            "end_logit": -3.4963488578796387
        },
        {
            "text": "thyroid.",
            "probability": 8.843232355860264e-06,
            "start_logit": 5.366455078125,
            "end_logit": -5.897887229919434
        },
        {
            "text": "Thy",
            "probability": 3.850261097117572e-06,
            "start_logit": 5.889997959136963,
            "end_logit": -7.252941608428955
        },
        {
            "text": "Thyroidectomy in a patient with multinodular dyshormonogenetic",
            "probability": 1.959822125305899e-06,
            "start_logit": 5.889997959136963,
            "end_logit": -7.928228855133057
        },
        {
            "text": "of the thyroid.",
            "probability": 1.3789603429129816e-06,
            "start_logit": -6.919567108154297,
            "end_logit": 4.529812335968018
        },
        {
            "text": "regular imaging of the thyroid.",
            "probability": 7.783057369703368e-07,
            "start_logit": -7.491532802581787,
            "end_logit": 4.529812335968018
        },
        {
            "text": "imaging of the thyroid.",
            "probability": 6.377932443059903e-07,
            "start_logit": -7.690638065338135,
            "end_logit": 4.529812335968018
        },
        {
            "text": "yroidectomy",
            "probability": 1.616087880649531e-07,
            "start_logit": -2.7429251670837402,
            "end_logit": -1.790736198425293
        },
        {
            "text": "roidectomy",
            "probability": 1.3354970139617904e-07,
            "start_logit": -2.9336299896240234,
            "end_logit": -1.790736198425293
        },
        {
            "text": "ectomy",
            "probability": 2.0472269295354694e-08,
            "start_logit": -4.809032440185547,
            "end_logit": -1.790736198425293
        },
        {
            "text": "y",
            "probability": 6.858976341097483e-10,
            "start_logit": -2.7429251670837402,
            "end_logit": -7.252941608428955
        },
        {
            "text": "Thyroidectomy in a patient with multinodular dyshormonogenetic goitre--a case of Pendred syndrome",
            "probability": 2.1268401069224578e-10,
            "start_logit": -2.7429251670837402,
            "end_logit": -8.42386245727539
        },
        {
            "text": "SLC26A4",
            "probability": 1.9467636592139424e-10,
            "start_logit": -6.822713375091553,
            "end_logit": -4.4325432777404785
        }
    ],
    "53148a07dae131f847000002_027": [
        {
            "text": "Thyroid",
            "probability": 0.6996220867629,
            "start_logit": 5.889997959136963,
            "end_logit": 4.857213020324707
        },
        {
            "text": "thyroid",
            "probability": 0.29874690633742473,
            "start_logit": 5.366455078125,
            "end_logit": 4.529812335968018
        },
        {
            "text": "Thyroidectomy",
            "probability": 0.0009071849773128763,
            "start_logit": 5.889997959136963,
            "end_logit": -1.790736198425293
        },
        {
            "text": "Th",
            "probability": 0.00024259302133131715,
            "start_logit": 5.889997959136963,
            "end_logit": -3.1096973419189453
        },
        {
            "text": "the thyroid.",
            "probability": 0.00013820665245517063,
            "start_logit": -2.3121469020843506,
            "end_logit": 4.529812335968018
        },
        {
            "text": "yroid",
            "probability": 0.00012463288124559747,
            "start_logit": -2.7429251670837402,
            "end_logit": 4.857213020324707
        },
        {
            "text": "roid",
            "probability": 0.0001029936816790262,
            "start_logit": -2.9336299896240234,
            "end_logit": 4.857213020324707
        },
        {
            "text": "thy",
            "probability": 9.763058673200596e-05,
            "start_logit": 5.366455078125,
            "end_logit": -3.4963488578796387
        },
        {
            "text": "thyroid.",
            "probability": 8.843232355860264e-06,
            "start_logit": 5.366455078125,
            "end_logit": -5.897887229919434
        },
        {
            "text": "Thy",
            "probability": 3.850261097117572e-06,
            "start_logit": 5.889997959136963,
            "end_logit": -7.252941608428955
        },
        {
            "text": "Thyroidectomy in a patient with multinodular dyshormonogenetic",
            "probability": 1.959822125305899e-06,
            "start_logit": 5.889997959136963,
            "end_logit": -7.928228855133057
        },
        {
            "text": "of the thyroid.",
            "probability": 1.3789603429129816e-06,
            "start_logit": -6.919567108154297,
            "end_logit": 4.529812335968018
        },
        {
            "text": "regular imaging of the thyroid.",
            "probability": 7.783057369703368e-07,
            "start_logit": -7.491532802581787,
            "end_logit": 4.529812335968018
        },
        {
            "text": "imaging of the thyroid.",
            "probability": 6.377932443059903e-07,
            "start_logit": -7.690638065338135,
            "end_logit": 4.529812335968018
        },
        {
            "text": "yroidectomy",
            "probability": 1.616087880649531e-07,
            "start_logit": -2.7429251670837402,
            "end_logit": -1.790736198425293
        },
        {
            "text": "roidectomy",
            "probability": 1.3354970139617904e-07,
            "start_logit": -2.9336299896240234,
            "end_logit": -1.790736198425293
        },
        {
            "text": "ectomy",
            "probability": 2.0472269295354694e-08,
            "start_logit": -4.809032440185547,
            "end_logit": -1.790736198425293
        },
        {
            "text": "y",
            "probability": 6.858976341097483e-10,
            "start_logit": -2.7429251670837402,
            "end_logit": -7.252941608428955
        },
        {
            "text": "Thyroidectomy in a patient with multinodular dyshormonogenetic goitre--a case of Pendred syndrome",
            "probability": 2.1268401069224578e-10,
            "start_logit": -2.7429251670837402,
            "end_logit": -8.42386245727539
        },
        {
            "text": "SLC26A4",
            "probability": 1.9467636592139424e-10,
            "start_logit": -6.822713375091553,
            "end_logit": -4.4325432777404785
        }
    ],
    "53148a07dae131f847000002_028": [
        {
            "text": "hypothyroidism",
            "probability": 0.5428470037130597,
            "start_logit": 7.070700168609619,
            "end_logit": 5.897567272186279
        },
        {
            "text": "thyroid hormone synthesis. Goiter development and development of hypothyroidism",
            "probability": 0.2870112190422526,
            "start_logit": 6.433393955230713,
            "end_logit": 5.897567272186279
        },
        {
            "text": "thyroid",
            "probability": 0.16969705353560013,
            "start_logit": 6.433393955230713,
            "end_logit": 5.372060775756836
        },
        {
            "text": "hyp",
            "probability": 0.00012886430957041633,
            "start_logit": 7.070700168609619,
            "end_logit": -2.4482555389404297
        },
        {
            "text": "development of hypothyroidism",
            "probability": 9.866766513439966e-05,
            "start_logit": -1.5421253442764282,
            "end_logit": 5.897567272186279
        },
        {
            "text": "ism",
            "probability": 9.312140419814238e-05,
            "start_logit": -1.5999785661697388,
            "end_logit": 5.897567272186279
        },
        {
            "text": "thy",
            "probability": 3.377177160129299e-05,
            "start_logit": 6.433393955230713,
            "end_logit": -3.1500840187072754
        },
        {
            "text": "hypothyroid",
            "probability": 2.0514463868013635e-05,
            "start_logit": 7.070700168609619,
            "end_logit": -4.285885334014893
        },
        {
            "text": "roid",
            "probability": 2.0364187425265924e-05,
            "start_logit": -2.5945982933044434,
            "end_logit": 5.372060775756836
        },
        {
            "text": "othyroidism",
            "probability": 1.7777758484215867e-05,
            "start_logit": -3.255934476852417,
            "end_logit": 5.897567272186279
        },
        {
            "text": "thyroid hormone synthesis. Goiter development and development",
            "probability": 1.0225128631549717e-05,
            "start_logit": 6.433393955230713,
            "end_logit": -4.344861030578613
        },
        {
            "text": "development and development of hypothyroidism",
            "probability": 5.377401726758174e-06,
            "start_logit": -4.451677322387695,
            "end_logit": 5.897567272186279
        },
        {
            "text": "of hypothyroidism",
            "probability": 2.9612880475682514e-06,
            "start_logit": -5.048258304595947,
            "end_logit": 5.897567272186279
        },
        {
            "text": "hormone synthesis. Goiter development and development of hypothyroidism",
            "probability": 2.2044895365535678e-06,
            "start_logit": -5.343386650085449,
            "end_logit": 5.897567272186279
        },
        {
            "text": "hypothy",
            "probability": 2.139552851000217e-06,
            "start_logit": 7.070700168609619,
            "end_logit": -6.5464186668396
        },
        {
            "text": "hypothyroidism are variable and depend on nutritional iodide intake.",
            "probability": 2.085761949002685e-06,
            "start_logit": 7.070700168609619,
            "end_logit": -6.571881294250488
        },
        {
            "text": "hypothyroidism are variable",
            "probability": 2.0206212432936107e-06,
            "start_logit": 7.070700168609619,
            "end_logit": -6.603610515594482
        },
        {
            "text": "roidism",
            "probability": 1.9031691343840578e-06,
            "start_logit": -5.490362167358398,
            "end_logit": 5.897567272186279
        },
        {
            "text": "thyroid hormone",
            "probability": 1.457755492335794e-06,
            "start_logit": 6.433393955230713,
            "end_logit": -6.292811393737793
        },
        {
            "text": "insufficient thyroid hormone synthesis. Goiter development and development of hypothyroidism",
            "probability": 1.2669801936110417e-06,
            "start_logit": -5.897246360778809,
            "end_logit": 5.897567272186279
        }
    ],
    "53148a07dae131f847000002_029": [
        {
            "text": "hypothyroidism",
            "probability": 0.5428470037130597,
            "start_logit": 7.070700168609619,
            "end_logit": 5.897567272186279
        },
        {
            "text": "thyroid hormone synthesis. Goiter development and development of hypothyroidism",
            "probability": 0.2870112190422526,
            "start_logit": 6.433393955230713,
            "end_logit": 5.897567272186279
        },
        {
            "text": "thyroid",
            "probability": 0.16969705353560013,
            "start_logit": 6.433393955230713,
            "end_logit": 5.372060775756836
        },
        {
            "text": "hyp",
            "probability": 0.00012886430957041633,
            "start_logit": 7.070700168609619,
            "end_logit": -2.4482555389404297
        },
        {
            "text": "development of hypothyroidism",
            "probability": 9.866766513439966e-05,
            "start_logit": -1.5421253442764282,
            "end_logit": 5.897567272186279
        },
        {
            "text": "ism",
            "probability": 9.312140419814238e-05,
            "start_logit": -1.5999785661697388,
            "end_logit": 5.897567272186279
        },
        {
            "text": "thy",
            "probability": 3.377177160129299e-05,
            "start_logit": 6.433393955230713,
            "end_logit": -3.1500840187072754
        },
        {
            "text": "hypothyroid",
            "probability": 2.0514463868013635e-05,
            "start_logit": 7.070700168609619,
            "end_logit": -4.285885334014893
        },
        {
            "text": "roid",
            "probability": 2.0364187425265924e-05,
            "start_logit": -2.5945982933044434,
            "end_logit": 5.372060775756836
        },
        {
            "text": "othyroidism",
            "probability": 1.7777758484215867e-05,
            "start_logit": -3.255934476852417,
            "end_logit": 5.897567272186279
        },
        {
            "text": "thyroid hormone synthesis. Goiter development and development",
            "probability": 1.0225128631549717e-05,
            "start_logit": 6.433393955230713,
            "end_logit": -4.344861030578613
        },
        {
            "text": "development and development of hypothyroidism",
            "probability": 5.377401726758174e-06,
            "start_logit": -4.451677322387695,
            "end_logit": 5.897567272186279
        },
        {
            "text": "of hypothyroidism",
            "probability": 2.9612880475682514e-06,
            "start_logit": -5.048258304595947,
            "end_logit": 5.897567272186279
        },
        {
            "text": "hormone synthesis. Goiter development and development of hypothyroidism",
            "probability": 2.2044895365535678e-06,
            "start_logit": -5.343386650085449,
            "end_logit": 5.897567272186279
        },
        {
            "text": "hypothy",
            "probability": 2.139552851000217e-06,
            "start_logit": 7.070700168609619,
            "end_logit": -6.5464186668396
        },
        {
            "text": "hypothyroidism are variable and depend on nutritional iodide intake.",
            "probability": 2.085761949002685e-06,
            "start_logit": 7.070700168609619,
            "end_logit": -6.571881294250488
        },
        {
            "text": "hypothyroidism are variable",
            "probability": 2.0206212432936107e-06,
            "start_logit": 7.070700168609619,
            "end_logit": -6.603610515594482
        },
        {
            "text": "roidism",
            "probability": 1.9031691343840578e-06,
            "start_logit": -5.490362167358398,
            "end_logit": 5.897567272186279
        },
        {
            "text": "thyroid hormone",
            "probability": 1.457755492335794e-06,
            "start_logit": 6.433393955230713,
            "end_logit": -6.292811393737793
        },
        {
            "text": "insufficient thyroid hormone synthesis. Goiter development and development of hypothyroidism",
            "probability": 1.2669801936110417e-06,
            "start_logit": -5.897246360778809,
            "end_logit": 5.897567272186279
        }
    ],
    "53148a07dae131f847000002_030": [
        {
            "text": "thyroid",
            "probability": 0.9987628763205734,
            "start_logit": 6.350843906402588,
            "end_logit": 5.488846778869629
        },
        {
            "text": "positive thyroid",
            "probability": 0.0007387575334220665,
            "start_logit": -0.7616024017333984,
            "end_logit": 5.3919901847839355
        },
        {
            "text": "thy",
            "probability": 0.00023181249607244283,
            "start_logit": 6.307036399841309,
            "end_logit": -2.8356895446777344
        },
        {
            "text": "roid",
            "probability": 0.00022657827816868813,
            "start_logit": -2.0403382778167725,
            "end_logit": 5.488846778869629
        },
        {
            "text": "thyroid hormones were essentially normal",
            "probability": 1.2928685268189052e-05,
            "start_logit": 6.350843906402588,
            "end_logit": -5.765977382659912
        },
        {
            "text": "thyroid hormones",
            "probability": 1.2836260467624703e-05,
            "start_logit": 6.350843906402588,
            "end_logit": -5.773151874542236
        },
        {
            "text": "Levels of thyroid",
            "probability": 1.1072103500199405e-05,
            "start_logit": -5.059000015258789,
            "end_logit": 5.488846778869629
        },
        {
            "text": "elevated serum thyroglobulin levels, whereas 2 other patients had positive thyroid",
            "probability": 1.6417020283029782e-06,
            "start_logit": -6.870838642120361,
            "end_logit": 5.3919901847839355
        },
        {
            "text": "of thyroid",
            "probability": 1.422723092208491e-06,
            "start_logit": -7.110856056213379,
            "end_logit": 5.488846778869629
        },
        {
            "text": "positive",
            "probability": 7.227147625471905e-08,
            "start_logit": -0.7616024017333984,
            "end_logit": -3.8403053283691406
        },
        {
            "text": "hearing loss, goiter, and a partial iodine organification defect. In this study, we characterized the thyroid",
            "probability": 4.293088280458003e-10,
            "start_logit": -6.267732620239258,
            "end_logit": -3.4601833820343018
        },
        {
            "text": "characterized by",
            "probability": 3.5140168341617314e-10,
            "start_logit": -3.9792819023132324,
            "end_logit": -5.948880672454834
        },
        {
            "text": "characterized",
            "probability": 1.817707838879692e-10,
            "start_logit": -3.9792819023132324,
            "end_logit": -6.6080641746521
        },
        {
            "text": "elevated serum thyroglobulin levels, whereas 2 other patients had positive",
            "probability": 1.6060510219939342e-10,
            "start_logit": -6.870838642120361,
            "end_logit": -3.8403053283691406
        },
        {
            "text": "Levels of thyroid hormones were essentially normal",
            "probability": 1.4332505222685738e-10,
            "start_logit": -5.059000015258789,
            "end_logit": -5.765977382659912
        },
        {
            "text": "Levels of thyroid hormones",
            "probability": 1.4230044770650946e-10,
            "start_logit": -5.059000015258789,
            "end_logit": -5.773151874542236
        },
        {
            "text": "characterized by congenital sensorineural hearing loss,",
            "probability": 6.873401720795077e-11,
            "start_logit": -3.9792819023132324,
            "end_logit": -7.58056640625
        },
        {
            "text": "characterized by congenital sensorineural hearing",
            "probability": 6.271528454908555e-11,
            "start_logit": -3.9792819023132324,
            "end_logit": -7.672205448150635
        },
        {
            "text": "hormones were essentially normal",
            "probability": 4.303856085347688e-11,
            "start_logit": -6.26201868057251,
            "end_logit": -5.765977382659912
        },
        {
            "text": "hormones",
            "probability": 4.273088607286739e-11,
            "start_logit": -6.26201868057251,
            "end_logit": -5.773151874542236
        }
    ],
    "53148a07dae131f847000002_031": [
        {
            "text": "thyroid",
            "probability": 0.9987628763205734,
            "start_logit": 6.350843906402588,
            "end_logit": 5.488846778869629
        },
        {
            "text": "positive thyroid",
            "probability": 0.0007387575334220665,
            "start_logit": -0.7616024017333984,
            "end_logit": 5.3919901847839355
        },
        {
            "text": "thy",
            "probability": 0.00023181249607244283,
            "start_logit": 6.307036399841309,
            "end_logit": -2.8356895446777344
        },
        {
            "text": "roid",
            "probability": 0.00022657827816868813,
            "start_logit": -2.0403382778167725,
            "end_logit": 5.488846778869629
        },
        {
            "text": "thyroid hormones were essentially normal",
            "probability": 1.2928685268189052e-05,
            "start_logit": 6.350843906402588,
            "end_logit": -5.765977382659912
        },
        {
            "text": "thyroid hormones",
            "probability": 1.2836260467624703e-05,
            "start_logit": 6.350843906402588,
            "end_logit": -5.773151874542236
        },
        {
            "text": "Levels of thyroid",
            "probability": 1.1072103500199405e-05,
            "start_logit": -5.059000015258789,
            "end_logit": 5.488846778869629
        },
        {
            "text": "elevated serum thyroglobulin levels, whereas 2 other patients had positive thyroid",
            "probability": 1.6417020283029782e-06,
            "start_logit": -6.870838642120361,
            "end_logit": 5.3919901847839355
        },
        {
            "text": "of thyroid",
            "probability": 1.422723092208491e-06,
            "start_logit": -7.110856056213379,
            "end_logit": 5.488846778869629
        },
        {
            "text": "positive",
            "probability": 7.227147625471905e-08,
            "start_logit": -0.7616024017333984,
            "end_logit": -3.8403053283691406
        },
        {
            "text": "hearing loss, goiter, and a partial iodine organification defect. In this study, we characterized the thyroid",
            "probability": 4.293088280458003e-10,
            "start_logit": -6.267732620239258,
            "end_logit": -3.4601833820343018
        },
        {
            "text": "characterized by",
            "probability": 3.5140168341617314e-10,
            "start_logit": -3.9792819023132324,
            "end_logit": -5.948880672454834
        },
        {
            "text": "characterized",
            "probability": 1.817707838879692e-10,
            "start_logit": -3.9792819023132324,
            "end_logit": -6.6080641746521
        },
        {
            "text": "elevated serum thyroglobulin levels, whereas 2 other patients had positive",
            "probability": 1.6060510219939342e-10,
            "start_logit": -6.870838642120361,
            "end_logit": -3.8403053283691406
        },
        {
            "text": "Levels of thyroid hormones were essentially normal",
            "probability": 1.4332505222685738e-10,
            "start_logit": -5.059000015258789,
            "end_logit": -5.765977382659912
        },
        {
            "text": "Levels of thyroid hormones",
            "probability": 1.4230044770650946e-10,
            "start_logit": -5.059000015258789,
            "end_logit": -5.773151874542236
        },
        {
            "text": "characterized by congenital sensorineural hearing loss,",
            "probability": 6.873401720795077e-11,
            "start_logit": -3.9792819023132324,
            "end_logit": -7.58056640625
        },
        {
            "text": "characterized by congenital sensorineural hearing",
            "probability": 6.271528454908555e-11,
            "start_logit": -3.9792819023132324,
            "end_logit": -7.672205448150635
        },
        {
            "text": "hormones were essentially normal",
            "probability": 4.303856085347688e-11,
            "start_logit": -6.26201868057251,
            "end_logit": -5.765977382659912
        },
        {
            "text": "hormones",
            "probability": 4.273088607286739e-11,
            "start_logit": -6.26201868057251,
            "end_logit": -5.773151874542236
        }
    ],
    "53148a07dae131f847000002_032": [
        {
            "text": "thyroid",
            "probability": 0.9993338751035526,
            "start_logit": 6.693722248077393,
            "end_logit": 5.606243133544922
        },
        {
            "text": "thy",
            "probability": 0.00036459698209361766,
            "start_logit": 6.693722248077393,
            "end_logit": -2.3098084926605225
        },
        {
            "text": "thyroid pathology",
            "probability": 0.00013791065107701938,
            "start_logit": 6.693722248077393,
            "end_logit": -3.2819950580596924
        },
        {
            "text": "roid",
            "probability": 0.0001306927705302463,
            "start_logit": -2.248272657394409,
            "end_logit": 5.606243133544922
        },
        {
            "text": "and thyroid",
            "probability": 1.0648758465107027e-05,
            "start_logit": -4.755678653717041,
            "end_logit": 5.606243133544922
        },
        {
            "text": "over 100 years after the first description of the disorder, the molecular pathology underlying the deafness and thyroid",
            "probability": 4.370556347847895e-06,
            "start_logit": -5.646231651306152,
            "end_logit": 5.606243133544922
        },
        {
            "text": "the molecular pathology underlying the deafness and thyroid",
            "probability": 3.4092879317819157e-06,
            "start_logit": -5.894618511199951,
            "end_logit": 5.606243133544922
        },
        {
            "text": "For over 100 years after the first description of the disorder, the molecular pathology underlying the deafness and thyroid",
            "probability": 2.1271209631145695e-06,
            "start_logit": -6.366352558135986,
            "end_logit": 5.606243133544922
        },
        {
            "text": "pathology underlying the deafness and thyroid",
            "probability": 1.6982589189637363e-06,
            "start_logit": -6.591518402099609,
            "end_logit": 5.606243133544922
        },
        {
            "text": "thyroid pathology in Pendred syndrome",
            "probability": 1.6370895514638938e-06,
            "start_logit": 6.693722248077393,
            "end_logit": -7.715681076049805
        },
        {
            "text": "molecular pathology underlying the deafness and thyroid",
            "probability": 1.5260276620071833e-06,
            "start_logit": -6.698453903198242,
            "end_logit": 5.606243133544922
        },
        {
            "text": "thyroid pathology in Pendred syndrome (PS) remained unknown.",
            "probability": 1.448668196269962e-06,
            "start_logit": 6.693722248077393,
            "end_logit": -7.837956428527832
        },
        {
            "text": "the deafness and thyroid",
            "probability": 1.135856111216623e-06,
            "start_logit": -6.993735313415527,
            "end_logit": 5.606243133544922
        },
        {
            "text": "deafness and thyroid",
            "probability": 9.765365761617153e-07,
            "start_logit": -7.144865036010742,
            "end_logit": 5.606243133544922
        },
        {
            "text": "thyroid pathology in Pendred syndrome (PS) remained",
            "probability": 7.929345650684067e-07,
            "start_logit": 6.693722248077393,
            "end_logit": -8.4406156539917
        },
        {
            "text": "the first description of the disorder, the molecular pathology underlying the deafness and thyroid",
            "probability": 7.717378407837054e-07,
            "start_logit": -7.380232334136963,
            "end_logit": 5.606243133544922
        },
        {
            "text": "underlying the deafness and thyroid",
            "probability": 7.412683151151942e-07,
            "start_logit": -7.4205145835876465,
            "end_logit": 5.606243133544922
        },
        {
            "text": "thyroid pathology in Pendred",
            "probability": 5.63983668336365e-07,
            "start_logit": 6.693722248077393,
            "end_logit": -8.781331062316895
        },
        {
            "text": "thyroid pathology in Pendred syndrome (PS)",
            "probability": 5.559568123357142e-07,
            "start_logit": 6.693722248077393,
            "end_logit": -8.795665740966797
        },
        {
            "text": "thyroid pathology in",
            "probability": 5.204508208790441e-07,
            "start_logit": 6.693722248077393,
            "end_logit": -8.861660957336426
        }
    ],
    "53148a07dae131f847000002_033": [
        {
            "text": "thyroid",
            "probability": 0.4589694163709022,
            "start_logit": 8.835104942321777,
            "end_logit": 8.215508460998535
        },
        {
            "text": "thyroid hormone synthesis, particularly defects in iodide transport from circulation into the thyroid",
            "probability": 0.4369154289070543,
            "start_logit": 8.835104942321777,
            "end_logit": 8.166264533996582
        },
        {
            "text": "thyroid cell, defects in iodide transport from the thyroid",
            "probability": 0.10399595856654881,
            "start_logit": 8.194977760314941,
            "end_logit": 7.371004104614258
        },
        {
            "text": "thy",
            "probability": 5.470816414276485e-05,
            "start_logit": 8.835104942321777,
            "end_logit": -0.8192174434661865
        },
        {
            "text": "roid",
            "probability": 5.243930630577753e-05,
            "start_logit": -0.2419774830341339,
            "end_logit": 8.215508460998535
        },
        {
            "text": "the thyroid",
            "probability": 2.867238122577548e-06,
            "start_logit": -3.148284673690796,
            "end_logit": 8.215508460998535
        },
        {
            "text": "the thyroid hormone synthesis, particularly defects in iodide transport from circulation into the thyroid",
            "probability": 2.7294641634514974e-06,
            "start_logit": -3.148284673690796,
            "end_logit": 8.166264533996582
        },
        {
            "text": "thyroid hormone",
            "probability": 2.314278463167804e-06,
            "start_logit": 8.835104942321777,
            "end_logit": -3.9821324348449707
        },
        {
            "text": "hormone synthesis, particularly defects in iodide transport from circulation into the thyroid",
            "probability": 1.094678030261013e-06,
            "start_logit": -4.061929702758789,
            "end_logit": 8.166264533996582
        },
        {
            "text": "thyroid hormone synthesis, particularly defects in iodide transport from circulation into the thyroid cell,",
            "probability": 5.904548179494059e-07,
            "start_logit": 8.835104942321777,
            "end_logit": -5.348092555999756
        },
        {
            "text": "the thyroid cell, defects in iodide transport from the thyroid",
            "probability": 4.4675298960995313e-07,
            "start_logit": -4.16287899017334,
            "end_logit": 7.371004104614258
        },
        {
            "text": "defects in iodide transport from circulation into the thyroid",
            "probability": 4.0267670677838793e-07,
            "start_logit": -4.2800703048706055,
            "end_logit": 7.384323596954346
        },
        {
            "text": "defects in iodide transport from circulation into the thyroid cell, defects in iodide transport from the thyroid",
            "probability": 3.9734881861735096e-07,
            "start_logit": -4.2800703048706055,
            "end_logit": 7.371004104614258
        },
        {
            "text": "defects in iodide transport from the thyroid",
            "probability": 3.127036179653648e-07,
            "start_logit": -4.519629001617432,
            "end_logit": 7.371004104614258
        },
        {
            "text": "genetic defects involved in the iodination process of the thyroid",
            "probability": 2.3798392802102574e-07,
            "start_logit": -5.637186050415039,
            "end_logit": 8.215508460998535
        },
        {
            "text": "thyroid hormone synthesis, particularly defects",
            "probability": 2.2129031054837424e-07,
            "start_logit": 8.835104942321777,
            "end_logit": -6.32951021194458
        },
        {
            "text": "hypothyroidism",
            "probability": 1.3077800243594868e-07,
            "start_logit": 1.2348538637161255,
            "end_logit": 0.7447666525840759
        },
        {
            "text": "thyroid hormone synthesis,",
            "probability": 1.1847036665313975e-07,
            "start_logit": 8.835104942321777,
            "end_logit": -6.954322814941406
        },
        {
            "text": "thyroid cell to the follicular lumen (Pendred syndrome),",
            "probability": 9.536753261121978e-08,
            "start_logit": 8.202778816223145,
            "end_logit": -6.538921356201172
        },
        {
            "text": "thyroid cell,",
            "probability": 8.919917526620494e-08,
            "start_logit": 8.194977760314941,
            "end_logit": -6.597986698150635
        }
    ],
    "53148a07dae131f847000002_034": [
        {
            "text": "thyroid",
            "probability": 0.4589694163709022,
            "start_logit": 8.835104942321777,
            "end_logit": 8.215508460998535
        },
        {
            "text": "thyroid hormone synthesis, particularly defects in iodide transport from circulation into the thyroid",
            "probability": 0.4369154289070543,
            "start_logit": 8.835104942321777,
            "end_logit": 8.166264533996582
        },
        {
            "text": "thyroid cell, defects in iodide transport from the thyroid",
            "probability": 0.10399595856654881,
            "start_logit": 8.194977760314941,
            "end_logit": 7.371004104614258
        },
        {
            "text": "thy",
            "probability": 5.470816414276485e-05,
            "start_logit": 8.835104942321777,
            "end_logit": -0.8192174434661865
        },
        {
            "text": "roid",
            "probability": 5.243930630577753e-05,
            "start_logit": -0.2419774830341339,
            "end_logit": 8.215508460998535
        },
        {
            "text": "the thyroid",
            "probability": 2.867238122577548e-06,
            "start_logit": -3.148284673690796,
            "end_logit": 8.215508460998535
        },
        {
            "text": "the thyroid hormone synthesis, particularly defects in iodide transport from circulation into the thyroid",
            "probability": 2.7294641634514974e-06,
            "start_logit": -3.148284673690796,
            "end_logit": 8.166264533996582
        },
        {
            "text": "thyroid hormone",
            "probability": 2.314278463167804e-06,
            "start_logit": 8.835104942321777,
            "end_logit": -3.9821324348449707
        },
        {
            "text": "hormone synthesis, particularly defects in iodide transport from circulation into the thyroid",
            "probability": 1.094678030261013e-06,
            "start_logit": -4.061929702758789,
            "end_logit": 8.166264533996582
        },
        {
            "text": "thyroid hormone synthesis, particularly defects in iodide transport from circulation into the thyroid cell,",
            "probability": 5.904548179494059e-07,
            "start_logit": 8.835104942321777,
            "end_logit": -5.348092555999756
        },
        {
            "text": "the thyroid cell, defects in iodide transport from the thyroid",
            "probability": 4.4675298960995313e-07,
            "start_logit": -4.16287899017334,
            "end_logit": 7.371004104614258
        },
        {
            "text": "defects in iodide transport from circulation into the thyroid",
            "probability": 4.0267670677838793e-07,
            "start_logit": -4.2800703048706055,
            "end_logit": 7.384323596954346
        },
        {
            "text": "defects in iodide transport from circulation into the thyroid cell, defects in iodide transport from the thyroid",
            "probability": 3.9734881861735096e-07,
            "start_logit": -4.2800703048706055,
            "end_logit": 7.371004104614258
        },
        {
            "text": "defects in iodide transport from the thyroid",
            "probability": 3.127036179653648e-07,
            "start_logit": -4.519629001617432,
            "end_logit": 7.371004104614258
        },
        {
            "text": "genetic defects involved in the iodination process of the thyroid",
            "probability": 2.3798392802102574e-07,
            "start_logit": -5.637186050415039,
            "end_logit": 8.215508460998535
        },
        {
            "text": "thyroid hormone synthesis, particularly defects",
            "probability": 2.2129031054837424e-07,
            "start_logit": 8.835104942321777,
            "end_logit": -6.32951021194458
        },
        {
            "text": "hypothyroidism",
            "probability": 1.3077800243594868e-07,
            "start_logit": 1.2348538637161255,
            "end_logit": 0.7447666525840759
        },
        {
            "text": "thyroid hormone synthesis,",
            "probability": 1.1847036665313975e-07,
            "start_logit": 8.835104942321777,
            "end_logit": -6.954322814941406
        },
        {
            "text": "thyroid cell to the follicular lumen (Pendred syndrome),",
            "probability": 9.536753261121978e-08,
            "start_logit": 8.202778816223145,
            "end_logit": -6.538921356201172
        },
        {
            "text": "thyroid cell,",
            "probability": 8.919917526620494e-08,
            "start_logit": 8.194977760314941,
            "end_logit": -6.597986698150635
        }
    ],
    "53148a07dae131f847000002_035": [
        {
            "text": "thyroid",
            "probability": 0.4589694163709022,
            "start_logit": 8.835104942321777,
            "end_logit": 8.215508460998535
        },
        {
            "text": "thyroid hormone synthesis, particularly defects in iodide transport from circulation into the thyroid",
            "probability": 0.4369154289070543,
            "start_logit": 8.835104942321777,
            "end_logit": 8.166264533996582
        },
        {
            "text": "thyroid cell, defects in iodide transport from the thyroid",
            "probability": 0.10399595856654881,
            "start_logit": 8.194977760314941,
            "end_logit": 7.371004104614258
        },
        {
            "text": "thy",
            "probability": 5.470816414276485e-05,
            "start_logit": 8.835104942321777,
            "end_logit": -0.8192174434661865
        },
        {
            "text": "roid",
            "probability": 5.243930630577753e-05,
            "start_logit": -0.2419774830341339,
            "end_logit": 8.215508460998535
        },
        {
            "text": "the thyroid",
            "probability": 2.867238122577548e-06,
            "start_logit": -3.148284673690796,
            "end_logit": 8.215508460998535
        },
        {
            "text": "the thyroid hormone synthesis, particularly defects in iodide transport from circulation into the thyroid",
            "probability": 2.7294641634514974e-06,
            "start_logit": -3.148284673690796,
            "end_logit": 8.166264533996582
        },
        {
            "text": "thyroid hormone",
            "probability": 2.314278463167804e-06,
            "start_logit": 8.835104942321777,
            "end_logit": -3.9821324348449707
        },
        {
            "text": "hormone synthesis, particularly defects in iodide transport from circulation into the thyroid",
            "probability": 1.094678030261013e-06,
            "start_logit": -4.061929702758789,
            "end_logit": 8.166264533996582
        },
        {
            "text": "thyroid hormone synthesis, particularly defects in iodide transport from circulation into the thyroid cell,",
            "probability": 5.904548179494059e-07,
            "start_logit": 8.835104942321777,
            "end_logit": -5.348092555999756
        },
        {
            "text": "the thyroid cell, defects in iodide transport from the thyroid",
            "probability": 4.4675298960995313e-07,
            "start_logit": -4.16287899017334,
            "end_logit": 7.371004104614258
        },
        {
            "text": "defects in iodide transport from circulation into the thyroid",
            "probability": 4.0267670677838793e-07,
            "start_logit": -4.2800703048706055,
            "end_logit": 7.384323596954346
        },
        {
            "text": "defects in iodide transport from circulation into the thyroid cell, defects in iodide transport from the thyroid",
            "probability": 3.9734881861735096e-07,
            "start_logit": -4.2800703048706055,
            "end_logit": 7.371004104614258
        },
        {
            "text": "defects in iodide transport from the thyroid",
            "probability": 3.127036179653648e-07,
            "start_logit": -4.519629001617432,
            "end_logit": 7.371004104614258
        },
        {
            "text": "genetic defects involved in the iodination process of the thyroid",
            "probability": 2.3798392802102574e-07,
            "start_logit": -5.637186050415039,
            "end_logit": 8.215508460998535
        },
        {
            "text": "thyroid hormone synthesis, particularly defects",
            "probability": 2.2129031054837424e-07,
            "start_logit": 8.835104942321777,
            "end_logit": -6.32951021194458
        },
        {
            "text": "hypothyroidism",
            "probability": 1.3077800243594868e-07,
            "start_logit": 1.2348538637161255,
            "end_logit": 0.7447666525840759
        },
        {
            "text": "thyroid hormone synthesis,",
            "probability": 1.1847036665313975e-07,
            "start_logit": 8.835104942321777,
            "end_logit": -6.954322814941406
        },
        {
            "text": "thyroid cell to the follicular lumen (Pendred syndrome),",
            "probability": 9.536753261121978e-08,
            "start_logit": 8.202778816223145,
            "end_logit": -6.538921356201172
        },
        {
            "text": "thyroid cell,",
            "probability": 8.919917526620494e-08,
            "start_logit": 8.194977760314941,
            "end_logit": -6.597986698150635
        }
    ],
    "53148a07dae131f847000002_036": [
        {
            "text": "thyroid",
            "probability": 0.9991764079849711,
            "start_logit": 8.39555835723877,
            "end_logit": 7.3823771476745605
        },
        {
            "text": "hypothyroidism. Among those causing dyshormonogenesis, the thyroid",
            "probability": 0.00030653655038544853,
            "start_logit": 0.5217310190200806,
            "end_logit": 7.1668548583984375
        },
        {
            "text": "THOX2 (thyroid",
            "probability": 0.0002406180185335619,
            "start_logit": 0.06408242136240005,
            "end_logit": 7.3823771476745605
        },
        {
            "text": "thy",
            "probability": 0.00013416441979712917,
            "start_logit": 8.39555835723877,
            "end_logit": -1.5332434177398682
        },
        {
            "text": "roid",
            "probability": 0.00010694156322325528,
            "start_logit": -0.7468457221984863,
            "end_logit": 7.3823771476745605
        },
        {
            "text": "the thyroid",
            "probability": 1.853855439759646e-05,
            "start_logit": -2.2837533950805664,
            "end_logit": 7.1668548583984375
        },
        {
            "text": "(thyroid oxidase 2) gene defects.",
            "probability": 7.271508872235191e-06,
            "start_logit": 8.39555835723877,
            "end_logit": -4.44834566116333
        },
        {
            "text": "(thyroid",
            "probability": 4.08213199692459e-06,
            "start_logit": -4.012508869171143,
            "end_logit": 7.3823771476745605
        },
        {
            "text": "and THOX2 (thyroid",
            "probability": 2.7434209665628795e-06,
            "start_logit": -4.4099225997924805,
            "end_logit": 7.3823771476745605
        },
        {
            "text": "(thyroid oxidase 2) gene defects. There is also early evidence for a third group of congenital hypothyroid",
            "probability": 1.1503113210013812e-06,
            "start_logit": 8.39555835723877,
            "end_logit": -6.292276859283447
        },
        {
            "text": "hypothyroidism.",
            "probability": 9.015129974527027e-07,
            "start_logit": 1.5669842958450317,
            "end_logit": 0.29258376359939575
        },
        {
            "text": "(Pendred syndrome), NIS (sodium iodide symporter), and THOX2 (thyroid",
            "probability": 6.401952135496283e-07,
            "start_logit": -5.865110397338867,
            "end_logit": 7.3823771476745605
        },
        {
            "text": "THOX2 (thyroid oxidase 2) gene defects.",
            "probability": 1.7510982471203067e-09,
            "start_logit": 0.06408242136240005,
            "end_logit": -4.44834566116333
        },
        {
            "text": "hyp",
            "probability": 8.721376222349109e-10,
            "start_logit": 1.5669842958450317,
            "end_logit": -6.648298740386963
        },
        {
            "text": "THOX2",
            "probability": 7.363046607950288e-10,
            "start_logit": 0.06408242136240005,
            "end_logit": -5.314700126647949
        },
        {
            "text": "THOX",
            "probability": 2.1869740211237284e-10,
            "start_logit": 0.06408242136240005,
            "end_logit": -6.528655052185059
        },
        {
            "text": "(thyroid oxidase 2) gene defects. There is also early evidence for a third group of congenital hypothyroid conditions",
            "probability": 8.333760262993022e-11,
            "start_logit": -0.7468457221984863,
            "end_logit": -6.682516098022461
        },
        {
            "text": "thyroid gland dysgenesis include the TSH receptor in non-syndromic congenital hypothyroidism,",
            "probability": 8.068949933842611e-11,
            "start_logit": -3.9314608573913574,
            "end_logit": -3.5301923751831055
        },
        {
            "text": "hypothyroidism,",
            "probability": 5.052435247170123e-11,
            "start_logit": -4.399613857269287,
            "end_logit": -3.5301923751831055
        },
        {
            "text": "hypothyroidism",
            "probability": 3.453483352406019e-11,
            "start_logit": -3.5988121032714844,
            "end_logit": -4.711481094360352
        }
    ],
    "53148a07dae131f847000002_037": [
        {
            "text": "thyroid",
            "probability": 0.9991764079849711,
            "start_logit": 8.39555835723877,
            "end_logit": 7.3823771476745605
        },
        {
            "text": "hypothyroidism. Among those causing dyshormonogenesis, the thyroid",
            "probability": 0.00030653655038544853,
            "start_logit": 0.5217310190200806,
            "end_logit": 7.1668548583984375
        },
        {
            "text": "THOX2 (thyroid",
            "probability": 0.0002406180185335619,
            "start_logit": 0.06408242136240005,
            "end_logit": 7.3823771476745605
        },
        {
            "text": "thy",
            "probability": 0.00013416441979712917,
            "start_logit": 8.39555835723877,
            "end_logit": -1.5332434177398682
        },
        {
            "text": "roid",
            "probability": 0.00010694156322325528,
            "start_logit": -0.7468457221984863,
            "end_logit": 7.3823771476745605
        },
        {
            "text": "the thyroid",
            "probability": 1.853855439759646e-05,
            "start_logit": -2.2837533950805664,
            "end_logit": 7.1668548583984375
        },
        {
            "text": "(thyroid oxidase 2) gene defects.",
            "probability": 7.271508872235191e-06,
            "start_logit": 8.39555835723877,
            "end_logit": -4.44834566116333
        },
        {
            "text": "(thyroid",
            "probability": 4.08213199692459e-06,
            "start_logit": -4.012508869171143,
            "end_logit": 7.3823771476745605
        },
        {
            "text": "and THOX2 (thyroid",
            "probability": 2.7434209665628795e-06,
            "start_logit": -4.4099225997924805,
            "end_logit": 7.3823771476745605
        },
        {
            "text": "(thyroid oxidase 2) gene defects. There is also early evidence for a third group of congenital hypothyroid",
            "probability": 1.1503113210013812e-06,
            "start_logit": 8.39555835723877,
            "end_logit": -6.292276859283447
        },
        {
            "text": "hypothyroidism.",
            "probability": 9.015129974527027e-07,
            "start_logit": 1.5669842958450317,
            "end_logit": 0.29258376359939575
        },
        {
            "text": "(Pendred syndrome), NIS (sodium iodide symporter), and THOX2 (thyroid",
            "probability": 6.401952135496283e-07,
            "start_logit": -5.865110397338867,
            "end_logit": 7.3823771476745605
        },
        {
            "text": "THOX2 (thyroid oxidase 2) gene defects.",
            "probability": 1.7510982471203067e-09,
            "start_logit": 0.06408242136240005,
            "end_logit": -4.44834566116333
        },
        {
            "text": "hyp",
            "probability": 8.721376222349109e-10,
            "start_logit": 1.5669842958450317,
            "end_logit": -6.648298740386963
        },
        {
            "text": "THOX2",
            "probability": 7.363046607950288e-10,
            "start_logit": 0.06408242136240005,
            "end_logit": -5.314700126647949
        },
        {
            "text": "THOX",
            "probability": 2.1869740211237284e-10,
            "start_logit": 0.06408242136240005,
            "end_logit": -6.528655052185059
        },
        {
            "text": "(thyroid oxidase 2) gene defects. There is also early evidence for a third group of congenital hypothyroid conditions",
            "probability": 8.333760262993022e-11,
            "start_logit": -0.7468457221984863,
            "end_logit": -6.682516098022461
        },
        {
            "text": "thyroid gland dysgenesis include the TSH receptor in non-syndromic congenital hypothyroidism,",
            "probability": 8.068949933842611e-11,
            "start_logit": -3.9314608573913574,
            "end_logit": -3.5301923751831055
        },
        {
            "text": "hypothyroidism,",
            "probability": 5.052435247170123e-11,
            "start_logit": -4.399613857269287,
            "end_logit": -3.5301923751831055
        },
        {
            "text": "hypothyroidism",
            "probability": 3.453483352406019e-11,
            "start_logit": -3.5988121032714844,
            "end_logit": -4.711481094360352
        }
    ],
    "53148a07dae131f847000002_038": [
        {
            "text": "thyroid",
            "probability": 0.5126986454008241,
            "start_logit": 4.117767333984375,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "thyroid hormone synthesis while in EVA thyroid",
            "probability": 0.44449537164956143,
            "start_logit": 3.9750187397003174,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "euthyroid.",
            "probability": 0.018361804724963703,
            "start_logit": 2.4190545082092285,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "hypothyroid and 2 euthyroid.",
            "probability": 0.013215992546715927,
            "start_logit": 2.090209484100342,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "hypothyroid",
            "probability": 0.01037554660251015,
            "start_logit": 2.090209484100342,
            "end_logit": 1.22128427028656
        },
        {
            "text": "thy",
            "probability": 0.0005526880889158573,
            "start_logit": 4.117767333984375,
            "end_logit": -3.7386868000030518
        },
        {
            "text": "roid",
            "probability": 0.00013572120123832407,
            "start_logit": -4.119073390960693,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "e",
            "probability": 4.429127387129124e-05,
            "start_logit": 2.4190545082092285,
            "end_logit": -4.5639801025390625
        },
        {
            "text": ".",
            "probability": 3.1247849016811385e-05,
            "start_logit": -3.9570229053497314,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "euthyroid",
            "probability": 2.551498435806075e-05,
            "start_logit": 2.4190545082092285,
            "end_logit": -5.115501880645752
        },
        {
            "text": "hyp",
            "probability": 1.6136196364470958e-05,
            "start_logit": 2.090209484100342,
            "end_logit": -5.2448577880859375
        },
        {
            "text": "othyroid",
            "probability": 1.1475846682691273e-05,
            "start_logit": -4.716753005981445,
            "end_logit": 1.22128427028656
        },
        {
            "text": "2 euthyroid.",
            "probability": 7.513516423803923e-06,
            "start_logit": -5.382269859313965,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "euth",
            "probability": 6.257702926955022e-06,
            "start_logit": 2.4190545082092285,
            "end_logit": -6.520954608917236
        },
        {
            "text": "thyroid function seems to be preserved.",
            "probability": 4.893040243357564e-06,
            "start_logit": 4.117767333984375,
            "end_logit": -8.465666770935059
        },
        {
            "text": "thyroid function seems to be preserved. The aim of this study was to evaluate thyroid",
            "probability": 4.612728482955611e-06,
            "start_logit": 4.117767333984375,
            "end_logit": -8.52466106414795
        },
        {
            "text": "thyroid hormone synthesis while in EVA thyroid function seems to be preserved.",
            "probability": 4.242128901602876e-06,
            "start_logit": 3.9750187397003174,
            "end_logit": -8.465666770935059
        },
        {
            "text": "thyroid hormone",
            "probability": 2.9058375456785428e-06,
            "start_logit": 3.9750187397003174,
            "end_logit": -8.844010353088379
        },
        {
            "text": "euthy",
            "probability": 2.9019555796593633e-06,
            "start_logit": 2.4190545082092285,
            "end_logit": -7.2893829345703125
        },
        {
            "text": "hypothy",
            "probability": 2.236724873009708e-06,
            "start_logit": 2.090209484100342,
            "end_logit": -7.22091007232666
        }
    ],
    "53148a07dae131f847000002_039": [
        {
            "text": "thyroid",
            "probability": 0.5126986454008241,
            "start_logit": 4.117767333984375,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "thyroid hormone synthesis while in EVA thyroid",
            "probability": 0.44449537164956143,
            "start_logit": 3.9750187397003174,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "euthyroid.",
            "probability": 0.018361804724963703,
            "start_logit": 2.4190545082092285,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "hypothyroid and 2 euthyroid.",
            "probability": 0.013215992546715927,
            "start_logit": 2.090209484100342,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "hypothyroid",
            "probability": 0.01037554660251015,
            "start_logit": 2.090209484100342,
            "end_logit": 1.22128427028656
        },
        {
            "text": "thy",
            "probability": 0.0005526880889158573,
            "start_logit": 4.117767333984375,
            "end_logit": -3.7386868000030518
        },
        {
            "text": "roid",
            "probability": 0.00013572120123832407,
            "start_logit": -4.119073390960693,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "e",
            "probability": 4.429127387129124e-05,
            "start_logit": 2.4190545082092285,
            "end_logit": -4.5639801025390625
        },
        {
            "text": ".",
            "probability": 3.1247849016811385e-05,
            "start_logit": -3.9570229053497314,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "euthyroid",
            "probability": 2.551498435806075e-05,
            "start_logit": 2.4190545082092285,
            "end_logit": -5.115501880645752
        },
        {
            "text": "hyp",
            "probability": 1.6136196364470958e-05,
            "start_logit": 2.090209484100342,
            "end_logit": -5.2448577880859375
        },
        {
            "text": "othyroid",
            "probability": 1.1475846682691273e-05,
            "start_logit": -4.716753005981445,
            "end_logit": 1.22128427028656
        },
        {
            "text": "2 euthyroid.",
            "probability": 7.513516423803923e-06,
            "start_logit": -5.382269859313965,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "euth",
            "probability": 6.257702926955022e-06,
            "start_logit": 2.4190545082092285,
            "end_logit": -6.520954608917236
        },
        {
            "text": "thyroid function seems to be preserved.",
            "probability": 4.893040243357564e-06,
            "start_logit": 4.117767333984375,
            "end_logit": -8.465666770935059
        },
        {
            "text": "thyroid function seems to be preserved. The aim of this study was to evaluate thyroid",
            "probability": 4.612728482955611e-06,
            "start_logit": 4.117767333984375,
            "end_logit": -8.52466106414795
        },
        {
            "text": "thyroid hormone synthesis while in EVA thyroid function seems to be preserved.",
            "probability": 4.242128901602876e-06,
            "start_logit": 3.9750187397003174,
            "end_logit": -8.465666770935059
        },
        {
            "text": "thyroid hormone",
            "probability": 2.9058375456785428e-06,
            "start_logit": 3.9750187397003174,
            "end_logit": -8.844010353088379
        },
        {
            "text": "euthy",
            "probability": 2.9019555796593633e-06,
            "start_logit": 2.4190545082092285,
            "end_logit": -7.2893829345703125
        },
        {
            "text": "hypothy",
            "probability": 2.236724873009708e-06,
            "start_logit": 2.090209484100342,
            "end_logit": -7.22091007232666
        }
    ],
    "53148a07dae131f847000002_040": [
        {
            "text": "thyroid",
            "probability": 0.5126986454008241,
            "start_logit": 4.117767333984375,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "thyroid hormone synthesis while in EVA thyroid",
            "probability": 0.44449537164956143,
            "start_logit": 3.9750187397003174,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "euthyroid.",
            "probability": 0.018361804724963703,
            "start_logit": 2.4190545082092285,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "hypothyroid and 2 euthyroid.",
            "probability": 0.013215992546715927,
            "start_logit": 2.090209484100342,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "hypothyroid",
            "probability": 0.01037554660251015,
            "start_logit": 2.090209484100342,
            "end_logit": 1.22128427028656
        },
        {
            "text": "thy",
            "probability": 0.0005526880889158573,
            "start_logit": 4.117767333984375,
            "end_logit": -3.7386868000030518
        },
        {
            "text": "roid",
            "probability": 0.00013572120123832407,
            "start_logit": -4.119073390960693,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "e",
            "probability": 4.429127387129124e-05,
            "start_logit": 2.4190545082092285,
            "end_logit": -4.5639801025390625
        },
        {
            "text": ".",
            "probability": 3.1247849016811385e-05,
            "start_logit": -3.9570229053497314,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "euthyroid",
            "probability": 2.551498435806075e-05,
            "start_logit": 2.4190545082092285,
            "end_logit": -5.115501880645752
        },
        {
            "text": "hyp",
            "probability": 1.6136196364470958e-05,
            "start_logit": 2.090209484100342,
            "end_logit": -5.2448577880859375
        },
        {
            "text": "othyroid",
            "probability": 1.1475846682691273e-05,
            "start_logit": -4.716753005981445,
            "end_logit": 1.22128427028656
        },
        {
            "text": "2 euthyroid.",
            "probability": 7.513516423803923e-06,
            "start_logit": -5.382269859313965,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "euth",
            "probability": 6.257702926955022e-06,
            "start_logit": 2.4190545082092285,
            "end_logit": -6.520954608917236
        },
        {
            "text": "thyroid function seems to be preserved.",
            "probability": 4.893040243357564e-06,
            "start_logit": 4.117767333984375,
            "end_logit": -8.465666770935059
        },
        {
            "text": "thyroid function seems to be preserved. The aim of this study was to evaluate thyroid",
            "probability": 4.612728482955611e-06,
            "start_logit": 4.117767333984375,
            "end_logit": -8.52466106414795
        },
        {
            "text": "thyroid hormone synthesis while in EVA thyroid function seems to be preserved.",
            "probability": 4.242128901602876e-06,
            "start_logit": 3.9750187397003174,
            "end_logit": -8.465666770935059
        },
        {
            "text": "thyroid hormone",
            "probability": 2.9058375456785428e-06,
            "start_logit": 3.9750187397003174,
            "end_logit": -8.844010353088379
        },
        {
            "text": "euthy",
            "probability": 2.9019555796593633e-06,
            "start_logit": 2.4190545082092285,
            "end_logit": -7.2893829345703125
        },
        {
            "text": "hypothy",
            "probability": 2.236724873009708e-06,
            "start_logit": 2.090209484100342,
            "end_logit": -7.22091007232666
        }
    ],
    "53148a07dae131f847000002_041": [
        {
            "text": "thyroid",
            "probability": 0.5126986454008241,
            "start_logit": 4.117767333984375,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "thyroid hormone synthesis while in EVA thyroid",
            "probability": 0.44449537164956143,
            "start_logit": 3.9750187397003174,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "euthyroid.",
            "probability": 0.018361804724963703,
            "start_logit": 2.4190545082092285,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "hypothyroid and 2 euthyroid.",
            "probability": 0.013215992546715927,
            "start_logit": 2.090209484100342,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "hypothyroid",
            "probability": 0.01037554660251015,
            "start_logit": 2.090209484100342,
            "end_logit": 1.22128427028656
        },
        {
            "text": "thy",
            "probability": 0.0005526880889158573,
            "start_logit": 4.117767333984375,
            "end_logit": -3.7386868000030518
        },
        {
            "text": "roid",
            "probability": 0.00013572120123832407,
            "start_logit": -4.119073390960693,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "e",
            "probability": 4.429127387129124e-05,
            "start_logit": 2.4190545082092285,
            "end_logit": -4.5639801025390625
        },
        {
            "text": ".",
            "probability": 3.1247849016811385e-05,
            "start_logit": -3.9570229053497314,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "euthyroid",
            "probability": 2.551498435806075e-05,
            "start_logit": 2.4190545082092285,
            "end_logit": -5.115501880645752
        },
        {
            "text": "hyp",
            "probability": 1.6136196364470958e-05,
            "start_logit": 2.090209484100342,
            "end_logit": -5.2448577880859375
        },
        {
            "text": "othyroid",
            "probability": 1.1475846682691273e-05,
            "start_logit": -4.716753005981445,
            "end_logit": 1.22128427028656
        },
        {
            "text": "2 euthyroid.",
            "probability": 7.513516423803923e-06,
            "start_logit": -5.382269859313965,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "euth",
            "probability": 6.257702926955022e-06,
            "start_logit": 2.4190545082092285,
            "end_logit": -6.520954608917236
        },
        {
            "text": "thyroid function seems to be preserved.",
            "probability": 4.893040243357564e-06,
            "start_logit": 4.117767333984375,
            "end_logit": -8.465666770935059
        },
        {
            "text": "thyroid function seems to be preserved. The aim of this study was to evaluate thyroid",
            "probability": 4.612728482955611e-06,
            "start_logit": 4.117767333984375,
            "end_logit": -8.52466106414795
        },
        {
            "text": "thyroid hormone synthesis while in EVA thyroid function seems to be preserved.",
            "probability": 4.242128901602876e-06,
            "start_logit": 3.9750187397003174,
            "end_logit": -8.465666770935059
        },
        {
            "text": "thyroid hormone",
            "probability": 2.9058375456785428e-06,
            "start_logit": 3.9750187397003174,
            "end_logit": -8.844010353088379
        },
        {
            "text": "euthy",
            "probability": 2.9019555796593633e-06,
            "start_logit": 2.4190545082092285,
            "end_logit": -7.2893829345703125
        },
        {
            "text": "hypothy",
            "probability": 2.236724873009708e-06,
            "start_logit": 2.090209484100342,
            "end_logit": -7.22091007232666
        }
    ],
    "53148a07dae131f847000002_042": [
        {
            "text": "thyroid",
            "probability": 0.5126986454008241,
            "start_logit": 4.117767333984375,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "thyroid hormone synthesis while in EVA thyroid",
            "probability": 0.44449537164956143,
            "start_logit": 3.9750187397003174,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "euthyroid.",
            "probability": 0.018361804724963703,
            "start_logit": 2.4190545082092285,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "hypothyroid and 2 euthyroid.",
            "probability": 0.013215992546715927,
            "start_logit": 2.090209484100342,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "hypothyroid",
            "probability": 0.01037554660251015,
            "start_logit": 2.090209484100342,
            "end_logit": 1.22128427028656
        },
        {
            "text": "thy",
            "probability": 0.0005526880889158573,
            "start_logit": 4.117767333984375,
            "end_logit": -3.7386868000030518
        },
        {
            "text": "roid",
            "probability": 0.00013572120123832407,
            "start_logit": -4.119073390960693,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "e",
            "probability": 4.429127387129124e-05,
            "start_logit": 2.4190545082092285,
            "end_logit": -4.5639801025390625
        },
        {
            "text": ".",
            "probability": 3.1247849016811385e-05,
            "start_logit": -3.9570229053497314,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "euthyroid",
            "probability": 2.551498435806075e-05,
            "start_logit": 2.4190545082092285,
            "end_logit": -5.115501880645752
        },
        {
            "text": "hyp",
            "probability": 1.6136196364470958e-05,
            "start_logit": 2.090209484100342,
            "end_logit": -5.2448577880859375
        },
        {
            "text": "othyroid",
            "probability": 1.1475846682691273e-05,
            "start_logit": -4.716753005981445,
            "end_logit": 1.22128427028656
        },
        {
            "text": "2 euthyroid.",
            "probability": 7.513516423803923e-06,
            "start_logit": -5.382269859313965,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "euth",
            "probability": 6.257702926955022e-06,
            "start_logit": 2.4190545082092285,
            "end_logit": -6.520954608917236
        },
        {
            "text": "thyroid function seems to be preserved.",
            "probability": 4.893040243357564e-06,
            "start_logit": 4.117767333984375,
            "end_logit": -8.465666770935059
        },
        {
            "text": "thyroid function seems to be preserved. The aim of this study was to evaluate thyroid",
            "probability": 4.612728482955611e-06,
            "start_logit": 4.117767333984375,
            "end_logit": -8.52466106414795
        },
        {
            "text": "thyroid hormone synthesis while in EVA thyroid function seems to be preserved.",
            "probability": 4.242128901602876e-06,
            "start_logit": 3.9750187397003174,
            "end_logit": -8.465666770935059
        },
        {
            "text": "thyroid hormone",
            "probability": 2.9058375456785428e-06,
            "start_logit": 3.9750187397003174,
            "end_logit": -8.844010353088379
        },
        {
            "text": "euthy",
            "probability": 2.9019555796593633e-06,
            "start_logit": 2.4190545082092285,
            "end_logit": -7.2893829345703125
        },
        {
            "text": "hypothy",
            "probability": 2.236724873009708e-06,
            "start_logit": 2.090209484100342,
            "end_logit": -7.22091007232666
        }
    ],
    "53148a07dae131f847000002_043": [
        {
            "text": "hypothyroid,",
            "probability": 0.39705047154214923,
            "start_logit": 6.1451544761657715,
            "end_logit": 5.852276802062988
        },
        {
            "text": "hypothyroid, two individuals were euthyroid.",
            "probability": 0.30689861751077174,
            "start_logit": 6.1451544761657715,
            "end_logit": 5.594730854034424
        },
        {
            "text": "euthyroid.",
            "probability": 0.2951098525549963,
            "start_logit": 6.105984687805176,
            "end_logit": 5.594730854034424
        },
        {
            "text": "were euthyroid.",
            "probability": 0.00021569094485377634,
            "start_logit": -1.1152716875076294,
            "end_logit": 5.594730854034424
        },
        {
            "text": "were hypothyroid,",
            "probability": 0.00017580423066776427,
            "start_logit": -1.5772931575775146,
            "end_logit": 5.852276802062988
        },
        {
            "text": "were hypothyroid, two individuals were euthyroid.",
            "probability": 0.00013588719624213851,
            "start_logit": -1.5772931575775146,
            "end_logit": 5.594730854034424
        },
        {
            "text": "e",
            "probability": 0.00010123663019418422,
            "start_logit": 6.105984687805176,
            "end_logit": -2.382911443710327
        },
        {
            "text": "hyp",
            "probability": 9.943966943965126e-05,
            "start_logit": 6.1451544761657715,
            "end_logit": -2.439990758895874
        },
        {
            "text": ",",
            "probability": 9.804532080422853e-05,
            "start_logit": -2.1612343788146973,
            "end_logit": 5.852276802062988
        },
        {
            "text": ".",
            "probability": 7.860161157233032e-05,
            "start_logit": -2.1247260570526123,
            "end_logit": 5.594730854034424
        },
        {
            "text": "Two patients were hypothyroid,",
            "probability": 1.0860164686451118e-05,
            "start_logit": -4.361562728881836,
            "end_logit": 5.852276802062988
        },
        {
            "text": "Two patients were hypothyroid, two individuals were euthyroid.",
            "probability": 8.394322049954644e-06,
            "start_logit": -4.361562728881836,
            "end_logit": 5.594730854034424
        },
        {
            "text": "hypothyroid",
            "probability": 5.680573093213498e-06,
            "start_logit": 6.1451544761657715,
            "end_logit": -5.302489757537842
        },
        {
            "text": "hypothyroid, two",
            "probability": 4.267843293646026e-06,
            "start_logit": 6.1451544761657715,
            "end_logit": -5.588433265686035
        },
        {
            "text": "euthyroid",
            "probability": 3.0071429920636626e-06,
            "start_logit": 6.105984687805176,
            "end_logit": -5.899381637573242
        },
        {
            "text": "euth",
            "probability": 1.339952507063289e-06,
            "start_logit": 6.105984687805176,
            "end_logit": -6.707737922668457
        },
        {
            "text": "two individuals were euthyroid.",
            "probability": 9.391198540635274e-07,
            "start_logit": -6.5519304275512695,
            "end_logit": 5.594730854034424
        },
        {
            "text": "hypothy",
            "probability": 6.960580827204118e-07,
            "start_logit": 6.1451544761657715,
            "end_logit": -7.401864051818848
        },
        {
            "text": "individuals were euthyroid.",
            "probability": 6.417345932557727e-07,
            "start_logit": -6.932698726654053,
            "end_logit": 5.594730854034424
        },
        {
            "text": "patients were hypothyroid,",
            "probability": 5.258771561207177e-07,
            "start_logit": -7.389351844787598,
            "end_logit": 5.852276802062988
        }
    ],
    "53148a07dae131f847000002_044": [
        {
            "text": "hypothyroid,",
            "probability": 0.39705047154214923,
            "start_logit": 6.1451544761657715,
            "end_logit": 5.852276802062988
        },
        {
            "text": "hypothyroid, two individuals were euthyroid.",
            "probability": 0.30689861751077174,
            "start_logit": 6.1451544761657715,
            "end_logit": 5.594730854034424
        },
        {
            "text": "euthyroid.",
            "probability": 0.2951098525549963,
            "start_logit": 6.105984687805176,
            "end_logit": 5.594730854034424
        },
        {
            "text": "were euthyroid.",
            "probability": 0.00021569094485377634,
            "start_logit": -1.1152716875076294,
            "end_logit": 5.594730854034424
        },
        {
            "text": "were hypothyroid,",
            "probability": 0.00017580423066776427,
            "start_logit": -1.5772931575775146,
            "end_logit": 5.852276802062988
        },
        {
            "text": "were hypothyroid, two individuals were euthyroid.",
            "probability": 0.00013588719624213851,
            "start_logit": -1.5772931575775146,
            "end_logit": 5.594730854034424
        },
        {
            "text": "e",
            "probability": 0.00010123663019418422,
            "start_logit": 6.105984687805176,
            "end_logit": -2.382911443710327
        },
        {
            "text": "hyp",
            "probability": 9.943966943965126e-05,
            "start_logit": 6.1451544761657715,
            "end_logit": -2.439990758895874
        },
        {
            "text": ",",
            "probability": 9.804532080422853e-05,
            "start_logit": -2.1612343788146973,
            "end_logit": 5.852276802062988
        },
        {
            "text": ".",
            "probability": 7.860161157233032e-05,
            "start_logit": -2.1247260570526123,
            "end_logit": 5.594730854034424
        },
        {
            "text": "Two patients were hypothyroid,",
            "probability": 1.0860164686451118e-05,
            "start_logit": -4.361562728881836,
            "end_logit": 5.852276802062988
        },
        {
            "text": "Two patients were hypothyroid, two individuals were euthyroid.",
            "probability": 8.394322049954644e-06,
            "start_logit": -4.361562728881836,
            "end_logit": 5.594730854034424
        },
        {
            "text": "hypothyroid",
            "probability": 5.680573093213498e-06,
            "start_logit": 6.1451544761657715,
            "end_logit": -5.302489757537842
        },
        {
            "text": "hypothyroid, two",
            "probability": 4.267843293646026e-06,
            "start_logit": 6.1451544761657715,
            "end_logit": -5.588433265686035
        },
        {
            "text": "euthyroid",
            "probability": 3.0071429920636626e-06,
            "start_logit": 6.105984687805176,
            "end_logit": -5.899381637573242
        },
        {
            "text": "euth",
            "probability": 1.339952507063289e-06,
            "start_logit": 6.105984687805176,
            "end_logit": -6.707737922668457
        },
        {
            "text": "two individuals were euthyroid.",
            "probability": 9.391198540635274e-07,
            "start_logit": -6.5519304275512695,
            "end_logit": 5.594730854034424
        },
        {
            "text": "hypothy",
            "probability": 6.960580827204118e-07,
            "start_logit": 6.1451544761657715,
            "end_logit": -7.401864051818848
        },
        {
            "text": "individuals were euthyroid.",
            "probability": 6.417345932557727e-07,
            "start_logit": -6.932698726654053,
            "end_logit": 5.594730854034424
        },
        {
            "text": "patients were hypothyroid,",
            "probability": 5.258771561207177e-07,
            "start_logit": -7.389351844787598,
            "end_logit": 5.852276802062988
        }
    ],
    "53148a07dae131f847000002_045": [
        {
            "text": "thyroid",
            "probability": 0.9332510516719161,
            "start_logit": 6.098844528198242,
            "end_logit": 5.345170497894287
        },
        {
            "text": "thyroid goiter. The thyroid",
            "probability": 0.06636865874488693,
            "start_logit": 6.098844528198242,
            "end_logit": 2.70172119140625
        },
        {
            "text": "thy",
            "probability": 0.0002102954997986133,
            "start_logit": 6.098844528198242,
            "end_logit": -3.0527453422546387
        },
        {
            "text": "roid",
            "probability": 0.00015183310576332644,
            "start_logit": -2.624803066253662,
            "end_logit": 5.345170497894287
        },
        {
            "text": "characterized by congenital deafness and thyroid",
            "probability": 6.650106679861139e-06,
            "start_logit": -5.7529520988464355,
            "end_logit": 5.345170497894287
        },
        {
            "text": "and thyroid",
            "probability": 3.800346124683276e-06,
            "start_logit": -6.312492847442627,
            "end_logit": 5.345170497894287
        },
        {
            "text": "thyroid goiter.",
            "probability": 2.0445663690814386e-06,
            "start_logit": 6.098844528198242,
            "end_logit": -7.686073303222656
        },
        {
            "text": "congenital deafness and thyroid",
            "probability": 1.4236864941865943e-06,
            "start_logit": -7.29433536529541,
            "end_logit": 5.345170497894287
        },
        {
            "text": "deafness and thyroid",
            "probability": 1.4121203609569301e-06,
            "start_logit": -7.302492618560791,
            "end_logit": 5.345170497894287
        },
        {
            "text": "thyroid goiter. The thyroid disease",
            "probability": 8.954053146291689e-07,
            "start_logit": 6.098844528198242,
            "end_logit": -8.511737823486328
        },
        {
            "text": "The thyroid",
            "probability": 4.7648224337530555e-07,
            "start_logit": -5.745460510253906,
            "end_logit": 2.70172119140625
        },
        {
            "text": "characterized by congenital deafness and thyroid goiter. The thyroid",
            "probability": 4.7292597212947617e-07,
            "start_logit": -5.7529520988464355,
            "end_logit": 2.70172119140625
        },
        {
            "text": "goiter. The thyroid",
            "probability": 4.1413368601726914e-07,
            "start_logit": -5.885702133178711,
            "end_logit": 2.70172119140625
        },
        {
            "text": "and thyroid goiter. The thyroid",
            "probability": 2.7026369229340765e-07,
            "start_logit": -6.312492847442627,
            "end_logit": 2.70172119140625
        },
        {
            "text": "congenital deafness and thyroid goiter. The thyroid",
            "probability": 1.0124624335873964e-07,
            "start_logit": -7.29433536529541,
            "end_logit": 2.70172119140625
        },
        {
            "text": "deafness and thyroid goiter. The thyroid",
            "probability": 1.0042371147094559e-07,
            "start_logit": -7.302492618560791,
            "end_logit": 2.70172119140625
        },
        {
            "text": "thyroid disease",
            "probability": 7.193404573630056e-08,
            "start_logit": 3.577317714691162,
            "end_logit": -8.511737823486328
        },
        {
            "text": "thyroid and encodes a 780-amino acid protein (pendrin)",
            "probability": 2.534409080753734e-08,
            "start_logit": 2.4629104137420654,
            "end_logit": -8.440534591674805
        },
        {
            "text": "the thyroid",
            "probability": 1.865459872794373e-09,
            "start_logit": -6.6453680992126465,
            "end_logit": -1.9412940740585327
        },
        {
            "text": "characterized by",
            "probability": 1.2714712858899645e-10,
            "start_logit": -5.7529520988464355,
            "end_logit": -5.519628047943115
        }
    ],
    "53148a07dae131f847000002_046": [
        {
            "text": "thyroid",
            "probability": 0.9995650933603434,
            "start_logit": 6.190830707550049,
            "end_logit": 5.3197150230407715
        },
        {
            "text": "thy",
            "probability": 0.0002476205377710628,
            "start_logit": 6.190830707550049,
            "end_logit": -2.9834630489349365
        },
        {
            "text": "roid",
            "probability": 8.773526331181579e-05,
            "start_logit": -3.14992094039917,
            "end_logit": 5.3197150230407715
        },
        {
            "text": "characterized by the association between sensorineural hearing loss and thyroid",
            "probability": 6.937803369673518e-05,
            "start_logit": -3.384674549102783,
            "end_logit": 5.3197150230407715
        },
        {
            "text": "association between sensorineural hearing loss and thyroid",
            "probability": 5.439486903313857e-06,
            "start_logit": -5.930560111999512,
            "end_logit": 5.3197150230407715
        },
        {
            "text": "by the association between sensorineural hearing loss and thyroid",
            "probability": 4.554780481397132e-06,
            "start_logit": -6.108067512512207,
            "end_logit": 5.3197150230407715
        },
        {
            "text": "and thyroid",
            "probability": 4.044855545251278e-06,
            "start_logit": -6.226799011230469,
            "end_logit": 5.3197150230407715
        },
        {
            "text": "autosomal recessive disorder characterized by the association between sensorineural hearing loss and thyroid",
            "probability": 3.807300548688341e-06,
            "start_logit": -6.28732442855835,
            "end_logit": 5.3197150230407715
        },
        {
            "text": "thyroid swelling or goitre and is likely to be the most common form of syndromic",
            "probability": 3.141024599315839e-06,
            "start_logit": 6.190830707550049,
            "end_logit": -7.35081148147583
        },
        {
            "text": "thyroid swelling",
            "probability": 2.533512289995541e-06,
            "start_logit": 6.190830707550049,
            "end_logit": -7.565753936767578
        },
        {
            "text": "hearing loss and thyroid",
            "probability": 1.7644210429687004e-06,
            "start_logit": -7.056422233581543,
            "end_logit": 5.3197150230407715
        },
        {
            "text": "thyroid swelling or goitre and is likely",
            "probability": 1.7148635293689754e-06,
            "start_logit": 6.190830707550049,
            "end_logit": -7.956027030944824
        },
        {
            "text": "thyroid swelling or goitre and",
            "probability": 1.66997072770477e-06,
            "start_logit": 6.190830707550049,
            "end_logit": -7.9825544357299805
        },
        {
            "text": "the association between sensorineural hearing loss and thyroid",
            "probability": 1.484957127431403e-06,
            "start_logit": -7.228858947753906,
            "end_logit": 5.3197150230407715
        },
        {
            "text": "characterized by",
            "probability": 1.0510267983085386e-08,
            "start_logit": -3.384674549102783,
            "end_logit": -3.4752578735351562
        },
        {
            "text": "Pendred syndrome is an autosomal recessive disorder characterized by",
            "probability": 4.776754292645179e-09,
            "start_logit": -4.1732659339904785,
            "end_logit": -3.4752578735351562
        },
        {
            "text": "by",
            "probability": 6.900161465063732e-10,
            "start_logit": -6.108067512512207,
            "end_logit": -3.4752578735351562
        },
        {
            "text": "characterized",
            "probability": 6.012246533707653e-10,
            "start_logit": -3.384674549102783,
            "end_logit": -6.336397171020508
        },
        {
            "text": "autosomal recessive disorder characterized by",
            "probability": 5.767783681183454e-10,
            "start_logit": -6.28732442855835,
            "end_logit": -3.4752578735351562
        },
        {
            "text": "Pendred syndrome is an autosomal recessive disorder characterized by the association between sensorineural hearing loss and thyroid",
            "probability": 4.770402350371012e-10,
            "start_logit": -6.9689764976501465,
            "end_logit": -2.9834630489349365
        }
    ],
    "53148a07dae131f847000002_047": [
        {
            "text": "thyroid",
            "probability": 0.5126986454008241,
            "start_logit": 4.117767333984375,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "thyroid hormone synthesis while in EVA thyroid",
            "probability": 0.44449537164956143,
            "start_logit": 3.9750187397003174,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "euthyroid.",
            "probability": 0.018361804724963703,
            "start_logit": 2.4190545082092285,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "hypothyroid and 2 euthyroid.",
            "probability": 0.013215992546715927,
            "start_logit": 2.090209484100342,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "hypothyroid",
            "probability": 0.01037554660251015,
            "start_logit": 2.090209484100342,
            "end_logit": 1.22128427028656
        },
        {
            "text": "thy",
            "probability": 0.0005526880889158573,
            "start_logit": 4.117767333984375,
            "end_logit": -3.7386868000030518
        },
        {
            "text": "roid",
            "probability": 0.00013572120123832407,
            "start_logit": -4.119073390960693,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "e",
            "probability": 4.429127387129124e-05,
            "start_logit": 2.4190545082092285,
            "end_logit": -4.5639801025390625
        },
        {
            "text": ".",
            "probability": 3.1247849016811385e-05,
            "start_logit": -3.9570229053497314,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "euthyroid",
            "probability": 2.551498435806075e-05,
            "start_logit": 2.4190545082092285,
            "end_logit": -5.115501880645752
        },
        {
            "text": "hyp",
            "probability": 1.6136196364470958e-05,
            "start_logit": 2.090209484100342,
            "end_logit": -5.2448577880859375
        },
        {
            "text": "othyroid",
            "probability": 1.1475846682691273e-05,
            "start_logit": -4.716753005981445,
            "end_logit": 1.22128427028656
        },
        {
            "text": "2 euthyroid.",
            "probability": 7.513516423803923e-06,
            "start_logit": -5.382269859313965,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "euth",
            "probability": 6.257702926955022e-06,
            "start_logit": 2.4190545082092285,
            "end_logit": -6.520954608917236
        },
        {
            "text": "thyroid function seems to be preserved.",
            "probability": 4.893040243357564e-06,
            "start_logit": 4.117767333984375,
            "end_logit": -8.465666770935059
        },
        {
            "text": "thyroid function seems to be preserved. The aim of this study was to evaluate thyroid",
            "probability": 4.612728482955611e-06,
            "start_logit": 4.117767333984375,
            "end_logit": -8.52466106414795
        },
        {
            "text": "thyroid hormone synthesis while in EVA thyroid function seems to be preserved.",
            "probability": 4.242128901602876e-06,
            "start_logit": 3.9750187397003174,
            "end_logit": -8.465666770935059
        },
        {
            "text": "thyroid hormone",
            "probability": 2.9058375456785428e-06,
            "start_logit": 3.9750187397003174,
            "end_logit": -8.844010353088379
        },
        {
            "text": "euthy",
            "probability": 2.9019555796593633e-06,
            "start_logit": 2.4190545082092285,
            "end_logit": -7.2893829345703125
        },
        {
            "text": "hypothy",
            "probability": 2.236724873009708e-06,
            "start_logit": 2.090209484100342,
            "end_logit": -7.22091007232666
        }
    ],
    "53148a07dae131f847000002_048": [
        {
            "text": "thyroid",
            "probability": 0.5126986454008241,
            "start_logit": 4.117767333984375,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "thyroid hormone synthesis while in EVA thyroid",
            "probability": 0.44449537164956143,
            "start_logit": 3.9750187397003174,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "euthyroid.",
            "probability": 0.018361804724963703,
            "start_logit": 2.4190545082092285,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "hypothyroid and 2 euthyroid.",
            "probability": 0.013215992546715927,
            "start_logit": 2.090209484100342,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "hypothyroid",
            "probability": 0.01037554660251015,
            "start_logit": 2.090209484100342,
            "end_logit": 1.22128427028656
        },
        {
            "text": "thy",
            "probability": 0.0005526880889158573,
            "start_logit": 4.117767333984375,
            "end_logit": -3.7386868000030518
        },
        {
            "text": "roid",
            "probability": 0.00013572120123832407,
            "start_logit": -4.119073390960693,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "e",
            "probability": 4.429127387129124e-05,
            "start_logit": 2.4190545082092285,
            "end_logit": -4.5639801025390625
        },
        {
            "text": ".",
            "probability": 3.1247849016811385e-05,
            "start_logit": -3.9570229053497314,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "euthyroid",
            "probability": 2.551498435806075e-05,
            "start_logit": 2.4190545082092285,
            "end_logit": -5.115501880645752
        },
        {
            "text": "hyp",
            "probability": 1.6136196364470958e-05,
            "start_logit": 2.090209484100342,
            "end_logit": -5.2448577880859375
        },
        {
            "text": "othyroid",
            "probability": 1.1475846682691273e-05,
            "start_logit": -4.716753005981445,
            "end_logit": 1.22128427028656
        },
        {
            "text": "2 euthyroid.",
            "probability": 7.513516423803923e-06,
            "start_logit": -5.382269859313965,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "euth",
            "probability": 6.257702926955022e-06,
            "start_logit": 2.4190545082092285,
            "end_logit": -6.520954608917236
        },
        {
            "text": "thyroid function seems to be preserved.",
            "probability": 4.893040243357564e-06,
            "start_logit": 4.117767333984375,
            "end_logit": -8.465666770935059
        },
        {
            "text": "thyroid function seems to be preserved. The aim of this study was to evaluate thyroid",
            "probability": 4.612728482955611e-06,
            "start_logit": 4.117767333984375,
            "end_logit": -8.52466106414795
        },
        {
            "text": "thyroid hormone synthesis while in EVA thyroid function seems to be preserved.",
            "probability": 4.242128901602876e-06,
            "start_logit": 3.9750187397003174,
            "end_logit": -8.465666770935059
        },
        {
            "text": "thyroid hormone",
            "probability": 2.9058375456785428e-06,
            "start_logit": 3.9750187397003174,
            "end_logit": -8.844010353088379
        },
        {
            "text": "euthy",
            "probability": 2.9019555796593633e-06,
            "start_logit": 2.4190545082092285,
            "end_logit": -7.2893829345703125
        },
        {
            "text": "hypothy",
            "probability": 2.236724873009708e-06,
            "start_logit": 2.090209484100342,
            "end_logit": -7.22091007232666
        }
    ],
    "53148a07dae131f847000002_049": [
        {
            "text": "thyroid",
            "probability": 0.9996003640653527,
            "start_logit": 6.979170799255371,
            "end_logit": 6.080498695373535
        },
        {
            "text": "thy",
            "probability": 0.0001134513583258925,
            "start_logit": 6.979170799255371,
            "end_logit": -3.0032379627227783
        },
        {
            "text": "thyroid enlargement",
            "probability": 9.661077850705807e-05,
            "start_logit": 6.979170799255371,
            "end_logit": -3.16392183303833
        },
        {
            "text": "developmental abnormalities of the cochlea, sensorineural hearing loss, and diffuse thyroid",
            "probability": 7.872094508238037e-05,
            "start_logit": -2.4700307846069336,
            "end_logit": 6.080498695373535
        },
        {
            "text": "roid",
            "probability": 6.977718733954135e-05,
            "start_logit": -2.590632915496826,
            "end_logit": 6.080498695373535
        },
        {
            "text": "diffuse thyroid",
            "probability": 2.293573264684699e-05,
            "start_logit": -3.7032439708709717,
            "end_logit": 6.080498695373535
        },
        {
            "text": "consists of developmental abnormalities of the cochlea, sensorineural hearing loss, and diffuse thyroid",
            "probability": 5.421914162951184e-06,
            "start_logit": -5.145491123199463,
            "end_logit": 6.080498695373535
        },
        {
            "text": "and diffuse thyroid",
            "probability": 4.466976982947474e-06,
            "start_logit": -5.33922815322876,
            "end_logit": 6.080498695373535
        },
        {
            "text": "that consists of developmental abnormalities of the cochlea, sensorineural hearing loss, and diffuse thyroid",
            "probability": 1.878169851661062e-06,
            "start_logit": -6.205642223358154,
            "end_logit": 6.080498695373535
        },
        {
            "text": "thyroid enlargement (goiter).",
            "probability": 1.7758589749196032e-06,
            "start_logit": 6.979170799255371,
            "end_logit": -7.160327911376953
        },
        {
            "text": "cochlea, sensorineural hearing loss, and diffuse thyroid",
            "probability": 1.6364972936003811e-06,
            "start_logit": -6.343381881713867,
            "end_logit": 6.080498695373535
        },
        {
            "text": "of developmental abnormalities of the cochlea, sensorineural hearing loss, and diffuse thyroid",
            "probability": 1.5567397542310425e-06,
            "start_logit": -6.393346309661865,
            "end_logit": 6.080498695373535
        },
        {
            "text": "hearing loss, and diffuse thyroid",
            "probability": 1.3887374826590873e-06,
            "start_logit": -6.507544994354248,
            "end_logit": 6.080498695373535
        },
        {
            "text": "developmental abnormalities of the cochlea, sensorineural hearing loss, and diffuse thyroid enlargement",
            "probability": 7.608332352230822e-09,
            "start_logit": -2.4700307846069336,
            "end_logit": -3.16392183303833
        },
        {
            "text": "diffuse thyroid enlargement",
            "probability": 2.2167248695567364e-09,
            "start_logit": -3.7032439708709717,
            "end_logit": -3.16392183303833
        },
        {
            "text": "development",
            "probability": 1.7370213351475501e-09,
            "start_logit": -2.4700307846069336,
            "end_logit": -4.640994071960449
        },
        {
            "text": "enlargement",
            "probability": 1.4041180933447527e-09,
            "start_logit": -4.159865379333496,
            "end_logit": -3.16392183303833
        },
        {
            "text": "developmental abnormalities of the cochlea, sensorineural hearing loss, and diffuse",
            "probability": 1.1601099793470641e-09,
            "start_logit": -2.4700307846069336,
            "end_logit": -5.044651031494141
        },
        {
            "text": "developmental abnormalities",
            "probability": 4.80205134564413e-10,
            "start_logit": -2.4700307846069336,
            "end_logit": -5.926707744598389
        },
        {
            "text": "and diffuse thyroid enlargement",
            "probability": 4.317306589810827e-10,
            "start_logit": -5.33922815322876,
            "end_logit": -3.16392183303833
        }
    ],
    "53148a07dae131f847000002_050": [
        {
            "text": "hypothyroidism",
            "probability": 0.9995805558242986,
            "start_logit": 8.329345703125,
            "end_logit": 7.380064964294434
        },
        {
            "text": "hyp",
            "probability": 0.00025346016925163,
            "start_logit": 8.329345703125,
            "end_logit": -0.8998193740844727
        },
        {
            "text": "ism",
            "probability": 0.0001371090776559499,
            "start_logit": -0.5649685263633728,
            "end_logit": 7.380064964294434
        },
        {
            "text": "othyroidism",
            "probability": 1.982124908814235e-05,
            "start_logit": -2.498990774154663,
            "end_logit": 7.380064964294434
        },
        {
            "text": "hypothyroid",
            "probability": 3.70755534258769e-06,
            "start_logit": 8.329345703125,
            "end_logit": -5.124653339385986
        },
        {
            "text": "roidism",
            "probability": 2.847709197238381e-06,
            "start_logit": -4.439230442047119,
            "end_logit": 7.380064964294434
        },
        {
            "text": "hypothy",
            "probability": 1.2351094613141117e-06,
            "start_logit": 8.329345703125,
            "end_logit": -6.2238664627075195
        },
        {
            "text": "hypothyroidism and goiter.",
            "probability": 5.615600931011227e-07,
            "start_logit": 8.329345703125,
            "end_logit": -7.0120625495910645
        },
        {
            "text": "to hypothyroidism",
            "probability": 5.363758539279772e-07,
            "start_logit": -6.108665466308594,
            "end_logit": 7.380064964294434
        },
        {
            "text": "hypothyroidism and",
            "probability": 1.6434832564776024e-07,
            "start_logit": 8.329345703125,
            "end_logit": -8.240793228149414
        },
        {
            "text": "thyroid",
            "probability": 6.961728445235494e-10,
            "start_logit": -3.1725547313690186,
            "end_logit": -2.203038215637207
        },
        {
            "text": "thyroid.",
            "probability": 1.8588019696791065e-10,
            "start_logit": -2.6764605045318604,
            "end_logit": -4.019628047943115
        },
        {
            "text": "othyroid",
            "probability": 7.35192151601046e-11,
            "start_logit": -2.498990774154663,
            "end_logit": -5.124653339385986
        },
        {
            "text": "thyroid. Accordingly pendrin protein expression was again significantly increased by DOCA treatment in kidney, heart, lung and thyroid.",
            "probability": 2.9500662028807957e-11,
            "start_logit": -2.6764605045318604,
            "end_logit": -5.860317707061768
        },
        {
            "text": "othy",
            "probability": 2.4491685178529578e-11,
            "start_logit": -2.498990774154663,
            "end_logit": -6.2238664627075195
        },
        {
            "text": "roid",
            "probability": 1.0562469814802102e-11,
            "start_logit": -4.439230442047119,
            "end_logit": -5.124653339385986
        },
        {
            "text": "CONCLUSION: The observations reveal mineralocorticoid sensitivity of pendrin expression in kidney, heart, thyroid",
            "probability": 4.3400966054094e-13,
            "start_logit": -6.911625862121582,
            "end_logit": -5.8442535400390625
        },
        {
            "text": "and goiter.",
            "probability": 3.555452547188623e-13,
            "start_logit": -5.943231105804443,
            "end_logit": -7.0120625495910645
        },
        {
            "text": "to hypothyroidism and goiter.",
            "probability": 3.0133366712060554e-13,
            "start_logit": -6.108665466308594,
            "end_logit": -7.0120625495910645
        },
        {
            "text": "thyroid tissues.",
            "probability": 2.1400569812071416e-13,
            "start_logit": -5.258266925811768,
            "end_logit": -8.204676628112793
        }
    ],
    "53148a07dae131f847000002_051": [
        {
            "text": "thyroid",
            "probability": 0.5126986454008241,
            "start_logit": 4.117767333984375,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "thyroid hormone synthesis while in EVA thyroid",
            "probability": 0.44449537164956143,
            "start_logit": 3.9750187397003174,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "euthyroid.",
            "probability": 0.018361804724963703,
            "start_logit": 2.4190545082092285,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "hypothyroid and 2 euthyroid.",
            "probability": 0.013215992546715927,
            "start_logit": 2.090209484100342,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "hypothyroid",
            "probability": 0.01037554660251015,
            "start_logit": 2.090209484100342,
            "end_logit": 1.22128427028656
        },
        {
            "text": "thy",
            "probability": 0.0005526880889158573,
            "start_logit": 4.117767333984375,
            "end_logit": -3.7386868000030518
        },
        {
            "text": "roid",
            "probability": 0.00013572120123832407,
            "start_logit": -4.119073390960693,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "e",
            "probability": 4.429127387129124e-05,
            "start_logit": 2.4190545082092285,
            "end_logit": -4.5639801025390625
        },
        {
            "text": ".",
            "probability": 3.1247849016811385e-05,
            "start_logit": -3.9570229053497314,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "euthyroid",
            "probability": 2.551498435806075e-05,
            "start_logit": 2.4190545082092285,
            "end_logit": -5.115501880645752
        },
        {
            "text": "hyp",
            "probability": 1.6136196364470958e-05,
            "start_logit": 2.090209484100342,
            "end_logit": -5.2448577880859375
        },
        {
            "text": "othyroid",
            "probability": 1.1475846682691273e-05,
            "start_logit": -4.716753005981445,
            "end_logit": 1.22128427028656
        },
        {
            "text": "2 euthyroid.",
            "probability": 7.513516423803923e-06,
            "start_logit": -5.382269859313965,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "euth",
            "probability": 6.257702926955022e-06,
            "start_logit": 2.4190545082092285,
            "end_logit": -6.520954608917236
        },
        {
            "text": "thyroid function seems to be preserved.",
            "probability": 4.893040243357564e-06,
            "start_logit": 4.117767333984375,
            "end_logit": -8.465666770935059
        },
        {
            "text": "thyroid function seems to be preserved. The aim of this study was to evaluate thyroid",
            "probability": 4.612728482955611e-06,
            "start_logit": 4.117767333984375,
            "end_logit": -8.52466106414795
        },
        {
            "text": "thyroid hormone synthesis while in EVA thyroid function seems to be preserved.",
            "probability": 4.242128901602876e-06,
            "start_logit": 3.9750187397003174,
            "end_logit": -8.465666770935059
        },
        {
            "text": "thyroid hormone",
            "probability": 2.9058375456785428e-06,
            "start_logit": 3.9750187397003174,
            "end_logit": -8.844010353088379
        },
        {
            "text": "euthy",
            "probability": 2.9019555796593633e-06,
            "start_logit": 2.4190545082092285,
            "end_logit": -7.2893829345703125
        },
        {
            "text": "hypothy",
            "probability": 2.236724873009708e-06,
            "start_logit": 2.090209484100342,
            "end_logit": -7.22091007232666
        }
    ],
    "53148a07dae131f847000002_052": [
        {
            "text": "thyroid",
            "probability": 0.5126986454008241,
            "start_logit": 4.117767333984375,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "thyroid hormone synthesis while in EVA thyroid",
            "probability": 0.44449537164956143,
            "start_logit": 3.9750187397003174,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "euthyroid.",
            "probability": 0.018361804724963703,
            "start_logit": 2.4190545082092285,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "hypothyroid and 2 euthyroid.",
            "probability": 0.013215992546715927,
            "start_logit": 2.090209484100342,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "hypothyroid",
            "probability": 0.01037554660251015,
            "start_logit": 2.090209484100342,
            "end_logit": 1.22128427028656
        },
        {
            "text": "thy",
            "probability": 0.0005526880889158573,
            "start_logit": 4.117767333984375,
            "end_logit": -3.7386868000030518
        },
        {
            "text": "roid",
            "probability": 0.00013572120123832407,
            "start_logit": -4.119073390960693,
            "end_logit": 3.0939629077911377
        },
        {
            "text": "e",
            "probability": 4.429127387129124e-05,
            "start_logit": 2.4190545082092285,
            "end_logit": -4.5639801025390625
        },
        {
            "text": ".",
            "probability": 3.1247849016811385e-05,
            "start_logit": -3.9570229053497314,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "euthyroid",
            "probability": 2.551498435806075e-05,
            "start_logit": 2.4190545082092285,
            "end_logit": -5.115501880645752
        },
        {
            "text": "hyp",
            "probability": 1.6136196364470958e-05,
            "start_logit": 2.090209484100342,
            "end_logit": -5.2448577880859375
        },
        {
            "text": "othyroid",
            "probability": 1.1475846682691273e-05,
            "start_logit": -4.716753005981445,
            "end_logit": 1.22128427028656
        },
        {
            "text": "2 euthyroid.",
            "probability": 7.513516423803923e-06,
            "start_logit": -5.382269859313965,
            "end_logit": 1.4632601737976074
        },
        {
            "text": "euth",
            "probability": 6.257702926955022e-06,
            "start_logit": 2.4190545082092285,
            "end_logit": -6.520954608917236
        },
        {
            "text": "thyroid function seems to be preserved.",
            "probability": 4.893040243357564e-06,
            "start_logit": 4.117767333984375,
            "end_logit": -8.465666770935059
        },
        {
            "text": "thyroid function seems to be preserved. The aim of this study was to evaluate thyroid",
            "probability": 4.612728482955611e-06,
            "start_logit": 4.117767333984375,
            "end_logit": -8.52466106414795
        },
        {
            "text": "thyroid hormone synthesis while in EVA thyroid function seems to be preserved.",
            "probability": 4.242128901602876e-06,
            "start_logit": 3.9750187397003174,
            "end_logit": -8.465666770935059
        },
        {
            "text": "thyroid hormone",
            "probability": 2.9058375456785428e-06,
            "start_logit": 3.9750187397003174,
            "end_logit": -8.844010353088379
        },
        {
            "text": "euthy",
            "probability": 2.9019555796593633e-06,
            "start_logit": 2.4190545082092285,
            "end_logit": -7.2893829345703125
        },
        {
            "text": "hypothy",
            "probability": 2.236724873009708e-06,
            "start_logit": 2.090209484100342,
            "end_logit": -7.22091007232666
        }
    ],
    "52eea4dcc8da89891000000c_001": [
        {
            "text": "autosomal recessive",
            "probability": 0.9996161031524144,
            "start_logit": 9.766983985900879,
            "end_logit": 8.9815673828125
        },
        {
            "text": "aut",
            "probability": 0.00021382579615634122,
            "start_logit": 9.766983985900879,
            "end_logit": 0.5316024422645569
        },
        {
            "text": "cessive",
            "probability": 0.0001502081245102021,
            "start_logit": 0.9638792276382446,
            "end_logit": 8.9815673828125
        },
        {
            "text": "autosomal recessive inheritance.",
            "probability": 1.3080197556894206e-05,
            "start_logit": 9.766983985900879,
            "end_logit": -2.2624597549438477
        },
        {
            "text": "recessive",
            "probability": 5.313638462884696e-06,
            "start_logit": -2.377865791320801,
            "end_logit": 8.9815673828125
        },
        {
            "text": "and autosomal recessive",
            "probability": 1.446998983976482e-06,
            "start_logit": -3.6786508560180664,
            "end_logit": 8.9815673828125
        },
        {
            "text": "characterized by",
            "probability": 1.9118284132367527e-08,
            "start_logit": 0.8484144806861877,
            "end_logit": 0.12790018320083618
        },
        {
            "text": "recessive inheritance.",
            "probability": 1.965506494991342e-09,
            "start_logit": 0.9638792276382446,
            "end_logit": -2.2624597549438477
        },
        {
            "text": "and autosomal",
            "probability": 3.095245352795323e-10,
            "start_logit": -3.6786508560180664,
            "end_logit": 0.5316024422645569
        },
        {
            "text": "by",
            "probability": 2.3107330384283543e-10,
            "start_logit": -3.567250967025757,
            "end_logit": 0.12790018320083618
        },
        {
            "text": "is characterized by",
            "probability": 1.1265123228960008e-10,
            "start_logit": -4.285689353942871,
            "end_logit": 0.12790018320083618
        },
        {
            "text": "characterized",
            "probability": 8.274194745302863e-11,
            "start_logit": 0.8484144806861877,
            "end_logit": -5.3147735595703125
        },
        {
            "text": "Jervell and Lange-Nielsen syndrome (JLNS) is characterized by",
            "probability": 6.274450621342609e-11,
            "start_logit": -4.870914936065674,
            "end_logit": 0.12790018320083618
        },
        {
            "text": "(JLNS) is characterized by",
            "probability": 5.012031238980729e-11,
            "start_logit": -5.095559597015381,
            "end_logit": 0.12790018320083618
        },
        {
            "text": "character",
            "probability": 4.101531054351254e-11,
            "start_logit": 0.8484144806861877,
            "end_logit": -6.016554832458496
        },
        {
            "text": "sensorineural deafness, QT prolongation, abnormal T waves, ventricular tachyarrhythmias, and autosomal",
            "probability": 3.355578839876484e-11,
            "start_logit": -5.900478839874268,
            "end_logit": 0.5316024422645569
        },
        {
            "text": "characterized by sensorineural deafness,",
            "probability": 2.952090018769655e-11,
            "start_logit": 0.8484144806861877,
            "end_logit": -6.345401763916016
        },
        {
            "text": "characterized by sensorineural deafness, QT prolongation, abnormal",
            "probability": 1.928347629872525e-11,
            "start_logit": 0.8484144806861877,
            "end_logit": -6.771251678466797
        },
        {
            "text": "and autosomal recessive inheritance.",
            "probability": 1.893430139365384e-11,
            "start_logit": -3.6786508560180664,
            "end_logit": -2.2624597549438477
        },
        {
            "text": "characterized by sensorineural deafness, QT prolongation,",
            "probability": 1.6959040360172508e-11,
            "start_logit": 0.8484144806861877,
            "end_logit": -6.8996992111206055
        }
    ],
    "52eea4dcc8da89891000000c_002": [
        {
            "text": "autosomal recessive",
            "probability": 0.9994708439501202,
            "start_logit": 9.864306449890137,
            "end_logit": 9.138967514038086
        },
        {
            "text": "aut",
            "probability": 0.00035377266912146486,
            "start_logit": 9.864306449890137,
            "end_logit": 1.192640781402588
        },
        {
            "text": "cessive",
            "probability": 0.0001704534070851945,
            "start_logit": 1.1877871751785278,
            "end_logit": 9.138967514038086
        },
        {
            "text": "recessive",
            "probability": 1.8846446201965593e-06,
            "start_logit": -3.3169355392456055,
            "end_logit": 9.138967514038086
        },
        {
            "text": "autosomal recessive syndrome characterised by",
            "probability": 1.6742597443549704e-06,
            "start_logit": 9.864306449890137,
            "end_logit": -4.160642623901367
        },
        {
            "text": "(JLNS) is an autosomal recessive",
            "probability": 4.5404537885225335e-07,
            "start_logit": -4.740232944488525,
            "end_logit": 9.138967514038086
        },
        {
            "text": "Jervell and Lange-Nielsen syndrome (JLNS) is an autosomal recessive",
            "probability": 2.601507730441989e-07,
            "start_logit": -5.297168731689453,
            "end_logit": 9.138967514038086
        },
        {
            "text": "autos",
            "probability": 2.332090994119217e-07,
            "start_logit": 9.864306449890137,
            "end_logit": -6.131833553314209
        },
        {
            "text": "is an autosomal recessive",
            "probability": 1.267533886191224e-07,
            "start_logit": -6.016186714172363,
            "end_logit": 9.138967514038086
        },
        {
            "text": "autosomal recessive syndrome",
            "probability": 1.054032746154667e-07,
            "start_logit": 9.864306449890137,
            "end_logit": -6.925975322723389
        },
        {
            "text": "autosomal recessive syndrome characterised",
            "probability": 9.676200076279919e-08,
            "start_logit": 9.864306449890137,
            "end_logit": -7.011514663696289
        },
        {
            "text": "autosomal",
            "probability": 9.409236408872439e-08,
            "start_logit": 9.864306449890137,
            "end_logit": -7.039492130279541
        },
        {
            "text": "recessive syndrome characterised by",
            "probability": 2.85534370010231e-10,
            "start_logit": 1.1877871751785278,
            "end_logit": -4.160642623901367
        },
        {
            "text": "(JLNS) is an autosomal",
            "probability": 1.6071388830512473e-10,
            "start_logit": -4.740232944488525,
            "end_logit": 1.192640781402588
        },
        {
            "text": "Jervell and Lange-Nielsen syndrome (JLNS) is an autosomal",
            "probability": 9.208295960902659e-11,
            "start_logit": -5.297168731689453,
            "end_logit": 1.192640781402588
        },
        {
            "text": "is an autosomal",
            "probability": 4.486562552915763e-11,
            "start_logit": -6.016186714172363,
            "end_logit": 1.192640781402588
        },
        {
            "text": "recessive syndrome characterised by profound congenital sensorineural deafness and prolongation of the QT interval",
            "probability": 1.9261818937079208e-11,
            "start_logit": 1.1877871751785278,
            "end_logit": -6.856880187988281
        },
        {
            "text": "recessive syndrome",
            "probability": 1.7975859310848816e-11,
            "start_logit": 1.1877871751785278,
            "end_logit": -6.925975322723389
        },
        {
            "text": "recessive syndrome characterised",
            "probability": 1.6502144916217724e-11,
            "start_logit": 1.1877871751785278,
            "end_logit": -7.011514663696289
        },
        {
            "text": "characterised by",
            "probability": 1.6092419035686756e-11,
            "start_logit": -1.6882269382476807,
            "end_logit": -4.160642623901367
        }
    ],
    "52eea4dcc8da89891000000c_003": [
        {
            "text": "autosomal recessive",
            "probability": 0.9996570562126634,
            "start_logit": 9.36149787902832,
            "end_logit": 8.704769134521484
        },
        {
            "text": "aut",
            "probability": 0.0001807958194967671,
            "start_logit": 9.36149787902832,
            "end_logit": 0.08696990460157394
        },
        {
            "text": "cessive",
            "probability": 0.00015550367628772252,
            "start_logit": 0.5929996967315674,
            "end_logit": 8.704769134521484
        },
        {
            "text": "recessive",
            "probability": 3.590926777942686e-06,
            "start_logit": -3.1752593517303467,
            "end_logit": 8.704769134521484
        },
        {
            "text": "autosomal recessive trait.",
            "probability": 2.678088405899686e-06,
            "start_logit": 9.36149787902832,
            "end_logit": -4.125295162200928
        },
        {
            "text": "an autosomal recessive",
            "probability": 3.747640932462629e-07,
            "start_logit": -5.435128211975098,
            "end_logit": 8.704769134521484
        },
        {
            "text": "recessive trait.",
            "probability": 4.165954613662357e-10,
            "start_logit": 0.5929996967315674,
            "end_logit": -4.125295162200928
        },
        {
            "text": "an autosomal",
            "probability": 6.77790257522144e-11,
            "start_logit": -5.435128211975098,
            "end_logit": 0.08696990460157394
        },
        {
            "text": "autosomal dominant or recessive",
            "probability": 1.318644903216249e-11,
            "start_logit": -4.121991157531738,
            "end_logit": -2.8632302284240723
        },
        {
            "text": "autosomal dominant",
            "probability": 3.3907193369131815e-12,
            "start_logit": -4.121991157531738,
            "end_logit": -4.221377849578857
        },
        {
            "text": "Jervell and Lange-Nielsen syndrome:",
            "probability": 3.0412471228185997e-12,
            "start_logit": -3.965327501296997,
            "end_logit": -4.486815929412842
        },
        {
            "text": "Jervell and Lange-Nielsen",
            "probability": 1.7522628601458511e-12,
            "start_logit": -3.965327501296997,
            "end_logit": -5.038175582885742
        },
        {
            "text": "Jervell and Lange-Nielsen syndrome: a Norwegian perspective. Jervell and Lange-Nielsen",
            "probability": 1.1812151049369605e-12,
            "start_logit": -3.965327501296997,
            "end_logit": -5.432539939880371
        },
        {
            "text": "an autosomal recessive trait.",
            "probability": 1.0039956871537475e-12,
            "start_logit": -5.435128211975098,
            "end_logit": -4.125295162200928
        },
        {
            "text": "caused by mutations",
            "probability": 9.849626431559526e-13,
            "start_logit": -3.273362159729004,
            "end_logit": -6.3062005043029785
        },
        {
            "text": "caused by mutations in four different ion channel genes; KCNQ1",
            "probability": 9.265901456904588e-13,
            "start_logit": -3.273362159729004,
            "end_logit": -6.367292881011963
        },
        {
            "text": "Lange-Nielsen syndrome:",
            "probability": 6.328188382986716e-13,
            "start_logit": -5.535166263580322,
            "end_logit": -4.486815929412842
        },
        {
            "text": "caused by",
            "probability": 6.173330581001299e-13,
            "start_logit": -3.273362159729004,
            "end_logit": -6.773395538330078
        },
        {
            "text": "or recessive",
            "probability": 6.151260196408951e-13,
            "start_logit": -7.187108993530273,
            "end_logit": -2.8632302284240723
        },
        {
            "text": "Jervell and Lange-Nielsen syndrome",
            "probability": 5.680921072664364e-13,
            "start_logit": -3.6827340126037598,
            "end_logit": -6.44714879989624
        }
    ],
    "56c85ed65795f9a73e000012_002": [
        {
            "text": "Dasatinib is an oral small molecule inhibitor of Abl and Src family tyrosine kinases",
            "probability": 0.6577235502785377,
            "start_logit": 4.2285027503967285,
            "end_logit": -1.0423744916915894
        },
        {
            "text": "Dasatinib",
            "probability": 0.16704303582485722,
            "start_logit": 3.7938740253448486,
            "end_logit": -1.9782789945602417
        },
        {
            "text": "Dasatinib,",
            "probability": 0.08204763812177185,
            "start_logit": 3.7938740253448486,
            "end_logit": -2.689230442047119
        },
        {
            "text": "Dasatinib is an oral small molecule inhibitor of Abl and Src family tyrosine kinases (SFK),",
            "probability": 0.05891166459487955,
            "start_logit": 4.2285027503967285,
            "end_logit": -3.455120086669922
        },
        {
            "text": "D",
            "probability": 0.01380291269126089,
            "start_logit": 4.2285027503967285,
            "end_logit": -4.906279563903809
        },
        {
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits",
            "probability": 0.006911759505010335,
            "start_logit": 3.7938740253448486,
            "end_logit": -5.16330623626709
        },
        {
            "text": "Dasatinib is an oral small molecule inhibitor",
            "probability": 0.003569145697953546,
            "start_logit": 4.2285027503967285,
            "end_logit": -6.258832931518555
        },
        {
            "text": "Dasatinib, a small-molecule protein tyrosine kinase",
            "probability": 0.00262291267827328,
            "start_logit": 3.7938740253448486,
            "end_logit": -6.132245063781738
        },
        {
            "text": "Dasatinib is an oral small molecule inhibitor of Abl",
            "probability": 0.0026192413123375417,
            "start_logit": 4.2285027503967285,
            "end_logit": -6.56827449798584
        },
        {
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell",
            "probability": 0.0025891959588930265,
            "start_logit": 3.7938740253448486,
            "end_logit": -6.145183086395264
        },
        {
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor,",
            "probability": 0.0015850314139904096,
            "start_logit": 3.7938740253448486,
            "end_logit": -6.635926246643066
        },
        {
            "text": "proliferation. Dasatinib is an oral small molecule inhibitor of Abl and Src family tyrosine kinases",
            "probability": 0.00022550969547467187,
            "start_logit": -3.749674081802368,
            "end_logit": -1.0423744916915894
        },
        {
            "text": "Abl and Src family tyrosine kinases",
            "probability": 0.00013001847498760735,
            "start_logit": -4.300360679626465,
            "end_logit": -1.0423744916915894
        },
        {
            "text": "Src family tyrosine kinases",
            "probability": 9.717950556809119e-05,
            "start_logit": -4.591477394104004,
            "end_logit": -1.0423744916915894
        },
        {
            "text": "inhibits T-cell activation and proliferation.",
            "probability": 3.715582624947235e-05,
            "start_logit": -3.49127197265625,
            "end_logit": -3.1040191650390625
        },
        {
            "text": "proliferation.",
            "probability": 2.8694873414115914e-05,
            "start_logit": -3.749674081802368,
            "end_logit": -3.1040191650390625
        },
        {
            "text": "of Abl and Src family tyrosine kinases",
            "probability": 2.39329704900019e-05,
            "start_logit": -5.9927802085876465,
            "end_logit": -1.0423744916915894
        },
        {
            "text": "Abl and Src family tyrosine kinases (SFK),",
            "probability": 1.1645629514655382e-05,
            "start_logit": -4.300360679626465,
            "end_logit": -3.455120086669922
        },
        {
            "text": "(SFK),",
            "probability": 1.1070671867723742e-05,
            "start_logit": -4.350992202758789,
            "end_logit": -3.455120086669922
        },
        {
            "text": "Src family tyrosine kinases (SFK),",
            "probability": 8.704274668436534e-06,
            "start_logit": -4.591477394104004,
            "end_logit": -3.455120086669922
        }
    ],
    "56c85ed65795f9a73e000012_004": [
        {
            "text": "Dasatinib is an oral small molecule inhibitor of Abl and Src family tyrosine kinases",
            "probability": 0.6577235502785377,
            "start_logit": 4.2285027503967285,
            "end_logit": -1.0423744916915894
        },
        {
            "text": "Dasatinib",
            "probability": 0.16704303582485722,
            "start_logit": 3.7938740253448486,
            "end_logit": -1.9782789945602417
        },
        {
            "text": "Dasatinib,",
            "probability": 0.08204763812177185,
            "start_logit": 3.7938740253448486,
            "end_logit": -2.689230442047119
        },
        {
            "text": "Dasatinib is an oral small molecule inhibitor of Abl and Src family tyrosine kinases (SFK),",
            "probability": 0.05891166459487955,
            "start_logit": 4.2285027503967285,
            "end_logit": -3.455120086669922
        },
        {
            "text": "D",
            "probability": 0.01380291269126089,
            "start_logit": 4.2285027503967285,
            "end_logit": -4.906279563903809
        },
        {
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits",
            "probability": 0.006911759505010335,
            "start_logit": 3.7938740253448486,
            "end_logit": -5.16330623626709
        },
        {
            "text": "Dasatinib is an oral small molecule inhibitor",
            "probability": 0.003569145697953546,
            "start_logit": 4.2285027503967285,
            "end_logit": -6.258832931518555
        },
        {
            "text": "Dasatinib, a small-molecule protein tyrosine kinase",
            "probability": 0.00262291267827328,
            "start_logit": 3.7938740253448486,
            "end_logit": -6.132245063781738
        },
        {
            "text": "Dasatinib is an oral small molecule inhibitor of Abl",
            "probability": 0.0026192413123375417,
            "start_logit": 4.2285027503967285,
            "end_logit": -6.56827449798584
        },
        {
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell",
            "probability": 0.0025891959588930265,
            "start_logit": 3.7938740253448486,
            "end_logit": -6.145183086395264
        },
        {
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor,",
            "probability": 0.0015850314139904096,
            "start_logit": 3.7938740253448486,
            "end_logit": -6.635926246643066
        },
        {
            "text": "proliferation. Dasatinib is an oral small molecule inhibitor of Abl and Src family tyrosine kinases",
            "probability": 0.00022550969547467187,
            "start_logit": -3.749674081802368,
            "end_logit": -1.0423744916915894
        },
        {
            "text": "Abl and Src family tyrosine kinases",
            "probability": 0.00013001847498760735,
            "start_logit": -4.300360679626465,
            "end_logit": -1.0423744916915894
        },
        {
            "text": "Src family tyrosine kinases",
            "probability": 9.717950556809119e-05,
            "start_logit": -4.591477394104004,
            "end_logit": -1.0423744916915894
        },
        {
            "text": "inhibits T-cell activation and proliferation.",
            "probability": 3.715582624947235e-05,
            "start_logit": -3.49127197265625,
            "end_logit": -3.1040191650390625
        },
        {
            "text": "proliferation.",
            "probability": 2.8694873414115914e-05,
            "start_logit": -3.749674081802368,
            "end_logit": -3.1040191650390625
        },
        {
            "text": "of Abl and Src family tyrosine kinases",
            "probability": 2.39329704900019e-05,
            "start_logit": -5.9927802085876465,
            "end_logit": -1.0423744916915894
        },
        {
            "text": "Abl and Src family tyrosine kinases (SFK),",
            "probability": 1.1645629514655382e-05,
            "start_logit": -4.300360679626465,
            "end_logit": -3.455120086669922
        },
        {
            "text": "(SFK),",
            "probability": 1.1070671867723742e-05,
            "start_logit": -4.350992202758789,
            "end_logit": -3.455120086669922
        },
        {
            "text": "Src family tyrosine kinases (SFK),",
            "probability": 8.704274668436534e-06,
            "start_logit": -4.591477394104004,
            "end_logit": -3.455120086669922
        }
    ],
    "56c85ed65795f9a73e000012_005": [
        {
            "text": "inhibitory effect on the proliferation",
            "probability": 0.3685806871026191,
            "start_logit": 0.9098764061927795,
            "end_logit": -2.954878568649292
        },
        {
            "text": "inhibitory",
            "probability": 0.18154304913513292,
            "start_logit": 0.9098764061927795,
            "end_logit": -3.6630454063415527
        },
        {
            "text": "the suppressive",
            "probability": 0.08611494364066224,
            "start_logit": -2.2608556747436523,
            "end_logit": -1.2381231784820557
        },
        {
            "text": "inhibitory effect on the proliferation and function of both Tregs and CD4+CD25-",
            "probability": 0.06780776636395311,
            "start_logit": 0.9098764061927795,
            "end_logit": -4.647861480712891
        },
        {
            "text": "inhibitory effect on the proliferation and function",
            "probability": 0.058155052365592715,
            "start_logit": 0.9098764061927795,
            "end_logit": -4.801425457000732
        },
        {
            "text": "inhibitory effect on the proliferation and function of both Tregs and CD4+CD25- T cells",
            "probability": 0.05509400218738987,
            "start_logit": 0.9098764061927795,
            "end_logit": -4.855497360229492
        },
        {
            "text": "suppressive",
            "probability": 0.038398442332487875,
            "start_logit": -3.068521738052368,
            "end_logit": -1.2381231784820557
        },
        {
            "text": "inhibitory effect on the proliferation and function of both Tregs",
            "probability": 0.030866760566679707,
            "start_logit": 0.9098764061927795,
            "end_logit": -5.434858322143555
        },
        {
            "text": "Tregs with dasatinib inhibited the suppressive",
            "probability": 0.026972090079198284,
            "start_logit": -3.421736001968384,
            "end_logit": -1.2381231784820557
        },
        {
            "text": "inhibited the suppressive",
            "probability": 0.017515599967072713,
            "start_logit": -3.8534467220306396,
            "end_logit": -1.2381231784820557
        },
        {
            "text": "proliferation",
            "probability": 0.012977169447365213,
            "start_logit": -2.436591625213623,
            "end_logit": -2.954878568649292
        },
        {
            "text": "inhibitory effect",
            "probability": 0.00891471388484534,
            "start_logit": 0.9098764061927795,
            "end_logit": -6.676835060119629
        },
        {
            "text": "Tregs and CD4+CD25-",
            "probability": 0.008154037557996405,
            "start_logit": -1.2082871198654175,
            "end_logit": -4.647861480712891
        },
        {
            "text": "inhibitory effect on",
            "probability": 0.0079809913359,
            "start_logit": 0.9098764061927795,
            "end_logit": -6.7874755859375
        },
        {
            "text": "Tregs and CD4+CD25- T cells",
            "probability": 0.006625178606312715,
            "start_logit": -1.2082871198654175,
            "end_logit": -4.855497360229492
        },
        {
            "text": "CD4",
            "probability": 0.006204679452912044,
            "start_logit": -1.4814965724945068,
            "end_logit": -4.647861480712891
        },
        {
            "text": "CD4+CD25-",
            "probability": 0.005205779806034402,
            "start_logit": -1.4814965724945068,
            "end_logit": -4.823395729064941
        },
        {
            "text": "CD4+CD25- T cells",
            "probability": 0.005041319625778338,
            "start_logit": -1.4814965724945068,
            "end_logit": -4.855497360229492
        },
        {
            "text": "(Tregs) can influence various immune responses. Little is known about the effects of the Abl/Src kinase",
            "probability": 0.00406156794708317,
            "start_logit": -4.479208946228027,
            "end_logit": -2.0738837718963623
        },
        {
            "text": "the proliferation",
            "probability": 0.0037861685949838668,
            "start_logit": -3.668428659439087,
            "end_logit": -2.954878568649292
        }
    ],
    "56c85ed65795f9a73e000012_007": [
        {
            "text": "Dasatinib is an oral small molecule inhibitor of Abl and Src family tyrosine kinases",
            "probability": 0.6577235502785377,
            "start_logit": 4.2285027503967285,
            "end_logit": -1.0423744916915894
        },
        {
            "text": "Dasatinib",
            "probability": 0.16704303582485722,
            "start_logit": 3.7938740253448486,
            "end_logit": -1.9782789945602417
        },
        {
            "text": "Dasatinib,",
            "probability": 0.08204763812177185,
            "start_logit": 3.7938740253448486,
            "end_logit": -2.689230442047119
        },
        {
            "text": "Dasatinib is an oral small molecule inhibitor of Abl and Src family tyrosine kinases (SFK),",
            "probability": 0.05891166459487955,
            "start_logit": 4.2285027503967285,
            "end_logit": -3.455120086669922
        },
        {
            "text": "D",
            "probability": 0.01380291269126089,
            "start_logit": 4.2285027503967285,
            "end_logit": -4.906279563903809
        },
        {
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits",
            "probability": 0.006911759505010335,
            "start_logit": 3.7938740253448486,
            "end_logit": -5.16330623626709
        },
        {
            "text": "Dasatinib is an oral small molecule inhibitor",
            "probability": 0.003569145697953546,
            "start_logit": 4.2285027503967285,
            "end_logit": -6.258832931518555
        },
        {
            "text": "Dasatinib, a small-molecule protein tyrosine kinase",
            "probability": 0.00262291267827328,
            "start_logit": 3.7938740253448486,
            "end_logit": -6.132245063781738
        },
        {
            "text": "Dasatinib is an oral small molecule inhibitor of Abl",
            "probability": 0.0026192413123375417,
            "start_logit": 4.2285027503967285,
            "end_logit": -6.56827449798584
        },
        {
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell",
            "probability": 0.0025891959588930265,
            "start_logit": 3.7938740253448486,
            "end_logit": -6.145183086395264
        },
        {
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor,",
            "probability": 0.0015850314139904096,
            "start_logit": 3.7938740253448486,
            "end_logit": -6.635926246643066
        },
        {
            "text": "proliferation. Dasatinib is an oral small molecule inhibitor of Abl and Src family tyrosine kinases",
            "probability": 0.00022550969547467187,
            "start_logit": -3.749674081802368,
            "end_logit": -1.0423744916915894
        },
        {
            "text": "Abl and Src family tyrosine kinases",
            "probability": 0.00013001847498760735,
            "start_logit": -4.300360679626465,
            "end_logit": -1.0423744916915894
        },
        {
            "text": "Src family tyrosine kinases",
            "probability": 9.717950556809119e-05,
            "start_logit": -4.591477394104004,
            "end_logit": -1.0423744916915894
        },
        {
            "text": "inhibits T-cell activation and proliferation.",
            "probability": 3.715582624947235e-05,
            "start_logit": -3.49127197265625,
            "end_logit": -3.1040191650390625
        },
        {
            "text": "proliferation.",
            "probability": 2.8694873414115914e-05,
            "start_logit": -3.749674081802368,
            "end_logit": -3.1040191650390625
        },
        {
            "text": "of Abl and Src family tyrosine kinases",
            "probability": 2.39329704900019e-05,
            "start_logit": -5.9927802085876465,
            "end_logit": -1.0423744916915894
        },
        {
            "text": "Abl and Src family tyrosine kinases (SFK),",
            "probability": 1.1645629514655382e-05,
            "start_logit": -4.300360679626465,
            "end_logit": -3.455120086669922
        },
        {
            "text": "(SFK),",
            "probability": 1.1070671867723742e-05,
            "start_logit": -4.350992202758789,
            "end_logit": -3.455120086669922
        },
        {
            "text": "Src family tyrosine kinases (SFK),",
            "probability": 8.704274668436534e-06,
            "start_logit": -4.591477394104004,
            "end_logit": -3.455120086669922
        }
    ],
    "534427f8aeec6fbd07000009_001": [
        {
            "text": "non-synonymous",
            "probability": 0.9988537098370494,
            "start_logit": 9.574368476867676,
            "end_logit": 8.865968704223633
        },
        {
            "text": "44 non-synonymous",
            "probability": 0.0007234217413824279,
            "start_logit": 2.3439972400665283,
            "end_logit": 8.865968704223633
        },
        {
            "text": "non",
            "probability": 0.0002962869168748873,
            "start_logit": 9.574368476867676,
            "end_logit": 0.7429333925247192
        },
        {
            "text": "onymous",
            "probability": 9.251102689087455e-05,
            "start_logit": 0.2873327136039734,
            "end_logit": 8.865968704223633
        },
        {
            "text": "non-synonymous somatic mutations in 42",
            "probability": 2.144118976761169e-05,
            "start_logit": 9.574368476867676,
            "end_logit": -1.883081078529358
        },
        {
            "text": "synonymous",
            "probability": 9.924008615884389e-06,
            "start_logit": -1.9450381994247437,
            "end_logit": 8.865968704223633
        },
        {
            "text": "44",
            "probability": 1.0875163618407305e-06,
            "start_logit": 2.3439972400665283,
            "end_logit": 2.365872859954834
        },
        {
            "text": "non-synonymous somatic mutations",
            "probability": 5.970012282824649e-07,
            "start_logit": 9.574368476867676,
            "end_logit": -5.464231014251709
        },
        {
            "text": "ATRX",
            "probability": 5.342223718943977e-07,
            "start_logit": 2.608757257461548,
            "end_logit": 1.3902732133865356
        },
        {
            "text": "non-synonymous somatic",
            "probability": 2.650544054820702e-07,
            "start_logit": 9.574368476867676,
            "end_logit": -6.276215076446533
        },
        {
            "text": "identified 44 non-synonymous",
            "probability": 1.0532453077362076e-07,
            "start_logit": -6.49070405960083,
            "end_logit": 8.865968704223633
        },
        {
            "text": "non-synonymous somatic mutations in 42 genes",
            "probability": 4.509970004177931e-08,
            "start_logit": 9.574368476867676,
            "end_logit": -8.047274589538574
        },
        {
            "text": "Whole genome sequencing of the index liver metastasis identified 44 non-synonymous",
            "probability": 2.8640306419032902e-08,
            "start_logit": -7.792935371398926,
            "end_logit": 8.865968704223633
        },
        {
            "text": "non-synonymous somatic mutations in 42 genes (0.85 mutation/MB)",
            "probability": 2.3228247150599342e-08,
            "start_logit": 9.574368476867676,
            "end_logit": -8.71078109741211
        },
        {
            "text": "44 non-synonymous somatic mutations in 42",
            "probability": 1.5528823376475397e-08,
            "start_logit": 2.3439972400665283,
            "end_logit": -1.883081078529358
        },
        {
            "text": "RX",
            "probability": 1.38351460477286e-09,
            "start_logit": -3.3474278450012207,
            "end_logit": 1.3902732133865356
        },
        {
            "text": "X",
            "probability": 9.809212346272443e-10,
            "start_logit": -3.6913180351257324,
            "end_logit": 1.3902732133865356
        },
        {
            "text": "AT",
            "probability": 4.6383391412242895e-10,
            "start_logit": 2.608757257461548,
            "end_logit": -5.6587677001953125
        },
        {
            "text": "44 non-synonymous somatic mutations",
            "probability": 4.323793003101582e-10,
            "start_logit": 2.3439972400665283,
            "end_logit": -5.464231014251709
        },
        {
            "text": "42 genes (0.85 mutation/MB) and a large hemizygous deletion in the ATRX",
            "probability": 4.027944956081211e-10,
            "start_logit": -4.58138370513916,
            "end_logit": 1.3902732133865356
        }
    ],
    "534427f8aeec6fbd07000009_002": [
        {
            "text": "non-synonymous",
            "probability": 0.9983465331567729,
            "start_logit": 9.565628051757812,
            "end_logit": 8.692666053771973
        },
        {
            "text": "77 non-synonymous",
            "probability": 0.0004858196490961435,
            "start_logit": 1.9363175630569458,
            "end_logit": 8.693958282470703
        },
        {
            "text": "non-synonymous somatic mutations in squamous cell lung cancer. We identified 101",
            "probability": 0.00039646819217013324,
            "start_logit": 9.565628051757812,
            "end_logit": 0.861406147480011
        },
        {
            "text": "non",
            "probability": 0.0003544968782505504,
            "start_logit": 9.547715187072754,
            "end_logit": 0.7674227356910706
        },
        {
            "text": "101 single-nucleotide variants (SNVs) including 77 non-synonymous",
            "probability": 0.00026770529767833286,
            "start_logit": 1.3403668403625488,
            "end_logit": 8.693958282470703
        },
        {
            "text": "novel non-synonymous",
            "probability": 6.958656389027557e-05,
            "start_logit": -0.005656169727444649,
            "end_logit": 8.692666053771973
        },
        {
            "text": "onymous",
            "probability": 6.418997272058051e-05,
            "start_logit": -0.08638066053390503,
            "end_logit": 8.692666053771973
        },
        {
            "text": "synonymous",
            "probability": 4.438042801387481e-06,
            "start_logit": -2.75801420211792,
            "end_logit": 8.692666053771973
        },
        {
            "text": "non-synonymous SNVs (67 missense and 10 nonsense",
            "probability": 2.7479699114856713e-06,
            "start_logit": 9.547715187072754,
            "end_logit": -4.092414379119873
        },
        {
            "text": "non-synonymous SNVs",
            "probability": 1.6972065057811141e-06,
            "start_logit": 9.547715187072754,
            "end_logit": -4.57429313659668
        },
        {
            "text": "single-nucleotide variants (SNVs) including 77 non-synonymous",
            "probability": 1.585508836160128e-06,
            "start_logit": -3.788614511489868,
            "end_logit": 8.693958282470703
        },
        {
            "text": "non-synonymous somatic mutations in squamous cell lung cancer.",
            "probability": 1.223058948013626e-06,
            "start_logit": 9.565628051757812,
            "end_logit": -4.919834613800049
        },
        {
            "text": "including 77 non-synonymous",
            "probability": 1.1200008958225533e-06,
            "start_logit": -4.136190414428711,
            "end_logit": 8.693958282470703
        },
        {
            "text": "non-synonymous SNVs (67",
            "probability": 4.0649850814166037e-07,
            "start_logit": 9.547715187072754,
            "end_logit": -6.003451824188232
        },
        {
            "text": "non-synonymous SNVs (67 missense",
            "probability": 4.055020699060564e-07,
            "start_logit": 9.547715187072754,
            "end_logit": -6.005906105041504
        },
        {
            "text": "identify novel non-synonymous",
            "probability": 3.922874475090109e-07,
            "start_logit": -5.183988094329834,
            "end_logit": 8.692666053771973
        },
        {
            "text": "non-synonymous somatic mutations",
            "probability": 3.773289556328209e-07,
            "start_logit": 9.565628051757812,
            "end_logit": -6.095827579498291
        },
        {
            "text": "non-synonymous SNVs (67 missense and 10",
            "probability": 2.974884560899524e-07,
            "start_logit": 9.547715187072754,
            "end_logit": -6.315656661987305
        },
        {
            "text": "to identify novel non-synonymous",
            "probability": 2.8817433139530605e-07,
            "start_logit": -5.492417335510254,
            "end_logit": 8.692666053771973
        },
        {
            "text": "non-synonymous somatic mutations in squamous cell lung cancer. We identified 101 single-nucleotide",
            "probability": 2.212217537363388e-07,
            "start_logit": 9.565628051757812,
            "end_logit": -6.62977933883667
        }
    ],
    "534427f8aeec6fbd07000009_003": [
        {
            "text": "non-synonymous",
            "probability": 0.9983465331567729,
            "start_logit": 9.565628051757812,
            "end_logit": 8.692666053771973
        },
        {
            "text": "77 non-synonymous",
            "probability": 0.0004858196490961435,
            "start_logit": 1.9363175630569458,
            "end_logit": 8.693958282470703
        },
        {
            "text": "non-synonymous somatic mutations in squamous cell lung cancer. We identified 101",
            "probability": 0.00039646819217013324,
            "start_logit": 9.565628051757812,
            "end_logit": 0.861406147480011
        },
        {
            "text": "non",
            "probability": 0.0003544968782505504,
            "start_logit": 9.547715187072754,
            "end_logit": 0.7674227356910706
        },
        {
            "text": "101 single-nucleotide variants (SNVs) including 77 non-synonymous",
            "probability": 0.00026770529767833286,
            "start_logit": 1.3403668403625488,
            "end_logit": 8.693958282470703
        },
        {
            "text": "novel non-synonymous",
            "probability": 6.958656389027557e-05,
            "start_logit": -0.005656169727444649,
            "end_logit": 8.692666053771973
        },
        {
            "text": "onymous",
            "probability": 6.418997272058051e-05,
            "start_logit": -0.08638066053390503,
            "end_logit": 8.692666053771973
        },
        {
            "text": "synonymous",
            "probability": 4.438042801387481e-06,
            "start_logit": -2.75801420211792,
            "end_logit": 8.692666053771973
        },
        {
            "text": "non-synonymous SNVs (67 missense and 10 nonsense",
            "probability": 2.7479699114856713e-06,
            "start_logit": 9.547715187072754,
            "end_logit": -4.092414379119873
        },
        {
            "text": "non-synonymous SNVs",
            "probability": 1.6972065057811141e-06,
            "start_logit": 9.547715187072754,
            "end_logit": -4.57429313659668
        },
        {
            "text": "single-nucleotide variants (SNVs) including 77 non-synonymous",
            "probability": 1.585508836160128e-06,
            "start_logit": -3.788614511489868,
            "end_logit": 8.693958282470703
        },
        {
            "text": "non-synonymous somatic mutations in squamous cell lung cancer.",
            "probability": 1.223058948013626e-06,
            "start_logit": 9.565628051757812,
            "end_logit": -4.919834613800049
        },
        {
            "text": "including 77 non-synonymous",
            "probability": 1.1200008958225533e-06,
            "start_logit": -4.136190414428711,
            "end_logit": 8.693958282470703
        },
        {
            "text": "non-synonymous SNVs (67",
            "probability": 4.0649850814166037e-07,
            "start_logit": 9.547715187072754,
            "end_logit": -6.003451824188232
        },
        {
            "text": "non-synonymous SNVs (67 missense",
            "probability": 4.055020699060564e-07,
            "start_logit": 9.547715187072754,
            "end_logit": -6.005906105041504
        },
        {
            "text": "identify novel non-synonymous",
            "probability": 3.922874475090109e-07,
            "start_logit": -5.183988094329834,
            "end_logit": 8.692666053771973
        },
        {
            "text": "non-synonymous somatic mutations",
            "probability": 3.773289556328209e-07,
            "start_logit": 9.565628051757812,
            "end_logit": -6.095827579498291
        },
        {
            "text": "non-synonymous SNVs (67 missense and 10",
            "probability": 2.974884560899524e-07,
            "start_logit": 9.547715187072754,
            "end_logit": -6.315656661987305
        },
        {
            "text": "to identify novel non-synonymous",
            "probability": 2.8817433139530605e-07,
            "start_logit": -5.492417335510254,
            "end_logit": 8.692666053771973
        },
        {
            "text": "non-synonymous somatic mutations in squamous cell lung cancer. We identified 101 single-nucleotide",
            "probability": 2.212217537363388e-07,
            "start_logit": 9.565628051757812,
            "end_logit": -6.62977933883667
        }
    ],
    "534427f8aeec6fbd07000009_004": [
        {
            "text": "non-synonymous",
            "probability": 0.9996285954169474,
            "start_logit": 9.214512825012207,
            "end_logit": 8.097737312316895
        },
        {
            "text": "non",
            "probability": 0.0003000468499061311,
            "start_logit": 9.214512825012207,
            "end_logit": -0.01346314325928688
        },
        {
            "text": "onymous",
            "probability": 4.1663410069815524e-05,
            "start_logit": -0.8710029721260071,
            "end_logit": 8.097737312316895
        },
        {
            "text": "more non-synonymous",
            "probability": 1.3302819536596324e-05,
            "start_logit": -2.01265025138855,
            "end_logit": 8.097737312316895
        },
        {
            "text": "non-synonymous mutations than expected",
            "probability": 6.5251209858604286e-06,
            "start_logit": 9.214512825012207,
            "end_logit": -3.8417422771453857
        },
        {
            "text": "synonymous",
            "probability": 4.322481015321603e-06,
            "start_logit": -3.136796712875366,
            "end_logit": 8.097737312316895
        },
        {
            "text": "non-synonymous to synonymous",
            "probability": 3.614537380954093e-06,
            "start_logit": 2.025237798690796,
            "end_logit": 2.7568371295928955
        },
        {
            "text": "non-synonymous mutations",
            "probability": 9.57423730646291e-07,
            "start_logit": 9.214512825012207,
            "end_logit": -5.760910987854004
        },
        {
            "text": "accomplished by choosing genes that have more non-synonymous",
            "probability": 3.8019834354469364e-07,
            "start_logit": -5.567688465118408,
            "end_logit": 8.097737312316895
        },
        {
            "text": "choosing genes that have more non-synonymous",
            "probability": 2.909923854641905e-07,
            "start_logit": -5.835084438323975,
            "end_logit": 8.097737312316895
        },
        {
            "text": "have more non-synonymous",
            "probability": 2.292731949891601e-07,
            "start_logit": -6.073467254638672,
            "end_logit": 8.097737312316895
        },
        {
            "text": "to synonymous",
            "probability": 7.093438398206821e-08,
            "start_logit": -1.9057260751724243,
            "end_logit": 2.7568371295928955
        },
        {
            "text": "synonymous mutation frequency is well suited for assessing a gene's non-synonymous",
            "probability": 2.445182804115254e-10,
            "start_logit": -4.941106796264648,
            "end_logit": 0.12199736386537552
        },
        {
            "text": "more",
            "probability": 1.2220735252613415e-10,
            "start_logit": -2.01265025138855,
            "end_logit": -3.500030040740967
        },
        {
            "text": "more non-synonymous mutations than expected",
            "probability": 8.683475775635776e-11,
            "start_logit": -2.01265025138855,
            "end_logit": -3.8417422771453857
        },
        {
            "text": "frequency. While this background frequency is unknown, it can be estimated using both the observed synonymous mutation frequency and the non-synonymous",
            "probability": 4.80825476983852e-11,
            "start_logit": -5.728152751922607,
            "end_logit": -0.7173274755477905
        },
        {
            "text": "non-synonymous mutation",
            "probability": 1.4827044802518072e-11,
            "start_logit": 0.06804054230451584,
            "end_logit": -7.6899871826171875
        },
        {
            "text": "more non-synonymous mutations",
            "probability": 1.2741167236747584e-11,
            "start_logit": -2.01265025138855,
            "end_logit": -5.760910987854004
        },
        {
            "text": "-",
            "probability": 6.4782643333091815e-12,
            "start_logit": -1.6496891975402832,
            "end_logit": -6.800257682800293
        },
        {
            "text": "expected",
            "probability": 6.429951507119206e-12,
            "start_logit": -4.615690231323242,
            "end_logit": -3.8417422771453857
        }
    ],
    "533abc76d6d3ac6a34000064_001": [
        {
            "text": "p16INK4",
            "probability": 0.9978493180613112,
            "start_logit": 7.263736248016357,
            "end_logit": 6.934913635253906
        },
        {
            "text": "up-regulation of p16INK4a,",
            "probability": 0.001743587037519162,
            "start_logit": 0.9140784740447998,
            "end_logit": 6.934913635253906
        },
        {
            "text": "4",
            "probability": 0.0002541524469043484,
            "start_logit": -1.0116870403289795,
            "end_logit": 6.934913635253906
        },
        {
            "text": "p",
            "probability": 0.00013030061012531268,
            "start_logit": 7.263736248016357,
            "end_logit": -2.0085997581481934
        },
        {
            "text": "INK4",
            "probability": 8.143120177326147e-06,
            "start_logit": -4.452447891235352,
            "end_logit": 6.934913635253906
        },
        {
            "text": "16INK4",
            "probability": 4.60436792740994e-06,
            "start_logit": -5.022615909576416,
            "end_logit": 6.934913635253906
        },
        {
            "text": "significant up-regulation of p16INK4a,",
            "probability": 3.52111040092966e-06,
            "start_logit": -5.290844917297363,
            "end_logit": 6.934913635253906
        },
        {
            "text": "p16INK4a",
            "probability": 3.312220105450379e-06,
            "start_logit": 7.263736248016357,
            "end_logit": -5.680825233459473
        },
        {
            "text": "p16",
            "probability": 1.6864748030844744e-06,
            "start_logit": 7.263736248016357,
            "end_logit": -6.355803489685059
        },
        {
            "text": "p16INK",
            "probability": 1.362539476223166e-06,
            "start_logit": 7.263736248016357,
            "end_logit": -6.569093704223633
        },
        {
            "text": "up-regulation",
            "probability": 6.72022847056696e-09,
            "start_logit": 0.9140784740447998,
            "end_logit": -5.531419277191162
        },
        {
            "text": "up-regulate p16INK4a,",
            "probability": 2.8957660831371686e-09,
            "start_logit": -7.479984760284424,
            "end_logit": 2.0207715034484863
        },
        {
            "text": "up",
            "probability": 1.470558706406019e-09,
            "start_logit": 0.9140784740447998,
            "end_logit": -7.050899028778076
        },
        {
            "text": "4a",
            "probability": 8.436232096861233e-10,
            "start_logit": -1.0116870403289795,
            "end_logit": -5.680825233459473
        },
        {
            "text": "INK4a",
            "probability": 2.7029939174424616e-11,
            "start_logit": -4.452447891235352,
            "end_logit": -5.680825233459473
        },
        {
            "text": "16INK4a",
            "probability": 1.5283550077168108e-11,
            "start_logit": -5.022615909576416,
            "end_logit": -5.680825233459473
        },
        {
            "text": "significant up-regulation",
            "probability": 1.3571256183462473e-11,
            "start_logit": -5.290844917297363,
            "end_logit": -5.531419277191162
        },
        {
            "text": "INK",
            "probability": 1.1119236642655631e-11,
            "start_logit": -4.452447891235352,
            "end_logit": -6.569093704223633
        },
        {
            "text": "16",
            "probability": 7.78188685721989e-12,
            "start_logit": -5.022615909576416,
            "end_logit": -6.355803489685059
        },
        {
            "text": "16INK",
            "probability": 6.2871547342846515e-12,
            "start_logit": -5.022615909576416,
            "end_logit": -6.569093704223633
        }
    ],
    "533abc76d6d3ac6a34000064_002": [
        {
            "text": "p16INK4",
            "probability": 0.9994035703454895,
            "start_logit": 7.631317138671875,
            "end_logit": 7.395384311676025
        },
        {
            "text": "p16INK4a",
            "probability": 0.00028346285707184915,
            "start_logit": 7.631317138671875,
            "end_logit": -0.7724485397338867
        },
        {
            "text": "4",
            "probability": 0.0001851577081851032,
            "start_logit": -0.9623888731002808,
            "end_logit": 7.395384311676025
        },
        {
            "text": "p",
            "probability": 9.927783040816369e-05,
            "start_logit": 7.631317138671875,
            "end_logit": -1.8216073513031006
        },
        {
            "text": "p16INK4a and p14ARF",
            "probability": 1.4790036058898583e-05,
            "start_logit": 7.631317138671875,
            "end_logit": -3.7255759239196777
        },
        {
            "text": "p16INK4a and p14ARF tumor",
            "probability": 4.158868747223715e-06,
            "start_logit": 7.631317138671875,
            "end_logit": -4.99428653717041
        },
        {
            "text": "INK4",
            "probability": 3.29763975820036e-06,
            "start_logit": -4.990389823913574,
            "end_logit": 7.395384311676025
        },
        {
            "text": "p16",
            "probability": 1.4725786777940262e-06,
            "start_logit": 7.631317138671875,
            "end_logit": -6.032514572143555
        },
        {
            "text": "p16INK4a and p14ARF tumor suppressors, human telomerase reverse transcriptase",
            "probability": 1.3887395275470262e-06,
            "start_logit": 7.631317138671875,
            "end_logit": -6.091133117675781
        },
        {
            "text": "p16INK4a and p14ARF tumor suppressors, human telomerase reverse transcriptase (h-TERT),",
            "probability": 1.3842121598877996e-06,
            "start_logit": 7.631317138671875,
            "end_logit": -6.094398498535156
        },
        {
            "text": "p16INK4a and p14ARF tumor suppressors,",
            "probability": 1.1872204843162563e-06,
            "start_logit": 7.631317138671875,
            "end_logit": -6.247914791107178
        },
        {
            "text": "p16INK",
            "probability": 7.752085318978891e-07,
            "start_logit": 7.631317138671875,
            "end_logit": -6.674152851104736
        },
        {
            "text": "4a",
            "probability": 5.251665546169813e-08,
            "start_logit": -0.9623888731002808,
            "end_logit": -0.7724485397338867
        },
        {
            "text": "(h-TERT), and oncoprotein c-Myc",
            "probability": 6.037097270270487e-09,
            "start_logit": -1.2739332914352417,
            "end_logit": -2.6241111755371094
        },
        {
            "text": "c-Myc",
            "probability": 5.683605984701446e-09,
            "start_logit": -1.334270715713501,
            "end_logit": -2.6241111755371094
        },
        {
            "text": "(h-TERT),",
            "probability": 4.302732118204719e-09,
            "start_logit": -1.2739332914352417,
            "end_logit": -2.9627842903137207
        },
        {
            "text": "p14ARF tumor suppressors, human telomerase reverse transcriptase (h-TERT),",
            "probability": 4.251773467826137e-09,
            "start_logit": -1.2858473062515259,
            "end_logit": -2.9627842903137207
        },
        {
            "text": "p14ARF",
            "probability": 1.9828685300706537e-09,
            "start_logit": -1.2858473062515259,
            "end_logit": -3.7255759239196777
        },
        {
            "text": "human telomerase reverse transcriptase (h-TERT), and oncoprotein c-Myc",
            "probability": 1.044850084004742e-09,
            "start_logit": -3.0279831886291504,
            "end_logit": -2.6241111755371094
        },
        {
            "text": "INK4a",
            "probability": 9.353162377937615e-10,
            "start_logit": -4.990389823913574,
            "end_logit": -0.7724485397338867
        }
    ],
    "533abc76d6d3ac6a34000064_003": [
        {
            "text": "p16Ink4",
            "probability": 0.999132778207537,
            "start_logit": 9.470069885253906,
            "end_logit": 8.881119728088379
        },
        {
            "text": "p16Ink4a is upregulated in neural stem cells, reducing the rate of proliferation. p16Ink4a",
            "probability": 0.0005230755260047232,
            "start_logit": 9.470069885253906,
            "end_logit": 1.326202630996704
        },
        {
            "text": "p",
            "probability": 0.00017974837171389323,
            "start_logit": 9.470069885253906,
            "end_logit": 0.25803470611572266
        },
        {
            "text": "4",
            "probability": 0.0001289818050665043,
            "start_logit": 0.5150982737541199,
            "end_logit": 8.881119728088379
        },
        {
            "text": "the cyclin-dependent kinase inhibitor gene p16Ink4a",
            "probability": 9.540527422600541e-06,
            "start_logit": -2.089024305343628,
            "end_logit": 8.881119728088379
        },
        {
            "text": "16Ink4",
            "probability": 6.804902867923675e-06,
            "start_logit": -2.4269297122955322,
            "end_logit": 8.881119728088379
        },
        {
            "text": "p16Ink",
            "probability": 5.84668130011822e-06,
            "start_logit": 9.470069885253906,
            "end_logit": -3.167649030685425
        },
        {
            "text": "Ink4",
            "probability": 4.940909839141624e-06,
            "start_logit": -2.747023582458496,
            "end_logit": 8.881119728088379
        },
        {
            "text": "p16",
            "probability": 3.7505815647177276e-06,
            "start_logit": 9.470069885253906,
            "end_logit": -3.611612319946289
        },
        {
            "text": "p16Ink4a",
            "probability": 1.9331995019682715e-06,
            "start_logit": 9.470069885253906,
            "end_logit": -4.274346828460693
        },
        {
            "text": "p16Ink4a is upregulated",
            "probability": 1.419675940943892e-06,
            "start_logit": 9.470069885253906,
            "end_logit": -4.583094596862793
        },
        {
            "text": "cyclin-dependent kinase inhibitor gene p16Ink4a",
            "probability": 9.10695817714018e-07,
            "start_logit": -4.438119411468506,
            "end_logit": 8.881119728088379
        },
        {
            "text": "p16In",
            "probability": 2.3021692624377002e-07,
            "start_logit": 9.470069885253906,
            "end_logit": -6.402256488800049
        },
        {
            "text": "repressor",
            "probability": 3.589514563370283e-08,
            "start_logit": -0.5146641135215759,
            "end_logit": 1.7240575551986694
        },
        {
            "text": "upregulated in neural stem cells, reducing the rate of proliferation. p16Ink4a",
            "probability": 2.2871553748302646e-09,
            "start_logit": -2.8701024055480957,
            "end_logit": 1.326202630996704
        },
        {
            "text": "4a",
            "probability": 2.495639886471036e-10,
            "start_logit": 0.5150982737541199,
            "end_logit": -4.274346828460693
        },
        {
            "text": "ressor",
            "probability": 9.670881989758895e-11,
            "start_logit": -6.43131685256958,
            "end_logit": 1.7240575551986694
        },
        {
            "text": "proliferation. p16Ink4a",
            "probability": 6.23744913847108e-11,
            "start_logit": -6.472010135650635,
            "end_logit": 1.326202630996704
        },
        {
            "text": "reducing the rate of proliferation. p16Ink4a",
            "probability": 5.6507716179592666e-11,
            "start_logit": -6.570789337158203,
            "end_logit": 1.326202630996704
        },
        {
            "text": "the polycomb family transcriptional repressor",
            "probability": 5.1040226113166606e-11,
            "start_logit": -7.070407390594482,
            "end_logit": 1.7240575551986694
        }
    ],
    "533abc76d6d3ac6a34000064_004": [
        {
            "text": "p16Ink4",
            "probability": 0.999385064340404,
            "start_logit": 8.623833656311035,
            "end_logit": 7.990452289581299
        },
        {
            "text": "p16Ink4a and p19Arf",
            "probability": 0.00020828570950917307,
            "start_logit": 8.623833656311035,
            "end_logit": -0.48553240299224854
        },
        {
            "text": "4",
            "probability": 0.00015011486998334276,
            "start_logit": -0.17966097593307495,
            "end_logit": 7.990452289581299
        },
        {
            "text": "p",
            "probability": 0.00011322870783064942,
            "start_logit": 8.623833656311035,
            "end_logit": -1.0950334072113037
        },
        {
            "text": "p16Ink",
            "probability": 4.9946991132699715e-05,
            "start_logit": 8.623833656311035,
            "end_logit": -1.9134808778762817
        },
        {
            "text": "including p16Ink4a",
            "probability": 3.882407301391388e-05,
            "start_logit": -1.5320212841033936,
            "end_logit": 7.990452289581299
        },
        {
            "text": "p16Ink4a",
            "probability": 3.6170461711813775e-05,
            "start_logit": 8.623833656311035,
            "end_logit": -2.2362003326416016
        },
        {
            "text": "proliferation including p16Ink4a",
            "probability": 5.726575488202578e-06,
            "start_logit": -3.44594407081604,
            "end_logit": 7.990452289581299
        },
        {
            "text": "Ink4",
            "probability": 3.991639485665106e-06,
            "start_logit": -3.8068597316741943,
            "end_logit": 7.990452289581299
        },
        {
            "text": "p16",
            "probability": 1.8381825268345042e-06,
            "start_logit": 8.623833656311035,
            "end_logit": -5.215665817260742
        },
        {
            "text": "survival genes, transcription factors, and genes modulating proliferation including p16Ink4a",
            "probability": 1.6250983331821683e-06,
            "start_logit": -4.705493450164795,
            "end_logit": 7.990452289581299
        },
        {
            "text": "16Ink4",
            "probability": 1.59045714265202e-06,
            "start_logit": -4.7270402908325195,
            "end_logit": 7.990452289581299
        },
        {
            "text": "cell survival genes, transcription factors, and genes modulating proliferation including p16Ink4a",
            "probability": 1.469211483053318e-06,
            "start_logit": -4.806335926055908,
            "end_logit": 7.990452289581299
        },
        {
            "text": "and genes modulating proliferation including p16Ink4a",
            "probability": 8.195435763752582e-07,
            "start_logit": -5.390069484710693,
            "end_logit": 7.990452289581299
        },
        {
            "text": "genes modulating proliferation including p16Ink4a",
            "probability": 5.136041733999428e-07,
            "start_logit": -5.857364177703857,
            "end_logit": 7.990452289581299
        },
        {
            "text": "modulating proliferation including p16Ink4a",
            "probability": 4.6358936421412475e-07,
            "start_logit": -5.959817886352539,
            "end_logit": 7.990452289581299
        },
        {
            "text": "p16Ink4a and p19Arf was altered",
            "probability": 2.85217982694979e-07,
            "start_logit": 8.623833656311035,
            "end_logit": -7.078944683074951
        },
        {
            "text": "p19Arf",
            "probability": 2.8202317942624373e-08,
            "start_logit": -0.2834281921386719,
            "end_logit": -0.48553240299224854
        },
        {
            "text": "including p16Ink4a and p19Arf",
            "probability": 8.091475330458433e-09,
            "start_logit": -1.5320212841033936,
            "end_logit": -0.48553240299224854
        },
        {
            "text": "4a",
            "probability": 5.433065142603497e-09,
            "start_logit": -0.17966097593307495,
            "end_logit": -2.2362003326416016
        }
    ],
    "533abc76d6d3ac6a34000064_005": [
        {
            "text": "p16Ink4",
            "probability": 0.550467366701847,
            "start_logit": 7.920575141906738,
            "end_logit": 7.191513538360596
        },
        {
            "text": "p16Ink4a occurred in parallel with an increase in Bmi-1 and/or p16Ink4a",
            "probability": 0.4492678734712722,
            "start_logit": 7.920575141906738,
            "end_logit": 6.988365173339844
        },
        {
            "text": "4",
            "probability": 9.428828626232934e-05,
            "start_logit": -0.7515908479690552,
            "end_logit": 7.191513538360596
        },
        {
            "text": "p",
            "probability": 8.967013638541526e-05,
            "start_logit": 7.920575141906738,
            "end_logit": -1.5308716297149658
        },
        {
            "text": "The suppression of p16Ink4a",
            "probability": 3.3463891135623675e-05,
            "start_logit": -1.7874808311462402,
            "end_logit": 7.191513538360596
        },
        {
            "text": "p16Ink4a by either the induction of Bmi-1 or the hypermethylation of p16Ink4",
            "probability": 2.0385864081231865e-05,
            "start_logit": 3.4762213230133057,
            "end_logit": 1.4321861267089844
        },
        {
            "text": "Ink4",
            "probability": 1.2663464203979633e-05,
            "start_logit": -2.7592267990112305,
            "end_logit": 7.191513538360596
        },
        {
            "text": "suppression of p16Ink4a",
            "probability": 4.869797354632658e-06,
            "start_logit": -3.714895486831665,
            "end_logit": 7.191513538360596
        },
        {
            "text": "16Ink4",
            "probability": 3.317922524581517e-06,
            "start_logit": -4.09860897064209,
            "end_logit": 7.191513538360596
        },
        {
            "text": "p16Ink4a expression. The suppression of p16Ink4a",
            "probability": 1.8113471313397905e-06,
            "start_logit": -4.703876972198486,
            "end_logit": 7.191513538360596
        },
        {
            "text": "p16",
            "probability": 1.6533298301741166e-06,
            "start_logit": 7.920575141906738,
            "end_logit": -5.5242180824279785
        },
        {
            "text": "and/or p16Ink4a",
            "probability": 1.012470519544007e-06,
            "start_logit": -5.082406044006348,
            "end_logit": 6.988365173339844
        },
        {
            "text": "occurred in parallel with an increase in Bmi-1 and/or p16Ink4a",
            "probability": 9.365665818221302e-07,
            "start_logit": -5.16033411026001,
            "end_logit": 6.988365173339844
        },
        {
            "text": "p16Ink",
            "probability": 6.822939335684603e-07,
            "start_logit": 7.920575141906738,
            "end_logit": -6.409304141998291
        },
        {
            "text": "The suppression of p16Ink4a occurred in parallel with an increase in Bmi-1 and/or p16Ink4a",
            "probability": 2.8706023048651173e-09,
            "start_logit": -1.7874808311462402,
            "end_logit": -2.172186851501465
        },
        {
            "text": "The suppression",
            "probability": 5.239495648847538e-10,
            "start_logit": -1.7874808311462402,
            "end_logit": -3.8730685710906982
        },
        {
            "text": "p16Ink4a suppression of lung adenocarcinoma",
            "probability": 4.639097442505708e-10,
            "start_logit": -1.0528532266616821,
            "end_logit": -4.729401588439941
        },
        {
            "text": "suppression of p16Ink4a occurred in parallel with an increase in Bmi-1 and/or p16Ink4a",
            "probability": 4.1774136348277434e-10,
            "start_logit": -3.714895486831665,
            "end_logit": -2.172186851501465
        },
        {
            "text": "p16Ink4a suppression",
            "probability": 9.155306536146645e-11,
            "start_logit": -1.0528532266616821,
            "end_logit": -6.3521728515625
        },
        {
            "text": "p16Ink4a suppression of lung",
            "probability": 8.918026832671221e-11,
            "start_logit": -1.0528532266616821,
            "end_logit": -6.378431797027588
        }
    ],
    "533abc76d6d3ac6a34000064_006": [
        {
            "text": "p16INK4",
            "probability": 0.9978451834077915,
            "start_logit": 7.39006233215332,
            "end_logit": 7.45462703704834
        },
        {
            "text": "p16INK4a",
            "probability": 0.0016370396141515866,
            "start_logit": 7.39006233215332,
            "end_logit": 1.041918396949768
        },
        {
            "text": "4",
            "probability": 0.00025220288356925545,
            "start_logit": -0.8930572271347046,
            "end_logit": 7.45462703704834
        },
        {
            "text": "p",
            "probability": 9.337062096007577e-05,
            "start_logit": 7.39006233215332,
            "end_logit": -1.822149634361267
        },
        {
            "text": "INK4",
            "probability": 5.309472620906997e-05,
            "start_logit": 1.4489799737930298,
            "end_logit": 3.554433584213257
        },
        {
            "text": "p16INK4a/p14ARF",
            "probability": 4.347338726650116e-05,
            "start_logit": 7.39006233215332,
            "end_logit": -2.5865774154663086
        },
        {
            "text": "reduced p16INK4a/p14ARF",
            "probability": 2.6032795065824833e-05,
            "start_logit": -3.1639339923858643,
            "end_logit": 7.45462703704834
        },
        {
            "text": "16INK4",
            "probability": 1.8475391354879593e-05,
            "start_logit": -3.5068514347076416,
            "end_logit": 7.45462703704834
        },
        {
            "text": "the reduced p16INK4a/p14ARF",
            "probability": 1.2671923180843217e-05,
            "start_logit": -3.8839023113250732,
            "end_logit": 7.45462703704834
        },
        {
            "text": "cancer and correlates with the reduced p16INK4a/p14ARF",
            "probability": 8.56893664554409e-06,
            "start_logit": -4.275147438049316,
            "end_logit": 7.45462703704834
        },
        {
            "text": "p16",
            "probability": 3.7341813179278366e-06,
            "start_logit": 7.39006233215332,
            "end_logit": -5.041197776794434
        },
        {
            "text": "colorectal cancer and correlates with the reduced p16INK4a/p14ARF",
            "probability": 2.5713773089922207e-06,
            "start_logit": -5.478849411010742,
            "end_logit": 7.45462703704834
        },
        {
            "text": "is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF",
            "probability": 1.3026806787774427e-06,
            "start_logit": -6.158866882324219,
            "end_logit": 7.45462703704834
        },
        {
            "text": "overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF",
            "probability": 1.2323803417741083e-06,
            "start_logit": -6.214343547821045,
            "end_logit": 7.45462703704834
        },
        {
            "text": "p16INK",
            "probability": 4.668258604225315e-07,
            "start_logit": 7.39006233215332,
            "end_logit": -7.120525360107422
        },
        {
            "text": "4a",
            "probability": 4.1375768312688705e-07,
            "start_logit": -0.8930572271347046,
            "end_logit": 1.041918396949768
        },
        {
            "text": "INK4a",
            "probability": 7.383554140352503e-08,
            "start_logit": -2.61649751663208,
            "end_logit": 1.041918396949768
        },
        {
            "text": "a",
            "probability": 3.272964982653496e-08,
            "start_logit": -3.43005633354187,
            "end_logit": 1.041918396949768
        },
        {
            "text": "16INK4a",
            "probability": 3.031026058731937e-08,
            "start_logit": -3.5068514347076416,
            "end_logit": 1.041918396949768
        },
        {
            "text": "carcinogenesis by repressing the INK4a/ARF",
            "probability": 2.8235162151582627e-08,
            "start_logit": -6.090284824371338,
            "end_logit": 3.554433584213257
        }
    ],
    "571f5c150fd6f91b68000009_001": [
        {
            "text": "frataxin",
            "probability": 0.9874908246629509,
            "start_logit": 9.486952781677246,
            "end_logit": 8.915946006774902
        },
        {
            "text": "frataxin expression, a mitochondrial protein involved in iron",
            "probability": 0.011898531769612506,
            "start_logit": 9.486952781677246,
            "end_logit": 4.497193813323975
        },
        {
            "text": "frataxin expression,",
            "probability": 0.0002466701130429387,
            "start_logit": 9.486952781677246,
            "end_logit": 0.6210753917694092
        },
        {
            "text": "fr",
            "probability": 0.000224862493311247,
            "start_logit": 9.486952781677246,
            "end_logit": 0.5285125970840454
        },
        {
            "text": "in",
            "probability": 9.126135231914606e-05,
            "start_logit": 0.19775769114494324,
            "end_logit": 8.915946006774902
        },
        {
            "text": "iron",
            "probability": 3.7031978847395844e-05,
            "start_logit": 3.714564323425293,
            "end_logit": 4.497193813323975
        },
        {
            "text": "caused by a deficiency in frataxin",
            "probability": 2.673919304282346e-06,
            "start_logit": -3.3324244022369385,
            "end_logit": 8.915946006774902
        },
        {
            "text": "deficiency in frataxin",
            "probability": 2.4427549608990478e-06,
            "start_logit": -3.4228432178497314,
            "end_logit": 8.915946006774902
        },
        {
            "text": "fratax",
            "probability": 1.1321031286228462e-06,
            "start_logit": 9.486952781677246,
            "end_logit": -4.762899398803711
        },
        {
            "text": "axin",
            "probability": 1.0515964274402486e-06,
            "start_logit": -4.265660285949707,
            "end_logit": 8.915946006774902
        },
        {
            "text": "accepted that Friedreich's ataxia (FRDA) is caused by a deficiency in frataxin",
            "probability": 6.752609360383668e-07,
            "start_logit": -4.708625793457031,
            "end_logit": 8.915946006774902
        },
        {
            "text": "Friedreich's ataxia (FRDA) is caused by a deficiency in frataxin",
            "probability": 6.281219785408488e-07,
            "start_logit": -4.7809906005859375,
            "end_logit": 8.915946006774902
        },
        {
            "text": "ataxin",
            "probability": 6.265159558513825e-07,
            "start_logit": -4.78355073928833,
            "end_logit": 8.915946006774902
        },
        {
            "text": "is caused by a deficiency in frataxin",
            "probability": 5.461857420332549e-07,
            "start_logit": -4.9207658767700195,
            "end_logit": 8.915946006774902
        },
        {
            "text": "in frataxin",
            "probability": 3.634644600593888e-07,
            "start_logit": -5.328043460845947,
            "end_logit": 8.915946006774902
        },
        {
            "text": "a deficiency in frataxin",
            "probability": 2.84222676055994e-07,
            "start_logit": -5.573966979980469,
            "end_logit": 8.915946006774902
        },
        {
            "text": "by a deficiency in frataxin",
            "probability": 2.1324529221086187e-07,
            "start_logit": -5.861281871795654,
            "end_logit": 8.915946006774902
        },
        {
            "text": "frat",
            "probability": 9.129368499603961e-08,
            "start_logit": 9.486952781677246,
            "end_logit": -7.2806501388549805
        },
        {
            "text": "expression, a mitochondrial protein involved in iron",
            "probability": 5.672662468296614e-08,
            "start_logit": -2.7667291164398193,
            "end_logit": 4.497193813323975
        },
        {
            "text": "caused by a deficiency in frataxin expression, a mitochondrial protein involved in iron",
            "probability": 3.221874370553565e-08,
            "start_logit": -3.3324244022369385,
            "end_logit": 4.497193813323975
        }
    ],
    "571f5c150fd6f91b68000009_002": [
        {
            "text": "frataxin",
            "probability": 0.9996682076377931,
            "start_logit": 9.488414764404297,
            "end_logit": 8.887432098388672
        },
        {
            "text": "fr",
            "probability": 0.00014709268163478668,
            "start_logit": 9.488414764404297,
            "end_logit": 0.06331626325845718
        },
        {
            "text": "in",
            "probability": 9.563325426739804e-05,
            "start_logit": 0.2337566614151001,
            "end_logit": 8.887432098388672
        },
        {
            "text": "frataxin,",
            "probability": 8.460085734268129e-05,
            "start_logit": 9.488414764404297,
            "end_logit": -0.48980221152305603
        },
        {
            "text": "axin",
            "probability": 1.5236028193631131e-06,
            "start_logit": -3.905686140060425,
            "end_logit": 8.887432098388672
        },
        {
            "text": "the decreased expression of frataxin,",
            "probability": 8.912591019938019e-07,
            "start_logit": -4.4418840408325195,
            "end_logit": 8.887432098388672
        },
        {
            "text": "ataxin",
            "probability": 6.762005651661017e-07,
            "start_logit": -4.718029499053955,
            "end_logit": 8.887432098388672
        },
        {
            "text": "decreased expression of frataxin,",
            "probability": 4.355978713594118e-07,
            "start_logit": -5.15779972076416,
            "end_logit": 8.887432098388672
        },
        {
            "text": "fratax",
            "probability": 2.266782820643106e-07,
            "start_logit": 9.488414764404297,
            "end_logit": -6.411970138549805
        },
        {
            "text": "caused by the decreased expression of frataxin,",
            "probability": 1.6232659431541112e-07,
            "start_logit": -6.144908905029297,
            "end_logit": 8.887432098388672
        },
        {
            "text": "by the decreased expression of frataxin,",
            "probability": 1.0439877048054702e-07,
            "start_logit": -6.586301326751709,
            "end_logit": 8.887432098388672
        },
        {
            "text": "expression of frataxin,",
            "probability": 9.178190106521414e-08,
            "start_logit": -6.715104103088379,
            "end_logit": 8.887432098388672
        },
        {
            "text": "frat",
            "probability": 9.071161466641007e-08,
            "start_logit": 9.488414764404297,
            "end_logit": -7.327816486358643
        },
        {
            "text": "of frataxin,",
            "probability": 8.717338495980503e-08,
            "start_logit": -6.76662015914917,
            "end_logit": 8.887432098388672
        },
        {
            "text": "frataxin, a mitochondrial protein that stimulates iron-sulfur",
            "probability": 4.497401385926912e-08,
            "start_logit": 9.488414764404297,
            "end_logit": -8.029417037963867
        },
        {
            "text": "frataxin, a",
            "probability": 4.4882364457332955e-08,
            "start_logit": 9.488414764404297,
            "end_logit": -8.03145694732666
        },
        {
            "text": "is a severe neurodegenerative disease caused by the decreased expression of frataxin,",
            "probability": 4.38056988163318e-08,
            "start_logit": -7.4547553062438965,
            "end_logit": 8.887432098388672
        },
        {
            "text": "frataxin, a mitochondrial protein that stimulates",
            "probability": 4.2080167966656665e-08,
            "start_logit": 9.488414764404297,
            "end_logit": -8.095925331115723
        },
        {
            "text": "Friedreich's ataxia is a severe neurodegenerative disease caused by the decreased expression of frataxin,",
            "probability": 4.948030215349653e-11,
            "start_logit": -5.416584014892578,
            "end_logit": 0.06331626325845718
        },
        {
            "text": ",",
            "probability": 4.633131522696647e-11,
            "start_logit": -4.929222106933594,
            "end_logit": -0.48980221152305603
        }
    ],
    "571f5c150fd6f91b68000009_003": [
        {
            "text": "FXN",
            "probability": 0.7019841741638357,
            "start_logit": 8.248591423034668,
            "end_logit": 7.440440654754639
        },
        {
            "text": "frataxin deficiency (FXN)",
            "probability": 0.21242810571118262,
            "start_logit": 7.053284168243408,
            "end_logit": 7.440440654754639
        },
        {
            "text": "frataxin",
            "probability": 0.08515989564598049,
            "start_logit": 7.053284168243408,
            "end_logit": 6.526367664337158
        },
        {
            "text": "frataxin deficiency",
            "probability": 0.00022716571540174605,
            "start_logit": 7.053284168243408,
            "end_logit": 0.5997615456581116
        },
        {
            "text": "FX",
            "probability": 9.39080051038272e-05,
            "start_logit": 8.248591423034668,
            "end_logit": -1.4789098501205444
        },
        {
            "text": "N",
            "probability": 7.145872495100428e-05,
            "start_logit": -0.9439547061920166,
            "end_logit": 7.440440654754639
        },
        {
            "text": "(FXN)",
            "probability": 1.5641185402460933e-05,
            "start_logit": -2.463167190551758,
            "end_logit": 7.440440654754639
        },
        {
            "text": "in",
            "probability": 9.175748506455567e-06,
            "start_logit": -2.082437753677368,
            "end_logit": 6.526367664337158
        },
        {
            "text": "fr",
            "probability": 8.396036310634597e-06,
            "start_logit": 7.053284168243408,
            "end_logit": -2.6981585025787354
        },
        {
            "text": "deficiency (FXN)",
            "probability": 5.50290170178154e-07,
            "start_logit": -5.810384273529053,
            "end_logit": 7.440440654754639
        },
        {
            "text": "axin",
            "probability": 4.466595015169871e-07,
            "start_logit": -5.1049604415893555,
            "end_logit": 6.526367664337158
        },
        {
            "text": "(FXN) causes severe phenotypes including loss of iron-sulfur (Fe-S) cluster protein activity,",
            "probability": 1.9313372939972378e-07,
            "start_logit": 8.248591423034668,
            "end_logit": -7.665597915649414
        },
        {
            "text": "eukaryotes, frataxin deficiency (FXN)",
            "probability": 1.8875148289015658e-07,
            "start_logit": -6.880398750305176,
            "end_logit": 7.440440654754639
        },
        {
            "text": "(FXN) causes severe phenotypes",
            "probability": 1.6443771160912145e-07,
            "start_logit": 8.248591423034668,
            "end_logit": -7.826448917388916
        },
        {
            "text": "(FXN) causes severe",
            "probability": 1.255748368453301e-07,
            "start_logit": 8.248591423034668,
            "end_logit": -8.096078872680664
        },
        {
            "text": "(FXN) causes severe phenotypes including loss of iron-sulfur (Fe-S) cluster protein activity, accumulation",
            "probability": 1.2123321369377575e-07,
            "start_logit": 8.248591423034668,
            "end_logit": -8.131264686584473
        },
        {
            "text": "frat",
            "probability": 8.657130677632768e-08,
            "start_logit": 7.053284168243408,
            "end_logit": -7.272705078125
        },
        {
            "text": "eukaryotes, frataxin",
            "probability": 7.566821975903746e-08,
            "start_logit": -6.880398750305176,
            "end_logit": 6.526367664337158
        },
        {
            "text": "ataxin",
            "probability": 6.591891833065862e-08,
            "start_logit": -7.018331527709961,
            "end_logit": 6.526367664337158
        },
        {
            "text": "fratax",
            "probability": 6.082423388949716e-08,
            "start_logit": 7.053284168243408,
            "end_logit": -7.625685214996338
        }
    ],
    "571f5c150fd6f91b68000009_004": [
        {
            "text": "frataxin",
            "probability": 0.43102444948832175,
            "start_logit": 2.135547637939453,
            "end_logit": -4.566269874572754
        },
        {
            "text": "frataxin, the mitochondrial protein defective",
            "probability": 0.24605450858287023,
            "start_logit": 2.135547637939453,
            "end_logit": -5.1268815994262695
        },
        {
            "text": "frataxin,",
            "probability": 0.20596184303225468,
            "start_logit": 2.135547637939453,
            "end_logit": -5.304743766784668
        },
        {
            "text": "fr",
            "probability": 0.061000882213681225,
            "start_logit": 2.135547637939453,
            "end_logit": -6.521546363830566
        },
        {
            "text": "frataxin, the",
            "probability": 0.009703591443572142,
            "start_logit": 2.135547637939453,
            "end_logit": -8.359938621520996
        },
        {
            "text": "frataxin, the mitochondrial protein",
            "probability": 0.008728332325507921,
            "start_logit": 2.135547637939453,
            "end_logit": -8.465860366821289
        },
        {
            "text": "frataxin, the mitochondrial protein defective in patients with Friedreich's ataxia, is lethal",
            "probability": 0.008711833150444995,
            "start_logit": 2.135547637939453,
            "end_logit": -8.467752456665039
        },
        {
            "text": "frataxin, the mitochondrial protein defective in patients with Friedreich's ataxia,",
            "probability": 0.0087117251438447,
            "start_logit": 2.135547637939453,
            "end_logit": -8.467764854431152
        },
        {
            "text": "frataxin, the mitochondrial",
            "probability": 0.008648827983540632,
            "start_logit": 2.135547637939453,
            "end_logit": -8.475010871887207
        },
        {
            "text": "frat",
            "probability": 0.008387225575550033,
            "start_logit": 2.135547637939453,
            "end_logit": -8.505724906921387
        },
        {
            "text": "Complete absence of frataxin,",
            "probability": 0.0011606530805382059,
            "start_logit": -3.7816343307495117,
            "end_logit": -4.566269874572754
        },
        {
            "text": "Complete absence of frataxin, the mitochondrial protein defective",
            "probability": 0.0006625701249802546,
            "start_logit": -3.7816343307495117,
            "end_logit": -5.1268815994262695
        },
        {
            "text": "Complete absence",
            "probability": 0.0006063307504217503,
            "start_logit": -3.7816343307495117,
            "end_logit": -5.215582370758057
        },
        {
            "text": "absence of frataxin,",
            "probability": 0.00018569846106834045,
            "start_logit": -5.614248275756836,
            "end_logit": -4.566269874572754
        },
        {
            "text": "the mitochondrial protein defective",
            "probability": 0.00010622419299081405,
            "start_logit": -5.612208843231201,
            "end_logit": -5.1268815994262695
        },
        {
            "text": "absence of frataxin, the mitochondrial protein defective",
            "probability": 0.00010600777667486763,
            "start_logit": -5.614248275756836,
            "end_logit": -5.1268815994262695
        },
        {
            "text": "absence",
            "probability": 9.700976901687095e-05,
            "start_logit": -5.614248275756836,
            "end_logit": -5.215582370758057
        },
        {
            "text": "Complete",
            "probability": 6.838116394421252e-05,
            "start_logit": -3.7816343307495117,
            "end_logit": -7.3979105949401855
        },
        {
            "text": "of frataxin,",
            "probability": 4.704795630169678e-05,
            "start_logit": -6.9872050285339355,
            "end_logit": -4.566269874572754
        },
        {
            "text": "of frataxin, the mitochondrial protein defective",
            "probability": 2.6857784474604394e-05,
            "start_logit": -6.9872050285339355,
            "end_logit": -5.1268815994262695
        }
    ],
    "571f5c150fd6f91b68000009_005": [
        {
            "text": "frataxin",
            "probability": 0.999708737358677,
            "start_logit": 9.657419204711914,
            "end_logit": 9.11858081817627
        },
        {
            "text": "fr",
            "probability": 0.00017052130673027844,
            "start_logit": 9.657419204711914,
            "end_logit": 0.44222182035446167
        },
        {
            "text": "in",
            "probability": 0.00011110418683726482,
            "start_logit": 0.5526683330535889,
            "end_logit": 9.11858081817627
        },
        {
            "text": "axin",
            "probability": 3.4530063773880147e-06,
            "start_logit": -2.9185547828674316,
            "end_logit": 9.11858081817627
        },
        {
            "text": "characterized by a decreased expression of the mitochondrial protein frataxin.",
            "probability": 2.4132770302041016e-06,
            "start_logit": -3.2768144607543945,
            "end_logit": 9.11858081817627
        },
        {
            "text": "decreased expression of the mitochondrial protein frataxin.",
            "probability": 1.0114069447037857e-06,
            "start_logit": -4.146457672119141,
            "end_logit": 9.11858081817627
        },
        {
            "text": "the mitochondrial protein frataxin.",
            "probability": 8.02402905550499e-07,
            "start_logit": -4.377944469451904,
            "end_logit": 9.11858081817627
        },
        {
            "text": "frataxin.",
            "probability": 3.574018236034311e-07,
            "start_logit": 9.657419204711914,
            "end_logit": -5.7255330085754395
        },
        {
            "text": "ataxin",
            "probability": 3.005907614700793e-07,
            "start_logit": -5.359805583953857,
            "end_logit": 9.11858081817627
        },
        {
            "text": "protein frataxin.",
            "probability": 2.7180804352919706e-07,
            "start_logit": -5.460459232330322,
            "end_logit": 9.11858081817627
        },
        {
            "text": "expression of the mitochondrial protein frataxin.",
            "probability": 2.4946671209734405e-07,
            "start_logit": -5.546229839324951,
            "end_logit": 9.11858081817627
        },
        {
            "text": "fratax",
            "probability": 2.0503924728804796e-07,
            "start_logit": 9.657419204711914,
            "end_logit": -6.281192302703857
        },
        {
            "text": "of the mitochondrial protein frataxin.",
            "probability": 1.6036598560866408e-07,
            "start_logit": -5.988096714019775,
            "end_logit": 9.11858081817627
        },
        {
            "text": "a decreased expression of the mitochondrial protein frataxin.",
            "probability": 1.5708555345001654e-07,
            "start_logit": -6.008764743804932,
            "end_logit": 9.11858081817627
        },
        {
            "text": "frat",
            "probability": 1.5456310177443315e-07,
            "start_logit": 9.657419204711914,
            "end_logit": -6.563791275024414
        },
        {
            "text": "by a decreased expression of the mitochondrial protein frataxin.",
            "probability": 1.0067113108525797e-07,
            "start_logit": -6.453696250915527,
            "end_logit": 9.11858081817627
        },
        {
            "text": "Bcl-xL",
            "probability": 5.2163388872613916e-11,
            "start_logit": -4.224200248718262,
            "end_logit": -0.6761486530303955
        },
        {
            "text": "L",
            "probability": 5.162653952285612e-12,
            "start_logit": -6.537130355834961,
            "end_logit": -0.6761486530303955
        },
        {
            "text": "BH4 domain of Bcl-xL",
            "probability": 3.4395642227589807e-12,
            "start_logit": -6.943236351013184,
            "end_logit": -0.6761486530303955
        },
        {
            "text": "characterized by",
            "probability": 1.3724920675851555e-12,
            "start_logit": -3.2768144607543945,
            "end_logit": -5.261287212371826
        }
    ],
    "571f5c150fd6f91b68000009_006": [
        {
            "text": "frataxin",
            "probability": 0.7674636291625784,
            "start_logit": 9.286325454711914,
            "end_logit": 8.854745864868164
        },
        {
            "text": "frataxin,",
            "probability": 0.23227524545831035,
            "start_logit": 9.286325454711914,
            "end_logit": 7.6595778465271
        },
        {
            "text": "fr",
            "probability": 0.0001426845895741193,
            "start_logit": 9.286325454711914,
            "end_logit": 0.2645360231399536
        },
        {
            "text": "in",
            "probability": 6.766369019862749e-05,
            "start_logit": -0.049971211701631546,
            "end_logit": 8.854745864868164
        },
        {
            "text": "iron",
            "probability": 1.4191974271409862e-05,
            "start_logit": 3.8515965938568115,
            "end_logit": 3.3913049697875977
        },
        {
            "text": "frataxin, which carries single point mutations",
            "probability": 8.31555496632835e-06,
            "start_logit": 9.286325454711914,
            "end_logit": -2.577972650527954
        },
        {
            "text": "the mitochondrial protein frataxin,",
            "probability": 8.00206812158613e-06,
            "start_logit": -2.1848208904266357,
            "end_logit": 8.854745864868164
        },
        {
            "text": ",",
            "probability": 5.875057592997205e-06,
            "start_logit": -1.29863703250885,
            "end_logit": 7.6595778465271
        },
        {
            "text": "axin",
            "probability": 3.5339396389426644e-06,
            "start_logit": -3.002107620239258,
            "end_logit": 8.854745864868164
        },
        {
            "text": "frataxin, which carries",
            "probability": 3.027555993830252e-06,
            "start_logit": 9.286325454711914,
            "end_logit": -3.5883448123931885
        },
        {
            "text": "results from a deficiency in the mitochondrial protein frataxin,",
            "probability": 2.166535815429491e-06,
            "start_logit": -3.49139142036438,
            "end_logit": 8.854745864868164
        },
        {
            "text": "frataxin, which carries single point",
            "probability": 1.5346298399846324e-06,
            "start_logit": 9.286325454711914,
            "end_logit": -4.267811298370361
        },
        {
            "text": "Friedreich's ataxia results from a deficiency in the mitochondrial protein frataxin,",
            "probability": 1.1747035046818208e-06,
            "start_logit": -4.1035051345825195,
            "end_logit": 8.854745864868164
        },
        {
            "text": "deficiency in the mitochondrial protein frataxin,",
            "probability": 1.1426772866847241e-06,
            "start_logit": -4.1311469078063965,
            "end_logit": 8.854745864868164
        },
        {
            "text": "ataxin",
            "probability": 5.170628065240718e-07,
            "start_logit": -4.924111843109131,
            "end_logit": 8.854745864868164
        },
        {
            "text": "frataxin, which carries single point mutations in some patients.",
            "probability": 3.230051192263687e-07,
            "start_logit": 9.286325454711914,
            "end_logit": -5.826187610626221
        },
        {
            "text": "protein frataxin,",
            "probability": 3.180548631022263e-07,
            "start_logit": -5.410052299499512,
            "end_logit": 8.854745864868164
        },
        {
            "text": "mitochondrial protein frataxin,",
            "probability": 2.2695677044956332e-07,
            "start_logit": -5.747516632080078,
            "end_logit": 8.854745864868164
        },
        {
            "text": "frat",
            "probability": 2.1768201601029924e-07,
            "start_logit": 9.286325454711914,
            "end_logit": -6.220820426940918
        },
        {
            "text": "a deficiency in the mitochondrial protein frataxin,",
            "probability": 2.0964073103468912e-07,
            "start_logit": -5.826880931854248,
            "end_logit": 8.854745864868164
        }
    ],
    "571f5c150fd6f91b68000009_007": [
        {
            "text": "frataxin",
            "probability": 0.9995413497846894,
            "start_logit": 5.823989391326904,
            "end_logit": 6.753832817077637
        },
        {
            "text": "in",
            "probability": 0.00039068653195002695,
            "start_logit": -2.0231568813323975,
            "end_logit": 6.753832817077637
        },
        {
            "text": "low expression of frataxin,",
            "probability": 1.8487854960480282e-05,
            "start_logit": -5.073948383331299,
            "end_logit": 6.753832817077637
        },
        {
            "text": "fr",
            "probability": 1.4530726649471481e-05,
            "start_logit": 5.823989391326904,
            "end_logit": -4.384953498840332
        },
        {
            "text": "caused by low expression of frataxin,",
            "probability": 1.3152630535535418e-05,
            "start_logit": -5.414440631866455,
            "end_logit": 6.753832817077637
        },
        {
            "text": "axin",
            "probability": 4.4556409055155515e-06,
            "start_logit": -6.496891498565674,
            "end_logit": 6.753832817077637
        },
        {
            "text": "is caused by low expression of frataxin,",
            "probability": 4.321946098607819e-06,
            "start_logit": -6.5273566246032715,
            "end_logit": 6.753832817077637
        },
        {
            "text": "autosomal recessive cardio- and neurodegenerative disease, is caused by low expression of frataxin,",
            "probability": 4.145524279150289e-06,
            "start_logit": -6.569033145904541,
            "end_logit": 6.753832817077637
        },
        {
            "text": "expression of frataxin,",
            "probability": 3.8203746381225695e-06,
            "start_logit": -6.650713920593262,
            "end_logit": 6.753832817077637
        },
        {
            "text": "of frataxin,",
            "probability": 2.9792446832149894e-06,
            "start_logit": -6.899392604827881,
            "end_logit": 6.753832817077637
        },
        {
            "text": "frataxin, a small mitochondrial protein, encoded in the nucleus.",
            "probability": 9.823143073727227e-07,
            "start_logit": 5.823989391326904,
            "end_logit": -7.0790629386901855
        },
        {
            "text": "fratax",
            "probability": 3.9593175241298576e-07,
            "start_logit": 5.823989391326904,
            "end_logit": -7.987732410430908
        },
        {
            "text": "frat",
            "probability": 3.6600436591543316e-07,
            "start_logit": 5.823989391326904,
            "end_logit": -8.066329002380371
        },
        {
            "text": "frataxin,",
            "probability": 3.236795023602012e-07,
            "start_logit": 5.823989391326904,
            "end_logit": -8.189220428466797
        },
        {
            "text": "iron",
            "probability": 1.6231461430526169e-09,
            "start_logit": -3.7270524501800537,
            "end_logit": -3.933566093444824
        },
        {
            "text": "iron-binding properties of phylogenetically different frataxins.",
            "probability": 6.885599768469692e-11,
            "start_logit": -3.7270524501800537,
            "end_logit": -7.09367036819458
        },
        {
            "text": "iron-binding properties of phylogenetically different frataxins. Friedreich's ataxia",
            "probability": 5.130434407978811e-11,
            "start_logit": -3.7270524501800537,
            "end_logit": -7.387912273406982
        },
        {
            "text": "nucleus",
            "probability": 2.5995629467301813e-11,
            "start_logit": -4.7157487869262695,
            "end_logit": -7.0790629386901855
        },
        {
            "text": "iron-binding properties of phylogenetically different frataxins. Friedreich's ataxia (FRDA), an autosomal",
            "probability": 2.3211368255985007e-11,
            "start_logit": -3.7270524501800537,
            "end_logit": -8.181045532226562
        },
        {
            "text": "low expression of frataxin, a small mitochondrial protein, encoded in the nucleus.",
            "probability": 1.816921775594733e-11,
            "start_logit": -5.073948383331299,
            "end_logit": -7.0790629386901855
        }
    ],
    "571f5c150fd6f91b68000009_008": [
        {
            "text": "frataxin",
            "probability": 0.997004867574263,
            "start_logit": 7.94297981262207,
            "end_logit": 7.641901016235352
        },
        {
            "text": "frataxin, encoded by the X25",
            "probability": 0.0017948505823922108,
            "start_logit": 7.94297981262207,
            "end_logit": 1.322067141532898
        },
        {
            "text": "frataxin,",
            "probability": 0.0010031633837132537,
            "start_logit": 7.94297981262207,
            "end_logit": 0.7403037548065186
        },
        {
            "text": "fr",
            "probability": 7.272004900402951e-05,
            "start_logit": 7.94297981262207,
            "end_logit": -1.8839927911758423
        },
        {
            "text": "in",
            "probability": 6.563547501326447e-05,
            "start_logit": -1.6854147911071777,
            "end_logit": 7.641901016235352
        },
        {
            "text": "The severe reduction in mRNA and protein levels of the mitochondrial protein frataxin,",
            "probability": 2.608805206672434e-05,
            "start_logit": -2.608053684234619,
            "end_logit": 7.641901016235352
        },
        {
            "text": "the mitochondrial protein frataxin,",
            "probability": 1.292877385270394e-05,
            "start_logit": -3.3100757598876953,
            "end_logit": 7.641901016235352
        },
        {
            "text": "X25",
            "probability": 9.98741818741411e-06,
            "start_logit": 2.751628875732422,
            "end_logit": 1.322067141532898
        },
        {
            "text": "axin",
            "probability": 4.083423197909798e-06,
            "start_logit": -4.462595462799072,
            "end_logit": 7.641901016235352
        },
        {
            "text": "ataxin",
            "probability": 1.4396230049912055e-06,
            "start_logit": -5.505149841308594,
            "end_logit": 7.641901016235352
        },
        {
            "text": "protein frataxin,",
            "probability": 1.260086229758985e-06,
            "start_logit": -5.638350963592529,
            "end_logit": 7.641901016235352
        },
        {
            "text": "reduction in mRNA and protein levels of the mitochondrial protein frataxin,",
            "probability": 1.0631871631333367e-06,
            "start_logit": -5.808259963989258,
            "end_logit": 7.641901016235352
        },
        {
            "text": "of the mitochondrial protein frataxin,",
            "probability": 8.844376609284884e-07,
            "start_logit": -5.992334365844727,
            "end_logit": 7.641901016235352
        },
        {
            "text": "frataxin, encoded by the X25 gene,",
            "probability": 4.835972090482955e-07,
            "start_logit": 7.94297981262207,
            "end_logit": -6.897112846374512
        },
        {
            "text": "frataxin, encoded by the X25 gene, causes Friedreich ataxia",
            "probability": 2.279588730408097e-07,
            "start_logit": 7.94297981262207,
            "end_logit": -7.649199962615967
        },
        {
            "text": "frataxin, encoded",
            "probability": 2.1788060742699187e-07,
            "start_logit": 7.94297981262207,
            "end_logit": -7.694417953491211
        },
        {
            "text": "The severe reduction in mRNA and protein levels of the mitochondrial protein frataxin, encoded by the X25",
            "probability": 4.696482130459685e-08,
            "start_logit": -2.608053684234619,
            "end_logit": 1.322067141532898
        },
        {
            "text": "encoded by the X25",
            "probability": 2.5566842024625513e-08,
            "start_logit": -3.216156244277954,
            "end_logit": 1.322067141532898
        },
        {
            "text": "the mitochondrial protein frataxin, encoded by the X25",
            "probability": 2.3274928773017635e-08,
            "start_logit": -3.3100757598876953,
            "end_logit": 1.322067141532898
        },
        {
            "text": "X25 gene,",
            "probability": 2.6909691583319897e-09,
            "start_logit": 2.751628875732422,
            "end_logit": -6.897112846374512
        }
    ],
    "571f5c150fd6f91b68000009_009": [
        {
            "text": "frataxin",
            "probability": 0.9996427214528066,
            "start_logit": 8.85174560546875,
            "end_logit": 8.406630516052246
        },
        {
            "text": "frataxin,",
            "probability": 0.00018668941816337128,
            "start_logit": 8.85174560546875,
            "end_logit": -0.17907632887363434
        },
        {
            "text": "fr",
            "probability": 8.180379789053145e-05,
            "start_logit": 8.85174560546875,
            "end_logit": -1.0041990280151367
        },
        {
            "text": "in",
            "probability": 7.591321438712696e-05,
            "start_logit": -0.6338168382644653,
            "end_logit": 8.406630516052246
        },
        {
            "text": "axin",
            "probability": 8.719120541252099e-06,
            "start_logit": -2.797889232635498,
            "end_logit": 8.406630516052246
        },
        {
            "text": "deficiency of frataxin,",
            "probability": 1.4235616071708082e-06,
            "start_logit": -4.610245704650879,
            "end_logit": 8.406630516052246
        },
        {
            "text": "ataxin",
            "probability": 9.559314016971214e-07,
            "start_logit": -5.008476734161377,
            "end_logit": 8.406630516052246
        },
        {
            "text": "frataxin, a conserved mitochondrial protein of unknown function. Mitochondrial iron",
            "probability": 6.451635672294885e-07,
            "start_logit": 8.85174560546875,
            "end_logit": -5.846774101257324
        },
        {
            "text": "caused by a deficiency of frataxin,",
            "probability": 4.237886503493838e-07,
            "start_logit": -5.821928024291992,
            "end_logit": 8.406630516052246
        },
        {
            "text": "a deficiency of frataxin,",
            "probability": 3.4109334507232095e-07,
            "start_logit": -6.03900671005249,
            "end_logit": 8.406630516052246
        },
        {
            "text": "frat",
            "probability": 1.7151994740129907e-07,
            "start_logit": 8.85174560546875,
            "end_logit": -7.171578407287598
        },
        {
            "text": "frataxin, a conserved mitochondrial protein of unknown function. Mitochondrial iron accumulation,",
            "probability": 1.474830680942863e-07,
            "start_logit": 8.85174560546875,
            "end_logit": -7.322564601898193
        },
        {
            "text": "human frataxin,",
            "probability": 3.612939147677332e-08,
            "start_logit": -3.728651285171509,
            "end_logit": 3.8512256145477295
        },
        {
            "text": "iron-binding properties of human frataxin,",
            "probability": 5.0650586182031515e-09,
            "start_logit": -5.693392276763916,
            "end_logit": 3.8512256145477295
        },
        {
            "text": "frataxin, the protein deficient",
            "probability": 2.2132102910254797e-09,
            "start_logit": 3.2138705253601074,
            "end_logit": -5.88395881652832
        },
        {
            "text": "frataxin, the protein deficient in Friedreich ataxia. Friedreich ataxia",
            "probability": 4.955578445949969e-10,
            "start_logit": 3.2138705253601074,
            "end_logit": -7.380474090576172
        },
        {
            "text": "frataxin, the protein deficient in Friedreich ataxia.",
            "probability": 4.949620171800462e-10,
            "start_logit": 3.2138705253601074,
            "end_logit": -7.381677150726318
        },
        {
            "text": ",",
            "probability": 4.472550987703791e-11,
            "start_logit": -6.392667293548584,
            "end_logit": -0.17907632887363434
        },
        {
            "text": "deficiency",
            "probability": 9.030208816485074e-12,
            "start_logit": -4.610245704650879,
            "end_logit": -3.5614664554595947
        },
        {
            "text": "caused by a deficiency",
            "probability": 2.688257387270307e-12,
            "start_logit": -5.821928024291992,
            "end_logit": -3.5614664554595947
        }
    ],
    "571f5c150fd6f91b68000009_010": [
        {
            "text": "frataxin",
            "probability": 0.999708737358677,
            "start_logit": 9.657419204711914,
            "end_logit": 9.11858081817627
        },
        {
            "text": "fr",
            "probability": 0.00017052130673027844,
            "start_logit": 9.657419204711914,
            "end_logit": 0.44222182035446167
        },
        {
            "text": "in",
            "probability": 0.00011110418683726482,
            "start_logit": 0.5526683330535889,
            "end_logit": 9.11858081817627
        },
        {
            "text": "axin",
            "probability": 3.4530063773880147e-06,
            "start_logit": -2.9185547828674316,
            "end_logit": 9.11858081817627
        },
        {
            "text": "characterized by a decreased expression of the mitochondrial protein frataxin.",
            "probability": 2.4132770302041016e-06,
            "start_logit": -3.2768144607543945,
            "end_logit": 9.11858081817627
        },
        {
            "text": "decreased expression of the mitochondrial protein frataxin.",
            "probability": 1.0114069447037857e-06,
            "start_logit": -4.146457672119141,
            "end_logit": 9.11858081817627
        },
        {
            "text": "the mitochondrial protein frataxin.",
            "probability": 8.02402905550499e-07,
            "start_logit": -4.377944469451904,
            "end_logit": 9.11858081817627
        },
        {
            "text": "frataxin.",
            "probability": 3.574018236034311e-07,
            "start_logit": 9.657419204711914,
            "end_logit": -5.7255330085754395
        },
        {
            "text": "ataxin",
            "probability": 3.005907614700793e-07,
            "start_logit": -5.359805583953857,
            "end_logit": 9.11858081817627
        },
        {
            "text": "protein frataxin.",
            "probability": 2.7180804352919706e-07,
            "start_logit": -5.460459232330322,
            "end_logit": 9.11858081817627
        },
        {
            "text": "expression of the mitochondrial protein frataxin.",
            "probability": 2.4946671209734405e-07,
            "start_logit": -5.546229839324951,
            "end_logit": 9.11858081817627
        },
        {
            "text": "fratax",
            "probability": 2.0503924728804796e-07,
            "start_logit": 9.657419204711914,
            "end_logit": -6.281192302703857
        },
        {
            "text": "of the mitochondrial protein frataxin.",
            "probability": 1.6036598560866408e-07,
            "start_logit": -5.988096714019775,
            "end_logit": 9.11858081817627
        },
        {
            "text": "a decreased expression of the mitochondrial protein frataxin.",
            "probability": 1.5708555345001654e-07,
            "start_logit": -6.008764743804932,
            "end_logit": 9.11858081817627
        },
        {
            "text": "frat",
            "probability": 1.5456310177443315e-07,
            "start_logit": 9.657419204711914,
            "end_logit": -6.563791275024414
        },
        {
            "text": "by a decreased expression of the mitochondrial protein frataxin.",
            "probability": 1.0067113108525797e-07,
            "start_logit": -6.453696250915527,
            "end_logit": 9.11858081817627
        },
        {
            "text": "Bcl-xL",
            "probability": 5.2163388872613916e-11,
            "start_logit": -4.224200248718262,
            "end_logit": -0.6761486530303955
        },
        {
            "text": "L",
            "probability": 5.162653952285612e-12,
            "start_logit": -6.537130355834961,
            "end_logit": -0.6761486530303955
        },
        {
            "text": "BH4 domain of Bcl-xL",
            "probability": 3.4395642227589807e-12,
            "start_logit": -6.943236351013184,
            "end_logit": -0.6761486530303955
        },
        {
            "text": "characterized by",
            "probability": 1.3724920675851555e-12,
            "start_logit": -3.2768144607543945,
            "end_logit": -5.261287212371826
        }
    ],
    "571f5c150fd6f91b68000009_011": [
        {
            "text": "frataxin",
            "probability": 0.9997531967488726,
            "start_logit": 9.328778266906738,
            "end_logit": 8.95665168762207
        },
        {
            "text": "in",
            "probability": 0.00011274564627808003,
            "start_logit": 0.2386489063501358,
            "end_logit": 8.95665168762207
        },
        {
            "text": "fr",
            "probability": 6.984117417965742e-05,
            "start_logit": 9.328778266906738,
            "end_logit": -0.6123883128166199
        },
        {
            "text": "decreased expression of the mitochondrial protein frataxin.",
            "probability": 4.760816040837073e-05,
            "start_logit": -0.623481273651123,
            "end_logit": 8.95665168762207
        },
        {
            "text": "frataxin.",
            "probability": 6.944393290096969e-06,
            "start_logit": 9.328778266906738,
            "end_logit": -2.920677423477173
        },
        {
            "text": "the mitochondrial protein frataxin.",
            "probability": 5.87738083239698e-06,
            "start_logit": -2.715374231338501,
            "end_logit": 8.95665168762207
        },
        {
            "text": "caused by decreased expression of the mitochondrial protein frataxin.",
            "probability": 1.231375412573117e-06,
            "start_logit": -4.278353691101074,
            "end_logit": 8.95665168762207
        },
        {
            "text": "axin",
            "probability": 8.90199515457063e-07,
            "start_logit": -4.602795124053955,
            "end_logit": 8.95665168762207
        },
        {
            "text": "expression of the mitochondrial protein frataxin.",
            "probability": 5.449244378561643e-07,
            "start_logit": -5.093593597412109,
            "end_logit": 8.95665168762207
        },
        {
            "text": "ataxin",
            "probability": 3.851361657161581e-07,
            "start_logit": -5.440643787384033,
            "end_logit": 8.95665168762207
        },
        {
            "text": "protein frataxin.",
            "probability": 3.1125036020752717e-07,
            "start_logit": -5.6536431312561035,
            "end_logit": 8.95665168762207
        },
        {
            "text": "of the mitochondrial protein frataxin.",
            "probability": 2.2343305897629093e-07,
            "start_logit": -5.985128879547119,
            "end_logit": 8.95665168762207
        },
        {
            "text": "frat",
            "probability": 1.1811382332424781e-07,
            "start_logit": 9.328778266906738,
            "end_logit": -6.994718551635742
        },
        {
            "text": "fratax",
            "probability": 8.191592457336027e-08,
            "start_logit": 9.328778266906738,
            "end_logit": -7.360673904418945
        },
        {
            "text": "decreased expression",
            "probability": 1.2334094066726148e-10,
            "start_logit": -0.623481273651123,
            "end_logit": -3.9069106578826904
        },
        {
            "text": "decreased",
            "probability": 9.517240542499218e-12,
            "start_logit": -0.623481273651123,
            "end_logit": -6.4687581062316895
        },
        {
            "text": "decreased expression of the",
            "probability": 6.810690649243966e-12,
            "start_logit": -0.623481273651123,
            "end_logit": -6.803369522094727
        },
        {
            "text": "caused by decreased expression",
            "probability": 3.190188413047803e-12,
            "start_logit": -4.278353691101074,
            "end_logit": -3.9069106578826904
        },
        {
            "text": "decreased expression of the mitochondrial protein",
            "probability": 2.308806539049018e-12,
            "start_logit": -0.623481273651123,
            "end_logit": -7.885132312774658
        },
        {
            "text": "decreased expression of the mitochondrial",
            "probability": 2.2723063303555146e-12,
            "start_logit": -0.623481273651123,
            "end_logit": -7.901067733764648
        }
    ],
    "571f5c150fd6f91b68000009_012": [
        {
            "text": "frataxin",
            "probability": 0.9985116841955575,
            "start_logit": 2.901995897293091,
            "end_logit": 3.5296154022216797
        },
        {
            "text": "in",
            "probability": 0.0010458732028034764,
            "start_logit": -3.9594178199768066,
            "end_logit": 3.5296154022216797
        },
        {
            "text": "fr",
            "probability": 0.00011810184441571595,
            "start_logit": 2.901995897293091,
            "end_logit": -5.5128583908081055
        },
        {
            "text": "axin",
            "probability": 9.131311356564576e-05,
            "start_logit": -6.397730827331543,
            "end_logit": 3.5296154022216797
        },
        {
            "text": "of frataxin,",
            "probability": 7.992521454413351e-05,
            "start_logit": -6.530933856964111,
            "end_logit": 3.5296154022216797
        },
        {
            "text": "ataxin",
            "probability": 6.965319890744331e-05,
            "start_logit": -6.668496608734131,
            "end_logit": 3.5296154022216797
        },
        {
            "text": "caused by abnormally low levels of frataxin,",
            "probability": 5.8893295009852694e-05,
            "start_logit": -6.836297988891602,
            "end_logit": 3.5296154022216797
        },
        {
            "text": "frataxin, an essential mitochondrial protein.",
            "probability": 1.5590246175922954e-05,
            "start_logit": 2.901995897293091,
            "end_logit": -7.537760257720947
        },
        {
            "text": "fratax",
            "probability": 8.868381220399687e-06,
            "start_logit": 2.901995897293091,
            "end_logit": -8.101913452148438
        },
        {
            "text": ".",
            "probability": 2.1352861607875115e-08,
            "start_logit": -7.3924479484558105,
            "end_logit": -3.836531400680542
        },
        {
            "text": "neurodegenerative disease.",
            "probability": 1.3087094477898982e-08,
            "start_logit": -7.882007122039795,
            "end_logit": -3.836531400680542
        },
        {
            "text": "Friedreich ataxia, a so far incurable neurodegenerative disease.",
            "probability": 8.360612963876692e-09,
            "start_logit": -8.33010196685791,
            "end_logit": -3.836531400680542
        },
        {
            "text": "pathological process in Friedreich ataxia, a so far incurable neurodegenerative disease.",
            "probability": 8.296262200948063e-09,
            "start_logit": -8.337828636169434,
            "end_logit": -3.836531400680542
        },
        {
            "text": "so far incurable neurodegenerative disease.",
            "probability": 7.879449378937728e-09,
            "start_logit": -8.389375686645508,
            "end_logit": -3.836531400680542
        },
        {
            "text": "incurable neurodegenerative disease.",
            "probability": 7.855484811302699e-09,
            "start_logit": -8.39242172241211,
            "end_logit": -3.836531400680542
        },
        {
            "text": "disease.",
            "probability": 7.433147758630319e-09,
            "start_logit": -8.447684288024902,
            "end_logit": -3.836531400680542
        },
        {
            "text": "BACKGROUND: Friedreich ataxia, an autosomal recessive neurodegenerative",
            "probability": 6.422792270899938e-09,
            "start_logit": -4.414541244506836,
            "end_logit": -8.01577091217041
        },
        {
            "text": "BACKGROUND:",
            "probability": 5.6923573740091956e-09,
            "start_logit": -4.414541244506836,
            "end_logit": -8.136499404907227
        },
        {
            "text": "BACKGROUND: Friedreich ataxia,",
            "probability": 5.510128570481083e-09,
            "start_logit": -4.414541244506836,
            "end_logit": -8.169035911560059
        },
        {
            "text": "BACKGROUND: Friedreich ataxia, an autosomal recessive neurodegenerative and cardiac",
            "probability": 5.4176086833330165e-09,
            "start_logit": -4.414541244506836,
            "end_logit": -8.185969352722168
        }
    ],
    "571f5c150fd6f91b68000009_013": [
        {
            "text": "frataxin",
            "probability": 0.9996427214528066,
            "start_logit": 8.85174560546875,
            "end_logit": 8.406630516052246
        },
        {
            "text": "frataxin,",
            "probability": 0.00018668941816337128,
            "start_logit": 8.85174560546875,
            "end_logit": -0.17907632887363434
        },
        {
            "text": "fr",
            "probability": 8.180379789053145e-05,
            "start_logit": 8.85174560546875,
            "end_logit": -1.0041990280151367
        },
        {
            "text": "in",
            "probability": 7.591321438712696e-05,
            "start_logit": -0.6338168382644653,
            "end_logit": 8.406630516052246
        },
        {
            "text": "axin",
            "probability": 8.719120541252099e-06,
            "start_logit": -2.797889232635498,
            "end_logit": 8.406630516052246
        },
        {
            "text": "deficiency of frataxin,",
            "probability": 1.4235616071708082e-06,
            "start_logit": -4.610245704650879,
            "end_logit": 8.406630516052246
        },
        {
            "text": "ataxin",
            "probability": 9.559314016971214e-07,
            "start_logit": -5.008476734161377,
            "end_logit": 8.406630516052246
        },
        {
            "text": "frataxin, a conserved mitochondrial protein of unknown function. Mitochondrial iron",
            "probability": 6.451635672294885e-07,
            "start_logit": 8.85174560546875,
            "end_logit": -5.846774101257324
        },
        {
            "text": "caused by a deficiency of frataxin,",
            "probability": 4.237886503493838e-07,
            "start_logit": -5.821928024291992,
            "end_logit": 8.406630516052246
        },
        {
            "text": "a deficiency of frataxin,",
            "probability": 3.4109334507232095e-07,
            "start_logit": -6.03900671005249,
            "end_logit": 8.406630516052246
        },
        {
            "text": "frat",
            "probability": 1.7151994740129907e-07,
            "start_logit": 8.85174560546875,
            "end_logit": -7.171578407287598
        },
        {
            "text": "frataxin, a conserved mitochondrial protein of unknown function. Mitochondrial iron accumulation,",
            "probability": 1.474830680942863e-07,
            "start_logit": 8.85174560546875,
            "end_logit": -7.322564601898193
        },
        {
            "text": "human frataxin,",
            "probability": 3.612939147677332e-08,
            "start_logit": -3.728651285171509,
            "end_logit": 3.8512256145477295
        },
        {
            "text": "iron-binding properties of human frataxin,",
            "probability": 5.0650586182031515e-09,
            "start_logit": -5.693392276763916,
            "end_logit": 3.8512256145477295
        },
        {
            "text": "frataxin, the protein deficient",
            "probability": 2.2132102910254797e-09,
            "start_logit": 3.2138705253601074,
            "end_logit": -5.88395881652832
        },
        {
            "text": "frataxin, the protein deficient in Friedreich ataxia. Friedreich ataxia",
            "probability": 4.955578445949969e-10,
            "start_logit": 3.2138705253601074,
            "end_logit": -7.380474090576172
        },
        {
            "text": "frataxin, the protein deficient in Friedreich ataxia.",
            "probability": 4.949620171800462e-10,
            "start_logit": 3.2138705253601074,
            "end_logit": -7.381677150726318
        },
        {
            "text": ",",
            "probability": 4.472550987703791e-11,
            "start_logit": -6.392667293548584,
            "end_logit": -0.17907632887363434
        },
        {
            "text": "deficiency",
            "probability": 9.030208816485074e-12,
            "start_logit": -4.610245704650879,
            "end_logit": -3.5614664554595947
        },
        {
            "text": "caused by a deficiency",
            "probability": 2.688257387270307e-12,
            "start_logit": -5.821928024291992,
            "end_logit": -3.5614664554595947
        }
    ],
    "571f5c150fd6f91b68000009_014": [
        {
            "text": "frataxin",
            "probability": 0.9997742180231521,
            "start_logit": 6.305553913116455,
            "end_logit": 6.307309627532959
        },
        {
            "text": "in",
            "probability": 0.00014091479608326491,
            "start_logit": -2.561575412750244,
            "end_logit": 6.307309627532959
        },
        {
            "text": "fr",
            "probability": 5.7624108640514115e-05,
            "start_logit": 6.305553913116455,
            "end_logit": -3.4540340900421143
        },
        {
            "text": "frataxin gene",
            "probability": 5.43914378995409e-06,
            "start_logit": 6.305553913116455,
            "end_logit": -5.8143534660339355
        },
        {
            "text": "fratax",
            "probability": 4.4988888964242015e-06,
            "start_logit": 6.305553913116455,
            "end_logit": -6.004144668579102
        },
        {
            "text": "the frataxin",
            "probability": 4.260878287825497e-06,
            "start_logit": -6.060255527496338,
            "end_logit": 6.307309627532959
        },
        {
            "text": "axin",
            "probability": 3.992513143804831e-06,
            "start_logit": -6.125309944152832,
            "end_logit": 6.307309627532959
        },
        {
            "text": "ataxin",
            "probability": 2.709288361681451e-06,
            "start_logit": -6.513044834136963,
            "end_logit": 6.307309627532959
        },
        {
            "text": "first intron of the frataxin",
            "probability": 1.254107593431927e-06,
            "start_logit": -7.28330659866333,
            "end_logit": 6.307309627532959
        },
        {
            "text": "intron of the frataxin",
            "probability": 1.0426765195954316e-06,
            "start_logit": -7.467939853668213,
            "end_logit": 6.307309627532959
        },
        {
            "text": "expansions of GAA repeats in the first intron of the frataxin",
            "probability": 8.876381140745913e-07,
            "start_logit": -7.628921985626221,
            "end_logit": 6.307309627532959
        },
        {
            "text": "the first intron of the frataxin",
            "probability": 8.262496242231954e-07,
            "start_logit": -7.700589179992676,
            "end_logit": 6.307309627532959
        },
        {
            "text": "Pathological expansions of GAA repeats in the first intron of the frataxin",
            "probability": 7.9578673429536e-07,
            "start_logit": -7.738154888153076,
            "end_logit": 6.307309627532959
        },
        {
            "text": "repeats in the first intron of the frataxin",
            "probability": 6.586732765546639e-07,
            "start_logit": -7.927258491516113,
            "end_logit": 6.307309627532959
        },
        {
            "text": "frat",
            "probability": 5.465678266952557e-07,
            "start_logit": 6.305553913116455,
            "end_logit": -8.112071990966797
        },
        {
            "text": "frataxin gene cause most cases of Friedreich ataxia, a progressively debilitating neurodegenerative",
            "probability": 3.3056840114374387e-07,
            "start_logit": 6.305553913116455,
            "end_logit": -8.614916801452637
        },
        {
            "text": "frataxin gene cause most cases of Friedreich ataxia, a progressively debilitating neurodegenerative disease.",
            "probability": 3.8215938974046026e-11,
            "start_logit": -2.561575412750244,
            "end_logit": -8.813103675842285
        },
        {
            "text": "the frataxin gene",
            "probability": 2.3180763477579075e-11,
            "start_logit": -6.060255527496338,
            "end_logit": -5.8143534660339355
        },
        {
            "text": "ax",
            "probability": 1.7965929434554875e-11,
            "start_logit": -6.125309944152832,
            "end_logit": -6.004144668579102
        },
        {
            "text": "atax",
            "probability": 1.2191539957572439e-11,
            "start_logit": -6.513044834136963,
            "end_logit": -6.004144668579102
        }
    ],
    "571f5c150fd6f91b68000009_015": [
        {
            "text": "Frataxin",
            "probability": 0.9997161651545217,
            "start_logit": 8.336874961853027,
            "end_logit": 8.289026260375977
        },
        {
            "text": "in",
            "probability": 0.00015850437542151336,
            "start_logit": -0.412569522857666,
            "end_logit": 8.289026260375977
        },
        {
            "text": "Fr",
            "probability": 0.00010914237772433891,
            "start_logit": 8.336874961853027,
            "end_logit": -0.8335471749305725
        },
        {
            "text": "axin",
            "probability": 1.034559776529716e-05,
            "start_logit": -3.1417906284332275,
            "end_logit": 8.289026260375977
        },
        {
            "text": "Frataxin is a mitochondrial protein deficient",
            "probability": 2.8527493916653303e-06,
            "start_logit": 8.336874961853027,
            "end_logit": -4.477917194366455
        },
        {
            "text": "ataxin",
            "probability": 1.061315236854293e-06,
            "start_logit": -5.418842792510986,
            "end_logit": 8.289026260375977
        },
        {
            "text": "Frataxin is a mitochondrial protein deficient in Friedreich ataxia",
            "probability": 6.494127732187038e-07,
            "start_logit": 8.336874961853027,
            "end_logit": -5.957887172698975
        },
        {
            "text": "peptidase. Frataxin",
            "probability": 1.6138313757778e-07,
            "start_logit": -7.30232572555542,
            "end_logit": 8.289026260375977
        },
        {
            "text": "Frataxin is a mitochondrial protein deficient in Friedreich ataxia (FRDA)",
            "probability": 1.5910007076338435e-07,
            "start_logit": 8.336874961853027,
            "end_logit": -7.36442232131958
        },
        {
            "text": "Frataxin is a mitochondrial protein deficient in Friedreich ataxia (FRDA) and which is associated",
            "probability": 1.5218290153989273e-07,
            "start_logit": 8.336874961853027,
            "end_logit": -7.408872604370117
        },
        {
            "text": "Frat",
            "probability": 1.2981704233342438e-07,
            "start_logit": 8.336874961853027,
            "end_logit": -7.567829608917236
        },
        {
            "text": "Frataxin is a mitochondrial protein deficient in Friedreich ataxia (FRDA) and which",
            "probability": 1.2313215421635344e-07,
            "start_logit": 8.336874961853027,
            "end_logit": -7.620697498321533
        },
        {
            "text": "Fratax",
            "probability": 1.2090007107948597e-07,
            "start_logit": 8.336874961853027,
            "end_logit": -7.638991355895996
        },
        {
            "text": "Frataxin is a mitochondrial protein deficient in",
            "probability": 1.1433191274841689e-07,
            "start_logit": 8.336874961853027,
            "end_logit": -7.694849967956543
        },
        {
            "text": "Frataxin is",
            "probability": 8.155270030286581e-08,
            "start_logit": 8.336874961853027,
            "end_logit": -8.032706260681152
        },
        {
            "text": "Frataxin is a mitochondrial",
            "probability": 8.029194169672898e-08,
            "start_logit": 8.336874961853027,
            "end_logit": -8.048286437988281
        },
        {
            "text": "Frataxin is a mitochondrial protein deficient in Friedreich ataxia (FRDA) and",
            "probability": 7.822431626121332e-08,
            "start_logit": 8.336874961853027,
            "end_logit": -8.07437515258789
        },
        {
            "text": "Frataxin is a",
            "probability": 7.808158663510572e-08,
            "start_logit": 8.336874961853027,
            "end_logit": -8.076201438903809
        },
        {
            "text": "Frataxin is a mitochondrial protein deficient in Friedreich ataxia (FRDA) and which is associated with abnormal",
            "probability": 1.7814359025364528e-11,
            "start_logit": -0.412569522857666,
            "end_logit": -7.71226167678833
        },
        {
            "text": "is a mitochondrial protein deficient",
            "probability": 1.5159831895888215e-12,
            "start_logit": -6.110854625701904,
            "end_logit": -4.477917194366455
        }
    ],
    "571f5c150fd6f91b68000009_016": [
        {
            "text": "frataxin",
            "probability": 0.9964815677261173,
            "start_logit": 9.515217781066895,
            "end_logit": 9.09347152709961
        },
        {
            "text": "frataxin, a putative iron",
            "probability": 0.0030787287656909128,
            "start_logit": 9.515217781066895,
            "end_logit": 3.3137576580047607
        },
        {
            "text": "fr",
            "probability": 0.0001477186019820961,
            "start_logit": 9.515217781066895,
            "end_logit": 0.2767947316169739
        },
        {
            "text": "frataxin, a putative iron chaperone,",
            "probability": 0.00011254284093597924,
            "start_logit": 9.515217781066895,
            "end_logit": 0.004819563124328852
        },
        {
            "text": "in",
            "probability": 9.036732181295921e-05,
            "start_logit": 0.207114577293396,
            "end_logit": 9.09347152709961
        },
        {
            "text": "iron",
            "probability": 7.063142011495425e-05,
            "start_logit": 5.740420818328857,
            "end_logit": 3.3137576580047607
        },
        {
            "text": "frataxin,",
            "probability": 1.0439475670227243e-05,
            "start_logit": 9.515217781066895,
            "end_logit": -2.372920036315918
        },
        {
            "text": "iron chaperone,",
            "probability": 2.5819295183334315e-06,
            "start_logit": 5.740420818328857,
            "end_logit": 0.004819563124328852
        },
        {
            "text": "axin",
            "probability": 1.9432065983219203e-06,
            "start_logit": -3.6324286460876465,
            "end_logit": 9.09347152709961
        },
        {
            "text": "results from a deficiency in frataxin,",
            "probability": 7.959658045091174e-07,
            "start_logit": -4.524967193603516,
            "end_logit": 9.09347152709961
        },
        {
            "text": "ataxin",
            "probability": 7.958701646452106e-07,
            "start_logit": -4.525087356567383,
            "end_logit": 9.09347152709961
        },
        {
            "text": "deficiency in frataxin,",
            "probability": 7.474686757312278e-07,
            "start_logit": -4.587831020355225,
            "end_logit": 9.09347152709961
        },
        {
            "text": "fratax",
            "probability": 2.0397876763906026e-07,
            "start_logit": 9.515217781066895,
            "end_logit": -6.308253765106201
        },
        {
            "text": "a deficiency in frataxin,",
            "probability": 1.9051054641687822e-07,
            "start_logit": -5.954815864562988,
            "end_logit": 9.09347152709961
        },
        {
            "text": "in frataxin,",
            "probability": 1.87412841743762e-07,
            "start_logit": -5.971209526062012,
            "end_logit": 9.09347152709961
        },
        {
            "text": "(Friedreich's ataxia) results from a deficiency in frataxin,",
            "probability": 1.6625160912261142e-07,
            "start_logit": -6.0910210609436035,
            "end_logit": 9.09347152709961
        },
        {
            "text": "The neurodegenerative disorder FRDA (Friedreich's ataxia) results from a deficiency in frataxin,",
            "probability": 1.397919662484855e-07,
            "start_logit": -6.264368057250977,
            "end_logit": 9.09347152709961
        },
        {
            "text": "frataxin, a putative",
            "probability": 1.2615573268885843e-07,
            "start_logit": 9.515217781066895,
            "end_logit": -6.788752555847168
        },
        {
            "text": "frat",
            "probability": 1.2284623433037897e-07,
            "start_logit": 9.515217781066895,
            "end_logit": -6.815336227416992
        },
        {
            "text": "results from a deficiency in frataxin, a putative iron",
            "probability": 2.4592154016862527e-09,
            "start_logit": -4.524967193603516,
            "end_logit": 3.3137576580047607
        }
    ],
    "571f5c150fd6f91b68000009_017": [
        {
            "text": "frataxin",
            "probability": 0.9964815677261173,
            "start_logit": 9.515217781066895,
            "end_logit": 9.09347152709961
        },
        {
            "text": "frataxin, a putative iron",
            "probability": 0.0030787287656909128,
            "start_logit": 9.515217781066895,
            "end_logit": 3.3137576580047607
        },
        {
            "text": "fr",
            "probability": 0.0001477186019820961,
            "start_logit": 9.515217781066895,
            "end_logit": 0.2767947316169739
        },
        {
            "text": "frataxin, a putative iron chaperone,",
            "probability": 0.00011254284093597924,
            "start_logit": 9.515217781066895,
            "end_logit": 0.004819563124328852
        },
        {
            "text": "in",
            "probability": 9.036732181295921e-05,
            "start_logit": 0.207114577293396,
            "end_logit": 9.09347152709961
        },
        {
            "text": "iron",
            "probability": 7.063142011495425e-05,
            "start_logit": 5.740420818328857,
            "end_logit": 3.3137576580047607
        },
        {
            "text": "frataxin,",
            "probability": 1.0439475670227243e-05,
            "start_logit": 9.515217781066895,
            "end_logit": -2.372920036315918
        },
        {
            "text": "iron chaperone,",
            "probability": 2.5819295183334315e-06,
            "start_logit": 5.740420818328857,
            "end_logit": 0.004819563124328852
        },
        {
            "text": "axin",
            "probability": 1.9432065983219203e-06,
            "start_logit": -3.6324286460876465,
            "end_logit": 9.09347152709961
        },
        {
            "text": "results from a deficiency in frataxin,",
            "probability": 7.959658045091174e-07,
            "start_logit": -4.524967193603516,
            "end_logit": 9.09347152709961
        },
        {
            "text": "ataxin",
            "probability": 7.958701646452106e-07,
            "start_logit": -4.525087356567383,
            "end_logit": 9.09347152709961
        },
        {
            "text": "deficiency in frataxin,",
            "probability": 7.474686757312278e-07,
            "start_logit": -4.587831020355225,
            "end_logit": 9.09347152709961
        },
        {
            "text": "fratax",
            "probability": 2.0397876763906026e-07,
            "start_logit": 9.515217781066895,
            "end_logit": -6.308253765106201
        },
        {
            "text": "a deficiency in frataxin,",
            "probability": 1.9051054641687822e-07,
            "start_logit": -5.954815864562988,
            "end_logit": 9.09347152709961
        },
        {
            "text": "in frataxin,",
            "probability": 1.87412841743762e-07,
            "start_logit": -5.971209526062012,
            "end_logit": 9.09347152709961
        },
        {
            "text": "(Friedreich's ataxia) results from a deficiency in frataxin,",
            "probability": 1.6625160912261142e-07,
            "start_logit": -6.0910210609436035,
            "end_logit": 9.09347152709961
        },
        {
            "text": "The neurodegenerative disorder FRDA (Friedreich's ataxia) results from a deficiency in frataxin,",
            "probability": 1.397919662484855e-07,
            "start_logit": -6.264368057250977,
            "end_logit": 9.09347152709961
        },
        {
            "text": "frataxin, a putative",
            "probability": 1.2615573268885843e-07,
            "start_logit": 9.515217781066895,
            "end_logit": -6.788752555847168
        },
        {
            "text": "frat",
            "probability": 1.2284623433037897e-07,
            "start_logit": 9.515217781066895,
            "end_logit": -6.815336227416992
        },
        {
            "text": "results from a deficiency in frataxin, a putative iron",
            "probability": 2.4592154016862527e-09,
            "start_logit": -4.524967193603516,
            "end_logit": 3.3137576580047607
        }
    ],
    "571f5c150fd6f91b68000009_018": [
        {
            "text": "Frataxin",
            "probability": 0.9107279374473767,
            "start_logit": 6.593118190765381,
            "end_logit": 6.793649673461914
        },
        {
            "text": "frataxin",
            "probability": 0.08886095860960312,
            "start_logit": 5.598823547363281,
            "end_logit": 5.46077299118042
        },
        {
            "text": "in",
            "probability": 0.00021073117706563426,
            "start_logit": -1.778298020362854,
            "end_logit": 6.793649673461914
        },
        {
            "text": "Frataxin deficiency",
            "probability": 9.40712024843475e-05,
            "start_logit": 6.593118190765381,
            "end_logit": -2.3842978477478027
        },
        {
            "text": "Fr",
            "probability": 5.180159387915001e-05,
            "start_logit": 6.593118190765381,
            "end_logit": -2.980928897857666
        },
        {
            "text": "frataxin is essential for the mitochondrial biosynthesis of ISCs. Frataxin",
            "probability": 2.3430174123685943e-05,
            "start_logit": -3.9748566150665283,
            "end_logit": 6.793649673461914
        },
        {
            "text": "axin",
            "probability": 1.2965913712621114e-05,
            "start_logit": -4.56655740737915,
            "end_logit": 6.793649673461914
        },
        {
            "text": "fr",
            "probability": 9.318799512394116e-06,
            "start_logit": 5.598823547363281,
            "end_logit": -3.702021360397339
        },
        {
            "text": "The Friedreich's ataxia protein frataxin",
            "probability": 4.134442009906636e-06,
            "start_logit": -4.376652240753174,
            "end_logit": 5.46077299118042
        },
        {
            "text": "ataxin",
            "probability": 1.7095846324772623e-06,
            "start_logit": -6.592630863189697,
            "end_logit": 6.793649673461914
        },
        {
            "text": "Friedreich's ataxia protein frataxin",
            "probability": 8.364148915266664e-07,
            "start_logit": -5.974635124206543,
            "end_logit": 5.46077299118042
        },
        {
            "text": "Fratax",
            "probability": 6.680950940010546e-07,
            "start_logit": 6.593118190765381,
            "end_logit": -7.331674575805664
        },
        {
            "text": "protein frataxin",
            "probability": 4.7026313736195086e-07,
            "start_logit": -6.550467491149902,
            "end_logit": 5.46077299118042
        },
        {
            "text": "fratax",
            "probability": 3.3410457572103016e-07,
            "start_logit": 5.598823547363281,
            "end_logit": -7.030356407165527
        },
        {
            "text": "frataxin modulates",
            "probability": 1.6565422061833915e-07,
            "start_logit": 5.598823547363281,
            "end_logit": -7.731907844543457
        },
        {
            "text": "frataxin modulates DNA base excision",
            "probability": 1.6060198689015172e-07,
            "start_logit": 5.598823547363281,
            "end_logit": -7.762881278991699
        },
        {
            "text": "frataxin modulates DNA base",
            "probability": 1.575264571937315e-07,
            "start_logit": 5.598823547363281,
            "end_logit": -7.782217025756836
        },
        {
            "text": "frataxin modulates DNA base excision repair in prokaryotes and mammals. DNA-repair",
            "probability": 1.4570580331418357e-07,
            "start_logit": 5.598823547363281,
            "end_logit": -7.860220909118652
        },
        {
            "text": "frataxin is essential for the mitochondrial biosynthesis of ISCs. Frataxin deficiency",
            "probability": 2.4201570673350917e-09,
            "start_logit": -3.9748566150665283,
            "end_logit": -2.3842978477478027
        },
        {
            "text": "deficiency",
            "probability": 2.6927631988332346e-10,
            "start_logit": -6.170706272125244,
            "end_logit": -2.3842978477478027
        }
    ],
    "571f5c150fd6f91b68000009_019": [
        {
            "text": "frataxin",
            "probability": 0.9997474792726727,
            "start_logit": 8.926002502441406,
            "end_logit": 8.723652839660645
        },
        {
            "text": "fr",
            "probability": 0.00010037711994410297,
            "start_logit": 8.926002502441406,
            "end_logit": -0.4826708734035492
        },
        {
            "text": "in",
            "probability": 9.784202459856692e-05,
            "start_logit": -0.30590131878852844,
            "end_logit": 8.723652839660645
        },
        {
            "text": "deficiency of frataxin,",
            "probability": 2.7181328025457118e-05,
            "start_logit": -1.5867252349853516,
            "end_logit": 8.723652839660645
        },
        {
            "text": "frataxin,",
            "probability": 1.0373550705135667e-05,
            "start_logit": 8.926002502441406,
            "end_logit": -2.7523458003997803
        },
        {
            "text": "caused by deficiency of frataxin,",
            "probability": 6.975889182373347e-06,
            "start_logit": -2.946795701980591,
            "end_logit": 8.723652839660645
        },
        {
            "text": "axin",
            "probability": 5.997996193885321e-06,
            "start_logit": -3.097830057144165,
            "end_logit": 8.723652839660645
        },
        {
            "text": "ataxin",
            "probability": 8.270103332589671e-07,
            "start_logit": -5.079193592071533,
            "end_logit": 8.723652839660645
        },
        {
            "text": "of frataxin,",
            "probability": 6.942815413373061e-07,
            "start_logit": -5.254133224487305,
            "end_logit": 8.723652839660645
        },
        {
            "text": "Caucasians. It is caused by deficiency of frataxin,",
            "probability": 5.388229883209429e-07,
            "start_logit": -5.507623672485352,
            "end_logit": 8.723652839660645
        },
        {
            "text": "is caused by deficiency of frataxin,",
            "probability": 5.217097676968773e-07,
            "start_logit": -5.5398993492126465,
            "end_logit": 8.723652839660645
        },
        {
            "text": "It is caused by deficiency of frataxin,",
            "probability": 4.521230726377252e-07,
            "start_logit": -5.683056354522705,
            "end_logit": 8.723652839660645
        },
        {
            "text": "by deficiency of frataxin,",
            "probability": 2.845899855563468e-07,
            "start_logit": -6.145961284637451,
            "end_logit": 8.723652839660645
        },
        {
            "text": "fratax",
            "probability": 1.7885267485424573e-07,
            "start_logit": 8.926002502441406,
            "end_logit": -6.812798023223877
        },
        {
            "text": "frataxin, a highly conserved nuclear-encoded protein localized in mitochondria.",
            "probability": 1.5333807263457997e-07,
            "start_logit": 8.926002502441406,
            "end_logit": -6.966715335845947
        },
        {
            "text": "frat",
            "probability": 1.1923113459678148e-07,
            "start_logit": 8.926002502441406,
            "end_logit": -7.218296527862549
        },
        {
            "text": "deficiency",
            "probability": 2.206680401751633e-09,
            "start_logit": -1.5867252349853516,
            "end_logit": -0.6951434016227722
        },
        {
            "text": "caused by deficiency",
            "probability": 5.663283975351535e-10,
            "start_logit": -2.946795701980591,
            "end_logit": -0.6951434016227722
        },
        {
            "text": "Caucasians. It is caused by deficiency",
            "probability": 4.3743636338426395e-11,
            "start_logit": -5.507623672485352,
            "end_logit": -0.6951434016227722
        },
        {
            "text": "is caused by deficiency",
            "probability": 4.23543220074044e-11,
            "start_logit": -5.5398993492126465,
            "end_logit": -0.6951434016227722
        }
    ],
    "571f5c150fd6f91b68000009_021": [
        {
            "text": "frataxin",
            "probability": 0.9997474792726727,
            "start_logit": 8.926002502441406,
            "end_logit": 8.723652839660645
        },
        {
            "text": "fr",
            "probability": 0.00010037711994410297,
            "start_logit": 8.926002502441406,
            "end_logit": -0.4826708734035492
        },
        {
            "text": "in",
            "probability": 9.784202459856692e-05,
            "start_logit": -0.30590131878852844,
            "end_logit": 8.723652839660645
        },
        {
            "text": "deficiency of frataxin,",
            "probability": 2.7181328025457118e-05,
            "start_logit": -1.5867252349853516,
            "end_logit": 8.723652839660645
        },
        {
            "text": "frataxin,",
            "probability": 1.0373550705135667e-05,
            "start_logit": 8.926002502441406,
            "end_logit": -2.7523458003997803
        },
        {
            "text": "caused by deficiency of frataxin,",
            "probability": 6.975889182373347e-06,
            "start_logit": -2.946795701980591,
            "end_logit": 8.723652839660645
        },
        {
            "text": "axin",
            "probability": 5.997996193885321e-06,
            "start_logit": -3.097830057144165,
            "end_logit": 8.723652839660645
        },
        {
            "text": "ataxin",
            "probability": 8.270103332589671e-07,
            "start_logit": -5.079193592071533,
            "end_logit": 8.723652839660645
        },
        {
            "text": "of frataxin,",
            "probability": 6.942815413373061e-07,
            "start_logit": -5.254133224487305,
            "end_logit": 8.723652839660645
        },
        {
            "text": "Caucasians. It is caused by deficiency of frataxin,",
            "probability": 5.388229883209429e-07,
            "start_logit": -5.507623672485352,
            "end_logit": 8.723652839660645
        },
        {
            "text": "is caused by deficiency of frataxin,",
            "probability": 5.217097676968773e-07,
            "start_logit": -5.5398993492126465,
            "end_logit": 8.723652839660645
        },
        {
            "text": "It is caused by deficiency of frataxin,",
            "probability": 4.521230726377252e-07,
            "start_logit": -5.683056354522705,
            "end_logit": 8.723652839660645
        },
        {
            "text": "by deficiency of frataxin,",
            "probability": 2.845899855563468e-07,
            "start_logit": -6.145961284637451,
            "end_logit": 8.723652839660645
        },
        {
            "text": "fratax",
            "probability": 1.7885267485424573e-07,
            "start_logit": 8.926002502441406,
            "end_logit": -6.812798023223877
        },
        {
            "text": "frataxin, a highly conserved nuclear-encoded protein localized in mitochondria.",
            "probability": 1.5333807263457997e-07,
            "start_logit": 8.926002502441406,
            "end_logit": -6.966715335845947
        },
        {
            "text": "frat",
            "probability": 1.1923113459678148e-07,
            "start_logit": 8.926002502441406,
            "end_logit": -7.218296527862549
        },
        {
            "text": "deficiency",
            "probability": 2.206680401751633e-09,
            "start_logit": -1.5867252349853516,
            "end_logit": -0.6951434016227722
        },
        {
            "text": "caused by deficiency",
            "probability": 5.663283975351535e-10,
            "start_logit": -2.946795701980591,
            "end_logit": -0.6951434016227722
        },
        {
            "text": "Caucasians. It is caused by deficiency",
            "probability": 4.3743636338426395e-11,
            "start_logit": -5.507623672485352,
            "end_logit": -0.6951434016227722
        },
        {
            "text": "is caused by deficiency",
            "probability": 4.23543220074044e-11,
            "start_logit": -5.5398993492126465,
            "end_logit": -0.6951434016227722
        }
    ],
    "571f5c150fd6f91b68000009_022": [
        {
            "text": "(dfh),",
            "probability": 0.6636998860906755,
            "start_logit": -1.0434459447860718,
            "end_logit": 1.0574625730514526
        },
        {
            "text": "Drosophila frataxin (dfh),",
            "probability": 0.14066697171977274,
            "start_logit": -2.5948808193206787,
            "end_logit": 1.0574625730514526
        },
        {
            "text": "Drosophila frataxin",
            "probability": 0.1253644845549167,
            "start_logit": -2.5948808193206787,
            "end_logit": 0.9422927498817444
        },
        {
            "text": "frataxin (dfh),",
            "probability": 0.03158807908015012,
            "start_logit": -4.088496208190918,
            "end_logit": 1.0574625730514526
        },
        {
            "text": "frataxin",
            "probability": 0.02815176301549917,
            "start_logit": -4.088496208190918,
            "end_logit": 0.9422927498817444
        },
        {
            "text": "in",
            "probability": 0.003037902068314903,
            "start_logit": -6.314939022064209,
            "end_logit": 0.9422927498817444
        },
        {
            "text": "Interestingly, Drosophila frataxin (dfh),",
            "probability": 0.0027581449949817607,
            "start_logit": -6.526717662811279,
            "end_logit": 1.0574625730514526
        },
        {
            "text": "Interestingly, Drosophila frataxin",
            "probability": 0.0024580995908011593,
            "start_logit": -6.526717662811279,
            "end_logit": 0.9422927498817444
        },
        {
            "text": "(dfh), which causes Friedreich's ataxia if mutated",
            "probability": 0.0013200457110200733,
            "start_logit": -1.0434459447860718,
            "end_logit": -5.16270112991333
        },
        {
            "text": "Drosophila frataxin (dfh), which causes Friedreich's ataxia if mutated",
            "probability": 0.00027977529692614595,
            "start_logit": -2.5948808193206787,
            "end_logit": -5.16270112991333
        },
        {
            "text": "(dfh), which causes Friedreich's ataxia",
            "probability": 0.00012807817331561628,
            "start_logit": -1.0434459447860718,
            "end_logit": -7.495481967926025
        },
        {
            "text": "(dfh), which causes Friedreich's ataxia if mutated in humans, displayed an interacting effect with Al,",
            "probability": 0.00012719974113788719,
            "start_logit": -1.0434459447860718,
            "end_logit": -7.502364158630371
        },
        {
            "text": "(dfh), which causes",
            "probability": 9.344711441204297e-05,
            "start_logit": -1.0434459447860718,
            "end_logit": -7.810727119445801
        },
        {
            "text": "dfh",
            "probability": 7.956306818727313e-05,
            "start_logit": -2.8227264881134033,
            "end_logit": -6.192292213439941
        },
        {
            "text": "(dfh), which causes Friedreich's",
            "probability": 6.465624687829772e-05,
            "start_logit": -1.0434459447860718,
            "end_logit": -8.179038047790527
        },
        {
            "text": "frataxin (dfh), which causes Friedreich's ataxia if mutated",
            "probability": 6.28261495639586e-05,
            "start_logit": -4.088496208190918,
            "end_logit": -5.16270112991333
        },
        {
            "text": "(dfh), which",
            "probability": 5.8423026441490103e-05,
            "start_logit": -1.0434459447860718,
            "end_logit": -8.280412673950195
        },
        {
            "text": "Drosophila frataxin (dfh), which causes Friedreich's ataxia",
            "probability": 2.714535464188181e-05,
            "start_logit": -2.5948808193206787,
            "end_logit": -7.495481967926025
        },
        {
            "text": "Drosophila frataxin (dfh), which causes",
            "probability": 1.9805521856752795e-05,
            "start_logit": -2.5948808193206787,
            "end_logit": -7.810727119445801
        },
        {
            "text": "Drosophila frataxin (dfh), which causes Friedreich's",
            "probability": 1.370348050638897e-05,
            "start_logit": -2.5948808193206787,
            "end_logit": -8.179038047790527
        }
    ],
    "571f5c150fd6f91b68000009_023": [
        {
            "text": "frataxin",
            "probability": 0.9997474792726727,
            "start_logit": 8.926002502441406,
            "end_logit": 8.723652839660645
        },
        {
            "text": "fr",
            "probability": 0.00010037711994410297,
            "start_logit": 8.926002502441406,
            "end_logit": -0.4826708734035492
        },
        {
            "text": "in",
            "probability": 9.784202459856692e-05,
            "start_logit": -0.30590131878852844,
            "end_logit": 8.723652839660645
        },
        {
            "text": "deficiency of frataxin,",
            "probability": 2.7181328025457118e-05,
            "start_logit": -1.5867252349853516,
            "end_logit": 8.723652839660645
        },
        {
            "text": "frataxin,",
            "probability": 1.0373550705135667e-05,
            "start_logit": 8.926002502441406,
            "end_logit": -2.7523458003997803
        },
        {
            "text": "caused by deficiency of frataxin,",
            "probability": 6.975889182373347e-06,
            "start_logit": -2.946795701980591,
            "end_logit": 8.723652839660645
        },
        {
            "text": "axin",
            "probability": 5.997996193885321e-06,
            "start_logit": -3.097830057144165,
            "end_logit": 8.723652839660645
        },
        {
            "text": "ataxin",
            "probability": 8.270103332589671e-07,
            "start_logit": -5.079193592071533,
            "end_logit": 8.723652839660645
        },
        {
            "text": "of frataxin,",
            "probability": 6.942815413373061e-07,
            "start_logit": -5.254133224487305,
            "end_logit": 8.723652839660645
        },
        {
            "text": "Caucasians. It is caused by deficiency of frataxin,",
            "probability": 5.388229883209429e-07,
            "start_logit": -5.507623672485352,
            "end_logit": 8.723652839660645
        },
        {
            "text": "is caused by deficiency of frataxin,",
            "probability": 5.217097676968773e-07,
            "start_logit": -5.5398993492126465,
            "end_logit": 8.723652839660645
        },
        {
            "text": "It is caused by deficiency of frataxin,",
            "probability": 4.521230726377252e-07,
            "start_logit": -5.683056354522705,
            "end_logit": 8.723652839660645
        },
        {
            "text": "by deficiency of frataxin,",
            "probability": 2.845899855563468e-07,
            "start_logit": -6.145961284637451,
            "end_logit": 8.723652839660645
        },
        {
            "text": "fratax",
            "probability": 1.7885267485424573e-07,
            "start_logit": 8.926002502441406,
            "end_logit": -6.812798023223877
        },
        {
            "text": "frataxin, a highly conserved nuclear-encoded protein localized in mitochondria.",
            "probability": 1.5333807263457997e-07,
            "start_logit": 8.926002502441406,
            "end_logit": -6.966715335845947
        },
        {
            "text": "frat",
            "probability": 1.1923113459678148e-07,
            "start_logit": 8.926002502441406,
            "end_logit": -7.218296527862549
        },
        {
            "text": "deficiency",
            "probability": 2.206680401751633e-09,
            "start_logit": -1.5867252349853516,
            "end_logit": -0.6951434016227722
        },
        {
            "text": "caused by deficiency",
            "probability": 5.663283975351535e-10,
            "start_logit": -2.946795701980591,
            "end_logit": -0.6951434016227722
        },
        {
            "text": "Caucasians. It is caused by deficiency",
            "probability": 4.3743636338426395e-11,
            "start_logit": -5.507623672485352,
            "end_logit": -0.6951434016227722
        },
        {
            "text": "is caused by deficiency",
            "probability": 4.23543220074044e-11,
            "start_logit": -5.5398993492126465,
            "end_logit": -0.6951434016227722
        }
    ],
    "571f5c150fd6f91b68000009_024": [
        {
            "text": "(dfh),",
            "probability": 0.6636998860906755,
            "start_logit": -1.0434459447860718,
            "end_logit": 1.0574625730514526
        },
        {
            "text": "Drosophila frataxin (dfh),",
            "probability": 0.14066697171977274,
            "start_logit": -2.5948808193206787,
            "end_logit": 1.0574625730514526
        },
        {
            "text": "Drosophila frataxin",
            "probability": 0.1253644845549167,
            "start_logit": -2.5948808193206787,
            "end_logit": 0.9422927498817444
        },
        {
            "text": "frataxin (dfh),",
            "probability": 0.03158807908015012,
            "start_logit": -4.088496208190918,
            "end_logit": 1.0574625730514526
        },
        {
            "text": "frataxin",
            "probability": 0.02815176301549917,
            "start_logit": -4.088496208190918,
            "end_logit": 0.9422927498817444
        },
        {
            "text": "in",
            "probability": 0.003037902068314903,
            "start_logit": -6.314939022064209,
            "end_logit": 0.9422927498817444
        },
        {
            "text": "Interestingly, Drosophila frataxin (dfh),",
            "probability": 0.0027581449949817607,
            "start_logit": -6.526717662811279,
            "end_logit": 1.0574625730514526
        },
        {
            "text": "Interestingly, Drosophila frataxin",
            "probability": 0.0024580995908011593,
            "start_logit": -6.526717662811279,
            "end_logit": 0.9422927498817444
        },
        {
            "text": "(dfh), which causes Friedreich's ataxia if mutated",
            "probability": 0.0013200457110200733,
            "start_logit": -1.0434459447860718,
            "end_logit": -5.16270112991333
        },
        {
            "text": "Drosophila frataxin (dfh), which causes Friedreich's ataxia if mutated",
            "probability": 0.00027977529692614595,
            "start_logit": -2.5948808193206787,
            "end_logit": -5.16270112991333
        },
        {
            "text": "(dfh), which causes Friedreich's ataxia",
            "probability": 0.00012807817331561628,
            "start_logit": -1.0434459447860718,
            "end_logit": -7.495481967926025
        },
        {
            "text": "(dfh), which causes Friedreich's ataxia if mutated in humans, displayed an interacting effect with Al,",
            "probability": 0.00012719974113788719,
            "start_logit": -1.0434459447860718,
            "end_logit": -7.502364158630371
        },
        {
            "text": "(dfh), which causes",
            "probability": 9.344711441204297e-05,
            "start_logit": -1.0434459447860718,
            "end_logit": -7.810727119445801
        },
        {
            "text": "dfh",
            "probability": 7.956306818727313e-05,
            "start_logit": -2.8227264881134033,
            "end_logit": -6.192292213439941
        },
        {
            "text": "(dfh), which causes Friedreich's",
            "probability": 6.465624687829772e-05,
            "start_logit": -1.0434459447860718,
            "end_logit": -8.179038047790527
        },
        {
            "text": "frataxin (dfh), which causes Friedreich's ataxia if mutated",
            "probability": 6.28261495639586e-05,
            "start_logit": -4.088496208190918,
            "end_logit": -5.16270112991333
        },
        {
            "text": "(dfh), which",
            "probability": 5.8423026441490103e-05,
            "start_logit": -1.0434459447860718,
            "end_logit": -8.280412673950195
        },
        {
            "text": "Drosophila frataxin (dfh), which causes Friedreich's ataxia",
            "probability": 2.714535464188181e-05,
            "start_logit": -2.5948808193206787,
            "end_logit": -7.495481967926025
        },
        {
            "text": "Drosophila frataxin (dfh), which causes",
            "probability": 1.9805521856752795e-05,
            "start_logit": -2.5948808193206787,
            "end_logit": -7.810727119445801
        },
        {
            "text": "Drosophila frataxin (dfh), which causes Friedreich's",
            "probability": 1.370348050638897e-05,
            "start_logit": -2.5948808193206787,
            "end_logit": -8.179038047790527
        }
    ],
    "571f5c150fd6f91b68000009_025": [
        {
            "text": "frataxin",
            "probability": 0.9997474792726727,
            "start_logit": 8.926002502441406,
            "end_logit": 8.723652839660645
        },
        {
            "text": "fr",
            "probability": 0.00010037711994410297,
            "start_logit": 8.926002502441406,
            "end_logit": -0.4826708734035492
        },
        {
            "text": "in",
            "probability": 9.784202459856692e-05,
            "start_logit": -0.30590131878852844,
            "end_logit": 8.723652839660645
        },
        {
            "text": "deficiency of frataxin,",
            "probability": 2.7181328025457118e-05,
            "start_logit": -1.5867252349853516,
            "end_logit": 8.723652839660645
        },
        {
            "text": "frataxin,",
            "probability": 1.0373550705135667e-05,
            "start_logit": 8.926002502441406,
            "end_logit": -2.7523458003997803
        },
        {
            "text": "caused by deficiency of frataxin,",
            "probability": 6.975889182373347e-06,
            "start_logit": -2.946795701980591,
            "end_logit": 8.723652839660645
        },
        {
            "text": "axin",
            "probability": 5.997996193885321e-06,
            "start_logit": -3.097830057144165,
            "end_logit": 8.723652839660645
        },
        {
            "text": "ataxin",
            "probability": 8.270103332589671e-07,
            "start_logit": -5.079193592071533,
            "end_logit": 8.723652839660645
        },
        {
            "text": "of frataxin,",
            "probability": 6.942815413373061e-07,
            "start_logit": -5.254133224487305,
            "end_logit": 8.723652839660645
        },
        {
            "text": "Caucasians. It is caused by deficiency of frataxin,",
            "probability": 5.388229883209429e-07,
            "start_logit": -5.507623672485352,
            "end_logit": 8.723652839660645
        },
        {
            "text": "is caused by deficiency of frataxin,",
            "probability": 5.217097676968773e-07,
            "start_logit": -5.5398993492126465,
            "end_logit": 8.723652839660645
        },
        {
            "text": "It is caused by deficiency of frataxin,",
            "probability": 4.521230726377252e-07,
            "start_logit": -5.683056354522705,
            "end_logit": 8.723652839660645
        },
        {
            "text": "by deficiency of frataxin,",
            "probability": 2.845899855563468e-07,
            "start_logit": -6.145961284637451,
            "end_logit": 8.723652839660645
        },
        {
            "text": "fratax",
            "probability": 1.7885267485424573e-07,
            "start_logit": 8.926002502441406,
            "end_logit": -6.812798023223877
        },
        {
            "text": "frataxin, a highly conserved nuclear-encoded protein localized in mitochondria.",
            "probability": 1.5333807263457997e-07,
            "start_logit": 8.926002502441406,
            "end_logit": -6.966715335845947
        },
        {
            "text": "frat",
            "probability": 1.1923113459678148e-07,
            "start_logit": 8.926002502441406,
            "end_logit": -7.218296527862549
        },
        {
            "text": "deficiency",
            "probability": 2.206680401751633e-09,
            "start_logit": -1.5867252349853516,
            "end_logit": -0.6951434016227722
        },
        {
            "text": "caused by deficiency",
            "probability": 5.663283975351535e-10,
            "start_logit": -2.946795701980591,
            "end_logit": -0.6951434016227722
        },
        {
            "text": "Caucasians. It is caused by deficiency",
            "probability": 4.3743636338426395e-11,
            "start_logit": -5.507623672485352,
            "end_logit": -0.6951434016227722
        },
        {
            "text": "is caused by deficiency",
            "probability": 4.23543220074044e-11,
            "start_logit": -5.5398993492126465,
            "end_logit": -0.6951434016227722
        }
    ],
    "571f5c150fd6f91b68000009_026": [
        {
            "text": "(dfh),",
            "probability": 0.6636998860906755,
            "start_logit": -1.0434459447860718,
            "end_logit": 1.0574625730514526
        },
        {
            "text": "Drosophila frataxin (dfh),",
            "probability": 0.14066697171977274,
            "start_logit": -2.5948808193206787,
            "end_logit": 1.0574625730514526
        },
        {
            "text": "Drosophila frataxin",
            "probability": 0.1253644845549167,
            "start_logit": -2.5948808193206787,
            "end_logit": 0.9422927498817444
        },
        {
            "text": "frataxin (dfh),",
            "probability": 0.03158807908015012,
            "start_logit": -4.088496208190918,
            "end_logit": 1.0574625730514526
        },
        {
            "text": "frataxin",
            "probability": 0.02815176301549917,
            "start_logit": -4.088496208190918,
            "end_logit": 0.9422927498817444
        },
        {
            "text": "in",
            "probability": 0.003037902068314903,
            "start_logit": -6.314939022064209,
            "end_logit": 0.9422927498817444
        },
        {
            "text": "Interestingly, Drosophila frataxin (dfh),",
            "probability": 0.0027581449949817607,
            "start_logit": -6.526717662811279,
            "end_logit": 1.0574625730514526
        },
        {
            "text": "Interestingly, Drosophila frataxin",
            "probability": 0.0024580995908011593,
            "start_logit": -6.526717662811279,
            "end_logit": 0.9422927498817444
        },
        {
            "text": "(dfh), which causes Friedreich's ataxia if mutated",
            "probability": 0.0013200457110200733,
            "start_logit": -1.0434459447860718,
            "end_logit": -5.16270112991333
        },
        {
            "text": "Drosophila frataxin (dfh), which causes Friedreich's ataxia if mutated",
            "probability": 0.00027977529692614595,
            "start_logit": -2.5948808193206787,
            "end_logit": -5.16270112991333
        },
        {
            "text": "(dfh), which causes Friedreich's ataxia",
            "probability": 0.00012807817331561628,
            "start_logit": -1.0434459447860718,
            "end_logit": -7.495481967926025
        },
        {
            "text": "(dfh), which causes Friedreich's ataxia if mutated in humans, displayed an interacting effect with Al,",
            "probability": 0.00012719974113788719,
            "start_logit": -1.0434459447860718,
            "end_logit": -7.502364158630371
        },
        {
            "text": "(dfh), which causes",
            "probability": 9.344711441204297e-05,
            "start_logit": -1.0434459447860718,
            "end_logit": -7.810727119445801
        },
        {
            "text": "dfh",
            "probability": 7.956306818727313e-05,
            "start_logit": -2.8227264881134033,
            "end_logit": -6.192292213439941
        },
        {
            "text": "(dfh), which causes Friedreich's",
            "probability": 6.465624687829772e-05,
            "start_logit": -1.0434459447860718,
            "end_logit": -8.179038047790527
        },
        {
            "text": "frataxin (dfh), which causes Friedreich's ataxia if mutated",
            "probability": 6.28261495639586e-05,
            "start_logit": -4.088496208190918,
            "end_logit": -5.16270112991333
        },
        {
            "text": "(dfh), which",
            "probability": 5.8423026441490103e-05,
            "start_logit": -1.0434459447860718,
            "end_logit": -8.280412673950195
        },
        {
            "text": "Drosophila frataxin (dfh), which causes Friedreich's ataxia",
            "probability": 2.714535464188181e-05,
            "start_logit": -2.5948808193206787,
            "end_logit": -7.495481967926025
        },
        {
            "text": "Drosophila frataxin (dfh), which causes",
            "probability": 1.9805521856752795e-05,
            "start_logit": -2.5948808193206787,
            "end_logit": -7.810727119445801
        },
        {
            "text": "Drosophila frataxin (dfh), which causes Friedreich's",
            "probability": 1.370348050638897e-05,
            "start_logit": -2.5948808193206787,
            "end_logit": -8.179038047790527
        }
    ],
    "571f5c150fd6f91b68000009_027": [
        {
            "text": "frataxin",
            "probability": 0.9976254226363116,
            "start_logit": 8.905220031738281,
            "end_logit": 8.53587818145752
        },
        {
            "text": "frataxin,",
            "probability": 0.0021717762294708493,
            "start_logit": 8.905220031738281,
            "end_logit": 2.40604567527771
        },
        {
            "text": "in",
            "probability": 9.293151016778972e-05,
            "start_logit": -0.37605035305023193,
            "end_logit": 8.53587818145752
        },
        {
            "text": "fr",
            "probability": 8.813385329966457e-05,
            "start_logit": 8.905220031738281,
            "end_logit": -0.7983982563018799
        },
        {
            "text": "decreased expression of a mitochondrially targeted protein, frataxin,",
            "probability": 1.6354219916532877e-05,
            "start_logit": -2.11342716217041,
            "end_logit": 8.53587818145752
        },
        {
            "text": "axin",
            "probability": 1.2207578661061515e-06,
            "start_logit": -4.708441257476807,
            "end_logit": 8.53587818145752
        },
        {
            "text": "results from decreased expression of a mitochondrially targeted protein, frataxin,",
            "probability": 1.0490053396904797e-06,
            "start_logit": -4.860070705413818,
            "end_logit": 8.53587818145752
        },
        {
            "text": "frataxin, mitochondrial myopathy has not been described as a feature of the disease. The association between the frataxin",
            "probability": 9.875980387360729e-07,
            "start_logit": -0.37605035305023193,
            "end_logit": 3.9915359020233154
        },
        {
            "text": "ataxin",
            "probability": 9.233192837853908e-07,
            "start_logit": -4.9876933097839355,
            "end_logit": 8.53587818145752
        },
        {
            "text": "protein, frataxin,",
            "probability": 3.4955291142801965e-07,
            "start_logit": -5.95901346206665,
            "end_logit": 8.53587818145752
        },
        {
            "text": "expression of a mitochondrially targeted protein, frataxin,",
            "probability": 2.644583433347289e-07,
            "start_logit": -6.237984657287598,
            "end_logit": 8.53587818145752
        },
        {
            "text": "of a mitochondrially targeted protein, frataxin,",
            "probability": 1.9226593324873623e-07,
            "start_logit": -6.556788921356201,
            "end_logit": 8.53587818145752
        },
        {
            "text": "phenotype results from decreased expression of a mitochondrially targeted protein, frataxin,",
            "probability": 1.3452581420075185e-07,
            "start_logit": -6.913912296295166,
            "end_logit": 8.53587818145752
        },
        {
            "text": "frataxin, mitochondrial myopathy",
            "probability": 1.2714809009023638e-07,
            "start_logit": 8.905220031738281,
            "end_logit": -7.339657783508301
        },
        {
            "text": "fratax",
            "probability": 1.2052866172793172e-07,
            "start_logit": 8.905220031738281,
            "end_logit": -7.393122673034668
        },
        {
            "text": "frataxin gene",
            "probability": 6.977015807729083e-09,
            "start_logit": 3.4980456829071045,
            "end_logit": -4.835214614868164
        },
        {
            "text": "the frataxin",
            "probability": 3.5732420550540977e-09,
            "start_logit": -5.997852802276611,
            "end_logit": 3.9915359020233154
        },
        {
            "text": "frataxin gene mutation",
            "probability": 1.158285353123966e-09,
            "start_logit": 3.4980456829071045,
            "end_logit": -6.630895137786865
        },
        {
            "text": ",",
            "probability": 5.854156139398283e-10,
            "start_logit": -6.221269130706787,
            "end_logit": 2.40604567527771
        },
        {
            "text": "decreased expression of a mitochondrially targeted protein,",
            "probability": 9.659261073145625e-11,
            "start_logit": -2.11342716217041,
            "end_logit": -3.5036160945892334
        }
    ],
    "51387022bee46bd34c000002_001": [
        {
            "text": "development",
            "probability": 0.9992672340600013,
            "start_logit": 4.3649139404296875,
            "end_logit": 3.9558517932891846
        },
        {
            "text": "development.",
            "probability": 0.0005547684036040869,
            "start_logit": 4.3649139404296875,
            "end_logit": -3.540374994277954
        },
        {
            "text": "including development.",
            "probability": 0.00011005642735482509,
            "start_logit": -4.748870372772217,
            "end_logit": 3.9558517932891846
        },
        {
            "text": "the regulation of crucially important processes, including development.",
            "probability": 1.392126817811699e-05,
            "start_logit": -6.816445827484131,
            "end_logit": 3.9558517932891846
        },
        {
            "text": "some of which have been implicated in the regulation of crucially important processes, including development.",
            "probability": 1.1191164303752041e-05,
            "start_logit": -7.034739017486572,
            "end_logit": 3.9558517932891846
        },
        {
            "text": "processes, including development.",
            "probability": 1.020167939478064e-05,
            "start_logit": -7.1273112297058105,
            "end_logit": 3.9558517932891846
        },
        {
            "text": "the regulation of development.",
            "probability": 9.958626644904368e-06,
            "start_logit": -6.452850818634033,
            "end_logit": 3.2572782039642334
        },
        {
            "text": "play a role in the regulation of development.",
            "probability": 6.9456876927077164e-06,
            "start_logit": -6.813169002532959,
            "end_logit": 3.2572782039642334
        },
        {
            "text": "of development.",
            "probability": 5.8165901389145634e-06,
            "start_logit": -6.990575790405273,
            "end_logit": 3.2572782039642334
        },
        {
            "text": "a role in the regulation of development.",
            "probability": 3.6133771929251026e-06,
            "start_logit": -7.466647148132324,
            "end_logit": 3.2572782039642334
        },
        {
            "text": "evidence that some CNEs play a role in the regulation of development.",
            "probability": 2.6650132325133346e-06,
            "start_logit": -7.77108097076416,
            "end_logit": 3.2572782039642334
        },
        {
            "text": "regulation of development.",
            "probability": 2.3331084951048755e-06,
            "start_logit": -7.904088497161865,
            "end_logit": 3.2572782039642334
        },
        {
            "text": "development. Here, we quantify negative and positive selection acting",
            "probability": 1.284661302935878e-06,
            "start_logit": 3.890920877456665,
            "end_logit": -9.134437561035156
        },
        {
            "text": "including",
            "probability": 5.401673116459097e-09,
            "start_logit": -4.748870372772217,
            "end_logit": -5.966187953948975
        },
        {
            "text": "the regulation of crucially important processes,",
            "probability": 1.0979529593519467e-09,
            "start_logit": -6.816445827484131,
            "end_logit": -5.491873741149902
        },
        {
            "text": "some of which have been implicated in the regulation of crucially important processes,",
            "probability": 8.826330912303729e-10,
            "start_logit": -7.034739017486572,
            "end_logit": -5.491873741149902
        },
        {
            "text": "processes,",
            "probability": 8.045936575998236e-10,
            "start_logit": -7.1273112297058105,
            "end_logit": -5.491873741149902
        },
        {
            "text": "the regulation of crucially important processes, including",
            "probability": 6.832689545910034e-10,
            "start_logit": -6.816445827484131,
            "end_logit": -5.966187953948975
        },
        {
            "text": "some of which have been implicated in the regulation of crucially important processes, including",
            "probability": 5.492728849588973e-10,
            "start_logit": -7.034739017486572,
            "end_logit": -5.966187953948975
        },
        {
            "text": "adaptation",
            "probability": 5.130681161014836e-10,
            "start_logit": -6.549664497375488,
            "end_logit": -6.519449234008789
        }
    ],
    "51387022bee46bd34c000002_002": [
        {
            "text": "development",
            "probability": 0.9992672340600013,
            "start_logit": 4.3649139404296875,
            "end_logit": 3.9558517932891846
        },
        {
            "text": "development.",
            "probability": 0.0005547684036040869,
            "start_logit": 4.3649139404296875,
            "end_logit": -3.540374994277954
        },
        {
            "text": "including development.",
            "probability": 0.00011005642735482509,
            "start_logit": -4.748870372772217,
            "end_logit": 3.9558517932891846
        },
        {
            "text": "the regulation of crucially important processes, including development.",
            "probability": 1.392126817811699e-05,
            "start_logit": -6.816445827484131,
            "end_logit": 3.9558517932891846
        },
        {
            "text": "some of which have been implicated in the regulation of crucially important processes, including development.",
            "probability": 1.1191164303752041e-05,
            "start_logit": -7.034739017486572,
            "end_logit": 3.9558517932891846
        },
        {
            "text": "processes, including development.",
            "probability": 1.020167939478064e-05,
            "start_logit": -7.1273112297058105,
            "end_logit": 3.9558517932891846
        },
        {
            "text": "the regulation of development.",
            "probability": 9.958626644904368e-06,
            "start_logit": -6.452850818634033,
            "end_logit": 3.2572782039642334
        },
        {
            "text": "play a role in the regulation of development.",
            "probability": 6.9456876927077164e-06,
            "start_logit": -6.813169002532959,
            "end_logit": 3.2572782039642334
        },
        {
            "text": "of development.",
            "probability": 5.8165901389145634e-06,
            "start_logit": -6.990575790405273,
            "end_logit": 3.2572782039642334
        },
        {
            "text": "a role in the regulation of development.",
            "probability": 3.6133771929251026e-06,
            "start_logit": -7.466647148132324,
            "end_logit": 3.2572782039642334
        },
        {
            "text": "evidence that some CNEs play a role in the regulation of development.",
            "probability": 2.6650132325133346e-06,
            "start_logit": -7.77108097076416,
            "end_logit": 3.2572782039642334
        },
        {
            "text": "regulation of development.",
            "probability": 2.3331084951048755e-06,
            "start_logit": -7.904088497161865,
            "end_logit": 3.2572782039642334
        },
        {
            "text": "development. Here, we quantify negative and positive selection acting",
            "probability": 1.284661302935878e-06,
            "start_logit": 3.890920877456665,
            "end_logit": -9.134437561035156
        },
        {
            "text": "including",
            "probability": 5.401673116459097e-09,
            "start_logit": -4.748870372772217,
            "end_logit": -5.966187953948975
        },
        {
            "text": "the regulation of crucially important processes,",
            "probability": 1.0979529593519467e-09,
            "start_logit": -6.816445827484131,
            "end_logit": -5.491873741149902
        },
        {
            "text": "some of which have been implicated in the regulation of crucially important processes,",
            "probability": 8.826330912303729e-10,
            "start_logit": -7.034739017486572,
            "end_logit": -5.491873741149902
        },
        {
            "text": "processes,",
            "probability": 8.045936575998236e-10,
            "start_logit": -7.1273112297058105,
            "end_logit": -5.491873741149902
        },
        {
            "text": "the regulation of crucially important processes, including",
            "probability": 6.832689545910034e-10,
            "start_logit": -6.816445827484131,
            "end_logit": -5.966187953948975
        },
        {
            "text": "some of which have been implicated in the regulation of crucially important processes, including",
            "probability": 5.492728849588973e-10,
            "start_logit": -7.034739017486572,
            "end_logit": -5.966187953948975
        },
        {
            "text": "adaptation",
            "probability": 5.130681161014836e-10,
            "start_logit": -6.549664497375488,
            "end_logit": -6.519449234008789
        }
    ],
    "51387022bee46bd34c000002_003": [
        {
            "text": "development",
            "probability": 0.9993545419826746,
            "start_logit": 5.498597145080566,
            "end_logit": 5.2235260009765625
        },
        {
            "text": "developmental genes.",
            "probability": 0.0005570927543814035,
            "start_logit": 5.498597145080566,
            "end_logit": -2.2686071395874023
        },
        {
            "text": "their potential regulatory role in gene expression, and their enrichment in gene deserts nearby master developmental",
            "probability": 1.4857456240820872e-05,
            "start_logit": -5.6177659034729,
            "end_logit": 5.2235260009765625
        },
        {
            "text": "developmental",
            "probability": 1.2944304053440759e-05,
            "start_logit": 5.498597145080566,
            "end_logit": -6.0306830406188965
        },
        {
            "text": "role in gene expression, and their enrichment in gene deserts nearby master developmental",
            "probability": 1.1443829369279688e-05,
            "start_logit": -5.878817081451416,
            "end_logit": 5.2235260009765625
        },
        {
            "text": "potential regulatory role in gene expression, and their enrichment in gene deserts nearby master developmental",
            "probability": 1.138461808585012e-05,
            "start_logit": -5.884004592895508,
            "end_logit": 5.2235260009765625
        },
        {
            "text": "nearby master developmental",
            "probability": 8.662158460236778e-06,
            "start_logit": -6.157303810119629,
            "end_logit": 5.2235260009765625
        },
        {
            "text": "expression, and their enrichment in gene deserts nearby master developmental",
            "probability": 8.246927025068416e-06,
            "start_logit": -6.206427097320557,
            "end_logit": 5.2235260009765625
        },
        {
            "text": "master developmental",
            "probability": 6.399934369083543e-06,
            "start_logit": -6.459980010986328,
            "end_logit": 5.2235260009765625
        },
        {
            "text": "deserts nearby master developmental",
            "probability": 6.303017390326965e-06,
            "start_logit": -6.475239276885986,
            "end_logit": 5.2235260009765625
        },
        {
            "text": "enrichment in gene deserts nearby master developmental",
            "probability": 6.159888931824392e-06,
            "start_logit": -6.498208999633789,
            "end_logit": 5.2235260009765625
        },
        {
            "text": "developmental genes. The abnormal development",
            "probability": 1.9177157170564404e-06,
            "start_logit": 5.498597145080566,
            "end_logit": -7.94020414352417
        },
        {
            "text": "their potential regulatory role in gene expression, and their enrichment in gene deserts nearby master developmental genes.",
            "probability": 8.282327114738392e-09,
            "start_logit": -5.6177659034729,
            "end_logit": -2.2686071395874023
        },
        {
            "text": "genes.",
            "probability": 7.897890626431784e-09,
            "start_logit": -5.665294170379639,
            "end_logit": -2.2686071395874023
        },
        {
            "text": "role in gene expression, and their enrichment in gene deserts nearby master developmental genes.",
            "probability": 6.379392053749576e-09,
            "start_logit": -5.878817081451416,
            "end_logit": -2.2686071395874023
        },
        {
            "text": "potential regulatory role in gene expression, and their enrichment in gene deserts nearby master developmental genes.",
            "probability": 6.346384571829505e-09,
            "start_logit": -5.884004592895508,
            "end_logit": -2.2686071395874023
        },
        {
            "text": "nearby master developmental genes.",
            "probability": 4.828742466039789e-09,
            "start_logit": -6.157303810119629,
            "end_logit": -2.2686071395874023
        },
        {
            "text": "expression, and their enrichment in gene deserts nearby master developmental genes.",
            "probability": 4.597270636768115e-09,
            "start_logit": -6.206427097320557,
            "end_logit": -2.2686071395874023
        },
        {
            "text": "master developmental genes.",
            "probability": 3.5676598401798954e-09,
            "start_logit": -6.459980010986328,
            "end_logit": -2.2686071395874023
        },
        {
            "text": "deserts nearby master developmental genes.",
            "probability": 3.5136332216239738e-09,
            "start_logit": -6.475239276885986,
            "end_logit": -2.2686071395874023
        }
    ],
    "51387022bee46bd34c000002_004": [
        {
            "text": "development",
            "probability": 0.9996553701371577,
            "start_logit": 4.131729602813721,
            "end_logit": 4.367260932922363
        },
        {
            "text": "and development.",
            "probability": 0.00018533658732684666,
            "start_logit": -4.4612627029418945,
            "end_logit": 4.367260932922363
        },
        {
            "text": "transcription and development.",
            "probability": 6.089530047839322e-05,
            "start_logit": -5.574280261993408,
            "end_logit": 4.367260932922363
        },
        {
            "text": "that regulate transcription and development.",
            "probability": 2.1963689814161243e-05,
            "start_logit": -6.594045639038086,
            "end_logit": 4.367260932922363
        },
        {
            "text": "genes that regulate transcription and development.",
            "probability": 1.8652940572417386e-05,
            "start_logit": -6.757432460784912,
            "end_logit": 4.367260932922363
        },
        {
            "text": "regulate transcription and development.",
            "probability": 1.3683311535565883e-05,
            "start_logit": -7.067259311676025,
            "end_logit": 4.367260932922363
        },
        {
            "text": "near genes that regulate transcription and development.",
            "probability": 1.1955672027223024e-05,
            "start_logit": -7.202230453491211,
            "end_logit": 4.367260932922363
        },
        {
            "text": "sequences that are often found near genes that regulate transcription and development.",
            "probability": 9.37758371493941e-06,
            "start_logit": -7.4451141357421875,
            "end_logit": 4.367260932922363
        },
        {
            "text": "cis-regulatory sequences that are often found near genes that regulate transcription and development.",
            "probability": 8.623728422347794e-06,
            "start_logit": -7.528918743133545,
            "end_logit": 4.367260932922363
        },
        {
            "text": "possess highly conserved cis-regulatory sequences that are often found near genes that regulate transcription and development.",
            "probability": 5.212124245193534e-06,
            "start_logit": -8.032448768615723,
            "end_logit": 4.367260932922363
        },
        {
            "text": "Animal genomes possess highly conserved cis-regulatory sequences that are often found near genes that regulate transcription and development.",
            "probability": 5.140756397470434e-06,
            "start_logit": -8.046236038208008,
            "end_logit": 4.367260932922363
        },
        {
            "text": "development.",
            "probability": 3.745567729257101e-06,
            "start_logit": 4.131729602813721,
            "end_logit": -8.127331733703613
        },
        {
            "text": "transcription",
            "probability": 1.5937287885215146e-08,
            "start_logit": -5.574280261993408,
            "end_logit": -3.880988836288452
        },
        {
            "text": "that regulate transcription",
            "probability": 5.748253885602494e-09,
            "start_logit": -6.594045639038086,
            "end_logit": -3.880988836288452
        },
        {
            "text": "genes that regulate transcription",
            "probability": 4.881777107149757e-09,
            "start_logit": -6.757432460784912,
            "end_logit": -3.880988836288452
        },
        {
            "text": "cription",
            "probability": 4.61188629074265e-09,
            "start_logit": -6.814304828643799,
            "end_logit": -3.880988836288452
        },
        {
            "text": "regulate transcription",
            "probability": 3.5811445785176117e-09,
            "start_logit": -7.067259311676025,
            "end_logit": -3.880988836288452
        },
        {
            "text": "near genes that regulate transcription",
            "probability": 3.128993296070106e-09,
            "start_logit": -7.202230453491211,
            "end_logit": -3.880988836288452
        },
        {
            "text": "sequences that are often found near genes that regulate transcription",
            "probability": 2.45426576695723e-09,
            "start_logit": -7.4451141357421875,
            "end_logit": -3.880988836288452
        },
        {
            "text": "cis-regulatory sequences that are often found near genes that regulate transcription",
            "probability": 2.2569696090034873e-09,
            "start_logit": -7.528918743133545,
            "end_logit": -3.880988836288452
        }
    ],
    "51387022bee46bd34c000002_005": [
        {
            "text": "development",
            "probability": 0.9975142821546374,
            "start_logit": 5.099449157714844,
            "end_logit": 4.70726203918457
        },
        {
            "text": "zebrafish function as specific developmental",
            "probability": 0.0014519688404147715,
            "start_logit": -1.4125735759735107,
            "end_logit": 4.686938762664795
        },
        {
            "text": "exhibited by developmental",
            "probability": 0.0004375429779144613,
            "start_logit": -2.6323976516723633,
            "end_logit": 4.70726203918457
        },
        {
            "text": "developmental genes.",
            "probability": 0.00011724839400776995,
            "start_logit": 5.099449157714844,
            "end_logit": -4.341464996337891
        },
        {
            "text": "function as specific developmental",
            "probability": 0.00010056561153592469,
            "start_logit": -4.082438945770264,
            "end_logit": 4.686938762664795
        },
        {
            "text": "developmental enhancers",
            "probability": 9.894513229764241e-05,
            "start_logit": 4.9135422706604,
            "end_logit": -4.325287342071533
        },
        {
            "text": "developmental",
            "probability": 7.765685108171105e-05,
            "start_logit": 5.099449157714844,
            "end_logit": -4.753459930419922
        },
        {
            "text": "specific developmental",
            "probability": 5.8074499233920906e-05,
            "start_logit": -4.6315226554870605,
            "end_logit": 4.686938762664795
        },
        {
            "text": "developmental enhancers in zebrafish.",
            "probability": 5.5474348503290934e-05,
            "start_logit": 4.9135422706604,
            "end_logit": -4.903932094573975
        },
        {
            "text": "human and zebrafish function as specific developmental",
            "probability": 2.6631813177321777e-05,
            "start_logit": -5.411142826080322,
            "end_logit": 4.686938762664795
        },
        {
            "text": "patterns exhibited by developmental",
            "probability": 1.5182926459960918e-05,
            "start_logit": -5.993401050567627,
            "end_logit": 4.70726203918457
        },
        {
            "text": "by developmental",
            "probability": 1.4103943230182211e-05,
            "start_logit": -6.067118167877197,
            "end_logit": 4.70726203918457
        },
        {
            "text": "and zebrafish function as specific developmental",
            "probability": 1.2937643623799624e-05,
            "start_logit": -6.133108139038086,
            "end_logit": 4.686938762664795
        },
        {
            "text": "and precise complex expression patterns exhibited by developmental",
            "probability": 8.42119460731851e-06,
            "start_logit": -6.582820892333984,
            "end_logit": 4.70726203918457
        },
        {
            "text": "suggesting that multiple regulatory inputs are required to achieve robust and precise complex expression patterns exhibited by developmental",
            "probability": 8.300434154330456e-06,
            "start_logit": -6.597264766693115,
            "end_logit": 4.70726203918457
        },
        {
            "text": "zebrafish",
            "probability": 1.572154019007105e-06,
            "start_logit": 1.350068211555481,
            "end_logit": -4.903932094573975
        },
        {
            "text": "zebrafish.",
            "probability": 6.908129452612088e-07,
            "start_logit": 1.350068211555481,
            "end_logit": -5.726264953613281
        },
        {
            "text": "zebrafish function as specific developmental enhancers",
            "probability": 1.770097666085357e-07,
            "start_logit": -1.4125735759735107,
            "end_logit": -4.325287342071533
        },
        {
            "text": "z",
            "probability": 1.2401650383310925e-07,
            "start_logit": 1.350068211555481,
            "end_logit": -7.443719387054443
        },
        {
            "text": "zebrafish function as specific developmental enhancers in zebrafish.",
            "probability": 9.924188540967842e-08,
            "start_logit": -1.4125735759735107,
            "end_logit": -4.903932094573975
        }
    ],
    "51387022bee46bd34c000002_006": [
        {
            "text": "development",
            "probability": 0.9975142821546374,
            "start_logit": 5.099449157714844,
            "end_logit": 4.70726203918457
        },
        {
            "text": "zebrafish function as specific developmental",
            "probability": 0.0014519688404147715,
            "start_logit": -1.4125735759735107,
            "end_logit": 4.686938762664795
        },
        {
            "text": "exhibited by developmental",
            "probability": 0.0004375429779144613,
            "start_logit": -2.6323976516723633,
            "end_logit": 4.70726203918457
        },
        {
            "text": "developmental genes.",
            "probability": 0.00011724839400776995,
            "start_logit": 5.099449157714844,
            "end_logit": -4.341464996337891
        },
        {
            "text": "function as specific developmental",
            "probability": 0.00010056561153592469,
            "start_logit": -4.082438945770264,
            "end_logit": 4.686938762664795
        },
        {
            "text": "developmental enhancers",
            "probability": 9.894513229764241e-05,
            "start_logit": 4.9135422706604,
            "end_logit": -4.325287342071533
        },
        {
            "text": "developmental",
            "probability": 7.765685108171105e-05,
            "start_logit": 5.099449157714844,
            "end_logit": -4.753459930419922
        },
        {
            "text": "specific developmental",
            "probability": 5.8074499233920906e-05,
            "start_logit": -4.6315226554870605,
            "end_logit": 4.686938762664795
        },
        {
            "text": "developmental enhancers in zebrafish.",
            "probability": 5.5474348503290934e-05,
            "start_logit": 4.9135422706604,
            "end_logit": -4.903932094573975
        },
        {
            "text": "human and zebrafish function as specific developmental",
            "probability": 2.6631813177321777e-05,
            "start_logit": -5.411142826080322,
            "end_logit": 4.686938762664795
        },
        {
            "text": "patterns exhibited by developmental",
            "probability": 1.5182926459960918e-05,
            "start_logit": -5.993401050567627,
            "end_logit": 4.70726203918457
        },
        {
            "text": "by developmental",
            "probability": 1.4103943230182211e-05,
            "start_logit": -6.067118167877197,
            "end_logit": 4.70726203918457
        },
        {
            "text": "and zebrafish function as specific developmental",
            "probability": 1.2937643623799624e-05,
            "start_logit": -6.133108139038086,
            "end_logit": 4.686938762664795
        },
        {
            "text": "and precise complex expression patterns exhibited by developmental",
            "probability": 8.42119460731851e-06,
            "start_logit": -6.582820892333984,
            "end_logit": 4.70726203918457
        },
        {
            "text": "suggesting that multiple regulatory inputs are required to achieve robust and precise complex expression patterns exhibited by developmental",
            "probability": 8.300434154330456e-06,
            "start_logit": -6.597264766693115,
            "end_logit": 4.70726203918457
        },
        {
            "text": "zebrafish",
            "probability": 1.572154019007105e-06,
            "start_logit": 1.350068211555481,
            "end_logit": -4.903932094573975
        },
        {
            "text": "zebrafish.",
            "probability": 6.908129452612088e-07,
            "start_logit": 1.350068211555481,
            "end_logit": -5.726264953613281
        },
        {
            "text": "zebrafish function as specific developmental enhancers",
            "probability": 1.770097666085357e-07,
            "start_logit": -1.4125735759735107,
            "end_logit": -4.325287342071533
        },
        {
            "text": "z",
            "probability": 1.2401650383310925e-07,
            "start_logit": 1.350068211555481,
            "end_logit": -7.443719387054443
        },
        {
            "text": "zebrafish function as specific developmental enhancers in zebrafish.",
            "probability": 9.924188540967842e-08,
            "start_logit": -1.4125735759735107,
            "end_logit": -4.903932094573975
        }
    ],
    "51387022bee46bd34c000002_007": [
        {
            "text": "development",
            "probability": 0.9137534854177799,
            "start_logit": 4.551767826080322,
            "end_logit": 4.210306167602539
        },
        {
            "text": "development. These results suggest important roles for SINEs in the development",
            "probability": 0.0860992957766054,
            "start_logit": 2.1897082328796387,
            "end_logit": 4.210306167602539
        },
        {
            "text": "development.",
            "probability": 0.00010213986184733503,
            "start_logit": 2.1897082328796387,
            "end_logit": -2.5266072750091553
        },
        {
            "text": "roles for SINEs in the development",
            "probability": 1.4142234673441229e-05,
            "start_logit": -6.524382591247559,
            "end_logit": 4.210306167602539
        },
        {
            "text": "important roles for SINEs in the development",
            "probability": 1.2495144602415586e-05,
            "start_logit": -6.648208141326904,
            "end_logit": 4.210306167602539
        },
        {
            "text": "during development. These results suggest important roles for SINEs in the development",
            "probability": 8.319791061705742e-06,
            "start_logit": -7.054911136627197,
            "end_logit": 4.210306167602539
        },
        {
            "text": "the development",
            "probability": 4.550058606326406e-06,
            "start_logit": -7.658408164978027,
            "end_logit": 4.210306167602539
        },
        {
            "text": "development of the mammalian",
            "probability": 2.2634102893766728e-06,
            "start_logit": 4.551767826080322,
            "end_logit": -8.698137283325195
        },
        {
            "text": "development of the mammalian neuronal",
            "probability": 2.0963969365758446e-06,
            "start_logit": 4.551767826080322,
            "end_logit": -8.774789810180664
        },
        {
            "text": "development. These results suggest important roles",
            "probability": 2.522096090587119e-07,
            "start_logit": 2.1897082328796387,
            "end_logit": -8.530445098876953
        },
        {
            "text": "FGF8",
            "probability": 2.3402932840300542e-07,
            "start_logit": -2.6939287185668945,
            "end_logit": -3.7216222286224365
        },
        {
            "text": "development. These results suggest important roles for SINEs in the development of the mammalian",
            "probability": 2.1327199849722422e-07,
            "start_logit": 2.1897082328796387,
            "end_logit": -8.698137283325195
        },
        {
            "text": "development. These results suggest important roles for SINEs in the development of the mammalian neuronal",
            "probability": 1.9753500565296006e-07,
            "start_logit": 2.1897082328796387,
            "end_logit": -8.774789810180664
        },
        {
            "text": "during development.",
            "probability": 1.5272532335197482e-07,
            "start_logit": -7.054911136627197,
            "end_logit": 0.21255478262901306
        },
        {
            "text": "development. These",
            "probability": 1.4376227494655315e-07,
            "start_logit": 2.1897082328796387,
            "end_logit": -9.092544555664062
        },
        {
            "text": "FGF8 (fibroblast growth factor 8),",
            "probability": 7.0518025908782195e-09,
            "start_logit": -2.6939287185668945,
            "end_logit": -7.223785400390625
        },
        {
            "text": ".",
            "probability": 4.9798240678755334e-09,
            "start_logit": -7.738995552062988,
            "end_logit": -2.5266072750091553
        },
        {
            "text": "FGF8 (fibroblast growth factor 8), is an enhancer that recapitulates FGF8",
            "probability": 3.1001001005431972e-09,
            "start_logit": -2.6939287185668945,
            "end_logit": -8.045634269714355
        },
        {
            "text": "(fibroblast growth factor 8),",
            "probability": 1.6592342490297767e-09,
            "start_logit": -4.14085578918457,
            "end_logit": -7.223785400390625
        },
        {
            "text": "FGF",
            "probability": 1.5830968680320144e-09,
            "start_logit": -2.6939287185668945,
            "end_logit": -8.71768569946289
        }
    ],
    "51387022bee46bd34c000002_008": [
        {
            "text": "development",
            "probability": 0.9973907242474863,
            "start_logit": 4.432789325714111,
            "end_logit": 4.329983234405518
        },
        {
            "text": "around genes involved in developmental",
            "probability": 0.001489259473975329,
            "start_logit": -2.0740742683410645,
            "end_logit": 4.329983234405518
        },
        {
            "text": "cluster around genes involved in developmental",
            "probability": 0.0005170239844493228,
            "start_logit": -3.132019281387329,
            "end_logit": 4.329983234405518
        },
        {
            "text": "involved in developmental",
            "probability": 0.00022722358863073956,
            "start_logit": -3.954174041748047,
            "end_logit": 4.329983234405518
        },
        {
            "text": "genes involved in developmental",
            "probability": 0.00022034315737031395,
            "start_logit": -3.984922409057617,
            "end_logit": 4.329983234405518
        },
        {
            "text": "developmental",
            "probability": 7.822082246600256e-05,
            "start_logit": 4.432789325714111,
            "end_logit": -5.123378753662109
        },
        {
            "text": "demonstrates that they cluster around genes involved in developmental",
            "probability": 2.060478593304373e-05,
            "start_logit": -6.35458517074585,
            "end_logit": 4.329983234405518
        },
        {
            "text": "developmental regulation.",
            "probability": 1.5905510930990375e-05,
            "start_logit": 4.432789325714111,
            "end_logit": -6.716248989105225
        },
        {
            "text": "(CNEs) in the genome demonstrates that they cluster around genes involved in developmental",
            "probability": 8.401802717674564e-06,
            "start_logit": -7.251662254333496,
            "end_logit": 4.329983234405518
        },
        {
            "text": "around",
            "probability": 7.402735565015737e-06,
            "start_logit": -2.0740742683410645,
            "end_logit": -0.9742014408111572
        },
        {
            "text": "in developmental",
            "probability": 6.787389682889292e-06,
            "start_logit": -7.4650421142578125,
            "end_logit": 4.329983234405518
        },
        {
            "text": "elements (CNEs) in the genome demonstrates that they cluster around genes involved in developmental",
            "probability": 5.268841915528084e-06,
            "start_logit": -7.718297958374023,
            "end_logit": 4.329983234405518
        },
        {
            "text": "they cluster around genes involved in developmental",
            "probability": 5.159480788012855e-06,
            "start_logit": -7.739272594451904,
            "end_logit": 4.329983234405518
        },
        {
            "text": "conserved noncoding elements (CNEs) in the genome demonstrates that they cluster around genes involved in developmental",
            "probability": 4.851570664499466e-06,
            "start_logit": -7.800806045532227,
            "end_logit": 4.329983234405518
        },
        {
            "text": "cluster around",
            "probability": 2.5699966355980685e-06,
            "start_logit": -3.132019281387329,
            "end_logit": -0.9742014408111572
        },
        {
            "text": "demonstrates that they cluster around",
            "probability": 1.02421226321912e-07,
            "start_logit": -6.35458517074585,
            "end_logit": -0.9742014408111572
        },
        {
            "text": "Further positional analysis of these conserved noncoding elements (CNEs) in the genome demonstrates that they cluster around",
            "probability": 5.658972843362053e-08,
            "start_logit": -6.947851657867432,
            "end_logit": -0.9742014408111572
        },
        {
            "text": "(CNEs) in the genome demonstrates that they cluster around",
            "probability": 4.1763255413344905e-08,
            "start_logit": -7.251662254333496,
            "end_logit": -0.9742014408111572
        },
        {
            "text": "elements (CNEs) in the genome demonstrates that they cluster around",
            "probability": 2.6190092536669353e-08,
            "start_logit": -7.718297958374023,
            "end_logit": -0.9742014408111572
        },
        {
            "text": "they cluster around",
            "probability": 2.5646485782954236e-08,
            "start_logit": -7.739272594451904,
            "end_logit": -0.9742014408111572
        }
    ],
    "51387022bee46bd34c000002_009": [
        {
            "text": "development",
            "probability": 0.9886891812275784,
            "start_logit": 5.840284824371338,
            "end_logit": 5.382471561431885
        },
        {
            "text": "development.",
            "probability": 0.010849267598826673,
            "start_logit": 5.840284824371338,
            "end_logit": 0.8701891303062439
        },
        {
            "text": "associated with genes involved in regulation of transcription and development.",
            "probability": 0.00026548046575188065,
            "start_logit": -2.3823091983795166,
            "end_logit": 5.382471561431885
        },
        {
            "text": "transcription and development.",
            "probability": 6.25790292735352e-05,
            "start_logit": -3.827420234680176,
            "end_logit": 5.382471561431885
        },
        {
            "text": "and development.",
            "probability": 5.74129863194877e-05,
            "start_logit": -3.9135799407958984,
            "end_logit": 5.382471561431885
        },
        {
            "text": "involved in regulation of transcription and development.",
            "probability": 3.4273347147237675e-05,
            "start_logit": -4.429482460021973,
            "end_logit": 5.382471561431885
        },
        {
            "text": "genes involved in regulation of transcription and development.",
            "probability": 1.5014083030898323e-05,
            "start_logit": -5.254861831665039,
            "end_logit": 5.382471561431885
        },
        {
            "text": "of transcription and development.",
            "probability": 7.77200003069481e-06,
            "start_logit": -5.913322925567627,
            "end_logit": 5.382471561431885
        },
        {
            "text": "regulation of transcription and development.",
            "probability": 6.101054523478802e-06,
            "start_logit": -6.155388832092285,
            "end_logit": 5.382471561431885
        },
        {
            "text": "with genes involved in regulation of transcription and development.",
            "probability": 4.426139724359647e-06,
            "start_logit": -6.476322650909424,
            "end_logit": 5.382471561431885
        },
        {
            "text": "noncoding and associated with genes involved in regulation of transcription and development.",
            "probability": 3.885312609756934e-06,
            "start_logit": -6.60664701461792,
            "end_logit": 5.382471561431885
        },
        {
            "text": "in regulation of transcription and development.",
            "probability": 2.3402669145820958e-06,
            "start_logit": -7.113585472106934,
            "end_logit": 5.382471561431885
        },
        {
            "text": "and associated with genes involved in regulation of transcription and development.",
            "probability": 2.0990224372120976e-06,
            "start_logit": -7.222378730773926,
            "end_logit": 5.382471561431885
        },
        {
            "text": "associated with genes involved in regulation of transcription",
            "probability": 8.3888159124401e-08,
            "start_logit": -2.3823091983795166,
            "end_logit": -2.677340507507324
        },
        {
            "text": ".",
            "probability": 4.2765833290231303e-08,
            "start_logit": -6.603583812713623,
            "end_logit": 0.8701891303062439
        },
        {
            "text": "transcription",
            "probability": 1.9774108617299206e-08,
            "start_logit": -3.827420234680176,
            "end_logit": -2.677340507507324
        },
        {
            "text": "involved in regulation of transcription",
            "probability": 1.082990415536041e-08,
            "start_logit": -4.429482460021973,
            "end_logit": -2.677340507507324
        },
        {
            "text": "genes involved in regulation of transcription",
            "probability": 4.7442427932912615e-09,
            "start_logit": -5.254861831665039,
            "end_logit": -2.677340507507324
        },
        {
            "text": "associated with genes involved in regulation",
            "probability": 3.007739394877197e-09,
            "start_logit": -2.3823091983795166,
            "end_logit": -6.005636215209961
        },
        {
            "text": "of transcription",
            "probability": 2.4558446266216747e-09,
            "start_logit": -5.913322925567627,
            "end_logit": -2.677340507507324
        }
    ],
    "51387022bee46bd34c000002_010": [
        {
            "text": "development",
            "probability": 0.9995589520797733,
            "start_logit": 4.943887710571289,
            "end_logit": 4.798699855804443
        },
        {
            "text": "associated with genes involved in transcriptional regulation of development.",
            "probability": 0.0001743109416671121,
            "start_logit": -3.710340976715088,
            "end_logit": 4.798699855804443
        },
        {
            "text": "of development.",
            "probability": 0.00010642628112939013,
            "start_logit": -4.203729152679443,
            "end_logit": 4.798699855804443
        },
        {
            "text": "involved in transcriptional regulation of development.",
            "probability": 4.664806998382683e-05,
            "start_logit": -5.028550148010254,
            "end_logit": 4.798699855804443
        },
        {
            "text": "enhancers associated with genes involved in transcriptional regulation of development.",
            "probability": 3.2583324052702264e-05,
            "start_logit": -5.387381076812744,
            "end_logit": 4.798699855804443
        },
        {
            "text": "and/or development",
            "probability": 2.8286658844390143e-05,
            "start_logit": -5.118188381195068,
            "end_logit": 4.388096809387207
        },
        {
            "text": "genes involved in transcriptional regulation of development.",
            "probability": 1.593632595839726e-05,
            "start_logit": -6.102580547332764,
            "end_logit": 4.798699855804443
        },
        {
            "text": "regulation of development.",
            "probability": 1.1794175465212314e-05,
            "start_logit": -6.403575897216797,
            "end_logit": 4.798699855804443
        },
        {
            "text": "transcriptional regulation of development.",
            "probability": 7.363855759328137e-06,
            "start_logit": -6.874598026275635,
            "end_logit": 4.798699855804443
        },
        {
            "text": "development.",
            "probability": 6.24974241558875e-06,
            "start_logit": 4.943887710571289,
            "end_logit": -7.183829307556152
        },
        {
            "text": "act as tissue-specific enhancers associated with genes involved in transcriptional regulation of development.",
            "probability": 3.902901688926246e-06,
            "start_logit": -7.509461402893066,
            "end_logit": 4.798699855804443
        },
        {
            "text": "to transcriptional regulation and/or development",
            "probability": 2.734058430566753e-06,
            "start_logit": -7.45479154586792,
            "end_logit": 4.388096809387207
        },
        {
            "text": "transcriptional regulation and/or development",
            "probability": 2.5508371731674502e-06,
            "start_logit": -7.5241570472717285,
            "end_logit": 4.388096809387207
        },
        {
            "text": "regulation and/or development",
            "probability": 2.2559941504035386e-06,
            "start_logit": -7.6469879150390625,
            "end_logit": 4.388096809387207
        },
        {
            "text": "associated",
            "probability": 2.1038877233982454e-09,
            "start_logit": -3.710340976715088,
            "end_logit": -6.526109218597412
        },
        {
            "text": "associated with genes",
            "probability": 7.120975536884566e-10,
            "start_logit": -3.710340976715088,
            "end_logit": -7.609436511993408
        },
        {
            "text": "associated with genes involved in transcriptional regulation of",
            "probability": 6.287221137905883e-10,
            "start_logit": -3.710340976715088,
            "end_logit": -7.733962059020996
        },
        {
            "text": "associated with",
            "probability": 4.809224026414833e-10,
            "start_logit": -3.710340976715088,
            "end_logit": -8.001945495605469
        },
        {
            "text": "associated with genes involved in transcriptional",
            "probability": 4.3460606571622535e-10,
            "start_logit": -3.710340976715088,
            "end_logit": -8.103211402893066
        },
        {
            "text": "enhancers associated",
            "probability": 3.9327224559949093e-10,
            "start_logit": -5.387381076812744,
            "end_logit": -6.526109218597412
        }
    ],
    "51387022bee46bd34c000002_011": [
        {
            "text": "development",
            "probability": 0.9995589520797733,
            "start_logit": 4.943887710571289,
            "end_logit": 4.798699855804443
        },
        {
            "text": "associated with genes involved in transcriptional regulation of development.",
            "probability": 0.0001743109416671121,
            "start_logit": -3.710340976715088,
            "end_logit": 4.798699855804443
        },
        {
            "text": "of development.",
            "probability": 0.00010642628112939013,
            "start_logit": -4.203729152679443,
            "end_logit": 4.798699855804443
        },
        {
            "text": "involved in transcriptional regulation of development.",
            "probability": 4.664806998382683e-05,
            "start_logit": -5.028550148010254,
            "end_logit": 4.798699855804443
        },
        {
            "text": "enhancers associated with genes involved in transcriptional regulation of development.",
            "probability": 3.2583324052702264e-05,
            "start_logit": -5.387381076812744,
            "end_logit": 4.798699855804443
        },
        {
            "text": "and/or development",
            "probability": 2.8286658844390143e-05,
            "start_logit": -5.118188381195068,
            "end_logit": 4.388096809387207
        },
        {
            "text": "genes involved in transcriptional regulation of development.",
            "probability": 1.593632595839726e-05,
            "start_logit": -6.102580547332764,
            "end_logit": 4.798699855804443
        },
        {
            "text": "regulation of development.",
            "probability": 1.1794175465212314e-05,
            "start_logit": -6.403575897216797,
            "end_logit": 4.798699855804443
        },
        {
            "text": "transcriptional regulation of development.",
            "probability": 7.363855759328137e-06,
            "start_logit": -6.874598026275635,
            "end_logit": 4.798699855804443
        },
        {
            "text": "development.",
            "probability": 6.24974241558875e-06,
            "start_logit": 4.943887710571289,
            "end_logit": -7.183829307556152
        },
        {
            "text": "act as tissue-specific enhancers associated with genes involved in transcriptional regulation of development.",
            "probability": 3.902901688926246e-06,
            "start_logit": -7.509461402893066,
            "end_logit": 4.798699855804443
        },
        {
            "text": "to transcriptional regulation and/or development",
            "probability": 2.734058430566753e-06,
            "start_logit": -7.45479154586792,
            "end_logit": 4.388096809387207
        },
        {
            "text": "transcriptional regulation and/or development",
            "probability": 2.5508371731674502e-06,
            "start_logit": -7.5241570472717285,
            "end_logit": 4.388096809387207
        },
        {
            "text": "regulation and/or development",
            "probability": 2.2559941504035386e-06,
            "start_logit": -7.6469879150390625,
            "end_logit": 4.388096809387207
        },
        {
            "text": "associated",
            "probability": 2.1038877233982454e-09,
            "start_logit": -3.710340976715088,
            "end_logit": -6.526109218597412
        },
        {
            "text": "associated with genes",
            "probability": 7.120975536884566e-10,
            "start_logit": -3.710340976715088,
            "end_logit": -7.609436511993408
        },
        {
            "text": "associated with genes involved in transcriptional regulation of",
            "probability": 6.287221137905883e-10,
            "start_logit": -3.710340976715088,
            "end_logit": -7.733962059020996
        },
        {
            "text": "associated with",
            "probability": 4.809224026414833e-10,
            "start_logit": -3.710340976715088,
            "end_logit": -8.001945495605469
        },
        {
            "text": "associated with genes involved in transcriptional",
            "probability": 4.3460606571622535e-10,
            "start_logit": -3.710340976715088,
            "end_logit": -8.103211402893066
        },
        {
            "text": "enhancers associated",
            "probability": 3.9327224559949093e-10,
            "start_logit": -5.387381076812744,
            "end_logit": -6.526109218597412
        }
    ],
    "51387022bee46bd34c000002_012": [
        {
            "text": "development",
            "probability": 0.9992304016967593,
            "start_logit": 4.996004581451416,
            "end_logit": 4.825634956359863
        },
        {
            "text": "involved in development.",
            "probability": 0.00022842406776298345,
            "start_logit": -3.3349571228027344,
            "end_logit": 4.773059844970703
        },
        {
            "text": "developmentally important",
            "probability": 0.00013940789904133528,
            "start_logit": 4.996004581451416,
            "end_logit": -4.051701545715332
        },
        {
            "text": "development.",
            "probability": 0.00013439504292094825,
            "start_logit": 5.023832321166992,
            "end_logit": -4.11614990234375
        },
        {
            "text": "encoding developmentally",
            "probability": 9.805708773274471e-05,
            "start_logit": -4.2331862449646,
            "end_logit": 4.825634956359863
        },
        {
            "text": "important transcription factors (TFs). This suggests that HCNE-rich regions may contain key regulatory controls involved in development.",
            "probability": 2.1171959412134947e-05,
            "start_logit": -5.7134833335876465,
            "end_logit": 4.773059844970703
        },
        {
            "text": "for genes encoding developmentally",
            "probability": 1.705855449171865e-05,
            "start_logit": -5.982084274291992,
            "end_logit": 4.825634956359863
        },
        {
            "text": "enriched for genes encoding developmentally",
            "probability": 1.66501532415717e-05,
            "start_logit": -6.006316661834717,
            "end_logit": 4.825634956359863
        },
        {
            "text": "may contain key regulatory controls involved in development.",
            "probability": 1.299645061220698e-05,
            "start_logit": -6.201484680175781,
            "end_logit": 4.773059844970703
        },
        {
            "text": "controls involved in development.",
            "probability": 1.2892661500120952e-05,
            "start_logit": -6.209502696990967,
            "end_logit": 4.773059844970703
        },
        {
            "text": "cluster within regions enriched for genes encoding developmentally",
            "probability": 1.0626717807950692e-05,
            "start_logit": -6.45536470413208,
            "end_logit": 4.825634956359863
        },
        {
            "text": "contain key regulatory controls involved in development.",
            "probability": 1.060658965196282e-05,
            "start_logit": -6.4046854972839355,
            "end_logit": 4.773059844970703
        },
        {
            "text": "developmentally important transcription factors (TFs). This suggests that HCNE-rich regions may contain key regulatory",
            "probability": 9.918693426122174e-06,
            "start_logit": 4.996004581451416,
            "end_logit": -6.6946845054626465
        },
        {
            "text": "developmentally important transcription factors (TFs). This suggests that HCNE-rich regions may contain",
            "probability": 9.410499772712297e-06,
            "start_logit": 4.996004581451416,
            "end_logit": -6.747279644012451
        },
        {
            "text": "factors (TFs). This suggests that HCNE-rich regions may contain key regulatory controls involved in development.",
            "probability": 9.353728178155935e-06,
            "start_logit": -6.530385971069336,
            "end_logit": 4.773059844970703
        },
        {
            "text": "key regulatory controls involved in development.",
            "probability": 8.652533588084115e-06,
            "start_logit": -6.608308792114258,
            "end_logit": 4.773059844970703
        },
        {
            "text": "suggests that HCNE-rich regions may contain key regulatory controls involved in development.",
            "probability": 8.035164734835328e-06,
            "start_logit": -6.682333469390869,
            "end_logit": 4.773059844970703
        },
        {
            "text": "mammalian genomes cluster within regions enriched for genes encoding developmentally",
            "probability": 7.730917378022272e-06,
            "start_logit": -6.773508548736572,
            "end_logit": 4.825634956359863
        },
        {
            "text": "developmentally important transcription factors (TFs).",
            "probability": 7.203602493208465e-06,
            "start_logit": 4.996004581451416,
            "end_logit": -7.014524459838867
        },
        {
            "text": "transcription factors (TFs). This suggests that HCNE-rich regions may contain key regulatory controls involved in development.",
            "probability": 7.00597949414136e-06,
            "start_logit": -6.81939697265625,
            "end_logit": 4.773059844970703
        }
    ],
    "51387022bee46bd34c000002_013": [
        {
            "text": "development",
            "probability": 0.9992304016967593,
            "start_logit": 4.996004581451416,
            "end_logit": 4.825634956359863
        },
        {
            "text": "involved in development.",
            "probability": 0.00022842406776298345,
            "start_logit": -3.3349571228027344,
            "end_logit": 4.773059844970703
        },
        {
            "text": "developmentally important",
            "probability": 0.00013940789904133528,
            "start_logit": 4.996004581451416,
            "end_logit": -4.051701545715332
        },
        {
            "text": "development.",
            "probability": 0.00013439504292094825,
            "start_logit": 5.023832321166992,
            "end_logit": -4.11614990234375
        },
        {
            "text": "encoding developmentally",
            "probability": 9.805708773274471e-05,
            "start_logit": -4.2331862449646,
            "end_logit": 4.825634956359863
        },
        {
            "text": "important transcription factors (TFs). This suggests that HCNE-rich regions may contain key regulatory controls involved in development.",
            "probability": 2.1171959412134947e-05,
            "start_logit": -5.7134833335876465,
            "end_logit": 4.773059844970703
        },
        {
            "text": "for genes encoding developmentally",
            "probability": 1.705855449171865e-05,
            "start_logit": -5.982084274291992,
            "end_logit": 4.825634956359863
        },
        {
            "text": "enriched for genes encoding developmentally",
            "probability": 1.66501532415717e-05,
            "start_logit": -6.006316661834717,
            "end_logit": 4.825634956359863
        },
        {
            "text": "may contain key regulatory controls involved in development.",
            "probability": 1.299645061220698e-05,
            "start_logit": -6.201484680175781,
            "end_logit": 4.773059844970703
        },
        {
            "text": "controls involved in development.",
            "probability": 1.2892661500120952e-05,
            "start_logit": -6.209502696990967,
            "end_logit": 4.773059844970703
        },
        {
            "text": "cluster within regions enriched for genes encoding developmentally",
            "probability": 1.0626717807950692e-05,
            "start_logit": -6.45536470413208,
            "end_logit": 4.825634956359863
        },
        {
            "text": "contain key regulatory controls involved in development.",
            "probability": 1.060658965196282e-05,
            "start_logit": -6.4046854972839355,
            "end_logit": 4.773059844970703
        },
        {
            "text": "developmentally important transcription factors (TFs). This suggests that HCNE-rich regions may contain key regulatory",
            "probability": 9.918693426122174e-06,
            "start_logit": 4.996004581451416,
            "end_logit": -6.6946845054626465
        },
        {
            "text": "developmentally important transcription factors (TFs). This suggests that HCNE-rich regions may contain",
            "probability": 9.410499772712297e-06,
            "start_logit": 4.996004581451416,
            "end_logit": -6.747279644012451
        },
        {
            "text": "factors (TFs). This suggests that HCNE-rich regions may contain key regulatory controls involved in development.",
            "probability": 9.353728178155935e-06,
            "start_logit": -6.530385971069336,
            "end_logit": 4.773059844970703
        },
        {
            "text": "key regulatory controls involved in development.",
            "probability": 8.652533588084115e-06,
            "start_logit": -6.608308792114258,
            "end_logit": 4.773059844970703
        },
        {
            "text": "suggests that HCNE-rich regions may contain key regulatory controls involved in development.",
            "probability": 8.035164734835328e-06,
            "start_logit": -6.682333469390869,
            "end_logit": 4.773059844970703
        },
        {
            "text": "mammalian genomes cluster within regions enriched for genes encoding developmentally",
            "probability": 7.730917378022272e-06,
            "start_logit": -6.773508548736572,
            "end_logit": 4.825634956359863
        },
        {
            "text": "developmentally important transcription factors (TFs).",
            "probability": 7.203602493208465e-06,
            "start_logit": 4.996004581451416,
            "end_logit": -7.014524459838867
        },
        {
            "text": "transcription factors (TFs). This suggests that HCNE-rich regions may contain key regulatory controls involved in development.",
            "probability": 7.00597949414136e-06,
            "start_logit": -6.81939697265625,
            "end_logit": 4.773059844970703
        }
    ],
    "56df03c751531f7e3300000a_001": [
        {
            "text": "Mettl3, an N(6)-methyladenosine",
            "probability": 0.383182678664484,
            "start_logit": -3.0369863510131836,
            "end_logit": -6.079060077667236
        },
        {
            "text": "N(6)-methyladenosine",
            "probability": 0.08946974664622968,
            "start_logit": -4.491597652435303,
            "end_logit": -6.079060077667236
        },
        {
            "text": "Mettl3",
            "probability": 0.07098845215923488,
            "start_logit": -3.0369863510131836,
            "end_logit": -7.765054702758789
        },
        {
            "text": "m6A",
            "probability": 0.06181148850803088,
            "start_logit": -3.8770663738250732,
            "end_logit": -7.0634026527404785
        },
        {
            "text": "Mettl3, an N(6)-methyladenosine (m(6)A) transferase,",
            "probability": 0.05738035133229012,
            "start_logit": -3.0369863510131836,
            "end_logit": -7.977869987487793
        },
        {
            "text": "m6A mRNA",
            "probability": 0.05518399968350119,
            "start_logit": -3.8770663738250732,
            "end_logit": -7.17681884765625
        },
        {
            "text": "Mettl3, an N(6)-methyladenosine (m(6)A)",
            "probability": 0.040381399436156366,
            "start_logit": -3.0369863510131836,
            "end_logit": -8.329202651977539
        },
        {
            "text": "Mettl3, an N(6)-methyladenosine (m(6)A) transferase, as a regulator",
            "probability": 0.03825046607191602,
            "start_logit": -3.0369863510131836,
            "end_logit": -8.383416175842285
        },
        {
            "text": "m6A mRNA methylation",
            "probability": 0.033444703114571636,
            "start_logit": -3.8770663738250732,
            "end_logit": -7.677598476409912
        },
        {
            "text": "m6A mRNA methylation facilitates resolution of na\u00efve",
            "probability": 0.031212563758179806,
            "start_logit": -3.8770663738250732,
            "end_logit": -7.746671199798584
        },
        {
            "text": "m6A mRNA methylation facilitates resolution of na\u00efve pluripotency toward differentiation. Na\u00efve",
            "probability": 0.028445691730377403,
            "start_logit": -3.8770663738250732,
            "end_logit": -7.8394951820373535
        },
        {
            "text": "m6A mRNA methylation facilitates",
            "probability": 0.021469897236084917,
            "start_logit": -3.8770663738250732,
            "end_logit": -8.120840072631836
        },
        {
            "text": "m6A mRNA methylation facilitates resolution of na\u00efve pluripotency toward differentiation.",
            "probability": 0.018740491020354737,
            "start_logit": -3.8770663738250732,
            "end_logit": -8.256805419921875
        },
        {
            "text": "m6",
            "probability": 0.014938557782807704,
            "start_logit": -3.8770663738250732,
            "end_logit": -8.483546257019043
        },
        {
            "text": "N(6)-methyladenosine (m(6)A) transferase,",
            "probability": 0.0133978015761689,
            "start_logit": -4.491597652435303,
            "end_logit": -7.977869987487793
        },
        {
            "text": "N(6)-methyladenosine (m(6)A)",
            "probability": 0.00942869753237617,
            "start_logit": -4.491597652435303,
            "end_logit": -8.329202651977539
        },
        {
            "text": "N(6)-methyladenosine (m(6)A) transferase, as a regulator",
            "probability": 0.008931143548769518,
            "start_logit": -4.491597652435303,
            "end_logit": -8.383416175842285
        },
        {
            "text": "adenosine",
            "probability": 0.00860641645727062,
            "start_logit": -6.8329901695251465,
            "end_logit": -6.079060077667236
        },
        {
            "text": "an N(6)-methyladenosine",
            "probability": 0.007594813546506614,
            "start_logit": -6.958032608032227,
            "end_logit": -6.079060077667236
        },
        {
            "text": "pluripotency toward differentiation. Na\u00efve and primed pluripotent states retain distinct",
            "probability": 0.007140640194688652,
            "start_logit": -6.372133255004883,
            "end_logit": -6.726622581481934
        }
    ],
    "56df03c751531f7e3300000a_002": [
        {
            "text": "N6-methyladenosine",
            "probability": 0.9873518470335547,
            "start_logit": 1.180240273475647,
            "end_logit": 1.2194968461990356
        },
        {
            "text": "m6A writers reveals two distinct classes of mRNA methylation at internal and 5' sites. N6-methyladenosine",
            "probability": 0.00845799122337416,
            "start_logit": -3.579674482345581,
            "end_logit": 1.2194968461990356
        },
        {
            "text": "reveals two distinct classes of mRNA methylation at internal and 5' sites. N6-methyladenosine",
            "probability": 0.0008095653311594018,
            "start_logit": -5.92604398727417,
            "end_logit": 1.2194968461990356
        },
        {
            "text": "adenosine",
            "probability": 0.0007964371032276503,
            "start_logit": -5.9423933029174805,
            "end_logit": 1.2194968461990356
        },
        {
            "text": "methylation at internal and 5' sites. N6-methyladenosine",
            "probability": 0.0006969042735167027,
            "start_logit": -6.075893402099609,
            "end_logit": 1.2194968461990356
        },
        {
            "text": "two distinct classes of mRNA methylation at internal and 5' sites. N6-methyladenosine",
            "probability": 0.0006447865374209096,
            "start_logit": -6.153622150421143,
            "end_logit": 1.2194968461990356
        },
        {
            "text": "N6-methyladenosine (m6A) is a common modification of mRNA",
            "probability": 0.0003929312872353189,
            "start_logit": 1.180240273475647,
            "end_logit": -6.609650135040283
        },
        {
            "text": "N6-methyladenosine (m6A) is a common modification",
            "probability": 0.0003229930613369197,
            "start_logit": 1.180240273475647,
            "end_logit": -6.805654048919678
        },
        {
            "text": "N6-methyladenosine (m6A)",
            "probability": 0.00021152031334395504,
            "start_logit": 1.180240273475647,
            "end_logit": -7.228963851928711
        },
        {
            "text": "N6",
            "probability": 0.00014798577051320516,
            "start_logit": 1.180240273475647,
            "end_logit": -7.5861687660217285
        },
        {
            "text": "N",
            "probability": 0.00014175837289986674,
            "start_logit": 1.180240273475647,
            "end_logit": -7.6291608810424805
        },
        {
            "text": "m6A writers reveals two distinct classes of mRNA methylation at internal and 5' sites.",
            "probability": 7.34846007579941e-06,
            "start_logit": -3.579674482345581,
            "end_logit": -5.828879356384277
        },
        {
            "text": "m6A writers reveals two distinct classes of mRNA methylation",
            "probability": 5.737987928502458e-06,
            "start_logit": -3.579674482345581,
            "end_logit": -6.076261520385742
        },
        {
            "text": "Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5' sites.",
            "probability": 2.5070192017849784e-06,
            "start_logit": -4.655070781707764,
            "end_logit": -5.828879356384277
        },
        {
            "text": "m6A writers reveals two distinct classes of mRNA",
            "probability": 2.3895062430774527e-06,
            "start_logit": -3.579674482345581,
            "end_logit": -6.9522833824157715
        },
        {
            "text": "the RNA life cycle.",
            "probability": 1.9871552128128267e-06,
            "start_logit": -4.636893272399902,
            "end_logit": -6.079447269439697
        },
        {
            "text": "Perturbation of m6A writers reveals two distinct classes of mRNA methylation",
            "probability": 1.957586455935281e-06,
            "start_logit": -4.655070781707764,
            "end_logit": -6.076261520385742
        },
        {
            "text": "fine-tuning the RNA life cycle.",
            "probability": 1.2766016368585621e-06,
            "start_logit": -5.079395771026611,
            "end_logit": -6.079447269439697
        },
        {
            "text": "life cycle.",
            "probability": 1.2240225796402029e-06,
            "start_logit": -5.12145471572876,
            "end_logit": -6.079447269439697
        },
        {
            "text": "potential roles in fine-tuning the RNA life cycle.",
            "probability": 8.513530824380409e-07,
            "start_logit": -5.484525680541992,
            "end_logit": -6.079447269439697
        }
    ],
    "533be71dfd9a95ea0d000009_001": [
        {
            "text": "H3K4",
            "probability": 0.9974997317453657,
            "start_logit": 9.80605411529541,
            "end_logit": 9.142467498779297
        },
        {
            "text": "3K4",
            "probability": 0.0012956973924404787,
            "start_logit": 3.159851312637329,
            "end_logit": 9.142467498779297
        },
        {
            "text": "4",
            "probability": 0.000612312229349384,
            "start_logit": 2.4102892875671387,
            "end_logit": 9.142467498779297
        },
        {
            "text": "H",
            "probability": 0.0005526116341077845,
            "start_logit": 9.80605411529541,
            "end_logit": 1.6441158056259155
        },
        {
            "text": "K4",
            "probability": 2.8560757425308695e-05,
            "start_logit": -0.6549193859100342,
            "end_logit": 9.142467498779297
        },
        {
            "text": "H3",
            "probability": 8.577604730515281e-06,
            "start_logit": 9.80605411529541,
            "end_logit": -2.5213849544525146
        },
        {
            "text": "decreased histone H3K4me3",
            "probability": 6.747656066915851e-07,
            "start_logit": -4.40034294128418,
            "end_logit": 9.142467498779297
        },
        {
            "text": "H3K",
            "probability": 4.429326954493077e-07,
            "start_logit": 9.80605411529541,
            "end_logit": -5.484877109527588
        },
        {
            "text": "the histone methyltransferase, MLL1, resulting in decreased histone H3K4me3",
            "probability": 3.486602764347668e-07,
            "start_logit": -5.060610294342041,
            "end_logit": 9.142467498779297
        },
        {
            "text": "H3K4me3",
            "probability": 2.674287210272783e-07,
            "start_logit": 9.80605411529541,
            "end_logit": -5.989441871643066
        },
        {
            "text": "histone H3K4me3",
            "probability": 2.420136928413901e-07,
            "start_logit": -5.425714015960693,
            "end_logit": 9.142467498779297
        },
        {
            "text": "histone methyltransferase, MLL1, resulting in decreased histone H3K4me3",
            "probability": 1.8026571679035462e-07,
            "start_logit": -5.720276355743408,
            "end_logit": 9.142467498779297
        },
        {
            "text": "lack of interaction with the histone methyltransferase, MLL1, resulting in decreased histone H3K4me3",
            "probability": 9.432924432464996e-08,
            "start_logit": -6.367917060852051,
            "end_logit": 9.142467498779297
        },
        {
            "text": "resulting in decreased histone H3K4me3",
            "probability": 8.678426656355395e-08,
            "start_logit": -6.451282978057861,
            "end_logit": 9.142467498779297
        },
        {
            "text": "methyltransferase, MLL1, resulting in decreased histone H3K4me3",
            "probability": 6.889572972330285e-08,
            "start_logit": -6.682114124298096,
            "end_logit": 9.142467498779297
        },
        {
            "text": "MLL1, resulting in decreased histone H3K4me3",
            "probability": 6.703415647717508e-08,
            "start_logit": -6.709506034851074,
            "end_logit": 9.142467498779297
        },
        {
            "text": "H3K4me3 and gene transcription,",
            "probability": 2.3461916371843462e-08,
            "start_logit": 9.80605411529541,
            "end_logit": -8.422916412353516
        },
        {
            "text": "3",
            "probability": 1.1141837665727673e-08,
            "start_logit": 3.159851312637329,
            "end_logit": -2.5213849544525146
        },
        {
            "text": "3K",
            "probability": 5.753452559993303e-10,
            "start_logit": 3.159851312637329,
            "end_logit": -5.484877109527588
        },
        {
            "text": "3K4me3",
            "probability": 3.473752277531342e-10,
            "start_logit": 3.159851312637329,
            "end_logit": -5.989441871643066
        }
    ],
    "533be71dfd9a95ea0d000009_002": [
        {
            "text": "H3K4",
            "probability": 0.9997009885522469,
            "start_logit": 9.078568458557129,
            "end_logit": 8.226834297180176
        },
        {
            "text": "H",
            "probability": 0.00015829695043444484,
            "start_logit": 9.078568458557129,
            "end_logit": -0.5239045023918152
        },
        {
            "text": "4",
            "probability": 0.00010177301718217408,
            "start_logit": -0.11389803141355515,
            "end_logit": 8.226834297180176
        },
        {
            "text": "3K4",
            "probability": 3.0261050172467767e-05,
            "start_logit": -1.3267816305160522,
            "end_logit": 8.226834297180176
        },
        {
            "text": "histone H3K4me3",
            "probability": 5.231083720619024e-06,
            "start_logit": -3.082024574279785,
            "end_logit": 8.226834297180176
        },
        {
            "text": "K4",
            "probability": 1.498454034535124e-06,
            "start_logit": -4.33220911026001,
            "end_logit": 8.226834297180176
        },
        {
            "text": "H3",
            "probability": 5.28049706950936e-07,
            "start_logit": 9.078568458557129,
            "end_logit": -6.22694206237793
        },
        {
            "text": "H3K4me3 methylase MLL1 complex.",
            "probability": 4.675538143707921e-07,
            "start_logit": 9.078568458557129,
            "end_logit": -6.348618030548096
        },
        {
            "text": "H3K4me3",
            "probability": 3.22617353304854e-07,
            "start_logit": 9.078568458557129,
            "end_logit": -6.71966552734375
        },
        {
            "text": "H3K",
            "probability": 2.7267686358270433e-07,
            "start_logit": 9.078568458557129,
            "end_logit": -6.887845039367676
        },
        {
            "text": "H3K4me3 methylase",
            "probability": 2.1527451329083785e-07,
            "start_logit": 9.078568458557129,
            "end_logit": -7.124218463897705
        },
        {
            "text": "H3K4me3 methylase MLL1",
            "probability": 5.480152429220668e-08,
            "start_logit": 9.078568458557129,
            "end_logit": -8.492414474487305
        },
        {
            "text": "and histone H3K4me3",
            "probability": 5.126682088892569e-08,
            "start_logit": -7.707354545593262,
            "end_logit": 8.226834297180176
        },
        {
            "text": "H3K4me",
            "probability": 3.85774393277872e-08,
            "start_logit": 9.078568458557129,
            "end_logit": -8.843464851379395
        },
        {
            "text": "4me3",
            "probability": 3.284356204219804e-11,
            "start_logit": -0.11389803141355515,
            "end_logit": -6.71966552734375
        },
        {
            "text": "3",
            "probability": 1.5984118109896274e-11,
            "start_logit": -1.3267816305160522,
            "end_logit": -6.22694206237793
        },
        {
            "text": "3K4me3",
            "probability": 9.765659958989548e-12,
            "start_logit": -1.3267816305160522,
            "end_logit": -6.71966552734375
        },
        {
            "text": "3K",
            "probability": 8.253956277163492e-12,
            "start_logit": -1.3267816305160522,
            "end_logit": -6.887845039367676
        },
        {
            "text": "4me",
            "probability": 3.92731670820587e-12,
            "start_logit": -0.11389803141355515,
            "end_logit": -8.843464851379395
        },
        {
            "text": "histone",
            "probability": 3.398263983318354e-12,
            "start_logit": -3.082024574279785,
            "end_logit": -6.0200300216674805
        }
    ],
    "533be71dfd9a95ea0d000009_003": [
        {
            "text": "H3K4",
            "probability": 0.9973644591306504,
            "start_logit": 9.558526992797852,
            "end_logit": 8.852973937988281
        },
        {
            "text": "H3K4me3",
            "probability": 0.0017836751462016168,
            "start_logit": 9.558526992797852,
            "end_logit": 2.526533603668213
        },
        {
            "text": "4",
            "probability": 0.0003611491857339291,
            "start_logit": 1.634946584701538,
            "end_logit": 8.852973937988281
        },
        {
            "text": "H",
            "probability": 0.00029520846174218993,
            "start_logit": 9.558526992797852,
            "end_logit": 0.7277841567993164
        },
        {
            "text": "3K4",
            "probability": 0.00011747346585487856,
            "start_logit": 0.5118679404258728,
            "end_logit": 8.852973937988281
        },
        {
            "text": "K4",
            "probability": 7.013523833639641e-05,
            "start_logit": -0.003919190727174282,
            "end_logit": 8.852973937988281
        },
        {
            "text": "H3",
            "probability": 1.856221097356826e-06,
            "start_logit": 9.558526992797852,
            "end_logit": -4.341354846954346
        },
        {
            "text": "(H3K4me3).",
            "probability": 1.3322053837918213e-06,
            "start_logit": 9.558526992797852,
            "end_logit": -4.673061847686768
        },
        {
            "text": "trimethylate histone H3 at lysine 4 (H3K4me3).",
            "probability": 1.2417389321390115e-06,
            "start_logit": -4.037831783294678,
            "end_logit": 8.852973937988281
        },
        {
            "text": "histone H3 at lysine 4 (H3K4me3).",
            "probability": 6.776888015286403e-07,
            "start_logit": -4.643411636352539,
            "end_logit": 8.852973937988281
        },
        {
            "text": "4me3",
            "probability": 6.4587505677318e-07,
            "start_logit": 1.634946584701538,
            "end_logit": 2.526533603668213
        },
        {
            "text": "H3K",
            "probability": 5.773391610626348e-07,
            "start_logit": 9.558526992797852,
            "end_logit": -5.509222984313965
        },
        {
            "text": "that trimethylate histone H3 at lysine 4 (H3K4me3).",
            "probability": 4.501335259399392e-07,
            "start_logit": -5.052555561065674,
            "end_logit": 8.852973937988281
        },
        {
            "text": "H3 at lysine 4 (H3K4me3).",
            "probability": 2.3419985600697015e-07,
            "start_logit": -5.705924987792969,
            "end_logit": 8.852973937988281
        },
        {
            "text": "3K4me3",
            "probability": 2.1008819741396363e-07,
            "start_logit": 0.5118679404258728,
            "end_logit": 2.526533603668213
        },
        {
            "text": "complexes that trimethylate histone H3 at lysine 4 (H3K4me3).",
            "probability": 1.552914707357037e-07,
            "start_logit": -6.116796016693115,
            "end_logit": 8.852973937988281
        },
        {
            "text": "4 (H3K4me3).",
            "probability": 1.4748883314515602e-07,
            "start_logit": -6.168347358703613,
            "end_logit": 8.852973937988281
        },
        {
            "text": "H3K4me",
            "probability": 1.463966918528753e-07,
            "start_logit": 9.558526992797852,
            "end_logit": -6.881332874298096
        },
        {
            "text": "K4me3",
            "probability": 1.2542905489393394e-07,
            "start_logit": -0.003919190727174282,
            "end_logit": 2.526533603668213
        },
        {
            "text": "histone methyltransferase complexes that trimethylate histone H3 at lysine 4 (H3K4me3).",
            "probability": 9.927541847400734e-08,
            "start_logit": -6.564201831817627,
            "end_logit": 8.852973937988281
        }
    ],
    "533be71dfd9a95ea0d000009_004": [
        {
            "text": "H3K4",
            "probability": 0.9992215138691722,
            "start_logit": 9.682801246643066,
            "end_logit": 9.110603332519531
        },
        {
            "text": "3K4",
            "probability": 0.000311059423983458,
            "start_logit": 1.60805344581604,
            "end_logit": 9.110603332519531
        },
        {
            "text": "4",
            "probability": 0.00021295117964141255,
            "start_logit": 1.2291324138641357,
            "end_logit": 9.110603332519531
        },
        {
            "text": "H",
            "probability": 0.00020023431151446495,
            "start_logit": 9.682801246643066,
            "end_logit": 0.5953598022460938
        },
        {
            "text": "K4",
            "probability": 3.101536187222548e-05,
            "start_logit": -0.6974478960037231,
            "end_logit": 9.110603332519531
        },
        {
            "text": "H3",
            "probability": 7.498033157193109e-06,
            "start_logit": 9.682801246643066,
            "end_logit": -2.6894876956939697
        },
        {
            "text": "H3K4 residues.",
            "probability": 7.414382654240114e-06,
            "start_logit": 9.682801246643066,
            "end_logit": -2.700706720352173
        },
        {
            "text": "that methylates H3K4",
            "probability": 4.458580940842675e-06,
            "start_logit": -2.6370999813079834,
            "end_logit": 9.110603332519531
        },
        {
            "text": "colocalizes with MLL1 (Mixed Lineage Leukemia 1), a histone methyltransferase that methylates H3K4",
            "probability": 1.8757877968234893e-06,
            "start_logit": -3.61517596244812,
            "end_logit": 9.222877502441406
        },
        {
            "text": "H3K",
            "probability": 6.086126371584941e-07,
            "start_logit": 9.682801246643066,
            "end_logit": -5.200701713562012
        },
        {
            "text": "(Mixed Lineage Leukemia 1), a histone methyltransferase that methylates H3K4",
            "probability": 5.396065288871996e-07,
            "start_logit": -4.861119747161865,
            "end_logit": 9.222877502441406
        },
        {
            "text": "MLL1 (Mixed Lineage Leukemia 1), a histone methyltransferase that methylates H3K4",
            "probability": 3.677174528887845e-07,
            "start_logit": -5.244645118713379,
            "end_logit": 9.222877502441406
        },
        {
            "text": "methylates H3K4",
            "probability": 2.7662468659346305e-07,
            "start_logit": -5.4170241355896,
            "end_logit": 9.110603332519531
        },
        {
            "text": "a histone methyltransferase that methylates H3K4",
            "probability": 9.575569248947813e-08,
            "start_logit": -6.477885723114014,
            "end_logit": 9.110603332519531
        },
        {
            "text": "histone methyltransferase that methylates H3K4",
            "probability": 5.733261647142657e-08,
            "start_logit": -6.990816116333008,
            "end_logit": 9.110603332519531
        },
        {
            "text": "H3K4 residues. Also, a reduction in hPaf1",
            "probability": 3.081933169734654e-08,
            "start_logit": 9.682801246643066,
            "end_logit": -8.183741569519043
        },
        {
            "text": "3",
            "probability": 2.3341509790498057e-09,
            "start_logit": 1.60805344581604,
            "end_logit": -2.6894876956939697
        },
        {
            "text": "3K",
            "probability": 1.8946219003082977e-10,
            "start_logit": 1.60805344581604,
            "end_logit": -5.200701713562012
        },
        {
            "text": "methylation of H3K4",
            "probability": 4.362495635701036e-11,
            "start_logit": -5.957452297210693,
            "end_logit": 0.8962439298629761
        },
        {
            "text": "that methylates H3K4 residues.",
            "probability": 3.3083380142911655e-11,
            "start_logit": -2.6370999813079834,
            "end_logit": -2.700706720352173
        }
    ],
    "533be71dfd9a95ea0d000009_005": [
        {
            "text": "H3K4",
            "probability": 0.9996419050881583,
            "start_logit": 8.575968742370605,
            "end_logit": 7.795426845550537
        },
        {
            "text": "H3K4 methylases in Drosophila. Methylation of histone H3 lysine 4 (H3K4)",
            "probability": 0.00011534780744969782,
            "start_logit": -0.49123167991638184,
            "end_logit": 7.795426845550537
        },
        {
            "text": "4",
            "probability": 0.00010646614656498341,
            "start_logit": -0.5713565945625305,
            "end_logit": 7.795426845550537
        },
        {
            "text": "H",
            "probability": 8.192292589264481e-05,
            "start_logit": 8.575968742370605,
            "end_logit": -1.6139466762542725
        },
        {
            "text": "K4",
            "probability": 2.5729896295154612e-05,
            "start_logit": -1.9915300607681274,
            "end_logit": 7.795426845550537
        },
        {
            "text": "3K4",
            "probability": 2.5591757901788786e-05,
            "start_logit": -1.9969133138656616,
            "end_logit": 7.795426845550537
        },
        {
            "text": "(H3K4)",
            "probability": 1.0888824586598573e-06,
            "start_logit": -5.154031753540039,
            "end_logit": 7.795426845550537
        },
        {
            "text": "Methylation of histone H3 lysine 4 (H3K4)",
            "probability": 3.834251777510323e-07,
            "start_logit": -6.197794437408447,
            "end_logit": 7.795426845550537
        },
        {
            "text": "4 (H3K4)",
            "probability": 3.7622643194787555e-07,
            "start_logit": -6.216747760772705,
            "end_logit": 7.795426845550537
        },
        {
            "text": "histone H3 lysine 4 (H3K4)",
            "probability": 2.9783922927424733e-07,
            "start_logit": -6.450385093688965,
            "end_logit": 7.795426845550537
        },
        {
            "text": "H3K",
            "probability": 2.8967731221760533e-07,
            "start_logit": 8.575968742370605,
            "end_logit": -7.258713245391846
        },
        {
            "text": "H3 lysine 4 (H3K4)",
            "probability": 2.3692610513811685e-07,
            "start_logit": -6.679190635681152,
            "end_logit": 7.795426845550537
        },
        {
            "text": "H3",
            "probability": 2.0180302931508408e-07,
            "start_logit": 8.575968742370605,
            "end_logit": -7.6201887130737305
        },
        {
            "text": "lysine 4 (H3K4)",
            "probability": 9.461163911442371e-08,
            "start_logit": -7.597158432006836,
            "end_logit": 7.795426845550537
        },
        {
            "text": "(H3K4) in Saccharomyces cerevisiae is implemented by Set1/COMPASS,",
            "probability": 6.691267083537373e-08,
            "start_logit": 8.575968742370605,
            "end_logit": -8.724092483520508
        },
        {
            "text": "H3K4 methylases in Drosophila. Methylation",
            "probability": 2.390251900606327e-11,
            "start_logit": -0.49123167991638184,
            "end_logit": -7.594051837921143
        },
        {
            "text": "H3K4 methylases in Drosophila. Methylation of histone",
            "probability": 2.2306576913380797e-11,
            "start_logit": -0.49123167991638184,
            "end_logit": -7.663154125213623
        },
        {
            "text": "H3K4 methylases",
            "probability": 1.0563055125561066e-11,
            "start_logit": -0.49123167991638184,
            "end_logit": -8.410673141479492
        },
        {
            "text": "H3K4 methylases in Drosophila. Methylation of histone H3 lysine",
            "probability": 9.455126073653258e-12,
            "start_logit": -0.49123167991638184,
            "end_logit": -8.521478652954102
        },
        {
            "text": "K",
            "probability": 7.456037171391688e-12,
            "start_logit": -1.9915300607681274,
            "end_logit": -7.258713245391846
        }
    ],
    "533be71dfd9a95ea0d000009_006": [
        {
            "text": "H3K4",
            "probability": 0.9992298471033745,
            "start_logit": 9.273200035095215,
            "end_logit": 8.46451187133789
        },
        {
            "text": "3K4",
            "probability": 0.0003724781359904873,
            "start_logit": 1.3786382675170898,
            "end_logit": 8.46451187133789
        },
        {
            "text": "H",
            "probability": 0.0002028691892680046,
            "start_logit": 9.273200035095215,
            "end_logit": -0.03766685351729393
        },
        {
            "text": "4",
            "probability": 0.00017307492578967528,
            "start_logit": 0.6121845245361328,
            "end_logit": 8.46451187133789
        },
        {
            "text": "H3",
            "probability": 1.0374178391082687e-05,
            "start_logit": 9.273200035095215,
            "end_logit": -3.010908365249634
        },
        {
            "text": "K4",
            "probability": 9.746184744049954e-06,
            "start_logit": -2.2646641731262207,
            "end_logit": 8.46451187133789
        },
        {
            "text": "MLL1, a mammalian homolog of Drosophila trithorax, is an H3K4-specific",
            "probability": 6.711111732088711e-07,
            "start_logit": -4.9403605461120605,
            "end_logit": 8.46451187133789
        },
        {
            "text": "H3K",
            "probability": 2.0456182058068056e-07,
            "start_logit": 9.273200035095215,
            "end_logit": -6.937113285064697
        },
        {
            "text": "H3K4-specific",
            "probability": 1.1411957722162422e-07,
            "start_logit": 9.273200035095215,
            "end_logit": -7.5207366943359375
        },
        {
            "text": "H3K4-specific methyltransferase",
            "probability": 1.1332634300879234e-07,
            "start_logit": 9.273200035095215,
            "end_logit": -7.527711868286133
        },
        {
            "text": "is an H3K4-specific",
            "probability": 1.1260019032460084e-07,
            "start_logit": -6.725451946258545,
            "end_logit": 8.46451187133789
        },
        {
            "text": "trithorax, is an H3K4-specific",
            "probability": 1.0182834086755504e-07,
            "start_logit": -6.826006889343262,
            "end_logit": 8.46451187133789
        },
        {
            "text": "H3K4-specific methyltransferase implicated in transcriptional control.",
            "probability": 9.58891345657099e-08,
            "start_logit": 9.273200035095215,
            "end_logit": -7.694790840148926
        },
        {
            "text": "mammalian homolog of Drosophila trithorax, is an H3K4-specific",
            "probability": 9.366871378183339e-08,
            "start_logit": -6.909531116485596,
            "end_logit": 8.46451187133789
        },
        {
            "text": "Drosophila trithorax, is an H3K4-specific",
            "probability": 9.158255743946325e-08,
            "start_logit": -6.93205451965332,
            "end_logit": 8.46451187133789
        },
        {
            "text": "control. We demonstrate that MLL1 is essential for circadian transcription and cyclic H3K4",
            "probability": 4.350444807819296e-09,
            "start_logit": -6.3332366943359375,
            "end_logit": 4.818731307983398
        },
        {
            "text": "3",
            "probability": 3.867132913157975e-09,
            "start_logit": 1.3786382675170898,
            "end_logit": -3.010908365249634
        },
        {
            "text": "implicated in transcriptional control. We demonstrate that MLL1 is essential for circadian transcription and cyclic H3K4",
            "probability": 3.2987645974340197e-09,
            "start_logit": -6.60996675491333,
            "end_logit": 4.818731307983398
        },
        {
            "text": "3K",
            "probability": 7.625353250364801e-11,
            "start_logit": 1.3786382675170898,
            "end_logit": -6.937113285064697
        },
        {
            "text": "K",
            "probability": 1.9952339301492627e-12,
            "start_logit": -2.2646641731262207,
            "end_logit": -6.937113285064697
        }
    ],
    "533be71dfd9a95ea0d000009_007": [
        {
            "text": "H3K4",
            "probability": 0.9992829246320774,
            "start_logit": 9.707231521606445,
            "end_logit": 9.095658302307129
        },
        {
            "text": "3K4",
            "probability": 0.00023716943274391692,
            "start_logit": 1.3612130880355835,
            "end_logit": 9.095658302307129
        },
        {
            "text": "4",
            "probability": 0.00023644545577596878,
            "start_logit": 1.3581558465957642,
            "end_logit": 9.095658302307129
        },
        {
            "text": "H",
            "probability": 0.00020024449310583527,
            "start_logit": 9.707231521606445,
            "end_logit": 0.5804041624069214
        },
        {
            "text": "the mixed lineage leukemia 1 (MLL1) protein, a histone methyltransferase specific for H3K4,",
            "probability": 2.078082717886794e-05,
            "start_logit": -1.073530912399292,
            "end_logit": 9.095658302307129
        },
        {
            "text": "K4",
            "probability": 1.3673811659883289e-05,
            "start_logit": -1.492079257965088,
            "end_logit": 9.095658302307129
        },
        {
            "text": "for H3K4,",
            "probability": 4.563682854429812e-06,
            "start_logit": -2.5894317626953125,
            "end_logit": 9.095658302307129
        },
        {
            "text": "H3",
            "probability": 1.6369623731857225e-06,
            "start_logit": 9.707231521606445,
            "end_logit": -4.226292610168457
        },
        {
            "text": "specific for H3K4,",
            "probability": 1.5299837019473198e-06,
            "start_logit": -3.682304620742798,
            "end_logit": 9.095658302307129
        },
        {
            "text": "mixed lineage leukemia 1 (MLL1) protein, a histone methyltransferase specific for H3K4,",
            "probability": 3.6206863805918753e-07,
            "start_logit": -5.123483180999756,
            "end_logit": 9.095658302307129
        },
        {
            "text": "H3K",
            "probability": 1.728155839332301e-07,
            "start_logit": 9.707231521606445,
            "end_logit": -6.47466516494751
        },
        {
            "text": "protein, a histone methyltransferase specific for H3K4,",
            "probability": 1.3129261719448228e-07,
            "start_logit": -6.137888431549072,
            "end_logit": 9.095658302307129
        },
        {
            "text": "(H3K4).",
            "probability": 1.1684826330773333e-07,
            "start_logit": -2.8170886039733887,
            "end_logit": 5.658306121826172
        },
        {
            "text": "histone methyltransferase specific for H3K4,",
            "probability": 1.0007275246896612e-07,
            "start_logit": -6.409419536590576,
            "end_logit": 9.095658302307129
        },
        {
            "text": "H3 (H3K4).",
            "probability": 1.0002456848176491e-07,
            "start_logit": -2.9725489616394043,
            "end_logit": 5.658306121826172
        },
        {
            "text": "H3K4, is required for MDR1 promoter methylation,",
            "probability": 4.0091965683054666e-08,
            "start_logit": 9.707231521606445,
            "end_logit": -7.935714244842529
        },
        {
            "text": "histone H3 (H3K4).",
            "probability": 6.9718208451530685e-09,
            "start_logit": -5.6360883712768555,
            "end_logit": 5.658306121826172
        },
        {
            "text": "3",
            "probability": 3.88516032748721e-10,
            "start_logit": 1.3612130880355835,
            "end_logit": -4.226292610168457
        },
        {
            "text": "(H3K4). In this study, we further investigated histone methylation in MDR1 regulation and function. We show that the",
            "probability": 1.0278673003838246e-10,
            "start_logit": 3.8727052211761475,
            "end_logit": -8.067462921142578
        },
        {
            "text": "3K",
            "probability": 4.101598556369174e-11,
            "start_logit": 1.3612130880355835,
            "end_logit": -6.47466516494751
        }
    ],
    "533be71dfd9a95ea0d000009_008": [
        {
            "text": "H3K4",
            "probability": 0.9997101086777285,
            "start_logit": 9.498929023742676,
            "end_logit": 8.709728240966797
        },
        {
            "text": "H",
            "probability": 0.00013635523321398155,
            "start_logit": 9.498929023742676,
            "end_logit": -0.1902288943529129
        },
        {
            "text": "4",
            "probability": 0.00013289636457620754,
            "start_logit": 0.57327800989151,
            "end_logit": 8.709728240966797
        },
        {
            "text": "3K4",
            "probability": 1.3889193004071433e-05,
            "start_logit": -1.6851805448532104,
            "end_logit": 8.709728240966797
        },
        {
            "text": "K4",
            "probability": 3.3083223028972336e-06,
            "start_logit": -3.1198503971099854,
            "end_logit": 8.709728240966797
        },
        {
            "text": "(H3K4me3)",
            "probability": 1.994432171928309e-06,
            "start_logit": -3.625932216644287,
            "end_logit": 8.709728240966797
        },
        {
            "text": "H3K4me3",
            "probability": 6.394913073738417e-07,
            "start_logit": 9.498929023742676,
            "end_logit": -5.552574634552002
        },
        {
            "text": "H3",
            "probability": 3.913018498751452e-07,
            "start_logit": 9.498929023742676,
            "end_logit": -6.043768405914307
        },
        {
            "text": "H3K",
            "probability": 1.067156284830329e-07,
            "start_logit": 9.498929023742676,
            "end_logit": -7.343080043792725
        },
        {
            "text": "histone methyltransferase (H3K4me3)",
            "probability": 7.581783464595196e-08,
            "start_logit": -6.8957133293151855,
            "end_logit": 8.709728240966797
        },
        {
            "text": "a subunit of the MLL1 histone methyltransferase (H3K4me3)",
            "probability": 4.690593564852954e-08,
            "start_logit": -7.3759026527404785,
            "end_logit": 8.709728240966797
        },
        {
            "text": "MLL1 histone methyltransferase (H3K4me3)",
            "probability": 4.5835793742733265e-08,
            "start_logit": -7.39898157119751,
            "end_logit": 8.709728240966797
        },
        {
            "text": "(H3K4me3) complex and that HIV-1 Tat transactivation requires c-Myc and Menin,",
            "probability": 4.059658808864813e-08,
            "start_logit": 9.498929023742676,
            "end_logit": -8.309563636779785
        },
        {
            "text": "the MLL1 histone methyltransferase (H3K4me3)",
            "probability": 3.896120306148302e-08,
            "start_logit": -7.561480522155762,
            "end_logit": 8.709728240966797
        },
        {
            "text": "methyltransferase (H3K4me3)",
            "probability": 3.688647682841296e-08,
            "start_logit": -7.616201877593994,
            "end_logit": 8.709728240966797
        },
        {
            "text": "(H3K4me3) complex and that HIV-1",
            "probability": 2.492513549611536e-08,
            "start_logit": 9.498929023742676,
            "end_logit": -8.797370910644531
        },
        {
            "text": "HIV-1 Tat transactivation requires c-Myc and Menin, but not MLL1 or H3K4me3.",
            "probability": 1.3739539239026832e-10,
            "start_logit": -6.2374267578125,
            "end_logit": 1.738215684890747
        },
        {
            "text": "4me3",
            "probability": 8.501071379629931e-11,
            "start_logit": 0.57327800989151,
            "end_logit": -5.552574634552002
        },
        {
            "text": "H3K4me3.",
            "probability": 7.09325761403902e-11,
            "start_logit": 3.3337392807006836,
            "end_logit": -8.494083404541016
        },
        {
            "text": "or H3K4me3.",
            "probability": 4.591095977529648e-11,
            "start_logit": -7.333585739135742,
            "end_logit": 1.738215684890747
        }
    ],
    "533be71dfd9a95ea0d000009_009": [
        {
            "text": "H3K4",
            "probability": 0.9996077488884476,
            "start_logit": 8.464914321899414,
            "end_logit": 7.471393585205078
        },
        {
            "text": "H",
            "probability": 0.00018981402770289646,
            "start_logit": 8.464914321899414,
            "end_logit": -1.097679853439331
        },
        {
            "text": "4",
            "probability": 9.371843007820764e-05,
            "start_logit": -0.8099090456962585,
            "end_logit": 7.471393585205078
        },
        {
            "text": "3K4",
            "probability": 8.667937760805384e-05,
            "start_logit": -0.8879879117012024,
            "end_logit": 7.471393585205078
        },
        {
            "text": "K4",
            "probability": 1.8199099436665404e-05,
            "start_logit": -2.448831796646118,
            "end_logit": 7.471393585205078
        },
        {
            "text": "H3",
            "probability": 1.0577057682492676e-06,
            "start_logit": 8.464914321899414,
            "end_logit": -6.287622451782227
        },
        {
            "text": "the H3K4",
            "probability": 7.337264286717031e-07,
            "start_logit": -5.53203821182251,
            "end_logit": 7.343608856201172
        },
        {
            "text": "Interestingly, MLL1 and MLL2 H3K4",
            "probability": 5.785237804265879e-07,
            "start_logit": -5.89747953414917,
            "end_logit": 7.471393585205078
        },
        {
            "text": "H3K",
            "probability": 3.4675990833043025e-07,
            "start_logit": 8.464914321899414,
            "end_logit": -7.4028472900390625
        },
        {
            "text": "MLL1 and MLL2 H3K4",
            "probability": 1.7261048326814965e-07,
            "start_logit": -7.106921672821045,
            "end_logit": 7.471393585205078
        },
        {
            "text": "MLL2 H3K4",
            "probability": 1.4669980552753608e-07,
            "start_logit": -7.269570827484131,
            "end_logit": 7.471393585205078
        },
        {
            "text": "H3K4 trimethyltransferase",
            "probability": 1.437109191910833e-07,
            "start_logit": 8.346122741699219,
            "end_logit": -8.164884567260742
        },
        {
            "text": "MMP9 but not on the IkappaBalpha promoter, and the H3K4",
            "probability": 1.3720291020682144e-07,
            "start_logit": -7.208713531494141,
            "end_logit": 7.343608856201172
        },
        {
            "text": "H3K4 methyltransferase",
            "probability": 1.3496104789196963e-07,
            "start_logit": 8.464914321899414,
            "end_logit": -8.3464937210083
        },
        {
            "text": "p52 on the MMP9 but not on the IkappaBalpha promoter, and the H3K4",
            "probability": 9.550249991739263e-08,
            "start_logit": -7.571022033691406,
            "end_logit": 7.343608856201172
        },
        {
            "text": "promoter, and the H3K4",
            "probability": 9.019598322737546e-08,
            "start_logit": -7.628189563751221,
            "end_logit": 7.343608856201172
        },
        {
            "text": "H3K4 methyltransferase complexes are tethered by p52 on the MMP9",
            "probability": 7.65759730630585e-08,
            "start_logit": 8.464914321899414,
            "end_logit": -8.913196563720703
        },
        {
            "text": "H3K4 methyltransferase complexes are tethered by p52",
            "probability": 6.637515478638213e-08,
            "start_logit": 8.464914321899414,
            "end_logit": -9.056157112121582
        },
        {
            "text": "H3K4 trimethyltransferase activity recruited on the MMP9",
            "probability": 5.953434630008402e-08,
            "start_logit": 8.346122741699219,
            "end_logit": -9.046134948730469
        },
        {
            "text": "3",
            "probability": 9.171725387907755e-11,
            "start_logit": -0.8879879117012024,
            "end_logit": -6.287622451782227
        }
    ],
    "533be71dfd9a95ea0d000009_010": [
        {
            "text": "H3K4",
            "probability": 0.9996077488884476,
            "start_logit": 8.464914321899414,
            "end_logit": 7.471393585205078
        },
        {
            "text": "H",
            "probability": 0.00018981402770289646,
            "start_logit": 8.464914321899414,
            "end_logit": -1.097679853439331
        },
        {
            "text": "4",
            "probability": 9.371843007820764e-05,
            "start_logit": -0.8099090456962585,
            "end_logit": 7.471393585205078
        },
        {
            "text": "3K4",
            "probability": 8.667937760805384e-05,
            "start_logit": -0.8879879117012024,
            "end_logit": 7.471393585205078
        },
        {
            "text": "K4",
            "probability": 1.8199099436665404e-05,
            "start_logit": -2.448831796646118,
            "end_logit": 7.471393585205078
        },
        {
            "text": "H3",
            "probability": 1.0577057682492676e-06,
            "start_logit": 8.464914321899414,
            "end_logit": -6.287622451782227
        },
        {
            "text": "the H3K4",
            "probability": 7.337264286717031e-07,
            "start_logit": -5.53203821182251,
            "end_logit": 7.343608856201172
        },
        {
            "text": "Interestingly, MLL1 and MLL2 H3K4",
            "probability": 5.785237804265879e-07,
            "start_logit": -5.89747953414917,
            "end_logit": 7.471393585205078
        },
        {
            "text": "H3K",
            "probability": 3.4675990833043025e-07,
            "start_logit": 8.464914321899414,
            "end_logit": -7.4028472900390625
        },
        {
            "text": "MLL1 and MLL2 H3K4",
            "probability": 1.7261048326814965e-07,
            "start_logit": -7.106921672821045,
            "end_logit": 7.471393585205078
        },
        {
            "text": "MLL2 H3K4",
            "probability": 1.4669980552753608e-07,
            "start_logit": -7.269570827484131,
            "end_logit": 7.471393585205078
        },
        {
            "text": "H3K4 trimethyltransferase",
            "probability": 1.437109191910833e-07,
            "start_logit": 8.346122741699219,
            "end_logit": -8.164884567260742
        },
        {
            "text": "MMP9 but not on the IkappaBalpha promoter, and the H3K4",
            "probability": 1.3720291020682144e-07,
            "start_logit": -7.208713531494141,
            "end_logit": 7.343608856201172
        },
        {
            "text": "H3K4 methyltransferase",
            "probability": 1.3496104789196963e-07,
            "start_logit": 8.464914321899414,
            "end_logit": -8.3464937210083
        },
        {
            "text": "p52 on the MMP9 but not on the IkappaBalpha promoter, and the H3K4",
            "probability": 9.550249991739263e-08,
            "start_logit": -7.571022033691406,
            "end_logit": 7.343608856201172
        },
        {
            "text": "promoter, and the H3K4",
            "probability": 9.019598322737546e-08,
            "start_logit": -7.628189563751221,
            "end_logit": 7.343608856201172
        },
        {
            "text": "H3K4 methyltransferase complexes are tethered by p52 on the MMP9",
            "probability": 7.65759730630585e-08,
            "start_logit": 8.464914321899414,
            "end_logit": -8.913196563720703
        },
        {
            "text": "H3K4 methyltransferase complexes are tethered by p52",
            "probability": 6.637515478638213e-08,
            "start_logit": 8.464914321899414,
            "end_logit": -9.056157112121582
        },
        {
            "text": "H3K4 trimethyltransferase activity recruited on the MMP9",
            "probability": 5.953434630008402e-08,
            "start_logit": 8.346122741699219,
            "end_logit": -9.046134948730469
        },
        {
            "text": "3",
            "probability": 9.171725387907755e-11,
            "start_logit": -0.8879879117012024,
            "end_logit": -6.287622451782227
        }
    ],
    "533be71dfd9a95ea0d000009_011": [
        {
            "text": "H3K4",
            "probability": 0.9995864933981156,
            "start_logit": 9.606608390808105,
            "end_logit": 8.813405990600586
        },
        {
            "text": "H",
            "probability": 0.00018595212816685319,
            "start_logit": 9.606608390808105,
            "end_logit": 0.22379828989505768
        },
        {
            "text": "4",
            "probability": 0.00014015568533860763,
            "start_logit": 0.7342652678489685,
            "end_logit": 8.813405990600586
        },
        {
            "text": "3K4",
            "probability": 5.6157873642946355e-05,
            "start_logit": -0.18032167851924896,
            "end_logit": 8.813405990600586
        },
        {
            "text": "H3K4 methyltransferase activity of the carboxyl-terminal SET domain.",
            "probability": 1.9212759645211706e-05,
            "start_logit": 9.606608390808105,
            "end_logit": -2.046116352081299
        },
        {
            "text": "K4",
            "probability": 7.019834479475078e-06,
            "start_logit": -2.259748935699463,
            "end_logit": 8.813405990600586
        },
        {
            "text": "development and hematopoiesis. The biological function of MLL1 is mediated by the histone H3K4",
            "probability": 2.2790060408513537e-06,
            "start_logit": -3.384749174118042,
            "end_logit": 8.813405990600586
        },
        {
            "text": "the histone H3K4",
            "probability": 1.014995909640401e-06,
            "start_logit": -4.193603992462158,
            "end_logit": 8.813405990600586
        },
        {
            "text": "H3",
            "probability": 6.330637164236233e-07,
            "start_logit": 9.606608390808105,
            "end_logit": -5.4588751792907715
        },
        {
            "text": "The biological function of MLL1 is mediated by the histone H3K4",
            "probability": 2.556205284614442e-07,
            "start_logit": -5.572549819946289,
            "end_logit": 8.813405990600586
        },
        {
            "text": "H3K",
            "probability": 1.8745201764232582e-07,
            "start_logit": 9.606608390808105,
            "end_logit": -6.6759233474731445
        },
        {
            "text": "early development and hematopoiesis. The biological function of MLL1 is mediated by the histone H3K4",
            "probability": 1.4793581583583673e-07,
            "start_logit": -6.119465351104736,
            "end_logit": 8.813405990600586
        },
        {
            "text": "is mediated by the histone H3K4",
            "probability": 1.3295324127619983e-07,
            "start_logit": -6.226246356964111,
            "end_logit": 8.813405990600586
        },
        {
            "text": "H3K4 methyltransferase activity of the carboxyl-terminal",
            "probability": 8.869404853308221e-08,
            "start_logit": 9.606608390808105,
            "end_logit": -7.424253463745117
        },
        {
            "text": "histone H3K4",
            "probability": 8.196352518191988e-08,
            "start_logit": -6.709969520568848,
            "end_logit": 8.813405990600586
        },
        {
            "text": "and hematopoiesis. The biological function of MLL1 is mediated by the histone H3K4",
            "probability": 7.85353818336209e-08,
            "start_logit": -6.752694606781006,
            "end_logit": 8.813405990600586
        },
        {
            "text": "hematopoiesis. The biological function of MLL1 is mediated by the histone H3K4",
            "probability": 6.730453213830214e-08,
            "start_logit": -6.907016277313232,
            "end_logit": 8.813405990600586
        },
        {
            "text": "H3K4 methyltransferase",
            "probability": 4.073769422631416e-08,
            "start_logit": 9.606608390808105,
            "end_logit": -8.202292442321777
        },
        {
            "text": "3",
            "probability": 3.556621906123776e-11,
            "start_logit": -0.18032167851924896,
            "end_logit": -5.4588751792907715
        },
        {
            "text": "SET domain.",
            "probability": 2.25931681580453e-11,
            "start_logit": -4.0468292236328125,
            "end_logit": -2.046116352081299
        }
    ],
    "533be71dfd9a95ea0d000009_012": [
        {
            "text": "H3K4",
            "probability": 0.9996820498856003,
            "start_logit": 8.480785369873047,
            "end_logit": 7.597726345062256
        },
        {
            "text": "H",
            "probability": 0.00017134427344387296,
            "start_logit": 8.480785369873047,
            "end_logit": -1.0737913846969604
        },
        {
            "text": "4",
            "probability": 7.589253011175575e-05,
            "start_logit": -1.0050889253616333,
            "end_logit": 7.597726345062256
        },
        {
            "text": "3K4",
            "probability": 4.647428331696901e-05,
            "start_logit": -1.495508074760437,
            "end_logit": 7.597726345062256
        },
        {
            "text": "K4",
            "probability": 1.243779586144541e-05,
            "start_logit": -2.8136672973632812,
            "end_logit": 7.597726345062256
        },
        {
            "text": "H3K4,",
            "probability": 1.0005789376659004e-05,
            "start_logit": 8.480785369873047,
            "end_logit": -3.914302349090576
        },
        {
            "text": "H3",
            "probability": 7.991907960526522e-07,
            "start_logit": 8.387051582336426,
            "end_logit": -6.347887992858887
        },
        {
            "text": "H3K",
            "probability": 4.290818331209504e-07,
            "start_logit": 8.480785369873047,
            "end_logit": -7.063573837280273
        },
        {
            "text": "methylating H3K4,",
            "probability": 2.853261407802654e-07,
            "start_logit": -6.588529586791992,
            "end_logit": 7.597726345062256
        },
        {
            "text": "of methylating H3K4,",
            "probability": 1.451387902342088e-07,
            "start_logit": -7.264472007751465,
            "end_logit": 7.597726345062256
        },
        {
            "text": "is capable of methylating H3K4,",
            "probability": 1.366079917601827e-07,
            "start_logit": -7.325047016143799,
            "end_logit": 7.597726345062256
        },
        {
            "text": "3",
            "probability": 4.5529744422198294e-11,
            "start_logit": -1.3859375715255737,
            "end_logit": -6.347887992858887
        },
        {
            "text": "H3K4 trimethylation",
            "probability": 2.5854282868584602e-11,
            "start_logit": 0.45630064606666565,
            "end_logit": -8.75601577758789
        },
        {
            "text": "3K",
            "probability": 1.9947613024470595e-11,
            "start_logit": -1.495508074760437,
            "end_logit": -7.063573837280273
        },
        {
            "text": "K",
            "probability": 5.3385296343211256e-12,
            "start_logit": -2.8136672973632812,
            "end_logit": -7.063573837280273
        },
        {
            "text": "methylating",
            "probability": 3.3624726262757275e-14,
            "start_logit": -6.588529586791992,
            "end_logit": -8.356155395507812
        },
        {
            "text": "of methylating",
            "probability": 1.710411839022975e-14,
            "start_logit": -7.264472007751465,
            "end_logit": -8.356155395507812
        },
        {
            "text": "is capable of methylating",
            "probability": 1.6098792475445166e-14,
            "start_logit": -7.325047016143799,
            "end_logit": -8.356155395507812
        }
    ],
    "533be71dfd9a95ea0d000009_013": [
        {
            "text": "H3K4",
            "probability": 0.9996820498856003,
            "start_logit": 8.480785369873047,
            "end_logit": 7.597726345062256
        },
        {
            "text": "H",
            "probability": 0.00017134427344387296,
            "start_logit": 8.480785369873047,
            "end_logit": -1.0737913846969604
        },
        {
            "text": "4",
            "probability": 7.589253011175575e-05,
            "start_logit": -1.0050889253616333,
            "end_logit": 7.597726345062256
        },
        {
            "text": "3K4",
            "probability": 4.647428331696901e-05,
            "start_logit": -1.495508074760437,
            "end_logit": 7.597726345062256
        },
        {
            "text": "K4",
            "probability": 1.243779586144541e-05,
            "start_logit": -2.8136672973632812,
            "end_logit": 7.597726345062256
        },
        {
            "text": "H3K4,",
            "probability": 1.0005789376659004e-05,
            "start_logit": 8.480785369873047,
            "end_logit": -3.914302349090576
        },
        {
            "text": "H3",
            "probability": 7.991907960526522e-07,
            "start_logit": 8.387051582336426,
            "end_logit": -6.347887992858887
        },
        {
            "text": "H3K",
            "probability": 4.290818331209504e-07,
            "start_logit": 8.480785369873047,
            "end_logit": -7.063573837280273
        },
        {
            "text": "methylating H3K4,",
            "probability": 2.853261407802654e-07,
            "start_logit": -6.588529586791992,
            "end_logit": 7.597726345062256
        },
        {
            "text": "of methylating H3K4,",
            "probability": 1.451387902342088e-07,
            "start_logit": -7.264472007751465,
            "end_logit": 7.597726345062256
        },
        {
            "text": "is capable of methylating H3K4,",
            "probability": 1.366079917601827e-07,
            "start_logit": -7.325047016143799,
            "end_logit": 7.597726345062256
        },
        {
            "text": "3",
            "probability": 4.5529744422198294e-11,
            "start_logit": -1.3859375715255737,
            "end_logit": -6.347887992858887
        },
        {
            "text": "H3K4 trimethylation",
            "probability": 2.5854282868584602e-11,
            "start_logit": 0.45630064606666565,
            "end_logit": -8.75601577758789
        },
        {
            "text": "3K",
            "probability": 1.9947613024470595e-11,
            "start_logit": -1.495508074760437,
            "end_logit": -7.063573837280273
        },
        {
            "text": "K",
            "probability": 5.3385296343211256e-12,
            "start_logit": -2.8136672973632812,
            "end_logit": -7.063573837280273
        },
        {
            "text": "methylating",
            "probability": 3.3624726262757275e-14,
            "start_logit": -6.588529586791992,
            "end_logit": -8.356155395507812
        },
        {
            "text": "of methylating",
            "probability": 1.710411839022975e-14,
            "start_logit": -7.264472007751465,
            "end_logit": -8.356155395507812
        },
        {
            "text": "is capable of methylating",
            "probability": 1.6098792475445166e-14,
            "start_logit": -7.325047016143799,
            "end_logit": -8.356155395507812
        }
    ],
    "533be71dfd9a95ea0d000009_014": [
        {
            "text": "H3K4",
            "probability": 0.9995419185123756,
            "start_logit": 9.484538078308105,
            "end_logit": 8.553147315979004
        },
        {
            "text": "H",
            "probability": 0.00016191108392854176,
            "start_logit": 9.484538078308105,
            "end_logit": -0.1748577356338501
        },
        {
            "text": "4",
            "probability": 0.0001506666026293201,
            "start_logit": 0.684555172920227,
            "end_logit": 8.553147315979004
        },
        {
            "text": "3K4",
            "probability": 0.0001354510345195001,
            "start_logit": 0.5780959129333496,
            "end_logit": 8.553147315979004
        },
        {
            "text": "K4",
            "probability": 3.089084329330582e-06,
            "start_logit": -3.202639579772949,
            "end_logit": 8.553147315979004
        },
        {
            "text": "H3",
            "probability": 2.8593850659777823e-06,
            "start_logit": 9.484538078308105,
            "end_logit": -4.21129846572876
        },
        {
            "text": "H3K4 histones and histone methyltransferase MLL1,",
            "probability": 1.0204926170499788e-06,
            "start_logit": 9.484538078308105,
            "end_logit": -5.24161958694458
        },
        {
            "text": "associated with trimethylated H3K4",
            "probability": 8.634286203374383e-07,
            "start_logit": -4.477358341217041,
            "end_logit": 8.553147315979004
        },
        {
            "text": "trimethylated H3K4",
            "probability": 7.569451728089028e-07,
            "start_logit": -4.608978748321533,
            "end_logit": 8.553147315979004
        },
        {
            "text": "H3K4 histones and histone",
            "probability": 3.6652380369968967e-07,
            "start_logit": 9.484538078308105,
            "end_logit": -6.265596866607666
        },
        {
            "text": "H3K4 histones and histone methyltransferase MLL1, suggesting a role in epigenetic",
            "probability": 3.3983703085904825e-07,
            "start_logit": 9.484538078308105,
            "end_logit": -6.341194152832031
        },
        {
            "text": "H3K4 histones",
            "probability": 2.899234557198304e-07,
            "start_logit": 9.484538078308105,
            "end_logit": -6.5000433921813965
        },
        {
            "text": "H3K",
            "probability": 1.2085675182950056e-07,
            "start_logit": 9.484538078308105,
            "end_logit": -7.375054359436035
        },
        {
            "text": "H3K4 histones and histone methyltransferase MLL1, suggesting",
            "probability": 1.1566227136956197e-07,
            "start_logit": 9.484538078308105,
            "end_logit": -7.418985843658447
        },
        {
            "text": "H3K4 histones and histone methyltransferase",
            "probability": 7.826593363146596e-08,
            "start_logit": 9.484538078308105,
            "end_logit": -7.8095479011535645
        },
        {
            "text": "H3K4 histones and histone methyltransferase MLL1, suggesting a role in epigenetic regulation",
            "probability": 7.788415016548866e-08,
            "start_logit": 9.484538078308105,
            "end_logit": -7.8144378662109375
        },
        {
            "text": "with trimethylated H3K4",
            "probability": 7.40585905032556e-08,
            "start_logit": -6.933413028717041,
            "end_logit": 8.553147315979004
        },
        {
            "text": "3",
            "probability": 3.8748416459885006e-10,
            "start_logit": 0.5780959129333496,
            "end_logit": -4.21129846572876
        },
        {
            "text": "3K",
            "probability": 1.6377674373413143e-11,
            "start_logit": 0.5780959129333496,
            "end_logit": -7.375054359436035
        },
        {
            "text": "H3K4 histones and histone methyltransferase MLL1, suggesting a role in epigenetic regulation of homeotic loci during ES cell",
            "probability": 1.489182090015046e-11,
            "start_logit": 0.684555172920227,
            "end_logit": -7.576620578765869
        }
    ],
    "533be71dfd9a95ea0d000009_015": [
        {
            "text": "H3K4",
            "probability": 0.9993420777729514,
            "start_logit": 8.729903221130371,
            "end_logit": 7.897051811218262
        },
        {
            "text": "H",
            "probability": 0.00019287582310720033,
            "start_logit": 8.729903221130371,
            "end_logit": -0.655754029750824
        },
        {
            "text": "decreased H3K4",
            "probability": 0.00018921628638958303,
            "start_logit": 0.157941535115242,
            "end_logit": 7.897051811218262
        },
        {
            "text": "3K4",
            "probability": 0.00012957684491357897,
            "start_logit": -0.22067509591579437,
            "end_logit": 7.897051811218262
        },
        {
            "text": "4",
            "probability": 0.00011411568904849612,
            "start_logit": -0.3477364480495453,
            "end_logit": 7.897051811218262
        },
        {
            "text": "K4",
            "probability": 2.8579742137863328e-05,
            "start_logit": -1.7322510480880737,
            "end_logit": 7.897051811218262
        },
        {
            "text": "H3",
            "probability": 1.5597267433668262e-06,
            "start_logit": 8.729903221130371,
            "end_logit": -5.473289966583252
        },
        {
            "text": "H3K4 methylation at GABAergic gene promoters. In contrast, Gad1 H3K4",
            "probability": 7.782600390468638e-07,
            "start_logit": 8.729903221130371,
            "end_logit": -6.168495178222656
        },
        {
            "text": "H3K",
            "probability": 3.6435618993971106e-07,
            "start_logit": 8.729903221130371,
            "end_logit": -6.92742395401001
        },
        {
            "text": "histone methyltransferase expressed in GABAergic and other cortical neurons, resulted in decreased H3K4",
            "probability": 2.3811871360898906e-07,
            "start_logit": -7.202310085296631,
            "end_logit": 8.579426765441895
        },
        {
            "text": "methyltransferase expressed in GABAergic and other cortical neurons, resulted in decreased H3K4",
            "probability": 2.2460021172904055e-07,
            "start_logit": -7.2607574462890625,
            "end_logit": 8.579426765441895
        },
        {
            "text": "H3K4 methylation",
            "probability": 1.8081520067127978e-07,
            "start_logit": 8.729903221130371,
            "end_logit": -7.628080368041992
        },
        {
            "text": "expressed in GABAergic and other cortical neurons, resulted in decreased H3K4",
            "probability": 1.2099310220807312e-07,
            "start_logit": -7.1969709396362305,
            "end_logit": 7.897051811218262
        },
        {
            "text": "resulted in decreased H3K4",
            "probability": 9.011303826404947e-08,
            "start_logit": -7.491639614105225,
            "end_logit": 7.897051811218262
        },
        {
            "text": "decreased",
            "probability": 3.8081796693412195e-10,
            "start_logit": 0.157941535115242,
            "end_logit": -5.219027996063232
        },
        {
            "text": "3",
            "probability": 2.0223752689689363e-10,
            "start_logit": -0.22067509591579437,
            "end_logit": -5.473289966583252
        },
        {
            "text": "decreased H3K4 methylation at GABAergic gene promoters. In contrast, Gad1 H3K4",
            "probability": 1.4735642350017862e-10,
            "start_logit": 0.157941535115242,
            "end_logit": -6.168495178222656
        },
        {
            "text": "3K",
            "probability": 4.724320787365762e-11,
            "start_logit": -0.22067509591579437,
            "end_logit": -6.92742395401001
        },
        {
            "text": "Heterozygosity",
            "probability": 4.632222295912177e-11,
            "start_logit": -1.110877513885498,
            "end_logit": -6.05690860748291
        },
        {
            "text": "decreased H3K4 methylation",
            "probability": 3.423570522523317e-11,
            "start_logit": 0.157941535115242,
            "end_logit": -7.628080368041992
        }
    ],
    "533be71dfd9a95ea0d000009_016": [
        {
            "text": "H3K4",
            "probability": 0.9840460249445897,
            "start_logit": 9.502952575683594,
            "end_logit": 8.573280334472656
        },
        {
            "text": "(H3K4) is associated with transcriptional activation. One of the chief effectors of H3K4",
            "probability": 0.015647660958326887,
            "start_logit": 5.36160135269165,
            "end_logit": 8.573280334472656
        },
        {
            "text": "H",
            "probability": 0.00020107755336644644,
            "start_logit": 9.502952575683594,
            "end_logit": 0.07754305750131607
        },
        {
            "text": "4",
            "probability": 9.546657837122258e-05,
            "start_logit": 0.26230084896087646,
            "end_logit": 8.573280334472656
        },
        {
            "text": "3K4",
            "probability": 3.879928801114893e-06,
            "start_logit": -2.9406585693359375,
            "end_logit": 8.573280334472656
        },
        {
            "text": "K4",
            "probability": 2.509224080166275e-06,
            "start_logit": -3.3765017986297607,
            "end_logit": 8.573280334472656
        },
        {
            "text": "One of the chief effectors of H3K4",
            "probability": 1.798123810404142e-06,
            "start_logit": -3.7097315788269043,
            "end_logit": 8.573280334472656
        },
        {
            "text": "H3",
            "probability": 8.12775211015753e-07,
            "start_logit": 9.502952575683594,
            "end_logit": -5.433448314666748
        },
        {
            "text": "H3 Lys4 (H3K4) is associated with transcriptional activation. One of the chief effectors of H3K4",
            "probability": 2.03714478485316e-07,
            "start_logit": -5.887511253356934,
            "end_logit": 8.573280334472656
        },
        {
            "text": "H3K4 methylation",
            "probability": 1.9180882189117795e-07,
            "start_logit": 9.502952575683594,
            "end_logit": -6.877403736114502
        },
        {
            "text": "H3K",
            "probability": 1.2544388174234485e-07,
            "start_logit": 9.502952575683594,
            "end_logit": -7.30204439163208
        },
        {
            "text": "of the chief effectors of H3K4",
            "probability": 9.270307516862856e-08,
            "start_logit": -6.674829006195068,
            "end_logit": 8.573280334472656
        },
        {
            "text": "of H3K4",
            "probability": 8.377345471126186e-08,
            "start_logit": -6.776114463806152,
            "end_logit": 8.573280334472656
        },
        {
            "text": "(H3K4)",
            "probability": 4.040154960842201e-08,
            "start_logit": -4.006373882293701,
            "end_logit": 5.074291706085205
        },
        {
            "text": "Trimethylation of histone H3 Lys4 (H3K4)",
            "probability": 9.526190268711114e-09,
            "start_logit": -5.451197147369385,
            "end_logit": 5.074291706085205
        },
        {
            "text": "(H3K4) is associated with transcriptional activation. One",
            "probability": 7.3130199518097045e-09,
            "start_logit": 5.36160135269165,
            "end_logit": -6.002895355224609
        },
        {
            "text": "H3 Lys4 (H3K4)",
            "probability": 6.157868961063682e-09,
            "start_logit": -5.887511253356934,
            "end_logit": 5.074291706085205
        },
        {
            "text": "histone H3 Lys4 (H3K4)",
            "probability": 4.485284406348527e-09,
            "start_logit": -6.204440116882324,
            "end_logit": 5.074291706085205
        },
        {
            "text": "(H3K4) is associated with transcriptional activation. One of the chief effectors of H3K4 methylation",
            "probability": 3.0500193463392758e-09,
            "start_logit": 5.36160135269165,
            "end_logit": -6.877403736114502
        },
        {
            "text": "(H3K4) is associated",
            "probability": 1.5357983011438713e-09,
            "start_logit": 5.36160135269165,
            "end_logit": -7.563501358032227
        }
    ],
    "533be71dfd9a95ea0d000009_017": [
        {
            "text": "H3K4",
            "probability": 0.9995353154782001,
            "start_logit": 9.51597785949707,
            "end_logit": 8.887738227844238
        },
        {
            "text": "4",
            "probability": 0.000199964990838329,
            "start_logit": 0.999074399471283,
            "end_logit": 8.887738227844238
        },
        {
            "text": "H",
            "probability": 0.00016468231387345856,
            "start_logit": 9.51597785949707,
            "end_logit": 0.17671070992946625
        },
        {
            "text": "K4",
            "probability": 4.79961544165176e-05,
            "start_logit": -0.4279470145702362,
            "end_logit": 8.887738227844238
        },
        {
            "text": "3K4",
            "probability": 2.8462045724786756e-05,
            "start_logit": -0.9504964351654053,
            "end_logit": 8.887738227844238
        },
        {
            "text": "menin",
            "probability": 1.6846073322118607e-05,
            "start_logit": 4.062619686126709,
            "end_logit": 3.350168228149414
        },
        {
            "text": "(H3K4).",
            "probability": 3.3285610419956476e-06,
            "start_logit": -3.0965278148651123,
            "end_logit": 8.887738227844238
        },
        {
            "text": "for Lys4 of histone H3 (H3K4).",
            "probability": 8.375611995640351e-07,
            "start_logit": -4.4763288497924805,
            "end_logit": 8.887738227844238
        },
        {
            "text": "histone H3 (H3K4).",
            "probability": 7.77229973145591e-07,
            "start_logit": -4.551086902618408,
            "end_logit": 8.887738227844238
        },
        {
            "text": "(H3K4). We show that menin",
            "probability": 5.731276042537462e-07,
            "start_logit": 9.51597785949707,
            "end_logit": -5.483954429626465
        },
        {
            "text": "Lys4 of histone H3 (H3K4).",
            "probability": 5.321180260746288e-07,
            "start_logit": -4.929957866668701,
            "end_logit": 8.887738227844238
        },
        {
            "text": "H3",
            "probability": 2.757459494972532e-07,
            "start_logit": 9.51597785949707,
            "end_logit": -6.215582847595215
        },
        {
            "text": "H3K",
            "probability": 2.139781969447246e-07,
            "start_logit": 9.51597785949707,
            "end_logit": -6.469188690185547
        },
        {
            "text": "H3 (H3K4).",
            "probability": 1.840517465689922e-07,
            "start_logit": -5.99160623550415,
            "end_logit": 8.887738227844238
        },
        {
            "text": "The product of the multiple endocrine neoplasia type 1 (MEN1) tumor suppressor gene, menin,",
            "probability": 5.321730550919165e-09,
            "start_logit": -3.9974546432495117,
            "end_logit": 3.350168228149414
        },
        {
            "text": "men",
            "probability": 3.01044901179396e-09,
            "start_logit": 4.062619686126709,
            "end_logit": -5.27961540222168
        },
        {
            "text": "in",
            "probability": 1.1914070118473437e-09,
            "start_logit": -5.4941182136535645,
            "end_logit": 3.350168228149414
        },
        {
            "text": "menin, is an integral component of MLL1/MLL2 histone",
            "probability": 4.849945051086456e-10,
            "start_logit": 4.062619686126709,
            "end_logit": -7.105322360992432
        },
        {
            "text": "menin, is an integral",
            "probability": 2.8384022470916034e-10,
            "start_logit": 4.062619686126709,
            "end_logit": -7.641048431396484
        },
        {
            "text": "menin, is an integral component of MLL1/MLL2 histone methyltransferase complexes specific for Lys4",
            "probability": 2.7746531163445664e-10,
            "start_logit": 4.062619686126709,
            "end_logit": -7.663763999938965
        }
    ],
    "56c8274f5795f9a73e00000d_001": [
        {
            "text": "microglia",
            "probability": 0.4689943891175004,
            "start_logit": 5.1257452964782715,
            "end_logit": -1.420360803604126
        },
        {
            "text": "microglia,",
            "probability": 0.46745223454454443,
            "start_logit": 5.1257452964782715,
            "end_logit": -1.4236544370651245
        },
        {
            "text": "micro",
            "probability": 0.054891164932137394,
            "start_logit": 5.1257452964782715,
            "end_logit": -3.565599203109741
        },
        {
            "text": "microglia, CNS resident immune cells, is a pathological",
            "probability": 0.0023170569993855544,
            "start_logit": 5.1257452964782715,
            "end_logit": -6.730653762817383
        },
        {
            "text": "microglia, CNS resident immune cells, is a pathological hallmark of amyotrophic lateral sclerosis (ALS),",
            "probability": 0.001835810214531719,
            "start_logit": 5.1257452964782715,
            "end_logit": -6.963465690612793
        },
        {
            "text": "microgl",
            "probability": 0.001787873099488915,
            "start_logit": 5.1257452964782715,
            "end_logit": -6.989924907684326
        },
        {
            "text": "microglia, CNS resident immune cells, is a pathological hallmark",
            "probability": 0.0009416452809916804,
            "start_logit": 5.1257452964782715,
            "end_logit": -7.631078243255615
        },
        {
            "text": "microglia, CNS resident immune cells, is a pathological hallmark of amyotrophic lateral sclerosis",
            "probability": 0.0008978389459742642,
            "start_logit": 5.1257452964782715,
            "end_logit": -7.67871618270874
        },
        {
            "text": "microglia, CNS",
            "probability": 0.0008166430968217154,
            "start_logit": 5.1257452964782715,
            "end_logit": -7.773504734039307
        },
        {
            "text": "Activation of microglia,",
            "probability": 3.736072664715209e-05,
            "start_logit": -4.311980724334717,
            "end_logit": -1.420360803604126
        },
        {
            "text": "of microglia,",
            "probability": 1.0758559998442672e-05,
            "start_logit": -5.556899070739746,
            "end_logit": -1.420360803604126
        },
        {
            "text": "ia",
            "probability": 1.0567891741794077e-05,
            "start_logit": -5.574780464172363,
            "end_logit": -1.420360803604126
        },
        {
            "text": ",",
            "probability": 2.4831998131319265e-06,
            "start_logit": -7.019759178161621,
            "end_logit": -1.4236544370651245
        },
        {
            "text": "glia",
            "probability": 2.3856766777348234e-06,
            "start_logit": -7.063117980957031,
            "end_logit": -1.420360803604126
        },
        {
            "text": "Activation",
            "probability": 4.4777288407487906e-07,
            "start_logit": -4.311980724334717,
            "end_logit": -5.844449996948242
        },
        {
            "text": "affecting motor neurons.",
            "probability": 3.6153802556364265e-07,
            "start_logit": -3.0030548572540283,
            "end_logit": -7.367294788360596
        },
        {
            "text": "affecting",
            "probability": 3.5738902847850767e-07,
            "start_logit": -3.0030548572540283,
            "end_logit": -7.3788371086120605
        },
        {
            "text": "affecting motor",
            "probability": 2.9019079449303983e-07,
            "start_logit": -3.0030548572540283,
            "end_logit": -7.587123394012451
        },
        {
            "text": "Activation of microglia, CNS resident immune cells, is a pathological",
            "probability": 1.8457989090830236e-07,
            "start_logit": -4.311980724334717,
            "end_logit": -6.730653762817383
        },
        {
            "text": "Activation of microglia, CNS resident immune cells, is a pathological hallmark of amyotrophic lateral sclerosis (ALS),",
            "probability": 1.4624312186384294e-07,
            "start_logit": -4.311980724334717,
            "end_logit": -6.963465690612793
        }
    ],
    "56c8274f5795f9a73e00000d_002": [
        {
            "text": "ALS",
            "probability": 0.5620812410729912,
            "start_logit": -3.3794283866882324,
            "end_logit": -3.9135231971740723
        },
        {
            "text": "(ALS)",
            "probability": 0.15100406526833146,
            "start_logit": -3.3794283866882324,
            "end_logit": -5.22786283493042
        },
        {
            "text": "Amyotrophic lateral sclerosis (ALS)",
            "probability": 0.12443260926262394,
            "start_logit": -4.88731050491333,
            "end_logit": -3.9135231971740723
        },
        {
            "text": "(ALS) is an adult-onset neurodegenerative",
            "probability": 0.03081458159850638,
            "start_logit": -3.3794283866882324,
            "end_logit": -6.817181587219238
        },
        {
            "text": "(ALS) is an adult-onset neurodegenerative disease caused by selective",
            "probability": 0.018797652346990146,
            "start_logit": -3.3794283866882324,
            "end_logit": -7.311437606811523
        },
        {
            "text": "(ALS) is an adult-onset neurodegenerative disease caused by selective loss of motor",
            "probability": 0.018399797174879055,
            "start_logit": -3.3794283866882324,
            "end_logit": -7.33282995223999
        },
        {
            "text": "(ALS) is an adult-onset neurodegenerative disease caused by",
            "probability": 0.013535529235534496,
            "start_logit": -3.3794283866882324,
            "end_logit": -7.6398515701293945
        },
        {
            "text": "(ALS) is an adult-onset neurodegenerative disease caused by selective loss of motor neurons.",
            "probability": 0.013297592703857653,
            "start_logit": -3.3794283866882324,
            "end_logit": -7.657586574554443
        },
        {
            "text": "(ALS) is an adult-onset neurodegenerative disease",
            "probability": 0.012841797003793799,
            "start_logit": -3.3794283866882324,
            "end_logit": -7.692464351654053
        },
        {
            "text": "(ALS) is an adult-onset",
            "probability": 0.010058784792695868,
            "start_logit": -3.3794283866882324,
            "end_logit": -7.936723232269287
        },
        {
            "text": "(ALS) is an adult-onset neurodegenerative disease caused",
            "probability": 0.00842466363834435,
            "start_logit": -3.3794283866882324,
            "end_logit": -8.114006042480469
        },
        {
            "text": "Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative",
            "probability": 0.00682168076685602,
            "start_logit": -4.88731050491333,
            "end_logit": -6.817181587219238
        },
        {
            "text": "lateral sclerosis (ALS)",
            "probability": 0.005079610360624166,
            "start_logit": -8.085840225219727,
            "end_logit": -3.9135231971740723
        },
        {
            "text": "Amyotrophic",
            "probability": 0.004602895991736224,
            "start_logit": -4.88731050491333,
            "end_logit": -7.210601806640625
        },
        {
            "text": "Amyotrophic lateral sclerosis",
            "probability": 0.004237950713203995,
            "start_logit": -4.88731050491333,
            "end_logit": -7.29320764541626
        },
        {
            "text": "Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease caused by selective",
            "probability": 0.004161392977788287,
            "start_logit": -4.88731050491333,
            "end_logit": -7.311437606811523
        },
        {
            "text": "Amyot",
            "probability": 0.0033419894984496453,
            "start_logit": -4.88731050491333,
            "end_logit": -7.530721187591553
        },
        {
            "text": "Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease caused by",
            "probability": 0.002996472925004396,
            "start_logit": -4.88731050491333,
            "end_logit": -7.6398515701293945
        },
        {
            "text": "Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease",
            "probability": 0.0028428956386315376,
            "start_logit": -4.88731050491333,
            "end_logit": -7.692464351654053
        },
        {
            "text": "Amyotrophic lateral sclerosis (ALS) is an adult-onset",
            "probability": 0.002226797029157236,
            "start_logit": -4.88731050491333,
            "end_logit": -7.936723232269287
        }
    ],
    "56c8274f5795f9a73e00000d_003": [
        {
            "text": "ALS",
            "probability": 0.5620812410729912,
            "start_logit": -3.3794283866882324,
            "end_logit": -3.9135231971740723
        },
        {
            "text": "(ALS)",
            "probability": 0.15100406526833146,
            "start_logit": -3.3794283866882324,
            "end_logit": -5.22786283493042
        },
        {
            "text": "Amyotrophic lateral sclerosis (ALS)",
            "probability": 0.12443260926262394,
            "start_logit": -4.88731050491333,
            "end_logit": -3.9135231971740723
        },
        {
            "text": "(ALS) is an adult-onset neurodegenerative",
            "probability": 0.03081458159850638,
            "start_logit": -3.3794283866882324,
            "end_logit": -6.817181587219238
        },
        {
            "text": "(ALS) is an adult-onset neurodegenerative disease caused by selective",
            "probability": 0.018797652346990146,
            "start_logit": -3.3794283866882324,
            "end_logit": -7.311437606811523
        },
        {
            "text": "(ALS) is an adult-onset neurodegenerative disease caused by selective loss of motor",
            "probability": 0.018399797174879055,
            "start_logit": -3.3794283866882324,
            "end_logit": -7.33282995223999
        },
        {
            "text": "(ALS) is an adult-onset neurodegenerative disease caused by",
            "probability": 0.013535529235534496,
            "start_logit": -3.3794283866882324,
            "end_logit": -7.6398515701293945
        },
        {
            "text": "(ALS) is an adult-onset neurodegenerative disease caused by selective loss of motor neurons.",
            "probability": 0.013297592703857653,
            "start_logit": -3.3794283866882324,
            "end_logit": -7.657586574554443
        },
        {
            "text": "(ALS) is an adult-onset neurodegenerative disease",
            "probability": 0.012841797003793799,
            "start_logit": -3.3794283866882324,
            "end_logit": -7.692464351654053
        },
        {
            "text": "(ALS) is an adult-onset",
            "probability": 0.010058784792695868,
            "start_logit": -3.3794283866882324,
            "end_logit": -7.936723232269287
        },
        {
            "text": "(ALS) is an adult-onset neurodegenerative disease caused",
            "probability": 0.00842466363834435,
            "start_logit": -3.3794283866882324,
            "end_logit": -8.114006042480469
        },
        {
            "text": "Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative",
            "probability": 0.00682168076685602,
            "start_logit": -4.88731050491333,
            "end_logit": -6.817181587219238
        },
        {
            "text": "lateral sclerosis (ALS)",
            "probability": 0.005079610360624166,
            "start_logit": -8.085840225219727,
            "end_logit": -3.9135231971740723
        },
        {
            "text": "Amyotrophic",
            "probability": 0.004602895991736224,
            "start_logit": -4.88731050491333,
            "end_logit": -7.210601806640625
        },
        {
            "text": "Amyotrophic lateral sclerosis",
            "probability": 0.004237950713203995,
            "start_logit": -4.88731050491333,
            "end_logit": -7.29320764541626
        },
        {
            "text": "Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease caused by selective",
            "probability": 0.004161392977788287,
            "start_logit": -4.88731050491333,
            "end_logit": -7.311437606811523
        },
        {
            "text": "Amyot",
            "probability": 0.0033419894984496453,
            "start_logit": -4.88731050491333,
            "end_logit": -7.530721187591553
        },
        {
            "text": "Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease caused by",
            "probability": 0.002996472925004396,
            "start_logit": -4.88731050491333,
            "end_logit": -7.6398515701293945
        },
        {
            "text": "Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease",
            "probability": 0.0028428956386315376,
            "start_logit": -4.88731050491333,
            "end_logit": -7.692464351654053
        },
        {
            "text": "Amyotrophic lateral sclerosis (ALS) is an adult-onset",
            "probability": 0.002226797029157236,
            "start_logit": -4.88731050491333,
            "end_logit": -7.936723232269287
        }
    ],
    "56c8274f5795f9a73e00000d_004": [
        {
            "text": "familial type of ALS (FALS).",
            "probability": 0.4834234082843136,
            "start_logit": -3.664952516555786,
            "end_logit": -5.733941078186035
        },
        {
            "text": "familial",
            "probability": 0.3274300664094393,
            "start_logit": -3.664952516555786,
            "end_logit": -6.123559474945068
        },
        {
            "text": "the familial type of ALS (FALS).",
            "probability": 0.05614909445357752,
            "start_logit": -5.817834854125977,
            "end_logit": -5.733941078186035
        },
        {
            "text": "the familial",
            "probability": 0.03803064024353603,
            "start_logit": -5.817834854125977,
            "end_logit": -6.123559474945068
        },
        {
            "text": "familial type of ALS",
            "probability": 0.03565623447487155,
            "start_logit": -3.664952516555786,
            "end_logit": -8.340909957885742
        },
        {
            "text": "(FALS).",
            "probability": 0.017406955765974272,
            "start_logit": -6.988975524902344,
            "end_logit": -5.733941078186035
        },
        {
            "text": "of ALS (FALS).",
            "probability": 0.012512263772918556,
            "start_logit": -7.319136142730713,
            "end_logit": -5.733941078186035
        },
        {
            "text": "type of ALS (FALS).",
            "probability": 0.008748198087593901,
            "start_logit": -7.676997661590576,
            "end_logit": -5.733941078186035
        },
        {
            "text": "closely mimics the familial type of ALS (FALS).",
            "probability": 0.007348432272462955,
            "start_logit": -7.851358413696289,
            "end_logit": -5.733941078186035
        },
        {
            "text": "closely mimics the familial",
            "probability": 0.004977205542274289,
            "start_logit": -7.851358413696289,
            "end_logit": -6.123559474945068
        },
        {
            "text": "the familial type of ALS",
            "probability": 0.004141432216726675,
            "start_logit": -5.817834854125977,
            "end_logit": -8.340909957885742
        },
        {
            "text": "of ALS",
            "probability": 0.0009228767230821363,
            "start_logit": -7.319136142730713,
            "end_logit": -8.340909957885742
        },
        {
            "text": "FALS",
            "probability": 0.0008448041600820072,
            "start_logit": -6.988975524902344,
            "end_logit": -8.759461402893066
        },
        {
            "text": "type of ALS",
            "probability": 0.0006452476170959811,
            "start_logit": -7.676997661590576,
            "end_logit": -8.340909957885742
        },
        {
            "text": "closely mimics the familial type of ALS",
            "probability": 0.0005420040065075896,
            "start_logit": -7.851358413696289,
            "end_logit": -8.340909957885742
        },
        {
            "text": ".",
            "probability": 0.00040420482548367807,
            "start_logit": -7.918823719024658,
            "end_logit": -8.56679630279541
        },
        {
            "text": "(ALS)",
            "probability": 0.0004012693150389606,
            "start_logit": -7.638716220855713,
            "end_logit": -8.854192733764648
        },
        {
            "text": "ALS patients.",
            "probability": 0.00014101650598705485,
            "start_logit": -8.154081344604492,
            "end_logit": -9.384583473205566
        },
        {
            "text": "ALS patients. The in vitro FALS model that we developed mimics the in vivo human ALS disease",
            "probability": 0.00013735029430780591,
            "start_logit": -8.154081344604492,
            "end_logit": -9.41092586517334
        },
        {
            "text": "ALS",
            "probability": 0.00013729502872631438,
            "start_logit": -8.154081344604492,
            "end_logit": -9.411328315734863
        }
    ],
    "56c8274f5795f9a73e00000d_005": [
        {
            "text": "serotonergic neurons in amyotrophic lateral sclerosis:",
            "probability": 0.13310994193376116,
            "start_logit": -7.637391090393066,
            "end_logit": -7.058682918548584
        },
        {
            "text": "serotonergic",
            "probability": 0.10241949808372654,
            "start_logit": -6.426895618438721,
            "end_logit": -8.53127670288086
        },
        {
            "text": "Degeneration of serotonergic neurons in amyotrophic lateral sclerosis:",
            "probability": 0.09692893634267669,
            "start_logit": -7.954588413238525,
            "end_logit": -7.058682918548584
        },
        {
            "text": "serotonergic neurons, might also represent a cause of spasticity.",
            "probability": 0.08297870575279057,
            "start_logit": -6.426895618438721,
            "end_logit": -8.741769790649414
        },
        {
            "text": "Spasticity",
            "probability": 0.0763834451652466,
            "start_logit": -7.082852840423584,
            "end_logit": -8.168630599975586
        },
        {
            "text": "a link to spasticity. Spasticity",
            "probability": 0.04915315328383795,
            "start_logit": -7.523677825927734,
            "end_logit": -8.168630599975586
        },
        {
            "text": "serotonergic neurons in amyotrophic lateral sclerosis: a link to spasticity. Spasticity",
            "probability": 0.0438698693213896,
            "start_logit": -7.637391090393066,
            "end_logit": -8.168630599975586
        },
        {
            "text": "link to spasticity. Spasticity",
            "probability": 0.04302656015544218,
            "start_logit": -7.656801223754883,
            "end_logit": -8.168630599975586
        },
        {
            "text": "spasticity. Spasticity",
            "probability": 0.04200815173588586,
            "start_logit": -7.680755138397217,
            "end_logit": -8.168630599975586
        },
        {
            "text": "affecting both upper and lower motor neurons. In amyotrophic lateral sclerosis, spasticity",
            "probability": 0.036041847899681866,
            "start_logit": -7.395552158355713,
            "end_logit": -8.607016563415527
        },
        {
            "text": "spasticity is traditionally thought to be the result of degeneration",
            "probability": 0.03556486995515277,
            "start_logit": -7.479247093200684,
            "end_logit": -8.536643981933594
        },
        {
            "text": "spasticity",
            "probability": 0.03314811227810144,
            "start_logit": -7.479247093200684,
            "end_logit": -8.607016563415527
        },
        {
            "text": "Degeneration of serotonergic neurons in amyotrophic lateral sclerosis: a link to spasticity. Spasticity",
            "probability": 0.03194547085694431,
            "start_logit": -7.954588413238525,
            "end_logit": -8.168630599975586
        },
        {
            "text": "neuronal",
            "probability": 0.031236718304777186,
            "start_logit": -7.715784549713135,
            "end_logit": -8.42987060546875
        },
        {
            "text": "Degeneration",
            "probability": 0.02899700115300501,
            "start_logit": -7.954588413238525,
            "end_logit": -8.26546859741211
        },
        {
            "text": "neuronal types, in particular serotonergic",
            "probability": 0.028224437316053202,
            "start_logit": -7.715784549713135,
            "end_logit": -8.53127670288086
        },
        {
            "text": "a link to spasticity.",
            "probability": 0.0274821393337081,
            "start_logit": -7.523677825927734,
            "end_logit": -8.750035285949707
        },
        {
            "text": "serotonergic neurons",
            "probability": 0.026544094962424297,
            "start_logit": -7.637391090393066,
            "end_logit": -8.671051025390625
        },
        {
            "text": "serotonergic neurons degenerate during amyotrophic lateral sclerosis,",
            "probability": 0.026408856604900634,
            "start_logit": -8.107645034790039,
            "end_logit": -8.205904960632324
        },
        {
            "text": "serotonergic neurons in amyotrophic lateral sclerosis: a link to spasticity.",
            "probability": 0.024528189560494,
            "start_logit": -7.637391090393066,
            "end_logit": -8.750035285949707
        }
    ],
    "5545e65bd355485447000001_001": [
        {
            "text": "Amyotrophic lateral sclerosis (ALS)",
            "probability": 0.9914155122144009,
            "start_logit": 8.046418190002441,
            "end_logit": 8.10583782196045
        },
        {
            "text": "(ALS)",
            "probability": 0.008491497049056496,
            "start_logit": 3.2863497734069824,
            "end_logit": 8.10583782196045
        },
        {
            "text": ")",
            "probability": 4.6712024004950896e-05,
            "start_logit": -1.9164692163467407,
            "end_logit": 8.10583782196045
        },
        {
            "text": "Amy",
            "probability": 3.3524710789583454e-05,
            "start_logit": 8.046418190002441,
            "end_logit": -2.1887683868408203
        },
        {
            "text": "sclerosis (ALS)",
            "probability": 3.777917916504349e-06,
            "start_logit": -4.431297779083252,
            "end_logit": 8.10583782196045
        },
        {
            "text": "lateral sclerosis (ALS)",
            "probability": 3.5746612707024793e-06,
            "start_logit": -4.486600399017334,
            "end_logit": 8.10583782196045
        },
        {
            "text": "ALS",
            "probability": 2.1677506400778867e-06,
            "start_logit": 2.8115973472595215,
            "end_logit": 0.3074597120285034
        },
        {
            "text": "Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease primarily affecting",
            "probability": 9.296123549220035e-07,
            "start_logit": 8.046418190002441,
            "end_logit": -5.774038791656494
        },
        {
            "text": "Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative",
            "probability": 4.466956755810589e-07,
            "start_logit": 8.046418190002441,
            "end_logit": -6.50692892074585
        },
        {
            "text": "Amyotrophic lateral sclerosis (ALS) is a devastating",
            "probability": 3.711215042081514e-07,
            "start_logit": 8.046418190002441,
            "end_logit": -6.692276954650879
        },
        {
            "text": "Amyotrophic",
            "probability": 3.530864420078523e-07,
            "start_logit": 8.046418190002441,
            "end_logit": -6.742093563079834
        },
        {
            "text": "Amyot",
            "probability": 3.213584339175821e-07,
            "start_logit": 8.046418190002441,
            "end_logit": -6.836249351501465
        },
        {
            "text": "Amyotrophic lateral",
            "probability": 2.7123399604468053e-07,
            "start_logit": 8.046418190002441,
            "end_logit": -7.005824565887451
        },
        {
            "text": "ALS.",
            "probability": 2.628601731608877e-07,
            "start_logit": 2.8115973472595215,
            "end_logit": -1.802363395690918
        },
        {
            "text": "Amyotrophic lateral sclerosis",
            "probability": 2.4197057296111473e-07,
            "start_logit": 8.046418190002441,
            "end_logit": -7.119990348815918
        },
        {
            "text": "DBR1",
            "probability": 2.054788006526415e-08,
            "start_logit": -0.26010653376579285,
            "end_logit": -1.2795239686965942
        },
        {
            "text": "(ALS) is a devastating neurodegenerative disease primarily affecting",
            "probability": 7.962151561412687e-09,
            "start_logit": 3.2863497734069824,
            "end_logit": -5.774038791656494
        },
        {
            "text": "(ALS) is a devastating neurodegenerative",
            "probability": 3.825958908541438e-09,
            "start_logit": 3.2863497734069824,
            "end_logit": -6.50692892074585
        },
        {
            "text": "(ALS) is a devastating",
            "probability": 3.1786643632255542e-09,
            "start_logit": 3.2863497734069824,
            "end_logit": -6.692276954650879
        },
        {
            "text": "with ALS.",
            "probability": 2.1811288426271961e-10,
            "start_logit": -6.392590522766113,
            "end_logit": 0.3074597120285034
        }
    ],
    "531464a6e3eabad021000014_001": [
        {
            "text": "XK",
            "probability": 0.9997973986605031,
            "start_logit": 7.9850850105285645,
            "end_logit": 7.014161586761475
        },
        {
            "text": "K",
            "probability": 0.0001053961397534203,
            "start_logit": -1.1724969148635864,
            "end_logit": 7.014161586761475
        },
        {
            "text": "X",
            "probability": 8.561813612708675e-05,
            "start_logit": 7.9850850105285645,
            "end_logit": -2.3512492179870605
        },
        {
            "text": "XK gene.",
            "probability": 6.841081398479577e-06,
            "start_logit": 7.9850850105285645,
            "end_logit": -4.878200531005859
        },
        {
            "text": "hemizygous mutation of XK",
            "probability": 9.79417364066379e-07,
            "start_logit": -5.851020336151123,
            "end_logit": 7.014161586761475
        },
        {
            "text": "showing a hemizygous mutation of XK",
            "probability": 7.733574209565628e-07,
            "start_logit": -6.0872368812561035,
            "end_logit": 7.014161586761475
        },
        {
            "text": "of XK",
            "probability": 6.160858495274092e-07,
            "start_logit": -6.314591884613037,
            "end_logit": 7.014161586761475
        },
        {
            "text": "genetic testing showing a hemizygous mutation of XK",
            "probability": 5.266009224189883e-07,
            "start_logit": -6.4715352058410645,
            "end_logit": 7.014161586761475
        },
        {
            "text": "testing showing a hemizygous mutation of XK",
            "probability": 4.895450170370095e-07,
            "start_logit": -6.544501781463623,
            "end_logit": 7.014161586761475
        },
        {
            "text": "The diagnosis of MLS was confirmed by genetic testing showing a hemizygous mutation of XK",
            "probability": 3.6464928105116165e-07,
            "start_logit": -6.8390421867370605,
            "end_logit": 7.014161586761475
        },
        {
            "text": "a hemizygous mutation of XK",
            "probability": 3.4947022180404203e-07,
            "start_logit": -6.8815598487854,
            "end_logit": 7.014161586761475
        },
        {
            "text": "mutation of XK",
            "probability": 3.3738555043501207e-07,
            "start_logit": -6.916751861572266,
            "end_logit": 7.014161586761475
        },
        {
            "text": "confirmed by genetic testing showing a hemizygous mutation of XK",
            "probability": 3.0944254239188673e-07,
            "start_logit": -7.0032057762146,
            "end_logit": 7.014161586761475
        },
        {
            "text": "hemizygous mutation of XK gene.",
            "probability": 6.701631670215605e-12,
            "start_logit": -5.851020336151123,
            "end_logit": -4.878200531005859
        },
        {
            "text": "showing a hemizygous mutation of XK gene.",
            "probability": 5.291673166953886e-12,
            "start_logit": -6.0872368812561035,
            "end_logit": -4.878200531005859
        },
        {
            "text": "of XK gene.",
            "probability": 4.215547520642841e-12,
            "start_logit": -6.314591884613037,
            "end_logit": -4.878200531005859
        },
        {
            "text": "genetic testing showing a hemizygous mutation of XK gene.",
            "probability": 3.6032497980183474e-12,
            "start_logit": -6.4715352058410645,
            "end_logit": -4.878200531005859
        },
        {
            "text": "testing showing a hemizygous mutation of XK gene.",
            "probability": 3.349695962659195e-12,
            "start_logit": -6.544501781463623,
            "end_logit": -4.878200531005859
        },
        {
            "text": "The diagnosis of MLS was confirmed by genetic testing showing a hemizygous mutation of XK gene.",
            "probability": 2.495100924357508e-12,
            "start_logit": -6.8390421867370605,
            "end_logit": -4.878200531005859
        },
        {
            "text": "a hemizygous mutation of XK gene.",
            "probability": 2.3912387018702193e-12,
            "start_logit": -6.8815598487854,
            "end_logit": -4.878200531005859
        }
    ],
    "531464a6e3eabad021000014_002": [
        {
            "text": "XK",
            "probability": 0.5124593673779116,
            "start_logit": 8.206976890563965,
            "end_logit": 6.9768805503845215
        },
        {
            "text": "XK, the gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK",
            "probability": 0.48738963628821,
            "start_logit": 8.206976890563965,
            "end_logit": 6.926723003387451
        },
        {
            "text": "X",
            "probability": 0.00010850183612068007,
            "start_logit": 8.229438781738281,
            "end_logit": -1.5057909488677979
        },
        {
            "text": "K",
            "probability": 3.417649079229714e-05,
            "start_logit": -1.4084618091583252,
            "end_logit": 6.9768805503845215
        },
        {
            "text": "the gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK",
            "probability": 3.9104686666985435e-06,
            "start_logit": -3.5261850357055664,
            "end_logit": 6.926723003387451
        },
        {
            "text": "XK,",
            "probability": 1.990148560750763e-06,
            "start_logit": 8.206976890563965,
            "end_logit": -5.481886863708496
        },
        {
            "text": "XK, the gene",
            "probability": 4.3924439425711093e-07,
            "start_logit": 8.206976890563965,
            "end_logit": -6.992795467376709
        },
        {
            "text": "XK, the",
            "probability": 3.833142159693599e-07,
            "start_logit": 8.206976890563965,
            "end_logit": -7.1289963722229
        },
        {
            "text": "VPS13A and XK,",
            "probability": 2.012464508370349e-07,
            "start_logit": -6.543224811553955,
            "end_logit": 6.9768805503845215
        },
        {
            "text": "XK in 86 schizophrenia",
            "probability": 1.990167476740472e-07,
            "start_logit": 8.229438781738281,
            "end_logit": -7.806924343109131
        },
        {
            "text": "XK, the gene responsible",
            "probability": 1.9136032264667733e-07,
            "start_logit": 8.206976890563965,
            "end_logit": -7.82369327545166
        },
        {
            "text": "XK, the gene responsible for",
            "probability": 1.33552819935569e-07,
            "start_logit": 8.206976890563965,
            "end_logit": -8.183354377746582
        },
        {
            "text": "gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK",
            "probability": 1.3243069090028002e-07,
            "start_logit": -6.911538124084473,
            "end_logit": 6.926723003387451
        },
        {
            "text": "and XK,",
            "probability": 1.2309471328824134e-07,
            "start_logit": -7.034801006317139,
            "end_logit": 6.9768805503845215
        },
        {
            "text": "mutation screen of VPS13A and XK,",
            "probability": 1.1810101313194984e-07,
            "start_logit": -7.076214790344238,
            "end_logit": 6.9768805503845215
        },
        {
            "text": "and XK, the gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK",
            "probability": 1.1707286734855259e-07,
            "start_logit": -7.034801006317139,
            "end_logit": 6.926723003387451
        },
        {
            "text": "and XK",
            "probability": 1.123804634353654e-07,
            "start_logit": -7.07570743560791,
            "end_logit": 6.926723003387451
        },
        {
            "text": "XK, the gene responsible for ChAc and MLS,",
            "probability": 1.0687832925224365e-07,
            "start_logit": 8.206976890563965,
            "end_logit": -8.406160354614258
        },
        {
            "text": "responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK",
            "probability": 9.917271536966095e-08,
            "start_logit": -7.200734615325928,
            "end_logit": 6.926723003387451
        },
        {
            "text": "of VPS13A and XK,",
            "probability": 6.052399381080317e-08,
            "start_logit": -7.744715213775635,
            "end_logit": 6.9768805503845215
        }
    ],
    "531464a6e3eabad021000014_003": [
        {
            "text": "XK",
            "probability": 0.5124593673779116,
            "start_logit": 8.206976890563965,
            "end_logit": 6.9768805503845215
        },
        {
            "text": "XK, the gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK",
            "probability": 0.48738963628821,
            "start_logit": 8.206976890563965,
            "end_logit": 6.926723003387451
        },
        {
            "text": "X",
            "probability": 0.00010850183612068007,
            "start_logit": 8.229438781738281,
            "end_logit": -1.5057909488677979
        },
        {
            "text": "K",
            "probability": 3.417649079229714e-05,
            "start_logit": -1.4084618091583252,
            "end_logit": 6.9768805503845215
        },
        {
            "text": "the gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK",
            "probability": 3.9104686666985435e-06,
            "start_logit": -3.5261850357055664,
            "end_logit": 6.926723003387451
        },
        {
            "text": "XK,",
            "probability": 1.990148560750763e-06,
            "start_logit": 8.206976890563965,
            "end_logit": -5.481886863708496
        },
        {
            "text": "XK, the gene",
            "probability": 4.3924439425711093e-07,
            "start_logit": 8.206976890563965,
            "end_logit": -6.992795467376709
        },
        {
            "text": "XK, the",
            "probability": 3.833142159693599e-07,
            "start_logit": 8.206976890563965,
            "end_logit": -7.1289963722229
        },
        {
            "text": "VPS13A and XK,",
            "probability": 2.012464508370349e-07,
            "start_logit": -6.543224811553955,
            "end_logit": 6.9768805503845215
        },
        {
            "text": "XK in 86 schizophrenia",
            "probability": 1.990167476740472e-07,
            "start_logit": 8.229438781738281,
            "end_logit": -7.806924343109131
        },
        {
            "text": "XK, the gene responsible",
            "probability": 1.9136032264667733e-07,
            "start_logit": 8.206976890563965,
            "end_logit": -7.82369327545166
        },
        {
            "text": "XK, the gene responsible for",
            "probability": 1.33552819935569e-07,
            "start_logit": 8.206976890563965,
            "end_logit": -8.183354377746582
        },
        {
            "text": "gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK",
            "probability": 1.3243069090028002e-07,
            "start_logit": -6.911538124084473,
            "end_logit": 6.926723003387451
        },
        {
            "text": "and XK,",
            "probability": 1.2309471328824134e-07,
            "start_logit": -7.034801006317139,
            "end_logit": 6.9768805503845215
        },
        {
            "text": "mutation screen of VPS13A and XK,",
            "probability": 1.1810101313194984e-07,
            "start_logit": -7.076214790344238,
            "end_logit": 6.9768805503845215
        },
        {
            "text": "and XK, the gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK",
            "probability": 1.1707286734855259e-07,
            "start_logit": -7.034801006317139,
            "end_logit": 6.926723003387451
        },
        {
            "text": "and XK",
            "probability": 1.123804634353654e-07,
            "start_logit": -7.07570743560791,
            "end_logit": 6.926723003387451
        },
        {
            "text": "XK, the gene responsible for ChAc and MLS,",
            "probability": 1.0687832925224365e-07,
            "start_logit": 8.206976890563965,
            "end_logit": -8.406160354614258
        },
        {
            "text": "responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK",
            "probability": 9.917271536966095e-08,
            "start_logit": -7.200734615325928,
            "end_logit": 6.926723003387451
        },
        {
            "text": "of VPS13A and XK,",
            "probability": 6.052399381080317e-08,
            "start_logit": -7.744715213775635,
            "end_logit": 6.9768805503845215
        }
    ],
    "531464a6e3eabad021000014_004": [
        {
            "text": "XK",
            "probability": 0.9996855462272185,
            "start_logit": 7.7040252685546875,
            "end_logit": 6.655485153198242
        },
        {
            "text": "X",
            "probability": 0.0001363536974348344,
            "start_logit": 7.7040252685546875,
            "end_logit": -2.2444586753845215
        },
        {
            "text": "K",
            "probability": 9.426751410464516e-05,
            "start_logit": -1.5650341510772705,
            "end_logit": 6.655485153198242
        },
        {
            "text": "because the XK",
            "probability": 4.403654652593747e-05,
            "start_logit": -2.142125129699707,
            "end_logit": 6.47145938873291
        },
        {
            "text": "the XK",
            "probability": 2.6838172429439297e-05,
            "start_logit": -2.637319803237915,
            "end_logit": 6.47145938873291
        },
        {
            "text": "XK gene is X-linked,",
            "probability": 8.050850813793758e-06,
            "start_logit": 7.5093817710876465,
            "end_logit": -4.879289627075195
        },
        {
            "text": "XK mutations.",
            "probability": 1.1294667332331103e-06,
            "start_logit": 7.7040252685546875,
            "end_logit": -7.037965297698975
        },
        {
            "text": "results from inherited XK",
            "probability": 8.89459990625717e-07,
            "start_logit": -6.228311538696289,
            "end_logit": 6.655485153198242
        },
        {
            "text": "the McLeod syndrome, which results from inherited XK",
            "probability": 7.078123456988901e-07,
            "start_logit": -6.456747055053711,
            "end_logit": 6.655485153198242
        },
        {
            "text": "inherited XK",
            "probability": 6.283294376435419e-07,
            "start_logit": -6.57586145401001,
            "end_logit": 6.655485153198242
        },
        {
            "text": "XK gene",
            "probability": 5.392676826430213e-07,
            "start_logit": 7.5093817710876465,
            "end_logit": -7.582610607147217
        },
        {
            "text": "which results from inherited XK",
            "probability": 5.236265950771412e-07,
            "start_logit": -6.758147239685059,
            "end_logit": 6.655485153198242
        },
        {
            "text": "resembling the McLeod syndrome, which results from inherited XK",
            "probability": 2.7049432525359155e-07,
            "start_logit": -7.418674945831299,
            "end_logit": 6.655485153198242
        },
        {
            "text": "phenotype resembling the McLeod syndrome, which results from inherited XK",
            "probability": 2.1754820570090588e-07,
            "start_logit": -7.636505603790283,
            "end_logit": 6.655485153198242
        },
        {
            "text": "because the XK gene is X-linked,",
            "probability": 5.178996171410824e-10,
            "start_logit": -2.142125129699707,
            "end_logit": -4.879289627075195
        },
        {
            "text": "the XK gene is X-linked,",
            "probability": 3.156350877284664e-10,
            "start_logit": -2.637319803237915,
            "end_logit": -4.879289627075195
        },
        {
            "text": "because",
            "probability": 6.93015009887055e-11,
            "start_logit": -2.142125129699707,
            "end_logit": -6.890604496002197
        },
        {
            "text": "because the XK gene",
            "probability": 3.469031197285009e-11,
            "start_logit": -2.142125129699707,
            "end_logit": -7.582610607147217
        },
        {
            "text": "because the",
            "probability": 2.48515709580825e-11,
            "start_logit": -2.142125129699707,
            "end_logit": -7.916150093078613
        },
        {
            "text": "X-linked,",
            "probability": 2.3778948119099585e-11,
            "start_logit": -5.2231059074401855,
            "end_logit": -4.879289627075195
        }
    ],
    "531464a6e3eabad021000014_005": [
        {
            "text": "XK",
            "probability": 0.9996855462272185,
            "start_logit": 7.7040252685546875,
            "end_logit": 6.655485153198242
        },
        {
            "text": "X",
            "probability": 0.0001363536974348344,
            "start_logit": 7.7040252685546875,
            "end_logit": -2.2444586753845215
        },
        {
            "text": "K",
            "probability": 9.426751410464516e-05,
            "start_logit": -1.5650341510772705,
            "end_logit": 6.655485153198242
        },
        {
            "text": "because the XK",
            "probability": 4.403654652593747e-05,
            "start_logit": -2.142125129699707,
            "end_logit": 6.47145938873291
        },
        {
            "text": "the XK",
            "probability": 2.6838172429439297e-05,
            "start_logit": -2.637319803237915,
            "end_logit": 6.47145938873291
        },
        {
            "text": "XK gene is X-linked,",
            "probability": 8.050850813793758e-06,
            "start_logit": 7.5093817710876465,
            "end_logit": -4.879289627075195
        },
        {
            "text": "XK mutations.",
            "probability": 1.1294667332331103e-06,
            "start_logit": 7.7040252685546875,
            "end_logit": -7.037965297698975
        },
        {
            "text": "results from inherited XK",
            "probability": 8.89459990625717e-07,
            "start_logit": -6.228311538696289,
            "end_logit": 6.655485153198242
        },
        {
            "text": "the McLeod syndrome, which results from inherited XK",
            "probability": 7.078123456988901e-07,
            "start_logit": -6.456747055053711,
            "end_logit": 6.655485153198242
        },
        {
            "text": "inherited XK",
            "probability": 6.283294376435419e-07,
            "start_logit": -6.57586145401001,
            "end_logit": 6.655485153198242
        },
        {
            "text": "XK gene",
            "probability": 5.392676826430213e-07,
            "start_logit": 7.5093817710876465,
            "end_logit": -7.582610607147217
        },
        {
            "text": "which results from inherited XK",
            "probability": 5.236265950771412e-07,
            "start_logit": -6.758147239685059,
            "end_logit": 6.655485153198242
        },
        {
            "text": "resembling the McLeod syndrome, which results from inherited XK",
            "probability": 2.7049432525359155e-07,
            "start_logit": -7.418674945831299,
            "end_logit": 6.655485153198242
        },
        {
            "text": "phenotype resembling the McLeod syndrome, which results from inherited XK",
            "probability": 2.1754820570090588e-07,
            "start_logit": -7.636505603790283,
            "end_logit": 6.655485153198242
        },
        {
            "text": "because the XK gene is X-linked,",
            "probability": 5.178996171410824e-10,
            "start_logit": -2.142125129699707,
            "end_logit": -4.879289627075195
        },
        {
            "text": "the XK gene is X-linked,",
            "probability": 3.156350877284664e-10,
            "start_logit": -2.637319803237915,
            "end_logit": -4.879289627075195
        },
        {
            "text": "because",
            "probability": 6.93015009887055e-11,
            "start_logit": -2.142125129699707,
            "end_logit": -6.890604496002197
        },
        {
            "text": "because the XK gene",
            "probability": 3.469031197285009e-11,
            "start_logit": -2.142125129699707,
            "end_logit": -7.582610607147217
        },
        {
            "text": "because the",
            "probability": 2.48515709580825e-11,
            "start_logit": -2.142125129699707,
            "end_logit": -7.916150093078613
        },
        {
            "text": "X-linked,",
            "probability": 2.3778948119099585e-11,
            "start_logit": -5.2231059074401855,
            "end_logit": -4.879289627075195
        }
    ],
    "531464a6e3eabad021000014_006": [
        {
            "text": "XK",
            "probability": 0.5101032119883928,
            "start_logit": 3.309901714324951,
            "end_logit": 2.284836530685425
        },
        {
            "text": "XK RNA and lack of XK",
            "probability": 0.4877811885517418,
            "start_logit": 3.3149499893188477,
            "end_logit": 2.235042095184326
        },
        {
            "text": "X",
            "probability": 0.0010496725584874015,
            "start_logit": 3.3149499893188477,
            "end_logit": -3.906346559524536
        },
        {
            "text": "K",
            "probability": 0.0008255737208407998,
            "start_logit": -3.094137668609619,
            "end_logit": 2.2625861167907715
        },
        {
            "text": "RESULTS: A novel XK",
            "probability": 9.150191033881665e-05,
            "start_logit": -5.316106796264648,
            "end_logit": 2.284836530685425
        },
        {
            "text": "CONCLUSION: The detailed characterization at the molecular biology level of this novel XK",
            "probability": 8.637782433464444e-05,
            "start_logit": -5.3157172203063965,
            "end_logit": 2.226818084716797
        },
        {
            "text": "XK splice site mutation in a patient with McLeod syndrome.",
            "probability": 3.324316931899411e-05,
            "start_logit": 2.7275514602661133,
            "end_logit": -6.771332263946533
        },
        {
            "text": "XK splice site mutation associated with the clinical description of the patient contributes to a better understanding of the phenotype-genotype",
            "probability": 1.422160874459777e-05,
            "start_logit": 3.310502529144287,
            "end_logit": -8.203370094299316
        },
        {
            "text": "XK splice site",
            "probability": 1.3545321853259535e-05,
            "start_logit": 3.309901714324951,
            "end_logit": -8.251490592956543
        },
        {
            "text": "XK protein at the RBC membrane. CONCLUSION: The detailed characterization at the molecular biology level of this novel XK",
            "probability": 1.3652636069153392e-06,
            "start_logit": -3.1803910732269287,
            "end_logit": -4.055891513824463
        },
        {
            "text": "XK gene whose product is expressed at the red blood cell (RBC) surface but whose function is currently unknown. A variety of XK",
            "probability": 5.278339874333287e-08,
            "start_logit": -3.9676222801208496,
            "end_logit": -6.521566390991211
        },
        {
            "text": "AND",
            "probability": 3.262469318858087e-08,
            "start_logit": -2.399749755859375,
            "end_logit": -8.570566177368164
        },
        {
            "text": "the McLeod syndrome.",
            "probability": 7.379649008283167e-09,
            "start_logit": -7.166943073272705,
            "end_logit": -5.2897162437438965
        },
        {
            "text": "RESULTS: A novel XK splice site",
            "probability": 2.4297491107653925e-09,
            "start_logit": -5.316106796264648,
            "end_logit": -8.251490592956543
        },
        {
            "text": "CONCLUSION: The detailed characterization at the molecular biology level of this novel XK splice site",
            "probability": 2.315308759937968e-09,
            "start_logit": -5.3157172203063965,
            "end_logit": -8.300125122070312
        },
        {
            "text": "STUDY DESIGN AND",
            "probability": 3.177331764153345e-10,
            "start_logit": -7.031362533569336,
            "end_logit": -8.570566177368164
        },
        {
            "text": "DESIGN AND",
            "probability": 2.318080342820254e-10,
            "start_logit": -7.346664905548096,
            "end_logit": -8.570566177368164
        }
    ],
    "531464a6e3eabad021000014_007": [
        {
            "text": "XK",
            "probability": 0.5101032119883928,
            "start_logit": 3.309901714324951,
            "end_logit": 2.284836530685425
        },
        {
            "text": "XK RNA and lack of XK",
            "probability": 0.4877811885517418,
            "start_logit": 3.3149499893188477,
            "end_logit": 2.235042095184326
        },
        {
            "text": "X",
            "probability": 0.0010496725584874015,
            "start_logit": 3.3149499893188477,
            "end_logit": -3.906346559524536
        },
        {
            "text": "K",
            "probability": 0.0008255737208407998,
            "start_logit": -3.094137668609619,
            "end_logit": 2.2625861167907715
        },
        {
            "text": "RESULTS: A novel XK",
            "probability": 9.150191033881665e-05,
            "start_logit": -5.316106796264648,
            "end_logit": 2.284836530685425
        },
        {
            "text": "CONCLUSION: The detailed characterization at the molecular biology level of this novel XK",
            "probability": 8.637782433464444e-05,
            "start_logit": -5.3157172203063965,
            "end_logit": 2.226818084716797
        },
        {
            "text": "XK splice site mutation in a patient with McLeod syndrome.",
            "probability": 3.324316931899411e-05,
            "start_logit": 2.7275514602661133,
            "end_logit": -6.771332263946533
        },
        {
            "text": "XK splice site mutation associated with the clinical description of the patient contributes to a better understanding of the phenotype-genotype",
            "probability": 1.422160874459777e-05,
            "start_logit": 3.310502529144287,
            "end_logit": -8.203370094299316
        },
        {
            "text": "XK splice site",
            "probability": 1.3545321853259535e-05,
            "start_logit": 3.309901714324951,
            "end_logit": -8.251490592956543
        },
        {
            "text": "XK protein at the RBC membrane. CONCLUSION: The detailed characterization at the molecular biology level of this novel XK",
            "probability": 1.3652636069153392e-06,
            "start_logit": -3.1803910732269287,
            "end_logit": -4.055891513824463
        },
        {
            "text": "XK gene whose product is expressed at the red blood cell (RBC) surface but whose function is currently unknown. A variety of XK",
            "probability": 5.278339874333287e-08,
            "start_logit": -3.9676222801208496,
            "end_logit": -6.521566390991211
        },
        {
            "text": "AND",
            "probability": 3.262469318858087e-08,
            "start_logit": -2.399749755859375,
            "end_logit": -8.570566177368164
        },
        {
            "text": "the McLeod syndrome.",
            "probability": 7.379649008283167e-09,
            "start_logit": -7.166943073272705,
            "end_logit": -5.2897162437438965
        },
        {
            "text": "RESULTS: A novel XK splice site",
            "probability": 2.4297491107653925e-09,
            "start_logit": -5.316106796264648,
            "end_logit": -8.251490592956543
        },
        {
            "text": "CONCLUSION: The detailed characterization at the molecular biology level of this novel XK splice site",
            "probability": 2.315308759937968e-09,
            "start_logit": -5.3157172203063965,
            "end_logit": -8.300125122070312
        },
        {
            "text": "STUDY DESIGN AND",
            "probability": 3.177331764153345e-10,
            "start_logit": -7.031362533569336,
            "end_logit": -8.570566177368164
        },
        {
            "text": "DESIGN AND",
            "probability": 2.318080342820254e-10,
            "start_logit": -7.346664905548096,
            "end_logit": -8.570566177368164
        }
    ],
    "531464a6e3eabad021000014_008": [
        {
            "text": "XK",
            "probability": 0.5101032119883928,
            "start_logit": 3.309901714324951,
            "end_logit": 2.284836530685425
        },
        {
            "text": "XK RNA and lack of XK",
            "probability": 0.4877811885517418,
            "start_logit": 3.3149499893188477,
            "end_logit": 2.235042095184326
        },
        {
            "text": "X",
            "probability": 0.0010496725584874015,
            "start_logit": 3.3149499893188477,
            "end_logit": -3.906346559524536
        },
        {
            "text": "K",
            "probability": 0.0008255737208407998,
            "start_logit": -3.094137668609619,
            "end_logit": 2.2625861167907715
        },
        {
            "text": "RESULTS: A novel XK",
            "probability": 9.150191033881665e-05,
            "start_logit": -5.316106796264648,
            "end_logit": 2.284836530685425
        },
        {
            "text": "CONCLUSION: The detailed characterization at the molecular biology level of this novel XK",
            "probability": 8.637782433464444e-05,
            "start_logit": -5.3157172203063965,
            "end_logit": 2.226818084716797
        },
        {
            "text": "XK splice site mutation in a patient with McLeod syndrome.",
            "probability": 3.324316931899411e-05,
            "start_logit": 2.7275514602661133,
            "end_logit": -6.771332263946533
        },
        {
            "text": "XK splice site mutation associated with the clinical description of the patient contributes to a better understanding of the phenotype-genotype",
            "probability": 1.422160874459777e-05,
            "start_logit": 3.310502529144287,
            "end_logit": -8.203370094299316
        },
        {
            "text": "XK splice site",
            "probability": 1.3545321853259535e-05,
            "start_logit": 3.309901714324951,
            "end_logit": -8.251490592956543
        },
        {
            "text": "XK protein at the RBC membrane. CONCLUSION: The detailed characterization at the molecular biology level of this novel XK",
            "probability": 1.3652636069153392e-06,
            "start_logit": -3.1803910732269287,
            "end_logit": -4.055891513824463
        },
        {
            "text": "XK gene whose product is expressed at the red blood cell (RBC) surface but whose function is currently unknown. A variety of XK",
            "probability": 5.278339874333287e-08,
            "start_logit": -3.9676222801208496,
            "end_logit": -6.521566390991211
        },
        {
            "text": "AND",
            "probability": 3.262469318858087e-08,
            "start_logit": -2.399749755859375,
            "end_logit": -8.570566177368164
        },
        {
            "text": "the McLeod syndrome.",
            "probability": 7.379649008283167e-09,
            "start_logit": -7.166943073272705,
            "end_logit": -5.2897162437438965
        },
        {
            "text": "RESULTS: A novel XK splice site",
            "probability": 2.4297491107653925e-09,
            "start_logit": -5.316106796264648,
            "end_logit": -8.251490592956543
        },
        {
            "text": "CONCLUSION: The detailed characterization at the molecular biology level of this novel XK splice site",
            "probability": 2.315308759937968e-09,
            "start_logit": -5.3157172203063965,
            "end_logit": -8.300125122070312
        },
        {
            "text": "STUDY DESIGN AND",
            "probability": 3.177331764153345e-10,
            "start_logit": -7.031362533569336,
            "end_logit": -8.570566177368164
        },
        {
            "text": "DESIGN AND",
            "probability": 2.318080342820254e-10,
            "start_logit": -7.346664905548096,
            "end_logit": -8.570566177368164
        }
    ],
    "531464a6e3eabad021000014_009": [
        {
            "text": "XK",
            "probability": 0.5101032119883928,
            "start_logit": 3.309901714324951,
            "end_logit": 2.284836530685425
        },
        {
            "text": "XK RNA and lack of XK",
            "probability": 0.4877811885517418,
            "start_logit": 3.3149499893188477,
            "end_logit": 2.235042095184326
        },
        {
            "text": "X",
            "probability": 0.0010496725584874015,
            "start_logit": 3.3149499893188477,
            "end_logit": -3.906346559524536
        },
        {
            "text": "K",
            "probability": 0.0008255737208407998,
            "start_logit": -3.094137668609619,
            "end_logit": 2.2625861167907715
        },
        {
            "text": "RESULTS: A novel XK",
            "probability": 9.150191033881665e-05,
            "start_logit": -5.316106796264648,
            "end_logit": 2.284836530685425
        },
        {
            "text": "CONCLUSION: The detailed characterization at the molecular biology level of this novel XK",
            "probability": 8.637782433464444e-05,
            "start_logit": -5.3157172203063965,
            "end_logit": 2.226818084716797
        },
        {
            "text": "XK splice site mutation in a patient with McLeod syndrome.",
            "probability": 3.324316931899411e-05,
            "start_logit": 2.7275514602661133,
            "end_logit": -6.771332263946533
        },
        {
            "text": "XK splice site mutation associated with the clinical description of the patient contributes to a better understanding of the phenotype-genotype",
            "probability": 1.422160874459777e-05,
            "start_logit": 3.310502529144287,
            "end_logit": -8.203370094299316
        },
        {
            "text": "XK splice site",
            "probability": 1.3545321853259535e-05,
            "start_logit": 3.309901714324951,
            "end_logit": -8.251490592956543
        },
        {
            "text": "XK protein at the RBC membrane. CONCLUSION: The detailed characterization at the molecular biology level of this novel XK",
            "probability": 1.3652636069153392e-06,
            "start_logit": -3.1803910732269287,
            "end_logit": -4.055891513824463
        },
        {
            "text": "XK gene whose product is expressed at the red blood cell (RBC) surface but whose function is currently unknown. A variety of XK",
            "probability": 5.278339874333287e-08,
            "start_logit": -3.9676222801208496,
            "end_logit": -6.521566390991211
        },
        {
            "text": "AND",
            "probability": 3.262469318858087e-08,
            "start_logit": -2.399749755859375,
            "end_logit": -8.570566177368164
        },
        {
            "text": "the McLeod syndrome.",
            "probability": 7.379649008283167e-09,
            "start_logit": -7.166943073272705,
            "end_logit": -5.2897162437438965
        },
        {
            "text": "RESULTS: A novel XK splice site",
            "probability": 2.4297491107653925e-09,
            "start_logit": -5.316106796264648,
            "end_logit": -8.251490592956543
        },
        {
            "text": "CONCLUSION: The detailed characterization at the molecular biology level of this novel XK splice site",
            "probability": 2.315308759937968e-09,
            "start_logit": -5.3157172203063965,
            "end_logit": -8.300125122070312
        },
        {
            "text": "STUDY DESIGN AND",
            "probability": 3.177331764153345e-10,
            "start_logit": -7.031362533569336,
            "end_logit": -8.570566177368164
        },
        {
            "text": "DESIGN AND",
            "probability": 2.318080342820254e-10,
            "start_logit": -7.346664905548096,
            "end_logit": -8.570566177368164
        }
    ],
    "531464a6e3eabad021000014_010": [
        {
            "text": "XK",
            "probability": 0.5101032119883928,
            "start_logit": 3.309901714324951,
            "end_logit": 2.284836530685425
        },
        {
            "text": "XK RNA and lack of XK",
            "probability": 0.4877811885517418,
            "start_logit": 3.3149499893188477,
            "end_logit": 2.235042095184326
        },
        {
            "text": "X",
            "probability": 0.0010496725584874015,
            "start_logit": 3.3149499893188477,
            "end_logit": -3.906346559524536
        },
        {
            "text": "K",
            "probability": 0.0008255737208407998,
            "start_logit": -3.094137668609619,
            "end_logit": 2.2625861167907715
        },
        {
            "text": "RESULTS: A novel XK",
            "probability": 9.150191033881665e-05,
            "start_logit": -5.316106796264648,
            "end_logit": 2.284836530685425
        },
        {
            "text": "CONCLUSION: The detailed characterization at the molecular biology level of this novel XK",
            "probability": 8.637782433464444e-05,
            "start_logit": -5.3157172203063965,
            "end_logit": 2.226818084716797
        },
        {
            "text": "XK splice site mutation in a patient with McLeod syndrome.",
            "probability": 3.324316931899411e-05,
            "start_logit": 2.7275514602661133,
            "end_logit": -6.771332263946533
        },
        {
            "text": "XK splice site mutation associated with the clinical description of the patient contributes to a better understanding of the phenotype-genotype",
            "probability": 1.422160874459777e-05,
            "start_logit": 3.310502529144287,
            "end_logit": -8.203370094299316
        },
        {
            "text": "XK splice site",
            "probability": 1.3545321853259535e-05,
            "start_logit": 3.309901714324951,
            "end_logit": -8.251490592956543
        },
        {
            "text": "XK protein at the RBC membrane. CONCLUSION: The detailed characterization at the molecular biology level of this novel XK",
            "probability": 1.3652636069153392e-06,
            "start_logit": -3.1803910732269287,
            "end_logit": -4.055891513824463
        },
        {
            "text": "XK gene whose product is expressed at the red blood cell (RBC) surface but whose function is currently unknown. A variety of XK",
            "probability": 5.278339874333287e-08,
            "start_logit": -3.9676222801208496,
            "end_logit": -6.521566390991211
        },
        {
            "text": "AND",
            "probability": 3.262469318858087e-08,
            "start_logit": -2.399749755859375,
            "end_logit": -8.570566177368164
        },
        {
            "text": "the McLeod syndrome.",
            "probability": 7.379649008283167e-09,
            "start_logit": -7.166943073272705,
            "end_logit": -5.2897162437438965
        },
        {
            "text": "RESULTS: A novel XK splice site",
            "probability": 2.4297491107653925e-09,
            "start_logit": -5.316106796264648,
            "end_logit": -8.251490592956543
        },
        {
            "text": "CONCLUSION: The detailed characterization at the molecular biology level of this novel XK splice site",
            "probability": 2.315308759937968e-09,
            "start_logit": -5.3157172203063965,
            "end_logit": -8.300125122070312
        },
        {
            "text": "STUDY DESIGN AND",
            "probability": 3.177331764153345e-10,
            "start_logit": -7.031362533569336,
            "end_logit": -8.570566177368164
        },
        {
            "text": "DESIGN AND",
            "probability": 2.318080342820254e-10,
            "start_logit": -7.346664905548096,
            "end_logit": -8.570566177368164
        }
    ],
    "531464a6e3eabad021000014_011": [
        {
            "text": "XK",
            "probability": 0.5101032119883928,
            "start_logit": 3.309901714324951,
            "end_logit": 2.284836530685425
        },
        {
            "text": "XK RNA and lack of XK",
            "probability": 0.4877811885517418,
            "start_logit": 3.3149499893188477,
            "end_logit": 2.235042095184326
        },
        {
            "text": "X",
            "probability": 0.0010496725584874015,
            "start_logit": 3.3149499893188477,
            "end_logit": -3.906346559524536
        },
        {
            "text": "K",
            "probability": 0.0008255737208407998,
            "start_logit": -3.094137668609619,
            "end_logit": 2.2625861167907715
        },
        {
            "text": "RESULTS: A novel XK",
            "probability": 9.150191033881665e-05,
            "start_logit": -5.316106796264648,
            "end_logit": 2.284836530685425
        },
        {
            "text": "CONCLUSION: The detailed characterization at the molecular biology level of this novel XK",
            "probability": 8.637782433464444e-05,
            "start_logit": -5.3157172203063965,
            "end_logit": 2.226818084716797
        },
        {
            "text": "XK splice site mutation in a patient with McLeod syndrome.",
            "probability": 3.324316931899411e-05,
            "start_logit": 2.7275514602661133,
            "end_logit": -6.771332263946533
        },
        {
            "text": "XK splice site mutation associated with the clinical description of the patient contributes to a better understanding of the phenotype-genotype",
            "probability": 1.422160874459777e-05,
            "start_logit": 3.310502529144287,
            "end_logit": -8.203370094299316
        },
        {
            "text": "XK splice site",
            "probability": 1.3545321853259535e-05,
            "start_logit": 3.309901714324951,
            "end_logit": -8.251490592956543
        },
        {
            "text": "XK protein at the RBC membrane. CONCLUSION: The detailed characterization at the molecular biology level of this novel XK",
            "probability": 1.3652636069153392e-06,
            "start_logit": -3.1803910732269287,
            "end_logit": -4.055891513824463
        },
        {
            "text": "XK gene whose product is expressed at the red blood cell (RBC) surface but whose function is currently unknown. A variety of XK",
            "probability": 5.278339874333287e-08,
            "start_logit": -3.9676222801208496,
            "end_logit": -6.521566390991211
        },
        {
            "text": "AND",
            "probability": 3.262469318858087e-08,
            "start_logit": -2.399749755859375,
            "end_logit": -8.570566177368164
        },
        {
            "text": "the McLeod syndrome.",
            "probability": 7.379649008283167e-09,
            "start_logit": -7.166943073272705,
            "end_logit": -5.2897162437438965
        },
        {
            "text": "RESULTS: A novel XK splice site",
            "probability": 2.4297491107653925e-09,
            "start_logit": -5.316106796264648,
            "end_logit": -8.251490592956543
        },
        {
            "text": "CONCLUSION: The detailed characterization at the molecular biology level of this novel XK splice site",
            "probability": 2.315308759937968e-09,
            "start_logit": -5.3157172203063965,
            "end_logit": -8.300125122070312
        },
        {
            "text": "STUDY DESIGN AND",
            "probability": 3.177331764153345e-10,
            "start_logit": -7.031362533569336,
            "end_logit": -8.570566177368164
        },
        {
            "text": "DESIGN AND",
            "probability": 2.318080342820254e-10,
            "start_logit": -7.346664905548096,
            "end_logit": -8.570566177368164
        }
    ],
    "531464a6e3eabad021000014_012": [
        {
            "text": "XK",
            "probability": 0.5101032119883928,
            "start_logit": 3.309901714324951,
            "end_logit": 2.284836530685425
        },
        {
            "text": "XK RNA and lack of XK",
            "probability": 0.4877811885517418,
            "start_logit": 3.3149499893188477,
            "end_logit": 2.235042095184326
        },
        {
            "text": "X",
            "probability": 0.0010496725584874015,
            "start_logit": 3.3149499893188477,
            "end_logit": -3.906346559524536
        },
        {
            "text": "K",
            "probability": 0.0008255737208407998,
            "start_logit": -3.094137668609619,
            "end_logit": 2.2625861167907715
        },
        {
            "text": "RESULTS: A novel XK",
            "probability": 9.150191033881665e-05,
            "start_logit": -5.316106796264648,
            "end_logit": 2.284836530685425
        },
        {
            "text": "CONCLUSION: The detailed characterization at the molecular biology level of this novel XK",
            "probability": 8.637782433464444e-05,
            "start_logit": -5.3157172203063965,
            "end_logit": 2.226818084716797
        },
        {
            "text": "XK splice site mutation in a patient with McLeod syndrome.",
            "probability": 3.324316931899411e-05,
            "start_logit": 2.7275514602661133,
            "end_logit": -6.771332263946533
        },
        {
            "text": "XK splice site mutation associated with the clinical description of the patient contributes to a better understanding of the phenotype-genotype",
            "probability": 1.422160874459777e-05,
            "start_logit": 3.310502529144287,
            "end_logit": -8.203370094299316
        },
        {
            "text": "XK splice site",
            "probability": 1.3545321853259535e-05,
            "start_logit": 3.309901714324951,
            "end_logit": -8.251490592956543
        },
        {
            "text": "XK protein at the RBC membrane. CONCLUSION: The detailed characterization at the molecular biology level of this novel XK",
            "probability": 1.3652636069153392e-06,
            "start_logit": -3.1803910732269287,
            "end_logit": -4.055891513824463
        },
        {
            "text": "XK gene whose product is expressed at the red blood cell (RBC) surface but whose function is currently unknown. A variety of XK",
            "probability": 5.278339874333287e-08,
            "start_logit": -3.9676222801208496,
            "end_logit": -6.521566390991211
        },
        {
            "text": "AND",
            "probability": 3.262469318858087e-08,
            "start_logit": -2.399749755859375,
            "end_logit": -8.570566177368164
        },
        {
            "text": "the McLeod syndrome.",
            "probability": 7.379649008283167e-09,
            "start_logit": -7.166943073272705,
            "end_logit": -5.2897162437438965
        },
        {
            "text": "RESULTS: A novel XK splice site",
            "probability": 2.4297491107653925e-09,
            "start_logit": -5.316106796264648,
            "end_logit": -8.251490592956543
        },
        {
            "text": "CONCLUSION: The detailed characterization at the molecular biology level of this novel XK splice site",
            "probability": 2.315308759937968e-09,
            "start_logit": -5.3157172203063965,
            "end_logit": -8.300125122070312
        },
        {
            "text": "STUDY DESIGN AND",
            "probability": 3.177331764153345e-10,
            "start_logit": -7.031362533569336,
            "end_logit": -8.570566177368164
        },
        {
            "text": "DESIGN AND",
            "probability": 2.318080342820254e-10,
            "start_logit": -7.346664905548096,
            "end_logit": -8.570566177368164
        }
    ],
    "531464a6e3eabad021000014_013": [
        {
            "text": "XK",
            "probability": 0.5101032119883928,
            "start_logit": 3.309901714324951,
            "end_logit": 2.284836530685425
        },
        {
            "text": "XK RNA and lack of XK",
            "probability": 0.4877811885517418,
            "start_logit": 3.3149499893188477,
            "end_logit": 2.235042095184326
        },
        {
            "text": "X",
            "probability": 0.0010496725584874015,
            "start_logit": 3.3149499893188477,
            "end_logit": -3.906346559524536
        },
        {
            "text": "K",
            "probability": 0.0008255737208407998,
            "start_logit": -3.094137668609619,
            "end_logit": 2.2625861167907715
        },
        {
            "text": "RESULTS: A novel XK",
            "probability": 9.150191033881665e-05,
            "start_logit": -5.316106796264648,
            "end_logit": 2.284836530685425
        },
        {
            "text": "CONCLUSION: The detailed characterization at the molecular biology level of this novel XK",
            "probability": 8.637782433464444e-05,
            "start_logit": -5.3157172203063965,
            "end_logit": 2.226818084716797
        },
        {
            "text": "XK splice site mutation in a patient with McLeod syndrome.",
            "probability": 3.324316931899411e-05,
            "start_logit": 2.7275514602661133,
            "end_logit": -6.771332263946533
        },
        {
            "text": "XK splice site mutation associated with the clinical description of the patient contributes to a better understanding of the phenotype-genotype",
            "probability": 1.422160874459777e-05,
            "start_logit": 3.310502529144287,
            "end_logit": -8.203370094299316
        },
        {
            "text": "XK splice site",
            "probability": 1.3545321853259535e-05,
            "start_logit": 3.309901714324951,
            "end_logit": -8.251490592956543
        },
        {
            "text": "XK protein at the RBC membrane. CONCLUSION: The detailed characterization at the molecular biology level of this novel XK",
            "probability": 1.3652636069153392e-06,
            "start_logit": -3.1803910732269287,
            "end_logit": -4.055891513824463
        },
        {
            "text": "XK gene whose product is expressed at the red blood cell (RBC) surface but whose function is currently unknown. A variety of XK",
            "probability": 5.278339874333287e-08,
            "start_logit": -3.9676222801208496,
            "end_logit": -6.521566390991211
        },
        {
            "text": "AND",
            "probability": 3.262469318858087e-08,
            "start_logit": -2.399749755859375,
            "end_logit": -8.570566177368164
        },
        {
            "text": "the McLeod syndrome.",
            "probability": 7.379649008283167e-09,
            "start_logit": -7.166943073272705,
            "end_logit": -5.2897162437438965
        },
        {
            "text": "RESULTS: A novel XK splice site",
            "probability": 2.4297491107653925e-09,
            "start_logit": -5.316106796264648,
            "end_logit": -8.251490592956543
        },
        {
            "text": "CONCLUSION: The detailed characterization at the molecular biology level of this novel XK splice site",
            "probability": 2.315308759937968e-09,
            "start_logit": -5.3157172203063965,
            "end_logit": -8.300125122070312
        },
        {
            "text": "STUDY DESIGN AND",
            "probability": 3.177331764153345e-10,
            "start_logit": -7.031362533569336,
            "end_logit": -8.570566177368164
        },
        {
            "text": "DESIGN AND",
            "probability": 2.318080342820254e-10,
            "start_logit": -7.346664905548096,
            "end_logit": -8.570566177368164
        }
    ],
    "531464a6e3eabad021000014_014": [
        {
            "text": "XK",
            "probability": 0.9997775989261585,
            "start_logit": 8.270500183105469,
            "end_logit": 7.3426008224487305
        },
        {
            "text": "X",
            "probability": 9.010024325120491e-05,
            "start_logit": 8.270500183105469,
            "end_logit": -1.9717644453048706
        },
        {
            "text": "K",
            "probability": 8.029075750422961e-05,
            "start_logit": -1.1591334342956543,
            "end_logit": 7.3426008224487305
        },
        {
            "text": "R133X mutation of the XK",
            "probability": 4.3307765062567786e-05,
            "start_logit": -1.7764559984207153,
            "end_logit": 7.3426008224487305
        },
        {
            "text": "XK gene,",
            "probability": 3.3012815131996925e-06,
            "start_logit": 8.270500183105469,
            "end_logit": -5.278376579284668
        },
        {
            "text": "the XK",
            "probability": 1.6056029621538526e-06,
            "start_logit": -5.071288585662842,
            "end_logit": 7.3426008224487305
        },
        {
            "text": "revealed a R133X mutation of the XK",
            "probability": 8.951965408504454e-07,
            "start_logit": -5.6554999351501465,
            "end_logit": 7.3426008224487305
        },
        {
            "text": "a R133X mutation of the XK",
            "probability": 8.454315039616148e-07,
            "start_logit": -5.712696075439453,
            "end_logit": 7.3426008224487305
        },
        {
            "text": "Genetic test revealed a R133X mutation of the XK",
            "probability": 4.967831902696927e-07,
            "start_logit": -6.244389533996582,
            "end_logit": 7.3426008224487305
        },
        {
            "text": "of the XK",
            "probability": 4.805473532504398e-07,
            "start_logit": -6.277617454528809,
            "end_logit": 7.3426008224487305
        },
        {
            "text": "test revealed a R133X mutation of the XK",
            "probability": 4.281632201339707e-07,
            "start_logit": -6.393038749694824,
            "end_logit": 7.3426008224487305
        },
        {
            "text": "mutation of the XK",
            "probability": 3.5777361457024136e-07,
            "start_logit": -6.572642803192139,
            "end_logit": 7.3426008224487305
        },
        {
            "text": "XK gene, confirming",
            "probability": 2.907895360952797e-07,
            "start_logit": 8.270500183105469,
            "end_logit": -7.707842826843262
        },
        {
            "text": "R133X",
            "probability": 4.918839897039464e-10,
            "start_logit": -1.7764559984207153,
            "end_logit": -4.042998790740967
        },
        {
            "text": "R133X mutation of the XK gene,",
            "probability": 1.430029281838411e-10,
            "start_logit": -1.7764559984207153,
            "end_logit": -5.278376579284668
        },
        {
            "text": "R133X mutation",
            "probability": 6.033664178926109e-11,
            "start_logit": -1.7764559984207153,
            "end_logit": -6.141302108764648
        },
        {
            "text": "R133X mutation of the XK gene, confirming",
            "probability": 1.259624633057774e-11,
            "start_logit": -1.7764559984207153,
            "end_logit": -7.707842826843262
        },
        {
            "text": "133X",
            "probability": 1.099930171411168e-11,
            "start_logit": -5.57686710357666,
            "end_logit": -4.042998790740967
        },
        {
            "text": "revealed a R133X",
            "probability": 1.016752643426714e-11,
            "start_logit": -5.6554999351501465,
            "end_logit": -4.042998790740967
        },
        {
            "text": "a R133X",
            "probability": 9.602301587007599e-12,
            "start_logit": -5.712696075439453,
            "end_logit": -4.042998790740967
        }
    ],
    "531464a6e3eabad021000014_015": [
        {
            "text": "XK",
            "probability": 0.9995728398606465,
            "start_logit": 6.09314489364624,
            "end_logit": 5.05212926864624
        },
        {
            "text": "X",
            "probability": 0.00021086382432628458,
            "start_logit": 6.09314489364624,
            "end_logit": -3.4117414951324463
        },
        {
            "text": "K",
            "probability": 0.00018721494728089378,
            "start_logit": -2.4896810054779053,
            "end_logit": 5.05212926864624
        },
        {
            "text": "the XK",
            "probability": 2.5212575183548667e-05,
            "start_logit": -4.494595527648926,
            "end_logit": 5.05212926864624
        },
        {
            "text": "XK gene",
            "probability": 1.6312378674733004e-06,
            "start_logit": 6.09314489364624,
            "end_logit": -8.273614883422852
        },
        {
            "text": "Molecular genetic analysis revealed a small deletion in the XK",
            "probability": 1.1710699044708952e-06,
            "start_logit": -7.56402063369751,
            "end_logit": 5.05212926864624
        },
        {
            "text": "revealed a small deletion in the XK",
            "probability": 1.066213321590891e-06,
            "start_logit": -7.657824993133545,
            "end_logit": 5.05212926864624
        },
        {
            "text": "Huntington's",
            "probability": 5.4093764984170115e-11,
            "start_logit": -5.664140224456787,
            "end_logit": -6.830460548400879
        },
        {
            "text": "Huntington's disease",
            "probability": 4.232155649681097e-11,
            "start_logit": -5.664140224456787,
            "end_logit": -7.075882911682129
        },
        {
            "text": "the XK gene",
            "probability": 4.1145283000742516e-11,
            "start_logit": -4.494595527648926,
            "end_logit": -8.273614883422852
        },
        {
            "text": "The X-linked",
            "probability": 2.3287159161312943e-11,
            "start_logit": -6.557458877563477,
            "end_logit": -6.779958724975586
        },
        {
            "text": "The X-linked McLeod neuroacanthocytosis syndrome strongly resembles Huntington's",
            "probability": 2.2140317688983974e-11,
            "start_logit": -6.557458877563477,
            "end_logit": -6.830460548400879
        },
        {
            "text": "The X-linked McLeod neuroacanthocytosis syndrome strongly resembles Huntington's disease",
            "probability": 1.732200940729276e-11,
            "start_logit": -6.557458877563477,
            "end_logit": -7.075882911682129
        },
        {
            "text": "strongly resembles Huntington's",
            "probability": 1.2991346198985513e-11,
            "start_logit": -7.090575695037842,
            "end_logit": -6.830460548400879
        },
        {
            "text": "strongly resembles Huntington's disease",
            "probability": 1.0164091781943674e-11,
            "start_logit": -7.090575695037842,
            "end_logit": -7.075882911682129
        },
        {
            "text": "Huntington's disease and has been reported",
            "probability": 9.818781952685365e-12,
            "start_logit": -5.664140224456787,
            "end_logit": -8.536882400512695
        },
        {
            "text": "Huntington's disease and",
            "probability": 9.694122255236141e-12,
            "start_logit": -5.664140224456787,
            "end_logit": -8.549659729003906
        },
        {
            "text": "Huntington",
            "probability": 9.522627230026468e-12,
            "start_logit": -5.664140224456787,
            "end_logit": -8.567508697509766
        },
        {
            "text": "The X-linked McLeod neuroacanthocytosis syndrome",
            "probability": 9.499977740544904e-12,
            "start_logit": -6.557458877563477,
            "end_logit": -7.676571369171143
        },
        {
            "text": "X-linked",
            "probability": 9.468248768809389e-12,
            "start_logit": -7.457417011260986,
            "end_logit": -6.779958724975586
        }
    ],
    "531464a6e3eabad021000014_016": [
        {
            "text": "XK",
            "probability": 0.549548921447284,
            "start_logit": 3.1162819862365723,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "XK mutations may have different effects upon the XK",
            "probability": 0.4472857296591205,
            "start_logit": 3.0413455963134766,
            "end_logit": 2.131147623062134
        },
        {
            "text": "K",
            "probability": 0.0009654785223745571,
            "start_logit": -3.227947235107422,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "X",
            "probability": 0.0009651408956005683,
            "start_logit": 3.1162819862365723,
            "end_logit": -4.082467555999756
        },
        {
            "text": "XK, neurologic and other clinical findings were minimal at ages expected to manifest MLS. CONCLUSIONS: The different XK",
            "probability": 0.0009359378682467282,
            "start_logit": 3.01876163482666,
            "end_logit": -4.015672206878662
        },
        {
            "text": "(XK)",
            "probability": 9.666811666490739e-05,
            "start_logit": -5.22788143157959,
            "end_logit": 1.9607053995132446
        },
        {
            "text": "the responsible gene (XK)",
            "probability": 3.665376177874624e-05,
            "start_logit": -6.197649002075195,
            "end_logit": 1.9607053995132446
        },
        {
            "text": "(R222G missense mutation) and the second case had a mutation in XK",
            "probability": 2.1408996658488143e-05,
            "start_logit": -7.036759853363037,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "effects upon the XK",
            "probability": 2.0752824438320554e-05,
            "start_logit": -6.936924934387207,
            "end_logit": 2.131147623062134
        },
        {
            "text": "XK mutations may have different effects upon the XK gene product and thus may account for the variable phenotype.",
            "probability": 1.7968917133353614e-05,
            "start_logit": 3.0413455963134766,
            "end_logit": -7.991161823272705
        },
        {
            "text": "XK gene product and thus may account for the variable phenotype.",
            "probability": 1.7735839084921992e-05,
            "start_logit": 3.028289556503296,
            "end_logit": -7.991161823272705
        },
        {
            "text": "XK mutations",
            "probability": 1.4790578719706087e-05,
            "start_logit": 3.0413455963134766,
            "end_logit": -8.18581485748291
        },
        {
            "text": "CONCLUSIONS: The different XK mutations may have different effects upon the XK",
            "probability": 1.4668883566028457e-05,
            "start_logit": -7.283878803253174,
            "end_logit": 2.131147623062134
        },
        {
            "text": "CONCLUSIONS: The different XK",
            "probability": 1.461385506209233e-05,
            "start_logit": -7.283878803253174,
            "end_logit": 2.1273891925811768
        },
        {
            "text": "mutations may have different effects upon the XK",
            "probability": 1.0705973553940123e-05,
            "start_logit": -7.5988054275512695,
            "end_logit": 2.131147623062134
        },
        {
            "text": "XK,",
            "probability": 1.0136018703509322e-05,
            "start_logit": 2.7385971546173096,
            "end_logit": -8.260961532592773
        },
        {
            "text": "and the second case had a mutation in XK",
            "probability": 9.753795499659444e-06,
            "start_logit": -7.8229146003723145,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "XK mutations may have different effects",
            "probability": 6.817133076613143e-06,
            "start_logit": 3.0413455963134766,
            "end_logit": -8.960366249084473
        },
        {
            "text": "XK, and different deletion mutations. To date no clear phenotype-genotype",
            "probability": 5.751376259233663e-06,
            "start_logit": 2.7385971546173096,
            "end_logit": -8.827617645263672
        },
        {
            "text": "(XK) including single nonsense and missense mutations, nucleotide mutations at or near the splice junctions of introns of XK,",
            "probability": 3.655371740290253e-07,
            "start_logit": -3.9383418560028076,
            "end_logit": -4.906505107879639
        }
    ],
    "531464a6e3eabad021000014_017": [
        {
            "text": "XK",
            "probability": 0.549548921447284,
            "start_logit": 3.1162819862365723,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "XK mutations may have different effects upon the XK",
            "probability": 0.4472857296591205,
            "start_logit": 3.0413455963134766,
            "end_logit": 2.131147623062134
        },
        {
            "text": "K",
            "probability": 0.0009654785223745571,
            "start_logit": -3.227947235107422,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "X",
            "probability": 0.0009651408956005683,
            "start_logit": 3.1162819862365723,
            "end_logit": -4.082467555999756
        },
        {
            "text": "XK, neurologic and other clinical findings were minimal at ages expected to manifest MLS. CONCLUSIONS: The different XK",
            "probability": 0.0009359378682467282,
            "start_logit": 3.01876163482666,
            "end_logit": -4.015672206878662
        },
        {
            "text": "(XK)",
            "probability": 9.666811666490739e-05,
            "start_logit": -5.22788143157959,
            "end_logit": 1.9607053995132446
        },
        {
            "text": "the responsible gene (XK)",
            "probability": 3.665376177874624e-05,
            "start_logit": -6.197649002075195,
            "end_logit": 1.9607053995132446
        },
        {
            "text": "(R222G missense mutation) and the second case had a mutation in XK",
            "probability": 2.1408996658488143e-05,
            "start_logit": -7.036759853363037,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "effects upon the XK",
            "probability": 2.0752824438320554e-05,
            "start_logit": -6.936924934387207,
            "end_logit": 2.131147623062134
        },
        {
            "text": "XK mutations may have different effects upon the XK gene product and thus may account for the variable phenotype.",
            "probability": 1.7968917133353614e-05,
            "start_logit": 3.0413455963134766,
            "end_logit": -7.991161823272705
        },
        {
            "text": "XK gene product and thus may account for the variable phenotype.",
            "probability": 1.7735839084921992e-05,
            "start_logit": 3.028289556503296,
            "end_logit": -7.991161823272705
        },
        {
            "text": "XK mutations",
            "probability": 1.4790578719706087e-05,
            "start_logit": 3.0413455963134766,
            "end_logit": -8.18581485748291
        },
        {
            "text": "CONCLUSIONS: The different XK mutations may have different effects upon the XK",
            "probability": 1.4668883566028457e-05,
            "start_logit": -7.283878803253174,
            "end_logit": 2.131147623062134
        },
        {
            "text": "CONCLUSIONS: The different XK",
            "probability": 1.461385506209233e-05,
            "start_logit": -7.283878803253174,
            "end_logit": 2.1273891925811768
        },
        {
            "text": "mutations may have different effects upon the XK",
            "probability": 1.0705973553940123e-05,
            "start_logit": -7.5988054275512695,
            "end_logit": 2.131147623062134
        },
        {
            "text": "XK,",
            "probability": 1.0136018703509322e-05,
            "start_logit": 2.7385971546173096,
            "end_logit": -8.260961532592773
        },
        {
            "text": "and the second case had a mutation in XK",
            "probability": 9.753795499659444e-06,
            "start_logit": -7.8229146003723145,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "XK mutations may have different effects",
            "probability": 6.817133076613143e-06,
            "start_logit": 3.0413455963134766,
            "end_logit": -8.960366249084473
        },
        {
            "text": "XK, and different deletion mutations. To date no clear phenotype-genotype",
            "probability": 5.751376259233663e-06,
            "start_logit": 2.7385971546173096,
            "end_logit": -8.827617645263672
        },
        {
            "text": "(XK) including single nonsense and missense mutations, nucleotide mutations at or near the splice junctions of introns of XK,",
            "probability": 3.655371740290253e-07,
            "start_logit": -3.9383418560028076,
            "end_logit": -4.906505107879639
        }
    ],
    "531464a6e3eabad021000014_018": [
        {
            "text": "XK",
            "probability": 0.549548921447284,
            "start_logit": 3.1162819862365723,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "XK mutations may have different effects upon the XK",
            "probability": 0.4472857296591205,
            "start_logit": 3.0413455963134766,
            "end_logit": 2.131147623062134
        },
        {
            "text": "K",
            "probability": 0.0009654785223745571,
            "start_logit": -3.227947235107422,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "X",
            "probability": 0.0009651408956005683,
            "start_logit": 3.1162819862365723,
            "end_logit": -4.082467555999756
        },
        {
            "text": "XK, neurologic and other clinical findings were minimal at ages expected to manifest MLS. CONCLUSIONS: The different XK",
            "probability": 0.0009359378682467282,
            "start_logit": 3.01876163482666,
            "end_logit": -4.015672206878662
        },
        {
            "text": "(XK)",
            "probability": 9.666811666490739e-05,
            "start_logit": -5.22788143157959,
            "end_logit": 1.9607053995132446
        },
        {
            "text": "the responsible gene (XK)",
            "probability": 3.665376177874624e-05,
            "start_logit": -6.197649002075195,
            "end_logit": 1.9607053995132446
        },
        {
            "text": "(R222G missense mutation) and the second case had a mutation in XK",
            "probability": 2.1408996658488143e-05,
            "start_logit": -7.036759853363037,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "effects upon the XK",
            "probability": 2.0752824438320554e-05,
            "start_logit": -6.936924934387207,
            "end_logit": 2.131147623062134
        },
        {
            "text": "XK mutations may have different effects upon the XK gene product and thus may account for the variable phenotype.",
            "probability": 1.7968917133353614e-05,
            "start_logit": 3.0413455963134766,
            "end_logit": -7.991161823272705
        },
        {
            "text": "XK gene product and thus may account for the variable phenotype.",
            "probability": 1.7735839084921992e-05,
            "start_logit": 3.028289556503296,
            "end_logit": -7.991161823272705
        },
        {
            "text": "XK mutations",
            "probability": 1.4790578719706087e-05,
            "start_logit": 3.0413455963134766,
            "end_logit": -8.18581485748291
        },
        {
            "text": "CONCLUSIONS: The different XK mutations may have different effects upon the XK",
            "probability": 1.4668883566028457e-05,
            "start_logit": -7.283878803253174,
            "end_logit": 2.131147623062134
        },
        {
            "text": "CONCLUSIONS: The different XK",
            "probability": 1.461385506209233e-05,
            "start_logit": -7.283878803253174,
            "end_logit": 2.1273891925811768
        },
        {
            "text": "mutations may have different effects upon the XK",
            "probability": 1.0705973553940123e-05,
            "start_logit": -7.5988054275512695,
            "end_logit": 2.131147623062134
        },
        {
            "text": "XK,",
            "probability": 1.0136018703509322e-05,
            "start_logit": 2.7385971546173096,
            "end_logit": -8.260961532592773
        },
        {
            "text": "and the second case had a mutation in XK",
            "probability": 9.753795499659444e-06,
            "start_logit": -7.8229146003723145,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "XK mutations may have different effects",
            "probability": 6.817133076613143e-06,
            "start_logit": 3.0413455963134766,
            "end_logit": -8.960366249084473
        },
        {
            "text": "XK, and different deletion mutations. To date no clear phenotype-genotype",
            "probability": 5.751376259233663e-06,
            "start_logit": 2.7385971546173096,
            "end_logit": -8.827617645263672
        },
        {
            "text": "(XK) including single nonsense and missense mutations, nucleotide mutations at or near the splice junctions of introns of XK,",
            "probability": 3.655371740290253e-07,
            "start_logit": -3.9383418560028076,
            "end_logit": -4.906505107879639
        }
    ],
    "531464a6e3eabad021000014_019": [
        {
            "text": "XK",
            "probability": 0.549548921447284,
            "start_logit": 3.1162819862365723,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "XK mutations may have different effects upon the XK",
            "probability": 0.4472857296591205,
            "start_logit": 3.0413455963134766,
            "end_logit": 2.131147623062134
        },
        {
            "text": "K",
            "probability": 0.0009654785223745571,
            "start_logit": -3.227947235107422,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "X",
            "probability": 0.0009651408956005683,
            "start_logit": 3.1162819862365723,
            "end_logit": -4.082467555999756
        },
        {
            "text": "XK, neurologic and other clinical findings were minimal at ages expected to manifest MLS. CONCLUSIONS: The different XK",
            "probability": 0.0009359378682467282,
            "start_logit": 3.01876163482666,
            "end_logit": -4.015672206878662
        },
        {
            "text": "(XK)",
            "probability": 9.666811666490739e-05,
            "start_logit": -5.22788143157959,
            "end_logit": 1.9607053995132446
        },
        {
            "text": "the responsible gene (XK)",
            "probability": 3.665376177874624e-05,
            "start_logit": -6.197649002075195,
            "end_logit": 1.9607053995132446
        },
        {
            "text": "(R222G missense mutation) and the second case had a mutation in XK",
            "probability": 2.1408996658488143e-05,
            "start_logit": -7.036759853363037,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "effects upon the XK",
            "probability": 2.0752824438320554e-05,
            "start_logit": -6.936924934387207,
            "end_logit": 2.131147623062134
        },
        {
            "text": "XK mutations may have different effects upon the XK gene product and thus may account for the variable phenotype.",
            "probability": 1.7968917133353614e-05,
            "start_logit": 3.0413455963134766,
            "end_logit": -7.991161823272705
        },
        {
            "text": "XK gene product and thus may account for the variable phenotype.",
            "probability": 1.7735839084921992e-05,
            "start_logit": 3.028289556503296,
            "end_logit": -7.991161823272705
        },
        {
            "text": "XK mutations",
            "probability": 1.4790578719706087e-05,
            "start_logit": 3.0413455963134766,
            "end_logit": -8.18581485748291
        },
        {
            "text": "CONCLUSIONS: The different XK mutations may have different effects upon the XK",
            "probability": 1.4668883566028457e-05,
            "start_logit": -7.283878803253174,
            "end_logit": 2.131147623062134
        },
        {
            "text": "CONCLUSIONS: The different XK",
            "probability": 1.461385506209233e-05,
            "start_logit": -7.283878803253174,
            "end_logit": 2.1273891925811768
        },
        {
            "text": "mutations may have different effects upon the XK",
            "probability": 1.0705973553940123e-05,
            "start_logit": -7.5988054275512695,
            "end_logit": 2.131147623062134
        },
        {
            "text": "XK,",
            "probability": 1.0136018703509322e-05,
            "start_logit": 2.7385971546173096,
            "end_logit": -8.260961532592773
        },
        {
            "text": "and the second case had a mutation in XK",
            "probability": 9.753795499659444e-06,
            "start_logit": -7.8229146003723145,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "XK mutations may have different effects",
            "probability": 6.817133076613143e-06,
            "start_logit": 3.0413455963134766,
            "end_logit": -8.960366249084473
        },
        {
            "text": "XK, and different deletion mutations. To date no clear phenotype-genotype",
            "probability": 5.751376259233663e-06,
            "start_logit": 2.7385971546173096,
            "end_logit": -8.827617645263672
        },
        {
            "text": "(XK) including single nonsense and missense mutations, nucleotide mutations at or near the splice junctions of introns of XK,",
            "probability": 3.655371740290253e-07,
            "start_logit": -3.9383418560028076,
            "end_logit": -4.906505107879639
        }
    ],
    "531464a6e3eabad021000014_020": [
        {
            "text": "XK",
            "probability": 0.549548921447284,
            "start_logit": 3.1162819862365723,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "XK mutations may have different effects upon the XK",
            "probability": 0.4472857296591205,
            "start_logit": 3.0413455963134766,
            "end_logit": 2.131147623062134
        },
        {
            "text": "K",
            "probability": 0.0009654785223745571,
            "start_logit": -3.227947235107422,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "X",
            "probability": 0.0009651408956005683,
            "start_logit": 3.1162819862365723,
            "end_logit": -4.082467555999756
        },
        {
            "text": "XK, neurologic and other clinical findings were minimal at ages expected to manifest MLS. CONCLUSIONS: The different XK",
            "probability": 0.0009359378682467282,
            "start_logit": 3.01876163482666,
            "end_logit": -4.015672206878662
        },
        {
            "text": "(XK)",
            "probability": 9.666811666490739e-05,
            "start_logit": -5.22788143157959,
            "end_logit": 1.9607053995132446
        },
        {
            "text": "the responsible gene (XK)",
            "probability": 3.665376177874624e-05,
            "start_logit": -6.197649002075195,
            "end_logit": 1.9607053995132446
        },
        {
            "text": "(R222G missense mutation) and the second case had a mutation in XK",
            "probability": 2.1408996658488143e-05,
            "start_logit": -7.036759853363037,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "effects upon the XK",
            "probability": 2.0752824438320554e-05,
            "start_logit": -6.936924934387207,
            "end_logit": 2.131147623062134
        },
        {
            "text": "XK mutations may have different effects upon the XK gene product and thus may account for the variable phenotype.",
            "probability": 1.7968917133353614e-05,
            "start_logit": 3.0413455963134766,
            "end_logit": -7.991161823272705
        },
        {
            "text": "XK gene product and thus may account for the variable phenotype.",
            "probability": 1.7735839084921992e-05,
            "start_logit": 3.028289556503296,
            "end_logit": -7.991161823272705
        },
        {
            "text": "XK mutations",
            "probability": 1.4790578719706087e-05,
            "start_logit": 3.0413455963134766,
            "end_logit": -8.18581485748291
        },
        {
            "text": "CONCLUSIONS: The different XK mutations may have different effects upon the XK",
            "probability": 1.4668883566028457e-05,
            "start_logit": -7.283878803253174,
            "end_logit": 2.131147623062134
        },
        {
            "text": "CONCLUSIONS: The different XK",
            "probability": 1.461385506209233e-05,
            "start_logit": -7.283878803253174,
            "end_logit": 2.1273891925811768
        },
        {
            "text": "mutations may have different effects upon the XK",
            "probability": 1.0705973553940123e-05,
            "start_logit": -7.5988054275512695,
            "end_logit": 2.131147623062134
        },
        {
            "text": "XK,",
            "probability": 1.0136018703509322e-05,
            "start_logit": 2.7385971546173096,
            "end_logit": -8.260961532592773
        },
        {
            "text": "and the second case had a mutation in XK",
            "probability": 9.753795499659444e-06,
            "start_logit": -7.8229146003723145,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "XK mutations may have different effects",
            "probability": 6.817133076613143e-06,
            "start_logit": 3.0413455963134766,
            "end_logit": -8.960366249084473
        },
        {
            "text": "XK, and different deletion mutations. To date no clear phenotype-genotype",
            "probability": 5.751376259233663e-06,
            "start_logit": 2.7385971546173096,
            "end_logit": -8.827617645263672
        },
        {
            "text": "(XK) including single nonsense and missense mutations, nucleotide mutations at or near the splice junctions of introns of XK,",
            "probability": 3.655371740290253e-07,
            "start_logit": -3.9383418560028076,
            "end_logit": -4.906505107879639
        }
    ],
    "531464a6e3eabad021000014_021": [
        {
            "text": "XK",
            "probability": 0.549548921447284,
            "start_logit": 3.1162819862365723,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "XK mutations may have different effects upon the XK",
            "probability": 0.4472857296591205,
            "start_logit": 3.0413455963134766,
            "end_logit": 2.131147623062134
        },
        {
            "text": "K",
            "probability": 0.0009654785223745571,
            "start_logit": -3.227947235107422,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "X",
            "probability": 0.0009651408956005683,
            "start_logit": 3.1162819862365723,
            "end_logit": -4.082467555999756
        },
        {
            "text": "XK, neurologic and other clinical findings were minimal at ages expected to manifest MLS. CONCLUSIONS: The different XK",
            "probability": 0.0009359378682467282,
            "start_logit": 3.01876163482666,
            "end_logit": -4.015672206878662
        },
        {
            "text": "(XK)",
            "probability": 9.666811666490739e-05,
            "start_logit": -5.22788143157959,
            "end_logit": 1.9607053995132446
        },
        {
            "text": "the responsible gene (XK)",
            "probability": 3.665376177874624e-05,
            "start_logit": -6.197649002075195,
            "end_logit": 1.9607053995132446
        },
        {
            "text": "(R222G missense mutation) and the second case had a mutation in XK",
            "probability": 2.1408996658488143e-05,
            "start_logit": -7.036759853363037,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "effects upon the XK",
            "probability": 2.0752824438320554e-05,
            "start_logit": -6.936924934387207,
            "end_logit": 2.131147623062134
        },
        {
            "text": "XK mutations may have different effects upon the XK gene product and thus may account for the variable phenotype.",
            "probability": 1.7968917133353614e-05,
            "start_logit": 3.0413455963134766,
            "end_logit": -7.991161823272705
        },
        {
            "text": "XK gene product and thus may account for the variable phenotype.",
            "probability": 1.7735839084921992e-05,
            "start_logit": 3.028289556503296,
            "end_logit": -7.991161823272705
        },
        {
            "text": "XK mutations",
            "probability": 1.4790578719706087e-05,
            "start_logit": 3.0413455963134766,
            "end_logit": -8.18581485748291
        },
        {
            "text": "CONCLUSIONS: The different XK mutations may have different effects upon the XK",
            "probability": 1.4668883566028457e-05,
            "start_logit": -7.283878803253174,
            "end_logit": 2.131147623062134
        },
        {
            "text": "CONCLUSIONS: The different XK",
            "probability": 1.461385506209233e-05,
            "start_logit": -7.283878803253174,
            "end_logit": 2.1273891925811768
        },
        {
            "text": "mutations may have different effects upon the XK",
            "probability": 1.0705973553940123e-05,
            "start_logit": -7.5988054275512695,
            "end_logit": 2.131147623062134
        },
        {
            "text": "XK,",
            "probability": 1.0136018703509322e-05,
            "start_logit": 2.7385971546173096,
            "end_logit": -8.260961532592773
        },
        {
            "text": "and the second case had a mutation in XK",
            "probability": 9.753795499659444e-06,
            "start_logit": -7.8229146003723145,
            "end_logit": 2.2621114253997803
        },
        {
            "text": "XK mutations may have different effects",
            "probability": 6.817133076613143e-06,
            "start_logit": 3.0413455963134766,
            "end_logit": -8.960366249084473
        },
        {
            "text": "XK, and different deletion mutations. To date no clear phenotype-genotype",
            "probability": 5.751376259233663e-06,
            "start_logit": 2.7385971546173096,
            "end_logit": -8.827617645263672
        },
        {
            "text": "(XK) including single nonsense and missense mutations, nucleotide mutations at or near the splice junctions of introns of XK,",
            "probability": 3.655371740290253e-07,
            "start_logit": -3.9383418560028076,
            "end_logit": -4.906505107879639
        }
    ],
    "531464a6e3eabad021000014_022": [
        {
            "text": "XK",
            "probability": 0.5434117614909058,
            "start_logit": 4.511144638061523,
            "end_logit": 3.4399871826171875
        },
        {
            "text": "XK gene defects that result in the absence of XK",
            "probability": 0.4557546982699328,
            "start_logit": 4.521910667419434,
            "end_logit": 3.2533085346221924
        },
        {
            "text": "X",
            "probability": 0.000514422564996146,
            "start_logit": 4.511144638061523,
            "end_logit": -3.522590398788452
        },
        {
            "text": "K",
            "probability": 0.00030977618185951085,
            "start_logit": -2.958627939224243,
            "end_logit": 3.4399871826171875
        },
        {
            "text": "XK alone,",
            "probability": 6.282949591497092e-06,
            "start_logit": 4.511144638061523,
            "end_logit": -7.927795886993408
        },
        {
            "text": "X-linked multi-system disorder caused by absence of XK",
            "probability": 2.5095919901952513e-06,
            "start_logit": -7.774357795715332,
            "end_logit": 3.4399871826171875
        },
        {
            "text": "XK locus with 7",
            "probability": 3.8132171722514926e-07,
            "start_logit": 2.6269278526306152,
            "end_logit": -8.84553050994873
        },
        {
            "text": "Case 1 has greater than 1.12 million base-pairs (mb) deletion around the XK",
            "probability": 1.6567137928904494e-07,
            "start_logit": -8.993673324584961,
            "end_logit": 1.9414334297180176
        },
        {
            "text": "XK defects derived from a large deletion at the XK",
            "probability": 1.7558738875625095e-09,
            "start_logit": -7.547473907470703,
            "end_logit": -4.05180549621582
        },
        {
            "text": "X-linked",
            "probability": 3.651136493428761e-11,
            "start_logit": -7.774357795715332,
            "end_logit": -7.698019981384277
        },
        {
            "text": "known as the McLeod syndrome (MLS). MLS is an X-linked",
            "probability": 3.1674133118675325e-11,
            "start_logit": -7.916481018066406,
            "end_logit": -7.698019981384277
        },
        {
            "text": "X-linked multi-system disorder caused by absence of XK alone,",
            "probability": 2.9016007909658587e-11,
            "start_logit": -7.774357795715332,
            "end_logit": -7.927795886993408
        },
        {
            "text": "20",
            "probability": 2.430682146655404e-11,
            "start_logit": -7.966714859008789,
            "end_logit": -7.912529468536377
        },
        {
            "text": ".",
            "probability": 2.34859157687667e-11,
            "start_logit": -7.924811363220215,
            "end_logit": -7.988789081573486
        },
        {
            "text": "XK and OTC are subject to selective constraint.",
            "probability": 1.540809586961537e-11,
            "start_logit": -8.346319198608398,
            "end_logit": -7.988789081573486
        },
        {
            "text": "20 genes. Phylogenetic analyses demonstrated that DMD, XK",
            "probability": 1.2800021040896381e-11,
            "start_logit": -7.966714859008789,
            "end_logit": -8.553839683532715
        },
        {
            "text": "affected. Case 2 has greater than 5.65 mb deletion from TCTE1L to DMD encompassing 20",
            "probability": 9.281673650578484e-12,
            "start_logit": -8.92943000793457,
            "end_logit": -7.912529468536377
        },
        {
            "text": "encompassing 20",
            "probability": 8.90058006553419e-12,
            "start_logit": -8.971355438232422,
            "end_logit": -7.912529468536377
        },
        {
            "text": "genes. Phylogenetic analyses demonstrated that DMD, XK",
            "probability": 5.681789839253992e-12,
            "start_logit": -8.778895378112793,
            "end_logit": -8.553839683532715
        },
        {
            "text": "encompassing 20 genes. Phylogenetic analyses demonstrated that DMD, XK",
            "probability": 4.687063352638841e-12,
            "start_logit": -8.971355438232422,
            "end_logit": -8.553839683532715
        }
    ],
    "531464a6e3eabad021000014_023": [
        {
            "text": "XK",
            "probability": 0.5434117614909058,
            "start_logit": 4.511144638061523,
            "end_logit": 3.4399871826171875
        },
        {
            "text": "XK gene defects that result in the absence of XK",
            "probability": 0.4557546982699328,
            "start_logit": 4.521910667419434,
            "end_logit": 3.2533085346221924
        },
        {
            "text": "X",
            "probability": 0.000514422564996146,
            "start_logit": 4.511144638061523,
            "end_logit": -3.522590398788452
        },
        {
            "text": "K",
            "probability": 0.00030977618185951085,
            "start_logit": -2.958627939224243,
            "end_logit": 3.4399871826171875
        },
        {
            "text": "XK alone,",
            "probability": 6.282949591497092e-06,
            "start_logit": 4.511144638061523,
            "end_logit": -7.927795886993408
        },
        {
            "text": "X-linked multi-system disorder caused by absence of XK",
            "probability": 2.5095919901952513e-06,
            "start_logit": -7.774357795715332,
            "end_logit": 3.4399871826171875
        },
        {
            "text": "XK locus with 7",
            "probability": 3.8132171722514926e-07,
            "start_logit": 2.6269278526306152,
            "end_logit": -8.84553050994873
        },
        {
            "text": "Case 1 has greater than 1.12 million base-pairs (mb) deletion around the XK",
            "probability": 1.6567137928904494e-07,
            "start_logit": -8.993673324584961,
            "end_logit": 1.9414334297180176
        },
        {
            "text": "XK defects derived from a large deletion at the XK",
            "probability": 1.7558738875625095e-09,
            "start_logit": -7.547473907470703,
            "end_logit": -4.05180549621582
        },
        {
            "text": "X-linked",
            "probability": 3.651136493428761e-11,
            "start_logit": -7.774357795715332,
            "end_logit": -7.698019981384277
        },
        {
            "text": "known as the McLeod syndrome (MLS). MLS is an X-linked",
            "probability": 3.1674133118675325e-11,
            "start_logit": -7.916481018066406,
            "end_logit": -7.698019981384277
        },
        {
            "text": "X-linked multi-system disorder caused by absence of XK alone,",
            "probability": 2.9016007909658587e-11,
            "start_logit": -7.774357795715332,
            "end_logit": -7.927795886993408
        },
        {
            "text": "20",
            "probability": 2.430682146655404e-11,
            "start_logit": -7.966714859008789,
            "end_logit": -7.912529468536377
        },
        {
            "text": ".",
            "probability": 2.34859157687667e-11,
            "start_logit": -7.924811363220215,
            "end_logit": -7.988789081573486
        },
        {
            "text": "XK and OTC are subject to selective constraint.",
            "probability": 1.540809586961537e-11,
            "start_logit": -8.346319198608398,
            "end_logit": -7.988789081573486
        },
        {
            "text": "20 genes. Phylogenetic analyses demonstrated that DMD, XK",
            "probability": 1.2800021040896381e-11,
            "start_logit": -7.966714859008789,
            "end_logit": -8.553839683532715
        },
        {
            "text": "affected. Case 2 has greater than 5.65 mb deletion from TCTE1L to DMD encompassing 20",
            "probability": 9.281673650578484e-12,
            "start_logit": -8.92943000793457,
            "end_logit": -7.912529468536377
        },
        {
            "text": "encompassing 20",
            "probability": 8.90058006553419e-12,
            "start_logit": -8.971355438232422,
            "end_logit": -7.912529468536377
        },
        {
            "text": "genes. Phylogenetic analyses demonstrated that DMD, XK",
            "probability": 5.681789839253992e-12,
            "start_logit": -8.778895378112793,
            "end_logit": -8.553839683532715
        },
        {
            "text": "encompassing 20 genes. Phylogenetic analyses demonstrated that DMD, XK",
            "probability": 4.687063352638841e-12,
            "start_logit": -8.971355438232422,
            "end_logit": -8.553839683532715
        }
    ],
    "531464a6e3eabad021000014_024": [
        {
            "text": "XK",
            "probability": 0.5434117614909058,
            "start_logit": 4.511144638061523,
            "end_logit": 3.4399871826171875
        },
        {
            "text": "XK gene defects that result in the absence of XK",
            "probability": 0.4557546982699328,
            "start_logit": 4.521910667419434,
            "end_logit": 3.2533085346221924
        },
        {
            "text": "X",
            "probability": 0.000514422564996146,
            "start_logit": 4.511144638061523,
            "end_logit": -3.522590398788452
        },
        {
            "text": "K",
            "probability": 0.00030977618185951085,
            "start_logit": -2.958627939224243,
            "end_logit": 3.4399871826171875
        },
        {
            "text": "XK alone,",
            "probability": 6.282949591497092e-06,
            "start_logit": 4.511144638061523,
            "end_logit": -7.927795886993408
        },
        {
            "text": "X-linked multi-system disorder caused by absence of XK",
            "probability": 2.5095919901952513e-06,
            "start_logit": -7.774357795715332,
            "end_logit": 3.4399871826171875
        },
        {
            "text": "XK locus with 7",
            "probability": 3.8132171722514926e-07,
            "start_logit": 2.6269278526306152,
            "end_logit": -8.84553050994873
        },
        {
            "text": "Case 1 has greater than 1.12 million base-pairs (mb) deletion around the XK",
            "probability": 1.6567137928904494e-07,
            "start_logit": -8.993673324584961,
            "end_logit": 1.9414334297180176
        },
        {
            "text": "XK defects derived from a large deletion at the XK",
            "probability": 1.7558738875625095e-09,
            "start_logit": -7.547473907470703,
            "end_logit": -4.05180549621582
        },
        {
            "text": "X-linked",
            "probability": 3.651136493428761e-11,
            "start_logit": -7.774357795715332,
            "end_logit": -7.698019981384277
        },
        {
            "text": "known as the McLeod syndrome (MLS). MLS is an X-linked",
            "probability": 3.1674133118675325e-11,
            "start_logit": -7.916481018066406,
            "end_logit": -7.698019981384277
        },
        {
            "text": "X-linked multi-system disorder caused by absence of XK alone,",
            "probability": 2.9016007909658587e-11,
            "start_logit": -7.774357795715332,
            "end_logit": -7.927795886993408
        },
        {
            "text": "20",
            "probability": 2.430682146655404e-11,
            "start_logit": -7.966714859008789,
            "end_logit": -7.912529468536377
        },
        {
            "text": ".",
            "probability": 2.34859157687667e-11,
            "start_logit": -7.924811363220215,
            "end_logit": -7.988789081573486
        },
        {
            "text": "XK and OTC are subject to selective constraint.",
            "probability": 1.540809586961537e-11,
            "start_logit": -8.346319198608398,
            "end_logit": -7.988789081573486
        },
        {
            "text": "20 genes. Phylogenetic analyses demonstrated that DMD, XK",
            "probability": 1.2800021040896381e-11,
            "start_logit": -7.966714859008789,
            "end_logit": -8.553839683532715
        },
        {
            "text": "affected. Case 2 has greater than 5.65 mb deletion from TCTE1L to DMD encompassing 20",
            "probability": 9.281673650578484e-12,
            "start_logit": -8.92943000793457,
            "end_logit": -7.912529468536377
        },
        {
            "text": "encompassing 20",
            "probability": 8.90058006553419e-12,
            "start_logit": -8.971355438232422,
            "end_logit": -7.912529468536377
        },
        {
            "text": "genes. Phylogenetic analyses demonstrated that DMD, XK",
            "probability": 5.681789839253992e-12,
            "start_logit": -8.778895378112793,
            "end_logit": -8.553839683532715
        },
        {
            "text": "encompassing 20 genes. Phylogenetic analyses demonstrated that DMD, XK",
            "probability": 4.687063352638841e-12,
            "start_logit": -8.971355438232422,
            "end_logit": -8.553839683532715
        }
    ],
    "531464a6e3eabad021000014_025": [
        {
            "text": "XK",
            "probability": 0.5434117614909058,
            "start_logit": 4.511144638061523,
            "end_logit": 3.4399871826171875
        },
        {
            "text": "XK gene defects that result in the absence of XK",
            "probability": 0.4557546982699328,
            "start_logit": 4.521910667419434,
            "end_logit": 3.2533085346221924
        },
        {
            "text": "X",
            "probability": 0.000514422564996146,
            "start_logit": 4.511144638061523,
            "end_logit": -3.522590398788452
        },
        {
            "text": "K",
            "probability": 0.00030977618185951085,
            "start_logit": -2.958627939224243,
            "end_logit": 3.4399871826171875
        },
        {
            "text": "XK alone,",
            "probability": 6.282949591497092e-06,
            "start_logit": 4.511144638061523,
            "end_logit": -7.927795886993408
        },
        {
            "text": "X-linked multi-system disorder caused by absence of XK",
            "probability": 2.5095919901952513e-06,
            "start_logit": -7.774357795715332,
            "end_logit": 3.4399871826171875
        },
        {
            "text": "XK locus with 7",
            "probability": 3.8132171722514926e-07,
            "start_logit": 2.6269278526306152,
            "end_logit": -8.84553050994873
        },
        {
            "text": "Case 1 has greater than 1.12 million base-pairs (mb) deletion around the XK",
            "probability": 1.6567137928904494e-07,
            "start_logit": -8.993673324584961,
            "end_logit": 1.9414334297180176
        },
        {
            "text": "XK defects derived from a large deletion at the XK",
            "probability": 1.7558738875625095e-09,
            "start_logit": -7.547473907470703,
            "end_logit": -4.05180549621582
        },
        {
            "text": "X-linked",
            "probability": 3.651136493428761e-11,
            "start_logit": -7.774357795715332,
            "end_logit": -7.698019981384277
        },
        {
            "text": "known as the McLeod syndrome (MLS). MLS is an X-linked",
            "probability": 3.1674133118675325e-11,
            "start_logit": -7.916481018066406,
            "end_logit": -7.698019981384277
        },
        {
            "text": "X-linked multi-system disorder caused by absence of XK alone,",
            "probability": 2.9016007909658587e-11,
            "start_logit": -7.774357795715332,
            "end_logit": -7.927795886993408
        },
        {
            "text": "20",
            "probability": 2.430682146655404e-11,
            "start_logit": -7.966714859008789,
            "end_logit": -7.912529468536377
        },
        {
            "text": ".",
            "probability": 2.34859157687667e-11,
            "start_logit": -7.924811363220215,
            "end_logit": -7.988789081573486
        },
        {
            "text": "XK and OTC are subject to selective constraint.",
            "probability": 1.540809586961537e-11,
            "start_logit": -8.346319198608398,
            "end_logit": -7.988789081573486
        },
        {
            "text": "20 genes. Phylogenetic analyses demonstrated that DMD, XK",
            "probability": 1.2800021040896381e-11,
            "start_logit": -7.966714859008789,
            "end_logit": -8.553839683532715
        },
        {
            "text": "affected. Case 2 has greater than 5.65 mb deletion from TCTE1L to DMD encompassing 20",
            "probability": 9.281673650578484e-12,
            "start_logit": -8.92943000793457,
            "end_logit": -7.912529468536377
        },
        {
            "text": "encompassing 20",
            "probability": 8.90058006553419e-12,
            "start_logit": -8.971355438232422,
            "end_logit": -7.912529468536377
        },
        {
            "text": "genes. Phylogenetic analyses demonstrated that DMD, XK",
            "probability": 5.681789839253992e-12,
            "start_logit": -8.778895378112793,
            "end_logit": -8.553839683532715
        },
        {
            "text": "encompassing 20 genes. Phylogenetic analyses demonstrated that DMD, XK",
            "probability": 4.687063352638841e-12,
            "start_logit": -8.971355438232422,
            "end_logit": -8.553839683532715
        }
    ],
    "531464a6e3eabad021000014_026": [
        {
            "text": "XK",
            "probability": 0.5434117614909058,
            "start_logit": 4.511144638061523,
            "end_logit": 3.4399871826171875
        },
        {
            "text": "XK gene defects that result in the absence of XK",
            "probability": 0.4557546982699328,
            "start_logit": 4.521910667419434,
            "end_logit": 3.2533085346221924
        },
        {
            "text": "X",
            "probability": 0.000514422564996146,
            "start_logit": 4.511144638061523,
            "end_logit": -3.522590398788452
        },
        {
            "text": "K",
            "probability": 0.00030977618185951085,
            "start_logit": -2.958627939224243,
            "end_logit": 3.4399871826171875
        },
        {
            "text": "XK alone,",
            "probability": 6.282949591497092e-06,
            "start_logit": 4.511144638061523,
            "end_logit": -7.927795886993408
        },
        {
            "text": "X-linked multi-system disorder caused by absence of XK",
            "probability": 2.5095919901952513e-06,
            "start_logit": -7.774357795715332,
            "end_logit": 3.4399871826171875
        },
        {
            "text": "XK locus with 7",
            "probability": 3.8132171722514926e-07,
            "start_logit": 2.6269278526306152,
            "end_logit": -8.84553050994873
        },
        {
            "text": "Case 1 has greater than 1.12 million base-pairs (mb) deletion around the XK",
            "probability": 1.6567137928904494e-07,
            "start_logit": -8.993673324584961,
            "end_logit": 1.9414334297180176
        },
        {
            "text": "XK defects derived from a large deletion at the XK",
            "probability": 1.7558738875625095e-09,
            "start_logit": -7.547473907470703,
            "end_logit": -4.05180549621582
        },
        {
            "text": "X-linked",
            "probability": 3.651136493428761e-11,
            "start_logit": -7.774357795715332,
            "end_logit": -7.698019981384277
        },
        {
            "text": "known as the McLeod syndrome (MLS). MLS is an X-linked",
            "probability": 3.1674133118675325e-11,
            "start_logit": -7.916481018066406,
            "end_logit": -7.698019981384277
        },
        {
            "text": "X-linked multi-system disorder caused by absence of XK alone,",
            "probability": 2.9016007909658587e-11,
            "start_logit": -7.774357795715332,
            "end_logit": -7.927795886993408
        },
        {
            "text": "20",
            "probability": 2.430682146655404e-11,
            "start_logit": -7.966714859008789,
            "end_logit": -7.912529468536377
        },
        {
            "text": ".",
            "probability": 2.34859157687667e-11,
            "start_logit": -7.924811363220215,
            "end_logit": -7.988789081573486
        },
        {
            "text": "XK and OTC are subject to selective constraint.",
            "probability": 1.540809586961537e-11,
            "start_logit": -8.346319198608398,
            "end_logit": -7.988789081573486
        },
        {
            "text": "20 genes. Phylogenetic analyses demonstrated that DMD, XK",
            "probability": 1.2800021040896381e-11,
            "start_logit": -7.966714859008789,
            "end_logit": -8.553839683532715
        },
        {
            "text": "affected. Case 2 has greater than 5.65 mb deletion from TCTE1L to DMD encompassing 20",
            "probability": 9.281673650578484e-12,
            "start_logit": -8.92943000793457,
            "end_logit": -7.912529468536377
        },
        {
            "text": "encompassing 20",
            "probability": 8.90058006553419e-12,
            "start_logit": -8.971355438232422,
            "end_logit": -7.912529468536377
        },
        {
            "text": "genes. Phylogenetic analyses demonstrated that DMD, XK",
            "probability": 5.681789839253992e-12,
            "start_logit": -8.778895378112793,
            "end_logit": -8.553839683532715
        },
        {
            "text": "encompassing 20 genes. Phylogenetic analyses demonstrated that DMD, XK",
            "probability": 4.687063352638841e-12,
            "start_logit": -8.971355438232422,
            "end_logit": -8.553839683532715
        }
    ],
    "531464a6e3eabad021000014_027": [
        {
            "text": "XK",
            "probability": 0.9997880722203073,
            "start_logit": 8.97205638885498,
            "end_logit": 8.079062461853027
        },
        {
            "text": "X",
            "probability": 0.00012579773791230334,
            "start_logit": 8.97205638885498,
            "end_logit": -0.9015607833862305
        },
        {
            "text": "K",
            "probability": 7.355153518052419e-05,
            "start_logit": -0.5452558994293213,
            "end_logit": 8.079062461853027
        },
        {
            "text": "XK gene, an X-chromosomal gene of unknown function characterized by",
            "probability": 3.593993657738268e-06,
            "start_logit": 8.97205638885498,
            "end_logit": -4.456972122192383
        },
        {
            "text": "the XK",
            "probability": 2.6476777388663025e-06,
            "start_logit": -3.8695592880249023,
            "end_logit": 8.079062461853027
        },
        {
            "text": "caused by mutations of the XK",
            "probability": 2.338434370686986e-06,
            "start_logit": -3.993760585784912,
            "end_logit": 8.079062461853027
        },
        {
            "text": "XK gene,",
            "probability": 1.7264771863101436e-06,
            "start_logit": 8.97205638885498,
            "end_logit": -5.190153121948242
        },
        {
            "text": "of the XK",
            "probability": 6.2220222701419e-07,
            "start_logit": -5.317732334136963,
            "end_logit": 8.079062461853027
        },
        {
            "text": "XK gene, an X-chromosomal gene of unknown function characterized",
            "probability": 4.845172851616789e-07,
            "start_logit": 8.97205638885498,
            "end_logit": -6.460838317871094
        },
        {
            "text": "X-linked disorder caused by mutations of the XK",
            "probability": 4.107868500687493e-07,
            "start_logit": -5.7329230308532715,
            "end_logit": 8.079062461853027
        },
        {
            "text": "XK gene, an X-chromosomal gene of unknown",
            "probability": 3.2709549543299416e-07,
            "start_logit": 8.97205638885498,
            "end_logit": -6.853739261627197
        },
        {
            "text": "XK gene, an X-chromosomal gene of unknown function characterized by haemopoietic abnormalities",
            "probability": 2.5540583421055424e-07,
            "start_logit": 8.97205638885498,
            "end_logit": -7.101137638092041
        },
        {
            "text": "XK gene, an X-chromosomal gene of unknown function characterized by haemopoietic",
            "probability": 1.7185731592482237e-07,
            "start_logit": 8.97205638885498,
            "end_logit": -7.497326850891113
        },
        {
            "text": "characterized by",
            "probability": 1.8135331543915447e-11,
            "start_logit": -3.22485613822937,
            "end_logit": -4.456972122192383
        },
        {
            "text": "caused by",
            "probability": 1.094032426035679e-11,
            "start_logit": -3.993760585784912,
            "end_logit": -4.193474292755127
        },
        {
            "text": "the XK gene, an X-chromosomal gene of unknown function characterized by",
            "probability": 9.517754077709638e-12,
            "start_logit": -3.8695592880249023,
            "end_logit": -4.456972122192383
        },
        {
            "text": "caused by mutations of the XK gene, an X-chromosomal gene of unknown function characterized by",
            "probability": 8.406099783349165e-12,
            "start_logit": -3.993760585784912,
            "end_logit": -4.456972122192383
        },
        {
            "text": "the XK gene,",
            "probability": 4.572124172978355e-12,
            "start_logit": -3.8695592880249023,
            "end_logit": -5.190153121948242
        },
        {
            "text": "caused by mutations of the XK gene,",
            "probability": 4.038109380229707e-12,
            "start_logit": -3.993760585784912,
            "end_logit": -5.190153121948242
        },
        {
            "text": "caused",
            "probability": 3.0282383977741373e-12,
            "start_logit": -3.993760585784912,
            "end_logit": -5.4779486656188965
        }
    ],
    "531464a6e3eabad021000014_028": [
        {
            "text": "XK",
            "probability": 0.5670455746664957,
            "start_logit": 7.295649528503418,
            "end_logit": 6.174532413482666
        },
        {
            "text": "XK gene mutation (McLeod syndrome). This illustrates the variable phenotype of XK",
            "probability": 0.4328032754650451,
            "start_logit": 7.295649528503418,
            "end_logit": 5.904376029968262
        },
        {
            "text": "X",
            "probability": 8.876642048830315e-05,
            "start_logit": 7.295649528503418,
            "end_logit": -2.5876541137695312
        },
        {
            "text": "K",
            "probability": 5.587193821018139e-05,
            "start_logit": -1.92948317527771,
            "end_logit": 6.174532413482666
        },
        {
            "text": "revealed a XK",
            "probability": 1.0621157863958918e-06,
            "start_logit": -5.892282485961914,
            "end_logit": 6.174532413482666
        },
        {
            "text": "revealed a XK gene mutation (McLeod syndrome). This illustrates the variable phenotype of XK",
            "probability": 8.106706265111692e-07,
            "start_logit": -5.892282485961914,
            "end_logit": 5.904376029968262
        },
        {
            "text": "(calpainopathy) and the others have a single CAPN3 mutation. Linkage analysis and sequencing revealed a XK",
            "probability": 7.662238922868412e-07,
            "start_logit": -6.2188262939453125,
            "end_logit": 6.174532413482666
        },
        {
            "text": "a XK",
            "probability": 4.7220993482882e-07,
            "start_logit": -6.702877044677734,
            "end_logit": 6.174532413482666
        },
        {
            "text": "XK gene mutation (McLeod syndrome). This illustrates the variable phenotype",
            "probability": 4.495713865928283e-07,
            "start_logit": 7.295649528503418,
            "end_logit": -7.8731231689453125
        },
        {
            "text": "XK gene",
            "probability": 4.4295761085984967e-07,
            "start_logit": 7.295649528503418,
            "end_logit": -7.887943744659424
        },
        {
            "text": "illustrates the variable phenotype of XK",
            "probability": 4.037288772519634e-07,
            "start_logit": -6.589400768280029,
            "end_logit": 5.904376029968262
        },
        {
            "text": "(McLeod syndrome). This illustrates the variable phenotype of XK",
            "probability": 3.857429734878919e-07,
            "start_logit": -6.634973049163818,
            "end_logit": 5.904376029968262
        },
        {
            "text": "a XK gene mutation (McLeod syndrome). This illustrates the variable phenotype of XK",
            "probability": 3.604190132711115e-07,
            "start_logit": -6.702877044677734,
            "end_logit": 5.904376029968262
        },
        {
            "text": "XK mutations and suggests the possibility that CAPN3 heterozygotes may have their condition caused by nonallelic mutations",
            "probability": 3.104833448796227e-07,
            "start_logit": 7.082309246063232,
            "end_logit": -8.029947280883789
        },
        {
            "text": "and the others have a single CAPN3 mutation. Linkage analysis and sequencing revealed a XK",
            "probability": 2.924984405238601e-07,
            "start_logit": -7.1818413734436035,
            "end_logit": 6.174532413482666
        },
        {
            "text": "the variable phenotype of XK",
            "probability": 2.8813357730037173e-07,
            "start_logit": -6.926720142364502,
            "end_logit": 5.904376029968262
        },
        {
            "text": "XK mutations and suggests the possibility",
            "probability": 2.453042486123273e-07,
            "start_logit": 7.082309246063232,
            "end_logit": -8.265578269958496
        },
        {
            "text": "mutation (McLeod syndrome). This illustrates the variable phenotype of XK",
            "probability": 2.2144712447691177e-07,
            "start_logit": -7.189960479736328,
            "end_logit": 5.904376029968262
        },
        {
            "text": "their condition caused by nonallelic mutations in other unrelated genes.",
            "probability": 1.8169659334672616e-12,
            "start_logit": -6.319617748260498,
            "end_logit": -6.6767377853393555
        },
        {
            "text": "possibility that CAPN3 heterozygotes may have their condition caused by nonallelic mutations in other unrelated genes.",
            "probability": 1.1065825357011045e-12,
            "start_logit": -6.81550931930542,
            "end_logit": -6.6767377853393555
        }
    ],
    "531464a6e3eabad021000014_029": [
        {
            "text": "XK",
            "probability": 0.9993809588727582,
            "start_logit": 6.643124580383301,
            "end_logit": 5.6534104347229
        },
        {
            "text": "K",
            "probability": 0.00022278983580759364,
            "start_logit": -1.7655378580093384,
            "end_logit": 5.6534104347229
        },
        {
            "text": "X",
            "probability": 0.0002046345833633539,
            "start_logit": 6.643124580383301,
            "end_logit": -2.84025502204895
        },
        {
            "text": "due to a novel mutation of the XK",
            "probability": 8.421069562644101e-05,
            "start_logit": -2.7384448051452637,
            "end_logit": 5.6534104347229
        },
        {
            "text": "the XK",
            "probability": 6.00087148787935e-05,
            "start_logit": -3.0772769451141357,
            "end_logit": 5.6534104347229
        },
        {
            "text": "XK gene.",
            "probability": 1.71731571893155e-05,
            "start_logit": 6.643124580383301,
            "end_logit": -5.318133354187012
        },
        {
            "text": "exon 1 of the XK",
            "probability": 7.0640969157592505e-06,
            "start_logit": -5.059214115142822,
            "end_logit": 5.495882987976074
        },
        {
            "text": "of the XK",
            "probability": 4.424820934536753e-06,
            "start_logit": -5.684536933898926,
            "end_logit": 5.6534104347229
        },
        {
            "text": "novel mutation of the XK",
            "probability": 3.4597872875956853e-06,
            "start_logit": -5.9305596351623535,
            "end_logit": 5.6534104347229
        },
        {
            "text": "life-long neuropsychiatric disorder due to a novel mutation of the XK",
            "probability": 2.7106425060544292e-06,
            "start_logit": -6.174581050872803,
            "end_logit": 5.6534104347229
        },
        {
            "text": "XK gene,",
            "probability": 2.443201093783915e-06,
            "start_logit": 6.553836345672607,
            "end_logit": -7.1788835525512695
        },
        {
            "text": "syndrome: life-long neuropsychiatric disorder due to a novel mutation of the XK",
            "probability": 1.7961777254567109e-06,
            "start_logit": -6.586105823516846,
            "end_logit": 5.6534104347229
        },
        {
            "text": "a novel mutation of the XK",
            "probability": 1.7701882850703137e-06,
            "start_logit": -6.600680828094482,
            "end_logit": 5.6534104347229
        },
        {
            "text": "mutation of the XK",
            "probability": 1.7070417343752442e-06,
            "start_logit": -6.637004852294922,
            "end_logit": 5.6534104347229
        },
        {
            "text": "neuropsychiatric disorder due to a novel mutation of the XK",
            "probability": 1.3302685339845575e-06,
            "start_logit": -6.886385917663574,
            "end_logit": 5.6534104347229
        },
        {
            "text": "phenotype. DNA studies demonstrated a single-base deletion at position 172 in exon 1 of the XK",
            "probability": 1.3102511494639146e-06,
            "start_logit": -6.744020462036133,
            "end_logit": 5.495882987976074
        },
        {
            "text": "the McLeod phenotype. DNA studies demonstrated a single-base deletion at position 172 in exon 1 of the XK",
            "probability": 1.2819802082332311e-06,
            "start_logit": -6.765833377838135,
            "end_logit": 5.495882987976074
        },
        {
            "text": "a single-base deletion at position 172 in exon 1 of the XK",
            "probability": 9.232057647270801e-07,
            "start_logit": -7.094142436981201,
            "end_logit": 5.495882987976074
        },
        {
            "text": "due to a novel mutation of the XK gene.",
            "probability": 1.4470593022361167e-09,
            "start_logit": -2.7384448051452637,
            "end_logit": -5.318133354187012
        },
        {
            "text": "the XK gene.",
            "probability": 1.0311774345838276e-09,
            "start_logit": -3.0772769451141357,
            "end_logit": -5.318133354187012
        }
    ],
    "531464a6e3eabad021000014_030": [
        {
            "text": "XK",
            "probability": 0.9993809588727582,
            "start_logit": 6.643124580383301,
            "end_logit": 5.6534104347229
        },
        {
            "text": "K",
            "probability": 0.00022278983580759364,
            "start_logit": -1.7655378580093384,
            "end_logit": 5.6534104347229
        },
        {
            "text": "X",
            "probability": 0.0002046345833633539,
            "start_logit": 6.643124580383301,
            "end_logit": -2.84025502204895
        },
        {
            "text": "due to a novel mutation of the XK",
            "probability": 8.421069562644101e-05,
            "start_logit": -2.7384448051452637,
            "end_logit": 5.6534104347229
        },
        {
            "text": "the XK",
            "probability": 6.00087148787935e-05,
            "start_logit": -3.0772769451141357,
            "end_logit": 5.6534104347229
        },
        {
            "text": "XK gene.",
            "probability": 1.71731571893155e-05,
            "start_logit": 6.643124580383301,
            "end_logit": -5.318133354187012
        },
        {
            "text": "exon 1 of the XK",
            "probability": 7.0640969157592505e-06,
            "start_logit": -5.059214115142822,
            "end_logit": 5.495882987976074
        },
        {
            "text": "of the XK",
            "probability": 4.424820934536753e-06,
            "start_logit": -5.684536933898926,
            "end_logit": 5.6534104347229
        },
        {
            "text": "novel mutation of the XK",
            "probability": 3.4597872875956853e-06,
            "start_logit": -5.9305596351623535,
            "end_logit": 5.6534104347229
        },
        {
            "text": "life-long neuropsychiatric disorder due to a novel mutation of the XK",
            "probability": 2.7106425060544292e-06,
            "start_logit": -6.174581050872803,
            "end_logit": 5.6534104347229
        },
        {
            "text": "XK gene,",
            "probability": 2.443201093783915e-06,
            "start_logit": 6.553836345672607,
            "end_logit": -7.1788835525512695
        },
        {
            "text": "syndrome: life-long neuropsychiatric disorder due to a novel mutation of the XK",
            "probability": 1.7961777254567109e-06,
            "start_logit": -6.586105823516846,
            "end_logit": 5.6534104347229
        },
        {
            "text": "a novel mutation of the XK",
            "probability": 1.7701882850703137e-06,
            "start_logit": -6.600680828094482,
            "end_logit": 5.6534104347229
        },
        {
            "text": "mutation of the XK",
            "probability": 1.7070417343752442e-06,
            "start_logit": -6.637004852294922,
            "end_logit": 5.6534104347229
        },
        {
            "text": "neuropsychiatric disorder due to a novel mutation of the XK",
            "probability": 1.3302685339845575e-06,
            "start_logit": -6.886385917663574,
            "end_logit": 5.6534104347229
        },
        {
            "text": "phenotype. DNA studies demonstrated a single-base deletion at position 172 in exon 1 of the XK",
            "probability": 1.3102511494639146e-06,
            "start_logit": -6.744020462036133,
            "end_logit": 5.495882987976074
        },
        {
            "text": "the McLeod phenotype. DNA studies demonstrated a single-base deletion at position 172 in exon 1 of the XK",
            "probability": 1.2819802082332311e-06,
            "start_logit": -6.765833377838135,
            "end_logit": 5.495882987976074
        },
        {
            "text": "a single-base deletion at position 172 in exon 1 of the XK",
            "probability": 9.232057647270801e-07,
            "start_logit": -7.094142436981201,
            "end_logit": 5.495882987976074
        },
        {
            "text": "due to a novel mutation of the XK gene.",
            "probability": 1.4470593022361167e-09,
            "start_logit": -2.7384448051452637,
            "end_logit": -5.318133354187012
        },
        {
            "text": "the XK gene.",
            "probability": 1.0311774345838276e-09,
            "start_logit": -3.0772769451141357,
            "end_logit": -5.318133354187012
        }
    ],
    "531464a6e3eabad021000014_031": [
        {
            "text": "XK",
            "probability": 0.9989874721676756,
            "start_logit": 5.325830459594727,
            "end_logit": 4.132358551025391
        },
        {
            "text": "X",
            "probability": 0.0004913655853265188,
            "start_logit": 5.325830459594727,
            "end_logit": -3.484950542449951
        },
        {
            "text": "K",
            "probability": 0.0004519163359020542,
            "start_logit": -2.3751699924468994,
            "end_logit": 4.132358551025391
        },
        {
            "text": "the XK",
            "probability": 2.6767183886060946e-05,
            "start_logit": -5.20149040222168,
            "end_logit": 4.132358551025391
        },
        {
            "text": "exon 2 of the XK",
            "probability": 9.357043079118052e-06,
            "start_logit": -4.526641368865967,
            "end_logit": 2.4064621925354004
        },
        {
            "text": "XK gene.",
            "probability": 8.16694833581713e-06,
            "start_logit": 5.325830459594727,
            "end_logit": -7.582043647766113
        },
        {
            "text": "caused by hemizygosity for mutations in the XK",
            "probability": 6.2118454370020955e-06,
            "start_logit": -6.6622090339660645,
            "end_logit": 4.132358551025391
        },
        {
            "text": "for mutations in the XK",
            "probability": 5.39245601623335e-06,
            "start_logit": -6.803666114807129,
            "end_logit": 4.132358551025391
        },
        {
            "text": "XK mutation.",
            "probability": 5.2170384892380725e-06,
            "start_logit": 5.0689496994018555,
            "end_logit": -7.7733283042907715
        },
        {
            "text": "XK mutation. McLeod Syndrome (MLS) is a rare X-linked",
            "probability": 4.376236825503174e-06,
            "start_logit": 5.0689496994018555,
            "end_logit": -7.949069023132324
        },
        {
            "text": "XK0 allele and is therefore likely to develop MLS.",
            "probability": 8.203268997071994e-07,
            "start_logit": 3.4036307334899902,
            "end_logit": -7.957991600036621
        },
        {
            "text": "7453-bp deletion that includes exon 2 of the XK",
            "probability": 6.607721709873312e-07,
            "start_logit": -7.177116870880127,
            "end_logit": 2.4064621925354004
        },
        {
            "text": "XK0 allele",
            "probability": 3.641511868644955e-07,
            "start_logit": 3.4036307334899902,
            "end_logit": -8.770125389099121
        },
        {
            "text": "XK0 allele. The molecular basis of MLS",
            "probability": 3.6302738473937895e-07,
            "start_logit": 3.388720989227295,
            "end_logit": -8.758306503295898
        },
        {
            "text": "XK0 allele. The molecular basis of MLS in this family is a novel mutation consisting of a 7453-bp",
            "probability": 2.802308894931623e-07,
            "start_logit": 3.388720989227295,
            "end_logit": -9.017170906066895
        },
        {
            "text": "XK0 allele.",
            "probability": 2.791471577644006e-07,
            "start_logit": 3.388720989227295,
            "end_logit": -9.021045684814453
        },
        {
            "text": "heterozygous for an XK0",
            "probability": 2.6816904179221744e-07,
            "start_logit": -8.00039291381836,
            "end_logit": 2.327946662902832
        },
        {
            "text": "2 of the XK",
            "probability": 2.6351956731917036e-07,
            "start_logit": -8.09639835357666,
            "end_logit": 2.4064621925354004
        },
        {
            "text": "novel mutation consisting of a 7453-bp deletion that includes exon 2 of the XK",
            "probability": 2.370695833602085e-07,
            "start_logit": -8.20217227935791,
            "end_logit": 2.4064621925354004
        },
        {
            "text": "daughters had two populations of red cells, consistent with them being heterozygous for an XK0",
            "probability": 2.2074514505168312e-07,
            "start_logit": -8.195001602172852,
            "end_logit": 2.327946662902832
        }
    ],
    "531464a6e3eabad021000014_032": [
        {
            "text": "XK",
            "probability": 0.9989874721676756,
            "start_logit": 5.325830459594727,
            "end_logit": 4.132358551025391
        },
        {
            "text": "X",
            "probability": 0.0004913655853265188,
            "start_logit": 5.325830459594727,
            "end_logit": -3.484950542449951
        },
        {
            "text": "K",
            "probability": 0.0004519163359020542,
            "start_logit": -2.3751699924468994,
            "end_logit": 4.132358551025391
        },
        {
            "text": "the XK",
            "probability": 2.6767183886060946e-05,
            "start_logit": -5.20149040222168,
            "end_logit": 4.132358551025391
        },
        {
            "text": "exon 2 of the XK",
            "probability": 9.357043079118052e-06,
            "start_logit": -4.526641368865967,
            "end_logit": 2.4064621925354004
        },
        {
            "text": "XK gene.",
            "probability": 8.16694833581713e-06,
            "start_logit": 5.325830459594727,
            "end_logit": -7.582043647766113
        },
        {
            "text": "caused by hemizygosity for mutations in the XK",
            "probability": 6.2118454370020955e-06,
            "start_logit": -6.6622090339660645,
            "end_logit": 4.132358551025391
        },
        {
            "text": "for mutations in the XK",
            "probability": 5.39245601623335e-06,
            "start_logit": -6.803666114807129,
            "end_logit": 4.132358551025391
        },
        {
            "text": "XK mutation.",
            "probability": 5.2170384892380725e-06,
            "start_logit": 5.0689496994018555,
            "end_logit": -7.7733283042907715
        },
        {
            "text": "XK mutation. McLeod Syndrome (MLS) is a rare X-linked",
            "probability": 4.376236825503174e-06,
            "start_logit": 5.0689496994018555,
            "end_logit": -7.949069023132324
        },
        {
            "text": "XK0 allele and is therefore likely to develop MLS.",
            "probability": 8.203268997071994e-07,
            "start_logit": 3.4036307334899902,
            "end_logit": -7.957991600036621
        },
        {
            "text": "7453-bp deletion that includes exon 2 of the XK",
            "probability": 6.607721709873312e-07,
            "start_logit": -7.177116870880127,
            "end_logit": 2.4064621925354004
        },
        {
            "text": "XK0 allele",
            "probability": 3.641511868644955e-07,
            "start_logit": 3.4036307334899902,
            "end_logit": -8.770125389099121
        },
        {
            "text": "XK0 allele. The molecular basis of MLS",
            "probability": 3.6302738473937895e-07,
            "start_logit": 3.388720989227295,
            "end_logit": -8.758306503295898
        },
        {
            "text": "XK0 allele. The molecular basis of MLS in this family is a novel mutation consisting of a 7453-bp",
            "probability": 2.802308894931623e-07,
            "start_logit": 3.388720989227295,
            "end_logit": -9.017170906066895
        },
        {
            "text": "XK0 allele.",
            "probability": 2.791471577644006e-07,
            "start_logit": 3.388720989227295,
            "end_logit": -9.021045684814453
        },
        {
            "text": "heterozygous for an XK0",
            "probability": 2.6816904179221744e-07,
            "start_logit": -8.00039291381836,
            "end_logit": 2.327946662902832
        },
        {
            "text": "2 of the XK",
            "probability": 2.6351956731917036e-07,
            "start_logit": -8.09639835357666,
            "end_logit": 2.4064621925354004
        },
        {
            "text": "novel mutation consisting of a 7453-bp deletion that includes exon 2 of the XK",
            "probability": 2.370695833602085e-07,
            "start_logit": -8.20217227935791,
            "end_logit": 2.4064621925354004
        },
        {
            "text": "daughters had two populations of red cells, consistent with them being heterozygous for an XK0",
            "probability": 2.2074514505168312e-07,
            "start_logit": -8.195001602172852,
            "end_logit": 2.327946662902832
        }
    ],
    "531464a6e3eabad021000014_033": [
        {
            "text": "XK",
            "probability": 0.9989874721676756,
            "start_logit": 5.325830459594727,
            "end_logit": 4.132358551025391
        },
        {
            "text": "X",
            "probability": 0.0004913655853265188,
            "start_logit": 5.325830459594727,
            "end_logit": -3.484950542449951
        },
        {
            "text": "K",
            "probability": 0.0004519163359020542,
            "start_logit": -2.3751699924468994,
            "end_logit": 4.132358551025391
        },
        {
            "text": "the XK",
            "probability": 2.6767183886060946e-05,
            "start_logit": -5.20149040222168,
            "end_logit": 4.132358551025391
        },
        {
            "text": "exon 2 of the XK",
            "probability": 9.357043079118052e-06,
            "start_logit": -4.526641368865967,
            "end_logit": 2.4064621925354004
        },
        {
            "text": "XK gene.",
            "probability": 8.16694833581713e-06,
            "start_logit": 5.325830459594727,
            "end_logit": -7.582043647766113
        },
        {
            "text": "caused by hemizygosity for mutations in the XK",
            "probability": 6.2118454370020955e-06,
            "start_logit": -6.6622090339660645,
            "end_logit": 4.132358551025391
        },
        {
            "text": "for mutations in the XK",
            "probability": 5.39245601623335e-06,
            "start_logit": -6.803666114807129,
            "end_logit": 4.132358551025391
        },
        {
            "text": "XK mutation.",
            "probability": 5.2170384892380725e-06,
            "start_logit": 5.0689496994018555,
            "end_logit": -7.7733283042907715
        },
        {
            "text": "XK mutation. McLeod Syndrome (MLS) is a rare X-linked",
            "probability": 4.376236825503174e-06,
            "start_logit": 5.0689496994018555,
            "end_logit": -7.949069023132324
        },
        {
            "text": "XK0 allele and is therefore likely to develop MLS.",
            "probability": 8.203268997071994e-07,
            "start_logit": 3.4036307334899902,
            "end_logit": -7.957991600036621
        },
        {
            "text": "7453-bp deletion that includes exon 2 of the XK",
            "probability": 6.607721709873312e-07,
            "start_logit": -7.177116870880127,
            "end_logit": 2.4064621925354004
        },
        {
            "text": "XK0 allele",
            "probability": 3.641511868644955e-07,
            "start_logit": 3.4036307334899902,
            "end_logit": -8.770125389099121
        },
        {
            "text": "XK0 allele. The molecular basis of MLS",
            "probability": 3.6302738473937895e-07,
            "start_logit": 3.388720989227295,
            "end_logit": -8.758306503295898
        },
        {
            "text": "XK0 allele. The molecular basis of MLS in this family is a novel mutation consisting of a 7453-bp",
            "probability": 2.802308894931623e-07,
            "start_logit": 3.388720989227295,
            "end_logit": -9.017170906066895
        },
        {
            "text": "XK0 allele.",
            "probability": 2.791471577644006e-07,
            "start_logit": 3.388720989227295,
            "end_logit": -9.021045684814453
        },
        {
            "text": "heterozygous for an XK0",
            "probability": 2.6816904179221744e-07,
            "start_logit": -8.00039291381836,
            "end_logit": 2.327946662902832
        },
        {
            "text": "2 of the XK",
            "probability": 2.6351956731917036e-07,
            "start_logit": -8.09639835357666,
            "end_logit": 2.4064621925354004
        },
        {
            "text": "novel mutation consisting of a 7453-bp deletion that includes exon 2 of the XK",
            "probability": 2.370695833602085e-07,
            "start_logit": -8.20217227935791,
            "end_logit": 2.4064621925354004
        },
        {
            "text": "daughters had two populations of red cells, consistent with them being heterozygous for an XK0",
            "probability": 2.2074514505168312e-07,
            "start_logit": -8.195001602172852,
            "end_logit": 2.327946662902832
        }
    ],
    "531464a6e3eabad021000014_034": [
        {
            "text": "XK",
            "probability": 0.9989874721676756,
            "start_logit": 5.325830459594727,
            "end_logit": 4.132358551025391
        },
        {
            "text": "X",
            "probability": 0.0004913655853265188,
            "start_logit": 5.325830459594727,
            "end_logit": -3.484950542449951
        },
        {
            "text": "K",
            "probability": 0.0004519163359020542,
            "start_logit": -2.3751699924468994,
            "end_logit": 4.132358551025391
        },
        {
            "text": "the XK",
            "probability": 2.6767183886060946e-05,
            "start_logit": -5.20149040222168,
            "end_logit": 4.132358551025391
        },
        {
            "text": "exon 2 of the XK",
            "probability": 9.357043079118052e-06,
            "start_logit": -4.526641368865967,
            "end_logit": 2.4064621925354004
        },
        {
            "text": "XK gene.",
            "probability": 8.16694833581713e-06,
            "start_logit": 5.325830459594727,
            "end_logit": -7.582043647766113
        },
        {
            "text": "caused by hemizygosity for mutations in the XK",
            "probability": 6.2118454370020955e-06,
            "start_logit": -6.6622090339660645,
            "end_logit": 4.132358551025391
        },
        {
            "text": "for mutations in the XK",
            "probability": 5.39245601623335e-06,
            "start_logit": -6.803666114807129,
            "end_logit": 4.132358551025391
        },
        {
            "text": "XK mutation.",
            "probability": 5.2170384892380725e-06,
            "start_logit": 5.0689496994018555,
            "end_logit": -7.7733283042907715
        },
        {
            "text": "XK mutation. McLeod Syndrome (MLS) is a rare X-linked",
            "probability": 4.376236825503174e-06,
            "start_logit": 5.0689496994018555,
            "end_logit": -7.949069023132324
        },
        {
            "text": "XK0 allele and is therefore likely to develop MLS.",
            "probability": 8.203268997071994e-07,
            "start_logit": 3.4036307334899902,
            "end_logit": -7.957991600036621
        },
        {
            "text": "7453-bp deletion that includes exon 2 of the XK",
            "probability": 6.607721709873312e-07,
            "start_logit": -7.177116870880127,
            "end_logit": 2.4064621925354004
        },
        {
            "text": "XK0 allele",
            "probability": 3.641511868644955e-07,
            "start_logit": 3.4036307334899902,
            "end_logit": -8.770125389099121
        },
        {
            "text": "XK0 allele. The molecular basis of MLS",
            "probability": 3.6302738473937895e-07,
            "start_logit": 3.388720989227295,
            "end_logit": -8.758306503295898
        },
        {
            "text": "XK0 allele. The molecular basis of MLS in this family is a novel mutation consisting of a 7453-bp",
            "probability": 2.802308894931623e-07,
            "start_logit": 3.388720989227295,
            "end_logit": -9.017170906066895
        },
        {
            "text": "XK0 allele.",
            "probability": 2.791471577644006e-07,
            "start_logit": 3.388720989227295,
            "end_logit": -9.021045684814453
        },
        {
            "text": "heterozygous for an XK0",
            "probability": 2.6816904179221744e-07,
            "start_logit": -8.00039291381836,
            "end_logit": 2.327946662902832
        },
        {
            "text": "2 of the XK",
            "probability": 2.6351956731917036e-07,
            "start_logit": -8.09639835357666,
            "end_logit": 2.4064621925354004
        },
        {
            "text": "novel mutation consisting of a 7453-bp deletion that includes exon 2 of the XK",
            "probability": 2.370695833602085e-07,
            "start_logit": -8.20217227935791,
            "end_logit": 2.4064621925354004
        },
        {
            "text": "daughters had two populations of red cells, consistent with them being heterozygous for an XK0",
            "probability": 2.2074514505168312e-07,
            "start_logit": -8.195001602172852,
            "end_logit": 2.327946662902832
        }
    ],
    "531464a6e3eabad021000014_035": [
        {
            "text": "XK",
            "probability": 0.9989874721676756,
            "start_logit": 5.325830459594727,
            "end_logit": 4.132358551025391
        },
        {
            "text": "X",
            "probability": 0.0004913655853265188,
            "start_logit": 5.325830459594727,
            "end_logit": -3.484950542449951
        },
        {
            "text": "K",
            "probability": 0.0004519163359020542,
            "start_logit": -2.3751699924468994,
            "end_logit": 4.132358551025391
        },
        {
            "text": "the XK",
            "probability": 2.6767183886060946e-05,
            "start_logit": -5.20149040222168,
            "end_logit": 4.132358551025391
        },
        {
            "text": "exon 2 of the XK",
            "probability": 9.357043079118052e-06,
            "start_logit": -4.526641368865967,
            "end_logit": 2.4064621925354004
        },
        {
            "text": "XK gene.",
            "probability": 8.16694833581713e-06,
            "start_logit": 5.325830459594727,
            "end_logit": -7.582043647766113
        },
        {
            "text": "caused by hemizygosity for mutations in the XK",
            "probability": 6.2118454370020955e-06,
            "start_logit": -6.6622090339660645,
            "end_logit": 4.132358551025391
        },
        {
            "text": "for mutations in the XK",
            "probability": 5.39245601623335e-06,
            "start_logit": -6.803666114807129,
            "end_logit": 4.132358551025391
        },
        {
            "text": "XK mutation.",
            "probability": 5.2170384892380725e-06,
            "start_logit": 5.0689496994018555,
            "end_logit": -7.7733283042907715
        },
        {
            "text": "XK mutation. McLeod Syndrome (MLS) is a rare X-linked",
            "probability": 4.376236825503174e-06,
            "start_logit": 5.0689496994018555,
            "end_logit": -7.949069023132324
        },
        {
            "text": "XK0 allele and is therefore likely to develop MLS.",
            "probability": 8.203268997071994e-07,
            "start_logit": 3.4036307334899902,
            "end_logit": -7.957991600036621
        },
        {
            "text": "7453-bp deletion that includes exon 2 of the XK",
            "probability": 6.607721709873312e-07,
            "start_logit": -7.177116870880127,
            "end_logit": 2.4064621925354004
        },
        {
            "text": "XK0 allele",
            "probability": 3.641511868644955e-07,
            "start_logit": 3.4036307334899902,
            "end_logit": -8.770125389099121
        },
        {
            "text": "XK0 allele. The molecular basis of MLS",
            "probability": 3.6302738473937895e-07,
            "start_logit": 3.388720989227295,
            "end_logit": -8.758306503295898
        },
        {
            "text": "XK0 allele. The molecular basis of MLS in this family is a novel mutation consisting of a 7453-bp",
            "probability": 2.802308894931623e-07,
            "start_logit": 3.388720989227295,
            "end_logit": -9.017170906066895
        },
        {
            "text": "XK0 allele.",
            "probability": 2.791471577644006e-07,
            "start_logit": 3.388720989227295,
            "end_logit": -9.021045684814453
        },
        {
            "text": "heterozygous for an XK0",
            "probability": 2.6816904179221744e-07,
            "start_logit": -8.00039291381836,
            "end_logit": 2.327946662902832
        },
        {
            "text": "2 of the XK",
            "probability": 2.6351956731917036e-07,
            "start_logit": -8.09639835357666,
            "end_logit": 2.4064621925354004
        },
        {
            "text": "novel mutation consisting of a 7453-bp deletion that includes exon 2 of the XK",
            "probability": 2.370695833602085e-07,
            "start_logit": -8.20217227935791,
            "end_logit": 2.4064621925354004
        },
        {
            "text": "daughters had two populations of red cells, consistent with them being heterozygous for an XK0",
            "probability": 2.2074514505168312e-07,
            "start_logit": -8.195001602172852,
            "end_logit": 2.327946662902832
        }
    ],
    "531464a6e3eabad021000014_036": [
        {
            "text": "XK",
            "probability": 0.429851948152562,
            "start_logit": 4.145132064819336,
            "end_logit": 3.093883514404297
        },
        {
            "text": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K). WBC XK",
            "probability": 0.42281627521943294,
            "start_logit": 4.145132064819336,
            "end_logit": 3.077380418777466
        },
        {
            "text": "XK protein seemed to be largely functional. These findings contribute to the understanding of the physiology of XK",
            "probability": 0.14631295532414448,
            "start_logit": 3.6144888401031494,
            "end_logit": 2.5468337535858154
        },
        {
            "text": "X",
            "probability": 0.00045511954302181933,
            "start_logit": 4.128338813781738,
            "end_logit": -3.739959239959717
        },
        {
            "text": "K",
            "probability": 0.00039415937310236714,
            "start_logit": -2.849308729171753,
            "end_logit": 3.093883514404297
        },
        {
            "text": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).",
            "probability": 5.867970410610351e-05,
            "start_logit": 4.145132064819336,
            "end_logit": -5.805218696594238
        },
        {
            "text": "(E327K). WBC XK",
            "probability": 5.198454779234815e-05,
            "start_logit": -4.858614444732666,
            "end_logit": 3.077380418777466
        },
        {
            "text": "XK missense mutation without hematologic, neuromuscular, or cerebral involvement.",
            "probability": 2.5240642441495543e-05,
            "start_logit": 3.4064154624938965,
            "end_logit": -5.910140514373779
        },
        {
            "text": "E327K missense mutation was associated with the immunohematologic characteristics of McLeod syndrome, the mutated XK",
            "probability": 9.082595945545345e-06,
            "start_logit": -6.167214393615723,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "exon 3 (E327K). WBC XK",
            "probability": 5.605329687655618e-06,
            "start_logit": -7.085843086242676,
            "end_logit": 3.077380418777466
        },
        {
            "text": "XK protein devoid of the Kell-protein binding site. Although the E327K",
            "probability": 5.193131603274717e-06,
            "start_logit": 3.576603889465332,
            "end_logit": -7.661447525024414
        },
        {
            "text": "CONCLUSION: Known disease-causing XK",
            "probability": 3.7309485232727637e-06,
            "start_logit": -7.376314163208008,
            "end_logit": 2.9607961177825928
        },
        {
            "text": "immunohematologic characteristics of McLeod syndrome, the mutated XK",
            "probability": 3.5863401291393078e-06,
            "start_logit": -7.096442222595215,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "of McLeod syndrome, the mutated XK",
            "probability": 3.3573205563505154e-06,
            "start_logit": -7.162431240081787,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "characteristics of McLeod syndrome, the mutated XK",
            "probability": 3.0549545980723106e-06,
            "start_logit": -7.256809711456299,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "AND",
            "probability": 1.77422449945934e-08,
            "start_logit": -1.6240384578704834,
            "end_logit": -8.139948844909668
        },
        {
            "text": "E327K",
            "probability": 7.214570633454144e-09,
            "start_logit": -4.858614444732666,
            "end_logit": -5.805218696594238
        },
        {
            "text": "exon 3 (E327K).",
            "probability": 7.779243770076898e-10,
            "start_logit": -7.085843086242676,
            "end_logit": -5.805218696594238
        },
        {
            "text": "327K",
            "probability": 6.787354802156521e-10,
            "start_logit": -7.222240924835205,
            "end_logit": -5.805218696594238
        },
        {
            "text": "E327K missense mutation was associated with the immunohematologic characteristics",
            "probability": 4.5887757719598697e-10,
            "start_logit": -6.167214393615723,
            "end_logit": -7.251693248748779
        }
    ],
    "531464a6e3eabad021000014_037": [
        {
            "text": "XK",
            "probability": 0.429851948152562,
            "start_logit": 4.145132064819336,
            "end_logit": 3.093883514404297
        },
        {
            "text": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K). WBC XK",
            "probability": 0.42281627521943294,
            "start_logit": 4.145132064819336,
            "end_logit": 3.077380418777466
        },
        {
            "text": "XK protein seemed to be largely functional. These findings contribute to the understanding of the physiology of XK",
            "probability": 0.14631295532414448,
            "start_logit": 3.6144888401031494,
            "end_logit": 2.5468337535858154
        },
        {
            "text": "X",
            "probability": 0.00045511954302181933,
            "start_logit": 4.128338813781738,
            "end_logit": -3.739959239959717
        },
        {
            "text": "K",
            "probability": 0.00039415937310236714,
            "start_logit": -2.849308729171753,
            "end_logit": 3.093883514404297
        },
        {
            "text": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).",
            "probability": 5.867970410610351e-05,
            "start_logit": 4.145132064819336,
            "end_logit": -5.805218696594238
        },
        {
            "text": "(E327K). WBC XK",
            "probability": 5.198454779234815e-05,
            "start_logit": -4.858614444732666,
            "end_logit": 3.077380418777466
        },
        {
            "text": "XK missense mutation without hematologic, neuromuscular, or cerebral involvement.",
            "probability": 2.5240642441495543e-05,
            "start_logit": 3.4064154624938965,
            "end_logit": -5.910140514373779
        },
        {
            "text": "E327K missense mutation was associated with the immunohematologic characteristics of McLeod syndrome, the mutated XK",
            "probability": 9.082595945545345e-06,
            "start_logit": -6.167214393615723,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "exon 3 (E327K). WBC XK",
            "probability": 5.605329687655618e-06,
            "start_logit": -7.085843086242676,
            "end_logit": 3.077380418777466
        },
        {
            "text": "XK protein devoid of the Kell-protein binding site. Although the E327K",
            "probability": 5.193131603274717e-06,
            "start_logit": 3.576603889465332,
            "end_logit": -7.661447525024414
        },
        {
            "text": "CONCLUSION: Known disease-causing XK",
            "probability": 3.7309485232727637e-06,
            "start_logit": -7.376314163208008,
            "end_logit": 2.9607961177825928
        },
        {
            "text": "immunohematologic characteristics of McLeod syndrome, the mutated XK",
            "probability": 3.5863401291393078e-06,
            "start_logit": -7.096442222595215,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "of McLeod syndrome, the mutated XK",
            "probability": 3.3573205563505154e-06,
            "start_logit": -7.162431240081787,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "characteristics of McLeod syndrome, the mutated XK",
            "probability": 3.0549545980723106e-06,
            "start_logit": -7.256809711456299,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "AND",
            "probability": 1.77422449945934e-08,
            "start_logit": -1.6240384578704834,
            "end_logit": -8.139948844909668
        },
        {
            "text": "E327K",
            "probability": 7.214570633454144e-09,
            "start_logit": -4.858614444732666,
            "end_logit": -5.805218696594238
        },
        {
            "text": "exon 3 (E327K).",
            "probability": 7.779243770076898e-10,
            "start_logit": -7.085843086242676,
            "end_logit": -5.805218696594238
        },
        {
            "text": "327K",
            "probability": 6.787354802156521e-10,
            "start_logit": -7.222240924835205,
            "end_logit": -5.805218696594238
        },
        {
            "text": "E327K missense mutation was associated with the immunohematologic characteristics",
            "probability": 4.5887757719598697e-10,
            "start_logit": -6.167214393615723,
            "end_logit": -7.251693248748779
        }
    ],
    "531464a6e3eabad021000014_038": [
        {
            "text": "XK",
            "probability": 0.429851948152562,
            "start_logit": 4.145132064819336,
            "end_logit": 3.093883514404297
        },
        {
            "text": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K). WBC XK",
            "probability": 0.42281627521943294,
            "start_logit": 4.145132064819336,
            "end_logit": 3.077380418777466
        },
        {
            "text": "XK protein seemed to be largely functional. These findings contribute to the understanding of the physiology of XK",
            "probability": 0.14631295532414448,
            "start_logit": 3.6144888401031494,
            "end_logit": 2.5468337535858154
        },
        {
            "text": "X",
            "probability": 0.00045511954302181933,
            "start_logit": 4.128338813781738,
            "end_logit": -3.739959239959717
        },
        {
            "text": "K",
            "probability": 0.00039415937310236714,
            "start_logit": -2.849308729171753,
            "end_logit": 3.093883514404297
        },
        {
            "text": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).",
            "probability": 5.867970410610351e-05,
            "start_logit": 4.145132064819336,
            "end_logit": -5.805218696594238
        },
        {
            "text": "(E327K). WBC XK",
            "probability": 5.198454779234815e-05,
            "start_logit": -4.858614444732666,
            "end_logit": 3.077380418777466
        },
        {
            "text": "XK missense mutation without hematologic, neuromuscular, or cerebral involvement.",
            "probability": 2.5240642441495543e-05,
            "start_logit": 3.4064154624938965,
            "end_logit": -5.910140514373779
        },
        {
            "text": "E327K missense mutation was associated with the immunohematologic characteristics of McLeod syndrome, the mutated XK",
            "probability": 9.082595945545345e-06,
            "start_logit": -6.167214393615723,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "exon 3 (E327K). WBC XK",
            "probability": 5.605329687655618e-06,
            "start_logit": -7.085843086242676,
            "end_logit": 3.077380418777466
        },
        {
            "text": "XK protein devoid of the Kell-protein binding site. Although the E327K",
            "probability": 5.193131603274717e-06,
            "start_logit": 3.576603889465332,
            "end_logit": -7.661447525024414
        },
        {
            "text": "CONCLUSION: Known disease-causing XK",
            "probability": 3.7309485232727637e-06,
            "start_logit": -7.376314163208008,
            "end_logit": 2.9607961177825928
        },
        {
            "text": "immunohematologic characteristics of McLeod syndrome, the mutated XK",
            "probability": 3.5863401291393078e-06,
            "start_logit": -7.096442222595215,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "of McLeod syndrome, the mutated XK",
            "probability": 3.3573205563505154e-06,
            "start_logit": -7.162431240081787,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "characteristics of McLeod syndrome, the mutated XK",
            "probability": 3.0549545980723106e-06,
            "start_logit": -7.256809711456299,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "AND",
            "probability": 1.77422449945934e-08,
            "start_logit": -1.6240384578704834,
            "end_logit": -8.139948844909668
        },
        {
            "text": "E327K",
            "probability": 7.214570633454144e-09,
            "start_logit": -4.858614444732666,
            "end_logit": -5.805218696594238
        },
        {
            "text": "exon 3 (E327K).",
            "probability": 7.779243770076898e-10,
            "start_logit": -7.085843086242676,
            "end_logit": -5.805218696594238
        },
        {
            "text": "327K",
            "probability": 6.787354802156521e-10,
            "start_logit": -7.222240924835205,
            "end_logit": -5.805218696594238
        },
        {
            "text": "E327K missense mutation was associated with the immunohematologic characteristics",
            "probability": 4.5887757719598697e-10,
            "start_logit": -6.167214393615723,
            "end_logit": -7.251693248748779
        }
    ],
    "531464a6e3eabad021000014_039": [
        {
            "text": "XK",
            "probability": 0.429851948152562,
            "start_logit": 4.145132064819336,
            "end_logit": 3.093883514404297
        },
        {
            "text": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K). WBC XK",
            "probability": 0.42281627521943294,
            "start_logit": 4.145132064819336,
            "end_logit": 3.077380418777466
        },
        {
            "text": "XK protein seemed to be largely functional. These findings contribute to the understanding of the physiology of XK",
            "probability": 0.14631295532414448,
            "start_logit": 3.6144888401031494,
            "end_logit": 2.5468337535858154
        },
        {
            "text": "X",
            "probability": 0.00045511954302181933,
            "start_logit": 4.128338813781738,
            "end_logit": -3.739959239959717
        },
        {
            "text": "K",
            "probability": 0.00039415937310236714,
            "start_logit": -2.849308729171753,
            "end_logit": 3.093883514404297
        },
        {
            "text": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).",
            "probability": 5.867970410610351e-05,
            "start_logit": 4.145132064819336,
            "end_logit": -5.805218696594238
        },
        {
            "text": "(E327K). WBC XK",
            "probability": 5.198454779234815e-05,
            "start_logit": -4.858614444732666,
            "end_logit": 3.077380418777466
        },
        {
            "text": "XK missense mutation without hematologic, neuromuscular, or cerebral involvement.",
            "probability": 2.5240642441495543e-05,
            "start_logit": 3.4064154624938965,
            "end_logit": -5.910140514373779
        },
        {
            "text": "E327K missense mutation was associated with the immunohematologic characteristics of McLeod syndrome, the mutated XK",
            "probability": 9.082595945545345e-06,
            "start_logit": -6.167214393615723,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "exon 3 (E327K). WBC XK",
            "probability": 5.605329687655618e-06,
            "start_logit": -7.085843086242676,
            "end_logit": 3.077380418777466
        },
        {
            "text": "XK protein devoid of the Kell-protein binding site. Although the E327K",
            "probability": 5.193131603274717e-06,
            "start_logit": 3.576603889465332,
            "end_logit": -7.661447525024414
        },
        {
            "text": "CONCLUSION: Known disease-causing XK",
            "probability": 3.7309485232727637e-06,
            "start_logit": -7.376314163208008,
            "end_logit": 2.9607961177825928
        },
        {
            "text": "immunohematologic characteristics of McLeod syndrome, the mutated XK",
            "probability": 3.5863401291393078e-06,
            "start_logit": -7.096442222595215,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "of McLeod syndrome, the mutated XK",
            "probability": 3.3573205563505154e-06,
            "start_logit": -7.162431240081787,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "characteristics of McLeod syndrome, the mutated XK",
            "probability": 3.0549545980723106e-06,
            "start_logit": -7.256809711456299,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "AND",
            "probability": 1.77422449945934e-08,
            "start_logit": -1.6240384578704834,
            "end_logit": -8.139948844909668
        },
        {
            "text": "E327K",
            "probability": 7.214570633454144e-09,
            "start_logit": -4.858614444732666,
            "end_logit": -5.805218696594238
        },
        {
            "text": "exon 3 (E327K).",
            "probability": 7.779243770076898e-10,
            "start_logit": -7.085843086242676,
            "end_logit": -5.805218696594238
        },
        {
            "text": "327K",
            "probability": 6.787354802156521e-10,
            "start_logit": -7.222240924835205,
            "end_logit": -5.805218696594238
        },
        {
            "text": "E327K missense mutation was associated with the immunohematologic characteristics",
            "probability": 4.5887757719598697e-10,
            "start_logit": -6.167214393615723,
            "end_logit": -7.251693248748779
        }
    ],
    "531464a6e3eabad021000014_040": [
        {
            "text": "XK",
            "probability": 0.429851948152562,
            "start_logit": 4.145132064819336,
            "end_logit": 3.093883514404297
        },
        {
            "text": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K). WBC XK",
            "probability": 0.42281627521943294,
            "start_logit": 4.145132064819336,
            "end_logit": 3.077380418777466
        },
        {
            "text": "XK protein seemed to be largely functional. These findings contribute to the understanding of the physiology of XK",
            "probability": 0.14631295532414448,
            "start_logit": 3.6144888401031494,
            "end_logit": 2.5468337535858154
        },
        {
            "text": "X",
            "probability": 0.00045511954302181933,
            "start_logit": 4.128338813781738,
            "end_logit": -3.739959239959717
        },
        {
            "text": "K",
            "probability": 0.00039415937310236714,
            "start_logit": -2.849308729171753,
            "end_logit": 3.093883514404297
        },
        {
            "text": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).",
            "probability": 5.867970410610351e-05,
            "start_logit": 4.145132064819336,
            "end_logit": -5.805218696594238
        },
        {
            "text": "(E327K). WBC XK",
            "probability": 5.198454779234815e-05,
            "start_logit": -4.858614444732666,
            "end_logit": 3.077380418777466
        },
        {
            "text": "XK missense mutation without hematologic, neuromuscular, or cerebral involvement.",
            "probability": 2.5240642441495543e-05,
            "start_logit": 3.4064154624938965,
            "end_logit": -5.910140514373779
        },
        {
            "text": "E327K missense mutation was associated with the immunohematologic characteristics of McLeod syndrome, the mutated XK",
            "probability": 9.082595945545345e-06,
            "start_logit": -6.167214393615723,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "exon 3 (E327K). WBC XK",
            "probability": 5.605329687655618e-06,
            "start_logit": -7.085843086242676,
            "end_logit": 3.077380418777466
        },
        {
            "text": "XK protein devoid of the Kell-protein binding site. Although the E327K",
            "probability": 5.193131603274717e-06,
            "start_logit": 3.576603889465332,
            "end_logit": -7.661447525024414
        },
        {
            "text": "CONCLUSION: Known disease-causing XK",
            "probability": 3.7309485232727637e-06,
            "start_logit": -7.376314163208008,
            "end_logit": 2.9607961177825928
        },
        {
            "text": "immunohematologic characteristics of McLeod syndrome, the mutated XK",
            "probability": 3.5863401291393078e-06,
            "start_logit": -7.096442222595215,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "of McLeod syndrome, the mutated XK",
            "probability": 3.3573205563505154e-06,
            "start_logit": -7.162431240081787,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "characteristics of McLeod syndrome, the mutated XK",
            "probability": 3.0549545980723106e-06,
            "start_logit": -7.256809711456299,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "AND",
            "probability": 1.77422449945934e-08,
            "start_logit": -1.6240384578704834,
            "end_logit": -8.139948844909668
        },
        {
            "text": "E327K",
            "probability": 7.214570633454144e-09,
            "start_logit": -4.858614444732666,
            "end_logit": -5.805218696594238
        },
        {
            "text": "exon 3 (E327K).",
            "probability": 7.779243770076898e-10,
            "start_logit": -7.085843086242676,
            "end_logit": -5.805218696594238
        },
        {
            "text": "327K",
            "probability": 6.787354802156521e-10,
            "start_logit": -7.222240924835205,
            "end_logit": -5.805218696594238
        },
        {
            "text": "E327K missense mutation was associated with the immunohematologic characteristics",
            "probability": 4.5887757719598697e-10,
            "start_logit": -6.167214393615723,
            "end_logit": -7.251693248748779
        }
    ],
    "531464a6e3eabad021000014_041": [
        {
            "text": "XK",
            "probability": 0.429851948152562,
            "start_logit": 4.145132064819336,
            "end_logit": 3.093883514404297
        },
        {
            "text": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K). WBC XK",
            "probability": 0.42281627521943294,
            "start_logit": 4.145132064819336,
            "end_logit": 3.077380418777466
        },
        {
            "text": "XK protein seemed to be largely functional. These findings contribute to the understanding of the physiology of XK",
            "probability": 0.14631295532414448,
            "start_logit": 3.6144888401031494,
            "end_logit": 2.5468337535858154
        },
        {
            "text": "X",
            "probability": 0.00045511954302181933,
            "start_logit": 4.128338813781738,
            "end_logit": -3.739959239959717
        },
        {
            "text": "K",
            "probability": 0.00039415937310236714,
            "start_logit": -2.849308729171753,
            "end_logit": 3.093883514404297
        },
        {
            "text": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).",
            "probability": 5.867970410610351e-05,
            "start_logit": 4.145132064819336,
            "end_logit": -5.805218696594238
        },
        {
            "text": "(E327K). WBC XK",
            "probability": 5.198454779234815e-05,
            "start_logit": -4.858614444732666,
            "end_logit": 3.077380418777466
        },
        {
            "text": "XK missense mutation without hematologic, neuromuscular, or cerebral involvement.",
            "probability": 2.5240642441495543e-05,
            "start_logit": 3.4064154624938965,
            "end_logit": -5.910140514373779
        },
        {
            "text": "E327K missense mutation was associated with the immunohematologic characteristics of McLeod syndrome, the mutated XK",
            "probability": 9.082595945545345e-06,
            "start_logit": -6.167214393615723,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "exon 3 (E327K). WBC XK",
            "probability": 5.605329687655618e-06,
            "start_logit": -7.085843086242676,
            "end_logit": 3.077380418777466
        },
        {
            "text": "XK protein devoid of the Kell-protein binding site. Although the E327K",
            "probability": 5.193131603274717e-06,
            "start_logit": 3.576603889465332,
            "end_logit": -7.661447525024414
        },
        {
            "text": "CONCLUSION: Known disease-causing XK",
            "probability": 3.7309485232727637e-06,
            "start_logit": -7.376314163208008,
            "end_logit": 2.9607961177825928
        },
        {
            "text": "immunohematologic characteristics of McLeod syndrome, the mutated XK",
            "probability": 3.5863401291393078e-06,
            "start_logit": -7.096442222595215,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "of McLeod syndrome, the mutated XK",
            "probability": 3.3573205563505154e-06,
            "start_logit": -7.162431240081787,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "characteristics of McLeod syndrome, the mutated XK",
            "probability": 3.0549545980723106e-06,
            "start_logit": -7.256809711456299,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "AND",
            "probability": 1.77422449945934e-08,
            "start_logit": -1.6240384578704834,
            "end_logit": -8.139948844909668
        },
        {
            "text": "E327K",
            "probability": 7.214570633454144e-09,
            "start_logit": -4.858614444732666,
            "end_logit": -5.805218696594238
        },
        {
            "text": "exon 3 (E327K).",
            "probability": 7.779243770076898e-10,
            "start_logit": -7.085843086242676,
            "end_logit": -5.805218696594238
        },
        {
            "text": "327K",
            "probability": 6.787354802156521e-10,
            "start_logit": -7.222240924835205,
            "end_logit": -5.805218696594238
        },
        {
            "text": "E327K missense mutation was associated with the immunohematologic characteristics",
            "probability": 4.5887757719598697e-10,
            "start_logit": -6.167214393615723,
            "end_logit": -7.251693248748779
        }
    ],
    "531464a6e3eabad021000014_042": [
        {
            "text": "XK",
            "probability": 0.429851948152562,
            "start_logit": 4.145132064819336,
            "end_logit": 3.093883514404297
        },
        {
            "text": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K). WBC XK",
            "probability": 0.42281627521943294,
            "start_logit": 4.145132064819336,
            "end_logit": 3.077380418777466
        },
        {
            "text": "XK protein seemed to be largely functional. These findings contribute to the understanding of the physiology of XK",
            "probability": 0.14631295532414448,
            "start_logit": 3.6144888401031494,
            "end_logit": 2.5468337535858154
        },
        {
            "text": "X",
            "probability": 0.00045511954302181933,
            "start_logit": 4.128338813781738,
            "end_logit": -3.739959239959717
        },
        {
            "text": "K",
            "probability": 0.00039415937310236714,
            "start_logit": -2.849308729171753,
            "end_logit": 3.093883514404297
        },
        {
            "text": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).",
            "probability": 5.867970410610351e-05,
            "start_logit": 4.145132064819336,
            "end_logit": -5.805218696594238
        },
        {
            "text": "(E327K). WBC XK",
            "probability": 5.198454779234815e-05,
            "start_logit": -4.858614444732666,
            "end_logit": 3.077380418777466
        },
        {
            "text": "XK missense mutation without hematologic, neuromuscular, or cerebral involvement.",
            "probability": 2.5240642441495543e-05,
            "start_logit": 3.4064154624938965,
            "end_logit": -5.910140514373779
        },
        {
            "text": "E327K missense mutation was associated with the immunohematologic characteristics of McLeod syndrome, the mutated XK",
            "probability": 9.082595945545345e-06,
            "start_logit": -6.167214393615723,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "exon 3 (E327K). WBC XK",
            "probability": 5.605329687655618e-06,
            "start_logit": -7.085843086242676,
            "end_logit": 3.077380418777466
        },
        {
            "text": "XK protein devoid of the Kell-protein binding site. Although the E327K",
            "probability": 5.193131603274717e-06,
            "start_logit": 3.576603889465332,
            "end_logit": -7.661447525024414
        },
        {
            "text": "CONCLUSION: Known disease-causing XK",
            "probability": 3.7309485232727637e-06,
            "start_logit": -7.376314163208008,
            "end_logit": 2.9607961177825928
        },
        {
            "text": "immunohematologic characteristics of McLeod syndrome, the mutated XK",
            "probability": 3.5863401291393078e-06,
            "start_logit": -7.096442222595215,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "of McLeod syndrome, the mutated XK",
            "probability": 3.3573205563505154e-06,
            "start_logit": -7.162431240081787,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "characteristics of McLeod syndrome, the mutated XK",
            "probability": 3.0549545980723106e-06,
            "start_logit": -7.256809711456299,
            "end_logit": 2.6413938999176025
        },
        {
            "text": "AND",
            "probability": 1.77422449945934e-08,
            "start_logit": -1.6240384578704834,
            "end_logit": -8.139948844909668
        },
        {
            "text": "E327K",
            "probability": 7.214570633454144e-09,
            "start_logit": -4.858614444732666,
            "end_logit": -5.805218696594238
        },
        {
            "text": "exon 3 (E327K).",
            "probability": 7.779243770076898e-10,
            "start_logit": -7.085843086242676,
            "end_logit": -5.805218696594238
        },
        {
            "text": "327K",
            "probability": 6.787354802156521e-10,
            "start_logit": -7.222240924835205,
            "end_logit": -5.805218696594238
        },
        {
            "text": "E327K missense mutation was associated with the immunohematologic characteristics",
            "probability": 4.5887757719598697e-10,
            "start_logit": -6.167214393615723,
            "end_logit": -7.251693248748779
        }
    ],
    "531464a6e3eabad021000014_043": [
        {
            "text": "XK",
            "probability": 0.998898116662412,
            "start_logit": 9.220088005065918,
            "end_logit": 8.381576538085938
        },
        {
            "text": "X-linked gene XK",
            "probability": 0.000913003796840871,
            "start_logit": 2.2224199771881104,
            "end_logit": 8.381576538085938
        },
        {
            "text": "X",
            "probability": 0.00012118318449214936,
            "start_logit": 9.220088005065918,
            "end_logit": -0.6355282068252563
        },
        {
            "text": "K",
            "probability": 5.764190876781784e-05,
            "start_logit": -0.5400701761245728,
            "end_logit": 8.381576538085938
        },
        {
            "text": "XK and autosomal recessive mutations",
            "probability": 6.506238534683643e-06,
            "start_logit": 9.220088005065918,
            "end_logit": -3.560070037841797
        },
        {
            "text": "XK and autosomal recessive",
            "probability": 1.3393859965105962e-06,
            "start_logit": 9.220088005065918,
            "end_logit": -5.140620231628418
        },
        {
            "text": "the X-linked gene XK",
            "probability": 7.476817058875184e-07,
            "start_logit": -4.885097980499268,
            "end_logit": 8.381576538085938
        },
        {
            "text": "gene XK",
            "probability": 5.915988921338291e-07,
            "start_logit": -5.119246482849121,
            "end_logit": 8.381576538085938
        },
        {
            "text": "mutations of the X-linked gene XK",
            "probability": 2.77458676689308e-07,
            "start_logit": -5.876403331756592,
            "end_logit": 8.381576538085938
        },
        {
            "text": "of the X-linked gene XK",
            "probability": 1.918367733226508e-07,
            "start_logit": -6.2454304695129395,
            "end_logit": 8.381576538085938
        },
        {
            "text": "XK and autosomal recessive mutations of the gene",
            "probability": 1.4397682103916747e-07,
            "start_logit": 9.220088005065918,
            "end_logit": -7.37093448638916
        },
        {
            "text": "their molecular bases, mutations of the X-linked gene XK",
            "probability": 1.0486040589928863e-07,
            "start_logit": -6.849445343017578,
            "end_logit": 8.381576538085938
        },
        {
            "text": "bases, mutations of the X-linked gene XK",
            "probability": 9.790754562206427e-08,
            "start_logit": -6.918051719665527,
            "end_logit": 8.381576538085938
        },
        {
            "text": "X-linked",
            "probability": 4.5157639640109065e-08,
            "start_logit": 2.2224199771881104,
            "end_logit": -1.5327593088150024
        },
        {
            "text": "X-linked gene XK and autosomal recessive mutations",
            "probability": 5.946773135549028e-09,
            "start_logit": 2.2224199771881104,
            "end_logit": -3.560070037841797
        },
        {
            "text": "X-linked gene XK and autosomal recessive",
            "probability": 1.224213440641562e-09,
            "start_logit": 2.2224199771881104,
            "end_logit": -5.140620231628418
        },
        {
            "text": "X-linked gene",
            "probability": 9.912091808350907e-10,
            "start_logit": 2.2224199771881104,
            "end_logit": -5.351748466491699
        },
        {
            "text": "X-linked gene XK and autosomal recessive mutations of the gene",
            "probability": 1.3159638813320927e-10,
            "start_logit": 2.2224199771881104,
            "end_logit": -7.37093448638916
        },
        {
            "text": "the X-linked",
            "probability": 3.698072358165152e-11,
            "start_logit": -4.885097980499268,
            "end_logit": -1.5327593088150024
        },
        {
            "text": "mutations of the X-linked",
            "probability": 1.3723249542127666e-11,
            "start_logit": -5.876403331756592,
            "end_logit": -1.5327593088150024
        }
    ],
    "531464a6e3eabad021000014_044": [
        {
            "text": "XK",
            "probability": 0.9991741911785451,
            "start_logit": 7.018604278564453,
            "end_logit": 6.0454630851745605
        },
        {
            "text": "caused by mutations of XK,",
            "probability": 0.00040337198309116693,
            "start_logit": -0.7962209582328796,
            "end_logit": 6.0454630851745605
        },
        {
            "text": "X",
            "probability": 0.00019744781416260822,
            "start_logit": 7.018604278564453,
            "end_logit": -2.4837470054626465
        },
        {
            "text": "K",
            "probability": 0.00013251111825763923,
            "start_logit": -1.9094135761260986,
            "end_logit": 6.0454630851745605
        },
        {
            "text": "Fifteen different XK",
            "probability": 5.748584380397611e-05,
            "start_logit": -2.5655882358551025,
            "end_logit": 5.866509914398193
        },
        {
            "text": "XK,",
            "probability": 9.244524823634058e-06,
            "start_logit": 7.018604278564453,
            "end_logit": -5.54518985748291
        },
        {
            "text": "of XK,",
            "probability": 8.772939125921453e-06,
            "start_logit": -4.62440824508667,
            "end_logit": 6.0454630851745605
        },
        {
            "text": "is caused by mutations of XK,",
            "probability": 4.1140962683837065e-06,
            "start_logit": -5.3816609382629395,
            "end_logit": 6.0454630851745605
        },
        {
            "text": "different XK",
            "probability": 3.624536504252452e-06,
            "start_logit": -5.329400539398193,
            "end_logit": 5.866509914398193
        },
        {
            "text": "XK, an X-chromosomal gene of unknown function.",
            "probability": 2.5622799861252288e-06,
            "start_logit": 7.018604278564453,
            "end_logit": -6.828323841094971
        },
        {
            "text": "XK, an X-chromosomal gene of unknown",
            "probability": 2.402816923688755e-06,
            "start_logit": 7.018604278564453,
            "end_logit": -6.892579555511475
        },
        {
            "text": "XK, an X-chromosomal",
            "probability": 2.29360512943027e-06,
            "start_logit": 7.018604278564453,
            "end_logit": -6.939096450805664
        },
        {
            "text": "XK mutations",
            "probability": 1.8886267348407903e-06,
            "start_logit": 6.908130645751953,
            "end_logit": -7.022897720336914
        },
        {
            "text": "novel, including the one of the eponymous case McLeod. Their common result is predicted absence or truncation of the XK",
            "probability": 5.4412913303787924e-08,
            "start_logit": -5.750240325927734,
            "end_logit": 2.0884695053100586
        },
        {
            "text": "caused by",
            "probability": 2.4883068759829278e-08,
            "start_logit": -0.7962209582328796,
            "end_logit": -3.647963762283325
        },
        {
            "text": "caused",
            "probability": 3.2350961729478374e-09,
            "start_logit": -0.7962209582328796,
            "end_logit": -5.6880927085876465
        },
        {
            "text": "caused by mutations",
            "probability": 2.091594517656945e-09,
            "start_logit": -0.7962209582328796,
            "end_logit": -6.124224662780762
        },
        {
            "text": "Fifteen",
            "probability": 2.0095339688382413e-09,
            "start_logit": -2.5655882358551025,
            "end_logit": -4.394881248474121
        },
        {
            "text": "caused by mutations of XK, an X-chromosomal gene of unknown function.",
            "probability": 1.034406180987368e-09,
            "start_logit": -0.7962209582328796,
            "end_logit": -6.828323841094971
        },
        {
            "text": "caused by mutations of XK, an X-chromosomal gene of unknown",
            "probability": 9.700300869162022e-10,
            "start_logit": -0.7962209582328796,
            "end_logit": -6.892579555511475
        }
    ],
    "531464a6e3eabad021000014_045": [
        {
            "text": "XK",
            "probability": 0.9991741911785451,
            "start_logit": 7.018604278564453,
            "end_logit": 6.0454630851745605
        },
        {
            "text": "caused by mutations of XK,",
            "probability": 0.00040337198309116693,
            "start_logit": -0.7962209582328796,
            "end_logit": 6.0454630851745605
        },
        {
            "text": "X",
            "probability": 0.00019744781416260822,
            "start_logit": 7.018604278564453,
            "end_logit": -2.4837470054626465
        },
        {
            "text": "K",
            "probability": 0.00013251111825763923,
            "start_logit": -1.9094135761260986,
            "end_logit": 6.0454630851745605
        },
        {
            "text": "Fifteen different XK",
            "probability": 5.748584380397611e-05,
            "start_logit": -2.5655882358551025,
            "end_logit": 5.866509914398193
        },
        {
            "text": "XK,",
            "probability": 9.244524823634058e-06,
            "start_logit": 7.018604278564453,
            "end_logit": -5.54518985748291
        },
        {
            "text": "of XK,",
            "probability": 8.772939125921453e-06,
            "start_logit": -4.62440824508667,
            "end_logit": 6.0454630851745605
        },
        {
            "text": "is caused by mutations of XK,",
            "probability": 4.1140962683837065e-06,
            "start_logit": -5.3816609382629395,
            "end_logit": 6.0454630851745605
        },
        {
            "text": "different XK",
            "probability": 3.624536504252452e-06,
            "start_logit": -5.329400539398193,
            "end_logit": 5.866509914398193
        },
        {
            "text": "XK, an X-chromosomal gene of unknown function.",
            "probability": 2.5622799861252288e-06,
            "start_logit": 7.018604278564453,
            "end_logit": -6.828323841094971
        },
        {
            "text": "XK, an X-chromosomal gene of unknown",
            "probability": 2.402816923688755e-06,
            "start_logit": 7.018604278564453,
            "end_logit": -6.892579555511475
        },
        {
            "text": "XK, an X-chromosomal",
            "probability": 2.29360512943027e-06,
            "start_logit": 7.018604278564453,
            "end_logit": -6.939096450805664
        },
        {
            "text": "XK mutations",
            "probability": 1.8886267348407903e-06,
            "start_logit": 6.908130645751953,
            "end_logit": -7.022897720336914
        },
        {
            "text": "novel, including the one of the eponymous case McLeod. Their common result is predicted absence or truncation of the XK",
            "probability": 5.4412913303787924e-08,
            "start_logit": -5.750240325927734,
            "end_logit": 2.0884695053100586
        },
        {
            "text": "caused by",
            "probability": 2.4883068759829278e-08,
            "start_logit": -0.7962209582328796,
            "end_logit": -3.647963762283325
        },
        {
            "text": "caused",
            "probability": 3.2350961729478374e-09,
            "start_logit": -0.7962209582328796,
            "end_logit": -5.6880927085876465
        },
        {
            "text": "caused by mutations",
            "probability": 2.091594517656945e-09,
            "start_logit": -0.7962209582328796,
            "end_logit": -6.124224662780762
        },
        {
            "text": "Fifteen",
            "probability": 2.0095339688382413e-09,
            "start_logit": -2.5655882358551025,
            "end_logit": -4.394881248474121
        },
        {
            "text": "caused by mutations of XK, an X-chromosomal gene of unknown function.",
            "probability": 1.034406180987368e-09,
            "start_logit": -0.7962209582328796,
            "end_logit": -6.828323841094971
        },
        {
            "text": "caused by mutations of XK, an X-chromosomal gene of unknown",
            "probability": 9.700300869162022e-10,
            "start_logit": -0.7962209582328796,
            "end_logit": -6.892579555511475
        }
    ],
    "531464a6e3eabad021000014_046": [
        {
            "text": "XK",
            "probability": 0.9995871462785644,
            "start_logit": 8.581084251403809,
            "end_logit": 7.636704444885254
        },
        {
            "text": "XK gene on the X-chromosome. We present six males (aged 29 to 60 years), with proven XK",
            "probability": 0.00019456862880876767,
            "start_logit": 0.03677158057689667,
            "end_logit": 7.636704444885254
        },
        {
            "text": "X",
            "probability": 0.00014147878795181415,
            "start_logit": 8.581084251403809,
            "end_logit": -1.2262433767318726
        },
        {
            "text": "K",
            "probability": 7.4924739938722e-05,
            "start_logit": -0.9175292253494263,
            "end_logit": 7.636704444885254
        },
        {
            "text": "proven XK",
            "probability": 9.530969277156255e-07,
            "start_logit": -5.282052040100098,
            "end_logit": 7.636704444885254
        },
        {
            "text": "XK mutations,",
            "probability": 1.6857882597524694e-07,
            "start_logit": 8.581084251403809,
            "end_logit": -7.958745002746582
        },
        {
            "text": "with proven XK",
            "probability": 1.5354767086798705e-07,
            "start_logit": -7.107757568359375,
            "end_logit": 7.636704444885254
        },
        {
            "text": "XK mutations, to discuss the chorea",
            "probability": 1.4281266515239274e-07,
            "start_logit": 8.581084251403809,
            "end_logit": -8.124614715576172
        },
        {
            "text": "six males (aged 29 to 60 years), with proven XK",
            "probability": 1.1243744714802569e-07,
            "start_logit": -7.419371604919434,
            "end_logit": 7.636704444885254
        },
        {
            "text": "(aged 29 to 60 years), with proven XK",
            "probability": 1.0793809263201836e-07,
            "start_logit": -7.460210800170898,
            "end_logit": 7.636704444885254
        },
        {
            "text": "XK mutations, to discuss the chorea associated with McLeod syndrome.",
            "probability": 9.968599773390583e-08,
            "start_logit": 8.581084251403809,
            "end_logit": -8.484123229980469
        },
        {
            "text": "29 to 60 years), with proven XK",
            "probability": 7.326942430646443e-08,
            "start_logit": -7.847625255584717,
            "end_logit": 7.636704444885254
        },
        {
            "text": "60 years), with proven XK",
            "probability": 7.009138702119814e-08,
            "start_logit": -7.891968727111816,
            "end_logit": 7.636704444885254
        },
        {
            "text": "XK gene on the X-chromosome. We present six males (aged 29 to 60 years), with proven XK mutations,",
            "probability": 3.2813698273642e-11,
            "start_logit": 0.03677158057689667,
            "end_logit": -7.958745002746582
        },
        {
            "text": "KX is coded for by the XK",
            "probability": 3.129546770208921e-11,
            "start_logit": -7.5965495109558105,
            "end_logit": -0.3727966845035553
        },
        {
            "text": "XK gene on the X-chromosome. We present six males (aged 29 to 60 years), with proven",
            "probability": 2.5567351868489765e-11,
            "start_logit": 0.03677158057689667,
            "end_logit": -8.208274841308594
        },
        {
            "text": "XK gene on the X-chromosome. We present six males (aged 29 to 60",
            "probability": 1.6198740114010542e-11,
            "start_logit": 0.03677158057689667,
            "end_logit": -8.664657592773438
        },
        {
            "text": "proven XK mutations,",
            "probability": 1.6073832252954858e-13,
            "start_logit": -5.282052040100098,
            "end_logit": -7.958745002746582
        },
        {
            "text": "proven XK mutations, to discuss the chorea",
            "probability": 1.3617053090606032e-13,
            "start_logit": -5.282052040100098,
            "end_logit": -8.124614715576172
        },
        {
            "text": "proven",
            "probability": 1.2524200157483905e-13,
            "start_logit": -5.282052040100098,
            "end_logit": -8.208274841308594
        }
    ],
    "531464a6e3eabad021000014_047": [
        {
            "text": "XK",
            "probability": 0.9987392387079982,
            "start_logit": 6.566129684448242,
            "end_logit": 5.251962661743164
        },
        {
            "text": "XK protein of 313 amino acids, compared with 444 amino acids in the normal XK",
            "probability": 0.0008254427706085017,
            "start_logit": 2.5655269622802734,
            "end_logit": 2.154236316680908
        },
        {
            "text": "X",
            "probability": 0.00024710297807638705,
            "start_logit": 6.566129684448242,
            "end_logit": -3.052481174468994
        },
        {
            "text": "K",
            "probability": 0.0001393119031667351,
            "start_logit": -2.31140398979187,
            "end_logit": 5.251962661743164
        },
        {
            "text": "XK gene",
            "probability": 1.0617858488693842e-05,
            "start_logit": 6.0775370597839355,
            "end_logit": -5.711156368255615
        },
        {
            "text": "XK gene mutation",
            "probability": 6.067886922515268e-06,
            "start_logit": 6.0775370597839355,
            "end_logit": -6.270683288574219
        },
        {
            "text": "XK gene revealed a novel TGG- to-TAG transition at position 1023",
            "probability": 5.822269314453146e-06,
            "start_logit": 6.566129684448242,
            "end_logit": -6.800596237182617
        },
        {
            "text": "XK gene revealed a novel TGG- to-TAG transition at position 1023 in exon 3. This point mutation",
            "probability": 5.343051587974194e-06,
            "start_logit": 6.566129684448242,
            "end_logit": -6.886489391326904
        },
        {
            "text": "XK gene revealed a novel TGG- to-TAG transition at position 1023 in exon 3.",
            "probability": 4.9001848969174895e-06,
            "start_logit": 6.566129684448242,
            "end_logit": -6.973013401031494
        },
        {
            "text": "Investigation of the patient's XK",
            "probability": 4.3671164344293044e-06,
            "start_logit": -5.774016380310059,
            "end_logit": 5.251962661743164
        },
        {
            "text": "A spontaneous novel XK",
            "probability": 4.205285564950323e-06,
            "start_logit": -5.439880847930908,
            "end_logit": 4.880066394805908
        },
        {
            "text": "novel XK",
            "probability": 2.9263675285408496e-06,
            "start_logit": -5.80246114730835,
            "end_logit": 4.880066394805908
        },
        {
            "text": "the patient's XK",
            "probability": 2.4263469994946608e-06,
            "start_logit": -6.361732482910156,
            "end_logit": 5.251962661743164
        },
        {
            "text": "patient's XK",
            "probability": 1.948926540951991e-06,
            "start_logit": -6.580840587615967,
            "end_logit": 5.251962661743164
        },
        {
            "text": "3. This point mutation creates an in-frame stop codon (W314X), and predicts a truncated XK",
            "probability": 1.0403983209565969e-07,
            "start_logit": -6.381430625915527,
            "end_logit": 2.1222925186157227
        },
        {
            "text": "(W314X), and predicts a truncated XK",
            "probability": 8.943537628390683e-08,
            "start_logit": -6.532688140869141,
            "end_logit": 2.1222925186157227
        },
        {
            "text": "This point mutation creates an in-frame stop codon (W314X), and predicts a truncated XK",
            "probability": 8.413679298682984e-08,
            "start_logit": -6.5937604904174805,
            "end_logit": 2.1222925186157227
        },
        {
            "text": "exon 3. This point mutation creates an in-frame stop codon (W314X), and predicts a truncated XK",
            "probability": 4.5973085991608075e-10,
            "start_logit": -3.962362766265869,
            "end_logit": -5.718663215637207
        },
        {
            "text": "exon 3. This point mutation",
            "probability": 1.429957708610344e-10,
            "start_logit": -3.962362766265869,
            "end_logit": -6.886489391326904
        },
        {
            "text": "exon 3.",
            "probability": 1.3114335603148945e-10,
            "start_logit": -3.962362766265869,
            "end_logit": -6.973013401031494
        }
    ],
    "531464a6e3eabad021000014_048": [
        {
            "text": "XK",
            "probability": 0.9987392387079982,
            "start_logit": 6.566129684448242,
            "end_logit": 5.251962661743164
        },
        {
            "text": "XK protein of 313 amino acids, compared with 444 amino acids in the normal XK",
            "probability": 0.0008254427706085017,
            "start_logit": 2.5655269622802734,
            "end_logit": 2.154236316680908
        },
        {
            "text": "X",
            "probability": 0.00024710297807638705,
            "start_logit": 6.566129684448242,
            "end_logit": -3.052481174468994
        },
        {
            "text": "K",
            "probability": 0.0001393119031667351,
            "start_logit": -2.31140398979187,
            "end_logit": 5.251962661743164
        },
        {
            "text": "XK gene",
            "probability": 1.0617858488693842e-05,
            "start_logit": 6.0775370597839355,
            "end_logit": -5.711156368255615
        },
        {
            "text": "XK gene mutation",
            "probability": 6.067886922515268e-06,
            "start_logit": 6.0775370597839355,
            "end_logit": -6.270683288574219
        },
        {
            "text": "XK gene revealed a novel TGG- to-TAG transition at position 1023",
            "probability": 5.822269314453146e-06,
            "start_logit": 6.566129684448242,
            "end_logit": -6.800596237182617
        },
        {
            "text": "XK gene revealed a novel TGG- to-TAG transition at position 1023 in exon 3. This point mutation",
            "probability": 5.343051587974194e-06,
            "start_logit": 6.566129684448242,
            "end_logit": -6.886489391326904
        },
        {
            "text": "XK gene revealed a novel TGG- to-TAG transition at position 1023 in exon 3.",
            "probability": 4.9001848969174895e-06,
            "start_logit": 6.566129684448242,
            "end_logit": -6.973013401031494
        },
        {
            "text": "Investigation of the patient's XK",
            "probability": 4.3671164344293044e-06,
            "start_logit": -5.774016380310059,
            "end_logit": 5.251962661743164
        },
        {
            "text": "A spontaneous novel XK",
            "probability": 4.205285564950323e-06,
            "start_logit": -5.439880847930908,
            "end_logit": 4.880066394805908
        },
        {
            "text": "novel XK",
            "probability": 2.9263675285408496e-06,
            "start_logit": -5.80246114730835,
            "end_logit": 4.880066394805908
        },
        {
            "text": "the patient's XK",
            "probability": 2.4263469994946608e-06,
            "start_logit": -6.361732482910156,
            "end_logit": 5.251962661743164
        },
        {
            "text": "patient's XK",
            "probability": 1.948926540951991e-06,
            "start_logit": -6.580840587615967,
            "end_logit": 5.251962661743164
        },
        {
            "text": "3. This point mutation creates an in-frame stop codon (W314X), and predicts a truncated XK",
            "probability": 1.0403983209565969e-07,
            "start_logit": -6.381430625915527,
            "end_logit": 2.1222925186157227
        },
        {
            "text": "(W314X), and predicts a truncated XK",
            "probability": 8.943537628390683e-08,
            "start_logit": -6.532688140869141,
            "end_logit": 2.1222925186157227
        },
        {
            "text": "This point mutation creates an in-frame stop codon (W314X), and predicts a truncated XK",
            "probability": 8.413679298682984e-08,
            "start_logit": -6.5937604904174805,
            "end_logit": 2.1222925186157227
        },
        {
            "text": "exon 3. This point mutation creates an in-frame stop codon (W314X), and predicts a truncated XK",
            "probability": 4.5973085991608075e-10,
            "start_logit": -3.962362766265869,
            "end_logit": -5.718663215637207
        },
        {
            "text": "exon 3. This point mutation",
            "probability": 1.429957708610344e-10,
            "start_logit": -3.962362766265869,
            "end_logit": -6.886489391326904
        },
        {
            "text": "exon 3.",
            "probability": 1.3114335603148945e-10,
            "start_logit": -3.962362766265869,
            "end_logit": -6.973013401031494
        }
    ],
    "531464a6e3eabad021000014_049": [
        {
            "text": "XK",
            "probability": 0.35285784278542454,
            "start_logit": 7.531887531280518,
            "end_logit": 6.512650966644287
        },
        {
            "text": "XK gene point mutation (C977T) using affinity-purified antibodies against XK",
            "probability": 0.3239441818546327,
            "start_logit": 7.531887531280518,
            "end_logit": 6.427156925201416
        },
        {
            "text": "XK gene encoding the XK",
            "probability": 0.32308801439673523,
            "start_logit": 7.538420677185059,
            "end_logit": 6.417977333068848
        },
        {
            "text": "X",
            "probability": 5.699935441101311e-05,
            "start_logit": 7.531887531280518,
            "end_logit": -2.2181296348571777
        },
        {
            "text": "K",
            "probability": 3.5286772488079506e-05,
            "start_logit": -1.6355500221252441,
            "end_logit": 6.469776153564453
        },
        {
            "text": "caused by mutations of the XK",
            "probability": 5.642695308697914e-06,
            "start_logit": -3.468696355819702,
            "end_logit": 6.469776153564453
        },
        {
            "text": "caused by mutations of the XK gene encoding the XK",
            "probability": 5.357851324802619e-06,
            "start_logit": -3.468696355819702,
            "end_logit": 6.417977333068848
        },
        {
            "text": "XK protein, a putative membrane transport protein of yet unknown function. In erythroid tissues, XK",
            "probability": 1.8258544388451393e-06,
            "start_logit": 7.5229926109313965,
            "end_logit": -5.650226593017578
        },
        {
            "text": "the XK",
            "probability": 1.3647553989611283e-06,
            "start_logit": -4.888082981109619,
            "end_logit": 6.469776153564453
        },
        {
            "text": "encoding the XK",
            "probability": 1.3457133674067018e-06,
            "start_logit": -4.850335121154785,
            "end_logit": 6.417977333068848
        },
        {
            "text": "the XK gene encoding the XK",
            "probability": 1.295862371140988e-06,
            "start_logit": -4.888082981109619,
            "end_logit": 6.417977333068848
        },
        {
            "text": "XK gene encoding",
            "probability": 4.686407986230832e-07,
            "start_logit": 7.538420677185059,
            "end_logit": -7.02562141418457
        },
        {
            "text": "against XK",
            "probability": 2.9841992351100575e-07,
            "start_logit": -6.365692615509033,
            "end_logit": 6.427156925201416
        },
        {
            "text": "XK and Kell in the McLeod muscle. Our results demonstrate that the lack of physiological XK",
            "probability": 4.066563825669109e-08,
            "start_logit": -1.067362666130066,
            "end_logit": -0.8642911911010742
        },
        {
            "text": "XK expression correlates to the type 2 fiber atrophy in McLeod myopathy, and suggest that the XK",
            "probability": 3.4257705365600665e-08,
            "start_logit": -0.6775389909744263,
            "end_logit": -1.4255868196487427
        },
        {
            "text": "XK immunohistochemistry in McLeod myopathy. The McLeod syndrome is an X-linked",
            "probability": 5.132053634652131e-11,
            "start_logit": -2.092280626296997,
            "end_logit": -6.514420986175537
        },
        {
            "text": "caused by",
            "probability": 4.048265312334984e-11,
            "start_logit": -3.468696355819702,
            "end_logit": -5.375222682952881
        },
        {
            "text": "caused by mutations",
            "probability": 1.084423200541651e-11,
            "start_logit": -3.468696355819702,
            "end_logit": -6.692462921142578
        },
        {
            "text": "caused",
            "probability": 9.613950824591631e-12,
            "start_logit": -3.468696355819702,
            "end_logit": -6.812880992889404
        },
        {
            "text": "caused by mutations of the XK gene encoding",
            "probability": 7.771590439365478e-12,
            "start_logit": -3.468696355819702,
            "end_logit": -7.02562141418457
        }
    ],
    "531464a6e3eabad021000014_050": [
        {
            "text": "XK",
            "probability": 0.35285784278542454,
            "start_logit": 7.531887531280518,
            "end_logit": 6.512650966644287
        },
        {
            "text": "XK gene point mutation (C977T) using affinity-purified antibodies against XK",
            "probability": 0.3239441818546327,
            "start_logit": 7.531887531280518,
            "end_logit": 6.427156925201416
        },
        {
            "text": "XK gene encoding the XK",
            "probability": 0.32308801439673523,
            "start_logit": 7.538420677185059,
            "end_logit": 6.417977333068848
        },
        {
            "text": "X",
            "probability": 5.699935441101311e-05,
            "start_logit": 7.531887531280518,
            "end_logit": -2.2181296348571777
        },
        {
            "text": "K",
            "probability": 3.5286772488079506e-05,
            "start_logit": -1.6355500221252441,
            "end_logit": 6.469776153564453
        },
        {
            "text": "caused by mutations of the XK",
            "probability": 5.642695308697914e-06,
            "start_logit": -3.468696355819702,
            "end_logit": 6.469776153564453
        },
        {
            "text": "caused by mutations of the XK gene encoding the XK",
            "probability": 5.357851324802619e-06,
            "start_logit": -3.468696355819702,
            "end_logit": 6.417977333068848
        },
        {
            "text": "XK protein, a putative membrane transport protein of yet unknown function. In erythroid tissues, XK",
            "probability": 1.8258544388451393e-06,
            "start_logit": 7.5229926109313965,
            "end_logit": -5.650226593017578
        },
        {
            "text": "the XK",
            "probability": 1.3647553989611283e-06,
            "start_logit": -4.888082981109619,
            "end_logit": 6.469776153564453
        },
        {
            "text": "encoding the XK",
            "probability": 1.3457133674067018e-06,
            "start_logit": -4.850335121154785,
            "end_logit": 6.417977333068848
        },
        {
            "text": "the XK gene encoding the XK",
            "probability": 1.295862371140988e-06,
            "start_logit": -4.888082981109619,
            "end_logit": 6.417977333068848
        },
        {
            "text": "XK gene encoding",
            "probability": 4.686407986230832e-07,
            "start_logit": 7.538420677185059,
            "end_logit": -7.02562141418457
        },
        {
            "text": "against XK",
            "probability": 2.9841992351100575e-07,
            "start_logit": -6.365692615509033,
            "end_logit": 6.427156925201416
        },
        {
            "text": "XK and Kell in the McLeod muscle. Our results demonstrate that the lack of physiological XK",
            "probability": 4.066563825669109e-08,
            "start_logit": -1.067362666130066,
            "end_logit": -0.8642911911010742
        },
        {
            "text": "XK expression correlates to the type 2 fiber atrophy in McLeod myopathy, and suggest that the XK",
            "probability": 3.4257705365600665e-08,
            "start_logit": -0.6775389909744263,
            "end_logit": -1.4255868196487427
        },
        {
            "text": "XK immunohistochemistry in McLeod myopathy. The McLeod syndrome is an X-linked",
            "probability": 5.132053634652131e-11,
            "start_logit": -2.092280626296997,
            "end_logit": -6.514420986175537
        },
        {
            "text": "caused by",
            "probability": 4.048265312334984e-11,
            "start_logit": -3.468696355819702,
            "end_logit": -5.375222682952881
        },
        {
            "text": "caused by mutations",
            "probability": 1.084423200541651e-11,
            "start_logit": -3.468696355819702,
            "end_logit": -6.692462921142578
        },
        {
            "text": "caused",
            "probability": 9.613950824591631e-12,
            "start_logit": -3.468696355819702,
            "end_logit": -6.812880992889404
        },
        {
            "text": "caused by mutations of the XK gene encoding",
            "probability": 7.771590439365478e-12,
            "start_logit": -3.468696355819702,
            "end_logit": -7.02562141418457
        }
    ],
    "531464a6e3eabad021000014_051": [
        {
            "text": "XK",
            "probability": 0.35285784278542454,
            "start_logit": 7.531887531280518,
            "end_logit": 6.512650966644287
        },
        {
            "text": "XK gene point mutation (C977T) using affinity-purified antibodies against XK",
            "probability": 0.3239441818546327,
            "start_logit": 7.531887531280518,
            "end_logit": 6.427156925201416
        },
        {
            "text": "XK gene encoding the XK",
            "probability": 0.32308801439673523,
            "start_logit": 7.538420677185059,
            "end_logit": 6.417977333068848
        },
        {
            "text": "X",
            "probability": 5.699935441101311e-05,
            "start_logit": 7.531887531280518,
            "end_logit": -2.2181296348571777
        },
        {
            "text": "K",
            "probability": 3.5286772488079506e-05,
            "start_logit": -1.6355500221252441,
            "end_logit": 6.469776153564453
        },
        {
            "text": "caused by mutations of the XK",
            "probability": 5.642695308697914e-06,
            "start_logit": -3.468696355819702,
            "end_logit": 6.469776153564453
        },
        {
            "text": "caused by mutations of the XK gene encoding the XK",
            "probability": 5.357851324802619e-06,
            "start_logit": -3.468696355819702,
            "end_logit": 6.417977333068848
        },
        {
            "text": "XK protein, a putative membrane transport protein of yet unknown function. In erythroid tissues, XK",
            "probability": 1.8258544388451393e-06,
            "start_logit": 7.5229926109313965,
            "end_logit": -5.650226593017578
        },
        {
            "text": "the XK",
            "probability": 1.3647553989611283e-06,
            "start_logit": -4.888082981109619,
            "end_logit": 6.469776153564453
        },
        {
            "text": "encoding the XK",
            "probability": 1.3457133674067018e-06,
            "start_logit": -4.850335121154785,
            "end_logit": 6.417977333068848
        },
        {
            "text": "the XK gene encoding the XK",
            "probability": 1.295862371140988e-06,
            "start_logit": -4.888082981109619,
            "end_logit": 6.417977333068848
        },
        {
            "text": "XK gene encoding",
            "probability": 4.686407986230832e-07,
            "start_logit": 7.538420677185059,
            "end_logit": -7.02562141418457
        },
        {
            "text": "against XK",
            "probability": 2.9841992351100575e-07,
            "start_logit": -6.365692615509033,
            "end_logit": 6.427156925201416
        },
        {
            "text": "XK and Kell in the McLeod muscle. Our results demonstrate that the lack of physiological XK",
            "probability": 4.066563825669109e-08,
            "start_logit": -1.067362666130066,
            "end_logit": -0.8642911911010742
        },
        {
            "text": "XK expression correlates to the type 2 fiber atrophy in McLeod myopathy, and suggest that the XK",
            "probability": 3.4257705365600665e-08,
            "start_logit": -0.6775389909744263,
            "end_logit": -1.4255868196487427
        },
        {
            "text": "XK immunohistochemistry in McLeod myopathy. The McLeod syndrome is an X-linked",
            "probability": 5.132053634652131e-11,
            "start_logit": -2.092280626296997,
            "end_logit": -6.514420986175537
        },
        {
            "text": "caused by",
            "probability": 4.048265312334984e-11,
            "start_logit": -3.468696355819702,
            "end_logit": -5.375222682952881
        },
        {
            "text": "caused by mutations",
            "probability": 1.084423200541651e-11,
            "start_logit": -3.468696355819702,
            "end_logit": -6.692462921142578
        },
        {
            "text": "caused",
            "probability": 9.613950824591631e-12,
            "start_logit": -3.468696355819702,
            "end_logit": -6.812880992889404
        },
        {
            "text": "caused by mutations of the XK gene encoding",
            "probability": 7.771590439365478e-12,
            "start_logit": -3.468696355819702,
            "end_logit": -7.02562141418457
        }
    ],
    "531464a6e3eabad021000014_052": [
        {
            "text": "XK",
            "probability": 0.35285784278542454,
            "start_logit": 7.531887531280518,
            "end_logit": 6.512650966644287
        },
        {
            "text": "XK gene point mutation (C977T) using affinity-purified antibodies against XK",
            "probability": 0.3239441818546327,
            "start_logit": 7.531887531280518,
            "end_logit": 6.427156925201416
        },
        {
            "text": "XK gene encoding the XK",
            "probability": 0.32308801439673523,
            "start_logit": 7.538420677185059,
            "end_logit": 6.417977333068848
        },
        {
            "text": "X",
            "probability": 5.699935441101311e-05,
            "start_logit": 7.531887531280518,
            "end_logit": -2.2181296348571777
        },
        {
            "text": "K",
            "probability": 3.5286772488079506e-05,
            "start_logit": -1.6355500221252441,
            "end_logit": 6.469776153564453
        },
        {
            "text": "caused by mutations of the XK",
            "probability": 5.642695308697914e-06,
            "start_logit": -3.468696355819702,
            "end_logit": 6.469776153564453
        },
        {
            "text": "caused by mutations of the XK gene encoding the XK",
            "probability": 5.357851324802619e-06,
            "start_logit": -3.468696355819702,
            "end_logit": 6.417977333068848
        },
        {
            "text": "XK protein, a putative membrane transport protein of yet unknown function. In erythroid tissues, XK",
            "probability": 1.8258544388451393e-06,
            "start_logit": 7.5229926109313965,
            "end_logit": -5.650226593017578
        },
        {
            "text": "the XK",
            "probability": 1.3647553989611283e-06,
            "start_logit": -4.888082981109619,
            "end_logit": 6.469776153564453
        },
        {
            "text": "encoding the XK",
            "probability": 1.3457133674067018e-06,
            "start_logit": -4.850335121154785,
            "end_logit": 6.417977333068848
        },
        {
            "text": "the XK gene encoding the XK",
            "probability": 1.295862371140988e-06,
            "start_logit": -4.888082981109619,
            "end_logit": 6.417977333068848
        },
        {
            "text": "XK gene encoding",
            "probability": 4.686407986230832e-07,
            "start_logit": 7.538420677185059,
            "end_logit": -7.02562141418457
        },
        {
            "text": "against XK",
            "probability": 2.9841992351100575e-07,
            "start_logit": -6.365692615509033,
            "end_logit": 6.427156925201416
        },
        {
            "text": "XK and Kell in the McLeod muscle. Our results demonstrate that the lack of physiological XK",
            "probability": 4.066563825669109e-08,
            "start_logit": -1.067362666130066,
            "end_logit": -0.8642911911010742
        },
        {
            "text": "XK expression correlates to the type 2 fiber atrophy in McLeod myopathy, and suggest that the XK",
            "probability": 3.4257705365600665e-08,
            "start_logit": -0.6775389909744263,
            "end_logit": -1.4255868196487427
        },
        {
            "text": "XK immunohistochemistry in McLeod myopathy. The McLeod syndrome is an X-linked",
            "probability": 5.132053634652131e-11,
            "start_logit": -2.092280626296997,
            "end_logit": -6.514420986175537
        },
        {
            "text": "caused by",
            "probability": 4.048265312334984e-11,
            "start_logit": -3.468696355819702,
            "end_logit": -5.375222682952881
        },
        {
            "text": "caused by mutations",
            "probability": 1.084423200541651e-11,
            "start_logit": -3.468696355819702,
            "end_logit": -6.692462921142578
        },
        {
            "text": "caused",
            "probability": 9.613950824591631e-12,
            "start_logit": -3.468696355819702,
            "end_logit": -6.812880992889404
        },
        {
            "text": "caused by mutations of the XK gene encoding",
            "probability": 7.771590439365478e-12,
            "start_logit": -3.468696355819702,
            "end_logit": -7.02562141418457
        }
    ],
    "531464a6e3eabad021000014_053": [
        {
            "text": "XK",
            "probability": 0.5241131530349471,
            "start_logit": 7.171385288238525,
            "end_logit": 5.999382495880127
        },
        {
            "text": "XK gene encoding the XK",
            "probability": 0.4756710544849339,
            "start_logit": 7.171385288238525,
            "end_logit": 5.902401447296143
        },
        {
            "text": "X",
            "probability": 9.93572265143301e-05,
            "start_logit": 7.171385288238525,
            "end_logit": -2.5713586807250977
        },
        {
            "text": "K",
            "probability": 6.776988618786526e-05,
            "start_logit": -1.7819596529006958,
            "end_logit": 5.999382495880127
        },
        {
            "text": "encoding the XK",
            "probability": 1.0148704457655116e-05,
            "start_logit": -3.5837504863739014,
            "end_logit": 5.902401447296143
        },
        {
            "text": "XK gene encoding",
            "probability": 6.655046585189531e-06,
            "start_logit": 7.171385288238525,
            "end_logit": -5.274704933166504
        },
        {
            "text": "the XK",
            "probability": 5.370532146831031e-06,
            "start_logit": -4.317150592803955,
            "end_logit": 5.999382495880127
        },
        {
            "text": "the XK gene encoding the XK",
            "probability": 4.874151077177823e-06,
            "start_logit": -4.317150592803955,
            "end_logit": 5.902401447296143
        },
        {
            "text": "XK gene encoding the XK protein.",
            "probability": 4.433121636166955e-06,
            "start_logit": 7.171385288238525,
            "end_logit": -5.680976390838623
        },
        {
            "text": "XK protein.",
            "probability": 4.201484349381444e-06,
            "start_logit": 7.1177191734313965,
            "end_logit": -5.680976390838623
        },
        {
            "text": "caused by mutations of the XK",
            "probability": 2.8793359374453067e-06,
            "start_logit": -4.940517902374268,
            "end_logit": 5.999382495880127
        },
        {
            "text": "caused by mutations of the XK gene encoding the XK",
            "probability": 2.613208147229327e-06,
            "start_logit": -4.940517902374268,
            "end_logit": 5.902401447296143
        },
        {
            "text": "XK gene",
            "probability": 2.4294178082437284e-06,
            "start_logit": 7.171385288238525,
            "end_logit": -6.282428741455078
        },
        {
            "text": "X-linked disorder caused by mutations of the XK",
            "probability": 1.0762165747056845e-06,
            "start_logit": -5.924625873565674,
            "end_logit": 5.999382495880127
        },
        {
            "text": "X-linked disorder caused by mutations of the XK gene encoding the XK",
            "probability": 9.767453268059504e-07,
            "start_logit": -5.924625873565674,
            "end_logit": 5.902401447296143
        },
        {
            "text": "of the XK",
            "probability": 6.630014397833475e-07,
            "start_logit": -6.409055709838867,
            "end_logit": 5.999382495880127
        },
        {
            "text": "The McLeod syndrome is an X-linked disorder caused by mutations of the XK",
            "probability": 6.44836699585054e-07,
            "start_logit": -6.436835765838623,
            "end_logit": 5.999382495880127
        },
        {
            "text": "of the XK gene encoding the XK",
            "probability": 6.017223421327604e-07,
            "start_logit": -6.409055709838867,
            "end_logit": 5.902401447296143
        },
        {
            "text": "The McLeod syndrome is an X-linked disorder caused by mutations of the XK gene encoding the XK",
            "probability": 5.852365106390583e-07,
            "start_logit": -6.436835765838623,
            "end_logit": 5.902401447296143
        },
        {
            "text": "gene encoding the XK",
            "probability": 5.126063779282165e-07,
            "start_logit": -6.569343566894531,
            "end_logit": 5.902401447296143
        }
    ],
    "531464a6e3eabad021000014_054": [
        {
            "text": "XK",
            "probability": 0.5241131530349471,
            "start_logit": 7.171385288238525,
            "end_logit": 5.999382495880127
        },
        {
            "text": "XK gene encoding the XK",
            "probability": 0.4756710544849339,
            "start_logit": 7.171385288238525,
            "end_logit": 5.902401447296143
        },
        {
            "text": "X",
            "probability": 9.93572265143301e-05,
            "start_logit": 7.171385288238525,
            "end_logit": -2.5713586807250977
        },
        {
            "text": "K",
            "probability": 6.776988618786526e-05,
            "start_logit": -1.7819596529006958,
            "end_logit": 5.999382495880127
        },
        {
            "text": "encoding the XK",
            "probability": 1.0148704457655116e-05,
            "start_logit": -3.5837504863739014,
            "end_logit": 5.902401447296143
        },
        {
            "text": "XK gene encoding",
            "probability": 6.655046585189531e-06,
            "start_logit": 7.171385288238525,
            "end_logit": -5.274704933166504
        },
        {
            "text": "the XK",
            "probability": 5.370532146831031e-06,
            "start_logit": -4.317150592803955,
            "end_logit": 5.999382495880127
        },
        {
            "text": "the XK gene encoding the XK",
            "probability": 4.874151077177823e-06,
            "start_logit": -4.317150592803955,
            "end_logit": 5.902401447296143
        },
        {
            "text": "XK gene encoding the XK protein.",
            "probability": 4.433121636166955e-06,
            "start_logit": 7.171385288238525,
            "end_logit": -5.680976390838623
        },
        {
            "text": "XK protein.",
            "probability": 4.201484349381444e-06,
            "start_logit": 7.1177191734313965,
            "end_logit": -5.680976390838623
        },
        {
            "text": "caused by mutations of the XK",
            "probability": 2.8793359374453067e-06,
            "start_logit": -4.940517902374268,
            "end_logit": 5.999382495880127
        },
        {
            "text": "caused by mutations of the XK gene encoding the XK",
            "probability": 2.613208147229327e-06,
            "start_logit": -4.940517902374268,
            "end_logit": 5.902401447296143
        },
        {
            "text": "XK gene",
            "probability": 2.4294178082437284e-06,
            "start_logit": 7.171385288238525,
            "end_logit": -6.282428741455078
        },
        {
            "text": "X-linked disorder caused by mutations of the XK",
            "probability": 1.0762165747056845e-06,
            "start_logit": -5.924625873565674,
            "end_logit": 5.999382495880127
        },
        {
            "text": "X-linked disorder caused by mutations of the XK gene encoding the XK",
            "probability": 9.767453268059504e-07,
            "start_logit": -5.924625873565674,
            "end_logit": 5.902401447296143
        },
        {
            "text": "of the XK",
            "probability": 6.630014397833475e-07,
            "start_logit": -6.409055709838867,
            "end_logit": 5.999382495880127
        },
        {
            "text": "The McLeod syndrome is an X-linked disorder caused by mutations of the XK",
            "probability": 6.44836699585054e-07,
            "start_logit": -6.436835765838623,
            "end_logit": 5.999382495880127
        },
        {
            "text": "of the XK gene encoding the XK",
            "probability": 6.017223421327604e-07,
            "start_logit": -6.409055709838867,
            "end_logit": 5.902401447296143
        },
        {
            "text": "The McLeod syndrome is an X-linked disorder caused by mutations of the XK gene encoding the XK",
            "probability": 5.852365106390583e-07,
            "start_logit": -6.436835765838623,
            "end_logit": 5.902401447296143
        },
        {
            "text": "gene encoding the XK",
            "probability": 5.126063779282165e-07,
            "start_logit": -6.569343566894531,
            "end_logit": 5.902401447296143
        }
    ],
    "531464a6e3eabad021000014_055": [
        {
            "text": "XK",
            "probability": 0.5241131530349471,
            "start_logit": 7.171385288238525,
            "end_logit": 5.999382495880127
        },
        {
            "text": "XK gene encoding the XK",
            "probability": 0.4756710544849339,
            "start_logit": 7.171385288238525,
            "end_logit": 5.902401447296143
        },
        {
            "text": "X",
            "probability": 9.93572265143301e-05,
            "start_logit": 7.171385288238525,
            "end_logit": -2.5713586807250977
        },
        {
            "text": "K",
            "probability": 6.776988618786526e-05,
            "start_logit": -1.7819596529006958,
            "end_logit": 5.999382495880127
        },
        {
            "text": "encoding the XK",
            "probability": 1.0148704457655116e-05,
            "start_logit": -3.5837504863739014,
            "end_logit": 5.902401447296143
        },
        {
            "text": "XK gene encoding",
            "probability": 6.655046585189531e-06,
            "start_logit": 7.171385288238525,
            "end_logit": -5.274704933166504
        },
        {
            "text": "the XK",
            "probability": 5.370532146831031e-06,
            "start_logit": -4.317150592803955,
            "end_logit": 5.999382495880127
        },
        {
            "text": "the XK gene encoding the XK",
            "probability": 4.874151077177823e-06,
            "start_logit": -4.317150592803955,
            "end_logit": 5.902401447296143
        },
        {
            "text": "XK gene encoding the XK protein.",
            "probability": 4.433121636166955e-06,
            "start_logit": 7.171385288238525,
            "end_logit": -5.680976390838623
        },
        {
            "text": "XK protein.",
            "probability": 4.201484349381444e-06,
            "start_logit": 7.1177191734313965,
            "end_logit": -5.680976390838623
        },
        {
            "text": "caused by mutations of the XK",
            "probability": 2.8793359374453067e-06,
            "start_logit": -4.940517902374268,
            "end_logit": 5.999382495880127
        },
        {
            "text": "caused by mutations of the XK gene encoding the XK",
            "probability": 2.613208147229327e-06,
            "start_logit": -4.940517902374268,
            "end_logit": 5.902401447296143
        },
        {
            "text": "XK gene",
            "probability": 2.4294178082437284e-06,
            "start_logit": 7.171385288238525,
            "end_logit": -6.282428741455078
        },
        {
            "text": "X-linked disorder caused by mutations of the XK",
            "probability": 1.0762165747056845e-06,
            "start_logit": -5.924625873565674,
            "end_logit": 5.999382495880127
        },
        {
            "text": "X-linked disorder caused by mutations of the XK gene encoding the XK",
            "probability": 9.767453268059504e-07,
            "start_logit": -5.924625873565674,
            "end_logit": 5.902401447296143
        },
        {
            "text": "of the XK",
            "probability": 6.630014397833475e-07,
            "start_logit": -6.409055709838867,
            "end_logit": 5.999382495880127
        },
        {
            "text": "The McLeod syndrome is an X-linked disorder caused by mutations of the XK",
            "probability": 6.44836699585054e-07,
            "start_logit": -6.436835765838623,
            "end_logit": 5.999382495880127
        },
        {
            "text": "of the XK gene encoding the XK",
            "probability": 6.017223421327604e-07,
            "start_logit": -6.409055709838867,
            "end_logit": 5.902401447296143
        },
        {
            "text": "The McLeod syndrome is an X-linked disorder caused by mutations of the XK gene encoding the XK",
            "probability": 5.852365106390583e-07,
            "start_logit": -6.436835765838623,
            "end_logit": 5.902401447296143
        },
        {
            "text": "gene encoding the XK",
            "probability": 5.126063779282165e-07,
            "start_logit": -6.569343566894531,
            "end_logit": 5.902401447296143
        }
    ],
    "531464a6e3eabad021000014_056": [
        {
            "text": "XK",
            "probability": 0.9991959786439674,
            "start_logit": 6.084327697753906,
            "end_logit": 4.797481060028076
        },
        {
            "text": "X",
            "probability": 0.0004330921982044375,
            "start_logit": 6.084327697753906,
            "end_logit": -2.946274518966675
        },
        {
            "text": "K",
            "probability": 0.00030804612584707026,
            "start_logit": -2.000128984451294,
            "end_logit": 4.797481060028076
        },
        {
            "text": "XK protein was absent from the RBC membranes. The XK",
            "probability": 3.573670952206313e-05,
            "start_logit": -4.154200077056885,
            "end_logit": 4.797481060028076
        },
        {
            "text": "The XK",
            "probability": 1.3850667913218722e-05,
            "start_logit": -5.102045059204102,
            "end_logit": 4.797481060028076
        },
        {
            "text": "XK gene had a point mutation",
            "probability": 4.872165112579127e-06,
            "start_logit": 6.084327697753906,
            "end_logit": -7.43368673324585
        },
        {
            "text": "XK gene",
            "probability": 3.7260617721614873e-06,
            "start_logit": 6.084327697753906,
            "end_logit": -7.701873302459717
        },
        {
            "text": "XK gene had a point mutation in the donor splice site of intron 1",
            "probability": 2.145951558371075e-06,
            "start_logit": 6.084327697753906,
            "end_logit": -8.253642082214355
        },
        {
            "text": "XK gene had a point mutation in the donor splice site of intron 1 (G>C). CONCLUSION:",
            "probability": 1.4985514501712544e-06,
            "start_logit": 6.084327697753906,
            "end_logit": -8.612726211547852
        },
        {
            "text": "XK gene had a point",
            "probability": 1.0439937623612813e-06,
            "start_logit": 6.084327697753906,
            "end_logit": -8.97417163848877
        },
        {
            "text": "Kx",
            "probability": 7.890577517733161e-09,
            "start_logit": -3.409212112426758,
            "end_logit": -4.365771293640137
        },
        {
            "text": "anti-Kx in a person with the McLeod phenotype and without chronic granulomatous disease. BACKGROUND: Kx",
            "probability": 2.933440382872938e-10,
            "start_logit": -6.701290607452393,
            "end_logit": -4.365771293640137
        },
        {
            "text": "XK protein was absent from the RBC membranes. The XK gene had a point mutation",
            "probability": 1.7425525431764251e-10,
            "start_logit": -4.154200077056885,
            "end_logit": -7.43368673324585
        },
        {
            "text": "XK protein was absent from the RBC membranes. The XK gene",
            "probability": 1.3326433458400184e-10,
            "start_logit": -4.154200077056885,
            "end_logit": -7.701873302459717
        },
        {
            "text": "BACKGROUND: Kx",
            "probability": 1.2290082114936515e-10,
            "start_logit": -7.571259021759033,
            "end_logit": -4.365771293640137
        },
        {
            "text": "Kx is lacking",
            "probability": 8.183809877763102e-11,
            "start_logit": -3.409212112426758,
            "end_logit": -8.934453010559082
        },
        {
            "text": "XK protein was absent from the RBC membranes. The",
            "probability": 7.818423975135557e-11,
            "start_logit": -4.154200077056885,
            "end_logit": -8.235139846801758
        },
        {
            "text": "The XK gene had a point mutation",
            "probability": 6.753704221696912e-11,
            "start_logit": -5.102045059204102,
            "end_logit": -7.43368673324585
        },
        {
            "text": "The XK gene",
            "probability": 5.1649971910802776e-11,
            "start_logit": -5.102045059204102,
            "end_logit": -7.701873302459717
        },
        {
            "text": "XK protein was absent from the RBC membranes. The XK gene had a point",
            "probability": 3.733892311995061e-11,
            "start_logit": -4.154200077056885,
            "end_logit": -8.97417163848877
        }
    ],
    "531464a6e3eabad021000014_057": [
        {
            "text": "XK",
            "probability": 0.9996899962489562,
            "start_logit": 6.967434883117676,
            "end_logit": 5.805670738220215
        },
        {
            "text": "X",
            "probability": 0.00017280601129365558,
            "start_logit": 6.967434883117676,
            "end_logit": -2.8573601245880127
        },
        {
            "text": "K",
            "probability": 0.00012802172424556478,
            "start_logit": -1.99556565284729,
            "end_logit": 5.805670738220215
        },
        {
            "text": "the XK",
            "probability": 3.235879780797105e-06,
            "start_logit": -5.673464775085449,
            "end_logit": 5.805670738220215
        },
        {
            "text": "exon 2 of the XK",
            "probability": 2.47999067660986e-06,
            "start_logit": -5.939510822296143,
            "end_logit": 5.805670738220215
        },
        {
            "text": "XK gene, which resulted in a 3'-frameshift.",
            "probability": 1.4417769921580873e-06,
            "start_logit": 6.967434883117676,
            "end_logit": -7.643653392791748
        },
        {
            "text": "XK gene,",
            "probability": 1.182368637859434e-06,
            "start_logit": 6.967434883117676,
            "end_logit": -7.842010021209717
        },
        {
            "text": "codon 151 in exon 2 of the XK",
            "probability": 8.350952745665746e-07,
            "start_logit": -7.027975082397461,
            "end_logit": 5.805670738220215
        },
        {
            "text": "Only four",
            "probability": 2.6356569632238325e-10,
            "start_logit": -4.545083522796631,
            "end_logit": -4.738219261169434
        },
        {
            "text": "four",
            "probability": 2.5298131798434187e-10,
            "start_logit": -4.586070537567139,
            "end_logit": -4.738219261169434
        },
        {
            "text": "Only four mutations",
            "probability": 9.648843766010312e-11,
            "start_logit": -4.545083522796631,
            "end_logit": -5.743098735809326
        },
        {
            "text": "four mutations",
            "probability": 9.261361577056605e-11,
            "start_logit": -4.586070537567139,
            "end_logit": -5.743098735809326
        },
        {
            "text": "A novel mutation of the McLeod syndrome",
            "probability": 3.1331797278051884e-11,
            "start_logit": -6.200523853302002,
            "end_logit": -5.2124481201171875
        },
        {
            "text": "hyperCKemia, and acanthocytosis. Only four",
            "probability": 3.1206521130106524e-11,
            "start_logit": -6.6787590980529785,
            "end_logit": -4.738219261169434
        },
        {
            "text": "areflexia, hyperCKemia, and acanthocytosis. Only four",
            "probability": 2.5464409841520238e-11,
            "start_logit": -6.882104396820068,
            "end_logit": -4.738219261169434
        },
        {
            "text": "chorea, myopathy, cardiomyopathy, areflexia, hyperCKemia, and acanthocytosis. Only four",
            "probability": 2.5162628610740442e-11,
            "start_logit": -6.894026279449463,
            "end_logit": -4.738219261169434
        },
        {
            "text": "Only four mutations have been reported in the gene",
            "probability": 2.502516695947156e-11,
            "start_logit": -4.545083522796631,
            "end_logit": -7.092639923095703
        },
        {
            "text": "four mutations have been reported in the gene",
            "probability": 2.4020196135242167e-11,
            "start_logit": -4.586070537567139,
            "end_logit": -7.092639923095703
        },
        {
            "text": "the gene",
            "probability": 2.1587109049784348e-11,
            "start_logit": -4.692869186401367,
            "end_logit": -7.092639923095703
        },
        {
            "text": "A novel mutation",
            "probability": 1.469573338786228e-11,
            "start_logit": -6.200523853302002,
            "end_logit": -5.969524383544922
        }
    ],
    "531464a6e3eabad021000014_058": [
        {
            "text": "XK",
            "probability": 0.9998426946496554,
            "start_logit": 8.6482572555542,
            "end_logit": 7.709928035736084
        },
        {
            "text": "X",
            "probability": 9.407593516185018e-05,
            "start_logit": 8.6482572555542,
            "end_logit": -1.5613229274749756
        },
        {
            "text": "K",
            "probability": 5.770036418438152e-05,
            "start_logit": -1.1118324995040894,
            "end_logit": 7.709928035736084
        },
        {
            "text": "caused by XK",
            "probability": 3.6777705403828488e-06,
            "start_logit": -3.8647892475128174,
            "end_logit": 7.709928035736084
        },
        {
            "text": "XK gene",
            "probability": 1.0870533294488082e-06,
            "start_logit": 8.6482572555542,
            "end_logit": -6.021954536437988
        },
        {
            "text": "XK gene defects",
            "probability": 3.555441198196474e-07,
            "start_logit": 8.6482572555542,
            "end_logit": -7.139531135559082
        },
        {
            "text": "XK gene defects and may include large deletions in the Xp21 region.",
            "probability": 2.1457099238003948e-07,
            "start_logit": 8.6482572555542,
            "end_logit": -7.644539833068848
        },
        {
            "text": "It is caused by XK",
            "probability": 1.0484351539409752e-07,
            "start_logit": -7.422382354736328,
            "end_logit": 7.709928035736084
        },
        {
            "text": "is caused by XK",
            "probability": 8.175545434768032e-08,
            "start_logit": -7.67111873626709,
            "end_logit": 7.709928035736084
        },
        {
            "text": "XK to RPGR loci (patient Bi) and from the XK",
            "probability": 6.760222826971188e-09,
            "start_logit": -0.5567955374717712,
            "end_logit": -1.8970718383789062
        },
        {
            "text": "ETX1 locus (patient Be), from the XK to RPGR loci (patient Bi) and from the XK",
            "probability": 3.522547035959734e-10,
            "start_logit": -3.5112521648406982,
            "end_logit": -1.8970718383789062
        },
        {
            "text": "ETX1 locus (patient Be), from the XK",
            "probability": 2.714111869474055e-10,
            "start_logit": -3.5112521648406982,
            "end_logit": -2.1577913761138916
        },
        {
            "text": "ETX1",
            "probability": 5.398479478621541e-11,
            "start_logit": -3.5112521648406982,
            "end_logit": -3.772723913192749
        },
        {
            "text": "Xp21 region. Analysis of three unrelated McLeod patients for the presence of the XK,",
            "probability": 4.6166681402977454e-11,
            "start_logit": -5.140055179595947,
            "end_logit": -2.3003649711608887
        },
        {
            "text": "XK, DMD, CYBB, ETX1,",
            "probability": 1.7579505130721247e-11,
            "start_logit": -0.4459637999534607,
            "end_logit": -7.9599809646606445
        },
        {
            "text": "caused by",
            "probability": 4.143949627161627e-12,
            "start_logit": -3.8647892475128174,
            "end_logit": -5.986239910125732
        },
        {
            "text": "caused by XK gene",
            "probability": 3.998561706021959e-12,
            "start_logit": -3.8647892475128174,
            "end_logit": -6.021954536437988
        },
        {
            "text": "caused by XK gene defects",
            "probability": 1.3078154160412555e-12,
            "start_logit": -3.8647892475128174,
            "end_logit": -7.139531135559082
        },
        {
            "text": "ETX",
            "probability": 1.1871035062606524e-12,
            "start_logit": -3.5112521648406982,
            "end_logit": -7.58991003036499
        },
        {
            "text": "caused by XK gene defects and may include large deletions in the Xp21 region.",
            "probability": 7.892670305227738e-13,
            "start_logit": -3.8647892475128174,
            "end_logit": -7.644539833068848
        }
    ],
    "531464a6e3eabad021000014_059": [
        {
            "text": "XK gene (XK)",
            "probability": 0.5056947436505722,
            "start_logit": 7.457155227661133,
            "end_logit": 6.416461944580078
        },
        {
            "text": "XK",
            "probability": 0.4941756455724337,
            "start_logit": 7.457155227661133,
            "end_logit": 6.3934197425842285
        },
        {
            "text": "X",
            "probability": 7.177056959677648e-05,
            "start_logit": 7.457155227661133,
            "end_logit": -2.4437520503997803
        },
        {
            "text": "K",
            "probability": 4.6280845190735566e-05,
            "start_logit": -1.841805100440979,
            "end_logit": 6.416461944580078
        },
        {
            "text": "(XK)",
            "probability": 5.0042627211571e-06,
            "start_logit": -4.0662431716918945,
            "end_logit": 6.416461944580078
        },
        {
            "text": "the XK gene (XK)",
            "probability": 1.3893976938079127e-06,
            "start_logit": -5.347662925720215,
            "end_logit": 6.416461944580078
        },
        {
            "text": "the XK",
            "probability": 1.3577489402753433e-06,
            "start_logit": -5.347662925720215,
            "end_logit": 6.3934197425842285
        },
        {
            "text": "XK. This deletion",
            "probability": 7.170360498993003e-07,
            "start_logit": 7.358135223388672,
            "end_logit": -6.950835704803467
        },
        {
            "text": "XK.",
            "probability": 4.566183439781891e-07,
            "start_logit": 7.358135223388672,
            "end_logit": -7.402113914489746
        },
        {
            "text": "a novel mutation in the XK gene (XK)",
            "probability": 4.4675365534680633e-07,
            "start_logit": -6.48228120803833,
            "end_logit": 6.416461944580078
        },
        {
            "text": "1095 in XK.",
            "probability": 4.460074005372061e-07,
            "start_logit": -6.395167827606201,
            "end_logit": 6.327676773071289
        },
        {
            "text": "a novel mutation in the XK",
            "probability": 4.3657716204265074e-07,
            "start_logit": -6.48228120803833,
            "end_logit": 6.3934197425842285
        },
        {
            "text": "XK. This deletion caused a frameshift in translation, leading to a premature stop codon",
            "probability": 2.7974344991814947e-07,
            "start_logit": 7.358135223388672,
            "end_logit": -7.892088890075684
        },
        {
            "text": "mutation in the XK gene (XK)",
            "probability": 2.7683155548165713e-07,
            "start_logit": -6.960879325866699,
            "end_logit": 6.416461944580078
        },
        {
            "text": "mutation in the XK",
            "probability": 2.705256765324381e-07,
            "start_logit": -6.960879325866699,
            "end_logit": 6.3934197425842285
        },
        {
            "text": "novel mutation in the XK gene (XK)",
            "probability": 2.4168093199114514e-07,
            "start_logit": -7.096670150756836,
            "end_logit": 6.416461944580078
        },
        {
            "text": "novel mutation in the XK",
            "probability": 2.361757405803648e-07,
            "start_logit": -7.096670150756836,
            "end_logit": 6.3934197425842285
        },
        {
            "text": "This deletion",
            "probability": 1.5266896334737895e-12,
            "start_logit": -5.701644420623779,
            "end_logit": -6.950835704803467
        },
        {
            "text": "1095 in XK. This deletion",
            "probability": 7.630576802649285e-13,
            "start_logit": -6.395167827606201,
            "end_logit": -6.950835704803467
        },
        {
            "text": "This deletion caused a frameshift in translation, leading to a premature stop codon",
            "probability": 5.956205759559953e-13,
            "start_logit": -5.701644420623779,
            "end_logit": -7.892088890075684
        }
    ],
    "531464a6e3eabad021000014_060": [
        {
            "text": "XK gene (XK)",
            "probability": 0.5056947436505722,
            "start_logit": 7.457155227661133,
            "end_logit": 6.416461944580078
        },
        {
            "text": "XK",
            "probability": 0.4941756455724337,
            "start_logit": 7.457155227661133,
            "end_logit": 6.3934197425842285
        },
        {
            "text": "X",
            "probability": 7.177056959677648e-05,
            "start_logit": 7.457155227661133,
            "end_logit": -2.4437520503997803
        },
        {
            "text": "K",
            "probability": 4.6280845190735566e-05,
            "start_logit": -1.841805100440979,
            "end_logit": 6.416461944580078
        },
        {
            "text": "(XK)",
            "probability": 5.0042627211571e-06,
            "start_logit": -4.0662431716918945,
            "end_logit": 6.416461944580078
        },
        {
            "text": "the XK gene (XK)",
            "probability": 1.3893976938079127e-06,
            "start_logit": -5.347662925720215,
            "end_logit": 6.416461944580078
        },
        {
            "text": "the XK",
            "probability": 1.3577489402753433e-06,
            "start_logit": -5.347662925720215,
            "end_logit": 6.3934197425842285
        },
        {
            "text": "XK. This deletion",
            "probability": 7.170360498993003e-07,
            "start_logit": 7.358135223388672,
            "end_logit": -6.950835704803467
        },
        {
            "text": "XK.",
            "probability": 4.566183439781891e-07,
            "start_logit": 7.358135223388672,
            "end_logit": -7.402113914489746
        },
        {
            "text": "a novel mutation in the XK gene (XK)",
            "probability": 4.4675365534680633e-07,
            "start_logit": -6.48228120803833,
            "end_logit": 6.416461944580078
        },
        {
            "text": "1095 in XK.",
            "probability": 4.460074005372061e-07,
            "start_logit": -6.395167827606201,
            "end_logit": 6.327676773071289
        },
        {
            "text": "a novel mutation in the XK",
            "probability": 4.3657716204265074e-07,
            "start_logit": -6.48228120803833,
            "end_logit": 6.3934197425842285
        },
        {
            "text": "XK. This deletion caused a frameshift in translation, leading to a premature stop codon",
            "probability": 2.7974344991814947e-07,
            "start_logit": 7.358135223388672,
            "end_logit": -7.892088890075684
        },
        {
            "text": "mutation in the XK gene (XK)",
            "probability": 2.7683155548165713e-07,
            "start_logit": -6.960879325866699,
            "end_logit": 6.416461944580078
        },
        {
            "text": "mutation in the XK",
            "probability": 2.705256765324381e-07,
            "start_logit": -6.960879325866699,
            "end_logit": 6.3934197425842285
        },
        {
            "text": "novel mutation in the XK gene (XK)",
            "probability": 2.4168093199114514e-07,
            "start_logit": -7.096670150756836,
            "end_logit": 6.416461944580078
        },
        {
            "text": "novel mutation in the XK",
            "probability": 2.361757405803648e-07,
            "start_logit": -7.096670150756836,
            "end_logit": 6.3934197425842285
        },
        {
            "text": "This deletion",
            "probability": 1.5266896334737895e-12,
            "start_logit": -5.701644420623779,
            "end_logit": -6.950835704803467
        },
        {
            "text": "1095 in XK. This deletion",
            "probability": 7.630576802649285e-13,
            "start_logit": -6.395167827606201,
            "end_logit": -6.950835704803467
        },
        {
            "text": "This deletion caused a frameshift in translation, leading to a premature stop codon",
            "probability": 5.956205759559953e-13,
            "start_logit": -5.701644420623779,
            "end_logit": -7.892088890075684
        }
    ],
    "531464a6e3eabad021000014_061": [
        {
            "text": "XK gene (XK)",
            "probability": 0.5056947436505722,
            "start_logit": 7.457155227661133,
            "end_logit": 6.416461944580078
        },
        {
            "text": "XK",
            "probability": 0.4941756455724337,
            "start_logit": 7.457155227661133,
            "end_logit": 6.3934197425842285
        },
        {
            "text": "X",
            "probability": 7.177056959677648e-05,
            "start_logit": 7.457155227661133,
            "end_logit": -2.4437520503997803
        },
        {
            "text": "K",
            "probability": 4.6280845190735566e-05,
            "start_logit": -1.841805100440979,
            "end_logit": 6.416461944580078
        },
        {
            "text": "(XK)",
            "probability": 5.0042627211571e-06,
            "start_logit": -4.0662431716918945,
            "end_logit": 6.416461944580078
        },
        {
            "text": "the XK gene (XK)",
            "probability": 1.3893976938079127e-06,
            "start_logit": -5.347662925720215,
            "end_logit": 6.416461944580078
        },
        {
            "text": "the XK",
            "probability": 1.3577489402753433e-06,
            "start_logit": -5.347662925720215,
            "end_logit": 6.3934197425842285
        },
        {
            "text": "XK. This deletion",
            "probability": 7.170360498993003e-07,
            "start_logit": 7.358135223388672,
            "end_logit": -6.950835704803467
        },
        {
            "text": "XK.",
            "probability": 4.566183439781891e-07,
            "start_logit": 7.358135223388672,
            "end_logit": -7.402113914489746
        },
        {
            "text": "a novel mutation in the XK gene (XK)",
            "probability": 4.4675365534680633e-07,
            "start_logit": -6.48228120803833,
            "end_logit": 6.416461944580078
        },
        {
            "text": "1095 in XK.",
            "probability": 4.460074005372061e-07,
            "start_logit": -6.395167827606201,
            "end_logit": 6.327676773071289
        },
        {
            "text": "a novel mutation in the XK",
            "probability": 4.3657716204265074e-07,
            "start_logit": -6.48228120803833,
            "end_logit": 6.3934197425842285
        },
        {
            "text": "XK. This deletion caused a frameshift in translation, leading to a premature stop codon",
            "probability": 2.7974344991814947e-07,
            "start_logit": 7.358135223388672,
            "end_logit": -7.892088890075684
        },
        {
            "text": "mutation in the XK gene (XK)",
            "probability": 2.7683155548165713e-07,
            "start_logit": -6.960879325866699,
            "end_logit": 6.416461944580078
        },
        {
            "text": "mutation in the XK",
            "probability": 2.705256765324381e-07,
            "start_logit": -6.960879325866699,
            "end_logit": 6.3934197425842285
        },
        {
            "text": "novel mutation in the XK gene (XK)",
            "probability": 2.4168093199114514e-07,
            "start_logit": -7.096670150756836,
            "end_logit": 6.416461944580078
        },
        {
            "text": "novel mutation in the XK",
            "probability": 2.361757405803648e-07,
            "start_logit": -7.096670150756836,
            "end_logit": 6.3934197425842285
        },
        {
            "text": "This deletion",
            "probability": 1.5266896334737895e-12,
            "start_logit": -5.701644420623779,
            "end_logit": -6.950835704803467
        },
        {
            "text": "1095 in XK. This deletion",
            "probability": 7.630576802649285e-13,
            "start_logit": -6.395167827606201,
            "end_logit": -6.950835704803467
        },
        {
            "text": "This deletion caused a frameshift in translation, leading to a premature stop codon",
            "probability": 5.956205759559953e-13,
            "start_logit": -5.701644420623779,
            "end_logit": -7.892088890075684
        }
    ],
    "531464a6e3eabad021000014_062": [
        {
            "text": "XK",
            "probability": 0.9632087046105141,
            "start_logit": 5.504722595214844,
            "end_logit": 4.35614538192749
        },
        {
            "text": "XK, correlates closely to the McLeod phenotype. XK",
            "probability": 0.03600623264489746,
            "start_logit": 5.504722595214844,
            "end_logit": 1.069567322731018
        },
        {
            "text": "X",
            "probability": 0.00042378562099018384,
            "start_logit": 5.504722595214844,
            "end_logit": -3.372652292251587
        },
        {
            "text": "K",
            "probability": 0.00029203020392095156,
            "start_logit": -2.5964455604553223,
            "end_logit": 4.35614538192749
        },
        {
            "text": "designated as XK,",
            "probability": 3.336288802553143e-05,
            "start_logit": -4.7658586502075195,
            "end_logit": 4.35614538192749
        },
        {
            "text": "The mRNA expression pattern of one of them, designated as XK,",
            "probability": 8.694638884074896e-06,
            "start_logit": -6.110596179962158,
            "end_logit": 4.35614538192749
        },
        {
            "text": "XK is responsible",
            "probability": 6.705295573525343e-06,
            "start_logit": 5.295895099639893,
            "end_logit": -7.310154914855957
        },
        {
            "text": "one of them, designated as XK,",
            "probability": 6.336276579275627e-06,
            "start_logit": -6.427011489868164,
            "end_logit": 4.35614538192749
        },
        {
            "text": "point mutations at conserved splice donor and acceptor sites. These findings provide direct evidence that XK",
            "probability": 4.032346178743266e-06,
            "start_logit": -6.732981204986572,
            "end_logit": 4.210172176361084
        },
        {
            "text": "as XK,",
            "probability": 3.663803193929613e-06,
            "start_logit": -6.974801063537598,
            "end_logit": 4.35614538192749
        },
        {
            "text": "pattern of one of them, designated as XK,",
            "probability": 2.27303344162741e-06,
            "start_logit": -7.452187538146973,
            "end_logit": 4.35614538192749
        },
        {
            "text": "that XK",
            "probability": 1.8823875475214777e-06,
            "start_logit": -7.494788646697998,
            "end_logit": 4.210172176361084
        },
        {
            "text": "designated as XK, correlates closely to the McLeod phenotype. XK",
            "probability": 1.2471564077472682e-06,
            "start_logit": -4.7658586502075195,
            "end_logit": 1.069567322731018
        },
        {
            "text": "The mRNA expression pattern of one of them, designated as XK, correlates closely to the McLeod phenotype. XK",
            "probability": 3.250190627689174e-07,
            "start_logit": -6.110596179962158,
            "end_logit": 1.069567322731018
        },
        {
            "text": "one of them, designated as XK, correlates closely to the McLeod phenotype. XK",
            "probability": 2.3685982853328435e-07,
            "start_logit": -6.427011489868164,
            "end_logit": 1.069567322731018
        },
        {
            "text": "as XK, correlates closely to the McLeod phenotype. XK",
            "probability": 1.3695863579128624e-07,
            "start_logit": -6.974801063537598,
            "end_logit": 1.069567322731018
        },
        {
            "text": "correlates closely to the McLeod phenotype. XK",
            "probability": 1.3418722000764536e-07,
            "start_logit": -6.995244026184082,
            "end_logit": 1.069567322731018
        },
        {
            "text": "the McLeod phenotype. XK",
            "probability": 1.308391707668487e-07,
            "start_logit": -7.020511150360107,
            "end_logit": 1.069567322731018
        },
        {
            "text": "pattern of one of them, designated as XK, correlates closely to the McLeod phenotype. XK",
            "probability": 8.496950922174536e-08,
            "start_logit": -7.452187538146973,
            "end_logit": 1.069567322731018
        },
        {
            "text": "X-linked",
            "probability": 2.604178298900447e-10,
            "start_logit": -7.078293323516846,
            "end_logit": -5.092087268829346
        }
    ],
    "531464a6e3eabad021000014_063": [
        {
            "text": "XK",
            "probability": 0.9632087046105141,
            "start_logit": 5.504722595214844,
            "end_logit": 4.35614538192749
        },
        {
            "text": "XK, correlates closely to the McLeod phenotype. XK",
            "probability": 0.03600623264489746,
            "start_logit": 5.504722595214844,
            "end_logit": 1.069567322731018
        },
        {
            "text": "X",
            "probability": 0.00042378562099018384,
            "start_logit": 5.504722595214844,
            "end_logit": -3.372652292251587
        },
        {
            "text": "K",
            "probability": 0.00029203020392095156,
            "start_logit": -2.5964455604553223,
            "end_logit": 4.35614538192749
        },
        {
            "text": "designated as XK,",
            "probability": 3.336288802553143e-05,
            "start_logit": -4.7658586502075195,
            "end_logit": 4.35614538192749
        },
        {
            "text": "The mRNA expression pattern of one of them, designated as XK,",
            "probability": 8.694638884074896e-06,
            "start_logit": -6.110596179962158,
            "end_logit": 4.35614538192749
        },
        {
            "text": "XK is responsible",
            "probability": 6.705295573525343e-06,
            "start_logit": 5.295895099639893,
            "end_logit": -7.310154914855957
        },
        {
            "text": "one of them, designated as XK,",
            "probability": 6.336276579275627e-06,
            "start_logit": -6.427011489868164,
            "end_logit": 4.35614538192749
        },
        {
            "text": "point mutations at conserved splice donor and acceptor sites. These findings provide direct evidence that XK",
            "probability": 4.032346178743266e-06,
            "start_logit": -6.732981204986572,
            "end_logit": 4.210172176361084
        },
        {
            "text": "as XK,",
            "probability": 3.663803193929613e-06,
            "start_logit": -6.974801063537598,
            "end_logit": 4.35614538192749
        },
        {
            "text": "pattern of one of them, designated as XK,",
            "probability": 2.27303344162741e-06,
            "start_logit": -7.452187538146973,
            "end_logit": 4.35614538192749
        },
        {
            "text": "that XK",
            "probability": 1.8823875475214777e-06,
            "start_logit": -7.494788646697998,
            "end_logit": 4.210172176361084
        },
        {
            "text": "designated as XK, correlates closely to the McLeod phenotype. XK",
            "probability": 1.2471564077472682e-06,
            "start_logit": -4.7658586502075195,
            "end_logit": 1.069567322731018
        },
        {
            "text": "The mRNA expression pattern of one of them, designated as XK, correlates closely to the McLeod phenotype. XK",
            "probability": 3.250190627689174e-07,
            "start_logit": -6.110596179962158,
            "end_logit": 1.069567322731018
        },
        {
            "text": "one of them, designated as XK, correlates closely to the McLeod phenotype. XK",
            "probability": 2.3685982853328435e-07,
            "start_logit": -6.427011489868164,
            "end_logit": 1.069567322731018
        },
        {
            "text": "as XK, correlates closely to the McLeod phenotype. XK",
            "probability": 1.3695863579128624e-07,
            "start_logit": -6.974801063537598,
            "end_logit": 1.069567322731018
        },
        {
            "text": "correlates closely to the McLeod phenotype. XK",
            "probability": 1.3418722000764536e-07,
            "start_logit": -6.995244026184082,
            "end_logit": 1.069567322731018
        },
        {
            "text": "the McLeod phenotype. XK",
            "probability": 1.308391707668487e-07,
            "start_logit": -7.020511150360107,
            "end_logit": 1.069567322731018
        },
        {
            "text": "pattern of one of them, designated as XK, correlates closely to the McLeod phenotype. XK",
            "probability": 8.496950922174536e-08,
            "start_logit": -7.452187538146973,
            "end_logit": 1.069567322731018
        },
        {
            "text": "X-linked",
            "probability": 2.604178298900447e-10,
            "start_logit": -7.078293323516846,
            "end_logit": -5.092087268829346
        }
    ],
    "531464a6e3eabad021000014_064": [
        {
            "text": "XK",
            "probability": 0.9995948059050335,
            "start_logit": 6.446634769439697,
            "end_logit": 5.327573299407959
        },
        {
            "text": "X",
            "probability": 0.00022030977707683197,
            "start_logit": 6.446634769439697,
            "end_logit": -3.0924973487854004
        },
        {
            "text": "K",
            "probability": 0.00014763354811787117,
            "start_logit": -2.373737335205078,
            "end_logit": 5.327573299407959
        },
        {
            "text": "(XK)",
            "probability": 1.6965208368309397e-05,
            "start_logit": -4.53730583190918,
            "end_logit": 5.327573299407959
        },
        {
            "text": "(XK) to a 150-380-kb region in Xp21. McLeod syndrome, characterized by",
            "probability": 6.815024717063727e-06,
            "start_logit": 6.446634769439697,
            "end_logit": -6.568402290344238
        },
        {
            "text": "(XK) to a 150-380-kb region in Xp21.",
            "probability": 3.488821549737188e-06,
            "start_logit": 6.446634769439697,
            "end_logit": -7.2379679679870605
        },
        {
            "text": "(XK) to a 150-380-kb region in Xp21. McLeod syndrome, characterized",
            "probability": 2.6690552813699644e-06,
            "start_logit": 6.446634769439697,
            "end_logit": -7.505807399749756
        },
        {
            "text": "(XK) to a 150-380-kb region in Xp21. McLeod syndrome,",
            "probability": 1.8362377698209763e-06,
            "start_logit": 6.446634769439697,
            "end_logit": -7.879813194274902
        },
        {
            "text": "(XK) to a 150-380-kb",
            "probability": 1.4141051134802441e-06,
            "start_logit": 6.446634769439697,
            "end_logit": -8.141035079956055
        },
        {
            "text": "locus (XK)",
            "probability": 1.4123011697049028e-06,
            "start_logit": -7.023250102996826,
            "end_logit": 5.327573299407959
        },
        {
            "text": "(XK) to a 150-380-kb region in Xp21. McLeod syndrome, characterized by acanthocytosis",
            "probability": 1.3944948700503508e-06,
            "start_logit": 6.446634769439697,
            "end_logit": -8.154999732971191
        },
        {
            "text": "(XK) to a 150-380-kb region in Xp21. McLeod",
            "probability": 1.2532519169887494e-06,
            "start_logit": 6.446634769439697,
            "end_logit": -8.26179027557373
        },
        {
            "text": "Xp21. McLeod syndrome, characterized by",
            "probability": 5.67073159172619e-10,
            "start_logit": -2.947517156600952,
            "end_logit": -6.568402290344238
        },
        {
            "text": "characterized by",
            "probability": 5.560284746882451e-10,
            "start_logit": -2.9671859741210938,
            "end_logit": -6.568402290344238
        },
        {
            "text": "Xp21.",
            "probability": 2.9030225716501677e-10,
            "start_logit": -2.947517156600952,
            "end_logit": -7.2379679679870605
        },
        {
            "text": "Xp21. McLeod syndrome, characterized",
            "probability": 2.2209011313240643e-10,
            "start_logit": -2.947517156600952,
            "end_logit": -7.505807399749756
        },
        {
            "text": "characterized",
            "probability": 2.1776454210692315e-10,
            "start_logit": -2.9671859741210938,
            "end_logit": -7.505807399749756
        },
        {
            "text": "Xp21. McLeod syndrome,",
            "probability": 1.527919848210183e-10,
            "start_logit": -2.947517156600952,
            "end_logit": -7.879813194274902
        },
        {
            "text": "Xp",
            "probability": 1.4346321320012614e-10,
            "start_logit": -2.947517156600952,
            "end_logit": -7.942811965942383
        },
        {
            "text": "characterized by acanthocytosis and the absence of a red-blood-cell Kell antigen (Kx),",
            "probability": 1.1950181059790305e-10,
            "start_logit": -2.9671859741210938,
            "end_logit": -8.105890274047852
        }
    ],
    "531464a6e3eabad021000014_065": [
        {
            "text": "Xk",
            "probability": 0.9996765739717935,
            "start_logit": 6.39301061630249,
            "end_logit": 5.630074501037598
        },
        {
            "text": "k",
            "probability": 0.0001508919465048804,
            "start_logit": -2.4056124687194824,
            "end_logit": 5.630074501037598
        },
        {
            "text": "X",
            "probability": 0.0001397644402987638,
            "start_logit": 6.39301061630249,
            "end_logit": -3.2451541423797607
        },
        {
            "text": "Xk gene",
            "probability": 2.3298621833715416e-05,
            "start_logit": 6.39301061630249,
            "end_logit": -5.036718368530273
        },
        {
            "text": "the Xk",
            "probability": 4.022463165600556e-06,
            "start_logit": -6.030282020568848,
            "end_logit": 5.630074501037598
        },
        {
            "text": "Xk gene locus.",
            "probability": 2.392526310385463e-06,
            "start_logit": 6.39301061630249,
            "end_logit": -7.31276273727417
        },
        {
            "text": "and McLeod syndrome: fine mapping of the Xk",
            "probability": 1.1487691337791889e-06,
            "start_logit": -7.283485412597656,
            "end_logit": 5.630074501037598
        },
        {
            "text": "fine mapping of the Xk",
            "probability": 1.0393354032467309e-06,
            "start_logit": -7.383594989776611,
            "end_logit": 5.630074501037598
        },
        {
            "text": "of the Xk",
            "probability": 8.675773205058217e-07,
            "start_logit": -7.564227104187012,
            "end_logit": 5.630074501037598
        },
        {
            "text": "deletion in a patient with chronic granulomatous disease and McLeod syndrome: fine mapping of the Xk",
            "probability": 1.2797097131101776e-10,
            "start_logit": -7.510654926300049,
            "end_logit": -3.2451541423797607
        },
        {
            "text": "the Xk gene",
            "probability": 9.374816873324216e-11,
            "start_logit": -6.030282020568848,
            "end_logit": -5.036718368530273
        },
        {
            "text": "and McLeod syndrome: fine mapping of the Xk gene",
            "probability": 2.6773396835566273e-11,
            "start_logit": -7.283485412597656,
            "end_logit": -5.036718368530273
        },
        {
            "text": "fine mapping of the Xk gene",
            "probability": 2.422291684042297e-11,
            "start_logit": -7.383594989776611,
            "end_logit": -5.036718368530273
        },
        {
            "text": "of the Xk gene",
            "probability": 2.0219895542479305e-11,
            "start_logit": -7.564227104187012,
            "end_logit": -5.036718368530273
        },
        {
            "text": "Gene deletion",
            "probability": 1.5690545663305458e-11,
            "start_logit": -6.910913944244385,
            "end_logit": -5.943640232086182
        },
        {
            "text": "Gene",
            "probability": 1.4738905540780228e-11,
            "start_logit": -6.910913944244385,
            "end_logit": -6.0062079429626465
        },
        {
            "text": "the Xk gene locus.",
            "probability": 9.62696256652231e-12,
            "start_logit": -6.030282020568848,
            "end_logit": -7.31276273727417
        },
        {
            "text": "deletion",
            "probability": 8.613384768991019e-12,
            "start_logit": -7.510654926300049,
            "end_logit": -5.943640232086182
        },
        {
            "text": "X-CGD",
            "probability": 3.5504521876613092e-12,
            "start_logit": -7.015696048736572,
            "end_logit": -7.324841499328613
        },
        {
            "text": "locus.",
            "probability": 3.0795057742340946e-12,
            "start_logit": -7.170080661773682,
            "end_logit": -7.31276273727417
        }
    ],
    "53124bdae3eabad02100000b_001": [
        {
            "text": "mTOR",
            "probability": 0.9995260899429087,
            "start_logit": 9.946805953979492,
            "end_logit": 9.136809349060059
        },
        {
            "text": "m",
            "probability": 0.00024593303960843604,
            "start_logit": 9.946805953979492,
            "end_logit": 0.826832115650177
        },
        {
            "text": "TOR",
            "probability": 0.00019987512090151769,
            "start_logit": 1.429462194442749,
            "end_logit": 9.136809349060059
        },
        {
            "text": "Akt/molecular target of rapamycin (mTOR),",
            "probability": 2.073230354586966e-05,
            "start_logit": -0.8365375399589539,
            "end_logit": 9.136809349060059
        },
        {
            "text": "(mTOR),",
            "probability": 7.265411753223771e-06,
            "start_logit": -1.8851056098937988,
            "end_logit": 9.136809349060059
        },
        {
            "text": "target of rapamycin (mTOR),",
            "probability": 6.00764211206418e-08,
            "start_logit": -6.680368423461914,
            "end_logit": 9.136809349060059
        },
        {
            "text": "rapamycin (mTOR),",
            "probability": 2.501617508375115e-08,
            "start_logit": -7.556463241577148,
            "end_logit": 9.136809349060059
        },
        {
            "text": "of rapamycin (mTOR),",
            "probability": 1.9069891370677208e-08,
            "start_logit": -7.827875137329102,
            "end_logit": 9.136809349060059
        },
        {
            "text": "Akt",
            "probability": 1.111950011607137e-11,
            "start_logit": -0.8365375399589539,
            "end_logit": -5.301693916320801
        },
        {
            "text": "Akt/molecular target of rapamycin",
            "probability": 2.4672453021483013e-12,
            "start_logit": -0.8365375399589539,
            "end_logit": -6.8072919845581055
        },
        {
            "text": "Akt/molecular target",
            "probability": 2.1059548283176432e-12,
            "start_logit": -0.8365375399589539,
            "end_logit": -6.965625286102295
        },
        {
            "text": "Akt/molecular",
            "probability": 1.81966986524353e-12,
            "start_logit": -0.8365375399589539,
            "end_logit": -7.111739158630371
        },
        {
            "text": "(",
            "probability": 8.705692839650698e-13,
            "start_logit": -1.8851056098937988,
            "end_logit": -6.800434112548828
        },
        {
            "text": "A",
            "probability": 3.1606257288897226e-13,
            "start_logit": -0.8365375399589539,
            "end_logit": -8.86220932006836
        },
        {
            "text": "/",
            "probability": 3.452613338044861e-14,
            "start_logit": -4.801231384277344,
            "end_logit": -7.111739158630371
        },
        {
            "text": "molecular",
            "probability": 2.218656174524525e-14,
            "start_logit": -5.053618907928467,
            "end_logit": -7.301581382751465
        },
        {
            "text": "kt",
            "probability": 1.3734064364713216e-14,
            "start_logit": -7.533113956451416,
            "end_logit": -5.301693916320801
        },
        {
            "text": "mole",
            "probability": 1.170894229503301e-14,
            "start_logit": -5.053618907928467,
            "end_logit": -7.940715312957764
        },
        {
            "text": "target of rapamycin",
            "probability": 7.14938730526719e-15,
            "start_logit": -6.680368423461914,
            "end_logit": -6.8072919845581055
        },
        {
            "text": "target",
            "probability": 6.102468490640294e-15,
            "start_logit": -6.680368423461914,
            "end_logit": -6.965625286102295
        }
    ],
    "53124bdae3eabad02100000b_002": [
        {
            "text": "mTOR",
            "probability": 0.9994808123266159,
            "start_logit": 9.901719093322754,
            "end_logit": 9.189358711242676
        },
        {
            "text": "TOR",
            "probability": 0.0002776599745134337,
            "start_logit": 1.7131251096725464,
            "end_logit": 9.189358711242676
        },
        {
            "text": "m",
            "probability": 0.0002141474181648977,
            "start_logit": 9.901719093322754,
            "end_logit": 0.7410321235656738
        },
        {
            "text": "(PI3K)/Akt/molecular target of rapamycin (mTOR)",
            "probability": 2.5405484749067616e-05,
            "start_logit": -0.678307056427002,
            "end_logit": 9.189358711242676
        },
        {
            "text": "(mTOR)",
            "probability": 1.8580770737217108e-06,
            "start_logit": -3.2937300205230713,
            "end_logit": 9.189358711242676
        },
        {
            "text": "target of rapamycin (mTOR)",
            "probability": 5.740089741466747e-08,
            "start_logit": -6.770967483520508,
            "end_logit": 9.189358711242676
        },
        {
            "text": "of rapamycin (mTOR)",
            "probability": 3.737944939352053e-08,
            "start_logit": -7.199906349182129,
            "end_logit": 9.189358711242676
        },
        {
            "text": "(mTOR) may lead to an enhanced activity of HIFs.",
            "probability": 2.189101769640659e-08,
            "start_logit": 9.901719093322754,
            "end_logit": -8.447311401367188
        },
        {
            "text": "Akt",
            "probability": 4.0345765577966913e-11,
            "start_logit": -0.678307056427002,
            "end_logit": -4.163630485534668
        },
        {
            "text": "(PI3K)/Akt/molecular",
            "probability": 2.6042874045259443e-12,
            "start_logit": -0.678307056427002,
            "end_logit": -6.903957843780518
        },
        {
            "text": "(PI3K)/Akt/molecular target",
            "probability": 2.1335164592857025e-12,
            "start_logit": -0.678307056427002,
            "end_logit": -7.1033453941345215
        },
        {
            "text": "(PI3K)/Akt/molecular target of rapamycin",
            "probability": 1.0509405493597207e-12,
            "start_logit": -0.678307056427002,
            "end_logit": -7.811431407928467
        },
        {
            "text": "(PI3K)/Akt/molecular target of rapamycin (mTOR) may lead to an enhanced activity of HIFs.",
            "probability": 5.564408134389323e-13,
            "start_logit": -0.678307056427002,
            "end_logit": -8.447311401367188
        },
        {
            "text": "A",
            "probability": 5.516684455100174e-13,
            "start_logit": -0.678307056427002,
            "end_logit": -8.455924987792969
        },
        {
            "text": "molecular",
            "probability": 8.732300801814821e-14,
            "start_logit": -4.073607444763184,
            "end_logit": -6.903957843780518
        },
        {
            "text": "kt",
            "probability": 7.085924239685508e-14,
            "start_logit": -7.022853374481201,
            "end_logit": -4.163630485534668
        },
        {
            "text": "mole",
            "probability": 5.4756405206299933e-14,
            "start_logit": -4.073607444763184,
            "end_logit": -7.370677471160889
        },
        {
            "text": "(",
            "probability": 5.083520142147299e-14,
            "start_logit": -3.2937300205230713,
            "end_logit": -8.224860191345215
        },
        {
            "text": "/",
            "probability": 7.653805157747135e-15,
            "start_logit": -5.6015214920043945,
            "end_logit": -7.810454845428467
        },
        {
            "text": "target",
            "probability": 4.820445688069687e-15,
            "start_logit": -6.770967483520508,
            "end_logit": -7.1033453941345215
        }
    ],
    "53124bdae3eabad02100000b_003": [
        {
            "text": "mTOR",
            "probability": 0.9996815633299456,
            "start_logit": 9.894993782043457,
            "end_logit": 8.756378173828125
        },
        {
            "text": "m",
            "probability": 0.00014072383038472305,
            "start_logit": 9.894993782043457,
            "end_logit": -0.11201457679271698
        },
        {
            "text": "TOR",
            "probability": 0.00010712563628746438,
            "start_logit": 0.7538040280342102,
            "end_logit": 8.756378173828125
        },
        {
            "text": "The molecular target of rapamycin (mTOR)",
            "probability": 6.308372929742351e-05,
            "start_logit": 0.22426459193229675,
            "end_logit": 8.756378173828125
        },
        {
            "text": "(mTOR)",
            "probability": 3.816375673673284e-06,
            "start_logit": -2.580897092819214,
            "end_logit": 8.756378173828125
        },
        {
            "text": "(mTOR) is up-regulated",
            "probability": 1.821544127814272e-06,
            "start_logit": 9.894993782043457,
            "end_logit": -4.459129333496094
        },
        {
            "text": "molecular target of rapamycin (mTOR)",
            "probability": 7.07117631287783e-07,
            "start_logit": -4.266756534576416,
            "end_logit": 8.756378173828125
        },
        {
            "text": "(mTOR) is up-regulated in glioblastoma",
            "probability": 3.982003994469931e-07,
            "start_logit": 9.894993782043457,
            "end_logit": -5.979613780975342
        },
        {
            "text": "(mTOR) is up-regulated in glioblastoma (GBM) and this is associated with the rate of cell growth, stem cell",
            "probability": 2.2011854048671745e-07,
            "start_logit": 9.894993782043457,
            "end_logit": -6.5724029541015625
        },
        {
            "text": "(mTOR) is up-regulated in glioblastoma (GBM)",
            "probability": 1.5103658422617022e-07,
            "start_logit": 9.894993782043457,
            "end_logit": -6.949047088623047
        },
        {
            "text": "target of rapamycin (mTOR)",
            "probability": 1.337192119757745e-07,
            "start_logit": -5.932211399078369,
            "end_logit": 8.756378173828125
        },
        {
            "text": "rapamycin (mTOR)",
            "probability": 1.3300501181336482e-07,
            "start_logit": -5.937566757202148,
            "end_logit": 8.756378173828125
        },
        {
            "text": "(mTOR) is up-regulated in glioblastoma (GBM) and this is associated with the rate of cell growth,",
            "probability": 1.2129298014511176e-07,
            "start_logit": 9.894993782043457,
            "end_logit": -7.168360233306885
        },
        {
            "text": "The molecular target of rapamycin",
            "probability": 7.593411585045444e-10,
            "start_logit": 0.22426459193229675,
            "end_logit": -2.5711441040039062
        },
        {
            "text": "The molecular target of rapamycin (mTOR) is up-regulated",
            "probability": 1.1494639981113753e-10,
            "start_logit": 0.22426459193229675,
            "end_logit": -4.459129333496094
        },
        {
            "text": "Rapamycin is a powerful mTOR",
            "probability": 5.955653307612223e-11,
            "start_logit": -5.396944522857666,
            "end_logit": 0.5045398473739624
        },
        {
            "text": "The",
            "probability": 4.13004329184023e-11,
            "start_logit": 0.22426459193229675,
            "end_logit": -5.482722282409668
        },
        {
            "text": "mTOR inhibitor",
            "probability": 3.2008439968318206e-11,
            "start_logit": -0.6145983934402466,
            "end_logit": -4.898732662200928
        },
        {
            "text": "cell growth, stem cell proliferation and disease relapse. Rapamycin is a powerful mTOR",
            "probability": 3.164325480839221e-11,
            "start_logit": -6.029345512390137,
            "end_logit": 0.5045398473739624
        },
        {
            "text": "The molecular target of rapamycin (mTOR) is up-regulated in glioblastoma",
            "probability": 2.5127967871254176e-11,
            "start_logit": 0.22426459193229675,
            "end_logit": -5.979613780975342
        }
    ],
    "53124bdae3eabad02100000b_004": [
        {
            "text": "mTOR",
            "probability": 0.999581273375555,
            "start_logit": 10.0203857421875,
            "end_logit": 9.12619400024414
        },
        {
            "text": "m",
            "probability": 0.00019243218850974783,
            "start_logit": 10.0203857421875,
            "end_logit": 0.5708460807800293
        },
        {
            "text": "TOR",
            "probability": 0.00015139417496566225,
            "start_logit": 1.2251808643341064,
            "end_logit": 9.12619400024414
        },
        {
            "text": "(PI3K)/Akt/ molecular target of rapamycin (mTOR),",
            "probability": 6.055965535301753e-05,
            "start_logit": 0.3089229166507721,
            "end_logit": 9.12619400024414
        },
        {
            "text": "(mTOR),",
            "probability": 1.3764825493745577e-05,
            "start_logit": -1.1725895404815674,
            "end_logit": 9.12619400024414
        },
        {
            "text": "molecular target of rapamycin (mTOR),",
            "probability": 3.096952001073604e-07,
            "start_logit": -4.966872692108154,
            "end_logit": 9.12619400024414
        },
        {
            "text": "rapamycin (mTOR),",
            "probability": 1.2036041082490972e-07,
            "start_logit": -5.911970615386963,
            "end_logit": 9.12619400024414
        },
        {
            "text": "of rapamycin (mTOR),",
            "probability": 9.373687159564e-08,
            "start_logit": -6.1619696617126465,
            "end_logit": 9.12619400024414
        },
        {
            "text": "target of rapamycin (mTOR),",
            "probability": 5.171255954322679e-08,
            "start_logit": -6.756760597229004,
            "end_logit": 9.12619400024414
        },
        {
            "text": "Akt",
            "probability": 1.5271782874901497e-10,
            "start_logit": 0.3089229166507721,
            "end_logit": -3.7643535137176514
        },
        {
            "text": "(PI3K)/Akt/ molecular target of rapamycin",
            "probability": 7.122945486369493e-11,
            "start_logit": 0.3089229166507721,
            "end_logit": -4.527039051055908
        },
        {
            "text": "(PI3K)/Akt/ molecular target",
            "probability": 1.999123061407657e-11,
            "start_logit": 0.3089229166507721,
            "end_logit": -5.797651767730713
        },
        {
            "text": "(PI3K)/Akt/",
            "probability": 1.0384576034361786e-11,
            "start_logit": 0.3089229166507721,
            "end_logit": -6.4526238441467285
        },
        {
            "text": "phosphatidylinositol 3'-kinase (PI3K)/Akt/ molecular target of rapamycin (mTOR),",
            "probability": 7.511820783866743e-12,
            "start_logit": -7.175760746002197,
            "end_logit": 0.7082160711288452
        },
        {
            "text": "(PI3K)/Akt/ molecular",
            "probability": 5.298540712471163e-12,
            "start_logit": 0.3089229166507721,
            "end_logit": -7.125514030456543
        },
        {
            "text": "A",
            "probability": 3.683339255880011e-12,
            "start_logit": 0.3089229166507721,
            "end_logit": -7.489125728607178
        },
        {
            "text": "(",
            "probability": 3.648031569289334e-12,
            "start_logit": -1.1725895404815674,
            "end_logit": -6.017245292663574
        },
        {
            "text": "molecular target of rapamycin",
            "probability": 3.642593431049147e-13,
            "start_logit": -4.966872692108154,
            "end_logit": -4.527039051055908
        },
        {
            "text": "rapamycin",
            "probability": 1.415663018597662e-13,
            "start_logit": -5.911970615386963,
            "end_logit": -4.527039051055908
        },
        {
            "text": "of rapamycin",
            "probability": 1.1025205188940888e-13,
            "start_logit": -6.1619696617126465,
            "end_logit": -4.527039051055908
        }
    ],
    "53124bdae3eabad02100000b_005": [
        {
            "text": "mTOR",
            "probability": 0.9995705418744997,
            "start_logit": 9.985062599182129,
            "end_logit": 9.247018814086914
        },
        {
            "text": "TOR",
            "probability": 0.00022759399478141214,
            "start_logit": 1.5975449085235596,
            "end_logit": 9.247018814086914
        },
        {
            "text": "m",
            "probability": 0.00019412506189458675,
            "start_logit": 9.985062599182129,
            "end_logit": 0.7004404067993164
        },
        {
            "text": "molecular target of rapamycin (mTOR)",
            "probability": 4.7274439671238826e-06,
            "start_logit": -2.2766337394714355,
            "end_logit": 9.247018814086914
        },
        {
            "text": "phosphorylated molecular target of rapamycin (mTOR)",
            "probability": 1.4445140162883837e-06,
            "start_logit": -3.462245464324951,
            "end_logit": 9.247018814086914
        },
        {
            "text": "(mTOR)",
            "probability": 1.3334275797988522e-06,
            "start_logit": -3.5422656536102295,
            "end_logit": 9.247018814086914
        },
        {
            "text": "of rapamycin (mTOR)",
            "probability": 7.732560279100115e-08,
            "start_logit": -6.389748573303223,
            "end_logit": 9.247018814086914
        },
        {
            "text": "rapamycin (mTOR)",
            "probability": 5.696860280224126e-08,
            "start_logit": -6.695273399353027,
            "end_logit": 9.247018814086914
        },
        {
            "text": "increased the levels of phosphorylated molecular target of rapamycin (mTOR)",
            "probability": 3.992302945631954e-08,
            "start_logit": -7.050820350646973,
            "end_logit": 9.247018814086914
        },
        {
            "text": "target of rapamycin (mTOR)",
            "probability": 3.9687310271487284e-08,
            "start_logit": -7.056742191314697,
            "end_logit": 9.247018814086914
        },
        {
            "text": "of phosphorylated molecular target of rapamycin (mTOR)",
            "probability": 1.9776813455209352e-08,
            "start_logit": -7.753263473510742,
            "end_logit": 9.247018814086914
        },
        {
            "text": "molecular target of rapamycin",
            "probability": 7.057488882013884e-13,
            "start_logit": -2.2766337394714355,
            "end_logit": -6.470372200012207
        },
        {
            "text": "molecular target",
            "probability": 3.6619741385223453e-13,
            "start_logit": -2.2766337394714355,
            "end_logit": -7.126459121704102
        },
        {
            "text": "phosphorylated molecular target of rapamycin",
            "probability": 2.1564806861308567e-13,
            "start_logit": -3.462245464324951,
            "end_logit": -6.470372200012207
        },
        {
            "text": "molecular",
            "probability": 1.9432041861209281e-13,
            "start_logit": -2.2766337394714355,
            "end_logit": -7.760123252868652
        },
        {
            "text": "phosphorylated molecular target",
            "probability": 1.1189499034082339e-13,
            "start_logit": -3.462245464324951,
            "end_logit": -7.126459121704102
        },
        {
            "text": "phosphorylated",
            "probability": 1.0972980349261758e-13,
            "start_logit": -3.462245464324951,
            "end_logit": -7.145998954772949
        },
        {
            "text": "mole",
            "probability": 1.0321017720433138e-13,
            "start_logit": -2.2766337394714355,
            "end_logit": -8.392864227294922
        },
        {
            "text": "phosphorylated molecular",
            "probability": 5.937639246245105e-14,
            "start_logit": -3.462245464324951,
            "end_logit": -7.760123252868652
        },
        {
            "text": "mTOR inhibitor) blocked all of the mitogenic effects of L-leucine. In addition, Akt",
            "probability": 3.596836389220943e-14,
            "start_logit": -2.5204176902770996,
            "end_logit": -9.203207969665527
        }
    ],
    "53124bdae3eabad02100000b_006": [
        {
            "text": "mTOR",
            "probability": 0.9995093788565282,
            "start_logit": 10.033151626586914,
            "end_logit": 9.340930938720703
        },
        {
            "text": "TOR",
            "probability": 0.0003037976849964323,
            "start_logit": 1.9344937801361084,
            "end_logit": 9.340930938720703
        },
        {
            "text": "m",
            "probability": 0.00013877883684766697,
            "start_logit": 10.033151626586914,
            "end_logit": 0.45879268646240234
        },
        {
            "text": "(PI3K)/AKT/molecular target of rapamycin (mTOR)",
            "probability": 4.709218357364925e-05,
            "start_logit": 0.07023884356021881,
            "end_logit": 9.340930938720703
        },
        {
            "text": "(mTOR)",
            "probability": 7.90794486157531e-07,
            "start_logit": -4.016585350036621,
            "end_logit": 9.340930938720703
        },
        {
            "text": "target of rapamycin (mTOR)",
            "probability": 6.005608363495136e-08,
            "start_logit": -6.594344615936279,
            "end_logit": 9.340930938720703
        },
        {
            "text": "of rapamycin (mTOR)",
            "probability": 5.1513509799282225e-08,
            "start_logit": -6.747779369354248,
            "end_logit": 9.340930938720703
        },
        {
            "text": "(mTOR) pathway",
            "probability": 4.976339155566048e-08,
            "start_logit": 10.033151626586914,
            "end_logit": -7.474564552307129
        },
        {
            "text": "phosphatidylinositol 3'-kinase (PI3K)/AKT/molecular target of rapamycin (mTOR)",
            "probability": 2.465204312839831e-10,
            "start_logit": -3.2077956199645996,
            "end_logit": 0.45879268646240234
        },
        {
            "text": "(PI3K)/AKT/molecular target of rapamycin",
            "probability": 3.9586986710273e-11,
            "start_logit": 0.07023884356021881,
            "end_logit": -4.648186206817627
        },
        {
            "text": "(PI3K)/AKT/molecular target",
            "probability": 1.1201854161040929e-11,
            "start_logit": 0.07023884356021881,
            "end_logit": -5.91060733795166
        },
        {
            "text": "molecular",
            "probability": 5.696966049427613e-12,
            "start_logit": 0.07023884356021881,
            "end_logit": -6.586752891540527
        },
        {
            "text": "mole",
            "probability": 2.8318293382667525e-12,
            "start_logit": 0.07023884356021881,
            "end_logit": -7.285763740539551
        },
        {
            "text": "(PI3K)/AKT/molecular target of rapamycin (mTOR) pathway",
            "probability": 2.3446170891038096e-12,
            "start_logit": 0.07023884356021881,
            "end_logit": -7.474564552307129
        },
        {
            "text": "phosphatidylinositol 3'-kinase (PI3K)/AKT/molecular target of rapamycin",
            "probability": 1.4925200235392116e-12,
            "start_logit": -3.2077956199645996,
            "end_logit": -4.648186206817627
        },
        {
            "text": "phosphatidylinositol 3'-kinase (PI3K)/AKT/molecular target",
            "probability": 4.2233554573076334e-13,
            "start_logit": -3.2077956199645996,
            "end_logit": -5.91060733795166
        },
        {
            "text": "phosphatidylinositol 3'-kinase (PI3K)/AKT/molecular",
            "probability": 2.1478866185051834e-13,
            "start_logit": -3.2077956199645996,
            "end_logit": -6.586752891540527
        },
        {
            "text": "phosphatidylinositol 3'-kinase",
            "probability": 1.0868995415592535e-13,
            "start_logit": -3.2077956199645996,
            "end_logit": -7.267908096313477
        },
        {
            "text": "The phosphatidylinositol 3'-kinase (PI3K)/AKT/molecular target of rapamycin",
            "probability": 8.624510457395343e-14,
            "start_logit": -6.058823585510254,
            "end_logit": -4.648186206817627
        },
        {
            "text": "phosphatidylinositol 3'-kinase/AKT/molecular",
            "probability": 7.543257776740618e-14,
            "start_logit": -4.392869472503662,
            "end_logit": -6.448094367980957
        }
    ],
    "53124bdae3eabad02100000b_007": [
        {
            "text": "mTOR",
            "probability": 0.9996730136954326,
            "start_logit": 10.022468566894531,
            "end_logit": 8.97834587097168
        },
        {
            "text": "m",
            "probability": 0.00017020784664458185,
            "start_logit": 10.022468566894531,
            "end_logit": 0.30018267035484314
        },
        {
            "text": "TOR",
            "probability": 0.00014254323944472186,
            "start_logit": 1.1669304370880127,
            "end_logit": 8.97834587097168
        },
        {
            "text": "The molecular target of rapamycin (mTOR)",
            "probability": 1.1927256966202117e-05,
            "start_logit": -1.313888669013977,
            "end_logit": 8.97834587097168
        },
        {
            "text": "(mTOR)",
            "probability": 9.720082316928508e-07,
            "start_logit": -3.82110595703125,
            "end_logit": 8.97834587097168
        },
        {
            "text": "molecular target of rapamycin (mTOR)",
            "probability": 4.404061144845929e-07,
            "start_logit": -4.6127729415893555,
            "end_logit": 8.97834587097168
        },
        {
            "text": "(mTOR) is central to a complex intracellular signaling pathway and is involved in diverse processes including cell growth and proliferation,",
            "probability": 1.3964884792889326e-07,
            "start_logit": 10.022468566894531,
            "end_logit": -6.805461883544922
        },
        {
            "text": "(mTOR) is central to a complex intracellular signaling pathway and is involved in diverse processes including cell growth",
            "probability": 1.280842301138873e-07,
            "start_logit": 10.022468566894531,
            "end_logit": -6.891904830932617
        },
        {
            "text": "target of rapamycin (mTOR)",
            "probability": 1.2655711818176172e-07,
            "start_logit": -5.859776496887207,
            "end_logit": 8.97834587097168
        },
        {
            "text": "(mTOR) is central to a complex intracellular signaling",
            "probability": 1.2523952596524029e-07,
            "start_logit": 10.022468566894531,
            "end_logit": -6.914364814758301
        },
        {
            "text": "(mTOR) is central to a complex",
            "probability": 9.805739318434572e-08,
            "start_logit": 10.022468566894531,
            "end_logit": -7.1590399742126465
        },
        {
            "text": "(mTOR) is central to a complex intracellular signaling pathway and is involved in diverse processes including cell",
            "probability": 9.690403816708637e-08,
            "start_logit": 10.022468566894531,
            "end_logit": -7.170871734619141
        },
        {
            "text": "rapamycin (mTOR)",
            "probability": 9.579420919644492e-08,
            "start_logit": -6.138267993927002,
            "end_logit": 8.97834587097168
        },
        {
            "text": "(mTOR) is central to a complex intracellular signaling pathway and is involved",
            "probability": 8.52492494094765e-08,
            "start_logit": 10.022468566894531,
            "end_logit": -7.299013614654541
        },
        {
            "text": "The molecular target of rapamycin",
            "probability": 5.509394898292692e-12,
            "start_logit": -1.313888669013977,
            "end_logit": -5.609536170959473
        },
        {
            "text": "The",
            "probability": 2.4817683590892057e-12,
            "start_logit": -1.313888669013977,
            "end_logit": -6.40701961517334
        },
        {
            "text": "The molecular target of rapamycin (mTOR) is central to a complex intracellular signaling",
            "probability": 1.4942526086513561e-12,
            "start_logit": -1.313888669013977,
            "end_logit": -6.914364814758301
        },
        {
            "text": "The molecular target of rapamycin (mTOR) is central to a complex",
            "probability": 1.1699382797402718e-12,
            "start_logit": -1.313888669013977,
            "end_logit": -7.1590399742126465
        },
        {
            "text": "The molecular target of rapamycin (mTOR) is central to a complex intracellular signaling pathway and is involved",
            "probability": 1.0171222889412343e-12,
            "start_logit": -1.313888669013977,
            "end_logit": -7.299013614654541
        },
        {
            "text": "The molecular target",
            "probability": 8.810358471727723e-13,
            "start_logit": -1.313888669013977,
            "end_logit": -7.442647933959961
        }
    ],
    "53124bdae3eabad02100000b_008": [
        {
            "text": "mTOR",
            "probability": 0.9996586822192018,
            "start_logit": 9.949365615844727,
            "end_logit": 9.2401123046875
        },
        {
            "text": "m",
            "probability": 0.00019446437335148348,
            "start_logit": 9.949365615844727,
            "end_logit": 0.6951920986175537
        },
        {
            "text": "TOR",
            "probability": 0.00014435448922053154,
            "start_logit": 1.1064684391021729,
            "end_logit": 9.2401123046875
        },
        {
            "text": "(mTOR)",
            "probability": 7.572646606137659e-07,
            "start_logit": -4.143846035003662,
            "end_logit": 9.2401123046875
        },
        {
            "text": "(mTOR) and its downstream target p70 S6 kinase and increased levels of Akt1",
            "probability": 7.490034937564945e-07,
            "start_logit": 9.949365615844727,
            "end_logit": -4.864068508148193
        },
        {
            "text": "the molecular target of rapamycin (mTOR)",
            "probability": 4.4586101844038914e-07,
            "start_logit": -4.673551559448242,
            "end_logit": 9.2401123046875
        },
        {
            "text": "molecular target of rapamycin (mTOR)",
            "probability": 2.653076060265908e-07,
            "start_logit": -5.192668914794922,
            "end_logit": 9.2401123046875
        },
        {
            "text": "(mTOR) and its downstream target p70 S6 kinase and increased levels of Akt1 and Akt2",
            "probability": 1.8355951504817992e-07,
            "start_logit": 9.949365615844727,
            "end_logit": -6.270273208618164
        },
        {
            "text": "phosphorylation of the molecular target of rapamycin (mTOR)",
            "probability": 3.648298017458185e-08,
            "start_logit": -7.176712989807129,
            "end_logit": 9.2401123046875
        },
        {
            "text": "increased phosphorylation of the molecular target of rapamycin (mTOR)",
            "probability": 3.468027008977691e-08,
            "start_logit": -7.22738790512085,
            "end_logit": 9.2401123046875
        },
        {
            "text": "target of rapamycin (mTOR)",
            "probability": 1.6772921930042764e-08,
            "start_logit": -7.953793048858643,
            "end_logit": 9.2401123046875
        },
        {
            "text": "(mTOR) and its downstream target p70 S6 kinase",
            "probability": 9.905168746059489e-09,
            "start_logit": 9.949365615844727,
            "end_logit": -9.1897554397583
        },
        {
            "text": "Akt1 and Akt2 were demonstrated in HCT 116R cells. Further experiments demonstrated that the mTOR",
            "probability": 6.10857632931851e-11,
            "start_logit": -1.0031416416168213,
            "end_logit": -3.3257813453674316
        },
        {
            "text": "Akt",
            "probability": 1.3118083125314269e-11,
            "start_logit": -1.0031416416168213,
            "end_logit": -4.864068508148193
        },
        {
            "text": "Akt1 and Akt2",
            "probability": 3.214870153365718e-12,
            "start_logit": -1.0031416416168213,
            "end_logit": -6.270273208618164
        },
        {
            "text": "Akt2 were demonstrated in HCT 116R cells. Further experiments demonstrated that the mTOR",
            "probability": 2.0006326549114908e-12,
            "start_logit": -4.421957015991211,
            "end_logit": -3.3257813453674316
        },
        {
            "text": "Akt1",
            "probability": 7.53907145442319e-13,
            "start_logit": -1.0031416416168213,
            "end_logit": -7.720546245574951
        },
        {
            "text": "molecular target of rapamycin (mTOR) and its downstream target p70 S6 kinase and increased levels of Akt1",
            "probability": 1.9878417240667175e-13,
            "start_logit": -5.192668914794922,
            "end_logit": -4.864068508148193
        },
        {
            "text": "and Akt2 were demonstrated in HCT 116R cells. Further experiments demonstrated that the mTOR",
            "probability": 1.1833392403656186e-13,
            "start_logit": -7.249665260314941,
            "end_logit": -3.3257813453674316
        },
        {
            "text": "Akt2",
            "probability": 1.0073406402222716e-13,
            "start_logit": -4.421957015991211,
            "end_logit": -6.314516067504883
        }
    ],
    "53124bdae3eabad02100000b_009": [
        {
            "text": "mTOR",
            "probability": 0.9996165047742362,
            "start_logit": 7.679803848266602,
            "end_logit": 6.814486503601074
        },
        {
            "text": "TOR",
            "probability": 0.00022513155036193075,
            "start_logit": -0.7186382412910461,
            "end_logit": 6.814486503601074
        },
        {
            "text": "m",
            "probability": 0.00013213167073052625,
            "start_logit": 7.679803848266602,
            "end_logit": -2.1168415546417236
        },
        {
            "text": "the molecular target of rapamycin (mTOR).",
            "probability": 1.5283992190878772e-05,
            "start_logit": -3.4085171222686768,
            "end_logit": 6.814486503601074
        },
        {
            "text": "(mTOR).",
            "probability": 5.184262487379012e-06,
            "start_logit": 7.679803848266602,
            "end_logit": -5.355012893676758
        },
        {
            "text": "molecular target of rapamycin (mTOR).",
            "probability": 3.405450295068531e-06,
            "start_logit": -4.909945964813232,
            "end_logit": 6.814486503601074
        },
        {
            "text": "(mTOR). PURPOSE OF REVIEW: The",
            "probability": 9.98583460649873e-07,
            "start_logit": 7.679803848266602,
            "end_logit": -7.002058029174805
        },
        {
            "text": "(mTOR). PURPOSE",
            "probability": 8.640618576623332e-07,
            "start_logit": 7.679803848266602,
            "end_logit": -7.146751403808594
        },
        {
            "text": "(mTOR). PURPOSE OF REVIEW: The molecular target of rapamycin,",
            "probability": 4.939553001497122e-07,
            "start_logit": 7.679803848266602,
            "end_logit": -7.705950736999512
        },
        {
            "text": "development",
            "probability": 1.1895251327902797e-09,
            "start_logit": -2.0899741649627686,
            "end_logit": -3.9650635719299316
        },
        {
            "text": "growth, is a unique and prime strategic target for anticancer therapeutic development.",
            "probability": 1.433590663637907e-10,
            "start_logit": -4.205931186676025,
            "end_logit": -3.9650635719299316
        },
        {
            "text": "The",
            "probability": 9.140374636125011e-11,
            "start_logit": -1.6190026998519897,
            "end_logit": -7.002058029174805
        },
        {
            "text": "The molecular target of rapamycin, which is a member of the phosphoinositide 3-kinase related kinase",
            "probability": 6.53515072375711e-11,
            "start_logit": -1.6190026998519897,
            "end_logit": -7.337563991546631
        },
        {
            "text": "development.",
            "probability": 5.1939599130258676e-11,
            "start_logit": -2.0899741649627686,
            "end_logit": -7.096291542053223
        },
        {
            "text": "The molecular target of rapamycin,",
            "probability": 4.521341154528684e-11,
            "start_logit": -1.6190026998519897,
            "end_logit": -7.705950736999512
        },
        {
            "text": "growth",
            "probability": 3.5258507538732465e-11,
            "start_logit": -4.205931186676025,
            "end_logit": -5.367709159851074
        },
        {
            "text": "cell growth, is a unique and prime strategic target for anticancer therapeutic development.",
            "probability": 2.651333657919517e-11,
            "start_logit": -5.8936357498168945,
            "end_logit": -3.9650635719299316
        },
        {
            "text": "development. RECENT",
            "probability": 1.779460679944062e-11,
            "start_logit": -2.0899741649627686,
            "end_logit": -8.16747760772705
        },
        {
            "text": "which is a member of the phosphoinositide 3-kinase related kinase family and a central modulator of cell growth,",
            "probability": 1.6448663583526165e-11,
            "start_logit": -4.968393802642822,
            "end_logit": -5.367709159851074
        },
        {
            "text": "PURPOSE OF REVIEW: The",
            "probability": 1.6271583904395886e-11,
            "start_logit": -3.3448688983917236,
            "end_logit": -7.002058029174805
        }
    ],
    "53124bdae3eabad02100000b_010": [
        {
            "text": "mTOR",
            "probability": 0.9994710809362229,
            "start_logit": 10.019240379333496,
            "end_logit": 9.246459007263184
        },
        {
            "text": "TOR",
            "probability": 0.0002928293875635716,
            "start_logit": 1.883849024772644,
            "end_logit": 9.246459007263184
        },
        {
            "text": "m",
            "probability": 0.00022805699332377764,
            "start_logit": 10.019240379333496,
            "end_logit": 0.8610730767250061
        },
        {
            "text": "(mTOR)",
            "probability": 5.562908020100542e-06,
            "start_logit": -2.079620122909546,
            "end_logit": 9.246459007263184
        },
        {
            "text": "molecular target of rapamycin (mTOR)",
            "probability": 1.8436921999737762e-06,
            "start_logit": -3.1839709281921387,
            "end_logit": 9.246459007263184
        },
        {
            "text": "of rapamycin (mTOR)",
            "probability": 2.3873738748973463e-07,
            "start_logit": -5.228132247924805,
            "end_logit": 9.246459007263184
        },
        {
            "text": "rapamycin (mTOR)",
            "probability": 2.298775262465459e-07,
            "start_logit": -5.265949726104736,
            "end_logit": 9.246459007263184
        },
        {
            "text": "target of rapamycin (mTOR)",
            "probability": 1.3304652142816962e-07,
            "start_logit": -5.812797546386719,
            "end_logit": 9.246459007263184
        },
        {
            "text": "and molecular target of rapamycin (mTOR)",
            "probability": 1.4951897552716283e-08,
            "start_logit": -7.998658180236816,
            "end_logit": 9.246459007263184
        },
        {
            "text": "(mTOR) with rapamycin",
            "probability": 9.464622692397867e-09,
            "start_logit": 10.019240379333496,
            "end_logit": -9.228716850280762
        },
        {
            "text": "molecular target of rapamycin",
            "probability": 2.596433058018509e-12,
            "start_logit": -3.1839709281921387,
            "end_logit": -4.226683139801025
        },
        {
            "text": "(",
            "probability": 7.336023592076349e-13,
            "start_logit": -2.079620122909546,
            "end_logit": -6.594960689544678
        },
        {
            "text": "of rapamycin",
            "probability": 3.3620885583403673e-13,
            "start_logit": -5.228132247924805,
            "end_logit": -4.226683139801025
        },
        {
            "text": "rapamycin",
            "probability": 3.2373169906047156e-13,
            "start_logit": -5.265949726104736,
            "end_logit": -4.226683139801025
        },
        {
            "text": "molecular target",
            "probability": 2.0204019483520879e-13,
            "start_logit": -3.1839709281921387,
            "end_logit": -6.7801103591918945
        },
        {
            "text": "target of rapamycin",
            "probability": 1.8736662578242777e-13,
            "start_logit": -5.812797546386719,
            "end_logit": -4.226683139801025
        },
        {
            "text": "molecular",
            "probability": 1.6719900028549031e-13,
            "start_logit": -3.1839709281921387,
            "end_logit": -6.9693922996521
        },
        {
            "text": "mole",
            "probability": 1.0256113494294755e-13,
            "start_logit": -3.1839709281921387,
            "end_logit": -7.458117961883545
        },
        {
            "text": "amycin",
            "probability": 4.3510690506429344e-14,
            "start_logit": -7.272858142852783,
            "end_logit": -4.226683139801025
        },
        {
            "text": "cin",
            "probability": 2.1901752920956633e-14,
            "start_logit": -7.959298133850098,
            "end_logit": -4.226683139801025
        }
    ],
    "53124bdae3eabad02100000b_011": [
        {
            "text": "mTOR",
            "probability": 0.9995685731857323,
            "start_logit": 9.661212921142578,
            "end_logit": 8.773516654968262
        },
        {
            "text": "The molecular target of rapamycin (mTOR),",
            "probability": 0.0001380003842594488,
            "start_logit": 0.7733903527259827,
            "end_logit": 8.773516654968262
        },
        {
            "text": "TOR",
            "probability": 0.00011927817646911763,
            "start_logit": 0.6275922656059265,
            "end_logit": 8.773516654968262
        },
        {
            "text": "m",
            "probability": 0.0001094128580726811,
            "start_logit": 9.661212921142578,
            "end_logit": -0.34643396735191345
        },
        {
            "text": "(mTOR) as a therapeutic target against cancer. The molecular target of rapamycin (mTOR),",
            "probability": 2.9679404180210983e-05,
            "start_logit": -0.7634127736091614,
            "end_logit": 8.773516654968262
        },
        {
            "text": "(mTOR),",
            "probability": 2.7600692938601064e-05,
            "start_logit": 9.661212921142578,
            "end_logit": -1.7237215042114258
        },
        {
            "text": "cancer. The molecular target of rapamycin (mTOR),",
            "probability": 3.24768701586331e-06,
            "start_logit": -2.9759230613708496,
            "end_logit": 8.773516654968262
        },
        {
            "text": "molecular target of rapamycin (mTOR),",
            "probability": 3.0569906662262674e-06,
            "start_logit": -3.036435127258301,
            "end_logit": 8.773516654968262
        },
        {
            "text": "(mTOR), which is a member of the phosphoinositide 3-kinase related kinase",
            "probability": 9.252985838280289e-07,
            "start_logit": 9.661212921142578,
            "end_logit": -5.119201183319092
        },
        {
            "text": "(mTOR), which is a member of the phosphoinositide 3-kinase related kinase (PIKK)",
            "probability": 1.356068280060085e-07,
            "start_logit": 9.661212921142578,
            "end_logit": -7.039557933807373
        },
        {
            "text": "(mTOR), which",
            "probability": 8.92618776033332e-08,
            "start_logit": 9.661212921142578,
            "end_logit": -7.457743167877197
        },
        {
            "text": "The molecular target of rapamycin",
            "probability": 1.8071083444844017e-10,
            "start_logit": 0.7733903527259827,
            "end_logit": -4.77235221862793
        },
        {
            "text": "The",
            "probability": 6.175920452487543e-11,
            "start_logit": 0.7733903527259827,
            "end_logit": -5.846007347106934
        },
        {
            "text": "The molecular target of rapamycin (mTOR)",
            "probability": 4.65924644765572e-11,
            "start_logit": -5.69030237197876,
            "end_logit": 0.33588117361068726
        },
        {
            "text": "(mTOR)",
            "probability": 4.49088598422138e-11,
            "start_logit": -5.727106094360352,
            "end_logit": 0.33588117361068726
        },
        {
            "text": "(mTOR) as a therapeutic target against cancer.",
            "probability": 4.226328357593579e-11,
            "start_logit": -0.7634127736091614,
            "end_logit": -4.688528537750244
        },
        {
            "text": "(mTOR) as a therapeutic target against cancer. The molecular target of rapamycin",
            "probability": 3.886503594986347e-11,
            "start_logit": -0.7634127736091614,
            "end_logit": -4.77235221862793
        },
        {
            "text": "(mTOR) as a therapeutic target against cancer. The",
            "probability": 1.3282400645319873e-11,
            "start_logit": -0.7634127736091614,
            "end_logit": -5.846007347106934
        },
        {
            "text": "The molecular target",
            "probability": 1.2670497930305615e-11,
            "start_logit": 0.7733903527259827,
            "end_logit": -7.42997407913208
        },
        {
            "text": "The molecular target of rapamycin (mTOR), which",
            "probability": 1.2323490093051372e-11,
            "start_logit": 0.7733903527259827,
            "end_logit": -7.457743167877197
        }
    ],
    "54fc91e96ad7dcbc12000001_001": [
        {
            "text": "Alzheimer's Disease:",
            "probability": 0.5308124887459159,
            "start_logit": 4.645676612854004,
            "end_logit": 4.621772766113281
        },
        {
            "text": "Alzheimer's disease",
            "probability": 0.46612874987037645,
            "start_logit": 5.242323875427246,
            "end_logit": 3.8951785564422607
        },
        {
            "text": "Alzheimer's disease (AD).",
            "probability": 0.0016273773356237635,
            "start_logit": 5.242323875427246,
            "end_logit": -1.7623136043548584
        },
        {
            "text": ":",
            "probability": 0.0004966793012457051,
            "start_logit": -2.328542947769165,
            "end_logit": 4.621772766113281
        },
        {
            "text": "Al",
            "probability": 0.00037738957182269445,
            "start_logit": 5.242323875427246,
            "end_logit": -3.2237606048583984
        },
        {
            "text": "ase",
            "probability": 9.905472988893552e-05,
            "start_logit": -3.2142207622528076,
            "end_logit": 3.8951785564422607
        },
        {
            "text": "cognition in Alzheimer's Disease:",
            "probability": 8.705870770077653e-05,
            "start_logit": -4.069904804229736,
            "end_logit": 4.621772766113281
        },
        {
            "text": "AD",
            "probability": 6.563074620092864e-05,
            "start_logit": 1.6490815877914429,
            "end_logit": -1.3797520399093628
        },
        {
            "text": "models of Alzheimer's disease",
            "probability": 4.280818324034344e-05,
            "start_logit": -4.053164005279541,
            "end_logit": 3.8951785564422607
        },
        {
            "text": "mouse models of Alzheimer's disease",
            "probability": 4.004611575881929e-05,
            "start_logit": -4.119861602783203,
            "end_logit": 3.8951785564422607
        },
        {
            "text": "PBT2 rapidly improves cognition in Alzheimer's Disease:",
            "probability": 3.854484945107489e-05,
            "start_logit": -4.884665012359619,
            "end_logit": 4.621772766113281
        },
        {
            "text": "improves cognition in Alzheimer's Disease:",
            "probability": 3.120671244325332e-05,
            "start_logit": -5.09585428237915,
            "end_logit": 4.621772766113281
        },
        {
            "text": "in Alzheimer's Disease:",
            "probability": 3.056220023794752e-05,
            "start_logit": -5.116723537445068,
            "end_logit": 4.621772766113281
        },
        {
            "text": "of Alzheimer's disease",
            "probability": 2.7505370544390932e-05,
            "start_logit": -4.495512008666992,
            "end_logit": 3.8951785564422607
        },
        {
            "text": "Alzheimer's",
            "probability": 2.5371591354457256e-05,
            "start_logit": 5.242323875427246,
            "end_logit": -5.923408508300781
        },
        {
            "text": "rapidly improves cognition in Alzheimer's Disease:",
            "probability": 2.0631964698975464e-05,
            "start_logit": -5.509645938873291,
            "end_logit": 4.621772766113281
        },
        {
            "text": "AD.",
            "probability": 1.7226393883809812e-05,
            "start_logit": 1.6490815877914429,
            "end_logit": -2.717353582382202
        },
        {
            "text": "cognition in mouse models of Alzheimer's disease",
            "probability": 1.5166408086110944e-05,
            "start_logit": -5.090810298919678,
            "end_logit": 3.8951785564422607
        },
        {
            "text": "restores cognition in mouse models of Alzheimer's disease",
            "probability": 1.0309498609126156e-05,
            "start_logit": -5.476827621459961,
            "end_logit": 3.8951785564422607
        },
        {
            "text": "Alz",
            "probability": 6.191702916477988e-06,
            "start_logit": 5.242323875427246,
            "end_logit": -7.333828449249268
        }
    ],
    "54fc91e96ad7dcbc12000001_002": [
        {
            "text": "Alzheimer's disease",
            "probability": 0.9983632634195574,
            "start_logit": 8.782434463500977,
            "end_logit": 7.974746227264404
        },
        {
            "text": "Alzheimer's disease (AD).",
            "probability": 0.0013745772501713102,
            "start_logit": 8.782434463500977,
            "end_logit": 1.386775255203247
        },
        {
            "text": "Al",
            "probability": 0.000199713310709772,
            "start_logit": 8.782434463500977,
            "end_logit": -0.5422433614730835
        },
        {
            "text": "ase",
            "probability": 4.976949772563054e-05,
            "start_logit": -1.1240357160568237,
            "end_logit": 7.974746227264404
        },
        {
            "text": "for Alzheimer's disease",
            "probability": 4.869924955976051e-06,
            "start_logit": -3.448359489440918,
            "end_logit": 7.974746227264404
        },
        {
            "text": "CQ and its analog PBT2 have shown encouraging effects in the animal and clinical trials for Alzheimer's disease",
            "probability": 4.313878721689638e-06,
            "start_logit": -3.5696005821228027,
            "end_logit": 7.974746227264404
        },
        {
            "text": "Alzheimer's",
            "probability": 6.572257848725997e-07,
            "start_logit": 8.782434463500977,
            "end_logit": -6.258853912353516
        },
        {
            "text": "encouraging effects in the animal and clinical trials for Alzheimer's disease",
            "probability": 4.3974794697366e-07,
            "start_logit": -5.852991580963135,
            "end_logit": 7.974746227264404
        },
        {
            "text": "PBT2 have shown encouraging effects in the animal and clinical trials for Alzheimer's disease",
            "probability": 3.6772217697559616e-07,
            "start_logit": -6.03186559677124,
            "end_logit": 7.974746227264404
        },
        {
            "text": "disease",
            "probability": 3.3317414884140835e-07,
            "start_logit": -6.130527973175049,
            "end_logit": 7.974746227264404
        },
        {
            "text": "shown encouraging effects in the animal and clinical trials for Alzheimer's disease",
            "probability": 3.042012720254569e-07,
            "start_logit": -6.221503734588623,
            "end_logit": 7.974746227264404
        },
        {
            "text": "effects in the animal and clinical trials for Alzheimer's disease",
            "probability": 2.5907448364819293e-07,
            "start_logit": -6.382077693939209,
            "end_logit": 7.974746227264404
        },
        {
            "text": "Alzheimer",
            "probability": 2.201413831090955e-07,
            "start_logit": 8.782434463500977,
            "end_logit": -7.352611541748047
        },
        {
            "text": "and clinical trials for Alzheimer's disease",
            "probability": 1.8662499484363782e-07,
            "start_logit": -6.710092067718506,
            "end_logit": 7.974746227264404
        },
        {
            "text": "the animal and clinical trials for Alzheimer's disease",
            "probability": 1.77841381502983e-07,
            "start_logit": -6.758301258087158,
            "end_logit": 7.974746227264404
        },
        {
            "text": "isease",
            "probability": 1.6734621039459495e-07,
            "start_logit": -6.819128513336182,
            "end_logit": 7.974746227264404
        },
        {
            "text": "Alz",
            "probability": 1.5728272116124512e-07,
            "start_logit": 8.782434463500977,
            "end_logit": -7.688836574554443
        },
        {
            "text": "trials for Alzheimer's disease",
            "probability": 1.379769824408548e-07,
            "start_logit": -7.012106418609619,
            "end_logit": 7.974746227264404
        },
        {
            "text": "disease (AD).",
            "probability": 6.85241753505454e-08,
            "start_logit": -1.1240357160568237,
            "end_logit": 1.386775255203247
        },
        {
            "text": "(AD).",
            "probability": 1.5834496233253194e-08,
            "start_logit": -2.589031457901001,
            "end_logit": 1.386775255203247
        }
    ],
    "54fc91e96ad7dcbc12000001_003": [
        {
            "text": "Alzheimer's disease",
            "probability": 0.9995036135858555,
            "start_logit": 8.365438461303711,
            "end_logit": 7.478052616119385
        },
        {
            "text": "Al",
            "probability": 0.00019809505606183277,
            "start_logit": 8.365438461303711,
            "end_logit": -1.0482144355773926
        },
        {
            "text": "ase",
            "probability": 0.00011139380192269204,
            "start_logit": -0.7365038990974426,
            "end_logit": 7.478052616119385
        },
        {
            "text": "Alzheimer's disease include dimebon, PBT2 and etanercept;",
            "probability": 9.750345286403656e-05,
            "start_logit": 8.365438461303711,
            "end_logit": -1.7570736408233643
        },
        {
            "text": "for Alzheimer's disease",
            "probability": 5.284569625269043e-05,
            "start_logit": -1.4821993112564087,
            "end_logit": 7.478052616119385
        },
        {
            "text": "Experimental treatments potentially useful for Alzheimer's disease",
            "probability": 1.5943952593674358e-05,
            "start_logit": -2.6804959774017334,
            "end_logit": 7.478052616119385
        },
        {
            "text": "Alzheimer's",
            "probability": 1.5027601663370042e-05,
            "start_logit": 8.365438461303711,
            "end_logit": -3.627072811126709
        },
        {
            "text": "disease",
            "probability": 1.729881571856678e-06,
            "start_logit": -4.901522636413574,
            "end_logit": 7.478052616119385
        },
        {
            "text": "Alzheimer's disease include",
            "probability": 9.966754706251892e-07,
            "start_logit": 8.365438461303711,
            "end_logit": -6.340291500091553
        },
        {
            "text": "Alzheimer's disease include dimebon, PBT2 and etanercept; the safety and efficacy",
            "probability": 9.0009886417529e-07,
            "start_logit": 8.365438461303711,
            "end_logit": -6.442212104797363
        },
        {
            "text": "etanercept; the safety and efficacy of the Alzheimer's",
            "probability": 5.12299019465102e-07,
            "start_logit": 2.9611034393310547,
            "end_logit": -1.6014732122421265
        },
        {
            "text": "potentially useful for Alzheimer's disease",
            "probability": 4.84236250518099e-07,
            "start_logit": -6.174757957458496,
            "end_logit": 7.478052616119385
        },
        {
            "text": "etanercept;",
            "probability": 4.3847730232081897e-07,
            "start_logit": 2.9611034393310547,
            "end_logit": -1.7570736408233643
        },
        {
            "text": "isease",
            "probability": 4.373085247937331e-07,
            "start_logit": -6.276691913604736,
            "end_logit": 7.478052616119385
        },
        {
            "text": "etanercept; the safety and efficacy of the Alzheimer's vaccine",
            "probability": 2.039829865606301e-08,
            "start_logit": 2.9611034393310547,
            "end_logit": -4.824930191040039
        },
        {
            "text": "etanercept",
            "probability": 1.82857624960582e-08,
            "start_logit": 2.9611034393310547,
            "end_logit": -4.934258937835693
        },
        {
            "text": "disease include dimebon, PBT2 and etanercept; the safety and efficacy of the Alzheimer's",
            "probability": 1.2696179717023906e-08,
            "start_logit": -0.7365038990974426,
            "end_logit": -1.6014732122421265
        },
        {
            "text": "disease include dimebon, PBT2 and etanercept;",
            "probability": 1.08666743846465e-08,
            "start_logit": -0.7365038990974426,
            "end_logit": -1.7570736408233643
        },
        {
            "text": "for Alzheimer's",
            "probability": 1.0473670149371678e-08,
            "start_logit": -1.4821993112564087,
            "end_logit": -1.0482144355773926
        },
        {
            "text": "for Alzheimer's disease include dimebon, PBT2 and etanercept;",
            "probability": 5.155196823306726e-09,
            "start_logit": -1.4821993112564087,
            "end_logit": -1.7570736408233643
        }
    ],
    "54fc91e96ad7dcbc12000001_004": [
        {
            "text": "Alzheimer's disease.",
            "probability": 0.9987216029923625,
            "start_logit": 5.069557189941406,
            "end_logit": 4.569708347320557
        },
        {
            "text": "for Alzheimer's disease.",
            "probability": 0.000561988107641475,
            "start_logit": -2.413193464279175,
            "end_logit": 4.569708347320557
        },
        {
            "text": ".",
            "probability": 0.0002889269483618099,
            "start_logit": -3.078500270843506,
            "end_logit": 4.569708347320557
        },
        {
            "text": "Al",
            "probability": 0.00027678014496577177,
            "start_logit": 5.069557189941406,
            "end_logit": -3.6212995052337646
        },
        {
            "text": "Alzheimer's",
            "probability": 6.351681469682405e-05,
            "start_logit": 5.069557189941406,
            "end_logit": -5.0932183265686035
        },
        {
            "text": "Alzheimer",
            "probability": 1.966850519953993e-05,
            "start_logit": 5.069557189941406,
            "end_logit": -6.265504360198975
        },
        {
            "text": "in Alzheimer's disease.",
            "probability": 1.4344649190721732e-05,
            "start_logit": -4.760511875152588,
            "end_logit": 3.2489230632781982
        },
        {
            "text": "Alz",
            "probability": 1.3080088636121699e-05,
            "start_logit": 5.069557189941406,
            "end_logit": -6.673431873321533
        },
        {
            "text": "disease.",
            "probability": 1.1472449967494573e-05,
            "start_logit": -6.304725646972656,
            "end_logit": 4.569708347320557
        },
        {
            "text": "disease-modifying candidate drug for Alzheimer's disease.",
            "probability": 6.393456858299376e-06,
            "start_logit": -6.88939905166626,
            "end_logit": 4.569708347320557
        },
        {
            "text": "candidate drug for Alzheimer's disease.",
            "probability": 5.698045488768977e-06,
            "start_logit": -7.004550933837891,
            "end_logit": 4.569708347320557
        },
        {
            "text": "Phase I clinical trials and is advancing as a disease-modifying candidate drug for Alzheimer's disease.",
            "probability": 4.300489002183956e-06,
            "start_logit": -7.285945415496826,
            "end_logit": 4.569708347320557
        },
        {
            "text": "drug for Alzheimer's disease.",
            "probability": 2.6312691642797878e-06,
            "start_logit": -7.777207851409912,
            "end_logit": 4.569708347320557
        },
        {
            "text": "target in Alzheimer's disease.",
            "probability": 2.4959292791721574e-06,
            "start_logit": -6.509227752685547,
            "end_logit": 3.2489230632781982
        },
        {
            "text": "advancing as a disease-modifying candidate drug for Alzheimer's disease.",
            "probability": 2.025504085102868e-06,
            "start_logit": -8.03885555267334,
            "end_logit": 4.569708347320557
        },
        {
            "text": "the value of abnormal transition metal metabolism as a potential therapeutic target in Alzheimer's disease.",
            "probability": 1.7749802667252406e-06,
            "start_logit": -6.850099563598633,
            "end_logit": 3.2489230632781982
        },
        {
            "text": "potential therapeutic target in Alzheimer's disease.",
            "probability": 1.6298716310121888e-06,
            "start_logit": -6.93538761138916,
            "end_logit": 3.2489230632781982
        },
        {
            "text": "therapeutic target in Alzheimer's disease.",
            "probability": 1.503615983275829e-06,
            "start_logit": -7.016016006469727,
            "end_logit": 3.2489230632781982
        },
        {
            "text": "for Alzheimer's",
            "probability": 1.557462554489639e-07,
            "start_logit": -2.413193464279175,
            "end_logit": -3.6212995052337646
        },
        {
            "text": "in Alzheimer's",
            "probability": 1.0390963271604379e-08,
            "start_logit": -4.760511875152588,
            "end_logit": -3.9812726974487305
        }
    ],
    "54fc91e96ad7dcbc12000001_005": [
        {
            "text": "Alzheimer's disease.",
            "probability": 0.9987216029923625,
            "start_logit": 5.069557189941406,
            "end_logit": 4.569708347320557
        },
        {
            "text": "for Alzheimer's disease.",
            "probability": 0.000561988107641475,
            "start_logit": -2.413193464279175,
            "end_logit": 4.569708347320557
        },
        {
            "text": ".",
            "probability": 0.0002889269483618099,
            "start_logit": -3.078500270843506,
            "end_logit": 4.569708347320557
        },
        {
            "text": "Al",
            "probability": 0.00027678014496577177,
            "start_logit": 5.069557189941406,
            "end_logit": -3.6212995052337646
        },
        {
            "text": "Alzheimer's",
            "probability": 6.351681469682405e-05,
            "start_logit": 5.069557189941406,
            "end_logit": -5.0932183265686035
        },
        {
            "text": "Alzheimer",
            "probability": 1.966850519953993e-05,
            "start_logit": 5.069557189941406,
            "end_logit": -6.265504360198975
        },
        {
            "text": "in Alzheimer's disease.",
            "probability": 1.4344649190721732e-05,
            "start_logit": -4.760511875152588,
            "end_logit": 3.2489230632781982
        },
        {
            "text": "Alz",
            "probability": 1.3080088636121699e-05,
            "start_logit": 5.069557189941406,
            "end_logit": -6.673431873321533
        },
        {
            "text": "disease.",
            "probability": 1.1472449967494573e-05,
            "start_logit": -6.304725646972656,
            "end_logit": 4.569708347320557
        },
        {
            "text": "disease-modifying candidate drug for Alzheimer's disease.",
            "probability": 6.393456858299376e-06,
            "start_logit": -6.88939905166626,
            "end_logit": 4.569708347320557
        },
        {
            "text": "candidate drug for Alzheimer's disease.",
            "probability": 5.698045488768977e-06,
            "start_logit": -7.004550933837891,
            "end_logit": 4.569708347320557
        },
        {
            "text": "Phase I clinical trials and is advancing as a disease-modifying candidate drug for Alzheimer's disease.",
            "probability": 4.300489002183956e-06,
            "start_logit": -7.285945415496826,
            "end_logit": 4.569708347320557
        },
        {
            "text": "drug for Alzheimer's disease.",
            "probability": 2.6312691642797878e-06,
            "start_logit": -7.777207851409912,
            "end_logit": 4.569708347320557
        },
        {
            "text": "target in Alzheimer's disease.",
            "probability": 2.4959292791721574e-06,
            "start_logit": -6.509227752685547,
            "end_logit": 3.2489230632781982
        },
        {
            "text": "advancing as a disease-modifying candidate drug for Alzheimer's disease.",
            "probability": 2.025504085102868e-06,
            "start_logit": -8.03885555267334,
            "end_logit": 4.569708347320557
        },
        {
            "text": "the value of abnormal transition metal metabolism as a potential therapeutic target in Alzheimer's disease.",
            "probability": 1.7749802667252406e-06,
            "start_logit": -6.850099563598633,
            "end_logit": 3.2489230632781982
        },
        {
            "text": "potential therapeutic target in Alzheimer's disease.",
            "probability": 1.6298716310121888e-06,
            "start_logit": -6.93538761138916,
            "end_logit": 3.2489230632781982
        },
        {
            "text": "therapeutic target in Alzheimer's disease.",
            "probability": 1.503615983275829e-06,
            "start_logit": -7.016016006469727,
            "end_logit": 3.2489230632781982
        },
        {
            "text": "for Alzheimer's",
            "probability": 1.557462554489639e-07,
            "start_logit": -2.413193464279175,
            "end_logit": -3.6212995052337646
        },
        {
            "text": "in Alzheimer's",
            "probability": 1.0390963271604379e-08,
            "start_logit": -4.760511875152588,
            "end_logit": -3.9812726974487305
        }
    ],
    "54fc91e96ad7dcbc12000001_006": [
        {
            "text": "Alzheimer's disease",
            "probability": 0.9995575423945608,
            "start_logit": 8.5720796585083,
            "end_logit": 7.538036823272705
        },
        {
            "text": "Al",
            "probability": 0.00024306276110799534,
            "start_logit": 8.5720796585083,
            "end_logit": -0.7837114930152893
        },
        {
            "text": "ase",
            "probability": 0.00011146436457434038,
            "start_logit": -0.5292834043502808,
            "end_logit": 7.538036823272705
        },
        {
            "text": "for Alzheimer's disease",
            "probability": 3.6758658693171895e-05,
            "start_logit": -1.638614535331726,
            "end_logit": 7.538036823272705
        },
        {
            "text": "Alzheimer's disease based",
            "probability": 3.392524499592641e-05,
            "start_logit": 8.5720796585083,
            "end_logit": -2.7528717517852783
        },
        {
            "text": "Alzheimer's disease based on the \"metal hypothesis.\"",
            "probability": 6.8132078148539464e-06,
            "start_logit": 8.5720796585083,
            "end_logit": -4.358168125152588
        },
        {
            "text": "Alzheimer's disease based on the \"metal",
            "probability": 5.994139303657266e-06,
            "start_logit": 8.5720796585083,
            "end_logit": -4.486248970031738
        },
        {
            "text": "show increasing promise as disease-modifying agents for Alzheimer's disease",
            "probability": 9.233503963608781e-07,
            "start_logit": -5.322734832763672,
            "end_logit": 7.538036823272705
        },
        {
            "text": "Alzheimer's",
            "probability": 7.611947696790508e-07,
            "start_logit": 8.5720796585083,
            "end_logit": -6.549897193908691
        },
        {
            "text": "and show increasing promise as disease-modifying agents for Alzheimer's disease",
            "probability": 6.393586532634863e-07,
            "start_logit": -5.690278053283691,
            "end_logit": 7.538036823272705
        },
        {
            "text": "disease",
            "probability": 6.200056844209268e-07,
            "start_logit": -5.721014976501465,
            "end_logit": 7.538036823272705
        },
        {
            "text": "Alzheimer's disease based on",
            "probability": 5.904476459084004e-07,
            "start_logit": 8.5720796585083,
            "end_logit": -6.803905487060547
        },
        {
            "text": "disease-modifying agents for Alzheimer's disease",
            "probability": 4.269807763155728e-07,
            "start_logit": -6.0940046310424805,
            "end_logit": 7.538036823272705
        },
        {
            "text": "increasing promise as disease-modifying agents for Alzheimer's disease",
            "probability": 4.157661219781008e-07,
            "start_logit": -6.1206207275390625,
            "end_logit": 7.538036823272705
        },
        {
            "text": "Alzheimer's Disease,\" which stipulates that the neuropathogenic effects of Abeta in Alzheimer's disease",
            "probability": 4.0874034752884167e-08,
            "start_logit": -1.2521240711212158,
            "end_logit": 0.34991228580474854
        },
        {
            "text": "for Alzheimer's",
            "probability": 8.938616035235667e-09,
            "start_logit": -1.638614535331726,
            "end_logit": -0.7837114930152893
        },
        {
            "text": "disease based",
            "probability": 3.783129751030464e-09,
            "start_logit": -0.5292834043502808,
            "end_logit": -2.7528717517852783
        },
        {
            "text": "Alzheimer's Disease,\"",
            "probability": 3.4937328196544956e-09,
            "start_logit": -1.2521240711212158,
            "end_logit": -2.109611988067627
        },
        {
            "text": "\"metal hypothesis.\"",
            "probability": 2.6787078555015455e-09,
            "start_logit": 0.7307958602905273,
            "end_logit": -4.358168125152588
        },
        {
            "text": "\"metal",
            "probability": 2.3566796252231275e-09,
            "start_logit": 0.7307958602905273,
            "end_logit": -4.486248970031738
        }
    ],
    "53318685d6d3ac6a3400003d_001": [
        {
            "text": "autosomal dominant",
            "probability": 0.9958611257054518,
            "start_logit": 9.151912689208984,
            "end_logit": 8.448186874389648
        },
        {
            "text": "AD has an autosomal dominant",
            "probability": 0.002661314187020972,
            "start_logit": 3.2271249294281006,
            "end_logit": 8.448186874389648
        },
        {
            "text": "autosomal dominant mode of inheritance,",
            "probability": 0.0012486197190066262,
            "start_logit": 9.151912689208984,
            "end_logit": 1.766617774963379
        },
        {
            "text": "aut",
            "probability": 0.00011670053498731216,
            "start_logit": 9.151912689208984,
            "end_logit": -0.6035650968551636
        },
        {
            "text": "inant",
            "probability": 9.964764446175728e-05,
            "start_logit": -0.05780999734997749,
            "end_logit": 8.448186874389648
        },
        {
            "text": "AD has an autosomal dominant mode of inheritance,",
            "probability": 3.3367798848785636e-06,
            "start_logit": 3.2271249294281006,
            "end_logit": 1.766617774963379
        },
        {
            "text": "autosomal dominant or recessive",
            "probability": 2.4950657917671164e-06,
            "start_logit": 7.622683048248291,
            "end_logit": -2.9196314811706543
        },
        {
            "text": "has an autosomal dominant",
            "probability": 1.7563654728385238e-06,
            "start_logit": -4.096203804016113,
            "end_logit": 8.448186874389648
        },
        {
            "text": "dominant",
            "probability": 1.5730968563677333e-06,
            "start_logit": -4.206404209136963,
            "end_logit": 8.448186874389648
        },
        {
            "text": "an autosomal dominant",
            "probability": 1.2624388591651352e-06,
            "start_logit": -4.42640495300293,
            "end_logit": 8.448186874389648
        },
        {
            "text": "AD",
            "probability": 6.840575288641679e-07,
            "start_logit": 3.2271249294281006,
            "end_logit": 0.18189828097820282
        },
        {
            "text": "autosomal dominant or recessive mode of inheritance.",
            "probability": 4.782250292150891e-07,
            "start_logit": 7.622683048248291,
            "end_logit": -4.571620464324951
        },
        {
            "text": "autos",
            "probability": 3.24627348990876e-07,
            "start_logit": 9.151912689208984,
            "end_logit": -6.488253593444824
        },
        {
            "text": "AD has an autosomal",
            "probability": 3.11867570063711e-07,
            "start_logit": 3.2271249294281006,
            "end_logit": -0.6035650968551636
        },
        {
            "text": "dominant mode of inheritance,",
            "probability": 1.2493912114439958e-07,
            "start_logit": -0.05780999734997749,
            "end_logit": 1.766617774963379
        },
        {
            "text": "autosomal dominant or",
            "probability": 1.1052291358015746e-07,
            "start_logit": 7.622683048248291,
            "end_logit": -6.0364789962768555
        },
        {
            "text": "has autosomal dominant",
            "probability": 6.568754678149058e-08,
            "start_logit": -3.6143300533294678,
            "end_logit": 4.680220603942871
        },
        {
            "text": "autosomal dominant or recessive mode of",
            "probability": 2.8803207801454207e-08,
            "start_logit": 7.622683048248291,
            "end_logit": -7.3812150955200195
        },
        {
            "text": "autosomal dominant or recessive mode",
            "probability": 2.6975326297279024e-08,
            "start_logit": 7.622683048248291,
            "end_logit": -7.446779251098633
        },
        {
            "text": "and has autosomal dominant",
            "probability": 1.2756613594300829e-08,
            "start_logit": -5.253189563751221,
            "end_logit": 4.680220603942871
        }
    ],
    "53318685d6d3ac6a3400003d_002": [
        {
            "text": "autosomal dominant",
            "probability": 0.991790343619013,
            "start_logit": 9.463079452514648,
            "end_logit": 8.94257926940918
        },
        {
            "text": "autosomal dominant mode of inheritance.",
            "probability": 0.0045898419791512105,
            "start_logit": 9.399320602416992,
            "end_logit": 3.630671977996826
        },
        {
            "text": "autosomal dominant or an autosomal recessive",
            "probability": 0.0032564100025192617,
            "start_logit": 9.463079452514648,
            "end_logit": 3.2236928939819336
        },
        {
            "text": "inant",
            "probability": 0.00014989130697147952,
            "start_logit": 0.7757425308227539,
            "end_logit": 8.832559585571289
        },
        {
            "text": "aut",
            "probability": 0.00013902799146317394,
            "start_logit": 9.463079452514648,
            "end_logit": 0.06998754292726517
        },
        {
            "text": "dominant",
            "probability": 2.333835516468127e-05,
            "start_logit": -1.0840697288513184,
            "end_logit": 8.832559585571289
        },
        {
            "text": "autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 1.7468873687708727e-05,
            "start_logit": -1.3737472295761108,
            "end_logit": 8.832559585571289
        },
        {
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive",
            "probability": 1.418811119991036e-05,
            "start_logit": 9.463079452514648,
            "end_logit": -2.2122833728790283
        },
        {
            "text": "autosomal recessive",
            "probability": 8.833229995547525e-06,
            "start_logit": 3.5532195568084717,
            "end_logit": 3.2236928939819336
        },
        {
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance,",
            "probability": 4.164617206783207e-06,
            "start_logit": 9.463079452514648,
            "end_logit": -3.438063383102417
        },
        {
            "text": "an autosomal dominant",
            "probability": 3.800606122809868e-06,
            "start_logit": -2.8990073204040527,
            "end_logit": 8.832559585571289
        },
        {
            "text": "dominant mode of inheritance.",
            "probability": 8.253256887297233e-07,
            "start_logit": 0.7757425308227539,
            "end_logit": 3.630671977996826
        },
        {
            "text": "AD by an autosomal dominant",
            "probability": 5.601640212843531e-07,
            "start_logit": -4.813693523406982,
            "end_logit": 8.832559585571289
        },
        {
            "text": "dominant or an autosomal recessive",
            "probability": 4.901105658950288e-07,
            "start_logit": 0.6615745425224304,
            "end_logit": 3.2236928939819336
        },
        {
            "text": "autosomal dominant or",
            "probability": 3.4402708349127085e-07,
            "start_logit": 9.463079452514648,
            "end_logit": -5.931722640991211
        },
        {
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD",
            "probability": 1.2006528078646498e-07,
            "start_logit": 9.463079452514648,
            "end_logit": -6.984407424926758
        },
        {
            "text": "autos",
            "probability": 1.1090935691208979e-07,
            "start_logit": 9.463079452514648,
            "end_logit": -7.063729763031006
        },
        {
            "text": "autosomal recessive mode of inheritance and AD by an autosomal dominant mode of inheritance.",
            "probability": 9.618643334922706e-08,
            "start_logit": -1.3737472295761108,
            "end_logit": 3.630671977996826
        },
        {
            "text": "autosomal dominant or an autosomal",
            "probability": 8.728377394855538e-08,
            "start_logit": 9.463079452514648,
            "end_logit": -7.30327844619751
        },
        {
            "text": "autosomal",
            "probability": 5.723530038863612e-08,
            "start_logit": 9.399320602416992,
            "end_logit": -7.661513328552246
        }
    ],
    "53318685d6d3ac6a3400003d_003": [
        {
            "text": "autosomal dominant",
            "probability": 0.991790343619013,
            "start_logit": 9.463079452514648,
            "end_logit": 8.94257926940918
        },
        {
            "text": "autosomal dominant mode of inheritance.",
            "probability": 0.0045898419791512105,
            "start_logit": 9.399320602416992,
            "end_logit": 3.630671977996826
        },
        {
            "text": "autosomal dominant or an autosomal recessive",
            "probability": 0.0032564100025192617,
            "start_logit": 9.463079452514648,
            "end_logit": 3.2236928939819336
        },
        {
            "text": "inant",
            "probability": 0.00014989130697147952,
            "start_logit": 0.7757425308227539,
            "end_logit": 8.832559585571289
        },
        {
            "text": "aut",
            "probability": 0.00013902799146317394,
            "start_logit": 9.463079452514648,
            "end_logit": 0.06998754292726517
        },
        {
            "text": "dominant",
            "probability": 2.333835516468127e-05,
            "start_logit": -1.0840697288513184,
            "end_logit": 8.832559585571289
        },
        {
            "text": "autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 1.7468873687708727e-05,
            "start_logit": -1.3737472295761108,
            "end_logit": 8.832559585571289
        },
        {
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive",
            "probability": 1.418811119991036e-05,
            "start_logit": 9.463079452514648,
            "end_logit": -2.2122833728790283
        },
        {
            "text": "autosomal recessive",
            "probability": 8.833229995547525e-06,
            "start_logit": 3.5532195568084717,
            "end_logit": 3.2236928939819336
        },
        {
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance,",
            "probability": 4.164617206783207e-06,
            "start_logit": 9.463079452514648,
            "end_logit": -3.438063383102417
        },
        {
            "text": "an autosomal dominant",
            "probability": 3.800606122809868e-06,
            "start_logit": -2.8990073204040527,
            "end_logit": 8.832559585571289
        },
        {
            "text": "dominant mode of inheritance.",
            "probability": 8.253256887297233e-07,
            "start_logit": 0.7757425308227539,
            "end_logit": 3.630671977996826
        },
        {
            "text": "AD by an autosomal dominant",
            "probability": 5.601640212843531e-07,
            "start_logit": -4.813693523406982,
            "end_logit": 8.832559585571289
        },
        {
            "text": "dominant or an autosomal recessive",
            "probability": 4.901105658950288e-07,
            "start_logit": 0.6615745425224304,
            "end_logit": 3.2236928939819336
        },
        {
            "text": "autosomal dominant or",
            "probability": 3.4402708349127085e-07,
            "start_logit": 9.463079452514648,
            "end_logit": -5.931722640991211
        },
        {
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD",
            "probability": 1.2006528078646498e-07,
            "start_logit": 9.463079452514648,
            "end_logit": -6.984407424926758
        },
        {
            "text": "autos",
            "probability": 1.1090935691208979e-07,
            "start_logit": 9.463079452514648,
            "end_logit": -7.063729763031006
        },
        {
            "text": "autosomal recessive mode of inheritance and AD by an autosomal dominant mode of inheritance.",
            "probability": 9.618643334922706e-08,
            "start_logit": -1.3737472295761108,
            "end_logit": 3.630671977996826
        },
        {
            "text": "autosomal dominant or an autosomal",
            "probability": 8.728377394855538e-08,
            "start_logit": 9.463079452514648,
            "end_logit": -7.30327844619751
        },
        {
            "text": "autosomal",
            "probability": 5.723530038863612e-08,
            "start_logit": 9.399320602416992,
            "end_logit": -7.661513328552246
        }
    ],
    "53318685d6d3ac6a3400003d_004": [
        {
            "text": "autosomal dominant",
            "probability": 0.9970799705684142,
            "start_logit": 8.128243446350098,
            "end_logit": 7.146535396575928
        },
        {
            "text": "autosomal dominant mode of inheritance.",
            "probability": 0.002510629662393626,
            "start_logit": 8.128243446350098,
            "end_logit": 1.1622380018234253
        },
        {
            "text": "inant",
            "probability": 0.00020583055008545337,
            "start_logit": -0.35728955268859863,
            "end_logit": 7.146535396575928
        },
        {
            "text": "aut",
            "probability": 0.00014364455057543866,
            "start_logit": 8.128243446350098,
            "end_logit": -1.6987090110778809
        },
        {
            "text": "an autosomal dominant",
            "probability": 4.5561552271759784e-05,
            "start_logit": -1.8652786016464233,
            "end_logit": 7.146535396575928
        },
        {
            "text": "dominant",
            "probability": 5.2757617694288215e-06,
            "start_logit": -4.021219730377197,
            "end_logit": 7.146535396575928
        },
        {
            "text": "autos",
            "probability": 4.847550459012758e-06,
            "start_logit": 8.128243446350098,
            "end_logit": -5.0875773429870605
        },
        {
            "text": "with an autosomal dominant",
            "probability": 1.8195919231630707e-06,
            "start_logit": -5.08573055267334,
            "end_logit": 7.146535396575928
        },
        {
            "text": "autosomal dominant mode",
            "probability": 5.477933093173872e-07,
            "start_logit": 8.128243446350098,
            "end_logit": -7.267908096313477
        },
        {
            "text": "dominant mode of inheritance.",
            "probability": 5.18277670522997e-07,
            "start_logit": -0.35728955268859863,
            "end_logit": 1.1622380018234253
        },
        {
            "text": "consistent with an autosomal dominant",
            "probability": 4.5982100489735267e-07,
            "start_logit": -6.461260795593262,
            "end_logit": 7.146535396575928
        },
        {
            "text": "autosomal",
            "probability": 3.7110911516893883e-07,
            "start_logit": 8.128243446350098,
            "end_logit": -7.6573100090026855
        },
        {
            "text": "autosomal dominant mode of",
            "probability": 2.205493226586789e-07,
            "start_logit": 8.128243446350098,
            "end_logit": -8.177684783935547
        },
        {
            "text": "families was consistent with an autosomal dominant",
            "probability": 1.5837174317566204e-07,
            "start_logit": -7.527153015136719,
            "end_logit": 7.146535396575928
        },
        {
            "text": "an autosomal dominant mode of inheritance.",
            "probability": 1.1472317965926798e-07,
            "start_logit": -1.8652786016464233,
            "end_logit": 1.1622380018234253
        },
        {
            "text": ".",
            "probability": 1.4481366308961731e-08,
            "start_logit": -3.9349379539489746,
            "end_logit": 1.1622380018234253
        },
        {
            "text": "an autosomal",
            "probability": 6.563835291832522e-09,
            "start_logit": -1.8652786016464233,
            "end_logit": -1.6987090110778809
        },
        {
            "text": "with an autosomal dominant mode of inheritance.",
            "probability": 4.5817001550445e-09,
            "start_logit": -5.08573055267334,
            "end_logit": 1.1622380018234253
        },
        {
            "text": "mode of inheritance.",
            "probability": 2.4676367690118987e-09,
            "start_logit": -5.704539775848389,
            "end_logit": 1.1622380018234253
        },
        {
            "text": "inheritance.",
            "probability": 1.4722241348160803e-09,
            "start_logit": -6.221026420593262,
            "end_logit": 1.1622380018234253
        }
    ],
    "511a3573df1ebcce7d000018_001": [
        {
            "text": "15",
            "probability": 0.9998481187676694,
            "start_logit": 7.008854389190674,
            "end_logit": 6.814809799194336
        },
        {
            "text": "15 genes.",
            "probability": 6.731201107913698e-05,
            "start_logit": 7.008854389190674,
            "end_logit": -2.791210174560547
        },
        {
            "text": "all 15",
            "probability": 5.771008082374686e-05,
            "start_logit": -2.751072406768799,
            "end_logit": 6.814809799194336
        },
        {
            "text": "direction of transcription of all 15",
            "probability": 1.1022999011857184e-05,
            "start_logit": -4.406520366668701,
            "end_logit": 6.814809799194336
        },
        {
            "text": "transcription of all 15",
            "probability": 7.066816036983851e-06,
            "start_logit": -4.8510942459106445,
            "end_logit": 6.814809799194336
        },
        {
            "text": "of all 15",
            "probability": 4.62304275222679e-06,
            "start_logit": -5.275451183319092,
            "end_logit": 6.814809799194336
        },
        {
            "text": "of transcription of all 15",
            "probability": 1.2774463673736724e-06,
            "start_logit": -6.561641216278076,
            "end_logit": 6.814809799194336
        },
        {
            "text": "the direction of transcription of all 15",
            "probability": 9.238606388459465e-07,
            "start_logit": -6.885698318481445,
            "end_logit": 6.814809799194336
        },
        {
            "text": "location, and the direction of transcription of all 15",
            "probability": 9.087355136557738e-07,
            "start_logit": -6.902205467224121,
            "end_logit": 6.814809799194336
        },
        {
            "text": "the relative location, and the direction of transcription of all 15",
            "probability": 5.893617500328472e-07,
            "start_logit": -7.335219383239746,
            "end_logit": 6.814809799194336
        },
        {
            "text": "15 genes. Determination of the true size of the kallikrein family",
            "probability": 2.4137365664817245e-07,
            "start_logit": 7.008854389190674,
            "end_logit": -8.421957969665527
        },
        {
            "text": "15 genes. Determination of the true size of the kallikrein family in humans is important",
            "probability": 1.9923879817826458e-07,
            "start_logit": 7.008854389190674,
            "end_logit": -8.613800048828125
        },
        {
            "text": "all 15 genes.",
            "probability": 3.885171684449189e-09,
            "start_logit": -2.751072406768799,
            "end_logit": -2.791210174560547
        },
        {
            "text": "direction of transcription of all 15 genes.",
            "probability": 7.42092941601921e-10,
            "start_logit": -4.406520366668701,
            "end_logit": -2.791210174560547
        },
        {
            "text": "genes.",
            "probability": 4.796761905969579e-10,
            "start_logit": -4.842883586883545,
            "end_logit": -2.791210174560547
        },
        {
            "text": "transcription of all 15 genes.",
            "probability": 4.757538574578365e-10,
            "start_logit": -4.8510942459106445,
            "end_logit": -2.791210174560547
        },
        {
            "text": "of all 15 genes.",
            "probability": 3.112335754962026e-10,
            "start_logit": -5.275451183319092,
            "end_logit": -2.791210174560547
        },
        {
            "text": "three",
            "probability": 1.4205675492144906e-10,
            "start_logit": -4.026258945465088,
            "end_logit": -4.824719429016113
        },
        {
            "text": "direction of transcription",
            "probability": 1.4009932742670065e-10,
            "start_logit": -4.406520366668701,
            "end_logit": -4.4583330154418945
        },
        {
            "text": "transcription",
            "probability": 8.98173149398525e-11,
            "start_logit": -4.8510942459106445,
            "end_logit": -4.4583330154418945
        }
    ],
    "511a3573df1ebcce7d000018_002": [
        {
            "text": "15",
            "probability": 0.9998308531973115,
            "start_logit": 7.238498210906982,
            "end_logit": 7.298301696777344
        },
        {
            "text": "consists of 15",
            "probability": 7.393889666463792e-05,
            "start_logit": -2.273604154586792,
            "end_logit": 7.298301696777344
        },
        {
            "text": "15 genes with the majority shown to be differentially expressed in cancers and/or indicators of cancer",
            "probability": 3.903306411774612e-05,
            "start_logit": 7.238498210906982,
            "end_logit": -2.852630615234375
        },
        {
            "text": "The human tissue Kallikrein family consists of 15",
            "probability": 2.9166660557290654e-05,
            "start_logit": -3.2038168907165527,
            "end_logit": 7.298301696777344
        },
        {
            "text": "15 genes with the majority shown to be differentially expressed in cancers",
            "probability": 6.329794029882086e-06,
            "start_logit": 7.238498210906982,
            "end_logit": -4.671772003173828
        },
        {
            "text": "15 genes with the majority shown to be differentially expressed",
            "probability": 4.742372568724903e-06,
            "start_logit": 7.238498210906982,
            "end_logit": -4.9605021476745605
        },
        {
            "text": "family consists of 15",
            "probability": 3.0746198491010964e-06,
            "start_logit": -5.453661918640137,
            "end_logit": 7.298301696777344
        },
        {
            "text": "15 genes",
            "probability": 2.7406035183826136e-06,
            "start_logit": 7.238498210906982,
            "end_logit": -5.508861541748047
        },
        {
            "text": "of 15",
            "probability": 1.991399090897894e-06,
            "start_logit": -5.88800573348999,
            "end_logit": 7.298301696777344
        },
        {
            "text": "15 genes with the majority",
            "probability": 1.7473654696103906e-06,
            "start_logit": 7.238498210906982,
            "end_logit": -5.958930492401123
        },
        {
            "text": "15 genes with the majority shown to be differentially expressed in cancers and/or indicators of cancer prognosis.",
            "probability": 1.667188775893261e-06,
            "start_logit": 7.238498210906982,
            "end_logit": -6.005900859832764
        },
        {
            "text": "15 genes with",
            "probability": 1.4319502459992361e-06,
            "start_logit": 7.238498210906982,
            "end_logit": -6.1580023765563965
        },
        {
            "text": "15 genes with the majority shown to be differentially",
            "probability": 1.3689093926355959e-06,
            "start_logit": 7.238498210906982,
            "end_logit": -6.2030253410339355
        },
        {
            "text": "15 genes with the majority shown",
            "probability": 1.040558567183405e-06,
            "start_logit": 7.238498210906982,
            "end_logit": -6.4772820472717285
        },
        {
            "text": "15 genes with the majority shown to be differentially expressed in cancers and/or indicators",
            "probability": 8.659342937397446e-07,
            "start_logit": 7.238498210906982,
            "end_logit": -6.660985946655273
        },
        {
            "text": "consists of 15 genes with the majority shown to be differentially expressed in cancers and/or indicators of cancer",
            "probability": 2.8865499450002144e-09,
            "start_logit": -2.273604154586792,
            "end_logit": -2.852630615234375
        },
        {
            "text": "cancer",
            "probability": 1.9639904019839307e-09,
            "start_logit": -2.6586878299713135,
            "end_logit": -2.852630615234375
        },
        {
            "text": "consists",
            "probability": 1.2009800843425477e-09,
            "start_logit": -2.273604154586792,
            "end_logit": -3.7295546531677246
        },
        {
            "text": "consists of",
            "probability": 9.602761020334365e-10,
            "start_logit": -2.273604154586792,
            "end_logit": -3.9532270431518555
        },
        {
            "text": "The human tissue Kallikrein family consists",
            "probability": 4.73750353822066e-10,
            "start_logit": -3.2038168907165527,
            "end_logit": -3.7295546531677246
        }
    ],
    "511a3573df1ebcce7d000018_003": [
        {
            "text": "15",
            "probability": 0.9996128411357588,
            "start_logit": 6.939066410064697,
            "end_logit": 7.055786609649658
        },
        {
            "text": "The 15",
            "probability": 0.00037548178635061493,
            "start_logit": -0.9478469491004944,
            "end_logit": 7.055786609649658
        },
        {
            "text": "15 members of the kallikrein-related serine peptidase (KLK) family have diverse",
            "probability": 4.3527062656166e-06,
            "start_logit": 6.939066410064697,
            "end_logit": -5.288538932800293
        },
        {
            "text": "15 members of the kallikrein-related serine peptidase (KLK) family",
            "probability": 2.095801625938357e-06,
            "start_logit": 6.939066410064697,
            "end_logit": -6.019400596618652
        },
        {
            "text": "15 members",
            "probability": 1.8510957026154478e-06,
            "start_logit": 6.939066410064697,
            "end_logit": -6.143558979034424
        },
        {
            "text": "15 members of the kallikrein-related serine peptidase",
            "probability": 1.75291064575761e-06,
            "start_logit": 6.939066410064697,
            "end_logit": -6.19805908203125
        },
        {
            "text": "15 members of the kallikrein-related serine peptidase (KLK) family have",
            "probability": 6.988750718568422e-07,
            "start_logit": 6.939066410064697,
            "end_logit": -7.11761999130249
        },
        {
            "text": "15 members of the kallikrein-related serine peptidase (KLK) family have diverse tissue-specific",
            "probability": 4.898237784832504e-07,
            "start_logit": 6.939066410064697,
            "end_logit": -7.47304630279541
        },
        {
            "text": "15 members of the kallikrein-related serine peptidase (KLK)",
            "probability": 4.3079444896220587e-07,
            "start_logit": 6.939066410064697,
            "end_logit": -7.601460933685303
        },
        {
            "text": "The 15 members of the kallikrein-related serine peptidase (KLK) family have diverse",
            "probability": 1.6349949268521553e-09,
            "start_logit": -0.9478469491004944,
            "end_logit": -5.288538932800293
        },
        {
            "text": "The 15 members of the kallikrein-related serine peptidase (KLK) family",
            "probability": 7.872401253366679e-10,
            "start_logit": -0.9478469491004944,
            "end_logit": -6.019400596618652
        },
        {
            "text": "The",
            "probability": 7.27896198821754e-10,
            "start_logit": -0.9478469491004944,
            "end_logit": -6.097775459289551
        },
        {
            "text": "The 15 members",
            "probability": 6.953219211692769e-10,
            "start_logit": -0.9478469491004944,
            "end_logit": -6.143558979034424
        },
        {
            "text": "The 15 members of the kallikrein-related serine peptidase",
            "probability": 6.584409418292858e-10,
            "start_logit": -0.9478469491004944,
            "end_logit": -6.19805908203125
        },
        {
            "text": "The 15 members of the kallikrein-related serine peptidase (KLK) family have",
            "probability": 2.625164960051594e-10,
            "start_logit": -0.9478469491004944,
            "end_logit": -7.11761999130249
        },
        {
            "text": "The 15 members of the kallikrein-related serine peptidase (KLK)",
            "probability": 1.6181811856525522e-10,
            "start_logit": -0.9478469491004944,
            "end_logit": -7.601460933685303
        },
        {
            "text": "diverse",
            "probability": 6.604320167843805e-11,
            "start_logit": -4.156932830810547,
            "end_logit": -5.288538932800293
        },
        {
            "text": "diverse tissue-specific expression profiles",
            "probability": 3.9824987680955683e-11,
            "start_logit": -4.156932830810547,
            "end_logit": -5.794353485107422
        },
        {
            "text": "diverse tissue-specific expression profiles and putative proteolytic functions.",
            "probability": 1.821759976601099e-11,
            "start_logit": -4.156932830810547,
            "end_logit": -6.576459884643555
        },
        {
            "text": "(KLK) family have diverse",
            "probability": 1.8036568304019506e-11,
            "start_logit": -5.454840660095215,
            "end_logit": -5.288538932800293
        }
    ],
    "511a3573df1ebcce7d000018_004": [
        {
            "text": "15",
            "probability": 0.9998290132390777,
            "start_logit": 7.280782222747803,
            "end_logit": 6.856063365936279
        },
        {
            "text": "The 15",
            "probability": 9.623854096020813e-05,
            "start_logit": -1.9677274227142334,
            "end_logit": 6.856063365936279
        },
        {
            "text": "15 human and 24",
            "probability": 5.32761695524424e-05,
            "start_logit": 7.280782222747803,
            "end_logit": -2.9837870597839355
        },
        {
            "text": "diverse tissue-specific patterns, and known to have highly diverse physiological functions. The 15",
            "probability": 1.1245913699672724e-05,
            "start_logit": -4.1145524978637695,
            "end_logit": 6.856063365936279
        },
        {
            "text": "expressed in diverse tissue-specific patterns, and known to have highly diverse physiological functions. The 15",
            "probability": 2.9942249023219517e-06,
            "start_logit": -5.437871932983398,
            "end_logit": 6.856063365936279
        },
        {
            "text": "known to have highly diverse physiological functions. The 15",
            "probability": 2.916411657425225e-06,
            "start_logit": -5.464203357696533,
            "end_logit": 6.856063365936279
        },
        {
            "text": "living organisms, expressed in diverse tissue-specific patterns, and known to have highly diverse physiological functions. The 15",
            "probability": 2.0067768074325956e-06,
            "start_logit": -5.838027477264404,
            "end_logit": 6.856063365936279
        },
        {
            "text": "15 human",
            "probability": 1.1822686300239274e-06,
            "start_logit": 7.280782222747803,
            "end_logit": -6.79184103012085
        },
        {
            "text": "15 human and 24 mouse",
            "probability": 1.1178634082769274e-06,
            "start_logit": 7.280782222747803,
            "end_logit": -6.8478569984436035
        },
        {
            "text": "The 15 human and 24",
            "probability": 5.128097662484723e-09,
            "start_logit": -1.9677274227142334,
            "end_logit": -2.9837870597839355
        },
        {
            "text": "belong to a family",
            "probability": 9.206034795598339e-10,
            "start_logit": -3.146604299545288,
            "end_logit": -3.5223708152770996
        },
        {
            "text": "diverse tissue-specific patterns, and known to have highly diverse physiological functions. The 15 human and 24",
            "probability": 5.99241667427622e-10,
            "start_logit": -4.1145524978637695,
            "end_logit": -2.9837870597839355
        },
        {
            "text": "24",
            "probability": 4.103175340606084e-10,
            "start_logit": -4.4932861328125,
            "end_logit": -2.9837870597839355
        },
        {
            "text": "belong to a family of serine proteases that are widespread",
            "probability": 3.696006770911426e-10,
            "start_logit": -3.146604299545288,
            "end_logit": -4.434977054595947
        },
        {
            "text": "belong to a family of serine proteases that are widespread throughout living organisms,",
            "probability": 2.919485552005277e-10,
            "start_logit": -3.146604299545288,
            "end_logit": -4.670822620391846
        },
        {
            "text": "family",
            "probability": 2.570266639460913e-10,
            "start_logit": -4.422453880310059,
            "end_logit": -3.5223708152770996
        },
        {
            "text": "diverse tissue-specific patterns, and known to have highly diverse physiological functions.",
            "probability": 1.8571892603925525e-10,
            "start_logit": -4.1145524978637695,
            "end_logit": -4.15521764755249
        },
        {
            "text": "expressed in diverse tissue-specific patterns, and known to have highly diverse physiological functions. The 15 human and 24",
            "probability": 1.5954811418950611e-10,
            "start_logit": -5.437871932983398,
            "end_logit": -2.9837870597839355
        },
        {
            "text": "known to have highly diverse physiological functions. The 15 human and 24",
            "probability": 1.554018135984545e-10,
            "start_logit": -5.464203357696533,
            "end_logit": -2.9837870597839355
        },
        {
            "text": "The 15 human",
            "probability": 1.1379926614444026e-10,
            "start_logit": -1.9677274227142334,
            "end_logit": -6.79184103012085
        }
    ],
    "511a3573df1ebcce7d000018_005": [
        {
            "text": "15",
            "probability": 0.5405929432502604,
            "start_logit": 6.8870720863342285,
            "end_logit": 7.265207767486572
        },
        {
            "text": "(hK1-hK15 encoded by the genes KLK1-KLK15)",
            "probability": 0.4558107083309548,
            "start_logit": 6.716483116149902,
            "end_logit": 7.265207767486572
        },
        {
            "text": "hK15",
            "probability": 0.0012681182788726688,
            "start_logit": 0.8094486594200134,
            "end_logit": 7.287698745727539
        },
        {
            "text": "KLK15",
            "probability": 0.0011069296074156599,
            "start_logit": 0.695995569229126,
            "end_logit": 7.265207767486572
        },
        {
            "text": "(hK1-hK15",
            "probability": 0.0003714911724863986,
            "start_logit": -0.4183156490325928,
            "end_logit": 7.287698745727539
        },
        {
            "text": "encoded by the genes KLK1-KLK15)",
            "probability": 0.00030822668015694795,
            "start_logit": -0.5825142860412598,
            "end_logit": 7.265207767486572
        },
        {
            "text": "The human tissue kallikrein family of serine proteases (hK1-hK15",
            "probability": 0.00019603438595295586,
            "start_logit": -1.0575506687164307,
            "end_logit": 7.287698745727539
        },
        {
            "text": "K15",
            "probability": 0.000112358444793981,
            "start_logit": -1.6141465902328491,
            "end_logit": 7.287698745727539
        },
        {
            "text": "KLK1-KLK15)",
            "probability": 4.962303960146941e-05,
            "start_logit": -2.4088945388793945,
            "end_logit": 7.265207767486572
        },
        {
            "text": "family of serine proteases (hK1-hK15",
            "probability": 3.7340387410973004e-05,
            "start_logit": -2.7157652378082275,
            "end_logit": 7.287698745727539
        },
        {
            "text": "family of serine proteases (hK1-hK15 encoded by the genes KLK1-KLK15)",
            "probability": 3.650993937074685e-05,
            "start_logit": -2.7157652378082275,
            "end_logit": 7.265207767486572
        },
        {
            "text": "KLK1-KLK15) is involved in several cancer-related",
            "probability": 3.391493564326685e-05,
            "start_logit": 6.8870720863342285,
            "end_logit": -2.411358594894409
        },
        {
            "text": "(hK1-hK15 encoded by the genes KLK1-KLK15) is involved in several cancer-related",
            "probability": 2.8595990812628422e-05,
            "start_logit": 6.716483116149902,
            "end_logit": -2.411358594894409
        },
        {
            "text": "the genes KLK1-KLK15)",
            "probability": 1.541445699819523e-05,
            "start_logit": -3.5780439376831055,
            "end_logit": 7.265207767486572
        },
        {
            "text": "of serine proteases (hK1-hK15",
            "probability": 1.2420157721678916e-05,
            "start_logit": -3.8165199756622314,
            "end_logit": 7.287698745727539
        },
        {
            "text": "of serine proteases (hK1-hK15 encoded by the genes KLK1-KLK15)",
            "probability": 1.2143934137661226e-05,
            "start_logit": -3.8165199756622314,
            "end_logit": 7.265207767486572
        },
        {
            "text": "(hK1-hK15 encoded by",
            "probability": 2.662350747276142e-06,
            "start_logit": 6.716483116149902,
            "end_logit": -4.7854156494140625
        },
        {
            "text": "KLK1-KLK15) is involved",
            "probability": 1.7357917563293894e-06,
            "start_logit": 6.8870720863342285,
            "end_logit": -5.3837504386901855
        },
        {
            "text": "(hK1-hK15 encoded by the genes KLK1-KLK15) is involved",
            "probability": 1.4635641841910963e-06,
            "start_logit": 6.716483116149902,
            "end_logit": -5.3837504386901855
        },
        {
            "text": "KLK1-KLK15) is involved in several cancer-related processes.",
            "probability": 1.3653007217470359e-06,
            "start_logit": 6.8870720863342285,
            "end_logit": -5.623839378356934
        }
    ],
    "511a3573df1ebcce7d000018_006": [
        {
            "text": "15",
            "probability": 0.5405929432502604,
            "start_logit": 6.8870720863342285,
            "end_logit": 7.265207767486572
        },
        {
            "text": "(hK1-hK15 encoded by the genes KLK1-KLK15)",
            "probability": 0.4558107083309548,
            "start_logit": 6.716483116149902,
            "end_logit": 7.265207767486572
        },
        {
            "text": "hK15",
            "probability": 0.0012681182788726688,
            "start_logit": 0.8094486594200134,
            "end_logit": 7.287698745727539
        },
        {
            "text": "KLK15",
            "probability": 0.0011069296074156599,
            "start_logit": 0.695995569229126,
            "end_logit": 7.265207767486572
        },
        {
            "text": "(hK1-hK15",
            "probability": 0.0003714911724863986,
            "start_logit": -0.4183156490325928,
            "end_logit": 7.287698745727539
        },
        {
            "text": "encoded by the genes KLK1-KLK15)",
            "probability": 0.00030822668015694795,
            "start_logit": -0.5825142860412598,
            "end_logit": 7.265207767486572
        },
        {
            "text": "The human tissue kallikrein family of serine proteases (hK1-hK15",
            "probability": 0.00019603438595295586,
            "start_logit": -1.0575506687164307,
            "end_logit": 7.287698745727539
        },
        {
            "text": "K15",
            "probability": 0.000112358444793981,
            "start_logit": -1.6141465902328491,
            "end_logit": 7.287698745727539
        },
        {
            "text": "KLK1-KLK15)",
            "probability": 4.962303960146941e-05,
            "start_logit": -2.4088945388793945,
            "end_logit": 7.265207767486572
        },
        {
            "text": "family of serine proteases (hK1-hK15",
            "probability": 3.7340387410973004e-05,
            "start_logit": -2.7157652378082275,
            "end_logit": 7.287698745727539
        },
        {
            "text": "family of serine proteases (hK1-hK15 encoded by the genes KLK1-KLK15)",
            "probability": 3.650993937074685e-05,
            "start_logit": -2.7157652378082275,
            "end_logit": 7.265207767486572
        },
        {
            "text": "KLK1-KLK15) is involved in several cancer-related",
            "probability": 3.391493564326685e-05,
            "start_logit": 6.8870720863342285,
            "end_logit": -2.411358594894409
        },
        {
            "text": "(hK1-hK15 encoded by the genes KLK1-KLK15) is involved in several cancer-related",
            "probability": 2.8595990812628422e-05,
            "start_logit": 6.716483116149902,
            "end_logit": -2.411358594894409
        },
        {
            "text": "the genes KLK1-KLK15)",
            "probability": 1.541445699819523e-05,
            "start_logit": -3.5780439376831055,
            "end_logit": 7.265207767486572
        },
        {
            "text": "of serine proteases (hK1-hK15",
            "probability": 1.2420157721678916e-05,
            "start_logit": -3.8165199756622314,
            "end_logit": 7.287698745727539
        },
        {
            "text": "of serine proteases (hK1-hK15 encoded by the genes KLK1-KLK15)",
            "probability": 1.2143934137661226e-05,
            "start_logit": -3.8165199756622314,
            "end_logit": 7.265207767486572
        },
        {
            "text": "(hK1-hK15 encoded by",
            "probability": 2.662350747276142e-06,
            "start_logit": 6.716483116149902,
            "end_logit": -4.7854156494140625
        },
        {
            "text": "KLK1-KLK15) is involved",
            "probability": 1.7357917563293894e-06,
            "start_logit": 6.8870720863342285,
            "end_logit": -5.3837504386901855
        },
        {
            "text": "(hK1-hK15 encoded by the genes KLK1-KLK15) is involved",
            "probability": 1.4635641841910963e-06,
            "start_logit": 6.716483116149902,
            "end_logit": -5.3837504386901855
        },
        {
            "text": "KLK1-KLK15) is involved in several cancer-related processes.",
            "probability": 1.3653007217470359e-06,
            "start_logit": 6.8870720863342285,
            "end_logit": -5.623839378356934
        }
    ],
    "511a3573df1ebcce7d000018_007": [
        {
            "text": "15",
            "probability": 0.9998385862211945,
            "start_logit": 7.5730814933776855,
            "end_logit": 7.019247531890869
        },
        {
            "text": "consists of 15",
            "probability": 0.00011071772596512384,
            "start_logit": -1.5352836847305298,
            "end_logit": 7.019247531890869
        },
        {
            "text": "The tissue kallikrein gene family consists of 15",
            "probability": 2.495588012776703e-05,
            "start_logit": -3.025158166885376,
            "end_logit": 7.019247531890869
        },
        {
            "text": "15 genes tandemly arranged on human chromosome 19q13.4. Most",
            "probability": 1.093203984367867e-05,
            "start_logit": 7.5730814933776855,
            "end_logit": -4.4044036865234375
        },
        {
            "text": "15 genes tandemly arranged on human chromosome 19q13.4.",
            "probability": 5.695411035147754e-06,
            "start_logit": 7.5730814933776855,
            "end_logit": -5.056440830230713
        },
        {
            "text": "15 genes",
            "probability": 3.204694012558992e-06,
            "start_logit": 7.5730814933776855,
            "end_logit": -5.6314849853515625
        },
        {
            "text": "family consists of 15",
            "probability": 2.1213432048433474e-06,
            "start_logit": -5.490218162536621,
            "end_logit": 7.019247531890869
        },
        {
            "text": "tissue kallikrein gene family consists of 15",
            "probability": 1.918839455394963e-06,
            "start_logit": -5.59054708480835,
            "end_logit": 7.019247531890869
        },
        {
            "text": "15 genes tandemly arranged",
            "probability": 1.849284951756896e-06,
            "start_logit": 7.5730814933776855,
            "end_logit": -6.181302547454834
        },
        {
            "text": "consists",
            "probability": 4.73613598413938e-09,
            "start_logit": -1.5352836847305298,
            "end_logit": -3.0402700901031494
        },
        {
            "text": "cancer",
            "probability": 4.704040932337323e-09,
            "start_logit": -1.8327089548110962,
            "end_logit": -2.7496445178985596
        },
        {
            "text": "consists of",
            "probability": 2.729768271636033e-09,
            "start_logit": -1.5352836847305298,
            "end_logit": -3.5912749767303467
        },
        {
            "text": "characterized by aberrant expression patterns in various human cancers, a feature that makes them ideal cancer",
            "probability": 1.2782718913389108e-09,
            "start_logit": -3.1356217861175537,
            "end_logit": -2.7496445178985596
        },
        {
            "text": "consists of 15 genes tandemly arranged on human chromosome 19q13.4. Most",
            "probability": 1.210565993683764e-09,
            "start_logit": -1.5352836847305298,
            "end_logit": -4.4044036865234375
        },
        {
            "text": "The tissue kallikrein gene family consists",
            "probability": 1.0675295293385782e-09,
            "start_logit": -3.025158166885376,
            "end_logit": -3.0402700901031494
        },
        {
            "text": "characterized by aberrant expression patterns in various human cancers,",
            "probability": 6.485150869146481e-10,
            "start_logit": -3.1356217861175537,
            "end_logit": -3.4282236099243164
        },
        {
            "text": "consists of 15 genes tandemly arranged on human chromosome 19q13.4.",
            "probability": 6.306847594584905e-10,
            "start_logit": -1.5352836847305298,
            "end_logit": -5.056440830230713
        },
        {
            "text": "The tissue kallikrein gene family consists of",
            "probability": 6.152923497091123e-10,
            "start_logit": -3.025158166885376,
            "end_logit": -3.5912749767303467
        },
        {
            "text": "Most kallikrein genes are characterized by aberrant expression patterns in various human cancers,",
            "probability": 5.845308915502026e-10,
            "start_logit": -3.239497423171997,
            "end_logit": -3.4282236099243164
        },
        {
            "text": "consists of 15 genes",
            "probability": 3.5487371499191523e-10,
            "start_logit": -1.5352836847305298,
            "end_logit": -5.6314849853515625
        }
    ],
    "511a3573df1ebcce7d000018_008": [
        {
            "text": "15",
            "probability": 0.9998710110022399,
            "start_logit": 7.31432580947876,
            "end_logit": 6.733095645904541
        },
        {
            "text": "cluster of 15",
            "probability": 9.886435137107954e-05,
            "start_logit": -1.9073070287704468,
            "end_logit": 6.733095645904541
        },
        {
            "text": "15 serine protease genes located in the chromosomal band 19q13.4,",
            "probability": 8.088869204669062e-06,
            "start_logit": 7.31432580947876,
            "end_logit": -4.991796970367432
        },
        {
            "text": "are a cluster of 15",
            "probability": 3.910734543316153e-06,
            "start_logit": -5.137330532073975,
            "end_logit": 6.733095645904541
        },
        {
            "text": "a cluster of 15",
            "probability": 3.4362188517110512e-06,
            "start_logit": -5.266684055328369,
            "end_logit": 6.733095645904541
        },
        {
            "text": "Human kallikreins are a cluster of 15",
            "probability": 3.2659163372223565e-06,
            "start_logit": -5.3175153732299805,
            "end_logit": 6.733095645904541
        },
        {
            "text": "15 serine",
            "probability": 3.186176525239354e-06,
            "start_logit": 7.31432580947876,
            "end_logit": -5.923464298248291
        },
        {
            "text": "of 15",
            "probability": 2.400180888920426e-06,
            "start_logit": -5.625511646270752,
            "end_logit": 6.733095645904541
        },
        {
            "text": "15 serine protease genes located",
            "probability": 1.6631640829164204e-06,
            "start_logit": 7.31432580947876,
            "end_logit": -6.573564052581787
        },
        {
            "text": "15 serine protease genes",
            "probability": 1.5791659305866948e-06,
            "start_logit": 7.31432580947876,
            "end_logit": -6.625389099121094
        },
        {
            "text": "15 serine protease",
            "probability": 1.3456368619636303e-06,
            "start_logit": 7.31432580947876,
            "end_logit": -6.785418510437012
        },
        {
            "text": "kallikreins are a cluster of 15",
            "probability": 1.2332070394378022e-06,
            "start_logit": -6.29143762588501,
            "end_logit": 6.733095645904541
        },
        {
            "text": "cluster",
            "probability": 1.0281909382408413e-08,
            "start_logit": -1.9073070287704468,
            "end_logit": -2.4380223751068115
        },
        {
            "text": "pancreatic cancer.",
            "probability": 1.7462805757659052e-09,
            "start_logit": -3.435657024383545,
            "end_logit": -2.682570219039917
        },
        {
            "text": "19q13.4, a non-randomly rearranged region in many solid tumors, including pancreatic cancer.",
            "probability": 9.96715881191738e-10,
            "start_logit": -3.9964346885681152,
            "end_logit": -2.682570219039917
        },
        {
            "text": "cluster of 15 serine protease genes located in the chromosomal band 19q13.4,",
            "probability": 7.99803973158009e-10,
            "start_logit": -1.9073070287704468,
            "end_logit": -4.991796970367432
        },
        {
            "text": "cancer.",
            "probability": 4.4767323994126565e-10,
            "start_logit": -4.796836853027344,
            "end_logit": -2.682570219039917
        },
        {
            "text": "are a cluster",
            "probability": 4.067170586302301e-10,
            "start_logit": -5.137330532073975,
            "end_logit": -2.4380223751068115
        },
        {
            "text": "a cluster",
            "probability": 3.573673458778363e-10,
            "start_logit": -5.266684055328369,
            "end_logit": -2.4380223751068115
        },
        {
            "text": "Human kallikreins are a cluster",
            "probability": 3.3965585536295216e-10,
            "start_logit": -5.3175153732299805,
            "end_logit": -2.4380223751068115
        }
    ],
    "511a3573df1ebcce7d000018_009": [
        {
            "text": "15",
            "probability": 0.999873751140605,
            "start_logit": 7.353979110717773,
            "end_logit": 7.020508289337158
        },
        {
            "text": "encoding 15",
            "probability": 9.519899546131258e-05,
            "start_logit": -1.9054358005523682,
            "end_logit": 7.020508289337158
        },
        {
            "text": "cluster encoding 15",
            "probability": 6.245161785833459e-06,
            "start_logit": -4.629598140716553,
            "end_logit": 7.020508289337158
        },
        {
            "text": "found on chromosome 19q13.3-4 as a gene cluster encoding 15",
            "probability": 4.916000800805795e-06,
            "start_logit": -4.86890983581543,
            "end_logit": 7.020508289337158
        },
        {
            "text": "(KLKs) are found on chromosome 19q13.3-4 as a gene cluster encoding 15",
            "probability": 4.909771704014e-06,
            "start_logit": -4.870177745819092,
            "end_logit": 7.020508289337158
        },
        {
            "text": "chromosome 19q13.3-4 as a gene cluster encoding 15",
            "probability": 4.46486127681666e-06,
            "start_logit": -4.965167045593262,
            "end_logit": 7.020508289337158
        },
        {
            "text": "15 different serine proteases.",
            "probability": 3.974827818059197e-06,
            "start_logit": 7.353979110717773,
            "end_logit": -5.4148945808410645
        },
        {
            "text": "19q13.3-4 as a gene cluster encoding 15",
            "probability": 3.4230520292971284e-06,
            "start_logit": -5.230872631072998,
            "end_logit": 7.020508289337158
        },
        {
            "text": "are found on chromosome 19q13.3-4 as a gene cluster encoding 15",
            "probability": 2.0757850932063174e-06,
            "start_logit": -5.73106575012207,
            "end_logit": 7.020508289337158
        },
        {
            "text": "15 different serine",
            "probability": 1.037678767369459e-06,
            "start_logit": 7.353979110717773,
            "end_logit": -6.757889747619629
        },
        {
            "text": "encoding",
            "probability": 8.366324605943748e-10,
            "start_logit": -1.9054358005523682,
            "end_logit": -4.621586799621582
        },
        {
            "text": "are a group",
            "probability": 4.257141525703146e-10,
            "start_logit": -4.34121036529541,
            "end_logit": -2.86142897605896
        },
        {
            "text": "encoding 15 different serine proteases.",
            "probability": 3.784473939627453e-10,
            "start_logit": -1.9054358005523682,
            "end_logit": -5.4148945808410645
        },
        {
            "text": "a group",
            "probability": 3.730923012640564e-10,
            "start_logit": -4.4731526374816895,
            "end_logit": -2.86142897605896
        },
        {
            "text": "group",
            "probability": 2.893346284361812e-10,
            "start_logit": -4.7273945808410645,
            "end_logit": -2.86142897605896
        },
        {
            "text": "Tissue kallikreins are a group",
            "probability": 1.8025802613933926e-10,
            "start_logit": -5.200589179992676,
            "end_logit": -2.86142897605896
        },
        {
            "text": "encoding 15 different serine",
            "probability": 9.879844945665946e-11,
            "start_logit": -1.9054358005523682,
            "end_logit": -6.757889747619629
        },
        {
            "text": "cluster encoding",
            "probability": 5.4884035765011086e-11,
            "start_logit": -4.629598140716553,
            "end_logit": -4.621586799621582
        },
        {
            "text": "Tissue kallikrein genes (KLKs) are found on chromosome 19q13.3-4",
            "probability": 4.4293923457150095e-11,
            "start_logit": -4.4396514892578125,
            "end_logit": -5.025908470153809
        },
        {
            "text": "found on chromosome 19q13.3-4 as a gene cluster encoding",
            "probability": 4.3203038291863945e-11,
            "start_logit": -4.86890983581543,
            "end_logit": -4.621586799621582
        }
    ],
    "511a3573df1ebcce7d000018_010": [
        {
            "text": "15",
            "probability": 0.9999648711728618,
            "start_logit": 7.19357967376709,
            "end_logit": 6.773828506469727
        },
        {
            "text": "15 human KLK",
            "probability": 1.3776310939698267e-05,
            "start_logit": 7.19357967376709,
            "end_logit": -4.418696403503418
        },
        {
            "text": "15 human KLK genes in normal and cancerous ovarian tissues and cell lines. We found that seven",
            "probability": 5.001363913883242e-06,
            "start_logit": 7.19357967376709,
            "end_logit": -5.431936264038086
        },
        {
            "text": "15 human KLK genes",
            "probability": 4.992521612631036e-06,
            "start_logit": 7.19357967376709,
            "end_logit": -5.433705806732178
        },
        {
            "text": "the 15",
            "probability": 4.210612847964483e-06,
            "start_logit": -5.1842875480651855,
            "end_logit": 6.773828506469727
        },
        {
            "text": "15 human KLK genes in normal and cancerous ovarian tissues and cell lines. We found that seven KLK",
            "probability": 2.260963601410391e-06,
            "start_logit": 7.19357967376709,
            "end_logit": -6.225855827331543
        },
        {
            "text": "pattern of the 15",
            "probability": 9.856707131778715e-07,
            "start_logit": -6.63632869720459,
            "end_logit": 6.773828506469727
        },
        {
            "text": "expression pattern of the 15",
            "probability": 9.828542482214208e-07,
            "start_logit": -6.639190196990967,
            "end_logit": 6.773828506469727
        },
        {
            "text": "Cancer Genome Anatomy Project to perform in silico analyses of the expression pattern of the 15",
            "probability": 9.166732271998189e-07,
            "start_logit": -6.708899974822998,
            "end_logit": 6.773828506469727
        },
        {
            "text": "of the 15",
            "probability": 6.675748292149913e-07,
            "start_logit": -7.025999546051025,
            "end_logit": 6.773828506469727
        },
        {
            "text": "15 human KLK genes in normal and cancerous ovarian tissues and cell lines. We found that seven KLK genes",
            "probability": 6.20907288172915e-07,
            "start_logit": 7.19357967376709,
            "end_logit": -7.5182204246521
        },
        {
            "text": "the expression pattern of the 15",
            "probability": 5.968952404437372e-07,
            "start_logit": -7.137909412384033,
            "end_logit": 6.773828506469727
        },
        {
            "text": "up-regulated",
            "probability": 1.1524743740183398e-07,
            "start_logit": -0.34592288732528687,
            "end_logit": -1.662818193435669
        },
        {
            "text": "regulated",
            "probability": 5.651698278542647e-10,
            "start_logit": -5.663633346557617,
            "end_logit": -1.662818193435669
        },
        {
            "text": "up",
            "probability": 4.2368876545203517e-10,
            "start_logit": -0.34592288732528687,
            "end_logit": -7.268655776977539
        },
        {
            "text": "KLK",
            "probability": 9.274621991666195e-11,
            "start_logit": -4.715014457702637,
            "end_logit": -4.418696403503418
        },
        {
            "text": "the 15 human KLK",
            "probability": 5.800874961958506e-11,
            "start_logit": -5.1842875480651855,
            "end_logit": -4.418696403503418
        },
        {
            "text": "KLK genes in normal and cancerous ovarian tissues and cell lines. We found that seven",
            "probability": 3.367066840104524e-11,
            "start_logit": -4.715014457702637,
            "end_logit": -5.431936264038086
        },
        {
            "text": "KLK genes",
            "probability": 3.3611139400858173e-11,
            "start_logit": -4.715014457702637,
            "end_logit": -5.433705806732178
        },
        {
            "text": "seven",
            "probability": 2.4343359076724117e-11,
            "start_logit": -5.039382457733154,
            "end_logit": -5.431936264038086
        }
    ],
    "511a3573df1ebcce7d000018_011": [
        {
            "text": "15",
            "probability": 0.9999220226796199,
            "start_logit": 7.624728202819824,
            "end_logit": 7.061591625213623
        },
        {
            "text": "contains 15",
            "probability": 5.131171911846089e-05,
            "start_logit": -2.2527852058410645,
            "end_logit": 7.061591625213623
        },
        {
            "text": "15 genes",
            "probability": 6.955480603540935e-06,
            "start_logit": 7.624728202819824,
            "end_logit": -4.8143110275268555
        },
        {
            "text": "the human kallikrein family contains 15",
            "probability": 5.654895120393702e-06,
            "start_logit": -4.4581828117370605,
            "end_logit": 7.061591625213623
        },
        {
            "text": "recently, and it was shown that the human kallikrein family contains 15",
            "probability": 2.1990289389109574e-06,
            "start_logit": -5.402688503265381,
            "end_logit": 7.061591625213623
        },
        {
            "text": "shown that the human kallikrein family contains 15",
            "probability": 2.065573901743279e-06,
            "start_logit": -5.465296268463135,
            "end_logit": 7.061591625213623
        },
        {
            "text": "and it was shown that the human kallikrein family contains 15",
            "probability": 2.0041843876784484e-06,
            "start_logit": -5.495467185974121,
            "end_logit": 7.061591625213623
        },
        {
            "text": "was shown that the human kallikrein family contains 15",
            "probability": 1.986335029241181e-06,
            "start_logit": -5.50441312789917,
            "end_logit": 7.061591625213623
        },
        {
            "text": "cloned recently, and it was shown that the human kallikrein family contains 15",
            "probability": 1.8140960192992898e-06,
            "start_logit": -5.595117092132568,
            "end_logit": 7.061591625213623
        },
        {
            "text": "it was shown that the human kallikrein family contains 15",
            "probability": 1.6961441619021906e-06,
            "start_logit": -5.662346839904785,
            "end_logit": 7.061591625213623
        },
        {
            "text": "were cloned recently, and it was shown that the human kallikrein family contains 15",
            "probability": 1.5997436804350829e-06,
            "start_logit": -5.720860958099365,
            "end_logit": 7.061591625213623
        },
        {
            "text": "15 genes tandemly aligned on chromosomal locus 19q13.3-q13.4.",
            "probability": 6.853538629393447e-07,
            "start_logit": 7.624728202819824,
            "end_logit": -7.1316609382629395
        },
        {
            "text": "Novel kallikrein genes were cloned recently, and it was shown that the human kallikrein family contains",
            "probability": 2.091112629162243e-09,
            "start_logit": -0.9923580288887024,
            "end_logit": -4.306813716888428
        },
        {
            "text": "Novel",
            "probability": 9.521165148586124e-10,
            "start_logit": -0.9923580288887024,
            "end_logit": -5.093577861785889
        },
        {
            "text": "contains",
            "probability": 5.928991901534137e-10,
            "start_logit": -2.2527852058410645,
            "end_logit": -4.306813716888428
        },
        {
            "text": "contains 15 genes",
            "probability": 3.569254991567948e-10,
            "start_logit": -2.2527852058410645,
            "end_logit": -4.8143110275268555
        },
        {
            "text": "Novel kallikrein genes were cloned recently,",
            "probability": 3.0238366978023544e-10,
            "start_logit": -0.9923580288887024,
            "end_logit": -6.2405686378479
        },
        {
            "text": "Novel kallikrein genes were cloned recently, and it was shown that the human",
            "probability": 2.2885678728502215e-10,
            "start_logit": -0.9923580288887024,
            "end_logit": -6.519168853759766
        },
        {
            "text": "Novel kallikrein genes were cloned recently, and it was shown that the human kallikrein family",
            "probability": 1.2642047491662357e-10,
            "start_logit": -0.9923580288887024,
            "end_logit": -7.112651824951172
        },
        {
            "text": "Novel kallikrein genes",
            "probability": 1.1484070854807298e-10,
            "start_logit": -0.9923580288887024,
            "end_logit": -7.208719253540039
        }
    ],
    "511a3573df1ebcce7d000018_012": [
        {
            "text": "15",
            "probability": 0.999490986360075,
            "start_logit": 6.5254364013671875,
            "end_logit": 6.756603240966797
        },
        {
            "text": "consists of 15",
            "probability": 0.00037734436497467364,
            "start_logit": -1.356406807899475,
            "end_logit": 6.756603240966797
        },
        {
            "text": "The human kallikrein gene family consists of 15",
            "probability": 8.056574323821209e-05,
            "start_logit": -2.90049147605896,
            "end_logit": 6.756603240966797
        },
        {
            "text": "15 serine",
            "probability": 1.3827341169024955e-05,
            "start_logit": 6.5254364013671875,
            "end_logit": -4.431750297546387
        },
        {
            "text": "family consists of 15",
            "probability": 9.729695988973947e-06,
            "start_logit": -5.014382362365723,
            "end_logit": 6.756603240966797
        },
        {
            "text": "of 15",
            "probability": 8.331060447133573e-06,
            "start_logit": -5.16957426071167,
            "end_logit": 6.756603240966797
        },
        {
            "text": "human kallikrein gene family consists of 15",
            "probability": 7.598455239389281e-06,
            "start_logit": -5.261620044708252,
            "end_logit": 6.756603240966797
        },
        {
            "text": "15 serine proteases.",
            "probability": 4.289288613651897e-06,
            "start_logit": 6.5254364013671875,
            "end_logit": -5.6022772789001465
        },
        {
            "text": "kallikrein gene family consists of 15",
            "probability": 3.1136495292173903e-06,
            "start_logit": -6.153769493103027,
            "end_logit": 6.756603240966797
        },
        {
            "text": "gene family consists of 15",
            "probability": 2.0658918517503884e-06,
            "start_logit": -6.564002990722656,
            "end_logit": 6.756603240966797
        },
        {
            "text": "15 serine proteases. We examined the expression of the kallikrein genes",
            "probability": 1.172293605896073e-06,
            "start_logit": 6.5254364013671875,
            "end_logit": -6.899435997009277
        },
        {
            "text": "15 serine proteases. We examined the expression",
            "probability": 8.775314471361822e-07,
            "start_logit": 6.5254364013671875,
            "end_logit": -7.189040660858154
        },
        {
            "text": "consists",
            "probability": 4.99213605500982e-08,
            "start_logit": -1.356406807899475,
            "end_logit": -2.173861265182495
        },
        {
            "text": "consists of",
            "probability": 2.2142653214650107e-08,
            "start_logit": -1.356406807899475,
            "end_logit": -2.986804485321045
        },
        {
            "text": "The human kallikrein gene family consists",
            "probability": 1.0658570498200934e-08,
            "start_logit": -2.90049147605896,
            "end_logit": -2.173861265182495
        },
        {
            "text": "consists of 15 serine",
            "probability": 5.220326490102207e-09,
            "start_logit": -1.356406807899475,
            "end_logit": -4.431750297546387
        },
        {
            "text": "The human kallikrein gene family consists of",
            "probability": 4.727616148777008e-09,
            "start_logit": -2.90049147605896,
            "end_logit": -2.986804485321045
        },
        {
            "text": "ists",
            "probability": 2.150109422019304e-09,
            "start_logit": -4.501337051391602,
            "end_logit": -2.173861265182495
        },
        {
            "text": "The human kallikrein gene family",
            "probability": 1.8838207773540233e-09,
            "start_logit": -2.90049147605896,
            "end_logit": -3.906923532485962
        },
        {
            "text": "consists of 15 serine proteases.",
            "probability": 1.6193631660510854e-09,
            "start_logit": -1.356406807899475,
            "end_logit": -5.6022772789001465
        }
    ],
    "511a3573df1ebcce7d000018_013": [
        {
            "text": "15",
            "probability": 0.9999646956186157,
            "start_logit": 7.362937927246094,
            "end_logit": 7.299508094787598
        },
        {
            "text": "includes 15",
            "probability": 1.2465656457565026e-05,
            "start_logit": -3.9295599460601807,
            "end_logit": 7.299508094787598
        },
        {
            "text": "chromosome 19q13.4, which includes 15",
            "probability": 8.007264838667276e-06,
            "start_logit": -4.372188091278076,
            "end_logit": 7.299508094787598
        },
        {
            "text": "the human kallikrein gene locus on chromosome 19q13.4, which includes 15",
            "probability": 3.529870738400066e-06,
            "start_logit": -5.1912760734558105,
            "end_logit": 7.299508094787598
        },
        {
            "text": "19q13.4, which includes 15",
            "probability": 3.381163980055546e-06,
            "start_logit": -5.234317302703857,
            "end_logit": 7.299508094787598
        },
        {
            "text": "characterized the human kallikrein gene locus on chromosome 19q13.4, which includes 15",
            "probability": 3.015278871750878e-06,
            "start_logit": -5.3488450050354,
            "end_logit": 7.299508094787598
        },
        {
            "text": "15 kallikrein genes.",
            "probability": 2.9941357771976394e-06,
            "start_logit": 7.362937927246094,
            "end_logit": -5.4193115234375
        },
        {
            "text": "which includes 15",
            "probability": 1.9075504459440054e-06,
            "start_logit": -5.806717395782471,
            "end_logit": 7.299508094787598
        },
        {
            "text": "cancer.",
            "probability": 2.0724207696004474e-09,
            "start_logit": -1.9544390439987183,
            "end_logit": -3.3776280879974365
        },
        {
            "text": "cancer",
            "probability": 8.372304779139522e-10,
            "start_logit": -1.9544390439987183,
            "end_logit": -4.284001350402832
        },
        {
            "text": "enhancers",
            "probability": 1.2342855147776223e-10,
            "start_logit": -4.029903888702393,
            "end_logit": -4.122973442077637
        },
        {
            "text": "promoters and enhancers",
            "probability": 8.823585896270703e-11,
            "start_logit": -4.36555290222168,
            "end_logit": -4.122973442077637
        },
        {
            "text": "chromosome 19q13.4,",
            "probability": 8.276542931609277e-11,
            "start_logit": -4.372188091278076,
            "end_logit": -4.1803412437438965
        },
        {
            "text": "including cancer.",
            "probability": 5.055696821770785e-11,
            "start_logit": -5.667810916900635,
            "end_logit": -3.3776280879974365
        },
        {
            "text": "includes 15 kallikrein genes.",
            "probability": 3.732518572844243e-11,
            "start_logit": -3.9295599460601807,
            "end_logit": -5.4193115234375
        },
        {
            "text": "the human kallikrein gene locus on chromosome 19q13.4,",
            "probability": 3.648577547768738e-11,
            "start_logit": -5.1912760734558105,
            "end_logit": -4.1803412437438965
        },
        {
            "text": "19q13.4,",
            "probability": 3.494869896722227e-11,
            "start_logit": -5.234317302703857,
            "end_logit": -4.1803412437438965
        },
        {
            "text": "Minisatellites are repetitive sequences",
            "probability": 3.3246150548505037e-11,
            "start_logit": -3.675156354904175,
            "end_logit": -5.789444446563721
        },
        {
            "text": "Minisatellites",
            "probability": 3.2463741889813156e-11,
            "start_logit": -3.675156354904175,
            "end_logit": -5.813259601593018
        },
        {
            "text": "characterized the human kallikrein gene locus on chromosome 19q13.4,",
            "probability": 3.1166803566065384e-11,
            "start_logit": -5.3488450050354,
            "end_logit": -4.1803412437438965
        }
    ],
    "511a3573df1ebcce7d000018_014": [
        {
            "text": "15",
            "probability": 0.9996678467452602,
            "start_logit": 7.297552585601807,
            "end_logit": 7.029934406280518
        },
        {
            "text": "constitute a family of 15",
            "probability": 0.00021460869163752015,
            "start_logit": -1.1488094329833984,
            "end_logit": 7.029934406280518
        },
        {
            "text": "15 highly conserved serine proteases encoded by",
            "probability": 3.1520270867374086e-05,
            "start_logit": 7.297552585601807,
            "end_logit": -3.334613084793091
        },
        {
            "text": "a family of 15",
            "probability": 2.4651647026650155e-05,
            "start_logit": -3.312782049179077,
            "end_logit": 7.029934406280518
        },
        {
            "text": "15 highly conserved serine proteases encoded by the largest uninterrupted cluster",
            "probability": 1.3582694941518505e-05,
            "start_logit": 7.297552585601807,
            "end_logit": -4.17644739151001
        },
        {
            "text": "15 highly conserved serine proteases encoded by the largest",
            "probability": 8.570641334344077e-06,
            "start_logit": 7.297552585601807,
            "end_logit": -4.636901378631592
        },
        {
            "text": "Kallikrein-related peptidases (KLKs) constitute a family of 15",
            "probability": 6.9675066306208475e-06,
            "start_logit": -4.57636833190918,
            "end_logit": 7.029934406280518
        },
        {
            "text": "of 15",
            "probability": 5.799468074261752e-06,
            "start_logit": -4.759859561920166,
            "end_logit": 7.029934406280518
        },
        {
            "text": "(KLKs) constitute a family of 15",
            "probability": 5.6523875472072e-06,
            "start_logit": -4.785547733306885,
            "end_logit": 7.029934406280518
        },
        {
            "text": "family of 15",
            "probability": 4.341956675100739e-06,
            "start_logit": -5.049300670623779,
            "end_logit": 7.029934406280518
        },
        {
            "text": "15 highly conserved serine proteases encoded by the",
            "probability": 2.7164404620504365e-06,
            "start_logit": 7.297552585601807,
            "end_logit": -5.785921573638916
        },
        {
            "text": "15 highly conserved serine proteases encoded by the largest uninterrupted cluster of protease-encoding genes",
            "probability": 2.706824378345026e-06,
            "start_logit": 7.297552585601807,
            "end_logit": -5.789467811584473
        },
        {
            "text": "15 highly",
            "probability": 2.655143119889869e-06,
            "start_logit": 7.297552585601807,
            "end_logit": -5.808745384216309
        },
        {
            "text": "15 highly conserved",
            "probability": 1.8265942859527462e-06,
            "start_logit": 7.297552585601807,
            "end_logit": -6.182790756225586
        },
        {
            "text": "15 highly conserved serine proteases encoded by the largest uninterrupted cluster of",
            "probability": 1.7789436252365149e-06,
            "start_logit": 7.297552585601807,
            "end_logit": -6.209224224090576
        },
        {
            "text": "15 highly conserved serine proteases encoded",
            "probability": 1.6843639404226726e-06,
            "start_logit": 7.297552585601807,
            "end_logit": -6.263855934143066
        },
        {
            "text": "15 highly conserved serine proteases encoded by the largest uninterrupted cluster of protease-encoding",
            "probability": 1.5407290294423023e-06,
            "start_logit": 7.297552585601807,
            "end_logit": -6.352988243103027
        },
        {
            "text": "15 highly conserved serine proteases",
            "probability": 1.5374082006320284e-06,
            "start_logit": 7.297552585601807,
            "end_logit": -6.3551459312438965
        },
        {
            "text": "constitute a family of 15 highly conserved serine proteases encoded by",
            "probability": 6.766771696150353e-09,
            "start_logit": -1.1488094329833984,
            "end_logit": -3.334613084793091
        },
        {
            "text": "encoded by",
            "probability": 4.7761913204332296e-09,
            "start_logit": -1.4971901178359985,
            "end_logit": -3.334613084793091
        }
    ],
    "511a3573df1ebcce7d000018_015": [
        {
            "text": "15",
            "probability": 0.9996544625569947,
            "start_logit": 7.664033889770508,
            "end_logit": 6.99794864654541
        },
        {
            "text": "containing 15",
            "probability": 0.0002804669104921069,
            "start_logit": -0.5146753191947937,
            "end_logit": 6.99794864654541
        },
        {
            "text": "The human tissue kallikrein gene family is the largest contiguous family of proteases in the human genome, containing 15",
            "probability": 2.2775331087710394e-05,
            "start_logit": -3.0254530906677246,
            "end_logit": 6.99794864654541
        },
        {
            "text": "15 genes.",
            "probability": 1.765592209539157e-05,
            "start_logit": 7.664033889770508,
            "end_logit": -3.9461450576782227
        },
        {
            "text": "15 genes. Many kallikreins have been reported as potential tumor",
            "probability": 7.39781627191668e-06,
            "start_logit": 7.664033889770508,
            "end_logit": -4.816031455993652
        },
        {
            "text": "the largest contiguous family of proteases in the human genome, containing 15",
            "probability": 7.047785171993924e-06,
            "start_logit": -4.198417663574219,
            "end_logit": 6.99794864654541
        },
        {
            "text": "15 genes. Many",
            "probability": 2.395924577440174e-06,
            "start_logit": 7.664033889770508,
            "end_logit": -5.943447113037109
        },
        {
            "text": "human tissue kallikrein gene family is the largest contiguous family of proteases in the human genome, containing 15",
            "probability": 1.6703326823218142e-06,
            "start_logit": -5.638108253479004,
            "end_logit": 6.99794864654541
        },
        {
            "text": "largest contiguous family of proteases in the human genome, containing 15",
            "probability": 1.4697490905898783e-06,
            "start_logit": -5.7660393714904785,
            "end_logit": 6.99794864654541
        },
        {
            "text": "15 genes. Many kallikreins have been reported as potential tumor markers.",
            "probability": 1.4001324551692686e-06,
            "start_logit": 7.664033889770508,
            "end_logit": -6.480649471282959
        },
        {
            "text": "is the largest contiguous family of proteases in the human genome, containing 15",
            "probability": 1.2168494963074127e-06,
            "start_logit": -5.9548659324646,
            "end_logit": 6.99794864654541
        },
        {
            "text": "tissue kallikrein gene family is the largest contiguous family of proteases in the human genome, containing 15",
            "probability": 9.687553926832224e-07,
            "start_logit": -6.1828742027282715,
            "end_logit": 6.99794864654541
        },
        {
            "text": "family is the largest contiguous family of proteases in the human genome, containing 15",
            "probability": 9.60175227481588e-07,
            "start_logit": -6.191770553588867,
            "end_logit": 6.99794864654541
        },
        {
            "text": "containing",
            "probability": 9.355261754119095e-08,
            "start_logit": -0.5146753191947937,
            "end_logit": -1.0077383518218994
        },
        {
            "text": "The human tissue kallikrein gene family is the largest contiguous family of proteases in the human genome, containing",
            "probability": 7.596945518043674e-09,
            "start_logit": -3.0254530906677246,
            "end_logit": -1.0077383518218994
        },
        {
            "text": "containing 15 genes.",
            "probability": 4.953613580954199e-09,
            "start_logit": -0.5146753191947937,
            "end_logit": -3.9461450576782227
        },
        {
            "text": "the largest contiguous family of proteases in the human genome, containing",
            "probability": 2.350861103547472e-09,
            "start_logit": -4.198417663574219,
            "end_logit": -1.0077383518218994
        },
        {
            "text": "containing 15 genes. Many kallikreins have been reported as potential tumor",
            "probability": 2.0755598578187826e-09,
            "start_logit": -0.5146753191947937,
            "end_logit": -4.816031455993652
        },
        {
            "text": "containing 15 genes. Many",
            "probability": 6.722098376752258e-10,
            "start_logit": -0.5146753191947937,
            "end_logit": -5.943447113037109
        },
        {
            "text": "human tissue kallikrein gene family is the largest contiguous family of proteases in the human genome, containing",
            "probability": 5.571566154510838e-10,
            "start_logit": -5.638108253479004,
            "end_logit": -1.0077383518218994
        }
    ],
    "56c865d25795f9a73e000016_001": [
        {
            "text": "Nox1- and Nox4-containing",
            "probability": 0.5795596593141222,
            "start_logit": 0.3962685763835907,
            "end_logit": -3.898007869720459
        },
        {
            "text": "Nox1",
            "probability": 0.23300490402729332,
            "start_logit": 0.3962685763835907,
            "end_logit": -4.8092169761657715
        },
        {
            "text": "Nox4",
            "probability": 0.08763583764546565,
            "start_logit": -1.4928100109100342,
            "end_logit": -3.898007869720459
        },
        {
            "text": "Nox",
            "probability": 0.026400647728287374,
            "start_logit": 0.3962685763835907,
            "end_logit": -6.9868879318237305
        },
        {
            "text": "Nox1-",
            "probability": 0.01894910848077334,
            "start_logit": 0.3962685763835907,
            "end_logit": -7.318519592285156
        },
        {
            "text": "N",
            "probability": 0.011450438405704994,
            "start_logit": 0.3962685763835907,
            "end_logit": -7.822248458862305
        },
        {
            "text": "specific inhibitor of Nox1- and Nox4-containing",
            "probability": 0.008620028990065486,
            "start_logit": -3.8119115829467773,
            "end_logit": -3.898007869720459
        },
        {
            "text": "specific",
            "probability": 0.005524215271727571,
            "start_logit": -3.8119115829467773,
            "end_logit": -4.342955112457275
        },
        {
            "text": "specific inhibitor",
            "probability": 0.004013919013860437,
            "start_logit": -3.8119115829467773,
            "end_logit": -4.662328243255615
        },
        {
            "text": "specific inhibitor of Nox1-",
            "probability": 0.0034655776937954196,
            "start_logit": -3.8119115829467773,
            "end_logit": -4.8092169761657715
        },
        {
            "text": "GKT136901, a specific inhibitor of Nox1- and Nox4-containing",
            "probability": 0.003219515519915289,
            "start_logit": -4.796769142150879,
            "end_logit": -3.898007869720459
        },
        {
            "text": "a specific inhibitor of Nox1- and Nox4-containing",
            "probability": 0.003114145533342839,
            "start_logit": -4.830045223236084,
            "end_logit": -3.898007869720459
        },
        {
            "text": "of Nox1- and Nox4-containing",
            "probability": 0.002882434315192818,
            "start_logit": -4.907364845275879,
            "end_logit": -3.898007869720459
        },
        {
            "text": "inhibitor of Nox1- and Nox4-containing",
            "probability": 0.0025767424920251805,
            "start_logit": -5.019474029541016,
            "end_logit": -3.898007869720459
        },
        {
            "text": "GKT136901, a specific",
            "probability": 0.0020632525509110674,
            "start_logit": -4.796769142150879,
            "end_logit": -4.342955112457275
        },
        {
            "text": "a specific",
            "probability": 0.001995725343093541,
            "start_logit": -4.830045223236084,
            "end_logit": -4.342955112457275
        },
        {
            "text": "GKT136901, a specific inhibitor",
            "probability": 0.0014991683410462138,
            "start_logit": -4.796769142150879,
            "end_logit": -4.662328243255615
        },
        {
            "text": "a specific inhibitor",
            "probability": 0.0014501027760602007,
            "start_logit": -4.830045223236084,
            "end_logit": -4.662328243255615
        },
        {
            "text": "GKT136901, a specific inhibitor of Nox1-",
            "probability": 0.0012943670123969993,
            "start_logit": -4.796769142150879,
            "end_logit": -4.8092169761657715
        },
        {
            "text": "Nox4-containing",
            "probability": 0.001280209544920064,
            "start_logit": -1.4928100109100342,
            "end_logit": -8.124174118041992
        }
    ],
    "56c865d25795f9a73e000016_002": [
        {
            "text": "(Nox1/4",
            "probability": 0.8235181324466294,
            "start_logit": -4.593855857849121,
            "end_logit": -1.9709107875823975
        },
        {
            "text": "4",
            "probability": 0.1600565044524771,
            "start_logit": -6.231914520263672,
            "end_logit": -1.9709107875823975
        },
        {
            "text": "Nox1",
            "probability": 0.006077854103573312,
            "start_logit": -4.593855857849121,
            "end_logit": -6.879844665527344
        },
        {
            "text": "Nox",
            "probability": 0.0035151893134276082,
            "start_logit": -4.593855857849121,
            "end_logit": -7.427402973175049
        },
        {
            "text": "(Nox1/4 inhibitor) and by Nox1 siRNA in WKY cells and by siNOX1",
            "probability": 0.002120714972920832,
            "start_logit": -4.593855857849121,
            "end_logit": -7.932743072509766
        },
        {
            "text": "(Nox1/4 inhibitor) and by Nox1 siRNA in WKY cells and by siNOX1 and siNOX2",
            "probability": 0.0017763921707812217,
            "start_logit": -4.593855857849121,
            "end_logit": -8.109911918640137
        },
        {
            "text": "(Nox1/4 inhibitor)",
            "probability": 0.000646371469542066,
            "start_logit": -4.593855857849121,
            "end_logit": -9.120877265930176
        },
        {
            "text": "1",
            "probability": 0.0006268642136061614,
            "start_logit": -6.865532875061035,
            "end_logit": -6.879844665527344
        },
        {
            "text": "NOX",
            "probability": 0.00024304773307760432,
            "start_logit": -6.760106563568115,
            "end_logit": -7.932743072509766
        },
        {
            "text": "siNOX1 and siNOX2",
            "probability": 0.00020358609981922264,
            "start_logit": -6.760106563568115,
            "end_logit": -8.109911918640137
        },
        {
            "text": "Nox4, implicating association between Nox1 and Nox2 but not between Nox1",
            "probability": 0.00017672540087060554,
            "start_logit": -6.8545823097229,
            "end_logit": -8.156928062438965
        },
        {
            "text": "Nox1 and Nox2 but not between Nox1",
            "probability": 0.00015496686457988062,
            "start_logit": -6.985968112945557,
            "end_logit": -8.156928062438965
        },
        {
            "text": "Nox1 and Nox4.",
            "probability": 0.00014747228795675138,
            "start_logit": -6.464099407196045,
            "end_logit": -8.728367805480957
        },
        {
            "text": "Nox4, implicating association between Nox1",
            "probability": 0.00013151402911493215,
            "start_logit": -6.8545823097229,
            "end_logit": -8.452411651611328
        },
        {
            "text": "Nox1 co-localized with Nox2 but not with Nox4, implicating association between Nox1",
            "probability": 0.00011413666818916312,
            "start_logit": -6.9962992668151855,
            "end_logit": -8.452411651611328
        },
        {
            "text": "NOX1",
            "probability": 0.00010796281594725027,
            "start_logit": -6.760106563568115,
            "end_logit": -8.744214057922363
        },
        {
            "text": "Nox2 but not with Nox4, implicating association between Nox1 and Nox2 but not between Nox1",
            "probability": 0.00010344739424768407,
            "start_logit": -7.390116214752197,
            "end_logit": -8.156928062438965
        },
        {
            "text": "Nox4, implicating association between Nox1 and Nox2 but not between Nox1 and Nox4.",
            "probability": 9.979892156951746e-05,
            "start_logit": -6.8545823097229,
            "end_logit": -8.728367805480957
        },
        {
            "text": "association between Nox1 and Nox2 but not between Nox1",
            "probability": 9.115972188762667e-05,
            "start_logit": -7.516566276550293,
            "end_logit": -8.156928062438965
        },
        {
            "text": "Nox4.",
            "probability": 8.815891978170987e-05,
            "start_logit": -6.978598594665527,
            "end_logit": -8.728367805480957
        }
    ],
    "56c865d25795f9a73e000016_003": [
        {
            "text": "Nox1- and Nox4-containing",
            "probability": 0.5795596593141222,
            "start_logit": 0.3962685763835907,
            "end_logit": -3.898007869720459
        },
        {
            "text": "Nox1",
            "probability": 0.23300490402729332,
            "start_logit": 0.3962685763835907,
            "end_logit": -4.8092169761657715
        },
        {
            "text": "Nox4",
            "probability": 0.08763583764546565,
            "start_logit": -1.4928100109100342,
            "end_logit": -3.898007869720459
        },
        {
            "text": "Nox",
            "probability": 0.026400647728287374,
            "start_logit": 0.3962685763835907,
            "end_logit": -6.9868879318237305
        },
        {
            "text": "Nox1-",
            "probability": 0.01894910848077334,
            "start_logit": 0.3962685763835907,
            "end_logit": -7.318519592285156
        },
        {
            "text": "N",
            "probability": 0.011450438405704994,
            "start_logit": 0.3962685763835907,
            "end_logit": -7.822248458862305
        },
        {
            "text": "specific inhibitor of Nox1- and Nox4-containing",
            "probability": 0.008620028990065486,
            "start_logit": -3.8119115829467773,
            "end_logit": -3.898007869720459
        },
        {
            "text": "specific",
            "probability": 0.005524215271727571,
            "start_logit": -3.8119115829467773,
            "end_logit": -4.342955112457275
        },
        {
            "text": "specific inhibitor",
            "probability": 0.004013919013860437,
            "start_logit": -3.8119115829467773,
            "end_logit": -4.662328243255615
        },
        {
            "text": "specific inhibitor of Nox1-",
            "probability": 0.0034655776937954196,
            "start_logit": -3.8119115829467773,
            "end_logit": -4.8092169761657715
        },
        {
            "text": "GKT136901, a specific inhibitor of Nox1- and Nox4-containing",
            "probability": 0.003219515519915289,
            "start_logit": -4.796769142150879,
            "end_logit": -3.898007869720459
        },
        {
            "text": "a specific inhibitor of Nox1- and Nox4-containing",
            "probability": 0.003114145533342839,
            "start_logit": -4.830045223236084,
            "end_logit": -3.898007869720459
        },
        {
            "text": "of Nox1- and Nox4-containing",
            "probability": 0.002882434315192818,
            "start_logit": -4.907364845275879,
            "end_logit": -3.898007869720459
        },
        {
            "text": "inhibitor of Nox1- and Nox4-containing",
            "probability": 0.0025767424920251805,
            "start_logit": -5.019474029541016,
            "end_logit": -3.898007869720459
        },
        {
            "text": "GKT136901, a specific",
            "probability": 0.0020632525509110674,
            "start_logit": -4.796769142150879,
            "end_logit": -4.342955112457275
        },
        {
            "text": "a specific",
            "probability": 0.001995725343093541,
            "start_logit": -4.830045223236084,
            "end_logit": -4.342955112457275
        },
        {
            "text": "GKT136901, a specific inhibitor",
            "probability": 0.0014991683410462138,
            "start_logit": -4.796769142150879,
            "end_logit": -4.662328243255615
        },
        {
            "text": "a specific inhibitor",
            "probability": 0.0014501027760602007,
            "start_logit": -4.830045223236084,
            "end_logit": -4.662328243255615
        },
        {
            "text": "GKT136901, a specific inhibitor of Nox1-",
            "probability": 0.0012943670123969993,
            "start_logit": -4.796769142150879,
            "end_logit": -4.8092169761657715
        },
        {
            "text": "Nox4-containing",
            "probability": 0.001280209544920064,
            "start_logit": -1.4928100109100342,
            "end_logit": -8.124174118041992
        }
    ],
    "550e828c71445a662f000002_001": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.2629777554549041,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.25663923917848885,
            "start_logit": 3.777345895767212,
            "end_logit": 2.9163947105407715
        },
        {
            "text": "anti-IL-1\u03b2 antibody being developed as a treatment for diseases in which IL-1\u03b2",
            "probability": 0.25366883555982117,
            "start_logit": 3.7768397331237793,
            "end_logit": 2.905259132385254
        },
        {
            "text": "IL-1\u03b2 has been associated with pathogenesis. Previous data indicated that gevokizumab negatively modulates IL-1\u03b2",
            "probability": 0.21605224888340385,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.708709955215454
        },
        {
            "text": "IL-1\u03b2-associated",
            "probability": 0.00590475319517464,
            "start_logit": 2.0655345916748047,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated",
            "probability": 0.0041504387868180215,
            "start_logit": 1.7129909992218018,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL",
            "probability": 0.00030767422818982643,
            "start_logit": 3.8128795623779297,
            "end_logit": -3.8455240726470947
        },
        {
            "text": "\u03b2",
            "probability": 0.00020221637295492645,
            "start_logit": -3.357606887817383,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2 (IL-1\u03b2)",
            "probability": 3.5798537175930336e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -5.961124897003174
        },
        {
            "text": "the IL-1\u03b2",
            "probability": 2.1988117817794837e-05,
            "start_logit": -4.856156826019287,
            "end_logit": 2.1849730014801025
        },
        {
            "text": "1\u03b2",
            "probability": 1.7189287808193626e-05,
            "start_logit": -5.276412010192871,
            "end_logit": 2.3590123653411865
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2",
            "probability": 1.6324037664221763e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -6.746393203735352
        },
        {
            "text": "IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 3.2513573803171887e-06,
            "start_logit": 2.0655345916748047,
            "end_logit": -6.648148059844971
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 2.28537236613094e-06,
            "start_logit": 1.7129909992218018,
            "end_logit": -6.648148059844971
        },
        {
            "text": "1",
            "probability": 1.3868474248177953e-09,
            "start_logit": -5.276412010192871,
            "end_logit": -7.065996170043945
        },
        {
            "text": "-",
            "probability": 2.431847916135054e-10,
            "start_logit": -5.760768890380859,
            "end_logit": -8.322606086730957
        }
    ],
    "550e828c71445a662f000002_002": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.2629777554549041,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.25663923917848885,
            "start_logit": 3.777345895767212,
            "end_logit": 2.9163947105407715
        },
        {
            "text": "anti-IL-1\u03b2 antibody being developed as a treatment for diseases in which IL-1\u03b2",
            "probability": 0.25366883555982117,
            "start_logit": 3.7768397331237793,
            "end_logit": 2.905259132385254
        },
        {
            "text": "IL-1\u03b2 has been associated with pathogenesis. Previous data indicated that gevokizumab negatively modulates IL-1\u03b2",
            "probability": 0.21605224888340385,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.708709955215454
        },
        {
            "text": "IL-1\u03b2-associated",
            "probability": 0.00590475319517464,
            "start_logit": 2.0655345916748047,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated",
            "probability": 0.0041504387868180215,
            "start_logit": 1.7129909992218018,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL",
            "probability": 0.00030767422818982643,
            "start_logit": 3.8128795623779297,
            "end_logit": -3.8455240726470947
        },
        {
            "text": "\u03b2",
            "probability": 0.00020221637295492645,
            "start_logit": -3.357606887817383,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2 (IL-1\u03b2)",
            "probability": 3.5798537175930336e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -5.961124897003174
        },
        {
            "text": "the IL-1\u03b2",
            "probability": 2.1988117817794837e-05,
            "start_logit": -4.856156826019287,
            "end_logit": 2.1849730014801025
        },
        {
            "text": "1\u03b2",
            "probability": 1.7189287808193626e-05,
            "start_logit": -5.276412010192871,
            "end_logit": 2.3590123653411865
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2",
            "probability": 1.6324037664221763e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -6.746393203735352
        },
        {
            "text": "IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 3.2513573803171887e-06,
            "start_logit": 2.0655345916748047,
            "end_logit": -6.648148059844971
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 2.28537236613094e-06,
            "start_logit": 1.7129909992218018,
            "end_logit": -6.648148059844971
        },
        {
            "text": "1",
            "probability": 1.3868474248177953e-09,
            "start_logit": -5.276412010192871,
            "end_logit": -7.065996170043945
        },
        {
            "text": "-",
            "probability": 2.431847916135054e-10,
            "start_logit": -5.760768890380859,
            "end_logit": -8.322606086730957
        }
    ],
    "550e828c71445a662f000002_003": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.2629777554549041,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.25663923917848885,
            "start_logit": 3.777345895767212,
            "end_logit": 2.9163947105407715
        },
        {
            "text": "anti-IL-1\u03b2 antibody being developed as a treatment for diseases in which IL-1\u03b2",
            "probability": 0.25366883555982117,
            "start_logit": 3.7768397331237793,
            "end_logit": 2.905259132385254
        },
        {
            "text": "IL-1\u03b2 has been associated with pathogenesis. Previous data indicated that gevokizumab negatively modulates IL-1\u03b2",
            "probability": 0.21605224888340385,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.708709955215454
        },
        {
            "text": "IL-1\u03b2-associated",
            "probability": 0.00590475319517464,
            "start_logit": 2.0655345916748047,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated",
            "probability": 0.0041504387868180215,
            "start_logit": 1.7129909992218018,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL",
            "probability": 0.00030767422818982643,
            "start_logit": 3.8128795623779297,
            "end_logit": -3.8455240726470947
        },
        {
            "text": "\u03b2",
            "probability": 0.00020221637295492645,
            "start_logit": -3.357606887817383,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2 (IL-1\u03b2)",
            "probability": 3.5798537175930336e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -5.961124897003174
        },
        {
            "text": "the IL-1\u03b2",
            "probability": 2.1988117817794837e-05,
            "start_logit": -4.856156826019287,
            "end_logit": 2.1849730014801025
        },
        {
            "text": "1\u03b2",
            "probability": 1.7189287808193626e-05,
            "start_logit": -5.276412010192871,
            "end_logit": 2.3590123653411865
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2",
            "probability": 1.6324037664221763e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -6.746393203735352
        },
        {
            "text": "IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 3.2513573803171887e-06,
            "start_logit": 2.0655345916748047,
            "end_logit": -6.648148059844971
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 2.28537236613094e-06,
            "start_logit": 1.7129909992218018,
            "end_logit": -6.648148059844971
        },
        {
            "text": "1",
            "probability": 1.3868474248177953e-09,
            "start_logit": -5.276412010192871,
            "end_logit": -7.065996170043945
        },
        {
            "text": "-",
            "probability": 2.431847916135054e-10,
            "start_logit": -5.760768890380859,
            "end_logit": -8.322606086730957
        }
    ],
    "550e828c71445a662f000002_004": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.2629777554549041,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.25663923917848885,
            "start_logit": 3.777345895767212,
            "end_logit": 2.9163947105407715
        },
        {
            "text": "anti-IL-1\u03b2 antibody being developed as a treatment for diseases in which IL-1\u03b2",
            "probability": 0.25366883555982117,
            "start_logit": 3.7768397331237793,
            "end_logit": 2.905259132385254
        },
        {
            "text": "IL-1\u03b2 has been associated with pathogenesis. Previous data indicated that gevokizumab negatively modulates IL-1\u03b2",
            "probability": 0.21605224888340385,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.708709955215454
        },
        {
            "text": "IL-1\u03b2-associated",
            "probability": 0.00590475319517464,
            "start_logit": 2.0655345916748047,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated",
            "probability": 0.0041504387868180215,
            "start_logit": 1.7129909992218018,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL",
            "probability": 0.00030767422818982643,
            "start_logit": 3.8128795623779297,
            "end_logit": -3.8455240726470947
        },
        {
            "text": "\u03b2",
            "probability": 0.00020221637295492645,
            "start_logit": -3.357606887817383,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2 (IL-1\u03b2)",
            "probability": 3.5798537175930336e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -5.961124897003174
        },
        {
            "text": "the IL-1\u03b2",
            "probability": 2.1988117817794837e-05,
            "start_logit": -4.856156826019287,
            "end_logit": 2.1849730014801025
        },
        {
            "text": "1\u03b2",
            "probability": 1.7189287808193626e-05,
            "start_logit": -5.276412010192871,
            "end_logit": 2.3590123653411865
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2",
            "probability": 1.6324037664221763e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -6.746393203735352
        },
        {
            "text": "IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 3.2513573803171887e-06,
            "start_logit": 2.0655345916748047,
            "end_logit": -6.648148059844971
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 2.28537236613094e-06,
            "start_logit": 1.7129909992218018,
            "end_logit": -6.648148059844971
        },
        {
            "text": "1",
            "probability": 1.3868474248177953e-09,
            "start_logit": -5.276412010192871,
            "end_logit": -7.065996170043945
        },
        {
            "text": "-",
            "probability": 2.431847916135054e-10,
            "start_logit": -5.760768890380859,
            "end_logit": -8.322606086730957
        }
    ],
    "550e828c71445a662f000002_005": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.2629777554549041,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.25663923917848885,
            "start_logit": 3.777345895767212,
            "end_logit": 2.9163947105407715
        },
        {
            "text": "anti-IL-1\u03b2 antibody being developed as a treatment for diseases in which IL-1\u03b2",
            "probability": 0.25366883555982117,
            "start_logit": 3.7768397331237793,
            "end_logit": 2.905259132385254
        },
        {
            "text": "IL-1\u03b2 has been associated with pathogenesis. Previous data indicated that gevokizumab negatively modulates IL-1\u03b2",
            "probability": 0.21605224888340385,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.708709955215454
        },
        {
            "text": "IL-1\u03b2-associated",
            "probability": 0.00590475319517464,
            "start_logit": 2.0655345916748047,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated",
            "probability": 0.0041504387868180215,
            "start_logit": 1.7129909992218018,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL",
            "probability": 0.00030767422818982643,
            "start_logit": 3.8128795623779297,
            "end_logit": -3.8455240726470947
        },
        {
            "text": "\u03b2",
            "probability": 0.00020221637295492645,
            "start_logit": -3.357606887817383,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2 (IL-1\u03b2)",
            "probability": 3.5798537175930336e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -5.961124897003174
        },
        {
            "text": "the IL-1\u03b2",
            "probability": 2.1988117817794837e-05,
            "start_logit": -4.856156826019287,
            "end_logit": 2.1849730014801025
        },
        {
            "text": "1\u03b2",
            "probability": 1.7189287808193626e-05,
            "start_logit": -5.276412010192871,
            "end_logit": 2.3590123653411865
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2",
            "probability": 1.6324037664221763e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -6.746393203735352
        },
        {
            "text": "IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 3.2513573803171887e-06,
            "start_logit": 2.0655345916748047,
            "end_logit": -6.648148059844971
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 2.28537236613094e-06,
            "start_logit": 1.7129909992218018,
            "end_logit": -6.648148059844971
        },
        {
            "text": "1",
            "probability": 1.3868474248177953e-09,
            "start_logit": -5.276412010192871,
            "end_logit": -7.065996170043945
        },
        {
            "text": "-",
            "probability": 2.431847916135054e-10,
            "start_logit": -5.760768890380859,
            "end_logit": -8.322606086730957
        }
    ],
    "550e828c71445a662f000002_006": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.2629777554549041,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.25663923917848885,
            "start_logit": 3.777345895767212,
            "end_logit": 2.9163947105407715
        },
        {
            "text": "anti-IL-1\u03b2 antibody being developed as a treatment for diseases in which IL-1\u03b2",
            "probability": 0.25366883555982117,
            "start_logit": 3.7768397331237793,
            "end_logit": 2.905259132385254
        },
        {
            "text": "IL-1\u03b2 has been associated with pathogenesis. Previous data indicated that gevokizumab negatively modulates IL-1\u03b2",
            "probability": 0.21605224888340385,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.708709955215454
        },
        {
            "text": "IL-1\u03b2-associated",
            "probability": 0.00590475319517464,
            "start_logit": 2.0655345916748047,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated",
            "probability": 0.0041504387868180215,
            "start_logit": 1.7129909992218018,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL",
            "probability": 0.00030767422818982643,
            "start_logit": 3.8128795623779297,
            "end_logit": -3.8455240726470947
        },
        {
            "text": "\u03b2",
            "probability": 0.00020221637295492645,
            "start_logit": -3.357606887817383,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2 (IL-1\u03b2)",
            "probability": 3.5798537175930336e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -5.961124897003174
        },
        {
            "text": "the IL-1\u03b2",
            "probability": 2.1988117817794837e-05,
            "start_logit": -4.856156826019287,
            "end_logit": 2.1849730014801025
        },
        {
            "text": "1\u03b2",
            "probability": 1.7189287808193626e-05,
            "start_logit": -5.276412010192871,
            "end_logit": 2.3590123653411865
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2",
            "probability": 1.6324037664221763e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -6.746393203735352
        },
        {
            "text": "IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 3.2513573803171887e-06,
            "start_logit": 2.0655345916748047,
            "end_logit": -6.648148059844971
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 2.28537236613094e-06,
            "start_logit": 1.7129909992218018,
            "end_logit": -6.648148059844971
        },
        {
            "text": "1",
            "probability": 1.3868474248177953e-09,
            "start_logit": -5.276412010192871,
            "end_logit": -7.065996170043945
        },
        {
            "text": "-",
            "probability": 2.431847916135054e-10,
            "start_logit": -5.760768890380859,
            "end_logit": -8.322606086730957
        }
    ],
    "550e828c71445a662f000002_007": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.9980346030967444,
            "start_logit": 6.041831970214844,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2.",
            "probability": 0.0009718581938357198,
            "start_logit": 2.6036458015441895,
            "end_logit": 1.3767414093017578
        },
        {
            "text": "IL",
            "probability": 0.0006345127628622436,
            "start_logit": 6.041831970214844,
            "end_logit": -2.487797260284424
        },
        {
            "text": "\u03b2",
            "probability": 0.000306051053402799,
            "start_logit": -2.047959327697754,
            "end_logit": 4.872888565063477
        },
        {
            "text": "1\u03b2",
            "probability": 2.4705276698032384e-05,
            "start_logit": -4.564694404602051,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 monoclonal antibodies. Canakinumab is known to neutralize IL-1\u03b2",
            "probability": 1.5083112604702053e-05,
            "start_logit": 6.041831970214844,
            "end_logit": -6.227078914642334
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific IL-1\u03b2",
            "probability": 1.295026337787918e-05,
            "start_logit": -5.21059513092041,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 and complex formation results in a minor reduction of binding affinity to IL-1RI.",
            "probability": 1.520413023032978e-07,
            "start_logit": 1.5449591875076294,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2",
            "probability": 2.78363110507252e-08,
            "start_logit": -7.369847774505615,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 pathway attenuation.",
            "probability": 2.316684817943206e-08,
            "start_logit": 1.5093516111373901,
            "end_logit": -8.17320728302002
        },
        {
            "text": "mechanisms of IL-1\u03b2",
            "probability": 1.7250505233567937e-08,
            "start_logit": -7.8483476638793945,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 bioactivity by reducing the affinity for its IL-1RI:IL-1RAcP signaling complex. How IL-1\u03b2",
            "probability": 8.085163537443894e-09,
            "start_logit": -3.730628252029419,
            "end_logit": -3.9859189987182617
        },
        {
            "text": "IL-1\u03b2 and provide insight into the mechanisms leading to their distinct modulation of IL-1\u03b2",
            "probability": 4.222132492791675e-09,
            "start_logit": -4.987427234649658,
            "end_logit": -3.378810405731201
        },
        {
            "text": "(IL-1\u03b2)",
            "probability": 3.2333675887242945e-09,
            "start_logit": -3.9696526527404785,
            "end_logit": -4.663401126861572
        },
        {
            "text": "-",
            "probability": 1.2529184219969058e-10,
            "start_logit": -4.243311405181885,
            "end_logit": -7.640376091003418
        },
        {
            "text": "1",
            "probability": 1.123992267636175e-10,
            "start_logit": -4.564694404602051,
            "end_logit": -7.427581787109375
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific",
            "probability": 1.0506586731518156e-10,
            "start_logit": -5.21059513092041,
            "end_logit": -6.849150657653809
        },
        {
            "text": "IL-1\u03b2 and its receptor. In contrast, gevokizumab occupies an allosteric site on IL-1\u03b2",
            "probability": 3.842876576209135e-11,
            "start_logit": -6.998785495758057,
            "end_logit": -6.066741466522217
        },
        {
            "text": "IL-1RI.",
            "probability": 2.043196378009984e-11,
            "start_logit": -7.369847774505615,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2 pathway attenuation.",
            "probability": 3.2261135978200603e-12,
            "start_logit": -7.369847774505615,
            "end_logit": -8.17320728302002
        }
    ],
    "550e828c71445a662f000002_008": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.9980346030967444,
            "start_logit": 6.041831970214844,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2.",
            "probability": 0.0009718581938357198,
            "start_logit": 2.6036458015441895,
            "end_logit": 1.3767414093017578
        },
        {
            "text": "IL",
            "probability": 0.0006345127628622436,
            "start_logit": 6.041831970214844,
            "end_logit": -2.487797260284424
        },
        {
            "text": "\u03b2",
            "probability": 0.000306051053402799,
            "start_logit": -2.047959327697754,
            "end_logit": 4.872888565063477
        },
        {
            "text": "1\u03b2",
            "probability": 2.4705276698032384e-05,
            "start_logit": -4.564694404602051,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 monoclonal antibodies. Canakinumab is known to neutralize IL-1\u03b2",
            "probability": 1.5083112604702053e-05,
            "start_logit": 6.041831970214844,
            "end_logit": -6.227078914642334
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific IL-1\u03b2",
            "probability": 1.295026337787918e-05,
            "start_logit": -5.21059513092041,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 and complex formation results in a minor reduction of binding affinity to IL-1RI.",
            "probability": 1.520413023032978e-07,
            "start_logit": 1.5449591875076294,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2",
            "probability": 2.78363110507252e-08,
            "start_logit": -7.369847774505615,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 pathway attenuation.",
            "probability": 2.316684817943206e-08,
            "start_logit": 1.5093516111373901,
            "end_logit": -8.17320728302002
        },
        {
            "text": "mechanisms of IL-1\u03b2",
            "probability": 1.7250505233567937e-08,
            "start_logit": -7.8483476638793945,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 bioactivity by reducing the affinity for its IL-1RI:IL-1RAcP signaling complex. How IL-1\u03b2",
            "probability": 8.085163537443894e-09,
            "start_logit": -3.730628252029419,
            "end_logit": -3.9859189987182617
        },
        {
            "text": "IL-1\u03b2 and provide insight into the mechanisms leading to their distinct modulation of IL-1\u03b2",
            "probability": 4.222132492791675e-09,
            "start_logit": -4.987427234649658,
            "end_logit": -3.378810405731201
        },
        {
            "text": "(IL-1\u03b2)",
            "probability": 3.2333675887242945e-09,
            "start_logit": -3.9696526527404785,
            "end_logit": -4.663401126861572
        },
        {
            "text": "-",
            "probability": 1.2529184219969058e-10,
            "start_logit": -4.243311405181885,
            "end_logit": -7.640376091003418
        },
        {
            "text": "1",
            "probability": 1.123992267636175e-10,
            "start_logit": -4.564694404602051,
            "end_logit": -7.427581787109375
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific",
            "probability": 1.0506586731518156e-10,
            "start_logit": -5.21059513092041,
            "end_logit": -6.849150657653809
        },
        {
            "text": "IL-1\u03b2 and its receptor. In contrast, gevokizumab occupies an allosteric site on IL-1\u03b2",
            "probability": 3.842876576209135e-11,
            "start_logit": -6.998785495758057,
            "end_logit": -6.066741466522217
        },
        {
            "text": "IL-1RI.",
            "probability": 2.043196378009984e-11,
            "start_logit": -7.369847774505615,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2 pathway attenuation.",
            "probability": 3.2261135978200603e-12,
            "start_logit": -7.369847774505615,
            "end_logit": -8.17320728302002
        }
    ],
    "550e828c71445a662f000002_009": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.9980346030967444,
            "start_logit": 6.041831970214844,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2.",
            "probability": 0.0009718581938357198,
            "start_logit": 2.6036458015441895,
            "end_logit": 1.3767414093017578
        },
        {
            "text": "IL",
            "probability": 0.0006345127628622436,
            "start_logit": 6.041831970214844,
            "end_logit": -2.487797260284424
        },
        {
            "text": "\u03b2",
            "probability": 0.000306051053402799,
            "start_logit": -2.047959327697754,
            "end_logit": 4.872888565063477
        },
        {
            "text": "1\u03b2",
            "probability": 2.4705276698032384e-05,
            "start_logit": -4.564694404602051,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 monoclonal antibodies. Canakinumab is known to neutralize IL-1\u03b2",
            "probability": 1.5083112604702053e-05,
            "start_logit": 6.041831970214844,
            "end_logit": -6.227078914642334
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific IL-1\u03b2",
            "probability": 1.295026337787918e-05,
            "start_logit": -5.21059513092041,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 and complex formation results in a minor reduction of binding affinity to IL-1RI.",
            "probability": 1.520413023032978e-07,
            "start_logit": 1.5449591875076294,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2",
            "probability": 2.78363110507252e-08,
            "start_logit": -7.369847774505615,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 pathway attenuation.",
            "probability": 2.316684817943206e-08,
            "start_logit": 1.5093516111373901,
            "end_logit": -8.17320728302002
        },
        {
            "text": "mechanisms of IL-1\u03b2",
            "probability": 1.7250505233567937e-08,
            "start_logit": -7.8483476638793945,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 bioactivity by reducing the affinity for its IL-1RI:IL-1RAcP signaling complex. How IL-1\u03b2",
            "probability": 8.085163537443894e-09,
            "start_logit": -3.730628252029419,
            "end_logit": -3.9859189987182617
        },
        {
            "text": "IL-1\u03b2 and provide insight into the mechanisms leading to their distinct modulation of IL-1\u03b2",
            "probability": 4.222132492791675e-09,
            "start_logit": -4.987427234649658,
            "end_logit": -3.378810405731201
        },
        {
            "text": "(IL-1\u03b2)",
            "probability": 3.2333675887242945e-09,
            "start_logit": -3.9696526527404785,
            "end_logit": -4.663401126861572
        },
        {
            "text": "-",
            "probability": 1.2529184219969058e-10,
            "start_logit": -4.243311405181885,
            "end_logit": -7.640376091003418
        },
        {
            "text": "1",
            "probability": 1.123992267636175e-10,
            "start_logit": -4.564694404602051,
            "end_logit": -7.427581787109375
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific",
            "probability": 1.0506586731518156e-10,
            "start_logit": -5.21059513092041,
            "end_logit": -6.849150657653809
        },
        {
            "text": "IL-1\u03b2 and its receptor. In contrast, gevokizumab occupies an allosteric site on IL-1\u03b2",
            "probability": 3.842876576209135e-11,
            "start_logit": -6.998785495758057,
            "end_logit": -6.066741466522217
        },
        {
            "text": "IL-1RI.",
            "probability": 2.043196378009984e-11,
            "start_logit": -7.369847774505615,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2 pathway attenuation.",
            "probability": 3.2261135978200603e-12,
            "start_logit": -7.369847774505615,
            "end_logit": -8.17320728302002
        }
    ],
    "550e828c71445a662f000002_010": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.9980346030967444,
            "start_logit": 6.041831970214844,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2.",
            "probability": 0.0009718581938357198,
            "start_logit": 2.6036458015441895,
            "end_logit": 1.3767414093017578
        },
        {
            "text": "IL",
            "probability": 0.0006345127628622436,
            "start_logit": 6.041831970214844,
            "end_logit": -2.487797260284424
        },
        {
            "text": "\u03b2",
            "probability": 0.000306051053402799,
            "start_logit": -2.047959327697754,
            "end_logit": 4.872888565063477
        },
        {
            "text": "1\u03b2",
            "probability": 2.4705276698032384e-05,
            "start_logit": -4.564694404602051,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 monoclonal antibodies. Canakinumab is known to neutralize IL-1\u03b2",
            "probability": 1.5083112604702053e-05,
            "start_logit": 6.041831970214844,
            "end_logit": -6.227078914642334
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific IL-1\u03b2",
            "probability": 1.295026337787918e-05,
            "start_logit": -5.21059513092041,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 and complex formation results in a minor reduction of binding affinity to IL-1RI.",
            "probability": 1.520413023032978e-07,
            "start_logit": 1.5449591875076294,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2",
            "probability": 2.78363110507252e-08,
            "start_logit": -7.369847774505615,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 pathway attenuation.",
            "probability": 2.316684817943206e-08,
            "start_logit": 1.5093516111373901,
            "end_logit": -8.17320728302002
        },
        {
            "text": "mechanisms of IL-1\u03b2",
            "probability": 1.7250505233567937e-08,
            "start_logit": -7.8483476638793945,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 bioactivity by reducing the affinity for its IL-1RI:IL-1RAcP signaling complex. How IL-1\u03b2",
            "probability": 8.085163537443894e-09,
            "start_logit": -3.730628252029419,
            "end_logit": -3.9859189987182617
        },
        {
            "text": "IL-1\u03b2 and provide insight into the mechanisms leading to their distinct modulation of IL-1\u03b2",
            "probability": 4.222132492791675e-09,
            "start_logit": -4.987427234649658,
            "end_logit": -3.378810405731201
        },
        {
            "text": "(IL-1\u03b2)",
            "probability": 3.2333675887242945e-09,
            "start_logit": -3.9696526527404785,
            "end_logit": -4.663401126861572
        },
        {
            "text": "-",
            "probability": 1.2529184219969058e-10,
            "start_logit": -4.243311405181885,
            "end_logit": -7.640376091003418
        },
        {
            "text": "1",
            "probability": 1.123992267636175e-10,
            "start_logit": -4.564694404602051,
            "end_logit": -7.427581787109375
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific",
            "probability": 1.0506586731518156e-10,
            "start_logit": -5.21059513092041,
            "end_logit": -6.849150657653809
        },
        {
            "text": "IL-1\u03b2 and its receptor. In contrast, gevokizumab occupies an allosteric site on IL-1\u03b2",
            "probability": 3.842876576209135e-11,
            "start_logit": -6.998785495758057,
            "end_logit": -6.066741466522217
        },
        {
            "text": "IL-1RI.",
            "probability": 2.043196378009984e-11,
            "start_logit": -7.369847774505615,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2 pathway attenuation.",
            "probability": 3.2261135978200603e-12,
            "start_logit": -7.369847774505615,
            "end_logit": -8.17320728302002
        }
    ],
    "550e828c71445a662f000002_011": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.9980346030967444,
            "start_logit": 6.041831970214844,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2.",
            "probability": 0.0009718581938357198,
            "start_logit": 2.6036458015441895,
            "end_logit": 1.3767414093017578
        },
        {
            "text": "IL",
            "probability": 0.0006345127628622436,
            "start_logit": 6.041831970214844,
            "end_logit": -2.487797260284424
        },
        {
            "text": "\u03b2",
            "probability": 0.000306051053402799,
            "start_logit": -2.047959327697754,
            "end_logit": 4.872888565063477
        },
        {
            "text": "1\u03b2",
            "probability": 2.4705276698032384e-05,
            "start_logit": -4.564694404602051,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 monoclonal antibodies. Canakinumab is known to neutralize IL-1\u03b2",
            "probability": 1.5083112604702053e-05,
            "start_logit": 6.041831970214844,
            "end_logit": -6.227078914642334
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific IL-1\u03b2",
            "probability": 1.295026337787918e-05,
            "start_logit": -5.21059513092041,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 and complex formation results in a minor reduction of binding affinity to IL-1RI.",
            "probability": 1.520413023032978e-07,
            "start_logit": 1.5449591875076294,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2",
            "probability": 2.78363110507252e-08,
            "start_logit": -7.369847774505615,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 pathway attenuation.",
            "probability": 2.316684817943206e-08,
            "start_logit": 1.5093516111373901,
            "end_logit": -8.17320728302002
        },
        {
            "text": "mechanisms of IL-1\u03b2",
            "probability": 1.7250505233567937e-08,
            "start_logit": -7.8483476638793945,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 bioactivity by reducing the affinity for its IL-1RI:IL-1RAcP signaling complex. How IL-1\u03b2",
            "probability": 8.085163537443894e-09,
            "start_logit": -3.730628252029419,
            "end_logit": -3.9859189987182617
        },
        {
            "text": "IL-1\u03b2 and provide insight into the mechanisms leading to their distinct modulation of IL-1\u03b2",
            "probability": 4.222132492791675e-09,
            "start_logit": -4.987427234649658,
            "end_logit": -3.378810405731201
        },
        {
            "text": "(IL-1\u03b2)",
            "probability": 3.2333675887242945e-09,
            "start_logit": -3.9696526527404785,
            "end_logit": -4.663401126861572
        },
        {
            "text": "-",
            "probability": 1.2529184219969058e-10,
            "start_logit": -4.243311405181885,
            "end_logit": -7.640376091003418
        },
        {
            "text": "1",
            "probability": 1.123992267636175e-10,
            "start_logit": -4.564694404602051,
            "end_logit": -7.427581787109375
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific",
            "probability": 1.0506586731518156e-10,
            "start_logit": -5.21059513092041,
            "end_logit": -6.849150657653809
        },
        {
            "text": "IL-1\u03b2 and its receptor. In contrast, gevokizumab occupies an allosteric site on IL-1\u03b2",
            "probability": 3.842876576209135e-11,
            "start_logit": -6.998785495758057,
            "end_logit": -6.066741466522217
        },
        {
            "text": "IL-1RI.",
            "probability": 2.043196378009984e-11,
            "start_logit": -7.369847774505615,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2 pathway attenuation.",
            "probability": 3.2261135978200603e-12,
            "start_logit": -7.369847774505615,
            "end_logit": -8.17320728302002
        }
    ],
    "550e828c71445a662f000002_012": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.9980346030967444,
            "start_logit": 6.041831970214844,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2.",
            "probability": 0.0009718581938357198,
            "start_logit": 2.6036458015441895,
            "end_logit": 1.3767414093017578
        },
        {
            "text": "IL",
            "probability": 0.0006345127628622436,
            "start_logit": 6.041831970214844,
            "end_logit": -2.487797260284424
        },
        {
            "text": "\u03b2",
            "probability": 0.000306051053402799,
            "start_logit": -2.047959327697754,
            "end_logit": 4.872888565063477
        },
        {
            "text": "1\u03b2",
            "probability": 2.4705276698032384e-05,
            "start_logit": -4.564694404602051,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 monoclonal antibodies. Canakinumab is known to neutralize IL-1\u03b2",
            "probability": 1.5083112604702053e-05,
            "start_logit": 6.041831970214844,
            "end_logit": -6.227078914642334
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific IL-1\u03b2",
            "probability": 1.295026337787918e-05,
            "start_logit": -5.21059513092041,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 and complex formation results in a minor reduction of binding affinity to IL-1RI.",
            "probability": 1.520413023032978e-07,
            "start_logit": 1.5449591875076294,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2",
            "probability": 2.78363110507252e-08,
            "start_logit": -7.369847774505615,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 pathway attenuation.",
            "probability": 2.316684817943206e-08,
            "start_logit": 1.5093516111373901,
            "end_logit": -8.17320728302002
        },
        {
            "text": "mechanisms of IL-1\u03b2",
            "probability": 1.7250505233567937e-08,
            "start_logit": -7.8483476638793945,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 bioactivity by reducing the affinity for its IL-1RI:IL-1RAcP signaling complex. How IL-1\u03b2",
            "probability": 8.085163537443894e-09,
            "start_logit": -3.730628252029419,
            "end_logit": -3.9859189987182617
        },
        {
            "text": "IL-1\u03b2 and provide insight into the mechanisms leading to their distinct modulation of IL-1\u03b2",
            "probability": 4.222132492791675e-09,
            "start_logit": -4.987427234649658,
            "end_logit": -3.378810405731201
        },
        {
            "text": "(IL-1\u03b2)",
            "probability": 3.2333675887242945e-09,
            "start_logit": -3.9696526527404785,
            "end_logit": -4.663401126861572
        },
        {
            "text": "-",
            "probability": 1.2529184219969058e-10,
            "start_logit": -4.243311405181885,
            "end_logit": -7.640376091003418
        },
        {
            "text": "1",
            "probability": 1.123992267636175e-10,
            "start_logit": -4.564694404602051,
            "end_logit": -7.427581787109375
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific",
            "probability": 1.0506586731518156e-10,
            "start_logit": -5.21059513092041,
            "end_logit": -6.849150657653809
        },
        {
            "text": "IL-1\u03b2 and its receptor. In contrast, gevokizumab occupies an allosteric site on IL-1\u03b2",
            "probability": 3.842876576209135e-11,
            "start_logit": -6.998785495758057,
            "end_logit": -6.066741466522217
        },
        {
            "text": "IL-1RI.",
            "probability": 2.043196378009984e-11,
            "start_logit": -7.369847774505615,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2 pathway attenuation.",
            "probability": 3.2261135978200603e-12,
            "start_logit": -7.369847774505615,
            "end_logit": -8.17320728302002
        }
    ],
    "550e828c71445a662f000002_013": [
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.999810384173108,
            "start_logit": 9.046475410461426,
            "end_logit": 7.935140609741211
        },
        {
            "text": "IL",
            "probability": 0.00014412808238895648,
            "start_logit": 9.046475410461426,
            "end_logit": -0.909477949142456
        },
        {
            "text": "\u03b2",
            "probability": 4.41481332127902e-05,
            "start_logit": -0.9812948703765869,
            "end_logit": 7.935140609741211
        },
        {
            "text": "1\u03b2",
            "probability": 1.0264055288251085e-06,
            "start_logit": -4.7427825927734375,
            "end_logit": 7.935140609741211
        },
        {
            "text": "anti-IL-1\u03b2 antibody.",
            "probability": 1.9712981091608907e-07,
            "start_logit": 9.046475410461426,
            "end_logit": -7.504073143005371
        },
        {
            "text": "monoclonal anti-IL-1\u03b2",
            "probability": 1.154544355150432e-07,
            "start_logit": -6.927724838256836,
            "end_logit": 7.935140609741211
        },
        {
            "text": "anti-IL-1\u03b2 antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.",
            "probability": 5.824677444790159e-10,
            "start_logit": -0.9812948703765869,
            "end_logit": -3.3006467819213867
        },
        {
            "text": "AND",
            "probability": 2.7530303782832534e-11,
            "start_logit": 0.08187484741210938,
            "end_logit": -7.415802955627441
        },
        {
            "text": "Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes.",
            "probability": 4.595193317976736e-12,
            "start_logit": -6.0695929527282715,
            "end_logit": -3.0546116828918457
        },
        {
            "text": "antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.",
            "probability": 2.9468741071621925e-12,
            "start_logit": -6.267823696136475,
            "end_logit": -3.3006467819213867
        },
        {
            "text": "type 2 diabetes.",
            "probability": 2.827879619897343e-12,
            "start_logit": -6.555076599121094,
            "end_logit": -3.0546116828918457
        },
        {
            "text": "1",
            "probability": 2.454200707724353e-13,
            "start_logit": -4.7427825927734375,
            "end_logit": -7.311216831207275
        },
        {
            "text": "-",
            "probability": 2.0503434101079503e-13,
            "start_logit": -4.711770534515381,
            "end_logit": -7.522022724151611
        },
        {
            "text": "RESEARCH DESIGN AND",
            "probability": 1.4820484169280344e-13,
            "start_logit": -5.142572402954102,
            "end_logit": -7.415802955627441
        },
        {
            "text": "DESIGN AND",
            "probability": 1.2486003685213467e-13,
            "start_logit": -5.313974380493164,
            "end_logit": -7.415802955627441
        },
        {
            "text": "RESEARCH DESIGN",
            "probability": 9.940522571250098e-14,
            "start_logit": -5.142572402954102,
            "end_logit": -7.8151936531066895
        },
        {
            "text": "Effects of gevokizumab on glycemia and inflammatory",
            "probability": 9.443171488162673e-14,
            "start_logit": -6.0695929527282715,
            "end_logit": -6.93950080871582
        },
        {
            "text": "DESIGN",
            "probability": 8.374719748687085e-14,
            "start_logit": -5.313974380493164,
            "end_logit": -7.8151936531066895
        },
        {
            "text": "diabetes.",
            "probability": 7.44253401974134e-14,
            "start_logit": -7.815128803253174,
            "end_logit": -5.4320454597473145
        },
        {
            "text": "RESEARCH",
            "probability": 7.14067036633162e-14,
            "start_logit": -5.142572402954102,
            "end_logit": -8.14600658416748
        }
    ],
    "550e828c71445a662f000002_014": [
        {
            "text": "IL-1\u03b2,",
            "probability": 0.45327885083341957,
            "start_logit": 6.408024311065674,
            "end_logit": 5.301055908203125
        },
        {
            "text": "IL-1\u03b2",
            "probability": 0.2808999487257736,
            "start_logit": 6.186962604522705,
            "end_logit": 5.043608665466309
        },
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.2653210743900134,
            "start_logit": 6.159540176391602,
            "end_logit": 5.013973236083984
        },
        {
            "text": "IL",
            "probability": 0.00019626186519819007,
            "start_logit": 6.408024311065674,
            "end_logit": -2.4437570571899414
        },
        {
            "text": "IL-1\u03b2, for the potential treatment of these diseases. Gevokizumab has a high affinity for IL-1\u03b2",
            "probability": 0.00015111743065942436,
            "start_logit": 6.408024311065674,
            "end_logit": -2.7051496505737305
        },
        {
            "text": "\u03b2",
            "probability": 8.12651569270689e-05,
            "start_logit": -2.2185211181640625,
            "end_logit": 5.301055908203125
        },
        {
            "text": "human IL-1\u03b2,",
            "probability": 3.912907122707493e-05,
            "start_logit": -2.9493727684020996,
            "end_logit": 5.301055908203125
        },
        {
            "text": "(XOMA-052), an IgG2 humanized mAb against human IL-1\u03b2,",
            "probability": 1.2233643775629296e-05,
            "start_logit": -4.112048625946045,
            "end_logit": 5.301055908203125
        },
        {
            "text": "for IL-1\u03b2",
            "probability": 5.820006579274888e-06,
            "start_logit": -4.597489833831787,
            "end_logit": 5.043608665466309
        },
        {
            "text": "1\u03b2",
            "probability": 4.359677801157266e-06,
            "start_logit": -5.143840312957764,
            "end_logit": 5.301055908203125
        },
        {
            "text": "high affinity for IL-1\u03b2",
            "probability": 4.119859425712158e-06,
            "start_logit": -4.942972183227539,
            "end_logit": 5.043608665466309
        },
        {
            "text": "IL-1\u03b2 and a long t1/2,",
            "probability": 2.9745308670922994e-06,
            "start_logit": 6.186962604522705,
            "end_logit": -6.4120588302612305
        },
        {
            "text": "IL-1\u03b2, for the potential treatment of these diseases. Gevokizumab has a high affinity",
            "probability": 1.078339802549862e-06,
            "start_logit": 6.408024311065674,
            "end_logit": -7.647784233093262
        },
        {
            "text": "anti-IL-1\u03b2 mAb",
            "probability": 9.123042459777054e-07,
            "start_logit": 6.159540176391602,
            "end_logit": -7.56650447845459
        },
        {
            "text": "anti-IL-1\u03b2 mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis",
            "probability": 7.600248307439703e-07,
            "start_logit": 6.159540176391602,
            "end_logit": -7.74912691116333
        },
        {
            "text": "IL-1\u03b2 has an essential role in the innate immune response. High levels of IL-1\u03b2",
            "probability": 8.043497571492116e-08,
            "start_logit": -0.6329473853111267,
            "end_logit": -3.2025413513183594
        },
        {
            "text": "human IL-1\u03b2, for the potential treatment of these diseases. Gevokizumab has a high affinity for IL-1\u03b2",
            "probability": 1.3045136999118976e-08,
            "start_logit": -2.9493727684020996,
            "end_logit": -2.7051496505737305
        },
        {
            "text": "XOMA",
            "probability": 3.125572380940672e-10,
            "start_logit": -3.0849897861480713,
            "end_logit": -6.300915718078613
        },
        {
            "text": "XOMA is developing gevokizumab (XOMA-052),",
            "probability": 1.7454119611967007e-10,
            "start_logit": -3.0849897861480713,
            "end_logit": -6.883542537689209
        },
        {
            "text": "human",
            "probability": 1.722421172494338e-10,
            "start_logit": -2.9493727684020996,
            "end_logit": -7.032419204711914
        }
    ],
    "550e828c71445a662f000002_015": [
        {
            "text": "IL-1\u03b2,",
            "probability": 0.45327885083341957,
            "start_logit": 6.408024311065674,
            "end_logit": 5.301055908203125
        },
        {
            "text": "IL-1\u03b2",
            "probability": 0.2808999487257736,
            "start_logit": 6.186962604522705,
            "end_logit": 5.043608665466309
        },
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.2653210743900134,
            "start_logit": 6.159540176391602,
            "end_logit": 5.013973236083984
        },
        {
            "text": "IL",
            "probability": 0.00019626186519819007,
            "start_logit": 6.408024311065674,
            "end_logit": -2.4437570571899414
        },
        {
            "text": "IL-1\u03b2, for the potential treatment of these diseases. Gevokizumab has a high affinity for IL-1\u03b2",
            "probability": 0.00015111743065942436,
            "start_logit": 6.408024311065674,
            "end_logit": -2.7051496505737305
        },
        {
            "text": "\u03b2",
            "probability": 8.12651569270689e-05,
            "start_logit": -2.2185211181640625,
            "end_logit": 5.301055908203125
        },
        {
            "text": "human IL-1\u03b2,",
            "probability": 3.912907122707493e-05,
            "start_logit": -2.9493727684020996,
            "end_logit": 5.301055908203125
        },
        {
            "text": "(XOMA-052), an IgG2 humanized mAb against human IL-1\u03b2,",
            "probability": 1.2233643775629296e-05,
            "start_logit": -4.112048625946045,
            "end_logit": 5.301055908203125
        },
        {
            "text": "for IL-1\u03b2",
            "probability": 5.820006579274888e-06,
            "start_logit": -4.597489833831787,
            "end_logit": 5.043608665466309
        },
        {
            "text": "1\u03b2",
            "probability": 4.359677801157266e-06,
            "start_logit": -5.143840312957764,
            "end_logit": 5.301055908203125
        },
        {
            "text": "high affinity for IL-1\u03b2",
            "probability": 4.119859425712158e-06,
            "start_logit": -4.942972183227539,
            "end_logit": 5.043608665466309
        },
        {
            "text": "IL-1\u03b2 and a long t1/2,",
            "probability": 2.9745308670922994e-06,
            "start_logit": 6.186962604522705,
            "end_logit": -6.4120588302612305
        },
        {
            "text": "IL-1\u03b2, for the potential treatment of these diseases. Gevokizumab has a high affinity",
            "probability": 1.078339802549862e-06,
            "start_logit": 6.408024311065674,
            "end_logit": -7.647784233093262
        },
        {
            "text": "anti-IL-1\u03b2 mAb",
            "probability": 9.123042459777054e-07,
            "start_logit": 6.159540176391602,
            "end_logit": -7.56650447845459
        },
        {
            "text": "anti-IL-1\u03b2 mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis",
            "probability": 7.600248307439703e-07,
            "start_logit": 6.159540176391602,
            "end_logit": -7.74912691116333
        },
        {
            "text": "IL-1\u03b2 has an essential role in the innate immune response. High levels of IL-1\u03b2",
            "probability": 8.043497571492116e-08,
            "start_logit": -0.6329473853111267,
            "end_logit": -3.2025413513183594
        },
        {
            "text": "human IL-1\u03b2, for the potential treatment of these diseases. Gevokizumab has a high affinity for IL-1\u03b2",
            "probability": 1.3045136999118976e-08,
            "start_logit": -2.9493727684020996,
            "end_logit": -2.7051496505737305
        },
        {
            "text": "XOMA",
            "probability": 3.125572380940672e-10,
            "start_logit": -3.0849897861480713,
            "end_logit": -6.300915718078613
        },
        {
            "text": "XOMA is developing gevokizumab (XOMA-052),",
            "probability": 1.7454119611967007e-10,
            "start_logit": -3.0849897861480713,
            "end_logit": -6.883542537689209
        },
        {
            "text": "human",
            "probability": 1.722421172494338e-10,
            "start_logit": -2.9493727684020996,
            "end_logit": -7.032419204711914
        }
    ],
    "550e828c71445a662f000002_016": [
        {
            "text": "IL-1\u03b2,",
            "probability": 0.45327885083341957,
            "start_logit": 6.408024311065674,
            "end_logit": 5.301055908203125
        },
        {
            "text": "IL-1\u03b2",
            "probability": 0.2808999487257736,
            "start_logit": 6.186962604522705,
            "end_logit": 5.043608665466309
        },
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.2653210743900134,
            "start_logit": 6.159540176391602,
            "end_logit": 5.013973236083984
        },
        {
            "text": "IL",
            "probability": 0.00019626186519819007,
            "start_logit": 6.408024311065674,
            "end_logit": -2.4437570571899414
        },
        {
            "text": "IL-1\u03b2, for the potential treatment of these diseases. Gevokizumab has a high affinity for IL-1\u03b2",
            "probability": 0.00015111743065942436,
            "start_logit": 6.408024311065674,
            "end_logit": -2.7051496505737305
        },
        {
            "text": "\u03b2",
            "probability": 8.12651569270689e-05,
            "start_logit": -2.2185211181640625,
            "end_logit": 5.301055908203125
        },
        {
            "text": "human IL-1\u03b2,",
            "probability": 3.912907122707493e-05,
            "start_logit": -2.9493727684020996,
            "end_logit": 5.301055908203125
        },
        {
            "text": "(XOMA-052), an IgG2 humanized mAb against human IL-1\u03b2,",
            "probability": 1.2233643775629296e-05,
            "start_logit": -4.112048625946045,
            "end_logit": 5.301055908203125
        },
        {
            "text": "for IL-1\u03b2",
            "probability": 5.820006579274888e-06,
            "start_logit": -4.597489833831787,
            "end_logit": 5.043608665466309
        },
        {
            "text": "1\u03b2",
            "probability": 4.359677801157266e-06,
            "start_logit": -5.143840312957764,
            "end_logit": 5.301055908203125
        },
        {
            "text": "high affinity for IL-1\u03b2",
            "probability": 4.119859425712158e-06,
            "start_logit": -4.942972183227539,
            "end_logit": 5.043608665466309
        },
        {
            "text": "IL-1\u03b2 and a long t1/2,",
            "probability": 2.9745308670922994e-06,
            "start_logit": 6.186962604522705,
            "end_logit": -6.4120588302612305
        },
        {
            "text": "IL-1\u03b2, for the potential treatment of these diseases. Gevokizumab has a high affinity",
            "probability": 1.078339802549862e-06,
            "start_logit": 6.408024311065674,
            "end_logit": -7.647784233093262
        },
        {
            "text": "anti-IL-1\u03b2 mAb",
            "probability": 9.123042459777054e-07,
            "start_logit": 6.159540176391602,
            "end_logit": -7.56650447845459
        },
        {
            "text": "anti-IL-1\u03b2 mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis",
            "probability": 7.600248307439703e-07,
            "start_logit": 6.159540176391602,
            "end_logit": -7.74912691116333
        },
        {
            "text": "IL-1\u03b2 has an essential role in the innate immune response. High levels of IL-1\u03b2",
            "probability": 8.043497571492116e-08,
            "start_logit": -0.6329473853111267,
            "end_logit": -3.2025413513183594
        },
        {
            "text": "human IL-1\u03b2, for the potential treatment of these diseases. Gevokizumab has a high affinity for IL-1\u03b2",
            "probability": 1.3045136999118976e-08,
            "start_logit": -2.9493727684020996,
            "end_logit": -2.7051496505737305
        },
        {
            "text": "XOMA",
            "probability": 3.125572380940672e-10,
            "start_logit": -3.0849897861480713,
            "end_logit": -6.300915718078613
        },
        {
            "text": "XOMA is developing gevokizumab (XOMA-052),",
            "probability": 1.7454119611967007e-10,
            "start_logit": -3.0849897861480713,
            "end_logit": -6.883542537689209
        },
        {
            "text": "human",
            "probability": 1.722421172494338e-10,
            "start_logit": -2.9493727684020996,
            "end_logit": -7.032419204711914
        }
    ],
    "550e828c71445a662f000002_017": [
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.9992531428843786,
            "start_logit": 7.229076385498047,
            "end_logit": 5.686222553253174
        },
        {
            "text": "IL",
            "probability": 0.00034206503084055473,
            "start_logit": 7.229076385498047,
            "end_logit": -2.2935400009155273
        },
        {
            "text": "IL-1\u03b2-mediated",
            "probability": 0.00018628317749682508,
            "start_logit": 2.535712718963623,
            "end_logit": 1.7920907735824585
        },
        {
            "text": "IL-1\u03b2",
            "probability": 9.27801340135069e-05,
            "start_logit": 2.3311538696289062,
            "end_logit": 1.2996141910552979
        },
        {
            "text": "\u03b2",
            "probability": 9.045303023704739e-05,
            "start_logit": -2.0808563232421875,
            "end_logit": 5.686222553253174
        },
        {
            "text": "anti-IL-1\u03b2 neutralizing",
            "probability": 1.7128616941279197e-05,
            "start_logit": 7.229076385498047,
            "end_logit": -5.287790298461914
        },
        {
            "text": "XOMA 052 (gevokizumab), a potent anti-IL-1\u03b2",
            "probability": 9.37195571918363e-06,
            "start_logit": -4.347965240478516,
            "end_logit": 5.686222553253174
        },
        {
            "text": "1\u03b2",
            "probability": 3.5120425988214205e-06,
            "start_logit": -5.329489231109619,
            "end_logit": 5.686222553253174
        },
        {
            "text": "IL-1\u03b2-mediated diseases. Interleukin-1\u03b2",
            "probability": 2.5900778341252193e-06,
            "start_logit": 2.535712718963623,
            "end_logit": -2.4834892749786377
        },
        {
            "text": "IL-1\u03b2-mediated diseases. Interleukin-1\u03b2 (IL-1\u03b2)",
            "probability": 2.3957074178743094e-06,
            "start_logit": 2.535712718963623,
            "end_logit": -2.5614986419677734
        },
        {
            "text": "XOMA 052 has a 300 femtomolar binding affinity for human IL-1\u03b2",
            "probability": 2.3085077949505854e-07,
            "start_logit": -5.588492393493652,
            "end_logit": 3.2230441570281982
        },
        {
            "text": "IL-1\u03b2 and an in vitro potency in the low picomolar range. XOMA 052 binds to a unique IL-1\u03b2",
            "probability": 3.992350489025308e-08,
            "start_logit": 2.3311538696289062,
            "end_logit": -6.451408386230469
        },
        {
            "text": "(IL-1\u03b2)",
            "probability": 3.3107107184547215e-09,
            "start_logit": -4.048558235168457,
            "end_logit": -2.5614986419677734
        },
        {
            "text": "IL-1\u03b2 is central to pathogenesis.",
            "probability": 3.0688546417650858e-09,
            "start_logit": 1.6186290979385376,
            "end_logit": -8.304544448852539
        },
        {
            "text": "XOMA 052 (gevokizumab), a potent anti-IL-1\u03b2 neutralizing",
            "probability": 1.6064862107028834e-10,
            "start_logit": -4.347965240478516,
            "end_logit": -5.287790298461914
        },
        {
            "text": "XOMA 052",
            "probability": 9.467874737715798e-12,
            "start_logit": -4.347965240478516,
            "end_logit": -8.119105339050293
        },
        {
            "text": "1",
            "probability": 9.386614416547947e-12,
            "start_logit": -5.329489231109619,
            "end_logit": -7.146201133728027
        },
        {
            "text": "-",
            "probability": 9.169492904140585e-12,
            "start_logit": -4.582733631134033,
            "end_logit": -7.9163594245910645
        }
    ],
    "550e828c71445a662f000002_018": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.2629777554549041,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.25663923917848885,
            "start_logit": 3.777345895767212,
            "end_logit": 2.9163947105407715
        },
        {
            "text": "anti-IL-1\u03b2 antibody being developed as a treatment for diseases in which IL-1\u03b2",
            "probability": 0.25366883555982117,
            "start_logit": 3.7768397331237793,
            "end_logit": 2.905259132385254
        },
        {
            "text": "IL-1\u03b2 has been associated with pathogenesis. Previous data indicated that gevokizumab negatively modulates IL-1\u03b2",
            "probability": 0.21605224888340385,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.708709955215454
        },
        {
            "text": "IL-1\u03b2-associated",
            "probability": 0.00590475319517464,
            "start_logit": 2.0655345916748047,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated",
            "probability": 0.0041504387868180215,
            "start_logit": 1.7129909992218018,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL",
            "probability": 0.00030767422818982643,
            "start_logit": 3.8128795623779297,
            "end_logit": -3.8455240726470947
        },
        {
            "text": "\u03b2",
            "probability": 0.00020221637295492645,
            "start_logit": -3.357606887817383,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2 (IL-1\u03b2)",
            "probability": 3.5798537175930336e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -5.961124897003174
        },
        {
            "text": "the IL-1\u03b2",
            "probability": 2.1988117817794837e-05,
            "start_logit": -4.856156826019287,
            "end_logit": 2.1849730014801025
        },
        {
            "text": "1\u03b2",
            "probability": 1.7189287808193626e-05,
            "start_logit": -5.276412010192871,
            "end_logit": 2.3590123653411865
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2",
            "probability": 1.6324037664221763e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -6.746393203735352
        },
        {
            "text": "IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 3.2513573803171887e-06,
            "start_logit": 2.0655345916748047,
            "end_logit": -6.648148059844971
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 2.28537236613094e-06,
            "start_logit": 1.7129909992218018,
            "end_logit": -6.648148059844971
        },
        {
            "text": "1",
            "probability": 1.3868474248177953e-09,
            "start_logit": -5.276412010192871,
            "end_logit": -7.065996170043945
        },
        {
            "text": "-",
            "probability": 2.431847916135054e-10,
            "start_logit": -5.760768890380859,
            "end_logit": -8.322606086730957
        }
    ],
    "550e828c71445a662f000002_019": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.2629777554549041,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.25663923917848885,
            "start_logit": 3.777345895767212,
            "end_logit": 2.9163947105407715
        },
        {
            "text": "anti-IL-1\u03b2 antibody being developed as a treatment for diseases in which IL-1\u03b2",
            "probability": 0.25366883555982117,
            "start_logit": 3.7768397331237793,
            "end_logit": 2.905259132385254
        },
        {
            "text": "IL-1\u03b2 has been associated with pathogenesis. Previous data indicated that gevokizumab negatively modulates IL-1\u03b2",
            "probability": 0.21605224888340385,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.708709955215454
        },
        {
            "text": "IL-1\u03b2-associated",
            "probability": 0.00590475319517464,
            "start_logit": 2.0655345916748047,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated",
            "probability": 0.0041504387868180215,
            "start_logit": 1.7129909992218018,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL",
            "probability": 0.00030767422818982643,
            "start_logit": 3.8128795623779297,
            "end_logit": -3.8455240726470947
        },
        {
            "text": "\u03b2",
            "probability": 0.00020221637295492645,
            "start_logit": -3.357606887817383,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2 (IL-1\u03b2)",
            "probability": 3.5798537175930336e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -5.961124897003174
        },
        {
            "text": "the IL-1\u03b2",
            "probability": 2.1988117817794837e-05,
            "start_logit": -4.856156826019287,
            "end_logit": 2.1849730014801025
        },
        {
            "text": "1\u03b2",
            "probability": 1.7189287808193626e-05,
            "start_logit": -5.276412010192871,
            "end_logit": 2.3590123653411865
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2",
            "probability": 1.6324037664221763e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -6.746393203735352
        },
        {
            "text": "IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 3.2513573803171887e-06,
            "start_logit": 2.0655345916748047,
            "end_logit": -6.648148059844971
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 2.28537236613094e-06,
            "start_logit": 1.7129909992218018,
            "end_logit": -6.648148059844971
        },
        {
            "text": "1",
            "probability": 1.3868474248177953e-09,
            "start_logit": -5.276412010192871,
            "end_logit": -7.065996170043945
        },
        {
            "text": "-",
            "probability": 2.431847916135054e-10,
            "start_logit": -5.760768890380859,
            "end_logit": -8.322606086730957
        }
    ],
    "550e828c71445a662f000002_020": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.9980346030967444,
            "start_logit": 6.041831970214844,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2.",
            "probability": 0.0009718581938357198,
            "start_logit": 2.6036458015441895,
            "end_logit": 1.3767414093017578
        },
        {
            "text": "IL",
            "probability": 0.0006345127628622436,
            "start_logit": 6.041831970214844,
            "end_logit": -2.487797260284424
        },
        {
            "text": "\u03b2",
            "probability": 0.000306051053402799,
            "start_logit": -2.047959327697754,
            "end_logit": 4.872888565063477
        },
        {
            "text": "1\u03b2",
            "probability": 2.4705276698032384e-05,
            "start_logit": -4.564694404602051,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 monoclonal antibodies. Canakinumab is known to neutralize IL-1\u03b2",
            "probability": 1.5083112604702053e-05,
            "start_logit": 6.041831970214844,
            "end_logit": -6.227078914642334
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific IL-1\u03b2",
            "probability": 1.295026337787918e-05,
            "start_logit": -5.21059513092041,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 and complex formation results in a minor reduction of binding affinity to IL-1RI.",
            "probability": 1.520413023032978e-07,
            "start_logit": 1.5449591875076294,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2",
            "probability": 2.78363110507252e-08,
            "start_logit": -7.369847774505615,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 pathway attenuation.",
            "probability": 2.316684817943206e-08,
            "start_logit": 1.5093516111373901,
            "end_logit": -8.17320728302002
        },
        {
            "text": "mechanisms of IL-1\u03b2",
            "probability": 1.7250505233567937e-08,
            "start_logit": -7.8483476638793945,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 bioactivity by reducing the affinity for its IL-1RI:IL-1RAcP signaling complex. How IL-1\u03b2",
            "probability": 8.085163537443894e-09,
            "start_logit": -3.730628252029419,
            "end_logit": -3.9859189987182617
        },
        {
            "text": "IL-1\u03b2 and provide insight into the mechanisms leading to their distinct modulation of IL-1\u03b2",
            "probability": 4.222132492791675e-09,
            "start_logit": -4.987427234649658,
            "end_logit": -3.378810405731201
        },
        {
            "text": "(IL-1\u03b2)",
            "probability": 3.2333675887242945e-09,
            "start_logit": -3.9696526527404785,
            "end_logit": -4.663401126861572
        },
        {
            "text": "-",
            "probability": 1.2529184219969058e-10,
            "start_logit": -4.243311405181885,
            "end_logit": -7.640376091003418
        },
        {
            "text": "1",
            "probability": 1.123992267636175e-10,
            "start_logit": -4.564694404602051,
            "end_logit": -7.427581787109375
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific",
            "probability": 1.0506586731518156e-10,
            "start_logit": -5.21059513092041,
            "end_logit": -6.849150657653809
        },
        {
            "text": "IL-1\u03b2 and its receptor. In contrast, gevokizumab occupies an allosteric site on IL-1\u03b2",
            "probability": 3.842876576209135e-11,
            "start_logit": -6.998785495758057,
            "end_logit": -6.066741466522217
        },
        {
            "text": "IL-1RI.",
            "probability": 2.043196378009984e-11,
            "start_logit": -7.369847774505615,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2 pathway attenuation.",
            "probability": 3.2261135978200603e-12,
            "start_logit": -7.369847774505615,
            "end_logit": -8.17320728302002
        }
    ],
    "550e828c71445a662f000002_021": [
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.999810384173108,
            "start_logit": 9.046475410461426,
            "end_logit": 7.935140609741211
        },
        {
            "text": "IL",
            "probability": 0.00014412808238895648,
            "start_logit": 9.046475410461426,
            "end_logit": -0.909477949142456
        },
        {
            "text": "\u03b2",
            "probability": 4.41481332127902e-05,
            "start_logit": -0.9812948703765869,
            "end_logit": 7.935140609741211
        },
        {
            "text": "1\u03b2",
            "probability": 1.0264055288251085e-06,
            "start_logit": -4.7427825927734375,
            "end_logit": 7.935140609741211
        },
        {
            "text": "anti-IL-1\u03b2 antibody.",
            "probability": 1.9712981091608907e-07,
            "start_logit": 9.046475410461426,
            "end_logit": -7.504073143005371
        },
        {
            "text": "monoclonal anti-IL-1\u03b2",
            "probability": 1.154544355150432e-07,
            "start_logit": -6.927724838256836,
            "end_logit": 7.935140609741211
        },
        {
            "text": "anti-IL-1\u03b2 antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.",
            "probability": 5.824677444790159e-10,
            "start_logit": -0.9812948703765869,
            "end_logit": -3.3006467819213867
        },
        {
            "text": "AND",
            "probability": 2.7530303782832534e-11,
            "start_logit": 0.08187484741210938,
            "end_logit": -7.415802955627441
        },
        {
            "text": "Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes.",
            "probability": 4.595193317976736e-12,
            "start_logit": -6.0695929527282715,
            "end_logit": -3.0546116828918457
        },
        {
            "text": "antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.",
            "probability": 2.9468741071621925e-12,
            "start_logit": -6.267823696136475,
            "end_logit": -3.3006467819213867
        },
        {
            "text": "type 2 diabetes.",
            "probability": 2.827879619897343e-12,
            "start_logit": -6.555076599121094,
            "end_logit": -3.0546116828918457
        },
        {
            "text": "1",
            "probability": 2.454200707724353e-13,
            "start_logit": -4.7427825927734375,
            "end_logit": -7.311216831207275
        },
        {
            "text": "-",
            "probability": 2.0503434101079503e-13,
            "start_logit": -4.711770534515381,
            "end_logit": -7.522022724151611
        },
        {
            "text": "RESEARCH DESIGN AND",
            "probability": 1.4820484169280344e-13,
            "start_logit": -5.142572402954102,
            "end_logit": -7.415802955627441
        },
        {
            "text": "DESIGN AND",
            "probability": 1.2486003685213467e-13,
            "start_logit": -5.313974380493164,
            "end_logit": -7.415802955627441
        },
        {
            "text": "RESEARCH DESIGN",
            "probability": 9.940522571250098e-14,
            "start_logit": -5.142572402954102,
            "end_logit": -7.8151936531066895
        },
        {
            "text": "Effects of gevokizumab on glycemia and inflammatory",
            "probability": 9.443171488162673e-14,
            "start_logit": -6.0695929527282715,
            "end_logit": -6.93950080871582
        },
        {
            "text": "DESIGN",
            "probability": 8.374719748687085e-14,
            "start_logit": -5.313974380493164,
            "end_logit": -7.8151936531066895
        },
        {
            "text": "diabetes.",
            "probability": 7.44253401974134e-14,
            "start_logit": -7.815128803253174,
            "end_logit": -5.4320454597473145
        },
        {
            "text": "RESEARCH",
            "probability": 7.14067036633162e-14,
            "start_logit": -5.142572402954102,
            "end_logit": -8.14600658416748
        }
    ],
    "550e828c71445a662f000002_022": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.2629777554549041,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.25663923917848885,
            "start_logit": 3.777345895767212,
            "end_logit": 2.9163947105407715
        },
        {
            "text": "anti-IL-1\u03b2 antibody being developed as a treatment for diseases in which IL-1\u03b2",
            "probability": 0.25366883555982117,
            "start_logit": 3.7768397331237793,
            "end_logit": 2.905259132385254
        },
        {
            "text": "IL-1\u03b2 has been associated with pathogenesis. Previous data indicated that gevokizumab negatively modulates IL-1\u03b2",
            "probability": 0.21605224888340385,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.708709955215454
        },
        {
            "text": "IL-1\u03b2-associated",
            "probability": 0.00590475319517464,
            "start_logit": 2.0655345916748047,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated",
            "probability": 0.0041504387868180215,
            "start_logit": 1.7129909992218018,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL",
            "probability": 0.00030767422818982643,
            "start_logit": 3.8128795623779297,
            "end_logit": -3.8455240726470947
        },
        {
            "text": "\u03b2",
            "probability": 0.00020221637295492645,
            "start_logit": -3.357606887817383,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2 (IL-1\u03b2)",
            "probability": 3.5798537175930336e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -5.961124897003174
        },
        {
            "text": "the IL-1\u03b2",
            "probability": 2.1988117817794837e-05,
            "start_logit": -4.856156826019287,
            "end_logit": 2.1849730014801025
        },
        {
            "text": "1\u03b2",
            "probability": 1.7189287808193626e-05,
            "start_logit": -5.276412010192871,
            "end_logit": 2.3590123653411865
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2",
            "probability": 1.6324037664221763e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -6.746393203735352
        },
        {
            "text": "IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 3.2513573803171887e-06,
            "start_logit": 2.0655345916748047,
            "end_logit": -6.648148059844971
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 2.28537236613094e-06,
            "start_logit": 1.7129909992218018,
            "end_logit": -6.648148059844971
        },
        {
            "text": "1",
            "probability": 1.3868474248177953e-09,
            "start_logit": -5.276412010192871,
            "end_logit": -7.065996170043945
        },
        {
            "text": "-",
            "probability": 2.431847916135054e-10,
            "start_logit": -5.760768890380859,
            "end_logit": -8.322606086730957
        }
    ],
    "550e828c71445a662f000002_023": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.2629777554549041,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.25663923917848885,
            "start_logit": 3.777345895767212,
            "end_logit": 2.9163947105407715
        },
        {
            "text": "anti-IL-1\u03b2 antibody being developed as a treatment for diseases in which IL-1\u03b2",
            "probability": 0.25366883555982117,
            "start_logit": 3.7768397331237793,
            "end_logit": 2.905259132385254
        },
        {
            "text": "IL-1\u03b2 has been associated with pathogenesis. Previous data indicated that gevokizumab negatively modulates IL-1\u03b2",
            "probability": 0.21605224888340385,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.708709955215454
        },
        {
            "text": "IL-1\u03b2-associated",
            "probability": 0.00590475319517464,
            "start_logit": 2.0655345916748047,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated",
            "probability": 0.0041504387868180215,
            "start_logit": 1.7129909992218018,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL",
            "probability": 0.00030767422818982643,
            "start_logit": 3.8128795623779297,
            "end_logit": -3.8455240726470947
        },
        {
            "text": "\u03b2",
            "probability": 0.00020221637295492645,
            "start_logit": -3.357606887817383,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2 (IL-1\u03b2)",
            "probability": 3.5798537175930336e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -5.961124897003174
        },
        {
            "text": "the IL-1\u03b2",
            "probability": 2.1988117817794837e-05,
            "start_logit": -4.856156826019287,
            "end_logit": 2.1849730014801025
        },
        {
            "text": "1\u03b2",
            "probability": 1.7189287808193626e-05,
            "start_logit": -5.276412010192871,
            "end_logit": 2.3590123653411865
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2",
            "probability": 1.6324037664221763e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -6.746393203735352
        },
        {
            "text": "IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 3.2513573803171887e-06,
            "start_logit": 2.0655345916748047,
            "end_logit": -6.648148059844971
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 2.28537236613094e-06,
            "start_logit": 1.7129909992218018,
            "end_logit": -6.648148059844971
        },
        {
            "text": "1",
            "probability": 1.3868474248177953e-09,
            "start_logit": -5.276412010192871,
            "end_logit": -7.065996170043945
        },
        {
            "text": "-",
            "probability": 2.431847916135054e-10,
            "start_logit": -5.760768890380859,
            "end_logit": -8.322606086730957
        }
    ],
    "550e828c71445a662f000002_024": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.9980346030967444,
            "start_logit": 6.041831970214844,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2.",
            "probability": 0.0009718581938357198,
            "start_logit": 2.6036458015441895,
            "end_logit": 1.3767414093017578
        },
        {
            "text": "IL",
            "probability": 0.0006345127628622436,
            "start_logit": 6.041831970214844,
            "end_logit": -2.487797260284424
        },
        {
            "text": "\u03b2",
            "probability": 0.000306051053402799,
            "start_logit": -2.047959327697754,
            "end_logit": 4.872888565063477
        },
        {
            "text": "1\u03b2",
            "probability": 2.4705276698032384e-05,
            "start_logit": -4.564694404602051,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 monoclonal antibodies. Canakinumab is known to neutralize IL-1\u03b2",
            "probability": 1.5083112604702053e-05,
            "start_logit": 6.041831970214844,
            "end_logit": -6.227078914642334
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific IL-1\u03b2",
            "probability": 1.295026337787918e-05,
            "start_logit": -5.21059513092041,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 and complex formation results in a minor reduction of binding affinity to IL-1RI.",
            "probability": 1.520413023032978e-07,
            "start_logit": 1.5449591875076294,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2",
            "probability": 2.78363110507252e-08,
            "start_logit": -7.369847774505615,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 pathway attenuation.",
            "probability": 2.316684817943206e-08,
            "start_logit": 1.5093516111373901,
            "end_logit": -8.17320728302002
        },
        {
            "text": "mechanisms of IL-1\u03b2",
            "probability": 1.7250505233567937e-08,
            "start_logit": -7.8483476638793945,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 bioactivity by reducing the affinity for its IL-1RI:IL-1RAcP signaling complex. How IL-1\u03b2",
            "probability": 8.085163537443894e-09,
            "start_logit": -3.730628252029419,
            "end_logit": -3.9859189987182617
        },
        {
            "text": "IL-1\u03b2 and provide insight into the mechanisms leading to their distinct modulation of IL-1\u03b2",
            "probability": 4.222132492791675e-09,
            "start_logit": -4.987427234649658,
            "end_logit": -3.378810405731201
        },
        {
            "text": "(IL-1\u03b2)",
            "probability": 3.2333675887242945e-09,
            "start_logit": -3.9696526527404785,
            "end_logit": -4.663401126861572
        },
        {
            "text": "-",
            "probability": 1.2529184219969058e-10,
            "start_logit": -4.243311405181885,
            "end_logit": -7.640376091003418
        },
        {
            "text": "1",
            "probability": 1.123992267636175e-10,
            "start_logit": -4.564694404602051,
            "end_logit": -7.427581787109375
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific",
            "probability": 1.0506586731518156e-10,
            "start_logit": -5.21059513092041,
            "end_logit": -6.849150657653809
        },
        {
            "text": "IL-1\u03b2 and its receptor. In contrast, gevokizumab occupies an allosteric site on IL-1\u03b2",
            "probability": 3.842876576209135e-11,
            "start_logit": -6.998785495758057,
            "end_logit": -6.066741466522217
        },
        {
            "text": "IL-1RI.",
            "probability": 2.043196378009984e-11,
            "start_logit": -7.369847774505615,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2 pathway attenuation.",
            "probability": 3.2261135978200603e-12,
            "start_logit": -7.369847774505615,
            "end_logit": -8.17320728302002
        }
    ],
    "550e828c71445a662f000002_025": [
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.999810384173108,
            "start_logit": 9.046475410461426,
            "end_logit": 7.935140609741211
        },
        {
            "text": "IL",
            "probability": 0.00014412808238895648,
            "start_logit": 9.046475410461426,
            "end_logit": -0.909477949142456
        },
        {
            "text": "\u03b2",
            "probability": 4.41481332127902e-05,
            "start_logit": -0.9812948703765869,
            "end_logit": 7.935140609741211
        },
        {
            "text": "1\u03b2",
            "probability": 1.0264055288251085e-06,
            "start_logit": -4.7427825927734375,
            "end_logit": 7.935140609741211
        },
        {
            "text": "anti-IL-1\u03b2 antibody.",
            "probability": 1.9712981091608907e-07,
            "start_logit": 9.046475410461426,
            "end_logit": -7.504073143005371
        },
        {
            "text": "monoclonal anti-IL-1\u03b2",
            "probability": 1.154544355150432e-07,
            "start_logit": -6.927724838256836,
            "end_logit": 7.935140609741211
        },
        {
            "text": "anti-IL-1\u03b2 antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.",
            "probability": 5.824677444790159e-10,
            "start_logit": -0.9812948703765869,
            "end_logit": -3.3006467819213867
        },
        {
            "text": "AND",
            "probability": 2.7530303782832534e-11,
            "start_logit": 0.08187484741210938,
            "end_logit": -7.415802955627441
        },
        {
            "text": "Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes.",
            "probability": 4.595193317976736e-12,
            "start_logit": -6.0695929527282715,
            "end_logit": -3.0546116828918457
        },
        {
            "text": "antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.",
            "probability": 2.9468741071621925e-12,
            "start_logit": -6.267823696136475,
            "end_logit": -3.3006467819213867
        },
        {
            "text": "type 2 diabetes.",
            "probability": 2.827879619897343e-12,
            "start_logit": -6.555076599121094,
            "end_logit": -3.0546116828918457
        },
        {
            "text": "1",
            "probability": 2.454200707724353e-13,
            "start_logit": -4.7427825927734375,
            "end_logit": -7.311216831207275
        },
        {
            "text": "-",
            "probability": 2.0503434101079503e-13,
            "start_logit": -4.711770534515381,
            "end_logit": -7.522022724151611
        },
        {
            "text": "RESEARCH DESIGN AND",
            "probability": 1.4820484169280344e-13,
            "start_logit": -5.142572402954102,
            "end_logit": -7.415802955627441
        },
        {
            "text": "DESIGN AND",
            "probability": 1.2486003685213467e-13,
            "start_logit": -5.313974380493164,
            "end_logit": -7.415802955627441
        },
        {
            "text": "RESEARCH DESIGN",
            "probability": 9.940522571250098e-14,
            "start_logit": -5.142572402954102,
            "end_logit": -7.8151936531066895
        },
        {
            "text": "Effects of gevokizumab on glycemia and inflammatory",
            "probability": 9.443171488162673e-14,
            "start_logit": -6.0695929527282715,
            "end_logit": -6.93950080871582
        },
        {
            "text": "DESIGN",
            "probability": 8.374719748687085e-14,
            "start_logit": -5.313974380493164,
            "end_logit": -7.8151936531066895
        },
        {
            "text": "diabetes.",
            "probability": 7.44253401974134e-14,
            "start_logit": -7.815128803253174,
            "end_logit": -5.4320454597473145
        },
        {
            "text": "RESEARCH",
            "probability": 7.14067036633162e-14,
            "start_logit": -5.142572402954102,
            "end_logit": -8.14600658416748
        }
    ],
    "550e828c71445a662f000002_026": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.2629777554549041,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.25663923917848885,
            "start_logit": 3.777345895767212,
            "end_logit": 2.9163947105407715
        },
        {
            "text": "anti-IL-1\u03b2 antibody being developed as a treatment for diseases in which IL-1\u03b2",
            "probability": 0.25366883555982117,
            "start_logit": 3.7768397331237793,
            "end_logit": 2.905259132385254
        },
        {
            "text": "IL-1\u03b2 has been associated with pathogenesis. Previous data indicated that gevokizumab negatively modulates IL-1\u03b2",
            "probability": 0.21605224888340385,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.708709955215454
        },
        {
            "text": "IL-1\u03b2-associated",
            "probability": 0.00590475319517464,
            "start_logit": 2.0655345916748047,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated",
            "probability": 0.0041504387868180215,
            "start_logit": 1.7129909992218018,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL",
            "probability": 0.00030767422818982643,
            "start_logit": 3.8128795623779297,
            "end_logit": -3.8455240726470947
        },
        {
            "text": "\u03b2",
            "probability": 0.00020221637295492645,
            "start_logit": -3.357606887817383,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2 (IL-1\u03b2)",
            "probability": 3.5798537175930336e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -5.961124897003174
        },
        {
            "text": "the IL-1\u03b2",
            "probability": 2.1988117817794837e-05,
            "start_logit": -4.856156826019287,
            "end_logit": 2.1849730014801025
        },
        {
            "text": "1\u03b2",
            "probability": 1.7189287808193626e-05,
            "start_logit": -5.276412010192871,
            "end_logit": 2.3590123653411865
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2",
            "probability": 1.6324037664221763e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -6.746393203735352
        },
        {
            "text": "IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 3.2513573803171887e-06,
            "start_logit": 2.0655345916748047,
            "end_logit": -6.648148059844971
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 2.28537236613094e-06,
            "start_logit": 1.7129909992218018,
            "end_logit": -6.648148059844971
        },
        {
            "text": "1",
            "probability": 1.3868474248177953e-09,
            "start_logit": -5.276412010192871,
            "end_logit": -7.065996170043945
        },
        {
            "text": "-",
            "probability": 2.431847916135054e-10,
            "start_logit": -5.760768890380859,
            "end_logit": -8.322606086730957
        }
    ],
    "550e828c71445a662f000002_027": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.2629777554549041,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.25663923917848885,
            "start_logit": 3.777345895767212,
            "end_logit": 2.9163947105407715
        },
        {
            "text": "anti-IL-1\u03b2 antibody being developed as a treatment for diseases in which IL-1\u03b2",
            "probability": 0.25366883555982117,
            "start_logit": 3.7768397331237793,
            "end_logit": 2.905259132385254
        },
        {
            "text": "IL-1\u03b2 has been associated with pathogenesis. Previous data indicated that gevokizumab negatively modulates IL-1\u03b2",
            "probability": 0.21605224888340385,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.708709955215454
        },
        {
            "text": "IL-1\u03b2-associated",
            "probability": 0.00590475319517464,
            "start_logit": 2.0655345916748047,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated",
            "probability": 0.0041504387868180215,
            "start_logit": 1.7129909992218018,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL",
            "probability": 0.00030767422818982643,
            "start_logit": 3.8128795623779297,
            "end_logit": -3.8455240726470947
        },
        {
            "text": "\u03b2",
            "probability": 0.00020221637295492645,
            "start_logit": -3.357606887817383,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2 (IL-1\u03b2)",
            "probability": 3.5798537175930336e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -5.961124897003174
        },
        {
            "text": "the IL-1\u03b2",
            "probability": 2.1988117817794837e-05,
            "start_logit": -4.856156826019287,
            "end_logit": 2.1849730014801025
        },
        {
            "text": "1\u03b2",
            "probability": 1.7189287808193626e-05,
            "start_logit": -5.276412010192871,
            "end_logit": 2.3590123653411865
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2",
            "probability": 1.6324037664221763e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -6.746393203735352
        },
        {
            "text": "IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 3.2513573803171887e-06,
            "start_logit": 2.0655345916748047,
            "end_logit": -6.648148059844971
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 2.28537236613094e-06,
            "start_logit": 1.7129909992218018,
            "end_logit": -6.648148059844971
        },
        {
            "text": "1",
            "probability": 1.3868474248177953e-09,
            "start_logit": -5.276412010192871,
            "end_logit": -7.065996170043945
        },
        {
            "text": "-",
            "probability": 2.431847916135054e-10,
            "start_logit": -5.760768890380859,
            "end_logit": -8.322606086730957
        }
    ],
    "550e828c71445a662f000002_028": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.9980346030967444,
            "start_logit": 6.041831970214844,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2.",
            "probability": 0.0009718581938357198,
            "start_logit": 2.6036458015441895,
            "end_logit": 1.3767414093017578
        },
        {
            "text": "IL",
            "probability": 0.0006345127628622436,
            "start_logit": 6.041831970214844,
            "end_logit": -2.487797260284424
        },
        {
            "text": "\u03b2",
            "probability": 0.000306051053402799,
            "start_logit": -2.047959327697754,
            "end_logit": 4.872888565063477
        },
        {
            "text": "1\u03b2",
            "probability": 2.4705276698032384e-05,
            "start_logit": -4.564694404602051,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 monoclonal antibodies. Canakinumab is known to neutralize IL-1\u03b2",
            "probability": 1.5083112604702053e-05,
            "start_logit": 6.041831970214844,
            "end_logit": -6.227078914642334
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific IL-1\u03b2",
            "probability": 1.295026337787918e-05,
            "start_logit": -5.21059513092041,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 and complex formation results in a minor reduction of binding affinity to IL-1RI.",
            "probability": 1.520413023032978e-07,
            "start_logit": 1.5449591875076294,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2",
            "probability": 2.78363110507252e-08,
            "start_logit": -7.369847774505615,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 pathway attenuation.",
            "probability": 2.316684817943206e-08,
            "start_logit": 1.5093516111373901,
            "end_logit": -8.17320728302002
        },
        {
            "text": "mechanisms of IL-1\u03b2",
            "probability": 1.7250505233567937e-08,
            "start_logit": -7.8483476638793945,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 bioactivity by reducing the affinity for its IL-1RI:IL-1RAcP signaling complex. How IL-1\u03b2",
            "probability": 8.085163537443894e-09,
            "start_logit": -3.730628252029419,
            "end_logit": -3.9859189987182617
        },
        {
            "text": "IL-1\u03b2 and provide insight into the mechanisms leading to their distinct modulation of IL-1\u03b2",
            "probability": 4.222132492791675e-09,
            "start_logit": -4.987427234649658,
            "end_logit": -3.378810405731201
        },
        {
            "text": "(IL-1\u03b2)",
            "probability": 3.2333675887242945e-09,
            "start_logit": -3.9696526527404785,
            "end_logit": -4.663401126861572
        },
        {
            "text": "-",
            "probability": 1.2529184219969058e-10,
            "start_logit": -4.243311405181885,
            "end_logit": -7.640376091003418
        },
        {
            "text": "1",
            "probability": 1.123992267636175e-10,
            "start_logit": -4.564694404602051,
            "end_logit": -7.427581787109375
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific",
            "probability": 1.0506586731518156e-10,
            "start_logit": -5.21059513092041,
            "end_logit": -6.849150657653809
        },
        {
            "text": "IL-1\u03b2 and its receptor. In contrast, gevokizumab occupies an allosteric site on IL-1\u03b2",
            "probability": 3.842876576209135e-11,
            "start_logit": -6.998785495758057,
            "end_logit": -6.066741466522217
        },
        {
            "text": "IL-1RI.",
            "probability": 2.043196378009984e-11,
            "start_logit": -7.369847774505615,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2 pathway attenuation.",
            "probability": 3.2261135978200603e-12,
            "start_logit": -7.369847774505615,
            "end_logit": -8.17320728302002
        }
    ],
    "550e828c71445a662f000002_029": [
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.999810384173108,
            "start_logit": 9.046475410461426,
            "end_logit": 7.935140609741211
        },
        {
            "text": "IL",
            "probability": 0.00014412808238895648,
            "start_logit": 9.046475410461426,
            "end_logit": -0.909477949142456
        },
        {
            "text": "\u03b2",
            "probability": 4.41481332127902e-05,
            "start_logit": -0.9812948703765869,
            "end_logit": 7.935140609741211
        },
        {
            "text": "1\u03b2",
            "probability": 1.0264055288251085e-06,
            "start_logit": -4.7427825927734375,
            "end_logit": 7.935140609741211
        },
        {
            "text": "anti-IL-1\u03b2 antibody.",
            "probability": 1.9712981091608907e-07,
            "start_logit": 9.046475410461426,
            "end_logit": -7.504073143005371
        },
        {
            "text": "monoclonal anti-IL-1\u03b2",
            "probability": 1.154544355150432e-07,
            "start_logit": -6.927724838256836,
            "end_logit": 7.935140609741211
        },
        {
            "text": "anti-IL-1\u03b2 antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.",
            "probability": 5.824677444790159e-10,
            "start_logit": -0.9812948703765869,
            "end_logit": -3.3006467819213867
        },
        {
            "text": "AND",
            "probability": 2.7530303782832534e-11,
            "start_logit": 0.08187484741210938,
            "end_logit": -7.415802955627441
        },
        {
            "text": "Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes.",
            "probability": 4.595193317976736e-12,
            "start_logit": -6.0695929527282715,
            "end_logit": -3.0546116828918457
        },
        {
            "text": "antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.",
            "probability": 2.9468741071621925e-12,
            "start_logit": -6.267823696136475,
            "end_logit": -3.3006467819213867
        },
        {
            "text": "type 2 diabetes.",
            "probability": 2.827879619897343e-12,
            "start_logit": -6.555076599121094,
            "end_logit": -3.0546116828918457
        },
        {
            "text": "1",
            "probability": 2.454200707724353e-13,
            "start_logit": -4.7427825927734375,
            "end_logit": -7.311216831207275
        },
        {
            "text": "-",
            "probability": 2.0503434101079503e-13,
            "start_logit": -4.711770534515381,
            "end_logit": -7.522022724151611
        },
        {
            "text": "RESEARCH DESIGN AND",
            "probability": 1.4820484169280344e-13,
            "start_logit": -5.142572402954102,
            "end_logit": -7.415802955627441
        },
        {
            "text": "DESIGN AND",
            "probability": 1.2486003685213467e-13,
            "start_logit": -5.313974380493164,
            "end_logit": -7.415802955627441
        },
        {
            "text": "RESEARCH DESIGN",
            "probability": 9.940522571250098e-14,
            "start_logit": -5.142572402954102,
            "end_logit": -7.8151936531066895
        },
        {
            "text": "Effects of gevokizumab on glycemia and inflammatory",
            "probability": 9.443171488162673e-14,
            "start_logit": -6.0695929527282715,
            "end_logit": -6.93950080871582
        },
        {
            "text": "DESIGN",
            "probability": 8.374719748687085e-14,
            "start_logit": -5.313974380493164,
            "end_logit": -7.8151936531066895
        },
        {
            "text": "diabetes.",
            "probability": 7.44253401974134e-14,
            "start_logit": -7.815128803253174,
            "end_logit": -5.4320454597473145
        },
        {
            "text": "RESEARCH",
            "probability": 7.14067036633162e-14,
            "start_logit": -5.142572402954102,
            "end_logit": -8.14600658416748
        }
    ],
    "550e828c71445a662f000002_030": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.2629777554549041,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.25663923917848885,
            "start_logit": 3.777345895767212,
            "end_logit": 2.9163947105407715
        },
        {
            "text": "anti-IL-1\u03b2 antibody being developed as a treatment for diseases in which IL-1\u03b2",
            "probability": 0.25366883555982117,
            "start_logit": 3.7768397331237793,
            "end_logit": 2.905259132385254
        },
        {
            "text": "IL-1\u03b2 has been associated with pathogenesis. Previous data indicated that gevokizumab negatively modulates IL-1\u03b2",
            "probability": 0.21605224888340385,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.708709955215454
        },
        {
            "text": "IL-1\u03b2-associated",
            "probability": 0.00590475319517464,
            "start_logit": 2.0655345916748047,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated",
            "probability": 0.0041504387868180215,
            "start_logit": 1.7129909992218018,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL",
            "probability": 0.00030767422818982643,
            "start_logit": 3.8128795623779297,
            "end_logit": -3.8455240726470947
        },
        {
            "text": "\u03b2",
            "probability": 0.00020221637295492645,
            "start_logit": -3.357606887817383,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2 (IL-1\u03b2)",
            "probability": 3.5798537175930336e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -5.961124897003174
        },
        {
            "text": "the IL-1\u03b2",
            "probability": 2.1988117817794837e-05,
            "start_logit": -4.856156826019287,
            "end_logit": 2.1849730014801025
        },
        {
            "text": "1\u03b2",
            "probability": 1.7189287808193626e-05,
            "start_logit": -5.276412010192871,
            "end_logit": 2.3590123653411865
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2",
            "probability": 1.6324037664221763e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -6.746393203735352
        },
        {
            "text": "IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 3.2513573803171887e-06,
            "start_logit": 2.0655345916748047,
            "end_logit": -6.648148059844971
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 2.28537236613094e-06,
            "start_logit": 1.7129909992218018,
            "end_logit": -6.648148059844971
        },
        {
            "text": "1",
            "probability": 1.3868474248177953e-09,
            "start_logit": -5.276412010192871,
            "end_logit": -7.065996170043945
        },
        {
            "text": "-",
            "probability": 2.431847916135054e-10,
            "start_logit": -5.760768890380859,
            "end_logit": -8.322606086730957
        }
    ],
    "550e828c71445a662f000002_031": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.2629777554549041,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.25663923917848885,
            "start_logit": 3.777345895767212,
            "end_logit": 2.9163947105407715
        },
        {
            "text": "anti-IL-1\u03b2 antibody being developed as a treatment for diseases in which IL-1\u03b2",
            "probability": 0.25366883555982117,
            "start_logit": 3.7768397331237793,
            "end_logit": 2.905259132385254
        },
        {
            "text": "IL-1\u03b2 has been associated with pathogenesis. Previous data indicated that gevokizumab negatively modulates IL-1\u03b2",
            "probability": 0.21605224888340385,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.708709955215454
        },
        {
            "text": "IL-1\u03b2-associated",
            "probability": 0.00590475319517464,
            "start_logit": 2.0655345916748047,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated",
            "probability": 0.0041504387868180215,
            "start_logit": 1.7129909992218018,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL",
            "probability": 0.00030767422818982643,
            "start_logit": 3.8128795623779297,
            "end_logit": -3.8455240726470947
        },
        {
            "text": "\u03b2",
            "probability": 0.00020221637295492645,
            "start_logit": -3.357606887817383,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2 (IL-1\u03b2)",
            "probability": 3.5798537175930336e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -5.961124897003174
        },
        {
            "text": "the IL-1\u03b2",
            "probability": 2.1988117817794837e-05,
            "start_logit": -4.856156826019287,
            "end_logit": 2.1849730014801025
        },
        {
            "text": "1\u03b2",
            "probability": 1.7189287808193626e-05,
            "start_logit": -5.276412010192871,
            "end_logit": 2.3590123653411865
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2",
            "probability": 1.6324037664221763e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -6.746393203735352
        },
        {
            "text": "IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 3.2513573803171887e-06,
            "start_logit": 2.0655345916748047,
            "end_logit": -6.648148059844971
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 2.28537236613094e-06,
            "start_logit": 1.7129909992218018,
            "end_logit": -6.648148059844971
        },
        {
            "text": "1",
            "probability": 1.3868474248177953e-09,
            "start_logit": -5.276412010192871,
            "end_logit": -7.065996170043945
        },
        {
            "text": "-",
            "probability": 2.431847916135054e-10,
            "start_logit": -5.760768890380859,
            "end_logit": -8.322606086730957
        }
    ],
    "550e828c71445a662f000002_032": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.9980346030967444,
            "start_logit": 6.041831970214844,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2.",
            "probability": 0.0009718581938357198,
            "start_logit": 2.6036458015441895,
            "end_logit": 1.3767414093017578
        },
        {
            "text": "IL",
            "probability": 0.0006345127628622436,
            "start_logit": 6.041831970214844,
            "end_logit": -2.487797260284424
        },
        {
            "text": "\u03b2",
            "probability": 0.000306051053402799,
            "start_logit": -2.047959327697754,
            "end_logit": 4.872888565063477
        },
        {
            "text": "1\u03b2",
            "probability": 2.4705276698032384e-05,
            "start_logit": -4.564694404602051,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 monoclonal antibodies. Canakinumab is known to neutralize IL-1\u03b2",
            "probability": 1.5083112604702053e-05,
            "start_logit": 6.041831970214844,
            "end_logit": -6.227078914642334
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific IL-1\u03b2",
            "probability": 1.295026337787918e-05,
            "start_logit": -5.21059513092041,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 and complex formation results in a minor reduction of binding affinity to IL-1RI.",
            "probability": 1.520413023032978e-07,
            "start_logit": 1.5449591875076294,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2",
            "probability": 2.78363110507252e-08,
            "start_logit": -7.369847774505615,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 pathway attenuation.",
            "probability": 2.316684817943206e-08,
            "start_logit": 1.5093516111373901,
            "end_logit": -8.17320728302002
        },
        {
            "text": "mechanisms of IL-1\u03b2",
            "probability": 1.7250505233567937e-08,
            "start_logit": -7.8483476638793945,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 bioactivity by reducing the affinity for its IL-1RI:IL-1RAcP signaling complex. How IL-1\u03b2",
            "probability": 8.085163537443894e-09,
            "start_logit": -3.730628252029419,
            "end_logit": -3.9859189987182617
        },
        {
            "text": "IL-1\u03b2 and provide insight into the mechanisms leading to their distinct modulation of IL-1\u03b2",
            "probability": 4.222132492791675e-09,
            "start_logit": -4.987427234649658,
            "end_logit": -3.378810405731201
        },
        {
            "text": "(IL-1\u03b2)",
            "probability": 3.2333675887242945e-09,
            "start_logit": -3.9696526527404785,
            "end_logit": -4.663401126861572
        },
        {
            "text": "-",
            "probability": 1.2529184219969058e-10,
            "start_logit": -4.243311405181885,
            "end_logit": -7.640376091003418
        },
        {
            "text": "1",
            "probability": 1.123992267636175e-10,
            "start_logit": -4.564694404602051,
            "end_logit": -7.427581787109375
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific",
            "probability": 1.0506586731518156e-10,
            "start_logit": -5.21059513092041,
            "end_logit": -6.849150657653809
        },
        {
            "text": "IL-1\u03b2 and its receptor. In contrast, gevokizumab occupies an allosteric site on IL-1\u03b2",
            "probability": 3.842876576209135e-11,
            "start_logit": -6.998785495758057,
            "end_logit": -6.066741466522217
        },
        {
            "text": "IL-1RI.",
            "probability": 2.043196378009984e-11,
            "start_logit": -7.369847774505615,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2 pathway attenuation.",
            "probability": 3.2261135978200603e-12,
            "start_logit": -7.369847774505615,
            "end_logit": -8.17320728302002
        }
    ],
    "550e828c71445a662f000002_033": [
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.999810384173108,
            "start_logit": 9.046475410461426,
            "end_logit": 7.935140609741211
        },
        {
            "text": "IL",
            "probability": 0.00014412808238895648,
            "start_logit": 9.046475410461426,
            "end_logit": -0.909477949142456
        },
        {
            "text": "\u03b2",
            "probability": 4.41481332127902e-05,
            "start_logit": -0.9812948703765869,
            "end_logit": 7.935140609741211
        },
        {
            "text": "1\u03b2",
            "probability": 1.0264055288251085e-06,
            "start_logit": -4.7427825927734375,
            "end_logit": 7.935140609741211
        },
        {
            "text": "anti-IL-1\u03b2 antibody.",
            "probability": 1.9712981091608907e-07,
            "start_logit": 9.046475410461426,
            "end_logit": -7.504073143005371
        },
        {
            "text": "monoclonal anti-IL-1\u03b2",
            "probability": 1.154544355150432e-07,
            "start_logit": -6.927724838256836,
            "end_logit": 7.935140609741211
        },
        {
            "text": "anti-IL-1\u03b2 antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.",
            "probability": 5.824677444790159e-10,
            "start_logit": -0.9812948703765869,
            "end_logit": -3.3006467819213867
        },
        {
            "text": "AND",
            "probability": 2.7530303782832534e-11,
            "start_logit": 0.08187484741210938,
            "end_logit": -7.415802955627441
        },
        {
            "text": "Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes.",
            "probability": 4.595193317976736e-12,
            "start_logit": -6.0695929527282715,
            "end_logit": -3.0546116828918457
        },
        {
            "text": "antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.",
            "probability": 2.9468741071621925e-12,
            "start_logit": -6.267823696136475,
            "end_logit": -3.3006467819213867
        },
        {
            "text": "type 2 diabetes.",
            "probability": 2.827879619897343e-12,
            "start_logit": -6.555076599121094,
            "end_logit": -3.0546116828918457
        },
        {
            "text": "1",
            "probability": 2.454200707724353e-13,
            "start_logit": -4.7427825927734375,
            "end_logit": -7.311216831207275
        },
        {
            "text": "-",
            "probability": 2.0503434101079503e-13,
            "start_logit": -4.711770534515381,
            "end_logit": -7.522022724151611
        },
        {
            "text": "RESEARCH DESIGN AND",
            "probability": 1.4820484169280344e-13,
            "start_logit": -5.142572402954102,
            "end_logit": -7.415802955627441
        },
        {
            "text": "DESIGN AND",
            "probability": 1.2486003685213467e-13,
            "start_logit": -5.313974380493164,
            "end_logit": -7.415802955627441
        },
        {
            "text": "RESEARCH DESIGN",
            "probability": 9.940522571250098e-14,
            "start_logit": -5.142572402954102,
            "end_logit": -7.8151936531066895
        },
        {
            "text": "Effects of gevokizumab on glycemia and inflammatory",
            "probability": 9.443171488162673e-14,
            "start_logit": -6.0695929527282715,
            "end_logit": -6.93950080871582
        },
        {
            "text": "DESIGN",
            "probability": 8.374719748687085e-14,
            "start_logit": -5.313974380493164,
            "end_logit": -7.8151936531066895
        },
        {
            "text": "diabetes.",
            "probability": 7.44253401974134e-14,
            "start_logit": -7.815128803253174,
            "end_logit": -5.4320454597473145
        },
        {
            "text": "RESEARCH",
            "probability": 7.14067036633162e-14,
            "start_logit": -5.142572402954102,
            "end_logit": -8.14600658416748
        }
    ],
    "550e828c71445a662f000002_034": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.2629777554549041,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.25663923917848885,
            "start_logit": 3.777345895767212,
            "end_logit": 2.9163947105407715
        },
        {
            "text": "anti-IL-1\u03b2 antibody being developed as a treatment for diseases in which IL-1\u03b2",
            "probability": 0.25366883555982117,
            "start_logit": 3.7768397331237793,
            "end_logit": 2.905259132385254
        },
        {
            "text": "IL-1\u03b2 has been associated with pathogenesis. Previous data indicated that gevokizumab negatively modulates IL-1\u03b2",
            "probability": 0.21605224888340385,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.708709955215454
        },
        {
            "text": "IL-1\u03b2-associated",
            "probability": 0.00590475319517464,
            "start_logit": 2.0655345916748047,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated",
            "probability": 0.0041504387868180215,
            "start_logit": 1.7129909992218018,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL",
            "probability": 0.00030767422818982643,
            "start_logit": 3.8128795623779297,
            "end_logit": -3.8455240726470947
        },
        {
            "text": "\u03b2",
            "probability": 0.00020221637295492645,
            "start_logit": -3.357606887817383,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2 (IL-1\u03b2)",
            "probability": 3.5798537175930336e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -5.961124897003174
        },
        {
            "text": "the IL-1\u03b2",
            "probability": 2.1988117817794837e-05,
            "start_logit": -4.856156826019287,
            "end_logit": 2.1849730014801025
        },
        {
            "text": "1\u03b2",
            "probability": 1.7189287808193626e-05,
            "start_logit": -5.276412010192871,
            "end_logit": 2.3590123653411865
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2",
            "probability": 1.6324037664221763e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -6.746393203735352
        },
        {
            "text": "IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 3.2513573803171887e-06,
            "start_logit": 2.0655345916748047,
            "end_logit": -6.648148059844971
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 2.28537236613094e-06,
            "start_logit": 1.7129909992218018,
            "end_logit": -6.648148059844971
        },
        {
            "text": "1",
            "probability": 1.3868474248177953e-09,
            "start_logit": -5.276412010192871,
            "end_logit": -7.065996170043945
        },
        {
            "text": "-",
            "probability": 2.431847916135054e-10,
            "start_logit": -5.760768890380859,
            "end_logit": -8.322606086730957
        }
    ],
    "550e828c71445a662f000002_035": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.2629777554549041,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.25663923917848885,
            "start_logit": 3.777345895767212,
            "end_logit": 2.9163947105407715
        },
        {
            "text": "anti-IL-1\u03b2 antibody being developed as a treatment for diseases in which IL-1\u03b2",
            "probability": 0.25366883555982117,
            "start_logit": 3.7768397331237793,
            "end_logit": 2.905259132385254
        },
        {
            "text": "IL-1\u03b2 has been associated with pathogenesis. Previous data indicated that gevokizumab negatively modulates IL-1\u03b2",
            "probability": 0.21605224888340385,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.708709955215454
        },
        {
            "text": "IL-1\u03b2-associated",
            "probability": 0.00590475319517464,
            "start_logit": 2.0655345916748047,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated",
            "probability": 0.0041504387868180215,
            "start_logit": 1.7129909992218018,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL",
            "probability": 0.00030767422818982643,
            "start_logit": 3.8128795623779297,
            "end_logit": -3.8455240726470947
        },
        {
            "text": "\u03b2",
            "probability": 0.00020221637295492645,
            "start_logit": -3.357606887817383,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2 (IL-1\u03b2)",
            "probability": 3.5798537175930336e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -5.961124897003174
        },
        {
            "text": "the IL-1\u03b2",
            "probability": 2.1988117817794837e-05,
            "start_logit": -4.856156826019287,
            "end_logit": 2.1849730014801025
        },
        {
            "text": "1\u03b2",
            "probability": 1.7189287808193626e-05,
            "start_logit": -5.276412010192871,
            "end_logit": 2.3590123653411865
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2",
            "probability": 1.6324037664221763e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -6.746393203735352
        },
        {
            "text": "IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 3.2513573803171887e-06,
            "start_logit": 2.0655345916748047,
            "end_logit": -6.648148059844971
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 2.28537236613094e-06,
            "start_logit": 1.7129909992218018,
            "end_logit": -6.648148059844971
        },
        {
            "text": "1",
            "probability": 1.3868474248177953e-09,
            "start_logit": -5.276412010192871,
            "end_logit": -7.065996170043945
        },
        {
            "text": "-",
            "probability": 2.431847916135054e-10,
            "start_logit": -5.760768890380859,
            "end_logit": -8.322606086730957
        }
    ],
    "550e828c71445a662f000002_036": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.2629777554549041,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.25663923917848885,
            "start_logit": 3.777345895767212,
            "end_logit": 2.9163947105407715
        },
        {
            "text": "anti-IL-1\u03b2 antibody being developed as a treatment for diseases in which IL-1\u03b2",
            "probability": 0.25366883555982117,
            "start_logit": 3.7768397331237793,
            "end_logit": 2.905259132385254
        },
        {
            "text": "IL-1\u03b2 has been associated with pathogenesis. Previous data indicated that gevokizumab negatively modulates IL-1\u03b2",
            "probability": 0.21605224888340385,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.708709955215454
        },
        {
            "text": "IL-1\u03b2-associated",
            "probability": 0.00590475319517464,
            "start_logit": 2.0655345916748047,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated",
            "probability": 0.0041504387868180215,
            "start_logit": 1.7129909992218018,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL",
            "probability": 0.00030767422818982643,
            "start_logit": 3.8128795623779297,
            "end_logit": -3.8455240726470947
        },
        {
            "text": "\u03b2",
            "probability": 0.00020221637295492645,
            "start_logit": -3.357606887817383,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2 (IL-1\u03b2)",
            "probability": 3.5798537175930336e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -5.961124897003174
        },
        {
            "text": "the IL-1\u03b2",
            "probability": 2.1988117817794837e-05,
            "start_logit": -4.856156826019287,
            "end_logit": 2.1849730014801025
        },
        {
            "text": "1\u03b2",
            "probability": 1.7189287808193626e-05,
            "start_logit": -5.276412010192871,
            "end_logit": 2.3590123653411865
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2",
            "probability": 1.6324037664221763e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -6.746393203735352
        },
        {
            "text": "IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 3.2513573803171887e-06,
            "start_logit": 2.0655345916748047,
            "end_logit": -6.648148059844971
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 2.28537236613094e-06,
            "start_logit": 1.7129909992218018,
            "end_logit": -6.648148059844971
        },
        {
            "text": "1",
            "probability": 1.3868474248177953e-09,
            "start_logit": -5.276412010192871,
            "end_logit": -7.065996170043945
        },
        {
            "text": "-",
            "probability": 2.431847916135054e-10,
            "start_logit": -5.760768890380859,
            "end_logit": -8.322606086730957
        }
    ],
    "550e828c71445a662f000002_037": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.2629777554549041,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.25663923917848885,
            "start_logit": 3.777345895767212,
            "end_logit": 2.9163947105407715
        },
        {
            "text": "anti-IL-1\u03b2 antibody being developed as a treatment for diseases in which IL-1\u03b2",
            "probability": 0.25366883555982117,
            "start_logit": 3.7768397331237793,
            "end_logit": 2.905259132385254
        },
        {
            "text": "IL-1\u03b2 has been associated with pathogenesis. Previous data indicated that gevokizumab negatively modulates IL-1\u03b2",
            "probability": 0.21605224888340385,
            "start_logit": 3.8128795623779297,
            "end_logit": 2.708709955215454
        },
        {
            "text": "IL-1\u03b2-associated",
            "probability": 0.00590475319517464,
            "start_logit": 2.0655345916748047,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated",
            "probability": 0.0041504387868180215,
            "start_logit": 1.7129909992218018,
            "end_logit": 0.8562923073768616
        },
        {
            "text": "IL",
            "probability": 0.00030767422818982643,
            "start_logit": 3.8128795623779297,
            "end_logit": -3.8455240726470947
        },
        {
            "text": "\u03b2",
            "probability": 0.00020221637295492645,
            "start_logit": -3.357606887817383,
            "end_logit": 2.905259132385254
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2 (IL-1\u03b2)",
            "probability": 3.5798537175930336e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -5.961124897003174
        },
        {
            "text": "the IL-1\u03b2",
            "probability": 2.1988117817794837e-05,
            "start_logit": -4.856156826019287,
            "end_logit": 2.1849730014801025
        },
        {
            "text": "1\u03b2",
            "probability": 1.7189287808193626e-05,
            "start_logit": -5.276412010192871,
            "end_logit": 2.3590123653411865
        },
        {
            "text": "anti-IL-1\u03b2 antibody with differential receptor-modulating properties. Interleukin-1\u03b2",
            "probability": 1.6324037664221763e-05,
            "start_logit": 3.777345895767212,
            "end_logit": -6.746393203735352
        },
        {
            "text": "IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 3.2513573803171887e-06,
            "start_logit": 2.0655345916748047,
            "end_logit": -6.648148059844971
        },
        {
            "text": "IL-1\u03b2 signaling that may offer an alternative to current therapies for IL-1\u03b2-associated autoinflammatory diseases.",
            "probability": 2.28537236613094e-06,
            "start_logit": 1.7129909992218018,
            "end_logit": -6.648148059844971
        },
        {
            "text": "1",
            "probability": 1.3868474248177953e-09,
            "start_logit": -5.276412010192871,
            "end_logit": -7.065996170043945
        },
        {
            "text": "-",
            "probability": 2.431847916135054e-10,
            "start_logit": -5.760768890380859,
            "end_logit": -8.322606086730957
        }
    ],
    "550e828c71445a662f000002_038": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.9980346030967444,
            "start_logit": 6.041831970214844,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2.",
            "probability": 0.0009718581938357198,
            "start_logit": 2.6036458015441895,
            "end_logit": 1.3767414093017578
        },
        {
            "text": "IL",
            "probability": 0.0006345127628622436,
            "start_logit": 6.041831970214844,
            "end_logit": -2.487797260284424
        },
        {
            "text": "\u03b2",
            "probability": 0.000306051053402799,
            "start_logit": -2.047959327697754,
            "end_logit": 4.872888565063477
        },
        {
            "text": "1\u03b2",
            "probability": 2.4705276698032384e-05,
            "start_logit": -4.564694404602051,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 monoclonal antibodies. Canakinumab is known to neutralize IL-1\u03b2",
            "probability": 1.5083112604702053e-05,
            "start_logit": 6.041831970214844,
            "end_logit": -6.227078914642334
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific IL-1\u03b2",
            "probability": 1.295026337787918e-05,
            "start_logit": -5.21059513092041,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 and complex formation results in a minor reduction of binding affinity to IL-1RI.",
            "probability": 1.520413023032978e-07,
            "start_logit": 1.5449591875076294,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2",
            "probability": 2.78363110507252e-08,
            "start_logit": -7.369847774505615,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 pathway attenuation.",
            "probability": 2.316684817943206e-08,
            "start_logit": 1.5093516111373901,
            "end_logit": -8.17320728302002
        },
        {
            "text": "mechanisms of IL-1\u03b2",
            "probability": 1.7250505233567937e-08,
            "start_logit": -7.8483476638793945,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 bioactivity by reducing the affinity for its IL-1RI:IL-1RAcP signaling complex. How IL-1\u03b2",
            "probability": 8.085163537443894e-09,
            "start_logit": -3.730628252029419,
            "end_logit": -3.9859189987182617
        },
        {
            "text": "IL-1\u03b2 and provide insight into the mechanisms leading to their distinct modulation of IL-1\u03b2",
            "probability": 4.222132492791675e-09,
            "start_logit": -4.987427234649658,
            "end_logit": -3.378810405731201
        },
        {
            "text": "(IL-1\u03b2)",
            "probability": 3.2333675887242945e-09,
            "start_logit": -3.9696526527404785,
            "end_logit": -4.663401126861572
        },
        {
            "text": "-",
            "probability": 1.2529184219969058e-10,
            "start_logit": -4.243311405181885,
            "end_logit": -7.640376091003418
        },
        {
            "text": "1",
            "probability": 1.123992267636175e-10,
            "start_logit": -4.564694404602051,
            "end_logit": -7.427581787109375
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific",
            "probability": 1.0506586731518156e-10,
            "start_logit": -5.21059513092041,
            "end_logit": -6.849150657653809
        },
        {
            "text": "IL-1\u03b2 and its receptor. In contrast, gevokizumab occupies an allosteric site on IL-1\u03b2",
            "probability": 3.842876576209135e-11,
            "start_logit": -6.998785495758057,
            "end_logit": -6.066741466522217
        },
        {
            "text": "IL-1RI.",
            "probability": 2.043196378009984e-11,
            "start_logit": -7.369847774505615,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2 pathway attenuation.",
            "probability": 3.2261135978200603e-12,
            "start_logit": -7.369847774505615,
            "end_logit": -8.17320728302002
        }
    ],
    "550e828c71445a662f000002_039": [
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.999810384173108,
            "start_logit": 9.046475410461426,
            "end_logit": 7.935140609741211
        },
        {
            "text": "IL",
            "probability": 0.00014412808238895648,
            "start_logit": 9.046475410461426,
            "end_logit": -0.909477949142456
        },
        {
            "text": "\u03b2",
            "probability": 4.41481332127902e-05,
            "start_logit": -0.9812948703765869,
            "end_logit": 7.935140609741211
        },
        {
            "text": "1\u03b2",
            "probability": 1.0264055288251085e-06,
            "start_logit": -4.7427825927734375,
            "end_logit": 7.935140609741211
        },
        {
            "text": "anti-IL-1\u03b2 antibody.",
            "probability": 1.9712981091608907e-07,
            "start_logit": 9.046475410461426,
            "end_logit": -7.504073143005371
        },
        {
            "text": "monoclonal anti-IL-1\u03b2",
            "probability": 1.154544355150432e-07,
            "start_logit": -6.927724838256836,
            "end_logit": 7.935140609741211
        },
        {
            "text": "anti-IL-1\u03b2 antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.",
            "probability": 5.824677444790159e-10,
            "start_logit": -0.9812948703765869,
            "end_logit": -3.3006467819213867
        },
        {
            "text": "AND",
            "probability": 2.7530303782832534e-11,
            "start_logit": 0.08187484741210938,
            "end_logit": -7.415802955627441
        },
        {
            "text": "Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes.",
            "probability": 4.595193317976736e-12,
            "start_logit": -6.0695929527282715,
            "end_logit": -3.0546116828918457
        },
        {
            "text": "antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.",
            "probability": 2.9468741071621925e-12,
            "start_logit": -6.267823696136475,
            "end_logit": -3.3006467819213867
        },
        {
            "text": "type 2 diabetes.",
            "probability": 2.827879619897343e-12,
            "start_logit": -6.555076599121094,
            "end_logit": -3.0546116828918457
        },
        {
            "text": "1",
            "probability": 2.454200707724353e-13,
            "start_logit": -4.7427825927734375,
            "end_logit": -7.311216831207275
        },
        {
            "text": "-",
            "probability": 2.0503434101079503e-13,
            "start_logit": -4.711770534515381,
            "end_logit": -7.522022724151611
        },
        {
            "text": "RESEARCH DESIGN AND",
            "probability": 1.4820484169280344e-13,
            "start_logit": -5.142572402954102,
            "end_logit": -7.415802955627441
        },
        {
            "text": "DESIGN AND",
            "probability": 1.2486003685213467e-13,
            "start_logit": -5.313974380493164,
            "end_logit": -7.415802955627441
        },
        {
            "text": "RESEARCH DESIGN",
            "probability": 9.940522571250098e-14,
            "start_logit": -5.142572402954102,
            "end_logit": -7.8151936531066895
        },
        {
            "text": "Effects of gevokizumab on glycemia and inflammatory",
            "probability": 9.443171488162673e-14,
            "start_logit": -6.0695929527282715,
            "end_logit": -6.93950080871582
        },
        {
            "text": "DESIGN",
            "probability": 8.374719748687085e-14,
            "start_logit": -5.313974380493164,
            "end_logit": -7.8151936531066895
        },
        {
            "text": "diabetes.",
            "probability": 7.44253401974134e-14,
            "start_logit": -7.815128803253174,
            "end_logit": -5.4320454597473145
        },
        {
            "text": "RESEARCH",
            "probability": 7.14067036633162e-14,
            "start_logit": -5.142572402954102,
            "end_logit": -8.14600658416748
        }
    ],
    "550e828c71445a662f000002_040": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.9980346030967444,
            "start_logit": 6.041831970214844,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2.",
            "probability": 0.0009718581938357198,
            "start_logit": 2.6036458015441895,
            "end_logit": 1.3767414093017578
        },
        {
            "text": "IL",
            "probability": 0.0006345127628622436,
            "start_logit": 6.041831970214844,
            "end_logit": -2.487797260284424
        },
        {
            "text": "\u03b2",
            "probability": 0.000306051053402799,
            "start_logit": -2.047959327697754,
            "end_logit": 4.872888565063477
        },
        {
            "text": "1\u03b2",
            "probability": 2.4705276698032384e-05,
            "start_logit": -4.564694404602051,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 monoclonal antibodies. Canakinumab is known to neutralize IL-1\u03b2",
            "probability": 1.5083112604702053e-05,
            "start_logit": 6.041831970214844,
            "end_logit": -6.227078914642334
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific IL-1\u03b2",
            "probability": 1.295026337787918e-05,
            "start_logit": -5.21059513092041,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 and complex formation results in a minor reduction of binding affinity to IL-1RI.",
            "probability": 1.520413023032978e-07,
            "start_logit": 1.5449591875076294,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2",
            "probability": 2.78363110507252e-08,
            "start_logit": -7.369847774505615,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 pathway attenuation.",
            "probability": 2.316684817943206e-08,
            "start_logit": 1.5093516111373901,
            "end_logit": -8.17320728302002
        },
        {
            "text": "mechanisms of IL-1\u03b2",
            "probability": 1.7250505233567937e-08,
            "start_logit": -7.8483476638793945,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 bioactivity by reducing the affinity for its IL-1RI:IL-1RAcP signaling complex. How IL-1\u03b2",
            "probability": 8.085163537443894e-09,
            "start_logit": -3.730628252029419,
            "end_logit": -3.9859189987182617
        },
        {
            "text": "IL-1\u03b2 and provide insight into the mechanisms leading to their distinct modulation of IL-1\u03b2",
            "probability": 4.222132492791675e-09,
            "start_logit": -4.987427234649658,
            "end_logit": -3.378810405731201
        },
        {
            "text": "(IL-1\u03b2)",
            "probability": 3.2333675887242945e-09,
            "start_logit": -3.9696526527404785,
            "end_logit": -4.663401126861572
        },
        {
            "text": "-",
            "probability": 1.2529184219969058e-10,
            "start_logit": -4.243311405181885,
            "end_logit": -7.640376091003418
        },
        {
            "text": "1",
            "probability": 1.123992267636175e-10,
            "start_logit": -4.564694404602051,
            "end_logit": -7.427581787109375
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific",
            "probability": 1.0506586731518156e-10,
            "start_logit": -5.21059513092041,
            "end_logit": -6.849150657653809
        },
        {
            "text": "IL-1\u03b2 and its receptor. In contrast, gevokizumab occupies an allosteric site on IL-1\u03b2",
            "probability": 3.842876576209135e-11,
            "start_logit": -6.998785495758057,
            "end_logit": -6.066741466522217
        },
        {
            "text": "IL-1RI.",
            "probability": 2.043196378009984e-11,
            "start_logit": -7.369847774505615,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2 pathway attenuation.",
            "probability": 3.2261135978200603e-12,
            "start_logit": -7.369847774505615,
            "end_logit": -8.17320728302002
        }
    ],
    "550e828c71445a662f000002_041": [
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.999810384173108,
            "start_logit": 9.046475410461426,
            "end_logit": 7.935140609741211
        },
        {
            "text": "IL",
            "probability": 0.00014412808238895648,
            "start_logit": 9.046475410461426,
            "end_logit": -0.909477949142456
        },
        {
            "text": "\u03b2",
            "probability": 4.41481332127902e-05,
            "start_logit": -0.9812948703765869,
            "end_logit": 7.935140609741211
        },
        {
            "text": "1\u03b2",
            "probability": 1.0264055288251085e-06,
            "start_logit": -4.7427825927734375,
            "end_logit": 7.935140609741211
        },
        {
            "text": "anti-IL-1\u03b2 antibody.",
            "probability": 1.9712981091608907e-07,
            "start_logit": 9.046475410461426,
            "end_logit": -7.504073143005371
        },
        {
            "text": "monoclonal anti-IL-1\u03b2",
            "probability": 1.154544355150432e-07,
            "start_logit": -6.927724838256836,
            "end_logit": 7.935140609741211
        },
        {
            "text": "anti-IL-1\u03b2 antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.",
            "probability": 5.824677444790159e-10,
            "start_logit": -0.9812948703765869,
            "end_logit": -3.3006467819213867
        },
        {
            "text": "AND",
            "probability": 2.7530303782832534e-11,
            "start_logit": 0.08187484741210938,
            "end_logit": -7.415802955627441
        },
        {
            "text": "Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes.",
            "probability": 4.595193317976736e-12,
            "start_logit": -6.0695929527282715,
            "end_logit": -3.0546116828918457
        },
        {
            "text": "antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.",
            "probability": 2.9468741071621925e-12,
            "start_logit": -6.267823696136475,
            "end_logit": -3.3006467819213867
        },
        {
            "text": "type 2 diabetes.",
            "probability": 2.827879619897343e-12,
            "start_logit": -6.555076599121094,
            "end_logit": -3.0546116828918457
        },
        {
            "text": "1",
            "probability": 2.454200707724353e-13,
            "start_logit": -4.7427825927734375,
            "end_logit": -7.311216831207275
        },
        {
            "text": "-",
            "probability": 2.0503434101079503e-13,
            "start_logit": -4.711770534515381,
            "end_logit": -7.522022724151611
        },
        {
            "text": "RESEARCH DESIGN AND",
            "probability": 1.4820484169280344e-13,
            "start_logit": -5.142572402954102,
            "end_logit": -7.415802955627441
        },
        {
            "text": "DESIGN AND",
            "probability": 1.2486003685213467e-13,
            "start_logit": -5.313974380493164,
            "end_logit": -7.415802955627441
        },
        {
            "text": "RESEARCH DESIGN",
            "probability": 9.940522571250098e-14,
            "start_logit": -5.142572402954102,
            "end_logit": -7.8151936531066895
        },
        {
            "text": "Effects of gevokizumab on glycemia and inflammatory",
            "probability": 9.443171488162673e-14,
            "start_logit": -6.0695929527282715,
            "end_logit": -6.93950080871582
        },
        {
            "text": "DESIGN",
            "probability": 8.374719748687085e-14,
            "start_logit": -5.313974380493164,
            "end_logit": -7.8151936531066895
        },
        {
            "text": "diabetes.",
            "probability": 7.44253401974134e-14,
            "start_logit": -7.815128803253174,
            "end_logit": -5.4320454597473145
        },
        {
            "text": "RESEARCH",
            "probability": 7.14067036633162e-14,
            "start_logit": -5.142572402954102,
            "end_logit": -8.14600658416748
        }
    ],
    "550e828c71445a662f000002_042": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.9980346030967444,
            "start_logit": 6.041831970214844,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2.",
            "probability": 0.0009718581938357198,
            "start_logit": 2.6036458015441895,
            "end_logit": 1.3767414093017578
        },
        {
            "text": "IL",
            "probability": 0.0006345127628622436,
            "start_logit": 6.041831970214844,
            "end_logit": -2.487797260284424
        },
        {
            "text": "\u03b2",
            "probability": 0.000306051053402799,
            "start_logit": -2.047959327697754,
            "end_logit": 4.872888565063477
        },
        {
            "text": "1\u03b2",
            "probability": 2.4705276698032384e-05,
            "start_logit": -4.564694404602051,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 monoclonal antibodies. Canakinumab is known to neutralize IL-1\u03b2",
            "probability": 1.5083112604702053e-05,
            "start_logit": 6.041831970214844,
            "end_logit": -6.227078914642334
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific IL-1\u03b2",
            "probability": 1.295026337787918e-05,
            "start_logit": -5.21059513092041,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 and complex formation results in a minor reduction of binding affinity to IL-1RI.",
            "probability": 1.520413023032978e-07,
            "start_logit": 1.5449591875076294,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2",
            "probability": 2.78363110507252e-08,
            "start_logit": -7.369847774505615,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 pathway attenuation.",
            "probability": 2.316684817943206e-08,
            "start_logit": 1.5093516111373901,
            "end_logit": -8.17320728302002
        },
        {
            "text": "mechanisms of IL-1\u03b2",
            "probability": 1.7250505233567937e-08,
            "start_logit": -7.8483476638793945,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 bioactivity by reducing the affinity for its IL-1RI:IL-1RAcP signaling complex. How IL-1\u03b2",
            "probability": 8.085163537443894e-09,
            "start_logit": -3.730628252029419,
            "end_logit": -3.9859189987182617
        },
        {
            "text": "IL-1\u03b2 and provide insight into the mechanisms leading to their distinct modulation of IL-1\u03b2",
            "probability": 4.222132492791675e-09,
            "start_logit": -4.987427234649658,
            "end_logit": -3.378810405731201
        },
        {
            "text": "(IL-1\u03b2)",
            "probability": 3.2333675887242945e-09,
            "start_logit": -3.9696526527404785,
            "end_logit": -4.663401126861572
        },
        {
            "text": "-",
            "probability": 1.2529184219969058e-10,
            "start_logit": -4.243311405181885,
            "end_logit": -7.640376091003418
        },
        {
            "text": "1",
            "probability": 1.123992267636175e-10,
            "start_logit": -4.564694404602051,
            "end_logit": -7.427581787109375
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific",
            "probability": 1.0506586731518156e-10,
            "start_logit": -5.21059513092041,
            "end_logit": -6.849150657653809
        },
        {
            "text": "IL-1\u03b2 and its receptor. In contrast, gevokizumab occupies an allosteric site on IL-1\u03b2",
            "probability": 3.842876576209135e-11,
            "start_logit": -6.998785495758057,
            "end_logit": -6.066741466522217
        },
        {
            "text": "IL-1RI.",
            "probability": 2.043196378009984e-11,
            "start_logit": -7.369847774505615,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2 pathway attenuation.",
            "probability": 3.2261135978200603e-12,
            "start_logit": -7.369847774505615,
            "end_logit": -8.17320728302002
        }
    ],
    "550e828c71445a662f000002_043": [
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.999810384173108,
            "start_logit": 9.046475410461426,
            "end_logit": 7.935140609741211
        },
        {
            "text": "IL",
            "probability": 0.00014412808238895648,
            "start_logit": 9.046475410461426,
            "end_logit": -0.909477949142456
        },
        {
            "text": "\u03b2",
            "probability": 4.41481332127902e-05,
            "start_logit": -0.9812948703765869,
            "end_logit": 7.935140609741211
        },
        {
            "text": "1\u03b2",
            "probability": 1.0264055288251085e-06,
            "start_logit": -4.7427825927734375,
            "end_logit": 7.935140609741211
        },
        {
            "text": "anti-IL-1\u03b2 antibody.",
            "probability": 1.9712981091608907e-07,
            "start_logit": 9.046475410461426,
            "end_logit": -7.504073143005371
        },
        {
            "text": "monoclonal anti-IL-1\u03b2",
            "probability": 1.154544355150432e-07,
            "start_logit": -6.927724838256836,
            "end_logit": 7.935140609741211
        },
        {
            "text": "anti-IL-1\u03b2 antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.",
            "probability": 5.824677444790159e-10,
            "start_logit": -0.9812948703765869,
            "end_logit": -3.3006467819213867
        },
        {
            "text": "AND",
            "probability": 2.7530303782832534e-11,
            "start_logit": 0.08187484741210938,
            "end_logit": -7.415802955627441
        },
        {
            "text": "Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes.",
            "probability": 4.595193317976736e-12,
            "start_logit": -6.0695929527282715,
            "end_logit": -3.0546116828918457
        },
        {
            "text": "antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.",
            "probability": 2.9468741071621925e-12,
            "start_logit": -6.267823696136475,
            "end_logit": -3.3006467819213867
        },
        {
            "text": "type 2 diabetes.",
            "probability": 2.827879619897343e-12,
            "start_logit": -6.555076599121094,
            "end_logit": -3.0546116828918457
        },
        {
            "text": "1",
            "probability": 2.454200707724353e-13,
            "start_logit": -4.7427825927734375,
            "end_logit": -7.311216831207275
        },
        {
            "text": "-",
            "probability": 2.0503434101079503e-13,
            "start_logit": -4.711770534515381,
            "end_logit": -7.522022724151611
        },
        {
            "text": "RESEARCH DESIGN AND",
            "probability": 1.4820484169280344e-13,
            "start_logit": -5.142572402954102,
            "end_logit": -7.415802955627441
        },
        {
            "text": "DESIGN AND",
            "probability": 1.2486003685213467e-13,
            "start_logit": -5.313974380493164,
            "end_logit": -7.415802955627441
        },
        {
            "text": "RESEARCH DESIGN",
            "probability": 9.940522571250098e-14,
            "start_logit": -5.142572402954102,
            "end_logit": -7.8151936531066895
        },
        {
            "text": "Effects of gevokizumab on glycemia and inflammatory",
            "probability": 9.443171488162673e-14,
            "start_logit": -6.0695929527282715,
            "end_logit": -6.93950080871582
        },
        {
            "text": "DESIGN",
            "probability": 8.374719748687085e-14,
            "start_logit": -5.313974380493164,
            "end_logit": -7.8151936531066895
        },
        {
            "text": "diabetes.",
            "probability": 7.44253401974134e-14,
            "start_logit": -7.815128803253174,
            "end_logit": -5.4320454597473145
        },
        {
            "text": "RESEARCH",
            "probability": 7.14067036633162e-14,
            "start_logit": -5.142572402954102,
            "end_logit": -8.14600658416748
        }
    ],
    "550e828c71445a662f000002_044": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.9980346030967444,
            "start_logit": 6.041831970214844,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2.",
            "probability": 0.0009718581938357198,
            "start_logit": 2.6036458015441895,
            "end_logit": 1.3767414093017578
        },
        {
            "text": "IL",
            "probability": 0.0006345127628622436,
            "start_logit": 6.041831970214844,
            "end_logit": -2.487797260284424
        },
        {
            "text": "\u03b2",
            "probability": 0.000306051053402799,
            "start_logit": -2.047959327697754,
            "end_logit": 4.872888565063477
        },
        {
            "text": "1\u03b2",
            "probability": 2.4705276698032384e-05,
            "start_logit": -4.564694404602051,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 monoclonal antibodies. Canakinumab is known to neutralize IL-1\u03b2",
            "probability": 1.5083112604702053e-05,
            "start_logit": 6.041831970214844,
            "end_logit": -6.227078914642334
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific IL-1\u03b2",
            "probability": 1.295026337787918e-05,
            "start_logit": -5.21059513092041,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 and complex formation results in a minor reduction of binding affinity to IL-1RI.",
            "probability": 1.520413023032978e-07,
            "start_logit": 1.5449591875076294,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2",
            "probability": 2.78363110507252e-08,
            "start_logit": -7.369847774505615,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 pathway attenuation.",
            "probability": 2.316684817943206e-08,
            "start_logit": 1.5093516111373901,
            "end_logit": -8.17320728302002
        },
        {
            "text": "mechanisms of IL-1\u03b2",
            "probability": 1.7250505233567937e-08,
            "start_logit": -7.8483476638793945,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 bioactivity by reducing the affinity for its IL-1RI:IL-1RAcP signaling complex. How IL-1\u03b2",
            "probability": 8.085163537443894e-09,
            "start_logit": -3.730628252029419,
            "end_logit": -3.9859189987182617
        },
        {
            "text": "IL-1\u03b2 and provide insight into the mechanisms leading to their distinct modulation of IL-1\u03b2",
            "probability": 4.222132492791675e-09,
            "start_logit": -4.987427234649658,
            "end_logit": -3.378810405731201
        },
        {
            "text": "(IL-1\u03b2)",
            "probability": 3.2333675887242945e-09,
            "start_logit": -3.9696526527404785,
            "end_logit": -4.663401126861572
        },
        {
            "text": "-",
            "probability": 1.2529184219969058e-10,
            "start_logit": -4.243311405181885,
            "end_logit": -7.640376091003418
        },
        {
            "text": "1",
            "probability": 1.123992267636175e-10,
            "start_logit": -4.564694404602051,
            "end_logit": -7.427581787109375
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific",
            "probability": 1.0506586731518156e-10,
            "start_logit": -5.21059513092041,
            "end_logit": -6.849150657653809
        },
        {
            "text": "IL-1\u03b2 and its receptor. In contrast, gevokizumab occupies an allosteric site on IL-1\u03b2",
            "probability": 3.842876576209135e-11,
            "start_logit": -6.998785495758057,
            "end_logit": -6.066741466522217
        },
        {
            "text": "IL-1RI.",
            "probability": 2.043196378009984e-11,
            "start_logit": -7.369847774505615,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2 pathway attenuation.",
            "probability": 3.2261135978200603e-12,
            "start_logit": -7.369847774505615,
            "end_logit": -8.17320728302002
        }
    ],
    "550e828c71445a662f000002_045": [
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.999810384173108,
            "start_logit": 9.046475410461426,
            "end_logit": 7.935140609741211
        },
        {
            "text": "IL",
            "probability": 0.00014412808238895648,
            "start_logit": 9.046475410461426,
            "end_logit": -0.909477949142456
        },
        {
            "text": "\u03b2",
            "probability": 4.41481332127902e-05,
            "start_logit": -0.9812948703765869,
            "end_logit": 7.935140609741211
        },
        {
            "text": "1\u03b2",
            "probability": 1.0264055288251085e-06,
            "start_logit": -4.7427825927734375,
            "end_logit": 7.935140609741211
        },
        {
            "text": "anti-IL-1\u03b2 antibody.",
            "probability": 1.9712981091608907e-07,
            "start_logit": 9.046475410461426,
            "end_logit": -7.504073143005371
        },
        {
            "text": "monoclonal anti-IL-1\u03b2",
            "probability": 1.154544355150432e-07,
            "start_logit": -6.927724838256836,
            "end_logit": 7.935140609741211
        },
        {
            "text": "anti-IL-1\u03b2 antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.",
            "probability": 5.824677444790159e-10,
            "start_logit": -0.9812948703765869,
            "end_logit": -3.3006467819213867
        },
        {
            "text": "AND",
            "probability": 2.7530303782832534e-11,
            "start_logit": 0.08187484741210938,
            "end_logit": -7.415802955627441
        },
        {
            "text": "Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes.",
            "probability": 4.595193317976736e-12,
            "start_logit": -6.0695929527282715,
            "end_logit": -3.0546116828918457
        },
        {
            "text": "antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.",
            "probability": 2.9468741071621925e-12,
            "start_logit": -6.267823696136475,
            "end_logit": -3.3006467819213867
        },
        {
            "text": "type 2 diabetes.",
            "probability": 2.827879619897343e-12,
            "start_logit": -6.555076599121094,
            "end_logit": -3.0546116828918457
        },
        {
            "text": "1",
            "probability": 2.454200707724353e-13,
            "start_logit": -4.7427825927734375,
            "end_logit": -7.311216831207275
        },
        {
            "text": "-",
            "probability": 2.0503434101079503e-13,
            "start_logit": -4.711770534515381,
            "end_logit": -7.522022724151611
        },
        {
            "text": "RESEARCH DESIGN AND",
            "probability": 1.4820484169280344e-13,
            "start_logit": -5.142572402954102,
            "end_logit": -7.415802955627441
        },
        {
            "text": "DESIGN AND",
            "probability": 1.2486003685213467e-13,
            "start_logit": -5.313974380493164,
            "end_logit": -7.415802955627441
        },
        {
            "text": "RESEARCH DESIGN",
            "probability": 9.940522571250098e-14,
            "start_logit": -5.142572402954102,
            "end_logit": -7.8151936531066895
        },
        {
            "text": "Effects of gevokizumab on glycemia and inflammatory",
            "probability": 9.443171488162673e-14,
            "start_logit": -6.0695929527282715,
            "end_logit": -6.93950080871582
        },
        {
            "text": "DESIGN",
            "probability": 8.374719748687085e-14,
            "start_logit": -5.313974380493164,
            "end_logit": -7.8151936531066895
        },
        {
            "text": "diabetes.",
            "probability": 7.44253401974134e-14,
            "start_logit": -7.815128803253174,
            "end_logit": -5.4320454597473145
        },
        {
            "text": "RESEARCH",
            "probability": 7.14067036633162e-14,
            "start_logit": -5.142572402954102,
            "end_logit": -8.14600658416748
        }
    ],
    "550e828c71445a662f000002_046": [
        {
            "text": "IL-1\u03b2",
            "probability": 0.9980346030967444,
            "start_logit": 6.041831970214844,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2.",
            "probability": 0.0009718581938357198,
            "start_logit": 2.6036458015441895,
            "end_logit": 1.3767414093017578
        },
        {
            "text": "IL",
            "probability": 0.0006345127628622436,
            "start_logit": 6.041831970214844,
            "end_logit": -2.487797260284424
        },
        {
            "text": "\u03b2",
            "probability": 0.000306051053402799,
            "start_logit": -2.047959327697754,
            "end_logit": 4.872888565063477
        },
        {
            "text": "1\u03b2",
            "probability": 2.4705276698032384e-05,
            "start_logit": -4.564694404602051,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 monoclonal antibodies. Canakinumab is known to neutralize IL-1\u03b2",
            "probability": 1.5083112604702053e-05,
            "start_logit": 6.041831970214844,
            "end_logit": -6.227078914642334
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific IL-1\u03b2",
            "probability": 1.295026337787918e-05,
            "start_logit": -5.21059513092041,
            "end_logit": 4.872888565063477
        },
        {
            "text": "IL-1\u03b2 and complex formation results in a minor reduction of binding affinity to IL-1RI.",
            "probability": 1.520413023032978e-07,
            "start_logit": 1.5449591875076294,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2",
            "probability": 2.78363110507252e-08,
            "start_logit": -7.369847774505615,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 pathway attenuation.",
            "probability": 2.316684817943206e-08,
            "start_logit": 1.5093516111373901,
            "end_logit": -8.17320728302002
        },
        {
            "text": "mechanisms of IL-1\u03b2",
            "probability": 1.7250505233567937e-08,
            "start_logit": -7.8483476638793945,
            "end_logit": 0.8896111249923706
        },
        {
            "text": "IL-1\u03b2 bioactivity by reducing the affinity for its IL-1RI:IL-1RAcP signaling complex. How IL-1\u03b2",
            "probability": 8.085163537443894e-09,
            "start_logit": -3.730628252029419,
            "end_logit": -3.9859189987182617
        },
        {
            "text": "IL-1\u03b2 and provide insight into the mechanisms leading to their distinct modulation of IL-1\u03b2",
            "probability": 4.222132492791675e-09,
            "start_logit": -4.987427234649658,
            "end_logit": -3.378810405731201
        },
        {
            "text": "(IL-1\u03b2)",
            "probability": 3.2333675887242945e-09,
            "start_logit": -3.9696526527404785,
            "end_logit": -4.663401126861572
        },
        {
            "text": "-",
            "probability": 1.2529184219969058e-10,
            "start_logit": -4.243311405181885,
            "end_logit": -7.640376091003418
        },
        {
            "text": "1",
            "probability": 1.123992267636175e-10,
            "start_logit": -4.564694404602051,
            "end_logit": -7.427581787109375
        },
        {
            "text": "Canakinumab and gevokizumab are highly specific",
            "probability": 1.0506586731518156e-10,
            "start_logit": -5.21059513092041,
            "end_logit": -6.849150657653809
        },
        {
            "text": "IL-1\u03b2 and its receptor. In contrast, gevokizumab occupies an allosteric site on IL-1\u03b2",
            "probability": 3.842876576209135e-11,
            "start_logit": -6.998785495758057,
            "end_logit": -6.066741466522217
        },
        {
            "text": "IL-1RI.",
            "probability": 2.043196378009984e-11,
            "start_logit": -7.369847774505615,
            "end_logit": -6.327384948730469
        },
        {
            "text": "IL-1RI. This suggests two different mechanisms of IL-1\u03b2 pathway attenuation.",
            "probability": 3.2261135978200603e-12,
            "start_logit": -7.369847774505615,
            "end_logit": -8.17320728302002
        }
    ],
    "550e828c71445a662f000002_047": [
        {
            "text": "anti-IL-1\u03b2",
            "probability": 0.999810384173108,
            "start_logit": 9.046475410461426,
            "end_logit": 7.935140609741211
        },
        {
            "text": "IL",
            "probability": 0.00014412808238895648,
            "start_logit": 9.046475410461426,
            "end_logit": -0.909477949142456
        },
        {
            "text": "\u03b2",
            "probability": 4.41481332127902e-05,
            "start_logit": -0.9812948703765869,
            "end_logit": 7.935140609741211
        },
        {
            "text": "1\u03b2",
            "probability": 1.0264055288251085e-06,
            "start_logit": -4.7427825927734375,
            "end_logit": 7.935140609741211
        },
        {
            "text": "anti-IL-1\u03b2 antibody.",
            "probability": 1.9712981091608907e-07,
            "start_logit": 9.046475410461426,
            "end_logit": -7.504073143005371
        },
        {
            "text": "monoclonal anti-IL-1\u03b2",
            "probability": 1.154544355150432e-07,
            "start_logit": -6.927724838256836,
            "end_logit": 7.935140609741211
        },
        {
            "text": "anti-IL-1\u03b2 antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.",
            "probability": 5.824677444790159e-10,
            "start_logit": -0.9812948703765869,
            "end_logit": -3.3006467819213867
        },
        {
            "text": "AND",
            "probability": 2.7530303782832534e-11,
            "start_logit": 0.08187484741210938,
            "end_logit": -7.415802955627441
        },
        {
            "text": "Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes.",
            "probability": 4.595193317976736e-12,
            "start_logit": -6.0695929527282715,
            "end_logit": -3.0546116828918457
        },
        {
            "text": "antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.",
            "probability": 2.9468741071621925e-12,
            "start_logit": -6.267823696136475,
            "end_logit": -3.3006467819213867
        },
        {
            "text": "type 2 diabetes.",
            "probability": 2.827879619897343e-12,
            "start_logit": -6.555076599121094,
            "end_logit": -3.0546116828918457
        },
        {
            "text": "1",
            "probability": 2.454200707724353e-13,
            "start_logit": -4.7427825927734375,
            "end_logit": -7.311216831207275
        },
        {
            "text": "-",
            "probability": 2.0503434101079503e-13,
            "start_logit": -4.711770534515381,
            "end_logit": -7.522022724151611
        },
        {
            "text": "RESEARCH DESIGN AND",
            "probability": 1.4820484169280344e-13,
            "start_logit": -5.142572402954102,
            "end_logit": -7.415802955627441
        },
        {
            "text": "DESIGN AND",
            "probability": 1.2486003685213467e-13,
            "start_logit": -5.313974380493164,
            "end_logit": -7.415802955627441
        },
        {
            "text": "RESEARCH DESIGN",
            "probability": 9.940522571250098e-14,
            "start_logit": -5.142572402954102,
            "end_logit": -7.8151936531066895
        },
        {
            "text": "Effects of gevokizumab on glycemia and inflammatory",
            "probability": 9.443171488162673e-14,
            "start_logit": -6.0695929527282715,
            "end_logit": -6.93950080871582
        },
        {
            "text": "DESIGN",
            "probability": 8.374719748687085e-14,
            "start_logit": -5.313974380493164,
            "end_logit": -7.8151936531066895
        },
        {
            "text": "diabetes.",
            "probability": 7.44253401974134e-14,
            "start_logit": -7.815128803253174,
            "end_logit": -5.4320454597473145
        },
        {
            "text": "RESEARCH",
            "probability": 7.14067036633162e-14,
            "start_logit": -5.142572402954102,
            "end_logit": -8.14600658416748
        }
    ],
    "54f608f85f206a0c06000007_001": [
        {
            "text": "Groucho (Gro) is a Drosophila melanogaster transcriptional corepressor",
            "probability": 0.999367808129407,
            "start_logit": 9.727066993713379,
            "end_logit": 8.568607330322266
        },
        {
            "text": "G",
            "probability": 0.00043866344818476876,
            "start_logit": 9.727066993713379,
            "end_logit": 0.8374616503715515
        },
        {
            "text": "or",
            "probability": 9.936204519515274e-05,
            "start_logit": 0.5109590291976929,
            "end_logit": 8.568607330322266
        },
        {
            "text": "Groucho",
            "probability": 6.460722195499732e-05,
            "start_logit": 9.727066993713379,
            "end_logit": -1.0779446363449097
        },
        {
            "text": "Groucho (Gro) is a Drosophila melanogaster transcriptional corepressor that",
            "probability": 6.3398076489312946e-06,
            "start_logit": 9.727066993713379,
            "end_logit": -3.3994224071502686
        },
        {
            "text": "Drosophila melanogaster transcriptional corepressor",
            "probability": 5.668067335677041e-06,
            "start_logit": -2.3529629707336426,
            "end_logit": 8.568607330322266
        },
        {
            "text": "corepressor",
            "probability": 5.620117844735994e-06,
            "start_logit": -2.3614585399627686,
            "end_logit": 8.568607330322266
        },
        {
            "text": "pressor",
            "probability": 2.612612536999022e-06,
            "start_logit": -3.127460479736328,
            "end_logit": 8.568607330322266
        },
        {
            "text": "(Gro) is a Drosophila melanogaster transcriptional corepressor",
            "probability": 2.5700615589250585e-06,
            "start_logit": -3.143881320953369,
            "end_logit": 8.568607330322266
        },
        {
            "text": "Groucho (Gro) is a Drosophila",
            "probability": 1.4918741918344788e-06,
            "start_logit": 9.727066993713379,
            "end_logit": -4.846237659454346
        },
        {
            "text": "Groucho (Gro)",
            "probability": 1.0611265422813323e-06,
            "start_logit": 9.727066993713379,
            "end_logit": -5.186939716339111
        },
        {
            "text": "Grou",
            "probability": 8.128726712736097e-07,
            "start_logit": 9.727066993713379,
            "end_logit": -5.453451633453369
        },
        {
            "text": "Groucho (Gro) is a Drosophila melanogaster",
            "probability": 5.835183261332579e-07,
            "start_logit": 9.727066993713379,
            "end_logit": -5.784950256347656
        },
        {
            "text": "melanogaster transcriptional corepressor",
            "probability": 5.467894881385076e-07,
            "start_logit": -4.691502571105957,
            "end_logit": 8.568607330322266
        },
        {
            "text": "transcriptional corepressor",
            "probability": 5.205925972745032e-07,
            "start_logit": -4.740598678588867,
            "end_logit": 8.568607330322266
        },
        {
            "text": "a Drosophila melanogaster transcriptional corepressor",
            "probability": 4.850268183153784e-07,
            "start_logit": -4.811362266540527,
            "end_logit": 8.568607330322266
        },
        {
            "text": "Groucho (Gro) is",
            "probability": 3.9393385754883457e-07,
            "start_logit": 9.727066993713379,
            "end_logit": -6.17784309387207
        },
        {
            "text": "Groucho (Gro) is a Drosophila melanogaster transcriptional",
            "probability": 3.112430027490024e-07,
            "start_logit": 9.727066993713379,
            "end_logit": -6.4134521484375
        },
        {
            "text": "Groucho (Gro) is a Drosophila melanogaster transcriptional corepressor that directly",
            "probability": 2.9094629643618926e-07,
            "start_logit": 9.727066993713379,
            "end_logit": -6.480887413024902
        },
        {
            "text": "Groucho (Gro) is a Drosophila melanogaster transcriptional corepressor that directly interacts",
            "probability": 2.505645402577353e-07,
            "start_logit": 9.727066993713379,
            "end_logit": -6.630309581756592
        }
    ],
    "56c048acef6e39474100001c_001": [
        {
            "text": "telomerase",
            "probability": 0.9963887831838663,
            "start_logit": 3.828627109527588,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "ase",
            "probability": 0.0016155873464689112,
            "start_logit": -2.5958118438720703,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "inhibited telomerase",
            "probability": 0.0013425750299816313,
            "start_logit": -2.78092098236084,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "telomerase activity",
            "probability": 0.0005312455086606161,
            "start_logit": 3.828627109527588,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "Imetelstat inhibited telomerase",
            "probability": 9.548241903159017e-05,
            "start_logit": -5.424323558807373,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "omerase",
            "probability": 1.0736277580402372e-05,
            "start_logit": -7.609637260437012,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "tel",
            "probability": 9.490878889379225e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -6.008081912994385
        },
        {
            "text": "telomerase activity in",
            "probability": 2.2068448072832828e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.466849327087402
        },
        {
            "text": "telomer",
            "probability": 1.8164552377251532e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.661526203155518
        },
        {
            "text": "inhibited telomerase activity",
            "probability": 7.158219429553916e-07,
            "start_logit": -2.78092098236084,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase activity in both subpopulations.",
            "probability": 5.657553087794565e-07,
            "start_logit": 3.828627109527588,
            "end_logit": -8.828006744384766
        },
        {
            "text": "activity",
            "probability": 4.24596200415884e-07,
            "start_logit": -3.3032138347625732,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase inhibition in anti-cancer therapy. The purpose of this study was to investigate the effects of a telomerase",
            "probability": 2.8346319467357703e-07,
            "start_logit": -7.6556501388549805,
            "end_logit": 1.965191125869751
        },
        {
            "text": "Imetelstat inhibited telomerase activity",
            "probability": 5.0908447709033335e-08,
            "start_logit": -5.424323558807373,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "The telomerase",
            "probability": 1.6266868151125048e-08,
            "start_logit": -7.169773101806641,
            "end_logit": -1.3786377906799316
        },
        {
            "text": "inhibited",
            "probability": 7.132996524177216e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -6.591888904571533
        },
        {
            "text": "telomerase antagonistic oligonucleotide, imetelstat",
            "probability": 6.610788593067375e-09,
            "start_logit": -1.1074668169021606,
            "end_logit": -8.341371536254883
        },
        {
            "text": "inhibited telomerase activity in",
            "probability": 2.973593022430098e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -7.466849327087402
        },
        {
            "text": "activity in",
            "probability": 1.7638133495799876e-09,
            "start_logit": -3.3032138347625732,
            "end_logit": -7.466849327087402
        },
        {
            "text": "inhibited telomerase activity in both subpopulations.",
            "probability": 7.623218601675894e-10,
            "start_logit": -2.78092098236084,
            "end_logit": -8.828006744384766
        }
    ],
    "56c048acef6e39474100001c_002": [
        {
            "text": "telomerase",
            "probability": 0.9963887831838663,
            "start_logit": 3.828627109527588,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "ase",
            "probability": 0.0016155873464689112,
            "start_logit": -2.5958118438720703,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "inhibited telomerase",
            "probability": 0.0013425750299816313,
            "start_logit": -2.78092098236084,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "telomerase activity",
            "probability": 0.0005312455086606161,
            "start_logit": 3.828627109527588,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "Imetelstat inhibited telomerase",
            "probability": 9.548241903159017e-05,
            "start_logit": -5.424323558807373,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "omerase",
            "probability": 1.0736277580402372e-05,
            "start_logit": -7.609637260437012,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "tel",
            "probability": 9.490878889379225e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -6.008081912994385
        },
        {
            "text": "telomerase activity in",
            "probability": 2.2068448072832828e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.466849327087402
        },
        {
            "text": "telomer",
            "probability": 1.8164552377251532e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.661526203155518
        },
        {
            "text": "inhibited telomerase activity",
            "probability": 7.158219429553916e-07,
            "start_logit": -2.78092098236084,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase activity in both subpopulations.",
            "probability": 5.657553087794565e-07,
            "start_logit": 3.828627109527588,
            "end_logit": -8.828006744384766
        },
        {
            "text": "activity",
            "probability": 4.24596200415884e-07,
            "start_logit": -3.3032138347625732,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase inhibition in anti-cancer therapy. The purpose of this study was to investigate the effects of a telomerase",
            "probability": 2.8346319467357703e-07,
            "start_logit": -7.6556501388549805,
            "end_logit": 1.965191125869751
        },
        {
            "text": "Imetelstat inhibited telomerase activity",
            "probability": 5.0908447709033335e-08,
            "start_logit": -5.424323558807373,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "The telomerase",
            "probability": 1.6266868151125048e-08,
            "start_logit": -7.169773101806641,
            "end_logit": -1.3786377906799316
        },
        {
            "text": "inhibited",
            "probability": 7.132996524177216e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -6.591888904571533
        },
        {
            "text": "telomerase antagonistic oligonucleotide, imetelstat",
            "probability": 6.610788593067375e-09,
            "start_logit": -1.1074668169021606,
            "end_logit": -8.341371536254883
        },
        {
            "text": "inhibited telomerase activity in",
            "probability": 2.973593022430098e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -7.466849327087402
        },
        {
            "text": "activity in",
            "probability": 1.7638133495799876e-09,
            "start_logit": -3.3032138347625732,
            "end_logit": -7.466849327087402
        },
        {
            "text": "inhibited telomerase activity in both subpopulations.",
            "probability": 7.623218601675894e-10,
            "start_logit": -2.78092098236084,
            "end_logit": -8.828006744384766
        }
    ],
    "56c048acef6e39474100001c_003": [
        {
            "text": "telomerase",
            "probability": 0.9963887831838663,
            "start_logit": 3.828627109527588,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "ase",
            "probability": 0.0016155873464689112,
            "start_logit": -2.5958118438720703,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "inhibited telomerase",
            "probability": 0.0013425750299816313,
            "start_logit": -2.78092098236084,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "telomerase activity",
            "probability": 0.0005312455086606161,
            "start_logit": 3.828627109527588,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "Imetelstat inhibited telomerase",
            "probability": 9.548241903159017e-05,
            "start_logit": -5.424323558807373,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "omerase",
            "probability": 1.0736277580402372e-05,
            "start_logit": -7.609637260437012,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "tel",
            "probability": 9.490878889379225e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -6.008081912994385
        },
        {
            "text": "telomerase activity in",
            "probability": 2.2068448072832828e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.466849327087402
        },
        {
            "text": "telomer",
            "probability": 1.8164552377251532e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.661526203155518
        },
        {
            "text": "inhibited telomerase activity",
            "probability": 7.158219429553916e-07,
            "start_logit": -2.78092098236084,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase activity in both subpopulations.",
            "probability": 5.657553087794565e-07,
            "start_logit": 3.828627109527588,
            "end_logit": -8.828006744384766
        },
        {
            "text": "activity",
            "probability": 4.24596200415884e-07,
            "start_logit": -3.3032138347625732,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase inhibition in anti-cancer therapy. The purpose of this study was to investigate the effects of a telomerase",
            "probability": 2.8346319467357703e-07,
            "start_logit": -7.6556501388549805,
            "end_logit": 1.965191125869751
        },
        {
            "text": "Imetelstat inhibited telomerase activity",
            "probability": 5.0908447709033335e-08,
            "start_logit": -5.424323558807373,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "The telomerase",
            "probability": 1.6266868151125048e-08,
            "start_logit": -7.169773101806641,
            "end_logit": -1.3786377906799316
        },
        {
            "text": "inhibited",
            "probability": 7.132996524177216e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -6.591888904571533
        },
        {
            "text": "telomerase antagonistic oligonucleotide, imetelstat",
            "probability": 6.610788593067375e-09,
            "start_logit": -1.1074668169021606,
            "end_logit": -8.341371536254883
        },
        {
            "text": "inhibited telomerase activity in",
            "probability": 2.973593022430098e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -7.466849327087402
        },
        {
            "text": "activity in",
            "probability": 1.7638133495799876e-09,
            "start_logit": -3.3032138347625732,
            "end_logit": -7.466849327087402
        },
        {
            "text": "inhibited telomerase activity in both subpopulations.",
            "probability": 7.623218601675894e-10,
            "start_logit": -2.78092098236084,
            "end_logit": -8.828006744384766
        }
    ],
    "56c048acef6e39474100001c_004": [
        {
            "text": "telomerase",
            "probability": 0.9957489666414991,
            "start_logit": 5.594794750213623,
            "end_logit": 5.616246223449707
        },
        {
            "text": "Telomerase",
            "probability": 0.0038777450321891235,
            "start_logit": 2.7009217739105225,
            "end_logit": 2.9618778228759766
        },
        {
            "text": "ase",
            "probability": 0.00025252346352577613,
            "start_logit": -2.6849515438079834,
            "end_logit": 5.616246223449707
        },
        {
            "text": "telomerase.",
            "probability": 3.6336727407241225e-05,
            "start_logit": 5.594794750213623,
            "end_logit": -4.602175235748291
        },
        {
            "text": "tel",
            "probability": 2.995069706981493e-05,
            "start_logit": 5.594794750213623,
            "end_logit": -4.795451641082764
        },
        {
            "text": "blocks the template region of telomerase.",
            "probability": 1.3023315396988144e-05,
            "start_logit": -5.649714469909668,
            "end_logit": 5.616246223449707
        },
        {
            "text": "template region of telomerase.",
            "probability": 1.0833534148688255e-05,
            "start_logit": -5.8338093757629395,
            "end_logit": 5.616246223449707
        },
        {
            "text": "the template region of telomerase.",
            "probability": 1.067876107270533e-05,
            "start_logit": -5.848198890686035,
            "end_logit": 5.616246223449707
        },
        {
            "text": "of telomerase.",
            "probability": 1.0079476755293255e-05,
            "start_logit": -5.905954360961914,
            "end_logit": 5.616246223449707
        },
        {
            "text": "that blocks the template region of telomerase.",
            "probability": 4.204009646347134e-06,
            "start_logit": -6.780416965484619,
            "end_logit": 5.616246223449707
        },
        {
            "text": "telomer",
            "probability": 2.8066610824107045e-06,
            "start_logit": 5.594794750213623,
            "end_logit": -7.163008689880371
        },
        {
            "text": "telomerase. The aim of this study was to define the effects of long-term GRN163L",
            "probability": 1.7544392695185573e-06,
            "start_logit": 5.594794750213623,
            "end_logit": -7.63285493850708
        },
        {
            "text": "Tel",
            "probability": 3.610689724399767e-07,
            "start_logit": 2.7009217739105225,
            "end_logit": -6.319817543029785
        },
        {
            "text": "Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic cancer",
            "probability": 1.5918716945108616e-07,
            "start_logit": 2.7009217739105225,
            "end_logit": -7.138805866241455
        },
        {
            "text": "Telomer",
            "probability": 1.5569725839808058e-07,
            "start_logit": 2.7009217739105225,
            "end_logit": -7.160973072052002
        },
        {
            "text": "Telomerase inhibitor",
            "probability": 1.3199804960423406e-07,
            "start_logit": 2.7009217739105225,
            "end_logit": -7.326099395751953
        },
        {
            "text": "Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic",
            "probability": 7.350403569949113e-08,
            "start_logit": 2.7009217739105225,
            "end_logit": -7.911546230316162
        },
        {
            "text": "Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan",
            "probability": 7.311779263415784e-08,
            "start_logit": 2.7009217739105225,
            "end_logit": -7.916814804077148
        },
        {
            "text": "Telomerase inhibitor Imetelstat",
            "probability": 7.135896631117701e-08,
            "start_logit": 2.7009217739105225,
            "end_logit": -7.941163539886475
        },
        {
            "text": "Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic cancer cells.",
            "probability": 7.130869270409066e-08,
            "start_logit": 2.7009217739105225,
            "end_logit": -7.941868305206299
        }
    ],
    "56c048acef6e39474100001c_005": [
        {
            "text": "telomerase",
            "probability": 0.9957489666414991,
            "start_logit": 5.594794750213623,
            "end_logit": 5.616246223449707
        },
        {
            "text": "Telomerase",
            "probability": 0.0038777450321891235,
            "start_logit": 2.7009217739105225,
            "end_logit": 2.9618778228759766
        },
        {
            "text": "ase",
            "probability": 0.00025252346352577613,
            "start_logit": -2.6849515438079834,
            "end_logit": 5.616246223449707
        },
        {
            "text": "telomerase.",
            "probability": 3.6336727407241225e-05,
            "start_logit": 5.594794750213623,
            "end_logit": -4.602175235748291
        },
        {
            "text": "tel",
            "probability": 2.995069706981493e-05,
            "start_logit": 5.594794750213623,
            "end_logit": -4.795451641082764
        },
        {
            "text": "blocks the template region of telomerase.",
            "probability": 1.3023315396988144e-05,
            "start_logit": -5.649714469909668,
            "end_logit": 5.616246223449707
        },
        {
            "text": "template region of telomerase.",
            "probability": 1.0833534148688255e-05,
            "start_logit": -5.8338093757629395,
            "end_logit": 5.616246223449707
        },
        {
            "text": "the template region of telomerase.",
            "probability": 1.067876107270533e-05,
            "start_logit": -5.848198890686035,
            "end_logit": 5.616246223449707
        },
        {
            "text": "of telomerase.",
            "probability": 1.0079476755293255e-05,
            "start_logit": -5.905954360961914,
            "end_logit": 5.616246223449707
        },
        {
            "text": "that blocks the template region of telomerase.",
            "probability": 4.204009646347134e-06,
            "start_logit": -6.780416965484619,
            "end_logit": 5.616246223449707
        },
        {
            "text": "telomer",
            "probability": 2.8066610824107045e-06,
            "start_logit": 5.594794750213623,
            "end_logit": -7.163008689880371
        },
        {
            "text": "telomerase. The aim of this study was to define the effects of long-term GRN163L",
            "probability": 1.7544392695185573e-06,
            "start_logit": 5.594794750213623,
            "end_logit": -7.63285493850708
        },
        {
            "text": "Tel",
            "probability": 3.610689724399767e-07,
            "start_logit": 2.7009217739105225,
            "end_logit": -6.319817543029785
        },
        {
            "text": "Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic cancer",
            "probability": 1.5918716945108616e-07,
            "start_logit": 2.7009217739105225,
            "end_logit": -7.138805866241455
        },
        {
            "text": "Telomer",
            "probability": 1.5569725839808058e-07,
            "start_logit": 2.7009217739105225,
            "end_logit": -7.160973072052002
        },
        {
            "text": "Telomerase inhibitor",
            "probability": 1.3199804960423406e-07,
            "start_logit": 2.7009217739105225,
            "end_logit": -7.326099395751953
        },
        {
            "text": "Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic",
            "probability": 7.350403569949113e-08,
            "start_logit": 2.7009217739105225,
            "end_logit": -7.911546230316162
        },
        {
            "text": "Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan",
            "probability": 7.311779263415784e-08,
            "start_logit": 2.7009217739105225,
            "end_logit": -7.916814804077148
        },
        {
            "text": "Telomerase inhibitor Imetelstat",
            "probability": 7.135896631117701e-08,
            "start_logit": 2.7009217739105225,
            "end_logit": -7.941163539886475
        },
        {
            "text": "Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic cancer cells.",
            "probability": 7.130869270409066e-08,
            "start_logit": 2.7009217739105225,
            "end_logit": -7.941868305206299
        }
    ],
    "56c048acef6e39474100001c_006": [
        {
            "text": "telomerase",
            "probability": 0.9883222198026839,
            "start_logit": 0.8494238257408142,
            "end_logit": 2.438828468322754
        },
        {
            "text": "the telomerase",
            "probability": 0.005450628120182198,
            "start_logit": -2.7648000717163086,
            "end_logit": 0.852774441242218
        },
        {
            "text": "ase",
            "probability": 0.0031823876338532495,
            "start_logit": -4.88895320892334,
            "end_logit": 2.438828468322754
        },
        {
            "text": "growth",
            "probability": 0.002291623086069396,
            "start_logit": -0.784719705581665,
            "end_logit": -1.9937764406204224
        },
        {
            "text": "cancer and critical for cancer cell immortality. We evaluated the effect of the telomerase",
            "probability": 0.0005461732037620062,
            "start_logit": -5.06535005569458,
            "end_logit": 0.852774441242218
        },
        {
            "text": "tel",
            "probability": 8.383286313428923e-05,
            "start_logit": 0.8494238257408142,
            "end_logit": -6.936110496520996
        },
        {
            "text": "effect of the telomerase",
            "probability": 3.9808831246821215e-05,
            "start_logit": -7.684197425842285,
            "end_logit": 0.852774441242218
        },
        {
            "text": "telomer",
            "probability": 3.307450679299746e-05,
            "start_logit": 0.8494238257408142,
            "end_logit": -7.866172790527344
        },
        {
            "text": "telomerase inhibitor imetelstat.",
            "probability": 2.8057497474089327e-05,
            "start_logit": 0.8494238257408142,
            "end_logit": -8.030679702758789
        },
        {
            "text": "growth inhibition",
            "probability": 6.021171843581845e-06,
            "start_logit": -0.784719705581665,
            "end_logit": -7.935510158538818
        },
        {
            "text": "telomerase inhibitor imetelstat",
            "probability": 5.146820311275162e-06,
            "start_logit": -2.675689935684204,
            "end_logit": -6.201442718505859
        },
        {
            "text": "the telomerase inhibitor imetelstat",
            "probability": 4.708027227760155e-06,
            "start_logit": -2.7648000717163086,
            "end_logit": -6.201442718505859
        },
        {
            "text": "growth inhibition. Imetelstat resulted in 40-50% growth",
            "probability": 2.465475991689212e-06,
            "start_logit": -7.619350433349609,
            "end_logit": -1.9937764406204224
        },
        {
            "text": "40-50% growth",
            "probability": 2.19622181374147e-06,
            "start_logit": -7.734996795654297,
            "end_logit": -1.9937764406204224
        },
        {
            "text": "cancer",
            "probability": 5.784230165373825e-07,
            "start_logit": -5.06535005569458,
            "end_logit": -5.9976115226745605
        },
        {
            "text": "cancer and critical for cancer cell immortality. We evaluated the effect of the telomerase inhibitor imetelstat",
            "probability": 4.7176183325795596e-07,
            "start_logit": -5.06535005569458,
            "end_logit": -6.201442718505859
        },
        {
            "text": "inhibition of telomerase",
            "probability": 2.6812140406663884e-07,
            "start_logit": -7.198421001434326,
            "end_logit": -4.633406162261963
        },
        {
            "text": "imetelstat",
            "probability": 2.4992282587810527e-07,
            "start_logit": -5.700672149658203,
            "end_logit": -6.201442718505859
        },
        {
            "text": "Telomerase is an attractive therapeutic target because it is specific to cancer",
            "probability": 5.4123310676516765e-08,
            "start_logit": -7.434390544891357,
            "end_logit": -5.9976115226745605
        },
        {
            "text": "effect of the telomerase inhibitor imetelstat",
            "probability": 3.4385222635419604e-08,
            "start_logit": -7.684197425842285,
            "end_logit": -6.201442718505859
        }
    ],
    "56c048acef6e39474100001c_007": [
        {
            "text": "telomerase",
            "probability": 0.9883222198026839,
            "start_logit": 0.8494238257408142,
            "end_logit": 2.438828468322754
        },
        {
            "text": "the telomerase",
            "probability": 0.005450628120182198,
            "start_logit": -2.7648000717163086,
            "end_logit": 0.852774441242218
        },
        {
            "text": "ase",
            "probability": 0.0031823876338532495,
            "start_logit": -4.88895320892334,
            "end_logit": 2.438828468322754
        },
        {
            "text": "growth",
            "probability": 0.002291623086069396,
            "start_logit": -0.784719705581665,
            "end_logit": -1.9937764406204224
        },
        {
            "text": "cancer and critical for cancer cell immortality. We evaluated the effect of the telomerase",
            "probability": 0.0005461732037620062,
            "start_logit": -5.06535005569458,
            "end_logit": 0.852774441242218
        },
        {
            "text": "tel",
            "probability": 8.383286313428923e-05,
            "start_logit": 0.8494238257408142,
            "end_logit": -6.936110496520996
        },
        {
            "text": "effect of the telomerase",
            "probability": 3.9808831246821215e-05,
            "start_logit": -7.684197425842285,
            "end_logit": 0.852774441242218
        },
        {
            "text": "telomer",
            "probability": 3.307450679299746e-05,
            "start_logit": 0.8494238257408142,
            "end_logit": -7.866172790527344
        },
        {
            "text": "telomerase inhibitor imetelstat.",
            "probability": 2.8057497474089327e-05,
            "start_logit": 0.8494238257408142,
            "end_logit": -8.030679702758789
        },
        {
            "text": "growth inhibition",
            "probability": 6.021171843581845e-06,
            "start_logit": -0.784719705581665,
            "end_logit": -7.935510158538818
        },
        {
            "text": "telomerase inhibitor imetelstat",
            "probability": 5.146820311275162e-06,
            "start_logit": -2.675689935684204,
            "end_logit": -6.201442718505859
        },
        {
            "text": "the telomerase inhibitor imetelstat",
            "probability": 4.708027227760155e-06,
            "start_logit": -2.7648000717163086,
            "end_logit": -6.201442718505859
        },
        {
            "text": "growth inhibition. Imetelstat resulted in 40-50% growth",
            "probability": 2.465475991689212e-06,
            "start_logit": -7.619350433349609,
            "end_logit": -1.9937764406204224
        },
        {
            "text": "40-50% growth",
            "probability": 2.19622181374147e-06,
            "start_logit": -7.734996795654297,
            "end_logit": -1.9937764406204224
        },
        {
            "text": "cancer",
            "probability": 5.784230165373825e-07,
            "start_logit": -5.06535005569458,
            "end_logit": -5.9976115226745605
        },
        {
            "text": "cancer and critical for cancer cell immortality. We evaluated the effect of the telomerase inhibitor imetelstat",
            "probability": 4.7176183325795596e-07,
            "start_logit": -5.06535005569458,
            "end_logit": -6.201442718505859
        },
        {
            "text": "inhibition of telomerase",
            "probability": 2.6812140406663884e-07,
            "start_logit": -7.198421001434326,
            "end_logit": -4.633406162261963
        },
        {
            "text": "imetelstat",
            "probability": 2.4992282587810527e-07,
            "start_logit": -5.700672149658203,
            "end_logit": -6.201442718505859
        },
        {
            "text": "Telomerase is an attractive therapeutic target because it is specific to cancer",
            "probability": 5.4123310676516765e-08,
            "start_logit": -7.434390544891357,
            "end_logit": -5.9976115226745605
        },
        {
            "text": "effect of the telomerase inhibitor imetelstat",
            "probability": 3.4385222635419604e-08,
            "start_logit": -7.684197425842285,
            "end_logit": -6.201442718505859
        }
    ],
    "56c048acef6e39474100001c_008": [
        {
            "text": "telomerase",
            "probability": 0.9883222198026839,
            "start_logit": 0.8494238257408142,
            "end_logit": 2.438828468322754
        },
        {
            "text": "the telomerase",
            "probability": 0.005450628120182198,
            "start_logit": -2.7648000717163086,
            "end_logit": 0.852774441242218
        },
        {
            "text": "ase",
            "probability": 0.0031823876338532495,
            "start_logit": -4.88895320892334,
            "end_logit": 2.438828468322754
        },
        {
            "text": "growth",
            "probability": 0.002291623086069396,
            "start_logit": -0.784719705581665,
            "end_logit": -1.9937764406204224
        },
        {
            "text": "cancer and critical for cancer cell immortality. We evaluated the effect of the telomerase",
            "probability": 0.0005461732037620062,
            "start_logit": -5.06535005569458,
            "end_logit": 0.852774441242218
        },
        {
            "text": "tel",
            "probability": 8.383286313428923e-05,
            "start_logit": 0.8494238257408142,
            "end_logit": -6.936110496520996
        },
        {
            "text": "effect of the telomerase",
            "probability": 3.9808831246821215e-05,
            "start_logit": -7.684197425842285,
            "end_logit": 0.852774441242218
        },
        {
            "text": "telomer",
            "probability": 3.307450679299746e-05,
            "start_logit": 0.8494238257408142,
            "end_logit": -7.866172790527344
        },
        {
            "text": "telomerase inhibitor imetelstat.",
            "probability": 2.8057497474089327e-05,
            "start_logit": 0.8494238257408142,
            "end_logit": -8.030679702758789
        },
        {
            "text": "growth inhibition",
            "probability": 6.021171843581845e-06,
            "start_logit": -0.784719705581665,
            "end_logit": -7.935510158538818
        },
        {
            "text": "telomerase inhibitor imetelstat",
            "probability": 5.146820311275162e-06,
            "start_logit": -2.675689935684204,
            "end_logit": -6.201442718505859
        },
        {
            "text": "the telomerase inhibitor imetelstat",
            "probability": 4.708027227760155e-06,
            "start_logit": -2.7648000717163086,
            "end_logit": -6.201442718505859
        },
        {
            "text": "growth inhibition. Imetelstat resulted in 40-50% growth",
            "probability": 2.465475991689212e-06,
            "start_logit": -7.619350433349609,
            "end_logit": -1.9937764406204224
        },
        {
            "text": "40-50% growth",
            "probability": 2.19622181374147e-06,
            "start_logit": -7.734996795654297,
            "end_logit": -1.9937764406204224
        },
        {
            "text": "cancer",
            "probability": 5.784230165373825e-07,
            "start_logit": -5.06535005569458,
            "end_logit": -5.9976115226745605
        },
        {
            "text": "cancer and critical for cancer cell immortality. We evaluated the effect of the telomerase inhibitor imetelstat",
            "probability": 4.7176183325795596e-07,
            "start_logit": -5.06535005569458,
            "end_logit": -6.201442718505859
        },
        {
            "text": "inhibition of telomerase",
            "probability": 2.6812140406663884e-07,
            "start_logit": -7.198421001434326,
            "end_logit": -4.633406162261963
        },
        {
            "text": "imetelstat",
            "probability": 2.4992282587810527e-07,
            "start_logit": -5.700672149658203,
            "end_logit": -6.201442718505859
        },
        {
            "text": "Telomerase is an attractive therapeutic target because it is specific to cancer",
            "probability": 5.4123310676516765e-08,
            "start_logit": -7.434390544891357,
            "end_logit": -5.9976115226745605
        },
        {
            "text": "effect of the telomerase inhibitor imetelstat",
            "probability": 3.4385222635419604e-08,
            "start_logit": -7.684197425842285,
            "end_logit": -6.201442718505859
        }
    ],
    "56c048acef6e39474100001c_009": [
        {
            "text": "telomerase",
            "probability": 0.5213211437731428,
            "start_logit": 2.871880054473877,
            "end_logit": 4.267018795013428
        },
        {
            "text": "telomerase inhibitor, was used to elucidate the effect of telomerase",
            "probability": 0.30463680440581054,
            "start_logit": 2.3346340656280518,
            "end_logit": 4.267018795013428
        },
        {
            "text": "Imetelstat, a phase 2 telomerase",
            "probability": 0.08617211459929155,
            "start_logit": 0.9529749155044556,
            "end_logit": 4.385904312133789
        },
        {
            "text": "Imetelstat, a phase 2 telomerase inhibitor, was used to elucidate the effect of telomerase",
            "probability": 0.07651303448053759,
            "start_logit": 0.9529749155044556,
            "end_logit": 4.267018795013428
        },
        {
            "text": "phase 2 telomerase",
            "probability": 0.004519250663750432,
            "start_logit": -1.9950255155563354,
            "end_logit": 4.385904312133789
        },
        {
            "text": "phase 2 telomerase inhibitor, was used to elucidate the effect of telomerase",
            "probability": 0.004012685350355462,
            "start_logit": -1.9950255155563354,
            "end_logit": 4.267018795013428
        },
        {
            "text": "telomerase inhibition",
            "probability": 0.0010640788210636834,
            "start_logit": 2.871880054473877,
            "end_logit": -1.9272379875183105
        },
        {
            "text": "ase",
            "probability": 0.0006677071282442888,
            "start_logit": -3.7883918285369873,
            "end_logit": 4.267018795013428
        },
        {
            "text": "telomerase inhibitor, was used to elucidate the effect of telomerase inhibition",
            "probability": 0.0006218001620624899,
            "start_logit": 2.3346340656280518,
            "end_logit": -1.9272379875183105
        },
        {
            "text": "Imetelstat, a phase 2 telomerase inhibitor, was used to elucidate the effect of telomerase inhibition",
            "probability": 0.0001561722567720833,
            "start_logit": 0.9529749155044556,
            "end_logit": -1.9272379875183105
        },
        {
            "text": "effect of telomerase",
            "probability": 9.308561366285459e-05,
            "start_logit": -5.758721828460693,
            "end_logit": 4.267018795013428
        },
        {
            "text": "of telomerase",
            "probability": 4.9474137534871676e-05,
            "start_logit": -6.390791416168213,
            "end_logit": 4.267018795013428
        },
        {
            "text": "a phase 2 telomerase",
            "probability": 4.24766568639935e-05,
            "start_logit": -6.662172317504883,
            "end_logit": 4.385904312133789
        },
        {
            "text": "a phase 2 telomerase inhibitor, was used to elucidate the effect of telomerase",
            "probability": 3.771542483743829e-05,
            "start_logit": -6.662172317504883,
            "end_logit": 4.267018795013428
        },
        {
            "text": "the effect of telomerase",
            "probability": 2.671338457911804e-05,
            "start_logit": -7.007076740264893,
            "end_logit": 4.267018795013428
        },
        {
            "text": "inhibitor, was used to elucidate the effect of telomerase",
            "probability": 1.7167195319125894e-05,
            "start_logit": -7.4492411613464355,
            "end_logit": 4.267018795013428
        },
        {
            "text": "2 telomerase",
            "probability": 1.616933778276141e-05,
            "start_logit": -7.628010272979736,
            "end_logit": 4.385904312133789
        },
        {
            "text": "2 telomerase inhibitor, was used to elucidate the effect of telomerase",
            "probability": 1.4356907742752018e-05,
            "start_logit": -7.628010272979736,
            "end_logit": 4.267018795013428
        },
        {
            "text": "tel",
            "probability": 9.859329801245526e-06,
            "start_logit": 2.871880054473877,
            "end_logit": -6.608684539794922
        },
        {
            "text": "phase 2 telomerase inhibitor, was used to elucidate the effect of telomerase inhibition",
            "probability": 8.190370845123056e-06,
            "start_logit": -1.9950255155563354,
            "end_logit": -1.9272379875183105
        }
    ],
    "56c048acef6e39474100001c_010": [
        {
            "text": "telomerase",
            "probability": 0.5213211437731428,
            "start_logit": 2.871880054473877,
            "end_logit": 4.267018795013428
        },
        {
            "text": "telomerase inhibitor, was used to elucidate the effect of telomerase",
            "probability": 0.30463680440581054,
            "start_logit": 2.3346340656280518,
            "end_logit": 4.267018795013428
        },
        {
            "text": "Imetelstat, a phase 2 telomerase",
            "probability": 0.08617211459929155,
            "start_logit": 0.9529749155044556,
            "end_logit": 4.385904312133789
        },
        {
            "text": "Imetelstat, a phase 2 telomerase inhibitor, was used to elucidate the effect of telomerase",
            "probability": 0.07651303448053759,
            "start_logit": 0.9529749155044556,
            "end_logit": 4.267018795013428
        },
        {
            "text": "phase 2 telomerase",
            "probability": 0.004519250663750432,
            "start_logit": -1.9950255155563354,
            "end_logit": 4.385904312133789
        },
        {
            "text": "phase 2 telomerase inhibitor, was used to elucidate the effect of telomerase",
            "probability": 0.004012685350355462,
            "start_logit": -1.9950255155563354,
            "end_logit": 4.267018795013428
        },
        {
            "text": "telomerase inhibition",
            "probability": 0.0010640788210636834,
            "start_logit": 2.871880054473877,
            "end_logit": -1.9272379875183105
        },
        {
            "text": "ase",
            "probability": 0.0006677071282442888,
            "start_logit": -3.7883918285369873,
            "end_logit": 4.267018795013428
        },
        {
            "text": "telomerase inhibitor, was used to elucidate the effect of telomerase inhibition",
            "probability": 0.0006218001620624899,
            "start_logit": 2.3346340656280518,
            "end_logit": -1.9272379875183105
        },
        {
            "text": "Imetelstat, a phase 2 telomerase inhibitor, was used to elucidate the effect of telomerase inhibition",
            "probability": 0.0001561722567720833,
            "start_logit": 0.9529749155044556,
            "end_logit": -1.9272379875183105
        },
        {
            "text": "effect of telomerase",
            "probability": 9.308561366285459e-05,
            "start_logit": -5.758721828460693,
            "end_logit": 4.267018795013428
        },
        {
            "text": "of telomerase",
            "probability": 4.9474137534871676e-05,
            "start_logit": -6.390791416168213,
            "end_logit": 4.267018795013428
        },
        {
            "text": "a phase 2 telomerase",
            "probability": 4.24766568639935e-05,
            "start_logit": -6.662172317504883,
            "end_logit": 4.385904312133789
        },
        {
            "text": "a phase 2 telomerase inhibitor, was used to elucidate the effect of telomerase",
            "probability": 3.771542483743829e-05,
            "start_logit": -6.662172317504883,
            "end_logit": 4.267018795013428
        },
        {
            "text": "the effect of telomerase",
            "probability": 2.671338457911804e-05,
            "start_logit": -7.007076740264893,
            "end_logit": 4.267018795013428
        },
        {
            "text": "inhibitor, was used to elucidate the effect of telomerase",
            "probability": 1.7167195319125894e-05,
            "start_logit": -7.4492411613464355,
            "end_logit": 4.267018795013428
        },
        {
            "text": "2 telomerase",
            "probability": 1.616933778276141e-05,
            "start_logit": -7.628010272979736,
            "end_logit": 4.385904312133789
        },
        {
            "text": "2 telomerase inhibitor, was used to elucidate the effect of telomerase",
            "probability": 1.4356907742752018e-05,
            "start_logit": -7.628010272979736,
            "end_logit": 4.267018795013428
        },
        {
            "text": "tel",
            "probability": 9.859329801245526e-06,
            "start_logit": 2.871880054473877,
            "end_logit": -6.608684539794922
        },
        {
            "text": "phase 2 telomerase inhibitor, was used to elucidate the effect of telomerase inhibition",
            "probability": 8.190370845123056e-06,
            "start_logit": -1.9950255155563354,
            "end_logit": -1.9272379875183105
        }
    ],
    "56c048acef6e39474100001c_011": [
        {
            "text": "telomerase.",
            "probability": 0.791991225284838,
            "start_logit": 5.947620868682861,
            "end_logit": 7.319763660430908
        },
        {
            "text": "of telomerase.",
            "probability": 0.1737368864575988,
            "start_logit": 4.430612564086914,
            "end_logit": 7.319763660430908
        },
        {
            "text": "telomerase",
            "probability": 0.013595917997410195,
            "start_logit": 5.947620868682861,
            "end_logit": 3.2549829483032227
        },
        {
            "text": "telomerase. It binds with high affinity to the template region of the RNA component of human telomerase",
            "probability": 0.0132032523407791,
            "start_logit": 5.947620868682861,
            "end_logit": 3.2256765365600586
        },
        {
            "text": "human telomerase (hTERC) and is a competitive inhibitor of telomerase",
            "probability": 0.003814924405131572,
            "start_logit": 2.616645336151123,
            "end_logit": 5.315109729766846
        },
        {
            "text": "of telomerase. It binds with high affinity to the template region of the RNA component of human telomerase",
            "probability": 0.0028963603125476173,
            "start_logit": 4.430612564086914,
            "end_logit": 3.2256765365600586
        },
        {
            "text": "human telomerase",
            "probability": 0.0004721246006363209,
            "start_logit": 2.616645336151123,
            "end_logit": 3.2256765365600586
        },
        {
            "text": ".",
            "probability": 0.00019702753199798333,
            "start_logit": -2.3513412475585938,
            "end_logit": 7.319763660430908
        },
        {
            "text": "inhibitor of telomerase.",
            "probability": 5.487950632885402e-05,
            "start_logit": -3.629544734954834,
            "end_logit": 7.319763660430908
        },
        {
            "text": "telomerase (hTERC) and is a competitive inhibitor of telomerase",
            "probability": 1.0515597774752637e-05,
            "start_logit": -3.2771711349487305,
            "end_logit": 5.315109729766846
        },
        {
            "text": "ase",
            "probability": 9.621971808527022e-06,
            "start_logit": -3.3659815788269043,
            "end_logit": 5.315109729766846
        },
        {
            "text": "of telomerase",
            "probability": 4.402550770157146e-06,
            "start_logit": -4.147846698760986,
            "end_logit": 5.315109729766846
        },
        {
            "text": "tel",
            "probability": 3.9658096193407856e-06,
            "start_logit": 5.947620868682861,
            "end_logit": -4.88483190536499
        },
        {
            "text": "specific inhibitor of telomerase.",
            "probability": 3.857872772055242e-06,
            "start_logit": -6.284568786621094,
            "end_logit": 7.319763660430908
        },
        {
            "text": "telomerase. It binds with high affinity to the template region of the RNA component of human",
            "probability": 1.5350168277076906e-06,
            "start_logit": 5.947620868682861,
            "end_logit": -5.834000587463379
        },
        {
            "text": "of",
            "probability": 1.0068297508767422e-06,
            "start_logit": 4.430612564086914,
            "end_logit": -4.73872709274292
        },
        {
            "text": "inhibitor of telomerase",
            "probability": 9.596600623585593e-07,
            "start_logit": -5.671206951141357,
            "end_logit": 5.315109729766846
        },
        {
            "text": "inhibitor of telomerase. It binds with high affinity to the template region of the RNA component of human telomerase",
            "probability": 9.148939372865484e-07,
            "start_logit": -3.629544734954834,
            "end_logit": 3.2256765365600586
        },
        {
            "text": "of telomerase. It binds with high affinity to the template region of the RNA component of human",
            "probability": 3.3673232201536113e-07,
            "start_logit": 4.430612564086914,
            "end_logit": -5.834000587463379
        },
        {
            "text": "telomer",
            "probability": 2.8462708641421493e-07,
            "start_logit": 5.947620868682861,
            "end_logit": -7.51911735534668
        }
    ],
    "56c048acef6e39474100001c_012": [
        {
            "text": "telomerase",
            "probability": 0.9963887831838663,
            "start_logit": 3.828627109527588,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "ase",
            "probability": 0.0016155873464689112,
            "start_logit": -2.5958118438720703,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "inhibited telomerase",
            "probability": 0.0013425750299816313,
            "start_logit": -2.78092098236084,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "telomerase activity",
            "probability": 0.0005312455086606161,
            "start_logit": 3.828627109527588,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "Imetelstat inhibited telomerase",
            "probability": 9.548241903159017e-05,
            "start_logit": -5.424323558807373,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "omerase",
            "probability": 1.0736277580402372e-05,
            "start_logit": -7.609637260437012,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "tel",
            "probability": 9.490878889379225e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -6.008081912994385
        },
        {
            "text": "telomerase activity in",
            "probability": 2.2068448072832828e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.466849327087402
        },
        {
            "text": "telomer",
            "probability": 1.8164552377251532e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.661526203155518
        },
        {
            "text": "inhibited telomerase activity",
            "probability": 7.158219429553916e-07,
            "start_logit": -2.78092098236084,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase activity in both subpopulations.",
            "probability": 5.657553087794565e-07,
            "start_logit": 3.828627109527588,
            "end_logit": -8.828006744384766
        },
        {
            "text": "activity",
            "probability": 4.24596200415884e-07,
            "start_logit": -3.3032138347625732,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase inhibition in anti-cancer therapy. The purpose of this study was to investigate the effects of a telomerase",
            "probability": 2.8346319467357703e-07,
            "start_logit": -7.6556501388549805,
            "end_logit": 1.965191125869751
        },
        {
            "text": "Imetelstat inhibited telomerase activity",
            "probability": 5.0908447709033335e-08,
            "start_logit": -5.424323558807373,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "The telomerase",
            "probability": 1.6266868151125048e-08,
            "start_logit": -7.169773101806641,
            "end_logit": -1.3786377906799316
        },
        {
            "text": "inhibited",
            "probability": 7.132996524177216e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -6.591888904571533
        },
        {
            "text": "telomerase antagonistic oligonucleotide, imetelstat",
            "probability": 6.610788593067375e-09,
            "start_logit": -1.1074668169021606,
            "end_logit": -8.341371536254883
        },
        {
            "text": "inhibited telomerase activity in",
            "probability": 2.973593022430098e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -7.466849327087402
        },
        {
            "text": "activity in",
            "probability": 1.7638133495799876e-09,
            "start_logit": -3.3032138347625732,
            "end_logit": -7.466849327087402
        },
        {
            "text": "inhibited telomerase activity in both subpopulations.",
            "probability": 7.623218601675894e-10,
            "start_logit": -2.78092098236084,
            "end_logit": -8.828006744384766
        }
    ],
    "56c048acef6e39474100001c_013": [
        {
            "text": "of telomerase,",
            "probability": 0.950372815916993,
            "start_logit": 3.622187376022339,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase",
            "probability": 0.023860462498418337,
            "start_logit": -0.06244416907429695,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase,",
            "probability": 0.016204098454032246,
            "start_logit": -0.06244416907429695,
            "end_logit": 7.632082462310791
        },
        {
            "text": "ase",
            "probability": 0.0067801006972684815,
            "start_logit": -1.320675015449524,
            "end_logit": 8.019041061401367
        },
        {
            "text": ",",
            "probability": 0.0026625865070359443,
            "start_logit": -1.868410348892212,
            "end_logit": 7.632082462310791
        },
        {
            "text": "inhibitor of telomerase,",
            "probability": 5.4078314541359064e-05,
            "start_logit": -6.151988983154297,
            "end_logit": 8.019041061401367
        },
        {
            "text": "omerase",
            "probability": 3.1878088088714595e-05,
            "start_logit": -6.6805033683776855,
            "end_logit": 8.019041061401367
        },
        {
            "text": "the thio-phosphoramidate oligonucleotide inhibitor of telomerase,",
            "probability": 2.997616587464747e-05,
            "start_logit": -6.7420196533203125,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase activity",
            "probability": 1.6432646418000063e-06,
            "start_logit": 0.9756625294685364,
            "end_logit": -2.602358818054199
        },
        {
            "text": "imetelstat inhibited telomerase",
            "probability": 9.321220946473755e-07,
            "start_logit": -4.640310287475586,
            "end_logit": 2.4466376304626465
        },
        {
            "text": "of",
            "probability": 4.993246826142896e-07,
            "start_logit": 3.622187376022339,
            "end_logit": -6.440067291259766
        },
        {
            "text": "of telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer.",
            "probability": 3.0836329315583296e-07,
            "start_logit": 3.622187376022339,
            "end_logit": -6.9220452308654785
        },
        {
            "text": "Telomerase",
            "probability": 2.2940472910886806e-07,
            "start_logit": -2.531186103820801,
            "end_logit": -1.0644625425338745
        },
        {
            "text": "inhibited telomerase",
            "probability": 2.1447426723671319e-07,
            "start_logit": -6.109584331512451,
            "end_logit": 2.4466376304626465
        },
        {
            "text": "imetelstat",
            "probability": 6.063116282849923e-08,
            "start_logit": -2.0138134956359863,
            "end_logit": -2.9125139713287354
        },
        {
            "text": "telomer",
            "probability": 4.95301318730786e-08,
            "start_logit": -0.06244416907429695,
            "end_logit": -5.066111087799072
        },
        {
            "text": "Telomerase antagonist imetelstat",
            "probability": 3.614130488157855e-08,
            "start_logit": -2.531186103820801,
            "end_logit": -2.9125139713287354
        },
        {
            "text": "tel",
            "probability": 1.4874809364284644e-08,
            "start_logit": 0.9756625294685364,
            "end_logit": -7.307129859924316
        },
        {
            "text": "telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer.",
            "probability": 7.741899461985626e-09,
            "start_logit": -0.06244416907429695,
            "end_logit": -6.9220452308654785
        },
        {
            "text": "activity",
            "probability": 7.484730558766733e-09,
            "start_logit": -4.415912628173828,
            "end_logit": -2.602358818054199
        }
    ],
    "56c048acef6e39474100001c_014": [
        {
            "text": "imetelstat (GRN163L), a potent telomerase",
            "probability": 0.7709314051008654,
            "start_logit": 4.086793899536133,
            "end_logit": 5.77642822265625
        },
        {
            "text": "telomerase",
            "probability": 0.2279882950036232,
            "start_logit": 2.8684887886047363,
            "end_logit": 5.77642822265625
        },
        {
            "text": "ase",
            "probability": 0.001041948064057737,
            "start_logit": -2.5197134017944336,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imet",
            "probability": 1.3058689848544426e-05,
            "start_logit": 4.086793899536133,
            "end_logit": -5.20947265625
        },
        {
            "text": "potent telomerase",
            "probability": 7.722480766195089e-06,
            "start_logit": -7.42442512512207,
            "end_logit": 5.77642822265625
        },
        {
            "text": "(GRN163L), a potent telomerase",
            "probability": 6.193915722242499e-06,
            "start_logit": -7.644993305206299,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imetelstat",
            "probability": 4.48336092358432e-06,
            "start_logit": 4.086793899536133,
            "end_logit": -6.278553485870361
        },
        {
            "text": "a potent telomerase",
            "probability": 4.262933146612445e-06,
            "start_logit": -8.018603324890137,
            "end_logit": 5.77642822265625
        },
        {
            "text": "tel",
            "probability": 1.3768195189551956e-06,
            "start_logit": 2.8684887886047363,
            "end_logit": -6.240845203399658
        },
        {
            "text": "imetelstat (GRN163L),",
            "probability": 5.40940966755591e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.39337158203125
        },
        {
            "text": "imetelstat (GRN163L), a potent telomerase inhibitor,",
            "probability": 4.514397885802167e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomerase inhibitor,",
            "probability": 1.335047281952844e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomer",
            "probability": 1.2519202456294062e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.638527870178223
        },
        {
            "text": "The telomerase",
            "probability": 2.2100744386592746e-09,
            "start_logit": -6.719935417175293,
            "end_logit": -3.086926221847534
        },
        {
            "text": "telomerase activity",
            "probability": 1.6677302977740793e-10,
            "start_logit": -4.562044620513916,
            "end_logit": -7.828964710235596
        },
        {
            "text": "telomerase inhibitor imetelstat",
            "probability": 7.621672018130344e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -7.122272968292236
        },
        {
            "text": "The telomerase inhibitor imetelstat",
            "probability": 3.907311873422548e-11,
            "start_logit": -6.719935417175293,
            "end_logit": -7.122272968292236
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer stem cells",
            "probability": 2.5600680430225308e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.213234901428223
        },
        {
            "text": "telomerase inhibitor",
            "probability": 1.869787621579506e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.527443885803223
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer",
            "probability": 1.75833143618782e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.588903427124023
        }
    ],
    "56c048acef6e39474100001c_015": [
        {
            "text": "imetelstat (GRN163L), a potent telomerase",
            "probability": 0.7709314051008654,
            "start_logit": 4.086793899536133,
            "end_logit": 5.77642822265625
        },
        {
            "text": "telomerase",
            "probability": 0.2279882950036232,
            "start_logit": 2.8684887886047363,
            "end_logit": 5.77642822265625
        },
        {
            "text": "ase",
            "probability": 0.001041948064057737,
            "start_logit": -2.5197134017944336,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imet",
            "probability": 1.3058689848544426e-05,
            "start_logit": 4.086793899536133,
            "end_logit": -5.20947265625
        },
        {
            "text": "potent telomerase",
            "probability": 7.722480766195089e-06,
            "start_logit": -7.42442512512207,
            "end_logit": 5.77642822265625
        },
        {
            "text": "(GRN163L), a potent telomerase",
            "probability": 6.193915722242499e-06,
            "start_logit": -7.644993305206299,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imetelstat",
            "probability": 4.48336092358432e-06,
            "start_logit": 4.086793899536133,
            "end_logit": -6.278553485870361
        },
        {
            "text": "a potent telomerase",
            "probability": 4.262933146612445e-06,
            "start_logit": -8.018603324890137,
            "end_logit": 5.77642822265625
        },
        {
            "text": "tel",
            "probability": 1.3768195189551956e-06,
            "start_logit": 2.8684887886047363,
            "end_logit": -6.240845203399658
        },
        {
            "text": "imetelstat (GRN163L),",
            "probability": 5.40940966755591e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.39337158203125
        },
        {
            "text": "imetelstat (GRN163L), a potent telomerase inhibitor,",
            "probability": 4.514397885802167e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomerase inhibitor,",
            "probability": 1.335047281952844e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomer",
            "probability": 1.2519202456294062e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.638527870178223
        },
        {
            "text": "The telomerase",
            "probability": 2.2100744386592746e-09,
            "start_logit": -6.719935417175293,
            "end_logit": -3.086926221847534
        },
        {
            "text": "telomerase activity",
            "probability": 1.6677302977740793e-10,
            "start_logit": -4.562044620513916,
            "end_logit": -7.828964710235596
        },
        {
            "text": "telomerase inhibitor imetelstat",
            "probability": 7.621672018130344e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -7.122272968292236
        },
        {
            "text": "The telomerase inhibitor imetelstat",
            "probability": 3.907311873422548e-11,
            "start_logit": -6.719935417175293,
            "end_logit": -7.122272968292236
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer stem cells",
            "probability": 2.5600680430225308e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.213234901428223
        },
        {
            "text": "telomerase inhibitor",
            "probability": 1.869787621579506e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.527443885803223
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer",
            "probability": 1.75833143618782e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.588903427124023
        }
    ],
    "56c048acef6e39474100001c_016": [
        {
            "text": "telomerase",
            "probability": 0.9963887831838663,
            "start_logit": 3.828627109527588,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "ase",
            "probability": 0.0016155873464689112,
            "start_logit": -2.5958118438720703,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "inhibited telomerase",
            "probability": 0.0013425750299816313,
            "start_logit": -2.78092098236084,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "telomerase activity",
            "probability": 0.0005312455086606161,
            "start_logit": 3.828627109527588,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "Imetelstat inhibited telomerase",
            "probability": 9.548241903159017e-05,
            "start_logit": -5.424323558807373,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "omerase",
            "probability": 1.0736277580402372e-05,
            "start_logit": -7.609637260437012,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "tel",
            "probability": 9.490878889379225e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -6.008081912994385
        },
        {
            "text": "telomerase activity in",
            "probability": 2.2068448072832828e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.466849327087402
        },
        {
            "text": "telomer",
            "probability": 1.8164552377251532e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.661526203155518
        },
        {
            "text": "inhibited telomerase activity",
            "probability": 7.158219429553916e-07,
            "start_logit": -2.78092098236084,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase activity in both subpopulations.",
            "probability": 5.657553087794565e-07,
            "start_logit": 3.828627109527588,
            "end_logit": -8.828006744384766
        },
        {
            "text": "activity",
            "probability": 4.24596200415884e-07,
            "start_logit": -3.3032138347625732,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase inhibition in anti-cancer therapy. The purpose of this study was to investigate the effects of a telomerase",
            "probability": 2.8346319467357703e-07,
            "start_logit": -7.6556501388549805,
            "end_logit": 1.965191125869751
        },
        {
            "text": "Imetelstat inhibited telomerase activity",
            "probability": 5.0908447709033335e-08,
            "start_logit": -5.424323558807373,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "The telomerase",
            "probability": 1.6266868151125048e-08,
            "start_logit": -7.169773101806641,
            "end_logit": -1.3786377906799316
        },
        {
            "text": "inhibited",
            "probability": 7.132996524177216e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -6.591888904571533
        },
        {
            "text": "telomerase antagonistic oligonucleotide, imetelstat",
            "probability": 6.610788593067375e-09,
            "start_logit": -1.1074668169021606,
            "end_logit": -8.341371536254883
        },
        {
            "text": "inhibited telomerase activity in",
            "probability": 2.973593022430098e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -7.466849327087402
        },
        {
            "text": "activity in",
            "probability": 1.7638133495799876e-09,
            "start_logit": -3.3032138347625732,
            "end_logit": -7.466849327087402
        },
        {
            "text": "inhibited telomerase activity in both subpopulations.",
            "probability": 7.623218601675894e-10,
            "start_logit": -2.78092098236084,
            "end_logit": -8.828006744384766
        }
    ],
    "56c048acef6e39474100001c_017": [
        {
            "text": "of telomerase,",
            "probability": 0.950372815916993,
            "start_logit": 3.622187376022339,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase",
            "probability": 0.023860462498418337,
            "start_logit": -0.06244416907429695,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase,",
            "probability": 0.016204098454032246,
            "start_logit": -0.06244416907429695,
            "end_logit": 7.632082462310791
        },
        {
            "text": "ase",
            "probability": 0.0067801006972684815,
            "start_logit": -1.320675015449524,
            "end_logit": 8.019041061401367
        },
        {
            "text": ",",
            "probability": 0.0026625865070359443,
            "start_logit": -1.868410348892212,
            "end_logit": 7.632082462310791
        },
        {
            "text": "inhibitor of telomerase,",
            "probability": 5.4078314541359064e-05,
            "start_logit": -6.151988983154297,
            "end_logit": 8.019041061401367
        },
        {
            "text": "omerase",
            "probability": 3.1878088088714595e-05,
            "start_logit": -6.6805033683776855,
            "end_logit": 8.019041061401367
        },
        {
            "text": "the thio-phosphoramidate oligonucleotide inhibitor of telomerase,",
            "probability": 2.997616587464747e-05,
            "start_logit": -6.7420196533203125,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase activity",
            "probability": 1.6432646418000063e-06,
            "start_logit": 0.9756625294685364,
            "end_logit": -2.602358818054199
        },
        {
            "text": "imetelstat inhibited telomerase",
            "probability": 9.321220946473755e-07,
            "start_logit": -4.640310287475586,
            "end_logit": 2.4466376304626465
        },
        {
            "text": "of",
            "probability": 4.993246826142896e-07,
            "start_logit": 3.622187376022339,
            "end_logit": -6.440067291259766
        },
        {
            "text": "of telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer.",
            "probability": 3.0836329315583296e-07,
            "start_logit": 3.622187376022339,
            "end_logit": -6.9220452308654785
        },
        {
            "text": "Telomerase",
            "probability": 2.2940472910886806e-07,
            "start_logit": -2.531186103820801,
            "end_logit": -1.0644625425338745
        },
        {
            "text": "inhibited telomerase",
            "probability": 2.1447426723671319e-07,
            "start_logit": -6.109584331512451,
            "end_logit": 2.4466376304626465
        },
        {
            "text": "imetelstat",
            "probability": 6.063116282849923e-08,
            "start_logit": -2.0138134956359863,
            "end_logit": -2.9125139713287354
        },
        {
            "text": "telomer",
            "probability": 4.95301318730786e-08,
            "start_logit": -0.06244416907429695,
            "end_logit": -5.066111087799072
        },
        {
            "text": "Telomerase antagonist imetelstat",
            "probability": 3.614130488157855e-08,
            "start_logit": -2.531186103820801,
            "end_logit": -2.9125139713287354
        },
        {
            "text": "tel",
            "probability": 1.4874809364284644e-08,
            "start_logit": 0.9756625294685364,
            "end_logit": -7.307129859924316
        },
        {
            "text": "telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer.",
            "probability": 7.741899461985626e-09,
            "start_logit": -0.06244416907429695,
            "end_logit": -6.9220452308654785
        },
        {
            "text": "activity",
            "probability": 7.484730558766733e-09,
            "start_logit": -4.415912628173828,
            "end_logit": -2.602358818054199
        }
    ],
    "56c048acef6e39474100001c_018": [
        {
            "text": "telomerase",
            "probability": 0.9562509259003759,
            "start_logit": -0.6880496740341187,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "ase",
            "probability": 0.01821324386899282,
            "start_logit": -4.648921012878418,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "Imetelstat (a telomerase",
            "probability": 0.009866486903661221,
            "start_logit": -5.261926174163818,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 0.006203283684320604,
            "start_logit": -0.6880496740341187,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomerase",
            "probability": 0.004570762663297862,
            "start_logit": -0.9934483766555786,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "(a telomerase",
            "probability": 0.004464816125569078,
            "start_logit": -6.054841995239258,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 0.0001043603313785203,
            "start_logit": -4.77303409576416,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Imetelstat (a telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 6.400476650353696e-05,
            "start_logit": -5.261926174163818,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 3.6369864706683125e-05,
            "start_logit": -5.82714319229126,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "telomerase antagonist)",
            "probability": 3.406506819683167e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -6.981463432312012
        },
        {
            "text": "Telomerase is a cellular ribonucleoprotein reverse transcriptase",
            "probability": 2.990908979685048e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -6.8061747550964355
        },
        {
            "text": "(a telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 2.896365407349124e-05,
            "start_logit": -6.054841995239258,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "telomerase antagonist) exerts off - target effects on the cytoskeleton.",
            "probability": 2.2198273686512296e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.409721374511719
        },
        {
            "text": "telomerase antagonist) exerts off - target",
            "probability": 2.1170330526620317e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.457135200500488
        },
        {
            "text": "off - target effects on the cytoskeleton. Telomerase",
            "probability": 2.0018827044145337e-05,
            "start_logit": -6.424210548400879,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomer",
            "probability": 1.8917571685184308e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -7.264245986938477
        },
        {
            "text": "telomerase antagonist) exerts",
            "probability": 1.33129510581008e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.920998573303223
        },
        {
            "text": "telomerase antagonist) exerts off - target effects",
            "probability": 1.3147671470881231e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.933491230010986
        },
        {
            "text": "effects on the cytoskeleton. Telomerase",
            "probability": 1.2173459329727276e-05,
            "start_logit": -6.92162561416626,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomerase is a cellular ribonucleoprotein",
            "probability": 1.186899432612024e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -7.73040771484375
        }
    ],
    "56c048acef6e39474100001c_019": [
        {
            "text": "human telomerase",
            "probability": 0.9996696591924479,
            "start_logit": 9.56663703918457,
            "end_logit": 8.64490795135498
        },
        {
            "text": "human",
            "probability": 0.0002715520467827873,
            "start_logit": 9.56663703918457,
            "end_logit": 0.43388161063194275
        },
        {
            "text": "ase",
            "probability": 4.359593427673389e-05,
            "start_logit": -0.4735792279243469,
            "end_logit": 8.64490795135498
        },
        {
            "text": "telomerase",
            "probability": 1.4978258143109647e-05,
            "start_logit": -1.5419434309005737,
            "end_logit": 8.64490795135498
        },
        {
            "text": "omerase",
            "probability": 8.716432558989415e-08,
            "start_logit": -6.688503265380859,
            "end_logit": 8.64490795135498
        },
        {
            "text": "human telomerase antagonist, imetelstat,",
            "probability": 6.839936195036e-08,
            "start_logit": 9.56663703918457,
            "end_logit": -7.852663993835449
        },
        {
            "text": "human telomerase antagonist, imetelstat, on primary human glioblastoma",
            "probability": 5.730961179533409e-08,
            "start_logit": 9.56663703918457,
            "end_logit": -8.029559135437012
        },
        {
            "text": "RESULTS: Imetelstat treatment produced a dose-dependent inhibition of telomerase",
            "probability": 4.6122577574872265e-10,
            "start_logit": -5.316318511962891,
            "end_logit": 2.0310604572296143
        },
        {
            "text": "inhibition of telomerase",
            "probability": 3.882068598556945e-10,
            "start_logit": -3.700751304626465,
            "end_logit": 0.24314391613006592
        },
        {
            "text": "produced a dose-dependent inhibition of telomerase",
            "probability": 2.336323230224272e-10,
            "start_logit": -5.996457576751709,
            "end_logit": 2.0310604572296143
        },
        {
            "text": "Imetelstat treatment produced a dose-dependent inhibition of telomerase",
            "probability": 2.2842524349410296e-10,
            "start_logit": -6.0189971923828125,
            "end_logit": 2.0310604572296143
        },
        {
            "text": "of telomerase",
            "probability": 1.7837736542180158e-10,
            "start_logit": -4.47838830947876,
            "end_logit": 0.24314391613006592
        },
        {
            "text": "a dose-dependent inhibition of telomerase",
            "probability": 9.722400943384258e-11,
            "start_logit": -6.873188495635986,
            "end_logit": 2.0310604572296143
        },
        {
            "text": "treatment produced a dose-dependent inhibition of telomerase",
            "probability": 9.64439034397471e-11,
            "start_logit": -6.881244659423828,
            "end_logit": 2.0310604572296143
        },
        {
            "text": "telomer",
            "probability": 3.0151667231976414e-12,
            "start_logit": -1.5419434309005737,
            "end_logit": -6.773547172546387
        },
        {
            "text": "telomerase antagonist, imetelstat,",
            "probability": 2.9829194681844107e-12,
            "start_logit": -0.4735792279243469,
            "end_logit": -7.852663993835449
        },
        {
            "text": "telomerase antagonist, imetelstat, on primary human glioblastoma",
            "probability": 2.499291687288806e-12,
            "start_logit": -0.4735792279243469,
            "end_logit": -8.029559135437012
        },
        {
            "text": "tel",
            "probability": 1.5765029062616923e-12,
            "start_logit": -1.5419434309005737,
            "end_logit": -7.421993255615234
        },
        {
            "text": "telomerase (IC(50) 0.45",
            "probability": 7.364106087818258e-13,
            "start_logit": -1.2342360019683838,
            "end_logit": -8.490877151489258
        },
        {
            "text": "telomerase (IC(50) 0.45 micromol/L).",
            "probability": 7.04191291179714e-13,
            "start_logit": -1.2342360019683838,
            "end_logit": -8.535614967346191
        }
    ],
    "56c048acef6e39474100001c_020": [
        {
            "text": "telomerase",
            "probability": 0.9883222198026839,
            "start_logit": 0.8494238257408142,
            "end_logit": 2.438828468322754
        },
        {
            "text": "the telomerase",
            "probability": 0.005450628120182198,
            "start_logit": -2.7648000717163086,
            "end_logit": 0.852774441242218
        },
        {
            "text": "ase",
            "probability": 0.0031823876338532495,
            "start_logit": -4.88895320892334,
            "end_logit": 2.438828468322754
        },
        {
            "text": "growth",
            "probability": 0.002291623086069396,
            "start_logit": -0.784719705581665,
            "end_logit": -1.9937764406204224
        },
        {
            "text": "cancer and critical for cancer cell immortality. We evaluated the effect of the telomerase",
            "probability": 0.0005461732037620062,
            "start_logit": -5.06535005569458,
            "end_logit": 0.852774441242218
        },
        {
            "text": "tel",
            "probability": 8.383286313428923e-05,
            "start_logit": 0.8494238257408142,
            "end_logit": -6.936110496520996
        },
        {
            "text": "effect of the telomerase",
            "probability": 3.9808831246821215e-05,
            "start_logit": -7.684197425842285,
            "end_logit": 0.852774441242218
        },
        {
            "text": "telomer",
            "probability": 3.307450679299746e-05,
            "start_logit": 0.8494238257408142,
            "end_logit": -7.866172790527344
        },
        {
            "text": "telomerase inhibitor imetelstat.",
            "probability": 2.8057497474089327e-05,
            "start_logit": 0.8494238257408142,
            "end_logit": -8.030679702758789
        },
        {
            "text": "growth inhibition",
            "probability": 6.021171843581845e-06,
            "start_logit": -0.784719705581665,
            "end_logit": -7.935510158538818
        },
        {
            "text": "telomerase inhibitor imetelstat",
            "probability": 5.146820311275162e-06,
            "start_logit": -2.675689935684204,
            "end_logit": -6.201442718505859
        },
        {
            "text": "the telomerase inhibitor imetelstat",
            "probability": 4.708027227760155e-06,
            "start_logit": -2.7648000717163086,
            "end_logit": -6.201442718505859
        },
        {
            "text": "growth inhibition. Imetelstat resulted in 40-50% growth",
            "probability": 2.465475991689212e-06,
            "start_logit": -7.619350433349609,
            "end_logit": -1.9937764406204224
        },
        {
            "text": "40-50% growth",
            "probability": 2.19622181374147e-06,
            "start_logit": -7.734996795654297,
            "end_logit": -1.9937764406204224
        },
        {
            "text": "cancer",
            "probability": 5.784230165373825e-07,
            "start_logit": -5.06535005569458,
            "end_logit": -5.9976115226745605
        },
        {
            "text": "cancer and critical for cancer cell immortality. We evaluated the effect of the telomerase inhibitor imetelstat",
            "probability": 4.7176183325795596e-07,
            "start_logit": -5.06535005569458,
            "end_logit": -6.201442718505859
        },
        {
            "text": "inhibition of telomerase",
            "probability": 2.6812140406663884e-07,
            "start_logit": -7.198421001434326,
            "end_logit": -4.633406162261963
        },
        {
            "text": "imetelstat",
            "probability": 2.4992282587810527e-07,
            "start_logit": -5.700672149658203,
            "end_logit": -6.201442718505859
        },
        {
            "text": "Telomerase is an attractive therapeutic target because it is specific to cancer",
            "probability": 5.4123310676516765e-08,
            "start_logit": -7.434390544891357,
            "end_logit": -5.9976115226745605
        },
        {
            "text": "effect of the telomerase inhibitor imetelstat",
            "probability": 3.4385222635419604e-08,
            "start_logit": -7.684197425842285,
            "end_logit": -6.201442718505859
        }
    ],
    "56c048acef6e39474100001c_021": [
        {
            "text": "telomerase",
            "probability": 0.9963887831838663,
            "start_logit": 3.828627109527588,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "ase",
            "probability": 0.0016155873464689112,
            "start_logit": -2.5958118438720703,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "inhibited telomerase",
            "probability": 0.0013425750299816313,
            "start_logit": -2.78092098236084,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "telomerase activity",
            "probability": 0.0005312455086606161,
            "start_logit": 3.828627109527588,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "Imetelstat inhibited telomerase",
            "probability": 9.548241903159017e-05,
            "start_logit": -5.424323558807373,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "omerase",
            "probability": 1.0736277580402372e-05,
            "start_logit": -7.609637260437012,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "tel",
            "probability": 9.490878889379225e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -6.008081912994385
        },
        {
            "text": "telomerase activity in",
            "probability": 2.2068448072832828e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.466849327087402
        },
        {
            "text": "telomer",
            "probability": 1.8164552377251532e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.661526203155518
        },
        {
            "text": "inhibited telomerase activity",
            "probability": 7.158219429553916e-07,
            "start_logit": -2.78092098236084,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase activity in both subpopulations.",
            "probability": 5.657553087794565e-07,
            "start_logit": 3.828627109527588,
            "end_logit": -8.828006744384766
        },
        {
            "text": "activity",
            "probability": 4.24596200415884e-07,
            "start_logit": -3.3032138347625732,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase inhibition in anti-cancer therapy. The purpose of this study was to investigate the effects of a telomerase",
            "probability": 2.8346319467357703e-07,
            "start_logit": -7.6556501388549805,
            "end_logit": 1.965191125869751
        },
        {
            "text": "Imetelstat inhibited telomerase activity",
            "probability": 5.0908447709033335e-08,
            "start_logit": -5.424323558807373,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "The telomerase",
            "probability": 1.6266868151125048e-08,
            "start_logit": -7.169773101806641,
            "end_logit": -1.3786377906799316
        },
        {
            "text": "inhibited",
            "probability": 7.132996524177216e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -6.591888904571533
        },
        {
            "text": "telomerase antagonistic oligonucleotide, imetelstat",
            "probability": 6.610788593067375e-09,
            "start_logit": -1.1074668169021606,
            "end_logit": -8.341371536254883
        },
        {
            "text": "inhibited telomerase activity in",
            "probability": 2.973593022430098e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -7.466849327087402
        },
        {
            "text": "activity in",
            "probability": 1.7638133495799876e-09,
            "start_logit": -3.3032138347625732,
            "end_logit": -7.466849327087402
        },
        {
            "text": "inhibited telomerase activity in both subpopulations.",
            "probability": 7.623218601675894e-10,
            "start_logit": -2.78092098236084,
            "end_logit": -8.828006744384766
        }
    ],
    "56c048acef6e39474100001c_022": [
        {
            "text": "of telomerase,",
            "probability": 0.950372815916993,
            "start_logit": 3.622187376022339,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase",
            "probability": 0.023860462498418337,
            "start_logit": -0.06244416907429695,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase,",
            "probability": 0.016204098454032246,
            "start_logit": -0.06244416907429695,
            "end_logit": 7.632082462310791
        },
        {
            "text": "ase",
            "probability": 0.0067801006972684815,
            "start_logit": -1.320675015449524,
            "end_logit": 8.019041061401367
        },
        {
            "text": ",",
            "probability": 0.0026625865070359443,
            "start_logit": -1.868410348892212,
            "end_logit": 7.632082462310791
        },
        {
            "text": "inhibitor of telomerase,",
            "probability": 5.4078314541359064e-05,
            "start_logit": -6.151988983154297,
            "end_logit": 8.019041061401367
        },
        {
            "text": "omerase",
            "probability": 3.1878088088714595e-05,
            "start_logit": -6.6805033683776855,
            "end_logit": 8.019041061401367
        },
        {
            "text": "the thio-phosphoramidate oligonucleotide inhibitor of telomerase,",
            "probability": 2.997616587464747e-05,
            "start_logit": -6.7420196533203125,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase activity",
            "probability": 1.6432646418000063e-06,
            "start_logit": 0.9756625294685364,
            "end_logit": -2.602358818054199
        },
        {
            "text": "imetelstat inhibited telomerase",
            "probability": 9.321220946473755e-07,
            "start_logit": -4.640310287475586,
            "end_logit": 2.4466376304626465
        },
        {
            "text": "of",
            "probability": 4.993246826142896e-07,
            "start_logit": 3.622187376022339,
            "end_logit": -6.440067291259766
        },
        {
            "text": "of telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer.",
            "probability": 3.0836329315583296e-07,
            "start_logit": 3.622187376022339,
            "end_logit": -6.9220452308654785
        },
        {
            "text": "Telomerase",
            "probability": 2.2940472910886806e-07,
            "start_logit": -2.531186103820801,
            "end_logit": -1.0644625425338745
        },
        {
            "text": "inhibited telomerase",
            "probability": 2.1447426723671319e-07,
            "start_logit": -6.109584331512451,
            "end_logit": 2.4466376304626465
        },
        {
            "text": "imetelstat",
            "probability": 6.063116282849923e-08,
            "start_logit": -2.0138134956359863,
            "end_logit": -2.9125139713287354
        },
        {
            "text": "telomer",
            "probability": 4.95301318730786e-08,
            "start_logit": -0.06244416907429695,
            "end_logit": -5.066111087799072
        },
        {
            "text": "Telomerase antagonist imetelstat",
            "probability": 3.614130488157855e-08,
            "start_logit": -2.531186103820801,
            "end_logit": -2.9125139713287354
        },
        {
            "text": "tel",
            "probability": 1.4874809364284644e-08,
            "start_logit": 0.9756625294685364,
            "end_logit": -7.307129859924316
        },
        {
            "text": "telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer.",
            "probability": 7.741899461985626e-09,
            "start_logit": -0.06244416907429695,
            "end_logit": -6.9220452308654785
        },
        {
            "text": "activity",
            "probability": 7.484730558766733e-09,
            "start_logit": -4.415912628173828,
            "end_logit": -2.602358818054199
        }
    ],
    "56c048acef6e39474100001c_023": [
        {
            "text": "telomerase",
            "probability": 0.9562509259003759,
            "start_logit": -0.6880496740341187,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "ase",
            "probability": 0.01821324386899282,
            "start_logit": -4.648921012878418,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "Imetelstat (a telomerase",
            "probability": 0.009866486903661221,
            "start_logit": -5.261926174163818,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 0.006203283684320604,
            "start_logit": -0.6880496740341187,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomerase",
            "probability": 0.004570762663297862,
            "start_logit": -0.9934483766555786,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "(a telomerase",
            "probability": 0.004464816125569078,
            "start_logit": -6.054841995239258,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 0.0001043603313785203,
            "start_logit": -4.77303409576416,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Imetelstat (a telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 6.400476650353696e-05,
            "start_logit": -5.261926174163818,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 3.6369864706683125e-05,
            "start_logit": -5.82714319229126,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "telomerase antagonist)",
            "probability": 3.406506819683167e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -6.981463432312012
        },
        {
            "text": "Telomerase is a cellular ribonucleoprotein reverse transcriptase",
            "probability": 2.990908979685048e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -6.8061747550964355
        },
        {
            "text": "(a telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 2.896365407349124e-05,
            "start_logit": -6.054841995239258,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "telomerase antagonist) exerts off - target effects on the cytoskeleton.",
            "probability": 2.2198273686512296e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.409721374511719
        },
        {
            "text": "telomerase antagonist) exerts off - target",
            "probability": 2.1170330526620317e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.457135200500488
        },
        {
            "text": "off - target effects on the cytoskeleton. Telomerase",
            "probability": 2.0018827044145337e-05,
            "start_logit": -6.424210548400879,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomer",
            "probability": 1.8917571685184308e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -7.264245986938477
        },
        {
            "text": "telomerase antagonist) exerts",
            "probability": 1.33129510581008e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.920998573303223
        },
        {
            "text": "telomerase antagonist) exerts off - target effects",
            "probability": 1.3147671470881231e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.933491230010986
        },
        {
            "text": "effects on the cytoskeleton. Telomerase",
            "probability": 1.2173459329727276e-05,
            "start_logit": -6.92162561416626,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomerase is a cellular ribonucleoprotein",
            "probability": 1.186899432612024e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -7.73040771484375
        }
    ],
    "56c048acef6e39474100001c_024": [
        {
            "text": "human telomerase",
            "probability": 0.9996696591924479,
            "start_logit": 9.56663703918457,
            "end_logit": 8.64490795135498
        },
        {
            "text": "human",
            "probability": 0.0002715520467827873,
            "start_logit": 9.56663703918457,
            "end_logit": 0.43388161063194275
        },
        {
            "text": "ase",
            "probability": 4.359593427673389e-05,
            "start_logit": -0.4735792279243469,
            "end_logit": 8.64490795135498
        },
        {
            "text": "telomerase",
            "probability": 1.4978258143109647e-05,
            "start_logit": -1.5419434309005737,
            "end_logit": 8.64490795135498
        },
        {
            "text": "omerase",
            "probability": 8.716432558989415e-08,
            "start_logit": -6.688503265380859,
            "end_logit": 8.64490795135498
        },
        {
            "text": "human telomerase antagonist, imetelstat,",
            "probability": 6.839936195036e-08,
            "start_logit": 9.56663703918457,
            "end_logit": -7.852663993835449
        },
        {
            "text": "human telomerase antagonist, imetelstat, on primary human glioblastoma",
            "probability": 5.730961179533409e-08,
            "start_logit": 9.56663703918457,
            "end_logit": -8.029559135437012
        },
        {
            "text": "RESULTS: Imetelstat treatment produced a dose-dependent inhibition of telomerase",
            "probability": 4.6122577574872265e-10,
            "start_logit": -5.316318511962891,
            "end_logit": 2.0310604572296143
        },
        {
            "text": "inhibition of telomerase",
            "probability": 3.882068598556945e-10,
            "start_logit": -3.700751304626465,
            "end_logit": 0.24314391613006592
        },
        {
            "text": "produced a dose-dependent inhibition of telomerase",
            "probability": 2.336323230224272e-10,
            "start_logit": -5.996457576751709,
            "end_logit": 2.0310604572296143
        },
        {
            "text": "Imetelstat treatment produced a dose-dependent inhibition of telomerase",
            "probability": 2.2842524349410296e-10,
            "start_logit": -6.0189971923828125,
            "end_logit": 2.0310604572296143
        },
        {
            "text": "of telomerase",
            "probability": 1.7837736542180158e-10,
            "start_logit": -4.47838830947876,
            "end_logit": 0.24314391613006592
        },
        {
            "text": "a dose-dependent inhibition of telomerase",
            "probability": 9.722400943384258e-11,
            "start_logit": -6.873188495635986,
            "end_logit": 2.0310604572296143
        },
        {
            "text": "treatment produced a dose-dependent inhibition of telomerase",
            "probability": 9.64439034397471e-11,
            "start_logit": -6.881244659423828,
            "end_logit": 2.0310604572296143
        },
        {
            "text": "telomer",
            "probability": 3.0151667231976414e-12,
            "start_logit": -1.5419434309005737,
            "end_logit": -6.773547172546387
        },
        {
            "text": "telomerase antagonist, imetelstat,",
            "probability": 2.9829194681844107e-12,
            "start_logit": -0.4735792279243469,
            "end_logit": -7.852663993835449
        },
        {
            "text": "telomerase antagonist, imetelstat, on primary human glioblastoma",
            "probability": 2.499291687288806e-12,
            "start_logit": -0.4735792279243469,
            "end_logit": -8.029559135437012
        },
        {
            "text": "tel",
            "probability": 1.5765029062616923e-12,
            "start_logit": -1.5419434309005737,
            "end_logit": -7.421993255615234
        },
        {
            "text": "telomerase (IC(50) 0.45",
            "probability": 7.364106087818258e-13,
            "start_logit": -1.2342360019683838,
            "end_logit": -8.490877151489258
        },
        {
            "text": "telomerase (IC(50) 0.45 micromol/L).",
            "probability": 7.04191291179714e-13,
            "start_logit": -1.2342360019683838,
            "end_logit": -8.535614967346191
        }
    ],
    "56c048acef6e39474100001c_025": [
        {
            "text": "telomerase",
            "probability": 0.9883222198026839,
            "start_logit": 0.8494238257408142,
            "end_logit": 2.438828468322754
        },
        {
            "text": "the telomerase",
            "probability": 0.005450628120182198,
            "start_logit": -2.7648000717163086,
            "end_logit": 0.852774441242218
        },
        {
            "text": "ase",
            "probability": 0.0031823876338532495,
            "start_logit": -4.88895320892334,
            "end_logit": 2.438828468322754
        },
        {
            "text": "growth",
            "probability": 0.002291623086069396,
            "start_logit": -0.784719705581665,
            "end_logit": -1.9937764406204224
        },
        {
            "text": "cancer and critical for cancer cell immortality. We evaluated the effect of the telomerase",
            "probability": 0.0005461732037620062,
            "start_logit": -5.06535005569458,
            "end_logit": 0.852774441242218
        },
        {
            "text": "tel",
            "probability": 8.383286313428923e-05,
            "start_logit": 0.8494238257408142,
            "end_logit": -6.936110496520996
        },
        {
            "text": "effect of the telomerase",
            "probability": 3.9808831246821215e-05,
            "start_logit": -7.684197425842285,
            "end_logit": 0.852774441242218
        },
        {
            "text": "telomer",
            "probability": 3.307450679299746e-05,
            "start_logit": 0.8494238257408142,
            "end_logit": -7.866172790527344
        },
        {
            "text": "telomerase inhibitor imetelstat.",
            "probability": 2.8057497474089327e-05,
            "start_logit": 0.8494238257408142,
            "end_logit": -8.030679702758789
        },
        {
            "text": "growth inhibition",
            "probability": 6.021171843581845e-06,
            "start_logit": -0.784719705581665,
            "end_logit": -7.935510158538818
        },
        {
            "text": "telomerase inhibitor imetelstat",
            "probability": 5.146820311275162e-06,
            "start_logit": -2.675689935684204,
            "end_logit": -6.201442718505859
        },
        {
            "text": "the telomerase inhibitor imetelstat",
            "probability": 4.708027227760155e-06,
            "start_logit": -2.7648000717163086,
            "end_logit": -6.201442718505859
        },
        {
            "text": "growth inhibition. Imetelstat resulted in 40-50% growth",
            "probability": 2.465475991689212e-06,
            "start_logit": -7.619350433349609,
            "end_logit": -1.9937764406204224
        },
        {
            "text": "40-50% growth",
            "probability": 2.19622181374147e-06,
            "start_logit": -7.734996795654297,
            "end_logit": -1.9937764406204224
        },
        {
            "text": "cancer",
            "probability": 5.784230165373825e-07,
            "start_logit": -5.06535005569458,
            "end_logit": -5.9976115226745605
        },
        {
            "text": "cancer and critical for cancer cell immortality. We evaluated the effect of the telomerase inhibitor imetelstat",
            "probability": 4.7176183325795596e-07,
            "start_logit": -5.06535005569458,
            "end_logit": -6.201442718505859
        },
        {
            "text": "inhibition of telomerase",
            "probability": 2.6812140406663884e-07,
            "start_logit": -7.198421001434326,
            "end_logit": -4.633406162261963
        },
        {
            "text": "imetelstat",
            "probability": 2.4992282587810527e-07,
            "start_logit": -5.700672149658203,
            "end_logit": -6.201442718505859
        },
        {
            "text": "Telomerase is an attractive therapeutic target because it is specific to cancer",
            "probability": 5.4123310676516765e-08,
            "start_logit": -7.434390544891357,
            "end_logit": -5.9976115226745605
        },
        {
            "text": "effect of the telomerase inhibitor imetelstat",
            "probability": 3.4385222635419604e-08,
            "start_logit": -7.684197425842285,
            "end_logit": -6.201442718505859
        }
    ],
    "56c048acef6e39474100001c_026": [
        {
            "text": "telomerase",
            "probability": 0.9562509259003759,
            "start_logit": -0.6880496740341187,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "ase",
            "probability": 0.01821324386899282,
            "start_logit": -4.648921012878418,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "Imetelstat (a telomerase",
            "probability": 0.009866486903661221,
            "start_logit": -5.261926174163818,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 0.006203283684320604,
            "start_logit": -0.6880496740341187,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomerase",
            "probability": 0.004570762663297862,
            "start_logit": -0.9934483766555786,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "(a telomerase",
            "probability": 0.004464816125569078,
            "start_logit": -6.054841995239258,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 0.0001043603313785203,
            "start_logit": -4.77303409576416,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Imetelstat (a telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 6.400476650353696e-05,
            "start_logit": -5.261926174163818,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 3.6369864706683125e-05,
            "start_logit": -5.82714319229126,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "telomerase antagonist)",
            "probability": 3.406506819683167e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -6.981463432312012
        },
        {
            "text": "Telomerase is a cellular ribonucleoprotein reverse transcriptase",
            "probability": 2.990908979685048e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -6.8061747550964355
        },
        {
            "text": "(a telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 2.896365407349124e-05,
            "start_logit": -6.054841995239258,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "telomerase antagonist) exerts off - target effects on the cytoskeleton.",
            "probability": 2.2198273686512296e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.409721374511719
        },
        {
            "text": "telomerase antagonist) exerts off - target",
            "probability": 2.1170330526620317e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.457135200500488
        },
        {
            "text": "off - target effects on the cytoskeleton. Telomerase",
            "probability": 2.0018827044145337e-05,
            "start_logit": -6.424210548400879,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomer",
            "probability": 1.8917571685184308e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -7.264245986938477
        },
        {
            "text": "telomerase antagonist) exerts",
            "probability": 1.33129510581008e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.920998573303223
        },
        {
            "text": "telomerase antagonist) exerts off - target effects",
            "probability": 1.3147671470881231e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.933491230010986
        },
        {
            "text": "effects on the cytoskeleton. Telomerase",
            "probability": 1.2173459329727276e-05,
            "start_logit": -6.92162561416626,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomerase is a cellular ribonucleoprotein",
            "probability": 1.186899432612024e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -7.73040771484375
        }
    ],
    "56c048acef6e39474100001c_027": [
        {
            "text": "telomerase",
            "probability": 0.9562509259003759,
            "start_logit": -0.6880496740341187,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "ase",
            "probability": 0.01821324386899282,
            "start_logit": -4.648921012878418,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "Imetelstat (a telomerase",
            "probability": 0.009866486903661221,
            "start_logit": -5.261926174163818,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 0.006203283684320604,
            "start_logit": -0.6880496740341187,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomerase",
            "probability": 0.004570762663297862,
            "start_logit": -0.9934483766555786,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "(a telomerase",
            "probability": 0.004464816125569078,
            "start_logit": -6.054841995239258,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 0.0001043603313785203,
            "start_logit": -4.77303409576416,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Imetelstat (a telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 6.400476650353696e-05,
            "start_logit": -5.261926174163818,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 3.6369864706683125e-05,
            "start_logit": -5.82714319229126,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "telomerase antagonist)",
            "probability": 3.406506819683167e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -6.981463432312012
        },
        {
            "text": "Telomerase is a cellular ribonucleoprotein reverse transcriptase",
            "probability": 2.990908979685048e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -6.8061747550964355
        },
        {
            "text": "(a telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 2.896365407349124e-05,
            "start_logit": -6.054841995239258,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "telomerase antagonist) exerts off - target effects on the cytoskeleton.",
            "probability": 2.2198273686512296e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.409721374511719
        },
        {
            "text": "telomerase antagonist) exerts off - target",
            "probability": 2.1170330526620317e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.457135200500488
        },
        {
            "text": "off - target effects on the cytoskeleton. Telomerase",
            "probability": 2.0018827044145337e-05,
            "start_logit": -6.424210548400879,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomer",
            "probability": 1.8917571685184308e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -7.264245986938477
        },
        {
            "text": "telomerase antagonist) exerts",
            "probability": 1.33129510581008e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.920998573303223
        },
        {
            "text": "telomerase antagonist) exerts off - target effects",
            "probability": 1.3147671470881231e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.933491230010986
        },
        {
            "text": "effects on the cytoskeleton. Telomerase",
            "probability": 1.2173459329727276e-05,
            "start_logit": -6.92162561416626,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomerase is a cellular ribonucleoprotein",
            "probability": 1.186899432612024e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -7.73040771484375
        }
    ],
    "56c048acef6e39474100001c_028": [
        {
            "text": "of telomerase,",
            "probability": 0.950372815916993,
            "start_logit": 3.622187376022339,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase",
            "probability": 0.023860462498418337,
            "start_logit": -0.06244416907429695,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase,",
            "probability": 0.016204098454032246,
            "start_logit": -0.06244416907429695,
            "end_logit": 7.632082462310791
        },
        {
            "text": "ase",
            "probability": 0.0067801006972684815,
            "start_logit": -1.320675015449524,
            "end_logit": 8.019041061401367
        },
        {
            "text": ",",
            "probability": 0.0026625865070359443,
            "start_logit": -1.868410348892212,
            "end_logit": 7.632082462310791
        },
        {
            "text": "inhibitor of telomerase,",
            "probability": 5.4078314541359064e-05,
            "start_logit": -6.151988983154297,
            "end_logit": 8.019041061401367
        },
        {
            "text": "omerase",
            "probability": 3.1878088088714595e-05,
            "start_logit": -6.6805033683776855,
            "end_logit": 8.019041061401367
        },
        {
            "text": "the thio-phosphoramidate oligonucleotide inhibitor of telomerase,",
            "probability": 2.997616587464747e-05,
            "start_logit": -6.7420196533203125,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase activity",
            "probability": 1.6432646418000063e-06,
            "start_logit": 0.9756625294685364,
            "end_logit": -2.602358818054199
        },
        {
            "text": "imetelstat inhibited telomerase",
            "probability": 9.321220946473755e-07,
            "start_logit": -4.640310287475586,
            "end_logit": 2.4466376304626465
        },
        {
            "text": "of",
            "probability": 4.993246826142896e-07,
            "start_logit": 3.622187376022339,
            "end_logit": -6.440067291259766
        },
        {
            "text": "of telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer.",
            "probability": 3.0836329315583296e-07,
            "start_logit": 3.622187376022339,
            "end_logit": -6.9220452308654785
        },
        {
            "text": "Telomerase",
            "probability": 2.2940472910886806e-07,
            "start_logit": -2.531186103820801,
            "end_logit": -1.0644625425338745
        },
        {
            "text": "inhibited telomerase",
            "probability": 2.1447426723671319e-07,
            "start_logit": -6.109584331512451,
            "end_logit": 2.4466376304626465
        },
        {
            "text": "imetelstat",
            "probability": 6.063116282849923e-08,
            "start_logit": -2.0138134956359863,
            "end_logit": -2.9125139713287354
        },
        {
            "text": "telomer",
            "probability": 4.95301318730786e-08,
            "start_logit": -0.06244416907429695,
            "end_logit": -5.066111087799072
        },
        {
            "text": "Telomerase antagonist imetelstat",
            "probability": 3.614130488157855e-08,
            "start_logit": -2.531186103820801,
            "end_logit": -2.9125139713287354
        },
        {
            "text": "tel",
            "probability": 1.4874809364284644e-08,
            "start_logit": 0.9756625294685364,
            "end_logit": -7.307129859924316
        },
        {
            "text": "telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer.",
            "probability": 7.741899461985626e-09,
            "start_logit": -0.06244416907429695,
            "end_logit": -6.9220452308654785
        },
        {
            "text": "activity",
            "probability": 7.484730558766733e-09,
            "start_logit": -4.415912628173828,
            "end_logit": -2.602358818054199
        }
    ],
    "56c048acef6e39474100001c_029": [
        {
            "text": "imetelstat (GRN163L), a potent telomerase",
            "probability": 0.7709314051008654,
            "start_logit": 4.086793899536133,
            "end_logit": 5.77642822265625
        },
        {
            "text": "telomerase",
            "probability": 0.2279882950036232,
            "start_logit": 2.8684887886047363,
            "end_logit": 5.77642822265625
        },
        {
            "text": "ase",
            "probability": 0.001041948064057737,
            "start_logit": -2.5197134017944336,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imet",
            "probability": 1.3058689848544426e-05,
            "start_logit": 4.086793899536133,
            "end_logit": -5.20947265625
        },
        {
            "text": "potent telomerase",
            "probability": 7.722480766195089e-06,
            "start_logit": -7.42442512512207,
            "end_logit": 5.77642822265625
        },
        {
            "text": "(GRN163L), a potent telomerase",
            "probability": 6.193915722242499e-06,
            "start_logit": -7.644993305206299,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imetelstat",
            "probability": 4.48336092358432e-06,
            "start_logit": 4.086793899536133,
            "end_logit": -6.278553485870361
        },
        {
            "text": "a potent telomerase",
            "probability": 4.262933146612445e-06,
            "start_logit": -8.018603324890137,
            "end_logit": 5.77642822265625
        },
        {
            "text": "tel",
            "probability": 1.3768195189551956e-06,
            "start_logit": 2.8684887886047363,
            "end_logit": -6.240845203399658
        },
        {
            "text": "imetelstat (GRN163L),",
            "probability": 5.40940966755591e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.39337158203125
        },
        {
            "text": "imetelstat (GRN163L), a potent telomerase inhibitor,",
            "probability": 4.514397885802167e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomerase inhibitor,",
            "probability": 1.335047281952844e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomer",
            "probability": 1.2519202456294062e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.638527870178223
        },
        {
            "text": "The telomerase",
            "probability": 2.2100744386592746e-09,
            "start_logit": -6.719935417175293,
            "end_logit": -3.086926221847534
        },
        {
            "text": "telomerase activity",
            "probability": 1.6677302977740793e-10,
            "start_logit": -4.562044620513916,
            "end_logit": -7.828964710235596
        },
        {
            "text": "telomerase inhibitor imetelstat",
            "probability": 7.621672018130344e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -7.122272968292236
        },
        {
            "text": "The telomerase inhibitor imetelstat",
            "probability": 3.907311873422548e-11,
            "start_logit": -6.719935417175293,
            "end_logit": -7.122272968292236
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer stem cells",
            "probability": 2.5600680430225308e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.213234901428223
        },
        {
            "text": "telomerase inhibitor",
            "probability": 1.869787621579506e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.527443885803223
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer",
            "probability": 1.75833143618782e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.588903427124023
        }
    ],
    "56c048acef6e39474100001c_030": [
        {
            "text": "telomerase",
            "probability": 0.9963887831838663,
            "start_logit": 3.828627109527588,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "ase",
            "probability": 0.0016155873464689112,
            "start_logit": -2.5958118438720703,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "inhibited telomerase",
            "probability": 0.0013425750299816313,
            "start_logit": -2.78092098236084,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "telomerase activity",
            "probability": 0.0005312455086606161,
            "start_logit": 3.828627109527588,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "Imetelstat inhibited telomerase",
            "probability": 9.548241903159017e-05,
            "start_logit": -5.424323558807373,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "omerase",
            "probability": 1.0736277580402372e-05,
            "start_logit": -7.609637260437012,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "tel",
            "probability": 9.490878889379225e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -6.008081912994385
        },
        {
            "text": "telomerase activity in",
            "probability": 2.2068448072832828e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.466849327087402
        },
        {
            "text": "telomer",
            "probability": 1.8164552377251532e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.661526203155518
        },
        {
            "text": "inhibited telomerase activity",
            "probability": 7.158219429553916e-07,
            "start_logit": -2.78092098236084,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase activity in both subpopulations.",
            "probability": 5.657553087794565e-07,
            "start_logit": 3.828627109527588,
            "end_logit": -8.828006744384766
        },
        {
            "text": "activity",
            "probability": 4.24596200415884e-07,
            "start_logit": -3.3032138347625732,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase inhibition in anti-cancer therapy. The purpose of this study was to investigate the effects of a telomerase",
            "probability": 2.8346319467357703e-07,
            "start_logit": -7.6556501388549805,
            "end_logit": 1.965191125869751
        },
        {
            "text": "Imetelstat inhibited telomerase activity",
            "probability": 5.0908447709033335e-08,
            "start_logit": -5.424323558807373,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "The telomerase",
            "probability": 1.6266868151125048e-08,
            "start_logit": -7.169773101806641,
            "end_logit": -1.3786377906799316
        },
        {
            "text": "inhibited",
            "probability": 7.132996524177216e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -6.591888904571533
        },
        {
            "text": "telomerase antagonistic oligonucleotide, imetelstat",
            "probability": 6.610788593067375e-09,
            "start_logit": -1.1074668169021606,
            "end_logit": -8.341371536254883
        },
        {
            "text": "inhibited telomerase activity in",
            "probability": 2.973593022430098e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -7.466849327087402
        },
        {
            "text": "activity in",
            "probability": 1.7638133495799876e-09,
            "start_logit": -3.3032138347625732,
            "end_logit": -7.466849327087402
        },
        {
            "text": "inhibited telomerase activity in both subpopulations.",
            "probability": 7.623218601675894e-10,
            "start_logit": -2.78092098236084,
            "end_logit": -8.828006744384766
        }
    ],
    "56c048acef6e39474100001c_031": [
        {
            "text": "imetelstat (GRN163L), a potent telomerase",
            "probability": 0.7709314051008654,
            "start_logit": 4.086793899536133,
            "end_logit": 5.77642822265625
        },
        {
            "text": "telomerase",
            "probability": 0.2279882950036232,
            "start_logit": 2.8684887886047363,
            "end_logit": 5.77642822265625
        },
        {
            "text": "ase",
            "probability": 0.001041948064057737,
            "start_logit": -2.5197134017944336,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imet",
            "probability": 1.3058689848544426e-05,
            "start_logit": 4.086793899536133,
            "end_logit": -5.20947265625
        },
        {
            "text": "potent telomerase",
            "probability": 7.722480766195089e-06,
            "start_logit": -7.42442512512207,
            "end_logit": 5.77642822265625
        },
        {
            "text": "(GRN163L), a potent telomerase",
            "probability": 6.193915722242499e-06,
            "start_logit": -7.644993305206299,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imetelstat",
            "probability": 4.48336092358432e-06,
            "start_logit": 4.086793899536133,
            "end_logit": -6.278553485870361
        },
        {
            "text": "a potent telomerase",
            "probability": 4.262933146612445e-06,
            "start_logit": -8.018603324890137,
            "end_logit": 5.77642822265625
        },
        {
            "text": "tel",
            "probability": 1.3768195189551956e-06,
            "start_logit": 2.8684887886047363,
            "end_logit": -6.240845203399658
        },
        {
            "text": "imetelstat (GRN163L),",
            "probability": 5.40940966755591e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.39337158203125
        },
        {
            "text": "imetelstat (GRN163L), a potent telomerase inhibitor,",
            "probability": 4.514397885802167e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomerase inhibitor,",
            "probability": 1.335047281952844e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomer",
            "probability": 1.2519202456294062e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.638527870178223
        },
        {
            "text": "The telomerase",
            "probability": 2.2100744386592746e-09,
            "start_logit": -6.719935417175293,
            "end_logit": -3.086926221847534
        },
        {
            "text": "telomerase activity",
            "probability": 1.6677302977740793e-10,
            "start_logit": -4.562044620513916,
            "end_logit": -7.828964710235596
        },
        {
            "text": "telomerase inhibitor imetelstat",
            "probability": 7.621672018130344e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -7.122272968292236
        },
        {
            "text": "The telomerase inhibitor imetelstat",
            "probability": 3.907311873422548e-11,
            "start_logit": -6.719935417175293,
            "end_logit": -7.122272968292236
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer stem cells",
            "probability": 2.5600680430225308e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.213234901428223
        },
        {
            "text": "telomerase inhibitor",
            "probability": 1.869787621579506e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.527443885803223
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer",
            "probability": 1.75833143618782e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.588903427124023
        }
    ],
    "56c048acef6e39474100001c_032": [
        {
            "text": "of telomerase,",
            "probability": 0.950372815916993,
            "start_logit": 3.622187376022339,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase",
            "probability": 0.023860462498418337,
            "start_logit": -0.06244416907429695,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase,",
            "probability": 0.016204098454032246,
            "start_logit": -0.06244416907429695,
            "end_logit": 7.632082462310791
        },
        {
            "text": "ase",
            "probability": 0.0067801006972684815,
            "start_logit": -1.320675015449524,
            "end_logit": 8.019041061401367
        },
        {
            "text": ",",
            "probability": 0.0026625865070359443,
            "start_logit": -1.868410348892212,
            "end_logit": 7.632082462310791
        },
        {
            "text": "inhibitor of telomerase,",
            "probability": 5.4078314541359064e-05,
            "start_logit": -6.151988983154297,
            "end_logit": 8.019041061401367
        },
        {
            "text": "omerase",
            "probability": 3.1878088088714595e-05,
            "start_logit": -6.6805033683776855,
            "end_logit": 8.019041061401367
        },
        {
            "text": "the thio-phosphoramidate oligonucleotide inhibitor of telomerase,",
            "probability": 2.997616587464747e-05,
            "start_logit": -6.7420196533203125,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase activity",
            "probability": 1.6432646418000063e-06,
            "start_logit": 0.9756625294685364,
            "end_logit": -2.602358818054199
        },
        {
            "text": "imetelstat inhibited telomerase",
            "probability": 9.321220946473755e-07,
            "start_logit": -4.640310287475586,
            "end_logit": 2.4466376304626465
        },
        {
            "text": "of",
            "probability": 4.993246826142896e-07,
            "start_logit": 3.622187376022339,
            "end_logit": -6.440067291259766
        },
        {
            "text": "of telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer.",
            "probability": 3.0836329315583296e-07,
            "start_logit": 3.622187376022339,
            "end_logit": -6.9220452308654785
        },
        {
            "text": "Telomerase",
            "probability": 2.2940472910886806e-07,
            "start_logit": -2.531186103820801,
            "end_logit": -1.0644625425338745
        },
        {
            "text": "inhibited telomerase",
            "probability": 2.1447426723671319e-07,
            "start_logit": -6.109584331512451,
            "end_logit": 2.4466376304626465
        },
        {
            "text": "imetelstat",
            "probability": 6.063116282849923e-08,
            "start_logit": -2.0138134956359863,
            "end_logit": -2.9125139713287354
        },
        {
            "text": "telomer",
            "probability": 4.95301318730786e-08,
            "start_logit": -0.06244416907429695,
            "end_logit": -5.066111087799072
        },
        {
            "text": "Telomerase antagonist imetelstat",
            "probability": 3.614130488157855e-08,
            "start_logit": -2.531186103820801,
            "end_logit": -2.9125139713287354
        },
        {
            "text": "tel",
            "probability": 1.4874809364284644e-08,
            "start_logit": 0.9756625294685364,
            "end_logit": -7.307129859924316
        },
        {
            "text": "telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer.",
            "probability": 7.741899461985626e-09,
            "start_logit": -0.06244416907429695,
            "end_logit": -6.9220452308654785
        },
        {
            "text": "activity",
            "probability": 7.484730558766733e-09,
            "start_logit": -4.415912628173828,
            "end_logit": -2.602358818054199
        }
    ],
    "56c048acef6e39474100001c_033": [
        {
            "text": "of telomerase,",
            "probability": 0.950372815916993,
            "start_logit": 3.622187376022339,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase",
            "probability": 0.023860462498418337,
            "start_logit": -0.06244416907429695,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase,",
            "probability": 0.016204098454032246,
            "start_logit": -0.06244416907429695,
            "end_logit": 7.632082462310791
        },
        {
            "text": "ase",
            "probability": 0.0067801006972684815,
            "start_logit": -1.320675015449524,
            "end_logit": 8.019041061401367
        },
        {
            "text": ",",
            "probability": 0.0026625865070359443,
            "start_logit": -1.868410348892212,
            "end_logit": 7.632082462310791
        },
        {
            "text": "inhibitor of telomerase,",
            "probability": 5.4078314541359064e-05,
            "start_logit": -6.151988983154297,
            "end_logit": 8.019041061401367
        },
        {
            "text": "omerase",
            "probability": 3.1878088088714595e-05,
            "start_logit": -6.6805033683776855,
            "end_logit": 8.019041061401367
        },
        {
            "text": "the thio-phosphoramidate oligonucleotide inhibitor of telomerase,",
            "probability": 2.997616587464747e-05,
            "start_logit": -6.7420196533203125,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase activity",
            "probability": 1.6432646418000063e-06,
            "start_logit": 0.9756625294685364,
            "end_logit": -2.602358818054199
        },
        {
            "text": "imetelstat inhibited telomerase",
            "probability": 9.321220946473755e-07,
            "start_logit": -4.640310287475586,
            "end_logit": 2.4466376304626465
        },
        {
            "text": "of",
            "probability": 4.993246826142896e-07,
            "start_logit": 3.622187376022339,
            "end_logit": -6.440067291259766
        },
        {
            "text": "of telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer.",
            "probability": 3.0836329315583296e-07,
            "start_logit": 3.622187376022339,
            "end_logit": -6.9220452308654785
        },
        {
            "text": "Telomerase",
            "probability": 2.2940472910886806e-07,
            "start_logit": -2.531186103820801,
            "end_logit": -1.0644625425338745
        },
        {
            "text": "inhibited telomerase",
            "probability": 2.1447426723671319e-07,
            "start_logit": -6.109584331512451,
            "end_logit": 2.4466376304626465
        },
        {
            "text": "imetelstat",
            "probability": 6.063116282849923e-08,
            "start_logit": -2.0138134956359863,
            "end_logit": -2.9125139713287354
        },
        {
            "text": "telomer",
            "probability": 4.95301318730786e-08,
            "start_logit": -0.06244416907429695,
            "end_logit": -5.066111087799072
        },
        {
            "text": "Telomerase antagonist imetelstat",
            "probability": 3.614130488157855e-08,
            "start_logit": -2.531186103820801,
            "end_logit": -2.9125139713287354
        },
        {
            "text": "tel",
            "probability": 1.4874809364284644e-08,
            "start_logit": 0.9756625294685364,
            "end_logit": -7.307129859924316
        },
        {
            "text": "telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer.",
            "probability": 7.741899461985626e-09,
            "start_logit": -0.06244416907429695,
            "end_logit": -6.9220452308654785
        },
        {
            "text": "activity",
            "probability": 7.484730558766733e-09,
            "start_logit": -4.415912628173828,
            "end_logit": -2.602358818054199
        }
    ],
    "56c048acef6e39474100001c_034": [
        {
            "text": "telomerase",
            "probability": 0.998880936782828,
            "start_logit": 5.416159629821777,
            "end_logit": 6.949803352355957
        },
        {
            "text": "ase",
            "probability": 0.0008120668516073414,
            "start_logit": -1.6986485719680786,
            "end_logit": 6.949803352355957
        },
        {
            "text": "Telomerase",
            "probability": 0.00027680550896719893,
            "start_logit": 0.882021963596344,
            "end_logit": 3.29286527633667
        },
        {
            "text": "inhibits telomerase",
            "probability": 1.4993067502339939e-05,
            "start_logit": -5.690643310546875,
            "end_logit": 6.949803352355957
        },
        {
            "text": "tel",
            "probability": 8.447655356493535e-06,
            "start_logit": 5.416159629821777,
            "end_logit": -4.730698585510254
        },
        {
            "text": "omerase",
            "probability": 4.057015389015513e-06,
            "start_logit": -6.997783660888672,
            "end_logit": 6.949803352355957
        },
        {
            "text": "telomerase enzymatic activity.",
            "probability": 1.541509844741156e-06,
            "start_logit": 5.416159629821777,
            "end_logit": -6.431825160980225
        },
        {
            "text": "telomer",
            "probability": 7.076488070875897e-07,
            "start_logit": 5.416159629821777,
            "end_logit": -7.210394859313965
        },
        {
            "text": "Telomerase Inhibitor Imetelstat",
            "probability": 2.858497297221854e-07,
            "start_logit": 0.882021963596344,
            "end_logit": -3.5827388763427734
        },
        {
            "text": "Telomerase Inhibitor",
            "probability": 9.904568686432725e-08,
            "start_logit": 0.882021963596344,
            "end_logit": -4.6426239013671875
        },
        {
            "text": "Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia.",
            "probability": 2.47166185876064e-08,
            "start_logit": 0.882021963596344,
            "end_logit": -6.030729293823242
        },
        {
            "text": "Telomerase Inhibitor Imetelstat in",
            "probability": 1.131998911422937e-08,
            "start_logit": 0.882021963596344,
            "end_logit": -6.8116350173950195
        },
        {
            "text": "Tel",
            "probability": 9.490809837917601e-09,
            "start_logit": 0.882021963596344,
            "end_logit": -6.987881183624268
        },
        {
            "text": "Telomer",
            "probability": 7.15740133797189e-09,
            "start_logit": 0.882021963596344,
            "end_logit": -7.2700581550598145
        },
        {
            "text": "Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia. BACKGROUND:",
            "probability": 4.142816721357078e-09,
            "start_logit": 0.882021963596344,
            "end_logit": -7.816829204559326
        },
        {
            "text": "Imetelstat",
            "probability": 1.2041718655453971e-09,
            "start_logit": -4.587652206420898,
            "end_logit": -3.5827388763427734
        },
        {
            "text": "Inhibitor Imetelstat",
            "probability": 6.363514208028885e-10,
            "start_logit": -5.2254486083984375,
            "end_logit": -3.5827388763427734
        },
        {
            "text": "Inhibitor",
            "probability": 2.204929968685603e-10,
            "start_logit": -5.2254486083984375,
            "end_logit": -4.6426239013671875
        },
        {
            "text": "Imetelstat in Patients with Essential Thrombocythemia.",
            "probability": 1.0412133936085393e-10,
            "start_logit": -4.587652206420898,
            "end_logit": -6.030729293823242
        },
        {
            "text": "BACKGROUND:",
            "probability": 7.150796100073938e-11,
            "start_logit": -3.177300453186035,
            "end_logit": -7.816829204559326
        }
    ],
    "56c048acef6e39474100001c_035": [
        {
            "text": "imetelstat (GRN163L), a potent telomerase",
            "probability": 0.7709314051008654,
            "start_logit": 4.086793899536133,
            "end_logit": 5.77642822265625
        },
        {
            "text": "telomerase",
            "probability": 0.2279882950036232,
            "start_logit": 2.8684887886047363,
            "end_logit": 5.77642822265625
        },
        {
            "text": "ase",
            "probability": 0.001041948064057737,
            "start_logit": -2.5197134017944336,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imet",
            "probability": 1.3058689848544426e-05,
            "start_logit": 4.086793899536133,
            "end_logit": -5.20947265625
        },
        {
            "text": "potent telomerase",
            "probability": 7.722480766195089e-06,
            "start_logit": -7.42442512512207,
            "end_logit": 5.77642822265625
        },
        {
            "text": "(GRN163L), a potent telomerase",
            "probability": 6.193915722242499e-06,
            "start_logit": -7.644993305206299,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imetelstat",
            "probability": 4.48336092358432e-06,
            "start_logit": 4.086793899536133,
            "end_logit": -6.278553485870361
        },
        {
            "text": "a potent telomerase",
            "probability": 4.262933146612445e-06,
            "start_logit": -8.018603324890137,
            "end_logit": 5.77642822265625
        },
        {
            "text": "tel",
            "probability": 1.3768195189551956e-06,
            "start_logit": 2.8684887886047363,
            "end_logit": -6.240845203399658
        },
        {
            "text": "imetelstat (GRN163L),",
            "probability": 5.40940966755591e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.39337158203125
        },
        {
            "text": "imetelstat (GRN163L), a potent telomerase inhibitor,",
            "probability": 4.514397885802167e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomerase inhibitor,",
            "probability": 1.335047281952844e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomer",
            "probability": 1.2519202456294062e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.638527870178223
        },
        {
            "text": "The telomerase",
            "probability": 2.2100744386592746e-09,
            "start_logit": -6.719935417175293,
            "end_logit": -3.086926221847534
        },
        {
            "text": "telomerase activity",
            "probability": 1.6677302977740793e-10,
            "start_logit": -4.562044620513916,
            "end_logit": -7.828964710235596
        },
        {
            "text": "telomerase inhibitor imetelstat",
            "probability": 7.621672018130344e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -7.122272968292236
        },
        {
            "text": "The telomerase inhibitor imetelstat",
            "probability": 3.907311873422548e-11,
            "start_logit": -6.719935417175293,
            "end_logit": -7.122272968292236
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer stem cells",
            "probability": 2.5600680430225308e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.213234901428223
        },
        {
            "text": "telomerase inhibitor",
            "probability": 1.869787621579506e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.527443885803223
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer",
            "probability": 1.75833143618782e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.588903427124023
        }
    ],
    "56c048acef6e39474100001c_036": [
        {
            "text": "telomerase",
            "probability": 0.8059034408919302,
            "start_logit": 8.434063911437988,
            "end_logit": 8.128963470458984
        },
        {
            "text": "telomerase reverse transcriptase.",
            "probability": 0.19060730481789992,
            "start_logit": 8.434063911437988,
            "end_logit": 6.6872148513793945
        },
        {
            "text": "human telomerase",
            "probability": 0.00273518584385065,
            "start_logit": 2.7482993602752686,
            "end_logit": 8.128963470458984
        },
        {
            "text": "human telomerase reverse transcriptase.",
            "probability": 0.0006469092640868337,
            "start_logit": 2.7482993602752686,
            "end_logit": 6.6872148513793945
        },
        {
            "text": "ase",
            "probability": 7.823979392228162e-05,
            "start_logit": -0.8058769106864929,
            "end_logit": 8.128963470458984
        },
        {
            "text": "tel",
            "probability": 2.1963293065685458e-05,
            "start_logit": 8.434063911437988,
            "end_logit": -2.381383180618286
        },
        {
            "text": "reverse transcriptase.",
            "probability": 4.489887495650896e-06,
            "start_logit": -2.222079038619995,
            "end_logit": 6.6872148513793945
        },
        {
            "text": ".",
            "probability": 2.086147504104598e-06,
            "start_logit": -2.9885876178741455,
            "end_logit": 6.6872148513793945
        },
        {
            "text": "omerase",
            "probability": 1.992366409708043e-07,
            "start_logit": -6.77891731262207,
            "end_logit": 8.128963470458984
        },
        {
            "text": "telomer",
            "probability": 1.2967302037079277e-07,
            "start_logit": 8.434063911437988,
            "end_logit": -7.513494968414307
        },
        {
            "text": "transcriptase.",
            "probability": 4.3643608129893314e-08,
            "start_logit": -6.855605125427246,
            "end_logit": 6.6872148513793945
        },
        {
            "text": "human",
            "probability": 3.579841245610243e-09,
            "start_logit": 2.7482993602752686,
            "end_logit": -5.417428016662598
        },
        {
            "text": "Telomerase",
            "probability": 2.158505673128483e-09,
            "start_logit": -2.3503692150115967,
            "end_logit": -0.8246617317199707
        },
        {
            "text": "the Telomerase",
            "probability": 1.541417385592102e-09,
            "start_logit": -2.6870830059051514,
            "end_logit": -0.8246617317199707
        },
        {
            "text": "Telomerase Inhibitor Imetelstat for Myelofibrosis.",
            "probability": 1.116937423292257e-10,
            "start_logit": -2.3503692150115967,
            "end_logit": -3.7860724925994873
        },
        {
            "text": "the Telomerase Inhibitor Imetelstat for Myelofibrosis.",
            "probability": 7.976197534777798e-11,
            "start_logit": -2.6870830059051514,
            "end_logit": -3.7860724925994873
        },
        {
            "text": "of the Telomerase",
            "probability": 2.1461134960511198e-11,
            "start_logit": -6.961297035217285,
            "end_logit": -0.8246617317199707
        },
        {
            "text": "Telomerase Inhibitor Imetelstat",
            "probability": 5.726611967421065e-12,
            "start_logit": -2.3503692150115967,
            "end_logit": -6.756709098815918
        },
        {
            "text": "BACKGROUND: Current drugs for myeloproliferative neoplasm-associated myelofibrosis, including Janus kinase",
            "probability": 4.477940027182089e-12,
            "start_logit": -4.663799285888672,
            "end_logit": -4.689239978790283
        },
        {
            "text": "the Telomerase Inhibitor Imetelstat",
            "probability": 4.089449176350253e-12,
            "start_logit": -2.6870830059051514,
            "end_logit": -6.756709098815918
        }
    ],
    "56c048acef6e39474100001c_037": [
        {
            "text": "of telomerase,",
            "probability": 0.950372815916993,
            "start_logit": 3.622187376022339,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase",
            "probability": 0.023860462498418337,
            "start_logit": -0.06244416907429695,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase,",
            "probability": 0.016204098454032246,
            "start_logit": -0.06244416907429695,
            "end_logit": 7.632082462310791
        },
        {
            "text": "ase",
            "probability": 0.0067801006972684815,
            "start_logit": -1.320675015449524,
            "end_logit": 8.019041061401367
        },
        {
            "text": ",",
            "probability": 0.0026625865070359443,
            "start_logit": -1.868410348892212,
            "end_logit": 7.632082462310791
        },
        {
            "text": "inhibitor of telomerase,",
            "probability": 5.4078314541359064e-05,
            "start_logit": -6.151988983154297,
            "end_logit": 8.019041061401367
        },
        {
            "text": "omerase",
            "probability": 3.1878088088714595e-05,
            "start_logit": -6.6805033683776855,
            "end_logit": 8.019041061401367
        },
        {
            "text": "the thio-phosphoramidate oligonucleotide inhibitor of telomerase,",
            "probability": 2.997616587464747e-05,
            "start_logit": -6.7420196533203125,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase activity",
            "probability": 1.6432646418000063e-06,
            "start_logit": 0.9756625294685364,
            "end_logit": -2.602358818054199
        },
        {
            "text": "imetelstat inhibited telomerase",
            "probability": 9.321220946473755e-07,
            "start_logit": -4.640310287475586,
            "end_logit": 2.4466376304626465
        },
        {
            "text": "of",
            "probability": 4.993246826142896e-07,
            "start_logit": 3.622187376022339,
            "end_logit": -6.440067291259766
        },
        {
            "text": "of telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer.",
            "probability": 3.0836329315583296e-07,
            "start_logit": 3.622187376022339,
            "end_logit": -6.9220452308654785
        },
        {
            "text": "Telomerase",
            "probability": 2.2940472910886806e-07,
            "start_logit": -2.531186103820801,
            "end_logit": -1.0644625425338745
        },
        {
            "text": "inhibited telomerase",
            "probability": 2.1447426723671319e-07,
            "start_logit": -6.109584331512451,
            "end_logit": 2.4466376304626465
        },
        {
            "text": "imetelstat",
            "probability": 6.063116282849923e-08,
            "start_logit": -2.0138134956359863,
            "end_logit": -2.9125139713287354
        },
        {
            "text": "telomer",
            "probability": 4.95301318730786e-08,
            "start_logit": -0.06244416907429695,
            "end_logit": -5.066111087799072
        },
        {
            "text": "Telomerase antagonist imetelstat",
            "probability": 3.614130488157855e-08,
            "start_logit": -2.531186103820801,
            "end_logit": -2.9125139713287354
        },
        {
            "text": "tel",
            "probability": 1.4874809364284644e-08,
            "start_logit": 0.9756625294685364,
            "end_logit": -7.307129859924316
        },
        {
            "text": "telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer.",
            "probability": 7.741899461985626e-09,
            "start_logit": -0.06244416907429695,
            "end_logit": -6.9220452308654785
        },
        {
            "text": "activity",
            "probability": 7.484730558766733e-09,
            "start_logit": -4.415912628173828,
            "end_logit": -2.602358818054199
        }
    ],
    "56c048acef6e39474100001c_038": [
        {
            "text": "imetelstat (GRN163L), a potent telomerase",
            "probability": 0.7709314051008654,
            "start_logit": 4.086793899536133,
            "end_logit": 5.77642822265625
        },
        {
            "text": "telomerase",
            "probability": 0.2279882950036232,
            "start_logit": 2.8684887886047363,
            "end_logit": 5.77642822265625
        },
        {
            "text": "ase",
            "probability": 0.001041948064057737,
            "start_logit": -2.5197134017944336,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imet",
            "probability": 1.3058689848544426e-05,
            "start_logit": 4.086793899536133,
            "end_logit": -5.20947265625
        },
        {
            "text": "potent telomerase",
            "probability": 7.722480766195089e-06,
            "start_logit": -7.42442512512207,
            "end_logit": 5.77642822265625
        },
        {
            "text": "(GRN163L), a potent telomerase",
            "probability": 6.193915722242499e-06,
            "start_logit": -7.644993305206299,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imetelstat",
            "probability": 4.48336092358432e-06,
            "start_logit": 4.086793899536133,
            "end_logit": -6.278553485870361
        },
        {
            "text": "a potent telomerase",
            "probability": 4.262933146612445e-06,
            "start_logit": -8.018603324890137,
            "end_logit": 5.77642822265625
        },
        {
            "text": "tel",
            "probability": 1.3768195189551956e-06,
            "start_logit": 2.8684887886047363,
            "end_logit": -6.240845203399658
        },
        {
            "text": "imetelstat (GRN163L),",
            "probability": 5.40940966755591e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.39337158203125
        },
        {
            "text": "imetelstat (GRN163L), a potent telomerase inhibitor,",
            "probability": 4.514397885802167e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomerase inhibitor,",
            "probability": 1.335047281952844e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomer",
            "probability": 1.2519202456294062e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.638527870178223
        },
        {
            "text": "The telomerase",
            "probability": 2.2100744386592746e-09,
            "start_logit": -6.719935417175293,
            "end_logit": -3.086926221847534
        },
        {
            "text": "telomerase activity",
            "probability": 1.6677302977740793e-10,
            "start_logit": -4.562044620513916,
            "end_logit": -7.828964710235596
        },
        {
            "text": "telomerase inhibitor imetelstat",
            "probability": 7.621672018130344e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -7.122272968292236
        },
        {
            "text": "The telomerase inhibitor imetelstat",
            "probability": 3.907311873422548e-11,
            "start_logit": -6.719935417175293,
            "end_logit": -7.122272968292236
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer stem cells",
            "probability": 2.5600680430225308e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.213234901428223
        },
        {
            "text": "telomerase inhibitor",
            "probability": 1.869787621579506e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.527443885803223
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer",
            "probability": 1.75833143618782e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.588903427124023
        }
    ],
    "56c048acef6e39474100001c_039": [
        {
            "text": "imetelstat (GRN163L), a potent telomerase",
            "probability": 0.7709314051008654,
            "start_logit": 4.086793899536133,
            "end_logit": 5.77642822265625
        },
        {
            "text": "telomerase",
            "probability": 0.2279882950036232,
            "start_logit": 2.8684887886047363,
            "end_logit": 5.77642822265625
        },
        {
            "text": "ase",
            "probability": 0.001041948064057737,
            "start_logit": -2.5197134017944336,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imet",
            "probability": 1.3058689848544426e-05,
            "start_logit": 4.086793899536133,
            "end_logit": -5.20947265625
        },
        {
            "text": "potent telomerase",
            "probability": 7.722480766195089e-06,
            "start_logit": -7.42442512512207,
            "end_logit": 5.77642822265625
        },
        {
            "text": "(GRN163L), a potent telomerase",
            "probability": 6.193915722242499e-06,
            "start_logit": -7.644993305206299,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imetelstat",
            "probability": 4.48336092358432e-06,
            "start_logit": 4.086793899536133,
            "end_logit": -6.278553485870361
        },
        {
            "text": "a potent telomerase",
            "probability": 4.262933146612445e-06,
            "start_logit": -8.018603324890137,
            "end_logit": 5.77642822265625
        },
        {
            "text": "tel",
            "probability": 1.3768195189551956e-06,
            "start_logit": 2.8684887886047363,
            "end_logit": -6.240845203399658
        },
        {
            "text": "imetelstat (GRN163L),",
            "probability": 5.40940966755591e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.39337158203125
        },
        {
            "text": "imetelstat (GRN163L), a potent telomerase inhibitor,",
            "probability": 4.514397885802167e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomerase inhibitor,",
            "probability": 1.335047281952844e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomer",
            "probability": 1.2519202456294062e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.638527870178223
        },
        {
            "text": "The telomerase",
            "probability": 2.2100744386592746e-09,
            "start_logit": -6.719935417175293,
            "end_logit": -3.086926221847534
        },
        {
            "text": "telomerase activity",
            "probability": 1.6677302977740793e-10,
            "start_logit": -4.562044620513916,
            "end_logit": -7.828964710235596
        },
        {
            "text": "telomerase inhibitor imetelstat",
            "probability": 7.621672018130344e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -7.122272968292236
        },
        {
            "text": "The telomerase inhibitor imetelstat",
            "probability": 3.907311873422548e-11,
            "start_logit": -6.719935417175293,
            "end_logit": -7.122272968292236
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer stem cells",
            "probability": 2.5600680430225308e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.213234901428223
        },
        {
            "text": "telomerase inhibitor",
            "probability": 1.869787621579506e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.527443885803223
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer",
            "probability": 1.75833143618782e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.588903427124023
        }
    ],
    "56c048acef6e39474100001c_040": [
        {
            "text": "telomerase",
            "probability": 0.998880936782828,
            "start_logit": 5.416159629821777,
            "end_logit": 6.949803352355957
        },
        {
            "text": "ase",
            "probability": 0.0008120668516073414,
            "start_logit": -1.6986485719680786,
            "end_logit": 6.949803352355957
        },
        {
            "text": "Telomerase",
            "probability": 0.00027680550896719893,
            "start_logit": 0.882021963596344,
            "end_logit": 3.29286527633667
        },
        {
            "text": "inhibits telomerase",
            "probability": 1.4993067502339939e-05,
            "start_logit": -5.690643310546875,
            "end_logit": 6.949803352355957
        },
        {
            "text": "tel",
            "probability": 8.447655356493535e-06,
            "start_logit": 5.416159629821777,
            "end_logit": -4.730698585510254
        },
        {
            "text": "omerase",
            "probability": 4.057015389015513e-06,
            "start_logit": -6.997783660888672,
            "end_logit": 6.949803352355957
        },
        {
            "text": "telomerase enzymatic activity.",
            "probability": 1.541509844741156e-06,
            "start_logit": 5.416159629821777,
            "end_logit": -6.431825160980225
        },
        {
            "text": "telomer",
            "probability": 7.076488070875897e-07,
            "start_logit": 5.416159629821777,
            "end_logit": -7.210394859313965
        },
        {
            "text": "Telomerase Inhibitor Imetelstat",
            "probability": 2.858497297221854e-07,
            "start_logit": 0.882021963596344,
            "end_logit": -3.5827388763427734
        },
        {
            "text": "Telomerase Inhibitor",
            "probability": 9.904568686432725e-08,
            "start_logit": 0.882021963596344,
            "end_logit": -4.6426239013671875
        },
        {
            "text": "Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia.",
            "probability": 2.47166185876064e-08,
            "start_logit": 0.882021963596344,
            "end_logit": -6.030729293823242
        },
        {
            "text": "Telomerase Inhibitor Imetelstat in",
            "probability": 1.131998911422937e-08,
            "start_logit": 0.882021963596344,
            "end_logit": -6.8116350173950195
        },
        {
            "text": "Tel",
            "probability": 9.490809837917601e-09,
            "start_logit": 0.882021963596344,
            "end_logit": -6.987881183624268
        },
        {
            "text": "Telomer",
            "probability": 7.15740133797189e-09,
            "start_logit": 0.882021963596344,
            "end_logit": -7.2700581550598145
        },
        {
            "text": "Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia. BACKGROUND:",
            "probability": 4.142816721357078e-09,
            "start_logit": 0.882021963596344,
            "end_logit": -7.816829204559326
        },
        {
            "text": "Imetelstat",
            "probability": 1.2041718655453971e-09,
            "start_logit": -4.587652206420898,
            "end_logit": -3.5827388763427734
        },
        {
            "text": "Inhibitor Imetelstat",
            "probability": 6.363514208028885e-10,
            "start_logit": -5.2254486083984375,
            "end_logit": -3.5827388763427734
        },
        {
            "text": "Inhibitor",
            "probability": 2.204929968685603e-10,
            "start_logit": -5.2254486083984375,
            "end_logit": -4.6426239013671875
        },
        {
            "text": "Imetelstat in Patients with Essential Thrombocythemia.",
            "probability": 1.0412133936085393e-10,
            "start_logit": -4.587652206420898,
            "end_logit": -6.030729293823242
        },
        {
            "text": "BACKGROUND:",
            "probability": 7.150796100073938e-11,
            "start_logit": -3.177300453186035,
            "end_logit": -7.816829204559326
        }
    ],
    "56c048acef6e39474100001c_041": [
        {
            "text": "of telomerase,",
            "probability": 0.950372815916993,
            "start_logit": 3.622187376022339,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase",
            "probability": 0.023860462498418337,
            "start_logit": -0.06244416907429695,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase,",
            "probability": 0.016204098454032246,
            "start_logit": -0.06244416907429695,
            "end_logit": 7.632082462310791
        },
        {
            "text": "ase",
            "probability": 0.0067801006972684815,
            "start_logit": -1.320675015449524,
            "end_logit": 8.019041061401367
        },
        {
            "text": ",",
            "probability": 0.0026625865070359443,
            "start_logit": -1.868410348892212,
            "end_logit": 7.632082462310791
        },
        {
            "text": "inhibitor of telomerase,",
            "probability": 5.4078314541359064e-05,
            "start_logit": -6.151988983154297,
            "end_logit": 8.019041061401367
        },
        {
            "text": "omerase",
            "probability": 3.1878088088714595e-05,
            "start_logit": -6.6805033683776855,
            "end_logit": 8.019041061401367
        },
        {
            "text": "the thio-phosphoramidate oligonucleotide inhibitor of telomerase,",
            "probability": 2.997616587464747e-05,
            "start_logit": -6.7420196533203125,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase activity",
            "probability": 1.6432646418000063e-06,
            "start_logit": 0.9756625294685364,
            "end_logit": -2.602358818054199
        },
        {
            "text": "imetelstat inhibited telomerase",
            "probability": 9.321220946473755e-07,
            "start_logit": -4.640310287475586,
            "end_logit": 2.4466376304626465
        },
        {
            "text": "of",
            "probability": 4.993246826142896e-07,
            "start_logit": 3.622187376022339,
            "end_logit": -6.440067291259766
        },
        {
            "text": "of telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer.",
            "probability": 3.0836329315583296e-07,
            "start_logit": 3.622187376022339,
            "end_logit": -6.9220452308654785
        },
        {
            "text": "Telomerase",
            "probability": 2.2940472910886806e-07,
            "start_logit": -2.531186103820801,
            "end_logit": -1.0644625425338745
        },
        {
            "text": "inhibited telomerase",
            "probability": 2.1447426723671319e-07,
            "start_logit": -6.109584331512451,
            "end_logit": 2.4466376304626465
        },
        {
            "text": "imetelstat",
            "probability": 6.063116282849923e-08,
            "start_logit": -2.0138134956359863,
            "end_logit": -2.9125139713287354
        },
        {
            "text": "telomer",
            "probability": 4.95301318730786e-08,
            "start_logit": -0.06244416907429695,
            "end_logit": -5.066111087799072
        },
        {
            "text": "Telomerase antagonist imetelstat",
            "probability": 3.614130488157855e-08,
            "start_logit": -2.531186103820801,
            "end_logit": -2.9125139713287354
        },
        {
            "text": "tel",
            "probability": 1.4874809364284644e-08,
            "start_logit": 0.9756625294685364,
            "end_logit": -7.307129859924316
        },
        {
            "text": "telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer.",
            "probability": 7.741899461985626e-09,
            "start_logit": -0.06244416907429695,
            "end_logit": -6.9220452308654785
        },
        {
            "text": "activity",
            "probability": 7.484730558766733e-09,
            "start_logit": -4.415912628173828,
            "end_logit": -2.602358818054199
        }
    ],
    "56c048acef6e39474100001c_042": [
        {
            "text": "telomerase",
            "probability": 0.998880936782828,
            "start_logit": 5.416159629821777,
            "end_logit": 6.949803352355957
        },
        {
            "text": "ase",
            "probability": 0.0008120668516073414,
            "start_logit": -1.6986485719680786,
            "end_logit": 6.949803352355957
        },
        {
            "text": "Telomerase",
            "probability": 0.00027680550896719893,
            "start_logit": 0.882021963596344,
            "end_logit": 3.29286527633667
        },
        {
            "text": "inhibits telomerase",
            "probability": 1.4993067502339939e-05,
            "start_logit": -5.690643310546875,
            "end_logit": 6.949803352355957
        },
        {
            "text": "tel",
            "probability": 8.447655356493535e-06,
            "start_logit": 5.416159629821777,
            "end_logit": -4.730698585510254
        },
        {
            "text": "omerase",
            "probability": 4.057015389015513e-06,
            "start_logit": -6.997783660888672,
            "end_logit": 6.949803352355957
        },
        {
            "text": "telomerase enzymatic activity.",
            "probability": 1.541509844741156e-06,
            "start_logit": 5.416159629821777,
            "end_logit": -6.431825160980225
        },
        {
            "text": "telomer",
            "probability": 7.076488070875897e-07,
            "start_logit": 5.416159629821777,
            "end_logit": -7.210394859313965
        },
        {
            "text": "Telomerase Inhibitor Imetelstat",
            "probability": 2.858497297221854e-07,
            "start_logit": 0.882021963596344,
            "end_logit": -3.5827388763427734
        },
        {
            "text": "Telomerase Inhibitor",
            "probability": 9.904568686432725e-08,
            "start_logit": 0.882021963596344,
            "end_logit": -4.6426239013671875
        },
        {
            "text": "Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia.",
            "probability": 2.47166185876064e-08,
            "start_logit": 0.882021963596344,
            "end_logit": -6.030729293823242
        },
        {
            "text": "Telomerase Inhibitor Imetelstat in",
            "probability": 1.131998911422937e-08,
            "start_logit": 0.882021963596344,
            "end_logit": -6.8116350173950195
        },
        {
            "text": "Tel",
            "probability": 9.490809837917601e-09,
            "start_logit": 0.882021963596344,
            "end_logit": -6.987881183624268
        },
        {
            "text": "Telomer",
            "probability": 7.15740133797189e-09,
            "start_logit": 0.882021963596344,
            "end_logit": -7.2700581550598145
        },
        {
            "text": "Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia. BACKGROUND:",
            "probability": 4.142816721357078e-09,
            "start_logit": 0.882021963596344,
            "end_logit": -7.816829204559326
        },
        {
            "text": "Imetelstat",
            "probability": 1.2041718655453971e-09,
            "start_logit": -4.587652206420898,
            "end_logit": -3.5827388763427734
        },
        {
            "text": "Inhibitor Imetelstat",
            "probability": 6.363514208028885e-10,
            "start_logit": -5.2254486083984375,
            "end_logit": -3.5827388763427734
        },
        {
            "text": "Inhibitor",
            "probability": 2.204929968685603e-10,
            "start_logit": -5.2254486083984375,
            "end_logit": -4.6426239013671875
        },
        {
            "text": "Imetelstat in Patients with Essential Thrombocythemia.",
            "probability": 1.0412133936085393e-10,
            "start_logit": -4.587652206420898,
            "end_logit": -6.030729293823242
        },
        {
            "text": "BACKGROUND:",
            "probability": 7.150796100073938e-11,
            "start_logit": -3.177300453186035,
            "end_logit": -7.816829204559326
        }
    ],
    "56c048acef6e39474100001c_043": [
        {
            "text": "imetelstat (GRN163L), a potent telomerase",
            "probability": 0.7709314051008654,
            "start_logit": 4.086793899536133,
            "end_logit": 5.77642822265625
        },
        {
            "text": "telomerase",
            "probability": 0.2279882950036232,
            "start_logit": 2.8684887886047363,
            "end_logit": 5.77642822265625
        },
        {
            "text": "ase",
            "probability": 0.001041948064057737,
            "start_logit": -2.5197134017944336,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imet",
            "probability": 1.3058689848544426e-05,
            "start_logit": 4.086793899536133,
            "end_logit": -5.20947265625
        },
        {
            "text": "potent telomerase",
            "probability": 7.722480766195089e-06,
            "start_logit": -7.42442512512207,
            "end_logit": 5.77642822265625
        },
        {
            "text": "(GRN163L), a potent telomerase",
            "probability": 6.193915722242499e-06,
            "start_logit": -7.644993305206299,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imetelstat",
            "probability": 4.48336092358432e-06,
            "start_logit": 4.086793899536133,
            "end_logit": -6.278553485870361
        },
        {
            "text": "a potent telomerase",
            "probability": 4.262933146612445e-06,
            "start_logit": -8.018603324890137,
            "end_logit": 5.77642822265625
        },
        {
            "text": "tel",
            "probability": 1.3768195189551956e-06,
            "start_logit": 2.8684887886047363,
            "end_logit": -6.240845203399658
        },
        {
            "text": "imetelstat (GRN163L),",
            "probability": 5.40940966755591e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.39337158203125
        },
        {
            "text": "imetelstat (GRN163L), a potent telomerase inhibitor,",
            "probability": 4.514397885802167e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomerase inhibitor,",
            "probability": 1.335047281952844e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomer",
            "probability": 1.2519202456294062e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.638527870178223
        },
        {
            "text": "The telomerase",
            "probability": 2.2100744386592746e-09,
            "start_logit": -6.719935417175293,
            "end_logit": -3.086926221847534
        },
        {
            "text": "telomerase activity",
            "probability": 1.6677302977740793e-10,
            "start_logit": -4.562044620513916,
            "end_logit": -7.828964710235596
        },
        {
            "text": "telomerase inhibitor imetelstat",
            "probability": 7.621672018130344e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -7.122272968292236
        },
        {
            "text": "The telomerase inhibitor imetelstat",
            "probability": 3.907311873422548e-11,
            "start_logit": -6.719935417175293,
            "end_logit": -7.122272968292236
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer stem cells",
            "probability": 2.5600680430225308e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.213234901428223
        },
        {
            "text": "telomerase inhibitor",
            "probability": 1.869787621579506e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.527443885803223
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer",
            "probability": 1.75833143618782e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.588903427124023
        }
    ],
    "56c048acef6e39474100001c_044": [
        {
            "text": "telomerase",
            "probability": 0.8059034408919302,
            "start_logit": 8.434063911437988,
            "end_logit": 8.128963470458984
        },
        {
            "text": "telomerase reverse transcriptase.",
            "probability": 0.19060730481789992,
            "start_logit": 8.434063911437988,
            "end_logit": 6.6872148513793945
        },
        {
            "text": "human telomerase",
            "probability": 0.00273518584385065,
            "start_logit": 2.7482993602752686,
            "end_logit": 8.128963470458984
        },
        {
            "text": "human telomerase reverse transcriptase.",
            "probability": 0.0006469092640868337,
            "start_logit": 2.7482993602752686,
            "end_logit": 6.6872148513793945
        },
        {
            "text": "ase",
            "probability": 7.823979392228162e-05,
            "start_logit": -0.8058769106864929,
            "end_logit": 8.128963470458984
        },
        {
            "text": "tel",
            "probability": 2.1963293065685458e-05,
            "start_logit": 8.434063911437988,
            "end_logit": -2.381383180618286
        },
        {
            "text": "reverse transcriptase.",
            "probability": 4.489887495650896e-06,
            "start_logit": -2.222079038619995,
            "end_logit": 6.6872148513793945
        },
        {
            "text": ".",
            "probability": 2.086147504104598e-06,
            "start_logit": -2.9885876178741455,
            "end_logit": 6.6872148513793945
        },
        {
            "text": "omerase",
            "probability": 1.992366409708043e-07,
            "start_logit": -6.77891731262207,
            "end_logit": 8.128963470458984
        },
        {
            "text": "telomer",
            "probability": 1.2967302037079277e-07,
            "start_logit": 8.434063911437988,
            "end_logit": -7.513494968414307
        },
        {
            "text": "transcriptase.",
            "probability": 4.3643608129893314e-08,
            "start_logit": -6.855605125427246,
            "end_logit": 6.6872148513793945
        },
        {
            "text": "human",
            "probability": 3.579841245610243e-09,
            "start_logit": 2.7482993602752686,
            "end_logit": -5.417428016662598
        },
        {
            "text": "Telomerase",
            "probability": 2.158505673128483e-09,
            "start_logit": -2.3503692150115967,
            "end_logit": -0.8246617317199707
        },
        {
            "text": "the Telomerase",
            "probability": 1.541417385592102e-09,
            "start_logit": -2.6870830059051514,
            "end_logit": -0.8246617317199707
        },
        {
            "text": "Telomerase Inhibitor Imetelstat for Myelofibrosis.",
            "probability": 1.116937423292257e-10,
            "start_logit": -2.3503692150115967,
            "end_logit": -3.7860724925994873
        },
        {
            "text": "the Telomerase Inhibitor Imetelstat for Myelofibrosis.",
            "probability": 7.976197534777798e-11,
            "start_logit": -2.6870830059051514,
            "end_logit": -3.7860724925994873
        },
        {
            "text": "of the Telomerase",
            "probability": 2.1461134960511198e-11,
            "start_logit": -6.961297035217285,
            "end_logit": -0.8246617317199707
        },
        {
            "text": "Telomerase Inhibitor Imetelstat",
            "probability": 5.726611967421065e-12,
            "start_logit": -2.3503692150115967,
            "end_logit": -6.756709098815918
        },
        {
            "text": "BACKGROUND: Current drugs for myeloproliferative neoplasm-associated myelofibrosis, including Janus kinase",
            "probability": 4.477940027182089e-12,
            "start_logit": -4.663799285888672,
            "end_logit": -4.689239978790283
        },
        {
            "text": "the Telomerase Inhibitor Imetelstat",
            "probability": 4.089449176350253e-12,
            "start_logit": -2.6870830059051514,
            "end_logit": -6.756709098815918
        }
    ],
    "56c048acef6e39474100001c_045": [
        {
            "text": "of telomerase,",
            "probability": 0.950372815916993,
            "start_logit": 3.622187376022339,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase",
            "probability": 0.023860462498418337,
            "start_logit": -0.06244416907429695,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase,",
            "probability": 0.016204098454032246,
            "start_logit": -0.06244416907429695,
            "end_logit": 7.632082462310791
        },
        {
            "text": "ase",
            "probability": 0.0067801006972684815,
            "start_logit": -1.320675015449524,
            "end_logit": 8.019041061401367
        },
        {
            "text": ",",
            "probability": 0.0026625865070359443,
            "start_logit": -1.868410348892212,
            "end_logit": 7.632082462310791
        },
        {
            "text": "inhibitor of telomerase,",
            "probability": 5.4078314541359064e-05,
            "start_logit": -6.151988983154297,
            "end_logit": 8.019041061401367
        },
        {
            "text": "omerase",
            "probability": 3.1878088088714595e-05,
            "start_logit": -6.6805033683776855,
            "end_logit": 8.019041061401367
        },
        {
            "text": "the thio-phosphoramidate oligonucleotide inhibitor of telomerase,",
            "probability": 2.997616587464747e-05,
            "start_logit": -6.7420196533203125,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase activity",
            "probability": 1.6432646418000063e-06,
            "start_logit": 0.9756625294685364,
            "end_logit": -2.602358818054199
        },
        {
            "text": "imetelstat inhibited telomerase",
            "probability": 9.321220946473755e-07,
            "start_logit": -4.640310287475586,
            "end_logit": 2.4466376304626465
        },
        {
            "text": "of",
            "probability": 4.993246826142896e-07,
            "start_logit": 3.622187376022339,
            "end_logit": -6.440067291259766
        },
        {
            "text": "of telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer.",
            "probability": 3.0836329315583296e-07,
            "start_logit": 3.622187376022339,
            "end_logit": -6.9220452308654785
        },
        {
            "text": "Telomerase",
            "probability": 2.2940472910886806e-07,
            "start_logit": -2.531186103820801,
            "end_logit": -1.0644625425338745
        },
        {
            "text": "inhibited telomerase",
            "probability": 2.1447426723671319e-07,
            "start_logit": -6.109584331512451,
            "end_logit": 2.4466376304626465
        },
        {
            "text": "imetelstat",
            "probability": 6.063116282849923e-08,
            "start_logit": -2.0138134956359863,
            "end_logit": -2.9125139713287354
        },
        {
            "text": "telomer",
            "probability": 4.95301318730786e-08,
            "start_logit": -0.06244416907429695,
            "end_logit": -5.066111087799072
        },
        {
            "text": "Telomerase antagonist imetelstat",
            "probability": 3.614130488157855e-08,
            "start_logit": -2.531186103820801,
            "end_logit": -2.9125139713287354
        },
        {
            "text": "tel",
            "probability": 1.4874809364284644e-08,
            "start_logit": 0.9756625294685364,
            "end_logit": -7.307129859924316
        },
        {
            "text": "telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer.",
            "probability": 7.741899461985626e-09,
            "start_logit": -0.06244416907429695,
            "end_logit": -6.9220452308654785
        },
        {
            "text": "activity",
            "probability": 7.484730558766733e-09,
            "start_logit": -4.415912628173828,
            "end_logit": -2.602358818054199
        }
    ],
    "56c048acef6e39474100001c_046": [
        {
            "text": "imetelstat (GRN163L), a potent telomerase",
            "probability": 0.7709314051008654,
            "start_logit": 4.086793899536133,
            "end_logit": 5.77642822265625
        },
        {
            "text": "telomerase",
            "probability": 0.2279882950036232,
            "start_logit": 2.8684887886047363,
            "end_logit": 5.77642822265625
        },
        {
            "text": "ase",
            "probability": 0.001041948064057737,
            "start_logit": -2.5197134017944336,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imet",
            "probability": 1.3058689848544426e-05,
            "start_logit": 4.086793899536133,
            "end_logit": -5.20947265625
        },
        {
            "text": "potent telomerase",
            "probability": 7.722480766195089e-06,
            "start_logit": -7.42442512512207,
            "end_logit": 5.77642822265625
        },
        {
            "text": "(GRN163L), a potent telomerase",
            "probability": 6.193915722242499e-06,
            "start_logit": -7.644993305206299,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imetelstat",
            "probability": 4.48336092358432e-06,
            "start_logit": 4.086793899536133,
            "end_logit": -6.278553485870361
        },
        {
            "text": "a potent telomerase",
            "probability": 4.262933146612445e-06,
            "start_logit": -8.018603324890137,
            "end_logit": 5.77642822265625
        },
        {
            "text": "tel",
            "probability": 1.3768195189551956e-06,
            "start_logit": 2.8684887886047363,
            "end_logit": -6.240845203399658
        },
        {
            "text": "imetelstat (GRN163L),",
            "probability": 5.40940966755591e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.39337158203125
        },
        {
            "text": "imetelstat (GRN163L), a potent telomerase inhibitor,",
            "probability": 4.514397885802167e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomerase inhibitor,",
            "probability": 1.335047281952844e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomer",
            "probability": 1.2519202456294062e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.638527870178223
        },
        {
            "text": "The telomerase",
            "probability": 2.2100744386592746e-09,
            "start_logit": -6.719935417175293,
            "end_logit": -3.086926221847534
        },
        {
            "text": "telomerase activity",
            "probability": 1.6677302977740793e-10,
            "start_logit": -4.562044620513916,
            "end_logit": -7.828964710235596
        },
        {
            "text": "telomerase inhibitor imetelstat",
            "probability": 7.621672018130344e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -7.122272968292236
        },
        {
            "text": "The telomerase inhibitor imetelstat",
            "probability": 3.907311873422548e-11,
            "start_logit": -6.719935417175293,
            "end_logit": -7.122272968292236
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer stem cells",
            "probability": 2.5600680430225308e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.213234901428223
        },
        {
            "text": "telomerase inhibitor",
            "probability": 1.869787621579506e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.527443885803223
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer",
            "probability": 1.75833143618782e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.588903427124023
        }
    ],
    "56c048acef6e39474100001c_047": [
        {
            "text": "imetelstat (GRN163L), a potent telomerase",
            "probability": 0.7709314051008654,
            "start_logit": 4.086793899536133,
            "end_logit": 5.77642822265625
        },
        {
            "text": "telomerase",
            "probability": 0.2279882950036232,
            "start_logit": 2.8684887886047363,
            "end_logit": 5.77642822265625
        },
        {
            "text": "ase",
            "probability": 0.001041948064057737,
            "start_logit": -2.5197134017944336,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imet",
            "probability": 1.3058689848544426e-05,
            "start_logit": 4.086793899536133,
            "end_logit": -5.20947265625
        },
        {
            "text": "potent telomerase",
            "probability": 7.722480766195089e-06,
            "start_logit": -7.42442512512207,
            "end_logit": 5.77642822265625
        },
        {
            "text": "(GRN163L), a potent telomerase",
            "probability": 6.193915722242499e-06,
            "start_logit": -7.644993305206299,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imetelstat",
            "probability": 4.48336092358432e-06,
            "start_logit": 4.086793899536133,
            "end_logit": -6.278553485870361
        },
        {
            "text": "a potent telomerase",
            "probability": 4.262933146612445e-06,
            "start_logit": -8.018603324890137,
            "end_logit": 5.77642822265625
        },
        {
            "text": "tel",
            "probability": 1.3768195189551956e-06,
            "start_logit": 2.8684887886047363,
            "end_logit": -6.240845203399658
        },
        {
            "text": "imetelstat (GRN163L),",
            "probability": 5.40940966755591e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.39337158203125
        },
        {
            "text": "imetelstat (GRN163L), a potent telomerase inhibitor,",
            "probability": 4.514397885802167e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomerase inhibitor,",
            "probability": 1.335047281952844e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomer",
            "probability": 1.2519202456294062e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.638527870178223
        },
        {
            "text": "The telomerase",
            "probability": 2.2100744386592746e-09,
            "start_logit": -6.719935417175293,
            "end_logit": -3.086926221847534
        },
        {
            "text": "telomerase activity",
            "probability": 1.6677302977740793e-10,
            "start_logit": -4.562044620513916,
            "end_logit": -7.828964710235596
        },
        {
            "text": "telomerase inhibitor imetelstat",
            "probability": 7.621672018130344e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -7.122272968292236
        },
        {
            "text": "The telomerase inhibitor imetelstat",
            "probability": 3.907311873422548e-11,
            "start_logit": -6.719935417175293,
            "end_logit": -7.122272968292236
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer stem cells",
            "probability": 2.5600680430225308e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.213234901428223
        },
        {
            "text": "telomerase inhibitor",
            "probability": 1.869787621579506e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.527443885803223
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer",
            "probability": 1.75833143618782e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.588903427124023
        }
    ],
    "56c048acef6e39474100001c_048": [
        {
            "text": "telomerase",
            "probability": 0.998880936782828,
            "start_logit": 5.416159629821777,
            "end_logit": 6.949803352355957
        },
        {
            "text": "ase",
            "probability": 0.0008120668516073414,
            "start_logit": -1.6986485719680786,
            "end_logit": 6.949803352355957
        },
        {
            "text": "Telomerase",
            "probability": 0.00027680550896719893,
            "start_logit": 0.882021963596344,
            "end_logit": 3.29286527633667
        },
        {
            "text": "inhibits telomerase",
            "probability": 1.4993067502339939e-05,
            "start_logit": -5.690643310546875,
            "end_logit": 6.949803352355957
        },
        {
            "text": "tel",
            "probability": 8.447655356493535e-06,
            "start_logit": 5.416159629821777,
            "end_logit": -4.730698585510254
        },
        {
            "text": "omerase",
            "probability": 4.057015389015513e-06,
            "start_logit": -6.997783660888672,
            "end_logit": 6.949803352355957
        },
        {
            "text": "telomerase enzymatic activity.",
            "probability": 1.541509844741156e-06,
            "start_logit": 5.416159629821777,
            "end_logit": -6.431825160980225
        },
        {
            "text": "telomer",
            "probability": 7.076488070875897e-07,
            "start_logit": 5.416159629821777,
            "end_logit": -7.210394859313965
        },
        {
            "text": "Telomerase Inhibitor Imetelstat",
            "probability": 2.858497297221854e-07,
            "start_logit": 0.882021963596344,
            "end_logit": -3.5827388763427734
        },
        {
            "text": "Telomerase Inhibitor",
            "probability": 9.904568686432725e-08,
            "start_logit": 0.882021963596344,
            "end_logit": -4.6426239013671875
        },
        {
            "text": "Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia.",
            "probability": 2.47166185876064e-08,
            "start_logit": 0.882021963596344,
            "end_logit": -6.030729293823242
        },
        {
            "text": "Telomerase Inhibitor Imetelstat in",
            "probability": 1.131998911422937e-08,
            "start_logit": 0.882021963596344,
            "end_logit": -6.8116350173950195
        },
        {
            "text": "Tel",
            "probability": 9.490809837917601e-09,
            "start_logit": 0.882021963596344,
            "end_logit": -6.987881183624268
        },
        {
            "text": "Telomer",
            "probability": 7.15740133797189e-09,
            "start_logit": 0.882021963596344,
            "end_logit": -7.2700581550598145
        },
        {
            "text": "Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia. BACKGROUND:",
            "probability": 4.142816721357078e-09,
            "start_logit": 0.882021963596344,
            "end_logit": -7.816829204559326
        },
        {
            "text": "Imetelstat",
            "probability": 1.2041718655453971e-09,
            "start_logit": -4.587652206420898,
            "end_logit": -3.5827388763427734
        },
        {
            "text": "Inhibitor Imetelstat",
            "probability": 6.363514208028885e-10,
            "start_logit": -5.2254486083984375,
            "end_logit": -3.5827388763427734
        },
        {
            "text": "Inhibitor",
            "probability": 2.204929968685603e-10,
            "start_logit": -5.2254486083984375,
            "end_logit": -4.6426239013671875
        },
        {
            "text": "Imetelstat in Patients with Essential Thrombocythemia.",
            "probability": 1.0412133936085393e-10,
            "start_logit": -4.587652206420898,
            "end_logit": -6.030729293823242
        },
        {
            "text": "BACKGROUND:",
            "probability": 7.150796100073938e-11,
            "start_logit": -3.177300453186035,
            "end_logit": -7.816829204559326
        }
    ],
    "56c048acef6e39474100001c_049": [
        {
            "text": "telomerase",
            "probability": 0.8059034408919302,
            "start_logit": 8.434063911437988,
            "end_logit": 8.128963470458984
        },
        {
            "text": "telomerase reverse transcriptase.",
            "probability": 0.19060730481789992,
            "start_logit": 8.434063911437988,
            "end_logit": 6.6872148513793945
        },
        {
            "text": "human telomerase",
            "probability": 0.00273518584385065,
            "start_logit": 2.7482993602752686,
            "end_logit": 8.128963470458984
        },
        {
            "text": "human telomerase reverse transcriptase.",
            "probability": 0.0006469092640868337,
            "start_logit": 2.7482993602752686,
            "end_logit": 6.6872148513793945
        },
        {
            "text": "ase",
            "probability": 7.823979392228162e-05,
            "start_logit": -0.8058769106864929,
            "end_logit": 8.128963470458984
        },
        {
            "text": "tel",
            "probability": 2.1963293065685458e-05,
            "start_logit": 8.434063911437988,
            "end_logit": -2.381383180618286
        },
        {
            "text": "reverse transcriptase.",
            "probability": 4.489887495650896e-06,
            "start_logit": -2.222079038619995,
            "end_logit": 6.6872148513793945
        },
        {
            "text": ".",
            "probability": 2.086147504104598e-06,
            "start_logit": -2.9885876178741455,
            "end_logit": 6.6872148513793945
        },
        {
            "text": "omerase",
            "probability": 1.992366409708043e-07,
            "start_logit": -6.77891731262207,
            "end_logit": 8.128963470458984
        },
        {
            "text": "telomer",
            "probability": 1.2967302037079277e-07,
            "start_logit": 8.434063911437988,
            "end_logit": -7.513494968414307
        },
        {
            "text": "transcriptase.",
            "probability": 4.3643608129893314e-08,
            "start_logit": -6.855605125427246,
            "end_logit": 6.6872148513793945
        },
        {
            "text": "human",
            "probability": 3.579841245610243e-09,
            "start_logit": 2.7482993602752686,
            "end_logit": -5.417428016662598
        },
        {
            "text": "Telomerase",
            "probability": 2.158505673128483e-09,
            "start_logit": -2.3503692150115967,
            "end_logit": -0.8246617317199707
        },
        {
            "text": "the Telomerase",
            "probability": 1.541417385592102e-09,
            "start_logit": -2.6870830059051514,
            "end_logit": -0.8246617317199707
        },
        {
            "text": "Telomerase Inhibitor Imetelstat for Myelofibrosis.",
            "probability": 1.116937423292257e-10,
            "start_logit": -2.3503692150115967,
            "end_logit": -3.7860724925994873
        },
        {
            "text": "the Telomerase Inhibitor Imetelstat for Myelofibrosis.",
            "probability": 7.976197534777798e-11,
            "start_logit": -2.6870830059051514,
            "end_logit": -3.7860724925994873
        },
        {
            "text": "of the Telomerase",
            "probability": 2.1461134960511198e-11,
            "start_logit": -6.961297035217285,
            "end_logit": -0.8246617317199707
        },
        {
            "text": "Telomerase Inhibitor Imetelstat",
            "probability": 5.726611967421065e-12,
            "start_logit": -2.3503692150115967,
            "end_logit": -6.756709098815918
        },
        {
            "text": "BACKGROUND: Current drugs for myeloproliferative neoplasm-associated myelofibrosis, including Janus kinase",
            "probability": 4.477940027182089e-12,
            "start_logit": -4.663799285888672,
            "end_logit": -4.689239978790283
        },
        {
            "text": "the Telomerase Inhibitor Imetelstat",
            "probability": 4.089449176350253e-12,
            "start_logit": -2.6870830059051514,
            "end_logit": -6.756709098815918
        }
    ],
    "56c048acef6e39474100001c_050": [
        {
            "text": "telomerase",
            "probability": 0.9562509259003759,
            "start_logit": -0.6880496740341187,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "ase",
            "probability": 0.01821324386899282,
            "start_logit": -4.648921012878418,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "Imetelstat (a telomerase",
            "probability": 0.009866486903661221,
            "start_logit": -5.261926174163818,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 0.006203283684320604,
            "start_logit": -0.6880496740341187,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomerase",
            "probability": 0.004570762663297862,
            "start_logit": -0.9934483766555786,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "(a telomerase",
            "probability": 0.004464816125569078,
            "start_logit": -6.054841995239258,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 0.0001043603313785203,
            "start_logit": -4.77303409576416,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Imetelstat (a telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 6.400476650353696e-05,
            "start_logit": -5.261926174163818,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 3.6369864706683125e-05,
            "start_logit": -5.82714319229126,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "telomerase antagonist)",
            "probability": 3.406506819683167e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -6.981463432312012
        },
        {
            "text": "Telomerase is a cellular ribonucleoprotein reverse transcriptase",
            "probability": 2.990908979685048e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -6.8061747550964355
        },
        {
            "text": "(a telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 2.896365407349124e-05,
            "start_logit": -6.054841995239258,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "telomerase antagonist) exerts off - target effects on the cytoskeleton.",
            "probability": 2.2198273686512296e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.409721374511719
        },
        {
            "text": "telomerase antagonist) exerts off - target",
            "probability": 2.1170330526620317e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.457135200500488
        },
        {
            "text": "off - target effects on the cytoskeleton. Telomerase",
            "probability": 2.0018827044145337e-05,
            "start_logit": -6.424210548400879,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomer",
            "probability": 1.8917571685184308e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -7.264245986938477
        },
        {
            "text": "telomerase antagonist) exerts",
            "probability": 1.33129510581008e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.920998573303223
        },
        {
            "text": "telomerase antagonist) exerts off - target effects",
            "probability": 1.3147671470881231e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.933491230010986
        },
        {
            "text": "effects on the cytoskeleton. Telomerase",
            "probability": 1.2173459329727276e-05,
            "start_logit": -6.92162561416626,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomerase is a cellular ribonucleoprotein",
            "probability": 1.186899432612024e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -7.73040771484375
        }
    ],
    "56c048acef6e39474100001c_051": [
        {
            "text": "telomerase",
            "probability": 0.9562509259003759,
            "start_logit": -0.6880496740341187,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "ase",
            "probability": 0.01821324386899282,
            "start_logit": -4.648921012878418,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "Imetelstat (a telomerase",
            "probability": 0.009866486903661221,
            "start_logit": -5.261926174163818,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 0.006203283684320604,
            "start_logit": -0.6880496740341187,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomerase",
            "probability": 0.004570762663297862,
            "start_logit": -0.9934483766555786,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "(a telomerase",
            "probability": 0.004464816125569078,
            "start_logit": -6.054841995239258,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 0.0001043603313785203,
            "start_logit": -4.77303409576416,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Imetelstat (a telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 6.400476650353696e-05,
            "start_logit": -5.261926174163818,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 3.6369864706683125e-05,
            "start_logit": -5.82714319229126,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "telomerase antagonist)",
            "probability": 3.406506819683167e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -6.981463432312012
        },
        {
            "text": "Telomerase is a cellular ribonucleoprotein reverse transcriptase",
            "probability": 2.990908979685048e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -6.8061747550964355
        },
        {
            "text": "(a telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 2.896365407349124e-05,
            "start_logit": -6.054841995239258,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "telomerase antagonist) exerts off - target effects on the cytoskeleton.",
            "probability": 2.2198273686512296e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.409721374511719
        },
        {
            "text": "telomerase antagonist) exerts off - target",
            "probability": 2.1170330526620317e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.457135200500488
        },
        {
            "text": "off - target effects on the cytoskeleton. Telomerase",
            "probability": 2.0018827044145337e-05,
            "start_logit": -6.424210548400879,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomer",
            "probability": 1.8917571685184308e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -7.264245986938477
        },
        {
            "text": "telomerase antagonist) exerts",
            "probability": 1.33129510581008e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.920998573303223
        },
        {
            "text": "telomerase antagonist) exerts off - target effects",
            "probability": 1.3147671470881231e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.933491230010986
        },
        {
            "text": "effects on the cytoskeleton. Telomerase",
            "probability": 1.2173459329727276e-05,
            "start_logit": -6.92162561416626,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomerase is a cellular ribonucleoprotein",
            "probability": 1.186899432612024e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -7.73040771484375
        }
    ],
    "56c048acef6e39474100001c_052": [
        {
            "text": "of telomerase,",
            "probability": 0.950372815916993,
            "start_logit": 3.622187376022339,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase",
            "probability": 0.023860462498418337,
            "start_logit": -0.06244416907429695,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase,",
            "probability": 0.016204098454032246,
            "start_logit": -0.06244416907429695,
            "end_logit": 7.632082462310791
        },
        {
            "text": "ase",
            "probability": 0.0067801006972684815,
            "start_logit": -1.320675015449524,
            "end_logit": 8.019041061401367
        },
        {
            "text": ",",
            "probability": 0.0026625865070359443,
            "start_logit": -1.868410348892212,
            "end_logit": 7.632082462310791
        },
        {
            "text": "inhibitor of telomerase,",
            "probability": 5.4078314541359064e-05,
            "start_logit": -6.151988983154297,
            "end_logit": 8.019041061401367
        },
        {
            "text": "omerase",
            "probability": 3.1878088088714595e-05,
            "start_logit": -6.6805033683776855,
            "end_logit": 8.019041061401367
        },
        {
            "text": "the thio-phosphoramidate oligonucleotide inhibitor of telomerase,",
            "probability": 2.997616587464747e-05,
            "start_logit": -6.7420196533203125,
            "end_logit": 8.019041061401367
        },
        {
            "text": "telomerase activity",
            "probability": 1.6432646418000063e-06,
            "start_logit": 0.9756625294685364,
            "end_logit": -2.602358818054199
        },
        {
            "text": "imetelstat inhibited telomerase",
            "probability": 9.321220946473755e-07,
            "start_logit": -4.640310287475586,
            "end_logit": 2.4466376304626465
        },
        {
            "text": "of",
            "probability": 4.993246826142896e-07,
            "start_logit": 3.622187376022339,
            "end_logit": -6.440067291259766
        },
        {
            "text": "of telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer.",
            "probability": 3.0836329315583296e-07,
            "start_logit": 3.622187376022339,
            "end_logit": -6.9220452308654785
        },
        {
            "text": "Telomerase",
            "probability": 2.2940472910886806e-07,
            "start_logit": -2.531186103820801,
            "end_logit": -1.0644625425338745
        },
        {
            "text": "inhibited telomerase",
            "probability": 2.1447426723671319e-07,
            "start_logit": -6.109584331512451,
            "end_logit": 2.4466376304626465
        },
        {
            "text": "imetelstat",
            "probability": 6.063116282849923e-08,
            "start_logit": -2.0138134956359863,
            "end_logit": -2.9125139713287354
        },
        {
            "text": "telomer",
            "probability": 4.95301318730786e-08,
            "start_logit": -0.06244416907429695,
            "end_logit": -5.066111087799072
        },
        {
            "text": "Telomerase antagonist imetelstat",
            "probability": 3.614130488157855e-08,
            "start_logit": -2.531186103820801,
            "end_logit": -2.9125139713287354
        },
        {
            "text": "tel",
            "probability": 1.4874809364284644e-08,
            "start_logit": 0.9756625294685364,
            "end_logit": -7.307129859924316
        },
        {
            "text": "telomerase, imetelstat, as a drug candidate for treatment of esophageal cancer.",
            "probability": 7.741899461985626e-09,
            "start_logit": -0.06244416907429695,
            "end_logit": -6.9220452308654785
        },
        {
            "text": "activity",
            "probability": 7.484730558766733e-09,
            "start_logit": -4.415912628173828,
            "end_logit": -2.602358818054199
        }
    ],
    "56c048acef6e39474100001c_053": [
        {
            "text": "imetelstat (GRN163L), a potent telomerase",
            "probability": 0.7709314051008654,
            "start_logit": 4.086793899536133,
            "end_logit": 5.77642822265625
        },
        {
            "text": "telomerase",
            "probability": 0.2279882950036232,
            "start_logit": 2.8684887886047363,
            "end_logit": 5.77642822265625
        },
        {
            "text": "ase",
            "probability": 0.001041948064057737,
            "start_logit": -2.5197134017944336,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imet",
            "probability": 1.3058689848544426e-05,
            "start_logit": 4.086793899536133,
            "end_logit": -5.20947265625
        },
        {
            "text": "potent telomerase",
            "probability": 7.722480766195089e-06,
            "start_logit": -7.42442512512207,
            "end_logit": 5.77642822265625
        },
        {
            "text": "(GRN163L), a potent telomerase",
            "probability": 6.193915722242499e-06,
            "start_logit": -7.644993305206299,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imetelstat",
            "probability": 4.48336092358432e-06,
            "start_logit": 4.086793899536133,
            "end_logit": -6.278553485870361
        },
        {
            "text": "a potent telomerase",
            "probability": 4.262933146612445e-06,
            "start_logit": -8.018603324890137,
            "end_logit": 5.77642822265625
        },
        {
            "text": "tel",
            "probability": 1.3768195189551956e-06,
            "start_logit": 2.8684887886047363,
            "end_logit": -6.240845203399658
        },
        {
            "text": "imetelstat (GRN163L),",
            "probability": 5.40940966755591e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.39337158203125
        },
        {
            "text": "imetelstat (GRN163L), a potent telomerase inhibitor,",
            "probability": 4.514397885802167e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomerase inhibitor,",
            "probability": 1.335047281952844e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomer",
            "probability": 1.2519202456294062e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.638527870178223
        },
        {
            "text": "The telomerase",
            "probability": 2.2100744386592746e-09,
            "start_logit": -6.719935417175293,
            "end_logit": -3.086926221847534
        },
        {
            "text": "telomerase activity",
            "probability": 1.6677302977740793e-10,
            "start_logit": -4.562044620513916,
            "end_logit": -7.828964710235596
        },
        {
            "text": "telomerase inhibitor imetelstat",
            "probability": 7.621672018130344e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -7.122272968292236
        },
        {
            "text": "The telomerase inhibitor imetelstat",
            "probability": 3.907311873422548e-11,
            "start_logit": -6.719935417175293,
            "end_logit": -7.122272968292236
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer stem cells",
            "probability": 2.5600680430225308e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.213234901428223
        },
        {
            "text": "telomerase inhibitor",
            "probability": 1.869787621579506e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.527443885803223
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer",
            "probability": 1.75833143618782e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.588903427124023
        }
    ],
    "56c048acef6e39474100001c_054": [
        {
            "text": "telomerase",
            "probability": 0.9963887831838663,
            "start_logit": 3.828627109527588,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "ase",
            "probability": 0.0016155873464689112,
            "start_logit": -2.5958118438720703,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "inhibited telomerase",
            "probability": 0.0013425750299816313,
            "start_logit": -2.78092098236084,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "telomerase activity",
            "probability": 0.0005312455086606161,
            "start_logit": 3.828627109527588,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "Imetelstat inhibited telomerase",
            "probability": 9.548241903159017e-05,
            "start_logit": -5.424323558807373,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "omerase",
            "probability": 1.0736277580402372e-05,
            "start_logit": -7.609637260437012,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "tel",
            "probability": 9.490878889379225e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -6.008081912994385
        },
        {
            "text": "telomerase activity in",
            "probability": 2.2068448072832828e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.466849327087402
        },
        {
            "text": "telomer",
            "probability": 1.8164552377251532e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.661526203155518
        },
        {
            "text": "inhibited telomerase activity",
            "probability": 7.158219429553916e-07,
            "start_logit": -2.78092098236084,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase activity in both subpopulations.",
            "probability": 5.657553087794565e-07,
            "start_logit": 3.828627109527588,
            "end_logit": -8.828006744384766
        },
        {
            "text": "activity",
            "probability": 4.24596200415884e-07,
            "start_logit": -3.3032138347625732,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase inhibition in anti-cancer therapy. The purpose of this study was to investigate the effects of a telomerase",
            "probability": 2.8346319467357703e-07,
            "start_logit": -7.6556501388549805,
            "end_logit": 1.965191125869751
        },
        {
            "text": "Imetelstat inhibited telomerase activity",
            "probability": 5.0908447709033335e-08,
            "start_logit": -5.424323558807373,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "The telomerase",
            "probability": 1.6266868151125048e-08,
            "start_logit": -7.169773101806641,
            "end_logit": -1.3786377906799316
        },
        {
            "text": "inhibited",
            "probability": 7.132996524177216e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -6.591888904571533
        },
        {
            "text": "telomerase antagonistic oligonucleotide, imetelstat",
            "probability": 6.610788593067375e-09,
            "start_logit": -1.1074668169021606,
            "end_logit": -8.341371536254883
        },
        {
            "text": "inhibited telomerase activity in",
            "probability": 2.973593022430098e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -7.466849327087402
        },
        {
            "text": "activity in",
            "probability": 1.7638133495799876e-09,
            "start_logit": -3.3032138347625732,
            "end_logit": -7.466849327087402
        },
        {
            "text": "inhibited telomerase activity in both subpopulations.",
            "probability": 7.623218601675894e-10,
            "start_logit": -2.78092098236084,
            "end_logit": -8.828006744384766
        }
    ],
    "56c048acef6e39474100001c_055": [
        {
            "text": "telomerase",
            "probability": 0.9963887831838663,
            "start_logit": 3.828627109527588,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "ase",
            "probability": 0.0016155873464689112,
            "start_logit": -2.5958118438720703,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "inhibited telomerase",
            "probability": 0.0013425750299816313,
            "start_logit": -2.78092098236084,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "telomerase activity",
            "probability": 0.0005312455086606161,
            "start_logit": 3.828627109527588,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "Imetelstat inhibited telomerase",
            "probability": 9.548241903159017e-05,
            "start_logit": -5.424323558807373,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "omerase",
            "probability": 1.0736277580402372e-05,
            "start_logit": -7.609637260437012,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "tel",
            "probability": 9.490878889379225e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -6.008081912994385
        },
        {
            "text": "telomerase activity in",
            "probability": 2.2068448072832828e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.466849327087402
        },
        {
            "text": "telomer",
            "probability": 1.8164552377251532e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.661526203155518
        },
        {
            "text": "inhibited telomerase activity",
            "probability": 7.158219429553916e-07,
            "start_logit": -2.78092098236084,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase activity in both subpopulations.",
            "probability": 5.657553087794565e-07,
            "start_logit": 3.828627109527588,
            "end_logit": -8.828006744384766
        },
        {
            "text": "activity",
            "probability": 4.24596200415884e-07,
            "start_logit": -3.3032138347625732,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase inhibition in anti-cancer therapy. The purpose of this study was to investigate the effects of a telomerase",
            "probability": 2.8346319467357703e-07,
            "start_logit": -7.6556501388549805,
            "end_logit": 1.965191125869751
        },
        {
            "text": "Imetelstat inhibited telomerase activity",
            "probability": 5.0908447709033335e-08,
            "start_logit": -5.424323558807373,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "The telomerase",
            "probability": 1.6266868151125048e-08,
            "start_logit": -7.169773101806641,
            "end_logit": -1.3786377906799316
        },
        {
            "text": "inhibited",
            "probability": 7.132996524177216e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -6.591888904571533
        },
        {
            "text": "telomerase antagonistic oligonucleotide, imetelstat",
            "probability": 6.610788593067375e-09,
            "start_logit": -1.1074668169021606,
            "end_logit": -8.341371536254883
        },
        {
            "text": "inhibited telomerase activity in",
            "probability": 2.973593022430098e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -7.466849327087402
        },
        {
            "text": "activity in",
            "probability": 1.7638133495799876e-09,
            "start_logit": -3.3032138347625732,
            "end_logit": -7.466849327087402
        },
        {
            "text": "inhibited telomerase activity in both subpopulations.",
            "probability": 7.623218601675894e-10,
            "start_logit": -2.78092098236084,
            "end_logit": -8.828006744384766
        }
    ],
    "56c048acef6e39474100001c_056": [
        {
            "text": "telomerase",
            "probability": 0.9963887831838663,
            "start_logit": 3.828627109527588,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "ase",
            "probability": 0.0016155873464689112,
            "start_logit": -2.5958118438720703,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "inhibited telomerase",
            "probability": 0.0013425750299816313,
            "start_logit": -2.78092098236084,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "telomerase activity",
            "probability": 0.0005312455086606161,
            "start_logit": 3.828627109527588,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "Imetelstat inhibited telomerase",
            "probability": 9.548241903159017e-05,
            "start_logit": -5.424323558807373,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "omerase",
            "probability": 1.0736277580402372e-05,
            "start_logit": -7.609637260437012,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "tel",
            "probability": 9.490878889379225e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -6.008081912994385
        },
        {
            "text": "telomerase activity in",
            "probability": 2.2068448072832828e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.466849327087402
        },
        {
            "text": "telomer",
            "probability": 1.8164552377251532e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.661526203155518
        },
        {
            "text": "inhibited telomerase activity",
            "probability": 7.158219429553916e-07,
            "start_logit": -2.78092098236084,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase activity in both subpopulations.",
            "probability": 5.657553087794565e-07,
            "start_logit": 3.828627109527588,
            "end_logit": -8.828006744384766
        },
        {
            "text": "activity",
            "probability": 4.24596200415884e-07,
            "start_logit": -3.3032138347625732,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase inhibition in anti-cancer therapy. The purpose of this study was to investigate the effects of a telomerase",
            "probability": 2.8346319467357703e-07,
            "start_logit": -7.6556501388549805,
            "end_logit": 1.965191125869751
        },
        {
            "text": "Imetelstat inhibited telomerase activity",
            "probability": 5.0908447709033335e-08,
            "start_logit": -5.424323558807373,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "The telomerase",
            "probability": 1.6266868151125048e-08,
            "start_logit": -7.169773101806641,
            "end_logit": -1.3786377906799316
        },
        {
            "text": "inhibited",
            "probability": 7.132996524177216e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -6.591888904571533
        },
        {
            "text": "telomerase antagonistic oligonucleotide, imetelstat",
            "probability": 6.610788593067375e-09,
            "start_logit": -1.1074668169021606,
            "end_logit": -8.341371536254883
        },
        {
            "text": "inhibited telomerase activity in",
            "probability": 2.973593022430098e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -7.466849327087402
        },
        {
            "text": "activity in",
            "probability": 1.7638133495799876e-09,
            "start_logit": -3.3032138347625732,
            "end_logit": -7.466849327087402
        },
        {
            "text": "inhibited telomerase activity in both subpopulations.",
            "probability": 7.623218601675894e-10,
            "start_logit": -2.78092098236084,
            "end_logit": -8.828006744384766
        }
    ],
    "56c048acef6e39474100001c_057": [
        {
            "text": "telomerase",
            "probability": 0.9562509259003759,
            "start_logit": -0.6880496740341187,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "ase",
            "probability": 0.01821324386899282,
            "start_logit": -4.648921012878418,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "Imetelstat (a telomerase",
            "probability": 0.009866486903661221,
            "start_logit": -5.261926174163818,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 0.006203283684320604,
            "start_logit": -0.6880496740341187,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomerase",
            "probability": 0.004570762663297862,
            "start_logit": -0.9934483766555786,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "(a telomerase",
            "probability": 0.004464816125569078,
            "start_logit": -6.054841995239258,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 0.0001043603313785203,
            "start_logit": -4.77303409576416,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Imetelstat (a telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 6.400476650353696e-05,
            "start_logit": -5.261926174163818,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 3.6369864706683125e-05,
            "start_logit": -5.82714319229126,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "telomerase antagonist)",
            "probability": 3.406506819683167e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -6.981463432312012
        },
        {
            "text": "Telomerase is a cellular ribonucleoprotein reverse transcriptase",
            "probability": 2.990908979685048e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -6.8061747550964355
        },
        {
            "text": "(a telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 2.896365407349124e-05,
            "start_logit": -6.054841995239258,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "telomerase antagonist) exerts off - target effects on the cytoskeleton.",
            "probability": 2.2198273686512296e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.409721374511719
        },
        {
            "text": "telomerase antagonist) exerts off - target",
            "probability": 2.1170330526620317e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.457135200500488
        },
        {
            "text": "off - target effects on the cytoskeleton. Telomerase",
            "probability": 2.0018827044145337e-05,
            "start_logit": -6.424210548400879,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomer",
            "probability": 1.8917571685184308e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -7.264245986938477
        },
        {
            "text": "telomerase antagonist) exerts",
            "probability": 1.33129510581008e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.920998573303223
        },
        {
            "text": "telomerase antagonist) exerts off - target effects",
            "probability": 1.3147671470881231e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.933491230010986
        },
        {
            "text": "effects on the cytoskeleton. Telomerase",
            "probability": 1.2173459329727276e-05,
            "start_logit": -6.92162561416626,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomerase is a cellular ribonucleoprotein",
            "probability": 1.186899432612024e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -7.73040771484375
        }
    ],
    "56c048acef6e39474100001c_058": [
        {
            "text": "telomerase",
            "probability": 0.9562509259003759,
            "start_logit": -0.6880496740341187,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "ase",
            "probability": 0.01821324386899282,
            "start_logit": -4.648921012878418,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "Imetelstat (a telomerase",
            "probability": 0.009866486903661221,
            "start_logit": -5.261926174163818,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 0.006203283684320604,
            "start_logit": -0.6880496740341187,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomerase",
            "probability": 0.004570762663297862,
            "start_logit": -0.9934483766555786,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "(a telomerase",
            "probability": 0.004464816125569078,
            "start_logit": -6.054841995239258,
            "end_logit": 3.2610397338867188
        },
        {
            "text": "exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 0.0001043603313785203,
            "start_logit": -4.77303409576416,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Imetelstat (a telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 6.400476650353696e-05,
            "start_logit": -5.261926174163818,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 3.6369864706683125e-05,
            "start_logit": -5.82714319229126,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "telomerase antagonist)",
            "probability": 3.406506819683167e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -6.981463432312012
        },
        {
            "text": "Telomerase is a cellular ribonucleoprotein reverse transcriptase",
            "probability": 2.990908979685048e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -6.8061747550964355
        },
        {
            "text": "(a telomerase antagonist) exerts off - target effects on the cytoskeleton. Telomerase",
            "probability": 2.896365407349124e-05,
            "start_logit": -6.054841995239258,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "telomerase antagonist) exerts off - target effects on the cytoskeleton.",
            "probability": 2.2198273686512296e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.409721374511719
        },
        {
            "text": "telomerase antagonist) exerts off - target",
            "probability": 2.1170330526620317e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.457135200500488
        },
        {
            "text": "off - target effects on the cytoskeleton. Telomerase",
            "probability": 2.0018827044145337e-05,
            "start_logit": -6.424210548400879,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomer",
            "probability": 1.8917571685184308e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -7.264245986938477
        },
        {
            "text": "telomerase antagonist) exerts",
            "probability": 1.33129510581008e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.920998573303223
        },
        {
            "text": "telomerase antagonist) exerts off - target effects",
            "probability": 1.3147671470881231e-05,
            "start_logit": -0.6880496740341187,
            "end_logit": -7.933491230010986
        },
        {
            "text": "effects on the cytoskeleton. Telomerase",
            "probability": 1.2173459329727276e-05,
            "start_logit": -6.92162561416626,
            "end_logit": -1.7769018411636353
        },
        {
            "text": "Telomerase is a cellular ribonucleoprotein",
            "probability": 1.186899432612024e-05,
            "start_logit": -0.9934483766555786,
            "end_logit": -7.73040771484375
        }
    ],
    "56c048acef6e39474100001c_059": [
        {
            "text": "imetelstat (GRN163L), a potent telomerase",
            "probability": 0.7709314051008654,
            "start_logit": 4.086793899536133,
            "end_logit": 5.77642822265625
        },
        {
            "text": "telomerase",
            "probability": 0.2279882950036232,
            "start_logit": 2.8684887886047363,
            "end_logit": 5.77642822265625
        },
        {
            "text": "ase",
            "probability": 0.001041948064057737,
            "start_logit": -2.5197134017944336,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imet",
            "probability": 1.3058689848544426e-05,
            "start_logit": 4.086793899536133,
            "end_logit": -5.20947265625
        },
        {
            "text": "potent telomerase",
            "probability": 7.722480766195089e-06,
            "start_logit": -7.42442512512207,
            "end_logit": 5.77642822265625
        },
        {
            "text": "(GRN163L), a potent telomerase",
            "probability": 6.193915722242499e-06,
            "start_logit": -7.644993305206299,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imetelstat",
            "probability": 4.48336092358432e-06,
            "start_logit": 4.086793899536133,
            "end_logit": -6.278553485870361
        },
        {
            "text": "a potent telomerase",
            "probability": 4.262933146612445e-06,
            "start_logit": -8.018603324890137,
            "end_logit": 5.77642822265625
        },
        {
            "text": "tel",
            "probability": 1.3768195189551956e-06,
            "start_logit": 2.8684887886047363,
            "end_logit": -6.240845203399658
        },
        {
            "text": "imetelstat (GRN163L),",
            "probability": 5.40940966755591e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.39337158203125
        },
        {
            "text": "imetelstat (GRN163L), a potent telomerase inhibitor,",
            "probability": 4.514397885802167e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomerase inhibitor,",
            "probability": 1.335047281952844e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomer",
            "probability": 1.2519202456294062e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.638527870178223
        },
        {
            "text": "The telomerase",
            "probability": 2.2100744386592746e-09,
            "start_logit": -6.719935417175293,
            "end_logit": -3.086926221847534
        },
        {
            "text": "telomerase activity",
            "probability": 1.6677302977740793e-10,
            "start_logit": -4.562044620513916,
            "end_logit": -7.828964710235596
        },
        {
            "text": "telomerase inhibitor imetelstat",
            "probability": 7.621672018130344e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -7.122272968292236
        },
        {
            "text": "The telomerase inhibitor imetelstat",
            "probability": 3.907311873422548e-11,
            "start_logit": -6.719935417175293,
            "end_logit": -7.122272968292236
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer stem cells",
            "probability": 2.5600680430225308e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.213234901428223
        },
        {
            "text": "telomerase inhibitor",
            "probability": 1.869787621579506e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.527443885803223
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer",
            "probability": 1.75833143618782e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.588903427124023
        }
    ],
    "56c048acef6e39474100001c_060": [
        {
            "text": "telomerase",
            "probability": 0.9963887831838663,
            "start_logit": 3.828627109527588,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "ase",
            "probability": 0.0016155873464689112,
            "start_logit": -2.5958118438720703,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "inhibited telomerase",
            "probability": 0.0013425750299816313,
            "start_logit": -2.78092098236084,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "telomerase activity",
            "probability": 0.0005312455086606161,
            "start_logit": 3.828627109527588,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "Imetelstat inhibited telomerase",
            "probability": 9.548241903159017e-05,
            "start_logit": -5.424323558807373,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "omerase",
            "probability": 1.0736277580402372e-05,
            "start_logit": -7.609637260437012,
            "end_logit": 5.5534796714782715
        },
        {
            "text": "tel",
            "probability": 9.490878889379225e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -6.008081912994385
        },
        {
            "text": "telomerase activity in",
            "probability": 2.2068448072832828e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.466849327087402
        },
        {
            "text": "telomer",
            "probability": 1.8164552377251532e-06,
            "start_logit": 3.828627109527588,
            "end_logit": -7.661526203155518
        },
        {
            "text": "inhibited telomerase activity",
            "probability": 7.158219429553916e-07,
            "start_logit": -2.78092098236084,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase activity in both subpopulations.",
            "probability": 5.657553087794565e-07,
            "start_logit": 3.828627109527588,
            "end_logit": -8.828006744384766
        },
        {
            "text": "activity",
            "probability": 4.24596200415884e-07,
            "start_logit": -3.3032138347625732,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "telomerase inhibition in anti-cancer therapy. The purpose of this study was to investigate the effects of a telomerase",
            "probability": 2.8346319467357703e-07,
            "start_logit": -7.6556501388549805,
            "end_logit": 1.965191125869751
        },
        {
            "text": "Imetelstat inhibited telomerase activity",
            "probability": 5.0908447709033335e-08,
            "start_logit": -5.424323558807373,
            "end_logit": -1.9831888675689697
        },
        {
            "text": "The telomerase",
            "probability": 1.6266868151125048e-08,
            "start_logit": -7.169773101806641,
            "end_logit": -1.3786377906799316
        },
        {
            "text": "inhibited",
            "probability": 7.132996524177216e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -6.591888904571533
        },
        {
            "text": "telomerase antagonistic oligonucleotide, imetelstat",
            "probability": 6.610788593067375e-09,
            "start_logit": -1.1074668169021606,
            "end_logit": -8.341371536254883
        },
        {
            "text": "inhibited telomerase activity in",
            "probability": 2.973593022430098e-09,
            "start_logit": -2.78092098236084,
            "end_logit": -7.466849327087402
        },
        {
            "text": "activity in",
            "probability": 1.7638133495799876e-09,
            "start_logit": -3.3032138347625732,
            "end_logit": -7.466849327087402
        },
        {
            "text": "inhibited telomerase activity in both subpopulations.",
            "probability": 7.623218601675894e-10,
            "start_logit": -2.78092098236084,
            "end_logit": -8.828006744384766
        }
    ],
    "56c048acef6e39474100001c_061": [
        {
            "text": "imetelstat (GRN163L), a potent telomerase",
            "probability": 0.7709314051008654,
            "start_logit": 4.086793899536133,
            "end_logit": 5.77642822265625
        },
        {
            "text": "telomerase",
            "probability": 0.2279882950036232,
            "start_logit": 2.8684887886047363,
            "end_logit": 5.77642822265625
        },
        {
            "text": "ase",
            "probability": 0.001041948064057737,
            "start_logit": -2.5197134017944336,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imet",
            "probability": 1.3058689848544426e-05,
            "start_logit": 4.086793899536133,
            "end_logit": -5.20947265625
        },
        {
            "text": "potent telomerase",
            "probability": 7.722480766195089e-06,
            "start_logit": -7.42442512512207,
            "end_logit": 5.77642822265625
        },
        {
            "text": "(GRN163L), a potent telomerase",
            "probability": 6.193915722242499e-06,
            "start_logit": -7.644993305206299,
            "end_logit": 5.77642822265625
        },
        {
            "text": "imetelstat",
            "probability": 4.48336092358432e-06,
            "start_logit": 4.086793899536133,
            "end_logit": -6.278553485870361
        },
        {
            "text": "a potent telomerase",
            "probability": 4.262933146612445e-06,
            "start_logit": -8.018603324890137,
            "end_logit": 5.77642822265625
        },
        {
            "text": "tel",
            "probability": 1.3768195189551956e-06,
            "start_logit": 2.8684887886047363,
            "end_logit": -6.240845203399658
        },
        {
            "text": "imetelstat (GRN163L),",
            "probability": 5.40940966755591e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.39337158203125
        },
        {
            "text": "imetelstat (GRN163L), a potent telomerase inhibitor,",
            "probability": 4.514397885802167e-07,
            "start_logit": 4.086793899536133,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomerase inhibitor,",
            "probability": 1.335047281952844e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.574239730834961
        },
        {
            "text": "telomer",
            "probability": 1.2519202456294062e-07,
            "start_logit": 2.8684887886047363,
            "end_logit": -8.638527870178223
        },
        {
            "text": "The telomerase",
            "probability": 2.2100744386592746e-09,
            "start_logit": -6.719935417175293,
            "end_logit": -3.086926221847534
        },
        {
            "text": "telomerase activity",
            "probability": 1.6677302977740793e-10,
            "start_logit": -4.562044620513916,
            "end_logit": -7.828964710235596
        },
        {
            "text": "telomerase inhibitor imetelstat",
            "probability": 7.621672018130344e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -7.122272968292236
        },
        {
            "text": "The telomerase inhibitor imetelstat",
            "probability": 3.907311873422548e-11,
            "start_logit": -6.719935417175293,
            "end_logit": -7.122272968292236
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer stem cells",
            "probability": 2.5600680430225308e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.213234901428223
        },
        {
            "text": "telomerase inhibitor",
            "probability": 1.869787621579506e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.527443885803223
        },
        {
            "text": "telomerase inhibitor imetelstat depletes cancer",
            "probability": 1.75833143618782e-11,
            "start_logit": -6.051789283752441,
            "end_logit": -8.588903427124023
        }
    ],
    "512d0e635274a5fb07000005_001": [
        {
            "text": "etanercept",
            "probability": 0.9993539366692301,
            "start_logit": 9.656695365905762,
            "end_logit": 8.866005897521973
        },
        {
            "text": "et",
            "probability": 0.00045925354366049126,
            "start_logit": 9.656695365905762,
            "end_logit": 1.1807440519332886
        },
        {
            "text": "cept",
            "probability": 9.642401673649602e-05,
            "start_logit": 0.4105863869190216,
            "end_logit": 8.866005897521973
        },
        {
            "text": "ercept",
            "probability": 7.819502983558362e-05,
            "start_logit": 0.20103716850280762,
            "end_logit": 8.866005897521973
        },
        {
            "text": "anercept",
            "probability": 8.273118198640642e-06,
            "start_logit": -2.0451574325561523,
            "end_logit": 8.866005897521973
        },
        {
            "text": "etan",
            "probability": 1.9548602953988943e-06,
            "start_logit": 9.656695365905762,
            "end_logit": -4.278539657592773
        },
        {
            "text": "anti-TNF Abs (e.g., infliximab) as compared with TNF receptor fusion protein (etanercept).",
            "probability": 8.021165995843126e-07,
            "start_logit": -4.3786702156066895,
            "end_logit": 8.866005897521973
        },
        {
            "text": "TNF receptor fusion protein (etanercept).",
            "probability": 6.064726071627687e-07,
            "start_logit": -4.658264636993408,
            "end_logit": 8.866005897521973
        },
        {
            "text": "(etanercept).",
            "probability": 2.6772520051056037e-07,
            "start_logit": -5.475963115692139,
            "end_logit": 8.866005897521973
        },
        {
            "text": "etaner",
            "probability": 1.1562541116038753e-07,
            "start_logit": 9.656695365905762,
            "end_logit": -7.106257915496826
        },
        {
            "text": "infliximab) as compared with TNF receptor fusion protein (etanercept).",
            "probability": 9.395578503375218e-08,
            "start_logit": -6.523099899291992,
            "end_logit": 8.866005897521973
        },
        {
            "text": "(e.g., infliximab) as compared with TNF receptor fusion protein (etanercept).",
            "probability": 7.582483788330234e-08,
            "start_logit": -6.7374982833862305,
            "end_logit": 8.866005897521973
        },
        {
            "text": "TNF-\u03b1",
            "probability": 9.403681525657484e-10,
            "start_logit": -1.7284947633743286,
            "end_logit": -0.5329073667526245
        },
        {
            "text": "Increased rates of tuberculosis (TB) reactivation have been reported in humans treated with TNF-\u03b1",
            "probability": 5.0831292090480075e-11,
            "start_logit": -4.646254062652588,
            "end_logit": -0.5329073667526245
        },
        {
            "text": "an",
            "probability": 1.6183245687276003e-11,
            "start_logit": -2.0451574325561523,
            "end_logit": -4.278539657592773
        },
        {
            "text": "er",
            "probability": 9.047177525084048e-12,
            "start_logit": 0.20103716850280762,
            "end_logit": -7.106257915496826
        },
        {
            "text": "TNF-\u03b1 (TNF)-neutralizing drugs, and higher rates are observed with anti-TNF Abs",
            "probability": 7.470445777185664e-12,
            "start_logit": -1.7284947633743286,
            "end_logit": -5.368224143981934
        },
        {
            "text": "tuberculosis (TB) reactivation have been reported in humans treated with TNF-\u03b1",
            "probability": 6.26591151122705e-12,
            "start_logit": -6.739642143249512,
            "end_logit": -0.5329073667526245
        },
        {
            "text": "TNF-\u03b1 (TNF)-neutralizing drugs, and higher rates are observed with anti-TNF Abs (e.g.,",
            "probability": 6.121487144135301e-12,
            "start_logit": -1.7284947633743286,
            "end_logit": -5.567373752593994
        },
        {
            "text": "TNF-\u03b1 (TNF)-neutralizing drugs, and higher rates are observed with anti-TNF",
            "probability": 5.313872234462907e-12,
            "start_logit": -1.7284947633743286,
            "end_logit": -5.708858013153076
        }
    ],
    "512d0e635274a5fb07000005_002": [
        {
            "text": "etanercept",
            "probability": 0.9995151012053679,
            "start_logit": 9.446653366088867,
            "end_logit": 8.643741607666016
        },
        {
            "text": "et",
            "probability": 0.00033984072711664744,
            "start_logit": 9.446653366088867,
            "end_logit": 0.657193124294281
        },
        {
            "text": "cept",
            "probability": 6.491644693825682e-05,
            "start_logit": -0.19527116417884827,
            "end_logit": 8.643741607666016
        },
        {
            "text": "ercept",
            "probability": 5.68559095551285e-05,
            "start_logit": -0.3278520107269287,
            "end_logit": 8.643741607666016
        },
        {
            "text": "lupus (DIL). Two of them received etanercept",
            "probability": 1.23973218091677e-05,
            "start_logit": -1.8508917093276978,
            "end_logit": 8.643741607666016
        },
        {
            "text": "received etanercept",
            "probability": 4.044942552715077e-06,
            "start_logit": -2.97090482711792,
            "end_logit": 8.643741607666016
        },
        {
            "text": "etan",
            "probability": 1.8608376353523442e-06,
            "start_logit": 9.446653366088867,
            "end_logit": -4.550257205963135
        },
        {
            "text": "Two of them received etanercept",
            "probability": 1.7296243160343724e-06,
            "start_logit": -3.820467948913574,
            "end_logit": 8.643741607666016
        },
        {
            "text": "etanercept and the remainder adalimumab.",
            "probability": 1.4224489670908832e-06,
            "start_logit": 9.446653366088867,
            "end_logit": -4.818903923034668
        },
        {
            "text": "anercept",
            "probability": 1.0419192804675584e-06,
            "start_logit": -4.32730770111084,
            "end_logit": 8.643741607666016
        },
        {
            "text": "drug-induced lupus (DIL). Two of them received etanercept",
            "probability": 2.244493685517221e-07,
            "start_logit": -5.8624773025512695,
            "end_logit": 8.643741607666016
        },
        {
            "text": "anti-TNF-\u03b1 agents and who developed drug-induced lupus (DIL). Two of them received etanercept",
            "probability": 1.6833301569167e-07,
            "start_logit": -6.150183200836182,
            "end_logit": 8.643741607666016
        },
        {
            "text": "developed drug-induced lupus (DIL). Two of them received etanercept",
            "probability": 1.3473995406218836e-07,
            "start_logit": -6.372780799865723,
            "end_logit": 8.643741607666016
        },
        {
            "text": "treated with anti-TNF-\u03b1 agents and who developed drug-induced lupus (DIL). Two of them received etanercept",
            "probability": 1.0113850934008875e-07,
            "start_logit": -6.659636497497559,
            "end_logit": 8.643741607666016
        },
        {
            "text": "etaner",
            "probability": 9.215350653531376e-08,
            "start_logit": 9.446653366088867,
            "end_logit": -7.555583477020264
        },
        {
            "text": "etanercept and",
            "probability": 6.582837230551815e-08,
            "start_logit": 9.446653366088867,
            "end_logit": -7.891988277435303
        },
        {
            "text": "lupus",
            "probability": 1.830046024195303e-09,
            "start_logit": -1.8508917093276978,
            "end_logit": -0.17715302109718323
        },
        {
            "text": "us",
            "probability": 7.990458684842482e-11,
            "start_logit": -4.982154846191406,
            "end_logit": -0.17715302109718323
        },
        {
            "text": "drug-induced lupus",
            "probability": 3.313237172301824e-11,
            "start_logit": -5.8624773025512695,
            "end_logit": -0.17715302109718323
        },
        {
            "text": "upus",
            "probability": 3.065193358251577e-11,
            "start_logit": -5.9402923583984375,
            "end_logit": -0.17715302109718323
        }
    ],
    "512d0e635274a5fb07000005_003": [
        {
            "text": "etanercept",
            "probability": 0.9994758712835707,
            "start_logit": 9.586495399475098,
            "end_logit": 8.939127922058105
        },
        {
            "text": "et",
            "probability": 0.0003128854332863442,
            "start_logit": 9.586495399475098,
            "end_logit": 0.8699787259101868
        },
        {
            "text": "cept",
            "probability": 0.00011793458438919242,
            "start_logit": 0.5416392087936401,
            "end_logit": 8.939127922058105
        },
        {
            "text": "ercept",
            "probability": 9.126210900371217e-05,
            "start_logit": 0.28524479269981384,
            "end_logit": 8.939127922058105
        },
        {
            "text": "etan",
            "probability": 1.070182500325266e-06,
            "start_logit": 9.586495399475098,
            "end_logit": -4.8080291748046875
        },
        {
            "text": "anercept",
            "probability": 5.675011394513679e-07,
            "start_logit": -4.795003414154053,
            "end_logit": 8.939127922058105
        },
        {
            "text": "or etanercept",
            "probability": 1.5666720550977856e-07,
            "start_logit": -6.082122325897217,
            "end_logit": 8.939127922058105
        },
        {
            "text": "etaner",
            "probability": 7.830499591310694e-08,
            "start_logit": 9.586495399475098,
            "end_logit": -7.423002243041992
        },
        {
            "text": "adalimumab (n=10) or etanercept",
            "probability": 5.1863636656774746e-08,
            "start_logit": -7.187628269195557,
            "end_logit": 8.939127922058105
        },
        {
            "text": "infliximab (n=29), adalimumab (n=10) or etanercept",
            "probability": 4.3937376355351185e-08,
            "start_logit": -7.353480815887451,
            "end_logit": 8.939127922058105
        },
        {
            "text": "etanercept (n=4) for rheumatoid arthritis",
            "probability": 3.171653323023895e-08,
            "start_logit": 9.586495399475098,
            "end_logit": -8.326775550842285
        },
        {
            "text": "etanercept (n=4) for rheumatoid",
            "probability": 2.412834393889138e-08,
            "start_logit": 9.586495399475098,
            "end_logit": -8.600226402282715
        },
        {
            "text": "etanercept (n=4) for rheumatoid arthritis (n=26), spondyloarthritides",
            "probability": 2.2280174940425855e-08,
            "start_logit": 9.586495399475098,
            "end_logit": -8.679916381835938
        },
        {
            "text": "er",
            "probability": 7.150026606825071e-12,
            "start_logit": 0.28524479269981384,
            "end_logit": -7.423002243041992
        },
        {
            "text": "an",
            "probability": 6.076482742655336e-13,
            "start_logit": -4.795003414154053,
            "end_logit": -4.8080291748046875
        },
        {
            "text": "aner",
            "probability": 4.446147794278761e-14,
            "start_logit": -4.795003414154053,
            "end_logit": -7.423002243041992
        },
        {
            "text": "RESULTS: 45",
            "probability": 2.2491554457996046e-14,
            "start_logit": -5.537650108337402,
            "end_logit": -7.3618388175964355
        },
        {
            "text": "RESULTS: 45 cases were collected of non-TB OIs in 43 patients receiving infliximab",
            "probability": 9.116771002947251e-15,
            "start_logit": -5.537650108337402,
            "end_logit": -8.264863014221191
        },
        {
            "text": "adalimumab",
            "probability": 5.1640936439664644e-15,
            "start_logit": -7.187628269195557,
            "end_logit": -7.1832709312438965
        },
        {
            "text": "or etanercept (n=4) for rheumatoid arthritis",
            "probability": 4.9715463598518235e-15,
            "start_logit": -6.082122325897217,
            "end_logit": -8.326775550842285
        }
    ]
}
